Psyllid ID: psy5368
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 406 | 2.2.26 [Sep-21-2011] | |||||||
| Q5ZJH6 | 468 | Serine/threonine-protein | yes | N/A | 0.559 | 0.485 | 0.480 | 1e-62 | |
| Q6PHR2 | 472 | Serine/threonine-protein | yes | N/A | 0.593 | 0.510 | 0.471 | 6e-61 | |
| Q4V7Q6 | 468 | Serine/threonine-protein | N/A | N/A | 0.559 | 0.485 | 0.489 | 6e-61 | |
| Q3U3Q1 | 472 | Serine/threonine-protein | yes | N/A | 0.593 | 0.510 | 0.467 | 1e-60 | |
| D3ZHP7 | 472 | Serine/threonine-protein | yes | N/A | 0.593 | 0.510 | 0.463 | 3e-60 | |
| Q86CS2 | 668 | Serine/threonine-protein | yes | N/A | 0.450 | 0.273 | 0.444 | 3e-42 | |
| Q23023 | 856 | Serine/threonine-protein | yes | N/A | 0.448 | 0.212 | 0.407 | 2e-34 | |
| Q6C7U0 | 710 | Serine/threonine-protein | yes | N/A | 0.445 | 0.254 | 0.350 | 5e-31 | |
| Q9QY01 | 1037 | Serine/threonine-protein | no | N/A | 0.443 | 0.173 | 0.374 | 7e-31 | |
| Q8TFN2 | 804 | Serine/threonine-protein | N/A | N/A | 0.559 | 0.282 | 0.315 | 9e-31 |
| >sp|Q5ZJH6|ULK3_CHICK Serine/threonine-protein kinase ULK3 OS=Gallus gallus GN=ULK3 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 241 bits (614), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 111/231 (48%), Positives = 161/231 (69%), Gaps = 4/231 (1%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
++Y+I+E+C GGDL FIR L E + F++QL ALKFL ++N+ H DLKPQNIL+
Sbjct: 86 HIYLIMEFCAGGDLSRFIRMRRILPEKVARIFLQQLACALKFLHDHNISHLDLKPQNILL 145
Query: 174 ---KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
+N LKLADFGFAQ+++P D+ ++GSPLYMAPE++ Y+A+ DLWS+GV+++E
Sbjct: 146 STPENPQLKLADFGFAQYMSPWDEKHVLRGSPLYMAPEMVCRQQYDARVDLWSVGVILYE 205
Query: 231 ALFGHAPYASCNLSQLRAQALSSAPITIPPN-SLSPDCMDFLSRLLQKDPMRRISYEDLF 289
ALFG P+AS + ++L + S I +P LSPDC D L RLL++DP++RIS+E+ F
Sbjct: 206 ALFGRPPFASRSFAELEEKIRSDRAIELPSRPPLSPDCRDLLQRLLERDPLKRISFEEFF 265
Query: 290 SHPYPDLIHAPCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIP 340
+HP+ D+ H P ES A +V +A+ D+E ++ A SLYC+AL Y +P
Sbjct: 266 AHPFVDMEHMPGPESFCKATNLVVEAVKKDQEGDASAALSLYCKALEYFVP 316
|
Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy. Gallus gallus (taxid: 9031) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q6PHR2|ULK3_HUMAN Serine/threonine-protein kinase ULK3 OS=Homo sapiens GN=ULK3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 235 bits (599), Expect = 6e-61, Method: Compositional matrix adjust.
Identities = 116/246 (47%), Positives = 165/246 (67%), Gaps = 5/246 (2%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
+Y+I+E+C GGDL FI + L E + F++QL AL+FL E N+ H DLKPQNIL+
Sbjct: 87 IYLIMEFCAGGDLSRFIHTRRILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLS 146
Query: 174 --KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEA 231
+ LKLADFGFAQ ++P D+ ++GSPLYMAPE++ Y+A+ DLWS+GV+++EA
Sbjct: 147 SLEKPHLKLADFGFAQHMSPWDEKHVLRGSPLYMAPEMVCQRQYDARVDLWSMGVILYEA 206
Query: 232 LFGHAPYASCNLSQLRAQALSSAPITIPPNS-LSPDCMDFLSRLLQKDPMRRISYEDLFS 290
LFG P+AS + S+L + S+ I +P LS DC D L RLL++DP RRIS++D F+
Sbjct: 207 LFGQPPFASRSFSELEEKIRSNRVIELPLRPLLSRDCRDLLQRLLERDPSRRISFQDFFA 266
Query: 291 HPYPDLIHAPCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIP-LAYDVLAEA 349
HP+ DL H P ES A +V A+ D+E +S A SLYC+AL++ +P L Y+V A+
Sbjct: 267 HPWVDLEHMPSGESLGRATALVVQAVKKDQEGDSAAALSLYCKALDFFVPALHYEVDAQR 326
Query: 350 IPNLKS 355
+K+
Sbjct: 327 KEAIKA 332
|
Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy. Acts as a negative regulator of SHH signaling in the absence of SHH ligand: interacts with SUFU, thereby inactivating the protein kinase activity and preventing phosphorylation of GLI proteins (GLI1, GLI2 and/or GLI3). Positively regulates SHH signaling in the presence of SHH: dissociates from SUFU, autophosphorylates and mediates phosphorylation of GLI2, activating it and promoting its nuclear translocation. Phosphorylates in vitro GLI2, as well as GLI1 and GLI3, although less efficiently. Also acts as a regulator of autophagy: following cellular senescence, able to induce autophagy. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q4V7Q6|ULK3_XENLA Serine/threonine-protein kinase ULK3 OS=Xenopus laevis GN=ulk3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 234 bits (598), Expect = 6e-61, Method: Compositional matrix adjust.
Identities = 113/231 (48%), Positives = 154/231 (66%), Gaps = 4/231 (1%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
Y+++I EYC GGDL FIR+ L E Q F++QL ALKFL E N+ H DLKPQNIL+
Sbjct: 85 YIFLITEYCAGGDLSRFIRTRRILPERIVQVFLQQLASALKFLHEKNISHLDLKPQNILL 144
Query: 174 KN---NTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
LKLADFGFAQ ++ D +++GSPLYMAPE++ Y+A+ DLWS+GV+++E
Sbjct: 145 SRLDRPHLKLADFGFAQHMSSEDAPQALRGSPLYMAPEMVCSKHYDARVDLWSVGVILYE 204
Query: 231 ALFGHAPYASCNLSQLRAQALSSAPITIPPN-SLSPDCMDFLSRLLQKDPMRRISYEDLF 289
ALFG AP+AS + S+L + LS I +P LSP+C D L +LLQ+DP +RIS+ + F
Sbjct: 205 ALFGKAPFASKSFSELEEKILSHKTIELPTRPRLSPECRDLLQQLLQRDPDKRISFIEFF 264
Query: 290 SHPYPDLIHAPCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIP 340
+H + DL H P AE+ + A R+V +A+ D A +LYC+AL Y IP
Sbjct: 265 AHLFVDLEHMPSAETLEKATRLVVEAVEKDSAGEHSAALTLYCKALEYFIP 315
|
Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3U3Q1|ULK3_MOUSE Serine/threonine-protein kinase ULK3 OS=Mus musculus GN=Ulk3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 234 bits (596), Expect = 1e-60, Method: Compositional matrix adjust.
Identities = 115/246 (46%), Positives = 166/246 (67%), Gaps = 5/246 (2%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
+Y+I+E+C GGDL FI + L E + F++QL AL+FL E N+ H DLKPQNIL+
Sbjct: 87 IYLIMEFCAGGDLSRFIHTRRILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLS 146
Query: 174 --KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEA 231
+ LKLADFGFAQ ++P D+ ++GSPLYMAPE++ Y+A+ DLWS+GV+++EA
Sbjct: 147 SLEKPHLKLADFGFAQHMSPWDEKHVLRGSPLYMAPEMVCRRQYDARVDLWSVGVILYEA 206
Query: 232 LFGHAPYASCNLSQLRAQALSSAPITIPPN-SLSPDCMDFLSRLLQKDPMRRISYEDLFS 290
LFG P+AS + S+L + S+ I +P LS DC D L RLL++DP RRIS++D F+
Sbjct: 207 LFGQPPFASRSFSELEEKIRSNRVIELPLRPQLSLDCRDLLQRLLERDPARRISFKDFFA 266
Query: 291 HPYPDLIHAPCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIP-LAYDVLAEA 349
HP+ DL H P ES A +V +A+ D+E ++ A SLYC+AL++ +P L Y+V A+
Sbjct: 267 HPWVDLEHMPSGESLAQARALVVEAVKKDQEGDAAAALSLYCKALDFFVPALHYEVDAQR 326
Query: 350 IPNLKS 355
+K+
Sbjct: 327 KEAIKA 332
|
Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy. Acts as a negative regulator of SHH signaling in the absence of SHH ligand: interacts with SUFU, thereby inactivating the protein kinase activity and preventing phosphorylation of GLI proteins (GLI1, GLI2 and/or GLI3). Positively regulates SHH signaling in the presence of SHH: dissociates from SUFU, autophosphorylates and mediates phosphorylation of GLI2, activating it and promoting its nuclear translocation. Phosphorylates in vitro GLI2, as well as GLI1 and GLI3, although less efficiently. Also acts as a regulator of autophagy: following cellular senescence, able to induce autophagy. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|D3ZHP7|ULK3_RAT Serine/threonine-protein kinase ULK3 OS=Rattus norvegicus GN=Ulk3 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 233 bits (593), Expect = 3e-60, Method: Compositional matrix adjust.
Identities = 114/246 (46%), Positives = 165/246 (67%), Gaps = 5/246 (2%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
+Y+I+E+C GGDL FI + L E + F++QL AL+FL E N+ H DLKPQNIL+
Sbjct: 87 IYLIMEFCAGGDLSRFIHTRRILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLS 146
Query: 174 --KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEA 231
+ LKLADFGFAQ ++P D+ ++GSPLYMAPE++ Y+A+ DLWS+GV+++EA
Sbjct: 147 SLEKPHLKLADFGFAQHMSPWDEKHVLRGSPLYMAPEMVCRRQYDARVDLWSVGVILYEA 206
Query: 232 LFGHAPYASCNLSQLRAQALSSAPITIPPN-SLSPDCMDFLSRLLQKDPMRRISYEDLFS 290
LFG P+AS + S+L + S+ I +P LS DC D L RLL++DP RIS++D F+
Sbjct: 207 LFGQPPFASRSFSELEEKIRSNRVIELPLRPQLSLDCRDLLQRLLERDPSHRISFQDFFA 266
Query: 291 HPYPDLIHAPCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIP-LAYDVLAEA 349
HP+ DL H P ES A +V +A+ D+E ++ A SLYC+AL++ +P L Y+V A+
Sbjct: 267 HPWVDLEHMPSGESLAQATALVVEAVKKDQEGDAAAALSLYCKALDFFVPALHYEVDAQR 326
Query: 350 IPNLKS 355
+K+
Sbjct: 327 KEAIKA 332
|
Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy. Acts as a negative regulator of SHH signaling in the absence of SHH ligand: interacts with SUFU, thereby inactivating the protein kinase activity and preventing phosphorylation of GLI proteins (GLI1, GLI2 and/or GLI3). Positively regulates SHH signaling in the presence of SHH: dissociates from SUFU, autophosphorylates and mediates phosphorylation of GLI2, activating it and promoting its nuclear translocation. Phosphorylates in vitro GLI2, as well as GLI1 and GLI3, although less efficiently. Also acts as a regulator of autophagy: following cellular senescence, able to induce autophagy. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q86CS2|ATG1_DICDI Serine/threonine-protein kinase atg1 OS=Dictyostelium discoideum GN=atg1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 172 bits (437), Expect = 3e-42, Method: Compositional matrix adjust.
Identities = 84/189 (44%), Positives = 125/189 (66%), Gaps = 6/189 (3%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
P ++Y+I+E C+GGD +IR+H+KL+E + F++QL LKFLR+ + H DLKPQN+
Sbjct: 82 PTFIYMIMECCEGGDFSKYIRTHKKLTEEKALYFMKQLANGLKFLRQKQIVHRDLKPQNL 141
Query: 172 LIKNNT----LKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVL 227
L+ +++ LK+ DFGFA+F+ P D+ GSPLYMAPEIL Y KADLWS+G++
Sbjct: 142 LLSDDSEHPILKIGDFGFAKFIDPFSLSDTFCGSPLYMAPEILHRKNYTVKADLWSVGII 201
Query: 228 VFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYED 287
++E L G Y S ++ L Q L + I +P + +S DC + + LLQ D +RIS+ED
Sbjct: 202 LYEMLVGEPAYNSGSVPDLLNQ-LQNKKIKLPSH-ISSDCQNLIYSLLQIDVEKRISWED 259
Query: 288 LFSHPYPDL 296
F+H + +L
Sbjct: 260 FFNHKWLNL 268
|
Serine/threonine protein kinase involved in autophagy. Involved in the control of autophagic vacuolar cell death. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q23023|UNC51_CAEEL Serine/threonine-protein kinase unc-51 OS=Caenorhabditis elegans GN=unc-51 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 146 bits (369), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 79/194 (40%), Positives = 120/194 (61%), Gaps = 12/194 (6%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
P +VY+++E+C+GGDL +++ L+E Q FV Q+ AL+ + + + H DLKPQNI
Sbjct: 81 PTHVYLVMEFCNGGDLADYLQQKTTLNEDTIQHFVVQIAHALEAINKKGIVHRDLKPQNI 140
Query: 172 LIKNNT-----------LKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKAD 220
L+ NN+ +KLADFGFA+FL ++ GSP+YMAPE++ Y+AKAD
Sbjct: 141 LLCNNSRTQNPHFTDIVIKLADFGFARFLNDGVMAATLCGSPMYMAPEVIMSMQYDAKAD 200
Query: 221 LWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIP-PNSLSPDCMDFLSRLLQKDP 279
LWS+G ++F+ L G AP+ + QL+A + + P SP+ D L RLL+++
Sbjct: 201 LWSIGTILFQCLTGKAPFVAQTPPQLKAYYEKTRELRPNIPEWCSPNLRDLLLRLLKRNA 260
Query: 280 MRRISYEDLFSHPY 293
RIS+ED F+HP+
Sbjct: 261 KDRISFEDFFNHPF 274
|
Protein kinase important for axonal elongation and axonal guidance. Functions in the CAN axons to direct both anterior and posterior migrations. Phosphorylates both unc-14 and vab-8. Caenorhabditis elegans (taxid: 6239) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6C7U0|ATG1_YARLI Serine/threonine-protein kinase ATG1 OS=Yarrowia lipolytica (strain CLIB 122 / E 150) GN=ATG1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 135 bits (341), Expect = 5e-31, Method: Compositional matrix adjust.
Identities = 80/228 (35%), Positives = 119/228 (52%), Gaps = 47/228 (20%)
Query: 109 RKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQ---------------------CQQFVR 147
++ P + ++++EYC GDL F++ ++LSE + FV
Sbjct: 73 QETPTHFHLVMEYCSLGDLSFFLKKKKELSETLPLVASLLRRYPSNTRGLHEELVRHFVH 132
Query: 148 QLVLALKFLRENNVCHFDLKPQNILI----------KNNTL---------KLADFGFAQF 188
QL AL+FLR+ N+ H D+KPQN+L+ +N L K+ADFGFA+
Sbjct: 133 QLSAALEFLRQKNLVHRDIKPQNLLLCPPSLSEMDAQNANLYGRWELPILKIADFGFARI 192
Query: 189 LAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRA 248
L + +++ GSPLYMAPEIL YNAKADLWS+G + +E + G P+ + N +L
Sbjct: 193 LPASALAETLCGSPLYMAPEILRYEKYNAKADLWSVGAVTYEMVVGKPPFKANNYVELLK 252
Query: 249 QALSSAPIT----IPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHP 292
S + PP S D DF+ LL+K+P RI +++ F HP
Sbjct: 253 TIEQSNDVIGFGREPP---SEDMQDFVRCLLKKNPADRIGFKEYFEHP 297
|
Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes. Yarrowia lipolytica (strain CLIB 122 / E 150) (taxid: 284591) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9QY01|ULK2_MOUSE Serine/threonine-protein kinase ULK2 OS=Mus musculus GN=Ulk2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 135 bits (339), Expect = 7e-31, Method: Compositional matrix adjust.
Identities = 73/195 (37%), Positives = 115/195 (58%), Gaps = 15/195 (7%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
P V++++EYC+GGDL ++++ LSE + F+ Q+ A++ L + H DLKPQNI
Sbjct: 78 PNSVFLVMEYCNGGDLADYLQAKGTLSEDTIRVFLHQIAAAMRILHSKGIIHRDLKPQNI 137
Query: 172 LI------KNNT----LKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADL 221
L+ K+N +K+ADFGFA++L N ++ GSP+YMAPE++ Y+AKADL
Sbjct: 138 LLSYANRRKSNVSGIRIKIADFGFARYLHSNTMAATLCGSPMYMAPEVIMSQHYDAKADL 197
Query: 222 WSLGVLVFEALFGHAPYASCNLSQLR---AQALSSAPITIPPNSLSPDCMDFLSRLLQKD 278
WS+G ++++ L G P+ + + LR + S P P SP + L LLQ++
Sbjct: 198 WSIGTVIYQCLVGKPPFQANSPQDLRMFYEKNRSLMPSI--PRETSPYLANLLLGLLQRN 255
Query: 279 PMRRISYEDLFSHPY 293
R+ +E FSHP+
Sbjct: 256 QKDRMDFEAFFSHPF 270
|
Serine/threonine-protein kinase involved in autophagy in response to starvation. Acts upstream of phosphatidylinositol 3-kinase PIK3C3 to regulate the formation of autophagophores, the precursors of autophagosomes. Part of regulatory feedback loops in autophagy: acts both as a downstream effector and negative regulator of mammalian target of rapamycin complex 1 (mTORC1) via interaction with RPTOR. Activated via phosphorylation by AMPK and also acts as a regulator of AMPK by mediating phosphorylation of AMPK subunits PRKAA1, PRKAB2 and PRKAG1, leading to negatively regulate AMPK activity. May phosphorylate ATG13/KIAA0652, FRS2, FRS3 and RPTOR; however such data need additional evidences. Not involved in ammonia-induced autophagy or in autophagic response of cerebellar granule neurons (CGN) to low potassium concentration. Plays a role early in neuronal differentiation and is required for granule cell axon formation: may govern axon formation via Ras-like GTPase signaling and through regulation of the Rab5-mediated endocytic pathways within developing axons. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8TFN2|ATG1_PICAN Serine/threonine-protein kinase ATG1 OS=Pichia angusta GN=ATG1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 134 bits (338), Expect = 9e-31, Method: Compositional matrix adjust.
Identities = 88/279 (31%), Positives = 139/279 (49%), Gaps = 52/279 (18%)
Query: 64 YDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAP------EGRKRPRYVYI 117
YD + + + +V S+++ + + E E + L NL+ P + K +Y ++
Sbjct: 30 YDNRTKAPVAVKSVFRSRLKNQKLVENLEIEI--SILKNLKNPHIVALLDCVKTDQYFHL 87
Query: 118 ILEYCDGGDLCSFIRSHEKL-----------------------SEFQCQQFVRQLVLALK 154
+EYC GDL FIR ++L ++ F++QL AL+
Sbjct: 88 FMEYCSLGDLSYFIRRRDQLVQTHPLISSILERYPSPPNSHGLNKVLVVNFLKQLASALE 147
Query: 155 FLRENNVCHFDLKPQNILIKNNT-------------------LKLADFGFAQFLAPNDQG 195
FLR+ N+ H D+KPQN+L+ LK+ADFGFA+FL
Sbjct: 148 FLRDQNLVHRDIKPQNLLLSPPVHSKEEFKRKGYSGLWELPVLKIADFGFARFLPSTSMA 207
Query: 196 DSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPY-ASCNLSQLRAQALSSA 254
+++ GSPLYMAPEIL YNAKADLWS+G +++E G P+ AS ++ LR S
Sbjct: 208 ETLCGSPLYMAPEILRYEKYNAKADLWSVGAVIYEMSVGKPPFRASNHVELLRKIEKSKD 267
Query: 255 PITIPPNSLSP-DCMDFLSRLLQKDPMRRISYEDLFSHP 292
IT P ++ P D + + LL+ +P R+ +++ F+ P
Sbjct: 268 EITFPVSAEVPDDLVRLICGLLKANPTERMGFQEFFNDP 306
|
Serine/threonine-protein kinase involved in glucose-induced peroxisome degradation (micropexophagy), ethanol-induced macropexophagy and microautophagy. Probably also involved in cytoplasm to vacuole transport (Cvt). Pichia angusta (taxid: 870730) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 406 | ||||||
| 383849298 | 481 | PREDICTED: serine/threonine-protein kina | 0.635 | 0.536 | 0.454 | 1e-64 | |
| 242017146 | 647 | cAMP-dependent protein kinase catalytic | 0.753 | 0.472 | 0.409 | 6e-64 | |
| 332029155 | 476 | Serine/threonine-protein kinase ULK3 [Ac | 0.568 | 0.485 | 0.485 | 2e-63 | |
| 380027669 | 481 | PREDICTED: serine/threonine-protein kina | 0.564 | 0.476 | 0.493 | 1e-62 | |
| 328717073 | 496 | PREDICTED: serine/threonine-protein kina | 0.559 | 0.457 | 0.493 | 1e-62 | |
| 380027671 | 480 | PREDICTED: serine/threonine-protein kina | 0.564 | 0.477 | 0.493 | 1e-62 | |
| 350401270 | 478 | PREDICTED: serine/threonine-protein kina | 0.564 | 0.479 | 0.489 | 1e-62 | |
| 340720576 | 478 | PREDICTED: serine/threonine-protein kina | 0.564 | 0.479 | 0.493 | 2e-62 | |
| 125773345 | 520 | GA21378, isoform A [Drosophila pseudoobs | 0.559 | 0.436 | 0.482 | 5e-61 | |
| 328788776 | 481 | PREDICTED: serine/threonine-protein kina | 0.564 | 0.476 | 0.489 | 5e-61 |
| >gi|383849298|ref|XP_003700282.1| PREDICTED: serine/threonine-protein kinase ULK3-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 253 bits (646), Expect = 1e-64, Method: Compositional matrix adjust.
Identities = 124/273 (45%), Positives = 178/273 (65%), Gaps = 15/273 (5%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
++YI++EYC+GGDL SFIR KL E C++F++QL LAL++LR +NV H DLKPQN+L+
Sbjct: 81 HIYIVMEYCNGGDLSSFIRKKHKLPEQICRRFLQQLALALRYLRNHNVSHMDLKPQNLLL 140
Query: 174 KNN---TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
LKL DFGFAQ+L+ ++Q +I+GSPLYMAPEIL Y+A+ DLWS+GV+++E
Sbjct: 141 TRRPQLVLKLGDFGFAQYLSNSEQKFAIRGSPLYMAPEILLKHKYDARVDLWSVGVIMYE 200
Query: 231 ALFGHAPYASCNLSQLRAQALSSAPITIPPNS-LSPDCMDFLSRLLQKDPMRRISYEDLF 289
LFG APY+S + +L + PI +P S +SP+C D L LL+ DP RI++++ F
Sbjct: 201 CLFGKAPYSSSSFQELAEKIKDRRPIELPKGSYISPECKDLLMSLLKHDPEERITFDEFF 260
Query: 290 SHPYPDLIHAPCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIPLAYDVLAEA 349
+H + DL HAP E++ A+ ++ +A+ +D E NS+ AF LYCEAL Y IP+
Sbjct: 261 AHDFLDLSHAPTKENYDKAVELIQEAVKNDSEKNSKEAFHLYCEALRYFIPI-------- 312
Query: 350 IPNLKSGLEIGETGDMYLAEGNYELALEKLKAS 382
L S + + + +Y EKLKAS
Sbjct: 313 ---LTSETDFKRKETLRIHVNDYIRRAEKLKAS 342
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242017146|ref|XP_002429053.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis] gi|212513908|gb|EEB16315.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 251 bits (640), Expect = 6e-64, Method: Compositional matrix adjust.
Identities = 136/332 (40%), Positives = 196/332 (59%), Gaps = 26/332 (7%)
Query: 30 GKVRYSQVRSDTVRSGTVRYDIVGSSTIRYGELQYDTVQNSQIRLGTVKYSQVRYDTITS 89
G YS V ++G +IV I L+ V N + +K +++D I
Sbjct: 193 GSGSYSTVYKAACKTGN--KEIVAIKCIERSILKGSAVDNVITEIKVLKL--LKHDNIVE 248
Query: 90 HSEFERPRAGLSNLRAPEGRKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQL 149
F + ++YIILEYCDGGDL +I+ +KLSE C++F++QL
Sbjct: 249 MKNFFWDQT---------------HIYIILEYCDGGDLSGYIKKCKKLSERTCKKFLQQL 293
Query: 150 VLALKFLRENNVCHFDLKPQNILIKNN---TLKLADFGFAQFLAPNDQGDSIQGSPLYMA 206
LA+K+LR NN+ H DLKPQN+L+ TLKLADFGF+QFL+ ++ +S++GSPLYMA
Sbjct: 294 ALAIKYLRNNNISHMDLKPQNLLLSTKPTLTLKLADFGFSQFLSLQEKQNSLRGSPLYMA 353
Query: 207 PEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPN-SLSP 265
PE+L Y+AK DLWS+GV+++E LFG APY+S + +L + PI IP +S
Sbjct: 354 PEMLLLQDYDAKVDLWSIGVIIYECLFGKAPYSSKTVEELIEKIKLQKPIEIPEQCGISS 413
Query: 266 DCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAESHQTAIRIVTDAIHHDRENNSR 325
+C D L RLLQ +P +RIS+ + FSH + DL H ES++ ++IV +A+ D+E
Sbjct: 414 ECRDLLLRLLQHNPNQRISFNEFFSHSFLDLEHIASPESYRKGVQIVCEAVQCDKEKKYI 473
Query: 326 RAFSLYCEALNYLIPLAYDVLAEAIPNLKSGL 357
AF+LYCEAL Y +PL ++AE K+ L
Sbjct: 474 DAFNLYCEALRYFVPL---IIAETNTKKKNAL 502
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|332029155|gb|EGI69166.1| Serine/threonine-protein kinase ULK3 [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 249 bits (636), Expect = 2e-63, Method: Compositional matrix adjust.
Identities = 114/235 (48%), Positives = 164/235 (69%), Gaps = 4/235 (1%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
++YI++EYCDGGDL SFI+ KL E C++F++QL LALK+LR++NVCH DLKPQN+L+
Sbjct: 81 HIYIVMEYCDGGDLSSFIKKKHKLPESTCRRFLQQLALALKYLRDHNVCHMDLKPQNLLL 140
Query: 174 KNN---TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
LK+ DFGFAQ+L+ ++ +I+GSPLYMAPE+L Y+A+ DLWS+GV+++E
Sbjct: 141 MRKPQLILKVGDFGFAQYLSNSEHKFTIRGSPLYMAPEMLLKHKYDARVDLWSVGVIMYE 200
Query: 231 ALFGHAPYASCNLSQLRAQALSSAPITIPPNS-LSPDCMDFLSRLLQKDPMRRISYEDLF 289
LFG APY+S + +L + S PI +P + +S C D L LL+ +P RI+Y++ F
Sbjct: 201 CLFGKAPYSSSSFQELAEKIKDSRPIEMPKAAHVSTTCKDLLMALLKHNPADRITYDEFF 260
Query: 290 SHPYPDLIHAPCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIPLAYD 344
+H + DL HAP E+++ A +V A+ D E N++ AF LYCEAL Y IP+ D
Sbjct: 261 AHDFLDLEHAPTKENYEKAATLVHKAVEMDTEKNAKEAFYLYCEALRYFIPILTD 315
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380027669|ref|XP_003697543.1| PREDICTED: serine/threonine-protein kinase ULK3-like isoform 1 [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 246 bits (629), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 115/233 (49%), Positives = 162/233 (69%), Gaps = 4/233 (1%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
++YI++EYCDGGDL SFI+ KL E C++F++QL LAL++LR NNV H DLKPQN+L+
Sbjct: 81 HIYIVMEYCDGGDLSSFIKKRHKLPEQICRKFLQQLALALRYLRNNNVSHMDLKPQNLLL 140
Query: 174 KNN---TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
TLK+ DFGFAQ+L+ ++Q +I+GSPLYMAPEIL Y+A+ DLWS+GV+++E
Sbjct: 141 MRKPQLTLKVGDFGFAQYLSNSEQKFAIRGSPLYMAPEILFKRKYDARVDLWSVGVIMYE 200
Query: 231 ALFGHAPYASCNLSQLRAQALSSAPITIPPNS-LSPDCMDFLSRLLQKDPMRRISYEDLF 289
LFG APY+S + +L + I +P S +S +C D L LL+ DP +RI++++ F
Sbjct: 201 CLFGKAPYSSGSFQELIEKIKDCRSIELPKGSHVSYECKDLLMSLLKHDPDKRITFDEFF 260
Query: 290 SHPYPDLIHAPCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIPLA 342
H + DL HAP E++ AI +V +A+ D E N + AF LYCEAL Y IP+
Sbjct: 261 GHDFLDLAHAPTKENYDKAIELVQNAVKMDAEKNLKEAFHLYCEALRYFIPIV 313
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328717073|ref|XP_001946960.2| PREDICTED: serine/threonine-protein kinase ULK3-like [Acyrthosiphon pisum] | Back alignment and taxonomy information |
|---|
Score = 246 bits (629), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 114/231 (49%), Positives = 159/231 (68%), Gaps = 4/231 (1%)
Query: 113 RYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+ +YIILE+CDGGDL +FI+ +KLSE C++F++QL LAL+FLR +NVCH DLKPQN+L
Sbjct: 81 KNIYIILEHCDGGDLSTFIQQRKKLSEKICRKFMQQLALALQFLRSHNVCHLDLKPQNLL 140
Query: 173 IKNN---TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVF 229
+ + TLK+ DFG A F++ Q ++I+GSPLYMAPE+L + Y+ KADLWS+GV+ +
Sbjct: 141 LMRSPQLTLKVGDFGLANFMSEKTQMENIRGSPLYMAPEMLLLNRYDVKADLWSVGVIAY 200
Query: 230 EALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLF 289
E ++GHAPYAS ++ L + + PI IPPN +SP+C D L LL+ +P R+SY F
Sbjct: 201 ECIYGHAPYASDSIKDL-CEKVKRVPIEIPPNQVSPECRDLLLGLLKHNPSERMSYHQFF 259
Query: 290 SHPYPDLIHAPCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIP 340
HP+ DL H P ES+ + + A+ D E + AF+ YC L YLIP
Sbjct: 260 KHPFVDLDHMPSTESYAKGLEAIHQAVKLDSEKQYKAAFNKYCTGLQYLIP 310
|
Source: Acyrthosiphon pisum Species: Acyrthosiphon pisum Genus: Acyrthosiphon Family: Aphididae Order: Hemiptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380027671|ref|XP_003697544.1| PREDICTED: serine/threonine-protein kinase ULK3-like isoform 2 [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 246 bits (628), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 115/233 (49%), Positives = 162/233 (69%), Gaps = 4/233 (1%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
++YI++EYCDGGDL SFI+ KL E C++F++QL LAL++LR NNV H DLKPQN+L+
Sbjct: 80 HIYIVMEYCDGGDLSSFIKKRHKLPEQICRKFLQQLALALRYLRNNNVSHMDLKPQNLLL 139
Query: 174 KNN---TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
TLK+ DFGFAQ+L+ ++Q +I+GSPLYMAPEIL Y+A+ DLWS+GV+++E
Sbjct: 140 MRKPQLTLKVGDFGFAQYLSNSEQKFAIRGSPLYMAPEILFKRKYDARVDLWSVGVIMYE 199
Query: 231 ALFGHAPYASCNLSQLRAQALSSAPITIPPNS-LSPDCMDFLSRLLQKDPMRRISYEDLF 289
LFG APY+S + +L + I +P S +S +C D L LL+ DP +RI++++ F
Sbjct: 200 CLFGKAPYSSGSFQELIEKIKDCRSIELPKGSHVSYECKDLLMSLLKHDPDKRITFDEFF 259
Query: 290 SHPYPDLIHAPCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIPLA 342
H + DL HAP E++ AI +V +A+ D E N + AF LYCEAL Y IP+
Sbjct: 260 GHDFLDLAHAPTKENYDKAIELVQNAVKMDAEKNLKEAFHLYCEALRYFIPIV 312
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350401270|ref|XP_003486105.1| PREDICTED: serine/threonine-protein kinase ULK3-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 246 bits (628), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 114/233 (48%), Positives = 161/233 (69%), Gaps = 4/233 (1%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
++YI++EYCDGGDL SFI+ KL E C++F++QL LALK+LR NNVCH DLKPQN+L+
Sbjct: 81 HIYIVMEYCDGGDLSSFIKKRHKLPEQICRRFLQQLALALKYLRNNNVCHMDLKPQNLLL 140
Query: 174 KNN---TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
TLK+ DFGFA+FL+ + +I GSPLYMAPEIL + Y+A+ DLWS+GV+++E
Sbjct: 141 IRRPQLTLKVGDFGFARFLSNSQTKFAICGSPLYMAPEILLKNKYDARVDLWSVGVIMYE 200
Query: 231 ALFGHAPYASCNLSQLRAQALSSAPITIPPNS-LSPDCMDFLSRLLQKDPMRRISYEDLF 289
LFG APY+S + +L + PI +P S +S +C D L LL+ +P RI++++ F
Sbjct: 201 CLFGEAPYSSNSFQELAEKIKDCRPIKLPKGSHVSSECKDLLMSLLRHNPDERITFDEFF 260
Query: 290 SHPYPDLIHAPCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIPLA 342
+H + DL HAP E++ A+ ++ A+ D E NS+ A LYCEAL Y IP+
Sbjct: 261 AHDFLDLAHAPTKENYDKAVELIQKAVKMDAEKNSKEALHLYCEALRYFIPIV 313
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340720576|ref|XP_003398710.1| PREDICTED: serine/threonine-protein kinase ULK3-like [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 246 bits (627), Expect = 2e-62, Method: Compositional matrix adjust.
Identities = 115/233 (49%), Positives = 160/233 (68%), Gaps = 4/233 (1%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
++YI++EYCDGGDL SFIR KL E C+QF++QL LALK+LR NNV H DLKPQN+L+
Sbjct: 81 HIYIVMEYCDGGDLSSFIRKRHKLPEQICRQFLQQLTLALKYLRNNNVSHMDLKPQNLLL 140
Query: 174 KNN---TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
TLK+ DFGFA+FL+ + +I GSPLYMAPEIL + Y+A+ DLWS+GV+++E
Sbjct: 141 MRRPQLTLKVGDFGFARFLSNSQTKFAICGSPLYMAPEILLKNKYDARVDLWSVGVIMYE 200
Query: 231 ALFGHAPYASCNLSQLRAQALSSAPITIPPNS-LSPDCMDFLSRLLQKDPMRRISYEDLF 289
LFG APY+S + +L + PI +P S +S +C D L LL+ +P RI++++ F
Sbjct: 201 CLFGEAPYSSNSFQELAEKIKDCRPIKLPKGSHVSSECKDLLMSLLRHNPDERITFDEFF 260
Query: 290 SHPYPDLIHAPCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIPLA 342
+H + DL HAP E++ A+ ++ A+ D E NS+ A LYCEAL Y IP+
Sbjct: 261 AHDFLDLAHAPTKENYDKAVELIQKAVKMDAEKNSKEALHLYCEALRYFIPIV 313
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|125773345|ref|XP_001357931.1| GA21378, isoform A [Drosophila pseudoobscura pseudoobscura] gi|54637665|gb|EAL27067.1| GA21378, isoform A [Drosophila pseudoobscura pseudoobscura] | Back alignment and taxonomy information |
|---|
Score = 241 bits (615), Expect = 5e-61, Method: Compositional matrix adjust.
Identities = 112/232 (48%), Positives = 161/232 (69%), Gaps = 5/232 (2%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
+YI+LEYC+ G+L +FIR+ + L E C+ F+RQL A++++R N+V HFDLKPQN+L+
Sbjct: 81 IYIVLEYCNAGNLSAFIRTKKALPETTCRYFLRQLAAAVQYMRANDVSHFDLKPQNLLLT 140
Query: 174 ---KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
N +LK+ADFGFAQ L + ++GSPLYMAPEI+ Y+AKADLWS+GV+++E
Sbjct: 141 RGANNVSLKVADFGFAQHLKLGEINQQLKGSPLYMAPEIVRKHQYDAKADLWSIGVILYE 200
Query: 231 ALFGHAPYASCNLSQLRAQALSSAPITIPPNS-LSPDCMDFLSRLLQKDPMRRISYEDLF 289
LFG APY+S + +L + ++ PIT+PPN+ +S +C D L RLL +P RIS+ D F
Sbjct: 201 CLFGKAPYSSRTIEELLLKIRTAEPITLPPNARISNECHDLLRRLLSHEPTARISFADFF 260
Query: 290 SHPYPDLIHAPCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIPL 341
+HP+ DL P + Q AI +VT A +D ++N + A+ LYC AL Y +PL
Sbjct: 261 AHPFLDLKTFPTEHTLQKAIDLVTQACEYDEKHNYKEAYYLYCSALQYFVPL 312
|
Source: Drosophila pseudoobscura pseudoobscura Species: Drosophila pseudoobscura Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328788776|ref|XP_003251181.1| PREDICTED: serine/threonine-protein kinase ULK3-like isoform 1 [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 241 bits (615), Expect = 5e-61, Method: Compositional matrix adjust.
Identities = 114/233 (48%), Positives = 160/233 (68%), Gaps = 4/233 (1%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
++YI++EYCDGGDL SFI+ KL E C++F++QL LAL++LR NNV H DLKPQN+L+
Sbjct: 81 HIYIVMEYCDGGDLSSFIKKRHKLPEQICRKFLQQLALALRYLRNNNVSHMDLKPQNLLL 140
Query: 174 KNN---TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
TLK+ DFGFAQ+L+ ++Q +I+GSPLYMAPEIL Y+A+ DLWS+GV+++E
Sbjct: 141 MRKPQLTLKVGDFGFAQYLSNSEQKFAIRGSPLYMAPEILFKRKYDARVDLWSVGVIMYE 200
Query: 231 ALFGHAPYASCNLSQLRAQALSSAPITIPPNS-LSPDCMDFLSRLLQKDPMRRISYEDLF 289
LFG APY+S + +L + I +P S +S +C D L LL+ DP +RI++++ F
Sbjct: 201 CLFGKAPYSSGSFQELIEKIKDCRSIELPKGSHVSHECKDLLMSLLKHDPDKRITFDEFF 260
Query: 290 SHPYPDLIHAPCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIPLA 342
H + DL HAP E++ AI +V + D E N + AF LYCEAL Y IP+
Sbjct: 261 GHDFLDLAHAPTKENYDKAIELVQISPKMDAEKNLKEAFHLYCEALRYFIPIV 313
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 406 | ||||||
| FB|FBgn0037679 | 520 | CG8866 [Drosophila melanogaste | 0.559 | 0.436 | 0.482 | 1.6e-61 | |
| ZFIN|ZDB-GENE-070410-33 | 468 | ulk3 "unc-51-like kinase 3 (C. | 0.556 | 0.482 | 0.484 | 8.8e-59 | |
| UNIPROTKB|Q5ZJH6 | 468 | ULK3 "Serine/threonine-protein | 0.568 | 0.493 | 0.478 | 4e-58 | |
| UNIPROTKB|F1N332 | 472 | ULK3 "Uncharacterized protein" | 0.603 | 0.519 | 0.460 | 2e-56 | |
| UNIPROTKB|B4DFT0 | 483 | ULK3 "cDNA FLJ50476, weakly si | 0.603 | 0.507 | 0.464 | 2.5e-56 | |
| UNIPROTKB|Q6PHR2 | 472 | ULK3 "Serine/threonine-protein | 0.603 | 0.519 | 0.464 | 2.5e-56 | |
| UNIPROTKB|Q4V7Q6 | 468 | ulk3 "Serine/threonine-protein | 0.568 | 0.493 | 0.487 | 5.3e-56 | |
| MGI|MGI:1918992 | 472 | Ulk3 "unc-51-like kinase 3" [M | 0.603 | 0.519 | 0.460 | 6.8e-56 | |
| UNIPROTKB|F1SJ29 | 479 | ULK3 "Uncharacterized protein" | 0.603 | 0.511 | 0.456 | 8.6e-56 | |
| RGD|1587417 | 472 | Ulk3 "unc-51-like kinase 3 (C. | 0.603 | 0.519 | 0.456 | 1.1e-55 |
| FB|FBgn0037679 CG8866 [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 579 (208.9 bits), Expect = 1.6e-61, Sum P(2) = 1.6e-61
Identities = 112/232 (48%), Positives = 159/232 (68%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
+YI+LEYC+ G+L +FIR+ + L E C+ F+RQL A++++R N+V HFDLKPQN+L+
Sbjct: 81 IYIVLEYCNAGNLSAFIRTKKALPESTCRYFLRQLAAAVQYMRANDVSHFDLKPQNLLLT 140
Query: 175 ---NN-TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
NN +LK+ADFGFAQ L + ++GSPLYMAPEI+ Y+AKADLWS+GV+++E
Sbjct: 141 RGANNVSLKVADFGFAQHLKLGEINQQLKGSPLYMAPEIVRKHQYDAKADLWSIGVILYE 200
Query: 231 ALFGHAPYASCNLSQLRAQALSSAPITIPPNS-LSPDCMDFLSRLLQKDPMRRISYEDLF 289
LFG APY+S + +L + + IT+PPN+ +S +C D L RLL +P RIS+ D F
Sbjct: 201 CLFGKAPYSSRTIEELLLRIRKAEAITLPPNARISNECHDLLHRLLAHEPTARISFADFF 260
Query: 290 SHPYPDLIHAPCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIPL 341
+HP+ DL P + Q AI +VT A +D + N + A+ LYC AL Y +PL
Sbjct: 261 AHPFLDLKTFPTEHTLQKAIDLVTQACGYDEKRNYKEAYYLYCSALQYFVPL 312
|
|
| ZFIN|ZDB-GENE-070410-33 ulk3 "unc-51-like kinase 3 (C. elegans)" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 583 (210.3 bits), Expect = 8.8e-59, Sum P(2) = 8.8e-59
Identities = 110/227 (48%), Positives = 155/227 (68%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
+Y+ILE+C GGDL FIRS L E ++ ++Q+ AL+FL E N+ H DLKPQNIL+
Sbjct: 87 IYLILEWCSGGDLSRFIRSRRILPERVARRCLQQIACALQFLHERNISHLDLKPQNILLS 146
Query: 175 NNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFG 234
N LKL+DFGFAQ+++P D+ +++GSPLYMAPEI+ Y+A+ DLWS+GV+++EALFG
Sbjct: 147 GNMLKLSDFGFAQYMSPWDEQHALRGSPLYMAPEIVCRKHYDARVDLWSVGVILYEALFG 206
Query: 235 HAPYASCNLSQLRAQALSSAPITIPPNS-LSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
AP+AS + ++L + S P+ +P + +S DC D L RLL +DP RRI +E+ F HP+
Sbjct: 207 RAPFASRSFTELEEKIRSERPVELPAAAGVSRDCRDLLLRLLLRDPDRRICFEEFFLHPF 266
Query: 294 PDLIHAPCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIP 340
DL H P AES A +V A+ D++ + A SLYC AL +P
Sbjct: 267 VDLEHMPSAESLPKAKALVLQAVQKDQDGDRSAALSLYCSALEQFVP 313
|
|
| UNIPROTKB|Q5ZJH6 ULK3 "Serine/threonine-protein kinase ULK3" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 597 (215.2 bits), Expect = 4.0e-58, P = 4.0e-58
Identities = 113/236 (47%), Positives = 164/236 (69%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
++Y+I+E+C GGDL FIR L E + F++QL ALKFL ++N+ H DLKPQNIL+
Sbjct: 86 HIYLIMEFCAGGDLSRFIRMRRILPEKVARIFLQQLACALKFLHDHNISHLDLKPQNILL 145
Query: 174 ---KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
+N LKLADFGFAQ+++P D+ ++GSPLYMAPE++ Y+A+ DLWS+GV+++E
Sbjct: 146 STPENPQLKLADFGFAQYMSPWDEKHVLRGSPLYMAPEMVCRQQYDARVDLWSVGVILYE 205
Query: 231 ALFGHAPYASCNLSQLRAQALSSAPITIPPNS-LSPDCMDFLSRLLQKDPMRRISYEDLF 289
ALFG P+AS + ++L + S I +P LSPDC D L RLL++DP++RIS+E+ F
Sbjct: 206 ALFGRPPFASRSFAELEEKIRSDRAIELPSRPPLSPDCRDLLQRLLERDPLKRISFEEFF 265
Query: 290 SHPYPDLIHAPCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIP-LAYD 344
+HP+ D+ H P ES A +V +A+ D+E ++ A SLYC+AL Y +P L Y+
Sbjct: 266 AHPFVDMEHMPGPESFCKATNLVVEAVKKDQEGDASAALSLYCKALEYFVPALHYE 321
|
|
| UNIPROTKB|F1N332 ULK3 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 581 (209.6 bits), Expect = 2.0e-56, P = 2.0e-56
Identities = 116/252 (46%), Positives = 169/252 (67%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
+Y+I+E+C GGDL FI + L E + F++QL AL+FL E N+ H DLKPQNIL+
Sbjct: 87 IYLIMEFCAGGDLSRFIHTRRILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLS 146
Query: 175 NNT---LKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEA 231
+ LKLADFGFAQ ++P D+ ++GSPLYMAPE++ Y+A+ DLWS+GV+++EA
Sbjct: 147 SLEKPHLKLADFGFAQHMSPRDEKHVLRGSPLYMAPEMVCQRQYDARVDLWSVGVILYEA 206
Query: 232 LFGHAPYASCNLSQLRAQALSSAPITIPPN-SLSPDCMDFLSRLLQKDPMRRISYEDLFS 290
LFG P+AS + S+L + S+ I +P LS DC D L RLL++DP RRIS++D F+
Sbjct: 207 LFGQPPFASRSFSELEEKIRSNRVIELPLRPQLSHDCRDLLQRLLERDPSRRISFQDFFA 266
Query: 291 HPYPDLIHAPCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIP-LAYDVLAEA 349
HP+ DL H P ES A +V A+ D+E ++ A SLYC+AL++ +P L Y+V A+
Sbjct: 267 HPWVDLEHMPSGESLGRATALVVQAVKKDQEGDAAAALSLYCKALDFFVPALHYEVDAQR 326
Query: 350 IPNLKSGLEIGE 361
+K+ ++G+
Sbjct: 327 KEAIKA--KVGQ 336
|
|
| UNIPROTKB|B4DFT0 ULK3 "cDNA FLJ50476, weakly similar to Serine/threonine-protein kinase ULK1 (EC2.7.11.1)" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 580 (209.2 bits), Expect = 2.5e-56, P = 2.5e-56
Identities = 117/252 (46%), Positives = 169/252 (67%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
+Y+I+E+C GGDL FI + L E + F++QL AL+FL E N+ H DLKPQNIL+
Sbjct: 98 IYLIMEFCAGGDLSRFIHTRRILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLS 157
Query: 175 NNT---LKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEA 231
+ LKLADFGFAQ ++P D+ ++GSPLYMAPE++ Y+A+ DLWS+GV+++EA
Sbjct: 158 SLEKPHLKLADFGFAQHMSPWDEKHVLRGSPLYMAPEMVCQRQYDARVDLWSMGVILYEA 217
Query: 232 LFGHAPYASCNLSQLRAQALSSAPITIPPNSL-SPDCMDFLSRLLQKDPMRRISYEDLFS 290
LFG P+AS + S+L + S+ I +P L S DC D L RLL++DP RRIS++D F+
Sbjct: 218 LFGQPPFASRSFSELEEKIRSNRVIELPLRPLLSRDCRDLLQRLLERDPSRRISFQDFFA 277
Query: 291 HPYPDLIHAPCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIP-LAYDVLAEA 349
HP+ DL H P ES A +V A+ D+E +S A SLYC+AL++ +P L Y+V A+
Sbjct: 278 HPWVDLEHMPSGESLGRATALVVQAVKKDQEGDSAAALSLYCKALDFFVPALHYEVDAQR 337
Query: 350 IPNLKSGLEIGE 361
+K+ ++G+
Sbjct: 338 KEAIKA--KVGQ 347
|
|
| UNIPROTKB|Q6PHR2 ULK3 "Serine/threonine-protein kinase ULK3" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 580 (209.2 bits), Expect = 2.5e-56, P = 2.5e-56
Identities = 117/252 (46%), Positives = 169/252 (67%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
+Y+I+E+C GGDL FI + L E + F++QL AL+FL E N+ H DLKPQNIL+
Sbjct: 87 IYLIMEFCAGGDLSRFIHTRRILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLS 146
Query: 175 NNT---LKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEA 231
+ LKLADFGFAQ ++P D+ ++GSPLYMAPE++ Y+A+ DLWS+GV+++EA
Sbjct: 147 SLEKPHLKLADFGFAQHMSPWDEKHVLRGSPLYMAPEMVCQRQYDARVDLWSMGVILYEA 206
Query: 232 LFGHAPYASCNLSQLRAQALSSAPITIPPNSL-SPDCMDFLSRLLQKDPMRRISYEDLFS 290
LFG P+AS + S+L + S+ I +P L S DC D L RLL++DP RRIS++D F+
Sbjct: 207 LFGQPPFASRSFSELEEKIRSNRVIELPLRPLLSRDCRDLLQRLLERDPSRRISFQDFFA 266
Query: 291 HPYPDLIHAPCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIP-LAYDVLAEA 349
HP+ DL H P ES A +V A+ D+E +S A SLYC+AL++ +P L Y+V A+
Sbjct: 267 HPWVDLEHMPSGESLGRATALVVQAVKKDQEGDSAAALSLYCKALDFFVPALHYEVDAQR 326
Query: 350 IPNLKSGLEIGE 361
+K+ ++G+
Sbjct: 327 KEAIKA--KVGQ 336
|
|
| UNIPROTKB|Q4V7Q6 ulk3 "Serine/threonine-protein kinase ULK3" [Xenopus laevis (taxid:8355)] | Back alignment and assigned GO terms |
|---|
Score = 577 (208.2 bits), Expect = 5.3e-56, P = 5.3e-56
Identities = 115/236 (48%), Positives = 157/236 (66%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
Y+++I EYC GGDL FIR+ L E Q F++QL ALKFL E N+ H DLKPQNIL+
Sbjct: 85 YIFLITEYCAGGDLSRFIRTRRILPERIVQVFLQQLASALKFLHEKNISHLDLKPQNILL 144
Query: 174 KNNT---LKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
LKLADFGFAQ ++ D +++GSPLYMAPE++ Y+A+ DLWS+GV+++E
Sbjct: 145 SRLDRPHLKLADFGFAQHMSSEDAPQALRGSPLYMAPEMVCSKHYDARVDLWSVGVILYE 204
Query: 231 ALFGHAPYASCNLSQLRAQALSSAPITIPPNS-LSPDCMDFLSRLLQKDPMRRISYEDLF 289
ALFG AP+AS + S+L + LS I +P LSP+C D L +LLQ+DP +RIS+ + F
Sbjct: 205 ALFGKAPFASKSFSELEEKILSHKTIELPTRPRLSPECRDLLQQLLQRDPDKRISFIEFF 264
Query: 290 SHPYPDLIHAPCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIP-LAYD 344
+H + DL H P AE+ + A R+V +A+ D A +LYC+AL Y IP L Y+
Sbjct: 265 AHLFVDLEHMPSAETLEKATRLVVEAVEKDSAGEHSAALTLYCKALEYFIPALHYE 320
|
|
| MGI|MGI:1918992 Ulk3 "unc-51-like kinase 3" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 576 (207.8 bits), Expect = 6.8e-56, P = 6.8e-56
Identities = 116/252 (46%), Positives = 170/252 (67%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
+Y+I+E+C GGDL FI + L E + F++QL AL+FL E N+ H DLKPQNIL+
Sbjct: 87 IYLIMEFCAGGDLSRFIHTRRILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLS 146
Query: 175 NNT---LKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEA 231
+ LKLADFGFAQ ++P D+ ++GSPLYMAPE++ Y+A+ DLWS+GV+++EA
Sbjct: 147 SLEKPHLKLADFGFAQHMSPWDEKHVLRGSPLYMAPEMVCRRQYDARVDLWSVGVILYEA 206
Query: 232 LFGHAPYASCNLSQLRAQALSSAPITIPPN-SLSPDCMDFLSRLLQKDPMRRISYEDLFS 290
LFG P+AS + S+L + S+ I +P LS DC D L RLL++DP RRIS++D F+
Sbjct: 207 LFGQPPFASRSFSELEEKIRSNRVIELPLRPQLSLDCRDLLQRLLERDPARRISFKDFFA 266
Query: 291 HPYPDLIHAPCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIP-LAYDVLAEA 349
HP+ DL H P ES A +V +A+ D+E ++ A SLYC+AL++ +P L Y+V A+
Sbjct: 267 HPWVDLEHMPSGESLAQARALVVEAVKKDQEGDAAAALSLYCKALDFFVPALHYEVDAQR 326
Query: 350 IPNLKSGLEIGE 361
+K+ ++G+
Sbjct: 327 KEAIKA--KVGQ 336
|
|
| UNIPROTKB|F1SJ29 ULK3 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 575 (207.5 bits), Expect = 8.6e-56, P = 8.6e-56
Identities = 115/252 (45%), Positives = 169/252 (67%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
+Y+I+E+C GGDL FI + L E + F++QL AL+FL E N+ H DLKPQNIL+
Sbjct: 94 IYLIMEFCAGGDLSRFIHTRRILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLS 153
Query: 175 NNT---LKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEA 231
+ LKLADFGFAQ ++P D+ ++GSPLYMAPE++ Y+A+ DLWS+GV+++EA
Sbjct: 154 SLEKPHLKLADFGFAQHMSPWDEKHVLRGSPLYMAPEMVCQRQYDARVDLWSVGVILYEA 213
Query: 232 LFGHAPYASCNLSQLRAQALSSAPITIPPNSL-SPDCMDFLSRLLQKDPMRRISYEDLFS 290
LFG P+AS + S+L + S+ I +P L S DC D L RLL++DP RRIS++D F+
Sbjct: 214 LFGQPPFASRSFSELEEKIRSNRVIELPLRPLLSQDCRDLLQRLLERDPNRRISFQDFFA 273
Query: 291 HPYPDLIHAPCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIP-LAYDVLAEA 349
HP+ DL H P ES A +V A+ D++ ++ A SLYC+AL++ +P L Y+V A+
Sbjct: 274 HPWVDLEHMPSGESLARATALVVQAVQKDQQGDAAAALSLYCKALDFFVPALHYEVDAQR 333
Query: 350 IPNLKSGLEIGE 361
+K+ ++G+
Sbjct: 334 KEAIKA--KVGQ 343
|
|
| RGD|1587417 Ulk3 "unc-51-like kinase 3 (C. elegans)" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 574 (207.1 bits), Expect = 1.1e-55, P = 1.1e-55
Identities = 115/252 (45%), Positives = 169/252 (67%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
+Y+I+E+C GGDL FI + L E + F++QL AL+FL E N+ H DLKPQNIL+
Sbjct: 87 IYLIMEFCAGGDLSRFIHTRRILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLS 146
Query: 175 NNT---LKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEA 231
+ LKLADFGFAQ ++P D+ ++GSPLYMAPE++ Y+A+ DLWS+GV+++EA
Sbjct: 147 SLEKPHLKLADFGFAQHMSPWDEKHVLRGSPLYMAPEMVCRRQYDARVDLWSVGVILYEA 206
Query: 232 LFGHAPYASCNLSQLRAQALSSAPITIPPN-SLSPDCMDFLSRLLQKDPMRRISYEDLFS 290
LFG P+AS + S+L + S+ I +P LS DC D L RLL++DP RIS++D F+
Sbjct: 207 LFGQPPFASRSFSELEEKIRSNRVIELPLRPQLSLDCRDLLQRLLERDPSHRISFQDFFA 266
Query: 291 HPYPDLIHAPCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIP-LAYDVLAEA 349
HP+ DL H P ES A +V +A+ D+E ++ A SLYC+AL++ +P L Y+V A+
Sbjct: 267 HPWVDLEHMPSGESLAQATALVVEAVKKDQEGDAAAALSLYCKALDFFVPALHYEVDAQR 326
Query: 350 IPNLKSGLEIGE 361
+K+ ++G+
Sbjct: 327 KEAIKA--KVGQ 336
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8SRL5 | IPL1_ENCCU | 2, ., 7, ., 1, 1, ., 1 | 0.3154 | 0.6330 | 0.9448 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 406 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-68 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-56 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-53 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-49 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-48 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-45 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-44 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-43 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-42 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-41 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-41 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-41 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-40 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-39 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-38 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-38 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-37 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-37 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-36 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-36 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-35 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-35 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-34 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-32 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-31 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-31 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-30 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-30 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-30 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-30 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-29 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-29 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-29 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-29 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-29 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-29 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-29 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-28 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-28 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-28 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-28 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-27 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-27 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-27 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-27 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-27 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-27 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-27 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-26 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-26 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-26 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-26 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-26 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-26 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-26 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-26 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-26 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-25 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-25 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-25 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-25 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-25 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-25 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-25 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-25 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-25 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-25 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-25 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-24 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-24 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-24 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-24 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-24 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-24 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-24 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-24 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-24 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-24 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-24 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-24 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-24 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 9e-24 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-23 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-23 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-23 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-23 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-22 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-22 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-22 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-22 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-22 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-22 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-22 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-22 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-22 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-22 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-21 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-21 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-21 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-21 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-21 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-21 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-21 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-21 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-20 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-20 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-20 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-20 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-19 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-19 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-19 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-19 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-19 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-19 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-19 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-19 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-19 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-18 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-18 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-18 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-18 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-18 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-18 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-18 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-18 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-18 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-18 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-18 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-18 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-18 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-18 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-18 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-18 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-17 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-17 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-17 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-17 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-17 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-17 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-17 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-16 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-16 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-16 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-16 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-16 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-16 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-15 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-14 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-14 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-14 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-14 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-12 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-10 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-09 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-08 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-08 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-08 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-07 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 5e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-05 | |
| cd02684 | 75 | cd02684, MIT_2, MIT: domain contained within Micro | 2e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-04 | |
| cd02678 | 75 | cd02678, MIT_VPS4, MIT: domain contained within Mi | 0.001 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.001 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.003 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 215 bits (549), Expect = 7e-68
Identities = 67/185 (36%), Positives = 112/185 (60%), Gaps = 3/185 (1%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+Y+++EYC+GGDL ++ +LSE + + ++RQ++ AL++L + H DLKP+NI
Sbjct: 69 EDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENI 128
Query: 172 LI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
L+ ++ +KLADFG A+ L P ++ + G+P YMAPE+L G Y D+WSLGV+++E
Sbjct: 129 LLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYE 188
Query: 231 ALFGHAPYASCNLSQLRAQALSSAPITIPPNS--LSPDCMDFLSRLLQKDPMRRISYEDL 288
L G P+ + + + PP +SP+ D + +LL KDP +R++ E+
Sbjct: 189 LLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEA 248
Query: 289 FSHPY 293
HP+
Sbjct: 249 LQHPF 253
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 183 bits (468), Expect = 9e-56
Identities = 68/191 (35%), Positives = 109/191 (57%), Gaps = 8/191 (4%)
Query: 111 RPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 170
++Y+++EYC+GGDL ++ LSE + ++ Q++ L++L N + H DLKP+N
Sbjct: 69 DKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPEN 128
Query: 171 ILIKNN-TLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGS-PYNAKADLWSLGVL 227
IL+ N +K+ADFG A + L + + G+P YMAPE+L G Y K D+WSLGV+
Sbjct: 129 ILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVI 188
Query: 228 VFEALFGHAPY-ASCNLSQLR--AQALSSAPITIPP--NSLSPDCMDFLSRLLQKDPMRR 282
++E L G P+ L QL+ + L P +S S + D + + L KDP +R
Sbjct: 189 LYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKR 248
Query: 283 ISYEDLFSHPY 293
+ E++ HP+
Sbjct: 249 PTAEEILQHPW 259
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 2e-53
Identities = 77/231 (33%), Positives = 122/231 (52%), Gaps = 15/231 (6%)
Query: 77 VKYSQVRYDTITSHSEFERPRAGLSNLRAP--------EGRKRPRYVYIILEYCDGGDLC 128
VK ++ D+ ER LS+L+ P E + + I LEY GG L
Sbjct: 30 VKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLS 89
Query: 129 SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLADFGFAQ 187
S ++ KL E +++ RQ++ L +L N + H D+K NIL+ ++ +KLADFG A+
Sbjct: 90 SLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAK 149
Query: 188 FLAPNDQGD---SIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCN-- 242
L + G+ S++G+P +MAPE++ G Y AD+WSLG V E G P++
Sbjct: 150 RLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP 209
Query: 243 LSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
++ L S P IP + LS + DFL + L++DP +R + ++L HP+
Sbjct: 210 MAALYKIGSSGEPPEIPEH-LSEEAKDFLRKCLRRDPKKRPTADELLQHPF 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 6e-49
Identities = 66/186 (35%), Positives = 100/186 (53%), Gaps = 7/186 (3%)
Query: 114 YVYIILEYCDGGDLCSFIRS----HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 169
+ I++EY DGGDL I+ + E Q + QL LALK+L + H D+KPQ
Sbjct: 73 KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQ 132
Query: 170 NILI-KNNTLKLADFGFAQFLAPN-DQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVL 227
NI + N +KL DFG ++ L+ D ++ G+P Y++PE+ PYN K+D+WSLG +
Sbjct: 133 NIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCV 192
Query: 228 VFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYED 287
++E P+ NL +L + L I P+ S + + +S LLQKDP R S
Sbjct: 193 LYELCTLKHPFEGENLLELALKILKGQYPPI-PSQYSSELRNLVSSLLQKDPEERPSIAQ 251
Query: 288 LFSHPY 293
+ P+
Sbjct: 252 ILQSPF 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 2e-48
Identities = 66/187 (35%), Positives = 110/187 (58%), Gaps = 7/187 (3%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+Y++LEY GG+L S + + SE + + + ++VLAL++L + + DLKP+NI
Sbjct: 65 EEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENI 124
Query: 172 LIKNNT-LKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVF 229
L+ + +KL DFG A + + + ++ G+P Y+APE+L G Y D WSLGVL++
Sbjct: 125 LLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLY 184
Query: 230 EALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY---E 286
E L G P+ + + ++ + L P+ P LSP+ D +S LLQKDP +R+ E
Sbjct: 185 EMLTGKPPFYAEDRKEIYEKILKD-PLRFPEF-LSPEARDLISGLLQKDPTKRLGSGGAE 242
Query: 287 DLFSHPY 293
++ +HP+
Sbjct: 243 EIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 2e-45
Identities = 67/184 (36%), Positives = 97/184 (52%), Gaps = 5/184 (2%)
Query: 113 RYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+YIILEY + G L I+ E +V Q++ L +L E V H D+K NIL
Sbjct: 72 DSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANIL 131
Query: 173 I-KNNTLKLADFGFAQFLAPNDQGD-SIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
K+ +KLADFG A L + D S+ G+P +MAPE++ S + +D+WSLG V E
Sbjct: 132 TTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIE 191
Query: 231 ALFGHAPYASCNLSQLRAQ-ALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLF 289
L G+ PY +L+ + A + P +SP+ DFL + QKDP R + + L
Sbjct: 192 LLTGNPPYY--DLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLL 249
Query: 290 SHPY 293
HP+
Sbjct: 250 KHPW 253
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 3e-44
Identities = 62/186 (33%), Positives = 103/186 (55%), Gaps = 38/186 (20%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 170
++Y+++EYC+GG L ++ +E KLSE + + + Q++ L++L N + H DLKP+N
Sbjct: 63 ENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPEN 122
Query: 171 ILIK--NNTLKLADFGFAQFLAPN-DQGDSIQGSPLYMAPEILAGSP-YNAKADLWSLGV 226
IL+ N +KLADFG ++ L + +I G+P YMAPE+L G Y+ K+D+WSLGV
Sbjct: 123 ILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGV 182
Query: 227 LVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYE 286
+++E L +L+ D + ++LQKDP +R S +
Sbjct: 183 ILYE------------LPELK---------------------DLIRKMLQKDPEKRPSAK 209
Query: 287 DLFSHP 292
++ H
Sbjct: 210 EILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 4e-43
Identities = 64/184 (34%), Positives = 106/184 (57%), Gaps = 7/184 (3%)
Query: 115 VYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
++I++E+C GG L ++S + L+E Q ++L+ L++L N + H D+K NIL+
Sbjct: 72 LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL 131
Query: 174 KNN-TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
++ +KL DFG + L+ +++ G+P +MAPE++ G PY+ KAD+WSLG+ E
Sbjct: 132 TSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELA 191
Query: 233 FGHAPYASCNLSQLRAQ---ALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLF 289
G PY+ L ++A A + P P S + DFL + LQK+P +R + E L
Sbjct: 192 EGKPPYS--ELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLL 249
Query: 290 SHPY 293
HP+
Sbjct: 250 KHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 3e-42
Identities = 63/188 (33%), Positives = 99/188 (52%), Gaps = 6/188 (3%)
Query: 111 RPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFL-RENNVCHFDLKPQ 169
+ + I+LEY DGG L ++ K+ E RQ++ L +L + ++ H D+KP
Sbjct: 70 KEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPS 129
Query: 170 NILI-KNNTLKLADFGFAQFLAPN-DQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVL 227
N+LI +K+ADFG ++ L DQ ++ G+ YM+PE + G Y+ AD+WSLG+
Sbjct: 130 NLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLT 189
Query: 228 VFEALFGHAPYAS---CNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRIS 284
+ E G P+ + +L P ++P SP+ DF+S LQKDP +R S
Sbjct: 190 LLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPS 249
Query: 285 YEDLFSHP 292
+L HP
Sbjct: 250 AAELLQHP 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 1e-41
Identities = 60/190 (31%), Positives = 104/190 (54%), Gaps = 10/190 (5%)
Query: 110 KRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 169
+ +Y+++EY GG+L S +R + E + + Q+VLAL++L ++ + DLKP+
Sbjct: 71 QDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPE 130
Query: 170 NILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLV 228
N+L+ + +K+ DFGFA+ + ++ G+P Y+APEI+ Y D W+LG+L+
Sbjct: 131 NLLLDSDGYIKITDFGFAKRVKGRTY--TLCGTPEYLAPEIILSKGYGKAVDWWALGILI 188
Query: 229 FEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY--- 285
+E L G+ P+ N Q+ + L + P SPD D + LLQ D +R+
Sbjct: 189 YEMLAGYPPFFDDNPIQIYEKILEGK-VRFPSF-FSPDAKDLIRNLLQVDLTKRLGNLKN 246
Query: 286 --EDLFSHPY 293
D+ +HP+
Sbjct: 247 GVNDIKNHPW 256
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 2e-41
Identities = 73/206 (35%), Positives = 111/206 (53%), Gaps = 19/206 (9%)
Query: 114 YVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+++++EY DGG L I + +++E Q R+++ L++L NV H D+K NIL
Sbjct: 89 ELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNIL 148
Query: 173 I-KNNTLKLADFGF-AQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
+ K+ ++KLADFGF AQ + +S+ G+P +MAPE++ Y K D+WSLG++ E
Sbjct: 149 LSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIE 208
Query: 231 ALFGHAPYASCNLSQLRAQALSSAPIT---IPP----NSLSPDCMDFLSRLLQKDPMRRI 283
G PY LRA L IT IPP SP+ DFL++ L KDP +R
Sbjct: 209 MAEGEPPYL--REPPLRALFL----ITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRP 262
Query: 284 SYEDLFSHPYPDLIHAPCAESHQTAI 309
S E+L HP+ + C + +
Sbjct: 263 SAEELLQHPF---LKKACPKEEFAPL 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 6e-41
Identities = 62/196 (31%), Positives = 104/196 (53%), Gaps = 17/196 (8%)
Query: 113 RYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+ +Y+++EY GGDL S + + L E + ++ ++VLAL++L N + H DLKP NIL
Sbjct: 66 KNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNIL 125
Query: 173 I-KNNTLKLADFGFAQF---------LAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLW 222
I N LKL DFG ++ + I G+P Y+APE++ G ++ D W
Sbjct: 126 IDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWW 185
Query: 223 SLGVLVFEALFGHAPYASCNLSQLRAQALSS--APITIPPNSLSPDCMDFLSRLLQKDPM 280
SLG +++E L G P+ ++ L+ +S + +D +S+LL DP
Sbjct: 186 SLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDV--EVSDEAIDLISKLLVPDPE 243
Query: 281 RRI---SYEDLFSHPY 293
+R+ S E++ +HP+
Sbjct: 244 KRLGAKSIEEIKNHPF 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 1e-40
Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 28/205 (13%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
+Y +LEY G+L +IR + L E + + +++LAL++L + H DLKP+NIL+
Sbjct: 77 LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD 136
Query: 174 KNNTLKLADFGFAQFLAPNDQGDSIQ---------------------GSPLYMAPEILAG 212
K+ +K+ DFG A+ L PN +S + G+ Y++PE+L
Sbjct: 137 KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE 196
Query: 213 SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLS 272
P +DLW+LG ++++ L G P+ N Q + + PPN PD D +
Sbjct: 197 KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT-FQKILKLEYSFPPN-FPPDAKDLIE 254
Query: 273 RLLQKDPMRRI----SYEDLFSHPY 293
+LL DP R+ Y++L +HP+
Sbjct: 255 KLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 3e-39
Identities = 67/190 (35%), Positives = 96/190 (50%), Gaps = 11/190 (5%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
VYI +EYC GG L + L E + + QL+ L +L + + H D+KP NI +
Sbjct: 74 VYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD 133
Query: 174 KNNTLKLADFGFAQFLAPN-----DQGDSIQGSPLYMAPEILAGSPYNAK---ADLWSLG 225
N +KL DFG A L N ++ S+ G+P YMAPE++ G AD+WSLG
Sbjct: 134 HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLG 193
Query: 226 VLVFEALFGHAPYASC-NLSQLRAQALSSAPITIP-PNSLSPDCMDFLSRLLQKDPMRRI 283
+V E G P++ N Q+ + IP LSP+ DFL R L+ DP +R
Sbjct: 194 CVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRP 253
Query: 284 SYEDLFSHPY 293
+ +L HP+
Sbjct: 254 TASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 2e-38
Identities = 55/190 (28%), Positives = 101/190 (53%), Gaps = 10/190 (5%)
Query: 113 RYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+Y+Y+++EYC GG+L + +R E+ + ++ +VLA ++L + + DLKP+N+L
Sbjct: 66 KYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLL 125
Query: 173 I-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEA 231
+ N +KL DFGFA+ L + + G+P Y+APEI+ Y+ D WSLG+L++E
Sbjct: 126 LDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYEL 185
Query: 232 LFGHAPYASCNLSQLRAQAL---SSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI----- 283
L G P+ + + + + P + D + +LL+++P R+
Sbjct: 186 LTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNY-IDKAAKDLIKQLLRRNPEERLGNLKG 244
Query: 284 SYEDLFSHPY 293
+D+ H +
Sbjct: 245 GIKDIKKHKW 254
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 8e-38
Identities = 62/188 (32%), Positives = 99/188 (52%), Gaps = 14/188 (7%)
Query: 115 VYIILEYCDGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
++I++EYC G + ++ K L+E + + Q + L++L N H D+K NIL+
Sbjct: 73 LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL 132
Query: 174 -KNNTLKLADFGFAQFLA-PNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEA 231
+ KLADFG + L + +++ G+P +MAPE++ YN KAD+WSLG+ E
Sbjct: 133 NEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEM 192
Query: 232 LFGHAPYASCNLSQLRAQALSSAPITIPPNSL------SPDCMDFLSRLLQKDPMRRISY 285
G PY+ ++ +RA + PP +L SP+ DF+ + L KDP R S
Sbjct: 193 AEGKPPYS--DIHPMRAIFMI---PNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSA 247
Query: 286 EDLFSHPY 293
L HP+
Sbjct: 248 IQLLQHPF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 1e-37
Identities = 62/186 (33%), Positives = 104/186 (55%), Gaps = 8/186 (4%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+Y++++ GGDL + K SE Q + ++ ++VLAL++L + H D+KP NIL+
Sbjct: 74 NMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL 133
Query: 174 KNNT-LKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
+ + DF A + P+ S G+P YMAPE+L Y+ D WSLGV +E L
Sbjct: 134 DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECL 193
Query: 233 FGHAPY---ASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY--ED 287
G PY + Q+RA+ ++ + P + S + +D +++LL++DP +R+ +D
Sbjct: 194 RGKRPYRGHSRTIRDQIRAKQETADVLY--PATWSTEAIDAINKLLERDPQKRLGDNLKD 251
Query: 288 LFSHPY 293
L +HPY
Sbjct: 252 LKNHPY 257
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 5e-37
Identities = 70/211 (33%), Positives = 107/211 (50%), Gaps = 8/211 (3%)
Query: 91 SEFERPRAGLSNLRAPE-----GRKRPR-YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQ 144
+ E+ A LS L+ P G +R +YI LE GG L ++ + E +
Sbjct: 47 KQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRL 106
Query: 145 FVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLADFGFAQFLAPNDQGDSIQGSPL 203
+ RQ++L L++L + N H D+K NIL+ N +KLADFG A+ + S +GSP
Sbjct: 107 YTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPY 166
Query: 204 YMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNS 262
+MAPE++A Y AD+WSLG V E G P++ + S + P+
Sbjct: 167 WMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDH 226
Query: 263 LSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
LS + DF+ + LQ+DP R + +L HP+
Sbjct: 227 LSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 2e-36
Identities = 70/212 (33%), Positives = 114/212 (53%), Gaps = 17/212 (8%)
Query: 91 SEFERPRAGLSNLRAPEGRKRPRY---------VYIILEYCDGGDLCSFIRSHEKLSEFQ 141
S+ +R A LS LR + +Y ++II+EY +GG + + +++ ++E
Sbjct: 44 SDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKY 102
Query: 142 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLADFGFAQFLAPNDQGDS-IQ 199
+R++++ALK++ + V H D+K NIL+ N +KL DFG A L N S
Sbjct: 103 ISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV 162
Query: 200 GSPLYMAPE-ILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQAL--SSAPI 256
G+P +MAPE I G Y+ KAD+WSLG+ ++E G+ PY ++ RA L S P
Sbjct: 163 GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPY--SDVDAFRAMMLIPKSKPP 220
Query: 257 TIPPNSLSPDCMDFLSRLLQKDPMRRISYEDL 288
+ N S +F++ L ++P R+S E+L
Sbjct: 221 RLEDNGYSKLLREFVAACLDEEPKERLSAEEL 252
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 2e-36
Identities = 70/187 (37%), Positives = 104/187 (55%), Gaps = 9/187 (4%)
Query: 116 YIILEYCDGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
+I++E+CDGG L S + E+ L+E Q + RQ++ AL FL + V H DLK NIL+
Sbjct: 78 WILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLT 137
Query: 174 KNNTLKLADFGFAQFLAPNDQG-DSIQGSPLYMAPEILA-----GSPYNAKADLWSLGVL 227
+ +KLADFG + Q D+ G+P +MAPE++A +PY+ KAD+WSLG+
Sbjct: 138 LDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGIT 197
Query: 228 VFEALFGHAPYASCNLSQLRAQALSSAPITI-PPNSLSPDCMDFLSRLLQKDPMRRISYE 286
+ E P+ N ++ + L S P T+ P+ S DFL L KDP R +
Sbjct: 198 LIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAA 257
Query: 287 DLFSHPY 293
+L HP+
Sbjct: 258 ELLKHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 1e-35
Identities = 66/190 (34%), Positives = 96/190 (50%), Gaps = 12/190 (6%)
Query: 115 VYIILEYCDGGDLCSFI----RSHEKLSEFQCQQFVRQLVLALK-----FLRENNVCHFD 165
+YI++EYC+GGDL I + + + E + + QL+LAL N V H D
Sbjct: 76 LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRD 135
Query: 166 LKPQNI-LIKNNTLKLADFGFAQFLAPNDQ-GDSIQGSPLYMAPEILAGSPYNAKADLWS 223
LKP NI L NN +KL DFG A+ L + + G+P YM+PE L Y+ K+D+WS
Sbjct: 136 LKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWS 195
Query: 224 LGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283
LG L++E P+ + N QL A + P S + + + +L DP +R
Sbjct: 196 LGCLIYELCALSPPFTARNQLQL-ASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRP 254
Query: 284 SYEDLFSHPY 293
S E+L P
Sbjct: 255 STEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-35
Identities = 63/182 (34%), Positives = 97/182 (53%), Gaps = 7/182 (3%)
Query: 116 YIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 175
+II+EYC GG ++ KL E +R+++L L++L E H D+K NIL+
Sbjct: 75 WIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSE 133
Query: 176 N-TLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF 233
+KLADFG + Q + + ++ G+P +MAPE++ S Y+ KAD+WSLG+ E
Sbjct: 134 EGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAK 193
Query: 234 GHAPYASCNLSQLRAQAL--SSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291
G P + L +R L + P ++ N S DF+S L KDP R S ++L H
Sbjct: 194 GEPPLSD--LHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251
Query: 292 PY 293
+
Sbjct: 252 KF 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-34
Identities = 64/187 (34%), Positives = 107/187 (57%), Gaps = 11/187 (5%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
Y+Y+++EY +GGD S I++ L E +Q++ ++VL ++ L + + H D+KP+N+LI
Sbjct: 71 YLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI 130
Query: 174 KNNT-LKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
LKL DFG ++ N + G+P Y+APE + G + +D WSLG ++FE L
Sbjct: 131 DQTGHLKLTDFGLSRNGLENKK---FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFL 187
Query: 233 FGHAPYASCNLSQLRAQALSSAPITIPP---NSLSPDCMDFLSRLLQKDPMRRIS---YE 286
FG+ P+ + + LS I P SP+ +D ++RLL DP +R+ Y+
Sbjct: 188 FGYPPFHAETPDAVFDNILSRR-INWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQ 246
Query: 287 DLFSHPY 293
++ SHP+
Sbjct: 247 EIKSHPF 253
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 3e-34
Identities = 68/278 (24%), Positives = 113/278 (40%), Gaps = 33/278 (11%)
Query: 85 DTITSHSEFERPRAGLSNLRAPEGRKR-------PRYVYIILEYCDGGDLCSFIRSH--- 134
F R L++L P + +Y+++EY DGG L ++
Sbjct: 36 SKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRK 95
Query: 135 EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI--KNNTLKLADFGFAQFLAPN 192
LSE + + Q++ AL++L + H D+KP+NIL+ +KL DFG A+ L
Sbjct: 96 GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155
Query: 193 DQG-------DSIQGSPLYMAPEILAGS---PYNAKADLWSLGVLVFEALFGHAPY---- 238
+ G+P YMAPE+L G ++ +D+WSLG+ ++E L G P+
Sbjct: 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215
Query: 239 -------ASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291
+ +L +L+S P +S D L +LL KDP R+S SH
Sbjct: 216 NSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275
Query: 292 PYPDLIHAPCAESHQTAIRIVTDAIHHDRENNSRRAFS 329
+ ++ + + + S
Sbjct: 276 DLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALIS 313
|
Length = 384 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 6e-32
Identities = 59/183 (32%), Positives = 105/183 (57%), Gaps = 5/183 (2%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+++ ++EY +GGDL I+S + E + + + +++ L+FL + + + DLK N+L+
Sbjct: 70 HLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL 129
Query: 174 -KNNTLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEA 231
K+ +K+ADFG + + + + G+P Y+APEIL G YN D WS GVL++E
Sbjct: 130 DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEM 189
Query: 232 LFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYE-DLFS 290
L G +P+ + +L L+ P P +S + D LS+L ++DP +R+ + D+
Sbjct: 190 LIGQSPFHGEDEDELFDSILNDRPHF--PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247
Query: 291 HPY 293
HP+
Sbjct: 248 HPF 250
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 66/215 (30%), Positives = 110/215 (51%), Gaps = 35/215 (16%)
Query: 113 RYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
++Y+++EY GGDL + + + E + ++ +LVLAL + + H D+KP NIL
Sbjct: 74 EHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNIL 133
Query: 173 I-KNNTLKLADFGFAQFLAPNDQG------------------------------DSIQGS 201
I + +KLADFG + + +S G+
Sbjct: 134 IDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGT 193
Query: 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALS-SAPITIPP 260
P Y+APE+L G+PY + D WSLGV+++E L+G P+ S L + + ++ + PP
Sbjct: 194 PDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPP 253
Query: 261 -NSLSPDCMDFLSRLLQKDPMRRI-SYEDLFSHPY 293
+SP+ +D + RLL DP R+ S+E++ SHP+
Sbjct: 254 DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 6e-31
Identities = 57/186 (30%), Positives = 99/186 (53%), Gaps = 9/186 (4%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
++ ++EY +GGDL I+ + E + + + ++VL L+FL E + + DLK N+L+
Sbjct: 71 LFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLD 130
Query: 174 KNNTLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
+K+ADFG + + + G+P Y+APEIL+ PY D W+LGVL++E L
Sbjct: 131 SEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEML 190
Query: 233 FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI-----SYED 287
G +P+ + +L Q++ + P LS + L L K+P +R+ +D
Sbjct: 191 AGQSPFEGDDEDEL-FQSILEDEVRY-PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQD 248
Query: 288 LFSHPY 293
+ HP+
Sbjct: 249 IKGHPF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 62/187 (33%), Positives = 96/187 (51%), Gaps = 9/187 (4%)
Query: 115 VYIILEYCDGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLREN-NVCHFDLKPQNIL 172
+ I +EY DGG L ++ + + E + ++ L +L E + H D+KP NIL
Sbjct: 74 ISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNIL 133
Query: 173 IKNN-TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEA 231
+ + +KL DFG + L N + G+ YMAPE + G+ Y+ K+D+WSLG+ + E
Sbjct: 134 VNSRGQIKLCDFGVSGQLV-NSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIEL 192
Query: 232 LFGHAPYASCNLS-----QLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYE 286
G PY N +L ++ P +P SPD DF++ L KDP R SY+
Sbjct: 193 ATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYK 252
Query: 287 DLFSHPY 293
+L HP+
Sbjct: 253 ELLEHPF 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (297), Expect = 2e-30
Identities = 66/229 (28%), Positives = 97/229 (42%), Gaps = 70/229 (30%)
Query: 115 VYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+Y++ EYCD DL ++ LS + + QL+ L + + + H DLKPQNILI
Sbjct: 73 LYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI 131
Query: 174 -KNNTLKLADFGFAQFLAPNDQGDSIQGSPL-----------YMAPEILAGSP-YNAKAD 220
++ LKLADFG A+ G PL Y APEIL GS Y+ D
Sbjct: 132 NRDGVLKLADFGLARAF----------GIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVD 181
Query: 221 LWSLG-----VLVFEALFGHAPYASCNLSQL----------------------------- 246
+WS+G ++ + LF + QL
Sbjct: 182 IWSVGCIFAEMITGKPLF----PGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237
Query: 247 --RAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
+ L +P L P+ +D LS++LQ +P +RIS ++ HPY
Sbjct: 238 KFPPKDLEK---VLP--RLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-30
Identities = 61/191 (31%), Positives = 111/191 (58%), Gaps = 14/191 (7%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
+++IL+Y +GG+L + + E +E + + ++ ++VLAL L + + + D+K +NIL+
Sbjct: 80 LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD 139
Query: 174 KNNTLKLADFGFAQ-FLAPN-DQGDSIQGSPLYMAPEILAGSP--YNAKADLWSLGVLVF 229
+ L DFG ++ FLA ++ S G+ YMAPE++ G ++ D WSLGVL F
Sbjct: 140 SEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTF 199
Query: 230 EALFGHAPY----ASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY 285
E L G +P+ + S++ + L S P P ++S + DF+ +LL+KDP +R+
Sbjct: 200 ELLTGASPFTVDGEQNSQSEISRRILKSKPPF--PKTMSAEARDFIQKLLEKDPKKRLGA 257
Query: 286 ---EDLFSHPY 293
+++ +HP+
Sbjct: 258 NGADEIKNHPF 268
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 9e-30
Identities = 70/241 (29%), Positives = 108/241 (44%), Gaps = 38/241 (15%)
Query: 99 GLSNLRAPEGRKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRE 158
GL ++ P + VYI+ E + DL I+S + L++ Q F+ Q++ LK+L
Sbjct: 63 GLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHS 121
Query: 159 NNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL----YMAPEILAGS 213
NV H DLKP NIL+ N LK+ DFG A+ + P++ + Y APE+L S
Sbjct: 122 ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSS 181
Query: 214 P-YNAKADLWSLGVLVFEALFGHAPY--ASCNLSQL---------------------RAQ 249
Y D+WS+G + E L P + QL +A+
Sbjct: 182 SRYTKAIDIWSVGCIFAE-LLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKAR 240
Query: 250 ALSSAPITIPPNSL-------SPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCA 302
+ P L SP+ +D L ++L DP +RI+ ++ +HPY +H P
Sbjct: 241 NYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPED 300
Query: 303 E 303
E
Sbjct: 301 E 301
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-29
Identities = 61/182 (33%), Positives = 93/182 (51%), Gaps = 7/182 (3%)
Query: 116 YIILEYCDGGDLCSFIRSHEK----LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
I++EY GDL I +K + E + + QL+ L+ L E + H DLK NI
Sbjct: 75 CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANI 134
Query: 172 LIKNNTL-KLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
L+ N L K+ D G ++ L N I G+P YMAPE+ G PY+ K+D+WSLG L++E
Sbjct: 135 LLVANDLVKIGDLGISKVLKKNMAKTQI-GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYE 193
Query: 231 ALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFS 290
P+ + ++ LR + IPP S D +F+ +LQ P R + + + +
Sbjct: 194 MATFAPPFEARSMQDLRYKVQRGKYPPIPPI-YSQDLQNFIRSMLQVKPKLRPNCDKILA 252
Query: 291 HP 292
P
Sbjct: 253 SP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 59/190 (31%), Positives = 99/190 (52%), Gaps = 11/190 (5%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
Y+Y+ +EY GGD + + + LSE + ++ ++ A+ L E H DLKP+N
Sbjct: 73 DEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENF 132
Query: 172 LI-KNNTLKLADFGFAQ-FLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVF 229
LI + +KL DFG ++ + +S+ GSP YMAPE+L G Y+ D WSLG +++
Sbjct: 133 LIDASGHIKLTDFGLSKGIVT---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLY 189
Query: 230 EALFGHAPYASCNLSQ-----LRAQALSSAPITIPPN-SLSPDCMDFLSRLLQKDPMRRI 283
E L G P++ ++ + P+ P +LS + D +++L+ R
Sbjct: 190 EFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFG 249
Query: 284 SYEDLFSHPY 293
S ED+ +HP+
Sbjct: 250 SLEDIKNHPF 259
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-29
Identities = 62/186 (33%), Positives = 105/186 (56%), Gaps = 12/186 (6%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
+++++E+ +GG L + +H +++E Q ++ AL FL V H D+K +IL+
Sbjct: 91 LWVVMEFLEGGALTDIV-THTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLT 149
Query: 175 NN-TLKLADFGF-AQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
++ +KL+DFGF AQ + S+ G+P +MAPE+++ PY + D+WSLG++V E +
Sbjct: 150 SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMV 209
Query: 233 FGHAPYASCNLSQLRAQALSSAPITIPPNS-----LSPDCMDFLSRLLQKDPMRRISYED 287
G PY N L QA+ +PP +SP FL R+L +DP +R + +
Sbjct: 210 DGEPPYF--NEPPL--QAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAE 265
Query: 288 LFSHPY 293
L +HP+
Sbjct: 266 LLNHPF 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 65/197 (32%), Positives = 101/197 (51%), Gaps = 16/197 (8%)
Query: 110 KRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 169
Y+ I LEY GG + S +R++ + E + F Q++ L +L + H DLK
Sbjct: 78 TTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKAD 137
Query: 170 NILIK-NNTLKLADFGFAQFLA---PNDQGDSIQGSPLYMAPEI--LAGSPYNAKADLWS 223
N+L+ + K++DFG ++ NDQ S+QGS +MAPE+ Y+AK D+WS
Sbjct: 138 NLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWS 197
Query: 224 LGVLVFEALFGHAPYASCNLSQLRAQ----ALSSAPITIPPN---SLSPDCMDFLSRLLQ 276
LG +V E G P++ + + A SAP IPP+ +LSP +DFL+
Sbjct: 198 LGCVVLEMFAGRRPWS--DEEAIAAMFKLGNKRSAP-PIPPDVSMNLSPVALDFLNACFT 254
Query: 277 KDPMRRISYEDLFSHPY 293
+P R + +L HP+
Sbjct: 255 INPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 4e-29
Identities = 65/185 (35%), Positives = 101/185 (54%), Gaps = 4/185 (2%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
+++++EY GG L + + + E Q R+ + AL+FL N V H D+K N+L+
Sbjct: 91 LFVVMEYLAGGSLTDVV-TETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG 149
Query: 174 KNNTLKLADFGF-AQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
+ ++KL DFGF AQ + ++ G+P +MAPE++ Y K D+WSLG++ E +
Sbjct: 150 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209
Query: 233 FGHAPYASCN-LSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291
G PY + N L L A + P P LSP DFL+R L+ D +R S ++L H
Sbjct: 210 EGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269
Query: 292 PYPDL 296
P+ L
Sbjct: 270 PFLKL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-29
Identities = 63/188 (33%), Positives = 100/188 (53%), Gaps = 9/188 (4%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
++ I LEY GG + + + ++ E + FVRQ++ L +L + H D+K NIL+
Sbjct: 80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV 139
Query: 174 KNN-TLKLADFGFAQFL-------APNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLG 225
N +K++DFG ++ L N S+QGS +MAPE++ + Y KAD+WSLG
Sbjct: 140 DNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLG 199
Query: 226 VLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY 285
LV E L G P+ C Q + +A IP N +S + +DFL + + D +R +
Sbjct: 200 CLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSN-ISSEAIDFLEKTFEIDHNKRPTA 258
Query: 286 EDLFSHPY 293
+L HP+
Sbjct: 259 AELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 5e-29
Identities = 64/182 (35%), Positives = 98/182 (53%), Gaps = 4/182 (2%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
+++++EY GG L + + + E Q R+ + AL+FL N V H D+K NIL+
Sbjct: 91 LWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 149
Query: 174 KNNTLKLADFGFAQFLAPNDQGDS-IQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
+ ++KL DFGF + P S + G+P +MAPE++ Y K D+WSLG++ E +
Sbjct: 150 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209
Query: 233 FGHAPYASCN-LSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291
G PY + N L L A + P P LS DFL+R L+ D +R S ++L H
Sbjct: 210 EGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269
Query: 292 PY 293
P+
Sbjct: 270 PF 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-28
Identities = 58/182 (31%), Positives = 96/182 (52%), Gaps = 9/182 (4%)
Query: 117 IILEYCDGGDLCSFI--RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
I++EY GG L +I R + L E F Q++LAL + + H DLK QNIL+
Sbjct: 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD 135
Query: 174 -KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
+K+ DFG ++ L+ + ++ G+P Y++PE+ G PYN K+D+W+LG +++E
Sbjct: 136 KHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELA 195
Query: 233 FGHAPYASCNLSQLRAQALSS--APITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFS 290
+ + NL L + +S API+ + SPD + +L DP +R + +
Sbjct: 196 SLKRAFEAANLPALVLKIMSGTFAPIS---DRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252
Query: 291 HP 292
P
Sbjct: 253 QP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 2e-28
Identities = 59/187 (31%), Positives = 105/187 (56%), Gaps = 7/187 (3%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
P +Y++L + +GG+L ++ + + + + +L+ AL+ L + NV + DLKP+NI
Sbjct: 65 PEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENI 124
Query: 172 LIK-NNTLKLADFGFAQF-LAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVF 229
L+ + L DFG + + +D+ ++ G+P Y+APE+L G Y D W+LGVL++
Sbjct: 125 LLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLY 184
Query: 230 EALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY---E 286
E L G P+ N++++ + L P+ P D D L LL +DP RR+ Y +
Sbjct: 185 EMLTGLPPFYDENVNEMYRKILQE-PLRFPDG-FDRDAKDLLIGLLSRDPTRRLGYNGAQ 242
Query: 287 DLFSHPY 293
++ +HP+
Sbjct: 243 EIKNHPF 249
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-28
Identities = 60/182 (32%), Positives = 102/182 (56%), Gaps = 4/182 (2%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
+++++E+ GG L + S +L+E Q ++ AL +L V H D+K +IL+
Sbjct: 93 LWVLMEFLQGGALTDIV-SQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLT 151
Query: 175 -NNTLKLADFGF-AQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
+ +KL+DFGF AQ + S+ G+P +MAPE+++ +PY + D+WSLG++V E +
Sbjct: 152 LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMV 211
Query: 233 FGHAPYASCNLSQLRAQALSSAPITIPPNS-LSPDCMDFLSRLLQKDPMRRISYEDLFSH 291
G PY S + Q + S P + +SP DFL R+L ++P R + ++L H
Sbjct: 212 DGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271
Query: 292 PY 293
P+
Sbjct: 272 PF 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-28
Identities = 66/185 (35%), Positives = 99/185 (53%), Gaps = 4/185 (2%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
+++++EY GG L + + + E Q R+ + AL FL N V H D+K NIL+
Sbjct: 91 LWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG 149
Query: 174 KNNTLKLADFGF-AQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
+ ++KL DFGF AQ + ++ G+P +MAPE++ Y K D+WSLG++ E +
Sbjct: 150 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209
Query: 233 FGHAPYASCN-LSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291
G PY + N L L A + P P LS DFL+R L+ D RR S ++L H
Sbjct: 210 EGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269
Query: 292 PYPDL 296
P+ L
Sbjct: 270 PFLKL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 56/172 (32%), Positives = 99/172 (57%), Gaps = 5/172 (2%)
Query: 113 RYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
R++Y+++EY GG+L S++R+ + S + ++V AL++L + + DLKP+NIL
Sbjct: 74 RFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENIL 133
Query: 173 I-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEA 231
+ K +KL DFGFA+ L D+ ++ G+P Y+APE++ +N D W+LG+L++E
Sbjct: 134 LDKEGHIKLTDFGFAKKLR--DRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEM 191
Query: 232 LFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283
L G+ P+ N + + + + + P L D + +LL D RR+
Sbjct: 192 LVGYPPFFDDNPFGIY-EKILAGKLEF-PRHLDLYAKDLIKKLLVVDRTRRL 241
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 50/174 (28%), Positives = 88/174 (50%), Gaps = 9/174 (5%)
Query: 115 VYIILEYCDGGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+ I++EY + GDL ++ L E Q +F Q++L L L + H D+K N+
Sbjct: 74 LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLF 133
Query: 173 I-KNNTLKLADFGFAQFLAPNDQ-GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
+ + +K+ D G A+ L+ N ++I G+P Y++PE+ PYN K+D+W+LGV+++E
Sbjct: 134 LDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYE 193
Query: 231 ALFGHAPYASCNLSQLRAQALSSA--PITIPPNSLSPDCMDFLSRLLQKDPMRR 282
G P+ + N L + + P+ S + + L KD +R
Sbjct: 194 CCTGKHPFDANNQGALILKIIRGVFPPV---SQMYSQQLAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 66/214 (30%), Positives = 111/214 (51%), Gaps = 15/214 (7%)
Query: 92 EFERPRAGLSNLRAP------EGRKRPRYVYIILEYCDGGDLCSFIRSHEKL--SEFQCQ 143
E + A LSN++ P E + +YI+++YC+GGDL I + + E Q
Sbjct: 45 ESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQIL 104
Query: 144 QFVRQLVLALKFLRENNVCHFDLKPQNI-LIKNNTLKLADFGFAQFLAPN-DQGDSIQGS 201
+ Q+ LALK + + + H D+K QNI L K+ T+KL DFG A+ L + + G+
Sbjct: 105 DWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGT 164
Query: 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPN 261
P Y++PEI PYN K+D+W+LG +++E + + N+ L + + + PP
Sbjct: 165 PYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG---SYPPV 221
Query: 262 SL--SPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
S S D + +S+L +++P R S + +
Sbjct: 222 SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 64/192 (33%), Positives = 104/192 (54%), Gaps = 16/192 (8%)
Query: 116 YIILEYCDGG---DLC-SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
++++E C GG DL + ++L E +R+ + L +L EN V H D+K QNI
Sbjct: 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNI 144
Query: 172 LI-KNNTLKLADFGF-AQFLAPNDQGDSIQGSPLYMAPEILA-----GSPYNAKADLWSL 224
L+ KN +KL DFG AQ + + ++ G+P +MAPE++A + Y+A++D+WSL
Sbjct: 145 LLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSL 204
Query: 225 GVLVFEALFGHAPYASCNLSQLRA--QALSSAPITI-PPNSLSPDCMDFLSRLLQKDPMR 281
G+ E G P C++ +RA + + P T+ P + S DF+S L K+ +
Sbjct: 205 GITAIELADGKPPL--CDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQ 262
Query: 282 RISYEDLFSHPY 293
R E+L HP+
Sbjct: 263 RPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 56/194 (28%), Positives = 96/194 (49%), Gaps = 18/194 (9%)
Query: 116 YIILEYCDGGDLCSFIRSHEK---LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
++++ Y GG L ++S L E +++++ L++L N H D+K NIL
Sbjct: 75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNIL 134
Query: 173 I-KNNTLKLADFGFAQFLAPNDQGDS-------IQGSPLYMAPEILA-GSPYNAKADLWS 223
+ ++ ++K+ADFG + LA D GD G+P +MAPE++ Y+ KAD+WS
Sbjct: 135 LGEDGSVKIADFGVSASLA--DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWS 192
Query: 224 LGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDC----MDFLSRLLQKDP 279
G+ E G APY+ ++ L + P ++ + +S LQKDP
Sbjct: 193 FGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDP 252
Query: 280 MRRISYEDLFSHPY 293
+R + E+L H +
Sbjct: 253 SKRPTAEELLKHKF 266
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 4e-27
Identities = 63/219 (28%), Positives = 93/219 (42%), Gaps = 47/219 (21%)
Query: 115 VYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+Y++ EY D DL + S E K +E Q + +++QL+ L++L N + H D+K NILI
Sbjct: 75 IYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI 133
Query: 174 KNN-TLKLADFGFAQFLAPNDQGDSIQGSPL--------YMAPEILAGSP-YNAKADLWS 223
N+ LKLADFG A+ + D Y PE+L G+ Y + D+WS
Sbjct: 134 NNDGVLKLADFGLARPYTKRNSAD------YTNRVITLWYRPPELLLGATRYGPEVDMWS 187
Query: 224 LGVLVFEALFGHAPYASCN-LSQLRA--QALSS------------------APITIPPNS 262
+G ++ E G + L QL + S P
Sbjct: 188 VGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRR 247
Query: 263 L--------SPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
L P +D L +LL DP +RIS + H Y
Sbjct: 248 LREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 5e-27
Identities = 60/186 (32%), Positives = 107/186 (57%), Gaps = 11/186 (5%)
Query: 115 VYIILEYCDGGDLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI- 171
+YI++ +C+GGDL ++ + L E Q ++ Q+ +AL++L E ++ H DLK QN+
Sbjct: 75 LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVF 134
Query: 172 LIKNNTLKLADFGFAQFL-APNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
L + N +K+ D G A+ L D ++ G+P YM+PE+ + PYN K+D+W+LG V+E
Sbjct: 135 LTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYE 194
Query: 231 -ALFGHAPYASCNLSQLRAQALSSAPITIP--PNSLSPDCMDFLSRLLQKDPMRRISYED 287
A HA + + +++ L + + +P P SP+ + ++ +L K P +R S +
Sbjct: 195 MATLKHA-FNAKDMNSLVYRIIEG---KLPPMPKDYSPELGELIATMLSKRPEKRPSVKS 250
Query: 288 LFSHPY 293
+ PY
Sbjct: 251 ILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 5e-27
Identities = 67/186 (36%), Positives = 95/186 (51%), Gaps = 10/186 (5%)
Query: 115 VYIILEYCDGGDLCSFI-RSHEKL-SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
++I++EYCDGGDL I R L SE Q + Q+ L LK + + + H D+K QNI
Sbjct: 74 LFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIF 133
Query: 173 IKNNTL--KLADFGFAQFLAPNDQGDSIQ---GSPLYMAPEILAGSPYNAKADLWSLGVL 227
+ N + KL DFG A+ L ND + G+P Y++PEI PYN K D+WSLG +
Sbjct: 134 LSKNGMVAKLGDFGIARQL--NDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCV 191
Query: 228 VFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYED 287
++E P+ NL QL + I PN S D +S+L + P R S
Sbjct: 192 LYELCTLKHPFEGNNLHQLVLKICQGYFAPISPN-FSRDLRSLISQLFKVSPRDRPSITS 250
Query: 288 LFSHPY 293
+ P+
Sbjct: 251 ILKRPF 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-27
Identities = 58/192 (30%), Positives = 99/192 (51%), Gaps = 15/192 (7%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+ I +EY GG + ++++ L+E +++ RQ++ +++L N + H D+K NI
Sbjct: 76 DETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANI 135
Query: 172 LIKNN-TLKLADFGFAQFL----APNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGV 226
L + +KL DFG ++ L + S+ G+P +M+PE+++G Y KAD+WS+G
Sbjct: 136 LRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGC 195
Query: 227 LVFEALFGHAPYASCNLSQLRAQALSSAPITIPPN-----SLSPDCMDFLSRLLQKDPMR 281
V E L P+A + A A T P N +SPD +FL R ++ +
Sbjct: 196 TVVEMLTEKPPWA-----EFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKK 250
Query: 282 RISYEDLFSHPY 293
R S E+L H +
Sbjct: 251 RPSAEELLRHFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-26
Identities = 66/207 (31%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
+++++EY +GGDL ++ KL E + + ++ +AL FL E + + DLK N+L+
Sbjct: 71 LFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD 130
Query: 174 KNNTLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
+ +KL D+G + L P D + G+P Y+APEIL G Y D W+LGVL+FE +
Sbjct: 131 ADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMM 190
Query: 233 FGHAPY------ASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI--- 283
G +P+ N Q + PI I P LS L L KDP R+
Sbjct: 191 AGRSPFDIITDNPDMNTEDYLFQVILEKPIRI-PRFLSVKASHVLKGFLNKDPKERLGCQ 249
Query: 284 ---SYEDLFSHPYPDLIHAPCAESHQT 307
+ D+ SH + I E Q
Sbjct: 250 PQTGFSDIKSHTFFRSIDWDLLEKKQV 276
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 60/183 (32%), Positives = 97/183 (53%), Gaps = 8/183 (4%)
Query: 117 IILEYCDGGDLCSFIR----SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
II EYC+G DL + + + LSE Q ++ QL+L + ++ + + H DLK +NI
Sbjct: 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIF 138
Query: 173 IKNNTLKLADFGFAQFLAPN-DQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE- 230
+KNN LK+ DFG ++ L + D + G+P YM+PE L Y++K+D+WSLG +++E
Sbjct: 139 LKNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
Query: 231 ALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFS 290
HA LS + + P P + S + +L KDP R S ++
Sbjct: 199 CCLAHAFEGQNFLSVV--LRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256
Query: 291 HPY 293
+P+
Sbjct: 257 NPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 56/186 (30%), Positives = 98/186 (52%), Gaps = 10/186 (5%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
V ++EY GGDL I + + SE + + +VL L++L EN + + DLK N+L+
Sbjct: 77 VCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD 135
Query: 174 KNNTLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
+K+ADFG + + D+ + G+P ++APE+L + Y D W LGVL++E L
Sbjct: 136 TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEML 195
Query: 233 FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY-----ED 287
G +P+ + ++ ++ P LS + + + RLL+++P RR+ ED
Sbjct: 196 VGESPFPGDDEEEVFDSIVNDEVRY--PRFLSREAISIMRRLLRRNPERRLGSGEKDAED 253
Query: 288 LFSHPY 293
+ P+
Sbjct: 254 VKKQPF 259
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 2e-26
Identities = 63/182 (34%), Positives = 96/182 (52%), Gaps = 4/182 (2%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
+++++EY GG L + + + E Q R+ + AL+FL N V H D+K NIL+
Sbjct: 92 LWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150
Query: 174 KNNTLKLADFGFAQFLAPNDQGDS-IQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
+ ++KL DFGF + P S + G+P +MAPE++ Y K D+WSLG++ E +
Sbjct: 151 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210
Query: 233 FGHAPYASCN-LSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291
G PY + N L L A + P P LS DFL+R L D +R S ++L H
Sbjct: 211 EGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270
Query: 292 PY 293
+
Sbjct: 271 QF 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 68/194 (35%), Positives = 99/194 (51%), Gaps = 18/194 (9%)
Query: 115 VYIILEYCDGGDLCSFI---RSHEKLSEFQCQQFVRQLVLALKFLREN-NVCHFDLKPQN 170
VY+ +EY D G L + E + E ++ +V LKFL+E N+ H D+KP N
Sbjct: 74 VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTN 133
Query: 171 ILIKNN-TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPE-ILAGSP-----YNAKADLWS 223
+L+ N +KL DFG + L + +I G YMAPE I +G P Y ++D+WS
Sbjct: 134 VLVNGNGQVKLCDFGVSGNLVASLAKTNI-GCQSYMAPERIKSGGPNQNPTYTVQSDVWS 192
Query: 224 LGVLVFEALFGHAPY----ASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDP 279
LG+ + E G PY + +QL A + P T+P S D DF+++ L K P
Sbjct: 193 LGLSILEMALGRYPYPPETYANIFAQLSA-IVDGDPPTLPS-GYSDDAQDFVAKCLNKIP 250
Query: 280 MRRISYEDLFSHPY 293
RR +Y L HP+
Sbjct: 251 NRRPTYAQLLEHPW 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 5e-26
Identities = 64/188 (34%), Positives = 101/188 (53%), Gaps = 9/188 (4%)
Query: 115 VYIILEYCDGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
++I++E+C GG + + + ++ L+E Q Q RQ++ AL++L + H DLK N+L+
Sbjct: 84 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL 143
Query: 174 K-NNTLKLADFGF-AQFLAPNDQGDSIQGSPLYMAPEI-----LAGSPYNAKADLWSLGV 226
+ +KLADFG A+ + + DS G+P +MAPE+ + +PY+ KAD+WSLG+
Sbjct: 144 TLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGI 203
Query: 227 LVFEALFGHAPYASCN-LSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY 285
+ E P+ N + L A S P P+ S + DFL L K P R S
Sbjct: 204 TLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSA 263
Query: 286 EDLFSHPY 293
L HP+
Sbjct: 264 AQLLEHPF 271
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-26
Identities = 58/188 (30%), Positives = 95/188 (50%), Gaps = 9/188 (4%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI-LI 173
+ I +E+ GG + S + L E ++ +Q++ + +L N V H D+K N+ L+
Sbjct: 77 ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLM 136
Query: 174 KNNTLKLADFGFAQFLA-------PNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGV 226
N +KL DFG A+ LA ++ S+ G+P +MAPE++ S Y K+D+WS+G
Sbjct: 137 PNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGC 196
Query: 227 LVFEALFGHAPYASCN-LSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY 285
VFE G P AS + L+ + + P+S S +DF++ L +D R S
Sbjct: 197 TVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSA 256
Query: 286 EDLFSHPY 293
L H +
Sbjct: 257 LQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 7e-26
Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 40/215 (18%)
Query: 115 VYIILEYCDGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+++EY DL +R E+ L E Q + ++R L+ + ++ N + H DLKP N+LI
Sbjct: 74 FVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI 132
Query: 174 -KNNTLKLADFGFAQFLAPNDQGDSIQGSP-----LYMAPEILAGSP-YNAKADLWSLGV 226
+ LK+ADFG A+ + + S Y APE+L G+ Y+ DLW++G
Sbjct: 133 SADGVLKIADFGLAR---LFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGC 189
Query: 227 LVFEALFGHAPYA--------SCNLSQLRAQALSSAP----------ITIPPN------- 261
+ E L G + + L + P IT P +
Sbjct: 190 IFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEE 249
Query: 262 ---SLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
SP+ +D L LL DP +R+S + HPY
Sbjct: 250 IFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 8e-26
Identities = 53/154 (34%), Positives = 83/154 (53%), Gaps = 11/154 (7%)
Query: 149 LVLALKFLREN-NVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQ-GSPLYM 205
+V AL++L +V H D+KP N+LI +N +KL DFG + +L + +I G YM
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV-DSVAKTIDAGCKPYM 170
Query: 206 APEILAG----SPYNAKADLWSLGVLVFEALFGHAPYASCN--LSQLRAQALSSAPITIP 259
APE + Y+ K+D+WSLG+ + E G PY S QL+ Q + +P
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK-QVVEEPSPQLP 229
Query: 260 PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
SP+ DF+++ L+K+ R +Y +L HP+
Sbjct: 230 AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPF 263
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 1e-25
Identities = 59/186 (31%), Positives = 104/186 (55%), Gaps = 12/186 (6%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
+++++E+ +GG L + +H +++E Q ++ AL L V H D+K +IL+
Sbjct: 92 LWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLT 150
Query: 175 NN-TLKLADFGF-AQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
++ +KL+DFGF AQ + S+ G+P +MAPE+++ PY + D+WSLG++V E +
Sbjct: 151 HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 210
Query: 233 FGHAPYASCNLSQLRAQALSSAPITIPP-----NSLSPDCMDFLSRLLQKDPMRRISYED 287
G PY ++ +A+ +PP + +SP FL RLL +DP +R + +
Sbjct: 211 DGEPPY----FNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAE 266
Query: 288 LFSHPY 293
L HP+
Sbjct: 267 LLKHPF 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-25
Identities = 65/186 (34%), Positives = 106/186 (56%), Gaps = 9/186 (4%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLS----EFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 170
+ ++L+Y + GDL I+S K + E + Q++LA+ + ++ H D+K N
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN 173
Query: 171 ILIKNNTL-KLADFGFAQFLA---PNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGV 226
IL+ +N L KL DFGF++ A +D G + G+P Y+APEI PY+ KAD++SLGV
Sbjct: 174 ILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGV 233
Query: 227 LVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYE 286
L++E L P+ N+ ++ + L+ +PP S+SP+ + ++ LL DP RR S
Sbjct: 234 LLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPP-SISPEMQEIVTALLSSDPKRRPSSS 292
Query: 287 DLFSHP 292
L + P
Sbjct: 293 KLLNMP 298
|
Length = 496 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 63/188 (33%), Positives = 102/188 (54%), Gaps = 9/188 (4%)
Query: 115 VYIILEYCDGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
++I++E+C GG + + + E+ L+E Q + +Q + AL +L EN + H DLK NIL
Sbjct: 77 LWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF 136
Query: 174 K-NNTLKLADFGF-AQFLAPNDQGDSIQGSPLYMAPEIL-----AGSPYNAKADLWSLGV 226
+ +KLADFG A+ + DS G+P +MAPE++ PY+ KAD+WSLG+
Sbjct: 137 TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGI 196
Query: 227 LVFEALFGHAPYASCNLSQLRAQALSSAPITIP-PNSLSPDCMDFLSRLLQKDPMRRISY 285
+ E P+ N ++ + S P T+ P+ S + DFL + L+K+ R +
Sbjct: 197 TLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTT 256
Query: 286 EDLFSHPY 293
L HP+
Sbjct: 257 TQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 66/193 (34%), Positives = 94/193 (48%), Gaps = 17/193 (8%)
Query: 114 YVYIILEYCDGG---DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 170
++I++EYC GG D+ R LSE Q R+ + L +L E H D+K N
Sbjct: 74 KLWIVMEYCGGGSLQDIYQVTRGP--LSELQIAYVCRETLKGLAYLHETGKIHRDIKGAN 131
Query: 171 ILI-KNNTLKLADFGF-AQFLAPNDQGDSIQGSPLYMAPEILA---GSPYNAKADLWSLG 225
IL+ ++ +KLADFG AQ A + S G+P +MAPE+ A Y+ K D+W+LG
Sbjct: 132 ILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALG 191
Query: 226 VLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP-----NSLSPDCMDFLSRLLQKDPM 280
+ E P +L +RA L S PP SP DF+ + L KDP
Sbjct: 192 ITAIELAELQPPMF--DLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPK 249
Query: 281 RRISYEDLFSHPY 293
+R + L HP+
Sbjct: 250 KRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 52/220 (23%), Positives = 101/220 (45%), Gaps = 39/220 (17%)
Query: 112 PRYVYIILEYCDGGDLCSFI--RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 169
Y+ ++++YC GG+L + + + LSE + + +++LAL++L + + DLKP+
Sbjct: 73 ETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPE 132
Query: 170 NILIKNNT-LKLADFGFAQFLAPNDQGDSIQGSPL------------------------- 203
NIL+ + + L+DF ++ S
Sbjct: 133 NILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSF 192
Query: 204 -----YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITI 258
Y+APE+++G + + D W+LG+L++E L+G P+ N + + L +T
Sbjct: 193 VGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKK-EVTF 251
Query: 259 PPN-SLSPDCMDFLSRLLQKDPMRRISY----EDLFSHPY 293
P + +S D + +LL KDP +R+ ++ HP+
Sbjct: 252 PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 66/213 (30%), Positives = 98/213 (46%), Gaps = 17/213 (7%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
++ ++E+ GGDL ++ KL E + + ++ LAL FL E + + DLK N+
Sbjct: 68 ESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNV 127
Query: 172 LIKNNT-LKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVF 229
L+ +KL D+G + + P D + G+P Y+APEIL G Y D W+LGVL+F
Sbjct: 128 LLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMF 187
Query: 230 EALFGHAPY--------ASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281
E + G +P+ N Q + I I P SLS L L KDP
Sbjct: 188 EMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRI-PRSLSVKASSVLKGFLNKDPKE 246
Query: 282 RI------SYEDLFSHPYPDLIHAPCAESHQTA 308
R+ + D+ SHP+ I E Q
Sbjct: 247 RLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVL 279
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 54/152 (35%), Positives = 78/152 (51%), Gaps = 8/152 (5%)
Query: 150 VLALKFLREN-NVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAP 207
V AL +L+E V H D+KP NIL+ + +KL DFG + L + G YMAP
Sbjct: 124 VKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAP 183
Query: 208 EILAGSP----YNAKADLWSLGVLVFEALFGHAPYASCNLS-QLRAQALSSAPITIPPN- 261
E + Y+ +AD+WSLG+ + E G PY +C ++ + L P ++PPN
Sbjct: 184 ERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNE 243
Query: 262 SLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
SPD F+ L KD +R Y +L HP+
Sbjct: 244 GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 60/185 (32%), Positives = 97/185 (52%), Gaps = 11/185 (5%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
++ ++EY +GGDL I+S K + + +++ L+FL + + DLK NIL+
Sbjct: 71 LFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD 130
Query: 174 KNNTLKLADFGFAQFLAPNDQGDS----IQGSPLYMAPEILAGSPYNAKADLWSLGVLVF 229
+ +K+ADFG + N GD+ G+P Y+APEIL G YN D WS GVL++
Sbjct: 131 TDGHIKIADFGMCK---ENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLY 187
Query: 230 EALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYE-DL 288
E L G +P+ + +L P P L+ + D L +L ++P RR+ + D+
Sbjct: 188 EMLIGQSPFHGHDEEELFQSIRMDNPCY--PRWLTREAKDILVKLFVREPERRLGVKGDI 245
Query: 289 FSHPY 293
HP+
Sbjct: 246 RQHPF 250
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-25
Identities = 57/188 (30%), Positives = 91/188 (48%), Gaps = 15/188 (7%)
Query: 111 RPRYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 169
+ +YI+ EY GGDL F+R H EKL+ Q Q+ +++L N H DL +
Sbjct: 72 QGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAAR 131
Query: 170 NILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPYNAKADLWSLG 225
N L+ +N +K++DFG ++ + +D G L +MAPE L + +K+D+WS G
Sbjct: 132 NCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFG 191
Query: 226 VLVFEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL----QKDPM 280
VL++E G PY + ++ + P N C D L L+ DP
Sbjct: 192 VLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPEN-----CPDELYELMLQCWAYDPE 246
Query: 281 RRISYEDL 288
R ++ +L
Sbjct: 247 DRPTFSEL 254
|
Length = 258 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 8e-25
Identities = 57/186 (30%), Positives = 83/186 (44%), Gaps = 10/186 (5%)
Query: 117 IILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN- 175
+ +E+ GG + + + E + QL+ L +L EN + H D+K N+LI +
Sbjct: 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDST 139
Query: 176 -NTLKLADFGFAQFLAPNDQG-DSIQGSPL----YMAPEILAGSPYNAKADLWSLGVLVF 229
L++ADFG A LA G QG L +MAPE+L G Y D+WS+G ++
Sbjct: 140 GQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVII 199
Query: 230 EALFGHAPYASCNLSQLRAQALSSAPITIPPN---SLSPDCMDFLSRLLQKDPMRRISYE 286
E P+ + S A A T P+ LSP D R L+ P R
Sbjct: 200 EMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSR 259
Query: 287 DLFSHP 292
+L HP
Sbjct: 260 ELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 8e-25
Identities = 53/185 (28%), Positives = 100/185 (54%), Gaps = 8/185 (4%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
+Y +L+Y +GG+L ++ E + + + ++ AL +L N+ + DLKP+NIL+
Sbjct: 71 LYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLD 130
Query: 175 NNT-LKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
+ + L DFG + + + + G+P Y+APE+L PY+ D W LG +++E L
Sbjct: 131 SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEML 190
Query: 233 FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI----SYEDL 288
+G P+ S + +++ L+ P+ + PN +S L LLQKD +R+ + ++
Sbjct: 191 YGLPPFYSRDTAEMYDNILNK-PLRLKPN-ISVSARHLLEGLLQKDRTKRLGAKDDFLEI 248
Query: 289 FSHPY 293
+H +
Sbjct: 249 KNHVF 253
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 31/208 (14%)
Query: 115 VYIILEYCDGGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+ ++ E+ D DL +++ K L + +RQL+ + FL + + H DLKPQNIL
Sbjct: 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNIL 139
Query: 173 IKNN-TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEA 231
+ ++ +K+ADFG A+ + S+ + Y APE+L S Y D+WS+G + E
Sbjct: 140 VTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAE- 198
Query: 232 LFGHAP--YASCNLSQLR--------------AQALSSAPITIPPNS----------LSP 265
LF P + QL + +S + P + +
Sbjct: 199 LFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICE 258
Query: 266 DCMDFLSRLLQKDPMRRISYEDLFSHPY 293
+ +D L ++L +P +RIS + HPY
Sbjct: 259 EGLDLLKKMLTFNPHKRISAFEALQHPY 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 72/230 (31%), Positives = 108/230 (46%), Gaps = 47/230 (20%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
+Y++ EY + DL + IR L + + + QL+ ALK++ NV H DLKP NIL+
Sbjct: 84 IYLVFEYMET-DLHAVIR-ANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLN 141
Query: 175 NN-TLKLADFGFAQFLAPNDQGDSIQGSPL---------YMAPEILAGSPYNAKA-DLWS 223
++ +KLADFG A+ L+ + + +P+ Y APEIL GS K D+WS
Sbjct: 142 SDCRVKLADFGLARSLS---ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWS 198
Query: 224 LGVLVFEALFGHAPYA-SCNLSQLR----------------------AQALSSAPITIPP 260
+G ++ E L G + + L+QL A L S P + P
Sbjct: 199 VGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLP-SRPR 257
Query: 261 NSL-------SPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAE 303
L S D +D L +LL +P +R++ E+ HPY H P E
Sbjct: 258 KPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDE 307
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 64/223 (28%), Positives = 96/223 (43%), Gaps = 49/223 (21%)
Query: 111 RPRYVYIILEYCDGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 169
+Y++ E+ D DL I+ ++ L E + ++ QL+ L F + + H DLKP+
Sbjct: 69 HKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPE 127
Query: 170 NILIKNN-TLKLADFGFAQFLAPNDQGDSIQGSPL--------YMAPEILAGSP-YNAKA 219
N+LI LKLADFG A+ P Y APE+L G Y+
Sbjct: 128 NLLINTEGVLKLADFGLARSFGS-------PVRPYTHYVVTRWYRAPELLLGDKGYSTPV 180
Query: 220 DLWSLGVLVFEALFGHAPYASCN-LSQL----------------------RAQALS---S 253
D+WS+G + E L + + + QL R S
Sbjct: 181 DIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKK 240
Query: 254 APITIP---PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
A + +P PN SP +D LS++L DP +RI+ E +HPY
Sbjct: 241 AGMPLPKLFPN-ASPQALDLLSQMLHYDPHKRITAEQALAHPY 282
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-24
Identities = 58/189 (30%), Positives = 102/189 (53%), Gaps = 8/189 (4%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+Y++ +Y GG+L ++ + SE + + ++ +LVLAL+ L + ++ + DLKP+NI
Sbjct: 68 DSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENI 127
Query: 172 LIK-NNTLKLADFGFAQF-LAPNDQGDSIQGSPLYMAPEILAGSP-YNAKADLWSLGVLV 228
L+ + L DFG ++ L N ++ G+ Y+APE+L Y D WSLGVLV
Sbjct: 128 LLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLV 187
Query: 229 FEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI----S 284
FE G +P+ + + Q+ + ++ + P N LS + F+ LL ++P R+
Sbjct: 188 FEMCCGWSPFYAEDTQQMY-RNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRD 246
Query: 285 YEDLFSHPY 293
+L HP+
Sbjct: 247 AVELKEHPF 255
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 52/185 (28%), Positives = 95/185 (51%), Gaps = 7/185 (3%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFV---RQLVLALKFLRENNVCHFDLKPQNI 171
+ I +EY +GG L I +K F+ + + Q+V A+ ++ + + H D+K NI
Sbjct: 74 LLIEMEYANGGTLYDKI-VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNI 132
Query: 172 -LIKNNTLKLADFGFAQFLAPNDQG-DSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVF 229
L K +KL DFG ++ L +++ G+P YM+PE+ G YN K+D+W+LG +++
Sbjct: 133 FLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLY 192
Query: 230 EALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLF 289
E L + + N L + + T + S + + + LLQ+DP +R + +++
Sbjct: 193 ELLTLKRTFDATNPLNLVVKIVQGN-YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVL 251
Query: 290 SHPYP 294
P
Sbjct: 252 DQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 56/179 (31%), Positives = 96/179 (53%), Gaps = 6/179 (3%)
Query: 115 VYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+YI++EY +GGDL S++R + KLS F Q+ +++L N H DL +N L+
Sbjct: 76 LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV 135
Query: 174 -KNNTLKLADFGFAQFLAPNDQGDSIQG-SPL-YMAPEILAGSPYNAKADLWSLGVLVFE 230
+N +K++DFG ++ L +D G P+ +MAPE L + +K+D+WS GVL++E
Sbjct: 136 GENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWE 195
Query: 231 AL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDL 288
G PY + ++ + + PPN P+ D + + +DP R ++ +L
Sbjct: 196 IFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNC-PPELYDLMLQCWAEDPEDRPTFSEL 253
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 52/180 (28%), Positives = 91/180 (50%), Gaps = 7/180 (3%)
Query: 115 VYIILEYCDGGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+ I++EY GGDL ++R + LS F Q+ +++L N H DL +N L
Sbjct: 76 LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCL 135
Query: 173 I-KNNTLKLADFGFAQFLAPNDQGDSIQG-SPL-YMAPEILAGSPYNAKADLWSLGVLVF 229
+ +N +K++DFG ++ L +D G P+ +MAPE L + +K+D+WS GVL++
Sbjct: 136 VGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLW 195
Query: 230 EAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDL 288
E G PY + +++ + PPN P+ + + +DP R ++ +L
Sbjct: 196 EIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNC-PPELYKLMLQCWAEDPEDRPTFSEL 254
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 36/218 (16%)
Query: 110 KRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 169
+R R ++++ EYCD L ++ + E ++ + Q + A+ F ++N H D+KP+
Sbjct: 70 RRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPE 129
Query: 170 NILI-KNNTLKLADFGFAQFLAPNDQG--DSIQGSPLYMAPEILAG-SPYNAKADLWSLG 225
NILI K +KL DFGFA+ L D + + Y APE+L G + Y D+W++G
Sbjct: 130 NILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGDTQYGPPVDVWAIG 188
Query: 226 VLVFEALFGHA--PYASCNLSQL-------------------RAQALSSAPITIPPN--- 261
+ E L G P S ++ QL Q I P
Sbjct: 189 CVFAELLTGQPLWPGKS-DVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREP 247
Query: 262 ------SLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
++S + FL LQ DP R+S E+L HPY
Sbjct: 248 LESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 55/177 (31%), Positives = 97/177 (54%), Gaps = 4/177 (2%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
+Y +L+Y +GG+L ++ E + + + ++ AL +L N+ + DLKP+NIL+
Sbjct: 71 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD 130
Query: 175 NNT-LKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
+ + L DFG + + N + G+P Y+APE+L PY+ D W LG +++E L
Sbjct: 131 SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 190
Query: 233 FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLF 289
+G P+ S N +++ L+ P+ + PN ++ L LLQKD +R+ +D F
Sbjct: 191 YGLPPFYSRNTAEMYDNILNK-PLQLKPN-ITNSARHLLEGLLQKDRTKRLGAKDDF 245
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 14/222 (6%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+Y +L+Y +GG+L ++ E + + + ++ A+ +L N+ + DLKP+NI
Sbjct: 68 AEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENI 127
Query: 172 LIK-NNTLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVF 229
L+ + L DFG + + P + + G+P Y+APE+L PY+ D W LG +++
Sbjct: 128 LLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLY 187
Query: 230 EALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI----SY 285
E L+G P+ S ++SQ+ L P+ +P C D L LL KD RR+ +
Sbjct: 188 EMLYGLPPFYSRDVSQMYDNILHK-PLQLPGGKTVAAC-DLLVGLLHKDQRRRLGAKADF 245
Query: 286 EDLFSHPY------PDLIHAPCAESHQTAIRIVTDAIHHDRE 321
++ +H + DL H + + D H D E
Sbjct: 246 LEIKNHVFFSPINWDDLYHKRITPPYNPNVAGPADLRHFDPE 287
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-24
Identities = 63/195 (32%), Positives = 96/195 (49%), Gaps = 17/195 (8%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
++ ++EY +GGDL ++ KL E + + ++ LAL +L E + + DLK N+L+
Sbjct: 71 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD 130
Query: 175 NNT-LKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
+ +KL D+G + L P D + G+P Y+APEIL G Y D W+LGVL+FE +
Sbjct: 131 SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 190
Query: 233 FGHAPY--------ASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI- 283
G +P+ N Q + I I P SLS L L KDP R+
Sbjct: 191 AGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI-PRSLSVKAASVLKSFLNKDPKERLG 249
Query: 284 -----SYEDLFSHPY 293
+ D+ HP+
Sbjct: 250 CHPQTGFADIQGHPF 264
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-24
Identities = 58/193 (30%), Positives = 106/193 (54%), Gaps = 12/193 (6%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
+++++E+ +GG L + +H +++E Q ++ AL +L V H D+K +IL+
Sbjct: 94 LWVVMEFLEGGALTDIV-THTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT 152
Query: 175 NN-TLKLADFGF-AQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
++ +KL+DFGF AQ + S+ G+P +MAPE+++ PY + D+WSLG++V E +
Sbjct: 153 SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMI 212
Query: 233 FGHAPYASCNLSQLRAQALSSAPITIPP-----NSLSPDCMDFLSRLLQKDPMRRISYED 287
G PY ++ QA+ +PP + +S FL +L ++P +R + ++
Sbjct: 213 DGEPPY----FNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQE 268
Query: 288 LFSHPYPDLIHAP 300
L HP+ L P
Sbjct: 269 LLQHPFLKLAGPP 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 59/194 (30%), Positives = 108/194 (55%), Gaps = 18/194 (9%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
+++IL+Y +GG+L + + E+ E + Q + ++VLAL+ L + + + D+K +NIL+
Sbjct: 80 LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD 139
Query: 175 NNT-LKLADFGFA-QFLA-PNDQGDSIQGSPLYMAPEILAG--SPYNAKADLWSLGVLVF 229
+N + L DFG + +F ++ S G+ YMAP+I+ G ++ D WS+GVL++
Sbjct: 140 SNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMY 199
Query: 230 EALFGHAPYA----SCNLSQLRAQALSSAPITIP-PNSLSPDCMDFLSRLLQKDPMRRI- 283
E L G +P+ + +++ + L S P P P +S D + RLL KDP +R+
Sbjct: 200 ELLTGASPFTVDGEKNSQAEISRRILKSEP---PYPQEMSALAKDIIQRLLMKDPKKRLG 256
Query: 284 ----SYEDLFSHPY 293
+++ HP+
Sbjct: 257 CGPSDADEIKKHPF 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 5e-24
Identities = 52/197 (26%), Positives = 93/197 (47%), Gaps = 28/197 (14%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+ +I++Y GDL ++ KLSE + ++ +RQLV AL L ++N+ H D+K +N+
Sbjct: 81 LKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENV 140
Query: 172 L--IKNNTLKLADFGFAQFLAPNDQGDSIQGSPL-------YMAPEILAGSPYNAKADLW 222
L + + L D+G + I G+P Y +PE + G Y+ D W
Sbjct: 141 LYDRAKDRIYLCDYGLCK----------IIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWW 190
Query: 223 SLGVLVFEALFGHAPYAS-----CNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQK 277
++GVL +E L G P+ +L L + ++S + DF+ +L+
Sbjct: 191 AVGVLTYELLTGKHPFKEDEDEELDLESLL--KRQQKKLP-FIKNVSKNANDFVQSMLKY 247
Query: 278 DPMRR-ISYEDLFSHPY 293
+ R +Y ++ HP+
Sbjct: 248 NINYRLTNYNEIIKHPF 264
|
Length = 267 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 7e-24
Identities = 61/191 (31%), Positives = 98/191 (51%), Gaps = 13/191 (6%)
Query: 115 VYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+Y+++EY GGDL S + +E + E Q ++ +LVLA+ + + H D+KP+N+LI
Sbjct: 76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI 135
Query: 174 -KNNTLKLADFGFAQFLAPNDQGDSIQ--GSPLYMAPEIL------AGSPYNAKADLWSL 224
+ +KLADFG A L N +S G+P Y+APE+L Y + D WSL
Sbjct: 136 DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSL 195
Query: 225 GVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSL--SPDCMDFLSRLLQKDPMRR 282
GV+ +E ++G +P+ ++ ++ P S D +D + LL R
Sbjct: 196 GVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKER 254
Query: 283 ISYEDLFSHPY 293
+ YE L HP+
Sbjct: 255 LGYEGLCCHPF 265
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 57/227 (25%), Positives = 104/227 (45%), Gaps = 46/227 (20%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
Y+Y+I+EY GGD+ + + + +E + + ++ + +LA+ + + H D+KP N+
Sbjct: 73 ENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNL 132
Query: 172 LIKNNT-LKLADFG------------FAQFLA-------------PNDQGDSIQ------ 199
L+ +KL+DFG F + L+ P +
Sbjct: 133 LLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNR 192
Query: 200 --------GSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQAL 251
G+P Y+APE+ + YN + D WSLGV+++E L G+ P+ S N + + +
Sbjct: 193 RALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKII 252
Query: 252 S-SAPITIPPN-SLSPDCMDFLSRLLQKDPMRRI---SYEDLFSHPY 293
+ + P LSP+ D + RL + RR+ ++ SHP+
Sbjct: 253 NWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPF 298
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 2e-23
Identities = 60/231 (25%), Positives = 117/231 (50%), Gaps = 15/231 (6%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+++ ++E+ +GGDL I+ + ++ + ++V L+FL + + DLK N+++
Sbjct: 70 HLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML 129
Query: 174 -KNNTLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEA 231
++ +K+ADFG + + +++ + G+P Y+APEIL G Y D WS GVL++E
Sbjct: 130 DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEM 189
Query: 232 LFGHAPYASCNLSQLRAQALSSAPITIP--PNSLSPDCMDFLSRLLQKDPMRRISYE-DL 288
L G +P+ + +L S + P P ++ + D L +L ++DP RR+ ++
Sbjct: 190 LIGQSPFHGDDEDEL----FESIRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVGNI 245
Query: 289 FSHPYPDLIHAPCAESHQT------AIRIVTDAIHHDRENNSRRAFSLYCE 333
HP+ I+ E + ++ +D + DRE S + Y +
Sbjct: 246 RGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDREFLSEKPRLSYSD 296
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 3e-23
Identities = 60/190 (31%), Positives = 95/190 (50%), Gaps = 10/190 (5%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
P ++ ++E+ +GGDL I+ + E + + + ++ AL FL + + + DLK N+
Sbjct: 68 PDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNV 127
Query: 172 LI-KNNTLKLADFGFAQFLAPNDQGDS-IQGSPLYMAPEILAGSPYNAKADLWSLGVLVF 229
L+ KLADFG + N + S G+P Y+APEIL Y D W++GVL++
Sbjct: 128 LLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLY 187
Query: 230 EALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDL- 288
E L GHAP+ + N L L+ + P LS D +D L + K+P R+ L
Sbjct: 188 EMLCGHAPFEAENEDDLFEAILNDE--VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLG 245
Query: 289 -----FSHPY 293
HP+
Sbjct: 246 GEEAILRHPF 255
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 6e-23
Identities = 68/231 (29%), Positives = 99/231 (42%), Gaps = 49/231 (21%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
Y+Y L D L IRS + L++ Q F+ Q++ LK++ NV H DLKP N+L+
Sbjct: 82 YLYEELMEAD---LHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV 138
Query: 174 KNN-TLKLADFGFAQFLAPNDQGDSIQGSPL---------YMAPEI-LAGSPYNAKADLW 222
+ LK+ DFG A+ + N + + Y APEI L+ Y D+W
Sbjct: 139 NADCELKICDFGLARGFSEN----PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVW 194
Query: 223 SLGVLVFEALFGHAPY--ASCNLSQL---------------------RAQALSSAPITIP 259
S+G ++ E L G P + QL +AQ + IP
Sbjct: 195 SVGCILAE-LLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIP 253
Query: 260 PNSL-------SPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAE 303
+P +D L +LL DP +RIS E+ HPY + H P E
Sbjct: 254 KKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDE 304
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 9e-23
Identities = 62/224 (27%), Positives = 99/224 (44%), Gaps = 46/224 (20%)
Query: 110 KRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 169
+R +Y++ EY + L S L + ++ QL+ A+ + +N+ H D+KP+
Sbjct: 70 RRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPE 129
Query: 170 NILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPL--------YMAPEILAGSP-YNAKA 219
NIL+ + LKL DFGFA+ L SPL Y APE+L G Y
Sbjct: 130 NILVSESGVLKLCDFGFARALRARPA------SPLTDYVATRWYRAPELLVGDTNYGKPV 183
Query: 220 DLWSLGVLVFEALFGHAPYA-SCNLSQL------------RAQALSSA------------ 254
D+W++G ++ E L G + ++ QL Q L S+
Sbjct: 184 DVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEP 243
Query: 255 --PITI---PPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
P ++ P +S +DFL L+ DP R++ ++L HPY
Sbjct: 244 SQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 1e-22
Identities = 55/174 (31%), Positives = 98/174 (56%), Gaps = 5/174 (2%)
Query: 110 KRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 169
K Y+Y++LE+ GG+ +F+R +++ + Q+VL ++L+ N+ + DLKP+
Sbjct: 101 KDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPE 160
Query: 170 NILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLV 228
N+L+ K+ +K+ DFGFA+ + + + ++ G+P Y+APEIL + AD W+LG+ +
Sbjct: 161 NLLLDKDGFIKMTDFGFAKVV--DTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFI 218
Query: 229 FEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRR 282
+E L G P+ + N L Q + I P L +C + +LL D +R
Sbjct: 219 YEILVGCPPFYA-NEPLLIYQKILEGIIYF-PKFLDNNCKHLMKKLLSHDLTKR 270
|
Length = 340 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-22
Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 17/222 (7%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
++ ++EY +GGDL I+ K E + + + ++ LAL FL + V + DLK NIL+
Sbjct: 71 LFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD 130
Query: 174 KNNTLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
KLADFG + + + G+P Y+APEIL Y D W+LGVL++E +
Sbjct: 131 AEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMM 190
Query: 233 FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI------SYE 286
G P+ + N L L + P LS + + L + K+P +R+ E
Sbjct: 191 AGQPPFEADNEDDLFESILHDD--VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGE 248
Query: 287 D-LFSHPYPDLIHAPCAESHQT------AIRIVTDAIHHDRE 321
D + HP+ I E + I+ D + D++
Sbjct: 249 DAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQD 290
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-22
Identities = 68/210 (32%), Positives = 95/210 (45%), Gaps = 34/210 (16%)
Query: 117 IILEYCDGGDLCSFIRSHEK---LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
++ EY D DL ++ +H L + F QL+ + F EN V H DLKPQN+LI
Sbjct: 75 LVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI 133
Query: 174 -KNNTLKLADFGFAQ-FLAPNDQGDSIQGSPLYMAPEILAGS-PYNAKADLWSLGVLVFE 230
K LKLADFG A+ F P + + + Y AP++L GS Y+ D+WS+G ++ E
Sbjct: 134 NKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAE 193
Query: 231 ALFGHAPYA-SCNLSQLRA-------------QALSSAP---ITIPPN----------SL 263
+ G + + N QL +S P T P
Sbjct: 194 MITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHA 253
Query: 264 SPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
P +D L RLLQ +P RIS D HP+
Sbjct: 254 DPLGIDLLHRLLQLNPELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 2e-22
Identities = 54/185 (29%), Positives = 99/185 (53%), Gaps = 10/185 (5%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
VY +LE+ GG+L + +R + + + +LVLA ++L ++ + DLKP+N+L+
Sbjct: 93 VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLD 152
Query: 175 NN-TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF 233
N +K+ DFGFA+ + D+ ++ G+P Y+APE++ + D W++GVL++E +
Sbjct: 153 NKGHVKVTDFGFAKKVP--DRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIA 210
Query: 234 GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI-----SYEDL 288
G+ P+ ++ + L+ PN D + LLQ D +R+ D+
Sbjct: 211 GYPPFFDDTPFRIYEKILAGR--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADV 268
Query: 289 FSHPY 293
+HPY
Sbjct: 269 KNHPY 273
|
Length = 329 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 2e-22
Identities = 76/234 (32%), Positives = 110/234 (47%), Gaps = 41/234 (17%)
Query: 106 PEGRKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFD 165
P R+ VYI+ E D DL IRS + LS+ CQ F+ QL+ LK++ NV H D
Sbjct: 75 PPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRD 133
Query: 166 LKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQG---SPLYMAPE-ILAGSPYNAKAD 220
LKP N+L+ N LK+ DFG A+ +++GD + + Y APE +L S Y D
Sbjct: 134 LKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAID 191
Query: 221 LWSLGVLVFEALFGHAPY--ASCNLSQLR----------------------AQALSSAPI 256
+WS+G +F L G P + QL+ + + S P
Sbjct: 192 VWSVGC-IFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPY 250
Query: 257 TIPPNSL-------SPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAE 303
T P S +P +D L ++L DP +RI+ E+ +HPY +H P E
Sbjct: 251 T-PRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDE 303
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 5e-22
Identities = 57/203 (28%), Positives = 104/203 (51%), Gaps = 23/203 (11%)
Query: 113 RYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
R++ +++EY +GGD + +++ L + + + VLAL++L + H DLKP N+L
Sbjct: 74 RHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLL 133
Query: 173 IKN-NTLKLADFGFAQF----LAPN-----DQGDSIQ-------GSPLYMAPEILAGSPY 215
I + +KL DFG ++ L N + D+ + G+P Y+APE++ Y
Sbjct: 134 ITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY 193
Query: 216 NAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP--NSLSPDCMDFLSR 273
D W++G++++E L G P+ +L Q +S I P +L D D +SR
Sbjct: 194 GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD-IEWPEGDEALPADAQDLISR 252
Query: 274 LLQKDPMRRI---SYEDLFSHPY 293
LL+++P+ R+ ++ H +
Sbjct: 253 LLRQNPLERLGTGGAFEVKQHRF 275
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 5e-22
Identities = 59/194 (30%), Positives = 92/194 (47%), Gaps = 16/194 (8%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKL----SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 170
+ I +EYC+GG L S + +K E + ++ L +L + H D+KP N
Sbjct: 76 IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSN 135
Query: 171 ILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVF 229
IL+ + +KL DFG + L N + G+ YMAPE + G PY+ +D+WSLG+ +
Sbjct: 136 ILLTRKGQVKLCDFGVSGELV-NSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLL 194
Query: 230 EALFGHAPYASCNLSQLRAQALSSAPITIPPNSL----------SPDCMDFLSRLLQKDP 279
E P+ L L S + +P L S + DF+ + L+KDP
Sbjct: 195 EVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDP 254
Query: 280 MRRISYEDLFSHPY 293
RR + D+ HP+
Sbjct: 255 TRRPTPWDMLEHPW 268
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 5e-22
Identities = 71/232 (30%), Positives = 101/232 (43%), Gaps = 53/232 (22%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
VYI+ E + DL I++ + LS Q F+ Q++ LK++ NV H DLKP N+L+
Sbjct: 83 VYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 140
Query: 175 NNT-LKLADFGFAQFLAPNDQGDSIQGSPL--------YMAPEI-LAGSPYNAKADLWSL 224
N LK+ DFG A+ P L Y APEI L Y D+WS+
Sbjct: 141 TNCDLKICDFGLARIADPE----HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSV 196
Query: 225 GVLVFE-----ALFGHAPYASCNLSQL---------------------RAQA-LSSAPIT 257
G ++ E LF Y L QL RA+ + S P
Sbjct: 197 GCILAEMLSNRPLFPGKDY----LHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFK 252
Query: 258 --IPPNSL----SPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAE 303
+P N L P +D L ++L +P +RI+ E+ +HPY + H P E
Sbjct: 253 PKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDE 304
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 5e-22
Identities = 56/181 (30%), Positives = 93/181 (51%), Gaps = 5/181 (2%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
++YI++EYCDGGDL I+ E Q+ Q+ L ++ + E V H D+K +NI
Sbjct: 72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNI 131
Query: 172 -LIKNNTLKLADFGFAQFLA-PNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVF 229
L +N +KL DFG A+ L P + G+P Y+ PEI PYN K+D+WSLG +++
Sbjct: 132 FLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILY 191
Query: 230 EALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLF 289
E P+ + + L + + P+ S + + ++ +++P R S +
Sbjct: 192 ELCTLKHPFQANSWKNLILK-VCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTIL 250
Query: 290 S 290
S
Sbjct: 251 S 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 8e-22
Identities = 59/224 (26%), Positives = 96/224 (42%), Gaps = 61/224 (27%)
Query: 116 YIILEYCDGGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
Y + EY +G +L ++ + SE + + Q++ L + ++ H DLKP+N+L+
Sbjct: 74 YFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV 132
Query: 174 KNN-TLKLADFGFAQFLAPNDQGDSIQGSP---------LYMAPEILAGSP-YNAKADLW 222
+K+ADFG A+ I+ P Y APEIL S Y++ D+W
Sbjct: 133 SGPEVVKIADFGLAR---------EIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIW 183
Query: 223 SLGVLVFE-----ALFGHAPYASCNLSQL----------------RAQALSSA-----PI 256
+LG ++ E LF P +S + QL L+S P
Sbjct: 184 ALGCIMAELYTLRPLF---PGSS-EIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQ 239
Query: 257 TIP-------PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
P PN+ SP+ +D + +L+ DP +R + HPY
Sbjct: 240 FAPTSLHQLIPNA-SPEAIDLIKDMLRWDPKKRPTASQALQHPY 282
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 8e-22
Identities = 63/201 (31%), Positives = 104/201 (51%), Gaps = 20/201 (9%)
Query: 103 LRAPEGRKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVC 162
LR PE +K + I +EY GG + ++++ L+E +++ RQ++ + +L N +
Sbjct: 73 LRDPEEKK----LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIV 128
Query: 163 HFDLKPQNILIKN-NTLKLADFGFA---QFLAPNDQG-DSIQGSPLYMAPEILAGSPYNA 217
H D+K NIL + +KL DFG + Q + + G S+ G+P +M+PE+++G Y
Sbjct: 129 HRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGR 188
Query: 218 KADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPD-----CMDFLS 272
KAD+WS+ V E L P+A + A A T P + PD C DFL
Sbjct: 189 KADVWSVACTVVEMLTEKPPWA-----EYEAMAAIFKIATQPTKPMLPDGVSDACRDFLK 243
Query: 273 RLLQKDPMRRISYEDLFSHPY 293
++ ++ RR + E L HP+
Sbjct: 244 QIFVEEK-RRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 9e-22
Identities = 51/195 (26%), Positives = 89/195 (45%), Gaps = 23/195 (11%)
Query: 115 VYIILEYCDGGDLCSFIRSH------EKLSEFQCQQ---FVRQLVLALKFLRENNVCHFD 165
+Y++LEY +GGDL ++R + S + F Q+ +++L H D
Sbjct: 71 LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRD 130
Query: 166 LKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPYNAKADL 221
L +N L+ ++ +K++DFG ++ + +D G L +MAPE L + +K+D+
Sbjct: 131 LAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDV 190
Query: 222 WSLGVLVFEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL----Q 276
WS GVL++E G PY + ++ + P C D L L+ Q
Sbjct: 191 WSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEY-----CPDELYELMLSCWQ 245
Query: 277 KDPMRRISYEDLFSH 291
DP R ++ +L
Sbjct: 246 LDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-21
Identities = 63/186 (33%), Positives = 94/186 (50%), Gaps = 15/186 (8%)
Query: 116 YIILEYCDG--GDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
++++EYC G D+ + H+K L E + + L +L + H D+K NIL
Sbjct: 91 WLVMEYCLGSASDI---LEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNIL 147
Query: 173 IKNN-TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPE-ILA--GSPYNAKADLWSLGVLV 228
+ T+KLADFG A ++P +S G+P +MAPE ILA Y+ K D+WSLG+
Sbjct: 148 LTEPGTVKLADFGSASLVSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204
Query: 229 FEALFGHAPYASCN-LSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYED 287
E P + N +S L A + +P T+ N S +F+ LQK P R S E+
Sbjct: 205 IELAERKPPLFNMNAMSALYHIAQNDSP-TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEE 263
Query: 288 LFSHPY 293
L H +
Sbjct: 264 LLKHRF 269
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 2e-21
Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 10/184 (5%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
++II+EY GG +R+ EFQ +++++ L +L H D+K N+L+
Sbjct: 77 LWIIMEYLGGGSALDLLRAG-PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS 135
Query: 174 KNNTLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
+ +KLADFG A Q + ++ G+P +MAPE++ S Y++KAD+WSLG+ E
Sbjct: 136 EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELA 195
Query: 233 FGHAPYASCNLSQLRAQALSSAPITIPPN---SLSPDCMDFLSRLLQKDPMRRISYEDLF 289
G P + ++ +R L P PP S +F+ L KDP R + ++L
Sbjct: 196 KGEPP--NSDMHPMR--VLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELL 251
Query: 290 SHPY 293
H +
Sbjct: 252 KHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 58/186 (31%), Positives = 97/186 (52%), Gaps = 9/186 (4%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
+Y+ILEY GG+L + E ++ ++ LAL+ L + + + DLKP+NIL+
Sbjct: 75 LYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD 134
Query: 174 KNNTLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
+KL DFG + + + G+ YMAPEIL S + D WSLG L+++ L
Sbjct: 135 AQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDML 194
Query: 233 FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI-----SYED 287
G P+ + N + + L + +PP L+P+ D L +LL+++P R+ +
Sbjct: 195 TGAPPFTAENRKKTIDKIL-KGKLNLPP-YLTPEARDLLKKLLKRNPSSRLGAGPGDAAE 252
Query: 288 LFSHPY 293
+ SHP+
Sbjct: 253 VQSHPF 258
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 3e-21
Identities = 50/188 (26%), Positives = 96/188 (51%), Gaps = 12/188 (6%)
Query: 117 IILEYCDGGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
+++ +GGDL I + + E + + Q++ L+ L + + + DLKP+N+L+
Sbjct: 70 LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLD 129
Query: 175 NN-TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF 233
++ ++++D G A L + G+P YMAPE+L G Y+ D ++LG ++E +
Sbjct: 130 DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIA 189
Query: 234 GHAPYASCNLSQLRAQALSSAPITIP---PNSLSPDCMDFLSRLLQKDPMRRI-----SY 285
G +P+ ++ + L + + P+ SP+ D LLQKDP +R+ S
Sbjct: 190 GRSPFRQ-RKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSA 248
Query: 286 EDLFSHPY 293
+++ HP
Sbjct: 249 DEVREHPL 256
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 4e-21
Identities = 53/185 (28%), Positives = 99/185 (53%), Gaps = 8/185 (4%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
+Y +L++ +GG+L ++ E + + + ++ AL +L N+ + DLKP+NIL+
Sbjct: 71 LYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLD 130
Query: 175 N-NTLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
+ + L DFG + +A +D + G+P Y+APE++ PY+ D W LG +++E L
Sbjct: 131 SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEML 190
Query: 233 FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLF--- 289
+G P+ +++++ L + P SL+ L LL+KD RR+ ++ F
Sbjct: 191 YGLPPFYCRDVAEMYDNILHKPLVLRPGASLT--AWSILEELLEKDRQRRLGAKEDFLEI 248
Query: 290 -SHPY 293
HP+
Sbjct: 249 QEHPF 253
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 4e-21
Identities = 59/194 (30%), Positives = 101/194 (52%), Gaps = 16/194 (8%)
Query: 113 RYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+ + I +EY GG + ++++ L+E +++ RQ++ + +L N + H D+K NIL
Sbjct: 79 KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANIL 138
Query: 173 IKN-NTLKLADFGFA---QFLAPNDQG-DSIQGSPLYMAPEILAGSPYNAKADLWSLGVL 227
+ +KL DFG + Q + + G S+ G+P +M+PE+++G Y KAD+WSLG
Sbjct: 139 RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCT 198
Query: 228 VFEALFGHAPYASCNLSQLRAQA----LSSAPITIP-PNSLSPDCMDFLSRLLQKDPMRR 282
V E L P+A + A A +++ P P+ +S DFL + + R
Sbjct: 199 VVEMLTEKPPWA-----EYEAMAAIFKIATQPTNPQLPSHISEHARDFLGCIFV-EARHR 252
Query: 283 ISYEDLFSHPYPDL 296
S E+L HP+ L
Sbjct: 253 PSAEELLRHPFAQL 266
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 4e-21
Identities = 49/174 (28%), Positives = 89/174 (51%), Gaps = 6/174 (3%)
Query: 115 VYIILEYCDGGDLCSFIRS----HEKLSEFQCQQFVRQLVLALKFL-RENNVCHFDLKPQ 169
+YI+++ +G L S ++ +E + Q+VLAL++L +E + H DL P
Sbjct: 84 LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPN 143
Query: 170 NILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLV 228
NI++ +++ + + DFG A+ P + S+ G+ LY PEI+ PY KAD+W+ G ++
Sbjct: 144 NIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCIL 203
Query: 229 FEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRR 282
++ P+ S N+ L + + + +P S D D ++ L D R
Sbjct: 204 YQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 7e-21
Identities = 56/193 (29%), Positives = 100/193 (51%), Gaps = 12/193 (6%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+Y+Y+++EY GGDL + + +++ + E + + ++VLAL + H D+KP N+
Sbjct: 115 DKYLYMVMEYMPGGDLVNLMSNYD-IPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNM 173
Query: 172 LI-KNNTLKLADFGFAQFLAPNDQ--GDSIQGSPLYMAPEILAG----SPYNAKADLWSL 224
L+ K+ LKLADFG + N D+ G+P Y++PE+L Y + D WS+
Sbjct: 174 LLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233
Query: 225 GVLVFEALFGHAPYASCNLSQLRAQALS-SAPITIPP-NSLSPDCMDFLSRLLQKDPMR- 281
GV ++E L G P+ + +L ++ + +T P +S D + L +R
Sbjct: 234 GVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRL 293
Query: 282 -RISYEDLFSHPY 293
R +++ SHP+
Sbjct: 294 GRNGVDEIKSHPF 306
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 8e-21
Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 33/211 (15%)
Query: 114 YVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+ ++ E+ + DL I+ L+ + ++ + L++L N + H DLKP N+L
Sbjct: 76 NINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLL 134
Query: 173 I-KNNTLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSP-YNAKADLWSLGVLVF 229
I + LKLADFG A F +PN + + Y APE+L G+ Y D+WS+G +
Sbjct: 135 IASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFA 194
Query: 230 EALFGHAPY--ASCNLSQLR----------------AQAL--SSAPITIPPNSL------ 263
E L P+ ++ QL +L PP L
Sbjct: 195 ELLLR-VPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPA 253
Query: 264 -SPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
S D +D L RLL +P +RI+ HPY
Sbjct: 254 ASDDALDLLQRLLTLNPNKRITARQALEHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 8e-21
Identities = 62/195 (31%), Positives = 99/195 (50%), Gaps = 20/195 (10%)
Query: 115 VYIILEYCDGG---DLCS-FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 170
++++LE C+GG DL F++ E++ E + + ++ L+ L N H D+K N
Sbjct: 95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNN 154
Query: 171 ILIKNN-TLKLADFGF-AQFLAPNDQGDSIQGSPLYMAPEILA-----GSPYNAKADLWS 223
IL+ +KL DFG AQ + + ++ G+P +MAPE++A S Y+A+ D+WS
Sbjct: 155 ILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWS 214
Query: 224 LGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSP-----DCMDFLSRLLQKD 278
LG+ E G P A +L +R AL P PP P + DF+ + L KD
Sbjct: 215 LGITAIELGDGDPPLA--DLHPMR--ALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKD 270
Query: 279 PMRRISYEDLFSHPY 293
+R + DL H +
Sbjct: 271 YEKRPTVSDLLQHVF 285
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 64/226 (28%), Positives = 93/226 (41%), Gaps = 65/226 (28%)
Query: 116 YIILEYCDGGDLCSFIRS--HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
Y++ E+ D DL ++ S L + ++ QL+ + + + V H DLKPQN+LI
Sbjct: 74 YLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI 132
Query: 174 -KNNTLKLADFGFAQFLAPNDQGDSIQGSPL-----------YMAPEILAGSP-YNAKAD 220
+ LKLADFG A+ G P+ Y APEIL GS Y+ D
Sbjct: 133 DREGALKLADFGLARAF----------GVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVD 182
Query: 221 LWSLGVLVFEALFGHAPY--ASCNLSQL-------------------------------R 247
+WS+G +F + P + QL
Sbjct: 183 IWSIGC-IFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWA 241
Query: 248 AQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
Q LS +P +L D +D LS++L DP +RIS + HPY
Sbjct: 242 RQDLSKV---VP--NLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 54/186 (29%), Positives = 92/186 (49%), Gaps = 9/186 (4%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
+Y ++EY +GGDL I+ K E + ++ + L FL + + DLK N+++
Sbjct: 76 LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD 135
Query: 174 KNNTLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
+K+ADFG + + + G+P Y+APEI+A PY D W+ GVL++E L
Sbjct: 136 AEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 195
Query: 233 FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI-----SYED 287
G P+ + +L Q++ ++ P SLS + + LL K P +R+ D
Sbjct: 196 AGQPPFDGEDEDEL-FQSIMEHNVSY-PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERD 253
Query: 288 LFSHPY 293
+ H +
Sbjct: 254 IREHAF 259
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 59/192 (30%), Positives = 107/192 (55%), Gaps = 15/192 (7%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
+++IL+Y GG++ + + + SE + + + +++LAL+ L + + + D+K +NIL+
Sbjct: 80 LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD 139
Query: 175 NNT-LKLADFGFA-QFLAPNDQGD-SIQGSPLYMAPEILAGSPYNAKA-DLWSLGVLVFE 230
+ + L DFG + +FL+ + S G+ YMAPEI+ G + KA D WSLG+L+FE
Sbjct: 140 SEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFE 199
Query: 231 ALFGHAPYA----SCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY- 285
L G +P+ S++ + L P P+ + P+ D L +LL+KDP +R+
Sbjct: 200 LLTGASPFTLEGERNTQSEVSRRILKCDPPF--PSFIGPEAQDLLHKLLRKDPKKRLGAG 257
Query: 286 ----EDLFSHPY 293
++ HP+
Sbjct: 258 PQGASEIKEHPF 269
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-20
Identities = 54/181 (29%), Positives = 94/181 (51%), Gaps = 4/181 (2%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
++II+EY GG + L E Q +R+++ L +L H D+K N+L+
Sbjct: 77 LWIIMEYLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS 135
Query: 174 KNNTLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
++ +KLADFG A Q + ++ G+P +MAPE++ S Y++KAD+WSLG+ E
Sbjct: 136 EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 195
Query: 233 FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHP 292
G P++ + ++ + P T+ N P +F+ L K+P R + ++L H
Sbjct: 196 KGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKP-LKEFVEACLNKEPSFRPTAKELLKHK 254
Query: 293 Y 293
+
Sbjct: 255 F 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 3e-20
Identities = 52/171 (30%), Positives = 90/171 (52%), Gaps = 4/171 (2%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
+Y ++EY +GGDL I+ K E Q + ++ + L FL + + DLK N+++
Sbjct: 76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD 135
Query: 175 NNT-LKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
+ +K+ADFG + + + G+P Y+APEI+A PY D W+ GVL++E L
Sbjct: 136 SEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEML 195
Query: 233 FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283
G P+ + +L Q++ ++ P SLS + + L+ K P +R+
Sbjct: 196 AGQPPFDGEDEDEL-FQSIMEHNVSY-PKSLSKEAVSICKGLMTKHPSKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 66/234 (28%), Positives = 102/234 (43%), Gaps = 42/234 (17%)
Query: 99 GLSNLRAPEGRKRP---RYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKF 155
G S E VYI+ EY + DL + + LSE + F+ QL+ LK+
Sbjct: 72 GPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVL-EQGPLSEEHARLFMYQLLRGLKY 129
Query: 156 LRENNVCHFDLKPQNILIKNNT--LKLADFGFAQFLAPN--DQGDSIQG--SPLYMAPEI 209
+ NV H DLKP N+ I LK+ DFG A+ + P+ +G +G + Y +P +
Sbjct: 130 IHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRL 189
Query: 210 LAGSP--YNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPIT---------- 257
L SP Y D+W+ G + E L G +A + + L S P+
Sbjct: 190 LL-SPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLN 248
Query: 258 -IPPN-----------------SLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
IP ++P+ +DFL ++L +PM R++ E+ HPY
Sbjct: 249 VIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPY 302
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 4e-20
Identities = 54/192 (28%), Positives = 87/192 (45%), Gaps = 14/192 (7%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFL-RENNVCHFDLKPQNILI 173
+ + +E+ D G L + + + +V L +L + + H D+KP NIL+
Sbjct: 78 ICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV 137
Query: 174 KNN-TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
+ +KL DFG + L N D+ G+ YM+PE + G Y K+D+WSLG+ + E
Sbjct: 138 NSRGQIKLCDFGVSGELI-NSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELA 196
Query: 233 FGHAPYASCN-----------LSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281
G P+A N + L Q + P +P + D DF+ L KDP
Sbjct: 197 LGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTE 256
Query: 282 RISYEDLFSHPY 293
R + + L + P
Sbjct: 257 RPTPQQLCAMPP 268
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 4e-20
Identities = 62/193 (32%), Positives = 98/193 (50%), Gaps = 17/193 (8%)
Query: 114 YVYIILEYCDGGDLCSFIRSH---EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 170
+ I +E GG L + +RS K +E + +Q++ LK+L +N + H D+K N
Sbjct: 79 FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDN 138
Query: 171 ILIKNNT----LKLADFGFAQFLAP-NDQGDSIQGSPLYMAPEILAGSP--YNAKADLWS 223
+L+ NT +K++DFG ++ LA N ++ G+ YMAPE++ P Y A AD+WS
Sbjct: 139 VLV--NTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWS 196
Query: 224 LGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPN---SLSPDCMDFLSRLLQKDPM 280
LG + E G P+ L + +A I P SLS + +F+ R + DP
Sbjct: 197 LGCTIVEMATGKPPFIE--LGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPD 254
Query: 281 RRISYEDLFSHPY 293
+R S DL P+
Sbjct: 255 KRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 4e-20
Identities = 57/184 (30%), Positives = 91/184 (49%), Gaps = 10/184 (5%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
++II+EY GG ++ L E +R+++ L +L H D+K N+L+
Sbjct: 77 LWIIMEYLGGGSALDLLKPG-PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS 135
Query: 174 KNNTLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
+ +KLADFG A Q + ++ G+P +MAPE++ S Y+ KAD+WSLG+ E
Sbjct: 136 EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELA 195
Query: 233 FGHAPYASCNLSQLRAQALSSAPITIPPN---SLSPDCMDFLSRLLQKDPMRRISYEDLF 289
G P + +L +R L P PP S +F+ L KDP R + ++L
Sbjct: 196 KGEPPNS--DLHPMRVLFL--IPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELL 251
Query: 290 SHPY 293
H +
Sbjct: 252 KHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 1e-19
Identities = 57/179 (31%), Positives = 89/179 (49%), Gaps = 10/179 (5%)
Query: 117 IILEYCDGGDLCSFIRSHEK----LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
I+LE D GDL I+ +K + E ++ QL AL+ + + H D+KP N+
Sbjct: 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVF 138
Query: 173 IK-NNTLKLADFGFAQFLAPND-QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
I +KL D G +F + S+ G+P YM+PE + + YN K+D+WSLG L++E
Sbjct: 139 ITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 198
Query: 231 ALFGHAPY--ASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRR--ISY 285
+P+ NL L + +P + S + D +SR + DP +R ISY
Sbjct: 199 MAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISY 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 61/183 (33%), Positives = 92/183 (50%), Gaps = 13/183 (7%)
Query: 117 IILEYCDGGDLCSFIRS----HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI- 171
+I+EY GGDL I+ H E++ Q+VLAL + + H DLK NI
Sbjct: 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIF 201
Query: 172 LIKNNTLKLADFGFAQFLAPN---DQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLV 228
L+ +KL DFGF++ + + D S G+P Y+APE+ Y+ KAD+WSLGV++
Sbjct: 202 LMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVIL 261
Query: 229 FEALFGHAPYASCNLSQLRAQALSSA--PITIPPNSLSPDCMDFLSRLLQKDPMRRISYE 286
+E L H P+ + ++ Q L P P +S +D LL K+P R + +
Sbjct: 262 YELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLD---PLLSKNPALRPTTQ 318
Query: 287 DLF 289
L
Sbjct: 319 QLL 321
|
Length = 478 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 59/188 (31%), Positives = 91/188 (48%), Gaps = 17/188 (9%)
Query: 117 IILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN- 175
++LE+ DGG L E RQ++ + +L ++ H D+KP N+LI +
Sbjct: 149 VLLEFMDGGSL----EGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSA 204
Query: 176 NTLKLADFGFAQFLAPN-DQGDSIQGSPLYMAPEI----LAGSPYNAKA-DLWSLGVLVF 229
+K+ADFG ++ LA D +S G+ YM+PE L Y+ A D+WSLGV +
Sbjct: 205 KNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSIL 264
Query: 230 EALFGHAPYASCN----LSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY 285
E G P+ S + A +S P P + S + F+S LQ++P +R S
Sbjct: 265 EFYLGRFPFGVGRQGDWASLMCAICMSQPPE--APATASREFRHFISCCLQREPAKRWSA 322
Query: 286 EDLFSHPY 293
L HP+
Sbjct: 323 MQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 62/203 (30%), Positives = 96/203 (47%), Gaps = 32/203 (15%)
Query: 130 FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN--TLKLADFGFAQ 187
+ R++ L F + + QL AL ++ +CH DLKPQN+LI N TLKL DFG A+
Sbjct: 160 YARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219
Query: 188 FLAPNDQGDSIQGSPLYMAPEILAGSP-YNAKADLWSLGVLVFEALFGHAPYASCNLS-- 244
L + S S Y APE++ G+ Y DLWSLG ++ E + G+ P S S
Sbjct: 220 NLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGY-PIFSGQSSVD 278
Query: 245 ---------------QLRAQALSSAPITIP-----------PNSLSPDCMDFLSRLLQKD 278
QL+ + A I P P D ++F+S+ L+ +
Sbjct: 279 QLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYE 338
Query: 279 PMRRISYEDLFSHPYPDLIHAPC 301
P++R++ + + P+ D + PC
Sbjct: 339 PLKRLNPIEALADPFFDDLRDPC 361
|
Length = 440 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 57/186 (30%), Positives = 97/186 (52%), Gaps = 9/186 (4%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
+Y+IL++ GGDL + + +E + ++ +L LAL L + + DLKP+NIL+
Sbjct: 73 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD 132
Query: 174 KNNTLKLADFGFAQFLAPNDQGD-SIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
+ +KL DFG ++ +++ S G+ YMAPE++ + AD WS GVL+FE L
Sbjct: 133 EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML 192
Query: 233 FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI-----SYED 287
G P+ + + L A + +P LSP+ L L +++P R+ E+
Sbjct: 193 TGSLPFQGKDRKETMTMIL-KAKLGMPQF-LSPEAQSLLRALFKRNPANRLGAGPDGVEE 250
Query: 288 LFSHPY 293
+ HP+
Sbjct: 251 IKRHPF 256
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-19
Identities = 57/187 (30%), Positives = 101/187 (54%), Gaps = 8/187 (4%)
Query: 113 RYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
R + I +E+ GG + ++S+ L+E +++ RQ++ + +L N + H D+K NIL
Sbjct: 79 RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANIL 138
Query: 173 IKN-NTLKLADFGFA---QFLAPNDQG-DSIQGSPLYMAPEILAGSPYNAKADLWSLGVL 227
+ +KL DFG + Q + + G S+ G+P +M+PE+++G Y KAD+WS+G
Sbjct: 139 RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCT 198
Query: 228 VFEALFGHAPYASCN-LSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYE 286
V E L P+A ++ + A +PP+ +S C DFL R+ + +R S +
Sbjct: 199 VVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPH-VSDHCRDFLKRIFVEAKLRP-SAD 256
Query: 287 DLFSHPY 293
+L H +
Sbjct: 257 ELLRHTF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 64/219 (29%), Positives = 96/219 (43%), Gaps = 39/219 (17%)
Query: 113 RYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+Y++ E DL I S + LS + F+ Q++ LK+L + H D+KP N+L
Sbjct: 77 EEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLL 135
Query: 173 IKNN-TLKLADFGFAQFLAPNDQGDSIQG--SPLYMAPEILAGSP-YNAKADLWSLGVLV 228
+ +N LK+ DFG A+ P++ Q + Y APEIL GS Y + D+WS+G +
Sbjct: 136 VNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIF 195
Query: 229 FEALFGHAPY-ASCNLSQL----------------------RAQALSSAPITIPP----- 260
E L + A + QL RA L PP
Sbjct: 196 AELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPH--KPPSLPVL 253
Query: 261 ----NSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPD 295
+ + + + L R+L DP +RIS D +HPY D
Sbjct: 254 YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLD 292
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 4e-19
Identities = 55/190 (28%), Positives = 97/190 (51%), Gaps = 13/190 (6%)
Query: 115 VYIILEYCDGGDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+++++E+C G + +++ + L E R+++ L L + V H D+K QN+L
Sbjct: 94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVL 153
Query: 173 IKNNT-LKLADFGF-AQFLAPNDQGDSIQGSPLYMAPEILA-----GSPYNAKADLWSLG 225
+ N +KL DFG AQ + ++ G+P +MAPE++A + Y+ ++D+WSLG
Sbjct: 154 LTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLG 213
Query: 226 VLVFEALFGHAPYASCNLSQLRAQAL--SSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283
+ E G P C++ +RA L + P + S +DF+ L K+ + R
Sbjct: 214 ITAIEMAEGAPPL--CDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRP 271
Query: 284 SYEDLFSHPY 293
S E L HP+
Sbjct: 272 STEQLLKHPF 281
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 5e-19
Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 46/221 (20%)
Query: 115 VYIILEYCDGGDLCSFIRSH-----EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 169
+Y++ EY D DL F+ S+ L + F+ QL+ + ++ V H DLKPQ
Sbjct: 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQ 139
Query: 170 NILIKN--NTLKLADFGFAQ-FLAPNDQGDSIQGSPLYMAPEILAGSP-YNAKADLWSLG 225
N+L+ LK+AD G + F P + Y APE+L GS Y+ D+WS+G
Sbjct: 140 NLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVG 199
Query: 226 VLVFEALFGHAPY-ASCNLSQL------------------------------RAQALSSA 254
+ E + L QL + Q LS A
Sbjct: 200 CIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRA 259
Query: 255 PITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPD 295
+P LSP+ +D L ++L+ DP +RIS + +HPY D
Sbjct: 260 ---VP--DLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 5e-19
Identities = 58/195 (29%), Positives = 92/195 (47%), Gaps = 20/195 (10%)
Query: 115 VYIILEYCDGGDLCSFI----RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 170
++++LE C+GG + + ++L E + +L L+ L N + H D+K N
Sbjct: 99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNN 158
Query: 171 ILIK-NNTLKLADFGF-AQFLAPNDQGDSIQGSPLYMAPEILA-----GSPYNAKADLWS 223
IL+ +KL DFG AQ + + ++ G+P +MAPE++A Y+A+ D+WS
Sbjct: 159 ILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWS 218
Query: 224 LGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPD--CMD---FLSRLLQKD 278
LG+ E G P + + L P PP L P+ C F+S+ L KD
Sbjct: 219 LGITAIELGDGDPPLFDMH----PVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKD 274
Query: 279 PMRRISYEDLFSHPY 293
R S L HP+
Sbjct: 275 FEARPSVTHLLEHPF 289
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 5e-19
Identities = 56/177 (31%), Positives = 97/177 (54%), Gaps = 8/177 (4%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
P + IL+ +GGDL + H SE + + + +++L L+ + V + DLKP NI
Sbjct: 69 PDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANI 128
Query: 172 LI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILA-GSPYNAKADLWSLGVLVF 229
L+ ++ ++++D G A + S+ G+ YMAPE+L G Y++ AD +SLG ++F
Sbjct: 129 LLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 187
Query: 230 EALFGHAPY---ASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283
+ L GH+P+ + + ++ L+ A P+S SP+ L LLQ+D RR+
Sbjct: 188 KLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL--PDSFSPELRSLLEGLLQRDVNRRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 6e-19
Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 15/191 (7%)
Query: 115 VYIILEYCDGGDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+++++E+C G + I++ + L E R+++ L L ++ V H D+K QN+L
Sbjct: 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVL 143
Query: 173 IKNNT-LKLADFGF-AQFLAPNDQGDSIQGSPLYMAPEILA-----GSPYNAKADLWSLG 225
+ N +KL DFG AQ + ++ G+P +MAPE++A + Y+ K+DLWSLG
Sbjct: 144 LTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 203
Query: 226 VLVFEALFGHAPYASCNLSQLRAQAL---SSAPITIPPNSLSPDCMDFLSRLLQKDPMRR 282
+ E G P C++ +RA L + AP + S F+ L K+ +R
Sbjct: 204 ITAIEMAEGAPPL--CDMHPMRALFLIPRNPAP-RLKSKKWSKKFQSFIESCLVKNHSQR 260
Query: 283 ISYEDLFSHPY 293
+ E L HP+
Sbjct: 261 PTTEQLMKHPF 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 8e-19
Identities = 54/169 (31%), Positives = 93/169 (55%), Gaps = 5/169 (2%)
Query: 118 ILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLR-ENNVCHFDLKPQNILI-KN 175
++EY +GG+L + SE + + + ++V AL +L E NV + DLK +N+++ K+
Sbjct: 73 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD 132
Query: 176 NTLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFG 234
+K+ DFG + + + G+P Y+APE+L + Y D W LGV+++E + G
Sbjct: 133 GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 192
Query: 235 HAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283
P+ + + +L L I P +LSP+ LS LL+KDP +R+
Sbjct: 193 RLPFYNQDHEKLFELILMEE-IRF-PRTLSPEAKSLLSGLLKKDPKQRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 57/197 (28%), Positives = 102/197 (51%), Gaps = 20/197 (10%)
Query: 114 YVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
Y+Y++++Y GGDL + + E +L E + ++ ++VLA+ + + + H D+KP N+L
Sbjct: 75 YLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVL 134
Query: 173 IK-NNTLKLADFGFAQFLAPNDQGDSIQ-----GSPLYMAPEILAG-----SPYNAKADL 221
+ N ++LADFG L N G ++Q G+P Y++PEIL Y + D
Sbjct: 135 LDMNGHIRLADFG--SCLKMNQDG-TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDW 191
Query: 222 WSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPN---SLSPDCMDFLSRLLQKD 278
WSLGV ++E L+G P+ + +L + + ++ P+ +S + D + RL+
Sbjct: 192 WSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSR 251
Query: 279 PMR--RISYEDLFSHPY 293
R + ED H +
Sbjct: 252 ERRLGQNGIEDFKKHAF 268
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 51/175 (29%), Positives = 90/175 (51%), Gaps = 12/175 (6%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
+Y ++EY +GGDL I+ + E + ++ + L FL + + DLK N+++
Sbjct: 76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD 135
Query: 175 NNT-LKLADFGFAQFLAPNDQGDSIQ-----GSPLYMAPEILAGSPYNAKADLWSLGVLV 228
+ +K+ADFG + + D + G+P Y+APEI+A PY D W+ GVL+
Sbjct: 136 SEGHIKIADFGMCK----ENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 191
Query: 229 FEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283
+E L G AP+ + +L Q++ + P S+S + + L+ K P +R+
Sbjct: 192 YEMLAGQAPFEGEDEDEL-FQSIMEHNVAY-PKSMSKEAVAICKGLMTKHPGKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 64/226 (28%), Positives = 96/226 (42%), Gaps = 61/226 (26%)
Query: 115 VYIILEYCDGGDLCSFIRSHEK---LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+Y+++EY + DL S + + ++ SE +C + QL+ + L +N + H DLK N+
Sbjct: 81 IYMVMEYVEH-DLKSLMETMKQPFLQSEVKC--LMLQLLSGVAHLHDNWILHRDLKTSNL 137
Query: 172 LIKNN-TLKLADFGFA-QFLAPNDQGDSIQGSPL-----------YMAPEILAGSP-YNA 217
L+ N LK+ DFG A ++ GSPL Y APE+L G+ Y+
Sbjct: 138 LLNNRGILKICDFGLAREY-----------GSPLKPYTQLVVTLWYRAPELLLGAKEYST 186
Query: 218 KADLWSLG-----VLVFEALF-------------------------GHAPYASCNLSQLR 247
D+WS+G +L + LF G +
Sbjct: 187 AIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFT 246
Query: 248 AQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
+ P SLS + D L+RLL DP +RIS ED HPY
Sbjct: 247 KYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 49/203 (24%)
Query: 130 FIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLADFGFAQF 188
I+ ++ L E + + ++ QL+ +L + N + H D+KP+NILIK++ LKLADFG +
Sbjct: 89 LIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDILKLADFGSCR- 147
Query: 189 LAPNDQGDSIQGSP---------LYMAPE-ILAGSPYNAKADLWSLGVLVFEALFGH--- 235
I P Y APE +L Y K D+W++G + FE L
Sbjct: 148 --------GIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLF 199
Query: 236 -----------------APYASCNLSQLRAQALSSA-----PITIP---PNSLSPDCMDF 270
P A +++ ++ + PN S + +D
Sbjct: 200 PGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPN-ASAEGLDL 258
Query: 271 LSRLLQKDPMRRISYEDLFSHPY 293
L +LL DP RI+ + HPY
Sbjct: 259 LKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 53/229 (23%), Positives = 98/229 (42%), Gaps = 51/229 (22%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
+Y +++Y GGD+ S + E + ++ +L A++ + + H D+KP NILI
Sbjct: 76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID 135
Query: 174 KNNTLKLADFGF---------AQFLAPND------------------------------- 193
++ +KL DFG +++ D
Sbjct: 136 RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQ 195
Query: 194 ----QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPY--ASCNLSQLR 247
S+ G+P Y+APE+L + Y D WS+GV+++E L G P+ + +QL+
Sbjct: 196 HQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLK 255
Query: 248 AQALSSAPITIPPNS-LSPDCMDFLSRLLQKDPMR--RISYEDLFSHPY 293
+ + IP + LS + D + RL R + +++ +HP+
Sbjct: 256 VINWETT-LHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPF 303
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 36/218 (16%)
Query: 110 KRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 169
+R + +Y++ E+ D L + L E + ++++ Q++ ++F +N+ H D+KP+
Sbjct: 70 RRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPE 129
Query: 170 NILI-KNNTLKLADFGFAQFLA-PNDQGDSIQGSPLYMAPEILAGSPYNAKA-DLWSLGV 226
NIL+ ++ +KL DFGFA+ LA P + + Y APE+L G +A D+W++G
Sbjct: 130 NILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGC 189
Query: 227 LVFEALFGHAPY--ASCNLSQL------------RAQALSS-----APITIP-------- 259
LV E L G P ++ QL R Q + A + +P
Sbjct: 190 LVTEMLTGE-PLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPL 248
Query: 260 ----PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
P LS +D + L+ DP R S L H +
Sbjct: 249 EKRFP-KLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 58/197 (29%), Positives = 104/197 (52%), Gaps = 22/197 (11%)
Query: 113 RYVYIILEYCDGGDLCSFIRSH---EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 169
RY+Y+++EY GGDL + + ++ EK + F + ++VLAL + H D+KP
Sbjct: 116 RYLYMVMEYMPGGDLVNLMSNYDVPEKWARF----YTAEVVLALDAIHSMGFIHRDVKPD 171
Query: 170 NILI-KNNTLKLADFGFAQFLAPNDQG----DSIQGSPLYMAPEILAGSP----YNAKAD 220
N+L+ K+ LKLADFG + N +G D+ G+P Y++PE+L Y + D
Sbjct: 172 NMLLDKSGHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 229
Query: 221 LWSLGVLVFEALFGHAPYASCNLSQLRAQALSSA-PITIPPNS-LSPDCMDFLSRLLQKD 278
WS+GV ++E L G P+ + +L ++ ++ +T P ++ +S + + + L
Sbjct: 230 WWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDR 289
Query: 279 PMR--RISYEDLFSHPY 293
+R R E++ H +
Sbjct: 290 EVRLGRNGVEEIKRHLF 306
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-18
Identities = 60/189 (31%), Positives = 88/189 (46%), Gaps = 12/189 (6%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
++I +EYC GG L LSE Q R+ + L +L H D+K NIL+
Sbjct: 81 LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT 140
Query: 175 NN-TLKLADFGF-AQFLAPNDQGDSIQGSPLYMAPEILA---GSPYNAKADLWSLGVLVF 229
+N +KLADFG A+ A + S G+P +MAPE+ A YN D+W++G+
Sbjct: 141 DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAI 200
Query: 230 EALFGHAPYASCNLSQLRAQALSSAPITIPPN-----SLSPDCMDFLSRLLQKDPMRRIS 284
E P +L +RA L S PP S +F+ L K+P +R +
Sbjct: 201 ELAELQPPMF--DLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPT 258
Query: 285 YEDLFSHPY 293
E L +H +
Sbjct: 259 AERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 49/168 (29%), Positives = 93/168 (55%), Gaps = 4/168 (2%)
Query: 118 ILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNN 176
++EY +GG+L + +E + + + ++V AL++L +V + D+K +N+++ K+
Sbjct: 73 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG 132
Query: 177 TLKLADFGFAQFLAPNDQG-DSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGH 235
+K+ DFG + + + G+P Y+APE+L + Y D W LGV+++E + G
Sbjct: 133 HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
Query: 236 APYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283
P+ + + +L L I P +LSP+ L+ LL+KDP +R+
Sbjct: 193 LPFYNQDHERLFELILMEE-IRF-PRTLSPEAKSLLAGLLKKDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 56/194 (28%), Positives = 101/194 (52%), Gaps = 14/194 (7%)
Query: 114 YVYIILEYCDGGDLCSFI-RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+Y++++Y GGDL + + + ++L E + ++ ++VLA+ + + H D+KP N+L
Sbjct: 75 NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVL 134
Query: 173 I-KNNTLKLADFGFAQFLAPNDQGDS--IQGSPLYMAPEILAG-----SPYNAKADLWSL 224
+ KN ++LADFG L + S G+P Y++PEIL Y + D WSL
Sbjct: 135 LDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSL 194
Query: 225 GVLVFEALFGHAPYASCNLSQLRAQALSSAP-ITIPPNS--LSPDCMDFLSRLLQKDPMR 281
GV ++E L+G P+ + +L + + ++ PP+ +S + D + RL+ R
Sbjct: 195 GVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETR 254
Query: 282 --RISYEDLFSHPY 293
R +D HP+
Sbjct: 255 LGRNGLQDFKDHPF 268
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 51/168 (30%), Positives = 92/168 (54%), Gaps = 4/168 (2%)
Query: 118 ILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNN 176
++EY +GG+L + SE + + + ++V AL +L +V + DLK +N+++ K+
Sbjct: 73 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG 132
Query: 177 TLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGH 235
+K+ DFG + ++ + G+P Y+APE+L + Y D W LGV+++E + G
Sbjct: 133 HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
Query: 236 APYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283
P+ + + +L L I P LSP+ L+ LL+KDP +R+
Sbjct: 193 LPFYNQDHEKLFELILMEE-IRFPRT-LSPEAKSLLAGLLKKDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 43/223 (19%)
Query: 113 RYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
R +Y+I+E+ GGD+ + + + LSE Q ++ + VLA+ + + H D+KP N+L
Sbjct: 74 RNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLL 133
Query: 173 I-KNNTLKLADFG------------FAQFLAPNDQGD----------------------- 196
+ +KL+DFG F + L N D
Sbjct: 134 LDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLA 193
Query: 197 -SIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALS-SA 254
S G+P Y+APE+ + YN D WSLGV+++E L G+ P+ S + + ++
Sbjct: 194 YSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKE 253
Query: 255 PITIPPN-SLSPDCMDFLSRLLQKDPMRRI---SYEDLFSHPY 293
+ PP +S D + R D RI E++ SHP+
Sbjct: 254 TLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPF 295
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 3e-18
Identities = 53/175 (30%), Positives = 94/175 (53%), Gaps = 4/175 (2%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
P + IL+ +GGDL + H SE + + + +++L L+ + V + DLKP NI
Sbjct: 69 PDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANI 128
Query: 172 LI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEIL-AGSPYNAKADLWSLGVLVF 229
L+ ++ ++++D G A + S+ G+ YMAPE+L G+ Y++ AD +SLG ++F
Sbjct: 129 LLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGTAYDSSADWFSLGCMLF 187
Query: 230 EALFGHAPYASCNLSQLRAQALSSAPITIP-PNSLSPDCMDFLSRLLQKDPMRRI 283
+ L GH+P+ + + + P+S SP+ L LLQ+D +R+
Sbjct: 188 KLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 3e-18
Identities = 57/189 (30%), Positives = 89/189 (47%), Gaps = 17/189 (8%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
+ I E+ DGG L + K+ E + +V L +L + H D+KP N+L+
Sbjct: 74 ISICTEFMDGGSL----DVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV- 128
Query: 175 NNT---LKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEA 231
NT +KL DFG + L N + G+ YMAPE ++G Y +D+WSLG+ E
Sbjct: 129 -NTRGQVKLCDFGVSTQLV-NSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMEL 186
Query: 232 LFGHAPYAS-----CNLS--QLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRIS 284
G PY +L QL + P +P S + F+++ ++K P R +
Sbjct: 187 ALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPA 246
Query: 285 YEDLFSHPY 293
E+L HP+
Sbjct: 247 PENLMDHPF 255
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 4e-18
Identities = 51/192 (26%), Positives = 97/192 (50%), Gaps = 17/192 (8%)
Query: 117 IILEYCDGGDLCSFIRSHEK----LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+++ +GGDL I + ++ E + + Q++ L+ L + + + DLKP+N+L
Sbjct: 70 LVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVL 129
Query: 173 IKNN-TLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
+ N+ ++++D G A + + G+P +MAPE+L G Y+ D ++LGV ++E
Sbjct: 130 LDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYE 189
Query: 231 ALFGHAPYAS----CNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYE 286
+ P+ + +L+ + L+ +T P+ SP F LL KDP +R+ +
Sbjct: 190 MIAARGPFRARGEKVENKELKQRILND-SVTY-PDKFSPASKSFCEALLAKDPEKRLGFR 247
Query: 287 D-----LFSHPY 293
D L +HP
Sbjct: 248 DGNCDGLRTHPL 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 4e-18
Identities = 49/185 (26%), Positives = 87/185 (47%), Gaps = 14/185 (7%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
V+++L++ +GG L S I + E +++ ++V+AL L + DL P NIL+
Sbjct: 60 VFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD 119
Query: 175 N-NTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF 233
+ ++L F + + G+++ +Y APE+ S D WSLG ++FE L
Sbjct: 120 DRGHIQLTYFSRWSEVEDSCDGEAV--ENMYCAPEVGGISEETEACDWWSLGAILFELLT 177
Query: 234 GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI-----SYEDL 288
G L + +++ P +S + L +LLQ +P R+ ED+
Sbjct: 178 GKT------LVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDI 231
Query: 289 FSHPY 293
SHP+
Sbjct: 232 KSHPF 236
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 6e-18
Identities = 55/159 (34%), Positives = 82/159 (51%), Gaps = 21/159 (13%)
Query: 150 VLALKFLREN-NVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQ-----GSP 202
V AL +L+E + H D+KP NIL+ +N +KL DFG + L DSI G
Sbjct: 117 VKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV-----DSIAKTRDAGCR 171
Query: 203 LYMAPEILAGS---PYNAKADLWSLGVLVFEALFGHAPYASCN--LSQLRAQALSSAPIT 257
YMAPE + S Y+ ++D+WSLG+ ++E G PY N QL Q + P
Sbjct: 172 PYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLT-QVVKGDPPI 230
Query: 258 IPPNS---LSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
+ + SP ++F++ L KD +R Y++L HP+
Sbjct: 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPF 269
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 7e-18
Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 39/215 (18%)
Query: 117 IILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLREN-NVCHFDLKPQNILIKN 175
I +E+ DGG L ++ ++ E + ++ L +LRE + H D+KP NIL+ +
Sbjct: 76 ICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNS 135
Query: 176 N-TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFG 234
+KL DFG + L + +S G+ YM+PE L G+ Y ++D+WSLG+ + E G
Sbjct: 136 RGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194
Query: 235 HAPYASCNLSQLRA------QALSSAPITIPPNS-------------------------- 262
P + +L A + P +
Sbjct: 195 RYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKL 254
Query: 263 ----LSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
S + DF+ + L+K+P R ++L HP+
Sbjct: 255 PSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 7e-18
Identities = 60/189 (31%), Positives = 87/189 (46%), Gaps = 12/189 (6%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
++I +E+C GG L LSE Q R+ + L +L H D+K NIL+
Sbjct: 81 LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT 140
Query: 175 NNT-LKLADFGF-AQFLAPNDQGDSIQGSPLYMAPEILA---GSPYNAKADLWSLGVLVF 229
+N +KLADFG AQ A + S G+P +MAPE+ A YN D+W++G+
Sbjct: 141 DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAI 200
Query: 230 EALFGHAPYASCNLSQLRAQALSSAPITIPPN-----SLSPDCMDFLSRLLQKDPMRRIS 284
E P +L +RA L + PP S F+ L K+P +R +
Sbjct: 201 ELAELQPPMF--DLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPT 258
Query: 285 YEDLFSHPY 293
E L HP+
Sbjct: 259 AEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 9e-18
Identities = 67/231 (29%), Positives = 101/231 (43%), Gaps = 51/231 (22%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
VY++++ DL I S + L+E + F+ QL+ LK++ NV H DLKP N+L+
Sbjct: 83 VYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN 141
Query: 174 KNNTLKLADFGFAQFLA--PNDQGDSIQ---GSPLYMAPEILAGSP-YNAKADLWSLGVL 227
++ L++ DFG A+ L+ P + + + Y APE+L P Y D+WS+G +
Sbjct: 142 EDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCI 201
Query: 228 VFE-----ALFGHAPYASCNLSQLRA-------------------------QALSSAPI- 256
E LF Y + QL+ Q L
Sbjct: 202 FAEMLGRRQLFPGKNY----VHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPV 257
Query: 257 ---TIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHP----YPDLIHAP 300
I P + SP+ +D LS++LQ DP RI+ E HP Y D P
Sbjct: 258 PWSKIFPKA-SPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEP 307
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-17
Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 13/181 (7%)
Query: 115 VYIILEYCDGGDLCSFIRSHEK-LSEFQCQ-QFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+YI+ EY G L ++RS + + Q F + +++L E N H DL +N+L
Sbjct: 75 LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVL 134
Query: 173 I-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPYNAKADLWSLGVLV 228
+ ++ K++DFG A+ + L + APE L ++ K+D+WS G+L+
Sbjct: 135 VSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILL 189
Query: 229 FEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYED 287
+E FG PY L + + P P+ + + DP +R +++
Sbjct: 190 WEIYSFGRVPYPRIPLKDV-VPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQ 248
Query: 288 L 288
L
Sbjct: 249 L 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-17
Identities = 48/178 (26%), Positives = 93/178 (52%), Gaps = 7/178 (3%)
Query: 115 VYIILEYCDGGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+YI++E G+L +F+R+ + +S Q QF + +++L + H DL +NIL
Sbjct: 73 LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNIL 132
Query: 173 I-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEA 231
+ ++ K++DFG A+ + D+ + + APE L +++K+D+WS GVL++E
Sbjct: 133 VSEDGVAKVSDFGLAR--VGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEV 190
Query: 232 L-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDL 288
+G APY +L +++ + + PP D ++ + +P +R S+ L
Sbjct: 191 FSYGRAPYPKMSLKEVK-ECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKL 247
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 67/242 (27%), Positives = 103/242 (42%), Gaps = 67/242 (27%)
Query: 115 VYIILEYCDGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
VY+++E D +LC I+ HE++S + Q++ +K L + H DLKP NI
Sbjct: 96 VYLVMELMDA-NLCQVIQMDLDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNI 149
Query: 172 LIKNN-TLKLADFGFAQFLAPNDQGDSIQGSP-----LYMAPEILAGSPYNAKADLWSLG 225
++K++ TLK+ DFG A+ G S +P Y APE++ G Y D+WS+G
Sbjct: 150 VVKSDCTLKILDFGLAR-----TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 204
Query: 226 ----------VL------------VFEALFGHAPYASCNLSQLRAQALSSAP-------- 255
VL + E L + L + + P
Sbjct: 205 CIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFE 264
Query: 256 -----ITIPPNSLSPDCM------DFLSRLLQKDPMRRISYEDLFSHPY------PDLIH 298
+ PP+S S + + D LS++L DP +RIS +D HPY P +
Sbjct: 265 ELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSEVE 324
Query: 299 AP 300
AP
Sbjct: 325 AP 326
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 66/220 (30%), Positives = 94/220 (42%), Gaps = 35/220 (15%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
+Y + E G DL + S +F Q F+ Q++ LK++ V H DLKP NILI
Sbjct: 85 IYFVTELL-GTDLHRLLTSRPLEKQF-IQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN 142
Query: 175 NNT-LKLADFGFAQFLAPNDQGDSIQGSPLYMAPEI-LAGSPYNAKADLWSLGVLVFEAL 232
N LK+ DFG A+ P G + Y APEI L Y+ + D+WS G + E L
Sbjct: 143 ENCDLKICDFGLARIQDPQMTG--YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200
Query: 233 FGHAPYAS-------------------------CNLSQLR-AQAL---SSAPITIPPNSL 263
G + C+ + LR Q+L P + +
Sbjct: 201 EGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNA 260
Query: 264 SPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAE 303
P +D L ++L DP +RIS + +HPY H P E
Sbjct: 261 DPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDE 300
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-17
Identities = 54/179 (30%), Positives = 85/179 (47%), Gaps = 10/179 (5%)
Query: 117 IILEYCDGGDLCSFIRSHEK----LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
I+LE D GDL I+ +K + E ++ QL A++ + V H D+KP N+
Sbjct: 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVF 138
Query: 173 IK-NNTLKLADFGFAQFLAP-NDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
I +KL D G +F + S+ G+P YM+PE + + YN K+D+WSLG L++E
Sbjct: 139 ITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 198
Query: 231 ALFGHAPYAS--CNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRR--ISY 285
+P+ NL L + +P S + +S + DP +R I Y
Sbjct: 199 MAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGY 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-17
Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 8/174 (4%)
Query: 117 IILEYCDGGDLCSFIRSHEK----LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
I+LE D GDL I+ +K + E ++ QL AL+ + V H D+KP N+
Sbjct: 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVF 138
Query: 173 IK-NNTLKLADFGFAQFLAPNDQG-DSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
I +KL D G +F + S+ G+P YM+PE + + YN K+D+WSLG L++E
Sbjct: 139 ITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 198
Query: 231 ALFGHAPY--ASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRR 282
+P+ NL L + +P + S + ++ + DP +R
Sbjct: 199 MAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 56/195 (28%), Positives = 101/195 (51%), Gaps = 18/195 (9%)
Query: 113 RYVYIILEYCDGGDLCSFIRSH---EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 169
+Y+Y+++EY GGDL + + ++ EK ++F + ++VLAL + + H D+KP
Sbjct: 116 KYLYMVMEYMPGGDLVNLMSNYDVPEKWAKF----YTAEVVLALDAIHSMGLIHRDVKPD 171
Query: 170 NILI-KNNTLKLADFGFAQFLAPND--QGDSIQGSPLYMAPEILAGSP----YNAKADLW 222
N+L+ K+ LKLADFG + + D+ G+P Y++PE+L Y + D W
Sbjct: 172 NMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 231
Query: 223 SLGVLVFEALFGHAPYASCNLSQLRAQALSSA-PITIPPNS-LSPDCMDFLSRLLQKDPM 280
S+GV +FE L G P+ + +L ++ + + P + +S + + L +
Sbjct: 232 SVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREV 291
Query: 281 R--RISYEDLFSHPY 293
R R E++ HP+
Sbjct: 292 RLGRNGVEEIKQHPF 306
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 2e-17
Identities = 60/231 (25%), Positives = 112/231 (48%), Gaps = 26/231 (11%)
Query: 76 TVKYSQVRYDTITSHSEFERPRAGLSNLRAPE--------GRKRPRYVYIILEYCDGGDL 127
TV ++ DT+ EF + A + ++ P R+ P YII E+ G+L
Sbjct: 33 TVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPP--FYIITEFMTYGNL 89
Query: 128 CSFIRS--HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLADFG 184
++R ++++ Q+ A+++L + N H DL +N L+ +N+ +K+ADFG
Sbjct: 90 LDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 149
Query: 185 FAQFLAPNDQGDSIQGS-----PL-YMAPEILAGSPYNAKADLWSLGVLVFE-ALFGHAP 237
++ + GD+ P+ + APE LA + ++ K+D+W+ GVL++E A +G +P
Sbjct: 150 LSRLM----TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 205
Query: 238 YASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDL 288
Y +LSQ+ + P P + + Q +P R S+ ++
Sbjct: 206 YPGIDLSQVYELLEKGYRMERPEGC-PPKVYELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 51/168 (30%), Positives = 89/168 (52%), Gaps = 4/168 (2%)
Query: 118 ILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNN 176
++EY +GG+L + SE + + + ++V AL +L + + DLK +N+++ K+
Sbjct: 73 VMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG 132
Query: 177 TLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGH 235
+K+ DFG + + + G+P Y+APE+L + Y D W LGV+++E + G
Sbjct: 133 HIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
Query: 236 APYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283
P+ + + +L L I P +LS D LS LL KDP +R+
Sbjct: 193 LPFYNQDHEKLFELILME-DIKF-PRTLSADAKSLLSGLLIKDPNKRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 5e-17
Identities = 59/189 (31%), Positives = 92/189 (48%), Gaps = 11/189 (5%)
Query: 111 RPRYVYIILEYCDGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 169
R ++++EYC G + H+K L E + + L +L +N+ H D+K
Sbjct: 96 REHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAG 154
Query: 170 NILIKN-NTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAG---SPYNAKADLWSLG 225
NIL+ +KLADFG A +P +S G+P +MAPE++ Y+ K D+WSLG
Sbjct: 155 NILLTEPGQVKLADFGSASIASP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 211
Query: 226 VLVFEALFGHAPYASCN-LSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRIS 284
+ E P + N +S L A + +P T+ N S +F+ LQK P R +
Sbjct: 212 ITCIELAERKPPLFNMNAMSALYHIAQNESP-TLQSNEWSDYFRNFVDSCLQKIPQDRPT 270
Query: 285 YEDLFSHPY 293
E+L H +
Sbjct: 271 SEELLKHMF 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 5e-17
Identities = 56/223 (25%), Positives = 90/223 (40%), Gaps = 22/223 (9%)
Query: 82 VRYDTITSHSEFERPRAGLS---NLRAP-------EGRKRPRYVYIILEYCDGGDLCSFI 131
+R D + R R + L P G P ++ + EY G L +
Sbjct: 11 LRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVL 70
Query: 132 RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL----KLADFGFAQ 187
+ L + + + Q++ AL + H DLKPQNI++ + K+ DFG
Sbjct: 71 AADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGT 130
Query: 188 FLAPNDQGDSIQ--------GSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYA 239
L D G+P Y APE L G P +DL++ G++ E L G
Sbjct: 131 LLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQ 190
Query: 240 SCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRR 282
+++++ Q LS +++PP L + L KDP +R
Sbjct: 191 GASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 5e-17
Identities = 55/193 (28%), Positives = 100/193 (51%), Gaps = 14/193 (7%)
Query: 115 VYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+Y++++Y GGDL + + E +L E + ++ ++V+A+ + + + H D+KP NIL+
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM 135
Query: 174 K-NNTLKLADFGFAQFLAPND--QGDSIQGSPLYMAPEILAG-----SPYNAKADLWSLG 225
N ++LADFG L + Q G+P Y++PEIL Y + D WSLG
Sbjct: 136 DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLG 195
Query: 226 VLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP---NSLSPDCMDFLSRLL--QKDPM 280
V ++E L+G P+ + +L + + ++ P +S D D + RL+ ++ +
Sbjct: 196 VCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRL 255
Query: 281 RRISYEDLFSHPY 293
+ ED HP+
Sbjct: 256 GQNGIEDFKQHPF 268
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 6e-17
Identities = 64/209 (30%), Positives = 91/209 (43%), Gaps = 33/209 (15%)
Query: 117 IILEYCDGGDLCSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-K 174
++ EYCD DL + S + + + F+ QL+ L F +NV H DLKPQN+LI K
Sbjct: 76 LVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINK 134
Query: 175 NNTLKLADFGFAQ-FLAPNDQGDSIQGSPLYMAPEILAGSP-YNAKADLWSLGVLVFEAL 232
N LKLADFG A+ F P + + Y P++L G+ Y+ D+WS G + E
Sbjct: 135 NGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 194
Query: 233 FGHAPYASCN--LSQLRA--QALSSAPITIPPN------------------------SLS 264
P N QL+ + L + P L+
Sbjct: 195 NAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLN 254
Query: 265 PDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
D L LL +P++RIS E+ HPY
Sbjct: 255 STGRDLLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 6e-17
Identities = 52/188 (27%), Positives = 91/188 (48%), Gaps = 21/188 (11%)
Query: 115 VYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+YI++E GG L +F+R + +L+ + Q +++L N H DL +N L+
Sbjct: 67 IYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV 126
Query: 174 -KNNTLKLADFGFAQFLAPNDQGDSIQGSPL------YMAPEILAGSPYNAKADLWSLGV 226
+NN LK++DFG ++ + G L + APE L Y +++D+WS G+
Sbjct: 127 GENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGI 183
Query: 227 LVFEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQK----DPMR 281
L++E G PY + Q R + S +P L P+ + RL+ + DP
Sbjct: 184 LLWETFSLGDTPYPGMSNQQTRERIESGY--RMPAPQLCPEEI---YRLMLQCWAYDPEN 238
Query: 282 RISYEDLF 289
R S+ +++
Sbjct: 239 RPSFSEIY 246
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 111 RPRYVYIILEYCDGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 169
R ++++EYC G + H+K L E + + L +L +N+ H D+K
Sbjct: 86 REHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAG 144
Query: 170 NILIKN-NTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAG---SPYNAKADLWSLG 225
NIL+ +KL DFG A +AP + G+P +MAPE++ Y+ K D+WSLG
Sbjct: 145 NILLSEPGLVKLGDFGSASIMAP---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 201
Query: 226 VLVFEALFGHAPYASCN-LSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRIS 284
+ E P + N +S L A + +P + S +F+ LQK P R +
Sbjct: 202 ITCIELAERKPPLFNMNAMSALYHIAQNESPA-LQSGHWSEYFRNFVDSCLQKIPQDRPT 260
Query: 285 YEDLFSHPYPDLIHAPCAESHQTAI 309
E L H + E T I
Sbjct: 261 SEVLLKHRF------VLRERPPTVI 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 67/234 (28%), Positives = 103/234 (44%), Gaps = 46/234 (19%)
Query: 104 RAPEGRKRPRYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVC 162
R + +++ VY++ Y D DL + + KL+E Q + ++ QL+ + +L EN++
Sbjct: 79 RPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHIL 137
Query: 163 HFDLKPQNILIKNN-TLKLADFGFAQFL---APNDQGDSIQG----SPL-----YMAPEI 209
H D+K NILI N LK+ADFG A+ PN +G G + L Y PE+
Sbjct: 138 HRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPEL 197
Query: 210 LAGSP-YNAKADLWSLGVLVFEALFGHAPY--ASCNLSQLR----------------AQA 250
L G Y D+W +G VF +F P ++ QL ++
Sbjct: 198 LLGERRYTTAVDIWGIGC-VFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRS 256
Query: 251 LSSAPITI-----PPN------SLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
L P L P+ +D LS+LL DP +R++ D HPY
Sbjct: 257 LPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-16
Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 27/202 (13%)
Query: 109 RKRPRYVYIILEYCDGGDLCSFIRS---HEKLSEFQCQQFVRQLVLALKFLRENNVCHFD 165
+K+P +YI++E GGD +F+R+ K+ E Q V +++L + H D
Sbjct: 64 QKQP--IYIVMELVQGGDFLTFLRTEGPRLKVKELI--QMVENAAAGMEYLESKHCIHRD 119
Query: 166 LKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGS-------PL-YMAPEILAGSPYN 216
L +N L+ + N LK++DFG ++ ++ D + S P+ + APE L Y+
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSR-----EEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 217 AKADLWSLGVLVFEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL 275
+++D+WS G+L++EA G PYA+ + Q R +A+ P + R
Sbjct: 175 SESDVWSFGILLWEAFSLGAVPYANLSNQQTR-EAIEQGVRLPCPELCPDAVYRLMERCW 233
Query: 276 QKDPMRRISYEDLFSHPYPDLI 297
+ DP +R S FS + +L
Sbjct: 234 EYDPGQRPS----FSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 59/196 (30%), Positives = 101/196 (51%), Gaps = 23/196 (11%)
Query: 109 RKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQL---VLALKFLRENNVCHFD 165
+ RP V II EY + G L F+R ++ +F Q V L +K+L E N H D
Sbjct: 76 KSRP--VMIITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMNYVHRD 131
Query: 166 LKPQNILIKNNTL-KLADFGFAQFLAPNDQGDSIQG--SPL-YMAPEILAGSPYNAKADL 221
L +NIL+ +N + K++DFG ++ L ++ + +G P+ + APE +A + + +D+
Sbjct: 132 LAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDV 191
Query: 222 WSLGVLVFEAL-FGHAPYASCNLS-QLRAQALSSAPITIPPNSLSPDCMDFLSRLL---- 275
WS G++++E + +G PY ++S Q +A+ PP DC L +L+
Sbjct: 192 WSFGIVMWEVMSYGERPYW--DMSNQDVIKAVEDGYRLPPPM----DCPSALYQLMLDCW 245
Query: 276 QKDPMRRISYEDLFSH 291
QKD R ++ + S
Sbjct: 246 QKDRNERPTFSQIVST 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 58/232 (25%), Positives = 105/232 (45%), Gaps = 53/232 (22%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
+Y +++Y GGD+ S + E E + ++ +L LA++ + + H D+KP NILI
Sbjct: 76 LYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILID 135
Query: 175 -NNTLKLADFGFA--------------------QFLAPNDQGD----------------- 196
+ +KL DFG + P+D D
Sbjct: 136 LDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQR 195
Query: 197 -----------SIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQ 245
S+ G+P Y+APE+L Y D WS+GV++FE L G P+ + ++
Sbjct: 196 ATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTE 255
Query: 246 LRAQALS-SAPITIPPN-SLSPDCMDFLSRLL--QKDPMRRISYEDLFSHPY 293
+ + ++ + IPP LSP+ +D +++L ++ + R +D+ +HP+
Sbjct: 256 TQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPF 307
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 62/233 (26%), Positives = 103/233 (44%), Gaps = 53/233 (22%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
Y+Y+I+E+ GGDL + + ++ SE + ++ + VLA++ + + H D+KP NILI
Sbjct: 75 YLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI 134
Query: 174 -KNNTLKLADFGFAQ-FLAPND--------QGDSIQ------------------------ 199
+ +KL+DFG + F +D QG S +
Sbjct: 135 DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQI 194
Query: 200 ---------------GSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLS 244
G+P Y+APEI Y + D WSLG ++FE L G P+ S N
Sbjct: 195 ATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSH 254
Query: 245 QLRAQALS-SAPITIPPN-SLSPDCMDFLSRLLQKDPMR--RISYEDLFSHPY 293
+ + ++ + P + LS + D + RL+ R R ++ SHP+
Sbjct: 255 ETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPF 307
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 56/184 (30%), Positives = 89/184 (48%), Gaps = 11/184 (5%)
Query: 116 YIILEYCDGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
++++EYC G + H+K L E + + L +L +N+ H D+K NIL+
Sbjct: 97 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT 155
Query: 175 N-NTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAG---SPYNAKADLWSLGVLVFE 230
+KLADFG A +P +S G+P +MAPE++ Y+ K D+WSLG+ E
Sbjct: 156 EPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 212
Query: 231 ALFGHAPYASCN-LSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLF 289
P + N +S L A + +P T+ N + F+ LQK P R + +L
Sbjct: 213 LAERKPPLFNMNAMSALYHIAQNDSP-TLQSNEWTDSFRGFVDYCLQKIPQERPASAELL 271
Query: 290 SHPY 293
H +
Sbjct: 272 RHDF 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 3e-16
Identities = 66/235 (28%), Positives = 102/235 (43%), Gaps = 60/235 (25%)
Query: 115 VYIILEYCDGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
VY+++E D +LC I+ HE++S + Q++ +K L + H DLKP NI
Sbjct: 97 VYLVMELMDA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNI 150
Query: 172 LIKNN-TLKLADFGFAQFLAPNDQGDSIQGSPL-----YMAPEILAGSPYNAKADLWSLG 225
++K++ TLK+ DFG A+ G S +P Y APE++ G Y D+WS+G
Sbjct: 151 VVKSDCTLKILDFGLAR-----TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 205
Query: 226 VL----------------------VFEALFGHAPYASCNLSQLRAQALSSAP----ITIP 259
+ V E L P L + + P +T P
Sbjct: 206 CIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFP 265
Query: 260 ---PNSLSP-----------DCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAP 300
P+SL P D LS++L DP +RIS ++ HPY ++ + P
Sbjct: 266 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 4e-16
Identities = 50/191 (26%), Positives = 101/191 (52%), Gaps = 16/191 (8%)
Query: 109 RKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFV---RQLVLALKFLRENNVCHFD 165
++RP ++I+ EY G L +++R + + + + A+++L N H D
Sbjct: 70 KQRP--IFIVTEYMANGCLLNYLRERKGK--LGTEWLLDMCSDVCEAMEYLESNGFIHRD 125
Query: 166 LKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGS--PL-YMAPEILAGSPYNAKADL 221
L +N L+ ++N +K++DFG A+++ +DQ S QG+ P+ + PE+ S +++K+D+
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVL-DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184
Query: 222 WSLGVLVFEALF--GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDP 279
WS GVL++E +F G PY + S++ +++S+ P + + + P
Sbjct: 185 WSFGVLMWE-VFSEGKMPYERFSNSEV-VESVSAGYRLYRPKLAPTEVYTIMYSCWHEKP 242
Query: 280 MRRISYEDLFS 290
R +++ L S
Sbjct: 243 EDRPAFKKLLS 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 5e-16
Identities = 68/226 (30%), Positives = 102/226 (45%), Gaps = 41/226 (18%)
Query: 106 PEGRKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFD 165
P R+ + +Y++ E + DL I++++ L+ Q F+ QL+ ALK++ NV H D
Sbjct: 70 PPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRD 128
Query: 166 LKPQNILIKNN-TLKLADFGFAQFLAPNDQGDSI-----QGSPLYMAPEILAGS---PYN 216
LKP+NIL + LK+ DFG A+ +A ND +I + Y APE L GS Y
Sbjct: 129 LKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYT 186
Query: 217 AKADLWSLGVLVFEALFGHAPYASCN-LSQL---------------------RAQALSSA 254
D+WS+G + E L G + N + QL +A+ S+
Sbjct: 187 PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSS 246
Query: 255 PITIPPNSLS-------PDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
P S P + L RLL DP R + E+ + PY
Sbjct: 247 MRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 6e-16
Identities = 56/190 (29%), Positives = 94/190 (49%), Gaps = 28/190 (14%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLA---LKFLRENNVCHFDLKPQNI 171
+YI++E GGD SF+R +K E + +Q V+ + A + +L N H DL +N
Sbjct: 67 IYIVMELVPGGDFLSFLR--KKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNC 124
Query: 172 LI-KNNTLKLADFGFAQFLAPNDQGDSIQGS------PL-YMAPEILAGSPYNAKADLWS 223
L+ +NN LK++DFG ++ + D I S P+ + APE L Y++++D+WS
Sbjct: 125 LVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWS 179
Query: 224 LGVLVFEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQK----D 278
G+L++E G PY Q R Q ++ P C D + +++Q+
Sbjct: 180 YGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQK-----CPDDVYKVMQRCWDYK 234
Query: 279 PMRRISYEDL 288
P R + +L
Sbjct: 235 PENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 51/199 (25%), Positives = 90/199 (45%), Gaps = 39/199 (19%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
+Y+I+E+ GGD+ + + + L+E + Q ++ + VLA+ + + H D+KP N+L+
Sbjct: 76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLD 135
Query: 175 NNT-LKLADFGFAQFLA---------------PND---------------------QGDS 197
+ +KL+DFG L P+D S
Sbjct: 136 SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFS 195
Query: 198 IQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALS-SAPI 256
G+P Y+APE+ + YN D WSLGV+++E L G+ P+ S + + ++ +
Sbjct: 196 TVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETL 255
Query: 257 TIPPN-SLSPDCMDFLSRL 274
PP +S D + R
Sbjct: 256 IFPPEVPISEKAKDLILRF 274
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 1e-15
Identities = 64/216 (29%), Positives = 107/216 (49%), Gaps = 30/216 (13%)
Query: 92 EFERPRAGLSNLRAPEG---RKRPRYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVR 147
+F+ P N+ EG + RP V II E+ + G L SF+R ++ + + Q +R
Sbjct: 61 QFDHP-----NIIHLEGVVTKSRP--VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR 113
Query: 148 QLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLADFGFAQFLAPNDQGDSIQGSPL--- 203
+ +K+L E N H DL +NIL+ +N + K++DFG ++FL +D D S L
Sbjct: 114 GIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE-DDTSDPTYTSSLGGK 172
Query: 204 ----YMAPEILAGSPYNAKADLWSLGVLVFEAL-FGHAPYASCNLSQLRAQALSSAPITI 258
+ APE +A + + +D+WS G++++E + +G PY + +Q A+
Sbjct: 173 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-NQDVINAIEQDYRLP 231
Query: 259 PPNSLSPDCMDFLSRLL----QKDPMRRISYEDLFS 290
PP DC L +L+ QKD R + + S
Sbjct: 232 PP----MDCPTALHQLMLDCWQKDRNARPKFGQIVS 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 63/228 (27%), Positives = 100/228 (43%), Gaps = 47/228 (20%)
Query: 113 RYVYIILEYCDGGDLCSFIRSHEKLSEFQ--CQQFVRQLVLALKFLRENNVCHFDLKPQN 170
+ +Y++ EY D DL + S ++ + ++ Q++ + + + V H DLKPQN
Sbjct: 74 KRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQN 132
Query: 171 ILI--KNNTLKLADFGFAQ-FLAPNDQGDSIQGSPLYMAPEILAGS-PYNAKADLWSLGV 226
+LI + N LKLADFG A+ F P + Y APEIL GS Y+ D+WS+G
Sbjct: 133 LLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGC 192
Query: 227 LVFEALFGHAPY--ASCNLSQL-------------------------------RAQALSS 253
+F + P + +L + L++
Sbjct: 193 -IFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLAT 251
Query: 254 APITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY-PDLIHAP 300
+P +L P +D LS++L+ DP +RI+ H Y DL AP
Sbjct: 252 V---VP--TLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDAP 294
|
Length = 294 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 50/178 (28%), Positives = 76/178 (42%), Gaps = 28/178 (15%)
Query: 143 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLADFGFAQFLAPNDQGDSIQGS 201
+ +RQ + L FL N + H DLKP+NIL+ + +KLADFG A+ + + +
Sbjct: 111 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVT 170
Query: 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCN-----------LSQLRAQA 250
Y APE+L S Y D+WS+G +F +F P N L L +
Sbjct: 171 LWYRAPEVLLQSTYATPVDMWSVGC-IFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 229
Query: 251 LSSAPITIPPNSLSP-------DCM--------DFLSRLLQKDPMRRISYEDLFSHPY 293
+T+P + SP + L +L +P +RIS HP+
Sbjct: 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 64/226 (28%), Positives = 90/226 (39%), Gaps = 63/226 (27%)
Query: 115 VYIILEYCDGGDLCSF--IRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+Y++ E+ DL F + + ++ QL+ L F + V H DLKPQN+L
Sbjct: 74 LYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 132
Query: 173 I-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL-----------YMAPEILAGSPYNAKA- 219
I +KLADFG A+ G P+ Y APEIL G Y + A
Sbjct: 133 INTEGAIKLADFGLARAF----------GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 182
Query: 220 DLWSLGVLVFE-----ALF---------------------------GHAPYASCNLSQLR 247
D+WSLG + E ALF P + +
Sbjct: 183 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWA 242
Query: 248 AQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
Q S +PP L D D LS++L DP +RIS + +HP+
Sbjct: 243 RQDFSK---VVPP--LDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 3e-15
Identities = 48/189 (25%), Positives = 86/189 (45%), Gaps = 20/189 (10%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLV-LALK------FLRENNVCHFDLK 167
YII+E +GGDL S++R +++L+ + L +L + + H DL
Sbjct: 74 QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLA 133
Query: 168 PQNILI------KNNTLKLADFGFAQFLAPNDQGDSIQGSPL----YMAPEILAGSPYNA 217
+N L+ + +K+ DFG A+ + +D +G L +MAPE L +
Sbjct: 134 ARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY-RKEGEGLLPVRWMAPESLLDGKFTT 192
Query: 218 KADLWSLGVLVFEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQ 276
++D+WS GVL++E L G PY + N ++ + + P N ++
Sbjct: 193 QSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENC-PDKIYQLMTNCWA 251
Query: 277 KDPMRRISY 285
+DP R ++
Sbjct: 252 QDPSERPTF 260
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-15
Identities = 57/223 (25%), Positives = 90/223 (40%), Gaps = 44/223 (19%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
++ ++++ DL + +L+E Q + + Q++ L L + H DL P NI I
Sbjct: 94 FINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI 152
Query: 174 -KNNTLKLADFGFAQ-FLAP---NDQGDSIQGSP-----------LYMAPEILAGSP-YN 216
K+ADFG A+ + P + Y APE+L G+ Y+
Sbjct: 153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYH 212
Query: 217 AKADLWSLGVLVFEALFGHAPYASCN-LSQL-RAQALSSAPIT--------IP------- 259
D+WS+G + E L G + N + QL R L P +P
Sbjct: 213 FAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTP 272
Query: 260 --PNSL-------SPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
P L S D +D L LL+ +P+ RIS ++ H Y
Sbjct: 273 RKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315
|
Length = 335 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 6e-15
Identities = 61/222 (27%), Positives = 92/222 (41%), Gaps = 54/222 (24%)
Query: 115 VYIILEY--CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+Y+I E+ D + + + + ++ Q++ + F V H DLKPQN+L
Sbjct: 74 LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLL 133
Query: 173 IKNN-TLKLADFGFAQFLAPNDQGDSIQGSPL-----------YMAPEILAGSP-YNAKA 219
I N +KLADFG A+ G P+ Y APE+L GSP Y+
Sbjct: 134 IDNKGVIKLADFGLARAF----------GIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPV 183
Query: 220 DLWSLGVLVFEALFGHAP--YASCNLSQL----RA------------QALSSAPITIP-- 259
D+WS+G +F + P + + QL R +L T P
Sbjct: 184 DIWSIGT-IFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKW 242
Query: 260 -PNSL-------SPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
SL D +D L ++L DP +RIS + +HPY
Sbjct: 243 KKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 66/249 (26%), Positives = 106/249 (42%), Gaps = 46/249 (18%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
VY+++E D +LC I H +L + + Q++ +K L + H DLKP NI++K
Sbjct: 101 VYLVMELMDA-NLCQVI--HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 157
Query: 175 NN-TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF 233
++ TLK+ DFG A+ N + Y APE++ G Y D+WS+G ++ E +
Sbjct: 158 SDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVK 217
Query: 234 GHAPYASCN--------LSQLRAQALSSAPITIPP----------------NSLSPD--- 266
G + + + QL + P L PD
Sbjct: 218 GSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIF 277
Query: 267 -------------CMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAESHQTAIRIVT 313
D LS++L DP +RIS ++ HPY + + P AE+ +I
Sbjct: 278 PSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDP-AEAEAPPPQI-Y 335
Query: 314 DAIHHDREN 322
DA +RE+
Sbjct: 336 DAQLEEREH 344
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 58/240 (24%), Positives = 91/240 (37%), Gaps = 60/240 (25%)
Query: 113 RYVYIILEYC--DGGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKP 168
+ VY++ +Y D + F R ++ + + + Q++ + +L N V H DLKP
Sbjct: 77 KSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKP 136
Query: 169 QNILI-----KNNTLKLADFGFAQF----LAPNDQGDSIQGSPLYMAPEILAGSPYNAKA 219
NIL+ + +K+ D G A+ L P D + + Y APE+L G+ + KA
Sbjct: 137 ANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKA 196
Query: 220 -DLWSLGVLVFEALFGHAPYASC-----------NLSQL--------------------- 246
D+W++G +F L P QL
Sbjct: 197 IDIWAIGC-IFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKM 255
Query: 247 ---RAQALSSAPITIPPNSL----------SPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
T P NSL D L +LL+ DP +RI+ E+ HPY
Sbjct: 256 PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 39/127 (30%), Positives = 71/127 (55%), Gaps = 3/127 (2%)
Query: 107 EGRKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDL 166
E +R +Y++ EY + L + + + ++ QL+ A+ + +N++ H D+
Sbjct: 67 EAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDI 126
Query: 167 KPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQ--GSPLYMAPEILAGSPYNAKADLWS 223
KP+N+LI N+ LKL DFGFA+ L+ + + + Y +PE+L G+PY D+WS
Sbjct: 127 KPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWS 186
Query: 224 LGVLVFE 230
+G ++ E
Sbjct: 187 VGCILGE 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 58/188 (30%), Positives = 91/188 (48%), Gaps = 19/188 (10%)
Query: 115 VYIILEYCDGGDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+YI+ EY G L F++S E KL Q Q+ + +L N H DL +NIL
Sbjct: 76 IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNIL 135
Query: 173 I-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPE-ILAGSPYNAKADLWSLGVL 227
+ +N K+ADFG A+ + +D+ + +G+ + APE G + K+D+WS G+L
Sbjct: 136 VGENLVCKIADFGLARLIE-DDEYTAREGAKFPIKWTAPEAANYGR-FTIKSDVWSFGIL 193
Query: 228 VFEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL----QKDPMRR 282
+ E + +G PY ++ Q + PPN C + L L+ KDP R
Sbjct: 194 LTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPN-----CPEELYDLMLQCWDKDPEER 248
Query: 283 ISYEDLFS 290
++E L S
Sbjct: 249 PTFEYLQS 256
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 54/232 (23%), Positives = 105/232 (45%), Gaps = 53/232 (22%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
+Y +++Y GGD+ S + E + ++ +L A++ + + H D+KP NILI
Sbjct: 76 LYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILID 135
Query: 174 KNNTLKLADFGF---------AQFLAPNDQ--------------------GD-------- 196
++ +KL DFG +++ D GD
Sbjct: 136 RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERR 195
Query: 197 -----------SIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQ 245
S+ G+P Y+APE+L + Y D WS+GV+++E L G P+ + +
Sbjct: 196 AARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLE 255
Query: 246 LRAQALS-SAPITIPPNS-LSPDCMDFLSRLLQ--KDPMRRISYEDLFSHPY 293
+ + ++ + IPP + LSP+ D + +L + +D + + +++ +HP+
Sbjct: 256 TQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPF 307
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 43/175 (24%), Positives = 87/175 (49%), Gaps = 7/175 (4%)
Query: 117 IILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI-LIKN 175
+++E + G L F++ ++ ++E + V Q+ + +K+L E N H DL +N+ L+
Sbjct: 72 LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQ 131
Query: 176 NTLKLADFGFAQFLAPNDQGDSIQGS---PL-YMAPEILAGSPYNAKADLWSLGVLVFEA 231
+ K++DFG ++ L ++ + P+ + APE + +++K+D+WS GVL++EA
Sbjct: 132 HYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEA 191
Query: 232 L-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY 285
+G PY +++ Q + S P P+ D + R +
Sbjct: 192 FSYGQKPYKGMKGNEV-TQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGF 245
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 3e-14
Identities = 52/169 (30%), Positives = 77/169 (45%), Gaps = 32/169 (18%)
Query: 110 KRPRYVYIILEYCDGGDLCSFIRS----HEKLSEFQCQQFVRQLVLALKFLRE------- 158
K + +YI++E+CD GDL I+ K+ E RQL+ AL +
Sbjct: 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNG 143
Query: 159 NNVCHFDLKPQNILIKN------------NTL------KLADFGFAQFLAPNDQGDSIQG 200
V H DLKPQNI + N L K+ DFG ++ + S G
Sbjct: 144 ERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVG 203
Query: 201 SPLYMAPEIL--AGSPYNAKADLWSLGVLVFEALFGHAPYASC-NLSQL 246
+P Y +PE+L Y+ K+D+W+LG +++E G P+ N SQL
Sbjct: 204 TPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 3e-14
Identities = 66/252 (26%), Positives = 107/252 (42%), Gaps = 61/252 (24%)
Query: 99 GLSNLRAPEGR-KRPRYVYIILEYCDGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALK 154
GL N+ P+ + + VYI++E D +LC I+ HE++S + Q++ +K
Sbjct: 87 GLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMS-----YLLYQMLCGIK 140
Query: 155 FLRENNVCHFDLKPQNILIKNN-TLKLADFGFAQFLAPNDQGDSIQGSP-----LYMAPE 208
L + H DLKP NI++K++ TLK+ DFG A+ G S +P Y APE
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----TAGTSFMMTPYVVTRYYRAPE 195
Query: 209 ILAGSPYNAKADLWSLGVLVFEALFGHAPY-----------------ASCNLSQLRAQAL 251
++ G Y D+WS+G ++ E + G + C + Q
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255
Query: 252 SSAPITIPPN-------SLSPDCM----------------DFLSRLLQKDPMRRISYEDL 288
+ P L PD + D LS++L D +RIS ++
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 289 FSHPYPDLIHAP 300
HPY ++ + P
Sbjct: 316 LQHPYINVWYDP 327
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-14
Identities = 47/157 (29%), Positives = 85/157 (54%), Gaps = 9/157 (5%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRE-NNVCHFDLKPQNILI 173
+ I +E+ DGG L ++ +++ E + ++ L +LRE + + H D+KP NIL+
Sbjct: 78 ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV 137
Query: 174 KN-NTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
+ +KL DFG + L + +S G+ YM+PE L G+ Y+ ++D+WS+G+ + E
Sbjct: 138 NSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELA 196
Query: 233 FGHAPYASCNLSQLRAQALSSAPIT----IPPNSLSP 265
G P + +L +A+ P+ P+S+SP
Sbjct: 197 IGRYPIPPPDAKEL--EAIFGRPVVDGEEGEPHSISP 231
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 41/129 (31%), Positives = 74/129 (57%), Gaps = 7/129 (5%)
Query: 117 IILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 175
II EY + G L ++R H+ + S +Q +R + +K+L + N H DL +NIL+ +
Sbjct: 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNS 142
Query: 176 NTL-KLADFGFAQFLAPNDQGD-SIQGSPL---YMAPEILAGSPYNAKADLWSLGVLVFE 230
N K++DFG ++ L + +G + G + + APE +A + + +D+WS G++++E
Sbjct: 143 NLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWE 202
Query: 231 AL-FGHAPY 238
+ FG PY
Sbjct: 203 VMSFGERPY 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 21/152 (13%)
Query: 116 YIILEYCDGGDLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLREN 159
Y+++EY G+L F+R+ E L++ F Q+ ++FL
Sbjct: 92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK 151
Query: 160 NVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPY 215
H DL +N+L+ +++ +K+ADFG A+ + D L +MAPE L Y
Sbjct: 152 KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY 211
Query: 216 NAKADLWSLGVLVFEAL-FGHAPYASCNLSQL 246
++D+WS GVL++E G +PY + +L
Sbjct: 212 THQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 43/132 (32%), Positives = 70/132 (53%), Gaps = 9/132 (6%)
Query: 115 VYIILEYCDGGDLCSFIRS--HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+ +I EYC GDL +F+R L+ F Q+ + FL N H DL +N+L
Sbjct: 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVL 173
Query: 173 IKNNTL-KLADFGFAQFLAPNDQGDSIQGS---PL-YMAPEILAGSPYNAKADLWSLGVL 227
+ + + K+ DFG A+ + ND ++G+ P+ +MAPE + Y ++D+WS G+L
Sbjct: 174 LTHGKIVKICDFGLARDIM-NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIL 232
Query: 228 VFEAL-FGHAPY 238
++E G PY
Sbjct: 233 LWEIFSLGSNPY 244
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 60/223 (26%), Positives = 93/223 (41%), Gaps = 36/223 (16%)
Query: 105 APEGRKRPRYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCH 163
A + +K Y++ EY D DL + S SE + F++QL+ L + + N H
Sbjct: 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLH 139
Query: 164 FDLKPQNILIKNN-TLKLADFGFAQFLAPNDQGDSIQG--SPLYMAPEILAGSP-YNAKA 219
D+K NIL+ N +KLADFG A+ + + Y PE+L G Y
Sbjct: 140 RDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAI 199
Query: 220 DLWSLGVLVFEALFGHAPY--ASCNLSQLRA-QALSSAPI--------------TIPPNS 262
D+WS G ++ E LF P A+ L+QL L +P T+ P
Sbjct: 200 DVWSCGCILGE-LFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKK 258
Query: 263 ------------LSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
+ +D L +L DP +R + E+ + P+
Sbjct: 259 QYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 6e-14
Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 35/212 (16%)
Query: 115 VYIILEYCDGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+++++EYC+ DL S + + SE Q + + QL+ L++L EN + H DLK N+L+
Sbjct: 83 IFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL 141
Query: 174 KNN-TLKLADFGFAQFLAPNDQGDSIQGSPL-YMAPEILAGSPYNAKA-DLWSLGVLVFE 230
+ LK+ADFG A+ + + + L Y APE+L G A D+W++G ++ E
Sbjct: 142 TDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAE 201
Query: 231 ALFGHAPY--ASCNLSQLR--AQALSSAPITIPPN------------------------- 261
L H P + QL Q L + +I P
Sbjct: 202 -LLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFP 260
Query: 262 SLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
LS + L+ LL DP +R + E+ Y
Sbjct: 261 WLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 6e-14
Identities = 44/145 (30%), Positives = 79/145 (54%), Gaps = 13/145 (8%)
Query: 109 RKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFV---RQLVLALKFLRENNVCHFD 165
++RP +YI+ EY G L +++R H K FQ Q + + + + +L H D
Sbjct: 70 KQRP--IYIVTEYMSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQFIHRD 125
Query: 166 LKPQNILIKNN-TLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPYNAKADL 221
L +N L+ + +K++DFG ++++ +D+ S GS + PE+L S +++K+D+
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDV 184
Query: 222 WSLGVLVFEAL-FGHAPYASCNLSQ 245
W+ GVL++E G PY N S+
Sbjct: 185 WAFGVLMWEVYSLGKMPYERFNNSE 209
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 8e-14
Identities = 39/130 (30%), Positives = 72/130 (55%), Gaps = 7/130 (5%)
Query: 115 VYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+ ++ E+ + G L ++R+ K S+ + + +L +NV H DL +N L+
Sbjct: 74 ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV 133
Query: 174 -KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPYNAKADLWSLGVLVF 229
+N +K++DFG +F+ +DQ S G+ + +PE+ + S Y++K+D+WS GVL++
Sbjct: 134 GENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMW 192
Query: 230 EALF-GHAPY 238
E G PY
Sbjct: 193 EVFSEGKTPY 202
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 9e-14
Identities = 50/182 (27%), Positives = 86/182 (47%), Gaps = 15/182 (8%)
Query: 115 VYIILEYCDGGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+YI+ EY G L ++RS + L +F + A+++L NN H DL +N+L
Sbjct: 75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVL 134
Query: 173 I-KNNTLKLADFGFAQFLAPNDQGDSIQGS---PL-YMAPEILAGSPYNAKADLWSLGVL 227
+ ++N K++DFG + + S Q + P+ + APE L ++ K+D+WS G+L
Sbjct: 135 VSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL 188
Query: 228 VFEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYE 286
++E FG PY L + + + P+ P D + + D R S+
Sbjct: 189 LWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD-APDGCPPVVYDVMKQCWHLDAATRPSFL 247
Query: 287 DL 288
L
Sbjct: 248 QL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 49/183 (26%), Positives = 84/183 (45%), Gaps = 9/183 (4%)
Query: 115 VYIILEYCDGGDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+YI+ EY G L F++ E L Q+ + ++ N H DL+ NIL
Sbjct: 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANIL 134
Query: 173 IKNNTL-KLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPYNAKADLWSLGVLV 228
+ + + K+ADFG A+ + N+ + QG+ + APE + K+D+WS G+L+
Sbjct: 135 VGDGLVCKIADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 193
Query: 229 FEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYED 287
E + G PY N ++ Q + P + + + + +KDP R ++E
Sbjct: 194 TELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDC-PISLHELMLQCWKKDPEERPTFEY 252
Query: 288 LFS 290
L S
Sbjct: 253 LQS 255
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 38/111 (34%), Positives = 63/111 (56%), Gaps = 6/111 (5%)
Query: 126 DLCSFI-RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLADF 183
DL +++ + L Q +Q++ L++L + H D+K +NI I + + + + D
Sbjct: 142 DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDL 201
Query: 184 GFAQF--LAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
G AQF +AP G + G+ APE+LA YN+KAD+WS G+++FE L
Sbjct: 202 GAAQFPVVAPAFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 59/212 (27%), Positives = 88/212 (41%), Gaps = 36/212 (16%)
Query: 117 IILEYCDGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 175
++ EY D DL ++ LS + F+ QL+ L + + V H DLKPQN+LI
Sbjct: 80 LVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISE 138
Query: 176 -NTLKLADFGFAQFLAPNDQGDSIQGSPL-YMAPEILAGSP-YNAKADLWSLGVLVFEAL 232
LKLADFG A+ + + S + L Y P++L GS Y+ D+W +G + +E
Sbjct: 139 RGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMA 198
Query: 233 FGHA--PYASCNLSQL-------------RAQALSSAP----------------ITIPPN 261
G P ++ QL +SS P P
Sbjct: 199 TGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRL 258
Query: 262 SLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
P + + LQ +P +RIS + HPY
Sbjct: 259 DRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-13
Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 10/146 (6%)
Query: 100 LSNLRAPEGRKRPRYVYIILEYCDGGDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLR 157
L L A ++ P +YII EY G L F++S E K+ + F Q+ + ++
Sbjct: 63 LVRLYAVVTKEEP--IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 120
Query: 158 ENNVCHFDLKPQNILIKNNTL-KLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGS 213
N H DL+ N+L+ + + K+ADFG A+ + +++ + +G+ + APE +
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFG 179
Query: 214 PYNAKADLWSLGVLVFEAL-FGHAPY 238
+ K+D+WS G+L++E + +G PY
Sbjct: 180 SFTIKSDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 46/186 (24%), Positives = 86/186 (46%), Gaps = 19/186 (10%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVR---QLVLALKFLRENNVCHFDLKPQNI 171
+YI+ E G L +++ + Q + Q+ + +L N H DL +N+
Sbjct: 76 IYIVTELMKYGSLLEYLQ-GGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNV 134
Query: 172 LI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPYNAKADLWSLGVL 227
L+ +NN K+ADFG A+ + + ++ +G+ + APE + ++ K+D+WS G+L
Sbjct: 135 LVGENNICKVADFGLARVIKEDIY-EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGIL 193
Query: 228 VFEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQK----DPMRR 282
+ E + +G PY +++ Q + PP C L ++ DP R
Sbjct: 194 LTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPG-----CPKELYDIMLDCWKEDPDDR 248
Query: 283 ISYEDL 288
++E L
Sbjct: 249 PTFETL 254
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 45/192 (23%), Positives = 87/192 (45%), Gaps = 18/192 (9%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQC-------QQFVR---QLVLALKFLRENNVCHF 164
+++E GDL S++RS +E Q+F++ ++ + +L H
Sbjct: 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHR 143
Query: 165 DLKPQNILIKNN-TLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPYNAKAD 220
DL +N ++ + T+K+ DFG + + D L +MAPE L + K+D
Sbjct: 144 DLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSD 203
Query: 221 LWSLGVLVFE-ALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPD-CMDFLSRLLQKD 278
+WS GV+++E A PY + ++ + + +P N PD ++ + Q +
Sbjct: 204 VWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPEN--CPDKLLELMRMCWQYN 261
Query: 279 PMRRISYEDLFS 290
P R ++ ++ S
Sbjct: 262 PKMRPTFLEIVS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 55/225 (24%), Positives = 96/225 (42%), Gaps = 47/225 (20%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENN-VCHFDLKPQNILI 173
+ I +E+ DGG L ++ ++ E + ++ L +LRE + + H D+KP NIL+
Sbjct: 78 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV 137
Query: 174 KN-NTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
+ +KL DFG + L + +S G+ YM+PE L G+ Y+ ++D+WS+G+ + E
Sbjct: 138 NSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 196
Query: 233 FGHAPYASCNLSQLR----------AQALSSAPITIPP----NSLSPDC----------- 267
G P + +L ++P PP +S PD
Sbjct: 197 IGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLD 256
Query: 268 -------------------MDFLSRLLQKDPMRRISYEDLFSHPY 293
DF+++ L K+P R + L H +
Sbjct: 257 YIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 3e-13
Identities = 55/199 (27%), Positives = 86/199 (43%), Gaps = 29/199 (14%)
Query: 85 DTITSHSEFERPRAGLSNLRAPE--------GRKRPRYVYIILEYCDGGDLCSFIRSHE- 135
D + +F++ L LR P VYII E + G L +F+RS E
Sbjct: 41 DDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEP--VYIITELMEKGSLLAFLRSPEG 98
Query: 136 ------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLADFGFAQF 188
L + CQ + + +L E N H DL +NIL+ + + K+ADFG A+
Sbjct: 99 QVLPVASLIDMACQ-----VAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARL 153
Query: 189 LAPNDQGDSIQGSPL-YMAPEILAGSPYNAKADLWSLGVLVFEAL-FGHAPYASCN---- 242
+ + S + P + APE + ++ K+D+WS G+L++E +G PY N
Sbjct: 154 IKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV 213
Query: 243 LSQLRAQALSSAPITIPPN 261
Q+ A P P
Sbjct: 214 YDQITAGYRMPCPAKCPQE 232
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 57/174 (32%), Positives = 76/174 (43%), Gaps = 30/174 (17%)
Query: 148 QLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLADFGFAQFLAPNDQGDSIQGSPLYMA 206
QL+ L FL + V H DLKPQNIL+ ++ +KLADFG A+ + S+ + Y A
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 177
Query: 207 PEILAGSPYNAKADLWSLGVLVFEALFGHAPY--ASCNLSQLRA---------------- 248
PE+L S Y DLWS+G +F +F P S ++ QL
Sbjct: 178 PEVLLQSSYATPVDLWSVGC-IFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236
Query: 249 -----QALSSAPITIPPNSLSPDC----MDFLSRLLQKDPMRRISYEDLFSHPY 293
QA S P D D L + L +P +RIS SHPY
Sbjct: 237 VALPRQAFHSKSAQ-PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 54/228 (23%), Positives = 97/228 (42%), Gaps = 44/228 (19%)
Query: 106 PEGRKRPRYVYIILEYCDGGDLCSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHF 164
P R + + Y++ E+C+ DL + + + K + + ++ ++ L+ L ++ N + H
Sbjct: 86 PYNRYKGSF-YLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHR 143
Query: 165 DLKPQNILI-KNNTLKLADFGFAQ-FLAP-NDQGDSIQGSPL---YMAPEILAGS-PYNA 217
D+K NILI K+ LKLADFG A+ F N + + + Y PE+L G Y
Sbjct: 144 DMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGP 203
Query: 218 KADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDC---------- 267
D+W G ++ E ++ +P N Q + +S +I P + P
Sbjct: 204 PIDMWGAGCIMAE-MWTRSPIMQGNTEQHQLTLISQLCGSITP-EVWPGVDKLELFKKME 261
Query: 268 ----------------------MDFLSRLLQKDPMRRISYEDLFSHPY 293
+D + +LL DP +RI + +H +
Sbjct: 262 LPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 6e-13
Identities = 40/137 (29%), Positives = 77/137 (56%), Gaps = 11/137 (8%)
Query: 111 RPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFV---RQLVLALKFLRENNVCHFDLK 167
+ + V I+ EY + G L +F+R H+ +F Q V R + +K+L + H DL
Sbjct: 76 KSKPVMIVTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLA 133
Query: 168 PQNILIKNNTL-KLADFGFAQFLAPN-DQGDSIQGSPL---YMAPEILAGSPYNAKADLW 222
+NIL+ +N + K++DFG ++ L + + + +G + + APE +A + + +D+W
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVW 193
Query: 223 SLGVLVFEAL-FGHAPY 238
S G++++E + +G PY
Sbjct: 194 SYGIVMWEVMSYGERPY 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 6e-13
Identities = 50/182 (27%), Positives = 85/182 (46%), Gaps = 11/182 (6%)
Query: 115 VYIILEYCDGGDLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+YI+ EY G L F++ + L Q Q+ + ++ N H DL+ NIL
Sbjct: 75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 134
Query: 173 IKNNTL-KLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPYNAKADLWSLGVLV 228
+ N + K+ADFG A+ + N+ + QG+ + APE + K+D+WS G+L+
Sbjct: 135 VGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 193
Query: 229 FE-ALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCM-DFLSRLLQKDPMRRISYE 286
E G PY ++ Q + PP P+ + D + + +K+P R ++E
Sbjct: 194 TELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE--CPESLHDLMCQCWRKEPEERPTFE 251
Query: 287 DL 288
L
Sbjct: 252 YL 253
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 9e-13
Identities = 57/186 (30%), Positives = 81/186 (43%), Gaps = 43/186 (23%)
Query: 145 FVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLADFGFAQFLAPNDQGDSIQGSPL 203
F+ QL+ L + V H DLKPQN+LI LKLADFG A+ + + S + L
Sbjct: 109 FLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTL 168
Query: 204 -YMAPEILAGSP-YNAKADLWSLGVLVFEALFG--------------------------- 234
Y P+IL GS Y+ + D+W +G + +E G
Sbjct: 169 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEET 228
Query: 235 ------HAPYASCNLSQLRAQAL-SSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYED 287
+ + S N + RA L + AP L D + LS+LLQ + +RIS E+
Sbjct: 229 WPGILSNEEFKSYNYPKYRADCLHNHAP------RLDSDGAELLSKLLQFEGRKRISAEE 282
Query: 288 LFSHPY 293
HPY
Sbjct: 283 AMKHPY 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 65/225 (28%), Positives = 103/225 (45%), Gaps = 45/225 (20%)
Query: 116 YIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 175
Y+++ + G DL ++ HEKLSE + Q V Q++ LK++ + H DLKP N+ +
Sbjct: 96 YLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNE 153
Query: 176 N-TLKLADFGFAQFLAPNDQGDS-IQG---SPLYMAPE-ILAGSPYNAKADLWSLGVLVF 229
+ LK+ DFG A+ Q DS + G + Y APE IL Y D+WS+G ++
Sbjct: 154 DCELKILDFGLAR------QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMA 207
Query: 230 EALFGHAPY-ASCNLSQLR-------------AQALSSAPI----------------TIP 259
E L G + +L QL Q L S ++
Sbjct: 208 EMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLL 267
Query: 260 PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAES 304
PN+ +P ++ L ++L D RI+ + +HPY + H P E+
Sbjct: 268 PNA-NPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDET 311
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 41/131 (31%), Positives = 69/131 (52%), Gaps = 8/131 (6%)
Query: 115 VYIILEYCDGGDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+YII EY + G L F+++ E KL+ + Q+ + F+ N H DL+ NIL
Sbjct: 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANIL 134
Query: 173 IKNN-TLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPYNAKADLWSLGVLV 228
+ K+ADFG A+ + N+ + +G+ + APE + + K+D+WS G+L+
Sbjct: 135 VSETLCCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 193
Query: 229 FEAL-FGHAPY 238
E + +G PY
Sbjct: 194 TEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 63/219 (28%), Positives = 93/219 (42%), Gaps = 45/219 (20%)
Query: 113 RYVYIILEYCDGGDLCSFIRSHEKL-SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
R + ++ EY D DL ++ + L S + F+ QL+ L + + + H DLKPQN+
Sbjct: 76 RCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNL 134
Query: 172 LIKNN-TLKLADFGFAQFLAPNDQGDSIQGSPL-YMAPEILAGSP-YNAKADLWSLGVLV 228
LI LKLADFG A+ + + S + L Y P++L GS Y+ D+W +G ++
Sbjct: 135 LINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCIL 194
Query: 229 FEALFG---------------------------------HAPYASCNLSQLRAQAL-SSA 254
+E G + + S Q RAQ L + A
Sbjct: 195 YEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHA 254
Query: 255 PITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
P L D +D LS LL + RIS E H Y
Sbjct: 255 P------RLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 39/136 (28%), Positives = 71/136 (52%), Gaps = 10/136 (7%)
Query: 106 PEGRKRPRYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHF 164
G + R +I+EY G L +++ H ++++ + F Q+ + +L H
Sbjct: 77 KPGGRSLR---LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHR 133
Query: 165 DLKPQNILIKNNTL-KLADFGFAQFLAPNDQ---GDSIQGSPL-YMAPEILAGSPYNAKA 219
DL +NIL+++ L K++DFG A+ L + SP+ + APE L S +++ +
Sbjct: 134 DLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSAS 193
Query: 220 DLWSLGVLVFEALFGH 235
D+WS GV ++E LF +
Sbjct: 194 DVWSFGVTLYE-LFTY 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 3e-12
Identities = 36/129 (27%), Positives = 71/129 (55%), Gaps = 7/129 (5%)
Query: 117 IILEYCDGGDLCSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 175
+++E GG L F+ ++++ + + Q+ + +K+L N H DL +N+L+ N
Sbjct: 71 LVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVN 130
Query: 176 NTL-KLADFGFAQFLAPND---QGDSIQGSPL-YMAPEILAGSPYNAKADLWSLGVLVFE 230
K++DFG ++ L +D + S PL + APE + +++++D+WS G+ ++E
Sbjct: 131 QHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWE 190
Query: 231 AL-FGHAPY 238
A +G PY
Sbjct: 191 AFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 58/209 (27%), Positives = 90/209 (43%), Gaps = 36/209 (17%)
Query: 131 IRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLADFGFAQFL 189
I H LSE + Q V Q++ LK++ + H DLKP N+ + + LK+ DFG A+
Sbjct: 109 IMGHP-LSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167
Query: 190 APNDQGDSIQGSPLYMAPE-ILAGSPYNAKADLWSLGVLVFEALFGHAPYASCN-LSQLR 247
G + + Y APE IL YN D+WS+G ++ E L G + + L QL
Sbjct: 168 DAEMTGYVV--TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT 225
Query: 248 A-------------------------QALSSAP----ITIPPNSLSPDCMDFLSRLLQKD 278
++L P T+ P + SP +D L ++L+ D
Sbjct: 226 QILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKA-SPQAVDLLEKMLELD 284
Query: 279 PMRRISYEDLFSHPYPDLIHAPCAESHQT 307
+R++ + HPY D E+ Q
Sbjct: 285 VDKRLTATEALEHPYFDSFRDADEETEQQ 313
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 4e-12
Identities = 46/187 (24%), Positives = 82/187 (43%), Gaps = 10/187 (5%)
Query: 117 IILEYCDGGDLCSFIRS--HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
++L +GGDL I + + E + + ++ L+ L + + DLKP+NIL+
Sbjct: 77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD 136
Query: 175 N-NTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF 233
+ ++++D G A + + G+ YMAPE++ Y D W LG L++E +
Sbjct: 137 DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIE 196
Query: 234 GHAPYASCNLSQLRAQALSSAPITIPPNS--LSPDCMDFLSRLLQKDPMRRI-----SYE 286
G +P+ R + S S +LL KDP R+ E
Sbjct: 197 GKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAE 256
Query: 287 DLFSHPY 293
++ +HP+
Sbjct: 257 EVKAHPF 263
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 5e-12
Identities = 49/183 (26%), Positives = 90/183 (49%), Gaps = 9/183 (4%)
Query: 115 VYIILEYCDGGDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+YII E+ G L F++S E K + F Q+ + F+ + N H DL+ NIL
Sbjct: 75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 134
Query: 173 IKNNTL-KLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPYNAKADLWSLGVLV 228
+ + + K+ADFG A+ + N+ + +G+ + APE + + K+D+WS G+L+
Sbjct: 135 VSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 193
Query: 229 FEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYED 287
E + +G PY + ++ +AL P + + + + R + P R ++E
Sbjct: 194 MEIVTYGRIPYPGMSNPEV-IRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEY 252
Query: 288 LFS 290
+ S
Sbjct: 253 IQS 255
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 36/211 (17%)
Query: 118 ILEYCDGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN- 175
+ EY DL ++ H L + + F+ QL+ L ++ ++ H DLKPQN+LI
Sbjct: 81 VFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYL 139
Query: 176 NTLKLADFGFAQFLAPNDQGDSIQGSPL-YMAPEILAGSP-YNAKADLWSLGVLVFEALF 233
LKLADFG A+ + Q S + L Y P++L G+ Y++ D+W G + E L
Sbjct: 140 GELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQ 199
Query: 234 GHA--PYASCNLSQLRA-------------QALSSAP-------ITIPPNSL-------- 263
G P S QL +S P + P L
Sbjct: 200 GQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLS 259
Query: 264 -SPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
P D S++L P RIS +D HPY
Sbjct: 260 RPPKAEDLASQMLMMFPKDRISAQDALLHPY 290
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 34/208 (16%)
Query: 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAD 182
G DL + ++ +KLS+ Q + QL+ LK++ + H DLKP N+ + + L++ D
Sbjct: 103 GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILD 161
Query: 183 FGFAQFLAPNDQGDSIQGSPLYMAPEI-LAGSPYNAKADLWSLGVLVFEALFGHAPYASC 241
FG A+ +D+ + Y APEI L YN D+WS+G ++ E L G A +
Sbjct: 162 FGLAR--QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219
Query: 242 N-LSQLR---------------------AQALSSAPITIPPNSLS-------PDCMDFLS 272
+ + QL+ A+ + +P L P +D L
Sbjct: 220 DYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLE 279
Query: 273 RLLQKDPMRRISYEDLFSHPYPDLIHAP 300
++L D +RIS + +HPY H P
Sbjct: 280 KMLVLDSDKRISASEALAHPYFSQYHDP 307
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 34/208 (16%)
Query: 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAD 182
G DL + ++ +KL++ Q + Q++ LK++ ++ H DLKP N+ + + LK+ D
Sbjct: 105 GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 163
Query: 183 FGFAQFLAPNDQGDSIQGSPLYMAPEI-LAGSPYNAKADLWSLGVLVFEALFGHAPYASC 241
FG A+ D+ + Y APEI L YN D+WS+G ++ E L G +
Sbjct: 164 FGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221
Query: 242 N-LSQLR----------AQALSSAPITIPPNSLS------------------PDCMDFLS 272
+ + QL+ A+ L N + P +D L
Sbjct: 222 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 281
Query: 273 RLLQKDPMRRISYEDLFSHPYPDLIHAP 300
++L D +RI+ +H Y H P
Sbjct: 282 KMLVLDSDKRITAAQALAHAYFAQYHDP 309
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 39/138 (28%), Positives = 70/138 (50%), Gaps = 6/138 (4%)
Query: 115 VYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
V +I + G L ++R+H + + + Q+ + +L E + H DL +N+L+
Sbjct: 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV 142
Query: 174 KN-NTLKLADFGFAQFLAPNDQGDSIQGS--PL-YMAPEILAGSPYNAKADLWSLGVLVF 229
K +K+ DFG A+ L +++ +G P+ +MA E + Y K+D+WS GV V+
Sbjct: 143 KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVW 202
Query: 230 EAL-FGHAPYASCNLSQL 246
E + FG PY ++
Sbjct: 203 ELMTFGAKPYEGIPAVEI 220
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 50/184 (27%), Positives = 85/184 (46%), Gaps = 19/184 (10%)
Query: 115 VYIILEYCDGGDLCSFIRS----HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 170
+YI+ E+ G L F++ + KL Q Q+ + ++ N H DL+ N
Sbjct: 75 IYIVTEFMGKGSLLDFLKEGDGKYLKLP--QLVDMAAQIADGMAYIERMNYIHRDLRAAN 132
Query: 171 ILIKNNTL-KLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPYNAKADLWSLGV 226
IL+ +N + K+ADFG A+ + N+ + QG+ + APE + K+D+WS G+
Sbjct: 133 ILVGDNLVCKIADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 191
Query: 227 LVFEALF-GHAPYASCNLSQLRAQALSSAPITIP---PNSLSPDCMDFLSRLLQKDPMRR 282
L+ E + G PY ++ Q + P P SL + + +KDP R
Sbjct: 192 LLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLH----ELMKLCWKKDPDER 247
Query: 283 ISYE 286
++E
Sbjct: 248 PTFE 251
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 38/138 (27%), Positives = 77/138 (55%), Gaps = 9/138 (6%)
Query: 109 RKRPRYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLK 167
+++P +YI+ E+ + G L +++R + KLS+ + + +++L N+ H DL
Sbjct: 70 QQKP--LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLA 127
Query: 168 PQNILIKN-NTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPYNAKADLWS 223
+N L+ + +K++DFG +++ +D+ S G+ + PE+ S Y++K+D+WS
Sbjct: 128 ARNCLVSSTGVVKVSDFGMTRYVL-DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWS 186
Query: 224 LGVLVFEALF-GHAPYAS 240
GVL++E G P+
Sbjct: 187 FGVLMWEVFTEGKMPFEK 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 45/176 (25%), Positives = 84/176 (47%), Gaps = 13/176 (7%)
Query: 117 IILEYCDGGDLCSFI--RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
++L +GGDL I E + + ++ L+ L + + + DLKP+NIL+
Sbjct: 77 LVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLD 136
Query: 175 NNT-LKLADFGFAQFLAPNDQGDSIQG---SPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
++ ++++D G A + +G +I+G + YMAPE++ Y D W+LG L++E
Sbjct: 137 DHGHIRISDLGLAVHVP---EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYE 193
Query: 231 ALFGHAPYASCNLSQLRAQALSSAPITIP---PNSLSPDCMDFLSRLLQKDPMRRI 283
+ G +P+ +++ + + + SPD LL KDP R+
Sbjct: 194 MIAGQSPFQQ-RKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 35/210 (16%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
VY++ G DL + ++ +KLS+ Q V Q++ LK++ + H DLKP NI +
Sbjct: 95 VYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 152
Query: 174 KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEI-LAGSPYNAKADLWSLGVLVFEAL 232
++ LK+ DFG A+ +D+ + Y APEI L YN D+WS+G ++ E L
Sbjct: 153 EDCELKILDFGLARHT--DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 210
Query: 233 FGHAPYASCN-LSQLR---------------------AQA-LSSAPITIPPN------SL 263
G + + + QL+ A+ + S P +
Sbjct: 211 TGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGA 270
Query: 264 SPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
+P +D L ++L DP +RI+ + +HPY
Sbjct: 271 NPLAIDLLEKMLVLDPDKRITAAEALAHPY 300
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 50/195 (25%), Positives = 91/195 (46%), Gaps = 16/195 (8%)
Query: 117 IILEYCDGGDLCSFIRS--HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
++L +GGDL I + + E + + +++ L+ L N + DLKP+NIL+
Sbjct: 77 LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD 136
Query: 175 NNT-LKLADFGFAQFLAPNDQGDSIQG---SPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
+ ++++D G A + +G+SI+G + YMAPE+L Y D W LG L++E
Sbjct: 137 DYGHIRISDLGLAVKIP---EGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYE 193
Query: 231 ALFGHAPYASCNLSQLRAQALSSAPIT--IPPNSLSPDCMDFLSRLLQKDPMRRISYE-- 286
+ G +P+ R + T + S + LL KDP +R+ +
Sbjct: 194 MIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEE 253
Query: 287 ---DLFSHPYPDLIH 298
++ HP+ ++
Sbjct: 254 GAGEVKRHPFFRNMN 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 92 EFERPRA----GLSNLRAPEGRKRPRYVYIILEYCDGGDLCSFI---RSHEKLSEFQCQQ 144
EF+ P G+S +GR V IL + GDL +F+ R E+ Q
Sbjct: 57 EFDHPNVIKLIGVSLRSRAKGRLPIPMV--ILPFMKHGDLHTFLLMSRIGEEPFTLPLQT 114
Query: 145 FVRQLV---LALKFLRENNVCHFDLKPQN-ILIKNNTLKLADFGFAQFLAPND---QGDS 197
VR ++ +++L N H DL +N +L +N T+ +ADFG ++ + D QG +
Sbjct: 115 LVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 198 IQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE-ALFGHAPYASCNLSQLRAQALSSAPI 256
+ ++A E LA + Y +D+W+ GV ++E G PYA S++ + +
Sbjct: 175 SKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRL 234
Query: 257 TIPPNSLSPDCMDFLSRLLQKDPMRRISYEDL 288
PP+ L D + + + +P R S++ L
Sbjct: 235 KQPPDCLE-DVYELMCQCWSPEPKCRPSFQHL 265
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 49/173 (28%), Positives = 84/173 (48%), Gaps = 14/173 (8%)
Query: 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLADFG 184
DL + + E L C F Q+ ++FL H DL +NIL+ +NN +K+ DFG
Sbjct: 170 DLYKKVLTLEDLI---CYSF--QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFG 224
Query: 185 FAQ--FLAPN--DQGDSIQGSPL-YMAPEILAGSPYNAKADLWSLGVLVFEAL-FGHAPY 238
A+ + P+ +GD+ PL +MAPE + Y ++D+WS GVL++E G +PY
Sbjct: 225 LARDIYKDPDYVRKGDA--RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282
Query: 239 ASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291
+ + + L P+ +P+ + +P +R ++ +L H
Sbjct: 283 PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 47/153 (30%), Positives = 75/153 (49%), Gaps = 9/153 (5%)
Query: 142 CQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQG 200
C F Q+ ++FL H DL +NIL+ +NN +K+ DFG A+ + D +G
Sbjct: 178 CYSF--QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIY-KDPDYVRKG 234
Query: 201 S---PL-YMAPEILAGSPYNAKADLWSLGVLVFEAL-FGHAPYASCNLSQLRAQALSSAP 255
S PL +MAPE + Y ++D+WS GVL++E G +PY +++ Q L
Sbjct: 235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT 294
Query: 256 ITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDL 288
P + +P+ + Q DP R ++ L
Sbjct: 295 RMRAPENATPEIYRIMLACWQGDPKERPTFSAL 327
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 21/153 (13%)
Query: 115 VYIILEYCDGGDLCSFIR----------------SHEKLSEFQCQQFVRQLVLALKFLRE 158
+Y+I+EY G+L ++R E+++ Q+ +++L
Sbjct: 96 LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS 155
Query: 159 NNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSP 214
H DL +N+L+ +NN +K+ADFG A+ + D L +MAPE L
Sbjct: 156 QKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV 215
Query: 215 YNAKADLWSLGVLVFEAL-FGHAPYASCNLSQL 246
Y ++D+WS GVL++E G +PY + +L
Sbjct: 216 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 9e-11
Identities = 44/202 (21%), Positives = 87/202 (43%), Gaps = 34/202 (16%)
Query: 117 IILEYCDGGDLCSFIRSHEKLSEFQCQ----------------QFVRQLVLALKFLRENN 160
++ EY GDL F+ + S+ + Q+ +++L ++
Sbjct: 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH 144
Query: 161 VCHFDLKPQNILIKNN-TLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPYN 216
H DL +N L+ T+K++DFG ++ + D S L +M PE + +
Sbjct: 145 FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFT 204
Query: 217 AKADLWSLGVLVFEAL-FGHAPYASCN----LSQLRAQALSSAPITIPPN--SLSPDCMD 269
++D+WS GV+++E +G PY + + +R++ L P P +L +C +
Sbjct: 205 TESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWN 264
Query: 270 FLSRLLQKDPMRRISYEDLFSH 291
+ P RR ++D+ +
Sbjct: 265 EI-------PARRPRFKDIHTR 279
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 44/151 (29%), Positives = 70/151 (46%), Gaps = 18/151 (11%)
Query: 114 YVYIILEYCDGGDLCSFIR----------------SHEKLSEFQCQQFVRQLVLALKFLR 157
Y+YI +EY G+L F+R + L+ Q QF + +++L
Sbjct: 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS 136
Query: 158 ENNVCHFDLKPQNILIKNNTL-KLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYN 216
E H DL +N+L+ N K+ADFG ++ + + +MA E L S Y
Sbjct: 137 EKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYT 196
Query: 217 AKADLWSLGVLVFEAL-FGHAPYASCNLSQL 246
K+D+WS GVL++E + G PY ++L
Sbjct: 197 TKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL 227
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 43/193 (22%), Positives = 90/193 (46%), Gaps = 22/193 (11%)
Query: 116 YIILEYCDGGDLCSFIRSH--------------EKLSEFQCQQFVRQLVLALKFLRENNV 161
++ EY + GDL F+RSH +L+ Q Q Q+ + +L +
Sbjct: 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHF 143
Query: 162 CHFDLKPQNILIKNNTL-KLADFGFAQFLAPNDQGDSIQGSPL----YMAPEILAGSPYN 216
H DL +N L+ + + K+ DFG ++ + D + G + +M PE + +
Sbjct: 144 VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMYRKFT 202
Query: 217 AKADLWSLGVLVFEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL 275
++D+WS GV+++E +G P+ + ++ + ++ + P + + D +
Sbjct: 203 TESDVWSFGVVLWEIFTYGKQPWYGLSNEEV-IECITQGRLLQRPRTCPSEVYDIMLGCW 261
Query: 276 QKDPMRRISYEDL 288
++DP +RI+ +D+
Sbjct: 262 KRDPQQRINIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 37/136 (27%), Positives = 71/136 (52%), Gaps = 6/136 (4%)
Query: 117 IILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 175
++ + G L +R H + L + + Q+ + +L E+ + H +L +NIL+K+
Sbjct: 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKS 144
Query: 176 NT-LKLADFGFAQFLAPNDQG---DSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEA 231
++ +++ADFG A L P+D+ + +MA E + Y ++D+WS GV V+E
Sbjct: 145 DSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEM 204
Query: 232 L-FGHAPYASCNLSQL 246
+ +G PYA ++
Sbjct: 205 MSYGAEPYAGMRPHEV 220
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 40/132 (30%), Positives = 67/132 (50%), Gaps = 17/132 (12%)
Query: 117 IILEYCDGGDLCSFIRSHE----------KLSEFQCQQFV-RQLVLALKFLRENNVCHFD 165
+I+EY + GDL F++ H K F ++ Q+ +++L N H D
Sbjct: 96 MIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRD 155
Query: 166 LKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL----YMAPEILAGSPYNAKAD 220
L +N L+ KN T+K+ADFG ++ L +D +QG +MA E + + K+D
Sbjct: 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYR-VQGRAPLPIRWMAWESVLLGKFTTKSD 214
Query: 221 LWSLGVLVFEAL 232
+W+ GV ++E L
Sbjct: 215 VWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 21/153 (13%)
Query: 115 VYIILEYCDGGDLCSFIRSHE-----------KLSEFQ--CQQFVR---QLVLALKFLRE 158
+Y+++EY G+L ++R+ KL E Q + V Q+ +++L
Sbjct: 93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS 152
Query: 159 NNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSP 214
H DL +N+L+ ++N +K+ADFG A+ + D L +MAPE L
Sbjct: 153 QKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV 212
Query: 215 YNAKADLWSLGVLVFEAL-FGHAPYASCNLSQL 246
Y ++D+WS GVL++E G +PY + +L
Sbjct: 213 YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 51/159 (32%), Positives = 74/159 (46%), Gaps = 18/159 (11%)
Query: 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLADFG 184
DL +++ L Q R+L+ AL +L + H D+K +NI + L DFG
Sbjct: 171 DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFG 230
Query: 185 FAQFL-----APNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE------ALF 233
A L P G S G+ +PE+LA PY AK D+WS G+++FE LF
Sbjct: 231 AACKLDAHPDTPQCYGWS--GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLF 288
Query: 234 GHAPYASCNLSQLRA--QALSSAPITIPPNSLSPDCMDF 270
G +S SQLR+ + + P+ P N + C F
Sbjct: 289 GKQVKSSS--SQLRSIIRCMQVHPLEFPQNGSTNLCKHF 325
|
Length = 392 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 49/189 (25%), Positives = 94/189 (49%), Gaps = 23/189 (12%)
Query: 64 YDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLRA-----------PEGRKRP 112
YD +Q++ + VK ++++ T +FER L +L+ GR+
Sbjct: 25 YDPLQDNTGEVVAVK--KLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82
Query: 113 RYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
R +++EY G L +++ H E+L + + Q+ +++L H DL +NI
Sbjct: 83 R---LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNI 139
Query: 172 LIKNNTL-KLADFGFAQFLAPNDQGDSIQ---GSPLY-MAPEILAGSPYNAKADLWSLGV 226
L+++ K+ DFG + L + + ++ SP++ APE L S ++ +D+WS GV
Sbjct: 140 LVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGV 199
Query: 227 LVFEALFGH 235
+++E LF +
Sbjct: 200 VLYE-LFTY 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 49/194 (25%), Positives = 89/194 (45%), Gaps = 14/194 (7%)
Query: 107 EGRKRPRYVYIILEYCDGGDLCSFI---RSHEKLSEFQCQQFVRQLV---LALKFLRENN 160
++ +IL + GDL SF+ R + Q ++ +V L +++L N
Sbjct: 74 SSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN 133
Query: 161 VCHFDLKPQNILIKNN-TLKLADFGFAQFLAPND---QGDSIQGSPL-YMAPEILAGSPY 215
H DL +N +++ + T+ +ADFG ++ + D QG I P+ ++A E LA Y
Sbjct: 134 FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQG-RIAKMPVKWIAIESLADRVY 192
Query: 216 NAKADLWSLGVLVFE-ALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRL 274
+K+D+W+ GV ++E A G PY ++ + P + L + D +
Sbjct: 193 TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLD-ELYDLMYSC 251
Query: 275 LQKDPMRRISYEDL 288
+ DP R ++ L
Sbjct: 252 WRADPKDRPTFTKL 265
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 36/212 (16%)
Query: 117 IILEYCDGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 175
++ EY DLC ++ H L + F+ QL+ L ++ + + H DLKPQN+LI +
Sbjct: 80 LVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISD 138
Query: 176 N-TLKLADFGFAQFLA-PNDQGDSIQGSPLYMAPEILAGSP-YNAKADLWSLGVLVFEAL 232
LKLADFG A+ + P+ + + Y P++L GS Y+ D+W +G + E +
Sbjct: 139 TGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198
Query: 233 FGHAPYASCNLSQLRAQAL-----------------------------SSAPITIPPNSL 263
G A + Q + + + S + N L
Sbjct: 199 QGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKL 258
Query: 264 S--PDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
S D S+LLQ P R+S + SH Y
Sbjct: 259 SYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 36/128 (28%), Positives = 69/128 (53%), Gaps = 9/128 (7%)
Query: 117 IILEYCDGGDLCSFIRS--HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
++L +GGDL I + + E + + +L L+ L+ + + DLKP+NIL+
Sbjct: 77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD 136
Query: 175 N-NTLKLADFGFAQFLAPNDQGDSIQG---SPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
+ ++++D G A + +G++++G + YMAPE++ Y D W LG L++E
Sbjct: 137 DRGHIRISDLGLAVQIP---EGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYE 193
Query: 231 ALFGHAPY 238
+ G +P+
Sbjct: 194 MIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 21/153 (13%)
Query: 115 VYIILEYCDGGDLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRE 158
+Y+I+EY G+L ++R+ E+LS Q+ +++L
Sbjct: 99 LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS 158
Query: 159 NNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSP 214
H DL +N+L+ ++N +K+ADFG A+ + D L +MAPE L
Sbjct: 159 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI 218
Query: 215 YNAKADLWSLGVLVFEAL-FGHAPYASCNLSQL 246
Y ++D+WS GVL++E G +PY + +L
Sbjct: 219 YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 44/179 (24%), Positives = 87/179 (48%), Gaps = 6/179 (3%)
Query: 115 VYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
V+I++E G+L S+++ + L + QL AL +L H D+ +N+L+
Sbjct: 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV 140
Query: 174 -KNNTLKLADFGFAQFLAPNDQGDSIQGS-PL-YMAPEILAGSPYNAKADLWSLGVLVFE 230
+ +KL DFG +++L + +G P+ +MAPE + + + +D+W GV ++E
Sbjct: 141 SSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 200
Query: 231 AL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDL 288
L G P+ + + + + + +PPN P +++ DP +R + +L
Sbjct: 201 ILMLGVKPFQGVKNNDVIGRIENGERLPMPPNC-PPTLYSLMTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 4e-10
Identities = 42/151 (27%), Positives = 67/151 (44%), Gaps = 18/151 (11%)
Query: 114 YVYIILEYCDGGDLCSFIR----------------SHEKLSEFQCQQFVRQLVLALKFLR 157
Y+Y+ +EY G+L F+R + LS Q F + + +L
Sbjct: 70 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 129
Query: 158 ENNVCHFDLKPQNILIKNN-TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYN 216
+ H DL +NIL+ N K+ADFG ++ + + +MA E L S Y
Sbjct: 130 QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT 189
Query: 217 AKADLWSLGVLVFEAL-FGHAPYASCNLSQL 246
+D+WS GVL++E + G PY ++L
Sbjct: 190 TNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 220
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 37/130 (28%), Positives = 66/130 (50%), Gaps = 6/130 (4%)
Query: 115 VYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
V +I + G L ++R H + + + Q+ + +L E + H DL +N+L+
Sbjct: 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV 142
Query: 174 KN-NTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPYNAKADLWSLGVLVF 229
K +K+ DFG A+ L +++ +G + +MA E + Y ++D+WS GV V+
Sbjct: 143 KTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVW 202
Query: 230 EAL-FGHAPY 238
E + FG PY
Sbjct: 203 ELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 6e-10
Identities = 36/101 (35%), Positives = 52/101 (51%), Gaps = 8/101 (7%)
Query: 137 LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLADFGFAQFL-----A 190
L Q RQL+ A+ ++ + H D+K +N+L+ + L DFG A F
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316
Query: 191 PNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEA 231
P G I G+ APE+LAG PY D+WS G+++FEA
Sbjct: 317 PFHYG--IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEA 355
|
Length = 461 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 6e-10
Identities = 44/148 (29%), Positives = 69/148 (46%), Gaps = 17/148 (11%)
Query: 109 RKRPRYVYIILEYCDGGDLCSFIRSH----EKLSEFQCQQFV---RQLVLALKFLRENNV 161
+ PR+ I+LE GGDL SF+R + E+ S + + R + K+L EN+
Sbjct: 80 ERLPRF--ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHF 137
Query: 162 CHFDLKPQNILIK----NNTLKLADFGFAQFLAPND---QGDSIQGSPLYMAPEILAGSP 214
H D+ +N L+ K+ADFG A+ + +G +M PE
Sbjct: 138 IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI 197
Query: 215 YNAKADLWSLGVLVFEAL-FGHAPYASC 241
+ +K D+WS GVL++E G+ PY
Sbjct: 198 FTSKTDVWSFGVLLWEIFSLGYMPYPGR 225
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 8e-10
Identities = 50/185 (27%), Positives = 84/185 (45%), Gaps = 14/185 (7%)
Query: 117 IILEYCDGGDLCSFI---RSHEKLSEFQCQ---QFVRQLVLALKFLRENNVCHFDLKPQN 170
+IL + GDL SF+ R + Q +F+ + +++L + H DL +N
Sbjct: 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARN 142
Query: 171 ILIKNN-TLKLADFGFAQFLAPND---QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGV 226
++ N + +ADFG ++ + D QG + ++A E LA Y K+D+WS GV
Sbjct: 143 CMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGV 202
Query: 227 LVFE-ALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCM-DFLSRLLQKDPMRRIS 284
++E A G PY S++ + PP+ L D + +S +P R S
Sbjct: 203 TMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCL--DGLYSLMSSCWLLNPKDRPS 260
Query: 285 YEDLF 289
+E L
Sbjct: 261 FETLR 265
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 8e-10
Identities = 49/233 (21%), Positives = 101/233 (43%), Gaps = 32/233 (13%)
Query: 86 TITSHSEFERPRAGLSNLRAPE--------GRKRPRYVYIILEYCDGGDLCSFIRSHE-- 135
T+ + +F+R L+NL+ G P + ++ EY GDL F+R+H
Sbjct: 47 TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP--LIMVFEYMKHGDLNKFLRAHGPD 104
Query: 136 --------------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KL 180
+L Q Q+ + +L + H DL +N L+ N L K+
Sbjct: 105 AMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKI 164
Query: 181 ADFGFAQFLAPNDQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL-FGHA 236
DFG ++ + D G +M PE + + ++D+WS GV+++E +G
Sbjct: 165 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224
Query: 237 PYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLF 289
P+ + +++ + ++ + P + D + Q++P +R++ ++++
Sbjct: 225 PWFQLSNTEV-IECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIY 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 9e-10
Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 21/153 (13%)
Query: 115 VYIILEYCDGGDLCSFIR----------------SHEKLSEFQCQQFVRQLVLALKFLRE 158
+Y+I+EY G+L F+R E+LS Q+ +++L
Sbjct: 93 LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES 152
Query: 159 NNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSP 214
H DL +N+L+ ++N +K+ADFG A+ + D L +MAPE L
Sbjct: 153 RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV 212
Query: 215 YNAKADLWSLGVLVFEAL-FGHAPYASCNLSQL 246
Y ++D+WS G+L++E G +PY + +L
Sbjct: 213 YTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 42/184 (22%), Positives = 84/184 (45%), Gaps = 19/184 (10%)
Query: 117 IILEYCDGGDLCSFIRSH-------------EKLSEFQCQQFVRQLVLALKFLRENNVCH 163
++ EY GDL F+R+H +L++ Q +Q+ + +L + H
Sbjct: 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVH 143
Query: 164 FDLKPQNILIKNNTL-KLADFGFAQFLAPNDQ---GDSIQGSPLYMAPEILAGSPYNAKA 219
DL +N L+ N L K+ DFG ++ + D G +M PE + + ++
Sbjct: 144 RDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES 203
Query: 220 DLWSLGVLVFEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKD 278
D+WSLGV+++E +G P+ + +++ + ++ + P + + D + Q++
Sbjct: 204 DVWSLGVVLWEIFTYGKQPWYQLSNNEV-IECITQGRVLQRPRTCPKEVYDLMLGCWQRE 262
Query: 279 PMRR 282
P R
Sbjct: 263 PHMR 266
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 60/246 (24%), Positives = 95/246 (38%), Gaps = 67/246 (27%)
Query: 113 RYVYIILEYCDGGDLCSFIRSHE---------KLSEFQCQQFVRQLVLALKFLRENNVCH 163
R V+++ +Y + DL I+ H +L + + Q++ + +L N V H
Sbjct: 73 RKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLH 131
Query: 164 FDLKPQNILI-----KNNTLKLADFGFAQF----LAPNDQGDSIQGSPLYMAPEILAGSP 214
DLKP NIL+ + +K+AD GFA+ L P D + + Y APE+L G+
Sbjct: 132 RDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR 191
Query: 215 YNAKA-DLWSLGVLVFEALFGHAPYASCNLSQLRAQ------------------------ 249
+ KA D+W++G +F L P C ++
Sbjct: 192 HYTKAIDIWAIGC-IFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWE 250
Query: 250 --------------------ALSSAPITIPPNSLSPDCMDF--LSRLLQKDPMRRISYED 287
A SS + + + PD F L +LL DP +RI+ E
Sbjct: 251 DIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQ 310
Query: 288 LFSHPY 293
PY
Sbjct: 311 ALQDPY 316
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 48/194 (24%), Positives = 84/194 (43%), Gaps = 19/194 (9%)
Query: 114 YVYIILEYCDGGDLCSFIR-------------SHEKLSEFQCQQ---FVRQLVLALKFLR 157
Y+Y+ +EY G+L F+R ++ S QQ F + + +L
Sbjct: 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 141
Query: 158 ENNVCHFDLKPQNILIKNNTL-KLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYN 216
+ H DL +NIL+ N + K+ADFG ++ + + +MA E L S Y
Sbjct: 142 QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT 201
Query: 217 AKADLWSLGVLVFEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL 275
+D+WS GVL++E + G PY ++L + + P N + D + +
Sbjct: 202 TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNC-DDEVYDLMRQCW 260
Query: 276 QKDPMRRISYEDLF 289
++ P R S+ +
Sbjct: 261 REKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 41/151 (27%), Positives = 72/151 (47%), Gaps = 9/151 (5%)
Query: 148 QLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPND----QGDSIQGSP 202
Q+ ++FL H DL +NIL+ +NN +K+ DFG A+ + + +GD+ P
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA--RLP 238
Query: 203 L-YMAPEILAGSPYNAKADLWSLGVLVFEAL-FGHAPYASCNLSQLRAQALSSAPITIPP 260
L +MAPE + Y ++D+WS GVL++E G +PY + + + L P
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAP 298
Query: 261 NSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291
+P+ + +P R ++ +L
Sbjct: 299 EYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 33/129 (25%), Positives = 68/129 (52%), Gaps = 6/129 (4%)
Query: 117 IILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN- 175
+++E G L +++ ++ ++ Q+ + + +L + H DL +N+L+ N
Sbjct: 72 LVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR 131
Query: 176 NTLKLADFGFAQFLAP-NDQGDSIQGS--PL-YMAPEILAGSPYNAKADLWSLGVLVFEA 231
+ K++DFG ++ L +D + PL + APE + +++K+D+WS GV ++EA
Sbjct: 132 HQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEA 191
Query: 232 L-FGHAPYA 239
+G PY
Sbjct: 192 FSYGAKPYG 200
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 58/246 (23%), Positives = 96/246 (39%), Gaps = 67/246 (27%)
Query: 113 RYVYIILEYCDGGDLCSFIRSHE---------KLSEFQCQQFVRQLVLALKFLRENNVCH 163
R V+++ +Y + DL I+ H +L + + Q++ + +L N V H
Sbjct: 73 RKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLH 131
Query: 164 FDLKPQNILI-----KNNTLKLADFGFAQF----LAPNDQGDSIQGSPLYMAPEILAGSP 214
DLKP NIL+ + +K+AD GFA+ L P D + + Y APE+L G+
Sbjct: 132 RDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR 191
Query: 215 YNAKA-DLWSLGVLVFEALFGHAPYASCN------------------------------- 242
+ KA D+W++G +F L P C
Sbjct: 192 HYTKAIDIWAIGC-IFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWE 250
Query: 243 -----------LSQLRAQALSSAPIT--IPPNSLSPDCMDF--LSRLLQKDPMRRISYED 287
+ R ++ + + + + PD F L +LL DP++RI+ E
Sbjct: 251 DIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 310
Query: 288 LFSHPY 293
PY
Sbjct: 311 AMQDPY 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 50/186 (26%), Positives = 80/186 (43%), Gaps = 43/186 (23%)
Query: 145 FVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL 203
F+ Q++ L + V H DLKPQN+LI + LKLADFG A+ + + S + L
Sbjct: 109 FLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTL 168
Query: 204 -YMAPEILAGSP-YNAKADLWSLGVLVFEALFGHA------------------------- 236
Y P++L GS Y+ + D+W +G + FE G
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEET 228
Query: 237 --------PYASCNLSQLRAQAL-SSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYED 287
+ + N + + Q L + AP L + ++ L++ LQ + +RIS E+
Sbjct: 229 WPGISSNDEFKNYNFPKYKPQPLINHAP------RLDTEGIELLTKFLQYESKKRISAEE 282
Query: 288 LFSHPY 293
H Y
Sbjct: 283 AMKHAY 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 45/187 (24%), Positives = 84/187 (44%), Gaps = 22/187 (11%)
Query: 117 IILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 175
I+ EY G L SF+R HE +L Q + L +K+L E H L +L+ +
Sbjct: 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNS 142
Query: 176 N-TLKLADFGFAQFLAPNDQGDSI------QGSPLYMAPEILAGSPYNAKADLWSLGVLV 228
+ K++ F D+ ++I + L+ APE + +++ +D+WS G+++
Sbjct: 143 DLVCKISGFR----RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVM 198
Query: 229 FEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL----QKDPMRRI 283
+E + +G PY + Q +A+ P +C + L +L+ QK+ R
Sbjct: 199 WEVMSYGERPYWDMS-GQDVIKAVEDGFRLPAPR----NCPNLLHQLMLDCWQKERGERP 253
Query: 284 SYEDLFS 290
+ + S
Sbjct: 254 RFSQIHS 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 40/172 (23%), Positives = 77/172 (44%), Gaps = 7/172 (4%)
Query: 125 GDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAD 182
G L ++R + +++ + Q+ + +L E + H DL +N+L+K+ N +K+ D
Sbjct: 93 GCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITD 152
Query: 183 FGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPYNAKADLWSLGVLVFEAL-FGHAPY 238
FG A+ L ++ G + +MA E + + ++D+WS GV V+E + FG PY
Sbjct: 153 FGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPY 212
Query: 239 ASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFS 290
++ + PP + D + + D R + +L
Sbjct: 213 DGIPAREIPDLLEKGERLPQPPIC-TIDVYMIMVKCWMIDSECRPRFRELVD 263
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 27/75 (36%), Positives = 45/75 (60%), Gaps = 1/75 (1%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
VY+++EY GGD+ S + + E +++ ++ LAL +L + + H DLKP N+LI
Sbjct: 78 NVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI 137
Query: 174 KNNT-LKLADFGFAQ 187
N +KL DFG ++
Sbjct: 138 SNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 147 RQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLADFGFAQFLAPNDQGD--SIQGSPL 203
R ++ A+++L EN + H D+K +NI I + + L DFG A F + G+
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIA 248
Query: 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGH 235
APE+LA PY D+WS G+++FE H
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 41/160 (25%), Positives = 73/160 (45%), Gaps = 7/160 (4%)
Query: 135 EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPND 193
E L+ F Q+ ++FL N H DL +N+L+ + +K+ DFG A+ + +D
Sbjct: 232 EGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIM-HD 290
Query: 194 QGDSIQGSPL----YMAPEILAGSPYNAKADLWSLGVLVFEAL-FGHAPYASCNLSQLRA 248
+GS +MAPE + + Y +D+WS G+L++E G PY +
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350
Query: 249 QALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDL 288
+ S P+ + + D + + +P +R S+ L
Sbjct: 351 NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHL 390
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 6e-09
Identities = 32/126 (25%), Positives = 68/126 (53%), Gaps = 6/126 (4%)
Query: 113 RYVYIILEYCDGGDLCSFI-RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+ +I+E+ G L ++ R+ K++ Q ++ Q+ + +L H DL +N+
Sbjct: 81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNV 140
Query: 172 LIKN-NTLKLADFGFAQFLAPNDQGDSIQG---SPLY-MAPEILAGSPYNAKADLWSLGV 226
L+++ + +K+ DFG + + + + +++ SP++ APE L S + +D+WS GV
Sbjct: 141 LVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGV 200
Query: 227 LVFEAL 232
++E L
Sbjct: 201 TLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 6e-09
Identities = 27/92 (29%), Positives = 48/92 (52%), Gaps = 1/92 (1%)
Query: 148 QLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLADFGFAQFLAPNDQGDSIQGSPLYMA 206
Q+ + L ++ + D+KP+N+L+ + +L+D G A L G+ YMA
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMA 162
Query: 207 PEILAGSPYNAKADLWSLGVLVFEALFGHAPY 238
PEIL PY+ D +++G ++E + G P+
Sbjct: 163 PEILKEEPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 7e-09
Identities = 30/96 (31%), Positives = 55/96 (57%), Gaps = 5/96 (5%)
Query: 148 QLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLADFGFAQFLAPNDQGDSIQGSPL--- 203
Q+ + +L E + H DL +N+L+K+ N +K+ DFG A+ L +++ + G +
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 176
Query: 204 YMAPEILAGSPYNAKADLWSLGVLVFEAL-FGHAPY 238
+MA E + + ++D+WS GV ++E + FG PY
Sbjct: 177 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 7e-09
Identities = 50/204 (24%), Positives = 85/204 (41%), Gaps = 45/204 (22%)
Query: 116 YIILEYCDGGDLCSFIRSHEK---------LSEFQCQQFVRQLVLALKFLRENNVCHFDL 166
Y+ILEY D GDL F+R+ + LS Q Q+ L + L H DL
Sbjct: 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDL 143
Query: 167 KPQNILI------KNNTLKLAD-------FGFAQFLAPNDQGDSIQGSPLYMAPEILAGS 213
+N L+ K + L L+ + L P ++APE +
Sbjct: 144 AARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR----------WLAPEAVQED 193
Query: 214 PYNAKADLWSLGVLVFEALF--GHAPYASCNLSQLRAQALS-SAPITIPPNSLSPDCMDF 270
++ K+D+WS GVL++E +F G P+ + ++ + + + +P C
Sbjct: 194 DFSTKSDVWSFGVLMWE-VFTQGELPFYGLSDEEVLNRLQAGKLELPVPEG-----CPSR 247
Query: 271 LSRLLQK----DPMRRISYEDLFS 290
L +L+ + +P R S+ +L S
Sbjct: 248 LYKLMTRCWAVNPKDRPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 9e-09
Identities = 44/172 (25%), Positives = 74/172 (43%), Gaps = 7/172 (4%)
Query: 123 DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLA 181
+ + I LS F Q+ ++FL N H DL +N+LI L K+
Sbjct: 222 ERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKIC 281
Query: 182 DFGFAQFLAPNDQGDSIQGS---PL-YMAPEILAGSPYNAKADLWSLGVLVFEAL-FGHA 236
DFG A+ + D +GS PL +MAPE + + Y +D+WS G+L++E G
Sbjct: 282 DFGLARDIM-RDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGT 340
Query: 237 PYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDL 288
PY +++ A+ P S + + + + ++ R + L
Sbjct: 341 PYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQL 392
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 48/190 (25%), Positives = 84/190 (44%), Gaps = 18/190 (9%)
Query: 117 IILEYCDGGDLCSFIRSHEKLSEF----------QCQQFVRQLVLALKFLRENNVCHFDL 166
+I+E GDL S++RS E + Q ++ + +L N H DL
Sbjct: 86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDL 145
Query: 167 KPQNILIKNN-TLKLADFGFAQFLAPND---QGDSIQGSPLYMAPEILAGSPYNAKADLW 222
+N ++ + T+K+ DFG + + D +G +M+PE L + +D+W
Sbjct: 146 AARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVW 205
Query: 223 SLGVLVFE-ALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL-QKDPM 280
S GV+++E A PY + Q+ + + P N PD + L R+ Q +P
Sbjct: 206 SFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDN--CPDMLFELMRMCWQYNPK 263
Query: 281 RRISYEDLFS 290
R S+ ++ S
Sbjct: 264 MRPSFLEIIS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-08
Identities = 45/153 (29%), Positives = 63/153 (41%), Gaps = 16/153 (10%)
Query: 149 LVLALKFLRENNVCHFDLKPQNILIKNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPE 208
+ L LRE H K NIL+ + L L G F P S P +MAPE
Sbjct: 23 CLQCLGALRE---LHRQAKSGNILLTWDGL-LKLDGSVAFKTPEQ---SRPD-PYFMAPE 74
Query: 209 ILAGSPYNAKADLWSLGVLVFEALFGHAPYAS-CNLSQLRAQALSSAPITIP-----PNS 262
++ G Y KAD++SLG+ ++EAL PY LS + L+ P P
Sbjct: 75 VIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLEG 134
Query: 263 LSPDCM--DFLSRLLQKDPMRRISYEDLFSHPY 293
+S DF+ + P RR + +H
Sbjct: 135 VSAARSFEDFMRLCASRLPQRREAANHYLAHCR 167
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 42/164 (25%), Positives = 75/164 (45%), Gaps = 17/164 (10%)
Query: 117 IILEYCDGGDLCSFIR--------SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKP 168
++ Y + G+L F++ + + LS Q Q+ + +L + V H D+
Sbjct: 86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAA 145
Query: 169 QNILIKNN-TLKLADFGFAQFLAPNDQ---GDSIQGSPL-YMAPEILAGSPYNAKADLWS 223
+N +I +K+ D ++ L P D GD+ + P+ +MA E L Y++ +D+WS
Sbjct: 146 RNCVIDEELQVKITDNALSRDLFPMDYHCLGDN-ENRPVKWMALESLVNKEYSSASDVWS 204
Query: 224 LGVLVFE-ALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPD 266
GVL++E G PY + ++ A + P N PD
Sbjct: 205 FGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPIN--CPD 246
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 43/133 (32%), Positives = 65/133 (48%), Gaps = 19/133 (14%)
Query: 117 IILEYCDGGDLCSFIRSHE-----------KLSEFQCQQFVRQLVLALKFLRENNVCHFD 165
+I EY + GDL F+ HE +S Q+ +K+L N H D
Sbjct: 96 MITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRD 155
Query: 166 LKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL----YMAPE-ILAGSPYNAKA 219
L +N L+ KN T+K+ADFG ++ L D IQG + +M+ E IL G + +
Sbjct: 156 LATRNCLVGKNYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMSWESILLGK-FTTAS 213
Query: 220 DLWSLGVLVFEAL 232
D+W+ GV ++E L
Sbjct: 214 DVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 35/139 (25%), Positives = 64/139 (46%), Gaps = 10/139 (7%)
Query: 117 IILEYCDGGDLCSFIRSHEKLSEFQCQ---QFVRQLVLALKFLRENNVCHFDLKPQNILI 173
++ E G L +R L F + Q+ +++L H DL +NIL+
Sbjct: 72 MVTELAPLGSLLDRLRKD-ALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL 130
Query: 174 -KNNTLKLADFGFAQFLAPNDQGDSIQGS---PL-YMAPEILAGSPYNAKADLWSLGVLV 228
++ +K+ DFG + L N+ ++ P + APE L ++ +D+W GV +
Sbjct: 131 ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTL 190
Query: 229 FEAL-FGHAPYASCNLSQL 246
+E +G P+A + SQ+
Sbjct: 191 WEMFTYGEEPWAGLSGSQI 209
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 36/205 (17%)
Query: 116 YIILEYCDGGDLCSFIRSHEK------------------------LSEFQCQQFVRQLVL 151
+I+EY G L SF+R K L+ F Q+
Sbjct: 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISR 138
Query: 152 ALKFLRENNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQ--GDSIQGSPL-YMAP 207
+++L E + H DL +N+L+ + +K++DFG ++ + D S P+ +MA
Sbjct: 139 GMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAI 198
Query: 208 EILAGSPYNAKADLWSLGVLVFEAL-FGHAPY---ASCNLSQLRAQALSSAPITIPPNSL 263
E L Y ++D+WS GVL++E + G PY A L L L + P +
Sbjct: 199 ESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNL----LKTGYRMERPENC 254
Query: 264 SPDCMDFLSRLLQKDPMRRISYEDL 288
S + + + +++P +R ++ D+
Sbjct: 255 SEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 5e-08
Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 38/203 (18%)
Query: 117 IILEYCDGGDLCSFIRSHEKLSEFQCQQFV------------RQLVLALKFLRENNVCHF 164
+I EY + GDL F+ E S F + Q+ +K+L N H
Sbjct: 94 MITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHR 153
Query: 165 DLKPQNILIKNN-TLKLADFGFAQFLAPNDQGDSIQGSPL----YMAPEILAGSPYNAKA 219
DL +N L+ N+ T+K+ADFG ++ L D IQG + +MA E + + +
Sbjct: 154 DLATRNCLVGNHYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMAWESILLGKFTTAS 212
Query: 220 DLWSLGVLVFE--ALFGHAPYASCNLSQL--------RAQA----LSSAPITIPPNSLSP 265
D+W+ GV ++E L PY+ + Q+ R Q LS P+ P+ +
Sbjct: 213 DVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLC--PSPV-- 268
Query: 266 DCMDFLSRLLQKDPMRRISYEDL 288
+ R +D R ++ +
Sbjct: 269 --FKLMMRCWSRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 5e-08
Identities = 32/103 (31%), Positives = 57/103 (55%), Gaps = 7/103 (6%)
Query: 144 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLADFGFAQFLAPNDQGDSIQGS- 201
+F Q+ + FL N H D+ +N+L+ + + K+ DFG A+ + ND ++G+
Sbjct: 216 RFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIM-NDSNYVVKGNA 274
Query: 202 --PL-YMAPEILAGSPYNAKADLWSLGVLVFEAL-FGHAPYAS 240
P+ +MAPE + Y ++D+WS G+L++E G +PY
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 6e-08
Identities = 41/138 (29%), Positives = 69/138 (50%), Gaps = 16/138 (11%)
Query: 117 IILEYCDGGDLCSFIRSHEKLSEFQ-CQQFVRQLVLALKFLRENNVCHFDLKPQN-ILIK 174
++L Y GDL +FIRS + F Q+ +++L H DL +N +L +
Sbjct: 74 VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDE 133
Query: 175 NNTLKLADFGFA------QFLAPNDQGDSIQGSPL---YMAPEILAGSPYNAKADLWSLG 225
+ T+K+ADFG A ++ + ++ G+ L +MA E L + K+D+WS G
Sbjct: 134 SFTVKVADFGLARDIYDKEYYSVHNH----TGAKLPVKWMALESLQTQKFTTKSDVWSFG 189
Query: 226 VLVFEALF-GHAPYASCN 242
VL++E + G PY +
Sbjct: 190 VLLWELMTRGAPPYPDVD 207
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 7e-08
Identities = 39/135 (28%), Positives = 67/135 (49%), Gaps = 14/135 (10%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
+ +I+EY G L ++ H KL+ Q F +Q+ + +L + H DL +N+L+
Sbjct: 83 LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD 141
Query: 175 NNTL-KLADFGFAQ-------FLAPNDQGDSIQGSPLY-MAPEILAGSPYNAKADLWSLG 225
N+ L K+ DFG A+ + + GDS P++ A E L + ++ +D+WS G
Sbjct: 142 NDRLVKIGDFGLAKAVPEGHEYYRVREDGDS----PVFWYAVECLKENKFSYASDVWSFG 197
Query: 226 VLVFEALFGHAPYAS 240
V ++E L S
Sbjct: 198 VTLYELLTHCDSKQS 212
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 9e-08
Identities = 39/150 (26%), Positives = 73/150 (48%), Gaps = 7/150 (4%)
Query: 145 FVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLADFGFAQFLAPNDQGDSIQGS-- 201
F Q+ + FL N H DL +NIL+ + + K+ DFG A+ + ND ++G+
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIR-NDSNYVVKGNAR 277
Query: 202 -PL-YMAPEILAGSPYNAKADLWSLGVLVFEAL-FGHAPYASCNLSQLRAQALSSAPITI 258
P+ +MAPE + Y ++D+WS G+L++E G +PY + + + +
Sbjct: 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML 337
Query: 259 PPNSLSPDCMDFLSRLLQKDPMRRISYEDL 288
P + D + DP++R +++ +
Sbjct: 338 SPECAPSEMYDIMKSCWDADPLKRPTFKQI 367
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 45/195 (23%), Positives = 84/195 (43%), Gaps = 23/195 (11%)
Query: 117 IILEYCDGGDLCSFIRSHE---------------KLSEFQCQQFVRQLVLALKFLRENNV 161
++ EY GDL F+RSH +L+ Q Q+ + +L +
Sbjct: 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHF 143
Query: 162 CHFDLKPQNILIKNN-TLKLADFGFAQFLAPNDQ---GDSIQGSPLYMAPEILAGSPYNA 217
H DL +N L+ +K+ DFG ++ + D G +M PE + +
Sbjct: 144 VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTT 203
Query: 218 KADLWSLGVLVFEAL-FGHAPYASCNLSQLRA-QALSSAPITIPPNSLSPDCMDFLSRLL 275
++D+WS GV+++E +G P+ LS A + ++ P + P+ +
Sbjct: 204 ESDIWSFGVVLWEIFTYGKQPWY--QLSNTEAIECITQGRELERPRTCPPEVYAIMQGCW 261
Query: 276 QKDPMRRISYEDLFS 290
Q++P +R+ +D+ S
Sbjct: 262 QREPQQRMVIKDIHS 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 51/200 (25%), Positives = 93/200 (46%), Gaps = 32/200 (16%)
Query: 117 IILEYCDGGDLCSFI--RS-HEKL----------SEFQCQQF---VRQLVLALKFLRENN 160
+I YC DL F+ RS H + S + F V Q+ ++FL ++
Sbjct: 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH 144
Query: 161 VCHFDLKPQNILIKNN-TLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPYN 216
V H DL +N+L+ + +K++D G + + D + S L +M+PE + ++
Sbjct: 145 VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFS 204
Query: 217 AKADLWSLGVLVFEAL-FGHAPYASCNLS-QLRAQALSSAPITIPPNSLSPDCMDFLSRL 274
+D+WS GV+++E +G PY C S Q + + + + P+ DC ++ L
Sbjct: 205 IDSDIWSYGVVLWEVFSYGLQPY--CGYSNQDVIEMIRNRQVLPCPD----DCPAWVYTL 258
Query: 275 L----QKDPMRRISYEDLFS 290
+ + P RR ++D+ S
Sbjct: 259 MLECWNEFPSRRPRFKDIHS 278
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 58/280 (20%), Positives = 114/280 (40%), Gaps = 54/280 (19%)
Query: 55 STIRY----GELQYDTVQNSQIRLGTVKYSQV-------RYDTITSHSEFERPRAGLSNL 103
S +R+ GE + + + L + ++Q+ + EF++ + ++ L
Sbjct: 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL 64
Query: 104 RAPE--------GRKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ------------ 143
P +++P V ++ EY + GDL F+ S+ C
Sbjct: 65 HHPNIVCLLGVVTQEQP--VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLD 122
Query: 144 -----QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT-LKLADFGFAQFLAPNDQGDS 197
Q+ +++L + H DL +NILI +K++D G ++ + D
Sbjct: 123 HGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYY-R 181
Query: 198 IQGSPL----YMAPEILAGSPYNAKADLWSLGVLVFEAL-FGHAPYASCN----LSQLRA 248
+Q L +M PE + +++ +D+WS GV+++E FG PY + + +R
Sbjct: 182 VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241
Query: 249 QALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDL 288
+ L PP S ++ Q+ P RR ++D+
Sbjct: 242 RQLLPCSEDCPPRMYS-----LMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 41/225 (18%), Positives = 84/225 (37%), Gaps = 45/225 (20%)
Query: 114 YVYIILEYCDGGDLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+Y++ G +++H E L E ++ ++ AL ++ H +K +I
Sbjct: 73 ELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHI 132
Query: 172 LIK-NNTLKLADFGFAQ-FLAPNDQGDSIQGSPLY-------MAPEILAGS--PYNAKAD 220
L+ + + L+ ++ + + + P ++PE+L + YN K+D
Sbjct: 133 LLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSD 192
Query: 221 LWSLGVLVFEALFGHAPYASCNLSQLRAQAL----------------------SSAPITI 258
++S+G+ E GH P+ +Q+ + + S +
Sbjct: 193 IYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEH 252
Query: 259 PPN----------SLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
P N + S F+ LQ+DP R S L +H +
Sbjct: 253 PNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 38/139 (27%), Positives = 66/139 (47%), Gaps = 17/139 (12%)
Query: 117 IILEYCDGGDLCSFIRSHEKLSEFQC-----QQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+++E+C GDL ++RS K Q+ ++ L L L +NN H DL +N
Sbjct: 72 LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNC 131
Query: 172 LIKNN-TLKLADFGFAQFLAPND---QGDSIQGSPLYMAPEILAGSPYN-------AKAD 220
L+ + T+K+ D+G + D D + ++APE++ N +++
Sbjct: 132 LLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESN 191
Query: 221 LWSLGVLVFEAL-FGHAPY 238
+WSLGV ++E G PY
Sbjct: 192 VWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 39/149 (26%), Positives = 67/149 (44%), Gaps = 27/149 (18%)
Query: 117 IILEYCDGGDLCSFIR----------SHEKLSEFQCQQ------------FVRQLVLALK 154
++ EY GDL F+R SH S +C +Q+ +
Sbjct: 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMA 144
Query: 155 FLRENNVCHFDLKPQNILIKNN-TLKLADFGFAQFLAPND--QGDSIQGSPL-YMAPEIL 210
+L E H DL +N L+ N +K+ADFG ++ + D + P+ +M PE +
Sbjct: 145 YLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESI 204
Query: 211 AGSPYNAKADLWSLGVLVFEAL-FGHAPY 238
+ Y ++D+W+ GV+++E +G PY
Sbjct: 205 FYNRYTTESDVWAYGVVLWEIFSYGMQPY 233
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 46/148 (31%), Positives = 67/148 (45%), Gaps = 27/148 (18%)
Query: 161 VCHFDLKPQNILI-KNNTLKLADFGFAQF--LAPNDQGDS-----------------IQG 200
V H DLKP NIL+ + + D+G A F L D D I G
Sbjct: 134 VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVG 193
Query: 201 SPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP 260
+P YMAPE L G P + D+++LGV++++ L PY ++ + + +PI + P
Sbjct: 194 TPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAP 253
Query: 261 NSLSPDCMDFLSRLLQK----DPMRRIS 284
P FLS++ K DP R S
Sbjct: 254 YREIP---PFLSQIAMKALAVDPAERYS 278
|
Length = 932 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 9e-07
Identities = 35/102 (34%), Positives = 52/102 (50%), Gaps = 3/102 (2%)
Query: 194 QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSS 253
+G+ I G+P Y+APE+L G P+ D W+LGV +FE L G P+ Q Q + +
Sbjct: 536 EGERILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFND-ETPQQVFQNILN 594
Query: 254 APITIPP--NSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
I P LS + + + LL DP +R ++L HP
Sbjct: 595 RDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPL 636
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 9e-07
Identities = 46/165 (27%), Positives = 78/165 (47%), Gaps = 19/165 (11%)
Query: 117 IILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQ-----LVLALKFLRENNVCHFDLKPQNI 171
++LE+C GDL +++RS+ + Q+ V Q + L +L + + H DL +N
Sbjct: 72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNC 131
Query: 172 LIKNN-TLKLADFGFAQFLAPND--QGDSIQGSPL-YMAPEI-------LAGSPYNAKAD 220
+ + ++K+ D+G A P D PL ++APE+ L K++
Sbjct: 132 QLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSN 191
Query: 221 LWSLGVLVFEALFGHA--PYASCNLSQLRAQALSSAPITIPPNSL 263
+WSLGV ++E LF A PY + Q+ Q + I +P L
Sbjct: 192 IWSLGVTMWE-LFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQL 235
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 33/145 (22%), Positives = 71/145 (48%), Gaps = 16/145 (11%)
Query: 117 IILEYCDGGDLCSFIRSHEKL----SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
++ EYC+ GDL S++ + Q+ ++ + + ++N H DL +N
Sbjct: 72 LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCF 131
Query: 173 IKNN-TLKLADF--GFAQFLAPNDQGDSIQGSPL-YMAPEI-------LAGSPYNAKADL 221
+ ++ T+K+ D+ G +++ + + + PL ++APE+ L + +++
Sbjct: 132 LTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNV 191
Query: 222 WSLGVLVFEALFGHAPYASCNLSQL 246
W+LGV ++E LF +A +LS
Sbjct: 192 WALGVTLWE-LFENAAQPYSHLSDR 215
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 43/195 (22%), Positives = 81/195 (41%), Gaps = 16/195 (8%)
Query: 117 IILEYCDGGDLCSFIRSHEKLSEF----------QCQQFVRQLVLALKFLRENNVCHFDL 166
+++E GDL S++RS +E + Q ++ + +L H DL
Sbjct: 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDL 145
Query: 167 KPQNILI-KNNTLKLADFGFAQFLAPND---QGDSIQGSPLYMAPEILAGSPYNAKADLW 222
+N ++ + T+K+ DFG + + D +G +MAPE L + +D+W
Sbjct: 146 AARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMW 205
Query: 223 SLGVLVFE-ALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281
S GV+++E PY + Q+ + + P N D + Q +P
Sbjct: 206 SFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNC-PERVTDLMRMCWQFNPKM 264
Query: 282 RISYEDLFSHPYPDL 296
R ++ ++ + DL
Sbjct: 265 RPTFLEIVNLLKDDL 279
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 40/140 (28%), Positives = 63/140 (45%), Gaps = 25/140 (17%)
Query: 117 IILEYCDGGDLCSFIRSHE-------------------KLSEFQCQQFVRQLVLALKFLR 157
+I EY + GDL F+ SH +S Q+ +K+L
Sbjct: 96 MITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS 155
Query: 158 ENNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL----YMAPEILAG 212
N H DL +N L+ +N T+K+ADFG ++ L D IQG + +MA E +
Sbjct: 156 SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY-RIQGRAVLPIRWMAWECILM 214
Query: 213 SPYNAKADLWSLGVLVFEAL 232
+ +D+W+ GV ++E L
Sbjct: 215 GKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 9e-06
Identities = 38/140 (27%), Positives = 68/140 (48%), Gaps = 13/140 (9%)
Query: 103 LRAPEGRKRPRYVYIILEYCDGGDLCSFIRS-----HEKLSEFQCQQFVRQLVLALKFLR 157
L+ E + Y+I + D DL SF+ ++ Q + ++QL+ A++++
Sbjct: 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH 284
Query: 158 ENNVCHFDLKPQNILIK-NNTLKLADFG----FAQFLAPNDQGDSIQGSPLYMAPEILAG 212
+ + H D+K +NI + + + L DFG F + D G G+ +PEILAG
Sbjct: 285 DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYG--WVGTVATNSPEILAG 342
Query: 213 SPYNAKADLWSLGVLVFEAL 232
Y D+WS G+++ + L
Sbjct: 343 DGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 5e-05
Identities = 21/77 (27%), Positives = 39/77 (50%), Gaps = 11/77 (14%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRE---NNVCHFDLKPQN 170
+ Y+++E+ +G L +++SE + + QL L L + +CH DL P N
Sbjct: 67 WSYLLMEWIEGETL-------DEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGN 119
Query: 171 ILIKNN-TLKLADFGFA 186
IL+ + L + D+ +A
Sbjct: 120 ILVDDGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 7e-05
Identities = 34/137 (24%), Positives = 62/137 (45%), Gaps = 22/137 (16%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKP-QNI- 171
+ +ILEYC G L + + LS F+ + + + K L N+ + KP +N+
Sbjct: 96 RLSLILEYCTRGYLREVLDKEKDLS-FKTK--LDMAIDCCKGL--YNLYKYTNKPYKNLT 150
Query: 172 -----LIKNNTLKLADFGFAQFLAP---NDQGDSIQGSPLYMAPEILAG--SPYNAKADL 221
+ +N LK+ G + L+ + + Y + ++L S Y K D+
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKDDI 205
Query: 222 WSLGVLVFEALFGHAPY 238
+SLGV+++E G P+
Sbjct: 206 YSLGVVLWEIFTGKIPF 222
|
Length = 283 |
| >gnl|CDD|239147 cd02684, MIT_2, MIT: domain contained within Microtubule Interacting and Trafficking molecules | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 2e-04
Identities = 16/39 (41%), Positives = 23/39 (58%)
Query: 303 ESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIPL 341
ES + AI +V A+ D+ ++ A SLYC AL Y +P
Sbjct: 1 ESLEKAIALVVQAVKKDQRGDAAAALSLYCSALQYFVPA 39
|
This sub-family of MIT domains is found in proteins with an n-terminal serine/threonine kinase domain. The molecular function of the MIT domain is unclear. Length = 75 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 50/238 (21%), Positives = 87/238 (36%), Gaps = 58/238 (24%)
Query: 114 YVYIILEYCDGGDLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
++++I + G S ++++ E +SE + + L +L +N H ++K +I
Sbjct: 73 WLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHI 132
Query: 172 LIKNNTL-KLADFGFAQFLAPNDQG-----DSIQGSPL---YMAPEILAG--SPYNAKAD 220
LI + L L+ L N Q D Q S +++PE+L YN K+D
Sbjct: 133 LISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSD 192
Query: 221 LWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI------------------------ 256
++S+G+ E G P+ +Q+ Q L P
Sbjct: 193 IYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDS 252
Query: 257 ---------------------TIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
T + SP + + LQ+DP +R S L SH +
Sbjct: 253 GIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|239141 cd02678, MIT_VPS4, MIT: domain contained within Microtubule Interacting and Trafficking molecules | Back alignment and domain information |
|---|
Score = 37.2 bits (87), Expect = 0.001
Identities = 14/34 (41%), Positives = 16/34 (47%)
Query: 306 QTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLI 339
Q AI +V AI D N A LY AL Y +
Sbjct: 4 QKAIELVKKAIEEDNAGNYEEALRLYQHALEYFM 37
|
This sub-family of MIT domains is found in intracellular protein transport proteins of the AAA-ATPase family. The molecular function of the MIT domain is unclear. Length = 75 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 42/194 (21%), Positives = 75/194 (38%), Gaps = 34/194 (17%)
Query: 117 IILEYCDGGDLCSFIRSHEKLSEFQCQQFV-RQLVLALKFLRENNVCHFDLKPQNILIKN 175
++ EY G L F+ + + V +QL AL +L + + H ++ +NIL+
Sbjct: 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVAR 136
Query: 176 NTL--------KLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAK--ADLWSLG 225
L KL+D G + ++ ++ P ++APE + + AD WS G
Sbjct: 137 YGLNEGYVPFIKLSDPGIPITVLSREE--RVERIP-WIAPECIRNGQASLTIAADKWSFG 193
Query: 226 VLVFEALF-GHAPYASCNLS--------QLRAQALSSAPITIPPNSLSPDCMDFLSRLLQ 276
+ E G P ++ + S Q R A + +L C +
Sbjct: 194 TTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDCAELA----NLINQCWTY------ 243
Query: 277 KDPMRRISYEDLFS 290
DP +R S+ +
Sbjct: 244 -DPTKRPSFRAILR 256
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 41/179 (22%), Positives = 76/179 (42%), Gaps = 27/179 (15%)
Query: 120 EYCDGGDLCSFI-RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL 178
E+ + G L F+ R + L+ + +QL AL +L + ++ H ++ +NIL+ +
Sbjct: 84 EFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGI 143
Query: 179 KLADFGFAQFLAPNDQG---------DSIQGSPLYMAPEILAGSP-YNAKADLWSLGVLV 228
D F+ +D G + ++ P ++APE + S + AD WS G +
Sbjct: 144 ---DGECGPFIKLSDPGIPITVLSRQECVERIP-WIAPECVEDSKNLSIAADKWSFGTTL 199
Query: 229 FEALF-GHAPYASCNLSQL-RAQALSSAPITIPPNSLSPDC---MDFLSRLLQKDPMRR 282
+E + G P L++ R +T P C D ++ + DP +R
Sbjct: 200 WEICYNGEIPLKDKTLAEKERFYEGQCMLVT-------PSCKELADLMTHCMNYDPNQR 251
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 30/136 (22%), Positives = 53/136 (38%), Gaps = 46/136 (33%)
Query: 204 YMAPEILAGS--PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALS-SAP----- 255
+++PE+L + Y+AK+D++S+G+ E GH P+ +Q+ + L+ + P
Sbjct: 174 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 233
Query: 256 ITIPPNSL--------------------------------------SPDCMDFLSRLLQK 277
TIP L SP F+ + LQ+
Sbjct: 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQR 293
Query: 278 DPMRRISYEDLFSHPY 293
+P R S L +H +
Sbjct: 294 NPDARPSASTLLNHSF 309
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 406 | |||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0660|consensus | 359 | 100.0 | ||
| KOG0033|consensus | 355 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0658|consensus | 364 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585|consensus | 576 | 100.0 | ||
| KOG0197|consensus | 468 | 100.0 | ||
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0582|consensus | 516 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| KOG0580|consensus | 281 | 100.0 | ||
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0599|consensus | 411 | 100.0 | ||
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0611|consensus | 668 | 100.0 | ||
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1290|consensus | 590 | 100.0 | ||
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG1026|consensus | 774 | 100.0 | ||
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0690|consensus | 516 | 100.0 | ||
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| KOG0586|consensus | 596 | 100.0 | ||
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG1095|consensus | 1025 | 100.0 | ||
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0669|consensus | 376 | 100.0 | ||
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0662|consensus | 292 | 100.0 | ||
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4257|consensus | 974 | 100.0 | ||
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0671|consensus | 415 | 100.0 | ||
| KOG0196|consensus | 996 | 100.0 | ||
| KOG0670|consensus | 752 | 100.0 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0199|consensus | 1039 | 100.0 | ||
| KOG4278|consensus | 1157 | 100.0 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0665|consensus | 369 | 100.0 | ||
| KOG1035|consensus | 1351 | 100.0 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1094|consensus | 807 | 100.0 | ||
| KOG4250|consensus | 732 | 100.0 | ||
| KOG0668|consensus | 338 | 100.0 | ||
| KOG1006|consensus | 361 | 100.0 | ||
| KOG0587|consensus | 953 | 100.0 | ||
| KOG0608|consensus | 1034 | 100.0 | ||
| KOG1027|consensus | 903 | 100.0 | ||
| KOG1151|consensus | 775 | 100.0 | ||
| KOG1025|consensus | 1177 | 100.0 | ||
| KOG0695|consensus | 593 | 100.0 | ||
| KOG0200|consensus | 609 | 100.0 | ||
| KOG0664|consensus | 449 | 100.0 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG2052|consensus | 513 | 99.97 | ||
| KOG3653|consensus | 534 | 99.97 | ||
| KOG0984|consensus | 282 | 99.97 | ||
| KOG1167|consensus | 418 | 99.97 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG0576|consensus | 829 | 99.96 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1024|consensus | 563 | 99.96 | ||
| KOG1345|consensus | 378 | 99.95 | ||
| KOG1152|consensus | 772 | 99.94 | ||
| KOG0590|consensus | 601 | 99.94 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG1164|consensus | 322 | 99.92 | ||
| KOG1240|consensus | 1431 | 99.9 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG0195|consensus | 448 | 99.89 | ||
| KOG0603|consensus | 612 | 99.88 | ||
| KOG1163|consensus | 341 | 99.88 | ||
| KOG1165|consensus | 449 | 99.87 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| KOG0606|consensus | 1205 | 99.86 | ||
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG4158|consensus | 598 | 99.83 | ||
| KOG1033|consensus | 516 | 99.82 | ||
| KOG1166|consensus | 974 | 99.78 | ||
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| KOG1023|consensus | 484 | 99.74 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| KOG0590|consensus | 601 | 99.69 | ||
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.65 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| KOG0606|consensus | 1205 | 99.53 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.5 | |
| KOG0601|consensus | 524 | 99.41 | ||
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.38 | |
| KOG1266|consensus | 458 | 99.36 | ||
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.31 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.3 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.3 | |
| KOG1243|consensus | 690 | 99.24 | ||
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.19 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.18 | |
| KOG3087|consensus | 229 | 99.14 | ||
| KOG2137|consensus | 700 | 99.12 | ||
| KOG0601|consensus | 524 | 99.06 | ||
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.98 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.93 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.93 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.79 | |
| KOG3741|consensus | 655 | 98.74 | ||
| PRK09902 | 216 | hypothetical protein; Provisional | 98.69 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.54 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.45 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.33 | |
| KOG1035|consensus | 1351 | 98.33 | ||
| KOG0576|consensus | 829 | 98.33 | ||
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.15 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.04 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.04 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.02 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.72 | |
| KOG1826|consensus | 2724 | 97.71 | ||
| KOG1235|consensus | 538 | 97.49 | ||
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.46 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.42 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.39 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.36 | |
| PF04212 | 69 | MIT: MIT (microtubule interacting and transport) d | 97.34 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.33 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.24 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.18 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.16 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.13 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.0 | |
| KOG1093|consensus | 725 | 96.91 | ||
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.89 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.83 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.77 | |
| KOG2268|consensus | 465 | 96.62 | ||
| KOG2270|consensus | 520 | 96.49 | ||
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.37 | |
| cd02683 | 77 | MIT_1 MIT: domain contained within Microtubule Int | 96.29 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.27 | |
| cd02682 | 75 | MIT_AAA_Arch MIT: domain contained within Microtub | 96.18 | |
| cd02656 | 75 | MIT MIT: domain contained within Microtubule Inter | 96.17 | |
| PLN02236 | 344 | choline kinase | 96.04 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.0 | |
| cd02684 | 75 | MIT_2 MIT: domain contained within Microtubule Int | 95.92 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.78 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.75 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.7 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.49 | |
| cd02678 | 75 | MIT_VPS4 MIT: domain contained within Microtubule | 95.48 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.43 | |
| smart00745 | 77 | MIT Microtubule Interacting and Trafficking molecu | 95.26 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.76 | |
| cd02677 | 75 | MIT_SNX15 MIT: domain contained within Microtubule | 94.46 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.29 |
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-53 Score=397.50 Aligned_cols=247 Identities=28% Similarity=0.459 Sum_probs=216.4
Q ss_pred ceeeecceeeeEEEeeeee--eceeEEeeeecCCccc-------hhhhhhHHhhcccCCCCCCcc------cCCeEEEEE
Q psy5368 55 STIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITS-------HSEFERPRAGLSNLRAPEGRK------RPRYVYIIL 119 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~-------~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~ 119 (406)
.++.+|+|+||.|-.+..+ ++.+|+|.+....... ...+.+|+++|++|+|||++. .+.+.|+||
T Consensus 176 i~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVl 255 (475)
T KOG0615|consen 176 ISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVL 255 (475)
T ss_pred eeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEE
Confidence 4567999999999999864 4678998776544332 234679999999999999776 667789999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeCC----eeEEEecccccccCCCCCC
Q psy5368 120 EYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN----TLKLADFGFAQFLAPNDQG 195 (406)
Q Consensus 120 E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~~----~~kL~DFGla~~~~~~~~~ 195 (406)
||++||+|.+.+-.++.+.+...+.+++|++.|+.|||++||+||||||+|||+++. .+||+|||+|+......-.
T Consensus 256 E~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm 335 (475)
T KOG0615|consen 256 EYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFM 335 (475)
T ss_pred EEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccccceeh
Confidence 999999999999999999999999999999999999999999999999999999833 7999999999998877888
Q ss_pred CcccCCCCCCChhhhcCCC--CC-chhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCCCCCCCC--CCChHHHH
Q psy5368 196 DSIQGSPLYMAPEILAGSP--YN-AKADLWSLGVLVFEALFGHAPYASCNLSQ-LRAQALSSAPITIPPN--SLSPDCMD 269 (406)
Q Consensus 196 ~~~~gt~~y~aPE~~~~~~--~~-~~~DiwSlG~il~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~--~~s~~l~~ 269 (406)
.+.+|||.|.|||++.++. ++ .++||||+|||||-+|+|.+||.+..... +..+|..+.....|+. .+|++..+
T Consensus 336 ~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~d 415 (475)
T KOG0615|consen 336 KTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALD 415 (475)
T ss_pred hhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHH
Confidence 9999999999999998765 33 37899999999999999999999887666 8888888877666553 79999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q psy5368 270 FLSRLLQKDPMRRISYEDLFSHPYPDLIHAPC 301 (406)
Q Consensus 270 li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~ 301 (406)
||.+||..||++|||++|+|+||||+....-+
T Consensus 416 lI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s 447 (475)
T KOG0615|consen 416 LINWMLVVDPENRPSADEALNHPWFKDAPCLS 447 (475)
T ss_pred HHHHhhEeCcccCcCHHHHhcChhhhcccccc
Confidence 99999999999999999999999999765433
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-52 Score=386.22 Aligned_cols=243 Identities=26% Similarity=0.452 Sum_probs=219.6
Q ss_pred eeeecceeeeEEEeeeeee--ceeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc------cCC-eEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIRL--GTVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK------RPR-YVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~------~~~-~~~lV~E~~~gg 125 (406)
-.+||+|+.|+||++.++. ...|.|.+.... ....+++.+|++++++++||+++. .++ .++|+||||+||
T Consensus 84 ~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgG 163 (364)
T KOG0581|consen 84 LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGG 163 (364)
T ss_pred hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCC
Confidence 4578999999999999874 456778774433 334668999999999999999876 555 599999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRE-NNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~-~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
+|.+++...+++++....+|+.++++||.|||+ ++|+||||||+|||++ .|.+||||||.|+.+.++ ..++.+||..
T Consensus 164 SLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a~tfvGT~~ 242 (364)
T KOG0581|consen 164 SLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IANTFVGTSA 242 (364)
T ss_pred CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-hccccccccc
Confidence 999999988999999999999999999999995 9999999999999999 889999999999988776 6788999999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASC-----NLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKD 278 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~-----~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~d 278 (406)
|||||.+.+..|+.++||||||+.++|+.+|+.||... +..++...|..+.++..|...+|+++++|+..||++|
T Consensus 243 YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kd 322 (364)
T KOG0581|consen 243 YMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKD 322 (364)
T ss_pred ccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCC
Confidence 99999999999999999999999999999999999885 7788899999988888888779999999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCCC
Q psy5368 279 PMRRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 279 P~~Rps~~ell~hp~~~~~~~ 299 (406)
|.+|||++|+++|||++....
T Consensus 323 p~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 323 PSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred cccCCCHHHHhcCHHHhhccc
Confidence 999999999999999986544
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-51 Score=379.84 Aligned_cols=243 Identities=36% Similarity=0.649 Sum_probs=218.3
Q ss_pred eeeecceeeeEEEeeeeee--ceeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIRL--GTVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...||.|+|++||+|..+. ..||||.+.... ....+.+..|+.+|+.++|||++. .++++|||||||.||
T Consensus 15 ~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gG 94 (429)
T KOG0595|consen 15 SREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGG 94 (429)
T ss_pred hhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCC
Confidence 3458999999999999754 568999887763 334556789999999999999875 888999999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeC-------CeeEEEecccccccCCCCCCCcc
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-------NTLKLADFGFAQFLAPNDQGDSI 198 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~-------~~~kL~DFGla~~~~~~~~~~~~ 198 (406)
||.++|+.++.+++..++.++.||+.||++||+++|+||||||+|||++. -.+||+|||+|+.+.+.....+.
T Consensus 95 DLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tl 174 (429)
T KOG0595|consen 95 DLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETL 174 (429)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHh
Confidence 99999999999999999999999999999999999999999999999982 36899999999999988888899
Q ss_pred cCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCCCCCCChHHHHHHHHhccc
Q psy5368 199 QGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI-TIPPNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 199 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~s~~l~~li~~~L~~ 277 (406)
+|+|.|||||++....|+.|+|+||+|+|+|+|++|++||...+..++...+..+... ..++..++..+.+|+...|..
T Consensus 175 cGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~ 254 (429)
T KOG0595|consen 175 CGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQR 254 (429)
T ss_pred hCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhc
Confidence 9999999999999999999999999999999999999999999999999887776443 334447888899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCC
Q psy5368 278 DPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 278 dP~~Rps~~ell~hp~~~~~~ 298 (406)
+|.+|.++.+.+.|++.....
T Consensus 255 ~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 255 NPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred CccccCchHHhhhhhhcccCc
Confidence 999999999999999987543
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-50 Score=392.81 Aligned_cols=246 Identities=25% Similarity=0.465 Sum_probs=221.0
Q ss_pred CceeeecceeeeEEEeeee--eeceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEecc
Q psy5368 54 SSTIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYC 122 (406)
Q Consensus 54 ~~~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~ 122 (406)
.-...||+|||..||.++. .+..+|+|.+.+... ...+.+.+|+++.++|+||||++ +.+++|||+|+|
T Consensus 21 ~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC 100 (592)
T KOG0575|consen 21 KRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELC 100 (592)
T ss_pred eeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEec
Confidence 5577899999999999997 345678887766433 34567899999999999999876 899999999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeCC-eeEEEecccccccCCC-CCCCcccC
Q psy5368 123 DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLADFGFAQFLAPN-DQGDSIQG 200 (406)
Q Consensus 123 ~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~~-~~kL~DFGla~~~~~~-~~~~~~~g 200 (406)
+.++|..+++.+++++|.+++.+++||+.||.|||+++|+|||||..|++++++ ++||+|||||..+... ....+.+|
T Consensus 101 ~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCG 180 (592)
T KOG0575|consen 101 HRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCG 180 (592)
T ss_pred CCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccceecC
Confidence 999999999988999999999999999999999999999999999999999955 9999999999998765 66788999
Q ss_pred CCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCC
Q psy5368 201 SPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPM 280 (406)
Q Consensus 201 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~ 280 (406)
||.|.|||++....++..+||||+|||||-||+|++||...+..+....|..... ..| ..+|.++++||.++|++||.
T Consensus 181 TPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y-~~P-~~ls~~A~dLI~~lL~~~P~ 258 (592)
T KOG0575|consen 181 TPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY-SMP-SHLSAEAKDLIRKLLRPNPS 258 (592)
T ss_pred CCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc-ccc-cccCHHHHHHHHHHhcCCcc
Confidence 9999999999999999999999999999999999999999999999999887733 333 38999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCC
Q psy5368 281 RRISYEDLFSHPYPDLIHAPC 301 (406)
Q Consensus 281 ~Rps~~ell~hp~~~~~~~~~ 301 (406)
+|||++++|.|+||+....|.
T Consensus 259 ~Rpsl~~vL~h~Ff~~g~~p~ 279 (592)
T KOG0575|consen 259 ERPSLDEVLDHPFFKSGFTPA 279 (592)
T ss_pred cCCCHHHHhcCHhhhCCCcCC
Confidence 999999999999996554443
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-50 Score=372.09 Aligned_cols=253 Identities=29% Similarity=0.527 Sum_probs=220.9
Q ss_pred ccccceeeecCceeeecceeeeEEEeeeeeec--eeEEeeeecCCccc---hhhhhhHHhhcccCCCCCCcc------cC
Q psy5368 44 SGTVRYDIVGSSTIRYGELQYDTVQNSQIRLG--TVKYSQVRYDTITS---HSEFERPRAGLSNLRAPEGRK------RP 112 (406)
Q Consensus 44 ~~~~~~~i~~~~~~~lG~G~~g~Vy~~~~~~~--~v~vk~~~~~~~~~---~~~~~~E~~~l~~l~h~ni~~------~~ 112 (406)
..-..| ..-++||+|+||.|+.++.+.+ -.|.|.+++..... .....+|..+|.+++||.+++ +.
T Consensus 22 ~~~~dF----~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~ 97 (357)
T KOG0598|consen 22 VGPDDF----EILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTE 97 (357)
T ss_pred CChhhe----eeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccC
Confidence 334456 3456789999999999987543 34666665544333 446788999999999999765 88
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccc-cC
Q psy5368 113 RYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQF-LA 190 (406)
Q Consensus 113 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~-~~ 190 (406)
..+|+|+||+.||+|..+|++.+.|++..++.++..|+.||.|||++||+||||||+|||+| +|+++|+|||+++. +.
T Consensus 98 ~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 98 EKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred CeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999999999999999999999999999999999999999999999999999999 88999999999985 44
Q ss_pred CCCCCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHH
Q psy5368 191 PNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDF 270 (406)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~l 270 (406)
.+....+.+||+.|||||++.+..|+..+|.||+|+++|||++|.+||.+.+.......+.... ...++..++.++++|
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-~~~~p~~ls~~ardl 256 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-LPLPPGYLSEEARDL 256 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-CCCCCccCCHHHHHH
Confidence 4456677899999999999999999999999999999999999999999999999999998885 344444699999999
Q ss_pred HHHhcccCCCCCC----CHHHHhcCCCCCCCCCCC
Q psy5368 271 LSRLLQKDPMRRI----SYEDLFSHPYPDLIHAPC 301 (406)
Q Consensus 271 i~~~L~~dP~~Rp----s~~ell~hp~~~~~~~~~ 301 (406)
++++|+.||++|. +++++-+||||+.+.|..
T Consensus 257 l~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~ 291 (357)
T KOG0598|consen 257 LKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEK 291 (357)
T ss_pred HHHHhccCHHHhcCCCCChHHhhcCcccccCCHHH
Confidence 9999999999996 789999999999988743
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=353.18 Aligned_cols=230 Identities=27% Similarity=0.463 Sum_probs=205.6
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCccc--hhhhhhHHhhcccCCCCCCcc--------cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITS--HSEFERPRAGLSNLRAPEGRK--------RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~--~~~~~~E~~~l~~l~h~ni~~--------~~~~~~lV~E~~~ 123 (406)
..+||.|+||+||++.. .+..+|.|++....... ..+...|+.+|++|+|||+++ +...++||||||.
T Consensus 24 l~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~ 103 (375)
T KOG0591|consen 24 LKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCD 103 (375)
T ss_pred HHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhc
Confidence 45679999999999985 45678888888765444 447889999999999999876 3444899999999
Q ss_pred CCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH--CC--cccccCCCcceEee-CCeeEEEecccccccCCCCC
Q psy5368 124 GGDLCSFIRS----HEKLSEFQCQQFVRQLVLALKFLRE--NN--VCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ 194 (406)
Q Consensus 124 ggsL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~lH~--~g--ivH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~ 194 (406)
+|||++.|+. ++.+++..+++++.|++.||..||+ .+ |+||||||.||+++ +|.+||+|||+++.+.....
T Consensus 104 ~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~t 183 (375)
T KOG0591|consen 104 AGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTT 183 (375)
T ss_pred ccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhH
Confidence 9999999953 3569999999999999999999999 45 99999999999999 88999999999999876643
Q ss_pred -CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHH
Q psy5368 195 -GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSR 273 (406)
Q Consensus 195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~ 273 (406)
..+.+|||.||+||.+.+.+|+.+|||||+||++|||+.-++||.+.+..++..+|..+..++.|...+|.++..||..
T Consensus 184 fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ 263 (375)
T KOG0591|consen 184 FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDLRELINM 263 (375)
T ss_pred HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHH
Confidence 4678999999999999999999999999999999999999999999999999999999977777777899999999999
Q ss_pred hcccCCCCCCCH
Q psy5368 274 LLQKDPMRRISY 285 (406)
Q Consensus 274 ~L~~dP~~Rps~ 285 (406)
|+..||+.||+.
T Consensus 264 ci~vd~~~RP~t 275 (375)
T KOG0591|consen 264 CIAVDPEQRPDT 275 (375)
T ss_pred HccCCcccCCCc
Confidence 999999999986
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=365.01 Aligned_cols=246 Identities=30% Similarity=0.479 Sum_probs=207.4
Q ss_pred CceeeecceeeeEEEeeeeee--ceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcccCC--------eEEEEEeccC
Q psy5368 54 SSTIRYGELQYDTVQNSQIRL--GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRKRPR--------YVYIILEYCD 123 (406)
Q Consensus 54 ~~~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~--------~~~lV~E~~~ 123 (406)
.....||+|+||+||.+.... ...+||..........+.+.+|+.+|.+|+|||+++..+ .++++|||++
T Consensus 20 ~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~ 99 (313)
T KOG0198|consen 20 SKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAP 99 (313)
T ss_pred hhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccC
Confidence 456689999999999999764 678899877654333667999999999999999988555 5999999999
Q ss_pred CCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeC--CeeEEEecccccccCC----CCCCC
Q psy5368 124 GGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN--NTLKLADFGFAQFLAP----NDQGD 196 (406)
Q Consensus 124 ggsL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~--~~~kL~DFGla~~~~~----~~~~~ 196 (406)
+|+|.+++.+.+ .+++..++++++||++||.|||++||+||||||+|||++. +.+||+|||+++.... .....
T Consensus 100 ~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~ 179 (313)
T KOG0198|consen 100 GGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSEL 179 (313)
T ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccccccc
Confidence 999999999877 7999999999999999999999999999999999999995 6999999999987663 22345
Q ss_pred cccCCCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHh
Q psy5368 197 SIQGSPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYAS-CNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRL 274 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~ 274 (406)
...||+.|||||++..+ ...+++||||+||++.||+||++||.. .........+......+..+..+|+++++|+.+|
T Consensus 180 ~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C 259 (313)
T KOG0198|consen 180 SVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKC 259 (313)
T ss_pred cccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHH
Confidence 67899999999999953 344699999999999999999999998 4444444444444322333447999999999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCCCC
Q psy5368 275 LQKDPMRRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 275 L~~dP~~Rps~~ell~hp~~~~~~~ 299 (406)
+..||++|||++++|+|||.+....
T Consensus 260 ~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 260 FKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred hhcCcccCcCHHHHhhChhhhcccc
Confidence 9999999999999999999976543
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=370.46 Aligned_cols=240 Identities=31% Similarity=0.583 Sum_probs=209.9
Q ss_pred ceeeecceeeeEEEeeeee--eceeEEeeeecCC----c-cchhhhhhHHhhcccCC-CCCCcc------cCCeEEEEEe
Q psy5368 55 STIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT----I-TSHSEFERPRAGLSNLR-APEGRK------RPRYVYIILE 120 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~----~-~~~~~~~~E~~~l~~l~-h~ni~~------~~~~~~lV~E 120 (406)
....||+|+||.|+.+... +..||+|.+.... . .....+.+|+.+++.++ |||+++ ....+|+|||
T Consensus 21 ~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmE 100 (370)
T KOG0583|consen 21 LGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVME 100 (370)
T ss_pred eeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEE
Confidence 3456789999999998763 3577888444431 1 23446778999999999 999766 6777999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-C-CeeEEEeccccccc-CCCCCCCc
Q psy5368 121 YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-N-NTLKLADFGFAQFL-APNDQGDS 197 (406)
Q Consensus 121 ~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~-~~~kL~DFGla~~~-~~~~~~~~ 197 (406)
||.||+|.+++.+.+++++.+++.+++||+.|++|||++||+||||||+|||++ + +++||+|||++... .......+
T Consensus 101 y~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t 180 (370)
T KOG0583|consen 101 YCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKT 180 (370)
T ss_pred ecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcccC
Confidence 999999999999989999999999999999999999999999999999999999 5 79999999999988 46667888
Q ss_pred ccCCCCCCChhhhcCCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC-ChHHHHHHHHh
Q psy5368 198 IQGSPLYMAPEILAGSP-YN-AKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSL-SPDCMDFLSRL 274 (406)
Q Consensus 198 ~~gt~~y~aPE~~~~~~-~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-s~~l~~li~~~ 274 (406)
.+||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||...+...+...+..+ ...+|. .+ |+++++|+.+|
T Consensus 181 ~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~-~~~~p~-~~~S~~~~~Li~~m 258 (370)
T KOG0583|consen 181 FCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG-EFKIPS-YLLSPEARSLIEKM 258 (370)
T ss_pred CCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC-CccCCC-CcCCHHHHHHHHHH
Confidence 99999999999999987 86 6899999999999999999999999988888886666 444444 46 99999999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCC
Q psy5368 275 LQKDPMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 275 L~~dP~~Rps~~ell~hp~~~~ 296 (406)
|..||.+|+|+.+++.||||+.
T Consensus 259 L~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 259 LVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred cCCCcccCCCHHHHhhChhhcc
Confidence 9999999999999999999997
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-48 Score=348.45 Aligned_cols=239 Identities=28% Similarity=0.423 Sum_probs=201.0
Q ss_pred eeecceeeeEEEeeeeee--ceeEEeeeecCCc-c-chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 57 IRYGELQYDTVQNSQIRL--GTVKYSQVRYDTI-T-SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~-~-~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
.++|+|+||.||+++.+. .-||||++..+.. + -.+-.+||+++|++|+|+|++. ..+.++||+|||+. +
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-T 86 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-T 86 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-H
Confidence 357999999999999754 4688998865432 2 2345689999999999999765 88899999999988 6
Q ss_pred HHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccC-CCCCCCcccCCCC
Q psy5368 127 LCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLA-PNDQGDSIQGSPL 203 (406)
Q Consensus 127 L~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~-~~~~~~~~~gt~~ 203 (406)
+.+-|... ..++...++.+++|++.|+.|||+++++||||||+|||++ +|.+||||||+|+.+. ++.....++.|.|
T Consensus 87 vL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRW 166 (396)
T KOG0593|consen 87 VLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRW 166 (396)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhh
Confidence 66666655 4799999999999999999999999999999999999999 8899999999999987 5556677889999
Q ss_pred CCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC------------------CCCC----
Q psy5368 204 YMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI------------------TIPP---- 260 (406)
Q Consensus 204 y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------------------~~~~---- 260 (406)
|+|||.+.+ .+|+..+||||+||++.||++|.+.|++.+.-+....|...... .+|.
T Consensus 167 YRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~ 246 (396)
T KOG0593|consen 167 YRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHP 246 (396)
T ss_pred ccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCc
Confidence 999999998 57999999999999999999999999998766655555432110 1111
Q ss_pred -------CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy5368 261 -------NSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 261 -------~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 296 (406)
..++.-+.+|+..||..||++|++.+|++.||||+.
T Consensus 247 epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 247 EPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred cchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 135667899999999999999999999999999964
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-48 Score=369.94 Aligned_cols=243 Identities=27% Similarity=0.495 Sum_probs=214.2
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc---chhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT---SHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~---~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~ 123 (406)
...||+|+|++|++++.. .+..|+|.+.+.-+. ..+.+.+|-.+|.+| .||.+++ +...+|+|+||++
T Consensus 78 g~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~ 157 (604)
T KOG0592|consen 78 GKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAP 157 (604)
T ss_pred hheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecC
Confidence 557899999999999964 345677765543322 234577899999999 9998766 8899999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC--------
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ-------- 194 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~-------- 194 (406)
+|+|.++|++.+.|++..++.++.+|+.||+|||++|||||||||+|||+| ++.++|+|||.|+.+.....
T Consensus 158 nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~ 237 (604)
T KOG0592|consen 158 NGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDP 237 (604)
T ss_pred CCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCc
Confidence 999999999999999999999999999999999999999999999999999 88999999999988754321
Q ss_pred ------CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHH
Q psy5368 195 ------GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCM 268 (406)
Q Consensus 195 ------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~ 268 (406)
..+.+||..|.+||++..+..++.+|||+||||||.|+.|.+||.+.+...+..+|..- ...+|+ .+++.++
T Consensus 238 ~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l-~y~fp~-~fp~~a~ 315 (604)
T KOG0592|consen 238 NQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL-DYEFPE-GFPEDAR 315 (604)
T ss_pred ccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh-cccCCC-CCCHHHH
Confidence 14588999999999999999999999999999999999999999999999999888876 344444 6999999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy5368 269 DFLSRLLQKDPMRRISYEDLFSHPYPDLIHAP 300 (406)
Q Consensus 269 ~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 300 (406)
+||.++|..||.+|+|+++|.+||||..+.|.
T Consensus 316 dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~ 347 (604)
T KOG0592|consen 316 DLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWE 347 (604)
T ss_pred HHHHHHHccCccccccHHHHhhCcccccCChh
Confidence 99999999999999999999999999988764
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=366.52 Aligned_cols=234 Identities=27% Similarity=0.438 Sum_probs=205.1
Q ss_pred eeecceeeeEEEeeeeeece-eEEeeeecCCccc--hhhhhhHHhhcccCCCCCCcc------cCC-eEEEEEeccCCCC
Q psy5368 57 IRYGELQYDTVQNSQIRLGT-VKYSQVRYDTITS--HSEFERPRAGLSNLRAPEGRK------RPR-YVYIILEYCDGGD 126 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~~~-v~vk~~~~~~~~~--~~~~~~E~~~l~~l~h~ni~~------~~~-~~~lV~E~~~ggs 126 (406)
..+|.|+||+||++.+++.. |++|.+....... ...|.+|+.+|.+++|||++. .+. .++|||||+++|+
T Consensus 47 ~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~Gs 126 (362)
T KOG0192|consen 47 EVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGS 126 (362)
T ss_pred hhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCc
Confidence 34899999999999999998 9999887655333 448999999999999999876 333 6899999999999
Q ss_pred HHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC-cccccCCCcceEee-CC-eeEEEecccccccCCC-CCCCcccC
Q psy5368 127 LCSFIRS--HEKLSEFQCQQFVRQLVLALKFLRENN-VCHFDLKPQNILIK-NN-TLKLADFGFAQFLAPN-DQGDSIQG 200 (406)
Q Consensus 127 L~~~l~~--~~~l~~~~~~~i~~ql~~aL~~lH~~g-ivH~Dlkp~NIll~-~~-~~kL~DFGla~~~~~~-~~~~~~~g 200 (406)
|.+++.. ++.+++..+.+++.||++|+.|||+++ ||||||||+|||++ +. ++||+|||+++..... .......|
T Consensus 127 L~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~G 206 (362)
T KOG0192|consen 127 LSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAG 206 (362)
T ss_pred HHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccccccccCCCC
Confidence 9999987 578999999999999999999999999 99999999999999 54 9999999999887665 44555789
Q ss_pred CCCCCChhhhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccC
Q psy5368 201 SPLYMAPEILA--GSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKD 278 (406)
Q Consensus 201 t~~y~aPE~~~--~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~d 278 (406)
|+.|||||++. ...|+.++||||||++||||+||+.||.+.........+.........+..+++.+..|+.+||..|
T Consensus 207 T~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~d 286 (362)
T KOG0192|consen 207 TYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVD 286 (362)
T ss_pred CccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCC
Confidence 99999999999 6689999999999999999999999999998877766666444444434469999999999999999
Q ss_pred CCCCCCHHHHhc
Q psy5368 279 PMRRISYEDLFS 290 (406)
Q Consensus 279 P~~Rps~~ell~ 290 (406)
|..||++.+++.
T Consensus 287 p~~RP~f~ei~~ 298 (362)
T KOG0192|consen 287 PSRRPSFLEIVS 298 (362)
T ss_pred CCcCCCHHHHHH
Confidence 999999999865
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=365.11 Aligned_cols=245 Identities=28% Similarity=0.429 Sum_probs=209.3
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCcc--------cCCeEEEEEeccCC
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRK--------RPRYVYIILEYCDG 124 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~--------~~~~~~lV~E~~~g 124 (406)
..||+|.||.||+++.. ++-||+|++..+. .....-..||+.+|++|+||||++ ..+.+|||+|||+.
T Consensus 123 ~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh 202 (560)
T KOG0600|consen 123 EKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH 202 (560)
T ss_pred HHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc
Confidence 46899999999999974 4559999998776 334556789999999999999876 35799999999998
Q ss_pred CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC--CCCcccC
Q psy5368 125 GDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND--QGDSIQG 200 (406)
Q Consensus 125 gsL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~--~~~~~~g 200 (406)
||..++...+ .|++.+++.+++||+.||+|||++||+|||||..||||| +|++||+|||||+...... ...+.+-
T Consensus 203 -DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVv 281 (560)
T KOG0600|consen 203 -DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVV 281 (560)
T ss_pred -hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceE
Confidence 9999997754 799999999999999999999999999999999999999 7899999999999765554 4567778
Q ss_pred CCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------CCC-----------
Q psy5368 201 SPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI---------TIP----------- 259 (406)
Q Consensus 201 t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---------~~~----------- 259 (406)
|+||+|||.+.|. .|+.++|+||+||||.||++|+++|.+.+..+....|....-. .+|
T Consensus 282 TLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y 361 (560)
T KOG0600|consen 282 TLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPY 361 (560)
T ss_pred EeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcc
Confidence 9999999999985 4999999999999999999999999999988887777653211 111
Q ss_pred -------CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCc
Q psy5368 260 -------PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCA 302 (406)
Q Consensus 260 -------~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~ 302 (406)
...+|..+.+|+..+|..||.+|.|+.++|.|+||+....++.
T Consensus 362 ~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~ 411 (560)
T KOG0600|consen 362 KRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCD 411 (560)
T ss_pred cchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCCC
Confidence 0135788999999999999999999999999999965555443
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=342.16 Aligned_cols=241 Identities=29% Similarity=0.507 Sum_probs=214.3
Q ss_pred eeeecceeeeEEEeeeeeece--eEEeeeecCCccchh---hhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIRLGT--VKYSQVRYDTITSHS---EFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~~--v~vk~~~~~~~~~~~---~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
-..+|.|+||+|...+.+... .|.|.+.+......+ ...+|..+|+.+.||.++. +.+++|+||||++|
T Consensus 49 ~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~G 128 (355)
T KOG0616|consen 49 LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPG 128 (355)
T ss_pred eeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCC
Confidence 456799999999998875443 466766665544433 4677999999999998765 88999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
|.|..++++.++|++..++.++.||+.||+|||+++|++|||||+|||+| +|.+||+|||+|+.... ...+.+|||.
T Consensus 129 GElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~--rT~TlCGTPe 206 (355)
T KOG0616|consen 129 GELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG--RTWTLCGTPE 206 (355)
T ss_pred ccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC--cEEEecCCcc
Confidence 99999999999999999999999999999999999999999999999999 88999999999998753 3678899999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
|+|||++.++.|+.++|.||||+++|||+.|.+||.+.+...+..+|..+ ...+|+ .+++++++|+.++|+.|-.+|.
T Consensus 207 YLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~-~v~fP~-~fs~~~kdLl~~LL~vD~t~R~ 284 (355)
T KOG0616|consen 207 YLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG-KVKFPS-YFSSDAKDLLKKLLQVDLTKRF 284 (355)
T ss_pred ccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC-cccCCc-ccCHHHHHHHHHHHhhhhHhhh
Confidence 99999999999999999999999999999999999999999999999988 445554 7999999999999999999994
Q ss_pred -----CHHHHhcCCCCCCCCCC
Q psy5368 284 -----SYEDLFSHPYPDLIHAP 300 (406)
Q Consensus 284 -----s~~ell~hp~~~~~~~~ 300 (406)
...++..||||+...|.
T Consensus 285 gnlknG~~dIk~H~wF~~v~W~ 306 (355)
T KOG0616|consen 285 GNLKNGVEDIKNHPWFKGVDWE 306 (355)
T ss_pred cCcCCCccccccCcccccccHH
Confidence 57899999999988764
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=350.61 Aligned_cols=247 Identities=28% Similarity=0.449 Sum_probs=210.0
Q ss_pred eeecceeeeEEEeeee--eeceeEEeeee--cCCccchhhhhhHHhhcccCCCCCCcc-----------cCCeEEEEEec
Q psy5368 57 IRYGELQYDTVQNSQI--RLGTVKYSQVR--YDTITSHSEFERPRAGLSNLRAPEGRK-----------RPRYVYIILEY 121 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~--~~~~v~vk~~~--~~~~~~~~~~~~E~~~l~~l~h~ni~~-----------~~~~~~lV~E~ 121 (406)
..+|.|+||.|..+.. .+..||+|++. .......++..||+.+|+.++|+|++. .-+.+|+|+|+
T Consensus 28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el 107 (359)
T KOG0660|consen 28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL 107 (359)
T ss_pred ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence 4579999999999876 34679999887 666677889999999999999999754 45678999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCC---CCCCCc
Q psy5368 122 CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAP---NDQGDS 197 (406)
Q Consensus 122 ~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~---~~~~~~ 197 (406)
|+. ||.+.|+.++.++...+..+++||++||.|+|+.||+||||||.|++++ +..+||+|||+|+.... ....+.
T Consensus 108 Met-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTe 186 (359)
T KOG0660|consen 108 MET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTE 186 (359)
T ss_pred Hhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcccchhc
Confidence 954 9999999988899999999999999999999999999999999999999 66999999999998864 444577
Q ss_pred ccCCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC----------------------
Q psy5368 198 IQGSPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSA---------------------- 254 (406)
Q Consensus 198 ~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~---------------------- 254 (406)
++.|.+|+|||++.. ..|+.+.||||+|||+.||++|++.|++.+.-.....+....
T Consensus 187 YVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~s 266 (359)
T KOG0660|consen 187 YVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKS 266 (359)
T ss_pred ceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHh
Confidence 889999999999866 569999999999999999999999999976444433333211
Q ss_pred CCCCCC-------CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCccc
Q psy5368 255 PITIPP-------NSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAES 304 (406)
Q Consensus 255 ~~~~~~-------~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~~~ 304 (406)
.+..++ .+.++.+.+|+.+||..||.+|+|++|+|+|||+...+.|+.|+
T Consensus 267 lp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 267 LPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred CCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 111111 25688999999999999999999999999999999999888775
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=335.23 Aligned_cols=242 Identities=24% Similarity=0.459 Sum_probs=209.6
Q ss_pred eeeecceeeeEEEeeeeeec--eeEEeeeec--CCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIRLG--TVKYSQVRY--DTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~--~v~vk~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
-.+||+|.|+.||++....+ ..++|.+.. -...+.+++.+|+.+.+.|+|||++. ..++.|||+|+|.|+
T Consensus 16 ~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~ 95 (355)
T KOG0033|consen 16 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 95 (355)
T ss_pred HHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccch
Confidence 44689999999999876433 223332211 11236788999999999999999876 778899999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee---C-CeeEEEecccccccCCCCCCCcccCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK---N-NTLKLADFGFAQFLAPNDQGDSIQGS 201 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~---~-~~~kL~DFGla~~~~~~~~~~~~~gt 201 (406)
+|..-|-.+--+++..+..+++||+++|.|||.+||||||+||+|+++. . --+||+|||+|.............||
T Consensus 96 dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~Gt 175 (355)
T KOG0033|consen 96 ELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGT 175 (355)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCC
Confidence 9988887767789999999999999999999999999999999999996 2 27999999999988866666778899
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCChHHHHHHHHhcccCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP--NSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~~li~~~L~~dP 279 (406)
|.|||||++...+|+..+|||+.|+|||-||.|.+||.+.+...+.++|..+.....++ ..+++++++|+++||..||
T Consensus 176 P~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP 255 (355)
T KOG0033|consen 176 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNP 255 (355)
T ss_pred CcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccCh
Confidence 99999999999999999999999999999999999999999999999999885443332 3799999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCC
Q psy5368 280 MRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 280 ~~Rps~~ell~hp~~~~~ 297 (406)
.+|+|+.|+|+|||+...
T Consensus 256 ~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 256 KKRITADEALKHPWICNR 273 (355)
T ss_pred hhhccHHHHhCCchhcch
Confidence 999999999999998753
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=363.97 Aligned_cols=241 Identities=26% Similarity=0.484 Sum_probs=216.4
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
-.+||+|+.|.||.+... ...||+|++........+-+.+|+.+|+..+|+|++. ..+.+|+|||||+||+|
T Consensus 278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 457999999999999863 4568999999888888888999999999999999876 55789999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCCCC
Q psy5368 128 CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPLYM 205 (406)
Q Consensus 128 ~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~y~ 205 (406)
.+.+... .+++.++..|.+++++||+|||.+||+|||||.+|||++ +|.+||+|||++..+.... ...+.+|||.||
T Consensus 358 TDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWM 436 (550)
T KOG0578|consen 358 TDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWM 436 (550)
T ss_pred hhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccccCCCCcc
Confidence 9998664 599999999999999999999999999999999999999 8899999999998776654 567889999999
Q ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC-CCCCChHHHHHHHHhcccCCCCCCC
Q psy5368 206 APEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIP-PNSLSPDCMDFLSRLLQKDPMRRIS 284 (406)
Q Consensus 206 aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~~li~~~L~~dP~~Rps 284 (406)
|||++....|+++.||||||++++||+-|.+||-..++-.....|.....+.+. +..+|+.+++|+.+||+.||.+|++
T Consensus 437 APEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~Ras 516 (550)
T KOG0578|consen 437 APEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRAS 516 (550)
T ss_pred chhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCC
Confidence 999999999999999999999999999999999987777766677666555544 3489999999999999999999999
Q ss_pred HHHHhcCCCCCCC
Q psy5368 285 YEDLFSHPYPDLI 297 (406)
Q Consensus 285 ~~ell~hp~~~~~ 297 (406)
+.|+|+||||+..
T Consensus 517 A~eLL~HpFl~~a 529 (550)
T KOG0578|consen 517 AKELLEHPFLKMA 529 (550)
T ss_pred HHHHhcChhhhhc
Confidence 9999999999643
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=328.64 Aligned_cols=247 Identities=24% Similarity=0.395 Sum_probs=208.8
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCccc--hhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITS--HSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~--~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
..++|+|.||.||+|.. .++.||+|+++.....+ .....||++.|+.++|+|++. ..+.+.||+|||+.
T Consensus 7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t- 85 (318)
T KOG0659|consen 7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT- 85 (318)
T ss_pred hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-
Confidence 45789999999999996 45789999988764332 446789999999999999765 77889999999987
Q ss_pred CHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC-CcccCCC
Q psy5368 126 DLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG-DSIQGSP 202 (406)
Q Consensus 126 sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~-~~~~gt~ 202 (406)
||..+|+.+. .++...++.++.++++||+|||++.|+||||||+|+|++ +|.+||+|||+|+........ ...+-|.
T Consensus 86 dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TR 165 (318)
T KOG0659|consen 86 DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTR 165 (318)
T ss_pred cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccccceeee
Confidence 9999998764 799999999999999999999999999999999999999 889999999999988755443 3336899
Q ss_pred CCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC-------------------C--
Q psy5368 203 LYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIP-------------------P-- 260 (406)
Q Consensus 203 ~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-------------------~-- 260 (406)
+|+|||.+.|. .|+..+||||+|||+.||+.|.+-|++.+.-+....+......+.+ .
T Consensus 166 WYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~ 245 (318)
T KOG0659|consen 166 WYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPP 245 (318)
T ss_pred eccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCc
Confidence 99999999885 5999999999999999999999999998877766666543211110 0
Q ss_pred -----CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCcc
Q psy5368 261 -----NSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAE 303 (406)
Q Consensus 261 -----~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~~ 303 (406)
...+.++.||+.+||..||.+|+|+.|+++|+||+....|+..
T Consensus 246 ~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~ 293 (318)
T KOG0659|consen 246 LNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPP 293 (318)
T ss_pred cccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCCh
Confidence 1246778999999999999999999999999999986665543
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=359.09 Aligned_cols=255 Identities=26% Similarity=0.453 Sum_probs=216.4
Q ss_pred cccccceeeecCceeeecceeeeEEEeeeeeec--eeEEeeeecCCccchh---hhhhHHhhcccCCCCCCcc------c
Q psy5368 43 RSGTVRYDIVGSSTIRYGELQYDTVQNSQIRLG--TVKYSQVRYDTITSHS---EFERPRAGLSNLRAPEGRK------R 111 (406)
Q Consensus 43 ~~~~~~~~i~~~~~~~lG~G~~g~Vy~~~~~~~--~v~vk~~~~~~~~~~~---~~~~E~~~l~~l~h~ni~~------~ 111 (406)
+.....|+ .=..||+|+||.||.++.+.+ -.|.|.+++....... -+..|-.+|....+|.+|+ +
T Consensus 137 r~~~~DFe----~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD 212 (550)
T KOG0605|consen 137 RLSLDDFE----LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD 212 (550)
T ss_pred cCCcccch----hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC
Confidence 33455563 335679999999999997543 4588888776544433 4667999999999999876 8
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccC
Q psy5368 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLA 190 (406)
Q Consensus 112 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~ 190 (406)
..++||||||++|||+..+|.+.+.|++..++.++.+++.|++.+|+.|++||||||+|+||| .|++||+||||+..+.
T Consensus 213 ~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 213 KEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred CCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999999999999999999999999999999999999999999999999999999 8999999999985321
Q ss_pred C----------------------C-CC-----C--------------------CcccCCCCCCChhhhcCCCCCchhhHH
Q psy5368 191 P----------------------N-DQ-----G--------------------DSIQGSPLYMAPEILAGSPYNAKADLW 222 (406)
Q Consensus 191 ~----------------------~-~~-----~--------------------~~~~gt~~y~aPE~~~~~~~~~~~Diw 222 (406)
. . .. . .+.+|||.|+|||++.+..|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 0 00 0 135699999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCC-CCCChHHHHHHHHhcccCCCCCC---CHHHHhcCCCCCCC
Q psy5368 223 SLGVLVFEALFGHAPYASCNLSQLRAQALSSAP-ITIPP-NSLSPDCMDFLSRLLQKDPMRRI---SYEDLFSHPYPDLI 297 (406)
Q Consensus 223 SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~-~~~s~~l~~li~~~L~~dP~~Rp---s~~ell~hp~~~~~ 297 (406)
|+|||+||||.|.+||.+.++.+...++..... ...|. ..++++++|||.+||. ||++|. +++||.+||||+.+
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence 999999999999999999999999999988742 33333 3789999999999999 999998 58999999999999
Q ss_pred CCCCc
Q psy5368 298 HAPCA 302 (406)
Q Consensus 298 ~~~~~ 302 (406)
.|..-
T Consensus 452 ~W~~l 456 (550)
T KOG0605|consen 452 DWDHL 456 (550)
T ss_pred Ccchh
Confidence 88543
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=356.19 Aligned_cols=241 Identities=22% Similarity=0.363 Sum_probs=202.7
Q ss_pred eeecceeeeEEEeeee--eeceeEEeeeecCCccc-hhhhhhHHhhcccCC-CCCCcc------cCC-eEEEEEeccCCC
Q psy5368 57 IRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITS-HSEFERPRAGLSNLR-APEGRK------RPR-YVYIILEYCDGG 125 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~-~~~~~~E~~~l~~l~-h~ni~~------~~~-~~~lV~E~~~gg 125 (406)
.++|.|.||.||+++. .+..||||+.+.....- .-.-.||+..|++|+ |||+++ +.+ .+|+|||||+.
T Consensus 16 ~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~- 94 (538)
T KOG0661|consen 16 RKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC- 94 (538)
T ss_pred HHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-
Confidence 3567888888888775 34568998776544221 223478999999998 999766 444 99999999976
Q ss_pred CHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCC
Q psy5368 126 DLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 126 sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
+|+++++.++ .|++..++.|+.||++||+|+|.+|+.|||+||+|||+. ...+||+|||+|+......+.+.++.|+|
T Consensus 95 NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYTeYVSTRW 174 (538)
T KOG0661|consen 95 NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYTEYVSTRW 174 (538)
T ss_pred hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCcchhhhccc
Confidence 9999998764 699999999999999999999999999999999999999 88999999999999998889999999999
Q ss_pred CCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC------------------CCC---C-
Q psy5368 204 YMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI------------------TIP---P- 260 (406)
Q Consensus 204 y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------------------~~~---~- 260 (406)
|+|||++.. +.|+.+.||||+|||++|+.+-++.|++.+..+...+|...... .+| +
T Consensus 175 YRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~ 254 (538)
T KOG0661|consen 175 YRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPS 254 (538)
T ss_pred ccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCC
Confidence 999999876 55999999999999999999999999999877766666542110 011 0
Q ss_pred ------CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 261 ------NSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 261 ------~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
...+.++.+||.+|+.+||.+|||+.++++||||....
T Consensus 255 ~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 255 PLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred ChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 13688999999999999999999999999999998654
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=350.35 Aligned_cols=242 Identities=27% Similarity=0.468 Sum_probs=209.3
Q ss_pred CceeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc--------cC---CeEEEEEe
Q psy5368 54 SSTIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK--------RP---RYVYIILE 120 (406)
Q Consensus 54 ~~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~--------~~---~~~~lV~E 120 (406)
....++|.|+||.||+|... ...||+|++..+ .+.--+|+.+|+.+.|||++. .+ -+..+|||
T Consensus 27 ~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d----~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVle 102 (364)
T KOG0658|consen 27 EAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQD----KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLE 102 (364)
T ss_pred EeeEEEeecccceEEEEEEcCCCceeEEEEecCC----CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence 67789999999999999974 468999987543 344467999999999999876 22 25569999
Q ss_pred ccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee--CCeeEEEecccccccCCCCC
Q psy5368 121 YCDGGDLCSFIRS----HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK--NNTLKLADFGFAQFLAPNDQ 194 (406)
Q Consensus 121 ~~~ggsL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~--~~~~kL~DFGla~~~~~~~~ 194 (406)
|||. ||.++++. +..++...++-++.||++||.|||+.||+||||||.|+|+| .|.+||||||.|+.+..+.+
T Consensus 103 ymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep 181 (364)
T KOG0658|consen 103 YMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP 181 (364)
T ss_pred hchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence 9987 99999974 56899999999999999999999999999999999999999 57999999999999999999
Q ss_pred CCcccCCCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-----------------
Q psy5368 195 GDSIQGSPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI----------------- 256 (406)
Q Consensus 195 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----------------- 256 (406)
..++..|+.|+|||.+.+. .|+.+.||||.|||+.||+-|++.|++.+..+....|......
T Consensus 182 niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~ 261 (364)
T KOG0658|consen 182 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFK 261 (364)
T ss_pred ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccccccc
Confidence 9999999999999999985 5999999999999999999999999998877766666542111
Q ss_pred ----------CCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy5368 257 ----------TIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAP 300 (406)
Q Consensus 257 ----------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 300 (406)
.......++++.+|+.++|.++|.+|.++.|++.||||+....|
T Consensus 262 ~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 262 FPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred CcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 00122568999999999999999999999999999999987765
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=364.38 Aligned_cols=242 Identities=29% Similarity=0.536 Sum_probs=214.7
Q ss_pred ceeeecceeeeEEEeeeee--eceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCc------ccCCeEEEEEeccC
Q psy5368 55 STIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGR------KRPRYVYIILEYCD 123 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~------~~~~~~~lV~E~~~ 123 (406)
-.+-||.|+.|.|..|++. +..+|||.+.... ......+.+|+-+|+.+.|||+. ....++|+|.||++
T Consensus 16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~ 95 (786)
T KOG0588|consen 16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVP 95 (786)
T ss_pred ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecC
Confidence 3456899999999999874 3456777665442 22345789999999999999954 48889999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCC
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSP 202 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~ 202 (406)
||.|.+++..++++++.++.++++||+.|+.|||..+|+||||||+|+|+| .+++||+|||+|..-.++.-..+.||+|
T Consensus 96 gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTSCGSP 175 (786)
T KOG0588|consen 96 GGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETSCGSP 175 (786)
T ss_pred CchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccccccCCCc
Confidence 999999999999999999999999999999999999999999999999999 5679999999998877777788999999
Q ss_pred CCCChhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCC
Q psy5368 203 LYMAPEILAGSPYN-AKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 203 ~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
.|.|||++.+.+|+ .++||||+|||||.||||+.||++.+...++.++..+. ...| ..+|+++++||.+||..||++
T Consensus 176 HYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~-f~MP-s~Is~eaQdLLr~ml~VDp~~ 253 (786)
T KOG0588|consen 176 HYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV-FEMP-SNISSEAQDLLRRMLDVDPST 253 (786)
T ss_pred ccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc-ccCC-CcCCHHHHHHHHHHhccCccc
Confidence 99999999999986 58999999999999999999999999999999998883 3344 589999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCC
Q psy5368 282 RISYEDLFSHPYPDLIH 298 (406)
Q Consensus 282 Rps~~ell~hp~~~~~~ 298 (406)
|+|.+||++|||+..-.
T Consensus 254 RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 254 RITTEEILKHPFLSGYT 270 (786)
T ss_pred cccHHHHhhCchhhcCC
Confidence 99999999999987653
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=359.01 Aligned_cols=237 Identities=33% Similarity=0.589 Sum_probs=211.3
Q ss_pred eecceeeeEEEeeeeee--ceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 58 RYGELQYDTVQNSQIRL--GTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
.||+|+||.||||+.+. ..||+|.+.+.... ..+.+.+|+++++.|+|||++. ...++++|+|||.| +|
T Consensus 9 ~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L 87 (808)
T KOG0597|consen 9 MIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DL 87 (808)
T ss_pred HhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hH
Confidence 57999999999999654 45777766544322 3446899999999999999876 88899999999987 99
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC-CCcccCCCCCC
Q psy5368 128 CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ-GDSIQGSPLYM 205 (406)
Q Consensus 128 ~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~-~~~~~gt~~y~ 205 (406)
..+|...+.++++.++.++.+++.||.|||+.+|+|||+||.|||++ .+.+|+||||+|+.+..+.. ..+..|||.||
T Consensus 88 ~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYm 167 (808)
T KOG0597|consen 88 FTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYM 167 (808)
T ss_pred HHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeeeccCccccc
Confidence 99999999999999999999999999999999999999999999999 67999999999999876653 46678999999
Q ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCCH
Q psy5368 206 APEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY 285 (406)
Q Consensus 206 aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~ 285 (406)
|||.+.+.+|+..+|+||+|||+||+.+|++||.......+...|.... .. ++...|..+..|++.+|.+||.+|.|.
T Consensus 168 APElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~-v~-~p~~~S~~f~nfl~gLL~kdP~~RltW 245 (808)
T KOG0597|consen 168 APELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDP-VK-PPSTASSSFVNFLQGLLIKDPAQRLTW 245 (808)
T ss_pred CHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCC-CC-CcccccHHHHHHHHHHhhcChhhcccH
Confidence 9999999999999999999999999999999999999999988888773 33 334799999999999999999999999
Q ss_pred HHHhcCCCCCCC
Q psy5368 286 EDLFSHPYPDLI 297 (406)
Q Consensus 286 ~ell~hp~~~~~ 297 (406)
.+++.|||.+..
T Consensus 246 ~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 246 TDLLGHPFWKGK 257 (808)
T ss_pred HHHhcChHHhhh
Confidence 999999998753
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=336.11 Aligned_cols=247 Identities=27% Similarity=0.371 Sum_probs=207.8
Q ss_pred eeeecceeeeEEEeeeeee--ceeEEeeeecCCccc--hhhhhhHHhhcccCCCCCCcc--------cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIRL--GTVKYSQVRYDTITS--HSEFERPRAGLSNLRAPEGRK--------RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~~~--~~~~~~E~~~l~~l~h~ni~~--------~~~~~~lV~E~~~ 123 (406)
-++|++|.||.||+++... .-||.|+++.+.... .-.-.||+.+|.+++||||+. .-+.+|||||||+
T Consensus 81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E 160 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE 160 (419)
T ss_pred HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence 3578999999999999754 457888887654221 235689999999999999876 5567999999998
Q ss_pred CCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCcccC
Q psy5368 124 GGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDSIQG 200 (406)
Q Consensus 124 ggsL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~~~g 200 (406)
. ||..++..-+ +|...+++.++.|+++|++|||.+.|+||||||+|+|++ .|.+||+|||+|+..+.. ......+-
T Consensus 161 h-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVV 239 (419)
T KOG0663|consen 161 H-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVV 239 (419)
T ss_pred h-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccCcceEE
Confidence 8 9999997655 899999999999999999999999999999999999998 789999999999988655 34566778
Q ss_pred CCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC------------------CC---
Q psy5368 201 SPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI------------------TI--- 258 (406)
Q Consensus 201 t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------------------~~--- 258 (406)
|.+|+|||.+.+. .|+.+.|+||+|||+.||+++++.|++.+..+...+|...... ..
T Consensus 240 TLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~ 319 (419)
T KOG0663|consen 240 TLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEH 319 (419)
T ss_pred EeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCC
Confidence 9999999999885 5999999999999999999999999999877777776542110 00
Q ss_pred C---------CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCcc
Q psy5368 259 P---------PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAE 303 (406)
Q Consensus 259 ~---------~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~~ 303 (406)
| ...+++...+|++.+|.+||.+|.|++|.|+|+||.....|+..
T Consensus 320 pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P 373 (419)
T KOG0663|consen 320 PYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDP 373 (419)
T ss_pred CchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCCh
Confidence 0 01245788999999999999999999999999999987766554
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=351.90 Aligned_cols=240 Identities=25% Similarity=0.428 Sum_probs=206.3
Q ss_pred eecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 58 RYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
.||+|+||.||++... +..+++|.+..... .....+.+|+.++.+++|||++. ..+++|+||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 6899999999999863 45688887765432 22346788999999999999765 6778999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCC-CCCCCcccCCCCC
Q psy5368 127 LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAP-NDQGDSIQGSPLY 204 (406)
Q Consensus 127 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~-~~~~~~~~gt~~y 204 (406)
|.+++..++.+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++.... ........||+.|
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y 161 (323)
T cd05571 82 LFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 161 (323)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCccc
Confidence 999999888999999999999999999999999999999999999998 67999999999875322 2334456799999
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC-
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI- 283 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp- 283 (406)
+|||++.+..++.++||||+||++|||++|..||.+.+.......+... ....+ ..+++++.+||.+||+.||++||
T Consensus 162 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-~~~~p-~~~~~~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05571 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFP-RTLSPEAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred cChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-CCCCC-CCCCHHHHHHHHHHccCCHHHcCC
Confidence 9999999999999999999999999999999999998887777666554 33333 36899999999999999999999
Q ss_pred ----CHHHHhcCCCCCCCCC
Q psy5368 284 ----SYEDLFSHPYPDLIHA 299 (406)
Q Consensus 284 ----s~~ell~hp~~~~~~~ 299 (406)
++.++++||||....+
T Consensus 240 ~~~~~~~~ll~h~~f~~~~~ 259 (323)
T cd05571 240 GGPEDAKEIMEHRFFASINW 259 (323)
T ss_pred CCCCCHHHHHcCCCcCCCCH
Confidence 8999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=343.01 Aligned_cols=240 Identities=26% Similarity=0.474 Sum_probs=207.6
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++... +..+++|.+..... .....+.+|+.++++++|||+++ +.+++|+||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 85 (291)
T cd05612 6 IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPG 85 (291)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCC
Confidence 457899999999999875 56688887764332 23456889999999999999765 67789999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
|+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++ ++.+||+|||+++.... ......||+.
T Consensus 86 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~ 163 (291)
T cd05612 86 GELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD--RTWTLCGTPE 163 (291)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC--CcccccCChh
Confidence 99999999888999999999999999999999999999999999999998 67999999999976543 2334578999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
|+|||++.+..++.++||||+||++|+|++|..||.+.+.......+.... ...+ ..+++.+++|+.+||+.||.+||
T Consensus 164 y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~~-~~~~~~~~~li~~~l~~dp~~R~ 241 (291)
T cd05612 164 YLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-LEFP-RHLDLYAKDLIKKLLVVDRTRRL 241 (291)
T ss_pred hcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-cCCC-ccCCHHHHHHHHHHcCCCHHHcc
Confidence 999999999999999999999999999999999999988888777776653 3333 35799999999999999999999
Q ss_pred C-----HHHHhcCCCCCCCCC
Q psy5368 284 S-----YEDLFSHPYPDLIHA 299 (406)
Q Consensus 284 s-----~~ell~hp~~~~~~~ 299 (406)
+ ++++++||||+...+
T Consensus 242 ~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 242 GNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred CCccCCHHHHhcCccccCCCH
Confidence 5 999999999986554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=344.60 Aligned_cols=237 Identities=27% Similarity=0.537 Sum_probs=204.0
Q ss_pred ecceeeeEEEeeeee--eceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 59 YGELQYDTVQNSQIR--LGTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 59 lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
||+|+||.||++... +..+++|.+.... ......+.+|+.++.+++|||++. ..+.+|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999874 3467888776432 223456788999999999999765 66789999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCcccCCCCCC
Q psy5368 128 CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDSIQGSPLYM 205 (406)
Q Consensus 128 ~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~~~gt~~y~ 205 (406)
.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++..... .......||+.|+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~ 160 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL 160 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccC
Confidence 99998888999999999999999999999999999999999999998 779999999998754322 2334567999999
Q ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC--
Q psy5368 206 APEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI-- 283 (406)
Q Consensus 206 aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-- 283 (406)
|||++.+..++.++||||+||++|+|++|..||.+.+..+....+... ....+ ..+++++.+|+.+||+.||.+||
T Consensus 161 aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~li~~~L~~dp~~R~~~ 238 (312)
T cd05585 161 APELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-PLRFP-DGFDRDAKDLLIGLLSRDPTRRLGY 238 (312)
T ss_pred CHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-CCCCC-CcCCHHHHHHHHHHcCCCHHHcCCC
Confidence 999999999999999999999999999999999998888777776654 33333 36899999999999999999997
Q ss_pred -CHHHHhcCCCCCCC
Q psy5368 284 -SYEDLFSHPYPDLI 297 (406)
Q Consensus 284 -s~~ell~hp~~~~~ 297 (406)
++.++++||||+..
T Consensus 239 ~~~~e~l~hp~~~~~ 253 (312)
T cd05585 239 NGAQEIKNHPFFSQL 253 (312)
T ss_pred CCHHHHHcCCCcCCC
Confidence 57999999999865
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=346.78 Aligned_cols=240 Identities=25% Similarity=0.469 Sum_probs=206.9
Q ss_pred eeeecceeeeEEEeeeeee---ceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIRL---GTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~---~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ 123 (406)
...||+|+||.||++.... ..+++|.+.... ......+.+|+.++..++|||+++ ..+..|+||||++
T Consensus 35 ~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~ 114 (340)
T PTZ00426 35 IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVI 114 (340)
T ss_pred EEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCC
Confidence 4578999999999998643 357888775432 223456788999999999999876 6678999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCC
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSP 202 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~ 202 (406)
+|+|.+++..++.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..... ......||+
T Consensus 115 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~--~~~~~~gt~ 192 (340)
T PTZ00426 115 GGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT--RTYTLCGTP 192 (340)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC--CcceecCCh
Confidence 999999999888999999999999999999999999999999999999998 77999999999976543 234567999
Q ss_pred CCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCC
Q psy5368 203 LYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRR 282 (406)
Q Consensus 203 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 282 (406)
.|+|||++.+..++.++||||+||++|+|++|..||.+.+.......+.... ...+ ..+++.+.+++.+||+.||++|
T Consensus 193 ~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~p-~~~~~~~~~li~~~l~~dp~~R 270 (340)
T PTZ00426 193 EYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI-IYFP-KFLDNNCKHLMKKLLSHDLTKR 270 (340)
T ss_pred hhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC-CCCC-CCCCHHHHHHHHHHcccCHHHc
Confidence 9999999999889999999999999999999999999988777777766553 3333 4689999999999999999999
Q ss_pred C-----CHHHHhcCCCCCCCCC
Q psy5368 283 I-----SYEDLFSHPYPDLIHA 299 (406)
Q Consensus 283 p-----s~~ell~hp~~~~~~~ 299 (406)
+ +++++++||||+...+
T Consensus 271 ~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 271 YGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred CCCCCCCHHHHHcCCCcCCCCH
Confidence 5 8999999999987654
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=344.06 Aligned_cols=239 Identities=24% Similarity=0.438 Sum_probs=204.7
Q ss_pred eecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 58 RYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
.||+|+||.||++... +..+++|.+..... .....+.+|+.+++.++|||++. ..+.+|+||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 6899999999999863 45788887765432 23345778999999999999765 6678999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCC-CCCCCcccCCCCC
Q psy5368 127 LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAP-NDQGDSIQGSPLY 204 (406)
Q Consensus 127 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~-~~~~~~~~gt~~y 204 (406)
|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++.... ........||+.|
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y 161 (323)
T cd05595 82 LFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 161 (323)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcCc
Confidence 999998888899999999999999999999999999999999999998 67999999999875322 2233456799999
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC-
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI- 283 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp- 283 (406)
+|||++.+..++.++|||||||++|+|++|+.||...+.......+.... ...+ ..+++++.+|+.+||+.||++||
T Consensus 162 ~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~-~~~p-~~~~~~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05595 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFP-RTLSPEAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred CCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCC-CCCCHHHHHHHHHHccCCHHHhCC
Confidence 99999999999999999999999999999999999888777766665442 2333 36899999999999999999998
Q ss_pred ----CHHHHhcCCCCCCCC
Q psy5368 284 ----SYEDLFSHPYPDLIH 298 (406)
Q Consensus 284 ----s~~ell~hp~~~~~~ 298 (406)
++.++++||||....
T Consensus 240 ~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 240 GGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred CCCCCHHHHHcCCCcCCCC
Confidence 899999999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=345.44 Aligned_cols=239 Identities=24% Similarity=0.437 Sum_probs=206.4
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++... +..+++|.+.... ......+.+|+.++.+++|||+++ ..+.+|+||||++|
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 102 (329)
T PTZ00263 23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVG 102 (329)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCC
Confidence 457899999999999874 3568888776432 223456889999999999999876 67889999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||++...... .....||+.
T Consensus 103 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~ 180 (329)
T PTZ00263 103 GELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--TFTLCGTPE 180 (329)
T ss_pred ChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--cceecCChh
Confidence 99999999888999999999999999999999999999999999999998 779999999999766432 334678999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.... ...+ ..++..+.+|+.+||+.||.+||
T Consensus 181 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~p-~~~~~~~~~li~~~L~~dP~~R~ 258 (329)
T PTZ00263 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR-LKFP-NWFDGRARDLVKGLLQTDHTKRL 258 (329)
T ss_pred hcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-cCCC-CCCCHHHHHHHHHHhhcCHHHcC
Confidence 999999999999999999999999999999999999988877777776553 3333 35899999999999999999999
Q ss_pred C-----HHHHhcCCCCCCCC
Q psy5368 284 S-----YEDLFSHPYPDLIH 298 (406)
Q Consensus 284 s-----~~ell~hp~~~~~~ 298 (406)
+ ++++++||||+...
T Consensus 259 ~~~~~~~~~ll~hp~f~~~~ 278 (329)
T PTZ00263 259 GTLKGGVADVKNHPYFHGAN 278 (329)
T ss_pred CCCCCCHHHHhcCCccCCCC
Confidence 7 79999999998643
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=345.10 Aligned_cols=240 Identities=24% Similarity=0.419 Sum_probs=205.1
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
+.||+|+||.||++... +..+++|.+..... .....+.+|+.+++.++|||++. ..+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999864 45788887765432 23456788999999999999765 677899999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCC-CCCCCcccCCCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAP-NDQGDSIQGSPL 203 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~-~~~~~~~~gt~~ 203 (406)
+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++.... ........||+.
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~ 160 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE 160 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcC
Confidence 9999998888899999999999999999999999999999999999998 77999999999875432 223345679999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
|+|||++.+..++.++||||+||++|+|++|+.||...+.......+... ....+ ..+++++.+|+.+||+.||++||
T Consensus 161 y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-~~~~p-~~~~~~~~~li~~~L~~dP~~R~ 238 (328)
T cd05593 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-DIKFP-RTLSADAKSLLSGLLIKDPNKRL 238 (328)
T ss_pred ccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC-CccCC-CCCCHHHHHHHHHHcCCCHHHcC
Confidence 99999999999999999999999999999999999988877776665544 23333 36899999999999999999997
Q ss_pred -----CHHHHhcCCCCCCCC
Q psy5368 284 -----SYEDLFSHPYPDLIH 298 (406)
Q Consensus 284 -----s~~ell~hp~~~~~~ 298 (406)
++.++++||||....
T Consensus 239 ~~~~~~~~~il~h~~~~~~~ 258 (328)
T cd05593 239 GGGPDDAKEIMRHSFFTGVN 258 (328)
T ss_pred CCCCCCHHHHhcCCCcCCCC
Confidence 899999999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=342.94 Aligned_cols=243 Identities=26% Similarity=0.398 Sum_probs=194.1
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCccc-----------CCeEEEEEe
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRKR-----------PRYVYIILE 120 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~-----------~~~~~lV~E 120 (406)
..+||+|+||.||++... +..+++|.+.... ......+.+|+.+++.++|||+++. ...+|+|||
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e 84 (338)
T cd07859 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 84 (338)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEe
Confidence 457899999999999863 4578888775422 2334568899999999999998652 135899999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC----C
Q psy5368 121 YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ----G 195 (406)
Q Consensus 121 ~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~----~ 195 (406)
||. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....... .
T Consensus 85 ~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 163 (338)
T cd07859 85 LME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 163 (338)
T ss_pred cCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCccccc
Confidence 995 59999998888899999999999999999999999999999999999999 67999999999976432221 2
Q ss_pred CcccCCCCCCChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------------------
Q psy5368 196 DSIQGSPLYMAPEILAG--SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALS--------------------- 252 (406)
Q Consensus 196 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~--------------------- 252 (406)
....||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+.......+..
T Consensus 164 ~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 243 (338)
T cd07859 164 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRY 243 (338)
T ss_pred cCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHH
Confidence 34578999999999876 6789999999999999999999999987654332211110
Q ss_pred ------cCCCCCC--CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy5368 253 ------SAPITIP--PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 253 ------~~~~~~~--~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 299 (406)
....... ...+++++.+++.+||+.||++|||++++++||||+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 244 LSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 0000000 0146788999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=337.93 Aligned_cols=243 Identities=21% Similarity=0.334 Sum_probs=200.2
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++... +..+++|.+..... .....+.+|+.++.+++|++++. ..+..++||||+++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05631 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCC
Confidence 457899999999999864 45788887764432 22345788999999999999765 66789999999999
Q ss_pred CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCC
Q psy5368 125 GDLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGS 201 (406)
Q Consensus 125 gsL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt 201 (406)
|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++ ++.++|+|||++.............||
T Consensus 85 g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~ 164 (285)
T cd05631 85 GDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGT 164 (285)
T ss_pred CcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCCCCC
Confidence 9999888643 3699999999999999999999999999999999999998 679999999999876544444556799
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhcCCCCCCCCCCChHHHHHHHHhcccC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQA---LSSAPITIPPNSLSPDCMDFLSRLLQKD 278 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~s~~l~~li~~~L~~d 278 (406)
+.|+|||++.+..++.++||||+||++|+|++|+.||...........+ ........ +..+++++.+|+.+||+.|
T Consensus 165 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~l~~~ 243 (285)
T cd05631 165 VGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEY-SEKFSEDAKSICRMLLTKN 243 (285)
T ss_pred CCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccC-CccCCHHHHHHHHHHhhcC
Confidence 9999999999999999999999999999999999999876543222221 12212222 3368999999999999999
Q ss_pred CCCCCC-----HHHHhcCCCCCCCCC
Q psy5368 279 PMRRIS-----YEDLFSHPYPDLIHA 299 (406)
Q Consensus 279 P~~Rps-----~~ell~hp~~~~~~~ 299 (406)
|.+||+ ++++++||||+...+
T Consensus 244 P~~R~~~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 244 PKERLGCRGNGAAGVKQHPIFKNINF 269 (285)
T ss_pred HHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence 999997 899999999987653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=342.45 Aligned_cols=260 Identities=27% Similarity=0.466 Sum_probs=209.5
Q ss_pred EEEeeeeecCCcceeeeeeccccccccceeeecCceeeecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhc
Q psy5368 21 QVQLSTVRYGKVRYSQVRSDTVRSGTVRYDIVGSSTIRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGL 100 (406)
Q Consensus 21 y~vv~~lg~G~~~~~~~~~d~~~~~~~~~~i~~~~~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l 100 (406)
|.+++.||.|.+|.|.+++++......+.+|+......-+.|.+..+ .......++..+|+.+|
T Consensus 99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~----------------a~~~~~~ekv~~EIail 162 (576)
T KOG0585|consen 99 YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQP----------------AMKLMPIEKVRREIAIL 162 (576)
T ss_pred eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhccccccc----------------ccccCcHHHHHHHHHHH
Confidence 77777777777777777777777777777766665333333332222 01123346789999999
Q ss_pred ccCCCCCCcc--------cCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceE
Q psy5368 101 SNLRAPEGRK--------RPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172 (406)
Q Consensus 101 ~~l~h~ni~~--------~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIl 172 (406)
++|+|||+|+ ....+|||+|||..|.+...=-....+++.+++.++++++.||+|||.+||+||||||.|+|
T Consensus 163 Kkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLL 242 (576)
T KOG0585|consen 163 KKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLL 242 (576)
T ss_pred HhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheE
Confidence 9999999887 66789999999998877543222223999999999999999999999999999999999999
Q ss_pred ee-CCeeEEEecccccccCCC------CCCCcccCCCCCCChhhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy5368 173 IK-NNTLKLADFGFAQFLAPN------DQGDSIQGSPLYMAPEILAGSP----YNAKADLWSLGVLVFEALFGHAPYASC 241 (406)
Q Consensus 173 l~-~~~~kL~DFGla~~~~~~------~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltg~~pf~~~ 241 (406)
++ +|.+||+|||.+...... .......|||.|+|||.+.++. .+.+.||||+||+||.|+.|+.||-+.
T Consensus 243 l~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 243 LSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred EcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 99 889999999999766322 1234478999999999998733 345789999999999999999999999
Q ss_pred CHHHHHHHHHhcCCCCCCCC-CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy5368 242 NLSQLRAQALSSAPITIPPN-SLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~-~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 297 (406)
...++..+|... +..+|.. .+.+++++||.+||.+||++|++..++..|||....
T Consensus 323 ~~~~l~~KIvn~-pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 323 FELELFDKIVND-PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred hHHHHHHHHhcC-cccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 999999999887 4555544 689999999999999999999999999999998755
|
|
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=344.60 Aligned_cols=233 Identities=24% Similarity=0.389 Sum_probs=205.8
Q ss_pred eeeecceeeeEEEeeeeeec-eeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHH
Q psy5368 56 TIRYGELQYDTVQNSQIRLG-TVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLC 128 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~-~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~ 128 (406)
.+.||+|.||.|+.|.+++. .|++|.++... .....|.+|+++|.+|+|+|+++ ..+-+|||||||+.|+|.
T Consensus 211 ~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl 289 (468)
T KOG0197|consen 211 IRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLL 289 (468)
T ss_pred HHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHH
Confidence 34689999999999999877 89999887653 55678999999999999999876 445699999999999999
Q ss_pred HHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCC--cccCCCC
Q psy5368 129 SFIRS--HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGD--SIQGSPL 203 (406)
Q Consensus 129 ~~l~~--~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~--~~~gt~~ 203 (406)
++|+. +..+...+.+.++.||++|++||+++++|||||-+.|||++ +..+||+|||+|+....+.... ...-...
T Consensus 290 ~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIk 369 (468)
T KOG0197|consen 290 DYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIK 369 (468)
T ss_pred HHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCce
Confidence 99987 45799999999999999999999999999999999999999 5699999999999654433221 1223456
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRR 282 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 282 (406)
|+|||.+..+.++.+|||||||++||||+| |+.||.+.+..+....+..+...+.|+ .+|+++.+++..||..+|++|
T Consensus 370 WtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~-~CP~~vY~lM~~CW~~~P~~R 448 (468)
T KOG0197|consen 370 WTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPE-GCPDEVYELMKSCWHEDPEDR 448 (468)
T ss_pred ecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCC-CCCHHHHHHHHHHhhCCcccC
Confidence 999999999999999999999999999998 999999999999999999998888877 699999999999999999999
Q ss_pred CCHHHHhc
Q psy5368 283 ISYEDLFS 290 (406)
Q Consensus 283 ps~~ell~ 290 (406)
||++.+..
T Consensus 449 PtF~~L~~ 456 (468)
T KOG0197|consen 449 PTFETLRE 456 (468)
T ss_pred CCHHHHHH
Confidence 99997643
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=340.27 Aligned_cols=240 Identities=27% Similarity=0.455 Sum_probs=204.8
Q ss_pred eecceeeeEEEeeeee--eceeEEeeeecCC---ccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccCCC
Q psy5368 58 RYGELQYDTVQNSQIR--LGTVKYSQVRYDT---ITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
.||+|+||.||++... +..+++|.+.... ......+.+|..++..+ +|||++. ..+.+|+||||++||
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 6899999999999874 3568888776432 22344667888888776 7999765 677899999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCC-CCCCCcccCCCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAP-NDQGDSIQGSPL 203 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~-~~~~~~~~gt~~ 203 (406)
+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++.... ........||+.
T Consensus 82 ~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~ 161 (320)
T cd05590 82 DLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPD 161 (320)
T ss_pred hHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCcc
Confidence 9999998888999999999999999999999999999999999999998 77999999999875432 223345679999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
|+|||++.+..++.++||||+||++|+|++|+.||.+.+...+...+.... ... +..+++++.+|+.+||+.||++||
T Consensus 162 y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~-~~~-~~~~~~~~~~li~~~L~~dP~~R~ 239 (320)
T cd05590 162 YIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-VVY-PTWLSQDAVDILKAFMTKNPTMRL 239 (320)
T ss_pred ccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-CCC-CCCCCHHHHHHHHHHcccCHHHCC
Confidence 999999999999999999999999999999999999998888877776553 233 336899999999999999999999
Q ss_pred CH------HHHhcCCCCCCCCC
Q psy5368 284 SY------EDLFSHPYPDLIHA 299 (406)
Q Consensus 284 s~------~ell~hp~~~~~~~ 299 (406)
++ +++++||||+...+
T Consensus 240 ~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 240 GSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred CCCCCCCHHHHHcCCCcCCCCH
Confidence 98 99999999987643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=342.25 Aligned_cols=241 Identities=27% Similarity=0.448 Sum_probs=205.4
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++... +..+++|.+..... .....+.+|+.++..++|||+++ ..++.|+||||++|
T Consensus 6 ~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g 85 (333)
T cd05600 6 LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPG 85 (333)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCC
Confidence 456899999999999874 45688887765432 23456888999999999999875 67789999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..... ......||+.
T Consensus 86 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~~~gt~~ 163 (333)
T cd05600 86 GDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSVVGSPD 163 (333)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCCcccCcc
Confidence 99999998888999999999999999999999999999999999999998 67999999999976543 3445679999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCC-----CCCCChHHHHHHHHhccc
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI-TIP-----PNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~-----~~~~s~~l~~li~~~L~~ 277 (406)
|+|||++.+..++.++||||+||++|||++|..||...+..+....+...... ..+ ...+++++.+|+.+||..
T Consensus 164 y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 243 (333)
T cd05600 164 YMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLIND 243 (333)
T ss_pred ccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhC
Confidence 99999999999999999999999999999999999998887776666543211 111 125689999999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCC
Q psy5368 278 DPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 278 dP~~Rps~~ell~hp~~~~~~ 298 (406)
+|.+||+++++++||||+...
T Consensus 244 ~~~rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 244 PSRRFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred hhhhcCCHHHHHhCcccCCCC
Confidence 999999999999999998654
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=333.09 Aligned_cols=244 Identities=25% Similarity=0.410 Sum_probs=211.3
Q ss_pred ceeeecceeeeEEEeeeee--eceeEEeeeecCCccc-hhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 55 STIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITS-HSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~-~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
-..+||.|.-++||++... +..|+||.+..+.... ...+.+|+..++.++|||+++ .+..+|+||.||.+|
T Consensus 30 L~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~G 109 (516)
T KOG0582|consen 30 LQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGG 109 (516)
T ss_pred EEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCC
Confidence 3557899999999999864 4678999988776554 478999999999999999877 778899999999999
Q ss_pred CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC-----Cc
Q psy5368 126 DLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG-----DS 197 (406)
Q Consensus 126 sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~-----~~ 197 (406)
++.++++.. ..+++..+..|++++++||.|||.+|.+|||||+.|||++ +|.+||+|||.+..+..+... +.
T Consensus 110 S~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~t 189 (516)
T KOG0582|consen 110 SLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNT 189 (516)
T ss_pred cHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeecc
Confidence 999999765 3699999999999999999999999999999999999999 889999999998776544321 55
Q ss_pred ccCCCCCCChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--------CCCChHH
Q psy5368 198 IQGSPLYMAPEILAG--SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP--------NSLSPDC 267 (406)
Q Consensus 198 ~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--------~~~s~~l 267 (406)
..||++|||||++.. ..|+.|+||||||++..||.+|..||....+...+...+.+.++.... ..++..+
T Consensus 190 fvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf 269 (516)
T KOG0582|consen 190 FVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSF 269 (516)
T ss_pred ccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHH
Confidence 689999999999543 459999999999999999999999999999888887777776653221 1467789
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 268 MDFLSRLLQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 268 ~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
+.++..||+.||.+|||++++|+|+||+...
T Consensus 270 ~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 270 REMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred HHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 9999999999999999999999999998654
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=355.08 Aligned_cols=245 Identities=25% Similarity=0.440 Sum_probs=212.3
Q ss_pred eeeecceeeeEEEeeeeeec--eeEEeeeecCCccch---hhhhhHHhhcccC-CCCCCc------ccCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIRLG--TVKYSQVRYDTITSH---SEFERPRAGLSNL-RAPEGR------KRPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~--~v~vk~~~~~~~~~~---~~~~~E~~~l~~l-~h~ni~------~~~~~~~lV~E~~~ 123 (406)
-++||+|+||.|+.++.+++ -.|||.++++.+... +..+.|.+++... +||-++ .+..++|.||||+.
T Consensus 373 l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~ 452 (694)
T KOG0694|consen 373 LAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVA 452 (694)
T ss_pred EEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecC
Confidence 45799999999999998654 468888877765443 3567788877776 599654 48999999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccC-CCCCCCcccCC
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLA-PNDQGDSIQGS 201 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~-~~~~~~~~~gt 201 (406)
|||+..+ ...+.|++..++.++..|+.||+|||++||+|||||.+|||+| +|.+||+|||+++..- ......+.+||
T Consensus 453 Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGT 531 (694)
T KOG0694|consen 453 GGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGT 531 (694)
T ss_pred CCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCCccccccCC
Confidence 9994443 3446899999999999999999999999999999999999999 8999999999998744 55677889999
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
|.|||||++.+..|+.++|.|||||+|||||.|..||++.+.+++...|...... + |..+|.+..++++++|.+||++
T Consensus 532 pey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~-y-P~~ls~ea~~il~~ll~k~p~k 609 (694)
T KOG0694|consen 532 PEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVR-Y-PRFLSKEAIAIMRRLLRKNPEK 609 (694)
T ss_pred hhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-C-CCcccHHHHHHHHHHhccCccc
Confidence 9999999999999999999999999999999999999999999999999887433 2 4479999999999999999999
Q ss_pred CCC-----HHHHhcCCCCCCCCCCCcc
Q psy5368 282 RIS-----YEDLFSHPYPDLIHAPCAE 303 (406)
Q Consensus 282 Rps-----~~ell~hp~~~~~~~~~~~ 303 (406)
|.. +++|..||||+.+.|...+
T Consensus 610 RLG~~e~d~~~i~~hpFFr~i~w~~L~ 636 (694)
T KOG0694|consen 610 RLGSGERDAEDIKKHPFFRSIDWDDLL 636 (694)
T ss_pred ccCCCCCCchhhhhCCccccCCHHHHh
Confidence 995 5889999999998875443
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=343.91 Aligned_cols=243 Identities=24% Similarity=0.397 Sum_probs=201.5
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||+||++... +..+++|.+..... .....+.+|+.++..++|||++. +...+|+|||||+|
T Consensus 6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (363)
T cd05628 6 LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPG 85 (363)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCC
Confidence 456889999999988764 45678887764322 22346788999999999999875 67789999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC----------
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND---------- 193 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~---------- 193 (406)
|+|.+++.+++.+++..++.++.|++.||+|||++||+||||||+|||++ ++.+||+|||+++......
T Consensus 86 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~ 165 (363)
T cd05628 86 GDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNH 165 (363)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccc
Confidence 99999999888999999999999999999999999999999999999998 7799999999987543211
Q ss_pred --------------------------CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy5368 194 --------------------------QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLR 247 (406)
Q Consensus 194 --------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~ 247 (406)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~ 245 (363)
T cd05628 166 SLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETY 245 (363)
T ss_pred cccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHH
Confidence 012357999999999999999999999999999999999999999998888877
Q ss_pred HHHHhcC-CCCCCCC-CCChHHHHHHHHhcccCCC---CCCCHHHHhcCCCCCCCCC
Q psy5368 248 AQALSSA-PITIPPN-SLSPDCMDFLSRLLQKDPM---RRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 248 ~~~~~~~-~~~~~~~-~~s~~l~~li~~~L~~dP~---~Rps~~ell~hp~~~~~~~ 299 (406)
..+.... ....++. .+++++.+|+.+++. +|. .||+++|+++||||+...+
T Consensus 246 ~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~ 301 (363)
T cd05628 246 KKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDW 301 (363)
T ss_pred HHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCH
Confidence 7776532 2333332 588999999999765 444 4689999999999997654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=339.42 Aligned_cols=240 Identities=27% Similarity=0.449 Sum_probs=204.6
Q ss_pred eeecceeeeEEEeeee-----eeceeEEeeeecCCc----cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEec
Q psy5368 57 IRYGELQYDTVQNSQI-----RLGTVKYSQVRYDTI----TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEY 121 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~-----~~~~v~vk~~~~~~~----~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~ 121 (406)
..||+|+||.||++.. .+..+++|.+..... .....+.+|+.+++.++|||+++ ..+.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 4689999999999875 245678887764321 22345778999999999999876 66789999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCccc
Q psy5368 122 CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDSIQ 199 (406)
Q Consensus 122 ~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~~~ 199 (406)
+++++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++..... .......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 161 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC 161 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccC
Confidence 99999999998888899999999999999999999999999999999999998 779999999998754322 2334567
Q ss_pred CCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCC
Q psy5368 200 GSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 200 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP 279 (406)
||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.... ...+ ..+++++.+|+.+||+.||
T Consensus 162 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~li~~~l~~~p 239 (323)
T cd05584 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK-LNLP-PYLTPEARDLLKKLLKRNP 239 (323)
T ss_pred CCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCC-CCCCHHHHHHHHHHcccCH
Confidence 9999999999999889999999999999999999999999988777777666553 3333 3689999999999999999
Q ss_pred CCCC-----CHHHHhcCCCCCCCC
Q psy5368 280 MRRI-----SYEDLFSHPYPDLIH 298 (406)
Q Consensus 280 ~~Rp-----s~~ell~hp~~~~~~ 298 (406)
++|| +++++++||||+...
T Consensus 240 ~~R~~~~~~~~~~l~~h~~~~~~~ 263 (323)
T cd05584 240 SSRLGAGPGDAAEVQSHPFFRHVN 263 (323)
T ss_pred hHcCCCCCCCHHHHhcCCCcCCCC
Confidence 9999 899999999998643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=344.18 Aligned_cols=243 Identities=30% Similarity=0.551 Sum_probs=206.5
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++... +..+++|.+..... .....+.+|+.++..++|||++. ..+++|+||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (350)
T cd05573 6 IKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPG 85 (350)
T ss_pred EEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCC
Confidence 456899999999999875 56788887765432 23456888999999999999765 67889999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC----------
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND---------- 193 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~---------- 193 (406)
++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus 86 ~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~ 165 (350)
T cd05573 86 GDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSH 165 (350)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccc
Confidence 99999998888999999999999999999999999999999999999999 7799999999997665433
Q ss_pred --------------------CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q psy5368 194 --------------------QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSS 253 (406)
Q Consensus 194 --------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 253 (406)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~ 245 (350)
T cd05573 166 NLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINW 245 (350)
T ss_pred cccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhcc
Confidence 233456899999999999999999999999999999999999999998877777666652
Q ss_pred C-CCCCCC-CCCChHHHHHHHHhcccCCCCCCC-HHHHhcCCCCCCCCC
Q psy5368 254 A-PITIPP-NSLSPDCMDFLSRLLQKDPMRRIS-YEDLFSHPYPDLIHA 299 (406)
Q Consensus 254 ~-~~~~~~-~~~s~~l~~li~~~L~~dP~~Rps-~~ell~hp~~~~~~~ 299 (406)
. ....+. ..+++++.+||.+||. ||.+||+ ++++++||||+...+
T Consensus 246 ~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~ 293 (350)
T cd05573 246 KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDW 293 (350)
T ss_pred CCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCH
Confidence 1 122222 2479999999999997 9999999 999999999987644
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=340.99 Aligned_cols=242 Identities=30% Similarity=0.542 Sum_probs=215.3
Q ss_pred eeeecceeeeEEEeeeeee--ceeEEeeeecCCccc---hhhhhhHHhhcccCC-CCCCcc------cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIRL--GTVKYSQVRYDTITS---HSEFERPRAGLSNLR-APEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~~~---~~~~~~E~~~l~~l~-h~ni~~------~~~~~~lV~E~~~ 123 (406)
...||.|.||.||.+..+. +.+|+|.+....... ...+.+|+.+|+++. |||++. +...+++|||+|.
T Consensus 40 ~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~ 119 (382)
T KOG0032|consen 40 GRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCE 119 (382)
T ss_pred hhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecC
Confidence 3678999999999999754 568998887766544 358999999999998 999765 7788999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee---C--CeeEEEecccccccCCCCCCCcc
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK---N--NTLKLADFGFAQFLAPNDQGDSI 198 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~---~--~~~kL~DFGla~~~~~~~~~~~~ 198 (406)
||.|.+.|... .+++..+..++.|++.++.|||+.||+||||||+|+|+. + +.+|++|||+|............
T Consensus 120 GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~ 198 (382)
T KOG0032|consen 120 GGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTI 198 (382)
T ss_pred CchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeee
Confidence 99999999776 499999999999999999999999999999999999997 2 37999999999998876677889
Q ss_pred cCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCChHHHHHHHHhcc
Q psy5368 199 QGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITI--PPNSLSPDCMDFLSRLLQ 276 (406)
Q Consensus 199 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~s~~l~~li~~~L~ 276 (406)
+||+.|+|||++....|+..+||||+|+++|.|++|.+||.+.+.......+..+..... +...+|..+++|+.+||.
T Consensus 199 ~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~ 278 (382)
T KOG0032|consen 199 VGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLE 278 (382)
T ss_pred cCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcc
Confidence 999999999999999999999999999999999999999999998888888887754222 223789999999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCCC
Q psy5368 277 KDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 277 ~dP~~Rps~~ell~hp~~~~~~ 298 (406)
.||.+|+|+.++|+|||++...
T Consensus 279 ~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 279 FDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred cCcccCCCHHHHhcCccccCCc
Confidence 9999999999999999988653
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=341.81 Aligned_cols=240 Identities=25% Similarity=0.425 Sum_probs=204.3
Q ss_pred eecceeeeEEEeeee--eeceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 58 RYGELQYDTVQNSQI--RLGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
.||+|+||.||++.. .+..+++|.+..... .....+.+|+.++..++|||++. ..+.+|+||||+++|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 689999999999886 345688887765432 22346778999999999999765 6778999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCcceEee-CCeeEEEecccccccCC-CCCCCcccCCCC
Q psy5368 127 LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRE-NNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAP-NDQGDSIQGSPL 203 (406)
Q Consensus 127 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~-~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~-~~~~~~~~gt~~ 203 (406)
|.+++...+.+++..+..++.||+.||+|||+ +||+||||||+|||++ ++.+||+|||+++.... ........||+.
T Consensus 82 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~ 161 (325)
T cd05594 82 LFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE 161 (325)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCcc
Confidence 99999888889999999999999999999997 7999999999999998 67999999999875332 233345679999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
|+|||++.+..++.++||||+||++|+|++|..||.+.+.......+... ....+ ..+++++.+|+.+||+.||++|+
T Consensus 162 y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-~~~~p-~~~~~~~~~li~~~L~~dP~~R~ 239 (325)
T cd05594 162 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFP-RTLSPEAKSLLSGLLKKDPKQRL 239 (325)
T ss_pred cCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-CCCCC-CCCCHHHHHHHHHHhhcCHHHhC
Confidence 99999999999999999999999999999999999988877776666544 23333 36899999999999999999997
Q ss_pred -----CHHHHhcCCCCCCCCC
Q psy5368 284 -----SYEDLFSHPYPDLIHA 299 (406)
Q Consensus 284 -----s~~ell~hp~~~~~~~ 299 (406)
++.++++||||+...+
T Consensus 240 ~~~~~~~~~il~h~~~~~~~~ 260 (325)
T cd05594 240 GGGPDDAKEIMQHKFFAGIVW 260 (325)
T ss_pred CCCCCCHHHHhcCCCcCCCCH
Confidence 8999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=324.22 Aligned_cols=242 Identities=30% Similarity=0.452 Sum_probs=203.0
Q ss_pred eecceeeeEEEeeeee--eceeEEeeeecCCcc--chhhhhhHHhhcccCCCCC-Ccc------cCC------eEEEEEe
Q psy5368 58 RYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPE-GRK------RPR------YVYIILE 120 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~n-i~~------~~~------~~~lV~E 120 (406)
++|+|.||+||+|... +..||+|++..+... -.....+|+.+|+.|+|+| ++. ..+ .+++|+|
T Consensus 18 klGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe 97 (323)
T KOG0594|consen 18 KLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFE 97 (323)
T ss_pred HhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEE
Confidence 4899999999999974 457899988876542 3446799999999999999 554 333 8999999
Q ss_pred ccCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCC-CCC
Q psy5368 121 YCDGGDLCSFIRSHE----KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAP-NDQ 194 (406)
Q Consensus 121 ~~~ggsL~~~l~~~~----~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~-~~~ 194 (406)
|++- +|.+++.... .++...++.+++||+.||+|||++||+||||||+|||++ +|.+||+|||+|+...- ...
T Consensus 98 ~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~ 176 (323)
T KOG0594|consen 98 FLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRT 176 (323)
T ss_pred eecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcCCccc
Confidence 9976 9999997765 588899999999999999999999999999999999999 78999999999987663 334
Q ss_pred CCcccCCCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----CC----------
Q psy5368 195 GDSIQGSPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPIT----IP---------- 259 (406)
Q Consensus 195 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~----~~---------- 259 (406)
....++|.+|+|||++.+. .|+...||||+|||++||+++++.|++.+..+....|......+ .|
T Consensus 177 yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~ 256 (323)
T KOG0594|consen 177 YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKA 256 (323)
T ss_pred ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccc
Confidence 5677899999999999987 69999999999999999999999999998877777766432111 00
Q ss_pred -------C-------CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy5368 260 -------P-------NSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAP 300 (406)
Q Consensus 260 -------~-------~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 300 (406)
+ ...+++..+++.+||+.+|.+|.|++.++.||||.....+
T Consensus 257 ~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~ 311 (323)
T KOG0594|consen 257 PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK 311 (323)
T ss_pred cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence 0 0123578999999999999999999999999999976543
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-44 Score=310.62 Aligned_cols=240 Identities=27% Similarity=0.483 Sum_probs=213.0
Q ss_pred CceeeecceeeeEEEeeeeeec--eeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEecc
Q psy5368 54 SSTIRYGELQYDTVQNSQIRLG--TVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYC 122 (406)
Q Consensus 54 ~~~~~lG~G~~g~Vy~~~~~~~--~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~ 122 (406)
.-.+.||.|-||.||.+..+.. -|++|...++. .....++.+|+++-+.|+|||+.+ +...+||++||.
T Consensus 25 eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya 104 (281)
T KOG0580|consen 25 EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYA 104 (281)
T ss_pred cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEec
Confidence 4566789999999999997543 46777665543 234568999999999999999754 888999999999
Q ss_pred CCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCccc
Q psy5368 123 DGGDLCSFIRS--HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQ 199 (406)
Q Consensus 123 ~ggsL~~~l~~--~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~ 199 (406)
+.|+|.+.|+. ...+++.....++.|++.||.|||.++|+||||||+|+|++ .+.+||+|||.+.... +....+.+
T Consensus 105 ~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~kR~tlc 183 (281)
T KOG0580|consen 105 PRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SNKRKTLC 183 (281)
T ss_pred CCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-CCCceeee
Confidence 99999999994 45799999999999999999999999999999999999999 8899999999997654 66677899
Q ss_pred CCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCC
Q psy5368 200 GSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 200 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP 279 (406)
||..|.|||++.+..++..+|+|++|++.||++.|.+||.+.+..+...++... ....| ..+|.++.|||.+||..+|
T Consensus 184 gt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~-~~~~p-~~is~~a~dlI~~ll~~~p 261 (281)
T KOG0580|consen 184 GTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV-DLKFP-STISGGAADLISRLLVKNP 261 (281)
T ss_pred cccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc-cccCC-cccChhHHHHHHHHhccCc
Confidence 999999999999999999999999999999999999999999988888888776 44455 4799999999999999999
Q ss_pred CCCCCHHHHhcCCCCCC
Q psy5368 280 MRRISYEDLFSHPYPDL 296 (406)
Q Consensus 280 ~~Rps~~ell~hp~~~~ 296 (406)
.+|.+..|++.|||+..
T Consensus 262 ~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 262 IERLALTEVMDHPWIVA 278 (281)
T ss_pred cccccHHHHhhhHHHHh
Confidence 99999999999999753
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=339.03 Aligned_cols=241 Identities=28% Similarity=0.484 Sum_probs=198.8
Q ss_pred eecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccCCC
Q psy5368 58 RYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
.||+|+||.||++... +..+++|.+..... .....+.+|..++..+ +|||++. ..+.+|+|||||+||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 6899999999999874 45688887765432 2234578899999888 7999875 667899999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEeccccccc-CCCCCCCcccCCCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFL-APNDQGDSIQGSPL 203 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~-~~~~~~~~~~gt~~ 203 (406)
+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.. ..........||+.
T Consensus 82 ~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~ 161 (329)
T cd05588 82 DLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPN 161 (329)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCcc
Confidence 9999998888999999999999999999999999999999999999998 679999999998753 22333445679999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhc
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCN--------LSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL 275 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~--------~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L 275 (406)
|+|||++.+..++.++|+||+||++|+|++|+.||.... ................| ..++.++.+++.+||
T Consensus 162 y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p-~~~~~~~~~li~~~L 240 (329)
T cd05588 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP-RSLSVKASSVLKGFL 240 (329)
T ss_pred ccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC-CCCCHHHHHHHHHHh
Confidence 999999999999999999999999999999999996321 12222222333334444 368999999999999
Q ss_pred ccCCCCCCC------HHHHhcCCCCCCCCC
Q psy5368 276 QKDPMRRIS------YEDLFSHPYPDLIHA 299 (406)
Q Consensus 276 ~~dP~~Rps------~~ell~hp~~~~~~~ 299 (406)
+.||.+||| ++++++||||....+
T Consensus 241 ~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 241 NKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred ccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 999999997 789999999976543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=337.82 Aligned_cols=240 Identities=27% Similarity=0.425 Sum_probs=204.6
Q ss_pred eecceeeeEEEeeeeee--ceeEEeeeecCCc---cchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccCCC
Q psy5368 58 RYGELQYDTVQNSQIRL--GTVKYSQVRYDTI---TSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
.||+|+||.||++.... ..+++|.+..... .....+..|..++..+ +|||++. ..+.+|+||||++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 68999999999998753 4688887765432 2334567888888765 8999755 667899999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCcccCCCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDSIQGSPL 203 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~~~gt~~ 203 (406)
+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...... .......||+.
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~ 161 (321)
T cd05591 82 DLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPD 161 (321)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCcc
Confidence 9999998888999999999999999999999999999999999999998 779999999998754322 23345678999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
|+|||++.+..++.++||||+||++|+|++|+.||...+.......+..... .. +..++.++.+|+.+||+.||++||
T Consensus 162 y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~-~~-p~~~~~~~~~ll~~~L~~dp~~R~ 239 (321)
T cd05591 162 YIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV-LY-PVWLSKEAVSILKAFMTKNPNKRL 239 (321)
T ss_pred ccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CC-CCCCCHHHHHHHHHHhccCHHHcC
Confidence 9999999999999999999999999999999999999988888877766532 22 336899999999999999999999
Q ss_pred -------CHHHHhcCCCCCCCCC
Q psy5368 284 -------SYEDLFSHPYPDLIHA 299 (406)
Q Consensus 284 -------s~~ell~hp~~~~~~~ 299 (406)
+++++++||||....+
T Consensus 240 ~~~~~~~~~~~~~~hp~~~~~~~ 262 (321)
T cd05591 240 GCVASQGGEDAIKQHPFFKEIDW 262 (321)
T ss_pred CCCCCCCCHHHHhcCCccCCCCH
Confidence 8999999999987554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=334.84 Aligned_cols=243 Identities=24% Similarity=0.410 Sum_probs=198.7
Q ss_pred eeeecceeeeEEEeeeeee--ceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIRL--GTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...||+|+||.||++.... ..+++|.+..... .....+.+|++++++++|||+++ ..+.+++||||+++++
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 89 (331)
T cd06649 10 ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 89 (331)
T ss_pred EEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCc
Confidence 3567889999999888753 3456666554322 23457899999999999999876 5678999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCC
Q psy5368 127 LCSFIRSHEKLSEFQCQQFVRQLVLALKFLREN-NVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLY 204 (406)
Q Consensus 127 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~-givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y 204 (406)
|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++ ++.+||+|||++...... ......||+.|
T Consensus 90 L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~g~~~y 168 (331)
T cd06649 90 LDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSY 168 (331)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-ccccCCCCcCc
Confidence 999998888899999999999999999999986 599999999999998 779999999998765432 33456789999
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----------------------------------
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQA---------------------------------- 250 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~---------------------------------- 250 (406)
+|||++.+..++.++|||||||++|+|++|+.||...+..++...+
T Consensus 169 ~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (331)
T cd06649 169 MSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSR 248 (331)
T ss_pred CCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccc
Confidence 9999999999999999999999999999999999876654443221
Q ss_pred ------------HhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy5368 251 ------------LSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 251 ------------~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 299 (406)
........+...+++++.+|+.+||+.||++|||++++++||||+....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~ 309 (331)
T cd06649 249 PAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEV 309 (331)
T ss_pred cchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence 1111222223357889999999999999999999999999999986543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=329.59 Aligned_cols=238 Identities=26% Similarity=0.410 Sum_probs=192.3
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
..+||+|+||.||++... +..+++|.+..... .....+.+|+.++++++|||+++ ..+..|+||||+++ +
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~ 88 (288)
T cd07871 10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-D 88 (288)
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-C
Confidence 356788888888888754 45678887754432 23446789999999999999765 56678999999976 9
Q ss_pred HHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCC
Q psy5368 127 LCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPL 203 (406)
Q Consensus 127 L~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~ 203 (406)
|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++...... ......+++.
T Consensus 89 l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~ 168 (288)
T cd07871 89 LKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLW 168 (288)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCceeccc
Confidence 999987654 589999999999999999999999999999999999998 6799999999997654322 2344568999
Q ss_pred CCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC------------------CCC-----
Q psy5368 204 YMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI------------------TIP----- 259 (406)
Q Consensus 204 y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------------------~~~----- 259 (406)
|+|||++.+ ..++.++||||+||++|+|+||++||.+.+..+....+...... ..+
T Consensus 169 y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (288)
T cd07871 169 YRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQ 248 (288)
T ss_pred ccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCC
Confidence 999999876 56899999999999999999999999987766555444321100 000
Q ss_pred -----CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 260 -----PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 260 -----~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
...+++++.+|+.+||+.||.+|||++|+++||||
T Consensus 249 ~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 249 PLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred chHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 12467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=327.76 Aligned_cols=239 Identities=24% Similarity=0.370 Sum_probs=193.2
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...||+|+||.||++... +..+++|.+..... .....+.+|+.+++.++|||+++ ..+.+|+||||++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 85 (287)
T cd07848 6 LGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKN 85 (287)
T ss_pred EEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCC
Confidence 456799999999999875 34577887664432 23456889999999999999765 667889999999987
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC--CCCcccCCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND--QGDSIQGSP 202 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~--~~~~~~gt~ 202 (406)
+|..+......+++..++.++.||+.||.|||+.||+||||||+||+++ ++.+||+|||++....... ......||+
T Consensus 86 ~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 165 (287)
T cd07848 86 MLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATR 165 (287)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccccccccc
Confidence 7766655556799999999999999999999999999999999999998 6799999999998764332 223456899
Q ss_pred CCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC------------------CCCC-----
Q psy5368 203 LYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP------------------ITIP----- 259 (406)
Q Consensus 203 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~------------------~~~~----- 259 (406)
.|+|||++.+..++.++||||+||++|+|++|++||.+.+..+....+..... ...+
T Consensus 166 ~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (287)
T cd07848 166 WYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHP 245 (287)
T ss_pred ccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCc
Confidence 99999999998899999999999999999999999988765443332221100 0000
Q ss_pred -------CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 260 -------PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 260 -------~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
...+|.++.+|+.+||+.||++|||++++++||||
T Consensus 246 ~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 246 QSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 01367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=343.77 Aligned_cols=243 Identities=26% Similarity=0.481 Sum_probs=203.5
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++... +..+++|.+..... .....+.+|+.++..++|||++. ...++|+|||||+|
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 85 (364)
T cd05599 6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPG 85 (364)
T ss_pred EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCC
Confidence 456899999999988864 45688888765432 22345788999999999999766 77789999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC----------
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND---------- 193 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~---------- 193 (406)
|+|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++ ++.++|+|||+++.+....
T Consensus 86 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 165 (364)
T cd05599 86 GDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSH 165 (364)
T ss_pred cHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccc
Confidence 99999998888999999999999999999999999999999999999998 7799999999987543211
Q ss_pred -----------------------------CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q psy5368 194 -----------------------------QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLS 244 (406)
Q Consensus 194 -----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~ 244 (406)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~ 245 (364)
T cd05599 166 ALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQ 245 (364)
T ss_pred cccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHH
Confidence 011346899999999999999999999999999999999999999998877
Q ss_pred HHHHHHHhcCC-CCCCCC-CCChHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCCC
Q psy5368 245 QLRAQALSSAP-ITIPPN-SLSPDCMDFLSRLLQKDPMRRIS---YEDLFSHPYPDLIHA 299 (406)
Q Consensus 245 ~~~~~~~~~~~-~~~~~~-~~s~~l~~li~~~L~~dP~~Rps---~~ell~hp~~~~~~~ 299 (406)
+....+..... ...+.. .+++++.+||.+||. +|.+|++ ++++++||||+...+
T Consensus 246 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~ 304 (364)
T cd05599 246 ETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDW 304 (364)
T ss_pred HHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 77666655322 222322 579999999999997 9999998 999999999987654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=341.55 Aligned_cols=228 Identities=25% Similarity=0.397 Sum_probs=202.0
Q ss_pred eecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHHHHH
Q psy5368 58 RYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLCSFI 131 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~~~l 131 (406)
-+|+|+.|.||.|++.+.+||||+++.- -..+++-|++|+||||+. ...++|||||||..|-|..+|
T Consensus 131 WlGSGaQGAVF~Grl~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VL 203 (904)
T KOG4721|consen 131 WLGSGAQGAVFLGRLHNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVL 203 (904)
T ss_pred hhccCcccceeeeeccCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHH
Confidence 5899999999999999999999987532 245688999999999876 667889999999999999999
Q ss_pred HhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCCCChhhh
Q psy5368 132 RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEIL 210 (406)
Q Consensus 132 ~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 210 (406)
+..+.++......+..+|+.|+.|||.+.|+|||||.-||||+ ++.+||+|||.++........-+++||..|||||++
T Consensus 204 ka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvI 283 (904)
T KOG4721|consen 204 KAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVI 283 (904)
T ss_pred hccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHh
Confidence 9999999999999999999999999999999999999999999 889999999999887766666778999999999999
Q ss_pred cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 211 AGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 211 ~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
...+.+.|+|||||||||||||||..||.+-+...+..-+-.+...-..|..+|+-++=|+++||+..|.+||+|.+++.
T Consensus 284 rnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~ 363 (904)
T KOG4721|consen 284 RNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILL 363 (904)
T ss_pred hcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHH
Confidence 99999999999999999999999999998876655544443332222233478999999999999999999999999999
Q ss_pred CC
Q psy5368 291 HP 292 (406)
Q Consensus 291 hp 292 (406)
|-
T Consensus 364 Hl 365 (904)
T KOG4721|consen 364 HL 365 (904)
T ss_pred HH
Confidence 94
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=326.41 Aligned_cols=243 Identities=26% Similarity=0.490 Sum_probs=210.7
Q ss_pred eeecceeeeEEEeeeeee--ceeEEeeeecCCccchh---hhhhHHhhcccCCCCCCc------ccCCeEEEEEeccCCC
Q psy5368 57 IRYGELQYDTVQNSQIRL--GTVKYSQVRYDTITSHS---EFERPRAGLSNLRAPEGR------KRPRYVYIILEYCDGG 125 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~~~~~---~~~~E~~~l~~l~h~ni~------~~~~~~~lV~E~~~gg 125 (406)
+.||.|.-|+||.+..++ ...|+|.+.+......+ +...|.+||+.+.||-+. ..+++.|+|||||+||
T Consensus 83 k~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGG 162 (459)
T KOG0610|consen 83 KRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGG 162 (459)
T ss_pred HHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCc
Confidence 468999999999999876 45688888776655444 556699999999999754 4889999999999999
Q ss_pred CHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCC-----------
Q psy5368 126 DLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAP----------- 191 (406)
Q Consensus 126 sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~----------- 191 (406)
+|..+++++. .|++..++.++..++.||+|||..|||+|||||+|||+. +|++-|+||.++.....
T Consensus 163 dL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~ 242 (459)
T KOG0610|consen 163 DLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPR 242 (459)
T ss_pred cHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCC
Confidence 9999997764 699999999999999999999999999999999999998 88999999998743210
Q ss_pred ----------------------C-C-----------------------CCCcccCCCCCCChhhhcCCCCCchhhHHHHH
Q psy5368 192 ----------------------N-D-----------------------QGDSIQGSPLYMAPEILAGSPYNAKADLWSLG 225 (406)
Q Consensus 192 ----------------------~-~-----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 225 (406)
. . ...+.+||-.|.|||++.+...+.++|+|+||
T Consensus 243 ~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfG 322 (459)
T KOG0610|consen 243 SSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFG 322 (459)
T ss_pred CCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHH
Confidence 0 0 01245689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC-CCChHHHHHHHHhcccCCCCCCC----HHHHhcCCCCCCCCCC
Q psy5368 226 VLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPN-SLSPDCMDFLSRLLQKDPMRRIS----YEDLFSHPYPDLIHAP 300 (406)
Q Consensus 226 ~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~s~~l~~li~~~L~~dP~~Rps----~~ell~hp~~~~~~~~ 300 (406)
+++||||.|..||.+.+.++....+.... ..+|.. .++..++|||+++|.+||.+|.. +.||-+||||++..|+
T Consensus 323 IflYEmLyG~TPFKG~~~~~Tl~NIv~~~-l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 323 IFLYEMLYGTTPFKGSNNKETLRNIVGQP-LKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred HHHHHHHhCCCCcCCCCchhhHHHHhcCC-CcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence 99999999999999999999988888773 444433 78899999999999999999998 9999999999999885
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=334.62 Aligned_cols=240 Identities=27% Similarity=0.485 Sum_probs=201.1
Q ss_pred eecceeeeEEEeeeeee--ceeEEeeeecCCc---cchhhhhhHHhhccc-CCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 58 RYGELQYDTVQNSQIRL--GTVKYSQVRYDTI---TSHSEFERPRAGLSN-LRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~---~~~~~~~~E~~~l~~-l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
.||+|+||.||++.... ..+++|.+..... .....+..|..++.. .+|||++. ..+.+|+||||++||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 68999999999998754 4588887765432 223345667666654 48999765 667899999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCcccCCCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDSIQGSPL 203 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~~~gt~~ 203 (406)
+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++..... .......||+.
T Consensus 82 ~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~ 161 (316)
T cd05592 82 DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPD 161 (316)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCcc
Confidence 9999998888999999999999999999999999999999999999998 779999999999764332 23345679999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
|+|||++.+..++.++||||+||++|+|++|..||.+.+..++...+... .... +..++.++.+|+.+||+.||.+||
T Consensus 162 y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~~~-~~~~~~~~~~ll~~~l~~~P~~R~ 239 (316)
T cd05592 162 YIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND-RPHF-PRWISKEAKDCLSKLFERDPTKRL 239 (316)
T ss_pred ccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCC-CCCCCHHHHHHHHHHccCCHHHcC
Confidence 99999999999999999999999999999999999998887777766554 2223 346899999999999999999999
Q ss_pred CH-HHHhcCCCCCCCCC
Q psy5368 284 SY-EDLFSHPYPDLIHA 299 (406)
Q Consensus 284 s~-~ell~hp~~~~~~~ 299 (406)
++ .++++||||+...+
T Consensus 240 ~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 240 GVDGDIRQHPFFRGIDW 256 (316)
T ss_pred CChHHHHcCcccCCCCH
Confidence 86 58899999986543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-45 Score=341.90 Aligned_cols=240 Identities=27% Similarity=0.463 Sum_probs=213.0
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
-.+||.|+||.||+|... .+.||+|.+..+... ...++++|+.+|.+++++|+.+ ....++++||||.||+
T Consensus 18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 367999999999999974 456889988766544 4668999999999999999855 5566789999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC-CCcccCCCCC
Q psy5368 127 LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ-GDSIQGSPLY 204 (406)
Q Consensus 127 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~-~~~~~gt~~y 204 (406)
+.+.++....+++..+..++++++.||.|||+++.+|||||+.|||+. +|.+||+|||.+..+..... ..+.+|||.|
T Consensus 98 v~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfw 177 (467)
T KOG0201|consen 98 VLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFW 177 (467)
T ss_pred hhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccccccccccc
Confidence 999999887889999999999999999999999999999999999999 78999999999988765543 4788999999
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRIS 284 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps 284 (406)
||||++.+..|+.++||||||++.+||++|.+|+....+......|....++.+.. .+|+.+++|+..||++||+.|||
T Consensus 178 MAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~-~~S~~~kEFV~~CL~k~P~~Rps 256 (467)
T KOG0201|consen 178 MAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDG-DFSPPFKEFVEACLDKNPEFRPS 256 (467)
T ss_pred cchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcccc-ccCHHHHHHHHHHhhcCcccCcC
Confidence 99999998899999999999999999999999999988876666666665554444 89999999999999999999999
Q ss_pred HHHHhcCCCCCC
Q psy5368 285 YEDLFSHPYPDL 296 (406)
Q Consensus 285 ~~ell~hp~~~~ 296 (406)
+.++|+|+|++.
T Consensus 257 A~~LLKh~FIk~ 268 (467)
T KOG0201|consen 257 AKELLKHKFIKR 268 (467)
T ss_pred HHHHhhhHHHHh
Confidence 999999999986
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=334.82 Aligned_cols=241 Identities=23% Similarity=0.454 Sum_probs=202.1
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhhccc-CCCCCCcc------cCCeEEEEEeccCC
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAGLSN-LRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~-l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
+.||+|+||.||++... +..+++|.+..... .....+..|..++.. ++|||++. ..+++|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36899999999999874 34688887765421 233456677777765 48999765 67789999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCC-CCCCCcccCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAP-NDQGDSIQGSP 202 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~-~~~~~~~~gt~ 202 (406)
|+|.+++..+..+++..+..++.||+.||+|||++||+||||||+|||++ ++.++|+|||+++.... ........||+
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence 99999998888899999999999999999999999999999999999998 67999999999875322 22334567899
Q ss_pred CCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCC
Q psy5368 203 LYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRR 282 (406)
Q Consensus 203 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 282 (406)
.|+|||++.+..++.++||||+||++|+|++|..||.+.+...+...+.... ... +..++.++.+|+.+||+.||++|
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~li~~~l~~dP~~R 238 (316)
T cd05620 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT-PHY-PRWITKESKDILEKLFERDPTRR 238 (316)
T ss_pred CccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCC-CCCCCHHHHHHHHHHccCCHHHc
Confidence 9999999999999999999999999999999999999988877777665442 233 33689999999999999999999
Q ss_pred CCH-HHHhcCCCCCCCCC
Q psy5368 283 ISY-EDLFSHPYPDLIHA 299 (406)
Q Consensus 283 ps~-~ell~hp~~~~~~~ 299 (406)
|++ +++++||||+...+
T Consensus 239 ~~~~~~~~~h~~f~~~~~ 256 (316)
T cd05620 239 LGVVGNIRGHPFFKTINW 256 (316)
T ss_pred CCChHHHHcCCCcCCCCH
Confidence 998 58999999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=343.46 Aligned_cols=244 Identities=25% Similarity=0.461 Sum_probs=200.5
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
-..||+|+||+||++... +..+++|.+..... .....+.+|+.++..++|||++. ..+++|+|||||+|
T Consensus 6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~g 85 (381)
T cd05626 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG 85 (381)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 356899999999999864 34678887765432 22346889999999999999765 67789999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC----------
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND---------- 193 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~---------- 193 (406)
|+|.+++...+.+++..++.++.||+.||+|||+.||+||||||+|||++ ++.+||+|||+++......
T Consensus 86 g~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~ 165 (381)
T cd05626 86 GDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSH 165 (381)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccccccc
Confidence 99999998888899999999999999999999999999999999999998 7799999999975331100
Q ss_pred --------------------------------------CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCC
Q psy5368 194 --------------------------------------QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGH 235 (406)
Q Consensus 194 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~ 235 (406)
......||+.|+|||++.+..++.++||||+||++|||++|.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~ 245 (381)
T cd05626 166 IRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQ 245 (381)
T ss_pred ccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCC
Confidence 012356999999999999989999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhcC-CCCCCCC-CCChHHHHHHHHhc--ccCCCCCCCHHHHhcCCCCCCCCC
Q psy5368 236 APYASCNLSQLRAQALSSA-PITIPPN-SLSPDCMDFLSRLL--QKDPMRRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 236 ~pf~~~~~~~~~~~~~~~~-~~~~~~~-~~s~~l~~li~~~L--~~dP~~Rps~~ell~hp~~~~~~~ 299 (406)
.||...+..+....+.... ....+.. .+++++.+||.+|+ ..+|..||+++++++||||....+
T Consensus 246 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 246 PPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred CCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCCh
Confidence 9999887766665555432 2333332 68999999999955 556666999999999999986543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=334.30 Aligned_cols=242 Identities=24% Similarity=0.416 Sum_probs=204.0
Q ss_pred eeeecceeeeEEEeeeeee--ceeEEeeeecCC---ccchhhhhhHHhhcccCCCCC-Cc------ccCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIRL--GTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPE-GR------KRPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~n-i~------~~~~~~~lV~E~~~ 123 (406)
...||+|+||.||++.... ..+++|.+.... ......+..|..++..++|++ ++ ...+.+|+||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 84 (324)
T cd05587 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 84 (324)
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCC
Confidence 4568999999999998654 468888776532 223456788999999998876 32 26678999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCC-CCCCCcccCC
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAP-NDQGDSIQGS 201 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~-~~~~~~~~gt 201 (406)
||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||++..... ........||
T Consensus 85 ~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 164 (324)
T cd05587 85 GGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGT 164 (324)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceeeecCC
Confidence 999999998888899999999999999999999999999999999999998 77999999999865322 2233456799
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
+.|+|||++.+..++.++||||+||++|+|+||+.||.+.+..+....+.... ...+ ..+++++.+++.+||..||.+
T Consensus 165 ~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~~-~~~~~~~~~li~~~l~~~P~~ 242 (324)
T cd05587 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYP-KSLSKEAVSICKGLLTKHPAK 242 (324)
T ss_pred ccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCC-CCCCHHHHHHHHHHhhcCHHH
Confidence 99999999999999999999999999999999999999988888777776543 3333 368999999999999999999
Q ss_pred CCCH-----HHHhcCCCCCCCCC
Q psy5368 282 RISY-----EDLFSHPYPDLIHA 299 (406)
Q Consensus 282 Rps~-----~ell~hp~~~~~~~ 299 (406)
|++. +++++||||+...+
T Consensus 243 R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 243 RLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred cCCCCCCCHHHHhcCCCcCCCCH
Confidence 9986 89999999987544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=333.17 Aligned_cols=240 Identities=26% Similarity=0.450 Sum_probs=202.6
Q ss_pred eecceeeeEEEeeeeee--ceeEEeeeecCCc---cchhhhhhHHhhccc-CCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 58 RYGELQYDTVQNSQIRL--GTVKYSQVRYDTI---TSHSEFERPRAGLSN-LRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~---~~~~~~~~E~~~l~~-l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
.||+|+||.||++.... ..+++|.+..... .....+..|..++.. ++|||+++ ..+.+|+||||++||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 68999999999998754 4688887765421 233456677777775 49999765 677899999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCC-CCCCCcccCCCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAP-NDQGDSIQGSPL 203 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~-~~~~~~~~gt~~ 203 (406)
+|.+++.....+++.++..++.|++.||.|||++||+||||||+|||++ ++.+||+|||+++.... ........||+.
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 161 (316)
T cd05619 82 DLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPD 161 (316)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCcc
Confidence 9999998888899999999999999999999999999999999999998 67999999999875322 223345678999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
|+|||++.+..++.++||||+||++|+|++|..||.+.+..++...+.... ...+ ..++.++.+|+.+||+.||++||
T Consensus 162 y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-~~~~-~~~~~~~~~li~~~l~~~P~~R~ 239 (316)
T cd05619 162 YIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN-PCYP-RWLTREAKDILVKLFVREPERRL 239 (316)
T ss_pred ccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCC-ccCCHHHHHHHHHHhccCHhhcC
Confidence 999999999999999999999999999999999999988877776665543 2233 36899999999999999999999
Q ss_pred CHH-HHhcCCCCCCCCC
Q psy5368 284 SYE-DLFSHPYPDLIHA 299 (406)
Q Consensus 284 s~~-ell~hp~~~~~~~ 299 (406)
++. ++++||||+...+
T Consensus 240 ~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 240 GVKGDIRQHPFFREIDW 256 (316)
T ss_pred CChHHHHcCcccCCCCH
Confidence 996 8999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=333.58 Aligned_cols=240 Identities=26% Similarity=0.457 Sum_probs=204.3
Q ss_pred eecceeeeEEEeeeee--eceeEEeeeecCC---ccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccCCC
Q psy5368 58 RYGELQYDTVQNSQIR--LGTVKYSQVRYDT---ITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
.||+|+||.||++... +..+++|.+.... ......+.+|..++..+ +|||++. ..+.+|+||||++||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6899999999999874 3568888776543 22344577888888877 7999765 567899999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCC-CCCCCcccCCCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAP-NDQGDSIQGSPL 203 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~-~~~~~~~~gt~~ 203 (406)
+|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||+++.... ........||+.
T Consensus 82 ~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~ 161 (318)
T cd05570 82 DLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPD 161 (318)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCcc
Confidence 9999998888999999999999999999999999999999999999998 77999999999865322 223344568999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+.... ... +..+++++.+|+.+||..||.+||
T Consensus 162 y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~-~~~-~~~~~~~~~~li~~~l~~dP~~R~ 239 (318)
T cd05570 162 YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE-VRY-PRWLSKEAKSILKSFLTKNPEKRL 239 (318)
T ss_pred ccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-CCC-CCcCCHHHHHHHHHHccCCHHHcC
Confidence 999999999999999999999999999999999999888777776665543 233 346899999999999999999999
Q ss_pred CH-----HHHhcCCCCCCCCC
Q psy5368 284 SY-----EDLFSHPYPDLIHA 299 (406)
Q Consensus 284 s~-----~ell~hp~~~~~~~ 299 (406)
|+ .++++||||+...+
T Consensus 240 s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 240 GCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred CCCCCCHHHHhcCCCcCCCCH
Confidence 99 99999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=335.96 Aligned_cols=240 Identities=25% Similarity=0.451 Sum_probs=202.2
Q ss_pred eecceeeeEEEeeeee--eceeEEeeeecCCcc---chhhhhhHHh-hcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 58 RYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT---SHSEFERPRA-GLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~---~~~~~~~E~~-~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
.||+|+||+||++... +..+++|.+...... ....+.+|.. +++.++|||+++ ..+..|+||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 6899999999999974 456888887654322 2234555544 567899999876 567889999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCC-CCCCCcccCCCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAP-NDQGDSIQGSPL 203 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~-~~~~~~~~gt~~ 203 (406)
+|.+++..++.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.... ........||+.
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 161 (323)
T cd05575 82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPE 161 (323)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCChh
Confidence 9999998888999999999999999999999999999999999999998 77999999999875322 233345678999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...+.... ...++ .+++++.+++.+||+.||.+||
T Consensus 162 y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~-~~~~~~~~li~~~l~~~p~~R~ 239 (323)
T cd05575 162 YLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP-LRLKP-NISVSARHLLEGLLQKDRTKRL 239 (323)
T ss_pred hcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-CCCCC-CCCHHHHHHHHHHhhcCHHhCC
Confidence 999999999999999999999999999999999999988888777776553 33333 5799999999999999999999
Q ss_pred CH----HHHhcCCCCCCCCC
Q psy5368 284 SY----EDLFSHPYPDLIHA 299 (406)
Q Consensus 284 s~----~ell~hp~~~~~~~ 299 (406)
++ .++++||||....+
T Consensus 240 ~~~~~~~~il~~~~~~~~~~ 259 (323)
T cd05575 240 GAKDDFLEIKNHVFFSSINW 259 (323)
T ss_pred CCCCCHHHHHcCCCcCCCCH
Confidence 87 69999999986543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=318.58 Aligned_cols=242 Identities=25% Similarity=0.440 Sum_probs=205.9
Q ss_pred CceeeecceeeeEEEeeeeee--ceeEEeeeecCCc----cc----hhhhhhHHhhcccC-CCCCCcc------cCCeEE
Q psy5368 54 SSTIRYGELQYDTVQNSQIRL--GTVKYSQVRYDTI----TS----HSEFERPRAGLSNL-RAPEGRK------RPRYVY 116 (406)
Q Consensus 54 ~~~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~----~~----~~~~~~E~~~l~~l-~h~ni~~------~~~~~~ 116 (406)
.+...+|.|..++|.++..+. +..++|.+..... +. .+.-.+|+.+|+++ .||+++. .+.+++
T Consensus 20 ~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~F 99 (411)
T KOG0599|consen 20 EPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVF 99 (411)
T ss_pred ChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhh
Confidence 556678888888888877643 3455554432221 11 22345789999998 8999765 677889
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeC-CeeEEEecccccccCCCCCC
Q psy5368 117 IILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLADFGFAQFLAPNDQG 195 (406)
Q Consensus 117 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~-~~~kL~DFGla~~~~~~~~~ 195 (406)
+|+|.|+.|.|.++|.+.-.++++..++|++|++.|++|||.++||||||||+|||+++ .++||+|||+|+.+......
T Consensus 100 lVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~GekL 179 (411)
T KOG0599|consen 100 LVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEKL 179 (411)
T ss_pred hhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCchhH
Confidence 99999999999999999889999999999999999999999999999999999999995 59999999999999988888
Q ss_pred CcccCCCCCCChhhhcCC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCChHH
Q psy5368 196 DSIQGSPLYMAPEILAGS------PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP--NSLSPDC 267 (406)
Q Consensus 196 ~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l 267 (406)
...+|||+|.|||.+... .|+..+|+||+|+|+|.||.|.+||.......+...|..+......+ .++|...
T Consensus 180 relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~ 259 (411)
T KOG0599|consen 180 RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATV 259 (411)
T ss_pred HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccH
Confidence 999999999999998653 47889999999999999999999999888777788887775443333 2789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy5368 268 MDFLSRLLQKDPMRRISYEDLFSHPYPD 295 (406)
Q Consensus 268 ~~li~~~L~~dP~~Rps~~ell~hp~~~ 295 (406)
++||++||+.||.+|.|++|+|+||||.
T Consensus 260 KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 260 KDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred HHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 9999999999999999999999999994
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=337.74 Aligned_cols=240 Identities=27% Similarity=0.439 Sum_probs=205.1
Q ss_pred eeecceeeeEEEeeee-----eeceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccC
Q psy5368 57 IRYGELQYDTVQNSQI-----RLGTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~-----~~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ 123 (406)
..||+|+||.||++.. .+..+++|.+..... .....+.+|+.++.+++|||+++ ..+.+|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4689999999998864 235678887765432 23345778999999999999866 6778999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCcccCC
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDSIQGS 201 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~~~gt 201 (406)
+|+|.+++.+...+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++...... .......||
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~ 161 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGT 161 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCC
Confidence 999999998888899999999999999999999999999999999999998 679999999998765443 233456789
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.... ...+ ..+++++.+|+.+||+.||++
T Consensus 162 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~-~~~p-~~~~~~~~~li~~~l~~~P~~ 239 (318)
T cd05582 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK-LGMP-QFLSPEAQSLLRALFKRNPAN 239 (318)
T ss_pred hhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC-CCCC-CCCCHHHHHHHHHHhhcCHhH
Confidence 99999999999889999999999999999999999999988877777666543 3333 368999999999999999999
Q ss_pred CCC-----HHHHhcCCCCCCCC
Q psy5368 282 RIS-----YEDLFSHPYPDLIH 298 (406)
Q Consensus 282 Rps-----~~ell~hp~~~~~~ 298 (406)
||+ ++++++||||....
T Consensus 240 R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 240 RLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred cCCCCCCCHHHHhCCCCcCCCC
Confidence 999 78899999998654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=348.00 Aligned_cols=241 Identities=26% Similarity=0.427 Sum_probs=195.0
Q ss_pred ceeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCccc--------------CCeEEEE
Q psy5368 55 STIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRKR--------------PRYVYII 118 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~--------------~~~~~lV 118 (406)
....||+|+||.||++... ...+++|++... .....+|+.+++.++|||++.. ..++++|
T Consensus 70 ~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lv 145 (440)
T PTZ00036 70 LGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145 (440)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEE
Confidence 3567899999999999874 457888877532 2334679999999999998752 1256799
Q ss_pred EeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC-eeEEEecccccccCCC
Q psy5368 119 LEYCDGGDLCSFIR----SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN-TLKLADFGFAQFLAPN 192 (406)
Q Consensus 119 ~E~~~ggsL~~~l~----~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~-~~kL~DFGla~~~~~~ 192 (406)
|||+++ +|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++ ++ .+||+|||+|+.....
T Consensus 146 mE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~ 224 (440)
T PTZ00036 146 MEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG 224 (440)
T ss_pred EecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCC
Confidence 999976 8877774 345799999999999999999999999999999999999998 43 7999999999877655
Q ss_pred CCCCcccCCCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----------------
Q psy5368 193 DQGDSIQGSPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP---------------- 255 (406)
Q Consensus 193 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~---------------- 255 (406)
.......||+.|+|||++.+. .++.++||||+||++|||++|.+||.+.+..+....+.....
T Consensus 225 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~ 304 (440)
T PTZ00036 225 QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYAD 304 (440)
T ss_pred CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhc
Confidence 555567889999999998764 689999999999999999999999998776554444432100
Q ss_pred CCC-----------CCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy5368 256 ITI-----------PPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAP 300 (406)
Q Consensus 256 ~~~-----------~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 300 (406)
... .+...|+++.+||.+||++||.+|||+.|+++||||+....+
T Consensus 305 ~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~ 360 (440)
T PTZ00036 305 IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP 360 (440)
T ss_pred ccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcc
Confidence 000 122467899999999999999999999999999999866443
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=343.59 Aligned_cols=243 Identities=24% Similarity=0.439 Sum_probs=200.6
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
-..||+|+||.||++... ...+++|.+..... .....+.+|+.++.+++|||+++ ..+.+|+|||||++
T Consensus 6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~g 85 (382)
T cd05625 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 85 (382)
T ss_pred EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCC
Confidence 456889999999998863 34678887764322 22446888999999999999876 67789999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-----------
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN----------- 192 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~----------- 192 (406)
|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 86 g~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~ 165 (382)
T cd05625 86 GDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDH 165 (382)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccc
Confidence 99999998888899999999999999999999999999999999999998 779999999997532100
Q ss_pred -------------------------------------CCCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCC
Q psy5368 193 -------------------------------------DQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGH 235 (406)
Q Consensus 193 -------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~ 235 (406)
.......||+.|+|||++.+..++.++||||+||++|||++|+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~ 245 (382)
T cd05625 166 VRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 245 (382)
T ss_pred cccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCC
Confidence 0012346899999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhcC-CCCCCC-CCCChHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCCC
Q psy5368 236 APYASCNLSQLRAQALSSA-PITIPP-NSLSPDCMDFLSRLLQKDPMRRIS---YEDLFSHPYPDLIHA 299 (406)
Q Consensus 236 ~pf~~~~~~~~~~~~~~~~-~~~~~~-~~~s~~l~~li~~~L~~dP~~Rps---~~ell~hp~~~~~~~ 299 (406)
+||.+.+..+....+.... ....++ ..+++++.++|.+|+ .+|.+|++ ++++++||||+...+
T Consensus 246 ~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 246 PPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred CCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence 9999888776666665432 223333 368999999999986 59999997 999999999987654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=335.05 Aligned_cols=240 Identities=28% Similarity=0.476 Sum_probs=196.8
Q ss_pred eecceeeeEEEeeeeee--ceeEEeeeecCCc---cchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccCCC
Q psy5368 58 RYGELQYDTVQNSQIRL--GTVKYSQVRYDTI---TSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
.||+|+||.||++.... ..+++|.+..... .....+.+|+.++.++ +|||++. ..+.+|+||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 68999999999998743 4678887765432 2334577888888776 8999776 667899999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCC-CCCCCcccCCCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAP-NDQGDSIQGSPL 203 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~-~~~~~~~~gt~~ 203 (406)
+|..++...+.+++..++.++.||+.||+|||++||+||||||+||+++ ++.+||+|||+++.... ........||+.
T Consensus 82 ~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~ 161 (329)
T cd05618 82 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN 161 (329)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCcc
Confidence 9999998888999999999999999999999999999999999999998 77999999999875322 223345679999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHh
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASC---------NLSQLRAQALSSAPITIPPNSLSPDCMDFLSRL 274 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~---------~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~ 274 (406)
|+|||++.+..++.++||||+||++|+|++|+.||... ....+...+. ......| ..++.++.+|+.+|
T Consensus 162 y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~-~~~~~~p-~~~~~~~~~ll~~~ 239 (329)
T cd05618 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-EKQIRIP-RSLSVKAASVLKSF 239 (329)
T ss_pred ccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh-cCCCCCC-CCCCHHHHHHHHHH
Confidence 99999999999999999999999999999999999521 1122223233 3333444 36899999999999
Q ss_pred cccCCCCCCC------HHHHhcCCCCCCCCC
Q psy5368 275 LQKDPMRRIS------YEDLFSHPYPDLIHA 299 (406)
Q Consensus 275 L~~dP~~Rps------~~ell~hp~~~~~~~ 299 (406)
|+.||++||+ +.++++||||+...+
T Consensus 240 L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 240 LNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred hcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 9999999998 589999999986543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=342.30 Aligned_cols=242 Identities=26% Similarity=0.438 Sum_probs=198.8
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++.. .+..+++|.+..... .....+.+|+.++..++|||+++ ...++|+||||++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~g 85 (377)
T cd05629 6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPG 85 (377)
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCC
Confidence 35678888888888875 345678887654321 22456788999999999999876 67789999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC----------
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND---------- 193 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~---------- 193 (406)
|+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++ ++.+||+|||+++......
T Consensus 86 g~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 165 (377)
T cd05629 86 GDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQ 165 (377)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccccccccc
Confidence 99999998888999999999999999999999999999999999999998 7799999999986321100
Q ss_pred --------------------------------------CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCC
Q psy5368 194 --------------------------------------QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGH 235 (406)
Q Consensus 194 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~ 235 (406)
......||+.|+|||++.+..++.++||||+||++|||++|.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~ 245 (377)
T cd05629 166 GKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGW 245 (377)
T ss_pred ccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCC
Confidence 001246999999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhcC-CCCCCCC-CCChHHHHHHHHhcccCCCCC---CCHHHHhcCCCCCCCC
Q psy5368 236 APYASCNLSQLRAQALSSA-PITIPPN-SLSPDCMDFLSRLLQKDPMRR---ISYEDLFSHPYPDLIH 298 (406)
Q Consensus 236 ~pf~~~~~~~~~~~~~~~~-~~~~~~~-~~s~~l~~li~~~L~~dP~~R---ps~~ell~hp~~~~~~ 298 (406)
.||.+.+..+....+.... ....+.. .++.++.+||.+||. +|.+| +++.+++.||||+...
T Consensus 246 ~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~ 312 (377)
T cd05629 246 PPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVD 312 (377)
T ss_pred CCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 9999888777766665432 2333332 588999999999998 67765 5999999999998654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=326.58 Aligned_cols=240 Identities=32% Similarity=0.518 Sum_probs=216.7
Q ss_pred ceeeecceeeeEEEeeee--eeceeEEeeeecCCccchh---hhhhHHhhcccCCCCCCcc------cCCeEEEEEeccC
Q psy5368 55 STIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITSHS---EFERPRAGLSNLRAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~~~---~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ 123 (406)
....||+|.||.|-++.. .+..|++|.++++.+.+.. .+.+|+++++.|+|||++. ..+.+.|||||..
T Consensus 57 ~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS 136 (668)
T KOG0611|consen 57 ITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYAS 136 (668)
T ss_pred HHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecC
Confidence 345689999999999986 3567899988887776655 4678999999999999654 7888999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCC
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSP 202 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~ 202 (406)
+|.|++++.+++.+++.+++.+++||+.|+.|||.++++|||||.+|||+| ++++||+|||++.......-..+++|+|
T Consensus 137 ~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTFCGSP 216 (668)
T KOG0611|consen 137 GGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTFCGSP 216 (668)
T ss_pred CccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHHHhcCCc
Confidence 999999999999999999999999999999999999999999999999999 7799999999998887777788999999
Q ss_pred CCCChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCC
Q psy5368 203 LYMAPEILAGSPY-NAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 203 ~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
.|.+||++.+.+| ++.+|-||+|++||.|..|..||++.+...+..+|..+..... .-|.++.-||..||-.||++
T Consensus 217 LYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP---~~PSdA~gLIRwmLmVNP~R 293 (668)
T KOG0611|consen 217 LYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP---ETPSDASGLIRWMLMVNPER 293 (668)
T ss_pred ccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC---CCCchHHHHHHHHHhcCccc
Confidence 9999999999987 5789999999999999999999999999999999988854432 35678999999999999999
Q ss_pred CCCHHHHhcCCCCCCC
Q psy5368 282 RISYEDLFSHPYPDLI 297 (406)
Q Consensus 282 Rps~~ell~hp~~~~~ 297 (406)
|.|++++-+|-|++..
T Consensus 294 RATieDiAsHWWvNwg 309 (668)
T KOG0611|consen 294 RATIEDIASHWWVNWG 309 (668)
T ss_pred chhHHHHhhhheeecc
Confidence 9999999999998754
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=325.94 Aligned_cols=238 Identities=28% Similarity=0.358 Sum_probs=192.9
Q ss_pred eeeecceeeeEEEeeeee---eceeEEeeeecCCcc--chhhhhhHHhhcccC---CCCCCcc-----------cCCeEE
Q psy5368 56 TIRYGELQYDTVQNSQIR---LGTVKYSQVRYDTIT--SHSEFERPRAGLSNL---RAPEGRK-----------RPRYVY 116 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~---~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l---~h~ni~~-----------~~~~~~ 116 (406)
...||+|+||.||++... +..+++|.+...... ....+.+|+.+++.+ +|||+++ ....++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~ 85 (290)
T cd07862 6 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 85 (290)
T ss_pred eeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEE
Confidence 356899999999999762 345788876644322 233566777766655 7999875 245689
Q ss_pred EEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC
Q psy5368 117 IILEYCDGGDLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND 193 (406)
Q Consensus 117 lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~ 193 (406)
+||||+++ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus 86 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 164 (290)
T cd07862 86 LVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 164 (290)
T ss_pred EEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCCc
Confidence 99999974 999999764 3589999999999999999999999999999999999998 7799999999998766555
Q ss_pred CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--------------
Q psy5368 194 QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIP-------------- 259 (406)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-------------- 259 (406)
......||+.|+|||++.+..++.++||||+||++|+|++|.+||.+.+..+....+........+
T Consensus 165 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 244 (290)
T cd07862 165 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF 244 (290)
T ss_pred ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhc
Confidence 555667899999999999888999999999999999999999999988766665555432111000
Q ss_pred -----------CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 260 -----------PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 260 -----------~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
...+++.+.+|+.+||+.||++|||+.++++||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 245 HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 02467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=325.59 Aligned_cols=235 Identities=17% Similarity=0.199 Sum_probs=201.2
Q ss_pred CceeeecceeeeEEEeeeeeeceeEEeeeecCCccc---hhhhhhHHhhcccCCCCCCcc------c----CCeEEEEEe
Q psy5368 54 SSTIRYGELQYDTVQNSQIRLGTVKYSQVRYDTITS---HSEFERPRAGLSNLRAPEGRK------R----PRYVYIILE 120 (406)
Q Consensus 54 ~~~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~---~~~~~~E~~~l~~l~h~ni~~------~----~~~~~lV~E 120 (406)
.....+|+|+++.||+|...++.+++|.+....... ...+.+|+.++.+++|||+++ + ..++++|||
T Consensus 23 ~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 23 YTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred CCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 344678999999999999999999999887654333 356789999999999999776 1 347899999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcc
Q psy5368 121 YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLREN-NVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSI 198 (406)
Q Consensus 121 ~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~-givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~ 198 (406)
|+++|+|.+++.+++.+++.....++.|++.||.|||+. +++||||||+||+++ ++.+||+|||+++..... ....
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~--~~~~ 180 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--PFKN 180 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc--cccc
Confidence 999999999999888899999999999999999999984 999999999999999 779999999999765432 2345
Q ss_pred cCCCCCCChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcc
Q psy5368 199 QGSPLYMAPEILAG--SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQ 276 (406)
Q Consensus 199 ~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~ 276 (406)
.|++.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..++...+.........+..+++++.+|+.+||+
T Consensus 181 ~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~ 260 (283)
T PHA02988 181 VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTS 260 (283)
T ss_pred cCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhc
Confidence 68899999999976 6799999999999999999999999999888877777654433222233689999999999999
Q ss_pred cCCCCCCCHHHHhc
Q psy5368 277 KDPMRRISYEDLFS 290 (406)
Q Consensus 277 ~dP~~Rps~~ell~ 290 (406)
.||++|||++++++
T Consensus 261 ~dp~~Rps~~ell~ 274 (283)
T PHA02988 261 HDSIKRPNIKEILY 274 (283)
T ss_pred CCcccCcCHHHHHH
Confidence 99999999999985
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=325.87 Aligned_cols=239 Identities=23% Similarity=0.419 Sum_probs=195.5
Q ss_pred ecceeeeEEEeeeee--eceeEEeeeecCCcc---chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 59 YGELQYDTVQNSQIR--LGTVKYSQVRYDTIT---SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 59 lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
||+|+||+||++... +..+++|.+...... ....+..|+.+++.++|+|++. .....|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999864 456888877654322 2345678999999999999765 56779999999999999
Q ss_pred HHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCC
Q psy5368 128 CSFIRS----HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGS 201 (406)
Q Consensus 128 ~~~l~~----~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt 201 (406)
.+++.. +..+++..+..++.||+.||.|||++||+||||||+||+++ ++.++|+|||++....... ......||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 988743 34699999999999999999999999999999999999998 6799999999997654332 23345789
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhcCCCCCCCCCCChHHHHHHHHhccc
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLS----QLRAQALSSAPITIPPNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~ 277 (406)
+.|+|||++.+..++.++||||+||++|+|++|+.||...... .....+... ....+ ..+++.+.+++.+||+.
T Consensus 161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~li~~~l~~ 238 (280)
T cd05608 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-SVTYP-DKFSPASKSFCEALLAK 238 (280)
T ss_pred cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc-CCCCc-ccCCHHHHHHHHHHhcC
Confidence 9999999999999999999999999999999999999865432 222222222 22222 36899999999999999
Q ss_pred CCCCCC-----CHHHHhcCCCCCCCCC
Q psy5368 278 DPMRRI-----SYEDLFSHPYPDLIHA 299 (406)
Q Consensus 278 dP~~Rp-----s~~ell~hp~~~~~~~ 299 (406)
||++|| +++++++||||+...+
T Consensus 239 ~P~~R~~~~~~~~~~~l~h~~~~~~~~ 265 (280)
T cd05608 239 DPEKRLGFRDGNCDGLRTHPLFRDLNW 265 (280)
T ss_pred CHHHhcCCCCCCHHHHhcChhhhcCCH
Confidence 999999 7899999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=341.71 Aligned_cols=242 Identities=24% Similarity=0.400 Sum_probs=197.6
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
..||+|+||.||++... ++.+++|.+..... .....+.+|+.++..++|||++. ..+.+|+|||||+||
T Consensus 7 ~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g 86 (376)
T cd05598 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGG 86 (376)
T ss_pred EEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCC
Confidence 45677888888877753 35677776654321 23456789999999999999876 678899999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC------------
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN------------ 192 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~------------ 192 (406)
+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 87 ~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~ 166 (376)
T cd05598 87 DMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHH 166 (376)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccccccccc
Confidence 9999998888899999999999999999999999999999999999999 779999999997532100
Q ss_pred --------------------------------CCCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy5368 193 --------------------------------DQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYAS 240 (406)
Q Consensus 193 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 240 (406)
.......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 246 (376)
T cd05598 167 RQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLA 246 (376)
T ss_pred ccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCC
Confidence 001234699999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHhcCC-CCCCC-CCCChHHHHHHHHhcccCCCCCC---CHHHHhcCCCCCCCCC
Q psy5368 241 CNLSQLRAQALSSAP-ITIPP-NSLSPDCMDFLSRLLQKDPMRRI---SYEDLFSHPYPDLIHA 299 (406)
Q Consensus 241 ~~~~~~~~~~~~~~~-~~~~~-~~~s~~l~~li~~~L~~dP~~Rp---s~~ell~hp~~~~~~~ 299 (406)
.+..+....+..... ...+. ..+++++.++|.+|+ .+|.+|+ ++.++++||||+....
T Consensus 247 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~~ 309 (376)
T cd05598 247 DTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGIDF 309 (376)
T ss_pred CCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCCH
Confidence 887766655554322 22222 268999999999977 5999999 9999999999987543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=332.68 Aligned_cols=241 Identities=28% Similarity=0.492 Sum_probs=198.5
Q ss_pred eecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccCCC
Q psy5368 58 RYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
.||+|+||.||++... +..+++|.+..... .....+.+|+.++.++ +||+++. ..+.+|+||||++||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 6899999999999864 35678887765432 2234578899998888 6898755 667899999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccC-CCCCCCcccCCCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLA-PNDQGDSIQGSPL 203 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~-~~~~~~~~~gt~~ 203 (406)
+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++... .........||+.
T Consensus 82 ~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 161 (327)
T cd05617 82 DLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPN 161 (327)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCcc
Confidence 9999998888999999999999999999999999999999999999998 6799999999987532 2233445679999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhccc
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASC------NLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~------~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~ 277 (406)
|+|||++.+..++.++||||+||++|+|++|..||... ...+.............| ..++..+.+++.+||+.
T Consensus 162 y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p-~~~~~~~~~li~~~L~~ 240 (327)
T cd05617 162 YIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP-RFLSVKASHVLKGFLNK 240 (327)
T ss_pred cCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHHhcc
Confidence 99999999999999999999999999999999999532 222223333333344444 36899999999999999
Q ss_pred CCCCCCC------HHHHhcCCCCCCCCC
Q psy5368 278 DPMRRIS------YEDLFSHPYPDLIHA 299 (406)
Q Consensus 278 dP~~Rps------~~ell~hp~~~~~~~ 299 (406)
||++|++ ++++++||||+...+
T Consensus 241 dP~~R~~~~~~~~~~~i~~h~~f~~~~~ 268 (327)
T cd05617 241 DPKERLGCQPQTGFSDIKSHTFFRSIDW 268 (327)
T ss_pred CHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence 9999997 579999999987654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=330.83 Aligned_cols=241 Identities=26% Similarity=0.445 Sum_probs=201.1
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhh---cccCCCCCCcc------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAG---LSNLRAPEGRK------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~---l~~l~h~ni~~------~~~~~~lV~E~ 121 (406)
...||+|+||.||++... +..+++|.+..... .....+.+|+.+ ++.++|||+++ ..+.+|+||||
T Consensus 4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~ 83 (324)
T cd05589 4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEY 83 (324)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcC
Confidence 357899999999999864 45688887764421 223456666554 56788999765 66789999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCC-CCCCCccc
Q psy5368 122 CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAP-NDQGDSIQ 199 (406)
Q Consensus 122 ~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~-~~~~~~~~ 199 (406)
++|++|..++.. +.+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||+++.... ........
T Consensus 84 ~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 162 (324)
T cd05589 84 AAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC 162 (324)
T ss_pred CCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcccccc
Confidence 999999998865 5799999999999999999999999999999999999998 77999999999875332 22334567
Q ss_pred CCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCC
Q psy5368 200 GSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 200 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP 279 (406)
|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..... .. +..+++++.+++.+||+.||
T Consensus 163 g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~-~~-p~~~~~~~~~li~~~L~~dP 240 (324)
T cd05589 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV-RY-PRFLSREAISIMRRLLRRNP 240 (324)
T ss_pred cCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CC-CCCCCHHHHHHHHHHhhcCH
Confidence 99999999999999999999999999999999999999999888887777766533 23 34689999999999999999
Q ss_pred CCCC-----CHHHHhcCCCCCCCCC
Q psy5368 280 MRRI-----SYEDLFSHPYPDLIHA 299 (406)
Q Consensus 280 ~~Rp-----s~~ell~hp~~~~~~~ 299 (406)
.+|| ++.++++||||+...+
T Consensus 241 ~~R~~~~~~~~~~l~~~~~f~~~~~ 265 (324)
T cd05589 241 ERRLGSGEKDAEDVKKQPFFRDINW 265 (324)
T ss_pred hHcCCCCCCCHHHHhhCCCcCCCCH
Confidence 9999 6999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=326.51 Aligned_cols=242 Identities=26% Similarity=0.358 Sum_probs=189.3
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...||+|+||.||++... ++.+++|.+..... .....+.+|+.+++.++|||++. .....|+||||++ ++
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~ 88 (303)
T cd07869 10 LEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TD 88 (303)
T ss_pred eeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cC
Confidence 456788888888888863 45678887654432 23446788999999999999765 6678999999996 58
Q ss_pred HHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCcccCCCC
Q psy5368 127 LCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDSIQGSPL 203 (406)
Q Consensus 127 L~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~~~gt~~ 203 (406)
|.+++..+ +.+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||++...... .......+|+.
T Consensus 89 l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 168 (303)
T cd07869 89 LCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLW 168 (303)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCCcccCC
Confidence 88888654 5799999999999999999999999999999999999998 679999999998754322 22344568999
Q ss_pred CCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcC-CC------------C-----------
Q psy5368 204 YMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNL-SQLRAQALSSA-PI------------T----------- 257 (406)
Q Consensus 204 y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~-~~~~~~~~~~~-~~------------~----------- 257 (406)
|+|||++.+. .++.++||||+||++|+|++|..||.+... ......+.... .. .
T Consensus 169 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (303)
T cd07869 169 YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSP 248 (303)
T ss_pred CCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCC
Confidence 9999998764 588999999999999999999999987532 22222211100 00 0
Q ss_pred ------CCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 258 ------IPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 258 ------~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
......++++.+|+.+||+.||++|||++|+++||||+...
T Consensus 249 ~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 249 KNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred ccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 00012457899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=338.92 Aligned_cols=243 Identities=27% Similarity=0.444 Sum_probs=202.6
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++... +..+++|.+.... ......+.+|+.++..++||++++ ..+++|+|||||+|
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (360)
T cd05627 6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPG 85 (360)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 356899999999988864 4567888775432 223456788999999999999765 67789999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC----------
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND---------- 193 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~---------- 193 (406)
|+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++ ++.++|+|||++.......
T Consensus 86 g~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~ 165 (360)
T cd05627 86 GDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTH 165 (360)
T ss_pred ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccccccccc
Confidence 99999998888999999999999999999999999999999999999998 7799999999986542210
Q ss_pred --------------------------CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy5368 194 --------------------------QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLR 247 (406)
Q Consensus 194 --------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~ 247 (406)
......||+.|+|||++.+..++.++||||+||++|||++|..||.+.+.....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~ 245 (360)
T cd05627 166 NPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETY 245 (360)
T ss_pred CCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHH
Confidence 012346999999999999999999999999999999999999999998888877
Q ss_pred HHHHhcC-CCCCCCC-CCChHHHHHHHHhcccCCCCCC---CHHHHhcCCCCCCCCC
Q psy5368 248 AQALSSA-PITIPPN-SLSPDCMDFLSRLLQKDPMRRI---SYEDLFSHPYPDLIHA 299 (406)
Q Consensus 248 ~~~~~~~-~~~~~~~-~~s~~l~~li~~~L~~dP~~Rp---s~~ell~hp~~~~~~~ 299 (406)
..+.... ....++. .+++++++||.+|+. ||.+|+ +++++++||||+...+
T Consensus 246 ~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~ 301 (360)
T cd05627 246 RKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDW 301 (360)
T ss_pred HHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCH
Confidence 7766532 2233332 589999999999874 999998 4899999999997654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=331.80 Aligned_cols=241 Identities=25% Similarity=0.437 Sum_probs=194.9
Q ss_pred eeeecceeeeEEEeeee-----eeceeEEeeeecCC----ccchhhhhhHHhhcccCC-CCCCcc------cCCeEEEEE
Q psy5368 56 TIRYGELQYDTVQNSQI-----RLGTVKYSQVRYDT----ITSHSEFERPRAGLSNLR-APEGRK------RPRYVYIIL 119 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~-----~~~~v~vk~~~~~~----~~~~~~~~~E~~~l~~l~-h~ni~~------~~~~~~lV~ 119 (406)
...||+|+||.||.+.. .+..+++|.+.... ......+.+|+.++..++ ||+++. ..+.+|+||
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (332)
T cd05614 5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLIL 84 (332)
T ss_pred EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEE
Confidence 35678888888887764 23457787765432 123446788999999994 788764 667889999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC--CCC
Q psy5368 120 EYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND--QGD 196 (406)
Q Consensus 120 E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~--~~~ 196 (406)
||+++|+|.+++..+..+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++...... ...
T Consensus 85 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~ 164 (332)
T cd05614 85 DYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY 164 (332)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCccc
Confidence 9999999999998888999999999999999999999999999999999999998 7799999999997653332 233
Q ss_pred cccCCCCCCChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhcCCCCCCCCCCChHHHHHH
Q psy5368 197 SIQGSPLYMAPEILAGSP-YNAKADLWSLGVLVFEALFGHAPYASC----NLSQLRAQALSSAPITIPPNSLSPDCMDFL 271 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~s~~l~~li 271 (406)
...||+.|+|||++.+.. ++.++|||||||++|+|+||..||... ....+...+... ....+ ..+++.+.+|+
T Consensus 165 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~li 242 (332)
T cd05614 165 SFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC-DPPFP-SFIGPEAQDLL 242 (332)
T ss_pred cccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC-CCCCC-CCCCHHHHHHH
Confidence 467999999999998754 788999999999999999999999643 233333333332 22332 36899999999
Q ss_pred HHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q psy5368 272 SRLLQKDPMRRI-----SYEDLFSHPYPDLIH 298 (406)
Q Consensus 272 ~~~L~~dP~~Rp-----s~~ell~hp~~~~~~ 298 (406)
.+||+.||++|| +++++++||||+...
T Consensus 243 ~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 243 HKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred HHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 999999999999 889999999998654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=332.34 Aligned_cols=242 Identities=24% Similarity=0.409 Sum_probs=202.5
Q ss_pred eeeecceeeeEEEeeeeee--ceeEEeeeecCCc---cchhhhhhHHhhcccCC-CCCCcc------cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIRL--GTVKYSQVRYDTI---TSHSEFERPRAGLSNLR-APEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~-h~ni~~------~~~~~~lV~E~~~ 123 (406)
...||+|+||.||++.... ..+++|.+..... .....+..|..++..+. |++++. ..+.+|+||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 84 (323)
T cd05616 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVN 84 (323)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCC
Confidence 4578999999999998653 4678887765432 22335667888887774 565432 6678999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCC-CCCCCcccCC
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAP-NDQGDSIQGS 201 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~-~~~~~~~~gt 201 (406)
+|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++.... ........||
T Consensus 85 ~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 164 (323)
T cd05616 85 GGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGT 164 (323)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccccCCCC
Confidence 999999998888999999999999999999999999999999999999998 67999999999875432 2233456799
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+...+...+.... ...+ ..++.++.+|+.+||+.||.+
T Consensus 165 ~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~p-~~~s~~~~~li~~~l~~~p~~ 242 (323)
T cd05616 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYP-KSMSKEAVAICKGLMTKHPGK 242 (323)
T ss_pred hhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCC-CcCCHHHHHHHHHHcccCHHh
Confidence 99999999999999999999999999999999999999988888877776653 3333 468999999999999999999
Q ss_pred CCCH-----HHHhcCCCCCCCCC
Q psy5368 282 RISY-----EDLFSHPYPDLIHA 299 (406)
Q Consensus 282 Rps~-----~ell~hp~~~~~~~ 299 (406)
|++. .++++||||+...+
T Consensus 243 R~~~~~~~~~~i~~h~~~~~~~~ 265 (323)
T cd05616 243 RLGCGPEGERDIKEHAFFRYIDW 265 (323)
T ss_pred cCCCCCCCHHHHhcCCCcCCCCH
Confidence 9984 89999999987654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=333.14 Aligned_cols=239 Identities=23% Similarity=0.470 Sum_probs=201.2
Q ss_pred eecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHh-hcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 58 RYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRA-GLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~-~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
.||+|+||.||++... +..+++|.+..... .....+.+|.. +++.++|||+++ ..+..|+||||++||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 6899999999999863 45678887764322 22334555654 567899999865 667899999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCC-CCCCCcccCCCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAP-NDQGDSIQGSPL 203 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~-~~~~~~~~gt~~ 203 (406)
+|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++.... ........||+.
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~ 161 (325)
T cd05604 82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPE 161 (325)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCChh
Confidence 9999998888999999999999999999999999999999999999998 77999999999875322 233445679999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
|+|||++.+..++.++||||+||++|+|++|..||...+..++...+.... ...++ ..+..+.+++.+||+.+|.+||
T Consensus 162 y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~ll~~ll~~~p~~R~ 239 (325)
T cd05604 162 YLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP-LVLRP-GASLTAWSILEELLEKDRQRRL 239 (325)
T ss_pred hCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC-ccCCC-CCCHHHHHHHHHHhccCHHhcC
Confidence 999999999999999999999999999999999999988888777776653 23333 5899999999999999999999
Q ss_pred CH----HHHhcCCCCCCCC
Q psy5368 284 SY----EDLFSHPYPDLIH 298 (406)
Q Consensus 284 s~----~ell~hp~~~~~~ 298 (406)
++ .++++||||+...
T Consensus 240 ~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 240 GAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred CCCCCHHHHhcCCCcCCCC
Confidence 76 5999999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=334.81 Aligned_cols=243 Identities=29% Similarity=0.490 Sum_probs=202.9
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++... +..+++|.+..... .....+.+|+.++..++|||++. ..+.+|+||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (330)
T cd05601 6 KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPG 85 (330)
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCC
Confidence 457899999999998863 45678887765432 23456888999999999999765 56789999999999
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC--CCcccC
Q psy5368 125 GDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ--GDSIQG 200 (406)
Q Consensus 125 gsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~--~~~~~g 200 (406)
|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........ .....|
T Consensus 86 ~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~g 165 (330)
T cd05601 86 GDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVG 165 (330)
T ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeecccC
Confidence 9999999876 6899999999999999999999999999999999999999 67999999999987654332 233468
Q ss_pred CCCCCChhhhc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCC-CCCChHHHHHHH
Q psy5368 201 SPLYMAPEILA------GSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP-ITIPP-NSLSPDCMDFLS 272 (406)
Q Consensus 201 t~~y~aPE~~~------~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~-~~~s~~l~~li~ 272 (406)
|+.|+|||++. ...++.++|||||||++|+|++|..||...+.......+..... ...+. ..+++++.+|+.
T Consensus 166 t~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 245 (330)
T cd05601 166 TPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQ 245 (330)
T ss_pred CccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHH
Confidence 99999999987 45678999999999999999999999998887777666655432 22232 258999999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy5368 273 RLLQKDPMRRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 273 ~~L~~dP~~Rps~~ell~hp~~~~~~~ 299 (406)
+||. +|.+|||++++++||||....+
T Consensus 246 ~ll~-~p~~R~t~~~l~~h~~~~~~~~ 271 (330)
T cd05601 246 SLLC-GQKERLGYEGLCCHPFFSKIDW 271 (330)
T ss_pred HHcc-ChhhCCCHHHHhCCCCcCCCCH
Confidence 9998 9999999999999999986543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=346.91 Aligned_cols=241 Identities=27% Similarity=0.375 Sum_probs=205.1
Q ss_pred ceeeecceeeeEEEeeeee---eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 55 STIRYGELQYDTVQNSQIR---LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~---~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
....+|.|++|.||.+... ...+++|............+.+|+.++..++|||+++ ..+++||||||++||
T Consensus 71 ~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg 150 (478)
T PTZ00267 71 LTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGG 150 (478)
T ss_pred EEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCC
Confidence 3567899999999999753 3356666554444444456788999999999999876 678899999999999
Q ss_pred CHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC---CCCc
Q psy5368 126 DLCSFIRS----HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND---QGDS 197 (406)
Q Consensus 126 sL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~---~~~~ 197 (406)
+|.+++.. ..++++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++...... ....
T Consensus 151 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~ 230 (478)
T PTZ00267 151 DLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230 (478)
T ss_pred CHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccc
Confidence 99998754 34699999999999999999999999999999999999999 7799999999998764432 2345
Q ss_pred ccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhccc
Q psy5368 198 IQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 198 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~ 277 (406)
..||+.|+|||++.+..++.++||||+||++|+|++|+.||...+..++...+........+ ..+++++.+||.+||..
T Consensus 231 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~L~~ 309 (478)
T PTZ00267 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFP-CPVSSGMKALLDPLLSK 309 (478)
T ss_pred cCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC-ccCCHHHHHHHHHHhcc
Confidence 67999999999999999999999999999999999999999998888887777766444333 36899999999999999
Q ss_pred CCCCCCCHHHHhcCCCCCC
Q psy5368 278 DPMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 278 dP~~Rps~~ell~hp~~~~ 296 (406)
||++||++++++.|||++.
T Consensus 310 dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 310 NPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred ChhhCcCHHHHHhCHHHHH
Confidence 9999999999999999863
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=335.69 Aligned_cols=243 Identities=25% Similarity=0.436 Sum_probs=203.1
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++... +..+++|.+.... ......+.+|+.+++.++|||++. ..+++|+|||||+|
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~g 127 (370)
T cd05596 48 IKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPG 127 (370)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCC
Confidence 457899999999998864 4567888775432 123345778999999999999776 66789999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC--CCCcccCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND--QGDSIQGS 201 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~--~~~~~~gt 201 (406)
|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||++....... ......||
T Consensus 128 g~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt 206 (370)
T cd05596 128 GDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGT 206 (370)
T ss_pred CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCC
Confidence 999999866 4689999999999999999999999999999999999998 7799999999997764332 22456799
Q ss_pred CCCCChhhhcCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCCC-CCChHHHHHHHHhc
Q psy5368 202 PLYMAPEILAGS----PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSA-PITIPPN-SLSPDCMDFLSRLL 275 (406)
Q Consensus 202 ~~y~aPE~~~~~----~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~-~~s~~l~~li~~~L 275 (406)
+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+.... ....+.. .+|.++.+||.+||
T Consensus 207 ~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 286 (370)
T cd05596 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFL 286 (370)
T ss_pred cCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHc
Confidence 999999998754 37889999999999999999999999988887777776543 2333332 68999999999999
Q ss_pred ccCCCC--CCCHHHHhcCCCCCCCCC
Q psy5368 276 QKDPMR--RISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 276 ~~dP~~--Rps~~ell~hp~~~~~~~ 299 (406)
+.+|.+ |+|++++++||||+...+
T Consensus 287 ~~~p~r~~R~s~~ell~h~~~~~~~~ 312 (370)
T cd05596 287 TDREVRLGRNGVDEIKSHPFFKNDQW 312 (370)
T ss_pred cChhhccCCCCHHHHhcCcccCCCCh
Confidence 999988 999999999999987543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=329.22 Aligned_cols=242 Identities=23% Similarity=0.398 Sum_probs=195.8
Q ss_pred eeeecceeeeEEEeeeeee--ceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIRL--GTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...||+|+||.||++.... ..+++|.+..... .....+.+|++++.+++|||++. ..+.+|+||||+++++
T Consensus 10 ~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 89 (333)
T cd06650 10 ISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 89 (333)
T ss_pred eccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCc
Confidence 4467888888998888653 3455665544321 23456899999999999999766 6778999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCC
Q psy5368 127 LCSFIRSHEKLSEFQCQQFVRQLVLALKFLREN-NVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLY 204 (406)
Q Consensus 127 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~-givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y 204 (406)
|.+++...+.+++..+..++.|++.||.|||+. +++|+||||+|||++ ++.+||+|||++...... ......|++.|
T Consensus 90 L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~y 168 (333)
T cd06650 90 LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSY 168 (333)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-ccccCCCCccc
Confidence 999998888899999999999999999999985 799999999999998 678999999998765322 23445689999
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----------------------------------
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQ----------------------------------- 249 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~----------------------------------- 249 (406)
+|||++.+..++.++|+|||||++|+|++|+.||.......+...
T Consensus 169 ~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (333)
T cd06650 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPP 248 (333)
T ss_pred cCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhccccccc
Confidence 999999998899999999999999999999999986554333211
Q ss_pred ---------HHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 250 ---------ALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 250 ---------~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
+........+...++.++.+|+.+||+.||++|||++|++.||||+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 249 MAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred ccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 1112122222234678999999999999999999999999999998654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=322.16 Aligned_cols=240 Identities=20% Similarity=0.339 Sum_probs=196.3
Q ss_pred ecceeeeEEEeeeee--eceeEEeeeecCCcc---chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 59 YGELQYDTVQNSQIR--LGTVKYSQVRYDTIT---SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 59 lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
||+|+||.||++... +..+++|.+...... ....+..|++++++++|||++. ...++|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999864 456788877543222 2334567999999999999765 56788999999999999
Q ss_pred HHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCC
Q psy5368 128 CSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLY 204 (406)
Q Consensus 128 ~~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y 204 (406)
.+++.... .+++..+..++.|++.||+|||+.|++||||||+||+++ ++.++|+|||++.............|++.|
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY 160 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence 99886543 589999999999999999999999999999999999998 678999999999876554444456789999
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNL----SQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPM 280 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~ 280 (406)
+|||++.+..++.++|+||+||++|+|++|..||..... ..+....... ....+...+++++.+|+.+||+.||+
T Consensus 161 ~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~~P~ 239 (277)
T cd05607 161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED-EVKFEHQNFTEESKDICRLFLAKKPE 239 (277)
T ss_pred cCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc-ccccccccCCHHHHHHHHHHhccCHh
Confidence 999999998899999999999999999999999976532 2222222222 22233346899999999999999999
Q ss_pred CCCCH----HHHhcCCCCCCCCC
Q psy5368 281 RRISY----EDLFSHPYPDLIHA 299 (406)
Q Consensus 281 ~Rps~----~ell~hp~~~~~~~ 299 (406)
+||++ ++++.||||+...+
T Consensus 240 ~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 240 DRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred hCCCCccchhhhhcChhhcCCCH
Confidence 99999 67889999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=327.61 Aligned_cols=242 Identities=24% Similarity=0.421 Sum_probs=203.7
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhhcccCCCCC-Cc------ccCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPE-GR------KRPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~n-i~------~~~~~~~lV~E~~~ 123 (406)
...||+|+||.||++... +..+++|.+..... .....+..|..++..+.|++ +. ...+.+|+||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~ 84 (323)
T cd05615 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVN 84 (323)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCC
Confidence 467999999999999864 45688887765422 23345778888988887654 33 25678999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCcccCC
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDSIQGS 201 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~~~gt 201 (406)
||+|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++..... .......||
T Consensus 85 ~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt 164 (323)
T cd05615 85 GGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGT 164 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccCccCC
Confidence 999999998888999999999999999999999999999999999999999 679999999998754322 223455689
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
+.|+|||++.+..++.++||||+||++|+|++|..||.+.+...+...+.... ...+ ..++.++.+++.+||+.+|.+
T Consensus 165 ~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~p-~~~~~~~~~li~~~l~~~p~~ 242 (323)
T cd05615 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYP-KSLSKEAVSICKGLMTKHPSK 242 (323)
T ss_pred ccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCC-ccCCHHHHHHHHHHcccCHhh
Confidence 99999999999999999999999999999999999999988887777776653 3333 368999999999999999999
Q ss_pred CCC-----HHHHhcCCCCCCCCC
Q psy5368 282 RIS-----YEDLFSHPYPDLIHA 299 (406)
Q Consensus 282 Rps-----~~ell~hp~~~~~~~ 299 (406)
|++ .+++++||||....+
T Consensus 243 R~~~~~~~~~~i~~h~~f~~~~~ 265 (323)
T cd05615 243 RLGCGPEGERDIREHAFFRRIDW 265 (323)
T ss_pred CCCCCCCCHHHHhcCcccCCCCH
Confidence 997 579999999987654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=329.83 Aligned_cols=239 Identities=26% Similarity=0.473 Sum_probs=200.2
Q ss_pred eecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHh-hcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 58 RYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRA-GLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~-~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
.||+|+||.||++... +..+++|.+..... .....+.+|.. +++.++|||+++ ..+..|+|||||+|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6899999999999874 45678887654322 22334555554 678899999876 567889999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCC-CCCCCcccCCCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAP-NDQGDSIQGSPL 203 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~-~~~~~~~~gt~~ 203 (406)
+|..++.....+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||+++.... ........||+.
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 161 (321)
T cd05603 82 ELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPE 161 (321)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCcc
Confidence 9999998888899999999999999999999999999999999999998 77999999999875322 233345678999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+... ....++ ..+.++.+++.+||+.||.+||
T Consensus 162 y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~~~~~-~~~~~~~~li~~~l~~~p~~R~ 239 (321)
T cd05603 162 YLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK-PLQLPG-GKTVAACDLLVGLLHKDQRRRL 239 (321)
T ss_pred cCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC-CCCCCC-CCCHHHHHHHHHHccCCHhhcC
Confidence 99999999989999999999999999999999999998887777766654 334443 6789999999999999999999
Q ss_pred CH----HHHhcCCCCCCCC
Q psy5368 284 SY----EDLFSHPYPDLIH 298 (406)
Q Consensus 284 s~----~ell~hp~~~~~~ 298 (406)
++ .++++||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~ 258 (321)
T cd05603 240 GAKADFLEIKNHVFFSPIN 258 (321)
T ss_pred CCCCCHHHHhCCCCcCCCC
Confidence 75 5999999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=334.50 Aligned_cols=239 Identities=27% Similarity=0.458 Sum_probs=199.3
Q ss_pred ecceeeeEEEeeeee--eceeEEeeeecCCccc---hhhhhhHHhhcccC---CCCCCcc------cCCeEEEEEeccCC
Q psy5368 59 YGELQYDTVQNSQIR--LGTVKYSQVRYDTITS---HSEFERPRAGLSNL---RAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 59 lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~---~~~~~~E~~~l~~l---~h~ni~~------~~~~~~lV~E~~~g 124 (406)
||+|+||+||++... +..+++|.+....... ...+..|..++..+ +|||++. ....+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999864 4678888775432222 22345566666555 6998765 67789999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCC-CCCCCcccCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAP-NDQGDSIQGSP 202 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~-~~~~~~~~gt~ 202 (406)
|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++ ++.++|+|||+++.... ........||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~ 160 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT 160 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence 99999998888999999999999999999999999999999999999998 67999999999875432 23344567999
Q ss_pred CCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCC
Q psy5368 203 LYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 203 ~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
.|+|||++.+. .++.++||||+||++|+|++|..||...+..+....+... ....+...+++++.+|+.+||+.||.+
T Consensus 161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~li~~~L~~~P~~ 239 (330)
T cd05586 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG-KVRFPKNVLSDEGRQFVKGLLNRNPQH 239 (330)
T ss_pred cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-CCCCCCccCCHHHHHHHHHHcCCCHHH
Confidence 99999999765 4899999999999999999999999998888777766655 334454568999999999999999999
Q ss_pred CC----CHHHHhcCCCCCCCC
Q psy5368 282 RI----SYEDLFSHPYPDLIH 298 (406)
Q Consensus 282 Rp----s~~ell~hp~~~~~~ 298 (406)
|| ++.++++||||....
T Consensus 240 R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 240 RLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred CCCCCCCHHHHhcCccccCCC
Confidence 98 789999999998654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=333.38 Aligned_cols=238 Identities=29% Similarity=0.493 Sum_probs=209.3
Q ss_pred eeecceeeeEEEeeee--eeceeEEeeeecCCccc--hhhhhhHHhhcccCCCCCCcc------cCCe-EEEEEeccCCC
Q psy5368 57 IRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITS--HSEFERPRAGLSNLRAPEGRK------RPRY-VYIILEYCDGG 125 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~--~~~~~~E~~~l~~l~h~ni~~------~~~~-~~lV~E~~~gg 125 (406)
..+|.|+||.++.... ..+.+++|++....... .....+|+.++++++|||++. .++. .+|||+||+||
T Consensus 10 ~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg 89 (426)
T KOG0589|consen 10 RQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGG 89 (426)
T ss_pred hhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCC
Confidence 4568888887766554 44577888777655333 346789999999999999775 4444 99999999999
Q ss_pred CHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCC
Q psy5368 126 DLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGS 201 (406)
Q Consensus 126 sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt 201 (406)
+|.+.|.+.+ .|+++.+..++.|++.|+.|||+++|+|||||+.||+++ ++.+||+|||+|+.+.+.. ...+..||
T Consensus 90 ~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGT 169 (426)
T KOG0589|consen 90 DLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGT 169 (426)
T ss_pred CHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhhhheecCC
Confidence 9999996654 699999999999999999999999999999999999999 7788999999999998876 67889999
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
|.||+||++.+.+|+.++|||||||++|||++-+++|...+...+..++......+.| ...+.+++.+|..||..+|..
T Consensus 170 p~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp-~~ys~el~~lv~~~l~~~P~~ 248 (426)
T KOG0589|consen 170 PYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP-SMYSSELRSLVKSMLRKNPEH 248 (426)
T ss_pred CcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC-ccccHHHHHHHHHHhhcCCcc
Confidence 9999999999999999999999999999999999999999999999999988644444 479999999999999999999
Q ss_pred CCCHHHHhcCCCCC
Q psy5368 282 RISYEDLFSHPYPD 295 (406)
Q Consensus 282 Rps~~ell~hp~~~ 295 (406)
||++.++|.+|...
T Consensus 249 RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 249 RPSALELLRRPHLL 262 (426)
T ss_pred CCCHHHHhhChhhh
Confidence 99999999998765
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=330.02 Aligned_cols=240 Identities=25% Similarity=0.475 Sum_probs=200.0
Q ss_pred eecceeeeEEEeeeeee--ceeEEeeeecCCc---cchhhhhhHH-hhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 58 RYGELQYDTVQNSQIRL--GTVKYSQVRYDTI---TSHSEFERPR-AGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~---~~~~~~~~E~-~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
.||+|+||.||++.... ..+++|.+..... .....+.+|. .+++.++|||++. ..+.+|+||||++|+
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 68999999999998743 4578887654321 2223444444 3568899999875 667889999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCC-CCCCCcccCCCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAP-NDQGDSIQGSPL 203 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~-~~~~~~~~gt~~ 203 (406)
+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.... ........||+.
T Consensus 82 ~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~ 161 (325)
T cd05602 82 ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPE 161 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCcc
Confidence 9999998888899999999999999999999999999999999999998 77999999999875432 233445679999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
|+|||++.+..++.++||||+||++|+|++|.+||.+.+..+....+... ....++ .+++++.+++.+||+.||.+||
T Consensus 162 y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~~~~~-~~~~~~~~li~~~l~~~p~~R~ 239 (325)
T cd05602 162 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-PLQLKP-NITNSARHLLEGLLQKDRTKRL 239 (325)
T ss_pred ccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC-CcCCCC-CCCHHHHHHHHHHcccCHHHCC
Confidence 99999999999999999999999999999999999998887777766554 233333 6899999999999999999999
Q ss_pred CHH----HHhcCCCCCCCCC
Q psy5368 284 SYE----DLFSHPYPDLIHA 299 (406)
Q Consensus 284 s~~----ell~hp~~~~~~~ 299 (406)
++. ++++|+||....+
T Consensus 240 ~~~~~~~~i~~~~~~~~~~~ 259 (325)
T cd05602 240 GAKDDFMEIKNHIFFSPINW 259 (325)
T ss_pred CCCCCHHHHhcCcccCCCCH
Confidence 875 8999999976543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=326.58 Aligned_cols=140 Identities=24% Similarity=0.316 Sum_probs=119.4
Q ss_pred cccccccceEEEeeeee-e-EEEeeeeecCCcceeeeeeccccccccceeeecCceeeecceeeeEEEeeeeeeceeEEe
Q psy5368 3 RYGTVRYGTVRLGSVKY-G-QVQLSTVRYGKVRYSQVRSDTVRSGTVRYDIVGSSTIRYGELQYDTVQNSQIRLGTVKYS 80 (406)
Q Consensus 3 ~~~~g~~~~V~ig~~~~-g-y~vv~~lg~G~~~~~~~~~d~~~~~~~~~~i~~~~~~~lG~G~~g~Vy~~~~~~~~v~vk 80 (406)
+|..||||||+||+.|+ | |+|++|||||.||+||++.|......++.+|+.+..
T Consensus 60 dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq------------------------ 115 (590)
T KOG1290|consen 60 DYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ------------------------ 115 (590)
T ss_pred hhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh------------------------
Confidence 69999999999999999 5 999999999999999999999999999998877761
Q ss_pred eeecCCccchhhhhhHHhhcccCC-----CCC---Ccc----------cCCeEEEEEeccCCCCHHHHHHhC--CCCCHH
Q psy5368 81 QVRYDTITSHSEFERPRAGLSNLR-----APE---GRK----------RPRYVYIILEYCDGGDLCSFIRSH--EKLSEF 140 (406)
Q Consensus 81 ~~~~~~~~~~~~~~~E~~~l~~l~-----h~n---i~~----------~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~ 140 (406)
.-.+....|+.+|++++ |++ +++ ...++|+|+|+. |.+|..+|... +.++..
T Consensus 116 -------hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~ 187 (590)
T KOG1290|consen 116 -------HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLS 187 (590)
T ss_pred -------HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHH
Confidence 11234577888888873 232 222 667899999999 77999999765 579999
Q ss_pred HHHHHHHHHHHHHHHHHH-CCcccccCCCcceEee
Q psy5368 141 QCQQFVRQLVLALKFLRE-NNVCHFDLKPQNILIK 174 (406)
Q Consensus 141 ~~~~i~~ql~~aL~~lH~-~givH~Dlkp~NIll~ 174 (406)
.++.|++||+.||.|||. .||+|-||||+|||+.
T Consensus 188 ~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 188 CVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred HHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 999999999999999995 6999999999999983
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=331.32 Aligned_cols=240 Identities=24% Similarity=0.338 Sum_probs=185.1
Q ss_pred eecceeeeEEEeeeee--eceeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCccc------------CCeEEEEEec
Q psy5368 58 RYGELQYDTVQNSQIR--LGTVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRKR------------PRYVYIILEY 121 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~------------~~~~~lV~E~ 121 (406)
.||+|+||.||++... +..+++|.+.... ......+.+|+.+++.++|||+++. ...+|+||||
T Consensus 28 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~ 107 (359)
T cd07876 28 PIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 107 (359)
T ss_pred EeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeC
Confidence 3445555556655542 3457777665432 2335578899999999999997651 1357999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccC
Q psy5368 122 CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQG 200 (406)
Q Consensus 122 ~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~g 200 (406)
+++ +|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++............|
T Consensus 108 ~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 184 (359)
T cd07876 108 MDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV 184 (359)
T ss_pred CCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccCccCCCCcc
Confidence 976 77777643 589999999999999999999999999999999999998 77999999999976655444556678
Q ss_pred CCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC---------------------CCCC-
Q psy5368 201 SPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSA---------------------PITI- 258 (406)
Q Consensus 201 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~---------------------~~~~- 258 (406)
|+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+.... ....
T Consensus 185 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (359)
T cd07876 185 TRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYP 264 (359)
T ss_pred cCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCC
Confidence 999999999999999999999999999999999999998765433222211110 0000
Q ss_pred ------------------CCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy5368 259 ------------------PPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAP 300 (406)
Q Consensus 259 ------------------~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 300 (406)
.....++++++|+.+||+.||++|||+.|+++||||.....|
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~ 324 (359)
T cd07876 265 GISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDP 324 (359)
T ss_pred CcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCc
Confidence 001246789999999999999999999999999999864433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=335.75 Aligned_cols=243 Identities=24% Similarity=0.434 Sum_probs=200.6
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++... +..+++|.+.... ......+.+|+.+++.++|||+++ ...++|+|||||+|
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~g 127 (370)
T cd05621 48 VKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPG 127 (370)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCC
Confidence 456899999999999874 3467777665322 123445788999999999999776 67789999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC--CCcccCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ--GDSIQGS 201 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~--~~~~~gt 201 (406)
|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||++........ .....||
T Consensus 128 g~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt 206 (370)
T cd05621 128 GDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGT 206 (370)
T ss_pred CcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCceecccCCCC
Confidence 9999999764 689999999999999999999999999999999999998 77999999999987643322 2456799
Q ss_pred CCCCChhhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCCC-CCChHHHHHHHHhc
Q psy5368 202 PLYMAPEILAGSP----YNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSA-PITIPPN-SLSPDCMDFLSRLL 275 (406)
Q Consensus 202 ~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~-~~s~~l~~li~~~L 275 (406)
+.|+|||++.+.. ++.++||||+||++|+|++|..||.+.+.......+.... ....+.. .++..+++++.+||
T Consensus 207 ~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L 286 (370)
T cd05621 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFL 286 (370)
T ss_pred cccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHc
Confidence 9999999997643 7889999999999999999999999988877777776543 2333332 67999999999999
Q ss_pred ccCCCC--CCCHHHHhcCCCCCCCCC
Q psy5368 276 QKDPMR--RISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 276 ~~dP~~--Rps~~ell~hp~~~~~~~ 299 (406)
..+|.+ |++++++++||||+...+
T Consensus 287 ~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 287 TDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred cCchhccCCCCHHHHhcCcccCCCCc
Confidence 865544 899999999999987544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=321.80 Aligned_cols=243 Identities=21% Similarity=0.321 Sum_probs=200.1
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc---chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT---SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
..+||+|+||.||++... +..+++|.+...... ....+.+|+.+++.++|||++. ..+..|+||||+++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05605 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCC
Confidence 457899999999999864 456888877654322 2345778999999999999765 55789999999999
Q ss_pred CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCC
Q psy5368 125 GDLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGS 201 (406)
Q Consensus 125 gsL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt 201 (406)
|+|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++ ++.++|+|||++.............|+
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 164 (285)
T cd05605 85 GDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGT 164 (285)
T ss_pred CcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccccccCC
Confidence 9999988654 4699999999999999999999999999999999999998 678999999999876544444455789
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCCCCCCCCCCChHHHHHHHHhcccC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQAL---SSAPITIPPNSLSPDCMDFLSRLLQKD 278 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~s~~l~~li~~~L~~d 278 (406)
+.|+|||++.+..++.++||||+||++|+|++|..||.+.+.......+. ....... +..+++.+.+|+.+||..|
T Consensus 165 ~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~ 243 (285)
T cd05605 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEY-SEKFSEAARSICRQLLTKD 243 (285)
T ss_pred CCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhccccc-CcccCHHHHHHHHHHccCC
Confidence 99999999998889999999999999999999999998866543322222 2222222 2368999999999999999
Q ss_pred CCCCC-----CHHHHhcCCCCCCCCC
Q psy5368 279 PMRRI-----SYEDLFSHPYPDLIHA 299 (406)
Q Consensus 279 P~~Rp-----s~~ell~hp~~~~~~~ 299 (406)
|++|| +++++++||||....+
T Consensus 244 P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05605 244 PGFRLGCRGEGAEEVKAHPFFRTANF 269 (285)
T ss_pred HHHhcCCCCCCHHHHhcCcCccCCCH
Confidence 99999 8999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=329.93 Aligned_cols=235 Identities=23% Similarity=0.393 Sum_probs=188.4
Q ss_pred eeeecceeeeEEEeeeee-------eceeEEeeeecCCc-cchhhhhhHHhhcccC-CCCCCcc-------cCCeEEEEE
Q psy5368 56 TIRYGELQYDTVQNSQIR-------LGTVKYSQVRYDTI-TSHSEFERPRAGLSNL-RAPEGRK-------RPRYVYIIL 119 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~-------~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~-------~~~~~~lV~ 119 (406)
...||+|+||.||++... ...|++|.+..... .....+.+|+.++..+ +|||+++ ..+.+++||
T Consensus 12 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ 91 (338)
T cd05102 12 GKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIV 91 (338)
T ss_pred eeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEE
Confidence 456899999999998642 24578887764332 2345789999999999 8999875 344689999
Q ss_pred eccCCCCHHHHHHhC--------------------------------------------------------------CCC
Q psy5368 120 EYCDGGDLCSFIRSH--------------------------------------------------------------EKL 137 (406)
Q Consensus 120 E~~~ggsL~~~l~~~--------------------------------------------------------------~~l 137 (406)
||+++|+|.+++... .++
T Consensus 92 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 171 (338)
T cd05102 92 EFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPL 171 (338)
T ss_pred ecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCC
Confidence 999999999999653 247
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC---CCCcccCCCCCCChhhhcCC
Q psy5368 138 SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND---QGDSIQGSPLYMAPEILAGS 213 (406)
Q Consensus 138 ~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~ 213 (406)
++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++...... ......+++.|+|||++.+.
T Consensus 172 ~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 251 (338)
T cd05102 172 TMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDK 251 (338)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcC
Confidence 8889999999999999999999999999999999999 7799999999997653322 12233456789999999999
Q ss_pred CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 214 PYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 214 ~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
.++.++|||||||++|||++ |..||.+....+..............+..+++++.+|+.+||+.||++|||+.++++
T Consensus 252 ~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 252 VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999997 999998865443333333332222334478999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=333.08 Aligned_cols=255 Identities=22% Similarity=0.302 Sum_probs=205.7
Q ss_pred ceeeeeeccccccccceeeecCceeeecceeeeEEEeeeeee-ceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc-
Q psy5368 33 RYSQVRSDTVRSGTVRYDIVGSSTIRYGELQYDTVQNSQIRL-GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK- 110 (406)
Q Consensus 33 ~~~~~~~d~~~~~~~~~~i~~~~~~~lG~G~~g~Vy~~~~~~-~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~- 110 (406)
...++..+++..+|.+| +.+..||+|+||.||+|...+ ..|+||+..........+|.+|+.++.+++|||+++
T Consensus 61 ~~~~fs~~el~~AT~~F----s~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~L 136 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNF----SESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKL 136 (361)
T ss_pred CcceeeHHHHHHHHhCC----chhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccE
Confidence 46789999999999999 889999999999999999987 678999776654331566999999999999999887
Q ss_pred -----cCC-eEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCCcceEee-CCee
Q psy5368 111 -----RPR-YVYIILEYCDGGDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENN---VCHFDLKPQNILIK-NNTL 178 (406)
Q Consensus 111 -----~~~-~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dlkp~NIll~-~~~~ 178 (406)
+.+ ..+||+|||++|+|.++|.... +++|.++.+|+.++|+||+|||+.. |+||||||.|||+| +.++
T Consensus 137 lGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 137 LGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 344 5899999999999999997665 8999999999999999999999854 99999999999999 6699
Q ss_pred EEEecccccccCC-CCCCCcc-cCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHH
Q psy5368 179 KLADFGFAQFLAP-NDQGDSI-QGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCN------LSQLRAQA 250 (406)
Q Consensus 179 kL~DFGla~~~~~-~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~------~~~~~~~~ 250 (406)
||+|||+|+.... ....... .||.+|+|||++..+..+.++||||||++|+||+||+.|.+... ..+.....
T Consensus 217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred EccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 9999999966544 3333333 79999999999999999999999999999999999998887532 11111111
Q ss_pred Hhc-CC-----CCCCCCCCC-----hHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 251 LSS-AP-----ITIPPNSLS-----PDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 251 ~~~-~~-----~~~~~~~~s-----~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
... .. +.+.....+ ..+..+..+|++.+|.+||++.|+++.
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~ 348 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE 348 (361)
T ss_pred HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence 111 11 111112233 226678899999999999999997553
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=342.71 Aligned_cols=241 Identities=29% Similarity=0.449 Sum_probs=204.9
Q ss_pred ceeeecceeeeEEEeeee--eeceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCcccC--------------CeEE
Q psy5368 55 STIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRKRP--------------RYVY 116 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~~~--------------~~~~ 116 (406)
....||+|+||+||++.. .+..+++|.+...... ....+.+|+..+..++|+|++... ..++
T Consensus 36 i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~ 115 (496)
T PTZ00283 36 ISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIA 115 (496)
T ss_pred EEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEE
Confidence 356789999999999986 3567888987654322 344678899999999999976521 1368
Q ss_pred EEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCC
Q psy5368 117 IILEYCDGGDLCSFIRSH----EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAP 191 (406)
Q Consensus 117 lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~ 191 (406)
+||||+++|+|.++++.+ ..+++..+..++.|++.||.|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus 116 lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~ 195 (496)
T PTZ00283 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAA 195 (496)
T ss_pred EEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeeccc
Confidence 999999999999999653 4699999999999999999999999999999999999998 77999999999976543
Q ss_pred C---CCCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHH
Q psy5368 192 N---DQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCM 268 (406)
Q Consensus 192 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~ 268 (406)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+........+ ..+++++.
T Consensus 196 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~ 274 (496)
T PTZ00283 196 TVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLP-PSISPEMQ 274 (496)
T ss_pred cccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC-CCCCHHHH
Confidence 2 2234567999999999999999999999999999999999999999999888887777766554444 36899999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy5368 269 DFLSRLLQKDPMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 269 ~li~~~L~~dP~~Rps~~ell~hp~~~~ 296 (406)
+|+.+||+.||.+||++.++++|||++.
T Consensus 275 ~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 275 EIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred HHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 9999999999999999999999999764
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=329.67 Aligned_cols=236 Identities=23% Similarity=0.340 Sum_probs=183.0
Q ss_pred cceeeeEEEeeee--eeceeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCccc------------CCeEEEEEeccC
Q psy5368 60 GELQYDTVQNSQI--RLGTVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRKR------------PRYVYIILEYCD 123 (406)
Q Consensus 60 G~G~~g~Vy~~~~--~~~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~------------~~~~~lV~E~~~ 123 (406)
|+|+||.||++.. .+..+++|.+.... ......+.+|+.+++.++|||++.. ....|+||||++
T Consensus 26 g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~ 105 (355)
T cd07874 26 GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD 105 (355)
T ss_pred eecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhc
Confidence 4444444544443 23456777665432 2234577889999999999997652 235799999997
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCC
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSP 202 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~ 202 (406)
+ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++ ++.+||+|||+++............||+
T Consensus 106 ~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~ 182 (355)
T cd07874 106 A-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 182 (355)
T ss_pred c-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCccccCCccccC
Confidence 6 78777754 589999999999999999999999999999999999998 6799999999998765555555677999
Q ss_pred CCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--------------------------
Q psy5368 203 LYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI-------------------------- 256 (406)
Q Consensus 203 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-------------------------- 256 (406)
.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+....+......
T Consensus 183 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (355)
T cd07874 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGL 262 (355)
T ss_pred CccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccc
Confidence 999999999999999999999999999999999999887654433322211000
Q ss_pred C---------C-----CCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 257 T---------I-----PPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 257 ~---------~-----~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
. . .....+.++++||.+||+.||++|||+.|+++||||....
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~ 318 (355)
T cd07874 263 TFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY 318 (355)
T ss_pred cchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence 0 0 0012356789999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=331.68 Aligned_cols=240 Identities=21% Similarity=0.263 Sum_probs=190.0
Q ss_pred ceeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 55 STIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
....||+|+||.||++... ...+++|... ...+.+|+.++++|+|||+++ .....++|+|++. ++
T Consensus 96 ~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~ 168 (391)
T PHA03212 96 ILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TD 168 (391)
T ss_pred EEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CC
Confidence 3467899999999999864 3457777532 245789999999999999876 4667899999995 59
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC--CCCCcccCCCC
Q psy5368 127 LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN--DQGDSIQGSPL 203 (406)
Q Consensus 127 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~--~~~~~~~gt~~ 203 (406)
|..++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...... .......||+.
T Consensus 169 L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~ 248 (391)
T PHA03212 169 LYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIA 248 (391)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccC
Confidence 999998888899999999999999999999999999999999999998 679999999999654322 22334579999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHh------------------------
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCN-------LSQLRAQALS------------------------ 252 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~-------~~~~~~~~~~------------------------ 252 (406)
|+|||++.+..++.++||||+||++|||++|..||.... .......+..
T Consensus 249 y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~ 328 (391)
T PHA03212 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGL 328 (391)
T ss_pred CCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHH
Confidence 999999999999999999999999999999998874321 0111111110
Q ss_pred --cCC---CCCCC----CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q psy5368 253 --SAP---ITIPP----NSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPC 301 (406)
Q Consensus 253 --~~~---~~~~~----~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~ 301 (406)
... ...+. ..++.++.+||.+||+.||++|||++|+++||||.....|.
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~ 386 (391)
T PHA03212 329 AKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDPY 386 (391)
T ss_pred HhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCCC
Confidence 000 00000 13567899999999999999999999999999998765543
|
|
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=334.97 Aligned_cols=246 Identities=28% Similarity=0.440 Sum_probs=213.3
Q ss_pred eeeecCceeeecceeeeEEEeeeeeecee--EEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEe
Q psy5368 49 YDIVGSSTIRYGELQYDTVQNSQIRLGTV--KYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILE 120 (406)
Q Consensus 49 ~~i~~~~~~~lG~G~~g~Vy~~~~~~~~v--~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E 120 (406)
..|+|. ||-|+||.||++..+...+ +.|.+.........++.-|+++|..+.||++++ ..+.++|+.|
T Consensus 34 WeIiGE----LGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 34 WEIIGE----LGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHhh----hcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 345655 5999999999999875544 445555555566778999999999999999876 6778899999
Q ss_pred ccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCC-CCCCCc
Q psy5368 121 YCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAP-NDQGDS 197 (406)
Q Consensus 121 ~~~ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~-~~~~~~ 197 (406)
||.||-....+-+- ..|++.++.-+++|++.||.|||+++|+|||||+.|||++ +|.++|+|||.+..... -....+
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDs 189 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDS 189 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhcc
Confidence 99999998887554 5799999999999999999999999999999999999999 99999999999854332 234578
Q ss_pred ccCCCCCCChhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC-CCCChHHHHHH
Q psy5368 198 IQGSPLYMAPEILAG-----SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP-NSLSPDCMDFL 271 (406)
Q Consensus 198 ~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~~li 271 (406)
+.|||.|||||++.. .+|++++||||||++|.||..+.+|....++.....++....++++.. ..++..+.||+
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfL 269 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFL 269 (1187)
T ss_pred ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHH
Confidence 899999999998753 579999999999999999999999999999999998988887776654 48899999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 272 SRLLQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 272 ~~~L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
.+||..||..||++.++|+||||....
T Consensus 270 k~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 270 KRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred HHHHhcCCccCCCHHHHhhCcccccCC
Confidence 999999999999999999999998554
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=326.36 Aligned_cols=241 Identities=24% Similarity=0.351 Sum_probs=191.6
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCcc------------cCCeEEEEEe
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRK------------RPRYVYIILE 120 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~------------~~~~~~lV~E 120 (406)
..||+|+||.||++... ...+++|++.... ......+.+|+.+++.++|||++. ....+|+|||
T Consensus 30 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e 109 (364)
T cd07875 30 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109 (364)
T ss_pred EEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEe
Confidence 45677777777777642 3457778765432 233457889999999999999765 1235799999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCccc
Q psy5368 121 YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQ 199 (406)
Q Consensus 121 ~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~ 199 (406)
|+++ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||++ ++.+||+|||+++............
T Consensus 110 ~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~ 186 (364)
T cd07875 110 LMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 186 (364)
T ss_pred CCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCCcccCCc
Confidence 9976 88888754 588999999999999999999999999999999999998 7799999999998765554455667
Q ss_pred CCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC---------------------
Q psy5368 200 GSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITI--------------------- 258 (406)
Q Consensus 200 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--------------------- 258 (406)
+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+........
T Consensus 187 ~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (364)
T cd07875 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKY 266 (364)
T ss_pred ccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCc
Confidence 89999999999999999999999999999999999999998776555444432111000
Q ss_pred --------------C-----CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy5368 259 --------------P-----PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAP 300 (406)
Q Consensus 259 --------------~-----~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 300 (406)
+ ....+.++++||.+||+.||.+|||++++++||||.....|
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~ 327 (364)
T cd07875 267 AGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDP 327 (364)
T ss_pred CCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCc
Confidence 0 01135678999999999999999999999999999864443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=320.88 Aligned_cols=236 Identities=25% Similarity=0.388 Sum_probs=183.6
Q ss_pred eeeecceeeeEEEeeeee----eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc--------cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIR----LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK--------RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~----~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~--------~~~~~~lV~E~~~ 123 (406)
..+||+|+||.||++... ...+++|.+... .....+.+|+.++++++|||+++ ....+|+||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 457999999999999853 245788776543 22346789999999999999875 3567899999996
Q ss_pred CCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-----CCeeEEEeccccccc
Q psy5368 124 GGDLCSFIRSH---------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-----NNTLKLADFGFAQFL 189 (406)
Q Consensus 124 ggsL~~~l~~~---------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-----~~~~kL~DFGla~~~ 189 (406)
+ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++..
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 5 999888532 2589999999999999999999999999999999999994 358999999999776
Q ss_pred CCCC----CCCcccCCCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHhcCC
Q psy5368 190 APND----QGDSIQGSPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLS---------QLRAQALSSAP 255 (406)
Q Consensus 190 ~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~---------~~~~~~~~~~~ 255 (406)
.... ......||+.|+|||++.+. .++.++||||+||++|+|++|++||...... .....+.....
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07868 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242 (317)
T ss_pred CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcC
Confidence 4332 22346789999999999874 5899999999999999999999999653311 11111110000
Q ss_pred ---------------------------C---------CCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 256 ---------------------------I---------TIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 256 ---------------------------~---------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
. .......+.++.+|+.+||+.||.+|||++|+++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 243 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 00001235678999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=310.65 Aligned_cols=240 Identities=26% Similarity=0.405 Sum_probs=200.1
Q ss_pred ceeeecceeeeEEEeeeee--eceeEEeeeecCCcc-----chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEec
Q psy5368 55 STIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT-----SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEY 121 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~-----~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~ 121 (406)
....+|+|++|.||.+... +..+++|.+...... ....+.+|+.++++++|||+++ .....|+|+||
T Consensus 6 ~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 85 (263)
T cd06625 6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEY 85 (263)
T ss_pred ccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEE
Confidence 3567899999999999753 467788876543211 2346888999999999999765 66789999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC----C
Q psy5368 122 CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG----D 196 (406)
Q Consensus 122 ~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~----~ 196 (406)
+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||+++........ .
T Consensus 86 ~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 165 (263)
T cd06625 86 MPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMK 165 (263)
T ss_pred CCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccccccc
Confidence 99999999998888899999999999999999999999999999999999999 679999999998765432211 3
Q ss_pred cccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcc
Q psy5368 197 SIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQ 276 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~ 276 (406)
...++..|+|||++.+..++.++||||+|+++|+|++|+.||...+.................+..++.++.+++.+||.
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 245 (263)
T cd06625 166 SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFV 245 (263)
T ss_pred CCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhh
Confidence 45678899999999998899999999999999999999999987665555444444333333334689999999999999
Q ss_pred cCCCCCCCHHHHhcCCCC
Q psy5368 277 KDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 277 ~dP~~Rps~~ell~hp~~ 294 (406)
.+|.+|||+.++++||||
T Consensus 246 ~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 246 ENAKKRPSAEELLRHFFV 263 (263)
T ss_pred cCcccCCCHHHHhhCCCC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=328.73 Aligned_cols=243 Identities=26% Similarity=0.369 Sum_probs=197.2
Q ss_pred ceeeecceeeeEEEeeee--eeceeEEeeeecC--CccchhhhhhHHhhcccCCCCCCcc------cCC-----eEEEEE
Q psy5368 55 STIRYGELQYDTVQNSQI--RLGTVKYSQVRYD--TITSHSEFERPRAGLSNLRAPEGRK------RPR-----YVYIIL 119 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~------~~~-----~~~lV~ 119 (406)
....||+|+||.||++.. .+..+++|++... .......+.+|+.+++.++|||++. ... ..|+||
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence 356789999999999985 3567888876543 2234457889999999999999865 222 789999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC--CCC
Q psy5368 120 EYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND--QGD 196 (406)
Q Consensus 120 E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~--~~~ 196 (406)
||+. ++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....... ...
T Consensus 84 e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~ 162 (372)
T cd07853 84 ELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT 162 (372)
T ss_pred eccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccccCC
Confidence 9996 49999998888899999999999999999999999999999999999999 6799999999997654322 223
Q ss_pred cccCCCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----------------------
Q psy5368 197 SIQGSPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSS---------------------- 253 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~---------------------- 253 (406)
...+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+.......+...
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 242 (372)
T cd07853 163 QEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILR 242 (372)
T ss_pred CCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHh
Confidence 45678999999999874 4799999999999999999999999887765544433221
Q ss_pred CCCCC--------CCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 254 APITI--------PPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 254 ~~~~~--------~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
..... .....++++.+||.+||+.||++|||++++++||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 243 GPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred CCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 00000 1124578999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=315.92 Aligned_cols=238 Identities=26% Similarity=0.347 Sum_probs=190.8
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc--chhhhhhHHhhcccC---CCCCCccc-----------CCeEEE
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT--SHSEFERPRAGLSNL---RAPEGRKR-----------PRYVYI 117 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l---~h~ni~~~-----------~~~~~l 117 (406)
...||+|+||.||++... +..+++|.+...... ....+.+|+.++..+ +|||+++. ...+++
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~l 84 (288)
T cd07863 5 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTL 84 (288)
T ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEE
Confidence 456899999999999864 346788876543222 233566777776655 79997651 345799
Q ss_pred EEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC
Q psy5368 118 ILEYCDGGDLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ 194 (406)
Q Consensus 118 V~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~ 194 (406)
||||+++ +|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++ ++.+||+|||++........
T Consensus 85 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd07863 85 VFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA 163 (288)
T ss_pred EEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccCccc
Confidence 9999975 999998764 3589999999999999999999999999999999999998 77999999999987655444
Q ss_pred CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----------C-----C-
Q psy5368 195 GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI----------T-----I- 258 (406)
Q Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----------~-----~- 258 (406)
.....+|+.|+|||++.+..++.++||||+||++|+|++|.+||.+....+....+...... . .
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (288)
T cd07863 164 LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFS 243 (288)
T ss_pred CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccC
Confidence 45567899999999999988999999999999999999999999887765554444321100 0 0
Q ss_pred ---------CCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 259 ---------PPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 259 ---------~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
....++.++.+|+.+||+.||++|||+.+++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 244 PRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred CCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 012467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=318.72 Aligned_cols=242 Identities=25% Similarity=0.407 Sum_probs=193.8
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...||+|+||.||++... ...+++|.+...... ....+.+|+.++++++|||++. .++..|+||||+++ +
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 89 (309)
T cd07872 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-D 89 (309)
T ss_pred EEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-C
Confidence 356788888888888753 345788877644322 3346788999999999999765 66789999999976 8
Q ss_pred HHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCC
Q psy5368 127 LCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPL 203 (406)
Q Consensus 127 L~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~ 203 (406)
|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++ ++.+||+|||++....... ......+|+.
T Consensus 90 l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 169 (309)
T cd07872 90 LKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLW 169 (309)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccccccccccc
Confidence 998886654 589999999999999999999999999999999999998 6799999999987643322 2234567899
Q ss_pred CCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC------------------CCCC-----
Q psy5368 204 YMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP------------------ITIP----- 259 (406)
Q Consensus 204 y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~------------------~~~~----- 259 (406)
|+|||++.+ ..++.++||||+||++|+|+||++||.+.+..+....+..... ...+
T Consensus 170 y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (309)
T cd07872 170 YRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQ 249 (309)
T ss_pred ccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCC
Confidence 999999875 4589999999999999999999999988776554443332100 0000
Q ss_pred -----CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 260 -----PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 260 -----~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
...+++++.+|+.+||+.||.+|||++|+++||||+...
T Consensus 250 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 250 PLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred chhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 114688999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=311.78 Aligned_cols=238 Identities=23% Similarity=0.386 Sum_probs=196.2
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccC-CCCCCccc------------CCeEEEEEe
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNL-RAPEGRKR------------PRYVYIILE 120 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~------------~~~~~lV~E 120 (406)
...+|+|+||.||++... ...+++|...... .....+.+|+.++.++ +|+|+++. ...+|+|||
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e 89 (272)
T cd06637 11 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME 89 (272)
T ss_pred HHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEE
Confidence 456899999999999864 3456777665432 3456788999999998 79997651 346899999
Q ss_pred ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCC
Q psy5368 121 YCDGGDLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGD 196 (406)
Q Consensus 121 ~~~ggsL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~ 196 (406)
|+++++|.+++... ..+++..+..++.|++.||+|||++||+|+||||+||+++ ++.++|+|||++...... ....
T Consensus 90 ~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 169 (272)
T cd06637 90 FCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 169 (272)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecccccccCC
Confidence 99999999999764 3689999999999999999999999999999999999999 678999999998765432 2334
Q ss_pred cccCCCCCCChhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHH
Q psy5368 197 SIQGSPLYMAPEILAG-----SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFL 271 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li 271 (406)
...|++.|+|||++.+ ..++.++|+||+||++|+|++|..||........................++.++.+|+
T Consensus 170 ~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 249 (272)
T cd06637 170 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFI 249 (272)
T ss_pred cccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHH
Confidence 5678999999999863 35888999999999999999999999876655555444444333444457889999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCC
Q psy5368 272 SRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 272 ~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
.+||..+|.+|||+.++++||||
T Consensus 250 ~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 250 ESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred HHHcCCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=328.34 Aligned_cols=240 Identities=26% Similarity=0.379 Sum_probs=191.9
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...||+|+||.||++... ++.+++|.+...... ....+.+|+.+++.++|+|++. ..+.+|+||||+++++
T Consensus 79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 158 (353)
T PLN00034 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS 158 (353)
T ss_pred hhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCc
Confidence 357999999999999864 467888877544322 2457889999999999999765 6678899999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCCC
Q psy5368 127 LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPLY 204 (406)
Q Consensus 127 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~y 204 (406)
|.+. ...++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++...... ......||..|
T Consensus 159 L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y 234 (353)
T PLN00034 159 LEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAY 234 (353)
T ss_pred cccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccccccccCccc
Confidence 8653 3467788899999999999999999999999999999999 6799999999998764332 23456789999
Q ss_pred CChhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcc
Q psy5368 205 MAPEILAG-----SPYNAKADLWSLGVLVFEALFGHAPYASCNL---SQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQ 276 (406)
Q Consensus 205 ~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~ 276 (406)
+|||++.. ...+.++|||||||++|||++|+.||..... ......+....... .+..++.++.+||.+||+
T Consensus 235 ~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~ 313 (353)
T PLN00034 235 MSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPE-APATASREFRHFISCCLQ 313 (353)
T ss_pred cCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCC-CCCccCHHHHHHHHHHcc
Confidence 99998853 2345689999999999999999999974332 22222222222222 233689999999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCCCCC
Q psy5368 277 KDPMRRISYEDLFSHPYPDLIHAP 300 (406)
Q Consensus 277 ~dP~~Rps~~ell~hp~~~~~~~~ 300 (406)
.||++|||+.|+++||||.....+
T Consensus 314 ~~P~~Rpt~~ell~hp~~~~~~~~ 337 (353)
T PLN00034 314 REPAKRWSAMQLLQHPFILRAQPG 337 (353)
T ss_pred CChhhCcCHHHHhcCcccccCCcc
Confidence 999999999999999999876543
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=310.58 Aligned_cols=240 Identities=27% Similarity=0.516 Sum_probs=204.3
Q ss_pred ecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 59 YGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 59 lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
||.|++|.||++... +..+++|.+..... .....+.+|+.+++.++|||+++ .....|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999986 56788887765432 23457899999999999999765 66778999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCCCC
Q psy5368 128 CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLYMA 206 (406)
Q Consensus 128 ~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y~a 206 (406)
.+++.+...+++..+..++.||+.||.|||++|++|+||+|+||+++ ++.++|+|||++.............+++.|+|
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 160 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVA 160 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccC
Confidence 99998888899999999999999999999999999999999999998 67999999999987765544445578999999
Q ss_pred hhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCC
Q psy5368 207 PEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCN--LSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRIS 284 (406)
Q Consensus 207 PE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps 284 (406)
||.+.+..++.++|+||+|+++|+|++|..||.... .......+.........+...++++.+++.+||..+|++||+
T Consensus 161 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~ 240 (262)
T cd05572 161 PEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLG 240 (262)
T ss_pred hhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcC
Confidence 999988889999999999999999999999998776 555555555322222223356899999999999999999999
Q ss_pred -----HHHHhcCCCCCCCC
Q psy5368 285 -----YEDLFSHPYPDLIH 298 (406)
Q Consensus 285 -----~~ell~hp~~~~~~ 298 (406)
++|+++||||+...
T Consensus 241 ~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 241 NLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred CcccCHHHHhcChhhhCCC
Confidence 99999999998653
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=327.67 Aligned_cols=243 Identities=25% Similarity=0.427 Sum_probs=198.8
Q ss_pred eeeecceeeeEEEeeeeee--ceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIRL--GTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++.... ..+++|.+.... ......+.+|+.++..++|||+++ ..+++|+|||||+|
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~g 127 (371)
T cd05622 48 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG 127 (371)
T ss_pred EEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence 4568999999999988743 456777664322 122345778999999999999866 66789999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC--CCCcccCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND--QGDSIQGS 201 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~--~~~~~~gt 201 (406)
|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||++....... ......||
T Consensus 128 g~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt 206 (371)
T cd05622 128 GDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 206 (371)
T ss_pred CcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccC
Confidence 9999998764 689999999999999999999999999999999999998 7799999999998764332 23456799
Q ss_pred CCCCChhhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCC-CCCChHHHHHHHHhc
Q psy5368 202 PLYMAPEILAGSP----YNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP-ITIPP-NSLSPDCMDFLSRLL 275 (406)
Q Consensus 202 ~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~-~~~s~~l~~li~~~L 275 (406)
+.|+|||++.+.. ++.++||||+||++|+|++|..||.+.+.......+..... ...+. ..++.++++||.+||
T Consensus 207 ~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 286 (371)
T cd05622 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL 286 (371)
T ss_pred ccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHc
Confidence 9999999997643 78899999999999999999999999888777777765432 23333 268999999999999
Q ss_pred ccCCCC--CCCHHHHhcCCCCCCCCC
Q psy5368 276 QKDPMR--RISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 276 ~~dP~~--Rps~~ell~hp~~~~~~~ 299 (406)
..++.+ |++++++++||||+...+
T Consensus 287 ~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 287 TDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred CChhhhcCCCCHHHHhcCcccCCCCh
Confidence 844433 789999999999987543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=321.46 Aligned_cols=244 Identities=25% Similarity=0.454 Sum_probs=198.2
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++... ++.+++|.+.... ......+.+|+.++..++|+|++. ..+++|+||||++|
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (331)
T cd05597 6 LKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVG 85 (331)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCC
Confidence 456899999999998864 4567888775422 223445888999999999999765 67789999999999
Q ss_pred CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC--CCcccC
Q psy5368 125 GDLCSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ--GDSIQG 200 (406)
Q Consensus 125 gsL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~--~~~~~g 200 (406)
|+|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||++........ .....|
T Consensus 86 ~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g 165 (331)
T cd05597 86 GDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVG 165 (331)
T ss_pred CcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccccceec
Confidence 999999976 45799999999999999999999999999999999999998 77999999999876543332 223468
Q ss_pred CCCCCChhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCC--CCCChHHHHHHH
Q psy5368 201 SPLYMAPEILAG-----SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP-ITIPP--NSLSPDCMDFLS 272 (406)
Q Consensus 201 t~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~--~~~s~~l~~li~ 272 (406)
|+.|+|||++.. ..++.++||||+||++|+|++|+.||.+.+..+....+..... ...++ ..+|+++++|+.
T Consensus 166 t~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~ 245 (331)
T cd05597 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIR 245 (331)
T ss_pred cccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHH
Confidence 999999999973 4578899999999999999999999998887777666654322 22222 257999999999
Q ss_pred HhcccCCCC--CCCHHHHhcCCCCCCCCC
Q psy5368 273 RLLQKDPMR--RISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 273 ~~L~~dP~~--Rps~~ell~hp~~~~~~~ 299 (406)
+||..++++ |++++++++||||....+
T Consensus 246 ~ll~~~~~r~~r~~~~~~l~hp~~~~~~~ 274 (331)
T cd05597 246 RLICSPETRLGRNGLQDFKDHPFFEGIDW 274 (331)
T ss_pred HHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence 988764443 789999999999987543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=315.59 Aligned_cols=241 Identities=22% Similarity=0.345 Sum_probs=196.9
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccc---hhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITS---HSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~---~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++... ++.+++|.+....... ...+.+|+.++++++|++++. ..+..|+||||++|
T Consensus 5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 84 (285)
T cd05630 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCC
Confidence 356899999999999875 3467888766443222 235778999999999999765 56789999999999
Q ss_pred CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCC
Q psy5368 125 GDLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGS 201 (406)
Q Consensus 125 gsL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt 201 (406)
++|.+++... ..+++..+..++.|++.||.|||+.||+|+||||+||+++ ++.++|+|||++.............|+
T Consensus 85 ~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~ 164 (285)
T cd05630 85 GDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGT 164 (285)
T ss_pred CcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCCCCC
Confidence 9999998654 3699999999999999999999999999999999999998 679999999999766544444455789
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLS---QLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKD 278 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~d 278 (406)
+.|+|||++.+..++.++||||+||++|+|++|..||...... ............. .+..+++++.+|+.+||+.|
T Consensus 165 ~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~ 243 (285)
T cd05630 165 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEE-YSEKFSPDARSLCKMLLCKD 243 (285)
T ss_pred ccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhh-cCccCCHHHHHHHHHHhhcC
Confidence 9999999999999999999999999999999999999875421 1122222221222 23468899999999999999
Q ss_pred CCCCCC-----HHHHhcCCCCCCC
Q psy5368 279 PMRRIS-----YEDLFSHPYPDLI 297 (406)
Q Consensus 279 P~~Rps-----~~ell~hp~~~~~ 297 (406)
|++||| ++++++||||+..
T Consensus 244 p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 244 PKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred HHHccCCCCCchHHHHcChhhhcc
Confidence 999999 8999999999854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=315.91 Aligned_cols=245 Identities=24% Similarity=0.434 Sum_probs=205.9
Q ss_pred eeecceeeeEEEeeee--eeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHH
Q psy5368 57 IRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLC 128 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~ 128 (406)
..||+|+||.||++.. .+..+++|.+..........+.+|+..++.++|+|+++ ..++.|+||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 4689999999999986 35678888876655555667899999999999999765 667899999999999999
Q ss_pred HHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCCCCC
Q psy5368 129 SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPLYMA 206 (406)
Q Consensus 129 ~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~y~a 206 (406)
+++.. +.+++.++..++.||+.||.|||++||+||||||+||+++ ++.++|+|||++....... ......+++.|+|
T Consensus 108 ~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~a 186 (292)
T cd06658 108 DIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMA 186 (292)
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCccccC
Confidence 98854 5689999999999999999999999999999999999999 6799999999987653322 2334568999999
Q ss_pred hhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC-CCCChHHHHHHHHhcccCCCCCCCH
Q psy5368 207 PEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP-NSLSPDCMDFLSRLLQKDPMRRISY 285 (406)
Q Consensus 207 PE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~~li~~~L~~dP~~Rps~ 285 (406)
||.+.+..++.++|+||+|+++|||++|..||...+.......+........+. ..++..+.+++.+||..||.+|||+
T Consensus 187 PE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 266 (292)
T cd06658 187 PEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATA 266 (292)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCH
Confidence 999998889999999999999999999999998877665555444332222222 2578899999999999999999999
Q ss_pred HHHhcCCCCCCCCCCCc
Q psy5368 286 EDLFSHPYPDLIHAPCA 302 (406)
Q Consensus 286 ~ell~hp~~~~~~~~~~ 302 (406)
+++++||||+....|+.
T Consensus 267 ~~il~~~~~~~~~~~~~ 283 (292)
T cd06658 267 QELLQHPFLKLAGPPSC 283 (292)
T ss_pred HHHhhChhhhccCCccc
Confidence 99999999998776654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=308.57 Aligned_cols=238 Identities=29% Similarity=0.498 Sum_probs=199.0
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccc---------hhhhhhHHhhcccCCCCCCcc------cCCeEEEE
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITS---------HSEFERPRAGLSNLRAPEGRK------RPRYVYII 118 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~---------~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV 118 (406)
...||+|++|.||++... ...+++|.+....... ...+.+|+.++++++|||+++ ..++.++|
T Consensus 5 ~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (267)
T cd06628 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIF 84 (267)
T ss_pred cceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEE
Confidence 357899999999999863 4567888765543322 245788999999999999765 66788999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC----
Q psy5368 119 LEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND---- 193 (406)
Q Consensus 119 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~---- 193 (406)
|||+++++|.+++...+.+++..+..++.|++.||+|||++|++|+||+|+||+++ ++.++|+|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06628 85 LEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTK 164 (267)
T ss_pred EEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccccccCC
Confidence 99999999999998888899999999999999999999999999999999999998 6689999999987764221
Q ss_pred ---CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHH
Q psy5368 194 ---QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDF 270 (406)
Q Consensus 194 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~l 270 (406)
......|++.|+|||.+.+..++.++|+||+||++|+|++|..||...+.......+........+ ..++..+.++
T Consensus 165 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l 243 (267)
T cd06628 165 TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIP-SNISSEAIDF 243 (267)
T ss_pred ccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCC-cccCHHHHHH
Confidence 112345788999999999888999999999999999999999999887655544444443333333 3689999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 271 LSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 271 i~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
+.+||+.||.+||++.++++||||
T Consensus 244 i~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 244 LEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHccCCchhCcCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=313.60 Aligned_cols=244 Identities=22% Similarity=0.331 Sum_probs=199.6
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc---chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT---SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
.+.||+|+||+||++... ++.+++|.+...... ....+.+|+.+++.++|+|++. ..+..|+||||+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05632 5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence 356899999999999874 456788876543322 2345788999999999999765 56789999999999
Q ss_pred CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCC
Q psy5368 125 GDLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGS 201 (406)
Q Consensus 125 gsL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt 201 (406)
++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++ ++.++|+|||++.............|+
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~ 164 (285)
T cd05632 85 GDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGT 164 (285)
T ss_pred ccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCCCCC
Confidence 9999988653 3699999999999999999999999999999999999998 668999999998765444444456789
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--CCCCCCCCChHHHHHHHHhcccCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP--ITIPPNSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~s~~l~~li~~~L~~dP 279 (406)
+.|+|||.+.+..++.++|+||+||++|+|++|..||...........+..... ....+..+++++.+|+.+||+.||
T Consensus 165 ~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 244 (285)
T cd05632 165 VGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDP 244 (285)
T ss_pred cCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCH
Confidence 999999999988899999999999999999999999987665433333222111 111223688999999999999999
Q ss_pred CCCCC-----HHHHhcCCCCCCCCC
Q psy5368 280 MRRIS-----YEDLFSHPYPDLIHA 299 (406)
Q Consensus 280 ~~Rps-----~~ell~hp~~~~~~~ 299 (406)
++||+ +.+++.||||+....
T Consensus 245 ~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 245 KQRLGCQEEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred hHcCCCcccChHHHHcChhhhcCCH
Confidence 99999 889999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=320.65 Aligned_cols=242 Identities=28% Similarity=0.500 Sum_probs=211.7
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCccc--hhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITS--HSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~--~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
++-||+|.|..|-.++. .+..||||.+.+..... ...+.+|++.++.+.|||++. ....+|||+|+-++|
T Consensus 23 ekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~G 102 (864)
T KOG4717|consen 23 EKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGG 102 (864)
T ss_pred hhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCc
Confidence 44567777777766663 45678888877655443 447899999999999999876 677899999999999
Q ss_pred CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee--CCeeEEEecccccccCCCCCCCcccCCC
Q psy5368 126 DLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK--NNTLKLADFGFAQFLAPNDQGDSIQGSP 202 (406)
Q Consensus 126 sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~--~~~~kL~DFGla~~~~~~~~~~~~~gt~ 202 (406)
+|+++|-++ ..+.+..+++++.||+.|+.|||+..+|||||||+||.+- -|-+||+|||++..+.+.....+.+|++
T Consensus 103 Dl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSL 182 (864)
T KOG4717|consen 103 DLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSL 182 (864)
T ss_pred hHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhcccchh
Confidence 999999655 5799999999999999999999999999999999999886 6799999999999888888889999999
Q ss_pred CCCChhhhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCC
Q psy5368 203 LYMAPEILAGSPYNA-KADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 203 ~y~aPE~~~~~~~~~-~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
.|.|||++.+..|+. ++||||+|||||.|.+|++||...+..+.+..|... ....| ..+|.+|++||..||..||.+
T Consensus 183 AYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC-KYtvP-shvS~eCrdLI~sMLvRdPkk 260 (864)
T KOG4717|consen 183 AYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC-KYTVP-SHVSKECRDLIQSMLVRDPKK 260 (864)
T ss_pred hccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc-cccCc-hhhhHHHHHHHHHHHhcCchh
Confidence 999999999999875 789999999999999999999998888887777665 33344 479999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCC
Q psy5368 282 RISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 282 Rps~~ell~hp~~~~~~~ 299 (406)
|.+.++|..++|++....
T Consensus 261 RAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 261 RASLEEIVSTSWLQAGDR 278 (864)
T ss_pred hccHHHHhccccccCCCC
Confidence 999999999999987654
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=304.78 Aligned_cols=238 Identities=24% Similarity=0.421 Sum_probs=203.3
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...+|+|++|.||++... +..+++|.+.... ......+.+|+.+++.++|||+++ ..+..|+||||++|+
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08529 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENG 84 (256)
T ss_pred eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCC
Confidence 457899999999999874 4567888765432 234567889999999999999765 567799999999999
Q ss_pred CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC-CCcccCC
Q psy5368 126 DLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ-GDSIQGS 201 (406)
Q Consensus 126 sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~-~~~~~gt 201 (406)
+|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++ ++.++|+|||++........ .....++
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 164 (256)
T cd08529 85 DLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGT 164 (256)
T ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhccccC
Confidence 999999764 5799999999999999999999999999999999999999 67999999999876654322 2345688
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
+.|+|||++.+..++.++|+|||||++++|++|+.||...+.......+........+. .++.++.+++.+||+.+|++
T Consensus 165 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~p~~ 243 (256)
T cd08529 165 PYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQ-MYSQQLAQLIDQCLTKDYRQ 243 (256)
T ss_pred ccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc-ccCHHHHHHHHHHccCCccc
Confidence 99999999999999999999999999999999999999888777776666654444333 68899999999999999999
Q ss_pred CCCHHHHhcCCCC
Q psy5368 282 RISYEDLFSHPYP 294 (406)
Q Consensus 282 Rps~~ell~hp~~ 294 (406)
||++.+++.|||+
T Consensus 244 Rp~~~~ll~~~~~ 256 (256)
T cd08529 244 RPDTFQLLRNPSL 256 (256)
T ss_pred CcCHHHHhhCCCC
Confidence 9999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=304.08 Aligned_cols=237 Identities=27% Similarity=0.508 Sum_probs=197.3
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCcc-------cCCeEEEEEeccCCC
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRK-------RPRYVYIILEYCDGG 125 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~-------~~~~~~lV~E~~~gg 125 (406)
..+|+|++|.||.+... ...+++|++..... .....+.+|+.++++++|+|++. ....+|+||||++++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~ 85 (257)
T cd08223 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGG 85 (257)
T ss_pred EEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCC
Confidence 45678888888877753 34577777754432 23456889999999999999765 344689999999999
Q ss_pred CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCC
Q psy5368 126 DLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGS 201 (406)
Q Consensus 126 sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt 201 (406)
+|.+++... ..+++.++..++.|++.||.+||++|++|+||||+||+++ ++.++|+|||++....... ......++
T Consensus 86 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 165 (257)
T cd08223 86 DLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGT 165 (257)
T ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccccccCC
Confidence 999999763 4689999999999999999999999999999999999999 6799999999997764332 23345688
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
+.|+|||++.+..++.++|+||+||++++|++|+.||...+.......+........ +..+++++.+++.+||+.+|++
T Consensus 166 ~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~ 244 (257)
T cd08223 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPM-PKDYSPELGELIATMLSKRPEK 244 (257)
T ss_pred cCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC-ccccCHHHHHHHHHHhccCccc
Confidence 999999999999999999999999999999999999998877766666555543333 3468999999999999999999
Q ss_pred CCCHHHHhcCCCC
Q psy5368 282 RISYEDLFSHPYP 294 (406)
Q Consensus 282 Rps~~ell~hp~~ 294 (406)
||++.++++||||
T Consensus 245 Rp~~~~~l~~~~~ 257 (257)
T cd08223 245 RPSVKSILRQPYI 257 (257)
T ss_pred CCCHHHHhcCCCC
Confidence 9999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=307.29 Aligned_cols=239 Identities=28% Similarity=0.409 Sum_probs=196.9
Q ss_pred eeeecceeeeEEEeeeee-eceeEEeeeecCCcc------chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEecc
Q psy5368 56 TIRYGELQYDTVQNSQIR-LGTVKYSQVRYDTIT------SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYC 122 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~-~~~v~vk~~~~~~~~------~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~ 122 (406)
...||.|+||.||++... +..+++|.+...... ....+.+|+.+++.++|+|+++ ..+..|+|+||+
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (265)
T cd06631 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFV 84 (265)
T ss_pred cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecC
Confidence 356899999999999764 345777766543211 1245888999999999999765 567889999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-------CC
Q psy5368 123 DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-------DQ 194 (406)
Q Consensus 123 ~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-------~~ 194 (406)
++++|.+++.+.+++++..+..++.|++.||+|||+.|++|+||+|+||+++ ++.++|+|||++...... ..
T Consensus 85 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 164 (265)
T cd06631 85 PGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNM 164 (265)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccccccccc
Confidence 9999999998888899999999999999999999999999999999999998 779999999998764321 12
Q ss_pred CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCCCCCCCCChHHHHHHHH
Q psy5368 195 GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSS-APITIPPNSLSPDCMDFLSR 273 (406)
Q Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~s~~l~~li~~ 273 (406)
.....++..|+|||++.+..++.++|+||+||++|+|++|..||...+.......+... ......+..++.++.+++.+
T Consensus 165 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 244 (265)
T cd06631 165 LKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTS 244 (265)
T ss_pred ccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHH
Confidence 23456889999999999988999999999999999999999999876654443333332 12222334689999999999
Q ss_pred hcccCCCCCCCHHHHhcCCCC
Q psy5368 274 LLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 274 ~L~~dP~~Rps~~ell~hp~~ 294 (406)
||..+|.+||++.++++||||
T Consensus 245 ~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 245 CLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=332.74 Aligned_cols=243 Identities=26% Similarity=0.419 Sum_probs=204.0
Q ss_pred ceeeecceeeeEEEeeeeeec--eeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 55 STIRYGELQYDTVQNSQIRLG--TVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~~--~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...++|+|.||+||.|+...+ .+++|.+.........-+..|+.+.+.|+|.||+. .++++-|.||-++||+
T Consensus 579 ervVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 579 ERVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred ceEEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 456899999999999997655 56778777666666667889999999999999876 7788889999999999
Q ss_pred HHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee--CCeeEEEecccccccCCCC-CCCcccC
Q psy5368 127 LCSFIRSH-EKL--SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK--NNTLKLADFGFAQFLAPND-QGDSIQG 200 (406)
Q Consensus 127 L~~~l~~~-~~l--~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~--~~~~kL~DFGla~~~~~~~-~~~~~~g 200 (406)
|+++++.. +++ .+.++-.+.+||++||.|||++.|||||||-+|||++ .|.+||+|||-++.+..-. -..++.|
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG 738 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG 738 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence 99999765 677 8889999999999999999999999999999999999 8999999999998875543 3457789
Q ss_pred CCCCCChhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCCCCCCCCChHHHHHHHHhccc
Q psy5368 201 SPLYMAPEILAGSP--YNAKADLWSLGVLVFEALFGHAPYASCNL-SQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 201 t~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~ 277 (406)
|..|||||++..++ |+.++|||||||++.||.||++||..... .....++-.....+..|..+|.+++.||.+|+.+
T Consensus 739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFep 818 (1226)
T KOG4279|consen 739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEP 818 (1226)
T ss_pred chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCC
Confidence 99999999998754 89999999999999999999999976432 2222222221122222337899999999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCC
Q psy5368 278 DPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 278 dP~~Rps~~ell~hp~~~~~ 297 (406)
||.+||++.++|.+||+...
T Consensus 819 d~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 819 DPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred CcccCccHHHhccCcccccC
Confidence 99999999999999998755
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=310.12 Aligned_cols=241 Identities=28% Similarity=0.468 Sum_probs=205.2
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...+|.|++|.||++... +..+++|.+.... ......+.+|+.+++.++|+|+++ .....|+|+||+++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (274)
T cd06609 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGS 85 (274)
T ss_pred hhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCc
Confidence 346799999999999864 4567888776543 334457889999999999999765 5678899999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCcccCCCCC
Q psy5368 127 LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDSIQGSPLY 204 (406)
Q Consensus 127 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~~~gt~~y 204 (406)
|.+++..+ ++++..+..++.|++.||.|||+++++|+||+|+||+++ ++.++|+|||+++..... .......+++.|
T Consensus 86 L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y 164 (274)
T cd06609 86 CLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFW 164 (274)
T ss_pred HHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccccccCCccc
Confidence 99999765 899999999999999999999999999999999999999 679999999999877544 233455688899
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRIS 284 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps 284 (406)
+|||.+.+..++.++|||||||++|+|+||..||...+.......+........+...++.++.+++.+||..+|++|||
T Consensus 165 ~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt 244 (274)
T cd06609 165 MAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPS 244 (274)
T ss_pred cChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcC
Confidence 99999999889999999999999999999999998877666665555554444444348999999999999999999999
Q ss_pred HHHHhcCCCCCCC
Q psy5368 285 YEDLFSHPYPDLI 297 (406)
Q Consensus 285 ~~ell~hp~~~~~ 297 (406)
++++++||||...
T Consensus 245 ~~~il~~~~~~~~ 257 (274)
T cd06609 245 AKELLKHKFIKKA 257 (274)
T ss_pred HHHHhhChhhcCC
Confidence 9999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=321.20 Aligned_cols=244 Identities=25% Similarity=0.439 Sum_probs=198.0
Q ss_pred eeeecceeeeEEEeeeeee--ceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIRL--GTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++.... ..+++|.+.... ......+.+|+.++..++|++++. ..+.+|+||||+++
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~ 85 (332)
T cd05623 6 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVG 85 (332)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCC
Confidence 4578999999999988743 456777664321 122335788999999999999754 67789999999999
Q ss_pred CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC--CCcccC
Q psy5368 125 GDLCSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ--GDSIQG 200 (406)
Q Consensus 125 gsL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~--~~~~~g 200 (406)
|+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++........ .....|
T Consensus 86 g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~g 165 (332)
T cd05623 86 GDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVG 165 (332)
T ss_pred CcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcceeccccc
Confidence 999999976 46799999999999999999999999999999999999998 77999999999876533322 234569
Q ss_pred CCCCCChhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCC--CCCChHHHHHHH
Q psy5368 201 SPLYMAPEILA-----GSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP-ITIPP--NSLSPDCMDFLS 272 (406)
Q Consensus 201 t~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~--~~~s~~l~~li~ 272 (406)
|+.|+|||++. ...++.++|||||||++|||++|+.||...+..+....+..... ...+. ..+++++.+|+.
T Consensus 166 t~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~ 245 (332)
T cd05623 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIR 245 (332)
T ss_pred CccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHH
Confidence 99999999986 34588999999999999999999999999888777777765432 22222 267999999999
Q ss_pred HhcccCCCC--CCCHHHHhcCCCCCCCCC
Q psy5368 273 RLLQKDPMR--RISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 273 ~~L~~dP~~--Rps~~ell~hp~~~~~~~ 299 (406)
+||..+|.+ |++++++++||||....+
T Consensus 246 ~ll~~~~~r~~r~~~~~~~~h~~f~~~~~ 274 (332)
T cd05623 246 RLICSREHRLGQNGIEDFKQHPFFTGIDW 274 (332)
T ss_pred HHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence 999765444 789999999999987654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=311.65 Aligned_cols=242 Identities=26% Similarity=0.434 Sum_probs=200.8
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
...+|+|++|.||++.. .+..+++|.+..........+.+|+.+++.++|+|+++ .....|+||||+++++|
T Consensus 25 ~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L 104 (296)
T cd06654 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (296)
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCH
Confidence 34678888899998875 34578888877666666678899999999999999766 56789999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC-CCcccCCCCCC
Q psy5368 128 CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ-GDSIQGSPLYM 205 (406)
Q Consensus 128 ~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~-~~~~~gt~~y~ 205 (406)
.+++.+ ..+++.++..++.|++.||.|||+.||+|+||||+||+++ ++.++|+|||++........ .....+++.|+
T Consensus 105 ~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~ 183 (296)
T cd06654 105 TDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 183 (296)
T ss_pred HHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcccCCcccc
Confidence 999865 4689999999999999999999999999999999999998 67999999999876543322 23456889999
Q ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-CCCCCChHHHHHHHHhcccCCCCCCC
Q psy5368 206 APEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITI-PPNSLSPDCMDFLSRLLQKDPMRRIS 284 (406)
Q Consensus 206 aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~~li~~~L~~dP~~Rps 284 (406)
|||.+.+..++.++|+|||||++|+|++|+.||...+................ .+..++..+.+++.+||..+|++||+
T Consensus 184 aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt 263 (296)
T cd06654 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS 263 (296)
T ss_pred CHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcC
Confidence 99999998899999999999999999999999988765444333332222221 23368899999999999999999999
Q ss_pred HHHHhcCCCCCCCC
Q psy5368 285 YEDLFSHPYPDLIH 298 (406)
Q Consensus 285 ~~ell~hp~~~~~~ 298 (406)
++++++||||....
T Consensus 264 ~~eil~~~~~~~~~ 277 (296)
T cd06654 264 AKELLQHQFLKIAK 277 (296)
T ss_pred HHHHhhChhhhccC
Confidence 99999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=314.16 Aligned_cols=244 Identities=25% Similarity=0.404 Sum_probs=196.6
Q ss_pred eeeecceeeeEEEeeeeee--ceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIRL--GTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...||+|+||.||++.... ..+++|....... ....++.+|++++.+++|||+++ .++.+|+||||+++++
T Consensus 6 ~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~ 85 (308)
T cd06615 6 LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 85 (308)
T ss_pred EeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCc
Confidence 4568999999999998643 3455555543322 22346889999999999999765 6788999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCC
Q psy5368 127 LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRE-NNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLY 204 (406)
Q Consensus 127 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~-~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y 204 (406)
|.++++..+.+++..+..++.|++.||.|||+ .+++|+||||.||+++ ++.++|+|||++...... ......+++.|
T Consensus 86 L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~ 164 (308)
T cd06615 86 LDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSY 164 (308)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-ccccCCCCcCc
Confidence 99999888889999999999999999999997 5999999999999998 678999999998765332 23445789999
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---------------------------------
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQAL--------------------------------- 251 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~--------------------------------- 251 (406)
+|||.+.+..++.++|+|||||++|+|++|+.||...+.........
T Consensus 165 ~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (308)
T cd06615 165 MSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLD 244 (308)
T ss_pred cChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHH
Confidence 99999988889999999999999999999999997655333222111
Q ss_pred ---hcCCCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy5368 252 ---SSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAP 300 (406)
Q Consensus 252 ---~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 300 (406)
....+..+...++.++.+|+.+||..+|++|||++++++||||.....+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 296 (308)
T cd06615 245 YIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE 296 (308)
T ss_pred HHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccc
Confidence 1112222223478899999999999999999999999999999865433
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=309.93 Aligned_cols=241 Identities=28% Similarity=0.443 Sum_probs=198.7
Q ss_pred eeecceeeeEEEeeeeee--ceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHH
Q psy5368 57 IRYGELQYDTVQNSQIRL--GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLC 128 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~ 128 (406)
..||+|+||.||++.... ..+++|............+.+|+.+++.++|||+++ ..+..|+|+||+++++|.
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~ 90 (282)
T cd06643 11 GELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVD 90 (282)
T ss_pred hhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHH
Confidence 458999999999998754 345666554444444567889999999999999765 567889999999999999
Q ss_pred HHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCcccCCCCCC
Q psy5368 129 SFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDSIQGSPLYM 205 (406)
Q Consensus 129 ~~l~~-~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~~~gt~~y~ 205 (406)
.++.. ..++++..+..++.|++.||.|||+.|++|+||||+||+++ ++.++|+|||++...... .......+++.|+
T Consensus 91 ~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~ 170 (282)
T cd06643 91 AVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWM 170 (282)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccccccccccccc
Confidence 98865 45799999999999999999999999999999999999998 779999999998664322 2234456899999
Q ss_pred Chhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-CCCCCChHHHHHHHHhcccCC
Q psy5368 206 APEILA-----GSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITI-PPNSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 206 aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~~li~~~L~~dP 279 (406)
|||++. +..++.++|+||+||++|+|++|.+||...+.......+........ .+..++.++.+|+.+||+.||
T Consensus 171 aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 250 (282)
T cd06643 171 APEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNV 250 (282)
T ss_pred CHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCCh
Confidence 999984 34578899999999999999999999998876666555554433322 233688999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCC
Q psy5368 280 MRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 280 ~~Rps~~ell~hp~~~~~ 297 (406)
.+||+++++++||||+..
T Consensus 251 ~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 251 DARWTTTQLLQHPFVTVN 268 (282)
T ss_pred hhCcCHHHHhcCCCEecc
Confidence 999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=307.93 Aligned_cols=238 Identities=24% Similarity=0.357 Sum_probs=194.7
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
...||+|+||.||++... ...+++|............+.+|+.+++.++|||+++ ..+.+|+||||+++++|
T Consensus 14 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 93 (267)
T cd06645 14 IQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSL 93 (267)
T ss_pred HHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcH
Confidence 356799999999999863 4567777776554444557889999999999999765 66789999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCCCC
Q psy5368 128 CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPLYM 205 (406)
Q Consensus 128 ~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~y~ 205 (406)
.+++...+.+++.++..++.|++.||.|||+.|++|+||||+||+++ ++.++|+|||++....... ......|++.|+
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~ 173 (267)
T cd06645 94 QDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWM 173 (267)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccccCccccc
Confidence 99998888999999999999999999999999999999999999998 6799999999987654322 234457899999
Q ss_pred Chhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CC-CC-CCCCChHHHHHHHHhcccCC
Q psy5368 206 APEILA---GSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP-IT-IP-PNSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 206 aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~-~~-~~~~s~~l~~li~~~L~~dP 279 (406)
|||++. ...++.++|+||+||++|+|++|..||................. .. .. ...++..+.+++.+||+.+|
T Consensus 174 aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 253 (267)
T cd06645 174 APEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNP 253 (267)
T ss_pred ChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCc
Confidence 999985 45588999999999999999999999976554333322222211 11 11 12578899999999999999
Q ss_pred CCCCCHHHHhcCCC
Q psy5368 280 MRRISYEDLFSHPY 293 (406)
Q Consensus 280 ~~Rps~~ell~hp~ 293 (406)
++|||++++++|||
T Consensus 254 ~~R~~~~~ll~~~~ 267 (267)
T cd06645 254 KKRPTAEKLLQHPF 267 (267)
T ss_pred hhCcCHHHHhcCCC
Confidence 99999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=317.65 Aligned_cols=236 Identities=25% Similarity=0.386 Sum_probs=182.8
Q ss_pred eeeecceeeeEEEeeeeee----ceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc--------cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIRL----GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK--------RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~----~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~--------~~~~~~lV~E~~~ 123 (406)
..+||+|+||.||++.... ..+++|.+.... ....+.+|+.+++.++|||++. ....+|+||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 4579999999999998643 457777665432 2346789999999999999764 4567899999996
Q ss_pred CCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-----CCeeEEEeccccccc
Q psy5368 124 GGDLCSFIRSH---------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-----NNTLKLADFGFAQFL 189 (406)
Q Consensus 124 ggsL~~~l~~~---------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-----~~~~kL~DFGla~~~ 189 (406)
+ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+. ++.+||+|||+++..
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 5 888887532 2488999999999999999999999999999999999994 458999999999876
Q ss_pred CCCC----CCCcccCCCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHhcCC
Q psy5368 190 APND----QGDSIQGSPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLS---------QLRAQALSSAP 255 (406)
Q Consensus 190 ~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~---------~~~~~~~~~~~ 255 (406)
.... ......+|+.|+|||++.+. .++.++||||+||++|||+||++||...... .....+.....
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcC
Confidence 4332 22345689999999999774 5899999999999999999999999753311 00000000000
Q ss_pred ------------------------------------CCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 256 ------------------------------------ITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 256 ------------------------------------~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
........+..+.+|+.+||+.||.+|||++|+++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000011245678999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=332.89 Aligned_cols=238 Identities=20% Similarity=0.262 Sum_probs=183.0
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCC------Ccc-------cCCeEEEEEe
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPE------GRK-------RPRYVYIILE 120 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~n------i~~-------~~~~~~lV~E 120 (406)
..+||+|+||+||++... ...|++|.+.... .....+..|+.++..++|.+ ++. ..+++|+|||
T Consensus 134 ~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~ 212 (467)
T PTZ00284 134 LSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMP 212 (467)
T ss_pred EEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEe
Confidence 345778888888888753 3457888765321 22344566777777776654 222 3467899999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCcceEeeC-C----------------eeEEEe
Q psy5368 121 YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRE-NNVCHFDLKPQNILIKN-N----------------TLKLAD 182 (406)
Q Consensus 121 ~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~-~givH~Dlkp~NIll~~-~----------------~~kL~D 182 (406)
++ |++|.+++.+++.+++..+..++.||+.||+|||+ .||+||||||+|||++. + .+||+|
T Consensus 213 ~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~D 291 (467)
T PTZ00284 213 KY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICD 291 (467)
T ss_pred cc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECC
Confidence 99 67999999888899999999999999999999998 59999999999999983 2 499999
Q ss_pred cccccccCCCCCCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-------
Q psy5368 183 FGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP------- 255 (406)
Q Consensus 183 FGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~------- 255 (406)
||.+... ........||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+....+.....
T Consensus 292 fG~~~~~--~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~ 369 (467)
T PTZ00284 292 LGGCCDE--RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWA 369 (467)
T ss_pred CCccccC--ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHH
Confidence 9987543 2334456799999999999999999999999999999999999999988765443332221100
Q ss_pred -------------------CCCC--------------CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy5368 256 -------------------ITIP--------------PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 256 -------------------~~~~--------------~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 297 (406)
.... ....++.+.+||.+||++||++|||++|+|+||||...
T Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 370 GRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY 444 (467)
T ss_pred hhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence 0000 00124567899999999999999999999999999864
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=313.70 Aligned_cols=247 Identities=23% Similarity=0.420 Sum_probs=204.7
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc---chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT---SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|++|.||++... +..+++|.+...... ....+.+|++++..++|||+++ .....|+||||+.|
T Consensus 6 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (316)
T cd05574 6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPG 85 (316)
T ss_pred eeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCC
Confidence 356899999999999874 467788877665433 3456889999999999999765 66778999999999
Q ss_pred CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC-------
Q psy5368 125 GDLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ------- 194 (406)
Q Consensus 125 gsL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~------- 194 (406)
++|.+++... ..+++..+..++.|++.||+|||+.|++|+||||+||+++ ++.++|+|||++........
T Consensus 86 ~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 165 (316)
T cd05574 86 GELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALR 165 (316)
T ss_pred CCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccc
Confidence 9999999764 4699999999999999999999999999999999999998 77999999999865432211
Q ss_pred -----------------------CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy5368 195 -----------------------GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQAL 251 (406)
Q Consensus 195 -----------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 251 (406)
.....||..|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~ 245 (316)
T cd05574 166 KGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNIL 245 (316)
T ss_pred cccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHh
Confidence 123457889999999999889999999999999999999999999888776666655
Q ss_pred hcCCCCCCCCCCChHHHHHHHHhcccCCCCCCC----HHHHhcCCCCCCCCCCCc
Q psy5368 252 SSAPITIPPNSLSPDCMDFLSRLLQKDPMRRIS----YEDLFSHPYPDLIHAPCA 302 (406)
Q Consensus 252 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps----~~ell~hp~~~~~~~~~~ 302 (406)
...........+++++.+++.+||..||++||| ++++++||||+...++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~ 300 (316)
T cd05574 246 KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALI 300 (316)
T ss_pred cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhc
Confidence 443222222247999999999999999999999 999999999998766443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=322.82 Aligned_cols=237 Identities=22% Similarity=0.362 Sum_probs=190.2
Q ss_pred ceeeecceeeeEEEeeeee-------eceeEEeeeecCC-ccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEE
Q psy5368 55 STIRYGELQYDTVQNSQIR-------LGTVKYSQVRYDT-ITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIIL 119 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~-------~~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~ 119 (406)
....||+|+||.||++... ...+++|.+.... ......+.+|+.++..+ +|||+++ ..+..++||
T Consensus 39 ~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~ 118 (375)
T cd05104 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVIT 118 (375)
T ss_pred hhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeee
Confidence 3578999999999999742 2367888776443 22345688999999999 8999876 566789999
Q ss_pred eccCCCCHHHHHHhCC----------------------------------------------------------------
Q psy5368 120 EYCDGGDLCSFIRSHE---------------------------------------------------------------- 135 (406)
Q Consensus 120 E~~~ggsL~~~l~~~~---------------------------------------------------------------- 135 (406)
|||+||+|.++++...
T Consensus 119 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (375)
T cd05104 119 EYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQD 198 (375)
T ss_pred hhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccc
Confidence 9999999999996532
Q ss_pred -----------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC---CCcccC
Q psy5368 136 -----------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ---GDSIQG 200 (406)
Q Consensus 136 -----------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~---~~~~~g 200 (406)
.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....... .....+
T Consensus 199 ~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 278 (375)
T cd05104 199 VTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278 (375)
T ss_pred cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCC
Confidence 478889999999999999999999999999999999999 56899999999976543322 122334
Q ss_pred CCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCC
Q psy5368 201 SPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 201 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP 279 (406)
+..|+|||++.+..++.++|||||||++|||++ |..||..........+..........+...+.++.+|+.+||+.||
T Consensus 279 ~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 358 (375)
T cd05104 279 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADP 358 (375)
T ss_pred CcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCCh
Confidence 567999999999999999999999999999998 8999987654443333333322222233578899999999999999
Q ss_pred CCCCCHHHHhcC
Q psy5368 280 MRRISYEDLFSH 291 (406)
Q Consensus 280 ~~Rps~~ell~h 291 (406)
++|||+.++++.
T Consensus 359 ~~RPs~~eil~~ 370 (375)
T cd05104 359 LKRPTFKQIVQL 370 (375)
T ss_pred hHCcCHHHHHHH
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=312.08 Aligned_cols=241 Identities=28% Similarity=0.465 Sum_probs=201.8
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
...+|.|++|.||++.. .+..+++|.+..........+.+|+.+++.++|||++. ..+.+|+|+||+++++|
T Consensus 24 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 103 (296)
T cd06655 24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL 103 (296)
T ss_pred EEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcH
Confidence 34578888888888874 44678888887666566678899999999999999765 56779999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC-CCcccCCCCCC
Q psy5368 128 CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ-GDSIQGSPLYM 205 (406)
Q Consensus 128 ~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~-~~~~~gt~~y~ 205 (406)
.+++.. ..+++.++..++.|++.||.|||+.|++|+||||+||+++ ++.++|+|||++........ .....+++.|+
T Consensus 104 ~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~ 182 (296)
T cd06655 104 TDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182 (296)
T ss_pred HHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcCCCcccc
Confidence 999865 4689999999999999999999999999999999999998 77999999999876543322 23456889999
Q ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-CCCCCCChHHHHHHHHhcccCCCCCCC
Q psy5368 206 APEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPIT-IPPNSLSPDCMDFLSRLLQKDPMRRIS 284 (406)
Q Consensus 206 aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~s~~l~~li~~~L~~dP~~Rps 284 (406)
|||.+.+..++.++|+|||||++|+|++|..||...+.......+....... ..+..+++.+.+++.+||..||.+||+
T Consensus 183 aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt 262 (296)
T cd06655 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGS 262 (296)
T ss_pred CcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCC
Confidence 9999999889999999999999999999999998877655444443332222 223468899999999999999999999
Q ss_pred HHHHhcCCCCCCC
Q psy5368 285 YEDLFSHPYPDLI 297 (406)
Q Consensus 285 ~~ell~hp~~~~~ 297 (406)
+.++++||||+..
T Consensus 263 ~~~il~~~~~~~~ 275 (296)
T cd06655 263 AKELLQHPFLKLA 275 (296)
T ss_pred HHHHhhChHhhhc
Confidence 9999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=319.96 Aligned_cols=242 Identities=24% Similarity=0.383 Sum_probs=193.2
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCccc------------CCeEEEEE
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRKR------------PRYVYIIL 119 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~~------------~~~~~lV~ 119 (406)
...||+|+||.||++... ...+++|.+..... .....+.+|+.++++++|||++.. ....|+++
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~ 99 (343)
T cd07878 20 LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVT 99 (343)
T ss_pred heecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEe
Confidence 356899999999999753 35688887764322 234567889999999999997651 24579999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcc
Q psy5368 120 EYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSI 198 (406)
Q Consensus 120 E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~ 198 (406)
|++ +++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||+++.... .....
T Consensus 100 ~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~ 175 (343)
T cd07878 100 NLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD--EMTGY 175 (343)
T ss_pred ecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC--CcCCc
Confidence 998 6799988754 5799999999999999999999999999999999999998 67999999999976543 33456
Q ss_pred cCCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----------------------
Q psy5368 199 QGSPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP---------------------- 255 (406)
Q Consensus 199 ~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~---------------------- 255 (406)
.||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..+....+.....
T Consensus 176 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (343)
T cd07878 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSL 255 (343)
T ss_pred cccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhcc
Confidence 78999999999987 5689999999999999999999999987665444333322100
Q ss_pred CCCCC-------CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q psy5368 256 ITIPP-------NSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPC 301 (406)
Q Consensus 256 ~~~~~-------~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~ 301 (406)
...+. ...++.+.+|+.+||..||.+|||+.++++||||.....|.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~ 308 (343)
T cd07878 256 PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPE 308 (343)
T ss_pred ccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCc
Confidence 00110 13567789999999999999999999999999998765543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=306.89 Aligned_cols=241 Identities=27% Similarity=0.395 Sum_probs=195.7
Q ss_pred CceeeecceeeeEEEeeeee--eceeEEeeeecCCc-----cchhhhhhHHhhcccCCCCCCcc--------cCCeEEEE
Q psy5368 54 SSTIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI-----TSHSEFERPRAGLSNLRAPEGRK--------RPRYVYII 118 (406)
Q Consensus 54 ~~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~-----~~~~~~~~E~~~l~~l~h~ni~~--------~~~~~~lV 118 (406)
.....+|+|+||.||++... ++.+++|....... .....+.+|+.++++++|||++. ....++++
T Consensus 5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~ 84 (266)
T cd06651 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF 84 (266)
T ss_pred cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence 34568899999999999863 45677876654321 12346888999999999999765 24678999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC----
Q psy5368 119 LEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND---- 193 (406)
Q Consensus 119 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~---- 193 (406)
+||+++++|.+++...+.+++.....++.|++.||+|||++|++|+||+|+||+++ ++.++|+|||++.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (266)
T cd06651 85 MEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGT 164 (266)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCC
Confidence 99999999999998878899999999999999999999999999999999999998 6689999999987653211
Q ss_pred CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHH
Q psy5368 194 QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSR 273 (406)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~ 273 (406)
......++..|+|||.+.+..++.++|+||+||++|+|++|+.||.....................+..+++.+.+++ +
T Consensus 165 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~ 243 (266)
T cd06651 165 GIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-G 243 (266)
T ss_pred ccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-H
Confidence 122345788999999999988999999999999999999999999877655444443333222222335788899999 6
Q ss_pred hcccCCCCCCCHHHHhcCCCCC
Q psy5368 274 LLQKDPMRRISYEDLFSHPYPD 295 (406)
Q Consensus 274 ~L~~dP~~Rps~~ell~hp~~~ 295 (406)
||..+|++||+++|+++||||+
T Consensus 244 ~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 244 CIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HhcCChhhCcCHHHHhcCcccc
Confidence 7778999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=310.18 Aligned_cols=240 Identities=31% Similarity=0.475 Sum_probs=201.1
Q ss_pred eecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHHH
Q psy5368 58 RYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLCS 129 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~~ 129 (406)
.||.|++|.||++... ...+++|............+.+|+.++++++|||+++ .....|+||||+++++|.+
T Consensus 12 ~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 91 (280)
T cd06611 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDS 91 (280)
T ss_pred HhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHH
Confidence 4699999999999874 4567777776555455667899999999999999765 6778999999999999999
Q ss_pred HHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCCCCC
Q psy5368 130 FIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPLYMA 206 (406)
Q Consensus 130 ~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~y~a 206 (406)
++... ..+++..+..++.|++.||.|||++||+|+||||+||+++ ++.++|+|||++....... ......+++.|+|
T Consensus 92 ~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~ 171 (280)
T cd06611 92 IMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMA 171 (280)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccceeecchhhcC
Confidence 99764 4799999999999999999999999999999999999998 7799999999986553322 2334568999999
Q ss_pred hhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-CCCCCChHHHHHHHHhcccCCC
Q psy5368 207 PEILA-----GSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITI-PPNSLSPDCMDFLSRLLQKDPM 280 (406)
Q Consensus 207 PE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~~li~~~L~~dP~ 280 (406)
||.+. ...++.++|+||+||++|+|++|..||...........+........ .+..++.++.+++.+||+.+|.
T Consensus 172 PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 251 (280)
T cd06611 172 PEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPD 251 (280)
T ss_pred HHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChh
Confidence 99985 34477899999999999999999999998877666666655543332 2336889999999999999999
Q ss_pred CCCCHHHHhcCCCCCCC
Q psy5368 281 RRISYEDLFSHPYPDLI 297 (406)
Q Consensus 281 ~Rps~~ell~hp~~~~~ 297 (406)
+||+++++++|||++..
T Consensus 252 ~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 252 DRPTAAELLKHPFVSDQ 268 (280)
T ss_pred hCcCHHHHhcChhhccc
Confidence 99999999999999854
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=311.54 Aligned_cols=243 Identities=28% Similarity=0.447 Sum_probs=201.3
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
...||+|++|.||++.. .+..+++|.+..........+.+|+.+++.++|+|+++ ..++.|+||||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 103 (297)
T cd06656 24 FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 103 (297)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCH
Confidence 35678899999998875 45678888887666566677899999999999999766 56789999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC-CCcccCCCCCC
Q psy5368 128 CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ-GDSIQGSPLYM 205 (406)
Q Consensus 128 ~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~-~~~~~gt~~y~ 205 (406)
.+++.+ ..+++.++..++.|++.||.|||+.|++|+||||+||+++ ++.++|+|||++........ .....+++.|+
T Consensus 104 ~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~ 182 (297)
T cd06656 104 TDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182 (297)
T ss_pred HHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcccCCcccc
Confidence 999865 5689999999999999999999999999999999999998 67999999999876543332 23456889999
Q ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCCCCCChHHHHHHHHhcccCCCCCCC
Q psy5368 206 APEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSA-PITIPPNSLSPDCMDFLSRLLQKDPMRRIS 284 (406)
Q Consensus 206 aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~s~~l~~li~~~L~~dP~~Rps 284 (406)
|||.+.+..++.++|+||+||++|+|++|..||...+.......+.... +....+..++..+.+|+.+||..+|++||+
T Consensus 183 aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 262 (297)
T cd06656 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGS 262 (297)
T ss_pred CHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcC
Confidence 9999999889999999999999999999999998765433322222221 121223467889999999999999999999
Q ss_pred HHHHhcCCCCCCCCC
Q psy5368 285 YEDLFSHPYPDLIHA 299 (406)
Q Consensus 285 ~~ell~hp~~~~~~~ 299 (406)
++++++||||+....
T Consensus 263 ~~~il~~~~~~~~~~ 277 (297)
T cd06656 263 AKELLQHPFLKLAKP 277 (297)
T ss_pred HHHHhcCchhccccc
Confidence 999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=311.25 Aligned_cols=239 Identities=32% Similarity=0.554 Sum_probs=196.0
Q ss_pred eeeecceeeeEEEeeeeeec--eeEEeeeecCCccchh--hhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIRLG--TVKYSQVRYDTITSHS--EFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~--~v~vk~~~~~~~~~~~--~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...||+|+||+||++..... .+++|.+......... ...+|+.++++++|||+++ .....++|||+++++
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~ 83 (260)
T PF00069_consen 4 VKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGG 83 (260)
T ss_dssp EEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTE
T ss_pred eEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccc
Confidence 45789999999999997554 5888887766543333 3456999999999999865 678899999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEeccccccc-CCCCCCCcccCCCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFL-APNDQGDSIQGSPL 203 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~-~~~~~~~~~~gt~~ 203 (406)
+|.+++...+.+++..+..++.||+.||.+||++|++|+||||+||+++ ++.++|+|||.+... ..........+++.
T Consensus 84 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 163 (260)
T PF00069_consen 84 SLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVGTPE 163 (260)
T ss_dssp BHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSSSGG
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999778999999999999999999999999999999999999999 779999999999763 22334456678999
Q ss_pred CCChhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhcCCCCCCC--CCCChHHHHHHHHhccc
Q psy5368 204 YMAPEILA-GSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQ---ALSSAPITIPP--NSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 204 y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~---~~~~~~~~~~~--~~~s~~l~~li~~~L~~ 277 (406)
|+|||++. +..++.++|+||+|+++++|++|..||........... ........... ...+.++.+++.+||+.
T Consensus 164 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 243 (260)
T PF00069_consen 164 YMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSK 243 (260)
T ss_dssp GSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccC
Confidence 99999998 78899999999999999999999999998732222222 22211111001 12348999999999999
Q ss_pred CCCCCCCHHHHhcCCCC
Q psy5368 278 DPMRRISYEDLFSHPYP 294 (406)
Q Consensus 278 dP~~Rps~~ell~hp~~ 294 (406)
||++|||+.++++||||
T Consensus 244 ~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 244 DPEQRPSAEELLKHPWF 260 (260)
T ss_dssp SGGGSTTHHHHHTSGGG
T ss_pred ChhHCcCHHHHhcCCCC
Confidence 99999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=326.19 Aligned_cols=239 Identities=26% Similarity=0.407 Sum_probs=212.8
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCccchh---hhhhHHhhcccCCCCCCcccCCe------EEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITSHS---EFERPRAGLSNLRAPEGRKRPRY------VYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~~~---~~~~E~~~l~~l~h~ni~~~~~~------~~lV~E~~~g 124 (406)
-..||.|+||.||-+.. +...|+||+.......+.. ++..|+..|.+|+|||.+...++ .|||||||-|
T Consensus 31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG 110 (948)
T KOG0577|consen 31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG 110 (948)
T ss_pred HHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc
Confidence 35689999999999986 3457899999887655544 68899999999999998875444 4799999965
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCC
Q psy5368 125 GDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSP 202 (406)
Q Consensus 125 gsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~ 202 (406)
+-.|++.-. .++.+.++..|..+.+.||+|||+.+.+|||||+.|||++ .|.+||+|||.|..+ .+.++++|||
T Consensus 111 -SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~---~PAnsFvGTP 186 (948)
T KOG0577|consen 111 -SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM---APANSFVGTP 186 (948)
T ss_pred -cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc---CchhcccCCc
Confidence 999988543 5899999999999999999999999999999999999998 779999999998765 4567889999
Q ss_pred CCCChhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCC
Q psy5368 203 LYMAPEILAG---SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 203 ~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP 279 (406)
.|||||++.. +.|+-++||||+|++..||.-.++|.-..+....+..|..+..+.++.+..|+.++.|+..||++-|
T Consensus 187 ywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKip 266 (948)
T KOG0577|consen 187 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIP 266 (948)
T ss_pred cccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCc
Confidence 9999999864 6799999999999999999999999999999999999999999999988999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCC
Q psy5368 280 MRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 280 ~~Rps~~ell~hp~~~~~~ 298 (406)
.+|||.+++|+|+|+....
T Consensus 267 qeRptse~ll~H~fv~R~R 285 (948)
T KOG0577|consen 267 QERPTSEELLKHRFVLRER 285 (948)
T ss_pred ccCCcHHHHhhcchhccCC
Confidence 9999999999999987443
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=305.22 Aligned_cols=239 Identities=27% Similarity=0.443 Sum_probs=194.2
Q ss_pred ceeeecceeeeEEEeeeeee--ceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 55 STIRYGELQYDTVQNSQIRL--GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
....||+|+||.||++.... ..+++|.+..........+.+|+.+++.++|+|+++ ..+..++|+||+++++
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 91 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGS 91 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCC
Confidence 45689999999999998643 457888776655555668999999999999999765 6678999999999999
Q ss_pred HHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee--CCeeEEEecccccccCCCC-CCCcccC
Q psy5368 127 LCSFIRSH-EKL--SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK--NNTLKLADFGFAQFLAPND-QGDSIQG 200 (406)
Q Consensus 127 L~~~l~~~-~~l--~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~--~~~~kL~DFGla~~~~~~~-~~~~~~g 200 (406)
|.+++... ..+ ++..+..++.||+.||.|||++||+|+||||+||+++ ++.++|+|||++....... ......+
T Consensus 92 L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 171 (268)
T cd06624 92 LSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTG 171 (268)
T ss_pred HHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCC
Confidence 99999764 456 8889999999999999999999999999999999997 4589999999987654322 2334457
Q ss_pred CCCCCChhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH-HhcCCCCCCCCCCChHHHHHHHHhcc
Q psy5368 201 SPLYMAPEILAGSP--YNAKADLWSLGVLVFEALFGHAPYASCNLSQ-LRAQA-LSSAPITIPPNSLSPDCMDFLSRLLQ 276 (406)
Q Consensus 201 t~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~pf~~~~~~~-~~~~~-~~~~~~~~~~~~~s~~l~~li~~~L~ 276 (406)
++.|+|||++.+.. ++.++|+||+|+++|+|++|..||....... ..... ........ +..+++++.+|+.+||+
T Consensus 172 ~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~ 250 (268)
T cd06624 172 TLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEI-PESLSAEAKNFILRCFE 250 (268)
T ss_pred CccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCC-CcccCHHHHHHHHHHcC
Confidence 89999999987643 7889999999999999999999997643221 11111 11212222 33688999999999999
Q ss_pred cCCCCCCCHHHHhcCCCC
Q psy5368 277 KDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 277 ~dP~~Rps~~ell~hp~~ 294 (406)
.+|.+|||+.+++.||||
T Consensus 251 ~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 251 PDPDKRASAHDLLQDPFL 268 (268)
T ss_pred CCchhCCCHHHHHhCCCC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=319.72 Aligned_cols=244 Identities=24% Similarity=0.443 Sum_probs=198.3
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++... ...+++|.+.... ......+.+|..++..++|++++. ..++.|+||||++|
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~g 85 (331)
T cd05624 6 IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVG 85 (331)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 457899999999998864 3457777665422 122345788999999999999754 67889999999999
Q ss_pred CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC--CcccC
Q psy5368 125 GDLCSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG--DSIQG 200 (406)
Q Consensus 125 gsL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~--~~~~g 200 (406)
|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++ ++.+||+|||++......... ....|
T Consensus 86 g~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g 165 (331)
T cd05624 86 GDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVG 165 (331)
T ss_pred CcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeeccccC
Confidence 999999977 46799999999999999999999999999999999999998 779999999999766443322 23569
Q ss_pred CCCCCChhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCC--CCCChHHHHHHH
Q psy5368 201 SPLYMAPEILAG-----SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP-ITIPP--NSLSPDCMDFLS 272 (406)
Q Consensus 201 t~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~--~~~s~~l~~li~ 272 (406)
|+.|+|||++.+ ..++.++||||+||++|+|++|+.||...+..+....+..... ...+. ..+++++.+|+.
T Consensus 166 t~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~ 245 (331)
T cd05624 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQ 245 (331)
T ss_pred CcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHH
Confidence 999999999876 4578899999999999999999999998887777766655422 22222 257899999999
Q ss_pred HhcccCCCC--CCCHHHHhcCCCCCCCCC
Q psy5368 273 RLLQKDPMR--RISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 273 ~~L~~dP~~--Rps~~ell~hp~~~~~~~ 299 (406)
+||..++.+ |++++++++||||+...+
T Consensus 246 ~ll~~~~~~~~~~~~~~~~~h~~f~~~~~ 274 (331)
T cd05624 246 RLICSRERRLGQNGIEDFKKHAFFEGIDW 274 (331)
T ss_pred HHccCchhhcCCCCHHHHhcCCCcCCCCH
Confidence 999876554 569999999999987543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=302.62 Aligned_cols=239 Identities=30% Similarity=0.466 Sum_probs=201.5
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc-----cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEecc
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI-----TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYC 122 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~-----~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~ 122 (406)
...||+|++|.||++... +..+++|....... .....+.+|+.+++.++|+|+++ ....+|+|+||+
T Consensus 5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (258)
T cd06632 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELV 84 (258)
T ss_pred cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEec
Confidence 357899999999999874 56788887654331 23457889999999999999765 567789999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCC
Q psy5368 123 DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGS 201 (406)
Q Consensus 123 ~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt 201 (406)
++++|.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++ ++.+||+|||++.............++
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 164 (258)
T cd06632 85 PGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGS 164 (258)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccccCCC
Confidence 9999999998888899999999999999999999999999999999999998 779999999998876554444556689
Q ss_pred CCCCChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCC
Q psy5368 202 PLYMAPEILAGSP-YNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPM 280 (406)
Q Consensus 202 ~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~ 280 (406)
+.|+|||.+.... ++.++|+||+||++|+|++|..||...........+.........+..+++++.+++.+||+.+|.
T Consensus 165 ~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 244 (258)
T cd06632 165 PYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPS 244 (258)
T ss_pred cceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcc
Confidence 9999999998776 899999999999999999999999877654544444442223233346889999999999999999
Q ss_pred CCCCHHHHhcCCCC
Q psy5368 281 RRISYEDLFSHPYP 294 (406)
Q Consensus 281 ~Rps~~ell~hp~~ 294 (406)
+||++.+++.|||+
T Consensus 245 ~Rp~~~~~l~~~~~ 258 (258)
T cd06632 245 LRPTAAELLEHPFV 258 (258)
T ss_pred cCcCHHHHhcCCCC
Confidence 99999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=309.43 Aligned_cols=244 Identities=27% Similarity=0.445 Sum_probs=199.6
Q ss_pred eeecceeeeEEEeeeeee--ceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHH
Q psy5368 57 IRYGELQYDTVQNSQIRL--GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLC 128 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~ 128 (406)
.+||.|+||.||++.... ..+++|............+.+|+.+++.++|||++. .++.+|+||||+++++|.
T Consensus 18 ~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 97 (292)
T cd06644 18 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVD 97 (292)
T ss_pred heecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHH
Confidence 457899999999988643 456777766554445667889999999999999765 567899999999999999
Q ss_pred HHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCcccCCCCCC
Q psy5368 129 SFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDSIQGSPLYM 205 (406)
Q Consensus 129 ~~l~~-~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~~~gt~~y~ 205 (406)
.++.+ ...+++..+..++.|++.+|.|||+.|++|+||||+||+++ ++.++|+|||++...... .......+++.|+
T Consensus 98 ~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~ 177 (292)
T cd06644 98 AIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWM 177 (292)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccceecCCcccc
Confidence 88754 45799999999999999999999999999999999999998 779999999998654322 2234456889999
Q ss_pred Chhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-CCCCCChHHHHHHHHhcccCC
Q psy5368 206 APEILA-----GSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITI-PPNSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 206 aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~~li~~~L~~dP 279 (406)
|||++. ...++.++|+|||||++|+|++|..||...+.......+........ .+..++.++.+++.+||..+|
T Consensus 178 aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 257 (292)
T cd06644 178 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHP 257 (292)
T ss_pred CceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCc
Confidence 999985 34478899999999999999999999988776665555544433222 233678999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCC
Q psy5368 280 MRRISYEDLFSHPYPDLIHAP 300 (406)
Q Consensus 280 ~~Rps~~ell~hp~~~~~~~~ 300 (406)
++||+++++++||||.....+
T Consensus 258 ~~Rp~~~~il~~~~~~~~~~~ 278 (292)
T cd06644 258 ETRPSAAQLLEHPFVSSVTSN 278 (292)
T ss_pred ccCcCHHHHhcCccccccccc
Confidence 999999999999999876543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=301.69 Aligned_cols=238 Identities=26% Similarity=0.465 Sum_probs=201.9
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...||+|++|.||++.. ....+++|.+..... .....+.+|+.+++.++|||++. ..+..++||||++++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08220 5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGG 84 (256)
T ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCC
Confidence 45678888999988775 345677777655432 23457889999999999999655 567899999999999
Q ss_pred CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee--CCeeEEEecccccccCCCCCCCcccCC
Q psy5368 126 DLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK--NNTLKLADFGFAQFLAPNDQGDSIQGS 201 (406)
Q Consensus 126 sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~--~~~~kL~DFGla~~~~~~~~~~~~~gt 201 (406)
+|.+++... ..+++..+..++.|++.+|.|||++|++|+||+|+||+++ ++.++|+|||++.............++
T Consensus 85 ~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 164 (256)
T cd08220 85 TLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGT 164 (256)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccccccC
Confidence 999999764 3589999999999999999999999999999999999998 346899999999877655555556789
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
+.|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+........+ ..+++++.+++.+||..+|++
T Consensus 165 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~ 243 (256)
T cd08220 165 PCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPIS-DRYSPDLRQLILSMLNLDPSK 243 (256)
T ss_pred CcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCC-CCcCHHHHHHHHHHccCChhh
Confidence 9999999999888999999999999999999999999988877777666665444333 368999999999999999999
Q ss_pred CCCHHHHhcCCCC
Q psy5368 282 RISYEDLFSHPYP 294 (406)
Q Consensus 282 Rps~~ell~hp~~ 294 (406)
|||+.++++|||+
T Consensus 244 Rpt~~~ll~~p~~ 256 (256)
T cd08220 244 RPQLSQIMAQPIC 256 (256)
T ss_pred CCCHHHHhhCCCC
Confidence 9999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=303.50 Aligned_cols=237 Identities=29% Similarity=0.484 Sum_probs=198.4
Q ss_pred eeeecceeeeEEEeeeeee--ceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQIRL--GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
...+|+|++|.||++.... ..+++|.+..... ...+.+|++++++++|||+++ ....+|+++||+++++|
T Consensus 8 ~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 85 (256)
T cd06612 8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSV 85 (256)
T ss_pred hhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcH
Confidence 4568999999999999754 5677777654432 678999999999999999765 66789999999999999
Q ss_pred HHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCCC
Q psy5368 128 CSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPLY 204 (406)
Q Consensus 128 ~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~y 204 (406)
.+++... ..+++..+..++.|++.||.|||+.|++|+||+|.||+++ ++.++|+|||++....... ......++..|
T Consensus 86 ~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y 165 (256)
T cd06612 86 SDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFW 165 (256)
T ss_pred HHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccccccCCccc
Confidence 9999764 5789999999999999999999999999999999999998 6789999999998765443 33445578899
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC-CCCCChHHHHHHHHhcccCCCCCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIP-PNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
+|||++.+..++.++||||+|+++|+|++|+.||...........+......... +..++.++.+++.+||+.||.+||
T Consensus 166 ~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp 245 (256)
T cd06612 166 MAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERP 245 (256)
T ss_pred cCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCc
Confidence 9999999989999999999999999999999999876655444333332222211 225788999999999999999999
Q ss_pred CHHHHhcCCCC
Q psy5368 284 SYEDLFSHPYP 294 (406)
Q Consensus 284 s~~ell~hp~~ 294 (406)
|+++++.||||
T Consensus 246 s~~~il~~~~~ 256 (256)
T cd06612 246 SAIQLLQHPFI 256 (256)
T ss_pred CHHHHhcCCCC
Confidence 99999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=319.46 Aligned_cols=257 Identities=24% Similarity=0.368 Sum_probs=198.3
Q ss_pred ccceEEEeeee---e-eEEEeeeeecCCcceeeeeeccccccccceeeecCceeeecceeeeEEEeeeeeeceeEEeeee
Q psy5368 8 RYGTVRLGSVK---Y-GQVQLSTVRYGKVRYSQVRSDTVRSGTVRYDIVGSSTIRYGELQYDTVQNSQIRLGTVKYSQVR 83 (406)
Q Consensus 8 ~~~~V~ig~~~---~-gy~vv~~lg~G~~~~~~~~~d~~~~~~~~~~i~~~~~~~lG~G~~g~Vy~~~~~~~~v~vk~~~ 83 (406)
||++|.+|+.. . +|.+++.||.|+++.+|.+.+.. .+..+++|.+.
T Consensus 1 ~~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~------------------------------~~~~vaiK~~~ 50 (353)
T cd07850 1 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTV------------------------------TGQNVAIKKLS 50 (353)
T ss_pred CceeecccchhhhhhcceEEEEEeccCCCEEEEEEEECC------------------------------CCCEEEEEecC
Confidence 68999998843 2 38887777766666655554322 22345666554
Q ss_pred cC--CccchhhhhhHHhhcccCCCCCCccc------------CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHH
Q psy5368 84 YD--TITSHSEFERPRAGLSNLRAPEGRKR------------PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQL 149 (406)
Q Consensus 84 ~~--~~~~~~~~~~E~~~l~~l~h~ni~~~------------~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql 149 (406)
.. .......+.+|+.++++++|||+++. ....|+||||+.+ +|.+.+... +++..+..++.|+
T Consensus 51 ~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql 127 (353)
T cd07850 51 RPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQM 127 (353)
T ss_pred ccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHH
Confidence 32 22334567889999999999998652 2357999999965 999988654 8999999999999
Q ss_pred HHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHH
Q psy5368 150 VLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLV 228 (406)
Q Consensus 150 ~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 228 (406)
+.||+|||++|++||||||+||+++ ++.+||+|||++.............+++.|+|||.+.+..++.++||||+||++
T Consensus 128 ~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l 207 (353)
T cd07850 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 207 (353)
T ss_pred HHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHH
Confidence 9999999999999999999999999 679999999999876554444556688999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhcCCCC-----------------------------------C------CCCCCChHH
Q psy5368 229 FEALFGHAPYASCNLSQLRAQALSSAPIT-----------------------------------I------PPNSLSPDC 267 (406)
Q Consensus 229 ~elltg~~pf~~~~~~~~~~~~~~~~~~~-----------------------------------~------~~~~~s~~l 267 (406)
|+|++|+.||...+.......+....... . ++...++.+
T Consensus 208 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
T cd07850 208 GEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQA 287 (353)
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHH
Confidence 99999999998776544333332110000 0 011246678
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy5368 268 MDFLSRLLQKDPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 268 ~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 297 (406)
.+||.+||+.||++|||+.|+|.||||+..
T Consensus 288 ~~li~~~L~~dP~~R~t~~eiL~~~~~~~~ 317 (353)
T cd07850 288 RDLLSKMLVIDPEKRISVDDALQHPYINVW 317 (353)
T ss_pred HHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence 999999999999999999999999998743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=308.72 Aligned_cols=235 Identities=20% Similarity=0.357 Sum_probs=196.2
Q ss_pred eeeecceeeeEEEeeeeee-------ceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIRL-------GTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-------~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~ 121 (406)
...||+|+||.||++.... ..+++|....... .....+.+|+.++..++|||+++ ..+..|++|||
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~ 89 (283)
T cd05048 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEY 89 (283)
T ss_pred hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEec
Confidence 3467999999999988643 3477776654332 22456899999999999999766 55678999999
Q ss_pred cCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecc
Q psy5368 122 CDGGDLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFG 184 (406)
Q Consensus 122 ~~ggsL~~~l~~~----------------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFG 184 (406)
+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++ ++.++|+|||
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg 169 (283)
T cd05048 90 LAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFG 169 (283)
T ss_pred CCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCc
Confidence 9999999999764 4578899999999999999999999999999999999998 5689999999
Q ss_pred cccccCCCC---CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCC
Q psy5368 185 FAQFLAPND---QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPP 260 (406)
Q Consensus 185 la~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (406)
++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..++...+........+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~- 248 (283)
T cd05048 170 LSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCP- 248 (283)
T ss_pred ceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCc-
Confidence 997653322 1233456788999999998889999999999999999998 99999998888887777666544433
Q ss_pred CCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 261 NSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 261 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
..+|+++.+|+.+||+.||.+||++.+++++
T Consensus 249 ~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 249 EDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 4789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=306.53 Aligned_cols=238 Identities=24% Similarity=0.345 Sum_probs=192.4
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
...||+|+||.||++... +..+++|............+.+|+.++.+++|||+++ ..+..|+||||+++++|
T Consensus 14 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L 93 (267)
T cd06646 14 IQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSL 93 (267)
T ss_pred hheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcH
Confidence 456789999999998863 3457777776554445557889999999999999776 56788999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCCCC
Q psy5368 128 CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPLYM 205 (406)
Q Consensus 128 ~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~y~ 205 (406)
.+++..++++++..+..++.|++.||.|||+.||+|+||||+||+++ ++.++|+|||++....... ......+++.|+
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~ 173 (267)
T cd06646 94 QDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWM 173 (267)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccCccccCcccc
Confidence 99998888899999999999999999999999999999999999998 6689999999998664332 234456889999
Q ss_pred Chhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCC--CCCCChHHHHHHHHhcccCC
Q psy5368 206 APEILA---GSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSA-PITIP--PNSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 206 aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~--~~~~s~~l~~li~~~L~~dP 279 (406)
|||.+. ...++.++|+||+||++|+|++|..||...........+.... ..... ...++..+.+|+.+||+.+|
T Consensus 174 ~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 253 (267)
T cd06646 174 APEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNP 253 (267)
T ss_pred CHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCCh
Confidence 999985 3447889999999999999999999997654333222221111 11111 12578899999999999999
Q ss_pred CCCCCHHHHhcCCC
Q psy5368 280 MRRISYEDLFSHPY 293 (406)
Q Consensus 280 ~~Rps~~ell~hp~ 293 (406)
++|||++++++|+|
T Consensus 254 ~~Rp~~~~il~~l~ 267 (267)
T cd06646 254 KKRPTAERLLTHLF 267 (267)
T ss_pred hhCcCHHHHhcCCC
Confidence 99999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=303.38 Aligned_cols=240 Identities=29% Similarity=0.488 Sum_probs=203.2
Q ss_pred ecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 59 YGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 59 lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
+|.|+||.||++... +..+++|.+..... .....+.+|+.++++++|||+++ .....|+|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 589999999999975 56678887765443 34557889999999999999765 67789999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC---------CCCc
Q psy5368 128 CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND---------QGDS 197 (406)
Q Consensus 128 ~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~---------~~~~ 197 (406)
.+++...+.+++..+..++.||+.||+|||++|++|+||+|+||+++ ++.++|+|||++....... ....
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 99998877899999999999999999999999999999999999999 7799999999987643321 2234
Q ss_pred ccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhccc
Q psy5368 198 IQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 198 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~ 277 (406)
..++..|+|||.+.+..++.++|+||||+++++|++|..||...........+............++..+.+++.+||+.
T Consensus 161 ~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 240 (265)
T cd05579 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVP 240 (265)
T ss_pred cccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcC
Confidence 45788999999999888999999999999999999999999988888777666654322211113589999999999999
Q ss_pred CCCCCCCH---HHHhcCCCCCCCC
Q psy5368 278 DPMRRISY---EDLFSHPYPDLIH 298 (406)
Q Consensus 278 dP~~Rps~---~ell~hp~~~~~~ 298 (406)
+|.+|||+ .++++||||+...
T Consensus 241 ~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 241 DPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred CHhhcCCCccHHHHhcCccccCCC
Confidence 99999999 9999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=303.18 Aligned_cols=232 Identities=22% Similarity=0.379 Sum_probs=195.2
Q ss_pred eecceeeeEEEeeeee----eceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCCCC
Q psy5368 58 RYGELQYDTVQNSQIR----LGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDGGD 126 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~----~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ggs 126 (406)
.||+|+||.||++.+. ...+++|........ ....+.+|+.+++.++|||+++ .....++||||+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 5899999999998753 355777766544322 3457889999999999999775 4556789999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC----CCcccCC
Q psy5368 127 LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ----GDSIQGS 201 (406)
Q Consensus 127 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~----~~~~~gt 201 (406)
|.+++.....+++..+..++.|++.||+|||++|++|+||||.||+++ ++.+||+|||++........ .....++
T Consensus 82 L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 161 (257)
T cd05116 82 LNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWP 161 (257)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCC
Confidence 999998878899999999999999999999999999999999999999 66899999999977644332 1122345
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPM 280 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~ 280 (406)
+.|+|||.+....++.++|+|||||++|||++ |..||...+..++...+........+ ..+++++.++|.+||+.||+
T Consensus 162 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~-~~~~~~l~~li~~~~~~~p~ 240 (257)
T cd05116 162 VKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECP-QRCPPEMYDLMKLCWTYGVD 240 (257)
T ss_pred ccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCC-CCCCHHHHHHHHHHhccCch
Confidence 78999999988889999999999999999998 99999988888877777766554444 36899999999999999999
Q ss_pred CCCCHHHHhc
Q psy5368 281 RRISYEDLFS 290 (406)
Q Consensus 281 ~Rps~~ell~ 290 (406)
+||++.+|..
T Consensus 241 ~Rp~~~~i~~ 250 (257)
T cd05116 241 ERPGFAVVEL 250 (257)
T ss_pred hCcCHHHHHH
Confidence 9999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=306.71 Aligned_cols=239 Identities=28% Similarity=0.433 Sum_probs=193.5
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...+|+|++|.||++... +..+++|.+..... ...+.+.+|+.++++++|||++. .....++||||++++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 85 (286)
T cd07847 6 LSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHT 85 (286)
T ss_pred eeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCcc
Confidence 346799999999998864 45678887654332 23356789999999999999655 667889999999998
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPL 203 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~ 203 (406)
+|..++.....+++..+..++.||+.||.|||+.|++|+||||+||+++ ++.++|+|||++....... ......++..
T Consensus 86 ~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 165 (286)
T cd07847 86 VLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRW 165 (286)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccCcccccc
Confidence 8888887767899999999999999999999999999999999999999 6799999999998765443 2334567889
Q ss_pred CCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC------------------CCCC-----
Q psy5368 204 YMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP------------------ITIP----- 259 (406)
Q Consensus 204 y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~------------------~~~~----- 259 (406)
|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+..+....+..... ...+
T Consensus 166 ~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (286)
T cd07847 166 YRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETR 245 (286)
T ss_pred cCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccc
Confidence 999999876 4578999999999999999999999987765444333221100 0000
Q ss_pred ------CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 260 ------PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 260 ------~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
...++..+.+|+.+||+.+|++||++.+++.||||
T Consensus 246 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 246 EPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 02467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=325.06 Aligned_cols=238 Identities=22% Similarity=0.225 Sum_probs=189.9
Q ss_pred eeeecceeeeEEEeeeeee----ceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIRL----GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~----~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...||+|+||.||++.... ..+++|.... .....+|+.++++++|||+++ .....|+|||++. +
T Consensus 97 ~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~-----~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 170 (392)
T PHA03207 97 LSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTG-----GKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-C 170 (392)
T ss_pred EEeecCCCCeEEEEEEEcCCccceeEEEEeccc-----cccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-C
Confidence 4578999999999987532 4566665532 234678999999999999876 4567899999996 5
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC---CCcccCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ---GDSIQGS 201 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~---~~~~~gt 201 (406)
+|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++ ++.++|+|||++........ .....||
T Consensus 171 ~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt 250 (392)
T PHA03207 171 DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGT 250 (392)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccc
Confidence 9999997778899999999999999999999999999999999999999 67999999999976544322 2345799
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhc-------------------------
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLS---QLRAQALSS------------------------- 253 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~---~~~~~~~~~------------------------- 253 (406)
+.|+|||++.+..++.++||||+||++|||++|+.||.+.... .....+...
T Consensus 251 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (392)
T PHA03207 251 LETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAI 330 (392)
T ss_pred cCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcc
Confidence 9999999999999999999999999999999999999764321 111111110
Q ss_pred -CCC--CCC----CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy5368 254 -API--TIP----PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 254 -~~~--~~~----~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 299 (406)
... ..+ ...++.++.+||.+||..||++|||+.+++.||||+..+.
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 331 VLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred cccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 000 000 1135678999999999999999999999999999986543
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=309.54 Aligned_cols=242 Identities=26% Similarity=0.417 Sum_probs=193.2
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...||+|+||.||++... +..+++|.+...... ....+.+|+.+++.++|||+++ ..+..|+||||+++ +
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~-~ 89 (301)
T cd07873 11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-D 89 (301)
T ss_pred eeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecccc-C
Confidence 345788888888888764 456788877644322 3446788999999999999766 67788999999975 9
Q ss_pred HHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCC
Q psy5368 127 LCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPL 203 (406)
Q Consensus 127 L~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~ 203 (406)
|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++ ++.++|+|||++....... ......+++.
T Consensus 90 l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 169 (301)
T cd07873 90 LKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLW 169 (301)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccccceeec
Confidence 99988764 4689999999999999999999999999999999999998 6799999999987644322 2234457899
Q ss_pred CCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC------------------CCCC-----
Q psy5368 204 YMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP------------------ITIP----- 259 (406)
Q Consensus 204 y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~------------------~~~~----- 259 (406)
|+|||++.+. .++.++||||+||++|+|+||++||...+..+....+..... ...+
T Consensus 170 y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (301)
T cd07873 170 YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRAD 249 (301)
T ss_pred ccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccc
Confidence 9999998764 478899999999999999999999998776554433322100 0001
Q ss_pred -----CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 260 -----PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 260 -----~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
...+++++.+||.+||+.||.+|||++++++||||....
T Consensus 250 ~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 250 CLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 124688999999999999999999999999999997554
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=304.46 Aligned_cols=234 Identities=19% Similarity=0.267 Sum_probs=193.8
Q ss_pred eeeecceeeeEEEeeeee-----eceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIR-----LGTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~-----~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ 123 (406)
...||+|+||.||++..+ ...+++|.+..... .....+.+|+..+.+++|||+++ ..+..++||||++
T Consensus 10 ~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 89 (266)
T cd05064 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMS 89 (266)
T ss_pred eeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCC
Confidence 456899999999999753 34577777665432 22357889999999999999776 6678999999999
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC--Cccc
Q psy5368 124 GGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG--DSIQ 199 (406)
Q Consensus 124 ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~--~~~~ 199 (406)
+|+|.+++... ..+++..++.++.||+.||+|||++|++||||||+||+++ ++.++++|||.+......... ....
T Consensus 90 ~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 169 (266)
T cd05064 90 NGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGK 169 (266)
T ss_pred CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchhcccCCC
Confidence 99999999764 4799999999999999999999999999999999999998 679999999987654322211 1223
Q ss_pred CCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccC
Q psy5368 200 GSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKD 278 (406)
Q Consensus 200 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~d 278 (406)
++..|+|||.+.+..++.++|||||||++||+++ |..||...+..+....+........ +..++..+.+++.+||+.+
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~c~~~~ 248 (266)
T cd05064 170 SPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPA-PRNCPNLLHQLMLDCWQKE 248 (266)
T ss_pred CceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC-CCCCCHHHHHHHHHHcCCC
Confidence 4678999999999999999999999999999775 9999999888777777665544443 3468999999999999999
Q ss_pred CCCCCCHHHHhc
Q psy5368 279 PMRRISYEDLFS 290 (406)
Q Consensus 279 P~~Rps~~ell~ 290 (406)
|.+||+++++++
T Consensus 249 p~~RP~~~~i~~ 260 (266)
T cd05064 249 RGERPRFSQIHS 260 (266)
T ss_pred chhCCCHHHHHH
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=326.26 Aligned_cols=234 Identities=24% Similarity=0.364 Sum_probs=196.9
Q ss_pred eeeecceeeeEEEeeeeeeceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCCCCHH
Q psy5368 56 TIRYGELQYDTVQNSQIRLGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDGGDLC 128 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ggsL~ 128 (406)
...||+|.||+||+|.|. +.||||.+..+... ..+.|++|+..+++-||.|++- ....+.||+-+|+|-+|+
T Consensus 397 ~~rIGsGsFGtV~Rg~wh-GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~AIiTqwCeGsSLY 475 (678)
T KOG0193|consen 397 GERIGSGSFGTVYRGRWH-GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPLAIITQWCEGSSLY 475 (678)
T ss_pred cceeccccccceeecccc-cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCceeeeehhccCchhh
Confidence 447999999999999985 67888877765543 4568999999999999999754 333349999999999999
Q ss_pred HHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeC-CeeEEEecccccccC---CCCCCCcccCCCC
Q psy5368 129 SFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLADFGFAQFLA---PNDQGDSIQGSPL 203 (406)
Q Consensus 129 ~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~-~~~kL~DFGla~~~~---~~~~~~~~~gt~~ 203 (406)
.+|+-. ..|+....+.|++||++|+.|||.++|+|||||..||++.+ +.+||+|||++..-. .........|...
T Consensus 476 ~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsil 555 (678)
T KOG0193|consen 476 THLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLL 555 (678)
T ss_pred hhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchh
Confidence 999754 47999999999999999999999999999999999999995 799999999985432 2233455668889
Q ss_pred CCChhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC---CCCCCCCCChHHHHHHHHhccc
Q psy5368 204 YMAPEILAG---SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP---ITIPPNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 204 y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~s~~l~~li~~~L~~ 277 (406)
|||||+++. .+|++.+|||||||++|||+||..||...+.+.+...+-.+.. .......++.++++|+..||.+
T Consensus 556 wmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~ 635 (678)
T KOG0193|consen 556 WMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKF 635 (678)
T ss_pred hhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhc
Confidence 999999985 3599999999999999999999999998888877776666622 2222336788999999999999
Q ss_pred CCCCCCCHHHHhc
Q psy5368 278 DPMRRISYEDLFS 290 (406)
Q Consensus 278 dP~~Rps~~ell~ 290 (406)
++++||.+.+|+.
T Consensus 636 ~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 636 DREERPLFPQLLS 648 (678)
T ss_pred CcccCccHHHHHH
Confidence 9999999999987
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=309.06 Aligned_cols=246 Identities=26% Similarity=0.458 Sum_probs=205.4
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
...||+|+||.||++... +..+++|.+..........+.+|+.++..++|||+++ ..+..|+||||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 346899999999999863 5678888876655555677899999999999999755 56789999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCCCC
Q psy5368 128 CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPLYM 205 (406)
Q Consensus 128 ~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~y~ 205 (406)
.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++ ++.++|+|||++....... ......+++.|+
T Consensus 106 ~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~ 184 (297)
T cd06659 106 TDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWM 184 (297)
T ss_pred HHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecCcccc
Confidence 998755 5789999999999999999999999999999999999999 7799999999987654332 234456899999
Q ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-CCCCCChHHHHHHHHhcccCCCCCCC
Q psy5368 206 APEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITI-PPNSLSPDCMDFLSRLLQKDPMRRIS 284 (406)
Q Consensus 206 aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~~li~~~L~~dP~~Rps 284 (406)
|||++.+..++.++|+||+||++++|++|+.||...........+........ ....++..+.+++.+||+.+|.+||+
T Consensus 185 aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps 264 (297)
T cd06659 185 APEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERAT 264 (297)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcC
Confidence 99999998899999999999999999999999987776555554433322211 12367889999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCCc
Q psy5368 285 YEDLFSHPYPDLIHAPCA 302 (406)
Q Consensus 285 ~~ell~hp~~~~~~~~~~ 302 (406)
++++++||||.....|..
T Consensus 265 ~~~ll~~~~~~~~~~~~~ 282 (297)
T cd06659 265 AQELLDHPFLLQTGLPEC 282 (297)
T ss_pred HHHHhhChhhccCCCccc
Confidence 999999999987665543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=306.34 Aligned_cols=243 Identities=25% Similarity=0.450 Sum_probs=204.9
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
-..||+|++|.||++... +..+++|+...........+.+|+.+++.++|||++. ..+..|+|+||++|++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 468999999999999853 4568888776555455667899999999999999765 56788999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCCCC
Q psy5368 128 CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPLYM 205 (406)
Q Consensus 128 ~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~y~ 205 (406)
.+++.. .++++..+..++.|++.||+|||++|++||||+|+||+++ ++.++|+|||++....... ......|++.|+
T Consensus 104 ~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~ 182 (285)
T cd06648 104 TDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWM 182 (285)
T ss_pred HHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCCcccc
Confidence 999977 6799999999999999999999999999999999999999 6799999999886554332 223456899999
Q ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC-CCCChHHHHHHHHhcccCCCCCCC
Q psy5368 206 APEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP-NSLSPDCMDFLSRLLQKDPMRRIS 284 (406)
Q Consensus 206 aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~~li~~~L~~dP~~Rps 284 (406)
|||.+.+..++.++|+||+||++|+|++|..||...+.......+.......... ..++..+.+++.+||+.+|++|||
T Consensus 183 aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt 262 (285)
T cd06648 183 APEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRAT 262 (285)
T ss_pred CHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcC
Confidence 9999998889999999999999999999999998877666666555543322222 247899999999999999999999
Q ss_pred HHHHhcCCCCCCCCC
Q psy5368 285 YEDLFSHPYPDLIHA 299 (406)
Q Consensus 285 ~~ell~hp~~~~~~~ 299 (406)
+.++++||||+....
T Consensus 263 ~~~il~~~~~~~~~~ 277 (285)
T cd06648 263 AAELLNHPFLAKAGP 277 (285)
T ss_pred HHHHccCcccccCCC
Confidence 999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=307.71 Aligned_cols=241 Identities=28% Similarity=0.479 Sum_probs=205.1
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|++|.||++... ...+++|.+..... .....+.+|+++++++.|||+++ ..+.+|+||||+++
T Consensus 6 ~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 85 (290)
T cd05580 6 IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPG 85 (290)
T ss_pred EEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCC
Confidence 356899999999998864 46678887654332 23456889999999999999765 66789999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
++|.+++...+.+++..+..++.||+.||.|||++|++|+||+|.||+++ ++.+||+|||++...... .....+++.
T Consensus 86 ~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~ 163 (290)
T cd05580 86 GELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYTLCGTPE 163 (290)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCCCCCCcc
Confidence 99999998888999999999999999999999999999999999999998 779999999999776443 344568999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
|+|||.+.+...+.++|+||||+++|+|++|..||...+.......+... ....+ ..++..+.+++.+||..||.+|+
T Consensus 164 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~-~~~~~~l~~li~~~l~~~p~~R~ 241 (290)
T cd05580 164 YLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG-KVRFP-SFFSPDAKDLIRNLLQVDLTKRL 241 (290)
T ss_pred ccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CccCC-ccCCHHHHHHHHHHccCCHHHcc
Confidence 99999998888899999999999999999999999888766666665543 33333 35799999999999999999999
Q ss_pred -----CHHHHhcCCCCCCCCCC
Q psy5368 284 -----SYEDLFSHPYPDLIHAP 300 (406)
Q Consensus 284 -----s~~ell~hp~~~~~~~~ 300 (406)
+++++++||||+...+.
T Consensus 242 ~~~~~~~~~l~~~~~~~~~~~~ 263 (290)
T cd05580 242 GNLKNGVNDIKNHPWFAGIDWI 263 (290)
T ss_pred CcccCCHHHHHcCcccccCCHH
Confidence 89999999999876543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=306.92 Aligned_cols=237 Identities=25% Similarity=0.403 Sum_probs=193.8
Q ss_pred eeecceeeeEEEeeee--eeceeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 57 IRYGELQYDTVQNSQI--RLGTVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
..||+|+||.||++.. ....+++|...... ......+.+|+.++.+++|||+++ ..+..++||||+++++|
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l 86 (279)
T cd06619 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSL 86 (279)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCCh
Confidence 4689999999999985 34567788765442 223457889999999999999776 66778999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCCCC
Q psy5368 128 CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLYMA 206 (406)
Q Consensus 128 ~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y~a 206 (406)
..+ ..+++..+..++.|++.||.|||+.||+|+||||+||+++ ++.++|+|||++...... ......+|+.|+|
T Consensus 87 ~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~a 161 (279)
T cd06619 87 DVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYVGTNAYMA 161 (279)
T ss_pred HHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCCCCChhhcC
Confidence 654 3578999999999999999999999999999999999999 779999999999765433 2344578999999
Q ss_pred hhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCC
Q psy5368 207 PEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNL-------SQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 207 PE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP 279 (406)
||++.+..++.++|+||+||++|+|++|+.||..... ......+........+....++++.+++.+||+.+|
T Consensus 162 PE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 241 (279)
T cd06619 162 PERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQP 241 (279)
T ss_pred ceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCCh
Confidence 9999998899999999999999999999999965321 122222233333334444688999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCC
Q psy5368 280 MRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 280 ~~Rps~~ell~hp~~~~~~ 298 (406)
++||+++++++||||....
T Consensus 242 ~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 242 KERPAPENLMDHPFIVQYN 260 (279)
T ss_pred hhCCCHHHHhcCccccccc
Confidence 9999999999999997653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=305.62 Aligned_cols=240 Identities=28% Similarity=0.460 Sum_probs=201.0
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
..||.|++|.||++... +..+++|.+..... ....++.+|++++++++|||+++ ..+.+++|+||+++++|
T Consensus 7 ~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (265)
T cd06605 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSL 86 (265)
T ss_pred HHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcH
Confidence 46899999999999875 45678887665432 34557899999999999999765 66789999999999999
Q ss_pred HHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCC
Q psy5368 128 CSFIRSH-EKLSEFQCQQFVRQLVLALKFLRE-NNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLY 204 (406)
Q Consensus 128 ~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~-~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y 204 (406)
.+++... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++ ++.++|+|||.+......... ...++..|
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~y 165 (265)
T cd06605 87 DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-TFVGTSSY 165 (265)
T ss_pred HHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-cccCChhc
Confidence 9999876 789999999999999999999999 9999999999999999 668999999998765433222 26688899
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASC-----NLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~-----~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP 279 (406)
+|||.+.+..++.++|+||+|+++++|++|..||... ........+........+...+++++.++|.+||..||
T Consensus 166 ~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 245 (265)
T cd06605 166 MAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDP 245 (265)
T ss_pred cCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCc
Confidence 9999999999999999999999999999999999764 23344444444444444443489999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCC
Q psy5368 280 MRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 280 ~~Rps~~ell~hp~~~~~ 297 (406)
++|||+.+++.||||+..
T Consensus 246 ~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 246 RERPSYKELLEHPFIKKY 263 (265)
T ss_pred hhCcCHHHHhhCchhhcc
Confidence 999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=302.85 Aligned_cols=237 Identities=30% Similarity=0.505 Sum_probs=199.9
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||.|+||.||++... +..+++|....... .....+.+|++++++++|||+++ .....|+|+||++|
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (258)
T cd05578 5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLG 84 (258)
T ss_pred EEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCC
Confidence 456788888888888864 45677777664432 23567899999999999999765 67789999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
++|.+++....++++..+..++.||++||.|||++|++|+||+|+||+++ ++.++|+|||++.............|+..
T Consensus 85 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 164 (258)
T cd05578 85 GDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPG 164 (258)
T ss_pred CCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccCCChh
Confidence 99999998877899999999999999999999999999999999999999 67999999999877655544455668899
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNL---SQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPM 280 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~ 280 (406)
|+|||.+.+..++.++|+||+|+++|+|++|..||...+. ...... ........ +..++.++.+++.+||..||.
T Consensus 165 y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~ 242 (258)
T cd05578 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK-QETADVLY-PATWSTEAIDAINKLLERDPQ 242 (258)
T ss_pred hcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH-hccccccC-cccCcHHHHHHHHHHccCChh
Confidence 9999999988899999999999999999999999988763 333332 22222233 336889999999999999999
Q ss_pred CCCCH--HHHhcCCCC
Q psy5368 281 RRISY--EDLFSHPYP 294 (406)
Q Consensus 281 ~Rps~--~ell~hp~~ 294 (406)
+||++ +|+++||||
T Consensus 243 ~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 243 KRLGDNLKDLKNHPYF 258 (258)
T ss_pred HcCCccHHHHhcCCCC
Confidence 99999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=308.58 Aligned_cols=240 Identities=23% Similarity=0.410 Sum_probs=197.3
Q ss_pred ecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 59 YGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 59 lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
||+|+||+||++... +..+++|....... .....+.+|+.+++.++|||++. ..+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999764 45678877654322 22445678999999999999765 56789999999999999
Q ss_pred HHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCC
Q psy5368 128 CSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLY 204 (406)
Q Consensus 128 ~~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y 204 (406)
.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++ ++.++|+|||++.............++..|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY 160 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence 99997765 799999999999999999999999999999999999998 679999999999776544444556678899
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNL----SQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPM 280 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~ 280 (406)
+|||++.+..++.++|+||+||++++|++|+.||..... ..+...+. ...... +..+++++.+++.+||+.||.
T Consensus 161 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~~l~~~p~ 238 (277)
T cd05577 161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL-EMAVEY-PDKFSPEAKDLCEALLQKDPE 238 (277)
T ss_pred CCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-cccccC-CccCCHHHHHHHHHHccCChh
Confidence 999999988899999999999999999999999977643 22222221 112222 235799999999999999999
Q ss_pred CCC-----CHHHHhcCCCCCCCCCC
Q psy5368 281 RRI-----SYEDLFSHPYPDLIHAP 300 (406)
Q Consensus 281 ~Rp-----s~~ell~hp~~~~~~~~ 300 (406)
+|| ++.++++||||+...++
T Consensus 239 ~R~~~~~~~~~~ll~h~~~~~~~~~ 263 (277)
T cd05577 239 KRLGCRGGSADEVREHPLFKDLNWR 263 (277)
T ss_pred HccCCCcccHHHHHhChhhhcCChh
Confidence 999 88889999999876653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=307.56 Aligned_cols=234 Identities=28% Similarity=0.503 Sum_probs=194.4
Q ss_pred eeeecceeeeEEEeeeee------eceeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEecc
Q psy5368 56 TIRYGELQYDTVQNSQIR------LGTVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYC 122 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~------~~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~ 122 (406)
...||+|.||.||+|.+. ...|++|.+...... ....+.+|++.+.+++|||+++ ..+.+++|+|||
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999998 677888888553322 3678999999999999999776 456689999999
Q ss_pred CCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC---CC
Q psy5368 123 DGGDLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ---GD 196 (406)
Q Consensus 123 ~ggsL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~---~~ 196 (406)
++|+|.++|... ..+++..+..++.||+.||.|||+++++|+||++.||+++ ++.+||+|||++........ ..
T Consensus 84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~ 163 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDS 163 (259)
T ss_dssp TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEEST
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999887 6899999999999999999999999999999999999999 77999999999987632221 23
Q ss_pred cccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhc
Q psy5368 197 SIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL 275 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L 275 (406)
.......|+|||.+....++.++||||||+++|||++ |+.||...+..++...+........ +..++..+.+++.+||
T Consensus 164 ~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~C~ 242 (259)
T PF07714_consen 164 SQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPI-PDNCPKDIYSLIQQCW 242 (259)
T ss_dssp TSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTS-BTTSBHHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccee-ccchhHHHHHHHHHHc
Confidence 3446778999999999889999999999999999999 7899999988888888866654443 3468999999999999
Q ss_pred ccCCCCCCCHHHHhc
Q psy5368 276 QKDPMRRISYEDLFS 290 (406)
Q Consensus 276 ~~dP~~Rps~~ell~ 290 (406)
..||++|||+.++++
T Consensus 243 ~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 243 SHDPEKRPSFQEILQ 257 (259)
T ss_dssp -SSGGGS--HHHHHH
T ss_pred CCChhhCcCHHHHHh
Confidence 999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=305.84 Aligned_cols=242 Identities=29% Similarity=0.468 Sum_probs=197.5
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
..||+|+||.||++... +..+++|.+..... .....+.+|+.++++++|||+++ ..+++|+||||+++++|
T Consensus 7 ~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l 86 (286)
T cd06622 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSL 86 (286)
T ss_pred hhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCH
Confidence 46799999999999875 56678887654322 22457889999999999999755 67889999999999999
Q ss_pred HHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCC
Q psy5368 128 CSFIRSH---EKLSEFQCQQFVRQLVLALKFLRE-NNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSP 202 (406)
Q Consensus 128 ~~~l~~~---~~l~~~~~~~i~~ql~~aL~~lH~-~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~ 202 (406)
..++... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++ ++.++|+|||++...... ......+++
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~ 165 (286)
T cd06622 87 DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-LAKTNIGCQ 165 (286)
T ss_pred HHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-ccccCCCcc
Confidence 9998763 379999999999999999999997 5999999999999999 678999999998765432 223445788
Q ss_pred CCCChhhhcCCC------CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhcCCCCCCCCCCChHHHHHHHH
Q psy5368 203 LYMAPEILAGSP------YNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQ---ALSSAPITIPPNSLSPDCMDFLSR 273 (406)
Q Consensus 203 ~y~aPE~~~~~~------~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~s~~l~~li~~ 273 (406)
.|+|||.+.+.. ++.++|+||+||++|+|++|..||........... +........++ .+++++.+|+.+
T Consensus 166 ~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~ 244 (286)
T cd06622 166 SYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPS-GYSDDAQDFVAK 244 (286)
T ss_pred CccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCc-ccCHHHHHHHHH
Confidence 999999986543 57899999999999999999999977655443332 33333344444 589999999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy5368 274 LLQKDPMRRISYEDLFSHPYPDLIHAP 300 (406)
Q Consensus 274 ~L~~dP~~Rps~~ell~hp~~~~~~~~ 300 (406)
||..+|++||++++++.||||.....+
T Consensus 245 ~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 245 CLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred HcccCcccCCCHHHHhcChhhhhccCC
Confidence 999999999999999999999866544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=300.11 Aligned_cols=233 Identities=23% Similarity=0.433 Sum_probs=201.7
Q ss_pred eecceeeeEEEeeeee-----eceeEEeeeecCCccc-hhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 58 RYGELQYDTVQNSQIR-----LGTVKYSQVRYDTITS-HSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~-----~~~v~vk~~~~~~~~~-~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
.||+|+||.||++... ...+++|......... ...+.+|+..+..++|+|+++ ....+++||||++++
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG 81 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence 6899999999999986 5567888776554333 568899999999999999765 667889999999999
Q ss_pred CHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC--
Q psy5368 126 DLCSFIRSH---------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-- 193 (406)
Q Consensus 126 sL~~~l~~~---------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-- 193 (406)
+|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++ ++.++|+|||.+.......
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 161 (262)
T cd00192 82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY 161 (262)
T ss_pred cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccccc
Confidence 999999875 6799999999999999999999999999999999999999 5799999999998765432
Q ss_pred -CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHH
Q psy5368 194 -QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFL 271 (406)
Q Consensus 194 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li 271 (406)
......+++.|+|||.+....++.++||||+||++|+|++ |..||...........+........+ ..+|.++.+++
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li 240 (262)
T cd00192 162 RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKP-EYCPDELYELM 240 (262)
T ss_pred ccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC-ccCChHHHHHH
Confidence 2334557889999999998889999999999999999999 69999999888887777765444443 36799999999
Q ss_pred HHhcccCCCCCCCHHHHhcC
Q psy5368 272 SRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 272 ~~~L~~dP~~Rps~~ell~h 291 (406)
.+||+.+|.+|||+.+++++
T Consensus 241 ~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 241 LSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHccCCcccCcCHHHHHHh
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=342.75 Aligned_cols=241 Identities=24% Similarity=0.415 Sum_probs=185.5
Q ss_pred ecceeeeEEEeeeeee--ceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCcc--------cCCeEEEEEeccCCCC
Q psy5368 59 YGELQYDTVQNSQIRL--GTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRK--------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 59 lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~--------~~~~~~lV~E~~~ggs 126 (406)
||+|+||+||++.... ..+++|.+..... .....+.+|+.++..|+|||++. ....+||||||+++|+
T Consensus 21 LG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGS 100 (1021)
T PTZ00266 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGD 100 (1021)
T ss_pred EecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCc
Confidence 3444444444444321 2345554443322 23457889999999999999876 3456899999999999
Q ss_pred HHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHC-------CcccccCCCcceEeeC------------------Ce
Q psy5368 127 LCSFIRSH----EKLSEFQCQQFVRQLVLALKFLREN-------NVCHFDLKPQNILIKN------------------NT 177 (406)
Q Consensus 127 L~~~l~~~----~~l~~~~~~~i~~ql~~aL~~lH~~-------givH~Dlkp~NIll~~------------------~~ 177 (406)
|.++|... +.+++..++.|+.||+.||.|||+. +|+||||||+||||+. +.
T Consensus 101 L~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~i 180 (1021)
T PTZ00266 101 LSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180 (1021)
T ss_pred HHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCc
Confidence 99999652 5799999999999999999999984 4999999999999962 24
Q ss_pred eEEEecccccccCCCCCCCcccCCCCCCChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Q psy5368 178 LKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAG--SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP 255 (406)
Q Consensus 178 ~kL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 255 (406)
+||+|||++..+..........||+.|+|||++.+ ..++.++||||||||||+|+||..||................
T Consensus 181 VKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~- 259 (1021)
T PTZ00266 181 AKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRG- 259 (1021)
T ss_pred eEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcC-
Confidence 89999999987655544556679999999999865 458899999999999999999999997655433333333222
Q ss_pred CCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy5368 256 ITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAP 300 (406)
Q Consensus 256 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 300 (406)
+..+....+.++.+||.+||..+|.+||++.++|.|||++....|
T Consensus 260 p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~p 304 (1021)
T PTZ00266 260 PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPP 304 (1021)
T ss_pred CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence 233334678999999999999999999999999999999865433
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=300.72 Aligned_cols=238 Identities=28% Similarity=0.420 Sum_probs=198.5
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
...+|+|+||.||++... ...+++|.+..........+.+|+.++++++|||+++ ..+.+|++|||+++++|
T Consensus 8 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l 87 (262)
T cd06613 8 IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSL 87 (262)
T ss_pred EEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcH
Confidence 456899999999998864 3567788776655556678999999999999999766 66789999999999999
Q ss_pred HHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCCC
Q psy5368 128 CSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPLY 204 (406)
Q Consensus 128 ~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~y 204 (406)
.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++ ++.++|+|||++....... ......++..|
T Consensus 88 ~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y 167 (262)
T cd06613 88 QDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYW 167 (262)
T ss_pred HHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccccccCCccc
Confidence 9999776 6899999999999999999999999999999999999999 6799999999987655432 23445688899
Q ss_pred CChhhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--C-CCCCCCChHHHHHHHHhcccC
Q psy5368 205 MAPEILAGS---PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI--T-IPPNSLSPDCMDFLSRLLQKD 278 (406)
Q Consensus 205 ~aPE~~~~~---~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--~-~~~~~~s~~l~~li~~~L~~d 278 (406)
+|||.+.+. .++.++|+||+||++|+|++|..||...+.............. . ..+..++.++.+++.+||..+
T Consensus 168 ~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 247 (262)
T cd06613 168 MAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKD 247 (262)
T ss_pred cCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCC
Confidence 999999877 7899999999999999999999999887655544443333111 1 112256788999999999999
Q ss_pred CCCCCCHHHHhcCCC
Q psy5368 279 PMRRISYEDLFSHPY 293 (406)
Q Consensus 279 P~~Rps~~ell~hp~ 293 (406)
|.+|||+.+++.|+|
T Consensus 248 p~~Rpt~~~il~~~~ 262 (262)
T cd06613 248 PKKRPTATKLLQHPF 262 (262)
T ss_pred hhhCCCHHHHhcCCC
Confidence 999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=299.59 Aligned_cols=237 Identities=25% Similarity=0.427 Sum_probs=199.0
Q ss_pred eeeecceeeeEEEeeeeeec--eeEEeeeecCCccchhhhhhHHhhcccC-CCCCCcc----------cCCeEEEEEecc
Q psy5368 56 TIRYGELQYDTVQNSQIRLG--TVKYSQVRYDTITSHSEFERPRAGLSNL-RAPEGRK----------RPRYVYIILEYC 122 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~--~v~vk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~----------~~~~~~lV~E~~ 122 (406)
..+||-|--|.|-.+..+.+ +.|+|.+ .+.....+|+++.-.. .|||++. ...++.+|||+|
T Consensus 67 ~qvLG~GinGkV~~C~~k~T~ekfALKvL-----~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 67 WQVLGAGINGKVVQCVHKRTQEKFALKVL-----LDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hhhhccccCCceEEEEeccchhhhHHHHH-----hcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 36899999999998876543 3455544 3445677888866555 7888655 566778999999
Q ss_pred CCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee----CCeeEEEecccccccCCCCCCC
Q psy5368 123 DGGDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK----NNTLKLADFGFAQFLAPNDQGD 196 (406)
Q Consensus 123 ~ggsL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~----~~~~kL~DFGla~~~~~~~~~~ 196 (406)
+||.|...|++++ .|++.++..|++||..|+.|||+.+|.||||||+|+|.. +-.+||+|||+|+.........
T Consensus 142 eGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~ 221 (400)
T KOG0604|consen 142 EGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLM 221 (400)
T ss_pred cchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCcccc
Confidence 9999999998886 499999999999999999999999999999999999997 3489999999999877667777
Q ss_pred cccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcCCCCCCCC---CCChHHHH
Q psy5368 197 SIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNL----SQLRAQALSSAPITIPPN---SLSPDCMD 269 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~----~~~~~~~~~~~~~~~~~~---~~s~~l~~ 269 (406)
+.+.||.|.|||++...+|+..+|+||+||++|-||+|.+||.+... ..+..+|..+. ..+|.. .+|+..++
T Consensus 222 TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gq-y~FP~pEWs~VSe~aKd 300 (400)
T KOG0604|consen 222 TPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQ-YEFPEPEWSCVSEAAKD 300 (400)
T ss_pred CCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccC-ccCCChhHhHHHHHHHH
Confidence 88899999999999999999999999999999999999999987642 34455555553 333332 68999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 270 FLSRLLQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 270 li~~~L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
+|+.+|..+|.+|.|++++++|||+....
T Consensus 301 lIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 301 LIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred HHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 99999999999999999999999998654
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=301.77 Aligned_cols=239 Identities=26% Similarity=0.404 Sum_probs=195.1
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc-----cchhhhhhHHhhcccCCCCCCcc------c--CCeEEEEEe
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI-----TSHSEFERPRAGLSNLRAPEGRK------R--PRYVYIILE 120 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~-----~~~~~~~~E~~~l~~l~h~ni~~------~--~~~~~lV~E 120 (406)
...+|+|+||.||.+... +..+++|.+..... .....+.+|+.++.+++|||+++ . ...+++|||
T Consensus 7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86 (265)
T ss_pred eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence 567899999999999864 35678887653221 12346788999999999999765 2 356889999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC----CCC
Q psy5368 121 YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN----DQG 195 (406)
Q Consensus 121 ~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~----~~~ 195 (406)
|+++++|.+++.....+++..+..++.|++.||.|||++|++|+||||+||+++ ++.++|+|||++...... ...
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 166 (265)
T cd06652 87 HMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGM 166 (265)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccccccccc
Confidence 999999999998877899999999999999999999999999999999999999 679999999998765321 122
Q ss_pred CcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhc
Q psy5368 196 DSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL 275 (406)
Q Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L 275 (406)
....++..|+|||.+.+..++.++|+|||||++|+|++|+.||.....................+..++..+.+++.+|+
T Consensus 167 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 246 (265)
T cd06652 167 KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIF 246 (265)
T ss_pred ccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHh
Confidence 33568889999999998889999999999999999999999998765554444443332222223467889999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCC
Q psy5368 276 QKDPMRRISYEDLFSHPYPD 295 (406)
Q Consensus 276 ~~dP~~Rps~~ell~hp~~~ 295 (406)
. +|++||+++++++|||++
T Consensus 247 ~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 247 V-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred c-ChhhCCCHHHHhcCcccC
Confidence 5 999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=320.45 Aligned_cols=235 Identities=21% Similarity=0.333 Sum_probs=189.5
Q ss_pred eeeecceeeeEEEeeeeee-------ceeEEeeeecCCcc-chhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEe
Q psy5368 56 TIRYGELQYDTVQNSQIRL-------GTVKYSQVRYDTIT-SHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILE 120 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-------~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E 120 (406)
...||+|+||.||++.... ..+++|.+...... ....+.+|+.+++.+ +|+|+++ ..+..|+|||
T Consensus 43 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~e 122 (374)
T cd05106 43 GKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITE 122 (374)
T ss_pred hheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHh
Confidence 4578999999999987522 35888877654322 245688999999999 8999876 5667899999
Q ss_pred ccCCCCHHHHHHhC------------------------------------------------------------------
Q psy5368 121 YCDGGDLCSFIRSH------------------------------------------------------------------ 134 (406)
Q Consensus 121 ~~~ggsL~~~l~~~------------------------------------------------------------------ 134 (406)
||++|+|.+++...
T Consensus 123 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (374)
T cd05106 123 YCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEED 202 (374)
T ss_pred hccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhc
Confidence 99999999998542
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC---CCcccCCCCCCC
Q psy5368 135 ----EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ---GDSIQGSPLYMA 206 (406)
Q Consensus 135 ----~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~---~~~~~gt~~y~a 206 (406)
.++++.++.+++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....... .....+++.|+|
T Consensus 203 ~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~a 282 (374)
T cd05106 203 TEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMA 282 (374)
T ss_pred cCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeC
Confidence 1478889999999999999999999999999999999999 66899999999976543321 112334567999
Q ss_pred hhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCCH
Q psy5368 207 PEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY 285 (406)
Q Consensus 207 PE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~ 285 (406)
||++.+..++.++|||||||++|+|++ |+.||.....................+..+++++.+++.+||+.||.+|||+
T Consensus 283 PE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~ 362 (374)
T cd05106 283 PESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTF 362 (374)
T ss_pred HHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence 999999899999999999999999997 9999988665444444443322222334578999999999999999999999
Q ss_pred HHHhc
Q psy5368 286 EDLFS 290 (406)
Q Consensus 286 ~ell~ 290 (406)
.++++
T Consensus 363 ~~l~~ 367 (374)
T cd05106 363 SQISQ 367 (374)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=323.60 Aligned_cols=242 Identities=25% Similarity=0.356 Sum_probs=195.8
Q ss_pred CceeeecceeeeEEEeeeeee--ceeEEeeeecCCccchhhhhhHHhhcccCC-CC-----CCc------ccCCeEEEEE
Q psy5368 54 SSTIRYGELQYDTVQNSQIRL--GTVKYSQVRYDTITSHSEFERPRAGLSNLR-AP-----EGR------KRPRYVYIIL 119 (406)
Q Consensus 54 ~~~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~-h~-----ni~------~~~~~~~lV~ 119 (406)
.....||+|+||.|-++.... ..||+|.++.. ..-..+-..|+.+|..|+ |- |++ ...+++|||+
T Consensus 189 ~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVf 267 (586)
T KOG0667|consen 189 EVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVF 267 (586)
T ss_pred EEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeee
Confidence 335678999999999998754 46777766543 234456677999999997 43 233 3778999999
Q ss_pred eccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee---CCeeEEEecccccccCCCCC
Q psy5368 120 EYCDGGDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK---NNTLKLADFGFAQFLAPNDQ 194 (406)
Q Consensus 120 E~~~ggsL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~---~~~~kL~DFGla~~~~~~~~ 194 (406)
|++.. +|+++|+.+. +|+...++.++.||+.||.+||+.||||+||||+||||. ...+||+|||.|......
T Consensus 268 ELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~-- 344 (586)
T KOG0667|consen 268 ELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR-- 344 (586)
T ss_pred hhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCc--
Confidence 99965 9999998875 699999999999999999999999999999999999997 348999999999876433
Q ss_pred CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC------------------
Q psy5368 195 GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI------------------ 256 (406)
Q Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------------------ 256 (406)
..+++.++.|+|||++.|.+|+.+.||||||||++||++|.+.|++.+..+....|......
T Consensus 345 vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~ 424 (586)
T KOG0667|consen 345 VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTS 424 (586)
T ss_pred ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhc
Confidence 34788899999999999999999999999999999999999999998877666655432100
Q ss_pred ---------------------------------CCCCC----------CCChHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q psy5368 257 ---------------------------------TIPPN----------SLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293 (406)
Q Consensus 257 ---------------------------------~~~~~----------~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~ 293 (406)
..|+. .-...+.+|+.+||.+||.+|+|..++++|||
T Consensus 425 ~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpf 504 (586)
T KOG0667|consen 425 LKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPF 504 (586)
T ss_pred cCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcc
Confidence 00100 01134799999999999999999999999999
Q ss_pred CCCCCC
Q psy5368 294 PDLIHA 299 (406)
Q Consensus 294 ~~~~~~ 299 (406)
++....
T Consensus 505 l~~~~~ 510 (586)
T KOG0667|consen 505 LTGTSL 510 (586)
T ss_pred cccccc
Confidence 996554
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=299.07 Aligned_cols=237 Identities=31% Similarity=0.530 Sum_probs=200.4
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCcc--------cCCeEEEEEeccCC
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRK--------RPRYVYIILEYCDG 124 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~--------~~~~~~lV~E~~~g 124 (406)
..+|.|+||.||++... +..+++|.+...... ....+.+|+.+++.++|||+++ .....|++|||+++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~ 85 (265)
T cd08217 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEG 85 (265)
T ss_pred eeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccC
Confidence 56799999999998763 355777766544322 3446888999999999999775 34567999999999
Q ss_pred CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----HCCcccccCCCcceEee-CCeeEEEecccccccCCCCC
Q psy5368 125 GDLCSFIRS----HEKLSEFQCQQFVRQLVLALKFLR-----ENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ 194 (406)
Q Consensus 125 gsL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~lH-----~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~ 194 (406)
++|.+++.. ..++++..+..++.||+.||.||| +.+++|+||+|+||+++ ++.+||+|||++........
T Consensus 86 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 165 (265)
T cd08217 86 GDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS 165 (265)
T ss_pred CCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCcc
Confidence 999999965 357999999999999999999999 89999999999999999 67999999999987655443
Q ss_pred -CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHH
Q psy5368 195 -GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSR 273 (406)
Q Consensus 195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~ 273 (406)
.....+++.|+|||.+.+..++.++|+||||+++++|++|..||...+.......+........ +..++.++.+++.+
T Consensus 166 ~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~ 244 (265)
T cd08217 166 FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRI-PYRYSSELNEVIKS 244 (265)
T ss_pred cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCC-ccccCHHHHHHHHH
Confidence 3445789999999999998899999999999999999999999999887777666665544333 34789999999999
Q ss_pred hcccCCCCCCCHHHHhcCCCC
Q psy5368 274 LLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 274 ~L~~dP~~Rps~~ell~hp~~ 294 (406)
||+.+|++||+++++++|||+
T Consensus 245 ~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 245 MLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HccCCcccCCCHHHHhhCCCC
Confidence 999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=302.13 Aligned_cols=239 Identities=26% Similarity=0.434 Sum_probs=199.6
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...+|.|++|+||++... +..+++|....... .....+.+|+..++.++|+|++. ..+..|+|||++++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (267)
T cd06610 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGS 85 (267)
T ss_pred eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCc
Confidence 456899999999999863 34677777654332 24567899999999999999765 6678899999999999
Q ss_pred HHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC-----Cc
Q psy5368 127 LCSFIRSH---EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG-----DS 197 (406)
Q Consensus 127 L~~~l~~~---~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~-----~~ 197 (406)
|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||++......... ..
T Consensus 86 l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 165 (267)
T cd06610 86 LLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT 165 (267)
T ss_pred HHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccccccccc
Confidence 99999764 4589999999999999999999999999999999999999 669999999998766543322 34
Q ss_pred ccCCCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC----CCCChHHHHHHH
Q psy5368 198 IQGSPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP----NSLSPDCMDFLS 272 (406)
Q Consensus 198 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~----~~~s~~l~~li~ 272 (406)
..|+..|+|||++... .++.++|+|||||++++|++|+.||...+................+. ..+++.+.+++.
T Consensus 166 ~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 245 (267)
T cd06610 166 FVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMIS 245 (267)
T ss_pred ccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHH
Confidence 4688999999999877 78999999999999999999999998877666655555543333322 257899999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCC
Q psy5368 273 RLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 273 ~~L~~dP~~Rps~~ell~hp~~ 294 (406)
+||..||++|||+++++.||||
T Consensus 246 ~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 246 LCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHcCCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=313.16 Aligned_cols=241 Identities=19% Similarity=0.282 Sum_probs=189.1
Q ss_pred eeecce--eeeEEEeeeee--eceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 57 IRYGEL--QYDTVQNSQIR--LGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 57 ~~lG~G--~~g~Vy~~~~~--~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
.+||+| +|++||++... +..+++|.+...... ....+.+|+.+++.++|||+++ .++..|+||||+++
T Consensus 4 ~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 83 (327)
T cd08227 4 TVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 83 (327)
T ss_pred hhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCC
Confidence 467888 78999999864 456788877654322 2346778999999999999876 66789999999999
Q ss_pred CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC-------
Q psy5368 125 GDLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ------- 194 (406)
Q Consensus 125 gsL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~------- 194 (406)
|+|.+++..+ ..+++..+..++.|++.||+|||++||+||||||+|||++ ++.++++||+.+........
T Consensus 84 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 163 (327)
T cd08227 84 GSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHD 163 (327)
T ss_pred CcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccccc
Confidence 9999999653 4699999999999999999999999999999999999999 67999999986543321111
Q ss_pred -CCcccCCCCCCChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--------------
Q psy5368 195 -GDSIQGSPLYMAPEILAG--SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPIT-------------- 257 (406)
Q Consensus 195 -~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-------------- 257 (406)
.....++..|+|||++.+ ..++.++||||+||++|+|++|..||...................
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (327)
T cd08227 164 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTM 243 (327)
T ss_pred ccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhccc
Confidence 122346778999999976 458999999999999999999999998755443332222211100
Q ss_pred ------------------------------CCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy5368 258 ------------------------------IPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 258 ------------------------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 297 (406)
.....+++++.+|+.+||+.||++|||++++++||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 244 KPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred CCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 0011356789999999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=304.05 Aligned_cols=233 Identities=23% Similarity=0.385 Sum_probs=195.8
Q ss_pred eeecceeeeEEEeeeeee-------ceeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEecc
Q psy5368 57 IRYGELQYDTVQNSQIRL-------GTVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYC 122 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~-------~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~ 122 (406)
..||+|+||.||++.... ..+++|.+...... ....+.+|++++..++|+|+++ .....++||||+
T Consensus 11 ~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 90 (280)
T cd05049 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYM 90 (280)
T ss_pred hhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecC
Confidence 468999999999987632 45788877654433 3568999999999999999765 557789999999
Q ss_pred CCCCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEeccccc
Q psy5368 123 DGGDLCSFIRSHE--------------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQ 187 (406)
Q Consensus 123 ~ggsL~~~l~~~~--------------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~ 187 (406)
++++|.+++...+ .+++..+..++.|++.||.|||++|++||||||+||+++ ++.++|+|||+++
T Consensus 91 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~ 170 (280)
T cd05049 91 EHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170 (280)
T ss_pred CCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCcccce
Confidence 9999999997642 478999999999999999999999999999999999998 7799999999987
Q ss_pred ccCCCC---CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q psy5368 188 FLAPND---QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSL 263 (406)
Q Consensus 188 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (406)
...... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+..+.... ++..+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~ 249 (280)
T cd05049 171 DVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQ-RPRTC 249 (280)
T ss_pred ecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCC-CCCCC
Confidence 653322 1233345778999999999999999999999999999998 999998888877777776554333 34478
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 264 SPDCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 264 s~~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
+..+.+++.+||+.||++||+++|+++
T Consensus 250 ~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 250 PSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=305.07 Aligned_cols=240 Identities=25% Similarity=0.389 Sum_probs=198.1
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
..||+|+||+||++... +..+++|...... ......+.+|++++..++|||+++ ..+.+|+||||+++++|
T Consensus 11 ~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 90 (284)
T cd06620 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL 90 (284)
T ss_pred HHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCH
Confidence 46799999999999875 4566777655433 223567899999999999999766 56789999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCCC
Q psy5368 128 CSFIRSHEKLSEFQCQQFVRQLVLALKFLRE-NNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLYM 205 (406)
Q Consensus 128 ~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~-~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y~ 205 (406)
.+++.+.+.+++..+..++.+++.||.|||+ .|++|+||+|+||+++ ++.++|+|||++...... ......|+..|+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-~~~~~~~~~~~~ 169 (284)
T cd06620 91 DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-IADTFVGTSTYM 169 (284)
T ss_pred HHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-ccCccccCcccC
Confidence 9999888889999999999999999999997 6899999999999999 668999999998654322 223457899999
Q ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHhcCCCCCCCCCCChHHHHHHHHh
Q psy5368 206 APEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLS-----------QLRAQALSSAPITIPPNSLSPDCMDFLSRL 274 (406)
Q Consensus 206 aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~-----------~~~~~~~~~~~~~~~~~~~s~~l~~li~~~ 274 (406)
|||++.+..++.++|+||+||++|+|++|..||...... +....+........+...++.++.+|+.+|
T Consensus 170 aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 249 (284)
T cd06620 170 SPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDAC 249 (284)
T ss_pred CHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHH
Confidence 999998888999999999999999999999999865432 233333333333333335888999999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCC
Q psy5368 275 LQKDPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 275 L~~dP~~Rps~~ell~hp~~~~~ 297 (406)
|+.||++|||++|+++||||...
T Consensus 250 l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 250 LLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred hcCCcccCcCHHHHhcCcccccc
Confidence 99999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=303.54 Aligned_cols=238 Identities=29% Similarity=0.411 Sum_probs=188.1
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...||+|+||.||++... +..+++|.+..... .....+.+|+.++++++|||+++ ..+..|+|+||+++
T Consensus 5 ~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~- 83 (284)
T cd07839 5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ- 83 (284)
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC-
Confidence 356899999999999873 45677787654322 22346788999999999999765 67789999999975
Q ss_pred CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCC
Q psy5368 126 DLCSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSP 202 (406)
Q Consensus 126 sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~ 202 (406)
+|.+++.. .+.+++..++.++.||+.||.|||++|++|+||||+||+++ ++.++|+|||+++...... ......+++
T Consensus 84 ~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 163 (284)
T cd07839 84 DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTL 163 (284)
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCcccc
Confidence 89888865 45799999999999999999999999999999999999998 7799999999987654332 223445788
Q ss_pred CCCChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhcCC-------------------CCC---
Q psy5368 203 LYMAPEILAGSP-YNAKADLWSLGVLVFEALFGHAPY-ASCNLSQLRAQALSSAP-------------------ITI--- 258 (406)
Q Consensus 203 ~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf-~~~~~~~~~~~~~~~~~-------------------~~~--- 258 (406)
.|+|||++.+.. ++.++||||+||++|+|+||..|| .+.+..+....+..... ...
T Consensus 164 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd07839 164 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPAT 243 (284)
T ss_pred CCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCc
Confidence 999999987754 789999999999999999988875 44444333332221100 000
Q ss_pred -----CCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 259 -----PPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 259 -----~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
....+++++.+|+.+||+.||.+|||++++++||||
T Consensus 244 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 244 TSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred chhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 012468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=307.45 Aligned_cols=215 Identities=25% Similarity=0.362 Sum_probs=171.1
Q ss_pred eeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHHHHHHhCC-------------
Q psy5368 76 TVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLCSFIRSHE------------- 135 (406)
Q Consensus 76 ~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~~~l~~~~------------- 135 (406)
.+++|.+...... ...++.+|+.++.+++|||+++ ..+..|+||||+++|+|.+++....
T Consensus 48 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 127 (304)
T cd05096 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127 (304)
T ss_pred EEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccc
Confidence 4777766544322 2457899999999999999776 5567899999999999999986532
Q ss_pred ------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC---CCcccCCCCCC
Q psy5368 136 ------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ---GDSIQGSPLYM 205 (406)
Q Consensus 136 ------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~---~~~~~gt~~y~ 205 (406)
.+++..+..++.||+.||.|||+.||+||||||+|||++ ++.+||+|||+++....... .....++..|+
T Consensus 128 ~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~ 207 (304)
T cd05096 128 PAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWM 207 (304)
T ss_pred cccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCcccc
Confidence 367888999999999999999999999999999999999 66899999999976543321 22334577899
Q ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHhc------CCCCCCCCCCChHHHHHHHHhccc
Q psy5368 206 APEILAGSPYNAKADLWSLGVLVFEALF--GHAPYASCNLSQLRAQALSS------APITIPPNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 206 aPE~~~~~~~~~~~DiwSlG~il~ellt--g~~pf~~~~~~~~~~~~~~~------~~~~~~~~~~s~~l~~li~~~L~~ 277 (406)
|||++.+..++.++|||||||++|+|++ +..||...+........... ......+..++..+.+|+.+||+.
T Consensus 208 aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 287 (304)
T cd05096 208 AWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSR 287 (304)
T ss_pred CHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccC
Confidence 9999998889999999999999999986 67888876655544433221 011112236789999999999999
Q ss_pred CCCCCCCHHHHhc
Q psy5368 278 DPMRRISYEDLFS 290 (406)
Q Consensus 278 dP~~Rps~~ell~ 290 (406)
||++|||+.++.+
T Consensus 288 ~p~~RPs~~~i~~ 300 (304)
T cd05096 288 DCRERPSFSDIHA 300 (304)
T ss_pred CchhCcCHHHHHH
Confidence 9999999999954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=303.99 Aligned_cols=238 Identities=23% Similarity=0.404 Sum_probs=193.9
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccC-CCCCCcc------------cCCeEEEEEe
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNL-RAPEGRK------------RPRYVYIILE 120 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~------------~~~~~~lV~E 120 (406)
...+|.|+||.||++... ...+++|...... .....+..|+.++.++ +|+|+++ ....+|+|||
T Consensus 21 ~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e 99 (282)
T cd06636 21 VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVME 99 (282)
T ss_pred heeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEE
Confidence 457899999999999873 3456666654432 3345688899999998 7999765 2457899999
Q ss_pred ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCC
Q psy5368 121 YCDGGDLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGD 196 (406)
Q Consensus 121 ~~~ggsL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~ 196 (406)
|+++|+|.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++ ++.++|+|||++...... ....
T Consensus 100 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 179 (282)
T cd06636 100 FCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 179 (282)
T ss_pred eCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccccCCC
Confidence 99999999999754 3588999999999999999999999999999999999999 678999999998765432 2234
Q ss_pred cccCCCCCCChhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHH
Q psy5368 197 SIQGSPLYMAPEILA-----GSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFL 271 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li 271 (406)
...|++.|+|||.+. ...++.++|+|||||++|+|++|..||...........+............++.++.+||
T Consensus 180 ~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 259 (282)
T cd06636 180 TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFI 259 (282)
T ss_pred cccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccCHHHHHHH
Confidence 566899999999986 345788999999999999999999999876654444444444344444457899999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCC
Q psy5368 272 SRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 272 ~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
.+||+.||.+|||+.++++||||
T Consensus 260 ~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 260 EGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred HHHhCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=297.66 Aligned_cols=232 Identities=21% Similarity=0.383 Sum_probs=194.9
Q ss_pred eeecceeeeEEEeeeeeec-eeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHHH
Q psy5368 57 IRYGELQYDTVQNSQIRLG-TVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLCS 129 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~~-~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~~ 129 (406)
..||+|+||.||++..+.+ .+++|..... ......+.+|+.+++.++|||+++ .....++||||+++|+|.+
T Consensus 10 ~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~ 88 (256)
T cd05114 10 KELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLN 88 (256)
T ss_pred eEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHH
Confidence 5689999999999987654 6677765533 234567899999999999999765 5667899999999999999
Q ss_pred HHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC--CcccCCCCCC
Q psy5368 130 FIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG--DSIQGSPLYM 205 (406)
Q Consensus 130 ~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~--~~~~gt~~y~ 205 (406)
++... +.+++..+..++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++......... ....++..|+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~ 168 (256)
T cd05114 89 YLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWS 168 (256)
T ss_pred HHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhC
Confidence 99754 4689999999999999999999999999999999999998 668999999998765432221 2223456799
Q ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCC
Q psy5368 206 APEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRIS 284 (406)
Q Consensus 206 aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps 284 (406)
|||++.+..++.++|+||||+++|+|++ |+.||...+..+....+........+ ...+.++.+++.+||+.+|++|||
T Consensus 169 aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~li~~c~~~~p~~Rps 247 (256)
T cd05114 169 PPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP-KLASMTVYEVMYSCWHEKPEGRPT 247 (256)
T ss_pred ChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC-CCCCHHHHHHHHHHccCCcccCcC
Confidence 9999998889999999999999999999 99999998888877777766444333 357889999999999999999999
Q ss_pred HHHHhc
Q psy5368 285 YEDLFS 290 (406)
Q Consensus 285 ~~ell~ 290 (406)
++++++
T Consensus 248 ~~~l~~ 253 (256)
T cd05114 248 FAELLR 253 (256)
T ss_pred HHHHHH
Confidence 999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=299.71 Aligned_cols=242 Identities=28% Similarity=0.491 Sum_probs=205.9
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...||+|++|.||++... +..+++|.+..... .....+.+|+..+.+++|+|+++ ..+..++||||+++++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (264)
T cd06623 6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGS 85 (264)
T ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCc
Confidence 357899999999999875 45678887765543 34567999999999999999765 6678999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCcceEee-CCeeEEEecccccccCCCCCC-CcccCCCC
Q psy5368 127 LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRE-NNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG-DSIQGSPL 203 (406)
Q Consensus 127 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~-~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~-~~~~gt~~ 203 (406)
|.+++.....+++..+..++.|++.||+|||+ .|++|+||+|+||+++ ++.++|+|||++......... ....++..
T Consensus 86 L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T cd06623 86 LADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVT 165 (264)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccceeeccc
Confidence 99999888889999999999999999999999 9999999999999998 779999999999876544433 25568899
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASC---NLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPM 280 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~---~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~ 280 (406)
|+|||.+.+..++.++|+||||+++|+|++|..||... ...+....+........+...++..+.+++.+||..+|+
T Consensus 166 y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 245 (264)
T cd06623 166 YMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPK 245 (264)
T ss_pred ccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChh
Confidence 99999999998999999999999999999999999877 455555555544444444333899999999999999999
Q ss_pred CCCCHHHHhcCCCCCCC
Q psy5368 281 RRISYEDLFSHPYPDLI 297 (406)
Q Consensus 281 ~Rps~~ell~hp~~~~~ 297 (406)
+|||+.++++|||++..
T Consensus 246 ~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 246 KRPSAAELLQHPFIKKA 262 (264)
T ss_pred hCCCHHHHHhCHHHHhc
Confidence 99999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=304.20 Aligned_cols=254 Identities=25% Similarity=0.399 Sum_probs=200.8
Q ss_pred eeeccccccccceeeecCceeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccC-CCCCCccc--
Q psy5368 37 VRSDTVRSGTVRYDIVGSSTIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNL-RAPEGRKR-- 111 (406)
Q Consensus 37 ~~~d~~~~~~~~~~i~~~~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~-- 111 (406)
+..+.......+|. ....+|+|+||.||++... .+.+++|..... ......+.+|+.++.++ +|||+++.
T Consensus 12 ~~~~~~~~~~~~y~----~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~ 86 (291)
T cd06639 12 LGLESLGDPTDTWE----IIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYG 86 (291)
T ss_pred hhcccCCCCCCCeE----EEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEE
Confidence 44455555667773 3456799999999999863 345677765432 22345678899999999 89997661
Q ss_pred ---------CCeEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCe
Q psy5368 112 ---------PRYVYIILEYCDGGDLCSFIRS----HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNT 177 (406)
Q Consensus 112 ---------~~~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~ 177 (406)
.+..|+||||+++++|.++++. ...+++..+..++.|++.||.|||+.|++|+||||+||+++ ++.
T Consensus 87 ~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred EEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC
Confidence 2468999999999999998853 35789999999999999999999999999999999999998 668
Q ss_pred eEEEecccccccCCCC-CCCcccCCCCCCChhhhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy5368 178 LKLADFGFAQFLAPND-QGDSIQGSPLYMAPEILAGS-----PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQAL 251 (406)
Q Consensus 178 ~kL~DFGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 251 (406)
++|+|||++....... ......|+..|+|||.+... .++.++||||+||++|+|++|+.||...........+.
T Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~ 246 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP 246 (291)
T ss_pred EEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHh
Confidence 9999999987654332 22345688999999998653 26889999999999999999999998876655554444
Q ss_pred hcCCCCC-CCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy5368 252 SSAPITI-PPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPD 295 (406)
Q Consensus 252 ~~~~~~~-~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~ 295 (406)
....... .+...+..+.+|+.+||+.+|++||++.++++||||+
T Consensus 247 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 247 RNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred cCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 4433222 1235778899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=316.41 Aligned_cols=235 Identities=23% Similarity=0.264 Sum_probs=183.1
Q ss_pred ceeeecceeeeEEEeeeeee--ceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 55 STIRYGELQYDTVQNSQIRL--GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
....||+|+||.||++.... ..+++|... ......|+.++++++|||+++ ..+..|+|||++.+ +
T Consensus 70 ~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 142 (357)
T PHA03209 70 VIKTLTPGSEGRVFVATKPGQPDPVVLKIGQ------KGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-D 142 (357)
T ss_pred EEEEecCCCCeEEEEEEECCCCceEEEEeCC------ccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccCC-c
Confidence 34578999999999999754 356666432 223467999999999999876 56678999999964 8
Q ss_pred HHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCC
Q psy5368 127 LCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLY 204 (406)
Q Consensus 127 L~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y 204 (406)
|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++............||+.|
T Consensus 143 l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y 222 (357)
T PHA03209 143 LYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVET 222 (357)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccccccccccc
Confidence 99888654 5799999999999999999999999999999999999999 679999999999765444444556799999
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCH----------HHHHHHHHh--cCCCCCC------------
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALFGHAP-YASCNL----------SQLRAQALS--SAPITIP------------ 259 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p-f~~~~~----------~~~~~~~~~--~~~~~~~------------ 259 (406)
+|||++.+..++.++|||||||++|||+++..| |..... ..+...+.. ..+...+
T Consensus 223 ~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (357)
T PHA03209 223 NAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFI 302 (357)
T ss_pred cCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHH
Confidence 999999999999999999999999999985444 433211 011111100 0000000
Q ss_pred -----------------CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy5368 260 -----------------PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 260 -----------------~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 296 (406)
...++.++.+||.+||+.||++|||++|+++||||+.
T Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 303 EYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred hhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 1145677888999999999999999999999999974
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=300.32 Aligned_cols=241 Identities=25% Similarity=0.389 Sum_probs=196.3
Q ss_pred ceeeecceeeeEEEeeee--eeceeEEeeeecCCcc------chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEe
Q psy5368 55 STIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTIT------SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILE 120 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~------~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E 120 (406)
....||+|++|.||.+.. .+..+++|.+...... ....+.+|+..++.++|+|++. ..+..++|+|
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 83 (268)
T cd06630 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVE 83 (268)
T ss_pred ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEe
Confidence 346789999999999875 3456788876543211 2357889999999999999765 6678899999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC-eeEEEecccccccCCCCC----
Q psy5368 121 YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN-TLKLADFGFAQFLAPNDQ---- 194 (406)
Q Consensus 121 ~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~-~~kL~DFGla~~~~~~~~---- 194 (406)
|+++++|.+++.+.+++++..+..++.||+.||.|||++|++|+||+|.||+++ ++ .++|+|||++........
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 163 (268)
T cd06630 84 WMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE 163 (268)
T ss_pred ccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCc
Confidence 999999999998888999999999999999999999999999999999999998 43 699999999877653321
Q ss_pred -CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhcCCCCCCCCCCChHHHHH
Q psy5368 195 -GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQA---LSSAPITIPPNSLSPDCMDF 270 (406)
Q Consensus 195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~s~~l~~l 270 (406)
.....++..|+|||.+.+..++.++|+||+||++++|++|..||...........+ .........+..+++++.++
T Consensus 164 ~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (268)
T cd06630 164 FQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDV 243 (268)
T ss_pred cccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHH
Confidence 22346788999999998888999999999999999999999999765432222222 11112222233688999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCCC
Q psy5368 271 LSRLLQKDPMRRISYEDLFSHPYPD 295 (406)
Q Consensus 271 i~~~L~~dP~~Rps~~ell~hp~~~ 295 (406)
+.+||..+|.+||++.++++||||+
T Consensus 244 i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 244 TLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHcCCCcccCcCHHHHhcCcccC
Confidence 9999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=298.36 Aligned_cols=238 Identities=26% Similarity=0.479 Sum_probs=201.9
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...+|+|+||.+|.+.. .+..+++|.+.... .....++.+|+.++++++|||+++ ..++.|+|+||++++
T Consensus 5 ~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08218 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGG 84 (256)
T ss_pred EEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCC
Confidence 45788999999998876 34567888776432 223457899999999999999665 667899999999999
Q ss_pred CHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC-CCcccCC
Q psy5368 126 DLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ-GDSIQGS 201 (406)
Q Consensus 126 sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~-~~~~~gt 201 (406)
+|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++ ++.++|+|||++........ .....|+
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 164 (256)
T cd08218 85 DLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGT 164 (256)
T ss_pred cHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhhccCC
Confidence 9999997643 589999999999999999999999999999999999998 67999999999976544322 2334578
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
+.|+|||++.+..++.++|+|||||++++|++|..||...+..+....+..+.....+ ..++.++.+++.+||+.+|.+
T Consensus 165 ~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~ 243 (256)
T cd08218 165 PYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVS-SHYSYDLRNLVSQLFKRNPRD 243 (256)
T ss_pred ccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCc-ccCCHHHHHHHHHHhhCChhh
Confidence 8999999999988999999999999999999999999988888777777666544433 468999999999999999999
Q ss_pred CCCHHHHhcCCCC
Q psy5368 282 RISYEDLFSHPYP 294 (406)
Q Consensus 282 Rps~~ell~hp~~ 294 (406)
||++.++++||||
T Consensus 244 Rp~~~~vl~~~~~ 256 (256)
T cd08218 244 RPSVNSILEKNFI 256 (256)
T ss_pred CcCHHHHhhCcCC
Confidence 9999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=304.31 Aligned_cols=234 Identities=22% Similarity=0.381 Sum_probs=193.9
Q ss_pred eeeecceeeeEEEeeeee-------eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEecc
Q psy5368 56 TIRYGELQYDTVQNSQIR-------LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYC 122 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~-------~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~ 122 (406)
...+|+|+||.||.+... ...+++|.+..........+.+|+.++.+++|||+++ ..+..++||||+
T Consensus 10 ~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (288)
T cd05093 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYM 89 (288)
T ss_pred ccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcC
Confidence 445788899999888642 2346677665544444567999999999999999766 567789999999
Q ss_pred CCCCHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccc
Q psy5368 123 DGGDLCSFIRSHE-------------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQF 188 (406)
Q Consensus 123 ~ggsL~~~l~~~~-------------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~ 188 (406)
++++|.+++...+ .+++..+..++.|++.||+|||++|++||||||+||+++ ++.++|+|||+++.
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 169 (288)
T cd05093 90 KHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRD 169 (288)
T ss_pred CCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCcccc
Confidence 9999999997543 489999999999999999999999999999999999998 67899999999976
Q ss_pred cCCCCC---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q psy5368 189 LAPNDQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLS 264 (406)
Q Consensus 189 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s 264 (406)
...... .....+++.|+|||++.+..++.++|+|||||++|+|++ |..||......+....+........ +..++
T Consensus 170 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~~-~~~~~ 248 (288)
T cd05093 170 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQR-PRTCP 248 (288)
T ss_pred ccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCCC-CCCCC
Confidence 543221 223345778999999999889999999999999999998 9999998888777777766644433 33688
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 265 PDCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 265 ~~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
.++.+|+.+||+.||.+|||+.++++
T Consensus 249 ~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 249 KEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHH
Confidence 99999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=297.53 Aligned_cols=239 Identities=31% Similarity=0.523 Sum_probs=197.8
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...||+|++|.||++.. .+..+++|.+...... ....+.+|+.+++.++|+|+++ ..+.+++|+||++++
T Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (264)
T cd06626 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGG 84 (264)
T ss_pred eeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCC
Confidence 46789999999999986 3456788877655443 4567899999999999999665 567889999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC-----Cccc
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG-----DSIQ 199 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~-----~~~~ 199 (406)
+|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.+||+|||++......... ....
T Consensus 85 ~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~ 164 (264)
T cd06626 85 TLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA 164 (264)
T ss_pred cHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCc
Confidence 9999998877899999999999999999999999999999999999999 678999999998776543321 1346
Q ss_pred CCCCCCChhhhcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCCCCCCC-CCChHHHHHHHHh
Q psy5368 200 GSPLYMAPEILAGSP---YNAKADLWSLGVLVFEALFGHAPYASCN-LSQLRAQALSSAPITIPPN-SLSPDCMDFLSRL 274 (406)
Q Consensus 200 gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~-~~s~~l~~li~~~ 274 (406)
+++.|+|||++.+.. ++.++||||||++++++++|..||.... .......+........+.. .+++.+.+++.+|
T Consensus 165 ~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 244 (264)
T cd06626 165 GTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRC 244 (264)
T ss_pred CCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHH
Confidence 788999999998766 8899999999999999999999997653 3333333333333333332 4589999999999
Q ss_pred cccCCCCCCCHHHHhcCCCC
Q psy5368 275 LQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 275 L~~dP~~Rps~~ell~hp~~ 294 (406)
|+.+|.+|||+.+++.|||+
T Consensus 245 l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 245 LESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ccCCcccCCCHHHHhcCCCC
Confidence 99999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=304.08 Aligned_cols=239 Identities=25% Similarity=0.389 Sum_probs=188.2
Q ss_pred eecceeeeEEEeeeee--eceeEEeeeecCCccc---hhhhhhHHh---hcccCCCCCCcc------cCCeEEEEEeccC
Q psy5368 58 RYGELQYDTVQNSQIR--LGTVKYSQVRYDTITS---HSEFERPRA---GLSNLRAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~---~~~~~~E~~---~l~~l~h~ni~~------~~~~~~lV~E~~~ 123 (406)
.||+|+||.||++... +..+++|.+....... ...+.+|.. ++...+|||++. ..+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4799999999999864 4567888765543221 223344443 344457888654 5678899999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCC
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSP 202 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~ 202 (406)
+++|.+++..++.+++..+..++.|++.||+|||++||+|+||||+||+++ ++.++|+|||++....... .....|++
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~ 159 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTH 159 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcCCCc
Confidence 999999998888899999999999999999999999999999999999998 6799999999986554322 23456899
Q ss_pred CCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCC
Q psy5368 203 LYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLS--QLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 203 ~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP 279 (406)
.|+|||.+.+ ..++.++|+||+||++|+|++|..||...... .............. +..+++++.+++.+||..||
T Consensus 160 ~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p 238 (279)
T cd05633 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVEL-PDSFSPELKSLLEGLLQRDV 238 (279)
T ss_pred CccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCC-ccccCHHHHHHHHHHhcCCH
Confidence 9999999874 55899999999999999999999999754321 11122222222233 33689999999999999999
Q ss_pred CCCC-----CHHHHhcCCCCCCCC
Q psy5368 280 MRRI-----SYEDLFSHPYPDLIH 298 (406)
Q Consensus 280 ~~Rp-----s~~ell~hp~~~~~~ 298 (406)
.+|| |++++++||||+...
T Consensus 239 ~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 239 SKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred HHhcCCCCCCHHHHHhCccccCCC
Confidence 9999 699999999999765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=296.94 Aligned_cols=238 Identities=23% Similarity=0.402 Sum_probs=201.5
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
-+.+|+|+||.||.+.. .+..+++|.+.... .....++.+|+.++++++|+|+++ ..+..++|||||+++
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (256)
T cd08221 5 IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGG 84 (256)
T ss_pred eeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCC
Confidence 45678888887766664 34567777765443 334557889999999999999765 667889999999999
Q ss_pred CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCC
Q psy5368 126 DLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGS 201 (406)
Q Consensus 126 sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt 201 (406)
+|.+++... ..+++.++..++.|++.||.|||+.|++|+||+|+||+++ ++.+||+|||++....... ......++
T Consensus 85 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (256)
T cd08221 85 TLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGT 164 (256)
T ss_pred cHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccccCCC
Confidence 999999765 4689999999999999999999999999999999999999 6689999999997764443 33456689
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
+.|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+....+........+ ..++.++.+++.+||..+|.+
T Consensus 165 ~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~ 243 (256)
T cd08221 165 PYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV-SVYSSELISLVHSLLQQDPEK 243 (256)
T ss_pred ccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc-cccCHHHHHHHHHHcccCccc
Confidence 9999999999888999999999999999999999999998888877777665444333 468999999999999999999
Q ss_pred CCCHHHHhcCCCC
Q psy5368 282 RISYEDLFSHPYP 294 (406)
Q Consensus 282 Rps~~ell~hp~~ 294 (406)
||+++++++|||+
T Consensus 244 R~s~~~ll~~~~l 256 (256)
T cd08221 244 RPTADEVLDQPLL 256 (256)
T ss_pred CCCHHHHhhCcCC
Confidence 9999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=302.12 Aligned_cols=238 Identities=26% Similarity=0.386 Sum_probs=189.0
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...||+|++|.||++... +..+++|.+..... .....+.+|+.++.+++|||+++ .++.+|+||||++ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (285)
T cd07861 5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-M 83 (285)
T ss_pred eeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-C
Confidence 356899999999999864 45678887654332 22456889999999999999765 6678999999997 5
Q ss_pred CHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccC
Q psy5368 126 DLCSFIRSH---EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQG 200 (406)
Q Consensus 126 sL~~~l~~~---~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~g 200 (406)
+|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||+++ ++.++|+|||++....... ......+
T Consensus 84 ~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 163 (285)
T cd07861 84 DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV 163 (285)
T ss_pred CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccCCcc
Confidence 999988643 4689999999999999999999999999999999999998 7799999999987654322 2233456
Q ss_pred CCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-------------------------
Q psy5368 201 SPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSA------------------------- 254 (406)
Q Consensus 201 t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~------------------------- 254 (406)
++.|+|||.+.+. .++.++|+||+||++|+|+||++||.+.+............
T Consensus 164 ~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (285)
T cd07861 164 TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWK 243 (285)
T ss_pred cccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccC
Confidence 8899999998764 47899999999999999999999998765433222221100
Q ss_pred --CCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 255 --PITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 255 --~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
........+++++.++|.+||+.||++|||+.++++||||
T Consensus 244 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 244 KGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred cchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0000112478999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=321.58 Aligned_cols=240 Identities=22% Similarity=0.379 Sum_probs=207.3
Q ss_pred ceeeecceeeeEEEeeeeeecee--EEeeeecCC----ccchhhhhhHHhhcccCCCCCCcc--------cCCeEEEEEe
Q psy5368 55 STIRYGELQYDTVQNSQIRLGTV--KYSQVRYDT----ITSHSEFERPRAGLSNLRAPEGRK--------RPRYVYIILE 120 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~~~v--~vk~~~~~~----~~~~~~~~~E~~~l~~l~h~ni~~--------~~~~~~lV~E 120 (406)
-..+||+|+|-+||+|-.....+ |+-.++... .....+|..|+.+|+.|+||||++ ..+++.+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 35689999999999998755544 444443322 223468999999999999999876 5567889999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCcceEee--CCeeEEEecccccccCCCCCCC
Q psy5368 121 YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENN--VCHFDLKPQNILIK--NNTLKLADFGFAQFLAPNDQGD 196 (406)
Q Consensus 121 ~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dlkp~NIll~--~~~~kL~DFGla~~~~~~~~~~ 196 (406)
++..|+|..|+++.+..+.+.++.+++||++||.|||++. |+|||||.+||+|+ .|.+||+|+|||..+..+.. .
T Consensus 124 L~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a-k 202 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA-K 202 (632)
T ss_pred cccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc-c
Confidence 9999999999999999999999999999999999999986 99999999999999 67999999999987765444 4
Q ss_pred cccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhc
Q psy5368 197 SIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYAS-CNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL 275 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L 275 (406)
+.+|||.|||||+.. ..|+..+||||||++++||.|+..||.. .+...+..++.++..+.....--.+++++||.+||
T Consensus 203 svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl 281 (632)
T KOG0584|consen 203 SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCL 281 (632)
T ss_pred eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHh
Confidence 489999999999998 6699999999999999999999999976 46888899998886665544444789999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCC
Q psy5368 276 QKDPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 276 ~~dP~~Rps~~ell~hp~~~~~ 297 (406)
.. .++|||+.|+|.||||+..
T Consensus 282 ~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 282 AT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred cC-chhccCHHHHhhChhhccc
Confidence 99 9999999999999999875
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=302.84 Aligned_cols=240 Identities=26% Similarity=0.449 Sum_probs=200.3
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
-..||+|+||.||++... +..+++|.+.... ......+.+|+.+++.++|||+++ ..+..|+||||++|++
T Consensus 9 ~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06640 9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGS 88 (277)
T ss_pred hhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCc
Confidence 356899999999999864 4567887665433 233557889999999999999765 6678999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCCC
Q psy5368 127 LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPLY 204 (406)
Q Consensus 127 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~y 204 (406)
|.+++.. +++++..+..++.|++.||+|||+.+++|+||+|+||+++ ++.++|+|||++....... ......++..|
T Consensus 89 L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y 167 (277)
T cd06640 89 ALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFW 167 (277)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccccCcccc
Confidence 9999865 5789999999999999999999999999999999999999 6789999999997664433 22334578899
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRIS 284 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps 284 (406)
+|||.+.+..++.++|+|||||++|+|++|..||...+.......+........ +..++..+.+++.+||+.+|++||+
T Consensus 168 ~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~ 246 (277)
T cd06640 168 MAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTL-TGEFSKPFKEFIDACLNKDPSFRPT 246 (277)
T ss_pred cCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCC-chhhhHHHHHHHHHHcccCcccCcC
Confidence 999999988899999999999999999999999988776665554443333322 2357889999999999999999999
Q ss_pred HHHHhcCCCCCCC
Q psy5368 285 YEDLFSHPYPDLI 297 (406)
Q Consensus 285 ~~ell~hp~~~~~ 297 (406)
++++++||||...
T Consensus 247 ~~~il~~~~~~~~ 259 (277)
T cd06640 247 AKELLKHKFIVKN 259 (277)
T ss_pred HHHHHhChHhhhc
Confidence 9999999998644
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=298.11 Aligned_cols=232 Identities=18% Similarity=0.352 Sum_probs=192.0
Q ss_pred eecceeeeEEEeeeee----eceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCCCCH
Q psy5368 58 RYGELQYDTVQNSQIR----LGTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~----~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ggsL 127 (406)
.||+|+||.||++.+. ...+++|....... .....+.+|+.++++++|||+++ .....++||||+++++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L 81 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL 81 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence 4899999999998764 22477776654432 22456899999999999999865 44568999999999999
Q ss_pred HHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC----CcccCC
Q psy5368 128 CSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG----DSIQGS 201 (406)
Q Consensus 128 ~~~l~~-~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~----~~~~gt 201 (406)
.+++.. ...+++..+..++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++......... ....++
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 161 (257)
T cd05115 82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWP 161 (257)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCC
Confidence 999975 35799999999999999999999999999999999999998 668999999999765433221 112235
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPM 280 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~ 280 (406)
+.|+|||.+.+..++.++|||||||++|++++ |..||.+....+....+..+.....+ ..+++++.+++.+||..+|+
T Consensus 162 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~c~~~~~~ 240 (257)
T cd05115 162 LKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCP-AECPPEMYALMKDCWIYKWE 240 (257)
T ss_pred cccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCC-CCCCHHHHHHHHHHcCCChh
Confidence 68999999998889999999999999999996 99999988887777766666554444 36899999999999999999
Q ss_pred CCCCHHHHhc
Q psy5368 281 RRISYEDLFS 290 (406)
Q Consensus 281 ~Rps~~ell~ 290 (406)
+||++.++.+
T Consensus 241 ~Rp~~~~i~~ 250 (257)
T cd05115 241 DRPNFAKVEE 250 (257)
T ss_pred hCcCHHHHHH
Confidence 9999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=304.98 Aligned_cols=243 Identities=23% Similarity=0.407 Sum_probs=200.1
Q ss_pred eeeecceeeeEEEeeeeee--ceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIRL--GTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...+|+|+||.||++.... ..+++|.+..... .....+.+|+.+++.++|||+++ ..++.|+||||++|
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (305)
T cd05609 6 IKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEG 85 (305)
T ss_pred eeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 3567889999999888643 4678887665432 22446789999999999999765 56778999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC----------
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND---------- 193 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~---------- 193 (406)
++|.+++...+.+++..+..++.|++.||.|||++|++|+||||.||+++ ++.++|+|||+++......
T Consensus 86 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 165 (305)
T cd05609 86 GDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIE 165 (305)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccc
Confidence 99999998888899999999999999999999999999999999999999 6799999999986421100
Q ss_pred ------CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCCCCCCChH
Q psy5368 194 ------QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI-TIPPNSLSPD 266 (406)
Q Consensus 194 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~s~~ 266 (406)
......++..|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+........... ......++.+
T Consensus 166 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (305)
T cd05609 166 KDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPAD 245 (305)
T ss_pred cchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHH
Confidence 011235788899999999888999999999999999999999999988887777766654322 1122268899
Q ss_pred HHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCC
Q psy5368 267 CMDFLSRLLQKDPMRRIS---YEDLFSHPYPDLIH 298 (406)
Q Consensus 267 l~~li~~~L~~dP~~Rps---~~ell~hp~~~~~~ 298 (406)
+.+++.+||+.||++||+ +.++++||||....
T Consensus 246 ~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 246 AQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280 (305)
T ss_pred HHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence 999999999999999998 79999999997543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=314.54 Aligned_cols=248 Identities=22% Similarity=0.373 Sum_probs=209.9
Q ss_pred CceeeecceeeeEEEeeeeeec--eeEEeeeecC---CccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEecc
Q psy5368 54 SSTIRYGELQYDTVQNSQIRLG--TVKYSQVRYD---TITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYC 122 (406)
Q Consensus 54 ~~~~~lG~G~~g~Vy~~~~~~~--~v~vk~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~ 122 (406)
+.-.+||+|+||.|+.+..+.+ -.|.|++.+. ........++|-.+|.+++.+-+|. +.+.+|+||..|
T Consensus 188 ~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlM 267 (591)
T KOG0986|consen 188 RVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLM 267 (591)
T ss_pred eeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEee
Confidence 5567899999999999987543 2344443322 2234456788999999999997665 888999999999
Q ss_pred CCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCccc
Q psy5368 123 DGGDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQ 199 (406)
Q Consensus 123 ~ggsL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~ 199 (406)
.||||.-+|.+.+ .|++..++.++.+|+.||++||+.+||+|||||+|||+| .|+++|+|+|+|..+.........+
T Consensus 268 NGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~rv 347 (591)
T KOG0986|consen 268 NGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRGRV 347 (591)
T ss_pred cCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCcccccc
Confidence 9999999997665 799999999999999999999999999999999999999 7899999999999998888888889
Q ss_pred CCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhcCCCCCCCCCCChHHHHHHHHhc
Q psy5368 200 GSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLS----QLRAQALSSAPITIPPNSLSPDCMDFLSRLL 275 (406)
Q Consensus 200 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L 275 (406)
||.+|||||++.+..|+...|.||+||+||||+.|+.||...... ++...+. .....++ ..+|+++++|...+|
T Consensus 348 GT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~-~~~~ey~-~kFS~eakslc~~LL 425 (591)
T KOG0986|consen 348 GTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL-EDPEEYS-DKFSEEAKSLCEGLL 425 (591)
T ss_pred CcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh-cchhhcc-cccCHHHHHHHHHHH
Confidence 999999999999999999999999999999999999999775433 3333333 3344444 589999999999999
Q ss_pred ccCCCCCCC-----HHHHhcCCCCCCCCCCCcc
Q psy5368 276 QKDPMRRIS-----YEDLFSHPYPDLIHAPCAE 303 (406)
Q Consensus 276 ~~dP~~Rps-----~~ell~hp~~~~~~~~~~~ 303 (406)
+.||.+|.. +.++.+||||+...++..+
T Consensus 426 ~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rle 458 (591)
T KOG0986|consen 426 TKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLE 458 (591)
T ss_pred ccCHHHhccCCCcCcchhhhCcccccCCHhHHh
Confidence 999999984 6799999999998876544
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=302.24 Aligned_cols=235 Identities=20% Similarity=0.358 Sum_probs=193.5
Q ss_pred eeeecceeeeEEEeeee------eeceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEecc
Q psy5368 56 TIRYGELQYDTVQNSQI------RLGTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYC 122 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~------~~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~ 122 (406)
...||+|+||.||+|.. ....+++|.+..... .....+.+|+.+++.++|||+++ .....|+||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 89 (283)
T cd05090 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYL 89 (283)
T ss_pred eeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcC
Confidence 35789999999999875 224577777654332 22357889999999999999765 557789999999
Q ss_pred CCCCHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecc
Q psy5368 123 DGGDLCSFIRSH-----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFG 184 (406)
Q Consensus 123 ~ggsL~~~l~~~-----------------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFG 184 (406)
++++|.+++..+ ..+++..+..++.|++.||.|||++|++|+||||+|||++ ++.+||+|||
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg 169 (283)
T cd05090 90 NQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLG 169 (283)
T ss_pred CCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEecccc
Confidence 999999998532 2478899999999999999999999999999999999999 6689999999
Q ss_pred cccccCCCC---CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCC
Q psy5368 185 FAQFLAPND---QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPP 260 (406)
Q Consensus 185 la~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (406)
+++...... ......++..|+|||++.+..++.++|+|||||++|||++ |..||.+.....+...+........+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 248 (283)
T cd05090 170 LSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCS- 248 (283)
T ss_pred ccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC-
Confidence 997654332 1233345677999999998889999999999999999998 99999888777776666655444433
Q ss_pred CCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 261 NSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 261 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
..+++.+.+++.+||+.||.+||++.+++++
T Consensus 249 ~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 249 EDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred CCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 3689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=303.56 Aligned_cols=234 Identities=22% Similarity=0.384 Sum_probs=194.1
Q ss_pred eeeecceeeeEEEeeeeee-------ceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEecc
Q psy5368 56 TIRYGELQYDTVQNSQIRL-------GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYC 122 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-------~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~ 122 (406)
...||+|+||.||.+.... ..+++|............+.+|+.++++++|+|+++ .....++||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (291)
T cd05094 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYM 89 (291)
T ss_pred eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecC
Confidence 3568899999999887432 236666665554444567999999999999999766 566789999999
Q ss_pred CCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEeccc
Q psy5368 123 DGGDLCSFIRSHE----------------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGF 185 (406)
Q Consensus 123 ~ggsL~~~l~~~~----------------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGl 185 (406)
++++|.+++..++ .+++..+..++.||+.||+|||++|++||||||+||+++ ++.++|+|||+
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~ 169 (291)
T cd05094 90 KHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGM 169 (291)
T ss_pred CCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCc
Confidence 9999999997643 389999999999999999999999999999999999999 67999999999
Q ss_pred ccccCCCC---CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q psy5368 186 AQFLAPND---QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPN 261 (406)
Q Consensus 186 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (406)
+....... ......+++.|+|||++.+..++.++|||||||++|+|+| |..||...+..+....+........ +.
T Consensus 170 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-~~ 248 (291)
T cd05094 170 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLER-PR 248 (291)
T ss_pred ccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCCCC-Cc
Confidence 97654322 1233446788999999999999999999999999999999 9999988887777666655544333 33
Q ss_pred CCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 262 SLSPDCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 262 ~~s~~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
.+|..+.+++.+||+.+|++|||+.++++
T Consensus 249 ~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 249 VCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 67899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=299.42 Aligned_cols=239 Identities=28% Similarity=0.430 Sum_probs=193.5
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc----------chhhhhhHHhhcccCCCCCCcc------cCCeEEE
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT----------SHSEFERPRAGLSNLRAPEGRK------RPRYVYI 117 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~----------~~~~~~~E~~~l~~l~h~ni~~------~~~~~~l 117 (406)
...||+|++|.||++... +..+++|.+...... ..+.+.+|+.++..++|||+++ ..+..++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI 85 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence 457899999999999753 456788866532111 1235778999999999999765 6678899
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC---
Q psy5368 118 ILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND--- 193 (406)
Q Consensus 118 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~--- 193 (406)
||||+++++|.+++...+.+++..+..++.||+.||.|||++|++|+||+|+||+++ ++.++|+|||++.......
T Consensus 86 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 165 (272)
T cd06629 86 FLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDND 165 (272)
T ss_pred EEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccccccc
Confidence 999999999999998888899999999999999999999999999999999999998 7799999999987654321
Q ss_pred CCCcccCCCCCCChhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCC---CCCChHH
Q psy5368 194 QGDSIQGSPLYMAPEILAGSP--YNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSA-PITIPP---NSLSPDC 267 (406)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~---~~~s~~l 267 (406)
......++..|+|||.+.... ++.++|+||+|+++|++++|..||...........+.... ....+. ..++.++
T Consensus 166 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (272)
T cd06629 166 QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVA 245 (272)
T ss_pred ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHH
Confidence 123345788999999988754 7889999999999999999999997665444333332221 222222 2568999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 268 MDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 268 ~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
.+++.+||..+|.+|||++++++|||+
T Consensus 246 ~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 246 LDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred HHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=296.85 Aligned_cols=230 Identities=24% Similarity=0.401 Sum_probs=195.6
Q ss_pred eeeecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc-------cCCeEEEEEeccCCCCHH
Q psy5368 56 TIRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK-------RPRYVYIILEYCDGGDLC 128 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~-------~~~~~~lV~E~~~ggsL~ 128 (406)
...+|+|+||.||++...+..+++|..... .....+.+|+.++++++|+|+++ ..+..|+||||+++++|.
T Consensus 11 ~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~ 88 (256)
T cd05082 11 LQTIGKGEFGDVMLGDYRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 88 (256)
T ss_pred eeeecccCCCeEEEEEEcCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHH
Confidence 356899999999999888888888876543 23457899999999999999765 445689999999999999
Q ss_pred HHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCCC
Q psy5368 129 SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLYM 205 (406)
Q Consensus 129 ~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y~ 205 (406)
+++.++. .+++..+..++.|++.||+|||++|++||||||+||+++ ++.+||+|||++....... ....++..|+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~ 166 (256)
T cd05082 89 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWT 166 (256)
T ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC--CCCccceeec
Confidence 9997654 489999999999999999999999999999999999998 7799999999987653322 2334466799
Q ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCC
Q psy5368 206 APEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRIS 284 (406)
Q Consensus 206 aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps 284 (406)
|||++.+..++.++|||||||++|+|++ |+.||...+.......+........+ ..+++.+.+++.+||+.+|++|||
T Consensus 167 aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rpt 245 (256)
T cd05082 167 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP-DGCPPVVYDVMKQCWHLDAATRPS 245 (256)
T ss_pred CHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC-CCCCHHHHHHHHHHhcCChhhCcC
Confidence 9999999889999999999999999998 99999988888877776655443333 468999999999999999999999
Q ss_pred HHHHhc
Q psy5368 285 YEDLFS 290 (406)
Q Consensus 285 ~~ell~ 290 (406)
+.++++
T Consensus 246 ~~~l~~ 251 (256)
T cd05082 246 FLQLRE 251 (256)
T ss_pred HHHHHH
Confidence 999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=297.66 Aligned_cols=233 Identities=19% Similarity=0.360 Sum_probs=195.4
Q ss_pred eeecceeeeEEEeeeeee-----ceeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCCC
Q psy5368 57 IRYGELQYDTVQNSQIRL-----GTVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDGG 125 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~-----~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~gg 125 (406)
++||+|+||.||++.... ..+++|........ ....+.+|+.+++.+.|||+++ .....++||||++++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 368999999999997633 35777776655432 3557899999999999999766 445679999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC----CcccC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG----DSIQG 200 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~----~~~~g 200 (406)
+|.+++.....+++..+..++.|++.||+|||+.|++|+||||+||+++ ++.+||+|||+++........ ....+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05060 81 PLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRW 160 (257)
T ss_pred cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccc
Confidence 9999998888899999999999999999999999999999999999999 678999999999866443321 11123
Q ss_pred CCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCC
Q psy5368 201 SPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 201 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP 279 (406)
+..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+........+ ..++..+.+++.+||..+|
T Consensus 161 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~~p 239 (257)
T cd05060 161 PLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRP-EECPQEIYSIMLSCWKYRP 239 (257)
T ss_pred cccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCC-CCCCHHHHHHHHHHhcCCh
Confidence 467999999999899999999999999999998 99999988877777666655444333 4688999999999999999
Q ss_pred CCCCCHHHHhc
Q psy5368 280 MRRISYEDLFS 290 (406)
Q Consensus 280 ~~Rps~~ell~ 290 (406)
++||++.++++
T Consensus 240 ~~Rp~~~~l~~ 250 (257)
T cd05060 240 EDRPTFSELES 250 (257)
T ss_pred hhCcCHHHHHH
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=304.38 Aligned_cols=246 Identities=28% Similarity=0.396 Sum_probs=196.9
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccc--hhhhhhHHhhcccCCCCCCcc--------cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITS--HSEFERPRAGLSNLRAPEGRK--------RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~--~~~~~~E~~~l~~l~h~ni~~--------~~~~~~lV~E~~~ 123 (406)
...||+|+||.||++... +..+++|.+....... ...+.+|+.++++++|+|+++ ..+.+++||||+.
T Consensus 12 ~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 91 (309)
T cd07845 12 LNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE 91 (309)
T ss_pred eeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC
Confidence 446788999999998864 4567888776443222 335678999999999999765 2256899999997
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccC
Q psy5368 124 GGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQG 200 (406)
Q Consensus 124 ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~g 200 (406)
+ +|.+++... ..+++..+..++.||+.||+|||+.|++|+||||+||+++ ++.+||+|||++....... ......+
T Consensus 92 ~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~ 170 (309)
T cd07845 92 Q-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV 170 (309)
T ss_pred C-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCCCCcccc
Confidence 5 899988753 5799999999999999999999999999999999999998 6799999999998765432 2233346
Q ss_pred CCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC------------------CCCC-
Q psy5368 201 SPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI------------------TIPP- 260 (406)
Q Consensus 201 t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------------------~~~~- 260 (406)
++.|+|||.+.+ ..++.++||||+||++|+|++|.+||...+..+....+...... ..+.
T Consensus 171 ~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (309)
T cd07845 171 TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQ 250 (309)
T ss_pred cccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCC
Confidence 788999999876 45789999999999999999999999988776665555442110 0000
Q ss_pred ---------CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCc
Q psy5368 261 ---------NSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCA 302 (406)
Q Consensus 261 ---------~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~ 302 (406)
...++++.+||.+||+.||++|||+++++.||||+....|+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~ 301 (309)
T cd07845 251 PYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCE 301 (309)
T ss_pred CCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCC
Confidence 125788999999999999999999999999999998777654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=300.54 Aligned_cols=239 Identities=28% Similarity=0.442 Sum_probs=194.0
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...||+|++|.||++... +..+++|....... .....+.+|+.++++++|||+++ ....+|+||||+ ++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~ 83 (286)
T cd07832 5 LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PS 83 (286)
T ss_pred EeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CC
Confidence 356899999999999863 45778887765542 23457899999999999999765 567889999999 99
Q ss_pred CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC--CCCcccCC
Q psy5368 126 DLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND--QGDSIQGS 201 (406)
Q Consensus 126 sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~--~~~~~~gt 201 (406)
+|.+++... ..+++.++..++.||+.||.|||+.|++|+||||+||+++ ++.++|+|||++....... ......++
T Consensus 84 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 163 (286)
T cd07832 84 DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVAT 163 (286)
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCc
Confidence 999998653 5799999999999999999999999999999999999999 6799999999998765433 13345688
Q ss_pred CCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC------------------CC---
Q psy5368 202 PLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPIT------------------IP--- 259 (406)
Q Consensus 202 ~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~------------------~~--- 259 (406)
..|+|||++.+. .++.++||||+||++++|++|.+||.+.+.......+....... .+
T Consensus 164 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (286)
T cd07832 164 RWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESK 243 (286)
T ss_pred ccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCC
Confidence 999999998764 46899999999999999999999998776544443333211000 00
Q ss_pred -------CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy5368 260 -------PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPD 295 (406)
Q Consensus 260 -------~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~ 295 (406)
....+.++.+|+.+||..+|++|||++++++||||.
T Consensus 244 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 244 PIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 014578899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=320.39 Aligned_cols=234 Identities=24% Similarity=0.282 Sum_probs=185.1
Q ss_pred eeeecceeeeEEEeeeeee--ceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQIRL--GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
...||+|+||.||++.... ..|++|... ...+.+|++++++|+|+|+++ ..+..++|||++. ++|
T Consensus 174 ~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L 246 (461)
T PHA03211 174 HRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDL 246 (461)
T ss_pred EEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCH
Confidence 4578999999999998754 457777432 234678999999999999876 5677899999995 599
Q ss_pred HHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC---CCcccCCC
Q psy5368 128 CSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ---GDSIQGSP 202 (406)
Q Consensus 128 ~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~---~~~~~gt~ 202 (406)
.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....... .....||+
T Consensus 247 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~ 326 (461)
T PHA03211 247 YTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326 (461)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCc
Confidence 9988664 4699999999999999999999999999999999999999 67999999999976543321 22456999
Q ss_pred CCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhcCC--CCCC-------------
Q psy5368 203 LYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCN--------LSQLRAQALSSAP--ITIP------------- 259 (406)
Q Consensus 203 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~--------~~~~~~~~~~~~~--~~~~------------- 259 (406)
.|+|||++.+..++.++|||||||++|||++|..|+-... ...+...+..... ...+
T Consensus 327 ~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~ 406 (461)
T PHA03211 327 DTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRH 406 (461)
T ss_pred CCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHh
Confidence 9999999999999999999999999999999876543211 1222222221110 0000
Q ss_pred -----------C------CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy5368 260 -----------P------NSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 260 -----------~------~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 296 (406)
. ..++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 407 RAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred hhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0 134668999999999999999999999999999973
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=303.73 Aligned_cols=244 Identities=25% Similarity=0.446 Sum_probs=203.7
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHH
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLC 128 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~ 128 (406)
.+||+|+||.||++... +..+++|++..........+.+|+.+++.++|+|+++ ..++.|+||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 56899999999999874 4578888776544445667899999999999999765 567899999999999999
Q ss_pred HHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCCCCC
Q psy5368 129 SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPLYMA 206 (406)
Q Consensus 129 ~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~y~a 206 (406)
+++.. +.+++..+..++.|++.||+|||+.|++|+||+|+||+++ ++.++|+|||++....... ......+++.|+|
T Consensus 106 ~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~ 184 (292)
T cd06657 106 DIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 184 (292)
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCccccC
Confidence 98754 5789999999999999999999999999999999999999 6789999999987654332 2334568899999
Q ss_pred hhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC-CCCCChHHHHHHHHhcccCCCCCCCH
Q psy5368 207 PEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIP-PNSLSPDCMDFLSRLLQKDPMRRISY 285 (406)
Q Consensus 207 PE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~~li~~~L~~dP~~Rps~ 285 (406)
||.+.+..++.++|+||+|+++|+|++|..||.+.........+....+.... ...+++.+.+++.+||+.+|.+||++
T Consensus 185 pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~ 264 (292)
T cd06657 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATA 264 (292)
T ss_pred HHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCH
Confidence 99998888999999999999999999999999887766555544433332221 23578999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCC
Q psy5368 286 EDLFSHPYPDLIHAPC 301 (406)
Q Consensus 286 ~ell~hp~~~~~~~~~ 301 (406)
.+++.||||.....|+
T Consensus 265 ~~ll~~~~~~~~~~~~ 280 (292)
T cd06657 265 AELLKHPFLAKAGPPS 280 (292)
T ss_pred HHHhcChHHhccCCCc
Confidence 9999999998776544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=312.05 Aligned_cols=236 Identities=22% Similarity=0.371 Sum_probs=190.0
Q ss_pred eeeecceeeeEEEeeeeee-------ceeEEeeeecCCc-cchhhhhhHHhhcccC-CCCCCcc-------cCCeEEEEE
Q psy5368 56 TIRYGELQYDTVQNSQIRL-------GTVKYSQVRYDTI-TSHSEFERPRAGLSNL-RAPEGRK-------RPRYVYIIL 119 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-------~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~-------~~~~~~lV~ 119 (406)
...||+|+||.||++.... +.+++|.+..... .....+.+|+.++.++ +|+|+++ ....++++|
T Consensus 12 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ 91 (337)
T cd05054 12 GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 91 (337)
T ss_pred hcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEE
Confidence 4678999999999986422 4688887764332 2245678899999999 8999765 345688999
Q ss_pred eccCCCCHHHHHHhC-------------------------------------------------------------CCCC
Q psy5368 120 EYCDGGDLCSFIRSH-------------------------------------------------------------EKLS 138 (406)
Q Consensus 120 E~~~ggsL~~~l~~~-------------------------------------------------------------~~l~ 138 (406)
||+++++|.+++... .+++
T Consensus 92 ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 171 (337)
T cd05054 92 EYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLT 171 (337)
T ss_pred ecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCC
Confidence 999999999998542 2689
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC---CCCcccCCCCCCChhhhcCCC
Q psy5368 139 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND---QGDSIQGSPLYMAPEILAGSP 214 (406)
Q Consensus 139 ~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~ 214 (406)
+..+..++.||+.||.|||++||+||||||+|||++ ++.++|+|||++..+.... ......++..|+|||++.+..
T Consensus 172 ~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 251 (337)
T cd05054 172 LEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKV 251 (337)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCC
Confidence 999999999999999999999999999999999999 6799999999998754322 122344567899999999999
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 215 YNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 215 ~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
++.++||||+||++|||++ |..||.+....+..............+...++++.+++.+||+.+|++||+++++++|
T Consensus 252 ~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 252 YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999998 9999987654444333333322223334688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=297.46 Aligned_cols=240 Identities=28% Similarity=0.481 Sum_probs=195.4
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCCccc---hhhhhhHHhh-cccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITS---HSEFERPRAG-LSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~---~~~~~~E~~~-l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
..+|+|++|.||++... ++.+++|.+....... ...+..|..+ ....+|+|+++ ..+.+|+|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 35899999999999873 4578888775443221 2234445443 45568999765 56788999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|.||+++ ++.++|+|||++..... .....+++.
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~ 158 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTPD 158 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCcC
Confidence 99999998888899999999999999999999999999999999999998 67999999999875433 234568889
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCChHHHHHHHHhcccCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPIT--IPPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+....... .....+++++.+++.+||+.+|++
T Consensus 159 y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~ 238 (260)
T cd05611 159 YLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAK 238 (260)
T ss_pred ccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHH
Confidence 999999998889999999999999999999999999888777666554432211 112257899999999999999999
Q ss_pred CC---CHHHHhcCCCCCCCCC
Q psy5368 282 RI---SYEDLFSHPYPDLIHA 299 (406)
Q Consensus 282 Rp---s~~ell~hp~~~~~~~ 299 (406)
|| +++|+++||||+...+
T Consensus 239 R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 239 RLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred ccCCCcHHHHHcChHhhcCCC
Confidence 99 5579999999987654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=300.90 Aligned_cols=242 Identities=20% Similarity=0.331 Sum_probs=196.3
Q ss_pred eeeecceeeeEEEeeeee-------eceeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIR-------LGTVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~-------~~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~ 121 (406)
..+||+|+||.||+|... ...+++|.+.... ......+.+|+.+++.++|||+++ .....|+||||
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 90 (288)
T cd05061 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMEL 90 (288)
T ss_pred eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeC
Confidence 456899999999988653 2357777665332 122346788999999999999765 56678999999
Q ss_pred cCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccC
Q psy5368 122 CDGGDLCSFIRSH----------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLA 190 (406)
Q Consensus 122 ~~ggsL~~~l~~~----------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~ 190 (406)
+++|+|.+++... ..++...+..++.|++.||.|||++||+||||||+||+++ ++.++|+|||+++...
T Consensus 91 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~ 170 (288)
T cd05061 91 MAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY 170 (288)
T ss_pred CCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCcccccc
Confidence 9999999999653 2356778899999999999999999999999999999999 6799999999987553
Q ss_pred CCCC---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChH
Q psy5368 191 PNDQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPD 266 (406)
Q Consensus 191 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 266 (406)
.... .....++..|+|||.+.+..++.++|+|||||++|||++ |..||.+....+....+........+ ..+++.
T Consensus 171 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 249 (288)
T cd05061 171 ETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP-DNCPER 249 (288)
T ss_pred ccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCHH
Confidence 3221 122335677999999999889999999999999999998 89999988877777666655444333 367899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc------CCCCCCCC
Q psy5368 267 CMDFLSRLLQKDPMRRISYEDLFS------HPYPDLIH 298 (406)
Q Consensus 267 l~~li~~~L~~dP~~Rps~~ell~------hp~~~~~~ 298 (406)
+.+++.+||+.||++|||+.++++ ||||+...
T Consensus 250 ~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 250 VTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 999999999999999999999987 89998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=296.66 Aligned_cols=233 Identities=25% Similarity=0.419 Sum_probs=195.1
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
...||+|++|.||++... .+.+++|..... ......+.+|+.+++.++|||+++ ..+.+++||||+++++|
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (263)
T cd05052 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 89 (263)
T ss_pred eeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcH
Confidence 467899999999999875 456777766533 334567899999999999999765 56678999999999999
Q ss_pred HHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC--CcccCCC
Q psy5368 128 CSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG--DSIQGSP 202 (406)
Q Consensus 128 ~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~--~~~~gt~ 202 (406)
.+++... ..+++..+..++.|++.||+|||++|++|+||||+||+++ ++.+||+|||++......... ....+++
T Consensus 90 ~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~ 169 (263)
T cd05052 90 LDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 169 (263)
T ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCcc
Confidence 9999764 3589999999999999999999999999999999999998 679999999999776543221 1223456
Q ss_pred CCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCC
Q psy5368 203 LYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 203 ~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+........+ ..+|.++.+++.+||+.||++
T Consensus 170 ~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~p~~ 248 (263)
T cd05052 170 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERP-EGCPPKVYELMRACWQWNPSD 248 (263)
T ss_pred ccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC-CCCCHHHHHHHHHHccCCccc
Confidence 7999999999999999999999999999998 99999998887777776655444433 368999999999999999999
Q ss_pred CCCHHHHhc
Q psy5368 282 RISYEDLFS 290 (406)
Q Consensus 282 Rps~~ell~ 290 (406)
|||+.++++
T Consensus 249 Rp~~~~l~~ 257 (263)
T cd05052 249 RPSFAEIHQ 257 (263)
T ss_pred CCCHHHHHH
Confidence 999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=302.85 Aligned_cols=238 Identities=25% Similarity=0.427 Sum_probs=197.5
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
..||+|+||.||++... +..+++|...... ......+.+|+.++++++|||+++ ..+..|+||||+++++|
T Consensus 10 ~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (277)
T cd06642 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSA 89 (277)
T ss_pred HHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcH
Confidence 45899999999999864 3457777665433 233457889999999999999765 66779999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC-CCcccCCCCCC
Q psy5368 128 CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ-GDSIQGSPLYM 205 (406)
Q Consensus 128 ~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~-~~~~~gt~~y~ 205 (406)
.+++.. +.+++..+..++.|++.|+.|||++|++|+||+|+||+++ ++.++|+|||++........ .....++..|+
T Consensus 90 ~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~ 168 (277)
T cd06642 90 LDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWM 168 (277)
T ss_pred HHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcccCccccc
Confidence 998865 5789999999999999999999999999999999999998 67999999999876543322 23345788999
Q ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCCH
Q psy5368 206 APEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY 285 (406)
Q Consensus 206 aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~ 285 (406)
|||++.+..++.++|+|||||++|+|++|+.||...........+........ +..++.++.+++.+||..+|++||++
T Consensus 169 aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~ 247 (277)
T cd06642 169 APEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTL-EGQYSKPFKEFVEACLNKDPRFRPTA 247 (277)
T ss_pred CHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCC-CcccCHHHHHHHHHHccCCcccCcCH
Confidence 99999998899999999999999999999999987665555444433333222 33678899999999999999999999
Q ss_pred HHHhcCCCCCC
Q psy5368 286 EDLFSHPYPDL 296 (406)
Q Consensus 286 ~ell~hp~~~~ 296 (406)
.++++|||+..
T Consensus 248 ~~il~~~~~~~ 258 (277)
T cd06642 248 KELLKHKFITR 258 (277)
T ss_pred HHHHHhHHHHH
Confidence 99999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=295.35 Aligned_cols=231 Identities=23% Similarity=0.415 Sum_probs=199.8
Q ss_pred eeeecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHHH
Q psy5368 56 TIRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLCS 129 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~~ 129 (406)
...+|.|+||.||++...+..+++|....... ...++.+|+.+++.++|+|+++ .....|+||||+++++|.+
T Consensus 11 ~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 89 (256)
T cd05039 11 GATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVD 89 (256)
T ss_pred eeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHH
Confidence 56789999999999999888999998875543 5668999999999999999765 5677899999999999999
Q ss_pred HHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCCCC
Q psy5368 130 FIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLYMA 206 (406)
Q Consensus 130 ~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y~a 206 (406)
++.... .+++..+..++.|++.||.|||++|++|+||||+||+++ ++.++|+|||.++....... ....+..|+|
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~a 167 (256)
T cd05039 90 YLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--SGKLPVKWTA 167 (256)
T ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc--cCCCcccccC
Confidence 997765 799999999999999999999999999999999999999 67999999999987633222 2334567999
Q ss_pred hhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCCH
Q psy5368 207 PEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY 285 (406)
Q Consensus 207 PE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~ 285 (406)
||.+.+..++.++|+||||+++++|++ |..||...+...+...+........+ ..+|+.+.+++.+||..+|++|||+
T Consensus 168 pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rp~~ 246 (256)
T cd05039 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAP-EGCPPEVYKVMKDCWELDPAKRPTF 246 (256)
T ss_pred chhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCc-cCCCHHHHHHHHHHhccChhhCcCH
Confidence 999998889999999999999999997 99999998888777766655444333 3689999999999999999999999
Q ss_pred HHHhc
Q psy5368 286 EDLFS 290 (406)
Q Consensus 286 ~ell~ 290 (406)
+++++
T Consensus 247 ~~l~~ 251 (256)
T cd05039 247 KQLRE 251 (256)
T ss_pred HHHHH
Confidence 99975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=302.33 Aligned_cols=244 Identities=25% Similarity=0.363 Sum_probs=197.5
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCCcc-----chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccC
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT-----SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~-----~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ 123 (406)
..||+|++|.||++... +..+++|.+...... ....+.+|+.+++.++|+|+++ ..+..|+||||+
T Consensus 6 ~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 84 (298)
T cd07841 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM- 84 (298)
T ss_pred eeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-
Confidence 46899999999999864 467888887655433 2345678999999999999765 567899999999
Q ss_pred CCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccC
Q psy5368 124 GGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQG 200 (406)
Q Consensus 124 ggsL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~g 200 (406)
+++|.+++.... .+++..+..++.||+.||.|||++|++|+||+|+||+++ ++.++|+|||++....... ......+
T Consensus 85 ~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 164 (298)
T cd07841 85 ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV 164 (298)
T ss_pred CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcccccccc
Confidence 889999998766 799999999999999999999999999999999999999 7799999999998765432 2233456
Q ss_pred CCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----------------------C
Q psy5368 201 SPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI----------------------T 257 (406)
Q Consensus 201 t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----------------------~ 257 (406)
++.|+|||.+.+ ..++.++|+||+||++++|++|.+||.+.+..+....+...... .
T Consensus 165 ~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (298)
T cd07841 165 TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPP 244 (298)
T ss_pred ceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCC
Confidence 788999999865 45789999999999999999999888876654444333321100 0
Q ss_pred C----CCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q psy5368 258 I----PPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPC 301 (406)
Q Consensus 258 ~----~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~ 301 (406)
. .....+.++.+++.+||+.||++|||+++++.||||.....|.
T Consensus 245 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~ 292 (298)
T cd07841 245 TPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT 292 (298)
T ss_pred cchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence 0 0123578899999999999999999999999999999876554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=295.97 Aligned_cols=232 Identities=25% Similarity=0.412 Sum_probs=190.8
Q ss_pred eecceeeeEEEeeeee--eceeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHH
Q psy5368 58 RYGELQYDTVQNSQIR--LGTVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLC 128 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~ 128 (406)
.||+|+||.||++... ++.+++|...... ......+.+|+++++.++|||+++ .....|+||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 5899999999999874 4567777654332 223457899999999999999766 566789999999999999
Q ss_pred HHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC---CcccCCCC
Q psy5368 129 SFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG---DSIQGSPL 203 (406)
Q Consensus 129 ~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~---~~~~gt~~ 203 (406)
+++...+ .+++..+..++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++......... .....+..
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 161 (252)
T cd05084 82 TFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK 161 (252)
T ss_pred HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCcee
Confidence 9997654 689999999999999999999999999999999999999 668999999998765432111 11122456
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRR 282 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 282 (406)
|+|||.+.+..++.++|+||+||++|+|++ |..||...+.......+........+ ..++..+.+|+.+||+.+|++|
T Consensus 162 y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R 240 (252)
T cd05084 162 WTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCP-ELCPDAVYRLMERCWEYDPGQR 240 (252)
T ss_pred ecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCc-ccCCHHHHHHHHHHcCCChhhC
Confidence 999999999889999999999999999998 99999887776666666554444333 3678999999999999999999
Q ss_pred CCHHHHhc
Q psy5368 283 ISYEDLFS 290 (406)
Q Consensus 283 ps~~ell~ 290 (406)
||+.++++
T Consensus 241 ps~~~~~~ 248 (252)
T cd05084 241 PSFSTVHQ 248 (252)
T ss_pred cCHHHHHH
Confidence 99999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=292.41 Aligned_cols=238 Identities=28% Similarity=0.530 Sum_probs=202.4
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
...+|+|++|.||++... +..+++|............+.+|+..+++++|+|+.. .....++++||+++++|
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 84 (253)
T cd05122 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL 84 (253)
T ss_pred eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcH
Confidence 467899999999999975 5568888776655556678999999999999999654 56788999999999999
Q ss_pred HHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCCC
Q psy5368 128 CSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLYM 205 (406)
Q Consensus 128 ~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y~ 205 (406)
.+++... ..+++..+..++.|++.||.+||++|++|+||+|+||+++ ++.++|+|||.+.............++..|+
T Consensus 85 ~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 164 (253)
T cd05122 85 KDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWM 164 (253)
T ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccceecCCccc
Confidence 9999776 5899999999999999999999999999999999999999 6799999999997765544345567889999
Q ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC-CCChHHHHHHHHhcccCCCCCCC
Q psy5368 206 APEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPN-SLSPDCMDFLSRLLQKDPMRRIS 284 (406)
Q Consensus 206 aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~s~~l~~li~~~L~~dP~~Rps 284 (406)
|||.+.+..++.++|+||||+++++|++|..||...+................+.. .++..+.+++.+||+.||++|||
T Consensus 165 ~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t 244 (253)
T cd05122 165 APEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPT 244 (253)
T ss_pred CHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCC
Confidence 99999988899999999999999999999999988755554444444333333332 34899999999999999999999
Q ss_pred HHHHhcCCC
Q psy5368 285 YEDLFSHPY 293 (406)
Q Consensus 285 ~~ell~hp~ 293 (406)
+.++++|||
T Consensus 245 ~~~~l~~~~ 253 (253)
T cd05122 245 AEQLLKHPF 253 (253)
T ss_pred HHHHhcCCC
Confidence 999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=293.82 Aligned_cols=239 Identities=31% Similarity=0.491 Sum_probs=201.9
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCcc------cC--CeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRK------RP--RYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~------~~--~~~~lV~E~~~ 123 (406)
...||+|++|.||++... +..+++|....... .....+.+|+..+++++|||+++ .. ..+++|+||++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 84 (260)
T cd06606 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS 84 (260)
T ss_pred eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence 467899999999999975 56678887765442 34567899999999999999765 34 78999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC---CCccc
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ---GDSIQ 199 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~---~~~~~ 199 (406)
+++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||.+........ .....
T Consensus 85 ~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 164 (260)
T cd06606 85 GGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVR 164 (260)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCC
Confidence 999999998888999999999999999999999999999999999999999 67999999999987765543 44566
Q ss_pred CCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccC
Q psy5368 200 GSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCN-LSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKD 278 (406)
Q Consensus 200 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~d 278 (406)
++..|+|||.+.+...+.++|+||+|+++++|++|..||.... .......+.........+..++..+.+++.+||+.+
T Consensus 165 ~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~ 244 (260)
T cd06606 165 GTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRD 244 (260)
T ss_pred CCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCC
Confidence 8899999999998889999999999999999999999998765 233333333222222333467899999999999999
Q ss_pred CCCCCCHHHHhcCCCC
Q psy5368 279 PMRRISYEDLFSHPYP 294 (406)
Q Consensus 279 P~~Rps~~ell~hp~~ 294 (406)
|.+||++.+++.||||
T Consensus 245 p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 245 PKKRPTADELLQHPFL 260 (260)
T ss_pred hhhCCCHHHHhhCCCC
Confidence 9999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=303.85 Aligned_cols=235 Identities=24% Similarity=0.383 Sum_probs=190.7
Q ss_pred eeeecceeeeEEEeeeeeec----eeEEeeeecC-CccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIRLG----TVKYSQVRYD-TITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~----~v~vk~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~ 123 (406)
...||+|+||.||++..... .+++|.+... .......+.+|+.++.++ +|||+++ ..+..|+||||++
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 86 (297)
T cd05089 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAP 86 (297)
T ss_pred eeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecC
Confidence 45789999999999986432 3466655432 122345788999999999 7999765 4567899999999
Q ss_pred CCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccc
Q psy5368 124 GGDLCSFIRSHE----------------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFA 186 (406)
Q Consensus 124 ggsL~~~l~~~~----------------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla 186 (406)
+++|.+++.... .+++..+..++.|++.||+|||++|++||||||+|||++ ++.+||+|||++
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~ 166 (297)
T cd05089 87 YGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLS 166 (297)
T ss_pred CCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCC
Confidence 999999997542 488999999999999999999999999999999999998 669999999998
Q ss_pred cccCCCCCCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCh
Q psy5368 187 QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSP 265 (406)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~ 265 (406)
..............+..|+|||++.+..++.++|||||||++|+|++ |..||...........+........+ ..++.
T Consensus 167 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~ 245 (297)
T cd05089 167 RGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKP-RNCDD 245 (297)
T ss_pred ccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCC-CCCCH
Confidence 64322212222223557999999999889999999999999999997 99999998888877776655433333 36899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 266 DCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 266 ~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
++.+|+.+||+.+|.+|||++++++.
T Consensus 246 ~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 246 EVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=294.29 Aligned_cols=238 Identities=30% Similarity=0.506 Sum_probs=204.4
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...+|.|++|.||++... +..+++|.+..... .....+.+|+++++.++|||++. .....++|+||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~ 84 (258)
T cd08215 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGG 84 (258)
T ss_pred EeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCC
Confidence 356788999999988875 56678887765443 34567889999999999999765 557899999999999
Q ss_pred CHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCccc
Q psy5368 126 DLCSFIRSH----EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQ 199 (406)
Q Consensus 126 sL~~~l~~~----~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~ 199 (406)
+|.+++... ..+++..+..++.+++.||.|||+.|++|+||+|+||+++ ++.++|+|||++....... ......
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 164 (258)
T cd08215 85 DLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV 164 (258)
T ss_pred cHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcceeccee
Confidence 999999764 6799999999999999999999999999999999999999 5799999999997654443 234456
Q ss_pred CCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCC
Q psy5368 200 GSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 200 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP 279 (406)
+++.|+|||.+.+..++.++|+||+|+++++|++|..||...+................+ ..++.++.+++.+||..+|
T Consensus 165 ~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p 243 (258)
T cd08215 165 GTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIP-SQYSSELRNLVSSLLQKDP 243 (258)
T ss_pred eeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCC-CCCCHHHHHHHHHHcCCCh
Confidence 889999999999988999999999999999999999999988877777777665444444 3789999999999999999
Q ss_pred CCCCCHHHHhcCCCC
Q psy5368 280 MRRISYEDLFSHPYP 294 (406)
Q Consensus 280 ~~Rps~~ell~hp~~ 294 (406)
++|||+.++++||||
T Consensus 244 ~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 244 EERPSIAQILQSPFI 258 (258)
T ss_pred hhCcCHHHHhcCCCC
Confidence 999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=299.34 Aligned_cols=237 Identities=27% Similarity=0.381 Sum_probs=190.0
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCC-ccchhhhhhHHhhcccCC-CCCCcc------cC--CeEEEEEeccCC
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDT-ITSHSEFERPRAGLSNLR-APEGRK------RP--RYVYIILEYCDG 124 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni~~------~~--~~~~lV~E~~~g 124 (406)
..+|+|+||.||++... +..+++|...... ........+|+..+.++. |+|+++ +. +..++||||+++
T Consensus 5 ~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 84 (282)
T cd07831 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM 84 (282)
T ss_pred eeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCc
Confidence 46799999999999863 4567788665432 122334567888888885 999765 33 789999999975
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeCCeeEEEecccccccCCCCCCCcccCCCC
Q psy5368 125 GDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 125 gsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~~~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
+|.+.+... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++++.+||+|||++.............+++.
T Consensus 85 -~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 163 (282)
T cd07831 85 -NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDILKLADFGSCRGIYSKPPYTEYISTRW 163 (282)
T ss_pred -cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcCCCeEEEecccccccccCCCcCCCCCCcc
Confidence 888888764 579999999999999999999999999999999999999999999999999987755554455668999
Q ss_pred CCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-----------------CCCC------
Q psy5368 204 YMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP-----------------ITIP------ 259 (406)
Q Consensus 204 y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-----------------~~~~------ 259 (406)
|+|||.+.. ..++.++||||+||++|+|++|..||.+.+..+....+..... ...+
T Consensus 164 y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (282)
T cd07831 164 YRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTG 243 (282)
T ss_pred cCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCccccccc
Confidence 999998754 4578899999999999999999999988776554443322110 0011
Q ss_pred ----CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 260 ----PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 260 ----~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
...+|.++.+++.+||+++|++||+++++++||||
T Consensus 244 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 244 LRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred HHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 12468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=296.14 Aligned_cols=232 Identities=22% Similarity=0.355 Sum_probs=192.6
Q ss_pred eeecceeeeEEEeeeeee-ceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHHH
Q psy5368 57 IRYGELQYDTVQNSQIRL-GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLCS 129 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~-~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~~ 129 (406)
.+||+|++|.||++.... ..+++|...... .....+.+|+.+++.++|+|+++ ..+..++||||+++++|.+
T Consensus 12 ~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 90 (261)
T cd05072 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLD 90 (261)
T ss_pred eecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHH
Confidence 457888899999887643 456777655432 34568899999999999999765 6677899999999999999
Q ss_pred HHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC--CCcccCCCCC
Q psy5368 130 FIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ--GDSIQGSPLY 204 (406)
Q Consensus 130 ~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~--~~~~~gt~~y 204 (406)
++... ..+++..+..++.|++.||+|||+.|++|+||||+||+++ ++.++|+|||++........ .....++..|
T Consensus 91 ~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y 170 (261)
T cd05072 91 FLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW 170 (261)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCccceec
Confidence 99653 4689999999999999999999999999999999999999 66899999999987643321 1223356789
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
+|||.+.+..++.++|||||||++|+|+| |..||...+.......+........+ ..++.++.+++.+||..+|++||
T Consensus 171 ~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rp 249 (261)
T cd05072 171 TAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRM-ENCPDELYDIMKTCWKEKAEERP 249 (261)
T ss_pred CCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCHHHHHHHHHHccCCcccCc
Confidence 99999998889999999999999999998 99999988877777776655433332 36899999999999999999999
Q ss_pred CHHHHhc
Q psy5368 284 SYEDLFS 290 (406)
Q Consensus 284 s~~ell~ 290 (406)
+++++++
T Consensus 250 ~~~~i~~ 256 (261)
T cd05072 250 TFDYLQS 256 (261)
T ss_pred CHHHHHH
Confidence 9999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=300.22 Aligned_cols=253 Identities=26% Similarity=0.422 Sum_probs=199.9
Q ss_pred eeeccccccccceeeecCceeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccC-CCCCCcc---
Q psy5368 37 VRSDTVRSGTVRYDIVGSSTIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNL-RAPEGRK--- 110 (406)
Q Consensus 37 ~~~d~~~~~~~~~~i~~~~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~--- 110 (406)
++.|........|.+. ..||+|+||.||++... +..+++|..... ......+.+|+.++.++ +|||+++
T Consensus 8 ~~~~~~~~~~~~~~~~----~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 82 (286)
T cd06638 8 IIFDSFPDPSDTWEII----ETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYG 82 (286)
T ss_pred EEeecCCCcccceeee----eeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeee
Confidence 4556666677777444 56799999999998863 345677755432 22345688899999999 6999765
Q ss_pred --------cCCeEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCe
Q psy5368 111 --------RPRYVYIILEYCDGGDLCSFIRS----HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNT 177 (406)
Q Consensus 111 --------~~~~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~ 177 (406)
..+..++||||++|++|.+++.. ...+++..+..++.|++.||.|||+.+++||||||+||+++ ++.
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG 162 (286)
T ss_pred eeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC
Confidence 33568999999999999998753 34689999999999999999999999999999999999999 678
Q ss_pred eEEEecccccccCCCC-CCCcccCCCCCCChhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy5368 178 LKLADFGFAQFLAPND-QGDSIQGSPLYMAPEILAG-----SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQAL 251 (406)
Q Consensus 178 ~kL~DFGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 251 (406)
++|+|||++....... ......|++.|+|||++.. ..++.++||||+||++|+|++|+.||.............
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~ 242 (286)
T cd06638 163 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP 242 (286)
T ss_pred EEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc
Confidence 9999999987664332 2334568999999999853 447889999999999999999999998776544443333
Q ss_pred hcCCCCC-CCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 252 SSAPITI-PPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 252 ~~~~~~~-~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
....... .+..++.++.+|+.+||+.||++|||+.++++|+||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 243 RNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 3322221 223467899999999999999999999999999996
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=306.36 Aligned_cols=235 Identities=24% Similarity=0.388 Sum_probs=190.0
Q ss_pred eeeecceeeeEEEeeeeee--c--eeEEeeeecCC-ccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIRL--G--TVKYSQVRYDT-ITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~--~--~v~vk~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~ 123 (406)
...||+|+||.||++.... . .+++|...... ......+.+|+.++.++ +|||+++ ..+.+|+||||++
T Consensus 12 ~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 91 (303)
T cd05088 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 91 (303)
T ss_pred eeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCC
Confidence 4578999999999998643 2 24555544322 22345788999999999 8999765 6678999999999
Q ss_pred CCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccc
Q psy5368 124 GGDLCSFIRSHE----------------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFA 186 (406)
Q Consensus 124 ggsL~~~l~~~~----------------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla 186 (406)
+++|.+++...+ .+++..++.++.||+.||+|||++|++||||||+|||++ ++.+||+|||++
T Consensus 92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~ 171 (303)
T cd05088 92 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 171 (303)
T ss_pred CCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCccccC
Confidence 999999997542 478999999999999999999999999999999999998 679999999998
Q ss_pred cccCCCCCCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCh
Q psy5368 187 QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSP 265 (406)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~ 265 (406)
.............++..|+|||.+.+..++.++|||||||++|+|+| |..||...+..+....+........+ ..+++
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 250 (303)
T cd05088 172 RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP-LNCDD 250 (303)
T ss_pred cccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcCCCC-CCCCH
Confidence 64322222222234567999999988889999999999999999998 99999888777766665544333322 35789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 266 DCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 266 ~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
++.+|+.+||+.+|++||++++++.+
T Consensus 251 ~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 251 EVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=299.88 Aligned_cols=235 Identities=22% Similarity=0.329 Sum_probs=192.1
Q ss_pred eeeecceeeeEEEeeeeee-------ceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIRL-------GTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-------~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~ 121 (406)
.+.||+|++|.||++.... ..+++|....... .....+.+|+.+++.++|+|+++ .....++||||
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 90 (277)
T cd05036 11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLEL 90 (277)
T ss_pred eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEec
Confidence 3467999999999998754 3456665543322 22456899999999999999765 55668899999
Q ss_pred cCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeC-C---eeEEEecccccccC
Q psy5368 122 CDGGDLCSFIRSHE-------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-N---TLKLADFGFAQFLA 190 (406)
Q Consensus 122 ~~ggsL~~~l~~~~-------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~-~---~~kL~DFGla~~~~ 190 (406)
++|++|.+++...+ .+++..+..++.||+.||+|||++|++|+||||+||++++ + .+||+|||+++...
T Consensus 91 ~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~ 170 (277)
T cd05036 91 MAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIY 170 (277)
T ss_pred CCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccC
Confidence 99999999997653 4899999999999999999999999999999999999983 2 69999999998763
Q ss_pred CCCC---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChH
Q psy5368 191 PNDQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPD 266 (406)
Q Consensus 191 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 266 (406)
.... ......+..|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+........ +..++..
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 249 (277)
T cd05036 171 RASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDP-PKGCPGP 249 (277)
T ss_pred CccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCC-CCCCCHH
Confidence 3221 112223567999999999899999999999999999997 9999998887777766665544443 3468999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 267 CMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 267 l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
+.+++.+||+.+|++|||+.++++|
T Consensus 250 ~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 250 VYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=319.44 Aligned_cols=234 Identities=21% Similarity=0.379 Sum_probs=200.0
Q ss_pred eeecceeeeEEEeeeeeec-----e-eEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEec
Q psy5368 57 IRYGELQYDTVQNSQIRLG-----T-VKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEY 121 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~~-----~-v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~ 121 (406)
++||+|+||.||+|.+..+ . ||+|....+. .....+|++|++++++++|||++. ...-++||||+
T Consensus 163 kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl 242 (474)
T KOG0194|consen 163 KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMEL 242 (474)
T ss_pred ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEe
Confidence 7999999999999998542 3 6888776422 344668999999999999999876 66678999999
Q ss_pred cCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeC-CeeEEEecccccccCCCCCCC-cc
Q psy5368 122 CDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLADFGFAQFLAPNDQGD-SI 198 (406)
Q Consensus 122 ~~ggsL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~-~~~kL~DFGla~~~~~~~~~~-~~ 198 (406)
|+||+|.++|++++ .++..+..+++.+.+.||+|||+++++||||-+.|+|++. +.+||+|||+++......... ..
T Consensus 243 ~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~ 322 (474)
T KOG0194|consen 243 CNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLK 322 (474)
T ss_pred cCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcceeeccccc
Confidence 99999999999887 4999999999999999999999999999999999999995 577999999987654222222 22
Q ss_pred cCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhccc
Q psy5368 199 QGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 199 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~ 277 (406)
.-...|+|||.+....|+.++|||||||++||+++ |..||.+.+..++...+.........+...|.++..++.+|+..
T Consensus 323 klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~ 402 (474)
T KOG0194|consen 323 KLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKK 402 (474)
T ss_pred cCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccC
Confidence 24567999999999999999999999999999998 89999999999999999554444444447899999999999999
Q ss_pred CCCCCCCHHHHhc
Q psy5368 278 DPMRRISYEDLFS 290 (406)
Q Consensus 278 dP~~Rps~~ell~ 290 (406)
+|++|||+.++.+
T Consensus 403 ~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 403 DPEDRPTMSTIKK 415 (474)
T ss_pred ChhhccCHHHHHH
Confidence 9999999998865
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=313.33 Aligned_cols=234 Identities=22% Similarity=0.372 Sum_probs=188.7
Q ss_pred eeeecceeeeEEEeeeeee-------ceeEEeeeecCCcc-chhhhhhHHhhcccCC-CCCCcc------cCCeEEEEEe
Q psy5368 56 TIRYGELQYDTVQNSQIRL-------GTVKYSQVRYDTIT-SHSEFERPRAGLSNLR-APEGRK------RPRYVYIILE 120 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-------~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~-h~ni~~------~~~~~~lV~E 120 (406)
..+||+|+||.||+|.... ..|++|.+...... ....+.+|+.++.++. |||+++ ..+.+|||||
T Consensus 42 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 121 (400)
T cd05105 42 GRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITE 121 (400)
T ss_pred hheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEE
Confidence 3578999999999998532 25788877654322 2457899999999996 999876 5678899999
Q ss_pred ccCCCCHHHHHHhC------------------------------------------------------------------
Q psy5368 121 YCDGGDLCSFIRSH------------------------------------------------------------------ 134 (406)
Q Consensus 121 ~~~ggsL~~~l~~~------------------------------------------------------------------ 134 (406)
||++|+|.+++..+
T Consensus 122 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (400)
T cd05105 122 YCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYS 201 (400)
T ss_pred ecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhh
Confidence 99999999998642
Q ss_pred ------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEec
Q psy5368 135 ------------------------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADF 183 (406)
Q Consensus 135 ------------------------------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DF 183 (406)
..+++..+..++.||+.||.|||+.||+|+||||+|||++ ++.+||+||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~Df 281 (400)
T cd05105 202 DIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDF 281 (400)
T ss_pred hcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeC
Confidence 2478888899999999999999999999999999999999 668999999
Q ss_pred ccccccCCCCC---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH-HHHHhcCCCCC
Q psy5368 184 GFAQFLAPNDQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLR-AQALSSAPITI 258 (406)
Q Consensus 184 Gla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~-~~~~~~~~~~~ 258 (406)
|+++....... .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||......... ..+.......
T Consensus 282 Gla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~- 360 (400)
T cd05105 282 GLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA- 360 (400)
T ss_pred CcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCC-
Confidence 99976543221 223346778999999999899999999999999999997 99999876544333 3333332222
Q ss_pred CCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 259 PPNSLSPDCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 259 ~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
.+..++.++.+++.+||+.||++|||+.++.+
T Consensus 361 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 361 KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 23468999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=299.59 Aligned_cols=236 Identities=20% Similarity=0.325 Sum_probs=192.0
Q ss_pred ceeeecceeeeEEEeeeee-------eceeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEe
Q psy5368 55 STIRYGELQYDTVQNSQIR-------LGTVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILE 120 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~-------~~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E 120 (406)
....||+|+||.||++... ...+++|...... .....++.+|+.+++.++|||+++ .....++|||
T Consensus 10 ~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e 89 (277)
T cd05062 10 MSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 89 (277)
T ss_pred eeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEe
Confidence 3466788999999987653 2357777664332 223456889999999999999765 5677899999
Q ss_pred ccCCCCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEeccccccc
Q psy5368 121 YCDGGDLCSFIRSHE----------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFL 189 (406)
Q Consensus 121 ~~~ggsL~~~l~~~~----------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~ 189 (406)
|+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++ ++.++|+|||++...
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 169 (277)
T cd05062 90 LMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 169 (277)
T ss_pred cCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCCcccc
Confidence 999999999996532 357888999999999999999999999999999999999 679999999998755
Q ss_pred CCCCC---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCh
Q psy5368 190 APNDQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSP 265 (406)
Q Consensus 190 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~ 265 (406)
..... .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+........ +..+++
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 248 (277)
T cd05062 170 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDK-PDNCPD 248 (277)
T ss_pred CCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCC-CCCCCH
Confidence 33221 122345678999999999889999999999999999999 7999998887777766665543333 346889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 266 DCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 266 ~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
.+.+++.+||+.||++|||+.+++++
T Consensus 249 ~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 249 MLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=294.45 Aligned_cols=233 Identities=19% Similarity=0.332 Sum_probs=195.5
Q ss_pred eecceeeeEEEeeeeee-----ceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCCCC
Q psy5368 58 RYGELQYDTVQNSQIRL-----GTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDGGD 126 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~-----~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ggs 126 (406)
.||+|++|.||++.+.. ..+++|....... .....+.+|+..+++++|||+++ .....++||||+++++
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~ 81 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLGS 81 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCCc
Confidence 58999999999998743 2468887766555 45668999999999999999776 2277899999999999
Q ss_pred HHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC----CCccc
Q psy5368 127 LCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ----GDSIQ 199 (406)
Q Consensus 127 L~~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~----~~~~~ 199 (406)
|.+++..+. .+++..+..++.|++.||+|||++|++|+||||+||+++ ++.+||+|||+++....... .....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 161 (257)
T cd05040 82 LLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLK 161 (257)
T ss_pred HHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccCCC
Confidence 999997764 689999999999999999999999999999999999999 77999999999987644221 12344
Q ss_pred CCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccC
Q psy5368 200 GSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKD 278 (406)
Q Consensus 200 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~d 278 (406)
++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+.........+..+|..+.+++.+||+.+
T Consensus 162 ~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 241 (257)
T cd05040 162 VPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHN 241 (257)
T ss_pred CCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCC
Confidence 6778999999999899999999999999999998 999998888777666665432222223367899999999999999
Q ss_pred CCCCCCHHHHhc
Q psy5368 279 PMRRISYEDLFS 290 (406)
Q Consensus 279 P~~Rps~~ell~ 290 (406)
|++|||+.++++
T Consensus 242 p~~Rps~~~~~~ 253 (257)
T cd05040 242 PADRPTFAALRE 253 (257)
T ss_pred cccCCCHHHHHH
Confidence 999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=295.36 Aligned_cols=234 Identities=23% Similarity=0.401 Sum_probs=194.2
Q ss_pred eeeecceeeeEEEeeeeeec-eeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHH
Q psy5368 56 TIRYGELQYDTVQNSQIRLG-TVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLC 128 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~-~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~ 128 (406)
...||+|+||.||++....+ .+++|..... ......+.+|+.+++.++|||+++ ..+..|+||||++|++|.
T Consensus 9 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 87 (256)
T cd05059 9 LKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLL 87 (256)
T ss_pred hhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHH
Confidence 45689999999999987544 5677765432 234557889999999999999765 566789999999999999
Q ss_pred HHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC--CcccCCCCC
Q psy5368 129 SFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG--DSIQGSPLY 204 (406)
Q Consensus 129 ~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~--~~~~gt~~y 204 (406)
+++..+ ..+++..+..++.|++.||.|||++|++|+||||+||+++ ++.+||+|||+++........ ....++..|
T Consensus 88 ~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y 167 (256)
T cd05059 88 NYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKW 167 (256)
T ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccc
Confidence 999764 4689999999999999999999999999999999999998 678999999998765432211 111234579
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+........+. .+|.++.+++.+||..+|++||
T Consensus 168 ~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rp 246 (256)
T cd05059 168 APPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPK-LAPTEVYTIMYSCWHEKPEDRP 246 (256)
T ss_pred cCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCC-CCCHHHHHHHHHHhcCChhhCc
Confidence 99999999899999999999999999999 899998887777777766554444443 5899999999999999999999
Q ss_pred CHHHHhcC
Q psy5368 284 SYEDLFSH 291 (406)
Q Consensus 284 s~~ell~h 291 (406)
|+.++++.
T Consensus 247 t~~~~l~~ 254 (256)
T cd05059 247 AFKKLLSQ 254 (256)
T ss_pred CHHHHHHH
Confidence 99999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=304.14 Aligned_cols=241 Identities=27% Similarity=0.449 Sum_probs=198.3
Q ss_pred eeecceeeeEEEeeee--eeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHH
Q psy5368 57 IRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLC 128 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~ 128 (406)
..+|+|+||.||++.. .++.+++|.+..........+.+|+.++++++|||++. ..+..|+|+||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 104 (293)
T cd06647 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT 104 (293)
T ss_pred eEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHH
Confidence 4678899999999875 34568888776555455667899999999999999765 556789999999999999
Q ss_pred HHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCCCCC
Q psy5368 129 SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPLYMA 206 (406)
Q Consensus 129 ~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~y~a 206 (406)
+++.+ ..+++..+..++.|++.||.|||++|++|+||||+||+++ ++.++|+|||++....... ......+++.|+|
T Consensus 105 ~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~ 183 (293)
T cd06647 105 DVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 183 (293)
T ss_pred HHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccccccCChhhcC
Confidence 99875 4689999999999999999999999999999999999998 6689999999987654332 2234468889999
Q ss_pred hhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-CCCCCChHHHHHHHHhcccCCCCCCCH
Q psy5368 207 PEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITI-PPNSLSPDCMDFLSRLLQKDPMRRISY 285 (406)
Q Consensus 207 PE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~~li~~~L~~dP~~Rps~ 285 (406)
||.+.+..++.++|+|||||++|++++|+.||...+.......+........ .+..++..+.+++.+||..+|.+||++
T Consensus 184 PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~ 263 (293)
T cd06647 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSA 263 (293)
T ss_pred chhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCH
Confidence 9999888899999999999999999999999987765444333322222222 223578899999999999999999999
Q ss_pred HHHhcCCCCCCCC
Q psy5368 286 EDLFSHPYPDLIH 298 (406)
Q Consensus 286 ~ell~hp~~~~~~ 298 (406)
.+++.||||+...
T Consensus 264 ~~il~h~~~~~~~ 276 (293)
T cd06647 264 KELLQHPFLKIAK 276 (293)
T ss_pred HHHhcCHHHhcCc
Confidence 9999999998543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=299.64 Aligned_cols=234 Identities=22% Similarity=0.376 Sum_probs=193.6
Q ss_pred eeeecceeeeEEEeeeee-------eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEecc
Q psy5368 56 TIRYGELQYDTVQNSQIR-------LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYC 122 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~-------~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~ 122 (406)
..++|+|+||.||++... ...+++|............+.+|+++++.++|+|+++ .....++||||+
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (280)
T cd05092 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYM 89 (280)
T ss_pred ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecC
Confidence 457899999999988642 2356677665544444568999999999999999765 566789999999
Q ss_pred CCCCHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccc
Q psy5368 123 DGGDLCSFIRSHE---------------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFA 186 (406)
Q Consensus 123 ~ggsL~~~l~~~~---------------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla 186 (406)
++++|.+++...+ .+++..+..++.||+.||+|||++|++|+||||+||+++ ++.++|+|||++
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~ 169 (280)
T cd05092 90 RHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMS 169 (280)
T ss_pred CCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCce
Confidence 9999999997643 488999999999999999999999999999999999998 668999999998
Q ss_pred cccCCCCC---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q psy5368 187 QFLAPNDQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNS 262 (406)
Q Consensus 187 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (406)
........ .....+++.|+|||.+.+..++.++|||||||++|+|++ |.+||......+....+........+ ..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~ 248 (280)
T cd05092 170 RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERP-RT 248 (280)
T ss_pred eEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccCCCC-CC
Confidence 76543221 222335678999999999999999999999999999998 99999887777776666665444433 36
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 263 LSPDCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 263 ~s~~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
+++.+.+|+.+||+.||.+||+++++++
T Consensus 249 ~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 249 CPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 8999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=299.75 Aligned_cols=239 Identities=25% Similarity=0.358 Sum_probs=192.7
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...||+|+||.||++... +..+++|.+...... ....+.+|+++++.++|||+++ ..+..|+||||++++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (286)
T cd07846 6 LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT 85 (286)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCcc
Confidence 357899999999999874 456777765543222 3456889999999999999765 777899999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPL 203 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~ 203 (406)
+|.++......+++.++..++.||+.||.|||+.|++|+||+|+||+++ ++.++|+|||++....... ......++..
T Consensus 86 ~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 165 (286)
T cd07846 86 VLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRW 165 (286)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcccceee
Confidence 9998887766799999999999999999999999999999999999998 6799999999987654432 2234567889
Q ss_pred CCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC------------------CCC------
Q psy5368 204 YMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP------------------ITI------ 258 (406)
Q Consensus 204 y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~------------------~~~------ 258 (406)
|+|||++.+. .++.++||||||+++|+|++|.+||......+....+..... ...
T Consensus 166 y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (286)
T cd07846 166 YRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEI 245 (286)
T ss_pred ccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCc
Confidence 9999998763 478899999999999999999999987664333222221000 000
Q ss_pred -----CCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 259 -----PPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 259 -----~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
....++..+.+|+.+||+.+|++||++.++++||||
T Consensus 246 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 246 EPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred chHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 012568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=310.57 Aligned_cols=244 Identities=25% Similarity=0.427 Sum_probs=192.0
Q ss_pred eeeecceeeeEEEeeeeeec-eeEEeeeecCC--ccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIRLG-TVKYSQVRYDT--ITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~-~v~vk~~~~~~--~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
-+.||.||.+.||++...+. .+++|++.... ......|.+|+..|.+| .|.+++. .++++|+||||-+.
T Consensus 366 lk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd~- 444 (677)
T KOG0596|consen 366 LKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGDI- 444 (677)
T ss_pred HHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecccc-
Confidence 45789999999999987544 45666554332 33456799999999999 5566665 78899999999865
Q ss_pred CHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeCCeeEEEecccccccCCCCC---CCcccCC
Q psy5368 126 DLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLADFGFAQFLAPNDQ---GDSIQGS 201 (406)
Q Consensus 126 sL~~~l~~~~~-l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~~~~kL~DFGla~~~~~~~~---~~~~~gt 201 (406)
||..+|++... .+.-.++.+..|++.|+.++|..||||.||||.|+|+-.|.+||+|||+|..+..... ..+.+||
T Consensus 445 DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT 524 (677)
T KOG0596|consen 445 DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKGRLKLIDFGIANAIQPDTTSIVKDSQVGT 524 (677)
T ss_pred cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEeeeEEeeeechhcccCccccceeeccccCc
Confidence 99999988754 3334888999999999999999999999999999999999999999999988765543 4577899
Q ss_pred CCCCChhhhcCCC-----------CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--CCCCCCCCCChHHH
Q psy5368 202 PLYMAPEILAGSP-----------YNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSA--PITIPPNSLSPDCM 268 (406)
Q Consensus 202 ~~y~aPE~~~~~~-----------~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~s~~l~ 268 (406)
+.||+||.+.... .+.++||||+|||||+|+.|++||......-.....+... .+++|...-..++.
T Consensus 525 ~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li 604 (677)
T KOG0596|consen 525 VNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELI 604 (677)
T ss_pred ccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCCchHHH
Confidence 9999999986432 4578999999999999999999997643221111222222 12333322334599
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy5368 269 DFLSRLLQKDPMRRISYEDLFSHPYPDLIHAP 300 (406)
Q Consensus 269 ~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 300 (406)
++++.||.+||.+||++.++|+|||+.....|
T Consensus 605 ~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~ 636 (677)
T KOG0596|consen 605 DVMKCCLARDPKKRWSIPELLQHPFLQIQPIP 636 (677)
T ss_pred HHHHHHHhcCcccCCCcHHHhcCccccccccc
Confidence 99999999999999999999999999865543
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=294.27 Aligned_cols=233 Identities=21% Similarity=0.392 Sum_probs=195.0
Q ss_pred eeecceeeeEEEeeeeeec-eeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHHH
Q psy5368 57 IRYGELQYDTVQNSQIRLG-TVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLCS 129 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~~-~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~~ 129 (406)
..+|+|+||.||.+....+ .+++|.+.... .....+.+|+.++.+++|||+++ .....|+||||+++++|.+
T Consensus 10 ~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 88 (256)
T cd05113 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLN 88 (256)
T ss_pred eEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHH
Confidence 4679999999999987554 47888765433 34567999999999999999766 4556799999999999999
Q ss_pred HHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC--CcccCCCCCC
Q psy5368 130 FIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG--DSIQGSPLYM 205 (406)
Q Consensus 130 ~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~--~~~~gt~~y~ 205 (406)
++... ..+++..+..++.||+.||+|||+.|++|+||||.||+++ ++.+||+|||.++........ ....++..|+
T Consensus 89 ~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~ 168 (256)
T cd05113 89 YLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 168 (256)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhC
Confidence 99764 4689999999999999999999999999999999999998 678999999998765433221 1223456799
Q ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCC
Q psy5368 206 APEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRIS 284 (406)
Q Consensus 206 aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps 284 (406)
|||.+.+..++.++|||||||++|+|++ |..||...+.......+........ +...+..+.+++.+||+.+|.+||+
T Consensus 169 ~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~Rp~ 247 (256)
T cd05113 169 PPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR-PHLASEKVYAIMYSCWHEKAEERPT 247 (256)
T ss_pred CHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCC-CCCCCHHHHHHHHHHcCCCcccCCC
Confidence 9999998889999999999999999998 9999998887777777766544433 3357899999999999999999999
Q ss_pred HHHHhcC
Q psy5368 285 YEDLFSH 291 (406)
Q Consensus 285 ~~ell~h 291 (406)
+.+++++
T Consensus 248 ~~~ll~~ 254 (256)
T cd05113 248 FQQLLSS 254 (256)
T ss_pred HHHHHHh
Confidence 9999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=292.08 Aligned_cols=244 Identities=25% Similarity=0.402 Sum_probs=204.8
Q ss_pred ceeeecceeeeEEEeeee--eeceeEEeeeecCCccchhhhhhHHhhcccC-CCCCCc------ccCCeEEEEEeccCCC
Q psy5368 55 STIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITSHSEFERPRAGLSNL-RAPEGR------KRPRYVYIILEYCDGG 125 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~------~~~~~~~lV~E~~~gg 125 (406)
.+..||+|+|+.|-.+.. .+...+||.+.+.......++.||++++.++ .|+|++ .++..+|||||-|.||
T Consensus 82 t~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 82 TSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG 161 (463)
T ss_pred HHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence 456799999999998875 3456688877766555677899999999999 889965 4889999999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeCC----eeEEEecccccccCCCCC-------
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN----TLKLADFGFAQFLAPNDQ------- 194 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~~----~~kL~DFGla~~~~~~~~------- 194 (406)
+|..+|+++..|++.++.++.++|+.||.|||.+||.||||||+|||..+. -+|||||.+..-+..+..
T Consensus 162 plLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP 241 (463)
T KOG0607|consen 162 PLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTP 241 (463)
T ss_pred hHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCc
Confidence 999999999999999999999999999999999999999999999999732 689999998765443322
Q ss_pred -CCcccCCCCCCChhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------------HHHHHHHHHhc
Q psy5368 195 -GDSIQGSPLYMAPEILAG-----SPYNAKADLWSLGVLVFEALFGHAPYASCN---------------LSQLRAQALSS 253 (406)
Q Consensus 195 -~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~pf~~~~---------------~~~~~~~~~~~ 253 (406)
..+.+|+..|||||++.- ..|+.++|+||||+|||-||+|.+||.+.- ...+...|..+
T Consensus 242 ~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEG 321 (463)
T KOG0607|consen 242 ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEG 321 (463)
T ss_pred cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhcc
Confidence 245678889999998742 358999999999999999999999997641 34455555555
Q ss_pred CCCCCCCC---CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy5368 254 APITIPPN---SLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 254 ~~~~~~~~---~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 299 (406)
..++|.. .+|.+.++|++.+|..|+.+|.++.++++|||+.....
T Consensus 322 -kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 322 -KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred -CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence 5555553 78999999999999999999999999999999986543
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=300.13 Aligned_cols=242 Identities=27% Similarity=0.419 Sum_probs=193.5
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc-cchhhhhhHHhh-cccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI-TSHSEFERPRAG-LSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~-~~~~~~~~E~~~-l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...||+|+||.||++... +..+++|.+..... ....++..|+.. ++.++|||+++ ..+..|+||||++ +
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~ 84 (283)
T cd06617 6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-T 84 (283)
T ss_pred EEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-c
Confidence 356899999999999874 56788887765432 233456666664 66679999876 5677999999997 4
Q ss_pred CHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCcceEee-CCeeEEEecccccccCCCCCCCccc
Q psy5368 126 DLCSFIRS----HEKLSEFQCQQFVRQLVLALKFLREN-NVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQ 199 (406)
Q Consensus 126 sL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~lH~~-givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~ 199 (406)
+|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++ ++.+||+|||++.............
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 164 (283)
T cd06617 85 SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA 164 (283)
T ss_pred cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccccccccc
Confidence 89888754 24699999999999999999999997 999999999999998 6799999999998765433334456
Q ss_pred CCCCCCChhhhcC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCCCCCCCCCChHHHHHHHHh
Q psy5368 200 GSPLYMAPEILAG----SPYNAKADLWSLGVLVFEALFGHAPYASCN-LSQLRAQALSSAPITIPPNSLSPDCMDFLSRL 274 (406)
Q Consensus 200 gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~elltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~ 274 (406)
++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||.... ..+.............+...+|.++.+++.+|
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 244 (283)
T cd06617 165 GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKC 244 (283)
T ss_pred CCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHHHHHHH
Confidence 8899999999865 446889999999999999999999997532 22333333444444555557899999999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 275 LQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 275 L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
|..+|.+||+++++++||||....
T Consensus 245 l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 245 LKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred ccCChhhCcCHHHHhcCchhhhcc
Confidence 999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=293.12 Aligned_cols=238 Identities=27% Similarity=0.480 Sum_probs=199.6
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...+|.|+||.||++... +..+++|.+..... .....+.+|+.+++.++|+|+++ .....|+|+||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (257)
T cd08225 5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGG 84 (257)
T ss_pred EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCC
Confidence 467899999999999874 45678887655432 23457889999999999999765 667889999999999
Q ss_pred CHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeCC--eeEEEecccccccCCCCC-CCcccC
Q psy5368 126 DLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN--TLKLADFGFAQFLAPNDQ-GDSIQG 200 (406)
Q Consensus 126 sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~~--~~kL~DFGla~~~~~~~~-~~~~~g 200 (406)
+|.+++.... .+++..+..++.|++.||.|||+.+++|+||||+||+++++ .++|+|||.+........ .....|
T Consensus 85 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 164 (257)
T cd08225 85 DLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVG 164 (257)
T ss_pred cHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccccccCC
Confidence 9999997643 58999999999999999999999999999999999999833 579999999876654332 233468
Q ss_pred CCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCC
Q psy5368 201 SPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPM 280 (406)
Q Consensus 201 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~ 280 (406)
++.|+|||++.+..++.++|+||||+++++|++|..||...+.......+........+ ..++.++.+++.+||..+|+
T Consensus 165 ~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~ 243 (257)
T cd08225 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPIS-PNFSRDLRSLISQLFKVSPR 243 (257)
T ss_pred CccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCC-CCCCHHHHHHHHHHhccChh
Confidence 89999999999888999999999999999999999999988777666665554333332 36789999999999999999
Q ss_pred CCCCHHHHhcCCCC
Q psy5368 281 RRISYEDLFSHPYP 294 (406)
Q Consensus 281 ~Rps~~ell~hp~~ 294 (406)
+|||+.++++||||
T Consensus 244 ~Rpt~~~ll~~~~~ 257 (257)
T cd08225 244 DRPSITSILKRPFL 257 (257)
T ss_pred hCcCHHHHhhCCCC
Confidence 99999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=305.90 Aligned_cols=236 Identities=21% Similarity=0.325 Sum_probs=193.1
Q ss_pred ceeeecceeeeEEEeeeeee--c----eeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEecc
Q psy5368 55 STIRYGELQYDTVQNSQIRL--G----TVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYC 122 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~--~----~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~ 122 (406)
....||+|+||.||++.+.. . .+++|.+.... .....++.+|+.+++.++|||+++ .....++|+||+
T Consensus 11 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v~e~~ 90 (316)
T cd05108 11 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLM 90 (316)
T ss_pred eeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceeeeecC
Confidence 34678999999999998632 2 36777765433 233557889999999999999877 334567999999
Q ss_pred CCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC---Cc
Q psy5368 123 DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG---DS 197 (406)
Q Consensus 123 ~ggsL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~---~~ 197 (406)
++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++........ ..
T Consensus 91 ~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 170 (316)
T cd05108 91 PFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG 170 (316)
T ss_pred CCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCcceeccC
Confidence 9999999998754 689999999999999999999999999999999999998 678999999999876543322 12
Q ss_pred ccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcc
Q psy5368 198 IQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQ 276 (406)
Q Consensus 198 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~ 276 (406)
..++..|+|||.+.+..++.++|||||||++|||++ |..||.+....++............+ ..++.++.+++.+||.
T Consensus 171 ~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~ 249 (316)
T cd05108 171 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP-PICTIDVYMIMVKCWM 249 (316)
T ss_pred CccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCC-CCCCHHHHHHHHHHcc
Confidence 234567999999999999999999999999999997 99999988777665544444333333 3678999999999999
Q ss_pred cCCCCCCCHHHHhcC
Q psy5368 277 KDPMRRISYEDLFSH 291 (406)
Q Consensus 277 ~dP~~Rps~~ell~h 291 (406)
.+|.+||++.+++.+
T Consensus 250 ~~p~~Rps~~~l~~~ 264 (316)
T cd05108 250 IDADSRPKFRELIIE 264 (316)
T ss_pred CChhhCcCHHHHHHH
Confidence 999999999999886
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=298.37 Aligned_cols=243 Identities=29% Similarity=0.499 Sum_probs=199.9
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc-cchhhhhhHHhhcccCC---CCCCcc------cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI-TSHSEFERPRAGLSNLR---APEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~---h~ni~~------~~~~~~lV~E~~~ 123 (406)
...+|+|+||.||++... +..+++|.+..... ....++.+|+.+++.++ |||+++ .....|+||||++
T Consensus 6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06917 6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAE 85 (277)
T ss_pred hhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCC
Confidence 356899999999999863 45677787654432 33457889999999986 999765 6677899999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCC
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGS 201 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt 201 (406)
+++|.++++. +.+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||++....... ......|+
T Consensus 86 ~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 164 (277)
T cd06917 86 GGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGT 164 (277)
T ss_pred CCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccccccCC
Confidence 9999999866 4799999999999999999999999999999999999999 7799999999997765433 23345688
Q ss_pred CCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCC
Q psy5368 202 PLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPM 280 (406)
Q Consensus 202 ~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~ 280 (406)
..|+|||.+.++ .++.++|+|||||++|+|++|..||...........+........+...++.++.+++.+||+.||+
T Consensus 165 ~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 244 (277)
T cd06917 165 PYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPK 244 (277)
T ss_pred cceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHcCCCcc
Confidence 999999998754 4788999999999999999999999887665544443333333333335889999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCC
Q psy5368 281 RRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 281 ~Rps~~ell~hp~~~~~~~ 299 (406)
+||++.+++.||||+....
T Consensus 245 ~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 245 ERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred cCcCHHHHhhChHhhcccc
Confidence 9999999999999976554
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=300.70 Aligned_cols=243 Identities=28% Similarity=0.465 Sum_probs=205.4
Q ss_pred CceeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 54 SSTIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 54 ~~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
.....+|+|++|.||++... ...+++|.+..... ....+.+|++.++.++|+|+++ ..+..|+|+||++++
T Consensus 22 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 100 (286)
T cd06614 22 KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGG 100 (286)
T ss_pred hHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCC
Confidence 34467899999999999986 56788887765433 5667899999999999999765 667899999999999
Q ss_pred CHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCC
Q psy5368 126 DLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSP 202 (406)
Q Consensus 126 sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~ 202 (406)
+|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||++....... ......+++
T Consensus 101 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 180 (286)
T cd06614 101 SLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTP 180 (286)
T ss_pred cHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccccCCc
Confidence 9999998876 899999999999999999999999999999999999999 6799999999986654332 223345788
Q ss_pred CCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC-CCChHHHHHHHHhcccCCCC
Q psy5368 203 LYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPN-SLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 203 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~s~~l~~li~~~L~~dP~~ 281 (406)
.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+........... .++.++.+++.+||+.+|.+
T Consensus 181 ~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 260 (286)
T cd06614 181 YWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEK 260 (286)
T ss_pred ccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhh
Confidence 99999999988899999999999999999999999988776665555544433333322 48899999999999999999
Q ss_pred CCCHHHHhcCCCCCCC
Q psy5368 282 RISYEDLFSHPYPDLI 297 (406)
Q Consensus 282 Rps~~ell~hp~~~~~ 297 (406)
|||+.+++.||||+..
T Consensus 261 Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 261 RPSAEELLQHPFLKKA 276 (286)
T ss_pred CcCHHHHhhChHhhcc
Confidence 9999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=298.32 Aligned_cols=235 Identities=22% Similarity=0.347 Sum_probs=192.6
Q ss_pred eeeecceeeeEEEeeeeeec----eeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCccc------------CCeEEE
Q psy5368 56 TIRYGELQYDTVQNSQIRLG----TVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRKR------------PRYVYI 117 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~----~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~------------~~~~~l 117 (406)
...||+|+||.||++..... .+++|...... ......+.+|+.++..++|+|+++. ....++
T Consensus 4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 83 (272)
T cd05075 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVV 83 (272)
T ss_pred ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEE
Confidence 35789999999999987443 46777655432 2234578899999999999998762 124689
Q ss_pred EEeccCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccC
Q psy5368 118 ILEYCDGGDLCSFIRSH------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLA 190 (406)
Q Consensus 118 V~E~~~ggsL~~~l~~~------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~ 190 (406)
||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++ ++.++|+|||+++...
T Consensus 84 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 163 (272)
T cd05075 84 ILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIY 163 (272)
T ss_pred EEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccC
Confidence 99999999999988421 3489999999999999999999999999999999999998 6789999999998764
Q ss_pred CCCC---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChH
Q psy5368 191 PNDQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPD 266 (406)
Q Consensus 191 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 266 (406)
.... .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.....+...+........+ ..++..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 242 (272)
T cd05075 164 NGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQP-PDCLDG 242 (272)
T ss_pred cccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCHH
Confidence 3321 222345678999999999999999999999999999999 89999988877777776665444433 368899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 267 CMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 267 l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
+.+++.+||+.||++|||+.+++++
T Consensus 243 ~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 243 LYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=307.27 Aligned_cols=247 Identities=29% Similarity=0.407 Sum_probs=196.5
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecC--CccchhhhhhHHhhcccCCCCCCccc-----------CCeEEEEEe
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYD--TITSHSEFERPRAGLSNLRAPEGRKR-----------PRYVYIILE 120 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~-----------~~~~~lV~E 120 (406)
...||+|+||+||++... +..+++|.+... .......+.+|+.+++.++|+|+++. ....|+|+|
T Consensus 10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e 89 (337)
T cd07858 10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE 89 (337)
T ss_pred EEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEe
Confidence 446899999999998864 456888876543 22334567889999999999998652 135899999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCcc
Q psy5368 121 YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDSI 198 (406)
Q Consensus 121 ~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~~ 198 (406)
|+. ++|.+++...+.+++..+..++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++...... ......
T Consensus 90 ~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 168 (337)
T cd07858 90 LMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEY 168 (337)
T ss_pred CCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCccccccc
Confidence 996 59999998888999999999999999999999999999999999999999 779999999999766443 223445
Q ss_pred cCCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-----------------------
Q psy5368 199 QGSPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSA----------------------- 254 (406)
Q Consensus 199 ~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~----------------------- 254 (406)
.++..|+|||.+.+ ..++.++|||||||++|+|++|++||.+.+.......+....
T Consensus 169 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (337)
T cd07858 169 VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSL 248 (337)
T ss_pred ccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhc
Confidence 68899999998875 468899999999999999999999998765433222111100
Q ss_pred C----C--CCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCcc
Q psy5368 255 P----I--TIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAE 303 (406)
Q Consensus 255 ~----~--~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~~ 303 (406)
. . ......+++++.+|+.+||+.+|++|||++++++||||.....++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~ 303 (337)
T cd07858 249 PYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDE 303 (337)
T ss_pred CcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccC
Confidence 0 0 00012578999999999999999999999999999999877665544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=329.25 Aligned_cols=234 Identities=22% Similarity=0.396 Sum_probs=205.3
Q ss_pred eeeecceeeeEEEeeeee-------eceeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIR-------LGTVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~-------~~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~ 121 (406)
...||+|+||.||+|+.. ...|+||.++..+.. ...+|.||++++..|+|||||+ ..+-+|+|+||
T Consensus 491 ~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEY 570 (774)
T KOG1026|consen 491 KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEY 570 (774)
T ss_pred hhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEe
Confidence 346899999999999862 245899988877655 6779999999999999999877 77788999999
Q ss_pred cCCCCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeCC-eeEEEecccc
Q psy5368 122 CDGGDLCSFIRSHE--------------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLADFGFA 186 (406)
Q Consensus 122 ~~ggsL~~~l~~~~--------------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~~-~~kL~DFGla 186 (406)
|..|||.++|+.+. +++..+.+.|+.||+.|++||-++.+|||||-..|+||.++ .+||+|||++
T Consensus 571 m~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLs 650 (774)
T KOG1026|consen 571 MDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLS 650 (774)
T ss_pred cccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccc
Confidence 99999999996432 28899999999999999999999999999999999999965 9999999999
Q ss_pred cccCCCCCCC---cccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q psy5368 187 QFLAPNDQGD---SIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNS 262 (406)
Q Consensus 187 ~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (406)
+..-..+... ...-...|||||.+.-++++.+|||||+||+|||+++ |+.||.+.+.++....+..+...+.|. .
T Consensus 651 RdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL~~Pe-~ 729 (774)
T KOG1026|consen 651 RDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLLSCPE-N 729 (774)
T ss_pred hhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCcccCCC-C
Confidence 8765554322 2223567999999999999999999999999999997 999999999999999999997766665 7
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 263 LSPDCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 263 ~s~~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
+|.++.+|+..||+.+|.+||+++||-+
T Consensus 730 CP~~vY~LM~~CW~~~P~~RPsF~eI~~ 757 (774)
T KOG1026|consen 730 CPTEVYSLMLECWNENPKRRPSFKEIHS 757 (774)
T ss_pred CCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 9999999999999999999999999843
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=294.61 Aligned_cols=233 Identities=23% Similarity=0.356 Sum_probs=191.8
Q ss_pred eeeecceeeeEEEeeeeee-ceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCCCCHHH
Q psy5368 56 TIRYGELQYDTVQNSQIRL-GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDGGDLCS 129 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ggsL~~ 129 (406)
..+||+|+||.||++.... ..+++|...... .....+.+|+.+++.++|||++. .....|+||||+++|+|.+
T Consensus 11 ~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~~L~~ 89 (262)
T cd05071 11 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLD 89 (262)
T ss_pred eeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCCCCcHHH
Confidence 3467888899999887644 356777665432 34567899999999999999765 4556789999999999999
Q ss_pred HHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC--CcccCCCCC
Q psy5368 130 FIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG--DSIQGSPLY 204 (406)
Q Consensus 130 ~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~--~~~~gt~~y 204 (406)
++... ..+++..+..++.|++.||+|||+.|++|+||||+||+++ ++.++|+|||.+......... ....++..|
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y 169 (262)
T cd05071 90 FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 169 (262)
T ss_pred HHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccccCCccccee
Confidence 99764 3589999999999999999999999999999999999998 668999999999766433321 233456789
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
+|||+..+..++.++|||||||++|+|+| |..||.+.........+........ +..++..+.+++.+||+.+|++||
T Consensus 170 ~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rp 248 (262)
T cd05071 170 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLHDLMCQCWRKEPEERP 248 (262)
T ss_pred cCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCC-ccccCHHHHHHHHHHccCCcccCC
Confidence 99999998889999999999999999999 8999988877777666655433333 236899999999999999999999
Q ss_pred CHHHHhc
Q psy5368 284 SYEDLFS 290 (406)
Q Consensus 284 s~~ell~ 290 (406)
++.++++
T Consensus 249 ~~~~~~~ 255 (262)
T cd05071 249 TFEYLQA 255 (262)
T ss_pred CHHHHHH
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=301.23 Aligned_cols=239 Identities=27% Similarity=0.457 Sum_probs=206.0
Q ss_pred eecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHHH
Q psy5368 58 RYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLCS 129 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~~ 129 (406)
+||+|+||.||++.++ +..+++|++..+ .+..++.+|+.++++++.|.+++ ....++||||||..|++.+
T Consensus 40 KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSD 117 (502)
T KOG0574|consen 40 KLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISD 117 (502)
T ss_pred HhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHH
Confidence 5699999999999874 456788877654 56778999999999999999887 3445789999999999999
Q ss_pred HHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCcccCCCCCCC
Q psy5368 130 FIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDSIQGSPLYMA 206 (406)
Q Consensus 130 ~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~~~gt~~y~a 206 (406)
.++-+ .++++.++..+++..+.||+|||...-+|||||+.|||++ +|..||+|||.|..+... ...++..|||.|||
T Consensus 118 I~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMA 197 (502)
T KOG0574|consen 118 IMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMA 197 (502)
T ss_pred HHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccccCccccc
Confidence 99754 5899999999999999999999999999999999999999 899999999999766443 34577889999999
Q ss_pred hhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC-CCCChHHHHHHHHhcccCCCCCCCH
Q psy5368 207 PEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP-NSLSPDCMDFLSRLLQKDPMRRISY 285 (406)
Q Consensus 207 PE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~~li~~~L~~dP~~Rps~ 285 (406)
||++..-.|+.++||||+|++..||..|++||.+..+......+....++.+.. ...|.++.||+++||..+|++|-|+
T Consensus 198 PEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA 277 (502)
T KOG0574|consen 198 PEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTA 277 (502)
T ss_pred HHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHH
Confidence 999999999999999999999999999999999877665544444444443332 2578899999999999999999999
Q ss_pred HHHhcCCCCCCCC
Q psy5368 286 EDLFSHPYPDLIH 298 (406)
Q Consensus 286 ~ell~hp~~~~~~ 298 (406)
-++++|||++...
T Consensus 278 ~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 278 LRLCEHTFIKNAP 290 (502)
T ss_pred HHHhhhhhhcCCC
Confidence 9999999998654
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=293.81 Aligned_cols=233 Identities=24% Similarity=0.355 Sum_probs=193.1
Q ss_pred eeeecceeeeEEEeeeeee-ceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCCCCHHH
Q psy5368 56 TIRYGELQYDTVQNSQIRL-GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDGGDLCS 129 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ggsL~~ 129 (406)
..++|+|+||.||++.... ..+++|.+.... .....+.+|+.++++++|+|+++ .....|+||||+++++|.+
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~~L~~ 89 (260)
T cd05070 11 IKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSKGSLLD 89 (260)
T ss_pred hheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCCCcHHH
Confidence 3468999999999998654 456777665433 34567999999999999999755 4456789999999999999
Q ss_pred HHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC--CcccCCCCC
Q psy5368 130 FIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG--DSIQGSPLY 204 (406)
Q Consensus 130 ~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~--~~~~gt~~y 204 (406)
++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++ ++.++|+|||++......... ....++..|
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y 169 (260)
T cd05070 90 FLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKW 169 (260)
T ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccc
Confidence 99764 3589999999999999999999999999999999999999 568999999999765433221 223345679
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+........+ ...+..+.+|+.+||..+|++||
T Consensus 170 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rp 248 (260)
T cd05070 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCP-QDCPISLHELMLQCWKKDPEERP 248 (260)
T ss_pred cChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC-CcCCHHHHHHHHHHcccCcccCc
Confidence 99999998889999999999999999999 99999988877777776655444333 36889999999999999999999
Q ss_pred CHHHHhc
Q psy5368 284 SYEDLFS 290 (406)
Q Consensus 284 s~~ell~ 290 (406)
|+.++.+
T Consensus 249 t~~~l~~ 255 (260)
T cd05070 249 TFEYLQS 255 (260)
T ss_pred CHHHHHH
Confidence 9998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=295.40 Aligned_cols=236 Identities=22% Similarity=0.364 Sum_probs=195.8
Q ss_pred ceeeecceeeeEEEeeeeee-----ceeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEecc
Q psy5368 55 STIRYGELQYDTVQNSQIRL-----GTVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYC 122 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~-----~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~ 122 (406)
....||+|+||.||+|.+.. ..+++|........ ....+.+|+.++.+++|||+++ ..+..++||||+
T Consensus 8 ~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 87 (266)
T cd05033 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYM 87 (266)
T ss_pred eeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcC
Confidence 35678999999999998743 35677766544322 3457889999999999999765 567789999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC---CCc
Q psy5368 123 DGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ---GDS 197 (406)
Q Consensus 123 ~ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~---~~~ 197 (406)
++++|.+++... +.+++..+..++.|++.||.|||++||+|+||||+||+++ ++.++|+|||++........ ...
T Consensus 88 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 167 (266)
T cd05033 88 ENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKG 167 (266)
T ss_pred CCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccC
Confidence 999999999764 4799999999999999999999999999999999999999 66899999999987652221 112
Q ss_pred ccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcc
Q psy5368 198 IQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQ 276 (406)
Q Consensus 198 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~ 276 (406)
..+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........+........ +..+++.+.+++.+||+
T Consensus 168 ~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~ 246 (266)
T cd05033 168 GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP-PMDCPSALYQLMLDCWQ 246 (266)
T ss_pred CCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC-CCCCCHHHHHHHHHHcC
Confidence 234577999999998889999999999999999998 9999988887777776665533333 34689999999999999
Q ss_pred cCCCCCCCHHHHhcC
Q psy5368 277 KDPMRRISYEDLFSH 291 (406)
Q Consensus 277 ~dP~~Rps~~ell~h 291 (406)
.+|++||++++++++
T Consensus 247 ~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 247 KDRNERPTFSQIVST 261 (266)
T ss_pred CCcccCcCHHHHHHH
Confidence 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=298.83 Aligned_cols=234 Identities=21% Similarity=0.347 Sum_probs=194.5
Q ss_pred eeecceeeeEEEeeeee-------eceeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEecc
Q psy5368 57 IRYGELQYDTVQNSQIR-------LGTVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYC 122 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~-------~~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~ 122 (406)
..||+|+||.||++... ...+++|.+...... ....+.+|+.++..++|||+++ .....++++||+
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~ 90 (283)
T cd05091 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYC 90 (283)
T ss_pred HHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcC
Confidence 45799999999999763 246788877644322 2356889999999999999875 556789999999
Q ss_pred CCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEeccc
Q psy5368 123 DGGDLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGF 185 (406)
Q Consensus 123 ~ggsL~~~l~~~----------------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGl 185 (406)
++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||+
T Consensus 91 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~ 170 (283)
T cd05091 91 SHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL 170 (283)
T ss_pred CCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEeccccc
Confidence 999999998532 2488899999999999999999999999999999999998 56899999999
Q ss_pred ccccCCCCC---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q psy5368 186 AQFLAPNDQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPN 261 (406)
Q Consensus 186 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (406)
++....... .....+++.|+|||.+.+..++.++||||+||++|||++ |..||.+....+....+........+ .
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~-~ 249 (283)
T cd05091 171 FREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCP-D 249 (283)
T ss_pred ccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC-C
Confidence 876543221 223345778999999998889999999999999999998 99999998888887777766544433 4
Q ss_pred CCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 262 SLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 262 ~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
.++.++.+|+.+||+.+|++||++.++++.
T Consensus 250 ~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 250 DCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred CCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=296.52 Aligned_cols=238 Identities=27% Similarity=0.442 Sum_probs=192.9
Q ss_pred eeeecceeeeEEEeeeeee--ceeEEeeeecCCccchhhhhhHHhhcccC-CCCCCccc------------CCeEEEEEe
Q psy5368 56 TIRYGELQYDTVQNSQIRL--GTVKYSQVRYDTITSHSEFERPRAGLSNL-RAPEGRKR------------PRYVYIILE 120 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~------------~~~~~lV~E 120 (406)
...+|+|++|.||++.... ..+++|.+.... .....+.+|+.+++++ .|+|+++. ...+|+|||
T Consensus 11 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e 89 (275)
T cd06608 11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVME 89 (275)
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEE
Confidence 4567888899999888643 456777655433 3456789999999999 79997651 345899999
Q ss_pred ccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-C
Q psy5368 121 YCDGGDLCSFIRS----HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-Q 194 (406)
Q Consensus 121 ~~~ggsL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~ 194 (406)
|+++++|.+++.. +..+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||++....... .
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~ 169 (275)
T cd06608 90 LCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR 169 (275)
T ss_pred cCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccchhh
Confidence 9999999999864 35799999999999999999999999999999999999998 7799999999987654332 2
Q ss_pred CCcccCCCCCCChhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC-CCChHHH
Q psy5368 195 GDSIQGSPLYMAPEILAG-----SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPN-SLSPDCM 268 (406)
Q Consensus 195 ~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~s~~l~ 268 (406)
.....+++.|+|||++.. ..++.++||||+||++|+|++|..||...........+........... .++.++.
T Consensus 170 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (275)
T cd06608 170 RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFN 249 (275)
T ss_pred hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchhhcCHHHH
Confidence 344568999999999864 3467899999999999999999999987665555555554433333322 4788999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 269 DFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 269 ~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
+|+.+||..||++|||+.++++|||+
T Consensus 250 ~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 250 DFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred HHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999995
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=297.07 Aligned_cols=234 Identities=20% Similarity=0.314 Sum_probs=192.5
Q ss_pred eeeecceeeeEEEeeeeeec------eeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIRLG------TVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~------~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ 123 (406)
...||+|+||+||++.+... .+++|....... .....+.+|+.++..+.|||++. .....++++||++
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~~~~~~ 91 (279)
T cd05109 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLVTQLMP 91 (279)
T ss_pred eeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEEEEcCC
Confidence 35689999999999986322 367776654332 23557889999999999999865 3445789999999
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC---Ccc
Q psy5368 124 GGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG---DSI 198 (406)
Q Consensus 124 ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~---~~~ 198 (406)
+|+|.+++..+ +.+++..+..++.|++.||.|||++|++||||||+|||++ ++.+||+|||+++........ ...
T Consensus 92 ~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~ 171 (279)
T cd05109 92 YGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGG 171 (279)
T ss_pred CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCC
Confidence 99999999774 4699999999999999999999999999999999999998 668999999999876533221 122
Q ss_pred cCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhccc
Q psy5368 199 QGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 199 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~ 277 (406)
.+++.|+|||.+.+..++.++|||||||++|||++ |..||.......+...+........+ ..++.++.+++.+||..
T Consensus 172 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~ 250 (279)
T cd05109 172 KVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQP-PICTIDVYMIMVKCWMI 250 (279)
T ss_pred ccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCC-ccCCHHHHHHHHHHcCC
Confidence 34677999999999889999999999999999998 99999887777766665555444333 36899999999999999
Q ss_pred CCCCCCCHHHHhc
Q psy5368 278 DPMRRISYEDLFS 290 (406)
Q Consensus 278 dP~~Rps~~ell~ 290 (406)
||++||++.+++.
T Consensus 251 dp~~Rp~~~~l~~ 263 (279)
T cd05109 251 DSECRPRFRELVD 263 (279)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=293.66 Aligned_cols=233 Identities=23% Similarity=0.334 Sum_probs=194.1
Q ss_pred eeeecceeeeEEEeeeeee-ceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHH
Q psy5368 56 TIRYGELQYDTVQNSQIRL-GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLC 128 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~ 128 (406)
...||+|++|.||++.... +.+++|.+.... .....+.+|+.++++++|||+++ ..+..|+||||+++++|.
T Consensus 11 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 89 (261)
T cd05068 11 LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLL 89 (261)
T ss_pred EEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHH
Confidence 4678999999999988644 457777765433 34567899999999999999765 566789999999999999
Q ss_pred HHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCC--cccCCCC
Q psy5368 129 SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGD--SIQGSPL 203 (406)
Q Consensus 129 ~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~--~~~gt~~ 203 (406)
+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++ ++.++|+|||+++......... ....+..
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 169 (261)
T cd05068 90 EYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK 169 (261)
T ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCcee
Confidence 9997654 699999999999999999999999999999999999998 6789999999998765332211 1122457
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRR 282 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 282 (406)
|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+.......+........ +..++..+.+++.+||+.+|.+|
T Consensus 170 y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R 248 (261)
T cd05068 170 WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPC-PPGCPKELYDIMLDCWKEDPDDR 248 (261)
T ss_pred ccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC-CCcCCHHHHHHHHHHhhcCcccC
Confidence 999999999889999999999999999999 9999999887777776655533333 33688999999999999999999
Q ss_pred CCHHHHhc
Q psy5368 283 ISYEDLFS 290 (406)
Q Consensus 283 ps~~ell~ 290 (406)
|+++++++
T Consensus 249 p~~~~l~~ 256 (261)
T cd05068 249 PTFETLQW 256 (261)
T ss_pred CCHHHHHH
Confidence 99999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=297.45 Aligned_cols=241 Identities=25% Similarity=0.455 Sum_probs=212.1
Q ss_pred eeecceeeeEEEeeeeee--ceeEEeeeecCCccchhhh---hhHHhhcccCCCCCC------cccCCeEEEEEeccCCC
Q psy5368 57 IRYGELQYDTVQNSQIRL--GTVKYSQVRYDTITSHSEF---ERPRAGLSNLRAPEG------RKRPRYVYIILEYCDGG 125 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~~~~~~~---~~E~~~l~~l~h~ni------~~~~~~~~lV~E~~~gg 125 (406)
+++|+|.||.|-.++.+. +-.|+|.++++.+....++ ..|-++|+..+||-+ ++..+.+|.||||..||
T Consensus 174 KvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGG 253 (516)
T KOG0690|consen 174 KVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGG 253 (516)
T ss_pred HHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCc
Confidence 478999999999988643 4457777766665555554 458889999999964 45888999999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccc-cCCCCCCCcccCCCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQF-LAPNDQGDSIQGSPL 203 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~-~~~~~~~~~~~gt~~ 203 (406)
.|.-+|...+.|++...+.+...|+.||.|||+++||+||||.+|+|+| +|++||+|||+++. +......++.+|||.
T Consensus 254 eLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPE 333 (516)
T KOG0690|consen 254 ELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPE 333 (516)
T ss_pred eEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccceeccccCChh
Confidence 9999998888999999999999999999999999999999999999999 89999999999876 334456788999999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
|.|||++....|+.++|.|.+|+++|||++|+.||...+...+...|... .+.+|. .++++++.|+..+|.+||.+|.
T Consensus 334 YLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-d~kFPr-~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 334 YLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-DLKFPR-TLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred hcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-hccCCc-cCCHHHHHHHHHHhhcChHhhc
Confidence 99999999999999999999999999999999999999988888877766 444544 7999999999999999999997
Q ss_pred -----CHHHHhcCCCCCCCCC
Q psy5368 284 -----SYEDLFSHPYPDLIHA 299 (406)
Q Consensus 284 -----s~~ell~hp~~~~~~~ 299 (406)
.+.|+.+|+||....|
T Consensus 412 GgGpdDakEi~~h~FF~~v~W 432 (516)
T KOG0690|consen 412 GGGPDDAKEIMRHRFFASVDW 432 (516)
T ss_pred CCCchhHHHHHhhhhhccCCH
Confidence 5899999999998876
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=296.83 Aligned_cols=241 Identities=25% Similarity=0.423 Sum_probs=192.8
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc--------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK--------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~--------~~~~~~lV~E~~~g 124 (406)
..+||.|++|.||.+... ...+++|.+..... ....++.+|++++++++|||+++ ..+.+|+||||+++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 85 (287)
T cd06621 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEG 85 (287)
T ss_pred EEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence 457899999999999873 35667776654332 23567899999999999999766 23468999999999
Q ss_pred CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCccc
Q psy5368 125 GDLCSFIRS----HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQ 199 (406)
Q Consensus 125 gsL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~ 199 (406)
++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|.||+++ ++.++|+|||++........ ....
T Consensus 86 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 164 (287)
T cd06621 86 GSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA-GTFT 164 (287)
T ss_pred CCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccccc-cccc
Confidence 999988753 34689999999999999999999999999999999999999 67899999999866543222 2445
Q ss_pred CCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhcCCCCCCC-----CCCChHHHH
Q psy5368 200 GSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASC-----NLSQLRAQALSSAPITIPP-----NSLSPDCMD 269 (406)
Q Consensus 200 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~-----~~~~~~~~~~~~~~~~~~~-----~~~s~~l~~ 269 (406)
++..|+|||.+.+..++.++|+||+||++|+|++|..||... ...+....+........+. ...++.+.+
T Consensus 165 ~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (287)
T cd06621 165 GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKD 244 (287)
T ss_pred CCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHH
Confidence 788999999999999999999999999999999999999865 2233333333322221111 134678999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy5368 270 FLSRLLQKDPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 270 li~~~L~~dP~~Rps~~ell~hp~~~~~ 297 (406)
++.+||..+|.+|||+.|++.||||+..
T Consensus 245 li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 245 FIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred HHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 9999999999999999999999999643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=297.21 Aligned_cols=232 Identities=24% Similarity=0.406 Sum_probs=189.2
Q ss_pred eecceeeeEEEeeeeeec----eeEEeeeecCC-ccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccCCC
Q psy5368 58 RYGELQYDTVQNSQIRLG----TVKYSQVRYDT-ITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~~----~v~vk~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
.||+|+||.||++..... .+++|...... ......+.+|+.++.++ +|||+++ ..+..|+||||++++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 589999999999987442 34666555322 23345788999999999 8999765 556789999999999
Q ss_pred CHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccc
Q psy5368 126 DLCSFIRSHE----------------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQF 188 (406)
Q Consensus 126 sL~~~l~~~~----------------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~ 188 (406)
+|.+++..+. .+++.++..++.|++.||+|||++|++|+||||+||+++ ++.+||+|||++..
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~ 161 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG 161 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccc
Confidence 9999997543 478999999999999999999999999999999999998 67999999999854
Q ss_pred cCCCCCCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHH
Q psy5368 189 LAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDC 267 (406)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l 267 (406)
............+..|+|||++....++.++|+|||||++|+|++ |..||.+.+..+....+........+ ..++.++
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 240 (270)
T cd05047 162 QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP-LNCDDEV 240 (270)
T ss_pred cchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCC-CcCCHHH
Confidence 322212222234567999999988889999999999999999997 99999988877777666555333333 3578999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q psy5368 268 MDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 268 ~~li~~~L~~dP~~Rps~~ell~ 290 (406)
.+|+.+||..+|.+|||+.++++
T Consensus 241 ~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 241 YDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred HHHHHHHcccChhhCCCHHHHHH
Confidence 99999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=293.34 Aligned_cols=238 Identities=26% Similarity=0.416 Sum_probs=196.8
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC-----ccchhhhhhHHhhcccCCCCCCcc--------cCCeEEEEEe
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT-----ITSHSEFERPRAGLSNLRAPEGRK--------RPRYVYIILE 120 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~-----~~~~~~~~~E~~~l~~l~h~ni~~--------~~~~~~lV~E 120 (406)
...||+|+||.||++... +..+++|...... ......+.+|+.++++++|+|+++ ..+.+++|+|
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (264)
T cd06653 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE 86 (264)
T ss_pred eeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEE
Confidence 567899999999999863 4567887664321 122347889999999999999765 2356889999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC----CC
Q psy5368 121 YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND----QG 195 (406)
Q Consensus 121 ~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~----~~ 195 (406)
|+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||||+||+++ ++.++|+|||+++...... ..
T Consensus 87 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 166 (264)
T cd06653 87 YMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGI 166 (264)
T ss_pred eCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccccCccc
Confidence 999999999998878899999999999999999999999999999999999999 6689999999997653211 12
Q ss_pred CcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhc
Q psy5368 196 DSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL 275 (406)
Q Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L 275 (406)
....++..|+|||.+.+..++.++|+|||||++++|++|+.||..........++.........+..+++.+.+++.+||
T Consensus 167 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l 246 (264)
T cd06653 167 KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIF 246 (264)
T ss_pred cccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHh
Confidence 23568899999999998889999999999999999999999998876555555554443333334578999999999999
Q ss_pred ccCCCCCCCHHHHhcCCCC
Q psy5368 276 QKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 276 ~~dP~~Rps~~ell~hp~~ 294 (406)
. +|..||++.+++.|||.
T Consensus 247 ~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 247 V-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred c-CcccCccHHHHhcCCCC
Confidence 9 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=293.02 Aligned_cols=235 Identities=26% Similarity=0.449 Sum_probs=197.6
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...+|+|+||.||.+... +..+++|.+.... ......+.+|+.+++.++|+|+++ ..+.+|+||||+++++
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 84 (255)
T cd08219 5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGD 84 (255)
T ss_pred EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCc
Confidence 356788899998888763 4567777765432 234567888999999999999765 7778999999999999
Q ss_pred HHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCC
Q psy5368 127 LCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSP 202 (406)
Q Consensus 127 L~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~ 202 (406)
|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++ ++.++|+|||++....... ......+++
T Consensus 85 l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 164 (255)
T cd08219 85 LMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTP 164 (255)
T ss_pred HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccccccCCc
Confidence 99998653 3589999999999999999999999999999999999998 6799999999987664332 233456889
Q ss_pred CCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCC
Q psy5368 203 LYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRR 282 (406)
Q Consensus 203 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 282 (406)
.|+|||++.+..++.++|+||+|+++|+|++|..||...+.......+........+ ..++..+.+|+.+||+.||++|
T Consensus 165 ~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R 243 (255)
T cd08219 165 YYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLP-SHYSYELRSLIKQMFKRNPRSR 243 (255)
T ss_pred cccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCC-cccCHHHHHHHHHHHhCCcccC
Confidence 999999999988999999999999999999999999998877777766655444333 4688999999999999999999
Q ss_pred CCHHHHhcC
Q psy5368 283 ISYEDLFSH 291 (406)
Q Consensus 283 ps~~ell~h 291 (406)
||+.++++-
T Consensus 244 p~~~~il~~ 252 (255)
T cd08219 244 PSATTILSR 252 (255)
T ss_pred CCHHHHhhc
Confidence 999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=296.48 Aligned_cols=238 Identities=29% Similarity=0.404 Sum_probs=189.9
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...||+|++|.||++... +..+++|.+..... .....+.+|++++++++|||+++ ..+..++||||+. +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (284)
T cd07860 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-Q 83 (284)
T ss_pred eeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-c
Confidence 456799999999999763 45678887654332 22356889999999999999765 6678999999996 5
Q ss_pred CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCC
Q psy5368 126 DLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGS 201 (406)
Q Consensus 126 sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt 201 (406)
+|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++ ++.+||+|||++....... ......++
T Consensus 84 ~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 163 (284)
T cd07860 84 DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT 163 (284)
T ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccccccc
Confidence 899998653 4689999999999999999999999999999999999998 7799999999987654332 22334568
Q ss_pred CCCCChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-----------------C-----
Q psy5368 202 PLYMAPEILAGSP-YNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPIT-----------------I----- 258 (406)
Q Consensus 202 ~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-----------------~----- 258 (406)
+.|+|||.+.+.. ++.++|||||||++|+|+||+.||.+.+......++....... .
T Consensus 164 ~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd07860 164 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWAR 243 (284)
T ss_pred ccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccc
Confidence 8999999887654 6889999999999999999999998876544333322211000 0
Q ss_pred -----CCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 259 -----PPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 259 -----~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
....++++++++|.+||+.||.+|||++++++||||
T Consensus 244 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 244 QDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred cCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 012468889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=305.21 Aligned_cols=244 Identities=27% Similarity=0.408 Sum_probs=193.1
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcccC--------------------C
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRKRP--------------------R 113 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~--------------------~ 113 (406)
...||.|+||.||++... ++.+++|++..........+.+|++++++++|||+++.. .
T Consensus 10 ~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (342)
T cd07854 10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89 (342)
T ss_pred EEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccc
Confidence 456788888888888763 456788877666555567789999999999999977621 3
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee--CCeeEEEecccccccCC
Q psy5368 114 YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK--NNTLKLADFGFAQFLAP 191 (406)
Q Consensus 114 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~--~~~~kL~DFGla~~~~~ 191 (406)
..|+||||+++ +|.+++.. +.+++..++.++.||+.||.|||+.|++||||||+||+++ ++.++|+|||++.....
T Consensus 90 ~~~lv~e~~~~-~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~ 167 (342)
T cd07854 90 SVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDP 167 (342)
T ss_pred eEEEEeecccc-cHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCC
Confidence 67999999975 99998864 4799999999999999999999999999999999999997 44789999999976533
Q ss_pred CCC----CCcccCCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---------
Q psy5368 192 NDQ----GDSIQGSPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPIT--------- 257 (406)
Q Consensus 192 ~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--------- 257 (406)
... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+....+..
T Consensus 168 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (342)
T cd07854 168 HYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELL 247 (342)
T ss_pred ccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence 211 123357889999998765 558889999999999999999999998776544444333221110
Q ss_pred ---------------CC----CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q psy5368 258 ---------------IP----PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPC 301 (406)
Q Consensus 258 ---------------~~----~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~ 301 (406)
.+ ...++.++.+|+.+||+.||.+|||++++++||||+....|.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~ 310 (342)
T cd07854 248 NVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPF 310 (342)
T ss_pred hhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCc
Confidence 00 124778899999999999999999999999999998665544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=299.48 Aligned_cols=238 Identities=26% Similarity=0.393 Sum_probs=191.1
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccc--hhhhhhHHhhcccCCCCCCcc------cC--CeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITS--HSEFERPRAGLSNLRAPEGRK------RP--RYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~--~~~~~~E~~~l~~l~h~ni~~------~~--~~~~lV~E~~~ 123 (406)
...||+|+||.||++... ...+++|.+....... ...+.+|+.++.+++|||++. .. +..|+||||++
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~ 89 (293)
T cd07843 10 LNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE 89 (293)
T ss_pred hhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC
Confidence 356799999999999875 4567788776543222 235678999999999999765 33 78999999997
Q ss_pred CCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCcccC
Q psy5368 124 GGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDSIQG 200 (406)
Q Consensus 124 ggsL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~~~g 200 (406)
+ +|.+++.... .+++..+..++.||+.||+|||++|++|+||||+||+++ ++.++|+|||++...... .......+
T Consensus 90 ~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 168 (293)
T cd07843 90 H-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV 168 (293)
T ss_pred c-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccccccccc
Confidence 5 9999987654 599999999999999999999999999999999999999 679999999999876544 23334557
Q ss_pred CCCCCChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC------------------------
Q psy5368 201 SPLYMAPEILAGSP-YNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP------------------------ 255 (406)
Q Consensus 201 t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~------------------------ 255 (406)
++.|+|||.+.+.. ++.++|+||+|+++|+|++|.+||...........+.....
T Consensus 169 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (293)
T cd07843 169 TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKY 248 (293)
T ss_pred cccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccc
Confidence 88999999987654 68899999999999999999999987765544443322110
Q ss_pred ------CCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 256 ------ITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 256 ------~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
...+...+++.+.++|.+||+.+|++|||++|++.||||
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 249 PYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 001111258889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=292.17 Aligned_cols=233 Identities=22% Similarity=0.341 Sum_probs=192.2
Q ss_pred eeeecceeeeEEEeeeeeec-eeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCCCCHHH
Q psy5368 56 TIRYGELQYDTVQNSQIRLG-TVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDGGDLCS 129 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~-~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ggsL~~ 129 (406)
...||+|++|.||++..... .+++|...... .....+.+|+.+++.++|||+++ ..+..|+||||+++++|.+
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~ 89 (260)
T cd05069 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGKGSLLD 89 (260)
T ss_pred eeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCCCCHHH
Confidence 34689999999999986543 56777654332 34567899999999999999765 4556789999999999999
Q ss_pred HHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC--CCcccCCCCC
Q psy5368 130 FIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ--GDSIQGSPLY 204 (406)
Q Consensus 130 ~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~--~~~~~gt~~y 204 (406)
++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++ ++.++|+|||++........ .....++..|
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y 169 (260)
T cd05069 90 FLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKW 169 (260)
T ss_pred HHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhh
Confidence 997643 489999999999999999999999999999999999998 66899999999976543321 1223456789
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
+|||.+.+..++.++||||||+++|+|+| |..||.+....+....+........+ ...+..+.+++.+||..||++||
T Consensus 170 ~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rp 248 (260)
T cd05069 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCP-QGCPESLHELMKLCWKKDPDERP 248 (260)
T ss_pred CCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC-cccCHHHHHHHHHHccCCcccCc
Confidence 99999998889999999999999999999 99999988877776666555333333 36889999999999999999999
Q ss_pred CHHHHhc
Q psy5368 284 SYEDLFS 290 (406)
Q Consensus 284 s~~ell~ 290 (406)
+++++++
T Consensus 249 ~~~~i~~ 255 (260)
T cd05069 249 TFEYIQS 255 (260)
T ss_pred CHHHHHH
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=296.72 Aligned_cols=239 Identities=25% Similarity=0.408 Sum_probs=190.7
Q ss_pred eecceeeeEEEeeeee--eceeEEeeeecCCccc---hhhhhhHH---hhcccCCCCCCcc------cCCeEEEEEeccC
Q psy5368 58 RYGELQYDTVQNSQIR--LGTVKYSQVRYDTITS---HSEFERPR---AGLSNLRAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~---~~~~~~E~---~~l~~l~h~ni~~------~~~~~~lV~E~~~ 123 (406)
.||+|+||.||++... .+.+++|.+....... ...+..|. ..++...||+++. ..+..|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4799999999998864 4578888776543221 12233343 3455567888764 5678999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCC
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSP 202 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~ 202 (406)
|++|.+++...+.+++..+..++.|++.||.|||+.+++|+||||+||+++ ++.++|+|||++...... ......|+.
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~ 159 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTH 159 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcCcCCCc
Confidence 999999998888899999999999999999999999999999999999998 679999999998765432 233457899
Q ss_pred CCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccC
Q psy5368 203 LYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASC---NLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKD 278 (406)
Q Consensus 203 ~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~---~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~d 278 (406)
.|+|||.+.++ .++.++||||+||++|+|++|+.||... ......... .......+. .+|.++.+++.+||..+
T Consensus 160 ~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~-~~s~~~~~li~~~l~~~ 237 (278)
T cd05606 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTMAVELPD-SFSPELRSLLEGLLQRD 237 (278)
T ss_pred CCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh-hccCCCCCC-cCCHHHHHHHHHHhhcC
Confidence 99999999754 5899999999999999999999999876 223322222 222333333 57999999999999999
Q ss_pred CCCCC-----CHHHHhcCCCCCCCCC
Q psy5368 279 PMRRI-----SYEDLFSHPYPDLIHA 299 (406)
Q Consensus 279 P~~Rp-----s~~ell~hp~~~~~~~ 299 (406)
|.+|| ++.++++||||+...+
T Consensus 238 p~~R~~~~~~~~~~ll~~~~~~~~~~ 263 (278)
T cd05606 238 VNRRLGCLGRGAQEVKEHPFFRSLDW 263 (278)
T ss_pred HHhccCCCCCCHHHHHhCccccCCCc
Confidence 99999 9999999999987653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=294.29 Aligned_cols=229 Identities=23% Similarity=0.438 Sum_probs=180.6
Q ss_pred eecceeeeEEEeeeeee--ceeEEeeeecCCccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccCCCCHH
Q psy5368 58 RYGELQYDTVQNSQIRL--GTVKYSQVRYDTITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCDGGDLC 128 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~ggsL~ 128 (406)
.+|+|+||.||++.... ..+++|.......... |+.....+ +|||+++ ..+..|+||||+++++|.
T Consensus 23 ~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~ 97 (267)
T PHA03390 23 KLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLF 97 (267)
T ss_pred eecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHH
Confidence 37999999999998643 3456665543322111 22222112 6999765 567899999999999999
Q ss_pred HHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC-eeEEEecccccccCCCCCCCcccCCCCCCC
Q psy5368 129 SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN-TLKLADFGFAQFLAPNDQGDSIQGSPLYMA 206 (406)
Q Consensus 129 ~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~-~~kL~DFGla~~~~~~~~~~~~~gt~~y~a 206 (406)
+++..+..+++..+..++.|++.||.|||+.|++|+||||+||+++ ++ .++|+|||++...... ....++..|+|
T Consensus 98 ~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~y~a 174 (267)
T PHA03390 98 DLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---SCYDGTLDYFS 174 (267)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---ccCCCCCcccC
Confidence 9998888999999999999999999999999999999999999999 55 7999999998765432 23468899999
Q ss_pred hhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-h--cCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 207 PEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQAL-S--SAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 207 PE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~-~--~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
||++.+..++.++|+||+|+++|+|++|..||............. . ...... ...+|+.+.+||.+||+.+|.+||
T Consensus 175 PE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~ 253 (267)
T PHA03390 175 PEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPF-IKNVSKNANDFVQSMLKYNINYRL 253 (267)
T ss_pred hhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCc-ccccCHHHHHHHHHHhccChhhCC
Confidence 999999899999999999999999999999998654332211111 1 112222 226899999999999999999999
Q ss_pred C-HHHHhcCCCCC
Q psy5368 284 S-YEDLFSHPYPD 295 (406)
Q Consensus 284 s-~~ell~hp~~~ 295 (406)
+ ++++++||||+
T Consensus 254 ~~~~~~l~h~~~~ 266 (267)
T PHA03390 254 TNYNEIIKHPFLK 266 (267)
T ss_pred chHHHHhcCCccc
Confidence 6 69999999996
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=297.01 Aligned_cols=240 Identities=25% Similarity=0.427 Sum_probs=200.2
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...||+|+||.||++... +..+++|...... ......+.+|+.++.+++|||+++ ...+.|+||||+++++
T Consensus 9 ~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06641 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 88 (277)
T ss_pred heeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCc
Confidence 356899999999999763 4567887665433 223457889999999999999765 6678999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCCC
Q psy5368 127 LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPLY 204 (406)
Q Consensus 127 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~y 204 (406)
|.+++.. ..+++..+..++.|++.++.+||+.|++|+||+|+||+++ ++.++|+|||++....... ......++..|
T Consensus 89 l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y 167 (277)
T cd06641 89 ALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFW 167 (277)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccccCCccc
Confidence 9999865 5789999999999999999999999999999999999998 6689999999987654332 12334678899
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRIS 284 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps 284 (406)
+|||.+.+..++.++|+||+||++|+|++|..||...........+........ +..++.++.+++.+||..+|.+||+
T Consensus 168 ~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~Rp~ 246 (277)
T cd06641 168 MAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTL-EGNYSKPLKEFVEACLNKEPSFRPT 246 (277)
T ss_pred cChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCC-CcccCHHHHHHHHHHccCChhhCcC
Confidence 999999888899999999999999999999999988776666655544433332 3368899999999999999999999
Q ss_pred HHHHhcCCCCCCC
Q psy5368 285 YEDLFSHPYPDLI 297 (406)
Q Consensus 285 ~~ell~hp~~~~~ 297 (406)
+.++++||||...
T Consensus 247 ~~~~l~~~~~~~~ 259 (277)
T cd06641 247 AKELLKHKFIVRF 259 (277)
T ss_pred HHHHHhCHHHhhh
Confidence 9999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=304.73 Aligned_cols=246 Identities=27% Similarity=0.404 Sum_probs=191.9
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCccc-----------CCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRKR-----------PRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~-----------~~~~~lV~E~ 121 (406)
...||+|+||.||++... +..+++|...... ......+.+|+.++++++|||+++. ....|+|+||
T Consensus 10 ~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 89 (336)
T cd07849 10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQEL 89 (336)
T ss_pred EEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehh
Confidence 456788889999988753 4567888765322 2334568889999999999997662 2357999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC----CC
Q psy5368 122 CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ----GD 196 (406)
Q Consensus 122 ~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~----~~ 196 (406)
+++ +|.+++.. ..+++..+..++.|++.||+|||+.||+||||||+||+++ ++.+||+|||++........ ..
T Consensus 90 ~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 167 (336)
T cd07849 90 MET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLT 167 (336)
T ss_pred ccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcC
Confidence 975 99888854 5799999999999999999999999999999999999999 67999999999876543221 12
Q ss_pred cccCCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--------------------
Q psy5368 197 SIQGSPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP-------------------- 255 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-------------------- 255 (406)
...|++.|+|||.+.+ ..++.++||||+||++|+|++|++||.+.+.......+.....
T Consensus 168 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (336)
T cd07849 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIK 247 (336)
T ss_pred CcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHh
Confidence 3568899999998765 4689999999999999999999999987654332222211000
Q ss_pred ---C--CC----CCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCcc
Q psy5368 256 ---I--TI----PPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAE 303 (406)
Q Consensus 256 ---~--~~----~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~~ 303 (406)
. .. .....++++.+++.+||+.+|++|||+.++++||||+....++.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~ 304 (336)
T cd07849 248 SLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDE 304 (336)
T ss_pred hcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCc
Confidence 0 00 012467889999999999999999999999999999987665443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=289.49 Aligned_cols=238 Identities=31% Similarity=0.471 Sum_probs=202.7
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...||+|++|.||++... +..+++|....... .....+.+|++++.+++|||+++ ..+..++||||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (254)
T cd06627 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENG 84 (254)
T ss_pred eeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCC
Confidence 467899999999999864 35678887766543 34567899999999999999655 567889999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC-CCcccCCCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ-GDSIQGSPL 203 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~-~~~~~gt~~ 203 (406)
+|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||++........ .....++..
T Consensus 85 ~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 164 (254)
T cd06627 85 SLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPY 164 (254)
T ss_pred cHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccccchh
Confidence 9999998888999999999999999999999999999999999999999 67999999999987654433 234568889
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
|+|||.+.+..++.++|+||+|+++++|++|..||...+................ +..++..+.+++.+||..+|++||
T Consensus 165 y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~ 243 (254)
T cd06627 165 WMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPL-PEGISPELKDFLMQCFQKDPNLRP 243 (254)
T ss_pred hcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCC-CCCCCHHHHHHHHHHHhCChhhCc
Confidence 9999999888889999999999999999999999987765555544444433333 346899999999999999999999
Q ss_pred CHHHHhcCCCC
Q psy5368 284 SYEDLFSHPYP 294 (406)
Q Consensus 284 s~~ell~hp~~ 294 (406)
|+.++++||||
T Consensus 244 ~~~~~l~~~~~ 254 (254)
T cd06627 244 TAKQLLKHPWI 254 (254)
T ss_pred CHHHHhcCCCC
Confidence 99999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=297.12 Aligned_cols=239 Identities=26% Similarity=0.392 Sum_probs=193.5
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...||+|++|.||++... +..+++|.+.... ......+.+|++++++++|+|+++ ..+..++||||++++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~ 85 (288)
T cd07833 6 LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERT 85 (288)
T ss_pred EEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCC
Confidence 456799999999999864 3467888665432 223467899999999999999765 567789999999987
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC--CCCcccCCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND--QGDSIQGSP 202 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~--~~~~~~gt~ 202 (406)
.|..++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++ ++.+||+|||++....... ......++.
T Consensus 86 ~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~ 165 (288)
T cd07833 86 LLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR 165 (288)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCccccc
Confidence 7777676667799999999999999999999999999999999999998 6799999999988765443 334566789
Q ss_pred CCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC------------------CCC------
Q psy5368 203 LYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSA------------------PIT------ 257 (406)
Q Consensus 203 ~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~------------------~~~------ 257 (406)
.|+|||++.+. .++.++|+||+|+++|+|++|++||.+.+..+....+.... ...
T Consensus 166 ~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (288)
T cd07833 166 WYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQ 245 (288)
T ss_pred CCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCC
Confidence 99999999888 78999999999999999999999998765544332221100 000
Q ss_pred ------CCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 258 ------IPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 258 ------~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
..+..++.++.+|+.+||..+|++|||++++++||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 246 PESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0112358899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=293.64 Aligned_cols=234 Identities=24% Similarity=0.378 Sum_probs=197.2
Q ss_pred eeeecceeeeEEEeeeeee-ceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHH
Q psy5368 56 TIRYGELQYDTVQNSQIRL-GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLC 128 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~ 128 (406)
...||.|+||.||++.... ..+++|.+..........+.+|+.+++.++|||+++ .....++||||+++++|.
T Consensus 11 ~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (261)
T cd05148 11 ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLL 90 (261)
T ss_pred hhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHH
Confidence 3567999999999998754 567777776655556678999999999999999765 666789999999999999
Q ss_pred HHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC-CCcccCCCCC
Q psy5368 129 SFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ-GDSIQGSPLY 204 (406)
Q Consensus 129 ~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~-~~~~~gt~~y 204 (406)
+++... ..+++..+..++.||+.||.|||++|++|+||||+||+++ ++.+||+|||++........ .....++..|
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~ 170 (261)
T cd05148 91 AFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKW 170 (261)
T ss_pred HHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccccCCCCceEe
Confidence 999764 4689999999999999999999999999999999999998 66999999999976543321 1233356779
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+........+ ..+++.+.+++.+||+.||.+||
T Consensus 171 ~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~Rp 249 (261)
T cd05148 171 TAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCP-AKCPQEIYKIMLECWAAEPEDRP 249 (261)
T ss_pred cCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCC-CCCCHHHHHHHHHHcCCCchhCc
Confidence 99999998889999999999999999998 89999988877777776655443333 47899999999999999999999
Q ss_pred CHHHHhc
Q psy5368 284 SYEDLFS 290 (406)
Q Consensus 284 s~~ell~ 290 (406)
|+.++++
T Consensus 250 t~~~l~~ 256 (261)
T cd05148 250 SFKALRE 256 (261)
T ss_pred CHHHHHH
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=293.83 Aligned_cols=236 Identities=25% Similarity=0.409 Sum_probs=192.5
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++.. .+..+++|.+..... .....+.+|+.+++.++|||+++ ..+..++|+||+++
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 86 (267)
T cd08228 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADA 86 (267)
T ss_pred eeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCC
Confidence 45689999999999986 346778886654222 22346889999999999999765 56778999999999
Q ss_pred CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC-CCcc
Q psy5368 125 GDLCSFIRS----HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ-GDSI 198 (406)
Q Consensus 125 gsL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~-~~~~ 198 (406)
++|.+++.. ...+++..+..++.|++.||.|||++|++|+||||+||+++ ++.++|+|||++........ ....
T Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 166 (267)
T cd08228 87 GDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL 166 (267)
T ss_pred CcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhHHHhcC
Confidence 999998853 34589999999999999999999999999999999999999 67899999999877643322 2345
Q ss_pred cCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcc
Q psy5368 199 QGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCN--LSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQ 276 (406)
Q Consensus 199 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~ 276 (406)
.+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.... .......+........+...++..+.+++.+||.
T Consensus 167 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 246 (267)
T cd08228 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIY 246 (267)
T ss_pred CCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCC
Confidence 68889999999998889999999999999999999999997653 3344444444444444444688999999999999
Q ss_pred cCCCCCCCHHHHhcC
Q psy5368 277 KDPMRRISYEDLFSH 291 (406)
Q Consensus 277 ~dP~~Rps~~ell~h 291 (406)
.+|++||++.++++.
T Consensus 247 ~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 247 PDPDQRPDIGYVHQI 261 (267)
T ss_pred CCcccCcCHHHHHHH
Confidence 999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=294.92 Aligned_cols=235 Identities=24% Similarity=0.381 Sum_probs=194.4
Q ss_pred eeeecceeeeEEEeeeeee-----ceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCccc------------CCeEE
Q psy5368 56 TIRYGELQYDTVQNSQIRL-----GTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRKR------------PRYVY 116 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-----~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~~------------~~~~~ 116 (406)
...+|+|+||.||.+.... ..+++|.+...... ....+.+|+..++.++|||+++. ....+
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05035 4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPM 83 (273)
T ss_pred ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccE
Confidence 3568999999999998643 45888877654322 24578999999999999997651 12479
Q ss_pred EEEeccCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEeccccccc
Q psy5368 117 IILEYCDGGDLCSFIRSH------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFL 189 (406)
Q Consensus 117 lV~E~~~ggsL~~~l~~~------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~ 189 (406)
+||||+++++|..++... ..+++..+..++.|++.||.|||++|++||||||+||+++ ++.+||+|||+++..
T Consensus 84 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 163 (273)
T cd05035 84 VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKI 163 (273)
T ss_pred EEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceeec
Confidence 999999999999998442 2589999999999999999999999999999999999998 669999999999876
Q ss_pred CCCCC---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCh
Q psy5368 190 APNDQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSP 265 (406)
Q Consensus 190 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~ 265 (406)
..... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+........+ ..++.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 242 (273)
T cd05035 164 YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQP-EDCLD 242 (273)
T ss_pred cccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC-cCCCH
Confidence 43321 122234678999999988889999999999999999999 99999988887777777666554444 36899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 266 DCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 266 ~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
++.+++.+||+.||.+|||+.+++++
T Consensus 243 ~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 243 ELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=298.91 Aligned_cols=236 Identities=21% Similarity=0.352 Sum_probs=191.2
Q ss_pred ceeeecceeeeEEEeeeee-------eceeEEeeeecCCc-cchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEE
Q psy5368 55 STIRYGELQYDTVQNSQIR-------LGTVKYSQVRYDTI-TSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIIL 119 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~-------~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~ 119 (406)
....||+|+||.||++... ...+++|.+..... .....+.+|+.+++++ +|||+++ ..+..|+||
T Consensus 39 ~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 118 (302)
T cd05055 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVIT 118 (302)
T ss_pred EcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEE
Confidence 3567899999999998742 23567776654322 2245688999999999 8999876 566789999
Q ss_pred eccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC--
Q psy5368 120 EYCDGGDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ-- 194 (406)
Q Consensus 120 E~~~ggsL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~-- 194 (406)
||+++|+|.+++.... .+++.++..++.|++.||+|||++|++|+||||+||+++ ++.++|+|||+++.......
T Consensus 119 e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 198 (302)
T cd05055 119 EYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV 198 (302)
T ss_pred EcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCCCcee
Confidence 9999999999997643 389999999999999999999999999999999999999 56899999999976543321
Q ss_pred -CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHH
Q psy5368 195 -GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLS 272 (406)
Q Consensus 195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~ 272 (406)
.....+++.|+|||.+.+..++.++||||+||++|+|++ |..||.+...................+...++++.+++.
T Consensus 199 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 278 (302)
T cd05055 199 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMK 278 (302)
T ss_pred ecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHH
Confidence 122345778999999999999999999999999999998 999998877655444444333222233467899999999
Q ss_pred HhcccCCCCCCCHHHHhc
Q psy5368 273 RLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 273 ~~L~~dP~~Rps~~ell~ 290 (406)
+||..+|++|||+.++++
T Consensus 279 ~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 279 TCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHcCCCchhCcCHHHHHH
Confidence 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=305.17 Aligned_cols=247 Identities=28% Similarity=0.413 Sum_probs=202.8
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCcc------cC-----CeEEEEEe
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRK------RP-----RYVYIILE 120 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~------~~-----~~~~lV~E 120 (406)
...||.|++|.||++... +..+++|++.... ....+.+.+|+.+++.++|+|+++ .. ..+|+|||
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e 84 (330)
T cd07834 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTE 84 (330)
T ss_pred eeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEec
Confidence 356899999999999864 4677888776543 334567899999999999999755 22 37899999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC----CC
Q psy5368 121 YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND----QG 195 (406)
Q Consensus 121 ~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~----~~ 195 (406)
|+++ +|.+++..+..+++..+..++.||+.||.|||+.||+|+||||.||+++ ++.++|+|||++....... ..
T Consensus 85 ~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~ 163 (330)
T cd07834 85 LMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163 (330)
T ss_pred chhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccc
Confidence 9975 9999998878999999999999999999999999999999999999999 6799999999998765543 23
Q ss_pred CcccCCCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC----------------
Q psy5368 196 DSIQGSPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITI---------------- 258 (406)
Q Consensus 196 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~---------------- 258 (406)
....+++.|+|||++.+. .++.++|+||+|+++|+|++|.+||.+.+..+....+........
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 243 (330)
T cd07834 164 TEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYL 243 (330)
T ss_pred cccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHH
Confidence 445678999999999887 789999999999999999999999998876655554443211100
Q ss_pred -------------CCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCcc
Q psy5368 259 -------------PPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAE 303 (406)
Q Consensus 259 -------------~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~~ 303 (406)
....++.++.+++.+||+.+|.+||++++++.||||+....++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~ 301 (330)
T cd07834 244 KSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDE 301 (330)
T ss_pred hhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccC
Confidence 012367889999999999999999999999999999877665443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=288.62 Aligned_cols=234 Identities=32% Similarity=0.574 Sum_probs=200.3
Q ss_pred ecceeeeEEEeeeee--eceeEEeeeecCCcc---chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 59 YGELQYDTVQNSQIR--LGTVKYSQVRYDTIT---SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 59 lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
||.|+||.||++... +..+++|.+...... ....+.+|+.++++++|||+.. ..+..|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999874 456777776554332 3447889999999999999654 77889999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCcccCCCCCC
Q psy5368 128 CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDSIQGSPLYM 205 (406)
Q Consensus 128 ~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~~~gt~~y~ 205 (406)
.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++ ++.++|+|||++...... .......++..|+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 160 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL 160 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcccc
Confidence 99998888899999999999999999999999999999999999999 679999999998776543 2344556888999
Q ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCCH
Q psy5368 206 APEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY 285 (406)
Q Consensus 206 aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~ 285 (406)
|||.+.+...+.++|+||||+++|++++|..||...........+... ....+ ...+..+.+++.+||..||++||++
T Consensus 161 ~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~-~~~~~~l~~~i~~~l~~~p~~R~~~ 238 (250)
T cd05123 161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD-PLRFP-EFLSPEARDLISGLLQKDPTKRLGS 238 (250)
T ss_pred ChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC-CCCCC-CCCCHHHHHHHHHHhcCCHhhCCCc
Confidence 999999888999999999999999999999999888776666665552 33333 3578999999999999999999999
Q ss_pred ---HHHhcCCCC
Q psy5368 286 ---EDLFSHPYP 294 (406)
Q Consensus 286 ---~ell~hp~~ 294 (406)
+++++||||
T Consensus 239 ~~~~~l~~~~~f 250 (250)
T cd05123 239 GGAEEIKAHPFF 250 (250)
T ss_pred ccHHHHHhCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=294.72 Aligned_cols=233 Identities=21% Similarity=0.316 Sum_probs=189.1
Q ss_pred eeecceeeeEEEeeeeee--c----eeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCC
Q psy5368 57 IRYGELQYDTVQNSQIRL--G----TVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDG 124 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~--~----~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~g 124 (406)
..||+|+||.||++.+.. . .+++|....... ....++..|+..+.+++|||+++ .....++|+||+++
T Consensus 13 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i~e~~~~ 92 (279)
T cd05111 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLVTQLSPL 92 (279)
T ss_pred cccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEEEEeCCC
Confidence 468999999999998632 2 355665543221 22356778888999999999876 34557899999999
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC---CCccc
Q psy5368 125 GDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ---GDSIQ 199 (406)
Q Consensus 125 gsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~---~~~~~ 199 (406)
|+|.+++... +.+++..+..++.||+.||.|||++|++|+||||+||+++ ++.+||+|||+++....... .....
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 172 (279)
T cd05111 93 GSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHK 172 (279)
T ss_pred CcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCC
Confidence 9999999764 5799999999999999999999999999999999999999 66899999999976543321 22344
Q ss_pred CCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccC
Q psy5368 200 GSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKD 278 (406)
Q Consensus 200 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~d 278 (406)
++..|+|||.+.+..++.++|||||||++|||++ |..||.+.........+..+..... +..++.++.+++.+||..|
T Consensus 173 ~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~c~~~~ 251 (279)
T cd05111 173 TPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQ-PQICTIDVYMVMVKCWMID 251 (279)
T ss_pred CcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC-CCCCCHHHHHHHHHHcCCC
Confidence 6778999999998889999999999999999998 9999998877666555554433333 3357889999999999999
Q ss_pred CCCCCCHHHHhc
Q psy5368 279 PMRRISYEDLFS 290 (406)
Q Consensus 279 P~~Rps~~ell~ 290 (406)
|++|||+.++++
T Consensus 252 p~~Rps~~el~~ 263 (279)
T cd05111 252 ENVRPTFKELAN 263 (279)
T ss_pred cccCcCHHHHHH
Confidence 999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=300.26 Aligned_cols=240 Identities=26% Similarity=0.409 Sum_probs=198.9
Q ss_pred ceeeecceeeeEEEeeeee--eceeEEeeeecCCcc---chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccC
Q psy5368 55 STIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT---SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ 123 (406)
....+|+|+||.||++... +..+++|.+...... ....+.+|+.+++.++|||+++ ..+..|+||||++
T Consensus 19 ~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 98 (307)
T cd06607 19 DLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL 98 (307)
T ss_pred hheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC
Confidence 3467899999999999863 567888877544322 2346889999999999999766 5677899999997
Q ss_pred CCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCC
Q psy5368 124 GGDLCSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGS 201 (406)
Q Consensus 124 ggsL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt 201 (406)
| +|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|.||+++ ++.++|+|||++...... ....++
T Consensus 99 g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---~~~~~~ 174 (307)
T cd06607 99 G-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---NSFVGT 174 (307)
T ss_pred C-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---CCccCC
Confidence 5 88887754 45799999999999999999999999999999999999998 679999999998765322 345678
Q ss_pred CCCCChhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccC
Q psy5368 202 PLYMAPEILA---GSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKD 278 (406)
Q Consensus 202 ~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~d 278 (406)
+.|+|||++. ...++.++||||||+++|+|+||..||...+.......+........++..++.++.+++.+||..+
T Consensus 175 ~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 254 (307)
T cd06607 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKI 254 (307)
T ss_pred ccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCC
Confidence 8999999874 3568899999999999999999999998877666655555554455555568899999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCC
Q psy5368 279 PMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 279 P~~Rps~~ell~hp~~~~~~ 298 (406)
|++||++.+++.||||....
T Consensus 255 p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 255 PQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred hhhCcCHHHHhcChhhcccC
Confidence 99999999999999998544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=312.95 Aligned_cols=240 Identities=30% Similarity=0.518 Sum_probs=206.2
Q ss_pred ceeeecceeeeEEEeeeee--eceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 55 STIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
.+.+||+|.||+||.|..+ ++.||||.+.+.... ....+.+|+.+|++++||.++. +...++.|||-+.|
T Consensus 568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred hHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 4568999999999999974 567899876554432 3467889999999999998765 88899999999966
Q ss_pred CCHHHHH--HhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeC----CeeEEEecccccccCCCCCCCcc
Q psy5368 125 GDLCSFI--RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN----NTLKLADFGFAQFLAPNDQGDSI 198 (406)
Q Consensus 125 gsL~~~l--~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~----~~~kL~DFGla~~~~~~~~~~~~ 198 (406)
|..+.| .+.+++++...+.++.||+.||.|||-+||+|+||||+|||+.+ ..+||||||+|+.+....-..+.
T Consensus 648 -DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsV 726 (888)
T KOG4236|consen 648 -DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSV 726 (888)
T ss_pred -hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhh
Confidence 777766 45578999999999999999999999999999999999999983 28999999999999988888999
Q ss_pred cCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCCChHHHHHHHHhcc
Q psy5368 199 QGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI--TIPPNSLSPDCMDFLSRLLQ 276 (406)
Q Consensus 199 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~s~~l~~li~~~L~ 276 (406)
+|||.|.|||++..+.|...-|+||+|+|+|--|+|..||... +++..+|...... ..|...+++++.|||+.+|+
T Consensus 727 VGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLq 804 (888)
T KOG4236|consen 727 VGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQ 804 (888)
T ss_pred cCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCHHHHHHHHHHHH
Confidence 9999999999999999999999999999999999999999754 3444555544322 22333899999999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCC
Q psy5368 277 KDPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 277 ~dP~~Rps~~ell~hp~~~~~ 297 (406)
..-++|.|.+..++|||++..
T Consensus 805 Vkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 805 VKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHhcchHhhccchhhhcc
Confidence 999999999999999998864
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=294.95 Aligned_cols=234 Identities=19% Similarity=0.347 Sum_probs=193.9
Q ss_pred eeeecceeeeEEEeeeeee-------ceeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIRL-------GTVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-------~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~ 121 (406)
...||+|+||.||++.... ..+++|...... ......+.+|+.++..++|||+++ .....|+||||
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 90 (277)
T cd05032 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMEL 90 (277)
T ss_pred EeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEec
Confidence 3567899999999887643 457778765432 223446889999999999999765 56778999999
Q ss_pred cCCCCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccC
Q psy5368 122 CDGGDLCSFIRSHE----------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLA 190 (406)
Q Consensus 122 ~~ggsL~~~l~~~~----------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~ 190 (406)
+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++ ++.+||+|||+++...
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~ 170 (277)
T cd05032 91 MAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY 170 (277)
T ss_pred CCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccchhhc
Confidence 99999999996532 368889999999999999999999999999999999999 7799999999987654
Q ss_pred CCC---CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChH
Q psy5368 191 PND---QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPD 266 (406)
Q Consensus 191 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 266 (406)
... ......++..|+|||.+.+..++.++|||||||++|++++ |..||...+.......+........+ ..++.+
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 249 (277)
T cd05032 171 ETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLP-ENCPDK 249 (277)
T ss_pred cCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCCC-CCCCHH
Confidence 332 1233446788999999998889999999999999999998 99999988888877777655444443 467999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 267 CMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 267 l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
+.+++.+||+.+|++|||+.++++
T Consensus 250 ~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 250 LLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred HHHHHHHHcCCChhhCCCHHHHHH
Confidence 999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=293.19 Aligned_cols=235 Identities=21% Similarity=0.357 Sum_probs=195.3
Q ss_pred eeeecceeeeEEEeeeeeec-----eeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIRLG-----TVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~-----~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~g 124 (406)
...+|+|+||.||+|..... .+++|...... ......+.+|+.+++.++|||+++ .....|+||||+++
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~e~~~~ 90 (270)
T cd05056 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVMELAPL 90 (270)
T ss_pred eeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEEEcCCC
Confidence 56889999999999986432 46777665443 233557899999999999999876 34567899999999
Q ss_pred CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC--CcccC
Q psy5368 125 GDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG--DSIQG 200 (406)
Q Consensus 125 gsL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~--~~~~g 200 (406)
++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++ ++.++|+|||+++........ ....+
T Consensus 91 ~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 170 (270)
T cd05056 91 GELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL 170 (270)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccceecCCCCc
Confidence 99999997654 689999999999999999999999999999999999999 679999999999766443221 12234
Q ss_pred CCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCC
Q psy5368 201 SPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 201 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP 279 (406)
++.|+|||.+....++.++||||||+++|++++ |..||.+.+..+....+........+ ..+|.++.+++.+|+..+|
T Consensus 171 ~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P 249 (270)
T cd05056 171 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMP-PNCPPTLYSLMTKCWAYDP 249 (270)
T ss_pred cccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCC-CCCCHHHHHHHHHHcCCCh
Confidence 567999999988889999999999999999996 99999988877777666665555444 3689999999999999999
Q ss_pred CCCCCHHHHhcC
Q psy5368 280 MRRISYEDLFSH 291 (406)
Q Consensus 280 ~~Rps~~ell~h 291 (406)
.+|||+.++++.
T Consensus 250 ~~Rpt~~~~~~~ 261 (270)
T cd05056 250 SKRPRFTELKAQ 261 (270)
T ss_pred hhCcCHHHHHHH
Confidence 999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=300.02 Aligned_cols=235 Identities=22% Similarity=0.350 Sum_probs=191.9
Q ss_pred eeeecceeeeEEEeeeeee---------ceeEEeeeecCC-ccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEE
Q psy5368 56 TIRYGELQYDTVQNSQIRL---------GTVKYSQVRYDT-ITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYII 118 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~---------~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV 118 (406)
...||+|+||.||.+.... ..+++|.+.... .....++.+|+.++..+ +|||+++ ..+..|+|
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 102 (307)
T cd05098 23 GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 102 (307)
T ss_pred eeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 4567899999999887522 347777665432 22345688899999999 8999765 56678999
Q ss_pred EeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEE
Q psy5368 119 LEYCDGGDLCSFIRSHE----------------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLA 181 (406)
Q Consensus 119 ~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~ 181 (406)
|||+++|+|.+++..+. .+++.++..++.|++.||+|||++|++||||||+||+++ ++.+||+
T Consensus 103 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~ 182 (307)
T cd05098 103 VEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 182 (307)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEEC
Confidence 99999999999997642 488999999999999999999999999999999999999 7799999
Q ss_pred ecccccccCCCCC---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCC
Q psy5368 182 DFGFAQFLAPNDQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPIT 257 (406)
Q Consensus 182 DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 257 (406)
|||++........ .....+++.|+|||++.+..++.++|+||+||++|+|++ |..||...+..+....+.......
T Consensus 183 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 262 (307)
T cd05098 183 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD 262 (307)
T ss_pred CCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCCCC
Confidence 9999876543221 112224568999999999889999999999999999998 999999888877777666554434
Q ss_pred CCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 258 IPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 258 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
.+ ..++.++.+|+.+||..+|.+|||+.+++++
T Consensus 263 ~~-~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 263 KP-SNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred CC-CcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 33 3688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=290.78 Aligned_cols=238 Identities=27% Similarity=0.460 Sum_probs=194.1
Q ss_pred eeeecceeeeEEEeeeeeec--eeEEeeeec---CC--ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEecc
Q psy5368 56 TIRYGELQYDTVQNSQIRLG--TVKYSQVRY---DT--ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYC 122 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~--~v~vk~~~~---~~--~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~ 122 (406)
...||+|+||.||++..... ..+++..+. .. ......+.+|+.+++.++|||+++ .....++|+||+
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (260)
T cd08222 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYC 84 (260)
T ss_pred eeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeC
Confidence 35678899999998876432 233332221 11 122335778999999999999765 667789999999
Q ss_pred CCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeCCeeEEEecccccccCCCC-CCCc
Q psy5368 123 DGGDLCSFIRS----HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLADFGFAQFLAPND-QGDS 197 (406)
Q Consensus 123 ~ggsL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~~~~kL~DFGla~~~~~~~-~~~~ 197 (406)
++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++++.++|+|||++....... ....
T Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~~~~l~d~g~~~~~~~~~~~~~~ 164 (260)
T cd08222 85 EGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSCDLATT 164 (260)
T ss_pred CCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecCCEeecccCceeecCCCcccccC
Confidence 99999998854 346999999999999999999999999999999999999998899999999987654332 2334
Q ss_pred ccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhccc
Q psy5368 198 IQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 198 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~ 277 (406)
..+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...........+........ +..++.++.+++.+||..
T Consensus 165 ~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~ 243 (260)
T cd08222 165 FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL-PETYSRQLNSIMQSMLNK 243 (260)
T ss_pred CCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCC-cchhcHHHHHHHHHHhcC
Confidence 5688899999999888899999999999999999999999988777666666655543333 346889999999999999
Q ss_pred CCCCCCCHHHHhcCCCC
Q psy5368 278 DPMRRISYEDLFSHPYP 294 (406)
Q Consensus 278 dP~~Rps~~ell~hp~~ 294 (406)
+|++||++.++++||||
T Consensus 244 ~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 244 DPSLRPSAAEILRNPFI 260 (260)
T ss_pred ChhhCcCHHHHhhCCCC
Confidence 99999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=302.44 Aligned_cols=244 Identities=25% Similarity=0.351 Sum_probs=195.6
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccc--------------hhhhhhHHhhcccCCCCCCcc------cCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITS--------------HSEFERPRAGLSNLRAPEGRK------RPR 113 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~--------------~~~~~~E~~~l~~l~h~ni~~------~~~ 113 (406)
...||+|+||.||++... +..+++|.+....... ...+.+|+.+++.++|+|++. ..+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 346899999999999853 4568888775543222 125778999999999999765 567
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC
Q psy5368 114 YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN 192 (406)
Q Consensus 114 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~ 192 (406)
..|+||||++ ++|.+++.....+++..+..++.|++.||+|||+.|++|+||+|+||+++ ++.++|+|||++......
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~ 172 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYP 172 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeecccc
Confidence 7899999997 49999998878899999999999999999999999999999999999999 679999999999765411
Q ss_pred ---------------CCCCcccCCCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC
Q psy5368 193 ---------------DQGDSIQGSPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI 256 (406)
Q Consensus 193 ---------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 256 (406)
.......+++.|+|||.+.+. .++.++|+||+||++|+|++|.+||.+.+..+....+......
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~ 252 (335)
T PTZ00024 173 PYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGT 252 (335)
T ss_pred cccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 111223467889999998764 4789999999999999999999999988766554444321100
Q ss_pred C--------------------CC------CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy5368 257 T--------------------IP------PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAP 300 (406)
Q Consensus 257 ~--------------------~~------~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 300 (406)
. .+ ....+.++.+++.+||+.+|++|||+++++.||||+....+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 253 PNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred CchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence 0 00 12357889999999999999999999999999999876544
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=291.06 Aligned_cols=233 Identities=23% Similarity=0.381 Sum_probs=191.7
Q ss_pred eeeecceeeeEEEeeeeee-ceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCCCCHHH
Q psy5368 56 TIRYGELQYDTVQNSQIRL-GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDGGDLCS 129 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ggsL~~ 129 (406)
..+||+|+||.||++.... ..+++|.+.... .....+.+|+.++++++|+|+++ ..+.+|+||||+++++|.+
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~ 89 (260)
T cd05067 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYMENGSLVD 89 (260)
T ss_pred eeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCCCCCHHH
Confidence 3467888888888877533 557777665433 34568999999999999999765 4556899999999999999
Q ss_pred HHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC--CCcccCCCCC
Q psy5368 130 FIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ--GDSIQGSPLY 204 (406)
Q Consensus 130 ~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~--~~~~~gt~~y 204 (406)
++... ..+++.++..++.|++.||+|||+.|++|+||||+||+++ ++.++|+|||++........ .....++..|
T Consensus 90 ~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y 169 (260)
T cd05067 90 FLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKW 169 (260)
T ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccc
Confidence 98654 3689999999999999999999999999999999999999 66899999999976542221 1233456789
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+....+........+ ...+.++.+++.+||+.+|++||
T Consensus 170 ~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rp 248 (260)
T cd05067 170 TAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRP-DNCPEELYELMRLCWKEKPEERP 248 (260)
T ss_pred cCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCC-CCCCHHHHHHHHHHccCChhhCC
Confidence 99999998889999999999999999999 99999988877776666555433333 36889999999999999999999
Q ss_pred CHHHHhc
Q psy5368 284 SYEDLFS 290 (406)
Q Consensus 284 s~~ell~ 290 (406)
+++++++
T Consensus 249 ~~~~l~~ 255 (260)
T cd05067 249 TFEYLRS 255 (260)
T ss_pred CHHHHHH
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=290.80 Aligned_cols=233 Identities=21% Similarity=0.333 Sum_probs=189.2
Q ss_pred eecceeeeEEEeeeeee-----ceeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc-------cCCeEEEEEeccCC
Q psy5368 58 RYGELQYDTVQNSQIRL-----GTVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK-------RPRYVYIILEYCDG 124 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~-----~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~-------~~~~~~lV~E~~~g 124 (406)
.||+|+||.||++.... ..+++|...... ......+.+|+.+++.++|||++. .++..++||||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 58999999999998632 357777664322 233457889999999999999765 34567899999999
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-----CCCc
Q psy5368 125 GDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-----QGDS 197 (406)
Q Consensus 125 gsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-----~~~~ 197 (406)
++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+|||++ ++.+||+|||+++...... ....
T Consensus 82 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 161 (262)
T cd05058 82 GDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTG 161 (262)
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccccc
Confidence 9999999764 3578888899999999999999999999999999999999 6699999999987553221 1123
Q ss_pred ccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcc
Q psy5368 198 IQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQ 276 (406)
Q Consensus 198 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~ 276 (406)
..+++.|+|||.+.+..++.++|||||||++|||++ |.+||...+..++...+........+ ..+|+.+.+++.+||.
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~ 240 (262)
T cd05058 162 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQP-EYCPDPLYEVMLSCWH 240 (262)
T ss_pred CcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCC-CcCCHHHHHHHHHHcC
Confidence 345678999999998889999999999999999999 57788887777766666555433333 3578999999999999
Q ss_pred cCCCCCCCHHHHhcC
Q psy5368 277 KDPMRRISYEDLFSH 291 (406)
Q Consensus 277 ~dP~~Rps~~ell~h 291 (406)
.+|++||++.++++.
T Consensus 241 ~~p~~Rp~~~~il~~ 255 (262)
T cd05058 241 PKPEMRPTFSELVSR 255 (262)
T ss_pred CChhhCCCHHHHHHH
Confidence 999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=297.04 Aligned_cols=238 Identities=24% Similarity=0.385 Sum_probs=197.2
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCcc---chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTIT---SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...+|+|+||.||++.. .+..+++|.+...... ....+.+|+.+++.++|||++. .....|+||||+.+
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 105 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG 105 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCCC
Confidence 45699999999999986 3456778777644322 2346788999999999999765 56778999999965
Q ss_pred CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCC
Q psy5368 125 GDLCSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSP 202 (406)
Q Consensus 125 gsL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~ 202 (406)
+|.+++.. ..++++..+..++.||+.||.|||++|++|+||+|+||+++ ++.++|+|||++... .......|+.
T Consensus 106 -~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~---~~~~~~~~~~ 181 (313)
T cd06633 106 -SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS---SPANSFVGTP 181 (313)
T ss_pred -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCccc---CCCCCccccc
Confidence 88888755 45799999999999999999999999999999999999998 679999999998643 2233456889
Q ss_pred CCCChhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCC
Q psy5368 203 LYMAPEILA---GSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 203 ~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP 279 (406)
.|+|||++. ...++.++|||||||++|+|++|..||...+.......+............++..+.+|+.+||+.+|
T Consensus 182 ~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P 261 (313)
T cd06633 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIP 261 (313)
T ss_pred cccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCh
Confidence 999999985 35688899999999999999999999988776666665555544444445678899999999999999
Q ss_pred CCCCCHHHHhcCCCCCCC
Q psy5368 280 MRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 280 ~~Rps~~ell~hp~~~~~ 297 (406)
.+||++.+++.||||+..
T Consensus 262 ~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 262 QERPASAELLRHDFVRRD 279 (313)
T ss_pred hhCcCHHHHhcCcccCCC
Confidence 999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=287.52 Aligned_cols=237 Identities=27% Similarity=0.440 Sum_probs=200.6
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
..++|+|++|.||++... +..+++|....... .....+.+|+.+++.++|+|+++ .....|+||||++++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd08530 5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFG 84 (256)
T ss_pred eeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCC
Confidence 456788999999988753 34567776654332 23446788999999999999765 667899999999999
Q ss_pred CHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccC
Q psy5368 126 DLCSFIRS----HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQG 200 (406)
Q Consensus 126 sL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~g 200 (406)
+|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|.||+++ ++.+||+|||++...... ......+
T Consensus 85 ~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~~~~~ 163 (256)
T cd08530 85 DLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAKTQIG 163 (256)
T ss_pred CHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-CcccccC
Confidence 99999866 35689999999999999999999999999999999999999 668999999999776544 3334568
Q ss_pred CCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCC
Q psy5368 201 SPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPM 280 (406)
Q Consensus 201 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~ 280 (406)
++.|+|||.+.+..++.++|+||+|+++++|++|+.||...+.......+........+. .++.++.+++.+||+.+|+
T Consensus 164 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~ 242 (256)
T cd08530 164 TPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPP-IYSQDLQNFIRSMLQVKPK 242 (256)
T ss_pred CccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCch-hhCHHHHHHHHHHcCCCcc
Confidence 899999999999989999999999999999999999999988877777666654444443 6889999999999999999
Q ss_pred CCCCHHHHhcCCCC
Q psy5368 281 RRISYEDLFSHPYP 294 (406)
Q Consensus 281 ~Rps~~ell~hp~~ 294 (406)
+|||+.++++||++
T Consensus 243 ~Rp~~~~~l~~p~~ 256 (256)
T cd08530 243 LRPNCDKILASPAV 256 (256)
T ss_pred cCCCHHHHhcCCCC
Confidence 99999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=295.27 Aligned_cols=243 Identities=27% Similarity=0.431 Sum_probs=193.1
Q ss_pred ceeeecceeeeEEEeeeee--eceeEEeeeecCCcc-chhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccCC
Q psy5368 55 STIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT-SHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~g 124 (406)
....+|+|++|.||++..+ +..+++|.+...... ....+.+|+..+.++ .|||++. .....|+||||+.+
T Consensus 19 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 98 (296)
T cd06618 19 NLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMST 98 (296)
T ss_pred eeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccCc
Confidence 3467899999999999986 567888877654322 334566777766666 5998765 66678999999955
Q ss_pred CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCC
Q psy5368 125 GDLCSFIRS-HEKLSEFQCQQFVRQLVLALKFLRE-NNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGS 201 (406)
Q Consensus 125 gsL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~lH~-~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt 201 (406)
+|.+++.. ...+++..+..++.|++.||+|||+ .||+||||+|+||+++ ++.++|+|||++.............++
T Consensus 99 -~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~ 177 (296)
T cd06618 99 -CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGC 177 (296)
T ss_pred -CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcccCCCCC
Confidence 88887755 4579999999999999999999997 5999999999999998 679999999998776544444445578
Q ss_pred CCCCChhhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCCCCCC-CCChHHHHHHHHhc
Q psy5368 202 PLYMAPEILAGSP----YNAKADLWSLGVLVFEALFGHAPYASCNL-SQLRAQALSSAPITIPPN-SLSPDCMDFLSRLL 275 (406)
Q Consensus 202 ~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~-~~s~~l~~li~~~L 275 (406)
+.|+|||.+.+.. ++.++||||||+++|+|++|+.||..... .+....+........+.. .++.++.+|+.+||
T Consensus 178 ~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 257 (296)
T cd06618 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCL 257 (296)
T ss_pred ccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHc
Confidence 8999999987654 78899999999999999999999976432 233344444433333332 47899999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 276 QKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 276 ~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
..||.+||++++++.||||....
T Consensus 258 ~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 258 TKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred cCChhhCCCHHHHhcChhhhccc
Confidence 99999999999999999998543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=296.12 Aligned_cols=234 Identities=22% Similarity=0.356 Sum_probs=191.0
Q ss_pred eeeecceeeeEEEeeeeee-------ceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIRL-------GTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-------~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~ 121 (406)
...||+|+||.||++.... ..+++|....... .....+.+|+.+++.++|||+++ ..+..++|+||
T Consensus 5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (290)
T cd05045 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEY 84 (290)
T ss_pred cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEe
Confidence 3568999999999987532 3456665543322 22457889999999999999776 55678999999
Q ss_pred cCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC
Q psy5368 122 CDGGDLCSFIRSH------------------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN 176 (406)
Q Consensus 122 ~~ggsL~~~l~~~------------------------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~ 176 (406)
+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++ ++
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~ 164 (290)
T cd05045 85 AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGR 164 (290)
T ss_pred cCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCC
Confidence 9999999998642 2478999999999999999999999999999999999999 66
Q ss_pred eeEEEecccccccCCCCC---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q psy5368 177 TLKLADFGFAQFLAPNDQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALS 252 (406)
Q Consensus 177 ~~kL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 252 (406)
.+||+|||+++....... .....++..|+|||.+.+..++.++||||||+++++|++ |..||.+.....+......
T Consensus 165 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~ 244 (290)
T cd05045 165 KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKT 244 (290)
T ss_pred cEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Confidence 899999999876533221 222345678999999988889999999999999999998 9999999888877766655
Q ss_pred cCCCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 253 SAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 253 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
...... +..++.++.+++.+||+.+|++||++.++++
T Consensus 245 ~~~~~~-~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 245 GYRMER-PENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCCCCC-CCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 433333 3468999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=303.50 Aligned_cols=246 Identities=27% Similarity=0.398 Sum_probs=196.2
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCcc----------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRK----------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~----------~~~~~~lV~E~ 121 (406)
...||+|++|.||++... +..+++|.+.... ......+.+|+.++++++|||+++ ....+|+||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 89 (334)
T cd07855 10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL 89 (334)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEeh
Confidence 356899999999999864 4567888765432 234556788999999999999865 34578999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC-----C
Q psy5368 122 CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ-----G 195 (406)
Q Consensus 122 ~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~-----~ 195 (406)
+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++........ .
T Consensus 90 ~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 168 (334)
T cd07855 90 ME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM 168 (334)
T ss_pred hh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCccc
Confidence 96 59999998778899999999999999999999999999999999999999 67999999999976543321 1
Q ss_pred CcccCCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---------------------
Q psy5368 196 DSIQGSPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSS--------------------- 253 (406)
Q Consensus 196 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~--------------------- 253 (406)
....++..|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.+.......+...
T Consensus 169 ~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~ 248 (334)
T cd07855 169 TEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYI 248 (334)
T ss_pred ccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHH
Confidence 23468899999999866 45889999999999999999999999876543322211110
Q ss_pred --C--CCCCC----CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCc
Q psy5368 254 --A--PITIP----PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCA 302 (406)
Q Consensus 254 --~--~~~~~----~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~ 302 (406)
. ....+ ....++++.++|.+||+.+|++|||+.+++.||||.....+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~ 305 (334)
T cd07855 249 QNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDD 305 (334)
T ss_pred hhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcc
Confidence 0 00010 1246889999999999999999999999999999987765544
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=296.73 Aligned_cols=240 Identities=26% Similarity=0.397 Sum_probs=191.0
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCCc-cchhhhhhHHhhcccCC-CCCCcc------cCCeEEEEEeccCCCC
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI-TSHSEFERPRAGLSNLR-APEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~-h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
..||+|+||.||++... +..+++|.+..... .....+.+|+.++.++. |+|+++ .++..+++|||+.+ +
T Consensus 10 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~ 88 (288)
T cd06616 10 GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-S 88 (288)
T ss_pred HHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-C
Confidence 46899999999998874 45678887764432 23457889999999996 999766 56678899999964 6
Q ss_pred HHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCcceEee-CCeeEEEecccccccCCCCCCCccc
Q psy5368 127 LCSFIR-----SHEKLSEFQCQQFVRQLVLALKFLREN-NVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQ 199 (406)
Q Consensus 127 L~~~l~-----~~~~l~~~~~~~i~~ql~~aL~~lH~~-givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~ 199 (406)
|.++.. ....+++..+..++.|++.||+|||+. |++||||||+||+++ ++.++|+|||++.............
T Consensus 89 l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 168 (288)
T cd06616 89 LDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA 168 (288)
T ss_pred HHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcccccc
Confidence 655432 235799999999999999999999974 999999999999998 6789999999997765554445556
Q ss_pred CCCCCCChhhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCCCCC---CCCChHHHHHHH
Q psy5368 200 GSPLYMAPEILAGS---PYNAKADLWSLGVLVFEALFGHAPYASCNL-SQLRAQALSSAPITIPP---NSLSPDCMDFLS 272 (406)
Q Consensus 200 gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltg~~pf~~~~~-~~~~~~~~~~~~~~~~~---~~~s~~l~~li~ 272 (406)
|++.|+|||++.+. .++.++||||+||++|+|++|+.||..... .+.............+. ..++.++.+|+.
T Consensus 169 ~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 248 (288)
T cd06616 169 GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFIN 248 (288)
T ss_pred CccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHH
Confidence 89999999999876 689999999999999999999999976542 12222222222222222 248899999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCCCCC
Q psy5368 273 RLLQKDPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 273 ~~L~~dP~~Rps~~ell~hp~~~~~ 297 (406)
+||+.+|++|||++++++||||+..
T Consensus 249 ~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 249 LCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred HHccCChhhCcCHHHHhcChhhhch
Confidence 9999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=300.01 Aligned_cols=240 Identities=18% Similarity=0.308 Sum_probs=191.1
Q ss_pred ecceeeeEEEeeeeeeceeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHHHH
Q psy5368 59 YGELQYDTVQNSQIRLGTVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLCSF 130 (406)
Q Consensus 59 lG~G~~g~Vy~~~~~~~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~~~ 130 (406)
+|.|+++.|+++...++.+++|++.... ......+.+|+.+++.++|+|+++ ..+..|++|||+++++|.++
T Consensus 10 ~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~ 89 (314)
T cd08216 10 FEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDL 89 (314)
T ss_pred hcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHH
Confidence 4667778888888777889999877552 334567999999999999999766 56788999999999999999
Q ss_pred HHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC--------CCccc
Q psy5368 131 IRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ--------GDSIQ 199 (406)
Q Consensus 131 l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~--------~~~~~ 199 (406)
+... ..+++..+..++.|++.||+|||++||+|+||||+||+++ ++.++|+|||.+........ .....
T Consensus 90 l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (314)
T cd08216 90 LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169 (314)
T ss_pred HHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccc
Confidence 9764 4689999999999999999999999999999999999999 68999999998865432211 23345
Q ss_pred CCCCCCChhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--------------------
Q psy5368 200 GSPLYMAPEILAGS--PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPIT-------------------- 257 (406)
Q Consensus 200 gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-------------------- 257 (406)
++..|+|||++.+. .++.++|+||+||++|+|++|..||..............+....
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (314)
T cd08216 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSS 249 (314)
T ss_pred ccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccccc
Confidence 67889999999763 58899999999999999999999998765433322221111000
Q ss_pred ------------CCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 258 ------------IPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 258 ------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
.....++.++.+|+.+||..||++|||++++++||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 250 NEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred ccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 00012346789999999999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=292.73 Aligned_cols=238 Identities=28% Similarity=0.401 Sum_probs=191.5
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...||.|++|.||++.. .+..+++|.+...... ....+.+|+..++.++|||+++ ..+..|+||||++ +
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~ 82 (283)
T cd07835 4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-L 82 (283)
T ss_pred heEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-c
Confidence 35689999999999986 3566788877654322 2356888999999999999765 6688999999995 5
Q ss_pred CHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCC
Q psy5368 126 DLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGS 201 (406)
Q Consensus 126 sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt 201 (406)
+|.+++.... .+++..+..++.|++.||+|||+++++|+||+|+||+++ ++.++|+|||++....... ......++
T Consensus 83 ~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 162 (283)
T cd07835 83 DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVT 162 (283)
T ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCccccc
Confidence 9999997765 799999999999999999999999999999999999998 6799999999987654322 22334568
Q ss_pred CCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-------------------------
Q psy5368 202 PLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP------------------------- 255 (406)
Q Consensus 202 ~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~------------------------- 255 (406)
+.|+|||++.+. .++.++|+||+|+++|+|++|++||...+.......+.....
T Consensus 163 ~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T cd07835 163 LWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWAR 242 (283)
T ss_pred cCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccc
Confidence 899999988764 578999999999999999999999987665443333221100
Q ss_pred C--CCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 256 I--TIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 256 ~--~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
. ......++.++.+++.+||+.+|++|||+++++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 243 QDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0 00012577899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=330.32 Aligned_cols=243 Identities=25% Similarity=0.459 Sum_probs=203.8
Q ss_pred eeeecceeeeEEEeeeeeece--eEEeeeec---CCccchhhhhhHHhhcccCCCCC------CcccCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIRLGT--VKYSQVRY---DTITSHSEFERPRAGLSNLRAPE------GRKRPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~~--v~vk~~~~---~~~~~~~~~~~E~~~l~~l~h~n------i~~~~~~~~lV~E~~~g 124 (406)
-++||.|+||.|...+.+.+. .|.|.+.+ .......-|..|-.+|..-+.+= -+.+++++|+|||||+|
T Consensus 80 lKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pG 159 (1317)
T KOG0612|consen 80 LKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPG 159 (1317)
T ss_pred HHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccC
Confidence 456799999999999876542 34454433 11223345777777776665542 34599999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC--CCcccCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ--GDSIQGS 201 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~--~~~~~gt 201 (406)
|||-.++.+..+++++.++.++..|+.||.-+|+.|+|||||||+|||+| .|++||+|||.+-.+..++. ....+||
T Consensus 160 GDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGT 239 (1317)
T KOG0612|consen 160 GDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGT 239 (1317)
T ss_pred chHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCC
Confidence 99999999888999999999999999999999999999999999999999 89999999999877765543 4567899
Q ss_pred CCCCChhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCC-CCCChHHHHHHHHh
Q psy5368 202 PLYMAPEILAG-----SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSA-PITIPP-NSLSPDCMDFLSRL 274 (406)
Q Consensus 202 ~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~-~~~s~~l~~li~~~ 274 (406)
|.|.+||++.. +.|++.+|.||+||++|||+.|..||...+..+...+|.... ...+|+ ..+|+++++||.++
T Consensus 240 PDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~l 319 (1317)
T KOG0612|consen 240 PDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEAL 319 (1317)
T ss_pred CCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHH
Confidence 99999999963 569999999999999999999999999999999999988763 344442 37999999999999
Q ss_pred cccCCCCCCC---HHHHhcCCCCCCCCC
Q psy5368 275 LQKDPMRRIS---YEDLFSHPYPDLIHA 299 (406)
Q Consensus 275 L~~dP~~Rps---~~ell~hp~~~~~~~ 299 (406)
+. +|+.|.. ++++-+||||.+..|
T Consensus 320 l~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 320 LC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred hc-ChhhhcccccHHHHHhCccccCCCh
Confidence 87 5888887 999999999999988
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=294.13 Aligned_cols=238 Identities=26% Similarity=0.414 Sum_probs=185.3
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...||+|++|.||++... +..+++|.+...... ....+.+|+.++++++|+|+++ ...+.|+||||+++ +
T Consensus 10 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~ 88 (291)
T cd07844 10 LDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-D 88 (291)
T ss_pred EEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-C
Confidence 356788899999988763 456788877654322 2345778999999999999765 66789999999985 9
Q ss_pred HHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCC
Q psy5368 127 LCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPL 203 (406)
Q Consensus 127 L~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~ 203 (406)
|.+++... ..+++..++.++.|++.||.|||++||+|+||||+||+++ ++.+||+|||+++...... ......++..
T Consensus 89 L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 168 (291)
T cd07844 89 LKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLW 168 (291)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccccccccc
Confidence 99998764 4689999999999999999999999999999999999999 6799999999986543221 2223346888
Q ss_pred CCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCC---------------------CC-C
Q psy5368 204 YMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCN-LSQLRAQALSSAPI---------------------TI-P 259 (406)
Q Consensus 204 y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~-~~~~~~~~~~~~~~---------------------~~-~ 259 (406)
|+|||++.+ ..++.++||||+|+++|+|++|..||.+.. ..+....+...... .. +
T Consensus 169 ~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (291)
T cd07844 169 YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPP 248 (291)
T ss_pred cCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCC
Confidence 999999876 458899999999999999999999997665 22222211110000 00 0
Q ss_pred ------CCCCC--hHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 260 ------PNSLS--PDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 260 ------~~~~s--~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
...++ .++.+++.+||+.+|++|||+.+++.||||
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 249 RPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 01233 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=323.18 Aligned_cols=232 Identities=22% Similarity=0.357 Sum_probs=192.9
Q ss_pred ceeeecceeeeEEEeeeeee--ceeEEeeeecCCccchhhhhhHHhhcccCC-CCCCcc------------c-CCeEEEE
Q psy5368 55 STIRYGELQYDTVQNSQIRL--GTVKYSQVRYDTITSHSEFERPRAGLSNLR-APEGRK------------R-PRYVYII 118 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~------------~-~~~~~lV 118 (406)
..++|.||||+.||.+.... +.+|+|+...........+.+|+.++++|+ |+|||. . .-.+.|.
T Consensus 41 V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllL 120 (738)
T KOG1989|consen 41 VEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLL 120 (738)
T ss_pred EEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEee
Confidence 36788999999999999744 578999887777677788999999999996 999876 1 2356799
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCcceEee-CCeeEEEecccccccCCCC
Q psy5368 119 LEYCDGGDLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENN--VCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND 193 (406)
Q Consensus 119 ~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~ 193 (406)
||||+||.|-+++..+ ..|++.++++|+.|+++|+.+||... |+|||||-+||||+ +|..||||||.+.......
T Consensus 121 mEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~ 200 (738)
T KOG1989|consen 121 MEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSP 200 (738)
T ss_pred hhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCC
Confidence 9999999999999744 56999999999999999999999988 99999999999999 7799999999986543332
Q ss_pred CCC----------cccCCCCCCChhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q psy5368 194 QGD----------SIQGSPLYMAPEILA---GSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP 260 (406)
Q Consensus 194 ~~~----------~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (406)
... ....|+.|+|||++. +.+.+.|+|||+|||+||-|+....||.....-. |+.+ ...+|+
T Consensus 201 ~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----Ilng-~Y~~P~ 275 (738)
T KOG1989|consen 201 TSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----ILNG-NYSFPP 275 (738)
T ss_pred ccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----EEec-cccCCC
Confidence 111 123799999999974 5678999999999999999999999998864332 2233 334444
Q ss_pred -CCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 261 -NSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 261 -~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
..++..+.+||..||+.||++||++-+++.+
T Consensus 276 ~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 276 FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred CccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 4799999999999999999999999988764
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=290.63 Aligned_cols=226 Identities=19% Similarity=0.281 Sum_probs=182.3
Q ss_pred eecceeeeEEEeeeeeece------------eEEeeeecCCccchhhhhhHHhhcccCCCCCCcccC-----CeEEEEEe
Q psy5368 58 RYGELQYDTVQNSQIRLGT------------VKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRKRP-----RYVYIILE 120 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~~~------------v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~-----~~~~lV~E 120 (406)
.||+|+||.||++...... +++|........ ...+.+|+.++++++|||+++.. ...++|||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e 80 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVEE 80 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEEE
Confidence 5899999999999986544 555554433322 67889999999999999987622 56789999
Q ss_pred ccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC-------eeEEEecccccccCC
Q psy5368 121 YCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN-------TLKLADFGFAQFLAP 191 (406)
Q Consensus 121 ~~~ggsL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~-------~~kL~DFGla~~~~~ 191 (406)
|+++++|.+++...+ .+++..+..++.||+.||+|||++||+|+||||+||+++ ++ .+||+|||++.....
T Consensus 81 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~ 160 (259)
T cd05037 81 YVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS 160 (259)
T ss_pred cCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccccc
Confidence 999999999998766 799999999999999999999999999999999999998 44 699999999876543
Q ss_pred CCCCCcccCCCCCCChhhhcCC--CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHH
Q psy5368 192 NDQGDSIQGSPLYMAPEILAGS--PYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCM 268 (406)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~ 268 (406)
.....++..|+|||++.+. .++.++||||+||++|+|++ |..||...+.............. +...+..+.
T Consensus 161 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 234 (259)
T cd05037 161 ---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRL---PMPDCAELA 234 (259)
T ss_pred ---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCC---CCCCchHHH
Confidence 2234567789999999876 78999999999999999999 68888776544333322222111 112347899
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q psy5368 269 DFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 269 ~li~~~L~~dP~~Rps~~ell~ 290 (406)
+++.+||..+|.+|||+.++++
T Consensus 235 ~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 235 NLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHHHHhccChhhCCCHHHHHH
Confidence 9999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=286.92 Aligned_cols=233 Identities=25% Similarity=0.394 Sum_probs=192.5
Q ss_pred eecceeeeEEEeeeeee-ceeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHHH
Q psy5368 58 RYGELQYDTVQNSQIRL-GTVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLCS 129 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~-~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~~ 129 (406)
.||+|+||.||++.... ..+++|........ ....+.+|+.++..++|||+++ ..+..++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 68999999999998654 45677765543322 2346889999999999999765 5667899999999999999
Q ss_pred HHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC--CcccCCCCCC
Q psy5368 130 FIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG--DSIQGSPLYM 205 (406)
Q Consensus 130 ~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~--~~~~gt~~y~ 205 (406)
++... ..+++..+..++.|++.+|.|+|++|++|+||||+||+++ ++.+||+|||++......... ....+++.|+
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~ 161 (250)
T cd05085 82 FLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWT 161 (250)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccccc
Confidence 98754 4689999999999999999999999999999999999998 678999999998754332211 1223456799
Q ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCC
Q psy5368 206 APEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRIS 284 (406)
Q Consensus 206 aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps 284 (406)
|||++.+..++.++||||||+++|++++ |..||.+.........+........+ ..++..+.+++.+||+.+|++||+
T Consensus 162 aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rp~ 240 (250)
T cd05085 162 APEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCP-QKCPDDVYKVMQRCWDYKPENRPK 240 (250)
T ss_pred CHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCHHHHHHHHHHcccCcccCCC
Confidence 9999998889999999999999999998 99999988877777666655444433 368999999999999999999999
Q ss_pred HHHHhcC
Q psy5368 285 YEDLFSH 291 (406)
Q Consensus 285 ~~ell~h 291 (406)
+.++++.
T Consensus 241 ~~~l~~~ 247 (250)
T cd05085 241 FSELQKE 247 (250)
T ss_pred HHHHHHH
Confidence 9999763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=289.52 Aligned_cols=230 Identities=24% Similarity=0.429 Sum_probs=194.3
Q ss_pred eeeecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCCCCHHHH
Q psy5368 56 TIRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDGGDLCSF 130 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ggsL~~~ 130 (406)
...+|+|+||.||++...+..+++|..... .....+.+|+.++..++|||+++ ..+..++||||+++++|.++
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~ 88 (254)
T cd05083 11 GEIIGEGEFGAVLQGEYTGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKGNLVNF 88 (254)
T ss_pred eeeeccCCCCceEecccCCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCCCHHHH
Confidence 467899999999999887888888877543 23457899999999999999766 34457899999999999999
Q ss_pred HHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCCCCh
Q psy5368 131 IRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAP 207 (406)
Q Consensus 131 l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y~aP 207 (406)
+.... .+++..+..++.|++.||.|||+.|++||||||+||+++ ++.++|+|||++...... ......+..|+||
T Consensus 89 l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~y~~p 166 (254)
T cd05083 89 LRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--VDNSKLPVKWTAP 166 (254)
T ss_pred HHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--CCCCCCCceecCH
Confidence 97654 589999999999999999999999999999999999999 679999999998754322 1223345679999
Q ss_pred hhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCCHH
Q psy5368 208 EILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYE 286 (406)
Q Consensus 208 E~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ 286 (406)
|.+.+..++.++|+|||||++|+|++ |+.||...+..+....+....... ++..+++++.+++.+||+.+|++||+++
T Consensus 167 e~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 245 (254)
T cd05083 167 EALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRME-PPEGCPADVYVLMTSCWETEPKKRPSFH 245 (254)
T ss_pred HHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCC-CCCcCCHHHHHHHHHHcCCChhhCcCHH
Confidence 99998889999999999999999998 999999988877776666553333 3347899999999999999999999999
Q ss_pred HHhc
Q psy5368 287 DLFS 290 (406)
Q Consensus 287 ell~ 290 (406)
+++.
T Consensus 246 ~l~~ 249 (254)
T cd05083 246 KLRE 249 (254)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=291.89 Aligned_cols=234 Identities=23% Similarity=0.371 Sum_probs=192.6
Q ss_pred eeeecceeeeEEEeeeeee-----ceeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIRL-----GTVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-----~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ 123 (406)
...||+|+||.||++.... ..+++|...... ......|.+|+.+++.++|||+++ .....++||||++
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T cd05065 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFME 88 (269)
T ss_pred EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCC
Confidence 5678999999999998643 247887765432 223457999999999999999766 6667899999999
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcc---
Q psy5368 124 GGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSI--- 198 (406)
Q Consensus 124 ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~--- 198 (406)
+++|.+++... +.+++..+..++.|++.||.|||++|++|+||||+||+++ ++.++|+|||++............
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 168 (269)
T cd05065 89 NGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS 168 (269)
T ss_pred CCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCccccccccc
Confidence 99999999764 4689999999999999999999999999999999999998 669999999998765433221111
Q ss_pred c---CCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHh
Q psy5368 199 Q---GSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRL 274 (406)
Q Consensus 199 ~---gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~ 274 (406)
. .+..|+|||.+.+..++.++||||+||++||+++ |..||...+..+....+........+ ..++..+.+++.+|
T Consensus 169 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~li~~~ 247 (269)
T cd05065 169 LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPP-MDCPTALHQLMLDC 247 (269)
T ss_pred cCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCc-ccCCHHHHHHHHHH
Confidence 1 1346999999999899999999999999999886 99999988877777766544333333 36889999999999
Q ss_pred cccCCCCCCCHHHHhc
Q psy5368 275 LQKDPMRRISYEDLFS 290 (406)
Q Consensus 275 L~~dP~~Rps~~ell~ 290 (406)
|..+|.+||+++++++
T Consensus 248 l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 248 WQKDRNARPKFGQIVS 263 (269)
T ss_pred cCCChhhCcCHHHHHH
Confidence 9999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=288.07 Aligned_cols=233 Identities=25% Similarity=0.428 Sum_probs=198.8
Q ss_pred eeecceeeeEEEeeeeee------ceeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccC
Q psy5368 57 IRYGELQYDTVQNSQIRL------GTVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~------~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ 123 (406)
..+|.|+||.||++.... ..+++|........ ....+.+|+..+..++|+|+++ ..+..|+||||++
T Consensus 5 ~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~ 84 (258)
T smart00219 5 KKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYME 84 (258)
T ss_pred ceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccC
Confidence 468999999999999865 56788877655433 4668899999999999999765 5578999999999
Q ss_pred CCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCC--cc
Q psy5368 124 GGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGD--SI 198 (406)
Q Consensus 124 ggsL~~~l~~~~~--l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~--~~ 198 (406)
+++|.+++..... +++..+..++.|++.||++||+.|++|+||||+||+++ ++.++|+|||++.......... ..
T Consensus 85 ~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 164 (258)
T smart00219 85 GGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGG 164 (258)
T ss_pred CCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccccccC
Confidence 9999999976554 99999999999999999999999999999999999999 5689999999997765442211 12
Q ss_pred cCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhccc
Q psy5368 199 QGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 199 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~ 277 (406)
.+++.|+|||.+.+..++.++|+||+|+++++|++ |.+||...+.......+........+. .++.++.+++.+||..
T Consensus 165 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~~ 243 (258)
T smart00219 165 KLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPE-NCPPEIYKLMLQCWAE 243 (258)
T ss_pred CCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCC-cCCHHHHHHHHHHCcC
Confidence 36788999999988889999999999999999998 899999888888877777665544443 5899999999999999
Q ss_pred CCCCCCCHHHHhc
Q psy5368 278 DPMRRISYEDLFS 290 (406)
Q Consensus 278 dP~~Rps~~ell~ 290 (406)
+|++|||+.++++
T Consensus 244 ~p~~Rpt~~~ll~ 256 (258)
T smart00219 244 DPEDRPTFSELVE 256 (258)
T ss_pred ChhhCcCHHHHHh
Confidence 9999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=291.23 Aligned_cols=235 Identities=25% Similarity=0.428 Sum_probs=192.2
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCcc---chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTIT---SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|++|.||++.. .+..+++|.+...... ...++.+|+.+++.++|||+++ ..+..++||||+++
T Consensus 7 ~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~ 86 (267)
T cd08229 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA 86 (267)
T ss_pred hhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCC
Confidence 35689999999999985 4567788866543222 2357889999999999999765 56788999999999
Q ss_pred CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC-CCcc
Q psy5368 125 GDLCSFIRS----HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ-GDSI 198 (406)
Q Consensus 125 gsL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~-~~~~ 198 (406)
++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++ ++.++|+|||++........ ....
T Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 166 (267)
T cd08229 87 GDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL 166 (267)
T ss_pred CCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcccccc
Confidence 999999863 34689999999999999999999999999999999999998 67999999999876543322 2345
Q ss_pred cCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcc
Q psy5368 199 QGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNL--SQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQ 276 (406)
Q Consensus 199 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~ 276 (406)
.++..|+|||.+.+..++.++|+||||+++|+|++|..||.+... ......+........++..+++.+.+++.+||.
T Consensus 167 ~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 246 (267)
T cd08229 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCIN 246 (267)
T ss_pred cCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcC
Confidence 688999999999998899999999999999999999999976543 233333333333334445688999999999999
Q ss_pred cCCCCCCCHHHHhc
Q psy5368 277 KDPMRRISYEDLFS 290 (406)
Q Consensus 277 ~dP~~Rps~~ell~ 290 (406)
.||.+|||+.++++
T Consensus 247 ~~p~~Rpt~~~i~~ 260 (267)
T cd08229 247 PDPEKRPDITYVYD 260 (267)
T ss_pred CCcccCCCHHHHHH
Confidence 99999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=297.43 Aligned_cols=235 Identities=23% Similarity=0.391 Sum_probs=193.7
Q ss_pred eeeecceeeeEEEeeeeee-------ceeEEeeeecCCc-cchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEe
Q psy5368 56 TIRYGELQYDTVQNSQIRL-------GTVKYSQVRYDTI-TSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILE 120 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-------~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E 120 (406)
...||+|+||.||++.... ..+++|....... .....+.+|+.++.++ +|+|+++ ..+.+++|||
T Consensus 17 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e 96 (293)
T cd05053 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVE 96 (293)
T ss_pred eeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEE
Confidence 3567999999999988643 3467776654321 2334688999999999 8999765 6667899999
Q ss_pred ccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEec
Q psy5368 121 YCDGGDLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADF 183 (406)
Q Consensus 121 ~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DF 183 (406)
|+++|+|.+++..+ +.+++..+..++.|++.||.|||++||+|+||||+||+++ ++.+||+||
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Df 176 (293)
T cd05053 97 YAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADF 176 (293)
T ss_pred eCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCcc
Confidence 99999999999642 3589999999999999999999999999999999999999 779999999
Q ss_pred ccccccCCCCC---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q psy5368 184 GFAQFLAPNDQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIP 259 (406)
Q Consensus 184 Gla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (406)
|+++....... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+........+
T Consensus 177 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 256 (293)
T cd05053 177 GLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKP 256 (293)
T ss_pred ccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence 99986543321 122234567999999998889999999999999999997 99999998888877777666444433
Q ss_pred CCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 260 PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 260 ~~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
. .++.++.+|+.+||..||++|||+.+++++
T Consensus 257 ~-~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 257 Q-NCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred C-CCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 3 678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=298.45 Aligned_cols=234 Identities=22% Similarity=0.356 Sum_probs=191.3
Q ss_pred eeeecceeeeEEEeeeee---------eceeEEeeeecCC-ccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEE
Q psy5368 56 TIRYGELQYDTVQNSQIR---------LGTVKYSQVRYDT-ITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYII 118 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~---------~~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV 118 (406)
...||+|+||.||++... ...+++|.+.... ......+.+|+.++.++ +|||+++ ..+.+|+|
T Consensus 17 ~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 96 (314)
T cd05099 17 GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVI 96 (314)
T ss_pred eeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEE
Confidence 456899999999988642 2346677655332 22345688999999999 6999765 55678999
Q ss_pred EeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEE
Q psy5368 119 LEYCDGGDLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLA 181 (406)
Q Consensus 119 ~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~ 181 (406)
|||+++|+|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||+++ ++.+||+
T Consensus 97 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~ 176 (314)
T cd05099 97 VEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIA 176 (314)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEc
Confidence 9999999999999763 2488999999999999999999999999999999999999 6789999
Q ss_pred ecccccccCCCCC---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCC
Q psy5368 182 DFGFAQFLAPNDQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPIT 257 (406)
Q Consensus 182 DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 257 (406)
|||+++....... .....++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+.......
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 256 (314)
T cd05099 177 DFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMD 256 (314)
T ss_pred cccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9999976543221 112234467999999999889999999999999999999 999999988888777776654444
Q ss_pred CCCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 258 IPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 258 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
.+ ..++.++.+++.+||..+|++|||+.++++
T Consensus 257 ~~-~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 257 KP-SNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred CC-CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 33 368899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=294.27 Aligned_cols=228 Identities=19% Similarity=0.259 Sum_probs=181.6
Q ss_pred eecceeeeEEEeeeeee--------------------------ceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc-
Q psy5368 58 RYGELQYDTVQNSQIRL--------------------------GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK- 110 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~--------------------------~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~- 110 (406)
.||+|+||.||+|.... ..|++|............+.+|+.+++.++|||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999987532 235666655443333457888999999999999876
Q ss_pred -----cCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeC--------C
Q psy5368 111 -----RPRYVYIILEYCDGGDLCSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN--------N 176 (406)
Q Consensus 111 -----~~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~--------~ 176 (406)
.....++||||+++|+|..++.. .+.+++..+..++.||+.||+|||++||+||||||.|||++. .
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~ 161 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP 161 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccc
Confidence 56678999999999999999965 457899999999999999999999999999999999999972 1
Q ss_pred eeEEEecccccccCCCCCCCcccCCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhcC
Q psy5368 177 TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAG-SPYNAKADLWSLGVLVFEAL-FGHAPYASCNLSQLRAQALSSA 254 (406)
Q Consensus 177 ~~kL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell-tg~~pf~~~~~~~~~~~~~~~~ 254 (406)
.++++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||......+........
T Consensus 162 ~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~- 237 (274)
T cd05076 162 FIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKK- 237 (274)
T ss_pred eeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHhc-
Confidence 4899999987543221 23357888999998876 56899999999999999985 699999887655543332222
Q ss_pred CCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 255 PITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 255 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
...+ ...++.+.+++.+||+.+|++|||+.+++++
T Consensus 238 -~~~~-~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 238 -HRLP-EPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred -cCCC-CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 2222 2456789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=292.43 Aligned_cols=228 Identities=17% Similarity=0.225 Sum_probs=181.7
Q ss_pred eecceeeeEEEeeeeee--------------ceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEE
Q psy5368 58 RYGELQYDTVQNSQIRL--------------GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYI 117 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~--------------~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~l 117 (406)
.||+|+||.||+|.... ..+++|............+.+|+.++..++|||+++ .....++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 58999999999998532 135666655443334457888999999999999776 4556889
Q ss_pred EEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC-------eeEEEecccccc
Q psy5368 118 ILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN-------TLKLADFGFAQF 188 (406)
Q Consensus 118 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~-------~~kL~DFGla~~ 188 (406)
||||+++++|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++ ++ .++++|||++..
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~ 161 (262)
T cd05077 82 VEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPIT 161 (262)
T ss_pred EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCcc
Confidence 99999999999998754 5799999999999999999999999999999999999997 33 389999999865
Q ss_pred cCCCCCCCcccCCCCCCChhhhc-CCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChH
Q psy5368 189 LAPNDQGDSIQGSPLYMAPEILA-GSPYNAKADLWSLGVLVFEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPD 266 (406)
Q Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 266 (406)
... .....++..|+|||.+. +..++.++|||||||++|+|+ +|..||......+..... .... .. ....+++
T Consensus 162 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~-~~~~-~~-~~~~~~~ 235 (262)
T cd05077 162 VLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY-EGQC-ML-VTPSCKE 235 (262)
T ss_pred ccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH-hcCc-cC-CCCChHH
Confidence 432 23345788899999987 466899999999999999998 589999876655443222 2111 11 1235688
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 267 CMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 267 l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
+.+|+.+||+.||.+||++.+++.+
T Consensus 236 ~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 236 LADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHh
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=293.01 Aligned_cols=240 Identities=26% Similarity=0.370 Sum_probs=187.8
Q ss_pred ceeeecceeeeEEEeeeee--eceeEEeeeecCCc--cchhhhhhHHhhcccCC-CCCCcc------cCC-----eEEEE
Q psy5368 55 STIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI--TSHSEFERPRAGLSNLR-APEGRK------RPR-----YVYII 118 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~-h~ni~~------~~~-----~~~lV 118 (406)
....||+|+||.||++... +..+++|....... .....+.+|+.++++++ |||+++ ... ..|+|
T Consensus 5 ~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv 84 (295)
T cd07837 5 KLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLV 84 (295)
T ss_pred EeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEE
Confidence 3467899999999999864 45678886654432 23456888999999995 588765 222 37999
Q ss_pred EeccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeC--CeeEEEecccccccCC
Q psy5368 119 LEYCDGGDLCSFIRSH-----EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN--NTLKLADFGFAQFLAP 191 (406)
Q Consensus 119 ~E~~~ggsL~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~--~~~kL~DFGla~~~~~ 191 (406)
|||+++ +|.+++... ..+++..+..++.||+.||.|||++|++||||+|+||++++ +.+||+|||++.....
T Consensus 85 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~ 163 (295)
T cd07837 85 FEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI 163 (295)
T ss_pred eeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCC
Confidence 999986 899988543 35899999999999999999999999999999999999994 5899999999876533
Q ss_pred CC-CCCcccCCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--------------
Q psy5368 192 ND-QGDSIQGSPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP-------------- 255 (406)
Q Consensus 192 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-------------- 255 (406)
.. ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.......+.....
T Consensus 164 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T cd07837 164 PVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLR 243 (295)
T ss_pred CccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhcc
Confidence 22 2233456888999998865 4578999999999999999999999988765444333322100
Q ss_pred -----CCC-------CCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy5368 256 -----ITI-------PPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPD 295 (406)
Q Consensus 256 -----~~~-------~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~ 295 (406)
... ....++.++.+||.+||..||.+||++++++.||||+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 244 DWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred chhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 000 0024788999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=296.69 Aligned_cols=235 Identities=22% Similarity=0.353 Sum_probs=194.1
Q ss_pred eeeecceeeeEEEeeeee---------eceeEEeeeecCC-ccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEE
Q psy5368 56 TIRYGELQYDTVQNSQIR---------LGTVKYSQVRYDT-ITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYII 118 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~---------~~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV 118 (406)
...||+|+||.||.+... ...+++|...... ......+.+|+.++..+ +|||+++ ..+..|+|
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 99 (304)
T cd05101 20 GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 99 (304)
T ss_pred cceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEE
Confidence 456899999999988742 1246777665432 23346789999999999 8999766 56678999
Q ss_pred EeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEE
Q psy5368 119 LEYCDGGDLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLA 181 (406)
Q Consensus 119 ~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~ 181 (406)
|||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++ ++.+||+
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~ 179 (304)
T cd05101 100 VEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 179 (304)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEEC
Confidence 9999999999999764 2478889999999999999999999999999999999998 6799999
Q ss_pred ecccccccCCCCC---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCC
Q psy5368 182 DFGFAQFLAPNDQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPIT 257 (406)
Q Consensus 182 DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 257 (406)
|||+++....... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..++...+.......
T Consensus 180 D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 259 (304)
T cd05101 180 DFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD 259 (304)
T ss_pred CCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCC
Confidence 9999987643321 222345678999999998889999999999999999998 899999988888877776654443
Q ss_pred CCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 258 IPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 258 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
.+ ..++.++.+|+.+||..+|.+|||+.++++.
T Consensus 260 ~~-~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 260 KP-ANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CC-CCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 33 4689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=308.71 Aligned_cols=248 Identities=22% Similarity=0.429 Sum_probs=221.7
Q ss_pred eecceeeeEEEeeeeeece--eEEeeee---cCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 58 RYGELQYDTVQNSQIRLGT--VKYSQVR---YDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~~~--v~vk~~~---~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
-||-|+||.|-....+... .|.|.++ .-.....+-+..|-.+|..++.|-+++ +.+++|+.||-|-||.
T Consensus 427 TLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGE 506 (732)
T KOG0614|consen 427 TLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGE 506 (732)
T ss_pred hcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCch
Confidence 4799999999998877665 3444333 333344556788999999999987765 8899999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCCC
Q psy5368 127 LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLYM 205 (406)
Q Consensus 127 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y~ 205 (406)
|+..++.++.|++..++.++..+++|++|||++||++|||||+|.+++ +|-+||.|||+|+.+..+....+.+|||.|.
T Consensus 507 lWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYV 586 (732)
T KOG0614|consen 507 LWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYV 586 (732)
T ss_pred hhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCceeeecCCcccc
Confidence 999999999999999999999999999999999999999999999999 8899999999999999999999999999999
Q ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCC-
Q psy5368 206 APEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRIS- 284 (406)
Q Consensus 206 aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps- 284 (406)
|||++..+..+.++|.||+|+++||||+|.+||.+.++......|+.+-..-..|..++....+|+.++-..+|.+|..
T Consensus 587 APEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~ 666 (732)
T KOG0614|consen 587 APEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGY 666 (732)
T ss_pred cchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhcc
Confidence 9999999999999999999999999999999999999999999999986655555689999999999999999999986
Q ss_pred ----HHHHhcCCCCCCCCCCCccch
Q psy5368 285 ----YEDLFSHPYPDLIHAPCAESH 305 (406)
Q Consensus 285 ----~~ell~hp~~~~~~~~~~~~~ 305 (406)
+.+|-+|.||.+..|....+.
T Consensus 667 ~~~gI~DIkkH~Wf~gfdweglr~~ 691 (732)
T KOG0614|consen 667 QKGGINDIKKHRWFEGFDWEGLRSR 691 (732)
T ss_pred ccCChHHHHhhhhhhcCChhhhhhc
Confidence 799999999998887544433
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=293.19 Aligned_cols=238 Identities=26% Similarity=0.374 Sum_probs=184.7
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCccc-hhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITS-HSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~-~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...||+|+||.||++.. .++.+++|.+....... ...+.+|+.+++.++|+|++. ..+..|+||||+. ++
T Consensus 10 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~ 88 (291)
T cd07870 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TD 88 (291)
T ss_pred EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CC
Confidence 45678999999999875 35678888776543332 336788999999999999754 6678999999996 58
Q ss_pred HHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCC
Q psy5368 127 LCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPL 203 (406)
Q Consensus 127 L~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~ 203 (406)
|.+++... ..+++..+..++.|++.||.|||+.||+|+||||+||+++ ++.++|+|||+++...... ......+++.
T Consensus 89 l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 168 (291)
T cd07870 89 LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLW 168 (291)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCcccccc
Confidence 87777543 5688999999999999999999999999999999999998 7799999999987643322 2334457899
Q ss_pred CCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCC-----------------CC----C-C
Q psy5368 204 YMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLS-QLRAQALSSAP-----------------IT----I-P 259 (406)
Q Consensus 204 y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~-~~~~~~~~~~~-----------------~~----~-~ 259 (406)
|+|||.+.+. .++.++||||+||++|+|++|..||...+.. +....+..... .. . +
T Consensus 169 y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (291)
T cd07870 169 YRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKP 248 (291)
T ss_pred ccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCC
Confidence 9999998764 4788999999999999999999999765421 11111110000 00 0 0
Q ss_pred --------CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 260 --------PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 260 --------~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
....++++.+++.+||..||++|||++|++.||||
T Consensus 249 ~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 249 QQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 01235789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=339.42 Aligned_cols=247 Identities=28% Similarity=0.463 Sum_probs=210.4
Q ss_pred eeecCceeeecceeeeEEEeeeeeec--eeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEE
Q psy5368 50 DIVGSSTIRYGELQYDTVQNSQIRLG--TVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIIL 119 (406)
Q Consensus 50 ~i~~~~~~~lG~G~~g~Vy~~~~~~~--~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~ 119 (406)
.+.......+|.|.||.||.+..... ..|+|.+.... ....+.+.+|+.++..|+|||++. +....+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 34445677899999999999986443 35777655443 333557889999999999999887 556678999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-----
Q psy5368 120 EYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND----- 193 (406)
Q Consensus 120 E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~----- 193 (406)
|||+||+|.++++..+..++...+.+..|++.|+.|||+.|||||||||.||+++ +|.+|++|||.|..+.++.
T Consensus 1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 9999999999999888899999999999999999999999999999999999999 7899999999998877653
Q ss_pred CCCcccCCCCCCChhhhcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCCCCCCChHHHH
Q psy5368 194 QGDSIQGSPLYMAPEILAGSP---YNAKADLWSLGVLVFEALFGHAPYASC-NLSQLRAQALSSAPITIPPNSLSPDCMD 269 (406)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~s~~l~~ 269 (406)
..+...||+.|||||++.+.. ...++||||+|||+.||+||+.||... +.-.+...+..+..+.+|.. +|.+.++
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~-ls~~g~d 1472 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPER-LSSEGRD 1472 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchh-hhHhHHH
Confidence 234678999999999998754 566899999999999999999999874 45566677777777777774 9999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy5368 270 FLSRLLQKDPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 270 li~~~L~~dP~~Rps~~ell~hp~~~~~ 297 (406)
||.+||..||++|.++.|+++|.|-+.-
T Consensus 1473 Fle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1473 FLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred HHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 9999999999999999999999997643
|
|
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=311.78 Aligned_cols=242 Identities=28% Similarity=0.521 Sum_probs=212.4
Q ss_pred ceeeecceeeeEEEeeeee--eceeEEeeeecCCccc--hhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 55 STIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITS--HSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~--~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
....||+|.|+.|..+... ...|++|.+.+..... ...+.+|++++..|+|||+++ ....+|+||||+.+
T Consensus 60 i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ 139 (596)
T KOG0586|consen 60 IIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASG 139 (596)
T ss_pred eeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccC
Confidence 3456788888888888763 4578888665544332 345899999999999999876 68889999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeCC-eeEEEecccccccCCCCCCCcccCCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~~-~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
|.+.+++.+++...+..++.++.|++.|++|||+++|+|||||++|||++.+ ++||+|||++..+.......+.+|++.
T Consensus 140 ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~cgspp 219 (596)
T KOG0586|consen 140 GELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQTFCGSPP 219 (596)
T ss_pred chhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccccccccCCCCC
Confidence 9999999999999999999999999999999999999999999999999954 799999999999988888899999999
Q ss_pred CCChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCC
Q psy5368 204 YMAPEILAGSPY-NAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRR 282 (406)
Q Consensus 204 y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 282 (406)
|.|||++.+..| ++++|+||+|++||-|+.|..||++.+..++....+.+. ..+|. .++.++.+||.++|..+|.+|
T Consensus 220 yAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk-~rIp~-~ms~dce~lLrk~lvl~Pskr 297 (596)
T KOG0586|consen 220 YAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK-YRIPF-YMSCDCEDLLRKFLVLNPSKR 297 (596)
T ss_pred ccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee-ecccc-eeechhHHHHHHhhccCcccc
Confidence 999999999876 568999999999999999999999999999888877763 33332 588999999999999999999
Q ss_pred CCHHHHhcCCCCCCCC
Q psy5368 283 ISYEDLFSHPYPDLIH 298 (406)
Q Consensus 283 ps~~ell~hp~~~~~~ 298 (406)
++.+++.+|.|.....
T Consensus 298 ~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 298 GPCDQIMKDRWRNDLL 313 (596)
T ss_pred CCHHHhhhhcccchhh
Confidence 9999999999987654
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=287.62 Aligned_cols=235 Identities=26% Similarity=0.437 Sum_probs=193.1
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...+|+|++|.||++... +..+++|.++.... .....+.+|+.++++++|+|++. ..+..++||||+++
T Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (267)
T cd08224 7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADA 86 (267)
T ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCC
Confidence 456899999999999875 55677886653222 22457889999999999999655 56788999999999
Q ss_pred CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcc
Q psy5368 125 GDLCSFIRS----HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSI 198 (406)
Q Consensus 125 gsL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~ 198 (406)
++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||++....... .....
T Consensus 87 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 166 (267)
T cd08224 87 GDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL 166 (267)
T ss_pred CCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCccccee
Confidence 999999864 24589999999999999999999999999999999999998 7799999999987654432 22345
Q ss_pred cCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcc
Q psy5368 199 QGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCN--LSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQ 276 (406)
Q Consensus 199 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~ 276 (406)
.+++.|+|||.+.+..++.++|+||+||++|+|++|+.||.... .......+........+...++.++.+++.+||.
T Consensus 167 ~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~ 246 (267)
T cd08224 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCIN 246 (267)
T ss_pred cCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcC
Confidence 68889999999998889999999999999999999999996543 3344444444444444444688899999999999
Q ss_pred cCCCCCCCHHHHhc
Q psy5368 277 KDPMRRISYEDLFS 290 (406)
Q Consensus 277 ~dP~~Rps~~ell~ 290 (406)
.+|++|||+.++++
T Consensus 247 ~~p~~Rp~~~~il~ 260 (267)
T cd08224 247 PDPEKRPDISYVLQ 260 (267)
T ss_pred CCcccCCCHHHHHH
Confidence 99999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=287.02 Aligned_cols=233 Identities=25% Similarity=0.376 Sum_probs=193.7
Q ss_pred eeeecceeeeEEEeeeeee-ceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHH
Q psy5368 56 TIRYGELQYDTVQNSQIRL-GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLC 128 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~ 128 (406)
...||+|++|.||++..+. ..+++|.+... .....++.+|+.++++++|+|+++ .....++||||+++++|.
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 89 (261)
T cd05034 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLL 89 (261)
T ss_pred eeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHH
Confidence 4578999999999988644 45677766543 345568999999999999999765 557789999999999999
Q ss_pred HHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC--CCcccCCCC
Q psy5368 129 SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ--GDSIQGSPL 203 (406)
Q Consensus 129 ~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~--~~~~~gt~~ 203 (406)
+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++ ++.++|+|||++........ .....++..
T Consensus 90 ~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 169 (261)
T cd05034 90 DFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK 169 (261)
T ss_pred HHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCcc
Confidence 9997653 689999999999999999999999999999999999998 77999999999876643211 112234568
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRR 282 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 282 (406)
|+|||.+.+..++.++|+||+|+++++|++ |+.||.+.+.......+........+ ...+.++.+++.+||+.+|.+|
T Consensus 170 y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R 248 (261)
T cd05034 170 WTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRP-PNCPEELYDLMLQCWDKDPEER 248 (261)
T ss_pred ccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCHHHHHHHHHHcccCcccC
Confidence 999999998889999999999999999998 99999988877777776655433333 3578999999999999999999
Q ss_pred CCHHHHhc
Q psy5368 283 ISYEDLFS 290 (406)
Q Consensus 283 ps~~ell~ 290 (406)
|+++++++
T Consensus 249 p~~~~l~~ 256 (261)
T cd05034 249 PTFEYLQS 256 (261)
T ss_pred CCHHHHHH
Confidence 99999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=306.57 Aligned_cols=235 Identities=23% Similarity=0.357 Sum_probs=190.7
Q ss_pred eeeecceeeeEEEeeeeee-------ceeEEeeeecCCccc-hhhhhhHHhhcccCC-CCCCcc------cCCeEEEEEe
Q psy5368 56 TIRYGELQYDTVQNSQIRL-------GTVKYSQVRYDTITS-HSEFERPRAGLSNLR-APEGRK------RPRYVYIILE 120 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-------~~v~vk~~~~~~~~~-~~~~~~E~~~l~~l~-h~ni~~------~~~~~~lV~E 120 (406)
...||+|+||.||++.+.. ..|++|.+....... ...+.+|+.++.++. |||++. ..+..++|||
T Consensus 42 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E 121 (401)
T cd05107 42 GRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITE 121 (401)
T ss_pred hhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEe
Confidence 4579999999999998642 468888886543222 346889999999997 999876 5567899999
Q ss_pred ccCCCCHHHHHHhCC-----------------------------------------------------------------
Q psy5368 121 YCDGGDLCSFIRSHE----------------------------------------------------------------- 135 (406)
Q Consensus 121 ~~~ggsL~~~l~~~~----------------------------------------------------------------- 135 (406)
||++|+|.++++.++
T Consensus 122 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (401)
T cd05107 122 YCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKY 201 (401)
T ss_pred ccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhh
Confidence 999999999996532
Q ss_pred ---------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEE
Q psy5368 136 ---------------------------------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLA 181 (406)
Q Consensus 136 ---------------------------------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~ 181 (406)
.+++..+..++.||+.||.|||+.|++||||||.|||++ ++.+||+
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~ 281 (401)
T cd05107 202 ADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKIC 281 (401)
T ss_pred hhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEE
Confidence 367778899999999999999999999999999999999 5689999
Q ss_pred ecccccccCCCC---CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh-cCCC
Q psy5368 182 DFGFAQFLAPND---QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALS-SAPI 256 (406)
Q Consensus 182 DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~-~~~~ 256 (406)
|||+++...... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+....... ....
T Consensus 282 DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~ 361 (401)
T cd05107 282 DFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM 361 (401)
T ss_pred ecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCC
Confidence 999997643222 1223456788999999999889999999999999999998 8999987665554444333 3223
Q ss_pred CCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 257 TIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 257 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
.. +..++.++.+|+.+||..+|.+||++.++++.
T Consensus 362 ~~-p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 362 AK-PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred CC-CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 33 33689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=289.25 Aligned_cols=232 Identities=22% Similarity=0.332 Sum_probs=182.3
Q ss_pred eecceeeeEEEeeeeee----ceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 58 RYGELQYDTVQNSQIRL----GTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~----~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
.||+|+||.||+|.... ..+++|....... .....+.+|+..++.++|||+++ .....|+||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997533 2455665443322 22346889999999999999876 5667899999999999
Q ss_pred HHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC---CCCc
Q psy5368 127 LCSFIRSHE-----KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND---QGDS 197 (406)
Q Consensus 127 L~~~l~~~~-----~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~---~~~~ 197 (406)
|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++ ++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 161 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDC 161 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccCC
Confidence 999997643 256788899999999999999999999999999999999 6799999999986543221 1223
Q ss_pred ccCCCCCCChhhhcC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCC----CCCCh
Q psy5368 198 IQGSPLYMAPEILAG-------SPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPP----NSLSP 265 (406)
Q Consensus 198 ~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~----~~~s~ 265 (406)
..+++.|+|||++.. ..++.++||||+||++|||++ |..||......+.............+. ..+++
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (269)
T cd05042 162 HAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSD 241 (269)
T ss_pred CCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCH
Confidence 345677999999753 356789999999999999999 889998877666655555444333322 26788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 266 DCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 266 ~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
.+.+++..|+ .||++|||++++++
T Consensus 242 ~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 242 RWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred HHHHHHHHHh-cCcccccCHHHHHH
Confidence 8999999999 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=286.74 Aligned_cols=232 Identities=24% Similarity=0.394 Sum_probs=193.4
Q ss_pred eecceeeeEEEeeeee-eceeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHHH
Q psy5368 58 RYGELQYDTVQNSQIR-LGTVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLCS 129 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~-~~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~~ 129 (406)
.||+|++|.||++... ++.+++|........ ....+.+|+.+++++.|+|++. .....++||||+++++|.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 81 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT 81 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence 6899999999999875 567888876654433 4557899999999999999764 6677899999999999999
Q ss_pred HHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC---CcccCCCCC
Q psy5368 130 FIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG---DSIQGSPLY 204 (406)
Q Consensus 130 ~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~---~~~~gt~~y 204 (406)
++... ..+++..+..++.+++.||.|||++|++||||||+||+++ ++.++|+|||++......... .....+..|
T Consensus 82 ~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y 161 (251)
T cd05041 82 FLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW 161 (251)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceecc
Confidence 99664 4689999999999999999999999999999999999998 679999999998765422111 112235669
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
+|||.+.+..++.++|+||+||++|+|+| |..||...........+........ +..++.++.+++.+||..+|.+||
T Consensus 162 ~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp 240 (251)
T cd05041 162 TAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPA-PQLCPEEIYRLMLQCWAYDPENRP 240 (251)
T ss_pred CChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCC-CccCCHHHHHHHHHHhccChhhCc
Confidence 99999998889999999999999999999 8999988877766666655433332 346889999999999999999999
Q ss_pred CHHHHhc
Q psy5368 284 SYEDLFS 290 (406)
Q Consensus 284 s~~ell~ 290 (406)
|+.++++
T Consensus 241 ~~~ell~ 247 (251)
T cd05041 241 SFSEIYN 247 (251)
T ss_pred CHHHHHH
Confidence 9999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=296.12 Aligned_cols=238 Identities=24% Similarity=0.389 Sum_probs=185.9
Q ss_pred eeeecceeeeEEEeeeeee----ceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cC--CeEEEEEe
Q psy5368 56 TIRYGELQYDTVQNSQIRL----GTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RP--RYVYIILE 120 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~----~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~--~~~~lV~E 120 (406)
...||+|++|.||++.... ..+++|.+.... ......+.+|+.++..++|||+++ .. ..+|+|||
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 84 (316)
T cd07842 5 EGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFD 84 (316)
T ss_pred EEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEe
Confidence 3468999999999998743 678888776633 233456788999999999999765 33 78999999
Q ss_pred ccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeC-----CeeEEEecccccccC
Q psy5368 121 YCDGGDLCSFIRSH-----EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-----NTLKLADFGFAQFLA 190 (406)
Q Consensus 121 ~~~ggsL~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~-----~~~kL~DFGla~~~~ 190 (406)
|+++ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++. +.+||+|||++....
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~ 163 (316)
T cd07842 85 YAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163 (316)
T ss_pred CCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccC
Confidence 9975 788777432 26899999999999999999999999999999999999974 589999999987654
Q ss_pred CCCC----CCcccCCCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHHh----
Q psy5368 191 PNDQ----GDSIQGSPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQ---------LRAQALS---- 252 (406)
Q Consensus 191 ~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~---------~~~~~~~---- 252 (406)
.... .....+++.|+|||.+.+. .++.++|||||||++++|++|++||.+..... ....+..
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 243 (316)
T cd07842 164 APLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGT 243 (316)
T ss_pred CCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCC
Confidence 3322 2345678899999988764 58899999999999999999999997654322 0000000
Q ss_pred ---------------------cCCCCCC--------C--CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 253 ---------------------SAPITIP--------P--NSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 253 ---------------------~~~~~~~--------~--~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
......+ + ...+.++.+++.+||+.||++|||+.+++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 244 PTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred CchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0000000 0 1456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=290.85 Aligned_cols=236 Identities=22% Similarity=0.328 Sum_probs=192.3
Q ss_pred eeeecceeeeEEEeeeee-------eceeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIR-------LGTVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~-------~~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~ 121 (406)
-..+|+|+||.||++... ...+++|........ ....+.+|+.++++++|+|+++ .....|+||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (275)
T cd05046 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEY 89 (275)
T ss_pred eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEe
Confidence 345789999999988853 234666665443322 2457899999999999999765 55678999999
Q ss_pred cCCCCHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCC
Q psy5368 122 CDGGDLCSFIRSHE---------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAP 191 (406)
Q Consensus 122 ~~ggsL~~~l~~~~---------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~ 191 (406)
+++++|.+++.... .+++..+..++.|++.||+|||++||+|+||||+||+++ ++.++++|||++.....
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~ 169 (275)
T cd05046 90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYN 169 (275)
T ss_pred cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccccCc
Confidence 99999999997665 699999999999999999999999999999999999999 77999999999865432
Q ss_pred CC--CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHH
Q psy5368 192 ND--QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCM 268 (406)
Q Consensus 192 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~ 268 (406)
.. ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+.........+..++..+.
T Consensus 170 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 249 (275)
T cd05046 170 SEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLY 249 (275)
T ss_pred ccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCCCCHHHH
Confidence 21 2233456777999999988889999999999999999998 88999877766666665544333223346899999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q psy5368 269 DFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 269 ~li~~~L~~dP~~Rps~~ell~h 291 (406)
+++.+||+.+|.+|||+.++++.
T Consensus 250 ~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 250 KLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred HHHHHHcCCCcccCCCHHHHHHH
Confidence 99999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=327.88 Aligned_cols=234 Identities=24% Similarity=0.386 Sum_probs=201.8
Q ss_pred eeeecceeeeEEEeeeeee--c-----eeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIRL--G-----TVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~--~-----~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~ 121 (406)
...||+|+||.||.|.... + .|++|.+.+.. .....+|.+|+.++++++|||+++ +....+|++||
T Consensus 697 ~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ley 776 (1025)
T KOG1095|consen 697 LRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEY 776 (1025)
T ss_pred eeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehh
Confidence 5679999999999999743 2 27788776554 445668999999999999999877 66778999999
Q ss_pred cCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC
Q psy5368 122 CDGGDLCSFIRSH-------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND 193 (406)
Q Consensus 122 ~~ggsL~~~l~~~-------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~ 193 (406)
|+||||..+|++. ..++......++.||++|+.||+++++|||||.+.|+|++ ...+||+|||+|+.+...+
T Consensus 777 M~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~ 856 (1025)
T KOG1095|consen 777 MEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKD 856 (1025)
T ss_pred cccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhch
Confidence 9999999999876 2489999999999999999999999999999999999999 6699999999998543332
Q ss_pred CC---CcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHH
Q psy5368 194 QG---DSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMD 269 (406)
Q Consensus 194 ~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ 269 (406)
.. ..-.-...|||||.+..+.++.++|||||||+|||++| |..||.+.+..++......+.....|+ .+|+.+.+
T Consensus 857 yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~-~CP~~ly~ 935 (1025)
T KOG1095|consen 857 YYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPS-YCPEKLYQ 935 (1025)
T ss_pred heeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCC-CCChHHHH
Confidence 11 11122356999999999999999999999999999998 999999999999998888887555554 79999999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q psy5368 270 FLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 270 li~~~L~~dP~~Rps~~ell~ 290 (406)
++.+||+.+|++||++..+++
T Consensus 936 lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 936 LMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred HHHHHccCChhhCccHHHHHh
Confidence 999999999999999999987
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=292.88 Aligned_cols=241 Identities=26% Similarity=0.368 Sum_probs=191.0
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...||+|++|.||++... +..+++|.+..... .....+.+|++++++++|||+++ ...+.|+||||+++
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~- 85 (294)
T PLN00009 7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL- 85 (294)
T ss_pred EEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecccc-
Confidence 456799999999999864 45678887654432 22356889999999999999765 66789999999965
Q ss_pred CHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee--CCeeEEEecccccccCCCC-CCCcccC
Q psy5368 126 DLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK--NNTLKLADFGFAQFLAPND-QGDSIQG 200 (406)
Q Consensus 126 sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~--~~~~kL~DFGla~~~~~~~-~~~~~~g 200 (406)
+|.+++.... .+++..+..++.||+.||+|||++|++|+||+|+||+++ ++.+||+|||++....... ......+
T Consensus 86 ~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 165 (294)
T PLN00009 86 DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV 165 (294)
T ss_pred cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccccCce
Confidence 8988886654 358889999999999999999999999999999999998 3479999999997654322 2234457
Q ss_pred CCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--------------------CC-
Q psy5368 201 SPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI--------------------TI- 258 (406)
Q Consensus 201 t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--------------------~~- 258 (406)
++.|+|||.+.+. .++.++||||+||++|+|+||.+||...+..+...++...... ..
T Consensus 166 ~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (294)
T PLN00009 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWP 245 (294)
T ss_pred eecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCC
Confidence 8899999998764 5789999999999999999999999877655444433221000 00
Q ss_pred ------CCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy5368 259 ------PPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 259 ------~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 297 (406)
....+++++.+++.+||+.+|++||++.+++.||||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 246 PKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred CCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 012468899999999999999999999999999999854
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=292.27 Aligned_cols=234 Identities=22% Similarity=0.375 Sum_probs=185.0
Q ss_pred eeeecceeeeEEEeeee------eeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc--------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQI------RLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK--------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~------~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~--------~~~~~~lV~E~ 121 (406)
...||+|+||.||++.. .+..+++|.+..........+.+|++++..++|||+++ ....+++||||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 88 (284)
T cd05081 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEY 88 (284)
T ss_pred eeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEe
Confidence 35679999999999874 24568888876655455668899999999999999765 23468899999
Q ss_pred cCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC----
Q psy5368 122 CDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG---- 195 (406)
Q Consensus 122 ~~ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~---- 195 (406)
+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++ ++.++|+|||++.........
T Consensus 89 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 168 (284)
T cd05081 89 LPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVR 168 (284)
T ss_pred cCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeec
Confidence 9999999999764 4689999999999999999999999999999999999998 678999999999876433221
Q ss_pred CcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhcCCCCCC
Q psy5368 196 DSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLS----------------QLRAQALSSAPITIP 259 (406)
Q Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~----------------~~~~~~~~~~~~~~~ 259 (406)
....++..|+|||++.+..++.++|||||||+++||++|..|+...... .+.. ..........
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 247 (284)
T cd05081 169 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE-LLKNNGRLPA 247 (284)
T ss_pred CCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH-HHhcCCcCCC
Confidence 1122344699999999888999999999999999999987776443211 1111 1111111122
Q ss_pred CCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 260 PNSLSPDCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 260 ~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
+..++.++.+|+.+||..+|++|||+.++++
T Consensus 248 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 248 PPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 3468899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=288.54 Aligned_cols=235 Identities=21% Similarity=0.384 Sum_probs=193.1
Q ss_pred ceeeecceeeeEEEeeeeee--c---eeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEecc
Q psy5368 55 STIRYGELQYDTVQNSQIRL--G---TVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYC 122 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~--~---~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~ 122 (406)
....+|+|+||.||++.... + .+++|...... ......+.+|+.++..++|||+++ ..+..|+||||+
T Consensus 9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (268)
T cd05063 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYM 88 (268)
T ss_pred EeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcC
Confidence 35689999999999998642 2 46777665432 223457889999999999999765 667789999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCC----
Q psy5368 123 DGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGD---- 196 (406)
Q Consensus 123 ~ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~---- 196 (406)
++++|.+++... +.+++..+..++.|++.||+|||+.|++|+||||+||+++ ++.++|+|||++..........
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 168 (268)
T cd05063 89 ENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTS 168 (268)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccccceecc
Confidence 999999999764 5799999999999999999999999999999999999998 6689999999987664332211
Q ss_pred cccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhc
Q psy5368 197 SIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL 275 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L 275 (406)
....++.|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+........ +..++.++.+++.+||
T Consensus 169 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~li~~c~ 247 (268)
T cd05063 169 GGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA-PMDCPSAVYQLMLQCW 247 (268)
T ss_pred CCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCC-CCCCCHHHHHHHHHHc
Confidence 1122456999999998889999999999999999997 9999988887777777665433322 2368899999999999
Q ss_pred ccCCCCCCCHHHHhc
Q psy5368 276 QKDPMRRISYEDLFS 290 (406)
Q Consensus 276 ~~dP~~Rps~~ell~ 290 (406)
+.+|++||++.++++
T Consensus 248 ~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 248 QQDRARRPRFVDIVN 262 (268)
T ss_pred CCCcccCcCHHHHHH
Confidence 999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=290.77 Aligned_cols=237 Identities=27% Similarity=0.419 Sum_probs=193.5
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
..||+|++|.||++... +..+++|.+...... ....+.+|+.++++++|+|+++ .....++|+||+++ +
T Consensus 5 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~ 83 (283)
T cd05118 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-D 83 (283)
T ss_pred eeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-C
Confidence 46899999999999863 456778876654332 3557889999999999999755 66789999999976 8
Q ss_pred HHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCC
Q psy5368 127 LCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPL 203 (406)
Q Consensus 127 L~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~ 203 (406)
|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+||+++ ++.++|+|||.+....... ......++..
T Consensus 84 l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 163 (283)
T cd05118 84 LYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW 163 (283)
T ss_pred HHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccCccc
Confidence 98888664 5899999999999999999999999999999999999999 6799999999997765443 2334567889
Q ss_pred CCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC------------------C------
Q psy5368 204 YMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPIT------------------I------ 258 (406)
Q Consensus 204 y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~------------------~------ 258 (406)
|+|||.+.+. .++.++|+||+|+++|+|+||+.||...+..+....+....... .
T Consensus 164 ~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (283)
T cd05118 164 YRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGM 243 (283)
T ss_pred ccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhcccccc
Confidence 9999999876 78999999999999999999999998877554433332211000 0
Q ss_pred ----CCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 259 ----PPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 259 ----~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
....++.++.++|.+||+.||.+||++.++++||||
T Consensus 244 ~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 244 PLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred CHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 011367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=285.03 Aligned_cols=247 Identities=24% Similarity=0.389 Sum_probs=193.5
Q ss_pred ceeeecceeeeEEEeeeeee------ceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCcc-------cCCeEEEEE
Q psy5368 55 STIRYGELQYDTVQNSQIRL------GTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRK-------RPRYVYIIL 119 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~------~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~-------~~~~~~lV~ 119 (406)
....||+|.||.||++.-.+ +..|+|+++.+.. .-.....||+.+++.|+|||++. .+..+++++
T Consensus 28 ~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~f 107 (438)
T KOG0666|consen 28 GIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLF 107 (438)
T ss_pred ccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEe
Confidence 34568999999999995422 2457787765432 12346789999999999999765 588999999
Q ss_pred eccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-C----CeeEEEeccccccc
Q psy5368 120 EYCDGGDLCSFIRSH-----EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-N----NTLKLADFGFAQFL 189 (406)
Q Consensus 120 E~~~ggsL~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~----~~~kL~DFGla~~~ 189 (406)
||.+. ||...|+-+ ..++..+++.|+.||+.|+.|||++-|+||||||.|||+. + |.+||+|||+++.+
T Consensus 108 dYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~ 186 (438)
T KOG0666|consen 108 DYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLF 186 (438)
T ss_pred hhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHh
Confidence 99988 999999644 3599999999999999999999999999999999999997 4 79999999999876
Q ss_pred CCCC----CCCcccCCCCCCChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHHhcCC
Q psy5368 190 APND----QGDSIQGSPLYMAPEILAGSP-YNAKADLWSLGVLVFEALFGHAPYASCNL---------SQLRAQALSSAP 255 (406)
Q Consensus 190 ~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~---------~~~~~~~~~~~~ 255 (406)
.+.- .....+-|.+|+|||.+.+.. |+++.||||+|||+.||||-.+.|.+... .+...+|.....
T Consensus 187 ~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG 266 (438)
T KOG0666|consen 187 NNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLG 266 (438)
T ss_pred hccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcC
Confidence 5432 345567799999999999854 99999999999999999999988866421 111122221100
Q ss_pred C----C------CCC-------------------------CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy5368 256 I----T------IPP-------------------------NSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAP 300 (406)
Q Consensus 256 ~----~------~~~-------------------------~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 300 (406)
. . .|. ..-++...+|+.++|++||.+|+|++++++|+||+....|
T Consensus 267 ~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~lp 346 (438)
T KOG0666|consen 267 TPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPLP 346 (438)
T ss_pred CCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCCCC
Confidence 0 0 000 0124558999999999999999999999999999988776
Q ss_pred Cc
Q psy5368 301 CA 302 (406)
Q Consensus 301 ~~ 302 (406)
+.
T Consensus 347 p~ 348 (438)
T KOG0666|consen 347 PL 348 (438)
T ss_pred CC
Confidence 43
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=294.54 Aligned_cols=238 Identities=22% Similarity=0.369 Sum_probs=183.8
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCccc--------------CCeEEE
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRKR--------------PRYVYI 117 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~~--------------~~~~~l 117 (406)
...||+|+||.||++... +..+++|.+...... ....+.+|+.++++++|||+++. ....|+
T Consensus 17 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l 96 (310)
T cd07865 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYL 96 (310)
T ss_pred EEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEE
Confidence 355778888888888753 456777766543222 23356789999999999997662 235699
Q ss_pred EEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC-
Q psy5368 118 ILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ- 194 (406)
Q Consensus 118 V~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~- 194 (406)
||||+.+ +|.+.+.... .+++.++..++.||+.||.|||++|++|+||||+||+++ ++.+||+|||++........
T Consensus 97 v~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 175 (310)
T cd07865 97 VFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNS 175 (310)
T ss_pred EEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCccc
Confidence 9999965 8988886653 799999999999999999999999999999999999999 67999999999976543322
Q ss_pred ----CCcccCCCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC---CC----------
Q psy5368 195 ----GDSIQGSPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSA---PI---------- 256 (406)
Q Consensus 195 ----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~---~~---------- 256 (406)
.....++..|+|||.+.+. .++.++||||+|+++|+|++|..||.+.+.......+.... +.
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (310)
T cd07865 176 KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLE 255 (310)
T ss_pred CCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchh
Confidence 1234578889999998765 37889999999999999999999998876544333222210 00
Q ss_pred -----CCC------------CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 257 -----TIP------------PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 257 -----~~~------------~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
..+ +...++.+.+||.+||..||.+|||++++++||||
T Consensus 256 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 256 LFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 000 11235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=290.09 Aligned_cols=237 Identities=28% Similarity=0.506 Sum_probs=198.3
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhhcccCC-CCCCcc------cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAGLSNLR-APEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~-h~ni~~------~~~~~~lV~E~~~ 123 (406)
...||+|++|.||++... +..+++|.+..... .....+.+|+.++.+++ |||+++ ..+..++|||+++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd05581 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP 85 (280)
T ss_pred eeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCC
Confidence 346799999999999863 45677776654322 22456888999999998 999765 6778999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC--------
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ-------- 194 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~-------- 194 (406)
+++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||++........
T Consensus 86 ~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 165 (280)
T cd05581 86 NGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDA 165 (280)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCC
Confidence 999999999888999999999999999999999999999999999999999 67999999999876543321
Q ss_pred -------------CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q psy5368 195 -------------GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPN 261 (406)
Q Consensus 195 -------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (406)
.....++..|+|||.+.+..++.++|+||+|++++++++|..||...+.......+... .... +.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~-~~ 243 (280)
T cd05581 166 TNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL-EYSF-PP 243 (280)
T ss_pred ccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc-CCCC-CC
Confidence 12345788999999999888999999999999999999999999987765555554432 2223 33
Q ss_pred CCChHHHHHHHHhcccCCCCCCCH----HHHhcCCCC
Q psy5368 262 SLSPDCMDFLSRLLQKDPMRRISY----EDLFSHPYP 294 (406)
Q Consensus 262 ~~s~~l~~li~~~L~~dP~~Rps~----~ell~hp~~ 294 (406)
.+++.+.+|+.+||+.+|.+|||+ +++++||||
T Consensus 244 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 244 NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 679999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=292.33 Aligned_cols=232 Identities=19% Similarity=0.289 Sum_probs=180.5
Q ss_pred eeecceeeeEEEeeee------eeceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc--------cCCeEEEEEec
Q psy5368 57 IRYGELQYDTVQNSQI------RLGTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK--------RPRYVYIILEY 121 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~------~~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~--------~~~~~~lV~E~ 121 (406)
..||+|+||+||.+.. ....+++|....... .....+.+|+.++++++|||+++ ....+|+||||
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (283)
T cd05080 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEY 89 (283)
T ss_pred eecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecC
Confidence 4578888888866542 234577776654432 23567889999999999999766 23468999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC----CC
Q psy5368 122 CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ----GD 196 (406)
Q Consensus 122 ~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~----~~ 196 (406)
+++++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++ ++.++|+|||++........ ..
T Consensus 90 ~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 168 (283)
T cd05080 90 VPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 168 (283)
T ss_pred CCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCC
Confidence 9999999999764 699999999999999999999999999999999999998 66899999999976643322 12
Q ss_pred cccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--H-------------HHHHHHhcCCCCCCCC
Q psy5368 197 SIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLS--Q-------------LRAQALSSAPITIPPN 261 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~--~-------------~~~~~~~~~~~~~~~~ 261 (406)
...++..|+|||.+.+..++.++||||||+++|+|+||..||...... + ............. +.
T Consensus 169 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 247 (283)
T cd05080 169 DGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPC-PK 247 (283)
T ss_pred CCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCC-CC
Confidence 233566799999999888999999999999999999999998653211 0 1111111111111 33
Q ss_pred CCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 262 SLSPDCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 262 ~~s~~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
.++.++.+++.+||+.+|++|||++++++
T Consensus 248 ~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 248 NCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred CCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 67899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=290.26 Aligned_cols=232 Identities=23% Similarity=0.375 Sum_probs=190.4
Q ss_pred eecceeeeEEEeeeeee--------ceeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEecc
Q psy5368 58 RYGELQYDTVQNSQIRL--------GTVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYC 122 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~--------~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~ 122 (406)
.+|+|+||.||++.... ..+++|.+.... ......+.+|+.+++.++|||+++ .....++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999998743 346667654432 234567899999999999999765 566789999999
Q ss_pred CCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC-----eeEEEeccccccc
Q psy5368 123 DGGDLCSFIRSH-------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN-----TLKLADFGFAQFL 189 (406)
Q Consensus 123 ~ggsL~~~l~~~-------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~-----~~kL~DFGla~~~ 189 (406)
++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||||+||+++ ++ .++|+|||++...
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~ 161 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI 161 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccccc
Confidence 999999999642 2478899999999999999999999999999999999998 34 6999999998765
Q ss_pred CCCCC---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCh
Q psy5368 190 APNDQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSP 265 (406)
Q Consensus 190 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~ 265 (406)
..... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+........+ ..+|.
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 240 (269)
T cd05044 162 YKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKP-ENCPD 240 (269)
T ss_pred ccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCc-ccchH
Confidence 43221 122345678999999999999999999999999999998 99999887777666665544333333 36889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 266 DCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 266 ~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
.+.+++.+||..+|.+||+++++++
T Consensus 241 ~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 241 KIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=324.47 Aligned_cols=234 Identities=25% Similarity=0.340 Sum_probs=185.8
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc---chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT---SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
..+||+|+||.||++... +..+++|++...... ...++.+|+.++++++|||+++ ..+..|+||||++|
T Consensus 7 i~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eG 86 (932)
T PRK13184 7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEG 86 (932)
T ss_pred EEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCC
Confidence 356788888889988763 456888877643322 2457899999999999999875 66788999999999
Q ss_pred CCHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC
Q psy5368 125 GDLCSFIRSH-----------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN 192 (406)
Q Consensus 125 gsL~~~l~~~-----------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~ 192 (406)
++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++ ++.++|+|||+++.....
T Consensus 87 GSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~ 166 (932)
T PRK13184 87 YTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLE 166 (932)
T ss_pred CCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceecccc
Confidence 9999998641 2356778899999999999999999999999999999998 679999999999765211
Q ss_pred C-------------------CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q psy5368 193 D-------------------QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSS 253 (406)
Q Consensus 193 ~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 253 (406)
. ......||+.|+|||++.+..++.++||||+||++|||+||..||...............
T Consensus 167 ~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~ 246 (932)
T PRK13184 167 EEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVIL 246 (932)
T ss_pred cccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhcc
Confidence 0 112346899999999999999999999999999999999999999876654443332222
Q ss_pred CCCCC-CCCCCChHHHHHHHHhcccCCCCCCCHHHHh
Q psy5368 254 APITI-PPNSLSPDCMDFLSRLLQKDPMRRISYEDLF 289 (406)
Q Consensus 254 ~~~~~-~~~~~s~~l~~li~~~L~~dP~~Rps~~ell 289 (406)
.+... +...+|+.+.+++.+||..||++||+..+.+
T Consensus 247 ~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL 283 (932)
T PRK13184 247 SPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283 (932)
T ss_pred ChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 22222 2236889999999999999999998765544
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=290.53 Aligned_cols=238 Identities=30% Similarity=0.439 Sum_probs=191.8
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...||+|++|.||++... +..+++|.+...... ....+.+|+.++++++|+|+++ ..+..++||||+++ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~ 83 (284)
T cd07836 5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-D 83 (284)
T ss_pred eeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-c
Confidence 467899999999999874 456788877655432 3456788999999999999765 56778999999986 9
Q ss_pred HHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCC
Q psy5368 127 LCSFIRSHE---KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGS 201 (406)
Q Consensus 127 L~~~l~~~~---~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt 201 (406)
|.+++.... .+++..+..++.|++.||+|||+.|++|+||||+||+++ ++.++|+|||++....... ......++
T Consensus 84 l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 163 (284)
T cd07836 84 LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVT 163 (284)
T ss_pred HHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccccccccc
Confidence 999886543 589999999999999999999999999999999999998 6799999999997654322 22344578
Q ss_pred CCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-----------------CCCC----
Q psy5368 202 PLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP-----------------ITIP---- 259 (406)
Q Consensus 202 ~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-----------------~~~~---- 259 (406)
+.|+|||.+.+. .++.++|+||+||++|+|++|+.||.+.+..+....+..... ...+
T Consensus 164 ~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd07836 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPP 243 (284)
T ss_pred ccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCCh
Confidence 899999998664 478899999999999999999999988776554444332110 0000
Q ss_pred ------CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 260 ------PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 260 ------~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
...++..+.+++.+||+.||.+||++.++++||||
T Consensus 244 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 244 QDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred HHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 01357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=301.16 Aligned_cols=235 Identities=22% Similarity=0.394 Sum_probs=186.2
Q ss_pred eeeecceeeeEEEeeee-------eeceeEEeeeecCCcc-chhhhhhHHhhcccC-CCCCCcc-------cCCeEEEEE
Q psy5368 56 TIRYGELQYDTVQNSQI-------RLGTVKYSQVRYDTIT-SHSEFERPRAGLSNL-RAPEGRK-------RPRYVYIIL 119 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~-------~~~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l-~h~ni~~-------~~~~~~lV~ 119 (406)
...||+|+||.||++.. ..+.+++|.+...... ....+.+|+.++.++ +|||+++ ....+++||
T Consensus 12 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ 91 (343)
T cd05103 12 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 91 (343)
T ss_pred cccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEE
Confidence 45689999999999863 2356888877654322 245688999999999 6799765 345678999
Q ss_pred eccCCCCHHHHHHhC-----------------------------------------------------------------
Q psy5368 120 EYCDGGDLCSFIRSH----------------------------------------------------------------- 134 (406)
Q Consensus 120 E~~~ggsL~~~l~~~----------------------------------------------------------------- 134 (406)
|||++|+|.+++...
T Consensus 92 ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (343)
T cd05103 92 EFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDL 171 (343)
T ss_pred eccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhh
Confidence 999999999998643
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC---CCcccCCCCCCChh
Q psy5368 135 --EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ---GDSIQGSPLYMAPE 208 (406)
Q Consensus 135 --~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~---~~~~~gt~~y~aPE 208 (406)
..+++..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++........ .....+++.|+|||
T Consensus 172 ~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 251 (343)
T cd05103 172 YKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 251 (343)
T ss_pred hhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcH
Confidence 1367888899999999999999999999999999999998 77999999999876532211 12234567799999
Q ss_pred hhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCCHH
Q psy5368 209 ILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQ-LRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYE 286 (406)
Q Consensus 209 ~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ 286 (406)
.+.+..++.++||||||+++|+|++ |..||....... ....+........ +...++++.+++.+||+.||++|||+.
T Consensus 252 ~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~cl~~~p~~Rps~~ 330 (343)
T cd05103 252 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFS 330 (343)
T ss_pred HhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCC-CCCCCHHHHHHHHHHccCChhhCcCHH
Confidence 9999899999999999999999997 999998765433 3333333333333 335788999999999999999999999
Q ss_pred HHhcC
Q psy5368 287 DLFSH 291 (406)
Q Consensus 287 ell~h 291 (406)
++++|
T Consensus 331 eil~~ 335 (343)
T cd05103 331 ELVEH 335 (343)
T ss_pred HHHHH
Confidence 99986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=295.88 Aligned_cols=239 Identities=25% Similarity=0.405 Sum_probs=198.7
Q ss_pred ceeeecceeeeEEEeeeee--eceeEEeeeecCCcc---chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccC
Q psy5368 55 STIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT---SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ 123 (406)
....||+|+||.||++... +..+++|.+...... ....+.+|+.++++++|||++. .....|+||||++
T Consensus 29 ~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 108 (317)
T cd06635 29 DLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL 108 (317)
T ss_pred hhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC
Confidence 4567899999999999863 456788877644322 2346888999999999999765 5567899999997
Q ss_pred CCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCC
Q psy5368 124 GGDLCSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGS 201 (406)
Q Consensus 124 ggsL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt 201 (406)
| +|.+.+.. ..++++..+..++.|++.||.|||++|++|+||+|+||+++ ++.++|+|||++..... .....++
T Consensus 109 g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~ 184 (317)
T cd06635 109 G-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---ANSFVGT 184 (317)
T ss_pred C-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---cccccCC
Confidence 5 88887754 45799999999999999999999999999999999999998 67999999999865432 3345688
Q ss_pred CCCCChhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccC
Q psy5368 202 PLYMAPEILA---GSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKD 278 (406)
Q Consensus 202 ~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~d 278 (406)
+.|+|||++. .+.++.++|+||+||++|+|++|..||...+.......+........+...+++.+.+++.+||+.+
T Consensus 185 ~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 264 (317)
T cd06635 185 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKI 264 (317)
T ss_pred ccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccCC
Confidence 9999999984 3568899999999999999999999998877766666666655555555578899999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCC
Q psy5368 279 PMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 279 P~~Rps~~ell~hp~~~~~ 297 (406)
|.+||++.++++|+|+...
T Consensus 265 p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 265 PQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred cccCcCHHHHHhChhhhcc
Confidence 9999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=286.64 Aligned_cols=233 Identities=23% Similarity=0.364 Sum_probs=191.0
Q ss_pred eeeecceeeeEEEeeeeee-ceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCCCCHHH
Q psy5368 56 TIRYGELQYDTVQNSQIRL-GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDGGDLCS 129 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ggsL~~ 129 (406)
.+.+|+|+||.||++.... ..+++|..... ......+.+|+.+++.++|+|+++ .....++||||+++++|.+
T Consensus 11 ~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~~~~L~~ 89 (260)
T cd05073 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLD 89 (260)
T ss_pred EeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCCCCcHHH
Confidence 5678899999999887543 44666655533 233567899999999999999766 3366899999999999999
Q ss_pred HHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC--CCcccCCCCC
Q psy5368 130 FIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ--GDSIQGSPLY 204 (406)
Q Consensus 130 ~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~--~~~~~gt~~y 204 (406)
++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++ ++.++|+|||++........ .....++..|
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y 169 (260)
T cd05073 90 FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW 169 (260)
T ss_pred HHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccc
Confidence 99764 3588899999999999999999999999999999999999 66999999999876543221 1223355679
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
+|||++....++.++|+|||||++|+++| |..||.+.+.......+........+ ...+.++.+++.+||+.+|++||
T Consensus 170 ~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~Rp 248 (260)
T cd05073 170 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP-ENCPEELYNIMMRCWKNRPEERP 248 (260)
T ss_pred cCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCc-ccCCHHHHHHHHHHcccCcccCc
Confidence 99999998889999999999999999999 99999988877777666655443333 36889999999999999999999
Q ss_pred CHHHHhc
Q psy5368 284 SYEDLFS 290 (406)
Q Consensus 284 s~~ell~ 290 (406)
++.++++
T Consensus 249 ~~~~l~~ 255 (260)
T cd05073 249 TFEYIQS 255 (260)
T ss_pred CHHHHHH
Confidence 9998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=320.53 Aligned_cols=207 Identities=23% Similarity=0.299 Sum_probs=161.6
Q ss_pred hhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHH
Q psy5368 90 HSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLCSFIRSH-----EKLSEFQCQQFVRQLVLALKFLRE 158 (406)
Q Consensus 90 ~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~lH~ 158 (406)
...+.+|+.++.+++|||++. ..+..|+|+|++.+ +|.+++... .......++.++.||+.||+|||+
T Consensus 207 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~ 285 (501)
T PHA03210 207 AIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD 285 (501)
T ss_pred HHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence 446889999999999999876 56778999999954 888887543 234466788899999999999999
Q ss_pred CCcccccCCCcceEee-CCeeEEEecccccccCCCCC--CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCC
Q psy5368 159 NNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ--GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGH 235 (406)
Q Consensus 159 ~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~ 235 (406)
+||+||||||+|||++ ++.+||+|||+++.+..... .....||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 286 ~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~ 365 (501)
T PHA03210 286 KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHD 365 (501)
T ss_pred CCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 9999999999999998 77999999999987654332 23457999999999999999999999999999999999987
Q ss_pred CC-CCCCC--HHHHHHHHHhcCC---CCC---------------------------CCCCCChHHHHHHHHhcccCCCCC
Q psy5368 236 AP-YASCN--LSQLRAQALSSAP---ITI---------------------------PPNSLSPDCMDFLSRLLQKDPMRR 282 (406)
Q Consensus 236 ~p-f~~~~--~~~~~~~~~~~~~---~~~---------------------------~~~~~s~~l~~li~~~L~~dP~~R 282 (406)
.+ |.... ......++..... ..+ ....++.++.+++.+||+.||.+|
T Consensus 366 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~R 445 (501)
T PHA03210 366 FCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLR 445 (501)
T ss_pred CCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccC
Confidence 54 43221 1111111111000 000 011356778889999999999999
Q ss_pred CCHHHHhcCCCCCCC
Q psy5368 283 ISYEDLFSHPYPDLI 297 (406)
Q Consensus 283 ps~~ell~hp~~~~~ 297 (406)
||+.|+|+||||...
T Consensus 446 psa~elL~hp~f~~~ 460 (501)
T PHA03210 446 PGAAELLALPLFSAE 460 (501)
T ss_pred cCHHHHhhChhhhcC
Confidence 999999999999754
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=288.83 Aligned_cols=234 Identities=21% Similarity=0.368 Sum_probs=192.2
Q ss_pred eeeecceeeeEEEeeeee-----eceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIR-----LGTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~-----~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ 123 (406)
...||+|+||.||++... ...+++|.+..... .....+.+|+.++..++|||+++ ..+..|+||||++
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (267)
T cd05066 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYME 88 (267)
T ss_pred eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCC
Confidence 457899999999999863 12467776654322 23457899999999999999876 5677899999999
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC----Cc
Q psy5368 124 GGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG----DS 197 (406)
Q Consensus 124 ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~----~~ 197 (406)
+++|.+++... +.+++.++..++.|++.||.|||++|++|+||||+||+++ ++.++|+|||++......... ..
T Consensus 89 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 168 (267)
T cd05066 89 NGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRG 168 (267)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCC
Confidence 99999999765 4689999999999999999999999999999999999998 679999999999876543221 11
Q ss_pred ccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcc
Q psy5368 198 IQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQ 276 (406)
Q Consensus 198 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~ 276 (406)
..++..|+|||.+.+..++.++|+|||||++|++++ |..||...+..+....+........ +..+++.+.+++.+||+
T Consensus 169 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~ 247 (267)
T cd05066 169 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPA-PMDCPAALHQLMLDCWQ 247 (267)
T ss_pred CccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCC-CCCCCHHHHHHHHHHcc
Confidence 223467999999998889999999999999999886 9999998877777666665533322 23688999999999999
Q ss_pred cCCCCCCCHHHHhc
Q psy5368 277 KDPMRRISYEDLFS 290 (406)
Q Consensus 277 ~dP~~Rps~~ell~ 290 (406)
.+|.+||++.++++
T Consensus 248 ~~p~~Rp~~~~i~~ 261 (267)
T cd05066 248 KDRNERPKFEQIVS 261 (267)
T ss_pred cCchhCCCHHHHHH
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=290.05 Aligned_cols=234 Identities=21% Similarity=0.293 Sum_probs=193.3
Q ss_pred eeeecceeeeEEEeeeeee------ceeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc-------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIRL------GTVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK-------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~------~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~-------~~~~~~lV~E~ 121 (406)
...||+|+||.||+|.... ..+++|.+.... ......+.+|+.+++.++|||+++ .....++++||
T Consensus 11 ~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~ 90 (280)
T cd05043 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPY 90 (280)
T ss_pred eeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEc
Confidence 4678999999999999754 456666654332 222456889999999999999766 34678899999
Q ss_pred cCCCCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC
Q psy5368 122 CDGGDLCSFIRSH--------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN 192 (406)
Q Consensus 122 ~~ggsL~~~l~~~--------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~ 192 (406)
+++++|.+++... ..+++..+..++.|++.||+|||++|++|+||||+||+++ ++.+||+|||+++.+...
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~ 170 (280)
T cd05043 91 MNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPM 170 (280)
T ss_pred CCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccCC
Confidence 9999999999653 3589999999999999999999999999999999999998 679999999999765433
Q ss_pred CC---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHH
Q psy5368 193 DQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCM 268 (406)
Q Consensus 193 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~ 268 (406)
.. .....++..|+|||++.+..++.++|||||||++|++++ |+.||...+..++...+........+ ..+++++.
T Consensus 171 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 249 (280)
T cd05043 171 DYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQP-INCPDELF 249 (280)
T ss_pred ceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCC-CcCCHHHH
Confidence 21 122345677999999998889999999999999999999 99999988877776666655443333 35789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q psy5368 269 DFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 269 ~li~~~L~~dP~~Rps~~ell~ 290 (406)
+++.+||..||++|||+.++++
T Consensus 250 ~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 250 AVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred HHHHHHcCCChhhCCCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=293.69 Aligned_cols=216 Identities=25% Similarity=0.360 Sum_probs=175.5
Q ss_pred ceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHHHHHHhCC-----------C
Q psy5368 75 GTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLCSFIRSHE-----------K 136 (406)
Q Consensus 75 ~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~~~l~~~~-----------~ 136 (406)
..+++|.+..... .....+.+|++++.+++|||+++ ..+..++|||++++++|.+++.... .
T Consensus 47 ~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 126 (296)
T cd05051 47 VLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKS 126 (296)
T ss_pred eeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCC
Confidence 3467776654432 23557889999999999999765 5578899999999999999997765 6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC---CCCcccCCCCCCChhhhcC
Q psy5368 137 LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND---QGDSIQGSPLYMAPEILAG 212 (406)
Q Consensus 137 l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~ 212 (406)
+++..+..++.|++.||.|||+.|++|+||||+||+++ ++.++|+|||++....... ......+++.|+|||++.+
T Consensus 127 ~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 206 (296)
T cd05051 127 LSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL 206 (296)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc
Confidence 89999999999999999999999999999999999998 6699999999987654332 1233446778999999998
Q ss_pred CCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHhc-----CCC-CCCCCCCChHHHHHHHHhcccCCCCCCC
Q psy5368 213 SPYNAKADLWSLGVLVFEALF--GHAPYASCNLSQLRAQALSS-----API-TIPPNSLSPDCMDFLSRLLQKDPMRRIS 284 (406)
Q Consensus 213 ~~~~~~~DiwSlG~il~ellt--g~~pf~~~~~~~~~~~~~~~-----~~~-~~~~~~~s~~l~~li~~~L~~dP~~Rps 284 (406)
..++.++|||||||++|+|++ +..||...+........... ... ...+..+|.++.+++.+||+.||.+|||
T Consensus 207 ~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt 286 (296)
T cd05051 207 GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPT 286 (296)
T ss_pred CCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCC
Confidence 889999999999999999998 78899877666655544432 111 1112357899999999999999999999
Q ss_pred HHHHhc
Q psy5368 285 YEDLFS 290 (406)
Q Consensus 285 ~~ell~ 290 (406)
+.++++
T Consensus 287 ~~el~~ 292 (296)
T cd05051 287 FREIHL 292 (296)
T ss_pred HHHHHH
Confidence 999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=284.35 Aligned_cols=234 Identities=22% Similarity=0.375 Sum_probs=194.1
Q ss_pred eeeecceeeeEEEeeeee-eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHH
Q psy5368 56 TIRYGELQYDTVQNSQIR-LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLC 128 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~-~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~ 128 (406)
...||+|+||.||++... ...+++|.+... ......+.+|+++++.++|||+++ .....|+||||+++++|.
T Consensus 9 ~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 87 (256)
T cd05112 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLS 87 (256)
T ss_pred EeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHH
Confidence 357899999999999875 456777766533 234567999999999999999765 556789999999999999
Q ss_pred HHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC--CCcccCCCCC
Q psy5368 129 SFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ--GDSIQGSPLY 204 (406)
Q Consensus 129 ~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~--~~~~~gt~~y 204 (406)
+++... +.+++..+..++.|++.||+|||+.|++|+||||+||+++ ++.++|+|||++........ .....++..|
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~ 167 (256)
T cd05112 88 DYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKW 167 (256)
T ss_pred HHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhh
Confidence 999764 4689999999999999999999999999999999999998 66899999999876543221 1122345689
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
+|||.+.+..++.++|+||+|+++|+|++ |..||...........+....... .+...+..+.+|+.+||+.+|++||
T Consensus 168 ~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~l~~~p~~Rp 246 (256)
T cd05112 168 SSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLY-KPRLASQSVYELMQHCWKERPEDRP 246 (256)
T ss_pred cCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCC-CCCCCCHHHHHHHHHHcccChhhCC
Confidence 99999998889999999999999999998 999999888777777665543332 2335789999999999999999999
Q ss_pred CHHHHhcC
Q psy5368 284 SYEDLFSH 291 (406)
Q Consensus 284 s~~ell~h 291 (406)
|+.+++++
T Consensus 247 ~~~~~l~~ 254 (256)
T cd05112 247 SFSLLLHQ 254 (256)
T ss_pred CHHHHHHh
Confidence 99999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=289.56 Aligned_cols=232 Identities=22% Similarity=0.345 Sum_probs=182.1
Q ss_pred eecceeeeEEEeeeeee----ceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 58 RYGELQYDTVQNSQIRL----GTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~----~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
.||+|+||.||++.... ..+++|....... .....+.+|+.+++.++|||+++ .....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998643 3467776654432 23347889999999999999766 5566899999999999
Q ss_pred HHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC---CCc
Q psy5368 127 LCSFIRSHE-----KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ---GDS 197 (406)
Q Consensus 127 L~~~l~~~~-----~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~---~~~ 197 (406)
|.+++.... ..++..+..++.|++.||+|||++|++|+||||+||+++ ++.++|+|||++........ ...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 161 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQ 161 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCC
Confidence 999996532 467788889999999999999999999999999999999 66999999999865433221 223
Q ss_pred ccCCCCCCChhhhcCC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCC----CCCCh
Q psy5368 198 IQGSPLYMAPEILAGS-------PYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPP----NSLSP 265 (406)
Q Consensus 198 ~~gt~~y~aPE~~~~~-------~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~----~~~s~ 265 (406)
..+++.|+|||++.+. .++.++||||||+++|||++ |..||......+.............+. ...++
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (269)
T cd05087 162 LWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSD 241 (269)
T ss_pred cCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCCh
Confidence 4567889999998642 35789999999999999996 999998876665544433332222222 24678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 266 DCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 266 ~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
.+.+++.+|+ .+|++|||+++++.
T Consensus 242 ~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 242 RWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred HHHHHHHHHh-cCcccCCCHHHHHH
Confidence 8999999999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=288.79 Aligned_cols=238 Identities=23% Similarity=0.384 Sum_probs=191.9
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc-cchhhhhhHHhhcccCC-CCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI-TSHSEFERPRAGLSNLR-APEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~-h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...||.|++|.||+|... +..+++|+...... .......+|+..+.+++ |+|++. ..+..|+||||+ ++
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 82 (283)
T cd07830 4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EG 82 (283)
T ss_pred heeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CC
Confidence 356899999999999974 35677887654432 22334567999999999 999655 678899999999 77
Q ss_pred CHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCC
Q psy5368 126 DLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSP 202 (406)
Q Consensus 126 sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~ 202 (406)
+|.+++.... .+++..+..++.|++.+|.|||++|++|+||+|+||+++ ++.++|+|||++.............++.
T Consensus 83 ~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 162 (283)
T cd07830 83 NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR 162 (283)
T ss_pred CHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCCCcc
Confidence 9999997764 789999999999999999999999999999999999999 6799999999998776555555567899
Q ss_pred CCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC------------------CCC----
Q psy5368 203 LYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI------------------TIP---- 259 (406)
Q Consensus 203 ~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------------------~~~---- 259 (406)
.|+|||++.+ ..++.++|+||||+++++|++|++||...+..+....+...... ..+
T Consensus 163 ~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T cd07830 163 WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAP 242 (283)
T ss_pred cccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccccccc
Confidence 9999998854 45789999999999999999999999877654443332211000 000
Q ss_pred ------CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 260 ------PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 260 ------~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
....+.++.+++.+||+.+|++|||++|++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 243 TSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 01236789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=291.26 Aligned_cols=234 Identities=21% Similarity=0.356 Sum_probs=191.6
Q ss_pred eeeecceeeeEEEeeeee-------eceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIR-------LGTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~-------~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~ 121 (406)
...||+|+||.||++... .+.+++|.+..... .....+.+|+.++..++|||+++ .....|+||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (288)
T cd05050 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEY 89 (288)
T ss_pred cccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEec
Confidence 346799999999998753 34677776654432 22456889999999999999765 55678999999
Q ss_pred cCCCCHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCee
Q psy5368 122 CDGGDLCSFIRSHE----------------------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTL 178 (406)
Q Consensus 122 ~~ggsL~~~l~~~~----------------------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~ 178 (406)
+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++ ++.+
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~ 169 (288)
T cd05050 90 MAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVV 169 (288)
T ss_pred CCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCce
Confidence 99999999997532 378889999999999999999999999999999999998 7799
Q ss_pred EEEecccccccCCCCC---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcC
Q psy5368 179 KLADFGFAQFLAPNDQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSA 254 (406)
Q Consensus 179 kL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 254 (406)
+|+|||++........ ......+..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 170 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~ 249 (288)
T cd05050 170 KIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGN 249 (288)
T ss_pred EECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC
Confidence 9999999876533221 122334667999999998899999999999999999997 889998888877777766554
Q ss_pred CCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 255 PITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 255 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
....+ ..++.++.+|+.+||+.+|.+|||+.|+++
T Consensus 250 ~~~~~-~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 250 VLSCP-DNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCCCC-CCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 44333 368899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=280.54 Aligned_cols=249 Identities=21% Similarity=0.335 Sum_probs=198.2
Q ss_pred eeeecceeeeEEEeeeeee--ceeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCcc--------------cCCeEEE
Q psy5368 56 TIRYGELQYDTVQNSQIRL--GTVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRK--------------RPRYVYI 117 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~--------------~~~~~~l 117 (406)
-.++|+|.||.|++++.++ +.|++|++..+. ..-.....+|+++|..|+|+|++. +...+|+
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 4578999999999998644 457777654422 122345789999999999998644 5556999
Q ss_pred EEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC
Q psy5368 118 ILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG 195 (406)
Q Consensus 118 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~ 195 (406)
||.+|+. +|..++.+. .+++..++.+++.+++.||.|+|...|+|||+||.|+|++ ++.+||+|||+++.++.+...
T Consensus 102 Vf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~ 180 (376)
T KOG0669|consen 102 VFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNV 180 (376)
T ss_pred eHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceeccccc
Confidence 9999987 999999766 5899999999999999999999999999999999999999 789999999999776544321
Q ss_pred -----CcccCCCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC----C----------
Q psy5368 196 -----DSIQGSPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSA----P---------- 255 (406)
Q Consensus 196 -----~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~----~---------- 255 (406)
...+-|.+|++||.+.+. .|+++.|||..|||+.||+|+.+.+.+.+.......|..-. .
T Consensus 181 ~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lp 260 (376)
T KOG0669|consen 181 VKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLP 260 (376)
T ss_pred CCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccch
Confidence 234469999999999885 59999999999999999999999999887655544443210 0
Q ss_pred -------CCCCCC------------CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCccch
Q psy5368 256 -------ITIPPN------------SLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAESH 305 (406)
Q Consensus 256 -------~~~~~~------------~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~~~~ 305 (406)
.+.+.. .-+++..+|+.++|..||.+|++++++++|.||.....|.+...
T Consensus 261 L~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~pqanl~ 329 (376)
T KOG0669|consen 261 LYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMPQANLQ 329 (376)
T ss_pred HHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcchhhHH
Confidence 001111 11457899999999999999999999999999987776644433
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=289.58 Aligned_cols=238 Identities=27% Similarity=0.450 Sum_probs=193.2
Q ss_pred eeeecceeeeEEEeeeeee--ceeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCcc------cC--CeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIRL--GTVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRK------RP--RYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~------~~--~~~~lV~E~~~ 123 (406)
...+|+|++|.||++.... ..+++|.+.... ......+.+|+.+++.++|+|+++ .. +..++|+||++
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (287)
T cd07840 4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD 83 (287)
T ss_pred eEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc
Confidence 3568999999999998754 668888777653 233456889999999999999655 34 78999999997
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC--CCCccc
Q psy5368 124 GGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND--QGDSIQ 199 (406)
Q Consensus 124 ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~--~~~~~~ 199 (406)
+ +|.+++... ..+++..+..++.||+.||+|||+.|++|+||+|+||+++ ++.++|+|||++....... ......
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 162 (287)
T cd07840 84 H-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRV 162 (287)
T ss_pred c-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccc
Confidence 5 999998765 5799999999999999999999999999999999999999 6799999999998765443 123345
Q ss_pred CCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---------------------
Q psy5368 200 GSPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPIT--------------------- 257 (406)
Q Consensus 200 gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--------------------- 257 (406)
++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+.......
T Consensus 163 ~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (287)
T cd07840 163 ITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKK 242 (287)
T ss_pred cccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccc
Confidence 6888999998765 457899999999999999999999998877655544443321000
Q ss_pred --------CCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 258 --------IPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 258 --------~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
.....+++++.+++.+||..+|.+||++++++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 243 PYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0001138889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=296.93 Aligned_cols=244 Identities=27% Similarity=0.378 Sum_probs=193.1
Q ss_pred eeeecceeeeEEEeeeeee----ceeEEeeeecCC--ccchhhhhhHHhhcccC-CCCCCccc----------CCeEEEE
Q psy5368 56 TIRYGELQYDTVQNSQIRL----GTVKYSQVRYDT--ITSHSEFERPRAGLSNL-RAPEGRKR----------PRYVYII 118 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~----~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l-~h~ni~~~----------~~~~~lV 118 (406)
...||+|+||.||++.... ..+++|.+.... ......+.+|+.++.++ .|||+++. ...+|++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 84 (332)
T cd07857 5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLY 84 (332)
T ss_pred EEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEE
Confidence 4568999999999999753 367888765322 22345678899999999 59997662 2357899
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC----
Q psy5368 119 LEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND---- 193 (406)
Q Consensus 119 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~---- 193 (406)
+||+. ++|.+++.....+++..++.++.||+.||.|||++|++||||||+||+++ ++.++|+|||+++......
T Consensus 85 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~ 163 (332)
T cd07857 85 EELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENA 163 (332)
T ss_pred Eeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccccccc
Confidence 99996 59999998888899999999999999999999999999999999999998 6799999999997654322
Q ss_pred -CCCcccCCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----------------
Q psy5368 194 -QGDSIQGSPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP---------------- 255 (406)
Q Consensus 194 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~---------------- 255 (406)
......||+.|+|||.+.+ ..++.++||||+||++|+|++|.+||...+.......+.....
T Consensus 164 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (332)
T cd07857 164 GFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQ 243 (332)
T ss_pred ccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHH
Confidence 1234568999999998766 4689999999999999999999999987664433332221100
Q ss_pred -----------C--CCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy5368 256 -----------I--TIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAP 300 (406)
Q Consensus 256 -----------~--~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 300 (406)
. .......+..+.+|+.+||+.||.+|||+++++.|||++..+.|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~ 301 (332)
T cd07857 244 NYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDP 301 (332)
T ss_pred HHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCc
Confidence 0 00112457899999999999999999999999999999766544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=293.68 Aligned_cols=240 Identities=24% Similarity=0.393 Sum_probs=197.1
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...+|+|++|.||++... +..+++|....... ....++.+|+.+++.++|+|+++ .....++||||+.
T Consensus 20 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 98 (308)
T cd06634 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL- 98 (308)
T ss_pred HHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-
Confidence 456899999999999863 34677877654322 22346788999999999999765 5667899999997
Q ss_pred CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCC
Q psy5368 125 GDLCSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSP 202 (406)
Q Consensus 125 gsL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~ 202 (406)
|+|.+++.. ..++++..+..++.|++.||.|||++|++|+||+|+||+++ ++.++|+|||++..... .....+++
T Consensus 99 ~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~~ 175 (308)
T cd06634 99 GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANXFVGTP 175 (308)
T ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC---cccccCCc
Confidence 488887754 45699999999999999999999999999999999999998 67999999999876543 23456788
Q ss_pred CCCChhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCC
Q psy5368 203 LYMAPEILA---GSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 203 ~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP 279 (406)
.|+|||.+. ...++.++|||||||++|+|++|..||...+.......+............++..+.+||.+||..+|
T Consensus 176 ~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P 255 (308)
T cd06634 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIP 255 (308)
T ss_pred cccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCc
Confidence 999999985 34578899999999999999999999987766555555555544444455788999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCC
Q psy5368 280 MRRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 280 ~~Rps~~ell~hp~~~~~~~ 299 (406)
.+||+++++++|||+.....
T Consensus 256 ~~Rp~~~~ll~~~~~~~~~~ 275 (308)
T cd06634 256 QDRPTSEVLLKHRFVLRERP 275 (308)
T ss_pred ccCCCHHHHhhCccccccCC
Confidence 99999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=292.28 Aligned_cols=242 Identities=27% Similarity=0.447 Sum_probs=194.1
Q ss_pred eeeecceeeeEEEeeee-----eeceeEEeeeecCCc----cchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEE
Q psy5368 56 TIRYGELQYDTVQNSQI-----RLGTVKYSQVRYDTI----TSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIIL 119 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~-----~~~~v~vk~~~~~~~----~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~ 119 (406)
...||+|+||.||.+.. .+..+++|.+..... .....+.+|+.++..+ +|+|++. .++..|+||
T Consensus 5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (290)
T cd05613 5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL 84 (290)
T ss_pred eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEE
Confidence 45678999999998875 345678887654322 2345678899999999 5888765 556789999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC--CCC
Q psy5368 120 EYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND--QGD 196 (406)
Q Consensus 120 E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~--~~~ 196 (406)
||+++++|.+++....++++..+..++.|++.||.|||+.|++||||+|+||+++ ++.++|+|||++....... ...
T Consensus 85 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 164 (290)
T cd05613 85 DYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAY 164 (290)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccccccc
Confidence 9999999999998888899999999999999999999999999999999999998 7799999999987654322 223
Q ss_pred cccCCCCCCChhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcCCCCCCCCCCChHHHHH
Q psy5368 197 SIQGSPLYMAPEILAGS--PYNAKADLWSLGVLVFEALFGHAPYASCN----LSQLRAQALSSAPITIPPNSLSPDCMDF 270 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~s~~l~~l 270 (406)
...|+..|+|||.+.+. .++.++||||+|+++|+|++|..||.... ...+...+... .... +..+++.+.++
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~l 242 (290)
T cd05613 165 SFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EPPY-PQEMSALAKDI 242 (290)
T ss_pred cccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc-CCCC-CccCCHHHHHH
Confidence 45688999999998763 46789999999999999999999996432 23333332222 2222 33688999999
Q ss_pred HHHhcccCCCCCC-----CHHHHhcCCCCCCCCC
Q psy5368 271 LSRLLQKDPMRRI-----SYEDLFSHPYPDLIHA 299 (406)
Q Consensus 271 i~~~L~~dP~~Rp-----s~~ell~hp~~~~~~~ 299 (406)
+.+||+.||++|| ++++++.||||....+
T Consensus 243 l~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 276 (290)
T cd05613 243 IQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276 (290)
T ss_pred HHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence 9999999999997 8999999999987653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=292.16 Aligned_cols=215 Identities=22% Similarity=0.322 Sum_probs=171.0
Q ss_pred eeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHHHHHHhCC------------C
Q psy5368 76 TVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLCSFIRSHE------------K 136 (406)
Q Consensus 76 ~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~~~l~~~~------------~ 136 (406)
.+++|....... .....+.+|++++.+++|+|+++ ..+..++||||+++++|.+++.... .
T Consensus 46 ~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 125 (295)
T cd05097 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS 125 (295)
T ss_pred EEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCc
Confidence 367776654322 22446899999999999999765 5677899999999999999996532 3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC---CCcccCCCCCCChhhhcC
Q psy5368 137 LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ---GDSIQGSPLYMAPEILAG 212 (406)
Q Consensus 137 l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~ 212 (406)
+++..+..++.|++.||+|||++|++|+||||+||+++ ++.+||+|||++........ .....+++.|+|||.+.+
T Consensus 126 ~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 205 (295)
T cd05097 126 VSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL 205 (295)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc
Confidence 78899999999999999999999999999999999998 56899999999876533221 122345678999999998
Q ss_pred CCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHhc-----C-CCCCCCCCCChHHHHHHHHhcccCCCCCCC
Q psy5368 213 SPYNAKADLWSLGVLVFEALF--GHAPYASCNLSQLRAQALSS-----A-PITIPPNSLSPDCMDFLSRLLQKDPMRRIS 284 (406)
Q Consensus 213 ~~~~~~~DiwSlG~il~ellt--g~~pf~~~~~~~~~~~~~~~-----~-~~~~~~~~~s~~l~~li~~~L~~dP~~Rps 284 (406)
..++.++|+|||||++++|++ |..||...+.......+... . .....+..+|+.+.+|+.+||+.||++|||
T Consensus 206 ~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs 285 (295)
T cd05097 206 GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPT 285 (295)
T ss_pred CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcC
Confidence 889999999999999999998 67888887665554443221 0 011112357899999999999999999999
Q ss_pred HHHHhc
Q psy5368 285 YEDLFS 290 (406)
Q Consensus 285 ~~ell~ 290 (406)
++++++
T Consensus 286 ~~~i~~ 291 (295)
T cd05097 286 FNKIHH 291 (295)
T ss_pred HHHHHH
Confidence 999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=261.46 Aligned_cols=240 Identities=30% Similarity=0.434 Sum_probs=199.6
Q ss_pred eeecceeeeEEEeeeeee--ceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 57 IRYGELQYDTVQNSQIRL--GTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
.+||+|.||+|++++... .-|+.|.++.+... -.....+|+-+|+.|+|.|++. .++.+-+|+|||+. +
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-d 86 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-D 86 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-H
Confidence 468999999999999654 45788877765432 2557899999999999999776 77888999999976 9
Q ss_pred HHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC-CCcccCCCC
Q psy5368 127 LCSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ-GDSIQGSPL 203 (406)
Q Consensus 127 L~~~l~~-~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~-~~~~~gt~~ 203 (406)
|.++... ++.++.+.++.++.|+++||.+||++++.||||||+|+|++ +|.+||+|||+++.++-.-. ....+-|.+
T Consensus 87 lkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysaevvtlw 166 (292)
T KOG0662|consen 87 LKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLW 166 (292)
T ss_pred HHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeeceeeeee
Confidence 9999854 46799999999999999999999999999999999999999 88999999999987764432 234567999
Q ss_pred CCChhhhcCCC-CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCC----CCC-----------------
Q psy5368 204 YMAPEILAGSP-YNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPIT----IPP----------------- 260 (406)
Q Consensus 204 y~aPE~~~~~~-~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~----~~~----------------- 260 (406)
|++|.++.+.. |+...|+||.|||+.|+.. |++.|++.+..+...+|....... .|.
T Consensus 167 yrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypatt 246 (292)
T KOG0662|consen 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATT 246 (292)
T ss_pred ccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccc
Confidence 99999999865 8999999999999999986 999999999888887776432110 110
Q ss_pred ------CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy5368 261 ------NSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 261 ------~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 297 (406)
..++..-++|++++|.-+|.+|++++.+++||||...
T Consensus 247 swsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 247 SWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred hHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 0123446899999999999999999999999999754
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=288.99 Aligned_cols=238 Identities=27% Similarity=0.413 Sum_probs=191.3
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccc--hhhhhhHHhhcccC---CCCCCcc------cCCe-----EEE
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITS--HSEFERPRAGLSNL---RAPEGRK------RPRY-----VYI 117 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~--~~~~~~E~~~l~~l---~h~ni~~------~~~~-----~~l 117 (406)
...+|+|+||.||++... ...+++|.+....... ...+.+|+.++.++ +|+|+++ .... .++
T Consensus 4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l 83 (287)
T cd07838 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL 83 (287)
T ss_pred EEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence 457899999999999975 4678888776433222 33566777766555 6999765 2333 899
Q ss_pred EEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC
Q psy5368 118 ILEYCDGGDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ 194 (406)
Q Consensus 118 V~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~ 194 (406)
+|||+++ +|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||++........
T Consensus 84 ~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~ 162 (287)
T cd07838 84 VFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA 162 (287)
T ss_pred Eehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCCcc
Confidence 9999975 8999987643 599999999999999999999999999999999999999 67999999999987755544
Q ss_pred CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---------------CC
Q psy5368 195 GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPIT---------------IP 259 (406)
Q Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~---------------~~ 259 (406)
.....++..|+|||.+.+..++.++|+||+||++|+|++|.+||.+.+..+....+....... .+
T Consensus 163 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (287)
T cd07838 163 LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFP 242 (287)
T ss_pred cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcc
Confidence 445567889999999999889999999999999999999999999887666555554321100 00
Q ss_pred ----------CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 260 ----------PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 260 ----------~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
...+++.+.+++.+||+.||.+||++++++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 243 SYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred cccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 01346788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=289.98 Aligned_cols=228 Identities=17% Similarity=0.264 Sum_probs=181.6
Q ss_pred eecceeeeEEEeeeeee---------ceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEecc
Q psy5368 58 RYGELQYDTVQNSQIRL---------GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYC 122 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~---------~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~ 122 (406)
.||.|+||.||++.... ..+++|............+.+|+.+++.+.|||++. .....++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 58999999999997632 225555554433334557889999999999999776 556788999999
Q ss_pred CCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC--------eeEEEecccccccCCC
Q psy5368 123 DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN--------TLKLADFGFAQFLAPN 192 (406)
Q Consensus 123 ~ggsL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~--------~~kL~DFGla~~~~~~ 192 (406)
++|+|.+++..++ .+++..+..++.||+.||.|||++||+||||||+||+++ ++ .++++|||++.....
T Consensus 82 ~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~- 160 (258)
T cd05078 82 KFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP- 160 (258)
T ss_pred CCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC-
Confidence 9999999997654 589999999999999999999999999999999999997 33 279999999865432
Q ss_pred CCCCcccCCCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHH
Q psy5368 193 DQGDSIQGSPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFG-HAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDF 270 (406)
Q Consensus 193 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~l 270 (406)
.....+++.|+|||.+.+. .++.++||||+||++|+|++| ..||............ .. ....+. ..+.++.+|
T Consensus 161 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-~~-~~~~~~-~~~~~~~~l 235 (258)
T cd05078 161 --KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-ED-RHQLPA-PKWTELANL 235 (258)
T ss_pred --chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-Hc-cccCCC-CCcHHHHHH
Confidence 2335678899999999874 589999999999999999998 5677665544433222 21 223332 567899999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q psy5368 271 LSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 271 i~~~L~~dP~~Rps~~ell~h 291 (406)
+.+||+.||++|||++++++.
T Consensus 236 i~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 236 INQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHhccChhhCCCHHHHHHh
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=297.74 Aligned_cols=241 Identities=22% Similarity=0.315 Sum_probs=187.5
Q ss_pred eecce--eeeEEEeeee--eeceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 58 RYGEL--QYDTVQNSQI--RLGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 58 ~lG~G--~~g~Vy~~~~--~~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
.||.| +|++||.+.. .++.+++|.+...... ..+.+.+|+.+++.++|||+++ ..+..|+||||++++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 34555 9999999986 4567888876644322 2457889999999999999875 667789999999999
Q ss_pred CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC-------
Q psy5368 126 DLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG------- 195 (406)
Q Consensus 126 sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~------- 195 (406)
+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++ ++.++++||+.+.........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDF 164 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccc
Confidence 999999764 3589999999999999999999999999999999999999 779999999865433221111
Q ss_pred -CcccCCCCCCChhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----------------
Q psy5368 196 -DSIQGSPLYMAPEILAGS--PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI---------------- 256 (406)
Q Consensus 196 -~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---------------- 256 (406)
....++..|+|||++.+. .++.++||||+||++|+|++|..||..................
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (328)
T cd08226 165 PQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMK 244 (328)
T ss_pred cccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhc
Confidence 112345679999999774 4789999999999999999999999876544433332221110
Q ss_pred -----------------------------CCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 257 -----------------------------TIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 257 -----------------------------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
...+..+++.+.+|+.+||+.||++|||++++++||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 245 NSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred cchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 000113567899999999999999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=292.58 Aligned_cols=250 Identities=25% Similarity=0.413 Sum_probs=212.4
Q ss_pred eeeecceeeeEEEeeeeeec--eeEEeeeecCCccchh---hhhhHHhhcccCCCCC-------CcccCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIRLG--TVKYSQVRYDTITSHS---EFERPRAGLSNLRAPE-------GRKRPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~--~v~vk~~~~~~~~~~~---~~~~E~~~l~~l~h~n-------i~~~~~~~~lV~E~~~ 123 (406)
-.+||+|+||.|..++.++. ..|||.++.+.+.... --+.|-++|.....|- .+.+-+.+|.||||+.
T Consensus 354 l~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvn 433 (683)
T KOG0696|consen 354 LMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVN 433 (683)
T ss_pred EEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEec
Confidence 46899999999999987654 3467766655433333 2356777777665553 2447788999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccC-CCCCCCcccCC
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLA-PNDQGDSIQGS 201 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~-~~~~~~~~~gt 201 (406)
||+|--+|++-+.+.+..+..++..|+-||-+||++||++||||.+|||+| +|.+||+|||+++.-- ......+.+||
T Consensus 434 GGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGT 513 (683)
T KOG0696|consen 434 GGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGT 513 (683)
T ss_pred CchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCcceeeecCC
Confidence 999999999999999999999999999999999999999999999999999 8999999999987533 33456788999
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
|.|+|||++.-.+|+.++|.||+|++|||||.|++||++.+.+++...|... ...+|. .+|.++.++....|...|.+
T Consensus 514 PdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh-nvsyPK-slSkEAv~ickg~ltK~P~k 591 (683)
T KOG0696|consen 514 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH-NVSYPK-SLSKEAVAICKGLLTKHPGK 591 (683)
T ss_pred CcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc-cCcCcc-cccHHHHHHHHHHhhcCCcc
Confidence 9999999999999999999999999999999999999999999999888776 444444 79999999999999999999
Q ss_pred CCCH-----HHHhcCCCCCCCCCCCccchHH
Q psy5368 282 RISY-----EDLFSHPYPDLIHAPCAESHQT 307 (406)
Q Consensus 282 Rps~-----~ell~hp~~~~~~~~~~~~~~~ 307 (406)
|... .++-.||||+.+.|...+..+.
T Consensus 592 RLGcg~~ge~di~~H~FFR~iDWek~E~~ei 622 (683)
T KOG0696|consen 592 RLGCGPEGERDIREHPFFRRIDWEKLERREI 622 (683)
T ss_pred ccCCCCccccchhhCcchhhccHHHHhhccC
Confidence 9854 6899999999998866654443
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=295.59 Aligned_cols=240 Identities=24% Similarity=0.367 Sum_probs=191.0
Q ss_pred ceeeecceeeeEEEeeeee--eceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCccc------------CCeEEEE
Q psy5368 55 STIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRKR------------PRYVYII 118 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~~------------~~~~~lV 118 (406)
....||+|+||.||++... +..+++|++..... .....+.+|+.+++.++|||+++. ...+|+|
T Consensus 19 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 98 (342)
T cd07879 19 SLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV 98 (342)
T ss_pred EEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEE
Confidence 3567899999999999863 56788887754321 223467899999999999997652 1346999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCc
Q psy5368 119 LEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDS 197 (406)
Q Consensus 119 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~ 197 (406)
+||+.. +|..++ ...+++..+..++.|++.||+|||+.|++||||||+||+++ ++.++|+|||+++.... ....
T Consensus 99 ~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~--~~~~ 173 (342)
T cd07879 99 MPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA--EMTG 173 (342)
T ss_pred eccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC--CCCC
Confidence 999965 887765 24689999999999999999999999999999999999999 77999999999876432 2334
Q ss_pred ccCCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC---------------------
Q psy5368 198 IQGSPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP--------------------- 255 (406)
Q Consensus 198 ~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~--------------------- 255 (406)
..+++.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+.......+.....
T Consensus 174 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (342)
T cd07879 174 YVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKS 253 (342)
T ss_pred ceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhh
Confidence 567889999999876 4588999999999999999999999998765444433332110
Q ss_pred -CCCCC-------CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy5368 256 -ITIPP-------NSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 256 -~~~~~-------~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 299 (406)
...+. ...++++.+|+.+||+.||.+||++++++.||||+....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 254 LPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred cCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00010 146788999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=295.92 Aligned_cols=235 Identities=21% Similarity=0.342 Sum_probs=190.8
Q ss_pred eeeecceeeeEEEeeeeee---------ceeEEeeeecCC-ccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEE
Q psy5368 56 TIRYGELQYDTVQNSQIRL---------GTVKYSQVRYDT-ITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYII 118 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~---------~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV 118 (406)
...||+|+||.||.+.... ..+++|...... ......+.+|+.++.++ +|||+++ ..+.+++|
T Consensus 17 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 96 (334)
T cd05100 17 GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVL 96 (334)
T ss_pred cceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEE
Confidence 3467888888888776421 246677555332 22345789999999999 8999875 55678999
Q ss_pred EeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEE
Q psy5368 119 LEYCDGGDLCSFIRSHE----------------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLA 181 (406)
Q Consensus 119 ~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~ 181 (406)
|||+++|+|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++ ++.+||+
T Consensus 97 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~ 176 (334)
T cd05100 97 VEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIA 176 (334)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEEC
Confidence 99999999999997532 478899999999999999999999999999999999999 7799999
Q ss_pred ecccccccCCCCC---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCC
Q psy5368 182 DFGFAQFLAPNDQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPIT 257 (406)
Q Consensus 182 DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 257 (406)
|||+++....... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.......
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 256 (334)
T cd05100 177 DFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMD 256 (334)
T ss_pred CcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9999976543221 122234567999999999999999999999999999998 899999988888877776654444
Q ss_pred CCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 258 IPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 258 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
.+ ..++.++.+|+.+||+.+|.+|||+.+++++
T Consensus 257 ~~-~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 257 KP-ANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred CC-CCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 33 3678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=286.54 Aligned_cols=233 Identities=22% Similarity=0.333 Sum_probs=192.5
Q ss_pred eeecceeeeEEEeeeeee------ceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCC
Q psy5368 57 IRYGELQYDTVQNSQIRL------GTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDG 124 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~------~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~g 124 (406)
..||+|+||.||++.... ..+++|....... .....+.+|+..+.+++|||+++ .....++||||+++
T Consensus 13 ~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 92 (279)
T cd05057 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLITQLMPL 92 (279)
T ss_pred ceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEEEecCCC
Confidence 568999999999988642 1356665554432 23457889999999999999776 33678899999999
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCC---ccc
Q psy5368 125 GDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGD---SIQ 199 (406)
Q Consensus 125 gsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~---~~~ 199 (406)
|+|.+++..+ ..+++..+..++.|++.||+|||++|++|+||||+||+++ ++.+||+|||+++......... ...
T Consensus 93 g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~ 172 (279)
T cd05057 93 GCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGK 172 (279)
T ss_pred CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCc
Confidence 9999999774 4699999999999999999999999999999999999998 6799999999998765332211 122
Q ss_pred CCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccC
Q psy5368 200 GSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKD 278 (406)
Q Consensus 200 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~d 278 (406)
++..|+|||.+....++.++|+|||||++||+++ |..||.+....++...+........+. ..+.++.+++.+||..+
T Consensus 173 ~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~ 251 (279)
T cd05057 173 VPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPP-ICTIDVYMVLVKCWMID 251 (279)
T ss_pred ccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCC-CCCHHHHHHHHHHcCCC
Confidence 3567999999988889999999999999999998 999999988888777776654444443 57899999999999999
Q ss_pred CCCCCCHHHHhc
Q psy5368 279 PMRRISYEDLFS 290 (406)
Q Consensus 279 P~~Rps~~ell~ 290 (406)
|.+||++.++++
T Consensus 252 p~~Rp~~~~l~~ 263 (279)
T cd05057 252 AESRPTFKELIN 263 (279)
T ss_pred hhhCCCHHHHHH
Confidence 999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=289.62 Aligned_cols=234 Identities=19% Similarity=0.344 Sum_probs=183.3
Q ss_pred eeecceeeeEEEeeee------eeceeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc--------cCCeEEEEEec
Q psy5368 57 IRYGELQYDTVQNSQI------RLGTVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK--------RPRYVYIILEY 121 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~------~~~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~--------~~~~~~lV~E~ 121 (406)
..||+|+||.||.+.. ....+++|.+.... ......+.+|+.+++.++|||+++ .....++||||
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (284)
T cd05079 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF 89 (284)
T ss_pred eecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEc
Confidence 4578888888888763 24567888765443 223457899999999999999765 13578999999
Q ss_pred cCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC----C
Q psy5368 122 CDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ----G 195 (406)
Q Consensus 122 ~~ggsL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~----~ 195 (406)
++|++|.+++.+.. .+++..+..++.|++.||+|||++|++||||||+||+++ ++.++|+|||+++....... .
T Consensus 90 ~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 169 (284)
T cd05079 90 LPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK 169 (284)
T ss_pred cCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCccceeec
Confidence 99999999997653 689999999999999999999999999999999999998 67999999999986643322 1
Q ss_pred CcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------------HHHHHHHHHhcCCCCCCC
Q psy5368 196 DSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCN---------------LSQLRAQALSSAPITIPP 260 (406)
Q Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~---------------~~~~~~~~~~~~~~~~~~ 260 (406)
....++..|+|||.+.+..++.++|||||||++|+|+|+..|+.... .......+........ +
T Consensus 170 ~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 248 (284)
T cd05079 170 DDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPR-P 248 (284)
T ss_pred CCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCC-C
Confidence 23456778999999998889999999999999999999877653211 1111111222222222 3
Q ss_pred CCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 261 NSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 261 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
..++.++.+|+.+||+.+|.+|||+++++++
T Consensus 249 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 249 PNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 3689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=277.61 Aligned_cols=240 Identities=26% Similarity=0.419 Sum_probs=201.7
Q ss_pred eecceeeeEEEeeeeee--ceeEEeeeecCC-ccchhhhhhHHhhcccCC-CCCCcccCCeE------EEEEeccCCCCH
Q psy5368 58 RYGELQYDTVQNSQIRL--GTVKYSQVRYDT-ITSHSEFERPRAGLSNLR-APEGRKRPRYV------YIILEYCDGGDL 127 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~------~lV~E~~~ggsL 127 (406)
.+|.|.-|.|+++..+. .-+|||...... ....+++.+.+.++...+ .|.++..-+++ ++.||.|.- -+
T Consensus 99 dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C~ 177 (391)
T KOG0983|consen 99 DLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-CA 177 (391)
T ss_pred hhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-HH
Confidence 47999999999999876 678999887654 334567788888776664 78888755544 478888843 55
Q ss_pred HHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCC
Q psy5368 128 CSFIR-SHEKLSEFQCQQFVRQLVLALKFLRE-NNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLY 204 (406)
Q Consensus 128 ~~~l~-~~~~l~~~~~~~i~~ql~~aL~~lH~-~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y 204 (406)
..+++ ..+++++..+-++...++.||.||-+ +||+|||+||+|||+| .|++||||||++..+..+.......|.+.|
T Consensus 178 ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsAGC~~Y 257 (391)
T KOG0983|consen 178 EKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSAGCAAY 257 (391)
T ss_pred HHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccccccccCCccc
Confidence 66554 34689999999999999999999985 5799999999999999 789999999999999888888888899999
Q ss_pred CChhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCCCCCCC-CCChHHHHHHHHhcccCC
Q psy5368 205 MAPEILAG---SPYNAKADLWSLGVLVFEALFGHAPYASCN-LSQLRAQALSSAPITIPPN-SLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 205 ~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~-~~s~~l~~li~~~L~~dP 279 (406)
||||.+.- ..|+.++||||||++++||.||+.||.+.+ ..+...++....++.++.. .+|+.+++|+..||++|+
T Consensus 258 MaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~ 337 (391)
T KOG0983|consen 258 MAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDH 337 (391)
T ss_pred cCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCc
Confidence 99999864 359999999999999999999999999853 4566677777777766665 599999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCC
Q psy5368 280 MRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 280 ~~Rps~~ell~hp~~~~~~ 298 (406)
.+||...++|+|||+...+
T Consensus 338 r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 338 RKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred ccCcchHHHhcCcceeecc
Confidence 9999999999999987543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=296.45 Aligned_cols=243 Identities=24% Similarity=0.364 Sum_probs=194.8
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCcc------cC------CeEEEEE
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRK------RP------RYVYIIL 119 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~------~~------~~~~lV~ 119 (406)
...||+|++|.||++... +..+++|.+.... ......+.+|+.++++++|||++. .. ...|+|+
T Consensus 20 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07851 20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVT 99 (343)
T ss_pred EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEE
Confidence 456799999999999874 4567888765432 223456788999999999999754 22 2489999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcc
Q psy5368 120 EYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSI 198 (406)
Q Consensus 120 E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~ 198 (406)
||+ +++|.+++.. ..+++..+..++.|++.||.|||+.||+|+||||+||+++ ++.++|+|||++...... ....
T Consensus 100 e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~~~~ 175 (343)
T cd07851 100 HLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--MTGY 175 (343)
T ss_pred ecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc--ccCC
Confidence 999 5699999875 5799999999999999999999999999999999999998 679999999999765432 3445
Q ss_pred cCCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-------------------
Q psy5368 199 QGSPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITI------------------- 258 (406)
Q Consensus 199 ~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~------------------- 258 (406)
.++..|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.+.......+........
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (343)
T cd07851 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSL 255 (343)
T ss_pred cccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhc
Confidence 67889999999876 3578899999999999999999999988776555444433211000
Q ss_pred ----------CCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCc
Q psy5368 259 ----------PPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCA 302 (406)
Q Consensus 259 ----------~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~ 302 (406)
....+++++.+|+.+||+.+|.+|||+.++++||||.....+..
T Consensus 256 ~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~ 309 (343)
T cd07851 256 PQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPED 309 (343)
T ss_pred cccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcc
Confidence 01135889999999999999999999999999999987665543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=291.43 Aligned_cols=242 Identities=28% Similarity=0.468 Sum_probs=193.7
Q ss_pred eeeecceeeeEEEeeeee-----eceeEEeeeecCCc----cchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEE
Q psy5368 56 TIRYGELQYDTVQNSQIR-----LGTVKYSQVRYDTI----TSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIIL 119 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~-----~~~v~vk~~~~~~~----~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~ 119 (406)
...||+|++|.||++... ...+++|.+..... .....+.+|+.++.++ +|||++. .....|+||
T Consensus 5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 84 (288)
T cd05583 5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLIL 84 (288)
T ss_pred EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEE
Confidence 356899999999988742 34578887654321 2345678899999999 5888654 567789999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC--CC
Q psy5368 120 EYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ--GD 196 (406)
Q Consensus 120 E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~--~~ 196 (406)
||+++++|.+++..+..+++..+..++.|++.+|.|||+.|++|+||+|.||+++ ++.++|+|||++........ ..
T Consensus 85 e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 164 (288)
T cd05583 85 DYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY 164 (288)
T ss_pred ecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccccccc
Confidence 9999999999998878899999999999999999999999999999999999998 67899999999876543322 22
Q ss_pred cccCCCCCCChhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcCCCCCCCCCCChHHHHH
Q psy5368 197 SIQGSPLYMAPEILAGSP--YNAKADLWSLGVLVFEALFGHAPYASCN----LSQLRAQALSSAPITIPPNSLSPDCMDF 270 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~s~~l~~l 270 (406)
...|+..|+|||.+.+.. .+.++|+||+|+++|+|++|..||.... ..++...+... .... +..++.++.++
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~l~~l 242 (288)
T cd05583 165 SFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS-KPPF-PKTMSAEARDF 242 (288)
T ss_pred cccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc-CCCC-CcccCHHHHHH
Confidence 346889999999987765 7889999999999999999999996432 22333333222 2222 33588999999
Q ss_pred HHHhcccCCCCCCC---HHHHhcCCCCCCCCC
Q psy5368 271 LSRLLQKDPMRRIS---YEDLFSHPYPDLIHA 299 (406)
Q Consensus 271 i~~~L~~dP~~Rps---~~ell~hp~~~~~~~ 299 (406)
+.+||+.||++||| +.++++||||+...+
T Consensus 243 i~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 243 IQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred HHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 99999999999998 567799999987765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=296.90 Aligned_cols=246 Identities=29% Similarity=0.447 Sum_probs=194.4
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecC--CccchhhhhhHHhhcccC-CCCCCcc--------cCCeEEEEEecc
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYD--TITSHSEFERPRAGLSNL-RAPEGRK--------RPRYVYIILEYC 122 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~--~~~~~~~~~~E~~~l~~l-~h~ni~~--------~~~~~~lV~E~~ 122 (406)
...||+|+||.||++... +..+++|++... .......+.+|+.++.++ +|||+++ .....|+||||+
T Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~ 91 (337)
T cd07852 12 LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM 91 (337)
T ss_pred hHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccc
Confidence 456899999999999864 456788876432 223345678899999999 9999765 234689999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC------CC
Q psy5368 123 DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND------QG 195 (406)
Q Consensus 123 ~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~------~~ 195 (406)
++ +|.+++..+ .+++..+..++.||+.||.|||+.||+|+||||+||+++ ++.+||+|||++....... ..
T Consensus 92 ~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~ 169 (337)
T cd07852 92 ET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL 169 (337)
T ss_pred cc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcch
Confidence 75 999999775 889999999999999999999999999999999999999 7799999999997654332 22
Q ss_pred CcccCCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC------------------
Q psy5368 196 DSIQGSPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI------------------ 256 (406)
Q Consensus 196 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------------------ 256 (406)
....|++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.........+......
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (337)
T cd07852 170 TDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATML 249 (337)
T ss_pred hcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhh
Confidence 33568899999998765 45788999999999999999999999876544333322211100
Q ss_pred -----------CCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCcc
Q psy5368 257 -----------TIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAE 303 (406)
Q Consensus 257 -----------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~~ 303 (406)
......++.++.+++.+||+.||++|||+.++++|||++....+..+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~ 307 (337)
T cd07852 250 DSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDE 307 (337)
T ss_pred hhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCC
Confidence 00011368899999999999999999999999999999887665444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=290.11 Aligned_cols=235 Identities=19% Similarity=0.307 Sum_probs=189.6
Q ss_pred eeeecceeeeEEEeeeeee--c----eeEEeeeecCCccc-hhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIRL--G----TVKYSQVRYDTITS-HSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~--~----~v~vk~~~~~~~~~-~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ 123 (406)
...||+|+||.||++.... . .+++|......... ...+.+|+.+++.++|||+++ .....++|+||++
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v~e~~~ 91 (303)
T cd05110 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMP 91 (303)
T ss_pred ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceeeehhcC
Confidence 3568999999999998632 1 35666554433222 336889999999999999877 3344679999999
Q ss_pred CCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC---CCcc
Q psy5368 124 GGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ---GDSI 198 (406)
Q Consensus 124 ggsL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~---~~~~ 198 (406)
+|+|.+++..+. .+++..+..++.|++.||.|||++||+|+||||+||+++ ++.+||+|||+++....... ....
T Consensus 92 ~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~ 171 (303)
T cd05110 92 HGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 171 (303)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcccccccCCC
Confidence 999999997654 689999999999999999999999999999999999998 67899999999987643322 1223
Q ss_pred cCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhccc
Q psy5368 199 QGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 199 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~ 277 (406)
.++..|+|||.+.+..++.++|||||||++|||++ |..||.+.........+........ +..++..+.+++.+||..
T Consensus 172 ~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~c~~~ 250 (303)
T cd05110 172 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQ-PPICTIDVYMVMVKCWMI 250 (303)
T ss_pred ccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCC-CCCCCHHHHHHHHHHcCC
Confidence 35678999999999899999999999999999997 9999988776666555544433333 235788999999999999
Q ss_pred CCCCCCCHHHHhcC
Q psy5368 278 DPMRRISYEDLFSH 291 (406)
Q Consensus 278 dP~~Rps~~ell~h 291 (406)
+|++||+++++++.
T Consensus 251 ~p~~Rp~~~~l~~~ 264 (303)
T cd05110 251 DADSRPKFKELAAE 264 (303)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999998774
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=295.11 Aligned_cols=241 Identities=24% Similarity=0.350 Sum_probs=191.1
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCcccC------------CeEEEEE
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRKRP------------RYVYIIL 119 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~~~------------~~~~lV~ 119 (406)
...||+|+||.||++... +..+++|....... .....+.+|+.+++.++|||++... ..+++||
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07880 20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99 (343)
T ss_pred EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEE
Confidence 456799999999998753 45688887654321 2234688999999999999976521 2468999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcc
Q psy5368 120 EYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSI 198 (406)
Q Consensus 120 E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~ 198 (406)
||+ +++|.+++.. ..+++..++.++.|++.||+|||+.||+||||||+||+++ ++.++|+|||++...... ....
T Consensus 100 e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~--~~~~ 175 (343)
T cd07880 100 PFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE--MTGY 175 (343)
T ss_pred ecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC--cccc
Confidence 999 6799988864 5799999999999999999999999999999999999998 679999999998765432 2345
Q ss_pred cCCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------------------
Q psy5368 199 QGSPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI--------------------- 256 (406)
Q Consensus 199 ~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--------------------- 256 (406)
.+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+.......+......
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (343)
T cd07880 176 VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKL 255 (343)
T ss_pred ccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhc
Confidence 67899999999876 45889999999999999999999999877654333332221000
Q ss_pred --C------CCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy5368 257 --T------IPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAP 300 (406)
Q Consensus 257 --~------~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 300 (406)
. .....+++++.+++.+||+.||.+|||+.+++.||||+....+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 256 PRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307 (343)
T ss_pred cccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence 0 0012578889999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=283.97 Aligned_cols=236 Identities=23% Similarity=0.426 Sum_probs=193.8
Q ss_pred eeeecceeeeEEEeeeeee---ceeEEeeeecCC----------ccchhhhhhHHhhccc-CCCCCCcc------cCCeE
Q psy5368 56 TIRYGELQYDTVQNSQIRL---GTVKYSQVRYDT----------ITSHSEFERPRAGLSN-LRAPEGRK------RPRYV 115 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~---~~v~vk~~~~~~----------~~~~~~~~~E~~~l~~-l~h~ni~~------~~~~~ 115 (406)
...||+|+||.||++.... ..+++|.+.... .....++.+|+.++.+ ++|||++. ..+..
T Consensus 5 ~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 84 (269)
T cd08528 5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRL 84 (269)
T ss_pred hhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeE
Confidence 3467899999999988754 456777654321 1123456778887765 79999765 66789
Q ss_pred EEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCcceEee-CCeeEEEeccccccc
Q psy5368 116 YIILEYCDGGDLCSFIRS----HEKLSEFQCQQFVRQLVLALKFLRE-NNVCHFDLKPQNILIK-NNTLKLADFGFAQFL 189 (406)
Q Consensus 116 ~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~lH~-~givH~Dlkp~NIll~-~~~~kL~DFGla~~~ 189 (406)
++||||++|++|.+++.. ...+++..+..++.|++.||.|||+ .|++|+||+|.||+++ ++.++|+|||++...
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 164 (269)
T cd08528 85 YIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQK 164 (269)
T ss_pred EEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceeec
Confidence 999999999999998743 3469999999999999999999996 7899999999999998 678999999999876
Q ss_pred CCCCCCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHH
Q psy5368 190 APNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMD 269 (406)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ 269 (406)
..........++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+........+...+++++.+
T Consensus 165 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 244 (269)
T cd08528 165 QPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTD 244 (269)
T ss_pred ccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCHHHHH
Confidence 55544455678999999999999889999999999999999999999998887777666666554444444468899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcC
Q psy5368 270 FLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 270 li~~~L~~dP~~Rps~~ell~h 291 (406)
++.+||+.||++||++.|+..+
T Consensus 245 li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 245 VITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHHCCCCCccCCCHHHHHHH
Confidence 9999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=290.19 Aligned_cols=238 Identities=26% Similarity=0.392 Sum_probs=185.7
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCccc--------------CCeEEE
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRKR--------------PRYVYI 117 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~~--------------~~~~~l 117 (406)
...||+|+||.||++... +..+++|.+...... ....+.+|++++++++|||+++. ...+|+
T Consensus 13 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~l 92 (311)
T cd07866 13 LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYM 92 (311)
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEE
Confidence 455788888888888764 356777766544322 23467889999999999997762 235799
Q ss_pred EEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC-
Q psy5368 118 ILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ- 194 (406)
Q Consensus 118 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~- 194 (406)
||||+.+ +|...+... ..+++..+..++.|+++||.|||++|++|+||||+||+++ ++.++|+|||++........
T Consensus 93 v~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 171 (311)
T cd07866 93 VTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN 171 (311)
T ss_pred EEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcc
Confidence 9999976 788777653 4799999999999999999999999999999999999998 67999999999976543221
Q ss_pred -----------CCcccCCCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC------
Q psy5368 195 -----------GDSIQGSPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI------ 256 (406)
Q Consensus 195 -----------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------ 256 (406)
.....+++.|+|||.+.+. .++.++||||+||++|+|++|++||.+.+.......+......
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (311)
T cd07866 172 PKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETW 251 (311)
T ss_pred cccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 1223568889999988664 5889999999999999999999999887765544443321100
Q ss_pred ----------------CCCC------CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 257 ----------------TIPP------NSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 257 ----------------~~~~------~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
..++ ..+++.+.+++.+||+.||.+|||+.+++.||||
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 252 PGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred hhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 0000 1345778999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=288.49 Aligned_cols=238 Identities=24% Similarity=0.331 Sum_probs=188.6
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCccc----------------CCeE
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRKR----------------PRYV 115 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~~----------------~~~~ 115 (406)
...+|+|+||.||++... +..+++|.+..... .....+.+|+.+++.++|||++.. .+.+
T Consensus 12 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 91 (302)
T cd07864 12 IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAF 91 (302)
T ss_pred eeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcE
Confidence 457899999999999974 35677787764432 223467889999999999997761 2378
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC
Q psy5368 116 YIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND 193 (406)
Q Consensus 116 ~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~ 193 (406)
|+|+||+++ +|.+.+... ..+++..+..++.|++.||+|||+.||+|+||||+||+++ ++.+||+|||++.......
T Consensus 92 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 170 (302)
T cd07864 92 YLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170 (302)
T ss_pred EEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCc
Confidence 999999986 888877654 4799999999999999999999999999999999999999 6699999999997654333
Q ss_pred C--CCcccCCCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-------------
Q psy5368 194 Q--GDSIQGSPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPIT------------- 257 (406)
Q Consensus 194 ~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~------------- 257 (406)
. .....++..|+|||.+.+. .++.++||||+||++++|++|++||...+.......+.......
T Consensus 171 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T cd07864 171 SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPY 250 (302)
T ss_pred ccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccccc
Confidence 1 1223457889999988754 47889999999999999999999998766544443333211000
Q ss_pred ---------------CCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 258 ---------------IPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 258 ---------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
.....+|..+.+++.+||..||.+|||+++++.||||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 251 FNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0011468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=284.99 Aligned_cols=237 Identities=31% Similarity=0.452 Sum_probs=193.2
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
..||+|++|.||++... +..+++|...... ......+.+|+.+++.++|+|+++ ..+..++||||+++ +
T Consensus 5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~ 83 (282)
T cd07829 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-D 83 (282)
T ss_pred hcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcCc-C
Confidence 46899999999999875 4667888776543 223456788999999999999765 56789999999975 9
Q ss_pred HHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCC
Q psy5368 127 LCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPL 203 (406)
Q Consensus 127 L~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~ 203 (406)
|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++ ++.++|+|||++....... ......++..
T Consensus 84 l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 163 (282)
T cd07829 84 LKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLW 163 (282)
T ss_pred HHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccccCcC
Confidence 99999876 5899999999999999999999999999999999999999 6799999999987764433 2233456788
Q ss_pred CCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--------------------CC-----
Q psy5368 204 YMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP--------------------IT----- 257 (406)
Q Consensus 204 y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~--------------------~~----- 257 (406)
|+|||.+.+. .++.++|+||+||++++|++|.+||...+..+....+..... ..
T Consensus 164 ~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (282)
T cd07829 164 YRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKD 243 (282)
T ss_pred cCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccc
Confidence 9999999876 789999999999999999999999988765544443322100 00
Q ss_pred --CCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 258 --IPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 258 --~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
.....++..+.+++.+||..+|++||++++++.||||
T Consensus 244 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 244 LEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred hHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0001347889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=288.19 Aligned_cols=215 Identities=23% Similarity=0.365 Sum_probs=170.8
Q ss_pred eeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHHHHHHhCC-----------CC
Q psy5368 76 TVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLCSFIRSHE-----------KL 137 (406)
Q Consensus 76 ~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~~~l~~~~-----------~l 137 (406)
.+++|....... .....+.+|+.+++.++|+|+++ ..+..|+||||+++++|.+++.... .+
T Consensus 48 ~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 127 (296)
T cd05095 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127 (296)
T ss_pred EEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCccccccccccccc
Confidence 467776654432 23457899999999999999765 5677899999999999999997643 36
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC---CCcccCCCCCCChhhhcCC
Q psy5368 138 SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ---GDSIQGSPLYMAPEILAGS 213 (406)
Q Consensus 138 ~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~ 213 (406)
++..+..++.|++.||+|||++|++|+||||+||+++ ++.++|+|||+++.+..... .....+++.|+|||...+.
T Consensus 128 ~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~ 207 (296)
T cd05095 128 SYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG 207 (296)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC
Confidence 7789999999999999999999999999999999998 67999999999976543321 1223346789999999888
Q ss_pred CCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHh-----cCCCCC-CCCCCChHHHHHHHHhcccCCCCCCCH
Q psy5368 214 PYNAKADLWSLGVLVFEALF--GHAPYASCNLSQLRAQALS-----SAPITI-PPNSLSPDCMDFLSRLLQKDPMRRISY 285 (406)
Q Consensus 214 ~~~~~~DiwSlG~il~ellt--g~~pf~~~~~~~~~~~~~~-----~~~~~~-~~~~~s~~l~~li~~~L~~dP~~Rps~ 285 (406)
.++.++|+|||||++|||++ |..||...+..+....... ...... .+..+++.+.+|+.+||+.||.+||++
T Consensus 208 ~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~ 287 (296)
T cd05095 208 KFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSF 287 (296)
T ss_pred CccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCH
Confidence 89999999999999999998 7899987765554433211 111111 123678999999999999999999999
Q ss_pred HHHhc
Q psy5368 286 EDLFS 290 (406)
Q Consensus 286 ~ell~ 290 (406)
.++++
T Consensus 288 ~~i~~ 292 (296)
T cd05095 288 QEIHA 292 (296)
T ss_pred HHHHH
Confidence 99865
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=294.52 Aligned_cols=244 Identities=24% Similarity=0.358 Sum_probs=192.9
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCccc------------CCeEEEEE
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRKR------------PRYVYIIL 119 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~------------~~~~~lV~ 119 (406)
...||+|+||.||++... +..+++|++.... ......+.+|+.++.+++|||+++. ....|+++
T Consensus 22 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 101 (345)
T cd07877 22 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 101 (345)
T ss_pred EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEe
Confidence 357899999999999753 4567888775432 2234567889999999999997662 23478999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcc
Q psy5368 120 EYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSI 198 (406)
Q Consensus 120 E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~ 198 (406)
+++ +++|.++++. ..+++..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++..... .....
T Consensus 102 ~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~--~~~~~ 177 (345)
T cd07877 102 HLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGY 177 (345)
T ss_pred hhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc--ccccc
Confidence 988 7799988865 4699999999999999999999999999999999999999 67999999999876432 33445
Q ss_pred cCCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----------------------
Q psy5368 199 QGSPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP---------------------- 255 (406)
Q Consensus 199 ~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~---------------------- 255 (406)
.+++.|+|||.+.+ ..++.++||||+||++|+|++|+.||...+.......+.....
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (345)
T cd07877 178 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 257 (345)
T ss_pred ccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHh
Confidence 68899999999876 5688999999999999999999999987654443332221100
Q ss_pred CCCCC-------CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCcc
Q psy5368 256 ITIPP-------NSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAE 303 (406)
Q Consensus 256 ~~~~~-------~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~~ 303 (406)
...+. ...++++.+||.+||+.||.+||++.+++.||||.....|..+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~ 312 (345)
T cd07877 258 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 312 (345)
T ss_pred cccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCcc
Confidence 00010 1357889999999999999999999999999999976655544
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=273.84 Aligned_cols=233 Identities=23% Similarity=0.331 Sum_probs=183.1
Q ss_pred eecceeeeEEEeeee--eeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc-----------cCCeEEEEEeccCC
Q psy5368 58 RYGELQYDTVQNSQI--RLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK-----------RPRYVYIILEYCDG 124 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~-----------~~~~~~lV~E~~~g 124 (406)
.+|+|||..||.++. ..+..|+|++......+.+..++|++..++++|||+.+ .....||+++|...
T Consensus 28 ~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~ 107 (302)
T KOG2345|consen 28 LLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKR 107 (302)
T ss_pred eecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhcc
Confidence 445555555555552 34567888888888788899999999999999999755 45579999999999
Q ss_pred CCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCcceEee-CCeeEEEecccccccCCCCCC--
Q psy5368 125 GDLCSFIRSH----EKLSEFQCQQFVRQLVLALKFLRENN--VCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG-- 195 (406)
Q Consensus 125 gsL~~~l~~~----~~l~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~-- 195 (406)
|||.+.++.. ..+++.++++|+.+|++||++||+.. +.||||||.|||++ ++.++|.|||.+....-.-..
T Consensus 108 Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~ 187 (302)
T KOG2345|consen 108 GSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSR 187 (302)
T ss_pred ccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeechH
Confidence 9999999643 36999999999999999999999998 99999999999999 589999999998654322111
Q ss_pred --------CcccCCCCCCChhhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcCCCCCCC-C
Q psy5368 196 --------DSIQGSPLYMAPEILAGS---PYNAKADLWSLGVLVFEALFGHAPYASCNL--SQLRAQALSSAPITIPP-N 261 (406)
Q Consensus 196 --------~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltg~~pf~~~~~--~~~~~~~~~~~~~~~~~-~ 261 (406)
.....|..|+|||.+.-+ ..+.++|||||||+||.|+.|..||+..-. ..+.-.+.+. ...+|. .
T Consensus 188 ~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~-q~s~P~~~ 266 (302)
T KOG2345|consen 188 QALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNA-QISIPNSS 266 (302)
T ss_pred HHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeecc-ccccCCCC
Confidence 233478999999998754 478899999999999999999999964211 0011111111 223332 3
Q ss_pred CCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 262 SLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 262 ~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
.+|+.+.+||+.||+.||.+||++.+++.+
T Consensus 267 ~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 267 RYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 689999999999999999999999999875
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=283.06 Aligned_cols=232 Identities=19% Similarity=0.317 Sum_probs=181.0
Q ss_pred eecceeeeEEEeeeeeec----eeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 58 RYGELQYDTVQNSQIRLG----TVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~~----~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
.||+|+||.||++..... .+++|.+.... ......+.+|+..++.++|||+++ .....|+||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999975332 23444444332 233567999999999999999876 5567899999999999
Q ss_pred HHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC---CCCcc
Q psy5368 127 LCSFIRSH----EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND---QGDSI 198 (406)
Q Consensus 127 L~~~l~~~----~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~---~~~~~ 198 (406)
|.+++.+. ..+++..+..++.||+.||+|||+.+++||||||+|||++ ++.++|+|||++....... .....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 161 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDK 161 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCC
Confidence 99999754 2467778889999999999999999999999999999998 6799999999986432221 22345
Q ss_pred cCCCCCCChhhhcC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCC----CCCCChH
Q psy5368 199 QGSPLYMAPEILAG-------SPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIP----PNSLSPD 266 (406)
Q Consensus 199 ~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~s~~ 266 (406)
.++..|+|||++.. ..++.++|||||||++|||++ |..||...+..+....+........+ +..+++.
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (268)
T cd05086 162 CVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSER 241 (268)
T ss_pred cCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHH
Confidence 67889999999853 235789999999999999997 67899887776666655444332211 2257889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 267 CMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 267 l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
+.+++..|| .+|++||+++++++
T Consensus 242 ~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 242 WYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred HHHHHHHHh-hCcccCCCHHHHHH
Confidence 999999999 67999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=302.14 Aligned_cols=234 Identities=22% Similarity=0.391 Sum_probs=204.0
Q ss_pred ceeeecceeeeEEEeeeeee----c--eeEEeeeecC-CccchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEecc
Q psy5368 55 STIRYGELQYDTVQNSQIRL----G--TVKYSQVRYD-TITSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYC 122 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~----~--~v~vk~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~ 122 (406)
....||+|.||.||+|.... . .||||..+.+ ...+.+.|..|+.++++++|||+++ ...-.|||||++
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~WivmEL~ 472 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVMELA 472 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEEecc
Confidence 45689999999999998632 2 4677776663 3455778999999999999999887 555679999999
Q ss_pred CCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccC
Q psy5368 123 DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQG 200 (406)
Q Consensus 123 ~ggsL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~g 200 (406)
+-|.|..+|+.+. .++......++.||+.||.|||+.++|||||-..|||+. ...+||+|||+++.+..+.......|
T Consensus 473 ~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~ 552 (974)
T KOG4257|consen 473 PLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRG 552 (974)
T ss_pred cchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhcccc
Confidence 9999999998764 799999999999999999999999999999999999999 55899999999999877655444344
Q ss_pred --CCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhccc
Q psy5368 201 --SPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 201 --t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~ 277 (406)
...|||||.+.-..++.+||||.|||.+||++. |..||.+-...+....+..+...+.|+ .+|+.+..|+.+||.+
T Consensus 553 kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~-nCPp~LYslmskcWay 631 (974)
T KOG4257|consen 553 KLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPP-NCPPALYSLMSKCWAY 631 (974)
T ss_pred ccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCC-CCChHHHHHHHHHhcc
Confidence 345999999999999999999999999999986 999999998888888888888888877 6999999999999999
Q ss_pred CCCCCCCHHHHh
Q psy5368 278 DPMRRISYEDLF 289 (406)
Q Consensus 278 dP~~Rps~~ell 289 (406)
+|.+||.+.++.
T Consensus 632 eP~kRPrftei~ 643 (974)
T KOG4257|consen 632 EPSKRPRFTEIK 643 (974)
T ss_pred CcccCCcHHHHH
Confidence 999999987754
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=278.76 Aligned_cols=220 Identities=26% Similarity=0.368 Sum_probs=178.2
Q ss_pred eeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHHHHHHh
Q psy5368 62 LQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLCSFIRS 133 (406)
Q Consensus 62 G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~~~l~~ 133 (406)
|.+|.||.+... +..+++|.+.... .+.+|...+....|||++. .....|+||||++||+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 788889988863 4567888775432 3344555555667898665 66789999999999999999988
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCCCChhhhcC
Q psy5368 134 HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAG 212 (406)
Q Consensus 134 ~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~ 212 (406)
...+++..+..++.|++.||.|||++|++||||||+||+++ ++.++++|||.+...... .....++..|+|||.+.+
T Consensus 79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~~ 156 (237)
T cd05576 79 FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGGI 156 (237)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCcccCC
Confidence 77899999999999999999999999999999999999999 778999999987665432 233456778999999988
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCCH-----HH
Q psy5368 213 SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY-----ED 287 (406)
Q Consensus 213 ~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~-----~e 287 (406)
..++.++|+||+|+++|+|++|..|+...... +........+ ..+++.+.+++.+||+.||++||++ ++
T Consensus 157 ~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~~~~~~~~-~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~ 230 (237)
T cd05576 157 SEETEACDWWSLGAILFELLTGKTLVECHPSG-----INTHTTLNIP-EWVSEEARSLLQQLLQFNPTERLGAGVAGVED 230 (237)
T ss_pred CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cccccccCCc-ccCCHHHHHHHHHHccCCHHHhcCCCccchHH
Confidence 88999999999999999999999887643211 1111112222 3688999999999999999999985 99
Q ss_pred HhcCCCC
Q psy5368 288 LFSHPYP 294 (406)
Q Consensus 288 ll~hp~~ 294 (406)
+++||||
T Consensus 231 ~~~h~~~ 237 (237)
T cd05576 231 IKSHPFF 237 (237)
T ss_pred HHcCCCC
Confidence 9999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=314.77 Aligned_cols=131 Identities=24% Similarity=0.399 Sum_probs=110.3
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCCccc---hhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITS---HSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~---~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
.+||.|+||.||++... ...+++|.+....... ...+.+|+.++..++|||++. ...++||||||++|+
T Consensus 10 ~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~ 89 (669)
T cd05610 10 KPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGG 89 (669)
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCC
Confidence 34566667777776654 4567787765433222 356888999999999999876 567899999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEeccccc
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQ 187 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~ 187 (406)
+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++
T Consensus 90 ~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 90 DVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999998888899999999999999999999999999999999999998 6799999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=301.85 Aligned_cols=226 Identities=29% Similarity=0.455 Sum_probs=186.8
Q ss_pred eecceeeeEEEeeeeeec--eeEEeeeecCCccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccCCCCHH
Q psy5368 58 RYGELQYDTVQNSQIRLG--TVKYSQVRYDTITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCDGGDLC 128 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~~--~v~vk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~ggsL~ 128 (406)
.+|.|+|+.|-.+....+ .-++|.+... ..+..+|+.++... .|||+++ +..+.|+|||.+.|+-|.
T Consensus 329 ~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell 404 (612)
T KOG0603|consen 329 ELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELL 404 (612)
T ss_pred ccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHH
Confidence 479999999999987543 3455554433 34456677666555 8899766 777899999999999999
Q ss_pred HHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee--CCeeEEEecccccccCCCCCCCcccCCCCCCC
Q psy5368 129 SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK--NNTLKLADFGFAQFLAPNDQGDSIQGSPLYMA 206 (406)
Q Consensus 129 ~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~--~~~~kL~DFGla~~~~~~~~~~~~~gt~~y~a 206 (406)
+.+...+.+. .++..|+.+|+.|+.|||++|++||||||+|||++ .++++|+|||.++....+ ..+.+-|..|.|
T Consensus 405 ~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~A 481 (612)
T KOG0603|consen 405 RRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CDTPALTLQYVA 481 (612)
T ss_pred HHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--hcccchhhcccC
Confidence 9998766565 88889999999999999999999999999999994 668999999999876544 334456888999
Q ss_pred hhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCCH
Q psy5368 207 PEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLS-QLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY 285 (406)
Q Consensus 207 PE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~ 285 (406)
||++....|++++||||||++||+||+|+.||...... ++...+.... . ...+|+++++|+++||+.||.+||++
T Consensus 482 PEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~---~-s~~vS~~AKdLl~~LL~~dP~~Rl~~ 557 (612)
T KOG0603|consen 482 PEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPK---F-SECVSDEAKDLLQQLLQVDPALRLGA 557 (612)
T ss_pred hhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCc---c-ccccCHHHHHHHHHhccCChhhCcCh
Confidence 99999999999999999999999999999999886655 4444433321 1 14799999999999999999999999
Q ss_pred HHHhcCCCC
Q psy5368 286 EDLFSHPYP 294 (406)
Q Consensus 286 ~ell~hp~~ 294 (406)
.++..|||+
T Consensus 558 ~~i~~h~w~ 566 (612)
T KOG0603|consen 558 DEIGAHPWF 566 (612)
T ss_pred hhhccCcch
Confidence 999999999
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=283.48 Aligned_cols=233 Identities=24% Similarity=0.366 Sum_probs=187.7
Q ss_pred eeecceeeeEEEeeeee------eceeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCcc--------cCCeEEEEEec
Q psy5368 57 IRYGELQYDTVQNSQIR------LGTVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRK--------RPRYVYIILEY 121 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~------~~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~--------~~~~~~lV~E~ 121 (406)
..||+|+||.||++... ...+++|.+...... ....+.+|+.+++.+.|+|+++ ...+.++||||
T Consensus 10 ~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 89 (284)
T cd05038 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEY 89 (284)
T ss_pred eeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEec
Confidence 57899999999999864 346788877655433 4568999999999999999766 24578999999
Q ss_pred cCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC----
Q psy5368 122 CDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG---- 195 (406)
Q Consensus 122 ~~ggsL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~---- 195 (406)
+++++|.+++.... .+++..+..++.|++.||+|||++|++|+||||+||+++ ++.++|+|||++.........
T Consensus 90 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 169 (284)
T cd05038 90 LPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVK 169 (284)
T ss_pred CCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceecc
Confidence 99999999997754 699999999999999999999999999999999999999 679999999999876532211
Q ss_pred CcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHHHhcCCCCCCC
Q psy5368 196 DSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLS---------------QLRAQALSSAPITIPP 260 (406)
Q Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~---------------~~~~~~~~~~~~~~~~ 260 (406)
....++..|+|||.+.+..++.++|||||||++++|++|..|+...... .....+... .....+
T Consensus 170 ~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 248 (284)
T cd05038 170 EPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG-ERLPRP 248 (284)
T ss_pred CCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcC-CcCCCC
Confidence 1223456699999999888999999999999999999999998654221 122222222 222223
Q ss_pred CCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 261 NSLSPDCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 261 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
..++.++.+|+.+||+.+|.+|||+.++++
T Consensus 249 ~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 249 PSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred ccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 367889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=281.24 Aligned_cols=235 Identities=23% Similarity=0.400 Sum_probs=190.6
Q ss_pred eeeecceeeeEEEeeeee-----eceeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCcccC------------CeEE
Q psy5368 56 TIRYGELQYDTVQNSQIR-----LGTVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRKRP------------RYVY 116 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~-----~~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~~------------~~~~ 116 (406)
...||+|+||.||++... ...+++|.+.... .....++.+|+.+++.++|||+++.. ...+
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05074 4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM 83 (273)
T ss_pred hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceE
Confidence 346899999999999863 3467888765443 22345688999999999999976621 1247
Q ss_pred EEEeccCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEeccccccc
Q psy5368 117 IILEYCDGGDLCSFIRSH------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFL 189 (406)
Q Consensus 117 lV~E~~~ggsL~~~l~~~------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~ 189 (406)
+++||+++|+|.+++... ..+++..+..++.|++.||+|||++||+|+||||+||+++ ++.+||+|||+++..
T Consensus 84 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~ 163 (273)
T cd05074 84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKI 163 (273)
T ss_pred EEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccccc
Confidence 899999999999887432 2478999999999999999999999999999999999999 669999999998865
Q ss_pred CCCC---CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCh
Q psy5368 190 APND---QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSP 265 (406)
Q Consensus 190 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~ 265 (406)
.... ......+++.|++||.+....++.++|||||||++|+|++ |.+||.+.+.......+........+ ...++
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 242 (273)
T cd05074 164 YSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQP-PDCLE 242 (273)
T ss_pred cCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCC-CCCCH
Confidence 4322 1223345678999999999889999999999999999999 99999988877776666655444333 35789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 266 DCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 266 ~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
.+.+++.+||+.+|++|||+.+++.+
T Consensus 243 ~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 243 DVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=287.05 Aligned_cols=244 Identities=28% Similarity=0.412 Sum_probs=190.0
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCcc-------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRK-------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~-------~~~~~~lV~E~~~g 124 (406)
...||.|+||.||++... +..+++|++.... ......+.+|+.++..++|||+++ .....|+|+||+ +
T Consensus 15 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~ 93 (328)
T cd07856 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-G 93 (328)
T ss_pred EEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-c
Confidence 456788888888888743 4567777665322 223456889999999999999766 345789999999 5
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
++|.++++. .++++..+..++.|++.||.|||++|++|+||+|.||+++ ++.++|+|||++..... ......+++.
T Consensus 94 ~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~ 170 (328)
T cd07856 94 TDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--QMTGYVSTRY 170 (328)
T ss_pred cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--CcCCCccccc
Confidence 599988864 4689999999999999999999999999999999999998 67899999999875432 2234567889
Q ss_pred CCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------------------cCC--CC
Q psy5368 204 YMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALS-----------------------SAP--IT 257 (406)
Q Consensus 204 y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~-----------------------~~~--~~ 257 (406)
|+|||.+.+ ..++.++|+||+||++|+|++|..||...........+.. ... ..
T Consensus 171 y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (328)
T cd07856 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREP 250 (328)
T ss_pred ccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCC
Confidence 999998866 5689999999999999999999999987654322111110 000 00
Q ss_pred CC----CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCcc
Q psy5368 258 IP----PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAE 303 (406)
Q Consensus 258 ~~----~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~~ 303 (406)
.+ ...+++++.++|.+||+.+|++|||+++++.||||...+.|..+
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~ 300 (328)
T cd07856 251 VPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDE 300 (328)
T ss_pred CcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccc
Confidence 01 02467899999999999999999999999999999876655443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=281.89 Aligned_cols=231 Identities=17% Similarity=0.202 Sum_probs=169.4
Q ss_pred eeeecceeeeEEEeeeeeec-----eeEEeeeecCCccc--h---------hhhhhHHhhcccCCCCCCcccC-------
Q psy5368 56 TIRYGELQYDTVQNSQIRLG-----TVKYSQVRYDTITS--H---------SEFERPRAGLSNLRAPEGRKRP------- 112 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~-----~v~vk~~~~~~~~~--~---------~~~~~E~~~l~~l~h~ni~~~~------- 112 (406)
..+||+|+||.||++..... .+++|......... . .....+...+..+.|+|++...
T Consensus 17 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 96 (294)
T PHA02882 17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKR 96 (294)
T ss_pred eeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEec
Confidence 34677888888888775433 22333222111110 0 1122334456677888875521
Q ss_pred ---CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccc
Q psy5368 113 ---RYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQF 188 (406)
Q Consensus 113 ---~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~ 188 (406)
.+.++++|++.. ++.+.+......++..+..++.|++.||+|||+++|+||||||+|||++ ++.++|+|||+|+.
T Consensus 97 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~ 175 (294)
T PHA02882 97 CRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASH 175 (294)
T ss_pred CCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcCCcee
Confidence 245788998854 8888887666688999999999999999999999999999999999998 67999999999976
Q ss_pred cCCCC--------CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HH--------HHHHHH
Q psy5368 189 LAPND--------QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNL-SQ--------LRAQAL 251 (406)
Q Consensus 189 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~-~~--------~~~~~~ 251 (406)
...+. ......||+.|+|||++.+..++.++||||+||++|||++|..||.+... .. ....+.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 255 (294)
T PHA02882 176 FIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLH 255 (294)
T ss_pred eccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhh
Confidence 53221 12234699999999999999999999999999999999999999987632 11 111221
Q ss_pred hcCCCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 252 SSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 252 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
.. .......++.+.+++..|+..+|++||++.++++
T Consensus 256 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 256 EG---KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred hh---hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 11 1222357899999999999999999999999875
|
|
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=286.47 Aligned_cols=204 Identities=25% Similarity=0.421 Sum_probs=163.3
Q ss_pred hhhhhHHhhcccCCC--CC----------CcccCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHH
Q psy5368 91 SEFERPRAGLSNLRA--PE----------GRKRPRYVYIILEYCDGGDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFL 156 (406)
Q Consensus 91 ~~~~~E~~~l~~l~h--~n----------i~~~~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~l 156 (406)
+..+-|+++|.++.+ |+ .+...++.|||+|.+ |-|+.+++.+++ +++...++.+++||+.++++|
T Consensus 130 eAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fL 208 (415)
T KOG0671|consen 130 EAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFL 208 (415)
T ss_pred hHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHH
Confidence 345668999999943 33 345788999999999 669999998765 799999999999999999999
Q ss_pred HHCCcccccCCCcceEeeC---------------------CeeEEEecccccccCCCCCCCcccCCCCCCChhhhcCCCC
Q psy5368 157 RENNVCHFDLKPQNILIKN---------------------NTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPY 215 (406)
Q Consensus 157 H~~givH~Dlkp~NIll~~---------------------~~~kL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 215 (406)
|+.+++|-||||+|||+.+ ..++++|||.|.... ......+.|..|+|||++.+-.+
T Consensus 209 h~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLgLGw 286 (415)
T KOG0671|consen 209 HDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILGLGW 286 (415)
T ss_pred HhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceec--cCcceeeeccccCCchheeccCc
Confidence 9999999999999999931 147999999997643 34467788999999999999999
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhcC-----------------CCCCCCC--------------
Q psy5368 216 NAKADLWSLGVLVFEALFGHAPYASCNLSQ---LRAQALSSA-----------------PITIPPN-------------- 261 (406)
Q Consensus 216 ~~~~DiwSlG~il~elltg~~pf~~~~~~~---~~~~~~~~~-----------------~~~~~~~-------------- 261 (406)
+.++||||+||||+|+.||...|......+ +.+.++... .+..+..
T Consensus 287 S~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ck 366 (415)
T KOG0671|consen 287 SQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCK 366 (415)
T ss_pred CCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCc
Confidence 999999999999999999999998765332 222222110 1111110
Q ss_pred ----------CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy5368 262 ----------SLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 262 ----------~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 297 (406)
.-..++.||+.+||.+||.+|+|+.|+|.||||+..
T Consensus 367 pl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 367 PLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred cHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence 011348899999999999999999999999999864
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=305.69 Aligned_cols=236 Identities=22% Similarity=0.389 Sum_probs=205.9
Q ss_pred ceeeecceeeeEEEeeeee-----eceeEEeeeecCCccc-hhhhhhHHhhcccCCCCCCcc------cCCeEEEEEecc
Q psy5368 55 STIRYGELQYDTVQNSQIR-----LGTVKYSQVRYDTITS-HSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYC 122 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~-----~~~v~vk~~~~~~~~~-~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~ 122 (406)
.+.+||.|.||.|++|.++ ...||+|.++....+. ..+|+.|+.++.++.|||++. ..+-+.||+|||
T Consensus 633 Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyM 712 (996)
T KOG0196|consen 633 IEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYM 712 (996)
T ss_pred EEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhh
Confidence 4779999999999999973 3468999887665443 558999999999999999765 556778999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeCC-eeEEEecccccccCCCCCC-Cccc
Q psy5368 123 DGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLADFGFAQFLAPNDQG-DSIQ 199 (406)
Q Consensus 123 ~ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~~-~~kL~DFGla~~~~~~~~~-~~~~ 199 (406)
++|+|..+|+++ +.|+..+..-+++.|+.|+.||-+.|+|||||-+.|||++.+ .+|++|||+++.+.++... .+..
T Consensus 713 ENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~ 792 (996)
T KOG0196|consen 713 ENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTL 792 (996)
T ss_pred hCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCcccccc
Confidence 999999999876 479999999999999999999999999999999999999955 9999999999987655421 1111
Q ss_pred -C--CCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhc
Q psy5368 200 -G--SPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL 275 (406)
Q Consensus 200 -g--t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L 275 (406)
| ...|.|||.+.-.+++.+|||||+|++|||.++ |..||.+.+..+....+..+...+.|. ++|..+.+|+..||
T Consensus 793 GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPm-DCP~aL~qLMldCW 871 (996)
T KOG0196|consen 793 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPM-DCPAALYQLMLDCW 871 (996)
T ss_pred CCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCC-CCcHHHHHHHHHHH
Confidence 1 356999999999999999999999999999885 999999999999999998887666554 79999999999999
Q ss_pred ccCCCCCCCHHHHhcC
Q psy5368 276 QKDPMRRISYEDLFSH 291 (406)
Q Consensus 276 ~~dP~~Rps~~ell~h 291 (406)
++|-.+||.+.||+++
T Consensus 872 qkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 872 QKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHhhcCCCHHHHHHH
Confidence 9999999999999874
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=295.35 Aligned_cols=258 Identities=26% Similarity=0.375 Sum_probs=205.5
Q ss_pred ccccceEEEeeeeee-EEEeeeeecCCcceeeeeeccccccccceeeecCceeeecceeeeEEEeeeeeeceeEEeeeec
Q psy5368 6 TVRYGTVRLGSVKYG-QVQLSTVRYGKVRYSQVRSDTVRSGTVRYDIVGSSTIRYGELQYDTVQNSQIRLGTVKYSQVRY 84 (406)
Q Consensus 6 ~g~~~~V~ig~~~~g-y~vv~~lg~G~~~~~~~~~d~~~~~~~~~~i~~~~~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~ 84 (406)
+-|||-|.||+.+.+ |.|+...|.|-||+|-.+.|+....+++.+|+...
T Consensus 418 aEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN----------------------------- 468 (752)
T KOG0670|consen 418 AEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN----------------------------- 468 (752)
T ss_pred ccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-----------------------------
Confidence 349999999999998 99999999888888888877776665555544443
Q ss_pred CCccchhhhhhHHhhcccCCCCC------------CcccCCeEEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHH
Q psy5368 85 DTITSHSEFERPRAGLSNLRAPE------------GRKRPRYVYIILEYCDGGDLCSFIRSHE---KLSEFQCQQFVRQL 149 (406)
Q Consensus 85 ~~~~~~~~~~~E~~~l~~l~h~n------------i~~~~~~~~lV~E~~~ggsL~~~l~~~~---~l~~~~~~~i~~ql 149 (406)
...++.=++|+++|++|+.-. -+...+++|||+|-. ..+|.++|++.+ .|....++.++.|+
T Consensus 469 --E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQL 545 (752)
T KOG0670|consen 469 --EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQL 545 (752)
T ss_pred --hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHH
Confidence 133445578899999885431 344788999999999 459999998765 58999999999999
Q ss_pred HHHHHHHHHCCcccccCCCcceEeeC--CeeEEEecccccccCCCCCCCcccCCCCCCChhhhcCCCCCchhhHHHHHHH
Q psy5368 150 VLALKFLRENNVCHFDLKPQNILIKN--NTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVL 227 (406)
Q Consensus 150 ~~aL~~lH~~givH~Dlkp~NIll~~--~~~kL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 227 (406)
..||..|-..||+|.||||.|||+++ +.+||||||.|.....+. ...+.-+..|.|||++.|-+|+...|+||+||+
T Consensus 546 flALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgct 624 (752)
T KOG0670|consen 546 FLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASENE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCT 624 (752)
T ss_pred HHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccccccc-ccHHHHHHhccCcceeecCcccCCccceeecee
Confidence 99999999999999999999999994 489999999998765443 345556888999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhcCCC----------------------------------------CCCC-------
Q psy5368 228 VFEALFGHAPYASCNLSQLRAQALSSAPI----------------------------------------TIPP------- 260 (406)
Q Consensus 228 l~elltg~~pf~~~~~~~~~~~~~~~~~~----------------------------------------~~~~------- 260 (406)
||||.||+..|++.+...++......... ..-|
T Consensus 625 LYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~ 704 (752)
T KOG0670|consen 625 LYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSE 704 (752)
T ss_pred eEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHH
Confidence 99999999999998655443332211000 0000
Q ss_pred -----------CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy5368 261 -----------NSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 261 -----------~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 296 (406)
..+-..+++|+.+||..||++|.|..++|+||||..
T Consensus 705 l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 705 LIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred HhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 001134899999999999999999999999999863
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=267.96 Aligned_cols=232 Identities=34% Similarity=0.639 Sum_probs=197.8
Q ss_pred eeeEEEeeeeee--ceeEEeeeecCCccc-hhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHHHHHHh
Q psy5368 63 QYDTVQNSQIRL--GTVKYSQVRYDTITS-HSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLCSFIRS 133 (406)
Q Consensus 63 ~~g~Vy~~~~~~--~~v~vk~~~~~~~~~-~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~~~l~~ 133 (406)
+||.||++.... ..+++|......... ...+.+|+..+++++|+|+++ .....++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 578999999854 678888876655444 678999999999999999765 55788999999999999999987
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCCCChhhhcC
Q psy5368 134 HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAG 212 (406)
Q Consensus 134 ~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~ 212 (406)
...+++..+..++.+++.++.+||+.|++|+||+|.||+++ ++.++|+|||.+.............++..|+|||.+.+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~ 160 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLG 160 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHHcc
Confidence 76799999999999999999999999999999999999999 67999999999988766555556678899999999998
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCCCCC-CChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 213 SPYNAKADLWSLGVLVFEALFGHAPYAS-CNLSQLRAQALSSAPITIPPNS-LSPDCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 213 ~~~~~~~DiwSlG~il~elltg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~-~s~~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
..++.++|+||+|++++++++|..||.. ...................... ++.++.+++.+||..+|++||++.++++
T Consensus 161 ~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 161 KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 8899999999999999999999999988 5555555544443332222222 8899999999999999999999999999
Q ss_pred CCCC
Q psy5368 291 HPYP 294 (406)
Q Consensus 291 hp~~ 294 (406)
||||
T Consensus 241 ~~~~ 244 (244)
T smart00220 241 HPFF 244 (244)
T ss_pred CCCC
Confidence 9997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=295.07 Aligned_cols=234 Identities=21% Similarity=0.343 Sum_probs=205.2
Q ss_pred eeecceeeeEEEeeeeee-----ceeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCccc-----CCeEEEEEeccCCC
Q psy5368 57 IRYGELQYDTVQNSQIRL-----GTVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRKR-----PRYVYIILEYCDGG 125 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~-----~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~~-----~~~~~lV~E~~~gg 125 (406)
.+||+|.||.|.+|.|.. -.||||.++.+... ...+|.+|+.+|.+|+|+|++.. +.-..+|||++++|
T Consensus 116 e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~ELaplG 195 (1039)
T KOG0199|consen 116 ELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFELAPLG 195 (1039)
T ss_pred HHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhhcccc
Confidence 368999999999999842 35788888776644 56789999999999999998763 34556999999999
Q ss_pred CHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCccc---
Q psy5368 126 DLCSFIRS--HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQ--- 199 (406)
Q Consensus 126 sL~~~l~~--~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~--- 199 (406)
+|.+.|++ +..|.......++.||+.|+.||.++++|||||-..|+|+- ...+||+|||+.+.+..+.......
T Consensus 196 SLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~r 275 (1039)
T KOG0199|consen 196 SLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQR 275 (1039)
T ss_pred hHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCC
Confidence 99999977 34688899999999999999999999999999999999998 6699999999999988776654332
Q ss_pred -CCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhccc
Q psy5368 200 -GSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 200 -gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~ 277 (406)
-...|+|||.+....++.++|+|++||+||||+| |..||.+.....++..+..+.....|+ .+|+++.+++..||..
T Consensus 276 kvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk-~csedIY~imk~cWah 354 (1039)
T KOG0199|consen 276 KVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPK-YCSEDIYQIMKNCWAH 354 (1039)
T ss_pred cCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCC-CChHHHHHHHHHhccC
Confidence 2456999999999999999999999999999998 999999999999999999877777666 6999999999999999
Q ss_pred CCCCCCCHHHHhcC
Q psy5368 278 DPMRRISYEDLFSH 291 (406)
Q Consensus 278 dP~~Rps~~ell~h 291 (406)
+|.+||||..|...
T Consensus 355 ~paDRptFsair~~ 368 (1039)
T KOG0199|consen 355 NPADRPTFSAIRED 368 (1039)
T ss_pred CccccccHHHHHHh
Confidence 99999999988644
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=286.82 Aligned_cols=233 Identities=24% Similarity=0.403 Sum_probs=202.7
Q ss_pred eeeecceeeeEEEeeeeee--ceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQIRL--GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
..+||-|.||.||.|.|+. -+|+||.++.+. ....+|+.|+.+++.++|||++. ...-+|||+|||..|+|
T Consensus 272 khKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNL 350 (1157)
T KOG4278|consen 272 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNL 350 (1157)
T ss_pred eeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccH
Confidence 3479999999999999975 467888887665 45678999999999999999765 66778999999999999
Q ss_pred HHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC--CcccCCC
Q psy5368 128 CSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG--DSIQGSP 202 (406)
Q Consensus 128 ~~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~--~~~~gt~ 202 (406)
.++|++.. -++.-..+.++.||..|++||..++++||||-..|.|+. +..+|++|||+++.|..+... ....-..
T Consensus 351 LdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPI 430 (1157)
T KOG4278|consen 351 LDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPI 430 (1157)
T ss_pred HHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCccCcc
Confidence 99998764 477778889999999999999999999999999999999 558999999999998755432 1222355
Q ss_pred CCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCC
Q psy5368 203 LYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 203 ~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
.|.|||-+.-..++.++|||+|||+|||+.| |..||++.+..........+.....|. .|++.+.+|+..||+++|.+
T Consensus 431 KWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~Pe-GCPpkVYeLMraCW~WsPsD 509 (1157)
T KOG4278|consen 431 KWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPE-GCPPKVYELMRACWNWSPSD 509 (1157)
T ss_pred cccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCC-CCCHHHHHHHHHHhcCCccc
Confidence 6999999999999999999999999999998 999999999999988888887777665 69999999999999999999
Q ss_pred CCCHHHHhc
Q psy5368 282 RISYEDLFS 290 (406)
Q Consensus 282 Rps~~ell~ 290 (406)
||++.|+-+
T Consensus 510 RPsFaeiHq 518 (1157)
T KOG4278|consen 510 RPSFAEIHQ 518 (1157)
T ss_pred CccHHHHHH
Confidence 999988743
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=295.93 Aligned_cols=243 Identities=21% Similarity=0.262 Sum_probs=165.9
Q ss_pred CceeeecceeeeEEEeeeeee------ceeEEeeeecCCccchhhhhhHH-h---------hcccCCCCCCcccCCeEEE
Q psy5368 54 SSTIRYGELQYDTVQNSQIRL------GTVKYSQVRYDTITSHSEFERPR-A---------GLSNLRAPEGRKRPRYVYI 117 (406)
Q Consensus 54 ~~~~~lG~G~~g~Vy~~~~~~------~~v~vk~~~~~~~~~~~~~~~E~-~---------~l~~l~h~ni~~~~~~~~l 117 (406)
.....||+|+||.||++.... ..+++|+..... ..+.+..+. . .+..+.++........+++
T Consensus 135 ~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~--~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 212 (566)
T PLN03225 135 VLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG--AVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDEYWL 212 (566)
T ss_pred EEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc--hhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCceEE
Confidence 345789999999999999753 467888764322 111111111 0 0001111111246678999
Q ss_pred EEeccCCCCHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee--C
Q psy5368 118 ILEYCDGGDLCSFIRSHEK--------------------LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK--N 175 (406)
Q Consensus 118 V~E~~~ggsL~~~l~~~~~--------------------l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~--~ 175 (406)
|+||+++++|.+++..... ..+..+..++.||+.||.|||++||+||||||+|||++ +
T Consensus 213 V~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~ 292 (566)
T PLN03225 213 VWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGS 292 (566)
T ss_pred EEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCC
Confidence 9999999999999875421 12345668999999999999999999999999999998 3
Q ss_pred CeeEEEecccccccCCC--CCCCcccCCCCCCChhhhcCCC----------------------CCchhhHHHHHHHHHHH
Q psy5368 176 NTLKLADFGFAQFLAPN--DQGDSIQGSPLYMAPEILAGSP----------------------YNAKADLWSLGVLVFEA 231 (406)
Q Consensus 176 ~~~kL~DFGla~~~~~~--~~~~~~~gt~~y~aPE~~~~~~----------------------~~~~~DiwSlG~il~el 231 (406)
+.+||+|||+|+.+... .......+++.|+|||.+.... ++.++||||+||+||||
T Consensus 293 ~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el 372 (566)
T PLN03225 293 GSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 372 (566)
T ss_pred CcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHH
Confidence 58999999999765432 2234567899999999764322 33456999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhcC----------CCCCCC---------CCCChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q psy5368 232 LFGHAPYASCNLSQLRAQALSSA----------PITIPP---------NSLSPDCMDFLSRLLQKDPMRRISYEDLFSHP 292 (406)
Q Consensus 232 ltg~~pf~~~~~~~~~~~~~~~~----------~~~~~~---------~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp 292 (406)
+++..|+.... ......+.... .....+ ...+....+||.+||+.||++|||++++|+||
T Consensus 373 ~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hp 451 (566)
T PLN03225 373 AFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHP 451 (566)
T ss_pred HhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCc
Confidence 99777654321 11111111100 000000 01233456899999999999999999999999
Q ss_pred CCCCCCC
Q psy5368 293 YPDLIHA 299 (406)
Q Consensus 293 ~~~~~~~ 299 (406)
||+....
T Consensus 452 ff~~~~~ 458 (566)
T PLN03225 452 YFDREGL 458 (566)
T ss_pred CcCCCCc
Confidence 9986543
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=270.52 Aligned_cols=217 Identities=25% Similarity=0.396 Sum_probs=178.4
Q ss_pred eeEEeeeec--CCccchhhhhhHHhhcccCCCCCCcc------------cCCeEEEEEeccCCCCHHHHHHhCCCCCHHH
Q psy5368 76 TVKYSQVRY--DTITSHSEFERPRAGLSNLRAPEGRK------------RPRYVYIILEYCDGGDLCSFIRSHEKLSEFQ 141 (406)
Q Consensus 76 ~v~vk~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~------------~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~ 141 (406)
.|++|+... ......++..+|..++..++|+|++. .-...|+|||+|.. +|.+.+.. .++-..
T Consensus 43 ~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~~--elDH~t 119 (369)
T KOG0665|consen 43 PVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVILM--ELDHET 119 (369)
T ss_pred ceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHHH--hcchHH
Confidence 445554332 33556778899999999999999876 33357899999976 99999973 578899
Q ss_pred HHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCCCChhhhcCCCCCchhh
Q psy5368 142 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKAD 220 (406)
Q Consensus 142 ~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 220 (406)
+..++.|++.|++|||+.||+||||||+||++. +..+||.|||+|+.....-..+.++.|..|.|||++.+..|...+|
T Consensus 120 is~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vd 199 (369)
T KOG0665|consen 120 ISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVD 199 (369)
T ss_pred HHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcccccCchhheeeccCchheeccCCcccch
Confidence 999999999999999999999999999999999 7799999999998876665677888999999999999988999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC------------------------------CCCC---------
Q psy5368 221 LWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPIT------------------------------IPPN--------- 261 (406)
Q Consensus 221 iwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~------------------------------~~~~--------- 261 (406)
|||+||++.||++|...|.+.+.-+.+.++....... +|..
T Consensus 200 iwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~ 279 (369)
T KOG0665|consen 200 IWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGS 279 (369)
T ss_pred hhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCC
Confidence 9999999999999999999876555444443321100 0000
Q ss_pred -CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy5368 262 -SLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPD 295 (406)
Q Consensus 262 -~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~ 295 (406)
.-+..+++|+.+||..||++|.|++++|+|||++
T Consensus 280 ~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 280 KLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred ccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 1134589999999999999999999999999998
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.38 Aligned_cols=236 Identities=25% Similarity=0.429 Sum_probs=183.5
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc----------------------
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK---------------------- 110 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~---------------------- 110 (406)
=..||+||||.||+++. ++...|+|++.... ......+.+|+..|.+|+|||++.
T Consensus 484 L~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~ 563 (1351)
T KOG1035|consen 484 LELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS 563 (1351)
T ss_pred HHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence 34789999999999986 56678999887664 223457899999999999997322
Q ss_pred --------------------------------------------------------------------------------
Q psy5368 111 -------------------------------------------------------------------------------- 110 (406)
Q Consensus 111 -------------------------------------------------------------------------------- 110 (406)
T Consensus 564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d 643 (1351)
T KOG1035|consen 564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD 643 (1351)
T ss_pred hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence
Q ss_pred ---------------cC--------CeEEEEEeccCCCCHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHHCCcccccC
Q psy5368 111 ---------------RP--------RYVYIILEYCDGGDLCSFIRSHEKL-SEFQCQQFVRQLVLALKFLRENNVCHFDL 166 (406)
Q Consensus 111 ---------------~~--------~~~~lV~E~~~ggsL~~~l~~~~~l-~~~~~~~i~~ql~~aL~~lH~~givH~Dl 166 (406)
.. -.+||=||||+.-+|.+++..+... .....++++++|++||.|+|++|||||||
T Consensus 644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDL 723 (1351)
T KOG1035|consen 644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDL 723 (1351)
T ss_pred cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccC
Confidence 00 3478999999996777777665433 47888999999999999999999999999
Q ss_pred CCcceEee-CCeeEEEecccccccC-------------------CCCCCCcccCCCCCCChhhhcCCC---CCchhhHHH
Q psy5368 167 KPQNILIK-NNTLKLADFGFAQFLA-------------------PNDQGDSIQGSPLYMAPEILAGSP---YNAKADLWS 223 (406)
Q Consensus 167 kp~NIll~-~~~~kL~DFGla~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwS 223 (406)
||.||+++ ++.+||+|||+|+... +....++.+||..|+|||++.+.. |+.|+||||
T Consensus 724 KP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYS 803 (1351)
T KOG1035|consen 724 KPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYS 803 (1351)
T ss_pred CcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHH
Confidence 99999999 7799999999998721 111345678999999999998754 999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCCCCC---CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy5368 224 LGVLVFEALFGHAPYASCNLS-QLRAQALSSAPITIP---PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPD 295 (406)
Q Consensus 224 lG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~---~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~ 295 (406)
+|+|++||+. ||...-.. .+...+. ....+.+ ...--+.-..+|.+||+.||.+|||+.|+|++.|+-
T Consensus 804 LGIVlFEM~y---PF~TsMERa~iL~~LR-~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 804 LGIVLFEMLY---PFGTSMERASILTNLR-KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHHHhc---cCCchHHHHHHHHhcc-cCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 9999999984 56553322 2222222 3233333 112334567899999999999999999999999986
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=290.51 Aligned_cols=248 Identities=17% Similarity=0.200 Sum_probs=177.3
Q ss_pred cccceeeecCceeeecceeeeEEEeeee------------------eeceeEEeeeecCCccchhhh-------------
Q psy5368 45 GTVRYDIVGSSTIRYGELQYDTVQNSQI------------------RLGTVKYSQVRYDTITSHSEF------------- 93 (406)
Q Consensus 45 ~~~~~~i~~~~~~~lG~G~~g~Vy~~~~------------------~~~~v~vk~~~~~~~~~~~~~------------- 93 (406)
...+| ...++||+|+||+||+|.. ....|++|++.........+|
T Consensus 143 ~~d~F----~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~ 218 (507)
T PLN03224 143 SSDDF----QLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAET 218 (507)
T ss_pred cccCc----eEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccch
Confidence 34556 4567889999999999863 224588888765433322333
Q ss_pred -hhHHhhcccCCCCCCcc-------------------cCCeEEEEEeccCCCCHHHHHHhC-------------------
Q psy5368 94 -ERPRAGLSNLRAPEGRK-------------------RPRYVYIILEYCDGGDLCSFIRSH------------------- 134 (406)
Q Consensus 94 -~~E~~~l~~l~h~ni~~-------------------~~~~~~lV~E~~~ggsL~~~l~~~------------------- 134 (406)
..|+..+.+++|.++.. ..+..+|||||+++++|.++++..
T Consensus 219 ~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~ 298 (507)
T PLN03224 219 GMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIP 298 (507)
T ss_pred hHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchh
Confidence 34666677776655311 245689999999999999998642
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCc--ccCCCCCCC
Q psy5368 135 -----EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDS--IQGSPLYMA 206 (406)
Q Consensus 135 -----~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~--~~gt~~y~a 206 (406)
..+++..++.++.|++.+|.|||+.+|+||||||+|||++ ++.+||+|||++..+........ ..+|+.|+|
T Consensus 299 ~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 299 DNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred hhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 1246778899999999999999999999999999999998 67999999999976543322222 234789999
Q ss_pred hhhhcCCCC--------------------C--chhhHHHHHHHHHHHHhCCC-CCCCCCHHHHH----------HHHHhc
Q psy5368 207 PEILAGSPY--------------------N--AKADLWSLGVLVFEALFGHA-PYASCNLSQLR----------AQALSS 253 (406)
Q Consensus 207 PE~~~~~~~--------------------~--~~~DiwSlG~il~elltg~~-pf~~~~~~~~~----------~~~~~~ 253 (406)
||.+..... + .+.|+||+|||+++|++|.. ||......... ......
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 999864321 1 24699999999999999875 77542211100 001111
Q ss_pred CCCCCC-CCCCChHHHHHHHHhcccCC---CCCCCHHHHhcCCCCCC
Q psy5368 254 APITIP-PNSLSPDCMDFLSRLLQKDP---MRRISYEDLFSHPYPDL 296 (406)
Q Consensus 254 ~~~~~~-~~~~s~~l~~li~~~L~~dP---~~Rps~~ell~hp~~~~ 296 (406)
....++ ....++..++|+.+||..+| .+|+|++|+|+||||..
T Consensus 459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 111221 23578999999999999866 68999999999999964
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=286.74 Aligned_cols=236 Identities=23% Similarity=0.332 Sum_probs=199.3
Q ss_pred eeeecceeeeEEEeeeeee-ceeEEeeeecCCccch-hhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQIRL-GTVKYSQVRYDTITSH-SEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-~~v~vk~~~~~~~~~~-~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
..+||+|-||.|..++..+ ..||+|.++.+..... .+|.+|+++|.+|+|||+++ .++-+++|+|||++|+|
T Consensus 543 ~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDL 622 (807)
T KOG1094|consen 543 KEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDL 622 (807)
T ss_pred hhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcH
Confidence 3478999999999999877 7899999998876665 78999999999999999877 57778999999999999
Q ss_pred HHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC---CcccCC
Q psy5368 128 CSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG---DSIQGS 201 (406)
Q Consensus 128 ~~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~---~~~~gt 201 (406)
.+++..+. .+......+|+.||+.|++||.+.++|||||.+.|+|++ +.++||+|||+++.+-..+.. ...+-.
T Consensus 623 nqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlp 702 (807)
T KOG1094|consen 623 NQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLP 702 (807)
T ss_pred HHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeeecceeee
Confidence 99998774 345667788999999999999999999999999999999 779999999999876544322 223345
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHhcCCCC------CCCCCCChHHHHHHHH
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEAL--FGHAPYASCNLSQLRAQALSSAPIT------IPPNSLSPDCMDFLSR 273 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ell--tg~~pf~~~~~~~~~~~~~~~~~~~------~~~~~~s~~l~~li~~ 273 (406)
..|||||.+..++++.+||+|+||+++||++ +...||...+.++..+......... ..|.-++..+.+|+.+
T Consensus 703 iRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~ 782 (807)
T KOG1094|consen 703 IRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLR 782 (807)
T ss_pred eeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHH
Confidence 7899999999999999999999999999986 5889999888777666554432221 1233688999999999
Q ss_pred hcccCCCCCCCHHHHhcC
Q psy5368 274 LLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 274 ~L~~dP~~Rps~~ell~h 291 (406)
||..|.++|||++++..+
T Consensus 783 Cw~~es~~RPsFe~lh~~ 800 (807)
T KOG1094|consen 783 CWRRESEQRPSFEQLHLF 800 (807)
T ss_pred HhchhhhcCCCHHHHHHH
Confidence 999999999999998653
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=295.12 Aligned_cols=229 Identities=30% Similarity=0.499 Sum_probs=184.9
Q ss_pred ceeeecceeeeEEEeeeee--eceeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc-----c-------CCeEEEEE
Q psy5368 55 STIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK-----R-------PRYVYIIL 119 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~-----~-------~~~~~lV~ 119 (406)
-...||+|+||.||++..+ +..||||.++... ....+...+|+++|++|+|+|||+ + ...-.+||
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 3456899999999999964 4578999887654 445668899999999999999887 1 23356999
Q ss_pred eccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee---CC--eeEEEecccccccCC
Q psy5368 120 EYCDGGDLCSFIRSH---EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK---NN--TLKLADFGFAQFLAP 191 (406)
Q Consensus 120 E~~~ggsL~~~l~~~---~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~---~~--~~kL~DFGla~~~~~ 191 (406)
|||.||||...+++- ..|++.+.+.++.++..||.|||++||+||||||.||++- +| ..||+|||.|+.+..
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d 176 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDD 176 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCC
Confidence 999999999999643 4799999999999999999999999999999999999996 23 579999999999999
Q ss_pred CCCCCcccCCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcCCC----------
Q psy5368 192 NDQGDSIQGSPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNL----SQLRAQALSSAPI---------- 256 (406)
Q Consensus 192 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~----~~~~~~~~~~~~~---------- 256 (406)
+....+..||+.|.+||+... +.|+..+|.|||||++|++.||..||..... .++...+....+.
T Consensus 177 ~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~e 256 (732)
T KOG4250|consen 177 NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEE 256 (732)
T ss_pred CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeeccc
Confidence 999999999999999999995 7899999999999999999999999965322 2233333322111
Q ss_pred --------CCC-CCCCCh----HHHHHHHHhcccCCCCCC
Q psy5368 257 --------TIP-PNSLSP----DCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 257 --------~~~-~~~~s~----~l~~li~~~L~~dP~~Rp 283 (406)
.+| +...++ .+-.++..+|..+|++|-
T Consensus 257 Ngpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 257 NGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred CCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 011 112332 255678889999999998
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=255.15 Aligned_cols=235 Identities=23% Similarity=0.436 Sum_probs=188.0
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCccchhhhhhHHhhcccCC-CCCCcc--------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITSHSEFERPRAGLSNLR-APEGRK--------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~--------~~~~~~lV~E~~~g 124 (406)
..++|.|-|+.|+.|.. ++.++.+|.++. ...+.+.||+.+|..|+ |||++. ......||+||+.+
T Consensus 43 vrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n 119 (338)
T KOG0668|consen 43 VRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNN 119 (338)
T ss_pred HHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhcc
Confidence 34568888888888873 455666665543 34567999999999996 999765 55667899999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee--CCeeEEEecccccccCCCCCCCcccCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK--NNTLKLADFGFAQFLAPNDQGDSIQGSP 202 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~--~~~~kL~DFGla~~~~~~~~~~~~~gt~ 202 (406)
.+...+. +.++...++.++.+++.||.||||+||+|||+||.|+++| ...++|+|+|+|.+..+...-+..+.+.
T Consensus 120 ~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASR 196 (338)
T KOG0668|consen 120 TDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR 196 (338)
T ss_pred ccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehh
Confidence 8877765 4688899999999999999999999999999999999999 5589999999999988887777778899
Q ss_pred CCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhc------------CCCCCC---------
Q psy5368 203 LYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYA-SCNLSQLRAQALSS------------APITIP--------- 259 (406)
Q Consensus 203 ~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~-~~~~~~~~~~~~~~------------~~~~~~--------- 259 (406)
.|-.||.+..- .|+.+-|+|||||++..|+..+.||- +.+..+...+|... ..+..+
T Consensus 197 yfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~ 276 (338)
T KOG0668|consen 197 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGR 276 (338)
T ss_pred hcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhc
Confidence 99999999874 59999999999999999999988873 33322222222110 000111
Q ss_pred --------------CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy5368 260 --------------PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 260 --------------~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 296 (406)
..-.++++.||+.++|.+|..+|+|++|++.||||..
T Consensus 277 ~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 277 HSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred cccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 0124689999999999999999999999999999974
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=265.93 Aligned_cols=243 Identities=24% Similarity=0.361 Sum_probs=198.4
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc-cchhhhhhHHhhccc-CCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI-TSHSEFERPRAGLSN-LRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~-l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
-..||.|+||+|+|-..+ ++.+|||+++.... ....++..|.+...+ =+.||+++ .++.+||.||+|+-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~- 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI- 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence 346899999999999875 45679998887665 446678888775544 47788776 77889999999964
Q ss_pred CHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcc
Q psy5368 126 DLCSFIR-----SHEKLSEFQCQQFVRQLVLALKFLRE-NNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSI 198 (406)
Q Consensus 126 sL~~~l~-----~~~~l~~~~~~~i~~ql~~aL~~lH~-~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~ 198 (406)
+|..+.+ ++..+++...-.|.-..+.||.||-. .+|+|||+||+|||++ .|.+||||||++..+..+-....-
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~d 227 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTVD 227 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhhc
Confidence 7766542 34579999999999999999999974 5899999999999999 889999999999887766666667
Q ss_pred cCCCCCCChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCCCCCCC----CCChHHHHHH
Q psy5368 199 QGSPLYMAPEILAG--SPYNAKADLWSLGVLVFEALFGHAPYASCN-LSQLRAQALSSAPITIPPN----SLSPDCMDFL 271 (406)
Q Consensus 199 ~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~----~~s~~l~~li 271 (406)
.|...|||||.+.. ..|+.+||+||||++|+|+.||+.|+.+-+ ..+...++..+.++.+... .++..+..+|
T Consensus 228 aGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fi 307 (361)
T KOG1006|consen 228 AGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFI 307 (361)
T ss_pred cCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHH
Confidence 79999999999975 348999999999999999999999997643 3444445555544443332 4899999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy5368 272 SRLLQKDPMRRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 272 ~~~L~~dP~~Rps~~ell~hp~~~~~~~ 299 (406)
.-||.+|-.+||++.+++++||++.-..
T Consensus 308 ntCl~Kd~~~Rpky~~Lk~~~fyr~y~~ 335 (361)
T KOG1006|consen 308 NTCLIKDRSDRPKYDDLKKFPFYRMYAV 335 (361)
T ss_pred HHHhhcccccCcchhhhhcCchhhhhhh
Confidence 9999999999999999999999987654
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=292.24 Aligned_cols=255 Identities=25% Similarity=0.435 Sum_probs=215.6
Q ss_pred eeeccccccccceeeecCceeeecceeeeEEEeeeee-eceeEEeeeecCCccchhhhhhHHhhcccC-CCCCCcc----
Q psy5368 37 VRSDTVRSGTVRYDIVGSSTIRYGELQYDTVQNSQIR-LGTVKYSQVRYDTITSHSEFERPRAGLSNL-RAPEGRK---- 110 (406)
Q Consensus 37 ~~~d~~~~~~~~~~i~~~~~~~lG~G~~g~Vy~~~~~-~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~---- 110 (406)
+-+|.+...++.| ....++|.|.+|.||+++.. .+..+..++........+++..|.++|+.+ .|||++.
T Consensus 9 ~~~~~lpdp~d~~----ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~ 84 (953)
T KOG0587|consen 9 IDLSSLPDPADIF----EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGA 84 (953)
T ss_pred cchhhCCCCCCcc----EEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEE
Confidence 4456666677777 44567799999999999863 344444444444456677888899999888 7888654
Q ss_pred -------cCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEE
Q psy5368 111 -------RPRYVYIILEYCDGGDLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKL 180 (406)
Q Consensus 111 -------~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL 180 (406)
.++.+|||||||.|||.-|++++- .++.|..+..|++.++.||.+||...++|||||-.|||++ ++.+||
T Consensus 85 ~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 85 FIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred EEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEE
Confidence 667899999999999999999654 5799999999999999999999999999999999999999 889999
Q ss_pred EecccccccCCC-CCCCcccCCCCCCChhhhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Q psy5368 181 ADFGFAQFLAPN-DQGDSIQGSPLYMAPEILAGS-----PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSA 254 (406)
Q Consensus 181 ~DFGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 254 (406)
+|||.+..+... ...++.+|||.|||||++... .|+.++|+||||++..||--|.+|+.+..+...+..|..+.
T Consensus 165 vDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNP 244 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 244 (953)
T ss_pred eeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCC
Confidence 999999776554 345778899999999999753 47889999999999999999999999999888888887776
Q ss_pred CCCCC-CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy5368 255 PITIP-PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPD 295 (406)
Q Consensus 255 ~~~~~-~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~ 295 (406)
++... +...+.++.+||..||..|-++||+..+++.|||++
T Consensus 245 PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 245 PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred CccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 66655 447889999999999999999999999999999998
|
|
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=282.89 Aligned_cols=243 Identities=23% Similarity=0.419 Sum_probs=190.9
Q ss_pred eecceeeeEEEeeeeeec--eeEEeeeecCCccchh---hhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 58 RYGELQYDTVQNSQIRLG--TVKYSQVRYDTITSHS---EFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~~--~v~vk~~~~~~~~~~~---~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
-||-|+||.|..+....+ ..|.|.+++.+..... -++.|-.||..-..+=+++ +.+++|+||+|++|||
T Consensus 636 ~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGD 715 (1034)
T KOG0608|consen 636 TIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGD 715 (1034)
T ss_pred eecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCcc
Confidence 467777887777664332 2344544443332222 3556777887777765544 8899999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccC---------CCCC--
Q psy5368 127 LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLA---------PNDQ-- 194 (406)
Q Consensus 127 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~---------~~~~-- 194 (406)
+-.+|-+-+-|++..++.++..+.+|+++.|..|+|||||||+||||| +|.+||+||||+.-+. ..+.
T Consensus 716 mMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~R 795 (1034)
T KOG0608|consen 716 MMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHR 795 (1034)
T ss_pred HHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccCCCccc
Confidence 999998889999999999999999999999999999999999999999 8999999999985331 0000
Q ss_pred --------------------------------CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy5368 195 --------------------------------GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCN 242 (406)
Q Consensus 195 --------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 242 (406)
..+.+||+.|+|||++....|+..+|.||.|||||||+.|++||...+
T Consensus 796 qDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~t 875 (1034)
T KOG0608|consen 796 QDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADT 875 (1034)
T ss_pred cccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCC
Confidence 013469999999999999999999999999999999999999998887
Q ss_pred HHHHHHHHHhcCCC-CCC-CCCCChHHHHHHHHhcccCCCCCC---CHHHHhcCCCCCCCCCCC
Q psy5368 243 LSQLRAQALSSAPI-TIP-PNSLSPDCMDFLSRLLQKDPMRRI---SYEDLFSHPYPDLIHAPC 301 (406)
Q Consensus 243 ~~~~~~~~~~~~~~-~~~-~~~~s~~l~~li~~~L~~dP~~Rp---s~~ell~hp~~~~~~~~~ 301 (406)
..+...+++..... .++ ..++|+++.+||.++.. ++++|. .++++..||||+.+++.+
T Consensus 876 p~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDfss 938 (1034)
T KOG0608|consen 876 PGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDFSS 938 (1034)
T ss_pred CCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccchHh
Confidence 76665555544322 222 34899999999998654 578887 467899999999998754
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=295.13 Aligned_cols=240 Identities=26% Similarity=0.315 Sum_probs=192.2
Q ss_pred eeecCceeeecceeeeE-EEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEec
Q psy5368 50 DIVGSSTIRYGELQYDT-VQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEY 121 (406)
Q Consensus 50 ~i~~~~~~~lG~G~~g~-Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~ 121 (406)
++.-++...+|.|+-|+ ||+|...++.||||++-.+ ...-..+|+..|+.- .|||+++ +..+.||..|.
T Consensus 508 k~~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 508 KLFFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eeeeccHHHcccCCCCcEEEEEeeCCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 45557778899998875 9999999999999987542 344568999999887 9999876 88899999999
Q ss_pred cCCCCHHHHHHhCC-C---CCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeC----C--eeEEEecccccccCC
Q psy5368 122 CDGGDLCSFIRSHE-K---LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN----N--TLKLADFGFAQFLAP 191 (406)
Q Consensus 122 ~~ggsL~~~l~~~~-~---l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~----~--~~kL~DFGla~~~~~ 191 (406)
|.. +|.+++.... . ......+.++.|++.||++||+.+||||||||+||||+. + .++|+|||+++.+..
T Consensus 585 C~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 585 CAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 976 9999997741 1 111445788999999999999999999999999999982 3 789999999998875
Q ss_pred CCC----CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcCC-CCCCCCCCCh
Q psy5368 192 NDQ----GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFG-HAPYASCNLSQLRAQALSSAP-ITIPPNSLSP 265 (406)
Q Consensus 192 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg-~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~s~ 265 (406)
... .....||.+|+|||++....-+.++||+|+|||+|+.++| .+||.+.-..+ ..|..+.. ..........
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~~~~d~ 741 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLEPLPDC 741 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeeccCchH
Confidence 543 3456799999999999998888899999999999999985 99997643322 23333321 1111111122
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy5368 266 DCMDFLSRLLQKDPMRRISYEDLFSHPYPD 295 (406)
Q Consensus 266 ~l~~li~~~L~~dP~~Rps~~ell~hp~~~ 295 (406)
++.+||.+|++++|..||++.++|.||+|-
T Consensus 742 eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 742 EAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 899999999999999999999999999985
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=273.59 Aligned_cols=252 Identities=26% Similarity=0.447 Sum_probs=195.0
Q ss_pred EEEeeeeecCCcceeeeeeccccccccceeeecCceeeecceeeeEEEeeeeeeceeEEeeeecCCc-cchhhhhhHHhh
Q psy5368 21 QVQLSTVRYGKVRYSQVRSDTVRSGTVRYDIVGSSTIRYGELQYDTVQNSQIRLGTVKYSQVRYDTI-TSHSEFERPRAG 99 (406)
Q Consensus 21 y~vv~~lg~G~~~~~~~~~d~~~~~~~~~~i~~~~~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~-~~~~~~~~E~~~ 99 (406)
|..++.||.|+||.||-++|..+.++++.+|-.-. |.++.+.. .-++-..+|..+
T Consensus 465 YLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlN------------------------K~WrdEKKeNYhKHAcREyrI 520 (775)
T KOG1151|consen 465 YLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLN------------------------KNWRDEKKENYHKHACREYRI 520 (775)
T ss_pred HHHHHHhccccHHHHHHhcccchhheeeEeeehhc------------------------cchhhHhhhhHHHHHHHHHhh
Confidence 66666666666666666666655555544322211 00000000 113346789999
Q ss_pred cccCCCCCCcc-------cCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCcc
Q psy5368 100 LSNLRAPEGRK-------RPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENN--VCHFDLKPQN 170 (406)
Q Consensus 100 l~~l~h~ni~~-------~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dlkp~N 170 (406)
.+.|.||.+++ +.+.+|-|+|||+|.+|.-+|+.+..+++++++.|+.||+.||.||.+.. |+|-||||.|
T Consensus 521 HKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgN 600 (775)
T KOG1151|consen 521 HKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGN 600 (775)
T ss_pred hhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCcc
Confidence 99999999887 66778999999999999999999999999999999999999999999764 9999999999
Q ss_pred eEeeC----CeeEEEecccccccCCCCCC--------CcccCCCCCCChhhhcCC----CCCchhhHHHHHHHHHHHHhC
Q psy5368 171 ILIKN----NTLKLADFGFAQFLAPNDQG--------DSIQGSPLYMAPEILAGS----PYNAKADLWSLGVLVFEALFG 234 (406)
Q Consensus 171 Ill~~----~~~kL~DFGla~~~~~~~~~--------~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~elltg 234 (406)
||+-+ |.+||+|||+++.+...... ....||.||+|||.+.-+ ..+.++||||+|||+|.++.|
T Consensus 601 ILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYG 680 (775)
T KOG1151|consen 601 ILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYG 680 (775)
T ss_pred EEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhcc
Confidence 99974 47999999999998755432 345799999999987643 367899999999999999999
Q ss_pred CCCCCCCC-HHHHHH--HHHhcCCCCCCCC-CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy5368 235 HAPYASCN-LSQLRA--QALSSAPITIPPN-SLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 235 ~~pf~~~~-~~~~~~--~~~~~~~~~~~~~-~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 296 (406)
+.||.... ..+++. .|+......+|+. .++.++.+||++||++--++|....++-.||||..
T Consensus 681 rKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 681 RKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred CCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 99997643 223322 2334444455544 78999999999999999999999999999999974
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=278.64 Aligned_cols=235 Identities=22% Similarity=0.330 Sum_probs=203.1
Q ss_pred ceeeecceeeeEEEeeeeee------ceeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEecc
Q psy5368 55 STIRYGELQYDTVQNSQIRL------GTVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYC 122 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~------~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~ 122 (406)
..++||+|+||+||+|.+-. -+|++|.+.... .....++.+|+-.+.+|+|||+++ -.....||++|+
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~m 779 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQLM 779 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHhc
Confidence 46789999999999999722 246777665544 334678999999999999999876 333477999999
Q ss_pred CCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCccc-
Q psy5368 123 DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQ- 199 (406)
Q Consensus 123 ~ggsL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~- 199 (406)
++|+|.++++.++ ++..+..+.+..||++|+.|||.++++||||-..|||+. -+.+|+.|||+++............
T Consensus 780 P~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~ 859 (1177)
T KOG1025|consen 780 PLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPG 859 (1177)
T ss_pred ccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccc
Confidence 9999999998764 799999999999999999999999999999999999999 5699999999999877655433222
Q ss_pred --CCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcc
Q psy5368 200 --GSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQ 276 (406)
Q Consensus 200 --gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~ 276 (406)
-.+.|||-|.+....|+.++|||||||++||++| |..|+.+...+++...+..+.+.+.|+ .++-++..++.+||.
T Consensus 860 gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPp-iCtiDVy~~mvkCwm 938 (1177)
T KOG1025|consen 860 GKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPP-ICTIDVYMVMVKCWM 938 (1177)
T ss_pred cccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCC-CccHHHHHHHHHHhc
Confidence 3456999999999999999999999999999998 999999999999999999888877776 699999999999999
Q ss_pred cCCCCCCCHHHHhc
Q psy5368 277 KDPMRRISYEDLFS 290 (406)
Q Consensus 277 ~dP~~Rps~~ell~ 290 (406)
.|+..||+++++..
T Consensus 939 id~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 939 IDADSRPTFKELAE 952 (1177)
T ss_pred cCcccCccHHHHHH
Confidence 99999999998754
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=257.83 Aligned_cols=246 Identities=29% Similarity=0.492 Sum_probs=202.2
Q ss_pred eeecceeeeEEEeeeeeece--eEEeeeecCCccc---hhhhhhHHhhcccC-CCCCC------cccCCeEEEEEeccCC
Q psy5368 57 IRYGELQYDTVQNSQIRLGT--VKYSQVRYDTITS---HSEFERPRAGLSNL-RAPEG------RKRPRYVYIILEYCDG 124 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~~~--v~vk~~~~~~~~~---~~~~~~E~~~l~~l-~h~ni------~~~~~~~~lV~E~~~g 124 (406)
.+||.|+|..|..++...+. .++|.++++.... ..=++.|-.+..+- +||-+ +.+...++.|.||++|
T Consensus 256 ~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~g 335 (593)
T KOG0695|consen 256 RVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNG 335 (593)
T ss_pred eeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecC
Confidence 47899999999998875543 3555554433222 22244555555544 66654 4488899999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccc-cCCCCCCCcccCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQF-LAPNDQGDSIQGSP 202 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~-~~~~~~~~~~~gt~ 202 (406)
|+|--+++.+++++++.++.+...|+.||.|||++||++||||.+|||+| +|.+||+|+|+.+. +.+.+...+.+|||
T Consensus 336 gdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~tstfcgtp 415 (593)
T KOG0695|consen 336 GDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTP 415 (593)
T ss_pred cceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCcccccccCCC
Confidence 99999999999999999999999999999999999999999999999999 89999999999875 34556678899999
Q ss_pred CCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC-------CCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhc
Q psy5368 203 LYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYA-------SCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL 275 (406)
Q Consensus 203 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~-------~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L 275 (406)
.|.|||++++..|+..+|.|++|++++||+.|+.||+ ..+.++...+++....+.+|. .+|-.+..+++.-|
T Consensus 416 nyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr-slsvkas~vlkgfl 494 (593)
T KOG0695|consen 416 NYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR-SLSVKASHVLKGFL 494 (593)
T ss_pred cccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc-eeehhhHHHHHHhh
Confidence 9999999999999999999999999999999999994 344556666666665666654 68888999999999
Q ss_pred ccCCCCCC------CHHHHhcCCCCCCCCCCCcc
Q psy5368 276 QKDPMRRI------SYEDLFSHPYPDLIHAPCAE 303 (406)
Q Consensus 276 ~~dP~~Rp------s~~ell~hp~~~~~~~~~~~ 303 (406)
++||.+|. .+.++..|+||+.+.|.-.+
T Consensus 495 nkdp~erlgc~~~~g~~dik~h~ffr~idwd~le 528 (593)
T KOG0695|consen 495 NKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLE 528 (593)
T ss_pred cCCcHHhcCCCcccchhhhhcchhhhhCCHHHHh
Confidence 99999997 46899999999988775443
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=283.26 Aligned_cols=233 Identities=25% Similarity=0.417 Sum_probs=195.6
Q ss_pred eeecceeeeEEEeeeee---------eceeEEeeeecCCcc-chhhhhhHHhhcccC-CCCCCcc------cCCeEEEEE
Q psy5368 57 IRYGELQYDTVQNSQIR---------LGTVKYSQVRYDTIT-SHSEFERPRAGLSNL-RAPEGRK------RPRYVYIIL 119 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~---------~~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~ 119 (406)
..+|+|+||.|++|... ...|+||..+..... ..+.+..|+++++.+ +|+|++. ..+..++|+
T Consensus 302 ~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~ 381 (609)
T KOG0200|consen 302 KYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIV 381 (609)
T ss_pred ceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEE
Confidence 38999999999999853 345788877655433 466899999999999 6999765 567899999
Q ss_pred eccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeCC-eeEEEe
Q psy5368 120 EYCDGGDLCSFIRSHE----------------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAD 182 (406)
Q Consensus 120 E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~~-~~kL~D 182 (406)
||+..|+|.++++.++ .++......++.||+.|++||++.+++||||-+.|||++.+ .+||+|
T Consensus 382 Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaD 461 (609)
T KOG0200|consen 382 EYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIAD 461 (609)
T ss_pred EeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEcc
Confidence 9999999999998765 38999999999999999999999999999999999999954 999999
Q ss_pred cccccccCCCCCCC--cccC--CCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC-HHHHHHHHHhcCCC
Q psy5368 183 FGFAQFLAPNDQGD--SIQG--SPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCN-LSQLRAQALSSAPI 256 (406)
Q Consensus 183 FGla~~~~~~~~~~--~~~g--t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~-~~~~~~~~~~~~~~ 256 (406)
||+|+......... ...+ ...|||||.+....|+.++||||||++|||++| |..||++.. ..++...+..+...
T Consensus 462 FGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~ 541 (609)
T KOG0200|consen 462 FGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRM 541 (609)
T ss_pred ccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCC
Confidence 99998654443321 1222 234999999999999999999999999999998 999999865 66666666666666
Q ss_pred CCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 257 TIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 257 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
..|. .+++++.+++..||+.+|++||++.++..
T Consensus 542 ~~P~-~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 542 EQPE-HCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred CCCC-CCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 6655 67999999999999999999999998865
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=258.08 Aligned_cols=245 Identities=25% Similarity=0.361 Sum_probs=196.9
Q ss_pred cCceeeecceeeeEEEeeee--eeceeEEeeeec--CCccchhhhhhHHhhcccCCCCCCcc-----------cCCeEEE
Q psy5368 53 GSSTIRYGELQYDTVQNSQI--RLGTVKYSQVRY--DTITSHSEFERPRAGLSNLRAPEGRK-----------RPRYVYI 117 (406)
Q Consensus 53 ~~~~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~-----------~~~~~~l 117 (406)
..+++-||.|+||.||..+. +++.++.|++.. ....+.+++.+|+++|..++|.|+.. --..+|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 35677899999999998886 456788887653 34556778999999999999999644 1123689
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC--
Q psy5368 118 ILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ-- 194 (406)
Q Consensus 118 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~-- 194 (406)
|+|+|.. +|.+.|-.-++++.+.++-+++||++||.|||+.||.||||||.|+|++ +..+||||||+++.......
T Consensus 135 ~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h 213 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN 213 (449)
T ss_pred HHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhh
Confidence 9999976 9999998888999999999999999999999999999999999999999 55899999999987654432
Q ss_pred CCcccCCCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-------------------
Q psy5368 195 GDSIQGSPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSA------------------- 254 (406)
Q Consensus 195 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~------------------- 254 (406)
....+-|-.|+|||++.+. .|+.+.||||+|||+.||+-.+..|...++-+....|..-.
T Consensus 214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~ 293 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHV 293 (449)
T ss_pred hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHh
Confidence 3445568889999999885 49999999999999999999999998776555544443211
Q ss_pred ---CCCCCC----------CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 255 ---PITIPP----------NSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 255 ---~~~~~~----------~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
....|. ..-..+..+++.++|..||++|.+.++++.|++.....
T Consensus 294 LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 294 LRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred hccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 011110 01224578899999999999999999999999987654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=296.48 Aligned_cols=226 Identities=19% Similarity=0.247 Sum_probs=171.4
Q ss_pred ceeeecceeeeEEEeeee--eeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 55 STIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
....+|+|+||.||+|.. .+..+++|++..... ....|++.+++++|||+++ ..+..|+||||+++|+
T Consensus 694 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~ 769 (968)
T PLN00113 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKN 769 (968)
T ss_pred cccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCc
Confidence 356899999999999986 456788887653321 2245688999999999876 5567899999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCCcceEeeC-CeeEEEecccccccCCCCCCCcccCCC
Q psy5368 127 LCSFIRSHEKLSEFQCQQFVRQLVLALKFLR---ENNVCHFDLKPQNILIKN-NTLKLADFGFAQFLAPNDQGDSIQGSP 202 (406)
Q Consensus 127 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH---~~givH~Dlkp~NIll~~-~~~kL~DFGla~~~~~~~~~~~~~gt~ 202 (406)
|.++++ .++|..+..++.|++.||+||| +.+|+||||||+||+++. +..++. ||.+..... .....+|+
T Consensus 770 L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---~~~~~~t~ 842 (968)
T PLN00113 770 LSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---DTKCFISS 842 (968)
T ss_pred HHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---CCCccccc
Confidence 999995 4899999999999999999999 679999999999999994 455554 665543321 22336789
Q ss_pred CCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhcC------CCCCCC-----CCCChH
Q psy5368 203 LYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCN-----LSQLRAQALSSA------PITIPP-----NSLSPD 266 (406)
Q Consensus 203 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~-----~~~~~~~~~~~~------~~~~~~-----~~~s~~ 266 (406)
.|+|||++.+..++.++|||||||++|||+||+.||.... ..+......... ...... .....+
T Consensus 843 ~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (968)
T PLN00113 843 AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVE 922 (968)
T ss_pred cccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHH
Confidence 9999999999999999999999999999999999985421 111111110000 000000 012235
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 267 CMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 267 l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
+.+++.+||+.||++|||+.|+++.
T Consensus 923 ~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 923 VMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred HHHHHHhhCcCCchhCcCHHHHHHH
Confidence 7789999999999999999999875
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=250.76 Aligned_cols=229 Identities=19% Similarity=0.297 Sum_probs=179.7
Q ss_pred eeeecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccC--CCCCCcc----------cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNL--RAPEGRK----------RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l--~h~ni~~----------~~~~~~lV~E~~~ 123 (406)
...+|+|.||.|++|.+++..||||.|.. .++..+.||.++.+.+ ||+||.. .-..+|||++|-+
T Consensus 216 ~e~IGkGRyGEVwrG~wrGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe 292 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRWRGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHE 292 (513)
T ss_pred EEEecCccccceeeccccCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeeccc
Confidence 34789999999999999999999999864 4566788888887765 9999654 2235799999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-----C---CcccccCCCcceEee-CCeeEEEecccccccCCCC-
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRE-----N---NVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND- 193 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~-----~---givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~- 193 (406)
.|||+|+|.. ..++.....+++..++.||++||. + .|.|||||+.|||+. ++.+.|+|+|+|.......
T Consensus 293 ~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~ 371 (513)
T KOG2052|consen 293 HGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTD 371 (513)
T ss_pred CCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCC
Confidence 9999999987 679999999999999999999994 2 399999999999998 7899999999997665442
Q ss_pred ----CCCcccCCCCCCChhhhcCCC----C--CchhhHHHHHHHHHHHHhC----------CCCCCC-----CCHHHHHH
Q psy5368 194 ----QGDSIQGSPLYMAPEILAGSP----Y--NAKADLWSLGVLVFEALFG----------HAPYAS-----CNLSQLRA 248 (406)
Q Consensus 194 ----~~~~~~gt~~y~aPE~~~~~~----~--~~~~DiwSlG~il~elltg----------~~pf~~-----~~~~~~~~ 248 (406)
..+..+||..|||||++.... + -..+||||||.|+||+... ++||.+ .+.+++..
T Consensus 372 ~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrk 451 (513)
T KOG2052|consen 372 TIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRK 451 (513)
T ss_pred cccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhc
Confidence 346778999999999997642 1 1268999999999999842 577754 34455544
Q ss_pred HHHhc-CCCCCCCCCCC----hHHHHHHHHhcccCCCCCCCHHHH
Q psy5368 249 QALSS-APITIPPNSLS----PDCMDFLSRLLQKDPMRRISYEDL 288 (406)
Q Consensus 249 ~~~~~-~~~~~~~~~~s----~~l~~li~~~L~~dP~~Rps~~el 288 (406)
-+... ..+.+|...-+ ..+.++++.||..||.-|.|+--+
T Consensus 452 VVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 452 VVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred ceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 44333 23333333222 236778999999999999987554
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=253.30 Aligned_cols=234 Identities=20% Similarity=0.333 Sum_probs=181.3
Q ss_pred eeecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhh--cccCCCCCCcc----------cCCeEEEEEeccCC
Q psy5368 57 IRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAG--LSNLRAPEGRK----------RPRYVYIILEYCDG 124 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~--l~~l~h~ni~~----------~~~~~~lV~E~~~g 124 (406)
..+|+|.||.||||...++.||||.+... ....|..|-++ +-.++|+|++. ....++||+||.+.
T Consensus 216 eli~~Grfg~V~KaqL~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~k 292 (534)
T KOG3653|consen 216 ELIGRGRFGCVWKAQLDNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPK 292 (534)
T ss_pred HHhhcCccceeehhhccCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccC
Confidence 46899999999999999999999998753 44556666554 44569999765 34478999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---------CCcccccCCCcceEee-CCeeEEEecccccccCCCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRE---------NNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ 194 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~---------~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~ 194 (406)
|+|.++|+.+ .++|....+|+..+++||+|||+ ..|+|||||..|||+. +.+..|+|||+|..+.....
T Consensus 293 GsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~ 371 (534)
T KOG3653|consen 293 GSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKP 371 (534)
T ss_pred CcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCC
Confidence 9999999874 68999999999999999999996 2499999999999998 67999999999987764432
Q ss_pred ---CCcccCCCCCCChhhhcCCC-CC-----chhhHHHHHHHHHHHHhCC------------CCCC-----CCCHHHHHH
Q psy5368 195 ---GDSIQGSPLYMAPEILAGSP-YN-----AKADLWSLGVLVFEALFGH------------APYA-----SCNLSQLRA 248 (406)
Q Consensus 195 ---~~~~~gt~~y~aPE~~~~~~-~~-----~~~DiwSlG~il~elltg~------------~pf~-----~~~~~~~~~ 248 (406)
....+||..|||||++.+.. +. .+.||||+|.|||||++.- .||. ..+.+++..
T Consensus 372 ~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~ 451 (534)
T KOG3653|consen 372 QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQE 451 (534)
T ss_pred CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHH
Confidence 33478999999999998753 22 2689999999999999753 2332 124555555
Q ss_pred HHHhcC-CCCCCCC----CCChHHHHHHHHhcccCCCCCCCHHHH------hcCCCC
Q psy5368 249 QALSSA-PITIPPN----SLSPDCMDFLSRLLQKDPMRRISYEDL------FSHPYP 294 (406)
Q Consensus 249 ~~~~~~-~~~~~~~----~~s~~l~~li~~~L~~dP~~Rps~~el------l~hp~~ 294 (406)
.+.... ++.++.. .-...+++.+..||+.||+-|.|+.=+ +.|+|-
T Consensus 452 ~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 452 LVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred HHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 554433 3333322 223558999999999999999998533 456653
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=224.65 Aligned_cols=209 Identities=26% Similarity=0.384 Sum_probs=168.4
Q ss_pred eeecceeeeEEEeeee--eeceeEEeeeecCC-ccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 57 IRYGELQYDTVQNSQI--RLGTVKYSQVRYDT-ITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
..||.|++|.|-+-++ .+.-.|+|.+...- .....+..+|+.+..+. ..|..+. ..+.++|.||.|+- |
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-S 130 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-S 130 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-h
Confidence 4689999998877775 44556888776443 23345677888766554 5565443 77789999999965 8
Q ss_pred HHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccC
Q psy5368 127 LCSFI----RSHEKLSEFQCQQFVRQLVLALKFLREN-NVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQG 200 (406)
Q Consensus 127 L~~~l----~~~~~l~~~~~~~i~~ql~~aL~~lH~~-givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~g 200 (406)
|..+- +..+..++..+-+|+..++.||.|||++ .++|||+||+|||++ +|.+|+||||.+..+.++-..+.-.|
T Consensus 131 ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~daG 210 (282)
T KOG0984|consen 131 LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMDAG 210 (282)
T ss_pred HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHhcC
Confidence 87654 4557899999999999999999999976 899999999999999 89999999999988876665555678
Q ss_pred CCCCCChhhhcC----CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCCCCCCChH
Q psy5368 201 SPLYMAPEILAG----SPYNAKADLWSLGVLVFEALFGHAPYAS-CNLSQLRAQALSSAPITIPPNSLSPD 266 (406)
Q Consensus 201 t~~y~aPE~~~~----~~~~~~~DiwSlG~il~elltg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~s~~ 266 (406)
...|||||.+.. ..|+.++||||||+++.||.+++.||+. .++.+.+.++.....+.+|...+|++
T Consensus 211 CkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp~~~FS~e 281 (282)
T KOG0984|consen 211 CKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLPADTFSPE 281 (282)
T ss_pred CCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCcccccCCC
Confidence 889999999864 3589999999999999999999999975 56778888888887777776666654
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=245.50 Aligned_cols=237 Identities=26% Similarity=0.386 Sum_probs=179.4
Q ss_pred ceeeecceeeeEEEeeeee-----eceeEEeeeecCCccchhhhhhHHhhcccCC-CCC------CcccCCeEEEEEecc
Q psy5368 55 STIRYGELQYDTVQNSQIR-----LGTVKYSQVRYDTITSHSEFERPRAGLSNLR-APE------GRKRPRYVYIILEYC 122 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~-----~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~-h~n------i~~~~~~~~lV~E~~ 122 (406)
...+||+|.|++||++... ...|++|.+... ....++.+|+++|..+. +.| .++.++...+||||+
T Consensus 40 ~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~ 117 (418)
T KOG1167|consen 40 VVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYF 117 (418)
T ss_pred hhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEeccc
Confidence 4567788888888888753 346788877654 45567899999999883 333 345788899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee--CCeeEEEecccccccC----------
Q psy5368 123 DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK--NNTLKLADFGFAQFLA---------- 190 (406)
Q Consensus 123 ~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~--~~~~kL~DFGla~~~~---------- 190 (406)
+..+-.++.. .++..+++.+++.++.||.++|.+|||||||||.|+|++ .+.-.|+|||+|....
T Consensus 118 ~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~ 194 (418)
T KOG1167|consen 118 EHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRS 194 (418)
T ss_pred CccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhh
Confidence 9999888885 467899999999999999999999999999999999999 5688999999997210
Q ss_pred -------C-CC-------------C--------------CCcccCCCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhC
Q psy5368 191 -------P-ND-------------Q--------------GDSIQGSPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFG 234 (406)
Q Consensus 191 -------~-~~-------------~--------------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg 234 (406)
. .. . .....||++|+|||++..- .-++++||||.|+|+..++++
T Consensus 195 ~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~ 274 (418)
T KOG1167|consen 195 YSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSR 274 (418)
T ss_pred hhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhcc
Confidence 0 00 0 0123599999999999874 478899999999999999999
Q ss_pred CCCCCCCC-----H---------HHHHHH--------------------------------HHhcCC----CCCCCCCCC
Q psy5368 235 HAPYASCN-----L---------SQLRAQ--------------------------------ALSSAP----ITIPPNSLS 264 (406)
Q Consensus 235 ~~pf~~~~-----~---------~~~~~~--------------------------------~~~~~~----~~~~~~~~s 264 (406)
+.||-... . .++..- +..... ...-...++
T Consensus 275 ~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~ 354 (418)
T KOG1167|consen 275 RYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFP 354 (418)
T ss_pred ccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccccccc
Confidence 99984321 0 000000 000000 000001345
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy5368 265 PDCMDFLSRLLQKDPMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 265 ~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 296 (406)
..+.+|+.+||..||.+|+|++++|+||||+.
T Consensus 355 ~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 355 ALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred HHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 68999999999999999999999999999984
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-29 Score=223.33 Aligned_cols=201 Identities=35% Similarity=0.630 Sum_probs=174.9
Q ss_pred ecceeeeEEEeeeee--eceeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHHH
Q psy5368 59 YGELQYDTVQNSQIR--LGTVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLCS 129 (406)
Q Consensus 59 lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~~ 129 (406)
||+|++|.||++... +..+++|.+...... ....+.+|+..++.++|+++.. .....++++|+++|++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 589999999999987 677888877655432 3467999999999999998655 4468899999999899999
Q ss_pred HHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeC--CeeEEEecccccccCCCC-CCCcccCCCCCC
Q psy5368 130 FIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN--NTLKLADFGFAQFLAPND-QGDSIQGSPLYM 205 (406)
Q Consensus 130 ~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~--~~~kL~DFGla~~~~~~~-~~~~~~gt~~y~ 205 (406)
++... ..+++..+..++.+++.++.+||+.|++|+||+|.||++++ +.++|+|||.+....... ......++..|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 160 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYM 160 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCcc
Confidence 99876 57999999999999999999999999999999999999996 799999999987664432 133455788899
Q ss_pred ChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCC
Q psy5368 206 APEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRIS 284 (406)
Q Consensus 206 aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps 284 (406)
+||.+... .++.++|+|++|+++++| ..+.+++.+|++.+|.+||+
T Consensus 161 ~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~~R~~ 207 (215)
T cd00180 161 APEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDPEKRPS 207 (215)
T ss_pred ChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCcccCcC
Confidence 99999887 788999999999999999 67999999999999999999
Q ss_pred HHHHhcCC
Q psy5368 285 YEDLFSHP 292 (406)
Q Consensus 285 ~~ell~hp 292 (406)
+.++++|+
T Consensus 208 ~~~l~~~~ 215 (215)
T cd00180 208 AKEILEHL 215 (215)
T ss_pred HHHHhhCC
Confidence 99999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=277.40 Aligned_cols=181 Identities=18% Similarity=0.223 Sum_probs=138.9
Q ss_pred CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-----------------
Q psy5368 113 RYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK----------------- 174 (406)
Q Consensus 113 ~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~----------------- 174 (406)
..++.++|++ +++|.++|... ..+++.+++.++.||+.||.|||++||+||||||+|||++
T Consensus 53 ~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~ 131 (793)
T PLN00181 53 DSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSG 131 (793)
T ss_pred chhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCccc
Confidence 4678899998 55999999753 4699999999999999999999999999999999999994
Q ss_pred ---CCeeEEEecccccccCCCC-----------------CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhC
Q psy5368 175 ---NNTLKLADFGFAQFLAPND-----------------QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFG 234 (406)
Q Consensus 175 ---~~~~kL~DFGla~~~~~~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg 234 (406)
++.+|++|||+++...... ......||+.|||||++.+..++.++|||||||+||||++|
T Consensus 132 ~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~ 211 (793)
T PLN00181 132 SDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCP 211 (793)
T ss_pred ccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhC
Confidence 2356777777775422100 01124578999999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy5368 235 HAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 235 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 297 (406)
.+|+.... .....+......... ....+...+++.+||+++|.+||++.|+++||||...
T Consensus 212 ~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 212 VSSREEKS--RTMSSLRHRVLPPQI-LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred CCchhhHH--HHHHHHHHhhcChhh-hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 98876432 111111111111111 1234567899999999999999999999999999753
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=254.38 Aligned_cols=243 Identities=26% Similarity=0.387 Sum_probs=201.7
Q ss_pred CceeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 54 SSTIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 54 ~~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
..-.++|+|.||.|||++.. ....++|.++........-+.+|+-+++.++|||++. .....+++||||.||
T Consensus 18 ellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycggg 97 (829)
T KOG0576|consen 18 ELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGG 97 (829)
T ss_pred hheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCC
Confidence 34457899999999999964 3456788887777777888999999999999999876 556789999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCcccCCCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDSIQGSPL 203 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~~~gt~~ 203 (406)
+|.+.-+-.+++++.++..+.+..++||+|||++|-+|||||-.|||++ .|.+|+.|||.+..+... ....+..|||.
T Consensus 98 slQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~KrksfiGtpy 177 (829)
T KOG0576|consen 98 SLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPY 177 (829)
T ss_pred cccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhcccCCcc
Confidence 9999988889999999999999999999999999999999999999998 789999999998665433 34577899999
Q ss_pred CCChhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CC-C-CCCCCChHHHHHHHHhccc
Q psy5368 204 YMAPEILA---GSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP-IT-I-PPNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 204 y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~-~-~~~~~s~~l~~li~~~L~~ 277 (406)
|||||+-. .+.|...+|||++|+...|+---++|.....+............ +. . .+...++.+-+|++.+|..
T Consensus 178 wmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altk 257 (829)
T KOG0576|consen 178 WMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTK 257 (829)
T ss_pred ccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcC
Confidence 99999864 45699999999999999999887777655444443333322211 11 1 1236788999999999999
Q ss_pred CCCCCCCHHHHhcCCCCCC
Q psy5368 278 DPMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 278 dP~~Rps~~ell~hp~~~~ 296 (406)
+|++||+++.+|.|||...
T Consensus 258 npKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 258 NPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred CCccCCChhhheeceeecc
Confidence 9999999999999999764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-30 Score=223.28 Aligned_cols=159 Identities=30% Similarity=0.421 Sum_probs=128.5
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCC
Q psy5368 125 GDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSP 202 (406)
Q Consensus 125 gsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~ 202 (406)
|||.+++..+ .++++.++..++.|++.||+|||+++ ||+|||++ ++.+++ ||++....... ..||+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~ 68 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDP 68 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcc
Confidence 6999999874 46999999999999999999999998 99999998 668888 99987654322 26899
Q ss_pred CCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCCCC-----CCCCCh--HHHHHHHHh
Q psy5368 203 LYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNL-SQLRAQALSSAPITIP-----PNSLSP--DCMDFLSRL 274 (406)
Q Consensus 203 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~-~~~~~~~~~~~~~~~~-----~~~~s~--~l~~li~~~ 274 (406)
.|+|||++.+..++.++||||+||++|||+||+.||..... ......+........+ +..++. ++.+++.+|
T Consensus 69 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~c 148 (176)
T smart00750 69 YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVC 148 (176)
T ss_pred cccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHH
Confidence 99999999999999999999999999999999999976543 2223333222221111 112333 699999999
Q ss_pred cccCCCCCCCHHHHhcCCCCC
Q psy5368 275 LQKDPMRRISYEDLFSHPYPD 295 (406)
Q Consensus 275 L~~dP~~Rps~~ell~hp~~~ 295 (406)
|..+|.+||++.++++|+|+.
T Consensus 149 l~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 149 ASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HhcccccccCHHHHHHHHHHH
Confidence 999999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-28 Score=218.52 Aligned_cols=201 Identities=33% Similarity=0.617 Sum_probs=169.6
Q ss_pred eeeecceeeeEEEeeeeee--ceeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIRL--GTVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...+|+|+++.||++.... ..+++|........ ....+.+|++.+.+++|+|++. .....++++|++++++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 83 (225)
T smart00221 4 GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGD 83 (225)
T ss_pred eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCC
Confidence 4578999999999999864 67888877765544 5678999999999999999665 4577899999999999
Q ss_pred HHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC--CCCcccCCC
Q psy5368 127 LCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND--QGDSIQGSP 202 (406)
Q Consensus 127 L~~~l~~~~~-l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~--~~~~~~gt~ 202 (406)
|.+++..... +++..+..++.+++.++.+||+.+++|+||+|.||+++ ++.++|+|||.+....... ......++.
T Consensus 84 L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 163 (225)
T smart00221 84 LFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTP 163 (225)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccC
Confidence 9999988766 89999999999999999999999999999999999999 6799999999998765543 334566788
Q ss_pred CCCChhhh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHhcCCC
Q psy5368 203 LYMAPEIL-AGSPYNAKADLWSLGVLVFEALFGHAPYAS--CNLSQLRAQALSSAPI 256 (406)
Q Consensus 203 ~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~pf~~--~~~~~~~~~~~~~~~~ 256 (406)
.|++||.+ ....++.++|+||||+++++|++|+.||.. .....+.+.+..+.+.
T Consensus 164 ~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 220 (225)
T smart00221 164 FYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPL 220 (225)
T ss_pred CcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcc
Confidence 99999999 666788899999999999999999999987 4444666666555433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=226.31 Aligned_cols=234 Identities=21% Similarity=0.300 Sum_probs=193.3
Q ss_pred eeeecceeeeEEEeeeeee-------ceeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCcc-------cCCeEEEEEe
Q psy5368 56 TIRYGELQYDTVQNSQIRL-------GTVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRK-------RPRYVYIILE 120 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-------~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~-------~~~~~~lV~E 120 (406)
+.++-+|.||.||+|.+.. +.|-+|.++....+ ....+..|.-.+..+.|||+.. +....+.++.
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~ 368 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP 368 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence 3467899999999997643 23455555433322 3446788888999999999654 5566788899
Q ss_pred ccCCCCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeCC-eeEEEecccccccCC
Q psy5368 121 YCDGGDLCSFIRSH--------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLADFGFAQFLAP 191 (406)
Q Consensus 121 ~~~ggsL~~~l~~~--------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~~-~~kL~DFGla~~~~~ 191 (406)
++.-|+|..++... +.++..+...++.|++.|++|||+.|++|.||-..|.++|+. .+||+|=.+++.+-+
T Consensus 369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP 448 (563)
T KOG1024|consen 369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFP 448 (563)
T ss_pred ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCc
Confidence 99889999999722 247788888999999999999999999999999999999965 999999999887644
Q ss_pred CCC---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHH
Q psy5368 192 NDQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDC 267 (406)
Q Consensus 192 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l 267 (406)
.+. +...-....||+||.+....|+.++|+||||++||||+| |+.|+...++.++..-+..+.+...|. ++|+++
T Consensus 449 ~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~-NCPDeL 527 (563)
T KOG1024|consen 449 GDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPF-NCPDEL 527 (563)
T ss_pred ccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCCC-CCcHHH
Confidence 432 222233567999999999999999999999999999998 999999999999999888887776655 799999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q psy5368 268 MDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 268 ~~li~~~L~~dP~~Rps~~ell~ 290 (406)
..++..||...|++||+++|+..
T Consensus 528 f~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 528 FTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred HHHHHHHHhcCcccCCCHHHHHH
Confidence 99999999999999999999865
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-28 Score=214.42 Aligned_cols=235 Identities=21% Similarity=0.310 Sum_probs=179.1
Q ss_pred eeeecceeeeEEEeeeeee--ceeEEeeeecCCccchhhhhhHHhhcccC-CCCCCcc-------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIRL--GTVKYSQVRYDTITSHSEFERPRAGLSNL-RAPEGRK-------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~-------~~~~~~lV~E~~~gg 125 (406)
.+.+|+|.||.+..++++. +.+++|.+..+ .....+|.+|...--.| .|.||+. ..+++..++||+|.|
T Consensus 29 ~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~g 107 (378)
T KOG1345|consen 29 NKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRG 107 (378)
T ss_pred HHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccc
Confidence 4567999999999999865 35566665544 35677899998876666 4556543 777899999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee---CCeeEEEecccccccCCCCCCCcccCCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK---NNTLKLADFGFAQFLAPNDQGDSIQGSP 202 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~---~~~~kL~DFGla~~~~~~~~~~~~~gt~ 202 (406)
||..-+.. ..+.+...++++.|+++||.|||++++||||||.+|||+- .-.+||||||++...+..-. ...-+.
T Consensus 108 dL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~--~~~~~~ 184 (378)
T KOG1345|consen 108 DLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK--YLEYVN 184 (378)
T ss_pred hhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceeh--hhhhhc
Confidence 99988755 4688999999999999999999999999999999999996 23899999999866533222 222356
Q ss_pred CCCChhhhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcCCCCCCCC--CCChHHHHHH
Q psy5368 203 LYMAPEILAGS-----PYNAKADLWSLGVLVFEALFGHAPYASCNL----SQLRAQALSSAPITIPPN--SLSPDCMDFL 271 (406)
Q Consensus 203 ~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltg~~pf~~~~~----~~~~~~~~~~~~~~~~~~--~~s~~l~~li 271 (406)
.|.+||..... ...+.+|+|.||+|++.+|||.+||..... .-...+......+..|.. .+|+.+..+.
T Consensus 185 ~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~F 264 (378)
T KOG1345|consen 185 NYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLF 264 (378)
T ss_pred ccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHH
Confidence 69999987542 257789999999999999999999975332 122233333333444432 6899999999
Q ss_pred HHhcccCCCCC---CCHHHHhcCCCC
Q psy5368 272 SRLLQKDPMRR---ISYEDLFSHPYP 294 (406)
Q Consensus 272 ~~~L~~dP~~R---ps~~ell~hp~~ 294 (406)
++-|.++|++| -+++.-....|.
T Consensus 265 kk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 265 KKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred HHhcCCcccccchhHHHHHHHHHHHH
Confidence 99999999999 455555555554
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=231.69 Aligned_cols=184 Identities=26% Similarity=0.435 Sum_probs=155.9
Q ss_pred eeeecceeeeEEEeeeeee--ceeEEeeeecCC-----ccchh---hhhhHHhhcccCC---CCCCcc------cCCeEE
Q psy5368 56 TIRYGELQYDTVQNSQIRL--GTVKYSQVRYDT-----ITSHS---EFERPRAGLSNLR---APEGRK------RPRYVY 116 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~-----~~~~~---~~~~E~~~l~~l~---h~ni~~------~~~~~~ 116 (406)
-..+|+|+||.|..+..+. ..|.+|.+.++. |...+ .+-.|+++|..|+ |+|+++ +++++|
T Consensus 566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy 645 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY 645 (772)
T ss_pred eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence 3468999999999999754 456666544432 22222 3456999999997 999655 899999
Q ss_pred EEEecc-CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC
Q psy5368 117 IILEYC-DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ 194 (406)
Q Consensus 117 lV~E~~-~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~ 194 (406)
|+||-- +|.+|.++|..++.+++.++..|++|++.|+++||++||||||||-+||.++ +|-+||+|||.|.... +.+
T Consensus 646 l~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~k-sgp 724 (772)
T KOG1152|consen 646 LETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTK-SGP 724 (772)
T ss_pred EEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhhc-CCC
Confidence 999975 4789999999999999999999999999999999999999999999999999 8899999999997654 556
Q ss_pred CCcccCCCCCCChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCC
Q psy5368 195 GDSIQGSPLYMAPEILAGSPY-NAKADLWSLGVLVFEALFGHAPYAS 240 (406)
Q Consensus 195 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~ 240 (406)
....+||..|.|||++.+.+| +..-|||++|++||.++....||..
T Consensus 725 fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 725 FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 678899999999999999886 4568999999999999999888853
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-27 Score=240.02 Aligned_cols=247 Identities=27% Similarity=0.408 Sum_probs=187.0
Q ss_pred ecCceeeecceeeeEEEeeeee--eceeEEeeeecC--Cccch----hhhhhHHhhcccCCCCCCcc------cCCeEEE
Q psy5368 52 VGSSTIRYGELQYDTVQNSQIR--LGTVKYSQVRYD--TITSH----SEFERPRAGLSNLRAPEGRK------RPRYVYI 117 (406)
Q Consensus 52 ~~~~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~--~~~~~----~~~~~E~~~l~~l~h~ni~~------~~~~~~l 117 (406)
.+....++|.|++|.|+..... ......+.+... ..... ..+..|.-+-..+.|||++. .....+-
T Consensus 319 y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~ 398 (601)
T KOG0590|consen 319 YGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQ 398 (601)
T ss_pred cCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchh
Confidence 3456788999999966665532 112222222110 11111 12556788888999999654 3334444
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC---
Q psy5368 118 ILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND--- 193 (406)
Q Consensus 118 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~--- 193 (406)
+||||++ ||..++...+.++..++-.+++|++.|++|+|+.||.|||+|++|+++. .+.+||+|||.+.......
T Consensus 399 ~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 5999999 9999998888899999999999999999999999999999999999999 6699999999987654332
Q ss_pred --CCCcccCCCCCCChhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcC--CCCCC----CCCC
Q psy5368 194 --QGDSIQGSPLYMAPEILAGSPYNAK-ADLWSLGVLVFEALFGHAPYASCNLSQLR-AQALSSA--PITIP----PNSL 263 (406)
Q Consensus 194 --~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~pf~~~~~~~~~-~~~~~~~--~~~~~----~~~~ 263 (406)
.....+|+..|+|||++.+..|++. .||||.|+++..|.+|+.||......+.. ....... ..... ...+
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 557 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL 557 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence 2356779999999999999999985 79999999999999999999765544332 1111110 11111 1256
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy5368 264 SPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 264 s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 299 (406)
+...+.+|.+||+.||.+|.|+++|++.+||+.+..
T Consensus 558 p~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 558 PRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred hhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 788999999999999999999999999999997764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-23 Score=196.16 Aligned_cols=241 Identities=31% Similarity=0.471 Sum_probs=190.8
Q ss_pred eeecceeeeEEEeeeeeeceeEEeeeecCCcc---chhhhhhHHhhcccCCCC-CCcc------cCCeEEEEEeccCCCC
Q psy5368 57 IRYGELQYDTVQNSQIRLGTVKYSQVRYDTIT---SHSEFERPRAGLSNLRAP-EGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~---~~~~~~~E~~~l~~l~h~-ni~~------~~~~~~lV~E~~~ggs 126 (406)
..+|.|+|+.||.+... ..+++|.+...... ....+.+|+.++..+.|+ +++. .....+++++++.+++
T Consensus 6 ~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 84 (384)
T COG0515 6 RKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGS 84 (384)
T ss_pred EeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCc
Confidence 45678888888888766 56666666554433 366799999999999988 5554 4455799999999999
Q ss_pred HHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC-eeEEEecccccccCCCC-------C
Q psy5368 127 LCSFIRSHE---KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN-TLKLADFGFAQFLAPND-------Q 194 (406)
Q Consensus 127 L~~~l~~~~---~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~-~~kL~DFGla~~~~~~~-------~ 194 (406)
|.+++.... .++......++.|++.++.|+|+.+++|||+||+||+++ .+ .++++|||.+....... .
T Consensus 85 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 164 (384)
T COG0515 85 LEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPAL 164 (384)
T ss_pred HHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccccccc
Confidence 998887765 799999999999999999999999999999999999999 44 69999999997654433 2
Q ss_pred CCcccCCCCCCChhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcCCC-CCCCCCC---
Q psy5368 195 GDSIQGSPLYMAPEILAG---SPYNAKADLWSLGVLVFEALFGHAPYASCNL----SQLRAQALSSAPI-TIPPNSL--- 263 (406)
Q Consensus 195 ~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~pf~~~~~----~~~~~~~~~~~~~-~~~~~~~--- 263 (406)
.....||..|+|||.+.+ ..++...|+||+|++++++++|..||..... ......+...... .......
T Consensus 165 ~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (384)
T COG0515 165 PSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNP 244 (384)
T ss_pred ccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCcccc
Confidence 366789999999999988 5788999999999999999999999887763 4444444443322 1111111
Q ss_pred ---ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 264 ---SPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 264 ---s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
...+.+++.+++..+|..|.+..+...+++.....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~ 282 (384)
T COG0515 245 ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282 (384)
T ss_pred chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence 25799999999999999999999999887665443
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-23 Score=202.31 Aligned_cols=237 Identities=19% Similarity=0.214 Sum_probs=176.4
Q ss_pred CceeeecceeeeEEEeeeeeec---eeEEeeeecCCccchhhhhhHHhhcccCCC-------CCCc----ccCCeEEEEE
Q psy5368 54 SSTIRYGELQYDTVQNSQIRLG---TVKYSQVRYDTITSHSEFERPRAGLSNLRA-------PEGR----KRPRYVYIIL 119 (406)
Q Consensus 54 ~~~~~lG~G~~g~Vy~~~~~~~---~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h-------~ni~----~~~~~~~lV~ 119 (406)
....+||+|+||.||.+..... ..++|............+..|..++..+.. |++. ....+.|+||
T Consensus 21 ~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM 100 (322)
T KOG1164|consen 21 KLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVM 100 (322)
T ss_pred EEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEE
Confidence 3456779999999999986553 345554443322333367888888888862 1222 3556889999
Q ss_pred eccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee--C----CeeEEEecccccccC-
Q psy5368 120 EYCDGGDLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK--N----NTLKLADFGFAQFLA- 190 (406)
Q Consensus 120 E~~~ggsL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~--~----~~~kL~DFGla~~~~- 190 (406)
+.+ |.+|.++.... +.++..++.+|+.|++.+|+++|+.|++||||||.|+++. . ..+.|.|||+++...
T Consensus 101 ~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~ 179 (322)
T KOG1164|consen 101 SLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKY 179 (322)
T ss_pred ecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccc
Confidence 999 78999988655 4799999999999999999999999999999999999998 2 369999999998322
Q ss_pred -CCC--------C-CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---cCCCC
Q psy5368 191 -PND--------Q-GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALS---SAPIT 257 (406)
Q Consensus 191 -~~~--------~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~---~~~~~ 257 (406)
... . .....||..|+++....+...+.+.|+||++.++.+++.|..||.............. .....
T Consensus 180 ~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~ 259 (322)
T KOG1164|consen 180 VGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTD 259 (322)
T ss_pred cCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccc
Confidence 111 1 1235599999999999999999999999999999999999999977553222222221 11111
Q ss_pred CCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 258 IPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 258 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
......+.++.++...+-..+...+|....+...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 260 RFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred cccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 1122456788888888888999999998877554
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.9e-25 Score=225.01 Aligned_cols=233 Identities=22% Similarity=0.336 Sum_probs=173.4
Q ss_pred eeeecceeeeEEEeeeeeeceeEEeeeecCC-ccchhhhh---hHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIRLGTVKYSQVRYDT-ITSHSEFE---RPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~-~~~~~~~~---~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...+|.+.|-.|.+++.+.+.|.||.+.+.. .-+...|. +|++ ...+++||.++ .++..|||-+|+.+
T Consensus 28 ~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh- 105 (1431)
T KOG1240|consen 28 VENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVKH- 105 (1431)
T ss_pred ecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHhh-
Confidence 4568999999999999999999999876654 33344444 4455 55669999765 67778999999977
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccC--CCCCC------C
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLA--PNDQG------D 196 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~--~~~~~------~ 196 (406)
+|+|.|..++-+..-+.+.|+.||+.||..||..||+|+|||.+|||++ -+.+.|+||..-+..- .+.+. .
T Consensus 106 nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFD 185 (1431)
T KOG1240|consen 106 NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFD 185 (1431)
T ss_pred hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEe
Confidence 9999999888899999999999999999999999999999999999999 6799999997654321 11111 1
Q ss_pred cccCCCCCCChhhhcCC----------C-CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q psy5368 197 SIQGSPLYMAPEILAGS----------P-YNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLS 264 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~~~----------~-~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s 264 (406)
+...-..|.|||.+... . .+++.||||+||+++||++ |++||.-...-..+... ...+......--+
T Consensus 186 TSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~-~~~~e~~Le~Ied 264 (1431)
T KOG1240|consen 186 TSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGN-ADDPEQLLEKIED 264 (1431)
T ss_pred cCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccC-ccCHHHHHHhCcC
Confidence 11223459999987541 2 6788999999999999998 89999532111111000 0000000001124
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 265 PDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 265 ~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
..++.|+..|++.||++|.++++.|+.
T Consensus 265 ~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 265 VSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccHHHHHHHHHccCchhccCHHHHHHh
Confidence 479999999999999999999999984
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-23 Score=202.43 Aligned_cols=163 Identities=18% Similarity=0.157 Sum_probs=121.5
Q ss_pred ccccccccceeeecCceeeecceeeeEEEeeeee---eceeEEeeeecCC-----ccchhhhhhHHhhcccCCCCCCcc-
Q psy5368 40 DTVRSGTVRYDIVGSSTIRYGELQYDTVQNSQIR---LGTVKYSQVRYDT-----ITSHSEFERPRAGLSNLRAPEGRK- 110 (406)
Q Consensus 40 d~~~~~~~~~~i~~~~~~~lG~G~~g~Vy~~~~~---~~~v~vk~~~~~~-----~~~~~~~~~E~~~l~~l~h~ni~~- 110 (406)
++.+.....| .....||+|+||+||++... ...+++|+..... ......+.+|+++|.+++|+|++.
T Consensus 11 ~~~~~~~~~Y----~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~ 86 (365)
T PRK09188 11 DQIPALSARF----VETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQ 86 (365)
T ss_pred cccccccCCc----eEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcE
Confidence 3344444445 44567899999999999864 2345777654221 112446899999999999999764
Q ss_pred --cCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccC-CCcceEee-CCeeEEEecccc
Q psy5368 111 --RPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDL-KPQNILIK-NNTLKLADFGFA 186 (406)
Q Consensus 111 --~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dl-kp~NIll~-~~~~kL~DFGla 186 (406)
..+..|||||||+|++|... . ... ...++.|++++|.|||++||+|||| ||+|||++ ++.+||+|||+|
T Consensus 87 l~~~~~~~LVmE~~~G~~L~~~-~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 87 LLATGKDGLVRGWTEGVPLHLA-R---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred EEEcCCcEEEEEccCCCCHHHh-C---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 45678999999999999732 1 111 1467899999999999999999999 99999998 678999999999
Q ss_pred cccCCCCCC---------CcccCCCCCCChhhhcCC
Q psy5368 187 QFLAPNDQG---------DSIQGSPLYMAPEILAGS 213 (406)
Q Consensus 187 ~~~~~~~~~---------~~~~gt~~y~aPE~~~~~ 213 (406)
+........ ....+++.|+|||.+...
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 876543321 234578889999998653
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.8e-23 Score=182.58 Aligned_cols=225 Identities=20% Similarity=0.336 Sum_probs=180.1
Q ss_pred eecceeeeEEEeeeeeeceeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHHH
Q psy5368 58 RYGELQYDTVQNSQIRLGTVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLCS 129 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~~ 129 (406)
+|.+...|..++|++.+..+.+|.+.... ....++|..|.-.|+-+.|||+.. .+.+..++..||+.|+|+.
T Consensus 197 kl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslyn 276 (448)
T KOG0195|consen 197 KLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYN 276 (448)
T ss_pred hhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHH
Confidence 56778889999999988877666544332 334568999999999999999754 6788999999999999999
Q ss_pred HHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCcceEeeCC-ee--EEEecccccccCCCCCCCcccCCC
Q psy5368 130 FIRSHEK--LSEFQCQQFVRQLVLALKFLRENN--VCHFDLKPQNILIKNN-TL--KLADFGFAQFLAPNDQGDSIQGSP 202 (406)
Q Consensus 130 ~l~~~~~--l~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dlkp~NIll~~~-~~--kL~DFGla~~~~~~~~~~~~~gt~ 202 (406)
++++... .+..++.+++.++++|++|||+.. |.-.-|+...|++|++ +. ..+|--++. ......-.|
T Consensus 277 vlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf------qe~gr~y~p 350 (448)
T KOG0195|consen 277 VLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF------QEVGRAYSP 350 (448)
T ss_pred HHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee------eccccccCc
Confidence 9988753 688899999999999999999876 5566799999999955 44 444433321 112233478
Q ss_pred CCCChhhhcCCCCC---chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cCCCCCCCCCCChHHHHHHHHhcccC
Q psy5368 203 LYMAPEILAGSPYN---AKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALS-SAPITIPPNSLSPDCMDFLSRLLQKD 278 (406)
Q Consensus 203 ~y~aPE~~~~~~~~---~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~s~~l~~li~~~L~~d 278 (406)
.||+||.+..++.+ .++|+|||++++|||.|...||.+-++.+.-.++.. +....+|| .+++.+..|++-|++.|
T Consensus 351 awmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ipp-gis~hm~klm~icmned 429 (448)
T KOG0195|consen 351 AWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPP-GISRHMNKLMNICMNED 429 (448)
T ss_pred ccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCC-CccHHHHHHHHHHhcCC
Confidence 99999999987644 378999999999999999999999888777666554 44555555 69999999999999999
Q ss_pred CCCCCCHHHHh
Q psy5368 279 PMRRISYEDLF 289 (406)
Q Consensus 279 P~~Rps~~ell 289 (406)
|.+||.++.++
T Consensus 430 pgkrpkfdmiv 440 (448)
T KOG0195|consen 430 PGKRPKFDMIV 440 (448)
T ss_pred CCcCCCcceeh
Confidence 99999998764
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-23 Score=207.61 Aligned_cols=231 Identities=25% Similarity=0.416 Sum_probs=183.1
Q ss_pred ecceeeeEEEeeeee-----eceeEEeeeecCC--ccchhhhhhHHhhcccCC-CCCCcc------cCCeEEEEEeccCC
Q psy5368 59 YGELQYDTVQNSQIR-----LGTVKYSQVRYDT--ITSHSEFERPRAGLSNLR-APEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 59 lG~G~~g~Vy~~~~~-----~~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~-h~ni~~------~~~~~~lV~E~~~g 124 (406)
+|+|+||.|+....- +...+.|..+... .........|..++..++ ||-++. .+...++++++..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 588888888765431 1222223222211 111224566777777776 776544 77889999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
|+|...+.+...+++.....+...++.+++++|+.+|+|||+|++||+++ +|++++.|||+++..-..... +||..
T Consensus 82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt~e 158 (612)
T KOG0603|consen 82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGTYE 158 (612)
T ss_pred chhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccchh
Confidence 99999999888999999999999999999999999999999999999999 889999999999876433333 89999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
|||||++. .....+|.||+|++++||+||..||.+ ++...|.... ... |..++..+++++..++..+|.+|.
T Consensus 159 ymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~-~~~-p~~l~~~a~~~~~~l~~r~p~nrL 230 (612)
T KOG0603|consen 159 YRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE-LEM-PRELSAEARSLFRQLFKRNPENRL 230 (612)
T ss_pred hhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc-cCC-chhhhHHHHHHHHHHHhhCHHHHh
Confidence 99999998 567899999999999999999999988 5555555432 222 346899999999999999999998
Q ss_pred C-----HHHHhcCCCCCCCCCC
Q psy5368 284 S-----YEDLFSHPYPDLIHAP 300 (406)
Q Consensus 284 s-----~~ell~hp~~~~~~~~ 300 (406)
. ..++++|+||..+.+.
T Consensus 231 g~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 231 GAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred ccCcchhHHHhccchheeeeHh
Confidence 5 4789999999877654
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.5e-22 Score=173.96 Aligned_cols=227 Identities=15% Similarity=0.199 Sum_probs=175.2
Q ss_pred eeecceeeeEEEeeee--eeceeEEeeeecCCccchhhhhhHHhhcccCCCCCC-------cccCCeEEEEEeccCCCCH
Q psy5368 57 IRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEG-------RKRPRYVYIILEYCDGGDL 127 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni-------~~~~~~~~lV~E~~~ggsL 127 (406)
++||+|+||.+|.+.. .+..||+|.-.. ...+..+..|..+...|++--. .....+-.+||++. |.||
T Consensus 21 rkiGsGSFGdIy~~~~i~~ge~VAiK~Es~--~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsL 97 (341)
T KOG1163|consen 21 RKIGSGSFGDIYLGISITSGEEVAIKLESS--KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSL 97 (341)
T ss_pred EeecCCchhheeeeeeccCCceEEEEeecc--cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccH
Confidence 3456777888887774 445677775432 2456778889988888877432 23566678999999 7899
Q ss_pred HHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee----CCeeEEEecccccccCCCC--------C
Q psy5368 128 CSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK----NNTLKLADFGFAQFLAPND--------Q 194 (406)
Q Consensus 128 ~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~----~~~~kL~DFGla~~~~~~~--------~ 194 (406)
.++..-. +.|+.++++-++-|++.-++|+|.++++||||||+|+|.. .+.+.|+|||+|+...... .
T Consensus 98 EdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre 177 (341)
T KOG1163|consen 98 EDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYRE 177 (341)
T ss_pred HHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccCcccc
Confidence 9998644 5799999999999999999999999999999999999997 3489999999998765433 2
Q ss_pred CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCC---CCCCCCCCChHHH
Q psy5368 195 GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNL---SQLRAQALSSAP---ITIPPNSLSPDCM 268 (406)
Q Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~---~~~~~~~~~~~~---~~~~~~~~s~~l~ 268 (406)
.....||..|.+-....+...+.+.|+-|+|.+|..+.-|..||.+... ..-.++|..... +......+|.++.
T Consensus 178 ~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~ 257 (341)
T KOG1163|consen 178 DRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFA 257 (341)
T ss_pred CCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHH
Confidence 3456799999999988888888999999999999999999999988542 233333333322 1222237889999
Q ss_pred HHHHHhcccCCCCCCCHH
Q psy5368 269 DFLSRLLQKDPMRRISYE 286 (406)
Q Consensus 269 ~li~~~L~~dP~~Rps~~ 286 (406)
-.+.-|-..--++-|+..
T Consensus 258 myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 258 MYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred HHHHHHhhcCCCCCCcHH
Confidence 999999888777778753
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=179.33 Aligned_cols=230 Identities=17% Similarity=0.252 Sum_probs=177.3
Q ss_pred CceeeecceeeeEEEeeee--eeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCc-------ccCCeEEEEEeccCC
Q psy5368 54 SSTIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGR-------KRPRYVYIILEYCDG 124 (406)
Q Consensus 54 ~~~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~-------~~~~~~~lV~E~~~g 124 (406)
...++||+|+||..+.|+. ++..||+|--.. .....++..|....+.|.+...+ .+..+-.||+|+. |
T Consensus 31 rVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G 107 (449)
T KOG1165|consen 31 RVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G 107 (449)
T ss_pred eeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence 4567899999999999985 667788874322 24456777787777777553322 2555556999999 7
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee------CCeeEEEecccccccCCCC----
Q psy5368 125 GDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK------NNTLKLADFGFAQFLAPND---- 193 (406)
Q Consensus 125 gsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~------~~~~kL~DFGla~~~~~~~---- 193 (406)
.+|.|+..-. +.|+.+++..++.|++.-++|+|++.+|+|||||+|+||. .+.+.++|||+|+......
T Consensus 108 PSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqH 187 (449)
T KOG1165|consen 108 PSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQH 187 (449)
T ss_pred cCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcccccc
Confidence 8999998544 5799999999999999999999999999999999999996 3489999999998765443
Q ss_pred ----CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcCCCCC---CCCCC
Q psy5368 194 ----QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCN---LSQLRAQALSSAPITI---PPNSL 263 (406)
Q Consensus 194 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~---~~~~~~~~~~~~~~~~---~~~~~ 263 (406)
...+..||..||+-....+..-+.+.|+-|+|-++++.|-|..||.+.. ..+-.++|-....... ....+
T Consensus 188 IPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~ 267 (449)
T KOG1165|consen 188 IPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEGF 267 (449)
T ss_pred CccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHhcC
Confidence 2456789999999999999999999999999999999999999998853 3444444443322221 12257
Q ss_pred ChHHHHHHHHhcccCCCCCCCHH
Q psy5368 264 SPDCMDFLSRLLQKDPMRRISYE 286 (406)
Q Consensus 264 s~~l~~li~~~L~~dP~~Rps~~ 286 (406)
|.++..-+.-.-..+-.+-|..+
T Consensus 268 P~efa~Yl~yvR~L~F~E~PDYd 290 (449)
T KOG1165|consen 268 PEEFATYLRYVRRLDFFETPDYD 290 (449)
T ss_pred HHHHHHHHHHHHhcCcccCCCHH
Confidence 77777777766666667777654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-21 Score=174.60 Aligned_cols=133 Identities=14% Similarity=0.113 Sum_probs=105.3
Q ss_pred eeecceeeeEEEeeeee-eceeEEeeeecCCccc---------hhhh-----------------hhHHhhcccCCCCCCc
Q psy5368 57 IRYGELQYDTVQNSQIR-LGTVKYSQVRYDTITS---------HSEF-----------------ERPRAGLSNLRAPEGR 109 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~-~~~v~vk~~~~~~~~~---------~~~~-----------------~~E~~~l~~l~h~ni~ 109 (406)
..||+|++|.||++... +..|++|..+...... ...| .+|+..+.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 46899999999999874 5688999876542211 1122 3489999999776542
Q ss_pred c----cCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCcccccCCCcceEeeCCeeEEEecc
Q psy5368 110 K----RPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFL-RENNVCHFDLKPQNILIKNNTLKLADFG 184 (406)
Q Consensus 110 ~----~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~l-H~~givH~Dlkp~NIll~~~~~kL~DFG 184 (406)
. .....+|||||++|+++...+....++++..+..++.|++.+|.++ |+.||+||||||+|||++++.++|+|||
T Consensus 83 ~p~~~~~~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~~~v~LiDFG 162 (190)
T cd05147 83 CPEPILLKSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHDGKLYIIDVS 162 (190)
T ss_pred CCcEEEecCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEECCcEEEEEcc
Confidence 2 1122389999999988776654557899999999999999999999 7999999999999999998899999999
Q ss_pred ccccc
Q psy5368 185 FAQFL 189 (406)
Q Consensus 185 la~~~ 189 (406)
+|...
T Consensus 163 ~a~~~ 167 (190)
T cd05147 163 QSVEH 167 (190)
T ss_pred ccccC
Confidence 98654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=8e-22 Score=203.55 Aligned_cols=213 Identities=25% Similarity=0.450 Sum_probs=163.7
Q ss_pred eeeecceeeeEEEeeeeeec--eeEEeeeecCCccchhhhhhHHhhcccCCCCCCcccCCeEEEEEeccCCCCHHHHHHh
Q psy5368 56 TIRYGELQYDTVQNSQIRLG--TVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRKRPRYVYIILEYCDGGDLCSFIRS 133 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~--~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~lV~E~~~ggsL~~~l~~ 133 (406)
-+.+-.|+||.||..+++.. +.+. ++..+. .+.|- ++.... +.+.| ||-...++.
T Consensus 88 IklisngAygavylvrh~~trqrfa~-kiNkq~-----lilRn--ilt~a~---------npfvv------gDc~tllk~ 144 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAM-KINKQN-----LILRN--ILTFAG---------NPFVV------GDCATLLKN 144 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhh-cccccc-----hhhhc--cccccC---------Cccee------chhhhhccc
Confidence 34567899999999876532 2333 222211 11111 222222 23333 466666766
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC----------------CCC
Q psy5368 134 HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND----------------QGD 196 (406)
Q Consensus 134 ~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~----------------~~~ 196 (406)
-++++... +.+++|+|+.||+|||+||+|++|+ -|.+|++|||+++...... ..+
T Consensus 145 ~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dK 216 (1205)
T KOG0606|consen 145 IGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDK 216 (1205)
T ss_pred CCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhc
Confidence 67777665 7899999999999999999999999 8899999999997542211 124
Q ss_pred cccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC--CCChHHHHHHHHh
Q psy5368 197 SIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPN--SLSPDCMDFLSRL 274 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~s~~l~~li~~~ 274 (406)
..+|||.|.|||++....|+..+|+|++|+|+||.+-|..||.+.++++++.+.+... +.+++. ..++++++++.++
T Consensus 217 qvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~-i~wpE~dea~p~Ea~dli~~L 295 (1205)
T KOG0606|consen 217 QVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD-IEWPEEDEALPPEAQDLIEQL 295 (1205)
T ss_pred cccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh-ccccccCcCCCHHHHHHHHHH
Confidence 5689999999999999999999999999999999999999999999999999988763 333332 6889999999999
Q ss_pred cccCCCCCC---CHHHHhcCCCCCCCCCC
Q psy5368 275 LQKDPMRRI---SYEDLFSHPYPDLIHAP 300 (406)
Q Consensus 275 L~~dP~~Rp---s~~ell~hp~~~~~~~~ 300 (406)
|+.+|..|. .+-++.+|+||.+..+.
T Consensus 296 L~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 296 LRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred HHhChHhhcccchhhhhhhccceeecccc
Confidence 999999996 56788899999988875
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.8e-21 Score=178.11 Aligned_cols=219 Identities=15% Similarity=0.217 Sum_probs=143.4
Q ss_pred ceeeecceeeeEEEeeeeee--ceeEEeeeecCCcc---chhhhhhHHhhcccCCCC-C---------------------
Q psy5368 55 STIRYGELQYDTVQNSQIRL--GTVKYSQVRYDTIT---SHSEFERPRAGLSNLRAP-E--------------------- 107 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~~---~~~~~~~E~~~l~~l~h~-n--------------------- 107 (406)
-...||.|+++.||.++... ...++|.+...... ..+++.+|.-....+.+. |
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 35679999999999999865 56788776554422 234566666555554331 1
Q ss_pred ---Ccc---cCC-----eEEEEEeccCCCCHHHHHH---hCCC----CCHHHHHHHHHHHHHHHHHHHHCCcccccCCCc
Q psy5368 108 ---GRK---RPR-----YVYIILEYCDGGDLCSFIR---SHEK----LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 169 (406)
Q Consensus 108 ---i~~---~~~-----~~~lV~E~~~ggsL~~~l~---~~~~----l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~ 169 (406)
... ... +.+++|+-+.+ ||.+++. .... +.......+..|+++.+++||+.|++|+||+|+
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~ 174 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPE 174 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGG
T ss_pred CCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccccee
Confidence 011 111 34788998865 9988864 2221 333444566789999999999999999999999
Q ss_pred ceEee-CCeeEEEecccccccCCCCCCCcccCCCCCCChhhhcCC--------CCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy5368 170 NILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGS--------PYNAKADLWSLGVLVFEALFGHAPYAS 240 (406)
Q Consensus 170 NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DiwSlG~il~elltg~~pf~~ 240 (406)
|++++ +|.++|+||+.....+..... ...+..|.|||..... .++.+.|.|++|+++|.|++|..||..
T Consensus 175 nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~ 252 (288)
T PF14531_consen 175 NFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGL 252 (288)
T ss_dssp GEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCC
T ss_pred eEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCC
Confidence 99999 889999999987654332222 3456789999987542 478899999999999999999999987
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCC
Q psy5368 241 CNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRR 282 (406)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 282 (406)
......... ...... ++|+.++.||..+|++||.+|
T Consensus 253 ~~~~~~~~~-----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 253 SSPEADPEW-----DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CGGGSTSGG-----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCccccccc-----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 643322211 111222 789999999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-20 Score=165.12 Aligned_cols=181 Identities=14% Similarity=0.041 Sum_probs=134.1
Q ss_pred ceeeecceeeeEEEeeeeeeceeEEeeeecCCccch----hhhhhHHhhcccCCC-CCCcc--cCCeEEEEEeccCCCCH
Q psy5368 55 STIRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSH----SEFERPRAGLSNLRA-PEGRK--RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~----~~~~~E~~~l~~l~h-~ni~~--~~~~~~lV~E~~~ggsL 127 (406)
....++.|+||+||.+.....++..+.+....+... ..+.+|+++|++|.| +++.. .-+..|++|||+.|.+|
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~G~~L 85 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLAGAAM 85 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeecCccH
Confidence 356789999999997777666676666655444222 257899999999955 33333 12457999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccC-CCcceEee-CCeeEEEecccccccCCCCCC----------
Q psy5368 128 CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDL-KPQNILIK-NNTLKLADFGFAQFLAPNDQG---------- 195 (406)
Q Consensus 128 ~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dl-kp~NIll~-~~~~kL~DFGla~~~~~~~~~---------- 195 (406)
.+.+.. ....++.|++.+|.++|++||+|||| ||+|||++ ++.++|+|||+|.........
T Consensus 86 ~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~ 158 (218)
T PRK12274 86 YQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLR 158 (218)
T ss_pred Hhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHH
Confidence 765422 12357889999999999999999999 79999998 678999999999855433211
Q ss_pred ----CcccCCCCCCChhhhcCC-CCC-chhhHHHHHHHHHHHHhCCCCCCCCC
Q psy5368 196 ----DSIQGSPLYMAPEILAGS-PYN-AKADLWSLGVLVFEALFGHAPYASCN 242 (406)
Q Consensus 196 ----~~~~gt~~y~aPE~~~~~-~~~-~~~DiwSlG~il~elltg~~pf~~~~ 242 (406)
.....++.|++|+.-.-- ..+ ...+.++.|+-+|.++|+..|+.+.+
T Consensus 159 ~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 159 HLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 012257788888865432 233 57899999999999999999886643
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.6e-21 Score=172.61 Aligned_cols=158 Identities=14% Similarity=0.174 Sum_probs=114.2
Q ss_pred eeeecceeeeEEEeeeeeeceeEEeeeecCCccchhh---------hhhHHhhcccCCCCCCccc--------------C
Q psy5368 56 TIRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSE---------FERPRAGLSNLRAPEGRKR--------------P 112 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~---------~~~E~~~l~~l~h~ni~~~--------------~ 112 (406)
.+.+|.|+||.||......+.+++|.+.......... +.+|+..+.++.|+++... .
T Consensus 36 ~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~ 115 (232)
T PRK10359 36 IKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYA 115 (232)
T ss_pred EEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccccccc
Confidence 3455666666666655555567788776544333332 6789999999999985431 2
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeCCeeEEEecccccccCCC
Q psy5368 113 RYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLADFGFAQFLAPN 192 (406)
Q Consensus 113 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~~~~kL~DFGla~~~~~~ 192 (406)
+..+|||||++|.+|.++. .+++ ....+++.+|..||+.|++|+|+||+||+++++.++|+|||........
T Consensus 116 ~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~gi~liDfg~~~~~~e~ 187 (232)
T PRK10359 116 HTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNGLRIIDLSGKRCTAQR 187 (232)
T ss_pred CCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCCEEEEECCCcccccch
Confidence 3578999999999998874 2333 3456999999999999999999999999999444999999987654221
Q ss_pred CCCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHH
Q psy5368 193 DQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232 (406)
Q Consensus 193 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 232 (406)
... ..++....|+.++|+||||+++..+.
T Consensus 188 ~a~-----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 188 KAK-----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred hhH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence 111 11344455778999999999987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.8e-20 Score=164.78 Aligned_cols=134 Identities=15% Similarity=0.073 Sum_probs=105.4
Q ss_pred eeecceeeeEEEeeeee-eceeEEeeeecCCccc--------------------------hhhhhhHHhhcccCCCCCCc
Q psy5368 57 IRYGELQYDTVQNSQIR-LGTVKYSQVRYDTITS--------------------------HSEFERPRAGLSNLRAPEGR 109 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~-~~~v~vk~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~ni~ 109 (406)
..||+|++|.||++... +..+++|......... ...+.+|...+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 46899999999999875 6788888776542110 11235788999999888753
Q ss_pred cc----CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCcceEeeCCeeEEEecc
Q psy5368 110 KR----PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRE-NNVCHFDLKPQNILIKNNTLKLADFG 184 (406)
Q Consensus 110 ~~----~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~-~givH~Dlkp~NIll~~~~~kL~DFG 184 (406)
.. ....||||||++|+++........+++...+..++.|++.++.++|+ .||+||||||+||+++++.++|+|||
T Consensus 83 ~p~~~~~~~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~~~~~~liDFG 162 (190)
T cd05145 83 VPEPILLKKNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYHDGKPYIIDVS 162 (190)
T ss_pred CceEEEecCCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEECCCEEEEEcc
Confidence 21 11237999999988665443344678899999999999999999999 99999999999999998899999999
Q ss_pred cccccC
Q psy5368 185 FAQFLA 190 (406)
Q Consensus 185 la~~~~ 190 (406)
++....
T Consensus 163 ~a~~~~ 168 (190)
T cd05145 163 QAVELD 168 (190)
T ss_pred cceecC
Confidence 997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-19 Score=167.99 Aligned_cols=174 Identities=26% Similarity=0.443 Sum_probs=135.3
Q ss_pred cCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee---CC--eeEEEeccc
Q psy5368 111 RPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK---NN--TLKLADFGF 185 (406)
Q Consensus 111 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~---~~--~~kL~DFGl 185 (406)
.+..+|+||.-.+. ||.+++..+ ..+.....-++.|+++|+.|||.+||.|||+|.+|||+. ++ .+.++|||+
T Consensus 314 ~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGC 391 (598)
T KOG4158|consen 314 EPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGC 391 (598)
T ss_pred CCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccce
Confidence 66788999999977 999999875 456777788999999999999999999999999999996 22 789999998
Q ss_pred ccccCC-------CCCCCcccCCCCCCChhhhcCCC-----C-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy5368 186 AQFLAP-------NDQGDSIQGSPLYMAPEILAGSP-----Y-NAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALS 252 (406)
Q Consensus 186 a~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~-----~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 252 (406)
+-.-.. ....-..-|+..-||||+....+ . -.++|.|+.|.+.||+++...||.+.....+......
T Consensus 392 cLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq 471 (598)
T KOG4158|consen 392 CLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ 471 (598)
T ss_pred eeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh
Confidence 732211 11122344788899999987643 1 2379999999999999999999988543333333333
Q ss_pred cCCCCCCCCCCChHHHHHHHHhcccCCCCCCCHH
Q psy5368 253 SAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYE 286 (406)
Q Consensus 253 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ 286 (406)
....+..+..+++.+++|+..+|+.||++|++..
T Consensus 472 e~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 472 ESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred hhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 3333344458999999999999999999999864
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.5e-21 Score=184.90 Aligned_cols=174 Identities=26% Similarity=0.489 Sum_probs=136.1
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEeccccc
Q psy5368 112 PRYVYIILEYCDGGDLCSFIRSHE---KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQ 187 (406)
Q Consensus 112 ~~~~~lV~E~~~ggsL~~~l~~~~---~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~ 187 (406)
..+.||.|++|...+|.++|..+. ..++...+.++.|++.|++| +|.+|+|+||.||++. ++.+||.|||+..
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhhee
Confidence 346899999999999999997543 47888999999999999999 9999999999999998 5679999999987
Q ss_pred ccCCCC-------CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q psy5368 188 FLAPND-------QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIP 259 (406)
Q Consensus 188 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (406)
.+.... ......||.+||+||.+.+..|+.++||||||+||+|++. =..+|... .....+..+ .+|
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~r~g---~ip 478 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI---ATLTDIRDG---IIP 478 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH---HhhhhhhcC---CCC
Confidence 766554 3456679999999999999999999999999999999997 22222211 111112122 222
Q ss_pred CC--CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 260 PN--SLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 260 ~~--~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
+. .=.++-.+|+.++|...|.+||++.+.--|+|.
T Consensus 479 ~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 479 PEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 11 112345689999999999999988877777664
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=183.36 Aligned_cols=179 Identities=22% Similarity=0.296 Sum_probs=141.4
Q ss_pred CceeeecceeeeEEEeeeeeec-eeEEeeeecCCccchhhhhhHHhhcccCCCCCCc----------ccCCeEEEEEecc
Q psy5368 54 SSTIRYGELQYDTVQNSQIRLG-TVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGR----------KRPRYVYIILEYC 122 (406)
Q Consensus 54 ~~~~~lG~G~~g~Vy~~~~~~~-~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~----------~~~~~~~lV~E~~ 122 (406)
+....+|+|+||.||.|...++ .+|+|.-+.. ..-+|.-=.+++.+|+ +... --.+..+||+||.
T Consensus 701 ~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~---~~WEfYI~~q~~~RLk-~~~~~~~~~~~~a~~~~~~S~lv~ey~ 776 (974)
T KOG1166|consen 701 CISKEIGEGSYGSVYVATHSNGKLVALKVEKPP---NPWEFYICLQVMERLK-PQMLPSIMHISSAHVFQNASVLVSEYS 776 (974)
T ss_pred EEEeeeccccceEEEEeecCCCcEEEEEeecCC---CceeeeehHHHHHhhc-hhhhcchHHHHHHHccCCcceeeeecc
Confidence 4567889999999999997554 4566643332 2222333333444444 2211 1445568999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee--------CCeeEEEecccccccCCCC-
Q psy5368 123 DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK--------NNTLKLADFGFAQFLAPND- 193 (406)
Q Consensus 123 ~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~--------~~~~kL~DFGla~~~~~~~- 193 (406)
+.|||.++++..+.++|..+..+..|++..++.||..+|||+||||+|+||. ...++|+|||.|.-+.--.
T Consensus 777 ~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~ 856 (974)
T KOG1166|consen 777 PYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPD 856 (974)
T ss_pred ccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCC
Confidence 9999999999888999999999999999999999999999999999999995 1269999999996654332
Q ss_pred --CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Q psy5368 194 --QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHA 236 (406)
Q Consensus 194 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~ 236 (406)
.....++|-.+-.+|+..|.++++..|.|.++.+++-||.|+.
T Consensus 857 ~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 857 GTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred CcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 3456678999999999999999999999999999999999965
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.9e-18 Score=154.98 Aligned_cols=128 Identities=18% Similarity=0.189 Sum_probs=106.4
Q ss_pred eeecceeeeEEEeeeeeeceeEEeeeecCCcc--------chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEecc
Q psy5368 57 IRYGELQYDTVQNSQIRLGTVKYSQVRYDTIT--------SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYC 122 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~--------~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~ 122 (406)
..||+|++|.||++...+..+++|........ ....+.+|+.++..++|+++.. .....++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 36899999999999988888888865433221 1235778999999998887532 556678999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeCCeeEEEecccccc
Q psy5368 123 DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLADFGFAQF 188 (406)
Q Consensus 123 ~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~~~~kL~DFGla~~ 188 (406)
+|++|.+++..... ....++.+++.+|.++|+.|++|+|++|.|||++++.++|+|||.+..
T Consensus 82 ~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILSGGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEECCCEEEEECCcccC
Confidence 99999999865432 788999999999999999999999999999999988999999999865
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.3e-18 Score=153.80 Aligned_cols=129 Identities=21% Similarity=0.188 Sum_probs=98.5
Q ss_pred CceeeecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccC-----CCCCCcc------cC---CeEE-EE
Q psy5368 54 SSTIRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNL-----RAPEGRK------RP---RYVY-II 118 (406)
Q Consensus 54 ~~~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l-----~h~ni~~------~~---~~~~-lV 118 (406)
+....||+|+|+.||..... ....+|............+.+|+.+++.+ .|||++. ++ +.++ +|
T Consensus 5 ~~~~~LG~G~~~~Vy~hp~~-~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 5 SEQSPLGTGRHRKCYAHPED-AQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CCcceecCCCceEEEECCCC-cCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 45678999999999973322 23356766555445567899999999999 5688765 22 3444 89
Q ss_pred Eec--cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHHCCcccccCCCcceEeeC-----CeeEEEecccc
Q psy5368 119 LEY--CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLAL-KFLRENNVCHFDLKPQNILIKN-----NTLKLADFGFA 186 (406)
Q Consensus 119 ~E~--~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL-~~lH~~givH~Dlkp~NIll~~-----~~~kL~DFGla 186 (406)
||| ++++||.+++++. .+++. ..++.|++.++ +|||+++|+||||||+|||++. ..++|+||+.+
T Consensus 84 ~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred ecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 999 5579999999764 56666 35678888887 9999999999999999999971 27999995443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.2e-18 Score=153.29 Aligned_cols=124 Identities=18% Similarity=0.236 Sum_probs=102.1
Q ss_pred eecceeeeEEEeeeeeeceeEEeeeecCCcc--------chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccC
Q psy5368 58 RYGELQYDTVQNSQIRLGTVKYSQVRYDTIT--------SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~--------~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ 123 (406)
.||+|++|.||++...+..+++|........ ...++.+|++++..++|+++.. .....++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 3799999999999988888888875443211 1245778999999998876422 4556689999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeCCeeEEEecccccc
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLADFGFAQF 188 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~~~~kL~DFGla~~ 188 (406)
|++|.+++..... .++.+++.+|.+||+.|++|+|++|.||+++++.++++|||++..
T Consensus 81 g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVRDDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEECCcEEEEECCCCcC
Confidence 9999998865321 789999999999999999999999999999988999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.74 E-value=9e-18 Score=165.82 Aligned_cols=191 Identities=28% Similarity=0.483 Sum_probs=148.7
Q ss_pred cccCCCCCCcc------cCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCc-ccccCCCcce
Q psy5368 100 LSNLRAPEGRK------RPRYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNV-CHFDLKPQNI 171 (406)
Q Consensus 100 l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~gi-vH~Dlkp~NI 171 (406)
|+.+.|.|+.+ +.+..++|.+||..|+|.+.+... ..+++.-...++++|+.||.|+|+-.| .|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 45678888544 668899999999999999999774 478999999999999999999998765 9999999999
Q ss_pred EeeCC-eeEEEecccccccCCC---CCCCcccCCCCCCChhhhcCCC-------CCchhhHHHHHHHHHHHHhCCCCCCC
Q psy5368 172 LIKNN-TLKLADFGFAQFLAPN---DQGDSIQGSPLYMAPEILAGSP-------YNAKADLWSLGVLVFEALFGHAPYAS 240 (406)
Q Consensus 172 ll~~~-~~kL~DFGla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwSlG~il~elltg~~pf~~ 240 (406)
++|.. .+||+|||+....... .......-...|.|||.+.... .+.+.|+||+|++++|+++...||+.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 99955 8999999998765321 1122223456699999998742 46679999999999999999999987
Q ss_pred CC----HHHHHHHHHh-cCCCCCCC---C-CCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 241 CN----LSQLRAQALS-SAPITIPP---N-SLSPDCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 241 ~~----~~~~~~~~~~-~~~~~~~~---~-~~s~~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
.. ..++...+.. ......|. . .+++++..++.+||..+|.+||+++++-.
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 33 2345444444 22212121 1 45667999999999999999999999855
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.3e-18 Score=155.39 Aligned_cols=135 Identities=15% Similarity=0.055 Sum_probs=105.4
Q ss_pred CceeeecceeeeEEEeee---eeeceeEEeeeecCCccc------------------------hhhhhhHHhhcccCCCC
Q psy5368 54 SSTIRYGELQYDTVQNSQ---IRLGTVKYSQVRYDTITS------------------------HSEFERPRAGLSNLRAP 106 (406)
Q Consensus 54 ~~~~~lG~G~~g~Vy~~~---~~~~~v~vk~~~~~~~~~------------------------~~~~~~E~~~l~~l~h~ 106 (406)
.-...||+|++|.||++. ..+..+++|......... ...+.+|+..+.++.+.
T Consensus 31 ~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~ 110 (237)
T smart00090 31 AIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEA 110 (237)
T ss_pred HhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence 345679999999999997 356788888776432110 12356899999988653
Q ss_pred C-----CcccCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccccCCCcceEeeCCeeEE
Q psy5368 107 E-----GRKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENN-VCHFDLKPQNILIKNNTLKL 180 (406)
Q Consensus 107 n-----i~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~g-ivH~Dlkp~NIll~~~~~kL 180 (406)
. ++. ....++||||++|++|.........+...++..++.|++.++++||+.| ++|+||||+||+++++.++|
T Consensus 111 ~i~~p~~~~-~~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~~~~i~L 189 (237)
T smart00090 111 GVPVPKPIA-WRRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVHDGKVVI 189 (237)
T ss_pred CCCCCeeeE-ecCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEECCCEEE
Confidence 2 222 2345899999999888776645556777788899999999999999999 99999999999999889999
Q ss_pred Eeccccccc
Q psy5368 181 ADFGFAQFL 189 (406)
Q Consensus 181 ~DFGla~~~ 189 (406)
+|||.+...
T Consensus 190 iDFg~a~~~ 198 (237)
T smart00090 190 IDVSQSVEL 198 (237)
T ss_pred EEChhhhcc
Confidence 999998654
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.7e-17 Score=169.08 Aligned_cols=127 Identities=18% Similarity=0.234 Sum_probs=103.8
Q ss_pred ceeeecceeeeEEEeeeeeeceeEEeeeecCCc--------cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEe
Q psy5368 55 STIRYGELQYDTVQNSQIRLGTVKYSQVRYDTI--------TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILE 120 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~--------~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E 120 (406)
....||+|+||+||++.+....+.+|+...... .....+.+|++++..++|+++.. .....++|||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E 416 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME 416 (535)
T ss_pred ccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence 467899999999999988666655554322111 11246889999999999998654 3456789999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeCCeeEEEeccccccc
Q psy5368 121 YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLADFGFAQFL 189 (406)
Q Consensus 121 ~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~~~~kL~DFGla~~~ 189 (406)
|++|++|.+++. ....++.+++.+|.+||+.|++||||||+|||++++.++|+|||+++..
T Consensus 417 ~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~~~~~~liDFGla~~~ 477 (535)
T PRK09605 417 YIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVRDDRLYLIDFGLGKYS 477 (535)
T ss_pred ecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEECCcEEEEeCcccccC
Confidence 999999999885 3567899999999999999999999999999999889999999998653
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.8e-18 Score=177.92 Aligned_cols=239 Identities=28% Similarity=0.400 Sum_probs=184.8
Q ss_pred eecceeeeEEEeeeee-ec--eeEEeeeecCC--ccchhhhhhHHhhcccCC-CCCCcc------cCCeEEEEEeccCCC
Q psy5368 58 RYGELQYDTVQNSQIR-LG--TVKYSQVRYDT--ITSHSEFERPRAGLSNLR-APEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~-~~--~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~-h~ni~~------~~~~~~lV~E~~~gg 125 (406)
-+|+|+|+.|-..... .. .++.+.+.... .........|..+-..+. |+|++. .....++++||..|+
T Consensus 27 ~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~ 106 (601)
T KOG0590|consen 27 SIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGG 106 (601)
T ss_pred cccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCccccc
Confidence 3789999988877652 22 23444333322 222344556777777776 988665 777889999999999
Q ss_pred CHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-HCCcccccCCCcceEee-CC-eeEEEecccccccCC-CC---CCC
Q psy5368 126 DLCSFI-RSHE-KLSEFQCQQFVRQLVLALKFLR-ENNVCHFDLKPQNILIK-NN-TLKLADFGFAQFLAP-ND---QGD 196 (406)
Q Consensus 126 sL~~~l-~~~~-~l~~~~~~~i~~ql~~aL~~lH-~~givH~Dlkp~NIll~-~~-~~kL~DFGla~~~~~-~~---~~~ 196 (406)
++.+.+ .... ..+...+..++.|+..++.|+| ..++.|+|+||+|.+++ .+ .++++|||+|..... +. ...
T Consensus 107 ~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~ 186 (601)
T KOG0590|consen 107 SLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLK 186 (601)
T ss_pred ccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeee
Confidence 999998 5544 6788889999999999999999 99999999999999999 56 899999999987655 22 234
Q ss_pred cccC-CCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--CC-CCCCCCCCChHHHHHH
Q psy5368 197 SIQG-SPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSS--AP-ITIPPNSLSPDCMDFL 271 (406)
Q Consensus 197 ~~~g-t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~--~~-~~~~~~~~s~~l~~li 271 (406)
..+| ++.|+|||...+. ...+..|+||.|+++.-+++|..||............... .. ...+...++....+++
T Consensus 187 ~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 266 (601)
T KOG0590|consen 187 DRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLL 266 (601)
T ss_pred cccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCChhhhhcc
Confidence 4567 9999999999885 4567899999999999999999999765433322111111 11 2334457889999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCCCC
Q psy5368 272 SRLLQKDPMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 272 ~~~L~~dP~~Rps~~ell~hp~~~~ 296 (406)
.+++..+|..|.+.+++..+||+..
T Consensus 267 ~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 267 HKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccccCCchhccccccccccccccc
Confidence 9999999999999999999999987
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=4e-16 Score=139.79 Aligned_cols=130 Identities=17% Similarity=0.098 Sum_probs=99.3
Q ss_pred CceeeecceeeeEEEeeeee-eceeEEeeeecCCcc----------------------chhhhhhHHhhcccCCCCCC--
Q psy5368 54 SSTIRYGELQYDTVQNSQIR-LGTVKYSQVRYDTIT----------------------SHSEFERPRAGLSNLRAPEG-- 108 (406)
Q Consensus 54 ~~~~~lG~G~~g~Vy~~~~~-~~~v~vk~~~~~~~~----------------------~~~~~~~E~~~l~~l~h~ni-- 108 (406)
.....||+|+||.||++... +..+++|.+...... ......+|..++..+.++++
T Consensus 18 ~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v 97 (198)
T cd05144 18 SLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPV 97 (198)
T ss_pred hcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCC
Confidence 33567999999999999874 567888865543200 01135678888888877642
Q ss_pred cc--cCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEeccc
Q psy5368 109 RK--RPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGF 185 (406)
Q Consensus 109 ~~--~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGl 185 (406)
.. .....++||||++|++|.+.... .....++.+++.++.++|+.|++|+||||+||+++ ++.++|+|||+
T Consensus 98 ~~~~~~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~ 171 (198)
T cd05144 98 PKPIDWNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQ 171 (198)
T ss_pred CceeecCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCc
Confidence 11 23456899999999999876431 34567889999999999999999999999999999 77999999999
Q ss_pred cccc
Q psy5368 186 AQFL 189 (406)
Q Consensus 186 a~~~ 189 (406)
+...
T Consensus 172 ~~~~ 175 (198)
T cd05144 172 MVST 175 (198)
T ss_pred cccC
Confidence 8554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.9e-15 Score=139.21 Aligned_cols=128 Identities=20% Similarity=0.185 Sum_probs=99.5
Q ss_pred eeeec-ceeeeEEEeeeeeeceeEEeeeecCCc-------------cchhhhhhHHhhcccCCCCCCc--c-------cC
Q psy5368 56 TIRYG-ELQYDTVQNSQIRLGTVKYSQVRYDTI-------------TSHSEFERPRAGLSNLRAPEGR--K-------RP 112 (406)
Q Consensus 56 ~~~lG-~G~~g~Vy~~~~~~~~v~vk~~~~~~~-------------~~~~~~~~E~~~l~~l~h~ni~--~-------~~ 112 (406)
...+| .|+.|+||.....+..+++|.+..... .....+.+|+.++..|+|+++. . ..
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 45687 899999999988878888876643211 2234678899999999987741 1 11
Q ss_pred Ce---EEEEEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEeccccc
Q psy5368 113 RY---VYIILEYCDG-GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQ 187 (406)
Q Consensus 113 ~~---~~lV~E~~~g-gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~ 187 (406)
+. .++|||+++| .+|.+++.. .++++.. +.+|+.+|.+||++||+|+||||.|||++ ++.++|+|||.+.
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~ 190 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGE 190 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence 22 2599999997 699998865 4566543 57899999999999999999999999998 6689999999876
Q ss_pred c
Q psy5368 188 F 188 (406)
Q Consensus 188 ~ 188 (406)
.
T Consensus 191 ~ 191 (239)
T PRK01723 191 L 191 (239)
T ss_pred c
Confidence 5
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.8e-15 Score=132.78 Aligned_cols=132 Identities=16% Similarity=0.138 Sum_probs=91.0
Q ss_pred eeecceeeeEEEeeeee-eceeEEeeeecCCccc--hhhh----------------------hhHHhhcccCCCCCC--c
Q psy5368 57 IRYGELQYDTVQNSQIR-LGTVKYSQVRYDTITS--HSEF----------------------ERPRAGLSNLRAPEG--R 109 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~-~~~v~vk~~~~~~~~~--~~~~----------------------~~E~~~l~~l~h~ni--~ 109 (406)
+.||+|+||+||++... +..+++|......... .... ..|...+..+.+..+ .
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 46899999999999876 6678888765432111 1111 234444544433321 1
Q ss_pred c--cCCeEEEEEeccCCCCHHH-HHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCcceEeeCCeeEEEeccc
Q psy5368 110 K--RPRYVYIILEYCDGGDLCS-FIRSHEKLSEFQCQQFVRQLVLALKFLRE-NNVCHFDLKPQNILIKNNTLKLADFGF 185 (406)
Q Consensus 110 ~--~~~~~~lV~E~~~ggsL~~-~l~~~~~l~~~~~~~i~~ql~~aL~~lH~-~givH~Dlkp~NIll~~~~~kL~DFGl 185 (406)
. .....++||||++|+++.. .+... ... ..+..++.+++.++.++|+ .||+|+||||+||+++++.++|+|||.
T Consensus 83 ~~~~~~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~~~~~~liDfg~ 160 (187)
T cd05119 83 KPIDLNRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVDDGKVYIIDVPQ 160 (187)
T ss_pred ceEecCCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEECCcEEEEECcc
Confidence 1 1134589999999854321 11111 111 6778899999999999999 999999999999999988999999999
Q ss_pred ccccC
Q psy5368 186 AQFLA 190 (406)
Q Consensus 186 a~~~~ 190 (406)
+....
T Consensus 161 a~~~~ 165 (187)
T cd05119 161 AVEID 165 (187)
T ss_pred ccccc
Confidence 86543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.53 E-value=9e-15 Score=151.96 Aligned_cols=251 Identities=25% Similarity=0.324 Sum_probs=187.7
Q ss_pred ccccceeeecCceeeecceeeeEEEeeeeeece----eEEee-eecCCccchhhhhhHHhhcccCCCCCCc------ccC
Q psy5368 44 SGTVRYDIVGSSTIRYGELQYDTVQNSQIRLGT----VKYSQ-VRYDTITSHSEFERPRAGLSNLRAPEGR------KRP 112 (406)
Q Consensus 44 ~~~~~~~i~~~~~~~lG~G~~g~Vy~~~~~~~~----v~vk~-~~~~~~~~~~~~~~E~~~l~~l~h~ni~------~~~ 112 (406)
...+.+.|..+. -.|+++.++-++-.... ..+.. .........+...++-.++-..++|-++ ...
T Consensus 801 sS~d~~~i~~p~----qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r 876 (1205)
T KOG0606|consen 801 SSPDGFEITKPS----QSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCR 876 (1205)
T ss_pred CCCccceecccc----cCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCC
Confidence 445555555533 56777777665532211 11111 1111111233344455555445555444 255
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCC
Q psy5368 113 RYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAP 191 (406)
Q Consensus 113 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~ 191 (406)
...+||++|..|++|...++.-+..+...++.....+.+++++||+..+.|+|++|.|++.. ++..+++|||......-
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred CCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence 67899999999999999999988899999999999999999999999999999999999998 78999999984322110
Q ss_pred ----------C----------------------CCCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy5368 192 ----------N----------------------DQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYA 239 (406)
Q Consensus 192 ----------~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~ 239 (406)
. .......||+.|.+||...+......+|+|++|++++|.++|.+||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 00123458999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHHhcCCCCCCC--CCCChHHHHHHHHhcccCCCCCCCHH---HHhcCCCCCCCCC
Q psy5368 240 SCNLSQLRAQALSSAPITIPP--NSLSPDCMDFLSRLLQKDPMRRISYE---DLFSHPYPDLIHA 299 (406)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~~li~~~L~~dP~~Rps~~---ell~hp~~~~~~~ 299 (406)
......+...+.... ...+. ...+.++++++.++|..+|.+|..+. ++-.|+||+...+
T Consensus 1037 a~tpq~~f~ni~~~~-~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1037 AETPQQIFENILNRD-IPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred CcchhhhhhccccCC-CCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCc
Confidence 999999988777663 33332 36889999999999999999999887 8899999997765
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.50 E-value=8.2e-14 Score=117.77 Aligned_cols=123 Identities=23% Similarity=0.240 Sum_probs=99.5
Q ss_pred eeecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccCCCC--CCcc------cCCeEEEEEeccCCCCHH
Q psy5368 57 IRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAP--EGRK------RPRYVYIILEYCDGGDLC 128 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~--ni~~------~~~~~~lV~E~~~ggsL~ 128 (406)
..+|+|.++.||++....+.+++|....... ...+.+|+..+..+++. ++.+ ..+..+++|||++|+++.
T Consensus 4 ~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~ 81 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD 81 (155)
T ss_pred eecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence 5689999999999998777788887654432 45788999999988664 3222 335689999999987776
Q ss_pred HHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCCcceEeeC-CeeEEEecccccc
Q psy5368 129 SFIRSHEKLSEFQCQQFVRQLVLALKFLREN---NVCHFDLKPQNILIKN-NTLKLADFGFAQF 188 (406)
Q Consensus 129 ~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~---givH~Dlkp~NIll~~-~~~kL~DFGla~~ 188 (406)
.+ +......++.+++.++..+|.. +++|+|++|.||++++ +.++++|||.+..
T Consensus 82 ~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 82 EV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 54 5567778899999999999985 7999999999999995 7999999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.5e-13 Score=133.65 Aligned_cols=239 Identities=21% Similarity=0.233 Sum_probs=175.4
Q ss_pred ceeeecc--eeeeEEEeeee--e--eceeEEeeeecCCc--cchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEE
Q psy5368 55 STIRYGE--LQYDTVQNSQI--R--LGTVKYSQVRYDTI--TSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIIL 119 (406)
Q Consensus 55 ~~~~lG~--G~~g~Vy~~~~--~--~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~ 119 (406)
....+|. |.+|.||.+.. . ....++|+-..... .....-.+|+....++ .|+|.+. ..+..|+-+
T Consensus 118 ~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqt 197 (524)
T KOG0601|consen 118 ISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQT 197 (524)
T ss_pred cccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeee
Confidence 3455688 99999999887 2 34456665333222 2333446677766666 5566544 778889999
Q ss_pred eccCCCCHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHHCCcccccCCCcceEee-C-CeeEEEecccccccCCC
Q psy5368 120 EYCDGGDLCSFIRSHEK-LSEFQCQQFVRQLVL----ALKFLRENNVCHFDLKPQNILIK-N-NTLKLADFGFAQFLAPN 192 (406)
Q Consensus 120 E~~~ggsL~~~l~~~~~-l~~~~~~~i~~ql~~----aL~~lH~~givH~Dlkp~NIll~-~-~~~kL~DFGla~~~~~~ 192 (406)
|+|. .+|..+...... ++...++.++.+... ||.++|+.+++|-|+||.||+.. + ...+++|||+...+...
T Consensus 198 E~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~ 276 (524)
T KOG0601|consen 198 ELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDG 276 (524)
T ss_pred cccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEccCC
Confidence 9995 599998876554 888999999999999 99999999999999999999998 5 58999999999887765
Q ss_pred CCCC------cccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChH
Q psy5368 193 DQGD------SIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPD 266 (406)
Q Consensus 193 ~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 266 (406)
.... ...|...|++||...+- ++..+|+||+|.++.+..++..++...... .+..+.............+.+
T Consensus 277 ~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-~W~~~r~~~ip~e~~~~~s~~ 354 (524)
T KOG0601|consen 277 NFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNS-SWSQLRQGYIPLEFCEGGSSS 354 (524)
T ss_pred ccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCC-CccccccccCchhhhcCcchh
Confidence 4222 22577889999998665 789999999999999999887766543110 011111111111111145677
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy5368 267 CMDFLSRLLQKDPMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 267 l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 296 (406)
+...+..+++.+|..|+++..+.+|++...
T Consensus 355 l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 355 LRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred hhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 778999999999999999999999998763
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.38 E-value=9.3e-13 Score=114.48 Aligned_cols=123 Identities=18% Similarity=0.178 Sum_probs=92.8
Q ss_pred eeecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCCCCHHHHH
Q psy5368 57 IRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDGGDLCSFI 131 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ggsL~~~l 131 (406)
..++.|.++.||+.+..++.+.+|...... .....+.+|+.++..+.+.+++. .....++||||++|.++.+.
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~~- 81 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGT-ELLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTE- 81 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCc-ccccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCccccc-
Confidence 356889999999999887788888654432 12345678888888886544322 33345799999999887653
Q ss_pred HhCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----ccccCCCcceEeeCCeeEEEecccccc
Q psy5368 132 RSHEKLSEFQCQQFVRQLVLALKFLRENNV-----CHFDLKPQNILIKNNTLKLADFGFAQF 188 (406)
Q Consensus 132 ~~~~~l~~~~~~~i~~ql~~aL~~lH~~gi-----vH~Dlkp~NIll~~~~~kL~DFGla~~ 188 (406)
. .....++.+++.+|..||+.++ +|+|++|.||+++++.++++|||.+..
T Consensus 82 ----~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~~~~~~liDf~~a~~ 136 (170)
T cd05151 82 ----D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDDGRLWLIDWEYAGM 136 (170)
T ss_pred ----c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEECCeEEEEecccccC
Confidence 0 1123456899999999999985 999999999999988999999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.36 E-value=8.4e-13 Score=121.71 Aligned_cols=181 Identities=18% Similarity=0.245 Sum_probs=127.6
Q ss_pred cCCeEEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCcceEee-CCeeEEEec
Q psy5368 111 RPRYVYIILEYCDGGDLCSFIRSH----EKLSEFQCQQFVRQLVLALKFLRENN--VCHFDLKPQNILIK-NNTLKLADF 183 (406)
Q Consensus 111 ~~~~~~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dlkp~NIll~-~~~~kL~DF 183 (406)
+.....+++|||..|+|..+|++- ..+......+++.||+.||.|||+.. |+|+++....|++. ++-+|+..
T Consensus 143 e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~- 221 (458)
T KOG1266|consen 143 EKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGS- 221 (458)
T ss_pred cccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecc-
Confidence 344578999999999999999653 36888999999999999999999875 99999999999998 55666543
Q ss_pred ccccccCCC------CCCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Q psy5368 184 GFAQFLAPN------DQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPIT 257 (406)
Q Consensus 184 Gla~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 257 (406)
+........ .......+.++|.+||.-.....+.++|||+||....+|..+..--......-............
T Consensus 222 ~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~ 301 (458)
T KOG1266|consen 222 VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIG 301 (458)
T ss_pred cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheee
Confidence 211111111 11122346788999998777777889999999999999987765432221111111111111111
Q ss_pred CCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy5368 258 IPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 258 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 296 (406)
. -...-++++.+|++.+|..||++.+++.||..-.
T Consensus 302 l----en~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 302 L----ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred c----cCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 0 1122467899999999999999999999998543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.31 E-value=5.4e-12 Score=126.17 Aligned_cols=131 Identities=20% Similarity=0.245 Sum_probs=90.4
Q ss_pred eeeecceeeeEEEeeeee-eceeEEeeeecCCccc----------------------------------------hhhhh
Q psy5368 56 TIRYGELQYDTVQNSQIR-LGTVKYSQVRYDTITS----------------------------------------HSEFE 94 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~-~~~v~vk~~~~~~~~~----------------------------------------~~~~~ 94 (406)
..-+|+|++|.||+|+.. +..|+||..+...... .-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 356999999999999974 5678888765431110 01244
Q ss_pred hHHhhcccCC----CCCCcc-------cCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHHHCCc
Q psy5368 95 RPRAGLSNLR----APEGRK-------RPRYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVL-ALKFLRENNV 161 (406)
Q Consensus 95 ~E~~~l~~l~----h~ni~~-------~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~ql~~-aL~~lH~~gi 161 (406)
+|+..+.+++ +.+.+. .....+|||||++|++|.++.... ... ....++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence 4555444442 222111 233457999999999999887532 122 23456666666 4788999999
Q ss_pred ccccCCCcceEee-CCeeEEEeccccccc
Q psy5368 162 CHFDLKPQNILIK-NNTLKLADFGFAQFL 189 (406)
Q Consensus 162 vH~Dlkp~NIll~-~~~~kL~DFGla~~~ 189 (406)
+|+|+||.||+++ ++.++++|||++..+
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 9999999999998 679999999998654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.3e-11 Score=109.37 Aligned_cols=94 Identities=16% Similarity=0.179 Sum_probs=72.2
Q ss_pred hHHhhcccCCCC-----CCcccCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCcccccCCC
Q psy5368 95 RPRAGLSNLRAP-----EGRKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFL-RENNVCHFDLKP 168 (406)
Q Consensus 95 ~E~~~l~~l~h~-----ni~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~l-H~~givH~Dlkp 168 (406)
+|...|.++..- ..+ ....-+|||||+.+..+..-.-+...++......+..+++.+|..| |+.|++|+||++
T Consensus 75 kE~r~L~rl~~~Gv~vP~pi-~~~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~ 153 (197)
T cd05146 75 KEMHNLKRMQKAGIPCPEVV-VLKKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSE 153 (197)
T ss_pred HHHHHHHHHHHcCCCCCeEE-EecCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 788888887443 333 2356689999997654422222223466677788899999999999 899999999999
Q ss_pred cceEeeCCeeEEEeccccccc
Q psy5368 169 QNILIKNNTLKLADFGFAQFL 189 (406)
Q Consensus 169 ~NIll~~~~~kL~DFGla~~~ 189 (406)
.|||++++.+.|+|||.+...
T Consensus 154 ~NIL~~~~~v~iIDF~qav~~ 174 (197)
T cd05146 154 YNMLWHDGKVWFIDVSQSVEP 174 (197)
T ss_pred HHEEEECCcEEEEECCCceeC
Confidence 999999999999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.5e-11 Score=105.74 Aligned_cols=124 Identities=16% Similarity=0.185 Sum_probs=92.9
Q ss_pred eecceeeeEEEeeeeeeceeEEeeeecCCccc--------hhhhhhHHhhcccCCCCC-----Ccc-cCCeEEEEEeccC
Q psy5368 58 RYGELQYDTVQNSQIRLGTVKYSQVRYDTITS--------HSEFERPRAGLSNLRAPE-----GRK-RPRYVYIILEYCD 123 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~--------~~~~~~E~~~l~~l~h~n-----i~~-~~~~~~lV~E~~~ 123 (406)
.+++|+-+.+|.+.+.+..+.+|......... ..+-.+|+.++.+++--. +.. +++...|+|||++
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 46788999999998766565555433322221 224567888888875543 222 6667789999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeCCeeEEEecccccc
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLADFGFAQF 188 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~~~~kL~DFGla~~ 188 (406)
|..|.+.+... ...++..+=.-+.-||..||+|+||.++||+++++.+.++|||++..
T Consensus 83 G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~i~~IDfGLg~~ 140 (204)
T COG3642 83 GELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGRIYFIDFGLGEF 140 (204)
T ss_pred ChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCcEEEEECCcccc
Confidence 99999899775 24556666667788999999999999999999999999999999864
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.24 E-value=6.3e-10 Score=111.93 Aligned_cols=201 Identities=15% Similarity=0.172 Sum_probs=134.9
Q ss_pred eeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHH
Q psy5368 76 TVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQL 149 (406)
Q Consensus 76 ~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql 149 (406)
.+.|...............+-++-|+.+||||+.. ..+.+|||+|-+. .|..++++.+ ...+...+.||
T Consensus 39 ~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~~~v~~Gl~qI 113 (690)
T KOG1243|consen 39 PVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---KEEVCLGLFQI 113 (690)
T ss_pred ceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---HHHHHHHHHHH
Confidence 34444433332222345677889999999999765 7779999999995 6888887644 67777889999
Q ss_pred HHHHHHHH-HCCcccccCCCcceEee-CCeeEEEecccccccCCCCC-CCcccCCCCCCChhhhcCCCCCchhhHHHHHH
Q psy5368 150 VLALKFLR-ENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ-GDSIQGSPLYMAPEILAGSPYNAKADLWSLGV 226 (406)
Q Consensus 150 ~~aL~~lH-~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 226 (406)
+.||.||| ..+++|++|.-..|+++ .|..||++|.++........ .......-.|..|+.+.... ...|.|-|||
T Consensus 114 l~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~ 191 (690)
T KOG1243|consen 114 LAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSIDSWGLGC 191 (690)
T ss_pred HHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchhhhhHHH
Confidence 99999998 66899999999999999 88999999998755433221 12222223366666554332 4579999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHH-----hcCCCCCCCC
Q psy5368 227 LVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDL-----FSHPYPDLIH 298 (406)
Q Consensus 227 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~el-----l~hp~~~~~~ 298 (406)
+++|++.|..+ ... + ......+|.....+-.+-+--.+..||..-.. +-|+||+..-
T Consensus 192 li~el~ng~~~--~~~--~-----------~~~~~~ipk~~~~~~~k~~~~~~~~r~n~~~~~~~~~~~~gff~n~f 253 (690)
T KOG1243|consen 192 LIEELFNGSLL--TKT--D-----------LSNTGKIPKALIELYCKKLGATELKRPNKLRFILECRLLGGFFRNDF 253 (690)
T ss_pred HHHHHhCcccC--cch--h-----------hhccCccchhHHHHHHHHhccccccccchhhHHHHHHhccccccchH
Confidence 99999998322 111 0 01122344445555545555566777764332 3388887543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=7.1e-10 Score=105.95 Aligned_cols=233 Identities=18% Similarity=0.200 Sum_probs=153.1
Q ss_pred ecCceeeecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccCCCCC-------------CcccCCeEEEE
Q psy5368 52 VGSSTIRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPE-------------GRKRPRYVYII 118 (406)
Q Consensus 52 ~~~~~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~n-------------i~~~~~~~~lV 118 (406)
..+.+..+|+|+-+.+|.-..-...|+ |...........+...|+ ..--.||- .......+.+.
T Consensus 12 ~i~~gr~LgqGgea~ly~l~e~~d~VA-KIYh~Pppa~~aqk~a~l--a~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 12 PIPPGRPLGQGGEADLYTLGEVRDQVA-KIYHAPPPAAQAQKVAEL--AATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred ccCCCccccCCccceeeecchhhchhh-eeecCCCchHHHHHHHHh--ccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 345677899999999997654333332 222222222222222222 12224442 11233447899
Q ss_pred EeccCCCC-HHHHH------HhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccC
Q psy5368 119 LEYCDGGD-LCSFI------RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLA 190 (406)
Q Consensus 119 ~E~~~ggs-L~~~l------~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~ 190 (406)
|..++|.. +..++ +......|.-..++++.|+.+.+.||+.|.+-+|++++|+|++ ++.+.|.|-..-+...
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ 168 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINA 168 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeecc
Confidence 99998753 22222 1123588999999999999999999999999999999999998 6689999865444444
Q ss_pred CCCCCCcccCCCCCCChhhhc-----CCCCCchhhHHHHHHHHHHHHhC-CCCCCCCC-----HHHHHHHHHhc------
Q psy5368 191 PNDQGDSIQGSPLYMAPEILA-----GSPYNAKADLWSLGVLVFEALFG-HAPYASCN-----LSQLRAQALSS------ 253 (406)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg-~~pf~~~~-----~~~~~~~~~~~------ 253 (406)
+.......+|.+.|++||.-. +-.-+...|.|.+|++++++|.| ++||.+.. .......|..+
T Consensus 169 ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~ 248 (637)
T COG4248 169 NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYAS 248 (637)
T ss_pred CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeech
Confidence 444555677999999999865 33457789999999999999986 99997742 11111111111
Q ss_pred --------CCCCCCCCCCChHHHHHHHHhccc--CCCCCCCHHH
Q psy5368 254 --------APITIPPNSLSPDCMDFLSRLLQK--DPMRRISYED 287 (406)
Q Consensus 254 --------~~~~~~~~~~s~~l~~li~~~L~~--dP~~Rps~~e 287 (406)
.+..+|-.-+++++..|..+|+.. ++.-|||++-
T Consensus 249 ~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 249 DQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred hccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 112223335788999999999985 4668999754
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.5e-10 Score=114.86 Aligned_cols=126 Identities=20% Similarity=0.245 Sum_probs=84.0
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCCcc----------------------------------------chhhhh
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT----------------------------------------SHSEFE 94 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~----------------------------------------~~~~~~ 94 (406)
.-+|+|++|.||++..+ +..|+||..+..... .+-++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 46899999999999985 567899877643100 001244
Q ss_pred hHHhhcccCC----CCCCcc-------cCCeEEEEEeccCCCCHHHH--HHhCC----CCCHHHHHHHHHHHHHHHHHHH
Q psy5368 95 RPRAGLSNLR----APEGRK-------RPRYVYIILEYCDGGDLCSF--IRSHE----KLSEFQCQQFVRQLVLALKFLR 157 (406)
Q Consensus 95 ~E~~~l~~l~----h~ni~~-------~~~~~~lV~E~~~ggsL~~~--l~~~~----~l~~~~~~~i~~ql~~aL~~lH 157 (406)
+|+..+.+++ +.+.+. .....+|||||++|++|.++ +...+ .+.+..+..++.|+ .
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence 5555444442 222111 23345699999999999875 33332 23344444444444 4
Q ss_pred HCCcccccCCCcceEee-CC----eeEEEeccccccc
Q psy5368 158 ENNVCHFDLKPQNILIK-NN----TLKLADFGFAQFL 189 (406)
Q Consensus 158 ~~givH~Dlkp~NIll~-~~----~~kL~DFGla~~~ 189 (406)
..|++|+|+||.||+++ ++ .++++|||++..+
T Consensus 278 ~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 278 RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 68999999999999998 55 8999999998665
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=99.14 E-value=3e-10 Score=97.39 Aligned_cols=132 Identities=19% Similarity=0.167 Sum_probs=98.7
Q ss_pred eeecceeeeEEEeeeeeeceeEEeeeecCCcc--------chhhhhhHHhhcccCCCCC-----Cc-ccCCeEEEEEecc
Q psy5368 57 IRYGELQYDTVQNSQIRLGTVKYSQVRYDTIT--------SHSEFERPRAGLSNLRAPE-----GR-KRPRYVYIILEYC 122 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~--------~~~~~~~E~~~l~~l~h~n-----i~-~~~~~~~lV~E~~ 122 (406)
..+-+|+-+.|+++.+.+....+|........ ...+..+|+++|.+++--. +. -+...-.|+|||+
T Consensus 13 ~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~ 92 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFI 92 (229)
T ss_pred eeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEec
Confidence 45678999999999998877677644333222 2346778999998885543 22 2555667999999
Q ss_pred CC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC---eeEEEecccccc
Q psy5368 123 DG-GDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN---TLKLADFGFAQF 188 (406)
Q Consensus 123 ~g-gsL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~---~~kL~DFGla~~ 188 (406)
+| .++.++++... .........++++|=+.+.-||..+|+|+||..+||++. ++ .+.++|||++..
T Consensus 93 ~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 93 DGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred cchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 87 58889887653 233333367889999999999999999999999999997 22 569999999854
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=99.12 E-value=5.2e-11 Score=120.01 Aligned_cols=152 Identities=26% Similarity=0.313 Sum_probs=115.4
Q ss_pred HHHHHHHHHHHH-CCcccccCCCcceEee-CCeeEEEecccccccCCCCC----------CCcccCCCCCCChhhhcCCC
Q psy5368 147 RQLVLALKFLRE-NNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ----------GDSIQGSPLYMAPEILAGSP 214 (406)
Q Consensus 147 ~ql~~aL~~lH~-~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~ 214 (406)
.+++.|+.|+|. .++||+.|.|++|.++ .+..||+.|+++........ ..-..-...|.|||++....
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 345599999995 5899999999999999 77999999998865543211 01112456699999999988
Q ss_pred CCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHH--HHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 215 YNAKADLWSLGVLVFEAL-FGHAPYASCNLSQLRAQ--ALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 215 ~~~~~DiwSlG~il~ell-tg~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
.++++|++|+||++|.+. .|+..+........... ...+.........+|.++++=+.+++..++..||++.+++..
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence 899999999999999998 57776665532222211 112222223335789999999999999999999999999999
Q ss_pred CCCCCCC
Q psy5368 292 PYPDLIH 298 (406)
Q Consensus 292 p~~~~~~ 298 (406)
|||.+..
T Consensus 266 ~ff~D~~ 272 (700)
T KOG2137|consen 266 PFFSDPG 272 (700)
T ss_pred cccCCch
Confidence 9998654
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.9e-10 Score=114.43 Aligned_cols=236 Identities=27% Similarity=0.245 Sum_probs=161.5
Q ss_pred CceeeecceeeeEEEeeeee---eceeEEeeeecCCccchh------hhhhHHhhcccCCCCC---CcccCCeEEEEEec
Q psy5368 54 SSTIRYGELQYDTVQNSQIR---LGTVKYSQVRYDTITSHS------EFERPRAGLSNLRAPE---GRKRPRYVYIILEY 121 (406)
Q Consensus 54 ~~~~~lG~G~~g~Vy~~~~~---~~~v~vk~~~~~~~~~~~------~~~~E~~~l~~l~h~n---i~~~~~~~~lV~E~ 121 (406)
.....||.|.|+.|++...+ +...+++........... +..-|+.+...+.+.+ ........|+=.||
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~ 347 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEF 347 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhh
Confidence 44567889999988887654 233444444332222222 2223333333333333 23355667799999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeC--CeeEEEecccccccCCCCCCCccc
Q psy5368 122 CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN--NTLKLADFGFAQFLAPNDQGDSIQ 199 (406)
Q Consensus 122 ~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~--~~~kL~DFGla~~~~~~~~~~~~~ 199 (406)
|.++++...+.-...+++...+++..|++.++.++|+..++|+|+||.||++.+ +..++.|||....+.... .....
T Consensus 348 ~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~-~~~~~ 426 (524)
T KOG0601|consen 348 CEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS-GVFHH 426 (524)
T ss_pred hcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceec-ccccc
Confidence 999999888765567899999999999999999999999999999999999985 689999999986532111 11112
Q ss_pred CCCCC-CChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccC
Q psy5368 200 GSPLY-MAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKD 278 (406)
Q Consensus 200 gt~~y-~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~d 278 (406)
.+..| .+|+......+..+.|++|||.-+.+.+++..--...... ..+..+. ....+ ..+.++..+...+...+
T Consensus 427 ~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i~~~~-~p~~~-~~~~~~q~~~kv~~~~~ 501 (524)
T KOG0601|consen 427 IDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTIRSGD-TPNLP-GLKLQLQVLLKVMINPD 501 (524)
T ss_pred cccccccchhhccccccccccccccccccccccccCcccCcccccc---eeeeccc-ccCCC-chHHhhhhhhhhhcCCc
Confidence 23334 3566666677889999999999999999986543332211 1112221 22222 34488899999999999
Q ss_pred CCCCCCHHHHhcCCCCC
Q psy5368 279 PMRRISYEDLFSHPYPD 295 (406)
Q Consensus 279 P~~Rps~~ell~hp~~~ 295 (406)
+..||.+.++..|+-|.
T Consensus 502 ~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 502 RKRRPSAVELSLHSEFY 518 (524)
T ss_pred cccchhhhhhcccchhh
Confidence 99999999998887654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.7e-09 Score=97.98 Aligned_cols=122 Identities=13% Similarity=0.077 Sum_probs=88.9
Q ss_pred EEeeeeeeceeEEeeeecCCcc-----------chhhhhhHHhhcccCCCCC-----Ccc-----c---CCeEEEEEecc
Q psy5368 67 VQNSQIRLGTVKYSQVRYDTIT-----------SHSEFERPRAGLSNLRAPE-----GRK-----R---PRYVYIILEYC 122 (406)
Q Consensus 67 Vy~~~~~~~~v~vk~~~~~~~~-----------~~~~~~~E~~~l~~l~h~n-----i~~-----~---~~~~~lV~E~~ 122 (406)
|.+.+..+..+.+|......+. ....+.+|...+..|..-+ .+- . ....+||||++
T Consensus 38 vvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l 117 (268)
T PRK15123 38 TLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDL 117 (268)
T ss_pred EEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeC
Confidence 4456666666777755332211 1114778888887774333 211 1 33578999999
Q ss_pred CCC-CHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeC--------CeeEEEecccccc
Q psy5368 123 DGG-DLCSFIRS--HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN--------NTLKLADFGFAQF 188 (406)
Q Consensus 123 ~gg-sL~~~l~~--~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~--------~~~kL~DFGla~~ 188 (406)
++. +|.+++.. ..+.+......++.+++..+.-||+.||+|+|+++.|||++. ..+.|+||+.++.
T Consensus 118 ~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 118 APTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred CCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 885 89999864 345677788899999999999999999999999999999973 3799999998753
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.93 E-value=3.8e-09 Score=95.65 Aligned_cols=131 Identities=16% Similarity=0.117 Sum_probs=95.6
Q ss_pred eeecceeeeEEEeeeeee-ceeEEeeeecCCc-cchhhhhhHHhhcccCCCCC-----Ccc-c-C----CeEEEEEeccC
Q psy5368 57 IRYGELQYDTVQNSQIRL-GTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPE-----GRK-R-P----RYVYIILEYCD 123 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~-~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~n-----i~~-~-~----~~~~lV~E~~~ 123 (406)
..+|.|..+.||+.+..+ ..+.+|....... .....+.+|.+++..+++.+ ++. . . +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 357899999999998766 5667765543322 13557889999998886532 222 1 1 36689999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------------
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRE--------------------------------------------- 158 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~--------------------------------------------- 158 (406)
|.++.+.+.. ..++......++.+++++|..||+
T Consensus 84 G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (223)
T cd05154 84 GRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLR 162 (223)
T ss_pred CEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHH
Confidence 9888775532 456777777788888888888873
Q ss_pred -----------CCcccccCCCcceEeeC--C-eeEEEecccccc
Q psy5368 159 -----------NNVCHFDLKPQNILIKN--N-TLKLADFGFAQF 188 (406)
Q Consensus 159 -----------~givH~Dlkp~NIll~~--~-~~kL~DFGla~~ 188 (406)
..++|+|++|.||++++ + .+.|+||+.+..
T Consensus 163 ~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 163 WLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23689999999999986 4 578999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.93 E-value=8.2e-09 Score=92.98 Aligned_cols=100 Identities=27% Similarity=0.376 Sum_probs=80.2
Q ss_pred chhhhhhHHhhcccCCCCCCcc------------cCCeEEEEEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHH
Q psy5368 89 SHSEFERPRAGLSNLRAPEGRK------------RPRYVYIILEYCDG-GDLCSFIRSHEKLSEFQCQQFVRQLVLALKF 155 (406)
Q Consensus 89 ~~~~~~~E~~~l~~l~h~ni~~------------~~~~~~lV~E~~~g-gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~ 155 (406)
......+|...+..|..-.+.. .....+||+|++++ .+|.+++......+......++.+++..+.-
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAK 133 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHH
Confidence 3456788888777775433211 11345899999998 4899999875557788889999999999999
Q ss_pred HHHCCcccccCCCcceEeeCC----eeEEEecccccc
Q psy5368 156 LRENNVCHFDLKPQNILIKNN----TLKLADFGFAQF 188 (406)
Q Consensus 156 lH~~givH~Dlkp~NIll~~~----~~kL~DFGla~~ 188 (406)
||+.||+|+|+++.|||++.+ .+.++||+-++.
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999944 699999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.6e-08 Score=89.26 Aligned_cols=95 Identities=21% Similarity=0.238 Sum_probs=63.1
Q ss_pred hhhHHhhcccCCCCCC-cc---cCCeEEEEEeccC--CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHHCCccccc
Q psy5368 93 FERPRAGLSNLRAPEG-RK---RPRYVYIILEYCD--GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKF-LRENNVCHFD 165 (406)
Q Consensus 93 ~~~E~~~l~~l~h~ni-~~---~~~~~~lV~E~~~--ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~-lH~~givH~D 165 (406)
..+|.+.|.++..-++ ++ .-..-+|||||++ |..+..+... .++......++.+++..+.. +|+.|++|+|
T Consensus 55 ~~~E~~~L~~l~~~Gv~vP~p~~~~~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGD 132 (188)
T PF01163_consen 55 AKKEFRNLKRLYEAGVPVPKPYDYNRNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGD 132 (188)
T ss_dssp HHHHHHHHHHCCCTT-SS--EEEEETTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS
T ss_pred HHHHHHHHHHHHHCCccCCcEEEEeCCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecC
Confidence 5568888888866543 11 1122359999998 6555543322 22245567788888885555 5899999999
Q ss_pred CCCcceEeeCCeeEEEeccccccc
Q psy5368 166 LKPQNILIKNNTLKLADFGFAQFL 189 (406)
Q Consensus 166 lkp~NIll~~~~~kL~DFGla~~~ 189 (406)
|++.||+++++.+.++|||.+...
T Consensus 133 Ls~~NIlv~~~~~~iIDf~qav~~ 156 (188)
T PF01163_consen 133 LSEYNILVDDGKVYIIDFGQAVDS 156 (188)
T ss_dssp -STTSEEEETTCEEE--GTTEEET
T ss_pred CChhhEEeecceEEEEecCcceec
Confidence 999999999889999999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=98.74 E-value=4.7e-07 Score=89.03 Aligned_cols=202 Identities=15% Similarity=0.138 Sum_probs=144.4
Q ss_pred eEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc----------cCCeEEEEEeccCC-CCHHHHH
Q psy5368 65 DTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK----------RPRYVYIILEYCDG-GDLCSFI 131 (406)
Q Consensus 65 g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~----------~~~~~~lV~E~~~g-gsL~~~l 131 (406)
.+.|++... +..+..|+++............-++.++++.|+|+++ .+..+++|++|.|+ ++|.++-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 456666642 3344555554444444445566688999999999876 56678999999995 6887765
Q ss_pred Hh---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeCC-eeEEEecccccccCCCCCC
Q psy5368 132 RS---------------HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLADFGFAQFLAPNDQG 195 (406)
Q Consensus 132 ~~---------------~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~~-~~kL~DFGla~~~~~~~~~ 195 (406)
-. +...++..++.++.||..||.++|+.|..-+-|.|.+|+++.. .++|+..|.......+.
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~-- 447 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP-- 447 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC--
Confidence 21 2247889999999999999999999999999999999999955 89998888765554332
Q ss_pred CcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHh
Q psy5368 196 DSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPY-ASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRL 274 (406)
Q Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~ 274 (406)
+ |-+. -..+-|.=.||.+++.|.||..-- ........... .....+|.++++++.-+
T Consensus 448 ----~-------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~--------~I~~~yS~D~rn~v~yl 505 (655)
T KOG3741|consen 448 ----T-------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT--------RITTTYSTDLRNVVEYL 505 (655)
T ss_pred ----C-------cchh---HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHH--------HhhhhhhHHHHHHHHHH
Confidence 0 0111 124679999999999999996542 22222222111 11235889999999999
Q ss_pred cccCCCCCCCHHHHhcC
Q psy5368 275 LQKDPMRRISYEDLFSH 291 (406)
Q Consensus 275 L~~dP~~Rps~~ell~h 291 (406)
...++++ -++.+++.+
T Consensus 506 ~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 506 ESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HhcCccc-ccHHHHHHH
Confidence 9999987 788898876
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.9e-07 Score=83.25 Aligned_cols=129 Identities=14% Similarity=0.090 Sum_probs=97.9
Q ss_pred cceeeeEEEeeeeeeceeEEeeee---cCC---ccchhhhhhHHhhcccCCCCCC-----cc-------cCCeEEEEEec
Q psy5368 60 GELQYDTVQNSQIRLGTVKYSQVR---YDT---ITSHSEFERPRAGLSNLRAPEG-----RK-------RPRYVYIILEY 121 (406)
Q Consensus 60 G~G~~g~Vy~~~~~~~~v~vk~~~---~~~---~~~~~~~~~E~~~l~~l~h~ni-----~~-------~~~~~~lV~E~ 121 (406)
|.||-+.|++-...+...-+|+-. ..+ .-....|.+|...+..|..-++ +- ....-+||+|-
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~ 106 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED 106 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence 667888888888777766666543 111 2256689999999998855432 11 12235799997
Q ss_pred cCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCe--eEEEecccccc
Q psy5368 122 CDG-GDLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNT--LKLADFGFAQF 188 (406)
Q Consensus 122 ~~g-gsL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~--~kL~DFGla~~ 188 (406)
++| .||.+++.+. .+.+......++.+++..+.-||+.|+.|+|+.+.||+++ ++. ++++||.-++.
T Consensus 107 L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 107 MAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred CCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 763 6899998664 3568888889999999999999999999999999999998 555 99999987654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=4.2e-07 Score=83.10 Aligned_cols=132 Identities=19% Similarity=0.140 Sum_probs=93.0
Q ss_pred eecCceeeecceeeeEEEeeeee-eceeEEeeeecCCcc-----------------------chhhhhhHHhhcccCCCC
Q psy5368 51 IVGSSTIRYGELQYDTVQNSQIR-LGTVKYSQVRYDTIT-----------------------SHSEFERPRAGLSNLRAP 106 (406)
Q Consensus 51 i~~~~~~~lG~G~~g~Vy~~~~~-~~~v~vk~~~~~~~~-----------------------~~~~~~~E~~~l~~l~h~ 106 (406)
++-.-...||.|--+.||.+... +.++++| ++..... +.....+|.++|..|...
T Consensus 91 ~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vK-fHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~ 169 (304)
T COG0478 91 IVEAIGTKIGVGKESDVYVAIDPKGRKVAVK-FHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPE 169 (304)
T ss_pred hHHhhccccccCccceEEEEECCCCCEEEEE-EeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhc
Confidence 33345678999999999999875 4556555 2221111 122346788888888554
Q ss_pred --CCcc--cCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEE
Q psy5368 107 --EGRK--RPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLA 181 (406)
Q Consensus 107 --ni~~--~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~ 181 (406)
.+.. ..+...+|||+++|-.|...- ++......++..|++-+.-+-..|++|+|+++.||+++ +|.+.++
T Consensus 170 G~~VP~P~~~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vI 244 (304)
T COG0478 170 GVKVPKPIAWNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVI 244 (304)
T ss_pred CCCCCCccccccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEE
Confidence 2222 556778999999997775532 24555666777777777777799999999999999999 6699999
Q ss_pred ecccccc
Q psy5368 182 DFGFAQF 188 (406)
Q Consensus 182 DFGla~~ 188 (406)
||--+..
T Consensus 245 DwPQ~v~ 251 (304)
T COG0478 245 DWPQAVP 251 (304)
T ss_pred eCccccc
Confidence 9976543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.45 E-value=7.4e-07 Score=79.78 Aligned_cols=67 Identities=25% Similarity=0.427 Sum_probs=54.7
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeCCeeEEEeccccc
Q psy5368 113 RYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLADFGFAQ 187 (406)
Q Consensus 113 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~~~~kL~DFGla~ 187 (406)
...++||||++|..|.+... +++ .+...+.+++.-+|+.|+.|+|.+|.|++++++.++++||+..+
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~i~iID~~~k~ 182 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNGIRIIDTQGKR 182 (229)
T ss_pred eEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCcEEEEECcccc
Confidence 34568999999988877542 232 24566778899999999999999999999999999999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.5e-06 Score=74.58 Aligned_cols=125 Identities=19% Similarity=0.180 Sum_probs=94.2
Q ss_pred ceeeecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc---cCCeEEEEEeccCCCCHHHHH
Q psy5368 55 STIRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK---RPRYVYIILEYCDGGDLCSFI 131 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~---~~~~~~lV~E~~~ggsL~~~l 131 (406)
....||+|.+|.||.+.+.+..+++|..+.+ .....+..|+++|..+.-.++.+ .-+..++.|||+.|-.|.+.-
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~~~i~me~i~G~~L~~~~ 103 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRGGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGEDFIRMEYIDGRPLGKLE 103 (201)
T ss_pred hhhhhhcccccEEEEeeccCceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEechhhhhhhhhcCcchhhhh
Confidence 3567899999999999999999999977665 44567899999999998877654 333445779999998887764
Q ss_pred HhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCC--cceEeeCCeeEEEecccccc
Q psy5368 132 RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKP--QNILIKNNTLKLADFGFAQF 188 (406)
Q Consensus 132 ~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp--~NIll~~~~~kL~DFGla~~ 188 (406)
... +.+. ...+++.---|-..||-|..|+- .||++.++.+.|+||..|+.
T Consensus 104 ~~~---~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 104 IGG---DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hcc---cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 321 2233 34455555556678999999975 67788888999999998864
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=98.33 E-value=9.5e-07 Score=94.33 Aligned_cols=194 Identities=20% Similarity=0.273 Sum_probs=141.2
Q ss_pred hhhHHhhcccCCCCCCcc---------cCC-eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q psy5368 93 FERPRAGLSNLRAPEGRK---------RPR-YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVC 162 (406)
Q Consensus 93 ~~~E~~~l~~l~h~ni~~---------~~~-~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~giv 162 (406)
..-|+..+.++.|+|+.. ..+ ...+..|+|.+.++...+..-+..+....+.+..++++||.|+|+....
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~ 308 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLE 308 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence 345778888999999765 111 1235568888889999998888999999999999999999999998655
Q ss_pred cccCCCc---ceEee-CCeeEEE--ecccccccCCCCCCCcccCCCCCCChhhhcCCCCCch--hhHHHHHHHHHHHHhC
Q psy5368 163 HFDLKPQ---NILIK-NNTLKLA--DFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAK--ADLWSLGVLVFEALFG 234 (406)
Q Consensus 163 H~Dlkp~---NIll~-~~~~kL~--DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~DiwSlG~il~elltg 234 (406)
|.-+... +...+ ++...++ ||+.++.............+..+.+||......++.+ .|+|.+|.....+..|
T Consensus 309 ~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~ 388 (1351)
T KOG1035|consen 309 HVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQG 388 (1351)
T ss_pred eeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhc
Confidence 5555444 22222 3455655 9998887766666555566777888888877666554 7999999999999887
Q ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy5368 235 HAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 235 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 297 (406)
..+-.... .+..+.+........+.+.+|+..++++|+++.+++.|||.+..
T Consensus 389 ~~i~~~~~-----------~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 389 EDISEKSA-----------VPVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred Cccccccc-----------chhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 65432211 01111122222378899999999999999999999999998754
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=98.33 E-value=2.9e-08 Score=99.57 Aligned_cols=230 Identities=17% Similarity=0.146 Sum_probs=154.9
Q ss_pred eecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccCCCCC-Ccc------cCCeEEEEEeccCCC-CHHH
Q psy5368 58 RYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPE-GRK------RPRYVYIILEYCDGG-DLCS 129 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~n-i~~------~~~~~~lV~E~~~gg-sL~~ 129 (406)
.+++++++.++|.+....+....++- .......-++++|.+++||| .+. .+.+.+++++++.++ +-..
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fv----s~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~ 324 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFV----SQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSAL 324 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceee----ccchhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccc
Confidence 46889999999887533332222221 22244566789999999999 333 556778999999876 2211
Q ss_pred HH-HhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeCCeeEEEecccccccCCCCCCCcccCCCCCCChh
Q psy5368 130 FI-RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPE 208 (406)
Q Consensus 130 ~l-~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~~~~kL~DFGla~~~~~~~~~~~~~gt~~y~aPE 208 (406)
.. ...-.+.+-+...+.+.-.++++++|+.--+|+| ||+..++..+..||+....+.......+..+++.++|||
T Consensus 325 ~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pe 400 (829)
T KOG0576|consen 325 EMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPE 400 (829)
T ss_pred cCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccccccccccCCcccCcccccccCCCCCCCCCch
Confidence 11 1111244445555666677899999988778998 999999999999999987776665677788999999999
Q ss_pred hhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCC-CCCChH-HHHHHHHhcccCCCCCCCH
Q psy5368 209 ILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSA-PITIPP-NSLSPD-CMDFLSRLLQKDPMRRISY 285 (406)
Q Consensus 209 ~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~-~~~s~~-l~~li~~~L~~dP~~Rps~ 285 (406)
+.....+....|.||.|.--.++--|.+|-.... .....+-.+. ...... ...++. -+++...|+...|..|+..
T Consensus 401 v~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~ 478 (829)
T KOG0576|consen 401 VIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVH 478 (829)
T ss_pred hhcccccccCCCccCCCcchhhcCCCCCCCCCCc--cccCCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcch
Confidence 9999999999999999987777777777654411 0000000000 000000 001111 1247788999999999999
Q ss_pred HHHhcCCCCCCC
Q psy5368 286 EDLFSHPYPDLI 297 (406)
Q Consensus 286 ~ell~hp~~~~~ 297 (406)
-.++.|-+|+.-
T Consensus 479 mgacfsKvfngC 490 (829)
T KOG0576|consen 479 MGACFSKVFNGC 490 (829)
T ss_pred hhHHHHHHhccC
Confidence 999888888753
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.15 E-value=1e-05 Score=73.40 Aligned_cols=132 Identities=14% Similarity=0.066 Sum_probs=83.9
Q ss_pred eecceeeeEEEeeee-eeceeEEeeeecCCccchh---------h---------------hhhHHhhcccCCCCCC--cc
Q psy5368 58 RYGELQYDTVQNSQI-RLGTVKYSQVRYDTITSHS---------E---------------FERPRAGLSNLRAPEG--RK 110 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~-~~~~v~vk~~~~~~~~~~~---------~---------------~~~E~~~l~~l~h~ni--~~ 110 (406)
.|.+|--..||+|.. ....+++|.+......... + ..+|..-|.++..-.+ .+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 456666678898775 3566788766543322111 1 1234555554422221 11
Q ss_pred --cCCeEEEEEeccCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCcceEeeCCeeEEEecccc
Q psy5368 111 --RPRYVYIILEYCDGG-DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRE-NNVCHFDLKPQNILIKNNTLKLADFGFA 186 (406)
Q Consensus 111 --~~~~~~lV~E~~~gg-sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~-~givH~Dlkp~NIll~~~~~kL~DFGla 186 (406)
.-..-.|||||+... .-.-.|+. -+++..++..+..++++.+.-|-. .|+||+||+..|||+.++.+.++|||-|
T Consensus 135 Pi~~~~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~~~p~iID~~Qa 213 (268)
T COG1718 135 PIAFRNNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHDGEPYIIDVSQA 213 (268)
T ss_pred ceeecCCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEECCeEEEEECccc
Confidence 112336999999642 11111222 123444788888999999988876 8999999999999999999999999988
Q ss_pred cccC
Q psy5368 187 QFLA 190 (406)
Q Consensus 187 ~~~~ 190 (406)
....
T Consensus 214 V~~~ 217 (268)
T COG1718 214 VTID 217 (268)
T ss_pred cccC
Confidence 6553
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.04 E-value=2.9e-05 Score=70.87 Aligned_cols=128 Identities=13% Similarity=0.082 Sum_probs=72.7
Q ss_pred eeeecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccCCC-----CCCc---ccCCeEEEEEeccCCCC-
Q psy5368 56 TIRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLRA-----PEGR---KRPRYVYIILEYCDGGD- 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h-----~ni~---~~~~~~~lV~E~~~ggs- 126 (406)
-..||+|..+.||+.. +....+|.... . .......+|.+++..+.. |.++ ...+...+|||+++|.+
T Consensus 6 ~~~i~~G~t~~~y~~~--~~~~VlR~~~~-~-~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 6 WTQTGEGGNGESYTHK--TGKWMLKLYNP-G-FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred heeecCCCCcceeEec--CCCEEEEeCCC-C-CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 3568999999999842 33444444332 2 234567889888877643 3322 24566789999999964
Q ss_pred HH--------------HHH-------HhC--CCCCHHH-HHHHHH----------HHHH-HHHHHH----HCCcccccCC
Q psy5368 127 LC--------------SFI-------RSH--EKLSEFQ-CQQFVR----------QLVL-ALKFLR----ENNVCHFDLK 167 (406)
Q Consensus 127 L~--------------~~l-------~~~--~~l~~~~-~~~i~~----------ql~~-aL~~lH----~~givH~Dlk 167 (406)
+. ..+ +.- ...+... ...+-. .+.. ...+|. ...++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 11 111 110 0111110 001100 1111 122222 1247899999
Q ss_pred CcceEeeCCeeEEEeccccc
Q psy5368 168 PQNILIKNNTLKLADFGFAQ 187 (406)
Q Consensus 168 p~NIll~~~~~kL~DFGla~ 187 (406)
|.||+++++.+.++||+.+.
T Consensus 162 ~~Nii~~~~~~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKGTYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCCcEEEechhcC
Confidence 99999995559999999864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.04 E-value=1.1e-05 Score=81.77 Aligned_cols=130 Identities=21% Similarity=0.277 Sum_probs=84.2
Q ss_pred eeecceeeeEEEeeeee-eceeEEeeeecCCccch----------------------------------------hhhhh
Q psy5368 57 IRYGELQYDTVQNSQIR-LGTVKYSQVRYDTITSH----------------------------------------SEFER 95 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~-~~~v~vk~~~~~~~~~~----------------------------------------~~~~~ 95 (406)
.-++.++-|.||+|++. +..|+||..+..-.... -++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 45789999999999987 67899997755321110 01223
Q ss_pred HHhhcccCCC----------CCCcc-cCCeEEEEEeccCCCCHHHHH--HhCCCCCHHHHHHHHHHHHHH-HHHHHHCCc
Q psy5368 96 PRAGLSNLRA----------PEGRK-RPRYVYIILEYCDGGDLCSFI--RSHEKLSEFQCQQFVRQLVLA-LKFLRENNV 161 (406)
Q Consensus 96 E~~~l~~l~h----------~ni~~-~~~~~~lV~E~~~ggsL~~~l--~~~~~l~~~~~~~i~~ql~~a-L~~lH~~gi 161 (406)
|+..+.++++ |.+.. ..+.-.|+|||++|..+.+.. +. ..++.+. ++..++++ +..+=..|+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~---ia~~~~~~f~~q~~~dgf 286 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKE---LAELLVRAFLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHH---HHHHHHHHHHHHHHhcCc
Confidence 3333333211 11111 234456999999999998884 44 4455333 33333332 344445899
Q ss_pred ccccCCCcceEee-CCeeEEEecccccccC
Q psy5368 162 CHFDLKPQNILIK-NNTLKLADFGFAQFLA 190 (406)
Q Consensus 162 vH~Dlkp~NIll~-~~~~kL~DFGla~~~~ 190 (406)
.|.|.+|.||+++ ++.+.+.|||+...++
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecCC
Confidence 9999999999999 7799999999976553
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.02 E-value=2e-05 Score=71.58 Aligned_cols=130 Identities=19% Similarity=0.236 Sum_probs=76.1
Q ss_pred eeecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccCCCC-----CCcc------cCCeEEEEEeccCCC
Q psy5368 57 IRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAP-----EGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~-----ni~~------~~~~~~lV~E~~~gg 125 (406)
..++.|..+.||+.....+.+.+|..... .....+.+|..++..|... .++. .....+++|++++|.
T Consensus 3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 35788899999999987777777765433 3456677888887777433 3322 344579999999998
Q ss_pred CHHH----------------HH---HhC----CCCCHHH---------HHHH------------HHHHHH-HHHHHHH--
Q psy5368 126 DLCS----------------FI---RSH----EKLSEFQ---------CQQF------------VRQLVL-ALKFLRE-- 158 (406)
Q Consensus 126 sL~~----------------~l---~~~----~~l~~~~---------~~~i------------~~ql~~-aL~~lH~-- 158 (406)
++.. .+ +.. .++.... .... ...+.. .++.+++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 8777 11 111 1111100 0000 011222 2333332
Q ss_pred -----CCcccccCCCcceEee--CCeeEEEecccccc
Q psy5368 159 -----NNVCHFDLKPQNILIK--NNTLKLADFGFAQF 188 (406)
Q Consensus 159 -----~givH~Dlkp~NIll~--~~~~kL~DFGla~~ 188 (406)
..++|+|+.|.||+++ ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 3599999999999999 56668999988643
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00015 Score=66.79 Aligned_cols=63 Identities=16% Similarity=0.093 Sum_probs=38.7
Q ss_pred eEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccCC----CCCCcc---cCCeEEEEEeccCCCCHHHH
Q psy5368 65 DTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLR----APEGRK---RPRYVYIILEYCDGGDLCSF 130 (406)
Q Consensus 65 g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~----h~ni~~---~~~~~~lV~E~~~ggsL~~~ 130 (406)
+.||+.......+.+|...... ...+.+|++++..+. .|.++. ..+..++|||+++|.+|...
T Consensus 13 ~~v~~~~~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 13 ATVYRLDGKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred CeEEEEcCCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 6788887655445555433221 345677887777663 333332 33457899999999877643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=97.71 E-value=3.1e-06 Score=92.44 Aligned_cols=199 Identities=17% Similarity=0.059 Sum_probs=135.4
Q ss_pred hHHhhcccCCCCCCcc--------cCCeEEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC--
Q psy5368 95 RPRAGLSNLRAPEGRK--------RPRYVYIILEYCDGGDLCSFIRSH----EKLSEFQCQQFVRQLVLALKFLRENN-- 160 (406)
Q Consensus 95 ~E~~~l~~l~h~ni~~--------~~~~~~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~ql~~aL~~lH~~g-- 160 (406)
.|...++...|+++.. ....-|.+++||.+|.+.+.|-++ .++.+..+.....+.+.+..-+|+..
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 3444555567876433 445568999999999999998543 45777777777777688888877542
Q ss_pred ---cccccCCCcceEee-CCeeEEEecccccccCC-CCCCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCC
Q psy5368 161 ---VCHFDLKPQNILIK-NNTLKLADFGFAQFLAP-NDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGH 235 (406)
Q Consensus 161 ---ivH~Dlkp~NIll~-~~~~kL~DFGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~ 235 (406)
.+|+++|+-|.++. +-.+|+.++|+.+...+ ........+++.|++|++...-.++.++|+|+.|+-+|+...|.
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n 1437 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGN 1437 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhccc
Confidence 78999999999998 55899999999983222 22345566788899999998888899999999999999998888
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 236 APYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 236 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
.+|-......+...+........+ .-.|.+.-.....+|-..-..||.-...+.-+.+
T Consensus 1438 ~~fi~flq~~Lkgiidn~tf~sIe-~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~ 1495 (2724)
T KOG1826|consen 1438 AYFIFFLQPALKGIIDNHTFFSIE-KLKPGDANVEALHRLLWKYMERPGQYISLSRDHF 1495 (2724)
T ss_pred HHHHHHHHHHHcCccccccccccc-ccCCCcccHHHHHHHHHHhhhcchhhhhcccccc
Confidence 877443322222222222111111 1233444444555555555667776666665554
|
|
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00053 Score=69.62 Aligned_cols=75 Identities=24% Similarity=0.422 Sum_probs=52.3
Q ss_pred CCeEEEEEeccCCCCHHHH--HHhCCCCCHHHHHHHHHHHHHHH-HHHHHCCcccccCCCcceEee-----CCeeEEEec
Q psy5368 112 PRYVYIILEYCDGGDLCSF--IRSHEKLSEFQCQQFVRQLVLAL-KFLRENNVCHFDLKPQNILIK-----NNTLKLADF 183 (406)
Q Consensus 112 ~~~~~lV~E~~~ggsL~~~--l~~~~~l~~~~~~~i~~ql~~aL-~~lH~~givH~Dlkp~NIll~-----~~~~kL~DF 183 (406)
.....|+||||+|..+.+. |.++ .++.. .++..+.++. +-+=..|++|+|=+|.||+++ +..+.+.||
T Consensus 274 st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~---~i~~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDh 349 (538)
T KOG1235|consen 274 STKRVLTMEYVDGIKINDLDAIDKR-GISPH---DILNKLVEAYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDH 349 (538)
T ss_pred CcceEEEEEecCCccCCCHHHHHHc-CCCHH---HHHHHHHHHHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcc
Confidence 3456799999999877654 3443 34544 3334444432 233367899999999999998 348999999
Q ss_pred ccccccC
Q psy5368 184 GFAQFLA 190 (406)
Q Consensus 184 Gla~~~~ 190 (406)
|+...++
T Consensus 350 Gl~~~is 356 (538)
T KOG1235|consen 350 GLYAVIS 356 (538)
T ss_pred ccccccc
Confidence 9986654
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00021 Score=66.45 Aligned_cols=128 Identities=16% Similarity=0.163 Sum_probs=70.1
Q ss_pred ecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccCCC----CCCcccCCeEEEEEeccCCCCHHH-----
Q psy5368 59 YGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLRA----PEGRKRPRYVYIILEYCDGGDLCS----- 129 (406)
Q Consensus 59 lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h----~ni~~~~~~~~lV~E~~~ggsL~~----- 129 (406)
+..|-.+.+|+.+..+..+.++........-.-...+|..+++.+.. |.++.... -++||||++|.++..
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~-~~~v~e~i~G~~~~~~~~~~ 82 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE-HWLLVEWLEGEVITLDQFVA 82 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC-CEEEEEeccCcccccccccC
Confidence 34566777887775555555554322211111245778888877754 33333222 368999999866532
Q ss_pred ---------HH---HhCC----CCCHH-HHHHHHHHH---------HHHHHHHHH--------CCcccccCCCcceEeeC
Q psy5368 130 ---------FI---RSHE----KLSEF-QCQQFVRQL---------VLALKFLRE--------NNVCHFDLKPQNILIKN 175 (406)
Q Consensus 130 ---------~l---~~~~----~l~~~-~~~~i~~ql---------~~aL~~lH~--------~givH~Dlkp~NIll~~ 175 (406)
.+ +.-. +++.. .+..+..++ ...+..+-. ..++|+|+.|.||++++
T Consensus 83 ~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~ 162 (256)
T TIGR02721 83 LDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTP 162 (256)
T ss_pred chhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEeC
Confidence 11 1111 12211 111221111 111222211 24899999999999996
Q ss_pred CeeEEEeccccc
Q psy5368 176 NTLKLADFGFAQ 187 (406)
Q Consensus 176 ~~~kL~DFGla~ 187 (406)
+.+.++||+.|.
T Consensus 163 ~~~~lIDwE~a~ 174 (256)
T TIGR02721 163 QGLKLIDWEYAS 174 (256)
T ss_pred CCCEEEeccccC
Confidence 668999999874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00076 Score=73.29 Aligned_cols=71 Identities=17% Similarity=0.143 Sum_probs=45.4
Q ss_pred eeeecceeeeEEEeeeeeec----eeEEeeeecCC-ccchhhhhhHHhhcccCC-CCCC-----cc---c---CCeEEEE
Q psy5368 56 TIRYGELQYDTVQNSQIRLG----TVKYSQVRYDT-ITSHSEFERPRAGLSNLR-APEG-----RK---R---PRYVYII 118 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~----~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni-----~~---~---~~~~~lV 118 (406)
-..++.|.++.+|......+ ...+++..... ......+.+|..+++.+. |+++ +. + .+..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 45678888889998765442 34444433222 223457889999998885 5543 11 1 1467899
Q ss_pred EeccCCCC
Q psy5368 119 LEYCDGGD 126 (406)
Q Consensus 119 ~E~~~ggs 126 (406)
|||++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99999864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.00065 Score=62.33 Aligned_cols=30 Identities=30% Similarity=0.453 Sum_probs=24.9
Q ss_pred CCcccccCCCcceEeeCCe-eEEEecccccc
Q psy5368 159 NNVCHFDLKPQNILIKNNT-LKLADFGFAQF 188 (406)
Q Consensus 159 ~givH~Dlkp~NIll~~~~-~kL~DFGla~~ 188 (406)
.+++|+|++|.||+++++. .-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 3489999999999999765 46999998643
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0023 Score=63.11 Aligned_cols=70 Identities=11% Similarity=0.029 Sum_probs=47.3
Q ss_pred eeecceeeeEEEeeeeeec--eeEEeeeec------CC-ccchhhhhhHHhhcccCC------CCCCcc-cCCeEEEEEe
Q psy5368 57 IRYGELQYDTVQNSQIRLG--TVKYSQVRY------DT-ITSHSEFERPRAGLSNLR------APEGRK-RPRYVYIILE 120 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~~--~v~vk~~~~------~~-~~~~~~~~~E~~~l~~l~------h~ni~~-~~~~~~lV~E 120 (406)
..+|.|.++.||+.....+ .+.+|.-.. .. .....+...|.+.|..+. -|.+.. +....++|||
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~~~~~lVME 111 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDEELAVTVME 111 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECCCCCEEEEe
Confidence 4689999999999998665 677776431 11 124456777888887762 233322 5566789999
Q ss_pred ccCCCC
Q psy5368 121 YCDGGD 126 (406)
Q Consensus 121 ~~~ggs 126 (406)
++++..
T Consensus 112 ~L~~~~ 117 (401)
T PRK09550 112 DLSDHK 117 (401)
T ss_pred cCCCcc
Confidence 998744
|
|
| >PF04212 MIT: MIT (microtubule interacting and transport) domain; InterPro: IPR007330 The MIT domain is found in vacuolar sorting proteins, spastin (probable ATPase involved in the assembly or function of nuclear protein complexes), and a sorting nexin, which may play a role in intracellular trafficking | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.00018 Score=52.62 Aligned_cols=44 Identities=30% Similarity=0.364 Sum_probs=39.8
Q ss_pred hhhhhhhchhhhhHHhccchHHHHHHHHHHHHHHHHhhhhcCCC
Q psy5368 353 LKSGLEIGETGDMYLAEGNYELALEKLKASLAILIQFCEAETSS 396 (406)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~~ 396 (406)
+.+|++....|..+++.|+++.|+++|+++++.|++++..++.+
T Consensus 2 ~~~A~~~~~~Av~~D~~g~~~~A~~~Y~~ai~~l~~~~~~~~~~ 45 (69)
T PF04212_consen 2 LDKAIELIKKAVEADEAGNYEEALELYKEAIEYLMQALKSESNP 45 (69)
T ss_dssp HHHHHHHHHHHHHHHHTTSHHHHHHHHHHHHHHHHHHHHHSTTH
T ss_pred HHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHhccCCCH
Confidence 35678888999999999999999999999999999999988655
|
; PDB: 2DL1_A 2JQK_A 1WR0_A 2CPT_A 2JQH_A 2V6Y_A 2JQ9_A 2K3W_A 1YXR_A 3EAB_E .... |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.00092 Score=63.47 Aligned_cols=128 Identities=18% Similarity=0.078 Sum_probs=74.5
Q ss_pred eeecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccCCCCC-----C---------cccCCeEEEEEecc
Q psy5368 57 IRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPE-----G---------RKRPRYVYIILEYC 122 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~n-----i---------~~~~~~~~lV~E~~ 122 (406)
..+..|..+.+|+....++...+|.... .....+..|+.++..|.+.+ . ....+..++|++|+
T Consensus 20 ~~i~~G~~n~~y~v~~~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 20 EGISAGIENTNYFVTTDSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred ecccCccccceEEEEeCCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 3456677788998876666666665432 33445666777666663322 1 12344568999999
Q ss_pred CCCCHHH-----------HH---HhC-CC----------CCHHHH--H--------HHHHHHHHHHHHHHH-------CC
Q psy5368 123 DGGDLCS-----------FI---RSH-EK----------LSEFQC--Q--------QFVRQLVLALKFLRE-------NN 160 (406)
Q Consensus 123 ~ggsL~~-----------~l---~~~-~~----------l~~~~~--~--------~i~~ql~~aL~~lH~-------~g 160 (406)
+|.++.. .+ +.. .. ..+... . .....+..++.++.+ .+
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 9866421 11 100 00 111110 0 011122334444443 46
Q ss_pred cccccCCCcceEeeCCe-eEEEeccccc
Q psy5368 161 VCHFDLKPQNILIKNNT-LKLADFGFAQ 187 (406)
Q Consensus 161 ivH~Dlkp~NIll~~~~-~kL~DFGla~ 187 (406)
++|+|++|.||+++++. +.|+||+.+.
T Consensus 177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 177 VIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCccCcCcccEEEeCCceEEEeehhhhc
Confidence 99999999999999664 5899999763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0015 Score=59.77 Aligned_cols=28 Identities=36% Similarity=0.678 Sum_probs=25.1
Q ss_pred CcccccCCCcceEeeC--CeeEEEeccccc
Q psy5368 160 NVCHFDLKPQNILIKN--NTLKLADFGFAQ 187 (406)
Q Consensus 160 givH~Dlkp~NIll~~--~~~kL~DFGla~ 187 (406)
+++|+|+++.|||+++ +.+.++||..|.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 5999999999999996 679999998774
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0035 Score=55.47 Aligned_cols=95 Identities=20% Similarity=0.180 Sum_probs=68.8
Q ss_pred hhHHhhcccCCCC-CCcccCCe--EEEEEeccCCCCHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccc
Q psy5368 94 ERPRAGLSNLRAP-EGRKRPRY--VYIILEYCDGGDLCSF---IRSHEKLSEFQCQQFVRQLVLALKFLRE---NNVCHF 164 (406)
Q Consensus 94 ~~E~~~l~~l~h~-ni~~~~~~--~~lV~E~~~ggsL~~~---l~~~~~l~~~~~~~i~~ql~~aL~~lH~---~givH~ 164 (406)
..|.-+++.+.+. ++.+.-+. .++|.||...+++... +..--..+|..+.+|+.++++.+.+++. ..+.-.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lc 86 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLC 86 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEe
Confidence 3466677777664 33332222 2479999987665421 1111246999999999999999999987 347889
Q ss_pred cCCCcceEee-CCeeEEEecccccc
Q psy5368 165 DLKPQNILIK-NNTLKLADFGFAQF 188 (406)
Q Consensus 165 Dlkp~NIll~-~~~~kL~DFGla~~ 188 (406)
|++|+|+-++ ++.+|++|...+..
T Consensus 87 Dv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 87 DVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred ecchHHeEEeCCCcEEEEechhcch
Confidence 9999999999 56999999987644
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.004 Score=59.80 Aligned_cols=29 Identities=38% Similarity=0.534 Sum_probs=25.0
Q ss_pred CCcccccCCCcceEeeCCee-EEEeccccc
Q psy5368 159 NNVCHFDLKPQNILIKNNTL-KLADFGFAQ 187 (406)
Q Consensus 159 ~givH~Dlkp~NIll~~~~~-kL~DFGla~ 187 (406)
.++||+|++|.||+++++.+ -++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 47999999999999996654 799999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0049 Score=54.92 Aligned_cols=123 Identities=15% Similarity=0.116 Sum_probs=80.9
Q ss_pred CceeeecceeeeEEEeeeeeeceeEEeeeecCC----------------ccchhhhhhHHhhcccCC-CCC---------
Q psy5368 54 SSTIRYGELQYDTVQNSQIRLGTVKYSQVRYDT----------------ITSHSEFERPRAGLSNLR-APE--------- 107 (406)
Q Consensus 54 ~~~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~----------------~~~~~~~~~E~~~l~~l~-h~n--------- 107 (406)
+.+..||+|+.-.||.-..+... .||...... .....+..+|+.....+. ..+
T Consensus 4 ~~~~~i~~G~~R~cy~HP~dp~~-cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQHPDDPNL-CIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCCcccccCCCceEEECCCCCCe-EEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 44567899999999987654332 233222222 123556777877666665 433
Q ss_pred --CcccCCeEEEEEeccCC------CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee---CC
Q psy5368 108 --GRKRPRYVYIILEYCDG------GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK---NN 176 (406)
Q Consensus 108 --i~~~~~~~~lV~E~~~g------gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~---~~ 176 (406)
.+.++--..+|+|.+.. .||.+++++. .++. .. ...+-+-.+||-+.+|+.+|++|.||++. ++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 33466666788888753 4688888553 4665 33 33444556788899999999999999997 22
Q ss_pred --eeEEEe
Q psy5368 177 --TLKLAD 182 (406)
Q Consensus 177 --~~kL~D 182 (406)
.+.|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 588888
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0047 Score=59.05 Aligned_cols=128 Identities=18% Similarity=0.159 Sum_probs=71.0
Q ss_pred eecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccCC-----CCCCcc---------cCCeEEEEEeccC
Q psy5368 58 RYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLR-----APEGRK---------RPRYVYIILEYCD 123 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~-----h~ni~~---------~~~~~~lV~E~~~ 123 (406)
.++.|..+.+|+.....++..+|..... .....+..|.+++..|. .|.++. ..+..++|+||++
T Consensus 29 ~~~~G~~n~~y~v~t~~~~~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i~ 106 (307)
T TIGR00938 29 GIAEGVENSNYLLTTDVGRYILTLYEKR--VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFLQ 106 (307)
T ss_pred ccCCccccceEEEEeCCCcEEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeCC
Confidence 3466666889987765555555544321 12334555666555553 232222 3456789999999
Q ss_pred CCCHH-----------HHH---HhC-CCC-----------CHHH--HH----------HHHHHHHHHHHHHHH-------
Q psy5368 124 GGDLC-----------SFI---RSH-EKL-----------SEFQ--CQ----------QFVRQLVLALKFLRE------- 158 (406)
Q Consensus 124 ggsL~-----------~~l---~~~-~~l-----------~~~~--~~----------~i~~ql~~aL~~lH~------- 158 (406)
|.++. ..+ +.. ..+ .|.. .. .....+...++++..
T Consensus 107 G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~~ 186 (307)
T TIGR00938 107 GLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDLP 186 (307)
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 85431 111 110 011 0000 00 011123334555542
Q ss_pred CCcccccCCCcceEeeCC-eeEEEeccccc
Q psy5368 159 NNVCHFDLKPQNILIKNN-TLKLADFGFAQ 187 (406)
Q Consensus 159 ~givH~Dlkp~NIll~~~-~~kL~DFGla~ 187 (406)
.+++|+|+++.||+++++ ...|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 679999999999999955 46899999763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0024 Score=63.79 Aligned_cols=159 Identities=18% Similarity=0.135 Sum_probs=100.9
Q ss_pred cchhhhhhHHhhcccCCCCCCcc-------cCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy5368 88 TSHSEFERPRAGLSNLRAPEGRK-------RPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENN 160 (406)
Q Consensus 88 ~~~~~~~~E~~~l~~l~h~ni~~-------~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~g 160 (406)
....++.--...++.+.|+|... ......+|||++ +.+|.+.+..+. +-.....
T Consensus 24 ~~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~----------------- 84 (725)
T KOG1093|consen 24 PNSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL----------------- 84 (725)
T ss_pred CcHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc-----------------
Confidence 34456667788888899998543 333478999999 569999987654 2111110
Q ss_pred cccccCCCcceEeeCCeeEEEecccccccCCCCCCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy5368 161 VCHFDLKPQNILIKNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYAS 240 (406)
Q Consensus 161 ivH~Dlkp~NIll~~~~~kL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 240 (406)
.|+= .+-| .++.+| -+ +... ... ..+++||||+|.++.++.-|...|..
T Consensus 85 -~~~~-~~~~------~~~~td-~~---~t~~---~~~----------------~~pKsdVwsl~~i~~el~L~~~l~~~ 133 (725)
T KOG1093|consen 85 -AHGV-LHLN------IIYITD-HF---LTKY---PSP----------------IGPKSDVWSLGFIILELYLGISLEAE 133 (725)
T ss_pred -cccc-ceeh------hhhccc-cc---cccC---CCC----------------CCcchhhhhHHHHHHHHHHhhHHHHH
Confidence 2221 1111 233333 01 1000 111 12499999999999999999888877
Q ss_pred CCHHHHHHHHHhcCCCCCCC----------CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy5368 241 CNLSQLRAQALSSAPITIPP----------NSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~----------~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 296 (406)
....+....+.......... ..++....++..+|+-..|..||...++.+++-|..
T Consensus 134 ~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~e 199 (725)
T KOG1093|consen 134 LTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTE 199 (725)
T ss_pred HHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHH
Confidence 66665555554432221110 135667889999999999999999999999988764
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0033 Score=59.88 Aligned_cols=28 Identities=46% Similarity=0.742 Sum_probs=25.0
Q ss_pred CcccccCCCcceEeeC-----CeeEEEeccccc
Q psy5368 160 NVCHFDLKPQNILIKN-----NTLKLADFGFAQ 187 (406)
Q Consensus 160 givH~Dlkp~NIll~~-----~~~kL~DFGla~ 187 (406)
.++|+|+.|.||++++ +.+.++||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 4899999999999985 789999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0075 Score=58.49 Aligned_cols=29 Identities=28% Similarity=0.382 Sum_probs=25.6
Q ss_pred CCcccccCCCcceEeeCCeeEEEeccccc
Q psy5368 159 NNVCHFDLKPQNILIKNNTLKLADFGFAQ 187 (406)
Q Consensus 159 ~givH~Dlkp~NIll~~~~~kL~DFGla~ 187 (406)
..++|+|+.+.||+++++.++++|+.++.
T Consensus 192 ~~llHGDl~~gNi~~~~~~~~~iD~e~~~ 220 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVSEHETKVIDPEFAF 220 (370)
T ss_pred ceeeeccCCcccEEEcCCCCEEEcCcccc
Confidence 45899999999999998889999998763
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.0055 Score=57.70 Aligned_cols=29 Identities=34% Similarity=0.444 Sum_probs=24.3
Q ss_pred CcccccCCCcceEeeC-Ce-eEEEecccccc
Q psy5368 160 NVCHFDLKPQNILIKN-NT-LKLADFGFAQF 188 (406)
Q Consensus 160 givH~Dlkp~NIll~~-~~-~kL~DFGla~~ 188 (406)
.++|+|++|.||++++ +. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 3899999999999996 54 56999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.0014 Score=61.98 Aligned_cols=130 Identities=15% Similarity=0.078 Sum_probs=85.4
Q ss_pred eecCceeeecceeeeEEEeeeeeeceeEEeeeecCC---------------------ccc--hhhhhhHHhhcccCCCCC
Q psy5368 51 IVGSSTIRYGELQYDTVQNSQIRLGTVKYSQVRYDT---------------------ITS--HSEFERPRAGLSNLRAPE 107 (406)
Q Consensus 51 i~~~~~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~---------------------~~~--~~~~~~E~~~l~~l~h~n 107 (406)
++.+-.+.||-|--+.+|.+....++..+.+++.-. |.- .-...+|...|+.|....
T Consensus 92 ~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 92 SVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 344667889999999999988764443332222111 111 112345777777763322
Q ss_pred --Ccc--cCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEe
Q psy5368 108 --GRK--RPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLAD 182 (406)
Q Consensus 108 --i~~--~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~D 182 (406)
+.. +.+..++|||++.|-.|.+.-+-. .+..+...+..-+--|-..|+||+|.+--||+++ ++.++++|
T Consensus 172 fpVPkpiD~~RH~Vvmelv~g~Pl~~v~~v~------d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vID 245 (465)
T KOG2268|consen 172 FPVPKPIDHNRHCVVMELVDGYPLRQVRHVE------DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVID 245 (465)
T ss_pred CCCCCcccccceeeHHHhhcccceeeeeecC------ChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEee
Confidence 111 556678999999998887654221 2233444555566778899999999999999999 67899999
Q ss_pred cccc
Q psy5368 183 FGFA 186 (406)
Q Consensus 183 FGla 186 (406)
|--.
T Consensus 246 FPQm 249 (465)
T KOG2268|consen 246 FPQM 249 (465)
T ss_pred chHh
Confidence 9754
|
|
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.012 Score=56.61 Aligned_cols=136 Identities=13% Similarity=0.108 Sum_probs=87.8
Q ss_pred cCceeeecceeeeEEEeeeeeec-eeEEeeeecCCcc---------chhh-----------------hhhHHhhcccCCC
Q psy5368 53 GSSTIRYGELQYDTVQNSQIRLG-TVKYSQVRYDTIT---------SHSE-----------------FERPRAGLSNLRA 105 (406)
Q Consensus 53 ~~~~~~lG~G~~g~Vy~~~~~~~-~v~vk~~~~~~~~---------~~~~-----------------~~~E~~~l~~l~h 105 (406)
......|..|--.-||.++...+ .+|||..+.+-.. +.-+ ...|++-|.+|+.
T Consensus 146 ~~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 146 VEINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred eecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 33444567788888999886443 4566644332111 0001 1236666666655
Q ss_pred CCCcc----cCCeEEEEEeccCCCCH-HHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCcccccCCCcceEeeCCeeE
Q psy5368 106 PEGRK----RPRYVYIILEYCDGGDL-CSFIRSHEKLSEFQCQQFVRQLVLALKFL-RENNVCHFDLKPQNILIKNNTLK 179 (406)
Q Consensus 106 ~ni~~----~~~~~~lV~E~~~ggsL-~~~l~~~~~l~~~~~~~i~~ql~~aL~~l-H~~givH~Dlkp~NIll~~~~~k 179 (406)
-.+.- .-....|||+|+..... +-.|+ .-.++...+..+-.|++.-+.-| |.++.||.||+-.|+|+.+|.+.
T Consensus 226 aGIP~PePIlLk~hVLVM~FlGrdgw~aPkLK-d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG~ly 304 (520)
T KOG2270|consen 226 AGIPCPEPILLKNHVLVMEFLGRDGWAAPKLK-DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDGKLY 304 (520)
T ss_pred cCCCCCCceeeecceEeeeeccCCCCcCcccc-cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECCEEE
Confidence 44322 11234699999953221 22222 23578888888888888888777 57799999999999999999999
Q ss_pred EEeccccccc
Q psy5368 180 LADFGFAQFL 189 (406)
Q Consensus 180 L~DFGla~~~ 189 (406)
++|.+-|...
T Consensus 305 iIDVSQSVE~ 314 (520)
T KOG2270|consen 305 IIDVSQSVEH 314 (520)
T ss_pred EEEccccccC
Confidence 9998876443
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.015 Score=57.20 Aligned_cols=76 Identities=12% Similarity=-0.073 Sum_probs=47.0
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeec------CCccchhhhhhHHhhcccCCC--CCCcc-----cCCeEEEEEe
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRY------DTITSHSEFERPRAGLSNLRA--PEGRK-----RPRYVYIILE 120 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~------~~~~~~~~~~~E~~~l~~l~h--~ni~~-----~~~~~~lV~E 120 (406)
...||-|.-+.||++... .+.+.||+-.. +......+..-|.+.|+.+.- |..++ +.....+|||
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e~~~~vME 113 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSVMNCCVME 113 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcHHhhHHHH
Confidence 457899999999999864 45687774321 212334566667777776522 33222 5556679999
Q ss_pred ccCC-CCHHHHH
Q psy5368 121 YCDG-GDLCSFI 131 (406)
Q Consensus 121 ~~~g-gsL~~~l 131 (406)
+++. ..|.+.|
T Consensus 114 dL~~~~ilR~~L 125 (409)
T PRK12396 114 DLSDHTILRTAL 125 (409)
T ss_pred hCcccHHHHHHH
Confidence 9964 2344443
|
|
| >cd02683 MIT_1 MIT: domain contained within Microtubule Interacting and Trafficking molecules | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.0037 Score=46.55 Aligned_cols=43 Identities=16% Similarity=0.201 Sum_probs=38.4
Q ss_pred hhhhhhchhhhhHHhccchHHHHHHHHHHHHHHHHhhhhcCCC
Q psy5368 354 KSGLEIGETGDMYLAEGNYELALEKLKASLAILIQFCEAETSS 396 (406)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~~ 396 (406)
.+|.+..+.|...++.|+|+.|+.+|+++|+.|+.++.-|+..
T Consensus 4 ~~a~~l~~~Ave~D~~g~y~eAl~~Y~~aie~l~~~lk~e~d~ 46 (77)
T cd02683 4 LAAKEVLKRAVELDQEGRFQEALVCYQEGIDLLMQVLKGTKDE 46 (77)
T ss_pred HHHHHHHHHHHHHHHhccHHHHHHHHHHHHHHHHHHHhhCCCH
Confidence 4577778888889999999999999999999999999988755
|
This sub-family of MIT domains is found in proteins with unknown function, co-occuring with an as yet undescribed domain. The molecular function of the MIT domain is unclear. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.026 Score=50.23 Aligned_cols=113 Identities=19% Similarity=0.176 Sum_probs=73.3
Q ss_pred eeecceee-eEEEeeeeeeceeEEeeeec---CCcc------------------chhhhhhHHhhcccCCCCC---C--c
Q psy5368 57 IRYGELQY-DTVQNSQIRLGTVKYSQVRY---DTIT------------------SHSEFERPRAGLSNLRAPE---G--R 109 (406)
Q Consensus 57 ~~lG~G~~-g~Vy~~~~~~~~v~vk~~~~---~~~~------------------~~~~~~~E~~~l~~l~h~n---i--~ 109 (406)
..+|.|.- |.|++.+..+...|+|.+.. .... -...|..|.+...+|+.-+ + +
T Consensus 43 efLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~Av 122 (207)
T PF13095_consen 43 EFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLWAV 122 (207)
T ss_pred eecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCceEE
Confidence 46899999 99999999988888887322 1110 0123566777777664432 2 2
Q ss_pred ccCCe------------------------EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCccccc
Q psy5368 110 KRPRY------------------------VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFD 165 (406)
Q Consensus 110 ~~~~~------------------------~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~D 165 (406)
++-++ ..||.||++... .+ ...-+.+|.+-+..+|..||+-+|
T Consensus 123 kc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~----~~~~~~~~~~dl~~~~k~gI~~~D 189 (207)
T PF13095_consen 123 KCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PL----QIRDIPQMLRDLKILHKLGIVPRD 189 (207)
T ss_pred EeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------cc----chhHHHHHHHHHHHHHHCCeeecc
Confidence 22222 235555554422 12 223456777888999999999999
Q ss_pred CCCcceEeeCCeeEEEecccc
Q psy5368 166 LKPQNILIKNNTLKLADFGFA 186 (406)
Q Consensus 166 lkp~NIll~~~~~kL~DFGla 186 (406)
+++.|.. .-+|+|||.+
T Consensus 190 v~~~ny~----~G~lvDfs~~ 206 (207)
T PF13095_consen 190 VKPRNYR----GGKLVDFSSS 206 (207)
T ss_pred Ccccccc----CCEEEecccC
Confidence 9999987 4589999864
|
|
| >cd02682 MIT_AAA_Arch MIT: domain contained within Microtubule Interacting and Trafficking molecules | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.0086 Score=44.08 Aligned_cols=44 Identities=20% Similarity=0.169 Sum_probs=39.6
Q ss_pred hhhhhhchhhhhHHhccchHHHHHHHHHHHHHHHHhhhhcCCCc
Q psy5368 354 KSGLEIGETGDMYLAEGNYELALEKLKASLAILIQFCEAETSSS 397 (406)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~~~ 397 (406)
.+|......|..++++|++.+||-||+.+++.|+.++..+|.++
T Consensus 4 ~~A~~~a~~AVe~D~~gr~~eAi~~Y~~aIe~L~q~~~~~pD~~ 47 (75)
T cd02682 4 EMARKYAINAVKAEKEGNAEDAITNYKKAIEVLSQIVKNYPDSP 47 (75)
T ss_pred HHHHHHHHHHHHHHhcCCHHHHHHHHHHHHHHHHHHHHhCCChH
Confidence 35677788899999999999999999999999999999988873
|
This sub-family of MIT domains is found in mostly archaebacterial AAA-ATPases. The molecular function of the MIT domain is unclear. |
| >cd02656 MIT MIT: domain contained within Microtubule Interacting and Trafficking molecules | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.0048 Score=45.77 Aligned_cols=44 Identities=34% Similarity=0.359 Sum_probs=38.0
Q ss_pred hhhhhhhchhhhhHHhccchHHHHHHHHHHHHHHHHhhhhcCCC
Q psy5368 353 LKSGLEIGETGDMYLAEGNYELALEKLKASLAILIQFCEAETSS 396 (406)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~~ 396 (406)
+..+++....|..+++.|+|+.|+++|.++++.|+..+..++..
T Consensus 3 ~~~a~~l~~~Av~~D~~g~~~~Al~~Y~~a~e~l~~~~~~~~~~ 46 (75)
T cd02656 3 LQQAKELIKQAVKEDEDGNYEEALELYKEALDYLLQALKAEKEP 46 (75)
T ss_pred HHHHHHHHHHHHHHHHcCCHHHHHHHHHHHHHHHHHHhccCCCH
Confidence 34667777888888999999999999999999999999777654
|
The MIT domain is found in sorting nexins, the nuclear thiol protease PalBH, the AAA protein spastin and archaebacterial proteins with similar domain architecture, vacuolar sorting proteins and others. The molecular function of the MIT domain is unclear. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.039 Score=53.70 Aligned_cols=28 Identities=32% Similarity=0.708 Sum_probs=24.5
Q ss_pred CcccccCCCcceEeeC--CeeEEEeccccc
Q psy5368 160 NVCHFDLKPQNILIKN--NTLKLADFGFAQ 187 (406)
Q Consensus 160 givH~Dlkp~NIll~~--~~~kL~DFGla~ 187 (406)
.++|+|+++.|||+++ +.+.++||..+.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 5899999999999984 479999998864
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.048 Score=52.66 Aligned_cols=28 Identities=29% Similarity=0.265 Sum_probs=24.1
Q ss_pred CCcccccCCCcceEeeCCeeEEEeccccc
Q psy5368 159 NNVCHFDLKPQNILIKNNTLKLADFGFAQ 187 (406)
Q Consensus 159 ~givH~Dlkp~NIll~~~~~kL~DFGla~ 187 (406)
.+++|+|+.+.|||+++ .+.++||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWRD-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhccccC-CcEEEeCCCCC
Confidence 46899999999999965 68899999763
|
|
| >cd02684 MIT_2 MIT: domain contained within Microtubule Interacting and Trafficking molecules | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.0074 Score=44.72 Aligned_cols=45 Identities=16% Similarity=0.127 Sum_probs=39.2
Q ss_pred chhhhhhhchhhhhHHhccchHHHHHHHHHHHHHHHHhhhhcCCC
Q psy5368 352 NLKSGLEIGETGDMYLAEGNYELALEKLKASLAILIQFCEAETSS 396 (406)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~~ 396 (406)
.+.+|.+..+.|...+..|+|+.|+.+|.++|+.+++.+.-|+..
T Consensus 2 ~l~~Ai~lv~~Av~~D~~g~y~eA~~lY~~ale~~~~~~k~e~~~ 46 (75)
T cd02684 2 SLEKAIALVVQAVKKDQRGDAAAALSLYCSALQYFVPALHYETDA 46 (75)
T ss_pred cHHHHHHHHHHHHHHHHhccHHHHHHHHHHHHHHHHHHHhhCCCH
Confidence 456777888888888999999999999999999999999877655
|
This sub-family of MIT domains is found in proteins with an n-terminal serine/threonine kinase domain. The molecular function of the MIT domain is unclear. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.047 Score=53.84 Aligned_cols=28 Identities=43% Similarity=0.502 Sum_probs=25.2
Q ss_pred CCcccccCCCcceEeeCCeeEEEecccc
Q psy5368 159 NNVCHFDLKPQNILIKNNTLKLADFGFA 186 (406)
Q Consensus 159 ~givH~Dlkp~NIll~~~~~kL~DFGla 186 (406)
...+|.|+-+.||+.+++.+.++||..|
T Consensus 227 ~VfCHNDL~~gNIL~~~~~l~lID~EYA 254 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQGIYFIDFDFA 254 (383)
T ss_pred eeeeeccCCcccEEecCCCEEEEEeccc
Confidence 4579999999999998889999999876
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.086 Score=52.14 Aligned_cols=69 Identities=13% Similarity=0.028 Sum_probs=43.1
Q ss_pred eeeecceeeeEEEeeeeeeceeEEeeeecCC------c-cchhhhhhHHhhcccC------CCCCCcc-cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIRLGTVKYSQVRYDT------I-TSHSEFERPRAGLSNL------RAPEGRK-RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~------~-~~~~~~~~E~~~l~~l------~h~ni~~-~~~~~~lV~E~ 121 (406)
...+|.|..+.||+.....+.+.+|+-.... + ....+-..|+..|..+ ..|.+.. +....+++||+
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~~vlvME~ 116 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTMALIGMRY 116 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCCCEEEEee
Confidence 4567999999999988766667777543111 1 1233344456655544 3344433 55667899999
Q ss_pred cCC
Q psy5368 122 CDG 124 (406)
Q Consensus 122 ~~g 124 (406)
+++
T Consensus 117 L~~ 119 (418)
T PLN02756 117 LEP 119 (418)
T ss_pred cCC
Confidence 977
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.039 Score=53.39 Aligned_cols=27 Identities=26% Similarity=0.540 Sum_probs=23.9
Q ss_pred cccccCCCcceEee--CCeeEEEeccccc
Q psy5368 161 VCHFDLKPQNILIK--NNTLKLADFGFAQ 187 (406)
Q Consensus 161 ivH~Dlkp~NIll~--~~~~kL~DFGla~ 187 (406)
.+|.|+.+.|||++ ++.++++||..|.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 79999999999997 3579999999874
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.49 E-value=0.037 Score=53.33 Aligned_cols=123 Identities=20% Similarity=0.142 Sum_probs=74.9
Q ss_pred eeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccCCCCC--------------CcccCC--eEEEEEeccCCCC
Q psy5368 63 QYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPE--------------GRKRPR--YVYIILEYCDGGD 126 (406)
Q Consensus 63 ~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~n--------------i~~~~~--~~~lV~E~~~ggs 126 (406)
.-+.+|+....++.. |.++.... ....++.-|+..+..|.-.+ +....+ +.+-|++|++|..
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~ 114 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRP 114 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcC
Confidence 567788888777777 44454444 55566666777666663322 222444 8899999999977
Q ss_pred HHH-----HH----------Hh--------CC----CCCHHH-------------HHHHHHHHHHHHHHHHH--------
Q psy5368 127 LCS-----FI----------RS--------HE----KLSEFQ-------------CQQFVRQLVLALKFLRE-------- 158 (406)
Q Consensus 127 L~~-----~l----------~~--------~~----~l~~~~-------------~~~i~~ql~~aL~~lH~-------- 158 (406)
+.. .+ +. ++ ...|.. ......++...+..+.+
T Consensus 115 ~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~ 194 (331)
T COG2334 115 LERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPA 194 (331)
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCc
Confidence 762 11 00 00 122220 00122334444444442
Q ss_pred CC--cccccCCCcceEeeCC--eeEEEeccccc
Q psy5368 159 NN--VCHFDLKPQNILIKNN--TLKLADFGFAQ 187 (406)
Q Consensus 159 ~g--ivH~Dlkp~NIll~~~--~~kL~DFGla~ 187 (406)
.+ +||+|+.|.||+++.+ .+-++||+-+.
T Consensus 195 ~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 195 LGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred ccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 34 9999999999999965 48999999764
|
|
| >cd02678 MIT_VPS4 MIT: domain contained within Microtubule Interacting and Trafficking molecules | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.023 Score=42.15 Aligned_cols=44 Identities=23% Similarity=0.272 Sum_probs=38.2
Q ss_pred hhhhhhhchhhhhHHhccchHHHHHHHHHHHHHHHHhhhhcCCC
Q psy5368 353 LKSGLEIGETGDMYLAEGNYELALEKLKASLAILIQFCEAETSS 396 (406)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~~ 396 (406)
+.++.+....|...+..|+|+.|+++|.++++.|+..+..|+..
T Consensus 3 ~~~A~~l~~~Av~~D~~g~y~eA~~~Y~~aie~l~~~~k~e~~~ 46 (75)
T cd02678 3 LQKAIELVKKAIEEDNAGNYEEALRLYQHALEYFMHALKYEKNP 46 (75)
T ss_pred HHHHHHHHHHHHHHHHcCCHHHHHHHHHHHHHHHHHHHhhCCCH
Confidence 34567777778888999999999999999999999999888765
|
This sub-family of MIT domains is found in intracellular protein transport proteins of the AAA-ATPase family. The molecular function of the MIT domain is unclear. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.43 E-value=0.035 Score=53.51 Aligned_cols=73 Identities=22% Similarity=0.349 Sum_probs=56.7
Q ss_pred cCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCcceEeeCCeeEEEecccccc
Q psy5368 111 RPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLREN-NVCHFDLKPQNILIKNNTLKLADFGFAQF 188 (406)
Q Consensus 111 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~-givH~Dlkp~NIll~~~~~kL~DFGla~~ 188 (406)
...+.|++|++- |++|.. + ..-.++++..++.+.+..++-+..+ ..-|||+.-.|||+++|++.|+||-+++.
T Consensus 297 e~~y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId~GnvtLIDfklsRl 370 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILIDEGNVTLIDFKLSRL 370 (488)
T ss_pred CceEEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeeecCceEEEEeeeeec
Confidence 344567888876 545533 2 2346788889999888887777654 68999999999999999999999999974
|
|
| >smart00745 MIT Microtubule Interacting and Trafficking molecule domain | Back alignment and domain information |
|---|
Probab=95.26 E-value=0.03 Score=41.67 Aligned_cols=44 Identities=27% Similarity=0.277 Sum_probs=38.8
Q ss_pred hhhhhhhchhhhhHHhccchHHHHHHHHHHHHHHHHhhhhcCCC
Q psy5368 353 LKSGLEIGETGDMYLAEGNYELALEKLKASLAILIQFCEAETSS 396 (406)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~~ 396 (406)
+.+|.+....|..+++.|+++.|+++|+++++.|+..+..|+..
T Consensus 5 ~~~A~~li~~Av~~d~~g~~~eAl~~Y~~a~e~l~~~~~~~~~~ 48 (77)
T smart00745 5 LSKAKELISKALKADEAGDYEEALELYKKAIEYLLEGIKVESDS 48 (77)
T ss_pred HHHHHHHHHHHHHHHHcCCHHHHHHHHHHHHHHHHHHhccCCCH
Confidence 55677788888899999999999999999999999999888654
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.76 E-value=0.058 Score=51.41 Aligned_cols=28 Identities=36% Similarity=0.713 Sum_probs=25.5
Q ss_pred CCcccccCCCcceEeeCCeeEEEecccc
Q psy5368 159 NNVCHFDLKPQNILIKNNTLKLADFGFA 186 (406)
Q Consensus 159 ~givH~Dlkp~NIll~~~~~kL~DFGla 186 (406)
.+++|+|+++.||+++++.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKDNEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeCCcEEEEECccc
Confidence 5789999999999999888899999865
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd02677 MIT_SNX15 MIT: domain contained within Microtubule Interacting and Trafficking molecules | Back alignment and domain information |
|---|
Probab=94.46 E-value=0.035 Score=41.11 Aligned_cols=43 Identities=23% Similarity=0.315 Sum_probs=35.7
Q ss_pred hhhhhhchhhhhHHhccchHHHHHHHHHHHHHHHHhhhhcCCC
Q psy5368 354 KSGLEIGETGDMYLAEGNYELALEKLKASLAILIQFCEAETSS 396 (406)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~~ 396 (406)
.+|.+..+.|...+..|+|+.|+++|.++|+.++..+.-|+..
T Consensus 4 ~~A~~l~~~Ave~d~~~~y~eA~~~Y~~~i~~~~~~~k~e~~~ 46 (75)
T cd02677 4 EQAAELIRLALEKEEEGDYEAAFEFYRAGVDLLLKGVQGDSSP 46 (75)
T ss_pred HHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHhccCCCH
Confidence 3455666677777888999999999999999999999877554
|
This MIT domain sub-family is found in sorting nexin 15 and related proteins. The molecular function of the MIT domain is unclear. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.29 E-value=0.12 Score=46.61 Aligned_cols=107 Identities=17% Similarity=0.181 Sum_probs=63.4
Q ss_pred EEEeeeeeeceeEEeeeecCCcc-chhhhhhHHhhcccCCCC-CCcc-cCCeEEEEEeccCCCCHHHHHHhCCCCCHHHH
Q psy5368 66 TVQNSQIRLGTVKYSQVRYDTIT-SHSEFERPRAGLSNLRAP-EGRK-RPRYVYIILEYCDGGDLCSFIRSHEKLSEFQC 142 (406)
Q Consensus 66 ~Vy~~~~~~~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~-ni~~-~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~ 142 (406)
+.-.+.-+.+...+|++...... ...-|..+.+++.++.-- ++-. ....+.++.|.|-.... .-
T Consensus 77 Tl~~~kt~iG~L~lKKi~slp~~~~~~~y~nky~v~ArmhGilrL~NDn~~~yGvIlE~Cy~~~i-------------~~ 143 (308)
T PF07387_consen 77 TLLIGKTKIGPLFLKKIRSLPCCINDALYFNKYRVFARMHGILRLKNDNNYKYGVILERCYKIKI-------------NF 143 (308)
T ss_pred EEEEeccccchhhhhhccCCCcccchhhhhhhhhHHHHhhheeEeecCCCceeEEEEeeccCccc-------------ch
Confidence 33333334455666665543333 334456666666655221 1112 33456799999954211 11
Q ss_pred HHHHHHHHHHHHHHHH--CCcccccCCCcceEee-CCeeEEEeccc
Q psy5368 143 QQFVRQLVLALKFLRE--NNVCHFDLKPQNILIK-NNTLKLADFGF 185 (406)
Q Consensus 143 ~~i~~ql~~aL~~lH~--~givH~Dlkp~NIll~-~~~~kL~DFGl 185 (406)
..++..=+.+|.-.|+ .+.+|+|-.|+|||-| .|.+||.|-+.
T Consensus 144 ~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 144 SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 1122222467778884 4699999999999999 88999999765
|
The function of this family is unknown. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 406 | ||||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-28 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-26 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-26 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-26 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-26 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-26 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-26 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-26 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-26 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-26 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-25 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-25 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-25 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-25 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-25 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-25 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-25 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-25 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-25 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-25 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-25 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-25 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-25 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-25 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-25 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-25 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-25 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-25 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-25 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-25 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-25 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-25 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-25 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-24 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-24 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-24 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-24 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-24 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-24 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-24 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-24 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-24 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-24 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-24 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-24 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-24 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-24 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-24 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-24 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-24 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-24 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-23 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-23 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-23 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-23 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-23 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-23 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-23 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-23 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-23 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-23 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-23 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-23 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-23 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-23 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-23 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-23 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-23 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-23 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-23 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-23 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-23 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-23 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-23 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-23 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-23 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-22 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-22 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-22 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-22 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-22 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-22 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-22 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-22 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-22 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-22 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-22 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-22 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-22 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-22 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-22 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-22 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-22 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-22 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-22 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-22 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-22 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-22 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-22 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-22 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-22 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-22 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-22 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-22 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-22 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-22 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-22 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-22 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-22 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-22 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-22 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-22 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-22 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-22 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-22 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-22 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-21 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-21 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-21 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-21 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-21 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-21 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-21 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-21 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-21 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-21 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-21 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-21 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-21 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-21 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-21 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-21 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-21 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-21 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-21 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-21 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-21 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-21 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-21 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-21 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-21 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-21 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-21 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-21 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-21 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-21 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-21 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-21 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-21 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-21 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-21 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-21 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-21 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-21 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-21 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-21 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-21 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-21 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-21 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-21 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-21 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-21 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-21 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-21 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-21 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-21 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-21 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-21 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-21 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-21 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-21 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-21 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 9e-21 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 9e-21 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-20 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-20 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-20 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-20 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-20 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-20 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-20 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-20 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-20 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-20 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-20 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-20 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-20 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-20 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-20 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-20 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-20 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-20 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-20 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-20 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-20 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-20 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-20 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-20 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-20 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-20 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-20 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-20 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-20 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-20 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-20 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-20 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-20 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-20 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-20 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-20 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-19 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-19 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-19 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-19 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-19 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-19 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-19 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-19 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-19 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-19 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-19 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-19 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-19 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-19 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-19 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-19 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-19 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-19 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-19 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-19 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-19 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-19 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-19 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-19 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-19 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-19 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-19 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-19 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-19 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-19 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-19 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-19 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-19 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-19 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-19 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-19 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-19 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-19 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-18 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-18 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-18 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-18 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-18 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-18 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-18 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-18 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-18 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-18 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-18 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-18 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-18 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-18 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-18 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-18 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-18 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-18 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-18 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-18 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-18 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-18 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-18 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-18 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-18 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-18 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 7e-18 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-18 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-18 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-18 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-18 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-18 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-17 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-17 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-17 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-17 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-17 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-17 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-17 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-17 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-17 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-17 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-17 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-17 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-17 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-17 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-17 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-17 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-17 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-17 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-17 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-17 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-17 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-17 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-17 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-17 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-17 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-17 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-16 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-16 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-16 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-16 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-16 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-16 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-16 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-16 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-16 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-16 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-16 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-16 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-16 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-16 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-16 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-16 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-16 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-16 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-16 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-16 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-16 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-16 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-16 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-16 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-16 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-16 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-16 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-16 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-15 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-15 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-15 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-15 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-15 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-15 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-15 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-15 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-15 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-15 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-15 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-15 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-15 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-14 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-14 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-14 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-14 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-14 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-14 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-14 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-14 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-14 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-14 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-14 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-14 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-14 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-14 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-14 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-13 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-13 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-13 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-13 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-13 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-13 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-13 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-13 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-13 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-13 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-13 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 3e-13 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-13 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-13 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-13 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-13 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-13 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 4e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-13 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-13 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-13 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-13 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-13 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-13 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-13 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 9e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-13 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-12 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-12 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-12 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-12 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-12 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-12 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-12 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-12 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-12 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-12 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-12 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-12 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-12 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-12 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-12 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 9e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-12 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 9e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-11 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-11 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-11 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-11 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-11 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-10 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-10 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-10 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 6e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-10 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 6e-10 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 6e-10 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 7e-10 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 7e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-10 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 8e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-09 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-08 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-08 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-08 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-07 |
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 3e-70
Identities = 60/240 (25%), Positives = 110/240 (45%), Gaps = 18/240 (7%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+Y+Y+++E DL S+++ + + ++ + + + ++ A+ + ++ + H DLKP N
Sbjct: 81 DQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANF 139
Query: 172 LIKNNTLKLADFGFAQFLAPNDQG---DSIQGSPLYMAPEILAGSP-----------YNA 217
LI + LKL DFG A + P+ DS G+ YM PE + +
Sbjct: 140 LIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISP 199
Query: 218 KADLWSLGVLVFEALFGHAPYASC--NLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL 275
K+D+WSLG +++ +G P+ +S+L A + I P D D L L
Sbjct: 200 KSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI-PEKDLQDVLKCCL 258
Query: 276 QKDPMRRISYEDLFSHPYPDLIHAPCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEAL 335
++DP +RIS +L +HPY + P + + + + NS + + L
Sbjct: 259 KRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTL 318
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 6e-69
Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+Y+Y+++E C DL S+++ + + ++ + + + ++ A+ + ++ + H DLKP N
Sbjct: 100 DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANF 158
Query: 172 LIKNNTLKLADFGFAQFLAPNDQG---DSIQGSPLYMAPEILAGSP-----------YNA 217
LI + LKL DFG A + P+ DS G+ YM PE + +
Sbjct: 159 LIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISP 218
Query: 218 KADLWSLGVLVFEALFGHAPYASC--NLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL 275
K+D+WSLG +++ +G P+ +S+L A + I P D D L L
Sbjct: 219 KSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI-PEKDLQDVLKCCL 277
Query: 276 QKDPMRRISYEDLFSHPYPDLIHAPCAESHQTA 308
++DP +RIS +L +HPY + P + +
Sbjct: 278 KRDPKQRISIPELLAHPYVQIQTHPVNQMAKGT 310
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 9e-69
Identities = 62/260 (23%), Positives = 115/260 (44%), Gaps = 26/260 (10%)
Query: 100 LSNLRAPEGR--------KRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVL 151
L+ L+ + +Y+Y+++E DL S+++ + + ++ + + + ++
Sbjct: 108 LNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLE 166
Query: 152 ALKFLRENNVCHFDLKPQNILIKNNTLKLADFGFAQFLAPNDQG---DSIQGSPLYMAPE 208
A+ + ++ + H DLKP N LI + LKL DFG A + P+ DS G+ YM PE
Sbjct: 167 AVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 209 ILAGSP-----------YNAKADLWSLGVLVFEALFGHAPYASC--NLSQLRAQALSSAP 255
+ + K+D+WSLG +++ +G P+ +S+L A +
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 286
Query: 256 ITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAESHQTAIRIVTDA 315
I P D D L L++DP +RIS +L +HPY + P + + +
Sbjct: 287 IEFPDI-PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYV 345
Query: 316 IHHDRENNSRRAFSLYCEAL 335
+ NS + + L
Sbjct: 346 LGQLVGLNSPNSILKAAKTL 365
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 4e-58
Identities = 57/182 (31%), Positives = 96/182 (52%), Gaps = 4/182 (2%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
VY+ILEY G + ++ K E + ++ +L AL + V H D+KP+N+
Sbjct: 81 ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 140
Query: 172 LI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
L+ LK+ADFG++ AP+ + + G+ Y+ PE++ G ++ K DLWSLGVL +E
Sbjct: 141 LLGSAGELKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYE 199
Query: 231 ALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFS 290
L G P+ + + + +S T P ++ D +SRLL+ +P +R ++
Sbjct: 200 FLVGKPPFEANTYQETY-KRISRVEFTFPD-FVTEGARDLISRLLKHNPSQRPMLREVLE 257
Query: 291 HP 292
HP
Sbjct: 258 HP 259
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 6e-58
Identities = 48/217 (22%), Positives = 89/217 (41%), Gaps = 18/217 (8%)
Query: 82 VRYDTITSHSEFERPRAGLSNLRAPEGRKRPRYVYIILEYCDGGDLCSFI--RSHEKLSE 139
V Y + ++ R + + ++I +E+CD G L +I R EKL +
Sbjct: 67 VHY-----NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121
Query: 140 FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSI 198
+ Q+ + ++ + + DLKP NI + +K+ DFG L + +
Sbjct: 122 VLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS 181
Query: 199 QGSPLYMAPEILAGSPYNAKADLWSLGVLVFE--ALFGHAPYASCNLSQLRAQALSSAPI 256
+G+ YM+PE ++ Y + DL++LG+++ E + A S + LR
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG------- 234
Query: 257 TIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
I + L +LL K P R + ++
Sbjct: 235 -IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLT 270
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 7e-58
Identities = 54/184 (29%), Positives = 99/184 (53%), Gaps = 5/184 (2%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+YI+++YC+GGDL I + + E Q + Q+ LALK + + + H D+K QNI
Sbjct: 97 SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNI 156
Query: 172 LI-KNNTLKLADFGFAQFLAPN-DQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVF 229
+ K+ T++L DFG A+ L + + G+P Y++PEI PYN K+D+W+LG +++
Sbjct: 157 FLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLY 216
Query: 230 EALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLF 289
E + + ++ L + +S + + + S D +S+L +++P R S +
Sbjct: 217 ELCTLKHAFEAGSMKNLVLKIISGSFPPVSLH-YSYDLRSLVSQLFKRNPRDRPSVNSIL 275
Query: 290 SHPY 293
+
Sbjct: 276 EKGF 279
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 9e-57
Identities = 48/224 (21%), Positives = 87/224 (38%), Gaps = 43/224 (19%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEK---LSEFQCQQFVRQLVLALKFLRENNVCHFDLKP 168
R+ +I+E+C G L + + L E + +R +V + LREN + H ++KP
Sbjct: 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKP 140
Query: 169 QNILI-----KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGS--------PY 215
NI+ + KL DFG A+ L ++Q S+ G+ Y+ P++ + Y
Sbjct: 141 GNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY 200
Query: 216 NAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQAL------------------------ 251
A DLWS+GV + A G P+ + + +
Sbjct: 201 GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPID 260
Query: 252 --SSAPITIP-PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHP 292
P++ L L+ +L+ D + ++ F+
Sbjct: 261 WSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-56
Identities = 56/182 (30%), Positives = 102/182 (56%), Gaps = 4/182 (2%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+ +Y++LE+ G+L ++ H + E + F+ +L AL + E V H D+KP+N+
Sbjct: 86 RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENL 145
Query: 172 LI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
L+ LK+ADFG++ AP+ + ++ G+ Y+ PE++ G ++ K DLW GVL +E
Sbjct: 146 LMGYKGELKIADFGWS-VHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYE 204
Query: 231 ALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFS 290
L G P+ S + ++ + + + + PP LS D +S+LL+ P +R+ + +
Sbjct: 205 FLVGMPPFDSPSHTETH-RRIVNVDLKFPPF-LSDGSKDLISKLLRYHPPQRLPLKGVME 262
Query: 291 HP 292
HP
Sbjct: 263 HP 264
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 8e-55
Identities = 61/195 (31%), Positives = 95/195 (48%), Gaps = 12/195 (6%)
Query: 110 KRPRYVYIILEYCDGGDLCSFIRSHEK----LSEFQCQQFVRQLVLALKFL-----RENN 160
+ +YI++EYC+GGDL S I K L E + + QL LALK +
Sbjct: 77 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT 136
Query: 161 VCHFDLKPQNILI-KNNTLKLADFGFAQFLAPN-DQGDSIQGSPLYMAPEILAGSPYNAK 218
V H DLKP N+ + +KL DFG A+ L + + G+P YM+PE + YN K
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEK 196
Query: 219 ADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKD 278
+D+WSLG L++E P+ + + +L + IP S + + ++R+L
Sbjct: 197 SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR-YSDELNEIITRMLNLK 255
Query: 279 PMRRISYEDLFSHPY 293
R S E++ +P
Sbjct: 256 DYHRPSVEEILENPL 270
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-54
Identities = 52/188 (27%), Positives = 87/188 (46%), Gaps = 8/188 (4%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEK----LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 169
+ I+LE D GDL I+ +K + E ++ QL AL+ + V H D+KP
Sbjct: 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPA 165
Query: 170 NILI-KNNTLKLADFGFAQFL-APNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVL 227
N+ I +KL D G +F + S+ G+P YM+PE + + YN K+D+WSLG L
Sbjct: 166 NVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCL 225
Query: 228 VFEALFGHAPYA--SCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY 285
++E +P+ NL L + +P + S + ++ + DP +R
Sbjct: 226 LYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDV 285
Query: 286 EDLFSHPY 293
++
Sbjct: 286 TYVYDVAK 293
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 8e-54
Identities = 58/183 (31%), Positives = 79/183 (43%), Gaps = 9/183 (4%)
Query: 114 YVYIILEYCDGGDLCSFI-RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+Y+ E C G L L E Q ++R +LAL L + H D+KP NI
Sbjct: 131 ILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIF 189
Query: 173 I-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEA 231
+ KL DFG L G+ +G P YMAPE+L G Y AD++SLG+ + E
Sbjct: 190 LGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEV 248
Query: 232 LFG-HAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFS 290
P+ QLR L P LS + L +L+ DP R + E L +
Sbjct: 249 ACNMELPHGGEGWQQLRQGYL---PPEFTAG-LSSELRSVLVMMLEPDPKLRATAEALLA 304
Query: 291 HPY 293
P
Sbjct: 305 LPV 307
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 9e-53
Identities = 54/184 (29%), Positives = 103/184 (55%), Gaps = 5/184 (2%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 170
YVY++LE C G++ ++++ K SE + + F+ Q++ + +L + + H DL N
Sbjct: 83 SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSN 142
Query: 171 ILI-KNNTLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLV 228
+L+ +N +K+ADFG A Q P+++ ++ G+P Y++PEI S + ++D+WSLG +
Sbjct: 143 LLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMF 202
Query: 229 FEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDL 288
+ L G P+ + + + A +P LS + D + +LL+++P R+S +
Sbjct: 203 YTLLIGRPPFDTDTVKNTL-NKVVLADYEMPSF-LSIEAKDLIHQLLRRNPADRLSLSSV 260
Query: 289 FSHP 292
HP
Sbjct: 261 LDHP 264
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 3e-52
Identities = 56/183 (30%), Positives = 104/183 (56%), Gaps = 4/183 (2%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+ +Y+I+EY GG++ ++ +H ++ E + + RQ+V A+++ + + H DLK +N+
Sbjct: 86 EKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENL 145
Query: 172 LI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYN-AKADLWSLGVLVF 229
L+ + +K+ADFGF+ + D+ G+P Y APE+ G Y+ + D+WSLGV+++
Sbjct: 146 LLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILY 205
Query: 230 EALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLF 289
+ G P+ NL +LR + + IP +S DC + L R L +P++R + E +
Sbjct: 206 TLVSGSLPFDGQNLKELRER-VLRGKYRIPFY-MSTDCENLLKRFLVLNPIKRGTLEQIM 263
Query: 290 SHP 292
Sbjct: 264 KDR 266
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 3e-52
Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 104 RAPEGRKRPRYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVC 162
+ K+ ++I +EYC+ G L I S + + RQ++ AL ++ +
Sbjct: 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGII 138
Query: 163 HFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQ---------------GSPLYMA 206
H DLKP NI I ++ +K+ DFG A+ + + + G+ +Y+A
Sbjct: 139 HRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVA 198
Query: 207 PEILAGSP-YNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP---NS 262
E+L G+ YN K D++SLG++ FE + + + + L S I PP ++
Sbjct: 199 TEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKK-LRSVSIEFPPDFDDN 255
Query: 263 LSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
+ L+ DP +R L + +
Sbjct: 256 KMKVEKKIIRLLIDHDPNKRPGARTLLNSGW 286
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 5e-52
Identities = 48/223 (21%), Positives = 87/223 (39%), Gaps = 43/223 (19%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEK---LSEFQCQQFVRQLVLALKFLRENNVCHFDLKP 168
R+ +I+E+C G L + + L E + +R +V + LREN + H ++KP
Sbjct: 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKP 140
Query: 169 QNILI-----KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGS--------PY 215
NI+ + KL DFG A+ L ++Q S+ G+ Y+ P++ + Y
Sbjct: 141 GNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY 200
Query: 216 NAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQAL------------------------ 251
A DLWS+GV + A G P+ + + +
Sbjct: 201 GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPID 260
Query: 252 --SSAPITIP-PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291
P++ L L+ +L+ D + ++ F+
Sbjct: 261 WSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 6e-52
Identities = 52/242 (21%), Positives = 91/242 (37%), Gaps = 29/242 (11%)
Query: 106 PEGRKRPRYVYIILEYCDGGDLCSFIRSHEK---LSEFQCQQFVRQLVLALKFLRENNVC 162
+ + +EYC+GGDL ++ E L E + + + AL++L EN +
Sbjct: 84 LQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRII 143
Query: 163 HFDLKPQNILIKNN----TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAK 218
H DLKP+NI+++ K+ D G+A+ L + G+ Y+APE+L Y
Sbjct: 144 HRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVT 203
Query: 219 ADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIP------------------P 260
D WS G L FE + G P+ + P
Sbjct: 204 VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTP 263
Query: 261 NSLSP----DCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAESHQTAIRIVTDAI 316
N LS +L +L +R + + + + + + + +V+ +
Sbjct: 264 NHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKLLSVMNMVSGRV 323
Query: 317 HH 318
H
Sbjct: 324 HT 325
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-51
Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 13/196 (6%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+V I +E +GG L I+ L E + ++ Q + L++L + H D+K N+L+
Sbjct: 124 WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL 183
Query: 174 KNN--TLKLADFGFAQFLAPND------QGDSIQGSPLYMAPEILAGSPYNAKADLWSLG 225
++ L DFG A L P+ GD I G+ +MAPE++ G P +AK D+WS
Sbjct: 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSC 243
Query: 226 VLVFEALFGHAPYASCNLSQLRA--QALSSAPITIP-PNSLSPDCMDFLSRLLQKDPMRR 282
++ L G P+ + + S P P S +P + L+K+P+ R
Sbjct: 244 CMMLHMLNGCHPWT--QYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHR 301
Query: 283 ISYEDLFSHPYPDLIH 298
S +L L
Sbjct: 302 ASAMELRRKVGKALQE 317
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 3e-51
Identities = 61/301 (20%), Positives = 131/301 (43%), Gaps = 26/301 (8%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+Y Y++ E+ +GG+L I + K E ++Q++ + +L ++N+ H D+KP+NI
Sbjct: 118 KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENI 177
Query: 172 LIKNN----TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVL 227
L++N +K+ DFG + F + + + G+ Y+APE+L YN K D+WS GV+
Sbjct: 178 LLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVI 236
Query: 228 VFEALFGHAPYASCNLSQLRAQALSSAPITIPP--NSLSPDCMDFLSRLLQKDPMRRISY 285
++ L G+ P+ N + + ++S + + + +L D +R +
Sbjct: 237 MYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTA 296
Query: 286 EDLFSHPYPDLIHAPCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIPLAYDV 345
E+ + + I +++ + + A+ + R+ + A+
Sbjct: 297 EEALNSRW---IKKYANNINKSDQKTLCGALSNMRKFEGSQKL--AQAAIL--------F 343
Query: 346 LAEAIPNLKSGLEIGETGDMYLA---EGNYELALEKLKASLAILIQFCEAETSSSQLKPL 402
+ L + E E D++ G+ +L ++L +L F ++
Sbjct: 344 IGS---KLTTLEERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEE 400
Query: 403 L 403
+
Sbjct: 401 V 401
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 4e-51
Identities = 56/223 (25%), Positives = 104/223 (46%), Gaps = 10/223 (4%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
Y Y++ E GG+L I S ++ SE + +RQ++ + ++ +N + H DLKP+N+
Sbjct: 98 KGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENL 157
Query: 172 LIKNN----TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVL 227
L+++ +++ DFG + + + G+ Y+APE+L G+ Y+ K D+WS GV+
Sbjct: 158 LLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVI 216
Query: 228 VFEALFGHAPYASCNLSQLRAQALSSAPITIPP--NSLSPDCMDFLSRLLQKDPMRRISY 285
++ L G P+ N + + P +S D + ++L P RIS
Sbjct: 217 LYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISA 276
Query: 286 EDLFSHPYPDLIHAPCAESHQTAIRIVTDAIHHDRENNSRRAF 328
D H + I E + + +AI + R+ +
Sbjct: 277 RDALDHEW---IQTYTKEQISVDVPSLDNAILNIRQFQGTQKL 316
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 4e-51
Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 33/212 (15%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKL--------SEFQCQQFVRQLVLALKFL-RENNVC 162
VYII EY + + F L + ++ ++ + ++ E N+C
Sbjct: 115 YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNIC 174
Query: 163 HFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSP--YNAKA 219
H D+KP NIL+ KN +KL+DFG +++ + + +G+ +M PE + AK
Sbjct: 175 HRDVKPSNILMDKNGRVKLSDFGESEY-MVDKKIKGSRGTYEFMPPEFFSNESSYNGAKV 233
Query: 220 DLWSLGVLVFEALFGHAP-YASCNLSQLRAQALSSAPITIPPNS---------------- 262
D+WSLG+ ++ + P +L +L + I P +
Sbjct: 234 DIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT-KNIEYPLDRNHFLYPLTNKKSTCSN 292
Query: 263 --LSPDCMDFLSRLLQKDPMRRISYEDLFSHP 292
LS + +DFL L+K+P RI+ ED H
Sbjct: 293 NFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 6e-51
Identities = 50/201 (24%), Positives = 102/201 (50%), Gaps = 10/201 (4%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+V+++LE C L + + L+E + + ++RQ+VL ++L N V H DLK N+
Sbjct: 113 NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 172
Query: 172 LI-KNNTLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVF 229
+ ++ +K+ DFG A + ++ + G+P Y+APE+L+ ++ + D+WS+G +++
Sbjct: 173 FLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMY 232
Query: 230 EALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLF 289
L G P+ + L + + +IP + ++P + ++LQ DP R + +L
Sbjct: 233 TLLVGKPPFETSCLKETY-LRIKKNEYSIPKH-INPVAASLIQKMLQTDPTARPTINELL 290
Query: 290 SHPY------PDLIHAPCAES 304
+ + P + C
Sbjct: 291 NDEFFTSGYIPARLPITCLTI 311
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 171 bits (437), Expect = 8e-51
Identities = 50/198 (25%), Positives = 102/198 (51%), Gaps = 10/198 (5%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+V+++LE C L + + L+E + + ++RQ+VL ++L N V H DLK N+
Sbjct: 87 NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 146
Query: 172 LI-KNNTLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVF 229
+ ++ +K+ DFG A + ++ + G+P Y+APE+L+ ++ + D+WS+G +++
Sbjct: 147 FLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMY 206
Query: 230 EALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLF 289
L G P+ + L + + +IP + ++P + ++LQ DP R + +L
Sbjct: 207 TLLVGKPPFETSCLKETY-LRIKKNEYSIPKH-INPVAASLIQKMLQTDPTARPTINELL 264
Query: 290 SHPY------PDLIHAPC 301
+ + P + C
Sbjct: 265 NDEFFTSGYIPARLPITC 282
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 1e-50
Identities = 55/223 (24%), Positives = 107/223 (47%), Gaps = 9/223 (4%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
R Y+++E GG+L I K +E ++Q++ + +L ++N+ H DLKP+N+
Sbjct: 108 KRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENL 167
Query: 172 LIKNN----TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVL 227
L+++ +K+ DFG + + G+ Y+APE+L Y+ K D+WS+GV+
Sbjct: 168 LLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKK-YDEKCDVWSIGVI 226
Query: 228 VFEALFGHAPYASCNLSQLRAQALSSAPITIPP--NSLSPDCMDFLSRLLQKDPMRRISY 285
+F L G+ P+ ++ + P ++S D + ++LQ D RRIS
Sbjct: 227 LFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISA 286
Query: 286 EDLFSHPYPDLIHAPCAESHQTAIRIVTDAIHHDRENNSRRAF 328
+ HP+ + + + + +AI + R+ + +
Sbjct: 287 QQALEHPW--IKEMCSKKESGIELPSLANAIENMRKFQNSQKL 327
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-50
Identities = 53/183 (28%), Positives = 100/183 (54%), Gaps = 4/183 (2%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
P ++++EY GG+L +I H ++ E + ++ +Q++ A+ + + V H DLKP+N+
Sbjct: 83 PTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENV 142
Query: 172 LI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYN-AKADLWSLGVLVF 229
L+ + K+ADFG + ++ + + GSP Y APE+++G Y + D+WS GV+++
Sbjct: 143 LLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILY 202
Query: 230 EALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLF 289
L G P+ ++ L + + IP L+ L +LQ DP++R + +D+
Sbjct: 203 ALLCGTLPFDDEHVPTLFKK-IRGGVFYIPEY-LNRSVATLLMHMLQVDPLKRATIKDIR 260
Query: 290 SHP 292
H
Sbjct: 261 EHE 263
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 1e-49
Identities = 52/187 (27%), Positives = 93/187 (49%), Gaps = 7/187 (3%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
YI+ E GG+L I ++ SE + ++Q+ + ++ ++N+ H DLKP+NI
Sbjct: 93 SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENI 152
Query: 172 LIKNN----TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVL 227
L+++ +K+ DFG + N + G+ Y+APE+L G+ Y+ K D+WS GV+
Sbjct: 153 LLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVI 211
Query: 228 VFEALFGHAPYASCNLSQLRAQALSSAPITIPP--NSLSPDCMDFLSRLLQKDPMRRISY 285
++ L G P+ N + + + P ++S D D + ++L P RI+
Sbjct: 212 LYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITA 271
Query: 286 EDLFSHP 292
HP
Sbjct: 272 TQCLEHP 278
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-49
Identities = 48/185 (25%), Positives = 99/185 (53%), Gaps = 8/185 (4%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
++Y++ E + G + + + + LSE Q + + + L+ +++L + H D+KP N+L+
Sbjct: 112 HLYMVFELVNQGPVME-VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170
Query: 174 -KNNTLKLADFGFAQFLAPNDQG-DSIQGSPLYMAPEILAGS--PYN-AKADLWSLGVLV 228
++ +K+ADFG + +D + G+P +MAPE L+ + ++ D+W++GV +
Sbjct: 171 GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
Query: 229 FEALFGHAPYASCNLSQLRAQALSSAPITIPP-NSLSPDCMDFLSRLLQKDPMRRISYED 287
+ +FG P+ + L + S + P ++ D D ++R+L K+P RI +
Sbjct: 231 YCFVFGQCPFMDERIMCLH-SKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPE 289
Query: 288 LFSHP 292
+ HP
Sbjct: 290 IKLHP 294
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 1e-49
Identities = 63/184 (34%), Positives = 98/184 (53%), Gaps = 11/184 (5%)
Query: 112 PRYVYIILE-YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 170
+ +++E + G DL +FI H +L E RQLV A+ +LR ++ H D+K +N
Sbjct: 101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDEN 160
Query: 171 ILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYN-AKADLWSLGVLV 228
I+I ++ T+KL DFG A +L + G+ Y APE+L G+PY + ++WSLGV +
Sbjct: 161 IVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTL 220
Query: 229 FEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDL 288
+ +F P+ C L + A I P +S + M +S LLQ P RR + E L
Sbjct: 221 YTLVFEENPF--CELEE-----TVEAAIHPPY-LVSKELMSLVSGLLQPVPERRTTLEKL 272
Query: 289 FSHP 292
+ P
Sbjct: 273 VTDP 276
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 166 bits (424), Expect = 3e-49
Identities = 51/187 (27%), Positives = 89/187 (47%), Gaps = 7/187 (3%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+Y+++E C GG+L + E + ++ ++ A+ + + NV H DLKP+N
Sbjct: 78 NTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENF 137
Query: 172 LIKNN----TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVL 227
L + LKL DFG A P + G+P Y++P++L G Y + D WS GV+
Sbjct: 138 LFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVM 196
Query: 228 VFEALFGHAPYASCNLSQLRAQALSSAPITIPP--NSLSPDCMDFLSRLLQKDPMRRISY 285
++ L G+ P+++ S++ + ++SP + RLL K P +RI+
Sbjct: 197 MYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITS 256
Query: 286 EDLFSHP 292
H
Sbjct: 257 LQALEHE 263
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 5e-49
Identities = 59/190 (31%), Positives = 99/190 (52%), Gaps = 10/190 (5%)
Query: 112 PRYVYIILEYCDGGDL----CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLK 167
+YI++E C+GG+L S + LSE + ++Q++ AL + +V H DLK
Sbjct: 92 YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLK 151
Query: 168 PQNILIKNN----TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWS 223
P+NIL ++ +K+ DFG A+ ++ + G+ LYMAPE+ K D+WS
Sbjct: 152 PENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRD-VTFKCDIWS 210
Query: 224 LGVLVFEALFGHAPYASCNLSQLRAQALSSAPI-TIPPNSLSPDCMDFLSRLLQKDPMRR 282
GV+++ L G P+ +L +++ +A P + L+P +D L ++L KDP RR
Sbjct: 211 AGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERR 270
Query: 283 ISYEDLFSHP 292
S + H
Sbjct: 271 PSAAQVLHHE 280
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-48
Identities = 52/186 (27%), Positives = 82/186 (44%), Gaps = 13/186 (6%)
Query: 111 RPRYVYIILEY-CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 169
++LE DL +I L E + F Q+V A++ V H D+K +
Sbjct: 109 TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDE 168
Query: 170 NILI--KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYN-AKADLWSLGV 226
NILI + KL DFG L ++ G+ +Y PE ++ Y+ A +WSLG+
Sbjct: 169 NILIDLRRGCAKLIDFGSGALL-HDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGI 227
Query: 227 LVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYE 286
L+++ + G P+ Q + A + P +SPDC + R L P R S E
Sbjct: 228 LLYDMVCGDIPFER-------DQEILEAELHFPA-HVSPDCCALIRRCLAPKPSSRPSLE 279
Query: 287 DLFSHP 292
++ P
Sbjct: 280 EILLDP 285
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-48
Identities = 43/210 (20%), Positives = 85/210 (40%), Gaps = 20/210 (9%)
Query: 101 SNLRAPEGRKRPRYVYIILEYCDGGDLCSFIRSHEKLSEF---QCQQFVRQLVLALKFLR 157
+ + Y+YI ++ C +L ++ + E C Q+ A++FL
Sbjct: 76 NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH 135
Query: 158 ENNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQ-------------GSPL 203
+ H DLKP NI ++ +K+ DFG + +++ ++ G+ L
Sbjct: 136 SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKL 195
Query: 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSL 263
YM+PE + G+ Y+ K D++SLG+++FE L + + + +
Sbjct: 196 YMSPEQIHGNSYSHKVDIFSLGLILFELL--YPFSTQMERVRT-LTDVRNLKFPPLFTQK 252
Query: 264 SPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
P + +L PM R ++ +
Sbjct: 253 YPCEYVMVQDMLSPSPMERPEAINIIENAV 282
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-48
Identities = 46/188 (24%), Positives = 96/188 (51%), Gaps = 8/188 (4%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+ Y++ + GG+L I + E SE ++Q++ ++ + N + H +LKP+N+
Sbjct: 77 ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENL 136
Query: 172 LIKNN----TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVL 227
L+ + +KLADFG A + ++ G+P Y++PE+L PY+ D+W+ GV+
Sbjct: 137 LLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVI 196
Query: 228 VFEALFGHAPYASCNLSQLRAQALSSAPITIPP---NSLSPDCMDFLSRLLQKDPMRRIS 284
++ L G+ P+ + +L + + P ++++P+ + +L +P +RI+
Sbjct: 197 LYILLVGYPPFWDEDQHRL-YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT 255
Query: 285 YEDLFSHP 292
+ P
Sbjct: 256 ADQALKVP 263
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 3e-48
Identities = 61/189 (32%), Positives = 99/189 (52%), Gaps = 12/189 (6%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
YI+LE +GG+L + +++L E C+ + Q++LA+++L EN + H DLKP+N+L+
Sbjct: 214 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS 273
Query: 175 NN----TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGS---PYNAKADLWSLGVL 227
+ +K+ DFG ++ L ++ G+P Y+APE+L YN D WSLGV+
Sbjct: 274 SQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 333
Query: 228 VFEALFGHAP-YASCNLSQLRAQALSSAPITIPP---NSLSPDCMDFLSRLLQKDPMRRI 283
+F L G+ P L+ Q S P +S +D + +LL DP R
Sbjct: 334 LFICLSGYPPFSEHRTQVSLKDQIT-SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF 392
Query: 284 SYEDLFSHP 292
+ E+ HP
Sbjct: 393 TTEEALRHP 401
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 4e-48
Identities = 46/222 (20%), Positives = 80/222 (36%), Gaps = 21/222 (9%)
Query: 107 EGRKRPRYVYIILEYCDGGDLCSFI----RSHEKLSEFQCQQFVRQLVLALKFLRENNVC 162
R +++L + G L + I L+E Q + + L+ +
Sbjct: 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYA 156
Query: 163 HFDLKPQNILI-KNNTLKLADFGFA----------QFLAPNDQGDSIQGSPLYMAPEILA 211
H DLKP NIL+ L D G + + + + Y APE+ +
Sbjct: 157 HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFS 216
Query: 212 GSPY---NAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNS-LSPDC 267
+ + + D+WSLG +++ +FG PY ++IP + S
Sbjct: 217 VQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSAL 276
Query: 268 MDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAESHQTAI 309
L+ ++ DP +R L S + + P H T I
Sbjct: 277 WQLLNSMMTVDPHQRPHIPLLLSQ--LEALQPPAPGQHTTQI 316
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 4e-48
Identities = 60/189 (31%), Positives = 99/189 (52%), Gaps = 9/189 (4%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
V +ILE GG+L F+ E L+E + QF++Q++ + +L + HFDLKP+NI
Sbjct: 80 KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENI 139
Query: 172 L-----IKNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGV 226
+ + N +KL DFG A + ++ +I G+P ++APEI+ P +AD+WS+GV
Sbjct: 140 MLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 199
Query: 227 LVFEALFGHAPYASCNLSQLRAQALSSAPITIPP---NSLSPDCMDFLSRLLQKDPMRRI 283
+ + L G +P+ + +S+ ++ S DF+ RLL KDP RR+
Sbjct: 200 ITYILLSGASPFLGETKQET-LTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRM 258
Query: 284 SYEDLFSHP 292
+ H
Sbjct: 259 TIAQSLEHS 267
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 7e-48
Identities = 52/189 (27%), Positives = 91/189 (48%), Gaps = 11/189 (5%)
Query: 112 PRYVYIILEYCDGG--DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 169
+ +Y+++EYC G ++ + ++ Q + QL+ L++L + H D+KP
Sbjct: 80 KQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPG 138
Query: 170 NILI-KNNTLKLADFGFAQFLAPNDQGD---SIQGSPLYMAPEILAGS-PYN-AKADLWS 223
N+L+ TLK++ G A+ L P D + QGSP + PEI G ++ K D+WS
Sbjct: 139 NLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWS 198
Query: 224 LGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283
GV ++ G P+ N+ +L + + IP + P D L +L+ +P +R
Sbjct: 199 AGVTLYNITTGLYPFEGDNIYKLF-ENIGKGSYAIPGD-CGPPLSDLLKGMLEYEPAKRF 256
Query: 284 SYEDLFSHP 292
S + H
Sbjct: 257 SIRQIRQHS 265
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 8e-48
Identities = 49/187 (26%), Positives = 88/187 (47%), Gaps = 6/187 (3%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
Y+ LEYC GG+L I + E Q+F QL+ + +L + H D+KP+N+
Sbjct: 77 GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136
Query: 172 LI-KNNTLKLADFGFAQFLAPNDQGDSIQ---GSPLYMAPEILAGSPYN-AKADLWSLGV 226
L+ + + LK++DFG A N++ + G+ Y+APE+L ++ D+WS G+
Sbjct: 137 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 196
Query: 227 LVFEALFGHAPY-ASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY 285
++ L G P+ + Q + P + + L ++L ++P RI+
Sbjct: 197 VLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITI 256
Query: 286 EDLFSHP 292
D+
Sbjct: 257 PDIKKDR 263
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-47
Identities = 56/221 (25%), Positives = 114/221 (51%), Gaps = 14/221 (6%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
P + +++EY GG+L +I ++++E + ++F +Q++ A+++ + + H DLKP+N+
Sbjct: 81 PTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENL 139
Query: 172 LI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYN-AKADLWSLGVLVF 229
L+ N +K+ADFG + + + + GSP Y APE++ G Y + D+WS G++++
Sbjct: 140 LLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLY 199
Query: 230 EALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLF 289
L G P+ + L + ++S +P LSP + R++ DPM+RI+ +++
Sbjct: 200 VMLVGRLPFDDEFIPNLFKK-VNSCVYVMPDF-LSPGAQSLIRRMIVADPMQRITIQEIR 257
Query: 290 SHP-----YPDLIHAPCAESHQT----AIRIVTDAIHHDRE 321
P PD + + + +A+ +
Sbjct: 258 RDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAMGFSED 298
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-47
Identities = 51/186 (27%), Positives = 83/186 (44%), Gaps = 13/186 (6%)
Query: 111 RPRYVYIILEYCDG-GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 169
RP +ILE + DL FI L E + F Q++ A++ V H D+K +
Sbjct: 119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDE 178
Query: 170 NILIKNNT--LKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNA-KADLWSLGV 226
NILI N LKL DFG L + G+ +Y PE + Y+ A +WSLG+
Sbjct: 179 NILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 237
Query: 227 LVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYE 286
L+++ + G P+ + + + +S +C + L P R ++E
Sbjct: 238 LLYDMVCGDIPFEH-------DEEIIRGQVFFRQ-RVSSECQHLIRWCLALRPSDRPTFE 289
Query: 287 DLFSHP 292
++ +HP
Sbjct: 290 EIQNHP 295
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-47
Identities = 56/189 (29%), Positives = 98/189 (51%), Gaps = 9/189 (4%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
V +ILE GG+L F+ E LSE + F++Q++ + +L + HFDLKP+NI
Sbjct: 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENI 146
Query: 172 LIKNNT-----LKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGV 226
++ + +KL DFG A + + +I G+P ++APEI+ P +AD+WS+GV
Sbjct: 147 MLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 227 LVFEALFGHAPYASCNLSQLRAQALSSAPITIPP---NSLSPDCMDFLSRLLQKDPMRRI 283
+ + L G +P+ + ++S + S DF+ +LL K+ +R+
Sbjct: 207 ITYILLSGASPFLGDTKQET-LANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRL 265
Query: 284 SYEDLFSHP 292
+ ++ HP
Sbjct: 266 TIQEALRHP 274
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-47
Identities = 42/205 (20%), Positives = 76/205 (37%), Gaps = 32/205 (15%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEK----LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 169
++ I EYC+GG L I + + E + + + Q+ L+++ ++ H D+KP
Sbjct: 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPS 144
Query: 170 NILIKNN--------------------TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEI 209
NI I K+ D G +G ++A E+
Sbjct: 145 NIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV---TRISSPQVEEGDSRFLANEV 201
Query: 210 LAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCM 268
L + + KAD+++L + V A + + + + P LS +
Sbjct: 202 LQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----WHEIRQGRLPRIPQVLSQEFT 257
Query: 269 DFLSRLLQKDPMRRISYEDLFSHPY 293
+ L ++ DP RR S L H
Sbjct: 258 ELLKVMIHPDPERRPSAMALVKHSV 282
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-47
Identities = 58/189 (30%), Positives = 101/189 (53%), Gaps = 9/189 (4%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
V +ILE GG+L F+ E L+E + +F++Q++ + +L + HFDLKP+NI
Sbjct: 86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 145
Query: 172 LI-----KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGV 226
++ +K+ DFG A + ++ +I G+P ++APEI+ P +AD+WS+GV
Sbjct: 146 MLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 227 LVFEALFGHAPYASCNLSQLRAQALSSAPITIPP---NSLSPDCMDFLSRLLQKDPMRRI 283
+ + L G +P+ + +S+ ++ S DF+ RLL KDP +R+
Sbjct: 206 ITYILLSGASPFLGDTKQET-LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 264
Query: 284 SYEDLFSHP 292
+ +D HP
Sbjct: 265 TIQDSLQHP 273
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-47
Identities = 55/193 (28%), Positives = 92/193 (47%), Gaps = 17/193 (8%)
Query: 114 YVYIILEYCDGGDLCSFIRSHE---KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 170
++ I +E GG L + +RS K +E + +Q++ LK+L +N + H D+K N
Sbjct: 93 FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDN 152
Query: 171 ILI--KNNTLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSP--YNAKADLWSLG 225
+LI + LK++DFG + + N ++ G+ YMAPEI+ P Y AD+WSLG
Sbjct: 153 VLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLG 212
Query: 226 VLVFEALFGHAPYASCNLSQLRAQAL-----SSAPITIPPNSLSPDCMDFLSRLLQKDPM 280
+ E G P+ L + A+ IP + +S + F+ + + DP
Sbjct: 213 CTIIEMATGKPPFY--ELGE-PQAAMFKVGMFKVHPEIPES-MSAEAKAFILKCFEPDPD 268
Query: 281 RRISYEDLFSHPY 293
+R DL +
Sbjct: 269 KRACANDLLVDEF 281
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 4e-47
Identities = 55/190 (28%), Positives = 97/190 (51%), Gaps = 10/190 (5%)
Query: 112 PRYVYIILEYCDGGDLCSFI--RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 169
+ +ILEY GG++ S E +SE + ++Q++ + +L +NN+ H DLKPQ
Sbjct: 101 TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQ 160
Query: 170 NILIKNNT----LKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLG 225
NIL+ + +K+ DFG ++ + + I G+P Y+APEIL P D+W++G
Sbjct: 161 NILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIG 220
Query: 226 VLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP---NSLSPDCMDFLSRLLQKDPMRR 282
++ + L +P+ + + +S + +S+S DF+ LL K+P +R
Sbjct: 221 IIAYMLLTHTSPFVGEDNQET-YLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKR 279
Query: 283 ISYEDLFSHP 292
+ E SH
Sbjct: 280 PTAEICLSHS 289
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 5e-47
Identities = 56/205 (27%), Positives = 105/205 (51%), Gaps = 9/205 (4%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
P +++++EY GG+L +I + +L E + ++ +Q++ + + + V H DLKP+N+
Sbjct: 88 PSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENV 147
Query: 172 LI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYN-AKADLWSLGVLVF 229
L+ + K+ADFG + ++ + + GSP Y APE+++G Y + D+WS GV+++
Sbjct: 148 LLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILY 207
Query: 230 EALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLF 289
L G P+ ++ L + + P L+P + L +LQ DPM+R + +D+
Sbjct: 208 ALLCGTLPFDDDHVPTLFKK-ICDGIFYTPQY-LNPSVISLLKHMLQVDPMKRATIKDIR 265
Query: 290 SHP-----YPDLIHAPCAESHQTAI 309
H P + T I
Sbjct: 266 EHEWFKQDLPKYLFPEDPSYSSTMI 290
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 5e-47
Identities = 52/187 (27%), Positives = 92/187 (49%), Gaps = 7/187 (3%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
YI+ E GG+L I ++ SE + ++Q+ + ++ ++N+ H DLKP+NI
Sbjct: 93 SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENI 152
Query: 172 LIKNN----TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVL 227
L+++ +K+ DFG + N + G+ Y+APE+L G Y+ K D+WS GV+
Sbjct: 153 LLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVI 211
Query: 228 VFEALFGHAPYASCNLSQLRAQALSSAPITIPP--NSLSPDCMDFLSRLLQKDPMRRISY 285
++ L G P+ N + + + P ++S D D + ++L P RI+
Sbjct: 212 LYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITA 271
Query: 286 EDLFSHP 292
HP
Sbjct: 272 TQCLEHP 278
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 5e-47
Identities = 49/187 (26%), Positives = 98/187 (52%), Gaps = 6/187 (3%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+ Y++ + GG+L I + E SE ++Q++ ++ + N + H +LKP+N+
Sbjct: 100 ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENL 159
Query: 172 LIKNN----TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVL 227
L+ + +KLADFG A + ++ G+P Y++PE+L PY+ D+W+ GV+
Sbjct: 160 LLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVI 219
Query: 228 VFEALFGHAPYASCNLSQLRAQALSSAPITIPP--NSLSPDCMDFLSRLLQKDPMRRISY 285
++ L G+ P+ + +L AQ + A P ++++P+ + +L +P +RI+
Sbjct: 220 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITA 279
Query: 286 EDLFSHP 292
+ P
Sbjct: 280 DQALKVP 286
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 5e-47
Identities = 49/187 (26%), Positives = 88/187 (47%), Gaps = 6/187 (3%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
Y+ LEYC GG+L I + E Q+F QL+ + +L + H D+KP+N+
Sbjct: 77 GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136
Query: 172 LI-KNNTLKLADFGFAQFLAPNDQGDSIQ---GSPLYMAPEILAGSPYN-AKADLWSLGV 226
L+ + + LK++DFG A N++ + G+ Y+APE+L ++ D+WS G+
Sbjct: 137 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 196
Query: 227 LVFEALFGHAPY-ASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY 285
++ L G P+ + Q + P + + L ++L ++P RI+
Sbjct: 197 VLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITI 256
Query: 286 EDLFSHP 292
D+
Sbjct: 257 PDIKKDR 263
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 6e-47
Identities = 58/234 (24%), Positives = 89/234 (38%), Gaps = 54/234 (23%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEK----------------------------------- 136
+Y+ +++E C GG L +
Sbjct: 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRE 159
Query: 137 -----LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI---KNNTLKLADFGFAQF 188
E +RQ+ AL +L +CH D+KP+N L K+ +KL DFG ++
Sbjct: 160 SLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKE 219
Query: 189 LAPNDQGDS-----IQGSPLYMAPEILAGS--PYNAKADLWSLGVLVFEALFGHAPYASC 241
+ G+ G+P ++APE+L + Y K D WS GVL+ L G P+
Sbjct: 220 FYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGV 279
Query: 242 NLSQLRAQALSSAPITIPP---NSLSPDCMDFLSRLLQKDPMRRISYEDLFSHP 292
N + +Q L + + N LSP D LS LL ++ R HP
Sbjct: 280 NDADTISQVL-NKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHP 332
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-46
Identities = 60/189 (31%), Positives = 99/189 (52%), Gaps = 8/189 (4%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
P ++ II+EY GG+L I + + SE + + F +QL+ + + +CH DLK +N
Sbjct: 88 PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENT 147
Query: 172 LI---KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYN-AKADLWSLGVL 227
L+ LK+ DFG+++ + Q S G+P Y+APE+L Y+ AD+WS GV
Sbjct: 148 LLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVT 207
Query: 228 VFEALFGHAPYASCNLSQL---RAQALSSAPITIPPNS-LSPDCMDFLSRLLQKDPMRRI 283
++ L G P+ + Q + S +IP + +SP+C +SR+ DP RI
Sbjct: 208 LYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRI 267
Query: 284 SYEDLFSHP 292
S ++ +H
Sbjct: 268 SIPEIKTHS 276
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-46
Identities = 57/188 (30%), Positives = 94/188 (50%), Gaps = 7/188 (3%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
P + ++LE GG+L I SE V+Q++ A+ +L EN + H DLKP+N+
Sbjct: 120 PTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENL 179
Query: 172 LIKNN----TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVL 227
L LK+ADFG ++ + ++ G+P Y APEIL G Y + D+WS+G++
Sbjct: 180 LYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGII 239
Query: 228 VFEALFGHAP-YASCNLSQLRAQALSSAPITIPP--NSLSPDCMDFLSRLLQKDPMRRIS 284
+ L G P Y + + L+ I P + +S + D + +L+ DP +R++
Sbjct: 240 TYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLT 299
Query: 285 YEDLFSHP 292
HP
Sbjct: 300 TFQALQHP 307
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-46
Identities = 55/189 (29%), Positives = 98/189 (51%), Gaps = 9/189 (4%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
V +ILE GG+L F+ E LSE + F++Q++ + +L + HFDLKP+NI
Sbjct: 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENI 146
Query: 172 LIKNNT-----LKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGV 226
++ + +KL DFG A + + +I G+P ++APEI+ P +AD+WS+GV
Sbjct: 147 MLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 227 LVFEALFGHAPYASCNLSQLRAQALSSAPITIPP---NSLSPDCMDFLSRLLQKDPMRRI 283
+ + L G +P+ + +++ + S DF+ +LL K+ +R+
Sbjct: 207 ITYILLSGASPFLGDTKQET-LANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRL 265
Query: 284 SYEDLFSHP 292
+ ++ HP
Sbjct: 266 TIQEALRHP 274
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-46
Identities = 53/191 (27%), Positives = 96/191 (50%), Gaps = 11/191 (5%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+ +++ + G+L ++ LSE + ++ +R L+ + L + N+ H DLKP+NI
Sbjct: 96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENI 155
Query: 172 LIKNN-TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGS------PYNAKADLWSL 224
L+ ++ +KL DFGF+ L P ++ + G+P Y+APEI+ S Y + D+WS
Sbjct: 156 LLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 215
Query: 225 GVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP---NSLSPDCMDFLSRLLQKDPMR 281
GV+++ L G P+ + + + S + S D +SR L P +
Sbjct: 216 GVIMYTLLAGSPPFWHRKQMLM-LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQK 274
Query: 282 RISYEDLFSHP 292
R + E+ +HP
Sbjct: 275 RYTAEEALAHP 285
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-46
Identities = 53/189 (28%), Positives = 96/189 (50%), Gaps = 8/189 (4%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
++++++ GGDL ++ + E + F+ +LV+AL +L+ + H D+KP NI
Sbjct: 87 EEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNI 146
Query: 172 LI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILA---GSPYNAKADLWSLGVL 227
L+ ++ + + DF A L Q ++ G+ YMAPE+ + G+ Y+ D WSLGV
Sbjct: 147 LLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVT 206
Query: 228 VFEALFGHAPYASCNLSQLRA--QALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI-S 284
+E L G PY + + + + +T P S + + L +LL+ +P +R
Sbjct: 207 AYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSA-WSQEMVSLLKKLLEPNPDQRFSQ 265
Query: 285 YEDLFSHPY 293
D+ + PY
Sbjct: 266 LSDVQNFPY 274
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 4e-46
Identities = 59/188 (31%), Positives = 100/188 (53%), Gaps = 10/188 (5%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
YI+LE +GG+L + +++L E C+ + Q++LA+++L EN + H DLKP+N+L+
Sbjct: 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS 148
Query: 175 NN----TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGS---PYNAKADLWSLGVL 227
+ +K+ DFG ++ L ++ G+P Y+APE+L YN D WSLGV+
Sbjct: 149 SQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 208
Query: 228 VFEALFGHAPYASCNLSQLRAQALSSAPITIPP---NSLSPDCMDFLSRLLQKDPMRRIS 284
+F L G+ P++ ++S P +S +D + +LL DP R +
Sbjct: 209 LFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFT 268
Query: 285 YEDLFSHP 292
E+ HP
Sbjct: 269 TEEALRHP 276
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 5e-46
Identities = 57/188 (30%), Positives = 100/188 (53%), Gaps = 8/188 (4%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 170
+ +I E+ G D+ I + +L+E + +V Q+ AL+FL +N+ HFD++P+N
Sbjct: 73 MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPEN 132
Query: 171 ILI---KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVL 227
I+ +++T+K+ +FG A+ L P D + +P Y APE+ + D+WSLG L
Sbjct: 133 IIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTL 192
Query: 228 VFEALFGHAPYASCNLSQLRAQALSSAPITIPP---NSLSPDCMDFLSRLLQKDPMRRIS 284
V+ L G P+ + Q+ + + +A T +S + MDF+ RLL K+ R++
Sbjct: 193 VYVLLSGINPFLAETNQQI-IENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT 251
Query: 285 YEDLFSHP 292
+ HP
Sbjct: 252 ASEALQHP 259
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 8e-46
Identities = 42/192 (21%), Positives = 86/192 (44%), Gaps = 7/192 (3%)
Query: 107 EGRKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENN--VCHF 164
K + + ++ E G L ++++ + + + + RQ++ L+FL + H
Sbjct: 96 STVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHR 155
Query: 165 DLKPQNILI--KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLW 222
DLK NI I ++K+ D G A ++ G+P +MAPE+ Y+ D++
Sbjct: 156 DLKCDNIFITGPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEEK-YDESVDVY 213
Query: 223 SLGVLVFEALFGHAPYASC-NLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281
+ G+ + E PY+ C N +Q+ + S P+ + + ++++
Sbjct: 214 AFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDE 273
Query: 282 RISYEDLFSHPY 293
R S +DL +H +
Sbjct: 274 RYSIKDLLNHAF 285
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 1e-45
Identities = 58/190 (30%), Positives = 99/190 (52%), Gaps = 12/190 (6%)
Query: 112 PRYVYIILEYCDGGDLCSF---IRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKP 168
+ +ILE+ GG+L F K+SE + ++RQ LK + E+++ H D+KP
Sbjct: 120 KYEMVLILEFLSGGEL--FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKP 177
Query: 169 QNILI---KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLG 225
+NI+ K +++K+ DFG A L P++ + + APEI+ P D+W++G
Sbjct: 178 ENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIG 237
Query: 226 VLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP---NSLSPDCMDFLSRLLQKDPMRR 282
VL + L G +P+A + + Q + +S+SP+ DF+ LLQK+P +R
Sbjct: 238 VLGYVLLSGLSPFAGEDDLET-LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKR 296
Query: 283 ISYEDLFSHP 292
++ D HP
Sbjct: 297 LTVHDALEHP 306
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-45
Identities = 54/188 (28%), Positives = 98/188 (52%), Gaps = 7/188 (3%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+ Y+I + GG+L I + E SE ++Q++ A+ + V H +LKP+N+
Sbjct: 82 EGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENL 141
Query: 172 LIKNN----TLKLADFGFAQFLAPNDQG-DSIQGSPLYMAPEILAGSPYNAKADLWSLGV 226
L+ + +KLADFG A + Q G+P Y++PE+L PY DLW+ GV
Sbjct: 142 LLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGV 201
Query: 227 LVFEALFGHAPYASCNLSQLRAQALSSAPITIPP--NSLSPDCMDFLSRLLQKDPMRRIS 284
+++ L G+ P+ + +L Q + A P ++++P+ D ++++L +P +RI+
Sbjct: 202 ILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRIT 261
Query: 285 YEDLFSHP 292
+ HP
Sbjct: 262 AAEALKHP 269
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-45
Identities = 60/190 (31%), Positives = 91/190 (47%), Gaps = 12/190 (6%)
Query: 112 PRYVYIILEYCDGGDLCSF---IRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKP 168
+ +I E+ GG+L F H K+SE + +++RQ+ L + ENN H DLKP
Sbjct: 226 DNEMVMIYEFMSGGEL--FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKP 283
Query: 169 QNILIKN---NTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLG 225
+NI+ N LKL DFG L P G+ + APE+ G P D+WS+G
Sbjct: 284 ENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVG 343
Query: 226 VLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP---NSLSPDCMDFLSRLLQKDPMRR 282
VL + L G +P+ N + + + S + + +S D DF+ +LL DP R
Sbjct: 344 VLSYILLSGLSPFGGENDDET-LRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTR 402
Query: 283 ISYEDLFSHP 292
++ HP
Sbjct: 403 MTIHQALEHP 412
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 5e-45
Identities = 52/190 (27%), Positives = 96/190 (50%), Gaps = 12/190 (6%)
Query: 112 PRYVYIILEYCDGGDLCSF---IRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKP 168
+ +++EY DGG+L F I L+E F++Q+ ++ + + + H DLKP
Sbjct: 158 KNDIVLVMEYVDGGEL--FDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKP 215
Query: 169 QNILIKN---NTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLG 225
+NIL N +K+ DFG A+ P ++ G+P ++APE++ + D+WS+G
Sbjct: 216 ENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVG 275
Query: 226 VLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP---NSLSPDCMDFLSRLLQKDPMRR 282
V+ + L G +P+ N ++ + + + +S + +F+S+LL K+ R
Sbjct: 276 VIAYMLLSGLSPFLGDNDAET-LNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWR 334
Query: 283 ISYEDLFSHP 292
IS + HP
Sbjct: 335 ISASEALKHP 344
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 5e-45
Identities = 55/192 (28%), Positives = 90/192 (46%), Gaps = 12/192 (6%)
Query: 112 PRYVYIILEYCDGGDLCSFI----RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLK 167
+Y++ E+ DG DLC I + SE ++RQ++ AL++ +NN+ H D+K
Sbjct: 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVK 157
Query: 168 PQNILIKNN----TLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLW 222
P +L+ + +KL FG A Q G+P +MAPE++ PY D+W
Sbjct: 158 PHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVW 217
Query: 223 SLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP--NSLSPDCMDFLSRLLQKDPM 280
GV++F L G P+ +L + P + +S D + R+L DP
Sbjct: 218 GCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPA 276
Query: 281 RRISYEDLFSHP 292
RI+ + +HP
Sbjct: 277 ERITVYEALNHP 288
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 8e-45
Identities = 54/192 (28%), Positives = 95/192 (49%), Gaps = 11/192 (5%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+YVY++ E GG+L I + SE + + + +++L V H DLKP NI
Sbjct: 88 GKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNI 147
Query: 172 LIKNN-----TLKLADFGFAQFLAPNDQG-DSIQGSPLYMAPEILAGSPYNAKADLWSLG 225
L + ++++ DFGFA+ L + + + ++APE+L Y+A D+WSLG
Sbjct: 148 LYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLG 207
Query: 226 VLVFEALFGHAP-YASCNLSQLR-AQALSSAPITIPP---NSLSPDCMDFLSRLLQKDPM 280
VL++ L G+ P + + + S ++ NS+S D +S++L DP
Sbjct: 208 VLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPH 267
Query: 281 RRISYEDLFSHP 292
+R++ + HP
Sbjct: 268 QRLTAALVLRHP 279
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-44
Identities = 52/192 (27%), Positives = 93/192 (48%), Gaps = 12/192 (6%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+Y L Y G+L +IR E + + ++V AL++L + H DLKP+NI
Sbjct: 102 DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENI 161
Query: 172 LI-KNNTLKLADFGFAQFLAPNDQGD---SIQGSPLYMAPEILAGSPYNAKADLWSLGVL 227
L+ ++ +++ DFG A+ L+P + S G+ Y++PE+L +DLW+LG +
Sbjct: 162 LLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCI 221
Query: 228 VFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI---- 283
+++ + G P+ + N + Q + P P D + +LL D +R+
Sbjct: 222 IYQLVAGLPPFRAGNEYLIF-QKIIKLEYDFPEK-FFPKARDLVEKLLVLDATKRLGCEE 279
Query: 284 --SYEDLFSHPY 293
Y L +HP+
Sbjct: 280 MEGYGPLKAHPF 291
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-44
Identities = 60/191 (31%), Positives = 99/191 (51%), Gaps = 11/191 (5%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+++++ + G+L ++ LSE + + +R L+ A+ FL NN+ H DLKP+NI
Sbjct: 172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENI 231
Query: 172 LIKNN-TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGS------PYNAKADLWSL 224
L+ +N ++L+DFGF+ L P ++ + G+P Y+APEIL S Y + DLW+
Sbjct: 232 LLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWAC 291
Query: 225 GVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP---NSLSPDCMDFLSRLLQKDPMR 281
GV++F L G P+ + + + + S D +SRLLQ DP
Sbjct: 292 GVILFTLLAGSPPFWHRRQILM-LRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEA 350
Query: 282 RISYEDLFSHP 292
R++ E HP
Sbjct: 351 RLTAEQALQHP 361
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 5e-44
Identities = 56/187 (29%), Positives = 93/187 (49%), Gaps = 7/187 (3%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+ Y++++ GG+L I +E ++Q++ A+K+L EN + H DLKP+N+
Sbjct: 78 TTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENL 137
Query: 172 LIKNN----TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVL 227
L + + DFG ++ + G+P Y+APE+LA PY+ D WS+GV+
Sbjct: 138 LYLTPEENSKIMITDFGLSKMEQNGIMSTAC-GTPGYVAPEVLAQKPYSKAVDCWSIGVI 196
Query: 228 VFEALFGHAPYASCNLSQLRAQALSSAPITIPP--NSLSPDCMDFLSRLLQKDPMRRISY 285
+ L G+ P+ S+L + P + +S DF+ LL+KDP R +
Sbjct: 197 TYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTC 256
Query: 286 EDLFSHP 292
E SHP
Sbjct: 257 EKALSHP 263
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-43
Identities = 53/195 (27%), Positives = 96/195 (49%), Gaps = 14/195 (7%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+ ++++E +GG+L I+ + SE + +R+LV A+ + + V H DLKP+N+
Sbjct: 78 QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENL 137
Query: 172 LIKNN----TLKLADFGFAQFLAPNDQG-DSIQGSPLYMAPEILAGSPYNAKADLWSLGV 226
L + +K+ DFGFA+ P++Q + + Y APE+L + Y+ DLWSLGV
Sbjct: 138 LFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGV 197
Query: 227 LVFEALFGHAPYASCNLSQLRA------QALSSAPITIPP---NSLSPDCMDFLSRLLQK 277
+++ L G P+ S + S + + + ++S + D + LL
Sbjct: 198 ILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTV 257
Query: 278 DPMRRISYEDLFSHP 292
DP +R+ L +
Sbjct: 258 DPNKRLKMSGLRYNE 272
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-43
Identities = 42/198 (21%), Positives = 77/198 (38%), Gaps = 17/198 (8%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 170
++ YI +E C L ++ + + ++Q L L N+ H DLKP N
Sbjct: 90 RQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHN 148
Query: 171 ILIKNNT------LKLADFGFAQFLAPNDQG----DSIQGSPLYMAPEILAGSP---YNA 217
ILI ++DFG + LA + G+ ++APE+L+
Sbjct: 149 ILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTY 208
Query: 218 KADLWSLGVLVFEAL-FGHAPYASCNLSQLRAQALS-SAPITIPPNSLSPDCMDFLSRLL 275
D++S G + + + G P+ Q + S P + + +++
Sbjct: 209 TVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMI 268
Query: 276 QKDPMRRISYEDLFSHPY 293
DP +R S + + HP+
Sbjct: 269 AMDPQKRPSAKHVLKHPF 286
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-43
Identities = 54/198 (27%), Positives = 101/198 (51%), Gaps = 12/198 (6%)
Query: 107 EGRKRPRYVYIILEYCDGGDLCSFI--RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHF 164
+ + I++E DGG+L S I R + +E + + ++ + A+++L N+ H
Sbjct: 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 185
Query: 165 DLKPQNILIKNN----TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKAD 220
D+KP+N+L + LKL DFGFA+ ++ + +P Y+APE+L Y+ D
Sbjct: 186 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 245
Query: 221 LWSLGVLVFEALFGHAP-YASCNL--SQLRAQALSSAPITIPP---NSLSPDCMDFLSRL 274
+WSLGV+++ L G+ P Y++ L S + P + +S + + L
Sbjct: 246 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 305
Query: 275 LQKDPMRRISYEDLFSHP 292
L+ +P +R++ + +HP
Sbjct: 306 LKTEPTQRMTITEFMNHP 323
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-43
Identities = 58/193 (30%), Positives = 97/193 (50%), Gaps = 13/193 (6%)
Query: 112 PRYVYIILEYCDGGDLCSFI--RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 169
R + II+E +GG+L S I R + +E + + +R + A++FL +N+ H D+KP+
Sbjct: 98 KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPE 157
Query: 170 NILIKNN----TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLG 225
N+L + LKL DFGFA+ N +P Y+APE+L Y+ D+WSLG
Sbjct: 158 NLLYTSKEKDAVLKLTDFGFAKETTQNALQT-PCYTPYYVAPEVLGPEKYDKSCDMWSLG 216
Query: 226 VLVFEALFGHAP-YASCNLSQLRA--QALSSAPITIPP---NSLSPDCMDFLSRLLQKDP 279
V+++ L G P Y++ + + + P + +S D + LL+ DP
Sbjct: 217 VIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDP 276
Query: 280 MRRISYEDLFSHP 292
R++ +HP
Sbjct: 277 TERLTITQFMNHP 289
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 6e-43
Identities = 56/188 (29%), Positives = 101/188 (53%), Gaps = 10/188 (5%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+Y+++EY GG++ S +R + SE + + Q+VL ++L ++ + DLKP+N+
Sbjct: 113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENL 172
Query: 172 LI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
LI + +++ DFGFA+ + + ++ G+P +APEI+ YN D W+LGVL++E
Sbjct: 173 LIDQQGYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 231 ALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY----- 285
G+ P+ + Q+ + + S + P + S D D L LLQ D +R
Sbjct: 231 MAAGYPPFFADQPIQIYEKIV-SGKVRFPSH-FSSDLKDLLRNLLQVDLTKRFGNLKNGV 288
Query: 286 EDLFSHPY 293
D+ +H +
Sbjct: 289 NDIKNHKW 296
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 1e-42
Identities = 44/202 (21%), Positives = 85/202 (42%), Gaps = 20/202 (9%)
Query: 109 RKRPRYVYIILEYCDGGDLCSFI---RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFD 165
Y+YI ++ C +L ++ S E C Q+ A++FL + H D
Sbjct: 130 SSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRD 189
Query: 166 LKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQ-------------GSPLYMAPEILA 211
LKP NI ++ +K+ DFG + +++ ++ G+ LYM+PE +
Sbjct: 190 LKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIH 249
Query: 212 GSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFL 271
G+ Y+ K D++SLG+++FE L ++ ++ + + + P +
Sbjct: 250 GNNYSHKVDIFSLGLILFELL--YSFSTQMERVRI-ITDVRNLKFPLLFTQKYPQEHMMV 306
Query: 272 SRLLQKDPMRRISYEDLFSHPY 293
+L P R D+ +
Sbjct: 307 QDMLSPSPTERPEATDIIENAI 328
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 5e-42
Identities = 62/188 (32%), Positives = 113/188 (60%), Gaps = 10/188 (5%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+ +++I++Y +GG+L S +R ++ + + ++ LAL++L ++ + DLKP+NI
Sbjct: 78 AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENI 137
Query: 172 LI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
L+ KN +K+ DFGFA+++ D ++ G+P Y+APE+++ PYN D WS G+L++E
Sbjct: 138 LLDKNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYE 195
Query: 231 ALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY----- 285
L G+ P+ N + + L +A + PP + D D LSRL+ +D +R+
Sbjct: 196 MLAGYTPFYDSNTMKTYEKIL-NAELRFPPF-FNEDVKDLLSRLITRDLSQRLGNLQNGT 253
Query: 286 EDLFSHPY 293
ED+ +HP+
Sbjct: 254 EDVKNHPW 261
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 6e-42
Identities = 30/198 (15%), Positives = 56/198 (28%), Gaps = 25/198 (12%)
Query: 111 RPRYVYIILEYCD----GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDL 166
R+ + G L S +H+ L Q Q++ L L + H L
Sbjct: 173 LSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 232
Query: 167 KPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILA-----------GSP 214
+P +I++ + + L F + S + PE+ A +
Sbjct: 233 RPVDIVLDQRGGVFLTGFEHLV---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTL 289
Query: 215 YNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRL 274
D W+LG++++ P S ++ L
Sbjct: 290 MTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRS------CKNIPQPVRALLEGF 343
Query: 275 LQKDPMRRISYEDLFSHP 292
L+ R+ P
Sbjct: 344 LRYPKEDRLLPLQAMETP 361
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-41
Identities = 56/185 (30%), Positives = 97/185 (52%), Gaps = 5/185 (2%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
++ ++EY +GGDL I+S K + + +++L L+FL + + DLK NI
Sbjct: 90 KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNI 149
Query: 172 LIKNNT-LKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVF 229
L+ + +K+ADFG + + + + ++ G+P Y+APEIL G YN D WS GVL++
Sbjct: 150 LLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLY 209
Query: 230 EALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI-SYEDL 288
E L G +P+ + +L ++ P L + D L +L ++P +R+ D+
Sbjct: 210 EMLIGQSPFHGQDEEEL-FHSIRMDNPFYPR-WLEKEAKDLLVKLFVREPEKRLGVRGDI 267
Query: 289 FSHPY 293
HP
Sbjct: 268 RQHPL 272
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 5e-41
Identities = 55/186 (29%), Positives = 95/186 (51%), Gaps = 9/186 (4%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
+Y+IL++ GGDL + + +E + ++ +L LAL L + + DLKP+NIL+
Sbjct: 101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD 160
Query: 174 KNNTLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
+ +KL DFG + + + + S G+ YMAPE++ + AD WS GVL+FE L
Sbjct: 161 EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML 220
Query: 233 FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY-----ED 287
G P+ + + + A + +P LSP+ L L +++P R+ E+
Sbjct: 221 TGTLPFQGKDRKET-MTMILKAKLGMPQF-LSPEAQSLLRMLFKRNPANRLGAGPDGVEE 278
Query: 288 LFSHPY 293
+ H +
Sbjct: 279 IKRHSF 284
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 6e-41
Identities = 48/219 (21%), Positives = 85/219 (38%), Gaps = 38/219 (17%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSH-------EKLSEFQCQQFVRQLVLALKFLRENNVCHF 164
R++YI LE C +L + S + E+ +RQ+ + L + H
Sbjct: 81 DRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHR 139
Query: 165 DLKPQNILI--------------KNNTLKLADFGFAQFLAPNDQGDSIQ-----GSPLYM 205
DLKPQNIL+ +N + ++DFG + L G+ +
Sbjct: 140 DLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWR 199
Query: 206 APEILAGS-------PYNAKADLWSLGVLVFEAL-FGHAPYASCNLSQ---LRAQALSSA 254
APE+L S D++S+G + + L G P+ + +R
Sbjct: 200 APELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDE 259
Query: 255 PITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
+ SL + D +S+++ DP++R + + HP
Sbjct: 260 MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 8e-41
Identities = 64/181 (35%), Positives = 95/181 (52%), Gaps = 8/181 (4%)
Query: 117 IILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 176
+++EY GG L + + E Q R+ + AL+FL N V H D+K NIL+ +
Sbjct: 94 VVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD 152
Query: 177 -TLKLADFGF-AQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFG 234
++KL DFGF AQ + ++ G+P +MAPE++ Y K D+WSLG++ E + G
Sbjct: 153 GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
Query: 235 HAPYASCNLSQLRAQAL---SSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291
PY N + LRA L + P P LS DFL+R L+ D +R S ++L H
Sbjct: 213 EPPY--LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270
Query: 292 P 292
Sbjct: 271 Q 271
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 8e-41
Identities = 53/186 (28%), Positives = 93/186 (50%), Gaps = 9/186 (4%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
+Y+ILEY GG+L + E ++ ++ +AL L + + + DLKP+NI++
Sbjct: 96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN 155
Query: 174 KNNTLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
+KL DFG + + + G+ YMAPEIL S +N D WSLG L+++ L
Sbjct: 156 HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDML 215
Query: 233 FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY-----ED 287
G P+ N + + + +PP L+ + D L +LL+++ R+ +
Sbjct: 216 TGAPPFTGENRKKT-IDKILKCKLNLPP-YLTQEARDLLKKLLKRNAASRLGAGPGDAGE 273
Query: 288 LFSHPY 293
+ +HP+
Sbjct: 274 VQAHPF 279
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 8e-41
Identities = 60/181 (33%), Positives = 98/181 (54%), Gaps = 8/181 (4%)
Query: 117 IILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 176
+++E+ GG L + +L+E Q ++ AL +L V H D+K +IL+ +
Sbjct: 119 VLMEFLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD 177
Query: 177 -TLKLADFGF-AQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFG 234
+KL+DFGF AQ + S+ G+P +MAPE+++ S Y + D+WSLG++V E + G
Sbjct: 178 GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237
Query: 235 HAPYASCNLSQLRAQAL---SSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291
PY + S ++A S P + +SP DFL R+L +DP R + ++L H
Sbjct: 238 EPPYF--SDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295
Query: 292 P 292
P
Sbjct: 296 P 296
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-40
Identities = 54/188 (28%), Positives = 99/188 (52%), Gaps = 8/188 (4%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+Y +L+Y +GG+L ++ E + + + ++ AL +L N+ + DLKP+NI
Sbjct: 111 ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENI 170
Query: 172 LI-KNNTLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVF 229
L+ + L DFG + + N + G+P Y+APE+L PY+ D W LG +++
Sbjct: 171 LLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLY 230
Query: 230 EALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI----SY 285
E L+G P+ S N +++ + + P+ + PN ++ L LLQKD +R+ +
Sbjct: 231 EMLYGLPPFYSRNTAEM-YDNILNKPLQLKPN-ITNSARHLLEGLLQKDRTKRLGAKDDF 288
Query: 286 EDLFSHPY 293
++ SH +
Sbjct: 289 MEIKSHVF 296
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-40
Identities = 54/187 (28%), Positives = 94/187 (50%), Gaps = 10/187 (5%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
++ ++E+ +GGDL I+ + E + + + +++ AL FL + + + DLK N+L+
Sbjct: 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD 158
Query: 175 NNT-LKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
+ KLADFG + + + G+P Y+APEIL Y D W++GVL++E L
Sbjct: 159 HEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEML 218
Query: 233 FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI------SYE 286
GHAP+ + N L +A+ + + P L D L + K+P R+
Sbjct: 219 CGHAPFEAENEDDL-FEAILNDEVVYPT-WLHEDATGILKSFMTKNPTMRLGSLTQGGEH 276
Query: 287 DLFSHPY 293
+ HP+
Sbjct: 277 AILRHPF 283
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-40
Identities = 57/183 (31%), Positives = 90/183 (49%), Gaps = 8/183 (4%)
Query: 117 IILEYCDGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 175
I++EYC G + IR K L+E + ++ + L++L H D+K NIL+
Sbjct: 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNT 160
Query: 176 N-TLKLADFGF-AQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF 233
KLADFG Q + +++ G+P +MAPE++ YN AD+WSLG+ E
Sbjct: 161 EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAE 220
Query: 234 GHAPYASCNLSQLRAQAL---SSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFS 290
G PY ++ +RA + + P P S + DF+ + L K P +R + L
Sbjct: 221 GKPPY--ADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278
Query: 291 HPY 293
HP+
Sbjct: 279 HPF 281
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-40
Identities = 49/186 (26%), Positives = 101/186 (54%), Gaps = 9/186 (4%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
+ ++EY +GG+L + +E + + + ++V AL++L +V + D+K +N+++
Sbjct: 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 139
Query: 174 KNNTLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
K+ +K+ DFG + ++ + G+P Y+APE+L + Y D W LGV+++E +
Sbjct: 140 KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199
Query: 233 FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI-----SYED 287
G P+ + + +L + + I P +LSP+ L+ LL+KDP +R+ ++
Sbjct: 200 CGRLPFYNQDHERL-FELILMEEIRFPR-TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 257
Query: 288 LFSHPY 293
+ H +
Sbjct: 258 VMEHRF 263
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-40
Identities = 63/195 (32%), Positives = 95/195 (48%), Gaps = 17/195 (8%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
++ ++EY +GGDL ++ KL E + + ++ LAL +L E + + DLK N+L+
Sbjct: 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD 144
Query: 174 KNNTLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
+KL D+G + L P D + G+P Y+APEIL G Y D W+LGVL+FE +
Sbjct: 145 SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 204
Query: 233 FGHAPYASCNLSQLRA--------QALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI- 283
G +P+ S Q + I IP SLS L L KDP R+
Sbjct: 205 AGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR-SLSVKAASVLKSFLNKDPKERLG 263
Query: 284 -----SYEDLFSHPY 293
+ D+ HP+
Sbjct: 264 CHPQTGFADIQGHPF 278
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 6e-40
Identities = 55/215 (25%), Positives = 86/215 (40%), Gaps = 34/215 (15%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
Y++ E GG + S I +E + V+ + AL FL + H DLKP+NI
Sbjct: 83 EDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENI 142
Query: 172 LIKNN----TLKLADFGFAQFLAPNDQGDSIQ--------GSPLYMAPEIL-----AGSP 214
L ++ +K+ DF + N I GS YMAPE++ S
Sbjct: 143 LCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASI 202
Query: 215 YNAKADLWSLGVLVFEALFGHAP-YASCNLSQLRAQALSSAPI---------------TI 258
Y+ + DLWSLGV+++ L G+ P C + +
Sbjct: 203 YDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPD 262
Query: 259 PP-NSLSPDCMDFLSRLLQKDPMRRISYEDLFSHP 292
+S D +S+LL +D +R+S + HP
Sbjct: 263 KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-39
Identities = 64/187 (34%), Positives = 98/187 (52%), Gaps = 13/187 (6%)
Query: 117 IILEYCDGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 175
I++E+C GG + + + ++ L+E Q Q RQ++ AL FL + H DLK N+L+
Sbjct: 93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTL 152
Query: 176 N-TLKLADFGF-AQFLAPNDQGDSIQGSPLYMAPEILA-----GSPYNAKADLWSLGVLV 228
++LADFG A+ L + DS G+P +MAPE++ +PY+ KAD+WSLG+ +
Sbjct: 153 EGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITL 212
Query: 229 FEALFGHAPYASCNLSQLRAQAL---SSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY 285
E P+ L+ +R S P + P+ S + DFL L K+P R S
Sbjct: 213 IEMAQIEPPH--HELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSA 270
Query: 286 EDLFSHP 292
L HP
Sbjct: 271 AQLLEHP 277
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-39
Identities = 56/190 (29%), Positives = 89/190 (46%), Gaps = 12/190 (6%)
Query: 115 VYIILEYCDGG---DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLREN-NVCHFDLKPQN 170
V+I +E D I + + E + +V AL+ L +V H D+KP N
Sbjct: 81 VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSN 140
Query: 171 ILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAG----SPYNAKADLWSLG 225
+LI +K+ DFG + +L + D G YMAPE + Y+ K+D+WSLG
Sbjct: 141 VLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLG 200
Query: 226 VLVFEALFGHAPYASCN--LSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283
+ + E PY S QL+ +P +P + S + +DF S+ L+K+ R
Sbjct: 201 ITMIELAILRFPYDSWGTPFQQLKQVVEEPSP-QLPADKFSAEFVDFTSQCLKKNSKERP 259
Query: 284 SYEDLFSHPY 293
+Y +L HP+
Sbjct: 260 TYPELMQHPF 269
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-39
Identities = 63/195 (32%), Positives = 96/195 (49%), Gaps = 17/195 (8%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
++ ++EY +GGDL ++ KL E + + ++ LAL +L E + + DLK N+L+
Sbjct: 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD 187
Query: 175 NNT-LKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
+ +KL D+G + L P D + G+P Y+APEIL G Y D W+LGVL+FE +
Sbjct: 188 SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 247
Query: 233 FGHAPYASCNLSQLRA--------QALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI- 283
G +P+ S Q + I IP SLS L L KDP R+
Sbjct: 248 AGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR-SLSVKAASVLKSFLNKDPKERLG 306
Query: 284 -----SYEDLFSHPY 293
+ D+ HP+
Sbjct: 307 CHPQTGFADIQGHPF 321
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-39
Identities = 52/186 (27%), Positives = 94/186 (50%), Gaps = 9/186 (4%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
+Y ++EY +GGDL I+ + E + ++ + L FL+ + + DLK N+++
Sbjct: 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD 155
Query: 175 NNT-LKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
+ +K+ADFG + + + G+P Y+APEI+A PY D W+ GVL++E L
Sbjct: 156 SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 215
Query: 233 FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI-----SYED 287
G AP+ + +L Q++ + P S+S + + L+ K P +R+ D
Sbjct: 216 AGQAPFEGEDEDEL-FQSIMEHNVAYPK-SMSKEAVAICKGLMTKHPGKRLGCGPEGERD 273
Query: 288 LFSHPY 293
+ H +
Sbjct: 274 IKEHAF 279
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-39
Identities = 55/187 (29%), Positives = 92/187 (49%), Gaps = 13/187 (6%)
Query: 117 IILEYCDGGDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
+++E+C G + I++ + L E R+++ L L ++ V H D+K QN+L+
Sbjct: 104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT 163
Query: 175 NN-TLKLADFGF-AQFLAPNDQGDSIQGSPLYMAPEILA-----GSPYNAKADLWSLGVL 227
N +KL DFG AQ + ++ G+P +MAPE++A + Y+ K+DLWSLG+
Sbjct: 164 ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGIT 223
Query: 228 VFEALFGHAPYASCNLSQLRAQAL--SSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY 285
E G P C++ +RA L + + S F+ L K+ +R +
Sbjct: 224 AIEMAEGAPPL--CDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPAT 281
Query: 286 EDLFSHP 292
E L HP
Sbjct: 282 EQLMKHP 288
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 8e-39
Identities = 54/188 (28%), Positives = 80/188 (42%), Gaps = 9/188 (4%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLR-ENNVCHFDLKPQNILI 173
V+I +E R + E + +V AL +L+ ++ V H D+KP NIL+
Sbjct: 99 VFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL 158
Query: 174 -KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEIL-----AGSPYNAKADLWSLGVL 227
+ +KL DFG + L + D G YMAPE + Y+ +AD+WSLG+
Sbjct: 159 DERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGIS 218
Query: 228 VFEALFGHAPYASCN--LSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY 285
+ E G PY +C L P+ S D F+ L KD +R Y
Sbjct: 219 LVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKY 278
Query: 286 EDLFSHPY 293
L H +
Sbjct: 279 NKLLEHSF 286
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-38
Identities = 55/192 (28%), Positives = 101/192 (52%), Gaps = 14/192 (7%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
+++IL+Y +GG+L + + E+ +E + Q +V ++VLAL+ L + + + D+K +NIL+
Sbjct: 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD 193
Query: 174 KNNTLKLADFGFA--QFLAPNDQGDSIQGSPLYMAPEILAGSP--YNAKADLWSLGVLVF 229
N + L DFG + ++ G+ YMAP+I+ G ++ D WSLGVL++
Sbjct: 194 SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMY 253
Query: 230 EALFGHAPYASCNLSQLRA---QALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY- 285
E L G +P+ +A + + + P +S D + RLL KDP +R+
Sbjct: 254 ELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE-MSALAKDLIQRLLMKDPKKRLGCG 312
Query: 286 ----EDLFSHPY 293
+++ H +
Sbjct: 313 PRDADEIKEHLF 324
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-38
Identities = 55/181 (30%), Positives = 88/181 (48%), Gaps = 10/181 (5%)
Query: 117 IILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 176
II+EY GG + L E Q +R+++ L +L H D+K N+L+ +
Sbjct: 97 IIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH 155
Query: 177 -TLKLADFGF-AQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFG 234
+KLADFG Q + ++ G+P +MAPE++ S Y++KAD+WSLG+ E G
Sbjct: 156 GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 215
Query: 235 HAPYASCNLSQLRAQALSSAPITIPP---NSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291
P+ L ++ L P PP + S +F+ L K+P R + ++L H
Sbjct: 216 EPPH--SELHPMK--VLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271
Query: 292 P 292
Sbjct: 272 K 272
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-38
Identities = 44/215 (20%), Positives = 84/215 (39%), Gaps = 28/215 (13%)
Query: 101 SNLRAPEGRKRPRYVYIILEYCDGGDLCSFI---RSHEKLSEFQCQQFVRQLVLALKFL- 156
+ E + +++L G L F+ S LS + Q A++ +
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 157 -RENNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQ-------------GS 201
++ + H DLK +N+L+ T+KL DFG A ++ +
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 202 PLYMAPEIL---AGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITI 258
P+Y PEI+ + P K D+W+LG +++ F P+ + + +I
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK-----LRIVNGKYSI 268
Query: 259 PPN-SLSPDCMDFLSRLLQKDPMRRISYEDLFSHP 292
PP+ + + +LQ +P R+S ++
Sbjct: 269 PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-38
Identities = 30/208 (14%), Positives = 52/208 (25%), Gaps = 20/208 (9%)
Query: 103 LRAPEGRKRPRYVYIILEYCDGGDLCSFIR-------SHEKLSEFQCQQFVRQLVLALKF 155
L + +++ DL QL+
Sbjct: 151 LSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAAN 209
Query: 156 LRENNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGS- 213
L+ + H P N+ I + L L D +G + Y E L S
Sbjct: 210 LQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW--KVGTRGPASSVPVTYAPREFLNAST 267
Query: 214 -PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP-------NSLSP 265
+ + W LG+ ++ P+ + S + L
Sbjct: 268 ATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPD 327
Query: 266 DCMDFLSRLLQKDPMRRISYEDLFSHPY 293
+ R L D RR+ + P
Sbjct: 328 FVKTLIGRFLNFDRRRRLLPLEAMETPE 355
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-38
Identities = 52/223 (23%), Positives = 90/223 (40%), Gaps = 45/223 (20%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLREN-NVCHFDLKPQNILI 173
+ I +E+ DGG L ++ ++ E + ++ L +LRE + H D+KP NIL+
Sbjct: 106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV 165
Query: 174 -KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
+KL DFG + L + +S G+ YM+PE L G+ Y+ ++D+WS+G+ + E
Sbjct: 166 NSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 224
Query: 233 FGHAPYASCNLSQLRAQALS---------------------------------------- 252
G P + +L
Sbjct: 225 VGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYI 284
Query: 253 --SAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
P +P S + DF+++ L K+P R + L H +
Sbjct: 285 VNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 7e-38
Identities = 53/190 (27%), Positives = 98/190 (51%), Gaps = 10/190 (5%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFL-RENNVCHFDLKPQN 170
+ ++EY +GG+L + SE + + + ++V AL +L E NV + DLK +N
Sbjct: 220 HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLEN 279
Query: 171 ILI-KNNTLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLV 228
+++ K+ +K+ DFG + + + G+P Y+APE+L + Y D W LGV++
Sbjct: 280 LMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 339
Query: 229 FEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY--- 285
+E + G P+ + + +L + + I P L P+ LS LL+KDP +R+
Sbjct: 340 YEMMCGRLPFYNQDHEKL-FELILMEEIRFPRT-LGPEAKSLLSGLLKKDPKQRLGGGSE 397
Query: 286 --EDLFSHPY 293
+++ H +
Sbjct: 398 DAKEIMQHRF 407
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 1e-37
Identities = 51/189 (26%), Positives = 94/189 (49%), Gaps = 9/189 (4%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+Y ++EY +GGDL I+ + E + ++ + L FL+ + + DLK N+
Sbjct: 414 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNV 473
Query: 172 LIKNNT-LKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVF 229
++ + +K+ADFG + + + G+P Y+APEI+A PY D W+ GVL++
Sbjct: 474 MLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLY 533
Query: 230 EALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI-----S 284
E L G AP+ + +L Q++ + P + +S + + L+ K P +R+
Sbjct: 534 EMLAGQAPFEGEDEDEL-FQSIMEHNVAYPKS-MSKEAVAICKGLMTKHPGKRLGCGPEG 591
Query: 285 YEDLFSHPY 293
D+ H +
Sbjct: 592 ERDIKEHAF 600
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 8e-37
Identities = 48/193 (24%), Positives = 84/193 (43%), Gaps = 12/193 (6%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 169
+ ++L +GGDL I + E + + ++ L+ L + + DLKP+
Sbjct: 256 KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPE 315
Query: 170 NILIKNNT-LKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLV 228
NIL+ ++ ++++D G A + G+ YMAPE++ Y D W+LG L+
Sbjct: 316 NILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLL 375
Query: 229 FEALFGHAPYASCNLSQLR---AQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI-- 283
+E + G +P+ R + + P SP S+LL KDP R+
Sbjct: 376 YEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSE-RFSPQARSLCSQLLCKDPAERLGC 434
Query: 284 ---SYEDLFSHPY 293
S ++ HP
Sbjct: 435 RGGSAREVKEHPL 447
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-36
Identities = 53/193 (27%), Positives = 99/193 (51%), Gaps = 14/193 (7%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
RY+Y+++EY GGDL + + ++ + E + + ++VLAL + H D+KP N+
Sbjct: 141 DRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNM 199
Query: 172 LIKNNT-LKLADFGFAQFLAPN--DQGDSIQGSPLYMAPEILAGSP----YNAKADLWSL 224
L+ + LKLADFG + + D+ G+P Y++PE+L Y + D WS+
Sbjct: 200 LLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 259
Query: 225 GVLVFEALFGHAPYASCNLSQLRAQALSS-APITIPPNS-LSPDCMDFLSRLLQKDPMRR 282
GV ++E L G P+ + +L ++ ++ +T P ++ +S + + + L D R
Sbjct: 260 GVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL-TDREVR 318
Query: 283 ISY---EDLFSHP 292
+ E++ H
Sbjct: 319 LGRNGVEEIKRHL 331
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-36
Identities = 52/193 (26%), Positives = 94/193 (48%), Gaps = 15/193 (7%)
Query: 115 VYIILEYCDGGDL----CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 170
+ +++ +GGD+ + + E + + Q+V L+ L + N+ + DLKP+N
Sbjct: 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPEN 319
Query: 171 ILI-KNNTLKLADFGFA-QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLV 228
+L+ + ++++D G A + A + G+P +MAPE+L G Y+ D ++LGV +
Sbjct: 320 VLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTL 379
Query: 229 FEALFGHAPYASCNLSQLRA---QALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI-- 283
+E + P+ + Q + +T P SP DF LLQKDP +R+
Sbjct: 380 YEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD-KFSPASKDFCEALLQKDPEKRLGF 438
Query: 284 ---SYEDLFSHPY 293
S + L +HP
Sbjct: 439 RDGSCDGLRTHPL 451
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-36
Identities = 58/198 (29%), Positives = 87/198 (43%), Gaps = 26/198 (13%)
Query: 115 VYIILEYCDGGDLCSFIRS-----HEKLSEFQCQQFVRQLVLALKFLREN-NVCHFDLKP 168
+I +E F + + + E + V AL L+EN + H D+KP
Sbjct: 96 CWICMELMSTS-FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKP 154
Query: 169 QNILI-KNNTLKLADFGFAQFLAPNDQGDSIQ-----GSPLYMAPEILAGS----PYNAK 218
NIL+ ++ +KL DFG + L DSI G YMAPE + S Y+ +
Sbjct: 155 SNILLDRSGNIKLCDFGISGQLV-----DSIAKTRDAGCRPYMAPERIDPSASRQGYDVR 209
Query: 219 ADLWSLGVLVFEALFGHAPYASCN--LSQLRAQALSSAPI--TIPPNSLSPDCMDFLSRL 274
+D+WSLG+ ++E G PY N QL P SP ++F++
Sbjct: 210 SDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLC 269
Query: 275 LQKDPMRRISYEDLFSHP 292
L KD +R Y++L HP
Sbjct: 270 LTKDESKRPKYKELLKHP 287
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-35
Identities = 52/183 (28%), Positives = 82/183 (44%), Gaps = 13/183 (7%)
Query: 117 IILEYCDGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 175
+++EYC G + H+K L E + + L +L +N+ H D+K NIL+
Sbjct: 131 LVMEYCLGS-ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE 189
Query: 176 N-TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAG---SPYNAKADLWSLGVLVFEA 231
+KL DFG A +A +S G+P +MAPE++ Y+ K D+WSLG+ E
Sbjct: 190 PGLVKLGDFGSASIMA---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246
Query: 232 LFGHAPYASCNLSQLRAQAL--SSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLF 289
P N++ + A + + S +F+ LQK P R + E L
Sbjct: 247 AERKPPL--FNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 304
Query: 290 SHP 292
H
Sbjct: 305 KHR 307
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 52/188 (27%), Positives = 95/188 (50%), Gaps = 11/188 (5%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
+ IL+ +GGDL + H SE + + +++L L+ + V + DLKP NIL+
Sbjct: 267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD 326
Query: 174 KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILA-GSPYNAKADLWSLGVLVFEAL 232
++ ++++D G A + + G+ YMAPE+L G Y++ AD +SLG ++F+ L
Sbjct: 327 EHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
Query: 233 FGHAPYASCNLSQLRA--QALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI-----SY 285
GH+P+ + + + +P + SP+ L LLQ+D RR+
Sbjct: 386 RGHSPFRQHKTKDKHEIDRMTLTMAVELPDS-FSPELRSLLEGLLQRDVNRRLGCLGRGA 444
Query: 286 EDLFSHPY 293
+++ P+
Sbjct: 445 QEVKESPF 452
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 55/195 (28%), Positives = 97/195 (49%), Gaps = 14/195 (7%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 170
+Y++++Y GGDL + + E +L E + ++ ++V+A+ + + + H D+KP N
Sbjct: 146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDN 205
Query: 171 ILIKNNT-LKLADFGFAQFLAPNDQGDSIQ--GSPLYMAPEILAGSP-----YNAKADLW 222
IL+ N ++LADFG L + S G+P Y++PEIL Y + D W
Sbjct: 206 ILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWW 265
Query: 223 SLGVLVFEALFGHAPYASCNLSQLRAQALSS-APITIPP--NSLSPDCMDFLSRLLQKDP 279
SLGV ++E L+G P+ + +L + + ++ P +S + D + RL+
Sbjct: 266 SLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSRE 325
Query: 280 MR--RISYEDLFSHP 292
R + ED HP
Sbjct: 326 HRLGQNGIEDFKKHP 340
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-35
Identities = 51/199 (25%), Positives = 96/199 (48%), Gaps = 18/199 (9%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 170
Y+Y+++EY GGDL + + ++ + ++ ++V+A+ + H D+KP N
Sbjct: 133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDN 192
Query: 171 ILIKNNT-LKLADFGFAQFLAPNDQGDSIQ--GSPLYMAPEILAG-------SPYNAKAD 220
IL+ ++LADFG L + S+ G+P Y++PEIL Y + D
Sbjct: 193 ILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECD 252
Query: 221 LWSLGVLVFEALFGHAPYASCNLSQLRAQALS-SAPITIP--PNSLSPDCMDFLSRLLQK 277
W+LGV +E +G P+ + + ++ + + +++P + + DF+ RLL
Sbjct: 253 WWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC- 311
Query: 278 DPMRRISY---EDLFSHPY 293
P R+ D +HP+
Sbjct: 312 PPETRLGRGGAGDFRTHPF 330
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 3e-35
Identities = 28/193 (14%), Positives = 51/193 (26%), Gaps = 18/193 (9%)
Query: 112 PRYVYIILEYCDGGD----LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLK 167
R+ + L S +H+ L Q Q++ L L + H L+
Sbjct: 179 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLR 238
Query: 168 PQNILI-KNNTLKLADFGFAQFL--APNDQGDSIQGSPLYMAPEILAGSP-----YNAKA 219
P +I++ + + L F + P A +L
Sbjct: 239 PVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAF 298
Query: 220 DLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDP 279
D W+LG+ ++ P S ++ L L+
Sbjct: 299 DTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCK------NIPQPVRALLEGFLRYPK 352
Query: 280 MRRISYEDLFSHP 292
R+ P
Sbjct: 353 EDRLLPLQAMETP 365
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-34
Identities = 56/275 (20%), Positives = 102/275 (37%), Gaps = 43/275 (15%)
Query: 75 GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRKRPRYVYIILEYCDGGDLCSFIRSH 134
G + + + + + + +Y+ +I+EY L ++S
Sbjct: 73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSF 131
Query: 135 EK----LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT--LKLADFGFAQF 188
+ + ++ QL A+ F+ +CH D+KPQN+L+ + LKL DFG A+
Sbjct: 132 IRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKK 191
Query: 189 LAPNDQGDSIQGSPLYMAPEILAGSP-YNAKADLWSLGVLVFEALFGHA----------- 236
L P++ + S Y APE++ G+ Y DLWS+G + E + G
Sbjct: 192 LIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQL 251
Query: 237 --------------------PYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQ 276
Y L+A+ I P +D L ++L+
Sbjct: 252 VRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRK----ILPEGTPSLAIDLLEQILR 307
Query: 277 KDPMRRISYEDLFSHPYPDLIHAPCAESHQTAIRI 311
+P RI+ + +HP+ D + +
Sbjct: 308 YEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNF 342
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-34
Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 116 YIILEYCDGGDLCSFIRSHEK--------LSEFQCQQFVRQLVLALKFLRENNVCHFDLK 167
+++++ GG + I+ L E +R+++ L++L +N H D+K
Sbjct: 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVK 148
Query: 168 PQNILIKNN-TLKLADFGFAQFLAPNDQGDSIQ------GSPLYMAPE-ILAGSPYNAKA 219
NIL+ + ++++ADFG + FLA + G+P +MAPE + Y+ KA
Sbjct: 149 AGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKA 208
Query: 220 DLWSLGVLVFEALFGHAPYASCNLSQLRAQAL----------SSAPITIPPNSLSPDCMD 269
D+WS G+ E G APY ++ L +
Sbjct: 209 DIWSFGITAIELATGAAPY--HKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRK 266
Query: 270 FLSRLLQKDPMRRISYEDLFSHP 292
+S LQKDP +R + +L H
Sbjct: 267 MISLCLQKDPEKRPTAAELLRHK 289
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 54/239 (22%), Positives = 97/239 (40%), Gaps = 43/239 (17%)
Query: 103 LRAPEGRKRPRYVYIILEYCDGGDLCSFIRSHEK----LSEFQCQQFVRQLVLALKFLRE 158
+ +K Y+ ++L+Y + R + + L + ++ QL +L ++
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 159 NNVCHFDLKPQNILIKNNT--LKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSP-Y 215
+CH D+KPQN+L+ +T LKL DFG A+ L + S S Y APE++ G+ Y
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 234
Query: 216 NAKADLWSLG----------------------VLVFEAL---------FGHAPYASCNLS 244
+ D+WS G V + + L + Y
Sbjct: 235 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 294
Query: 245 QLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAE 303
Q++A + P P+ + SRLL+ P R++ + +H + D + P +
Sbjct: 295 QIKAHPWTK---VFRPR-TPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVK 349
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 57/239 (23%), Positives = 96/239 (40%), Gaps = 43/239 (17%)
Query: 103 LRAPEGRKRPRYVYIILEYCDGGDLCSFIRSHEK----LSEFQCQQFVRQLVLALKFLRE 158
+ +K ++ ++LEY + R + K + + ++ QL+ +L ++
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS 159
Query: 159 NNVCHFDLKPQNILI--KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSP-Y 215
+CH D+KPQN+L+ + LKL DFG A+ L + S S Y APE++ G+ Y
Sbjct: 160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNY 219
Query: 216 NAKADLWSLGVLVFEALFGH-------------------------------APYASCNLS 244
D+WS G ++ E + G Y
Sbjct: 220 TTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFP 279
Query: 245 QLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAE 303
Q+R S P PD +D +SRLL+ P R++ + HP+ D + A
Sbjct: 280 QIRPHPFSK---VFRPR-TPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEAR 334
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-33
Identities = 38/197 (19%), Positives = 75/197 (38%), Gaps = 16/197 (8%)
Query: 111 RPRYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 169
P ++ II C G L S +R + L + +Q +++V + +L + H DLK +
Sbjct: 100 SPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSK 159
Query: 170 NILIKNNTLKLADFGFAQFLAPNDQGD------SIQGSPLYMAPEIL---------AGSP 214
N+ N + + DFG G G ++APEI+ P
Sbjct: 160 NVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLP 219
Query: 215 YNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRL 274
++ +D+++LG + +E P+ + + Q + + + + D L
Sbjct: 220 FSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFC 279
Query: 275 LQKDPMRRISYEDLFSH 291
+ R ++ L
Sbjct: 280 WAFEQEERPTFTKLMDM 296
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-32
Identities = 58/241 (24%), Positives = 95/241 (39%), Gaps = 56/241 (23%)
Query: 110 KRPRYVYIILEYCDGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKP 168
+R R ++++ EYCD + + +++ + E + Q + A+ F ++N H D+KP
Sbjct: 72 RRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKP 130
Query: 169 QNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL-----------YMAPEILAGSP-Y 215
+NILI K++ +KL DFGFA+ L P Y +PE+L G Y
Sbjct: 131 ENILITKHSVIKLCDFGFARLL----------TGPSDYYDDEVATRWYRSPELLVGDTQY 180
Query: 216 NAKADLWSLGVLVFEALFGHAPY--ASCNLSQLRA--QAL-------------------S 252
D+W++G + E L P ++ QL + L
Sbjct: 181 GPPVDVWAIGCVFAE-LLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239
Query: 253 SAPITIPPNSL-------SPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAESH 305
P L S + L L DP R++ E L HPY + I +
Sbjct: 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLAK 299
Query: 306 Q 306
+
Sbjct: 300 E 300
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 1e-32
Identities = 31/202 (15%), Positives = 67/202 (33%), Gaps = 28/202 (13%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSH-----EKLSEFQCQQFVRQLVLALKFLRENNVCHFDL 166
++ E G L + I + + + + F +++ ++ + + + H D+
Sbjct: 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDI 198
Query: 167 KPQNILIKNNT------------LKLADFGFAQFLAPNDQGDSIQ---GSPLYMAPEILA 211
KP N ++ N L L D G + + +G + + E+L+
Sbjct: 199 KPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLS 258
Query: 212 GSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCM-DF 270
P+N + D + + V+ LFG + + P + D +F
Sbjct: 259 NKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK-------PEGLFRRLPHLDMWNEF 311
Query: 271 LSRLLQKDPMRRISYEDLFSHP 292
+L + DL
Sbjct: 312 FHVMLNIPDCHHLPSLDLLRQK 333
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-32
Identities = 47/198 (23%), Positives = 88/198 (44%), Gaps = 33/198 (16%)
Query: 107 EGRKRPRYVYIILEYCDGGDLCSFI--RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHF 164
+ + I++E DGG+L S I R + +E + + ++ + A+++L N+ H
Sbjct: 82 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 141
Query: 165 DLKPQNILIKNN----TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKAD 220
D+KP+N+L + LKL DFGF A E Y+ D
Sbjct: 142 DVKPENLLYTSKRPNAILKLTDFGF--------------------AKETTGEK-YDKSCD 180
Query: 221 LWSLGVLVFEALFGHAPYASCNLSQLRA---QALSSAPITIPP---NSLSPDCMDFLSRL 274
+WSLGV+++ L G+ P+ S + + + P + +S + + L
Sbjct: 181 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 240
Query: 275 LQKDPMRRISYEDLFSHP 292
L+ +P +R++ + +HP
Sbjct: 241 LKTEPTQRMTITEFMNHP 258
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-32
Identities = 55/251 (21%), Positives = 96/251 (38%), Gaps = 58/251 (23%)
Query: 110 KRPRYVYIILEYCDGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKP 168
K+ + Y++ E+ D + + L Q+++ Q++ + F +N+ H D+KP
Sbjct: 94 KKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKP 152
Query: 169 QNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL-----------YMAPEILAGSP-Y 215
+NIL+ ++ +KL DFGFA+ L +P Y APE+L G Y
Sbjct: 153 ENILVSQSGVVKLCDFGFARTL----------AAPGEVYDDEVATRWYRAPELLVGDVKY 202
Query: 216 NAKADLWSLGVLVFEALFGHAPY--ASCNLSQL----------------------RAQAL 251
D+W++G LV E +F P ++ QL +
Sbjct: 203 GKAVDVWAIGCLVTE-MFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261
Query: 252 SSAPITIPPNSL-------SPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAES 304
P L S +D + L DP +R +L H + + S
Sbjct: 262 RL-PEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFS 320
Query: 305 HQTAIRIVTDA 315
+ +++ DA
Sbjct: 321 QELQLKVQKDA 331
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 56/230 (24%), Positives = 94/230 (40%), Gaps = 42/230 (18%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEK----LSEFQCQQFVRQLVLALKFLREN--NVCHFDLK 167
Y+ +++EY L R++ + + F+ QL+ ++ L NVCH D+K
Sbjct: 100 YLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIK 158
Query: 168 PQNILI--KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSP-YNAKADLWSL 224
P N+L+ + TLKL DFG A+ L+P++ + S Y APE++ G+ Y D+WS+
Sbjct: 159 PHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSV 218
Query: 225 G----------------------VLVFEAL---------FGHAPYASCNLSQLRAQALSS 253
G + L + + +L + S+
Sbjct: 219 GCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSN 278
Query: 254 APITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAE 303
+ + D LS LLQ P R+ + HPY D +H P +
Sbjct: 279 VFSDHSLK-DAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATK 327
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-31
Identities = 46/185 (24%), Positives = 84/185 (45%), Gaps = 19/185 (10%)
Query: 111 RPRYVYIILEYCDGGDLCSFIRSHE---KLSEFQCQQFVRQLVLALKFL--RENNVCHFD 165
+P + I+ EY G L + +L E + + + +L R + H +
Sbjct: 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRN 164
Query: 166 LKPQNILI-KNNTLKLADFGFAQFLAPND-QGDSIQGSPLYMAPEILAGSPYNAKADLWS 223
LK N+L+ K T+K+ DFG ++ A S G+P +MAPE+L P N K+D++S
Sbjct: 165 LKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYS 224
Query: 224 LGVLVFEALFGHAPYASCNLSQLRAQALSSA--PITIPPNSLSPDCMDFLSRLLQK---- 277
GV+++E P+ + N +Q+ A IP + ++ +++
Sbjct: 225 FGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL-EIP-----RNLNPQVAAIIEGCWTN 278
Query: 278 DPMRR 282
+P +R
Sbjct: 279 EPWKR 283
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-31
Identities = 49/185 (26%), Positives = 83/185 (44%), Gaps = 17/185 (9%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVR---QLVLALKFL---RENNVCHFDLKP 168
V +++EY +GG L + + E L + + Q + +L + + H DLKP
Sbjct: 74 VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKP 133
Query: 169 QNILI--KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGV 226
N+L+ LK+ DFG A + + +GS +MAPE+ GS Y+ K D++S G+
Sbjct: 134 PNLLLVAGGTVLKICDFGTACDI--QTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGI 191
Query: 227 LVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQ----KDPMRR 282
+++E + P+ R PP L + + L+ KDP +R
Sbjct: 192 ILWEVITRRKPFDEIGGPAFRIMWAVHNGTR-PP--LIKNLPKPIESLMTRCWSKDPSQR 248
Query: 283 ISYED 287
S E+
Sbjct: 249 PSMEE 253
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-30
Identities = 70/268 (26%), Positives = 109/268 (40%), Gaps = 49/268 (18%)
Query: 99 GLSNLRAPEGRKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRE 158
+ N++ P+ + VYII E DL I + + LS+ Q F+ Q + A+K L
Sbjct: 73 TIFNIQRPDSFENFNEVYIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHG 130
Query: 159 NNVCHFDLKPQNILIKNN-TLKLADFGFAQFLAPNDQGDSIQGSPL-----------YMA 206
+NV H DLKP N+LI +N LK+ DFG A+ + + +S Y A
Sbjct: 131 SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRA 190
Query: 207 PEILAGSP-YNAKADLWSLGVLVFEALFGHA--------------------PYASCNLSQ 245
PE++ S Y+ D+WS G ++ E P++ +L
Sbjct: 191 PEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRC 250
Query: 246 LRAQA----LSSAPITIPPNSL-------SPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294
+ + + S P+ P L +P +D L R+L DP +RI+ ++ HPY
Sbjct: 251 IESPRAREYIKSLPM-YPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309
Query: 295 DLIHAPCAESHQTAIRIVTDAIHHDREN 322
H P E I D
Sbjct: 310 QTYHDPNDEP--EGEPIPPSFFEFDHYK 335
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 55/219 (25%), Positives = 81/219 (36%), Gaps = 53/219 (24%)
Query: 115 VYIILEYCDGGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
V ++ E+ D DL +++ L + +RQ + L FL N + H DLKP+NIL
Sbjct: 94 VTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENIL 152
Query: 173 I-KNNTLKLADFGFA-QFLAPNDQGDSIQGSPL----------YMAPEILAGSPYNAKAD 220
+ T+KLADFG A + + Y APE+L S Y D
Sbjct: 153 VTSGGTVKLADFGLARIY-----------SYQMALTPVVVTLWYRAPEVLLQSTYATPVD 201
Query: 221 LWSLGVLVFEALFGHAPY--ASCNLSQLRA--QAL-----------SSAPITIPPN---- 261
+WS+G + E +F P + QL + S P P
Sbjct: 202 MWSVGCIFAE-MFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPR 260
Query: 262 -------SLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
+ L +L +P +RIS H Y
Sbjct: 261 PVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-30
Identities = 46/194 (23%), Positives = 95/194 (48%), Gaps = 22/194 (11%)
Query: 115 VYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+ I+ ++C+G L + + E K + RQ + +L ++ H DLK NI +
Sbjct: 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL 153
Query: 174 -KNNTLKLADFGFAQFLAP---NDQGDSIQGSPLYMAPEILAG---SPYNAKADLWSLGV 226
++NT+K+ DFG A + + Q + + GS L+MAPE++ +PY+ ++D+++ G+
Sbjct: 154 HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGI 213
Query: 227 LVFEALFGHAPYASCN-----LSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQK---- 277
+++E + G PY++ N + + +LS + +C + RL+ +
Sbjct: 214 VLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR-----SNCPKRMKRLMAECLKK 268
Query: 278 DPMRRISYEDLFSH 291
R S+ + +
Sbjct: 269 KRDERPSFPRILAE 282
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-30
Identities = 38/184 (20%), Positives = 76/184 (41%), Gaps = 22/184 (11%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFL--RENNVCHFDLK 167
+ +I + G L + + + + Q +F + + FL E + L
Sbjct: 81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALN 140
Query: 168 PQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNA---KADLWS 223
++++I ++ T +++ Q +P ++APE L P + AD+WS
Sbjct: 141 SRSVMIDEDMTARISMADVKFSF----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWS 196
Query: 224 LGVLVFEALFGHAPYASCNLSQLRAQ-ALSSAPITIPPNSLSPDCMDFLSRLLQK----D 278
VL++E + P+A + ++ + AL TIPP +S+L++ D
Sbjct: 197 FAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPG-----ISPHVSKLMKICMNED 251
Query: 279 PMRR 282
P +R
Sbjct: 252 PAKR 255
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 9e-30
Identities = 62/221 (28%), Positives = 91/221 (41%), Gaps = 53/221 (23%)
Query: 115 VYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+ ++ E+CD DL + S L + F+ QL+ L F NV H DLKPQN+LI
Sbjct: 76 LTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI 134
Query: 174 -KNNTLKLADFGFAQFLAPNDQGDSIQGSPL-----------YMAPEILAGSP-YNAKAD 220
+N LKLA+FG A+ G P+ Y P++L G+ Y+ D
Sbjct: 135 NRNGELKLANFGLARAF----------GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID 184
Query: 221 LWSLGVLVFEALFGHAPY--ASCNLSQLRA--QAL-----------------SSAPITIP 259
+WS G + E P + QL+ + L P+
Sbjct: 185 MWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPA 244
Query: 260 PNSL-------SPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
SL + D L LL+ +P++RIS E+ HPY
Sbjct: 245 TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-30
Identities = 56/219 (25%), Positives = 87/219 (39%), Gaps = 53/219 (24%)
Query: 115 VYIILEYCDGGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+ ++ E+ D DL +++ + + + + QL+ L FL + V H DLKPQNIL
Sbjct: 94 LTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNIL 152
Query: 173 I-KNNTLKLADFGFA-QFLAPNDQGDSIQGSPL----------YMAPEILAGSPYNAKAD 220
+ + +KLADFG A + + Y APE+L S Y D
Sbjct: 153 VTSSGQIKLADFGLARIY-----------SFQMALTSVVVTLWYRAPEVLLQSSYATPVD 201
Query: 221 LWSLGVLVFEALFGHAPY--ASCNLSQLRA--QAL-----------SSAP----ITIPPN 261
LWS+G + E +F P S ++ QL + + P +
Sbjct: 202 LWSVGCIFAE-MFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQ 260
Query: 262 SL-------SPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
+ D L + L +P +RIS SHPY
Sbjct: 261 PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-29
Identities = 46/195 (23%), Positives = 85/195 (43%), Gaps = 24/195 (12%)
Query: 111 RPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENN---VCHFDLK 167
+ + +++E+ GG L + ++ + Q+ + +L + + H DLK
Sbjct: 77 KEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLK 135
Query: 168 PQNILI---------KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAK 218
NILI N LK+ DFG A+ S G+ +MAPE++ S ++
Sbjct: 136 SSNILILQKVENGDLSNKILKITDFGLAREWH-RTTKMSAAGAYAWMAPEVIRASMFSKG 194
Query: 219 ADLWSLGVLVFEALFGHAPYASCNLSQLRAQALS-SAPITIPPNSLSPDCMDFLSRLLQK 277
+D+WS GVL++E L G P+ + + + IP C + ++L++
Sbjct: 195 SDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST-----CPEPFAKLMED 249
Query: 278 ----DPMRRISYEDL 288
DP R S+ ++
Sbjct: 250 CWNPDPHSRPSFTNI 264
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 49/177 (27%), Positives = 88/177 (49%), Gaps = 10/177 (5%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
Y+++EY +G L +I SH LS F Q++ +K + + H D+KPQNILI
Sbjct: 85 CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI 144
Query: 174 -KNNTLKLADFGFAQFLAPND--QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
N TLK+ DFG A+ L+ Q + + G+ Y +PE G + D++S+G++++E
Sbjct: 145 DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYE 204
Query: 231 ALFGHAPYA-----SCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRR 282
L G P+ S + ++ ++ + + + + + + R +KD R
Sbjct: 205 MLVGEPPFNGETAVSIAIKHIQ-DSVPNVTTDVRKD-IPQSLSNVILRATEKDKANR 259
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 55/221 (24%), Positives = 88/221 (39%), Gaps = 54/221 (24%)
Query: 115 VYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+ ++ E+ D DL + L + F+ QL+ + + + V H DLKPQN+LI
Sbjct: 75 LVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI 133
Query: 174 -KNNTLKLADFGFAQFLAPNDQGDSIQGSPL-----------YMAPEILAGSP-YNAKAD 220
+ LK+ADFG A+ G P+ Y AP++L GS Y+ D
Sbjct: 134 NREGELKIADFGLARAF----------GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 221 LWSLGVLVFEALFGHAPY--ASCNLSQLRA--QAL------------------SSAPITI 258
+WS+G + E + P QL + L + +
Sbjct: 184 IWSVGCIFAE-MVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242
Query: 259 PPN------SLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
P L +D LS++L+ DP +RI+ + H Y
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-29
Identities = 56/226 (24%), Positives = 90/226 (39%), Gaps = 59/226 (26%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
+++I EY + DL ++ + +S + F+ QL+ + F H DLKPQN+L+
Sbjct: 108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLS 166
Query: 174 -----KNNTLKLADFGFAQFLAPNDQGDSIQGSPL-----------YMAPEILAGSP-YN 216
+ LK+ DFG A+ G P+ Y PEIL GS Y+
Sbjct: 167 VSDASETPVLKIGDFGLARAF----------GIPIRQFTHEIITLWYRPPEILLGSRHYS 216
Query: 217 AKADLWSLGVLVFEALFGHAPY--ASCNLSQLRA----------------QALSSAPITI 258
D+WS+ + E + P + QL AL +
Sbjct: 217 TSVDIWSIACIWAE-MLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSF 275
Query: 259 P-----------PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
P L + +D L+ +L+ DP++RIS ++ HPY
Sbjct: 276 PKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 37/234 (15%), Positives = 78/234 (33%), Gaps = 57/234 (24%)
Query: 116 YIILEYCDGGDLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+++ + G I +H + ++E ++ ++ AL ++ H +K +ILI
Sbjct: 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI 161
Query: 174 KNN-TLKLADFGFAQFL--------APNDQGDSIQGSPLYMAPEILA--GSPYNAKADLW 222
+ + L+ + +D +++PE+L Y+AK+D++
Sbjct: 162 SVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIY 221
Query: 223 SLGVLVFEALFGHAPYA------------------------------------------- 239
S+G+ E GH P+
Sbjct: 222 SVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGL 281
Query: 240 -SCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHP 292
+ + +P + SP F+ + LQ++P R S L +H
Sbjct: 282 SDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-29
Identities = 44/201 (21%), Positives = 78/201 (38%), Gaps = 28/201 (13%)
Query: 111 RPRYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 169
+ + + I EY GG L I+S + + Q F + + + +L N+ H DL
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSH 137
Query: 170 NILI-KNNTLKLADFGFAQFLAPNDQGD---------------SIQGSPLYMAPEILAGS 213
N L+ +N + +ADFG A+ + ++ G+P +MAPE++ G
Sbjct: 138 NCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR 197
Query: 214 PYNAKADLWSLGVLVFEALFGHAPYASCNLSQ--LRAQALSSAPITIPPNSLSPDCMDFL 271
Y+ K D++S G+++ E + P P+C
Sbjct: 198 SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP-----PNCPPSF 252
Query: 272 SRLL----QKDPMRRISYEDL 288
+ DP +R S+ L
Sbjct: 253 FPITVRCCDLDPEKRPSFVKL 273
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-29
Identities = 56/222 (25%), Positives = 90/222 (40%), Gaps = 55/222 (24%)
Query: 115 VYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+ ++ E+ + DL + + L + Q + ++ QL+ + ++ + H DLKPQN+LI
Sbjct: 94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI 152
Query: 174 -KNNTLKLADFGFAQFLAPNDQGDSIQGSPL-----------YMAPEILAGSP-YNAKAD 220
+ LKLADFG A+ G P+ Y AP++L GS Y+ D
Sbjct: 153 NSDGALKLADFGLARAF----------GIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVD 202
Query: 221 LWSLGVLVFEALFGHAPY--ASCNLSQLRA--QALSS---------------APITIPPN 261
+WS+G + E + P + QL L + T
Sbjct: 203 IWSIGCIFAE-MITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVF 261
Query: 262 S----------LSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
+ +D LS +L DP +RIS D +HPY
Sbjct: 262 EKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-29
Identities = 49/174 (28%), Positives = 81/174 (46%), Gaps = 10/174 (5%)
Query: 116 YIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-K 174
Y+ + +G DL + +R L+ + VRQ+ AL H D+KP+NIL+
Sbjct: 110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSA 169
Query: 175 NNTLKLADFGFAQFLAPND--QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
++ L DFG A Q + G+ YMAPE + S +AD+++L +++E L
Sbjct: 170 DDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECL 229
Query: 233 FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCM----DFLSRLLQKDPMRR 282
G PY LS + A + P P+++ P ++R + K+P R
Sbjct: 230 TGSPPYQGDQLSVMGAHINQAIP---RPSTVRPGIPVAFDAVIARGMAKNPEDR 280
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 65/228 (28%), Positives = 100/228 (43%), Gaps = 45/228 (19%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
VYI+ EY + DL + + L E + F+ QL+ LK++ NV H DLKP N+ I
Sbjct: 97 VYIVQEYMET-DLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN 154
Query: 174 -KNNTLKLADFGFAQFLAPNDQGDSIQGSPL--------YMAPEILAGSP-YNAKADLWS 223
++ LK+ DFG A+ + P+ L Y +P +L Y D+W+
Sbjct: 155 TEDLVLKIGDFGLARIMDPHYSHKGH----LSEGLVTKWYRSPRLLLSPNNYTKAIDMWA 210
Query: 224 LGVLVFEALFGHAPYASCN-LSQLR--------------AQALSSAPITI------PPNS 262
G + E L G +A + L Q++ + LS P+ I P
Sbjct: 211 AGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKP 270
Query: 263 L-------SPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAE 303
L S + +DFL ++L PM R++ E+ SHPY + P E
Sbjct: 271 LTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDE 318
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 50/179 (27%), Positives = 91/179 (50%), Gaps = 11/179 (6%)
Query: 113 RYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
YI++EY DG L + + ++ + + + AL F +N + H D+KP NI+
Sbjct: 89 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIM 148
Query: 173 I-KNNTLKLADFGFAQFLAPND----QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVL 227
I N +K+ DFG A+ +A + Q ++ G+ Y++PE G +A++D++SLG +
Sbjct: 149 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 228 VFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDC---MDFL-SRLLQKDPMRR 282
++E L G P+ + + Q + P IPP++ +D + + L K+P R
Sbjct: 209 LYEVLTGEPPFTGDSPVSVAYQHVREDP--IPPSARHEGLSADLDAVVLKALAKNPENR 265
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 56/243 (23%), Positives = 96/243 (39%), Gaps = 46/243 (18%)
Query: 103 LRAPEGRKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVC 162
+ + + VYI++E D +LC I+ +L + + Q++ +K L +
Sbjct: 93 FTPQKSLEEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGII 149
Query: 163 HFDLKPQNILIKNN-TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADL 221
H DLKP NI++K++ TLK+ DFG A+ + + Y APE++ G Y D+
Sbjct: 150 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 209
Query: 222 WSLGVLVFEALFGHA-----------------------------------------PYAS 240
WS+G ++ E + G YA
Sbjct: 210 WSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAG 269
Query: 241 CNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAP 300
+ +L L A + D LS++L D +RIS ++ HPY ++ + P
Sbjct: 270 YSFEKLFPDVLFPADSEHNKL-KASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDP 328
Query: 301 CAE 303
Sbjct: 329 SEA 331
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 62/251 (24%), Positives = 91/251 (36%), Gaps = 71/251 (28%)
Query: 115 VYIILEYCDGGDLCSFIRSH------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKP 168
+ ++ E+ D DL ++ S L + F QL+ L F EN + H DLKP
Sbjct: 78 LTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKP 136
Query: 169 QNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL-----------YMAPEILAGSP-Y 215
QN+LI K LKL DFG A+ G P+ Y AP++L GS Y
Sbjct: 137 QNLLINKRGQLKLGDFGLARAF----------GIPVNTFSSEVVTLWYRAPDVLMGSRTY 186
Query: 216 NAKADLWSLGVLVFEALFGHAPY--ASCNLSQL--------------------------- 246
+ D+WS G ++ E + P + + QL
Sbjct: 187 STSIDIWSCGCILAE-MITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPN 245
Query: 247 ----RAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY-------PD 295
+ L L + MDFL LLQ +P R+S + HP+
Sbjct: 246 IQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHAS 305
Query: 296 LIHAPCAESHQ 306
+ + H
Sbjct: 306 MGGSRSHHHHH 316
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 47/232 (20%), Positives = 92/232 (39%), Gaps = 47/232 (20%)
Query: 104 RAPEGRKRPRYVYIILEYCDGGDLCSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVC 162
+A + +Y++ ++C+ DL + + K + + ++ ++ L+ L ++ N +
Sbjct: 88 KASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKIL 146
Query: 163 HFDLKPQNILIKNN-TLKLADFGFAQFLAPNDQGDSIQGSPL-----YMAPEILAGSP-Y 215
H D+K N+LI + LKLADFG A+ + + + Y PE+L G Y
Sbjct: 147 HRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDY 206
Query: 216 NAKADLWSLGVLVFEALFGHAP----------------------------------YASC 241
DLW G ++ E ++ +P Y
Sbjct: 207 GPPIDLWGAGCIMAE-MWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKL 265
Query: 242 NLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
L + + + + + P +D + +LL DP +RI +D +H +
Sbjct: 266 ELVKGQKRKVKD---RLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-28
Identities = 45/224 (20%), Positives = 91/224 (40%), Gaps = 42/224 (18%)
Query: 116 YIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-- 173
++ E+ + D + L+++ + ++ +++ AL + + H D+KP N++I
Sbjct: 109 ALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 165
Query: 174 KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSP-YNAKADLWSLGVLVFEAL 232
++ L+L D+G A+F P + + S + PE+L Y+ D+WSLG ++ +
Sbjct: 166 EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 225
Query: 233 FGHAPY--ASCNLSQLR----------------------------------AQALSSAPI 256
F P+ N QL +
Sbjct: 226 FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH 285
Query: 257 TIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAP 300
+ + +SP+ +DFL +LL+ D R++ + HPY +
Sbjct: 286 SENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 329
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-28
Identities = 43/218 (19%), Positives = 82/218 (37%), Gaps = 43/218 (19%)
Query: 108 GRKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRE--------N 159
R +++I Y + G L +++ L C + V + L L
Sbjct: 74 SRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 132
Query: 160 NVCHFDLKPQNILIKNN-TLKLADFGFAQFLAPNDQGDSIQ-----GSPLYMAPEILAGS 213
+ H DLK +NIL+K N +AD G A + + + G+ YMAPE+L +
Sbjct: 133 AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDET 192
Query: 214 P------YNAKADLWSLGVLVFEALFGHA----------PYASCNLSQLRAQALSSA--- 254
+ D+W+ G++++E P+ + + +
Sbjct: 193 IQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCV 252
Query: 255 ----PITIPPNSLSPDCMDFLSRLLQK----DPMRRIS 284
P IP S + L++L+++ +P R++
Sbjct: 253 DQQRP-NIPNRWFSDPTLTSLAKLMKECWYQNPSARLT 289
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 62/246 (25%), Positives = 101/246 (41%), Gaps = 49/246 (19%)
Query: 99 GLSNLRAPEGRKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRE 158
G++++ ++ + VYI+ + + DL +++ + LS F+ Q++ LK++
Sbjct: 89 GINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHS 146
Query: 159 NNVCHFDLKPQNILIKNN-TLKLADFGFAQFLAPNDQGDSIQGSPL--------YMAPEI 209
NV H DLKP N+L+ LK+ DFG A+ P+ L Y APEI
Sbjct: 147 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF----LTEYVATRWYRAPEI 202
Query: 210 LAGSP-YNAKADLWSLGVLVFEALFGHA--PYASCNLSQL-------------------- 246
+ S Y D+WS+G ++ E L P L QL
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY-LDQLNHILGILGSPSQEDLNCIIN 261
Query: 247 -RAQA-LSSAPITIPPNSL-------SPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLI 297
+A+ L S P +D L ++L +P +RI E +HPY +
Sbjct: 262 LKARNYLLSLPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320
Query: 298 HAPCAE 303
+ P E
Sbjct: 321 YDPSDE 326
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-28
Identities = 39/176 (22%), Positives = 69/176 (39%), Gaps = 14/176 (7%)
Query: 107 EGRKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDL 166
R YI++EY G L +KL + ++ +++ AL +L + + DL
Sbjct: 151 TDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPALSYLHSIGLVYNDL 208
Query: 167 KPQNILIKNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGV 226
KP+NI++ LKL D G + + + G+P + APEI+ P D++++G
Sbjct: 209 KPENIMLTEEQLKLIDLGAVSRI---NSFGYLYGTPGFQAPEIVRTGP-TVATDIYTVGR 264
Query: 227 LVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRR 282
+ + + P P L R + DP +R
Sbjct: 265 TLAALTLDLPTR--------NGRYVDGLPEDDPVLKTYDSYGRLLRRAIDPDPRQR 312
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-28
Identities = 56/246 (22%), Positives = 92/246 (37%), Gaps = 50/246 (20%)
Query: 99 GLSNLRAPEGRKRPRYVYIILEYCDGGDLCSFIRS-HEKLSEFQCQQFVRQLVLALKFLR 157
GL ++ +Y++ E DL I +S Q F+ ++L L L
Sbjct: 93 GLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH 151
Query: 158 ENNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL--------YMAPE 208
E V H DL P NIL+ NN + + DF A+ + Y APE
Sbjct: 152 EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN--------KTHYVTHRWYRAPE 203
Query: 209 ILAGSP-YNAKADLWSLGVLVFEALFGHAPY-ASCNLSQL-------------------- 246
++ + D+WS G ++ E A + S +QL
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSS 263
Query: 247 -RAQA-LSSAPITIPPNSL-------SPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLI 297
A+ L ++ +P + P +D ++++L+ +P RRIS E HPY + +
Sbjct: 264 PSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323
Query: 298 HAPCAE 303
P
Sbjct: 324 FDPLDL 329
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-28
Identities = 65/261 (24%), Positives = 96/261 (36%), Gaps = 65/261 (24%)
Query: 115 VYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+ ++ EY D DL ++ ++ + F+ QL+ L + V H DLKPQN+LI
Sbjct: 75 LTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI 133
Query: 174 -KNNTLKLADFGFAQFLAPNDQGDSIQGSPL-----------YMAPEILAGSP-YNAKAD 220
+ LKLADFG A+ P Y P+IL GS Y+ + D
Sbjct: 134 NERGELKLADFGLARAK----------SIPTKTYDNEVVTLWYRPPDILLGSTDYSTQID 183
Query: 221 LWSLGVLVFEALFGHAPY--ASCNLSQLRA--QALSS---------------APITIPPN 261
+W +G + +E + P S QL + L + P
Sbjct: 184 MWGVGCIFYE-MATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKY 242
Query: 262 S----------LSPDCMDFLSRLLQKDPMRRISYEDLFSHPY-----PDLIHAPCAESHQ 306
L D D L++LLQ + RIS ED HP+ + P S
Sbjct: 243 RAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIF 302
Query: 307 TAIRIVTDAIHHDRENNSRRA 327
I +E + R A
Sbjct: 303 A-----LKEIQLQKEASLRSA 318
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-28
Identities = 53/221 (23%), Positives = 90/221 (40%), Gaps = 55/221 (24%)
Query: 115 VYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+ ++ ++ + DL I+ + L+ + ++ + L++L ++ + H DLKP N+L+
Sbjct: 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL 145
Query: 174 -KNNTLKLADFGFA-QFLAPNDQGDSIQGSPL-----------YMAPEILAGSP-YNAKA 219
+N LKLADFG A F GSP Y APE+L G+ Y
Sbjct: 146 DENGVLKLADFGLAKSF-----------GSPNRAYTHQVVTRWYRAPELLFGARMYGVGV 194
Query: 220 DLWSLGVLVFEALFGHAPY--ASCNLSQLRA--QAL-----------SSAP--ITIPPN- 261
D+W++G ++ E L P+ +L QL + L S P +T
Sbjct: 195 DMWAVGCILAE-LLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 253
Query: 262 ---------SLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
+ D +D + L +P RI+ Y
Sbjct: 254 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 52/241 (21%), Positives = 93/241 (38%), Gaps = 53/241 (21%)
Query: 103 LRAPEGRKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVC 162
E Y+++ + DL ++ EKL E + Q V Q++ L+++ +
Sbjct: 93 FTPDETLDDFTDFYLVMPFMGT-DLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGII 150
Query: 163 HFDLKPQNILIKNN-TLKLADFGFAQFLAPNDQGDSIQGSPL--------YMAPEILAGS 213
H DLKP N+ + + LK+ DFG A+ + Y APE++
Sbjct: 151 HRDLKPGNLAVNEDCELKILDFGLARQADSE----------MTGYVVTRWYRAPEVILNW 200
Query: 214 P-YNAKADLWSLGVLVFEALFGHAPY-ASCNLSQL---------------------RAQA 250
Y D+WS+G ++ E + G + S +L QL A+
Sbjct: 201 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 260
Query: 251 -LSSAPITIPPNSL-------SPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCA 302
+ P SP ++ L ++L D +R++ + +HPY + +H
Sbjct: 261 YMKGLPEL-EKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 319
Query: 303 E 303
E
Sbjct: 320 E 320
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 54/241 (22%), Positives = 96/241 (39%), Gaps = 53/241 (21%)
Query: 103 LRAPEGRKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVC 162
+ VY++ DL + ++ +KL++ Q + Q++ LK++ ++
Sbjct: 97 FTPARSLEEFNDVYLVTHLMGA-DLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADII 154
Query: 163 HFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL--------YMAPEILAGS 213
H DLKP N+ + ++ LK+ DFG A+ A + Y APEI+
Sbjct: 155 HRDLKPSNLAVNEDCELKILDFGLARHTADE----------MTGYVATRWYRAPEIMLNW 204
Query: 214 P-YNAKADLWSLGVLVFEALFGHAPY-ASCNLSQL---------------------RAQA 250
YN D+WS+G ++ E L G + + ++ QL A+
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 264
Query: 251 -LSSAPITIPPNSL-------SPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCA 302
+ S P + +P +D L ++L D +RI+ +H Y H P
Sbjct: 265 YIQSLTQM-PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 323
Query: 303 E 303
E
Sbjct: 324 E 324
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 40/194 (20%), Positives = 79/194 (40%), Gaps = 31/194 (15%)
Query: 116 YIILEYCDGGDLCSFIRS-HEKLSEFQCQQFVRQLVLALKFL--RENNVCHFDLKPQNIL 172
+++E+ GDL + + + + + L ++++ + + H DL+ NI
Sbjct: 97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIF 156
Query: 173 I------KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAG--SPYNAKADLWSL 224
+ K+ADFG +Q + G+ +MAPE + Y KAD +S
Sbjct: 157 LQSLDENAPVCAKVADFGLSQQS--VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSF 214
Query: 225 GVLVFEALFGHAPYASCNLSQLRAQALSSA------PITIPPNSLSPDCMDFLSRLLQK- 277
++++ L G P+ S + + ++ P TIP DC L +++
Sbjct: 215 AMILYTILTGEGPFD--EYSYGKIKFINMIREEGLRP-TIP-----EDCPPRLRNVIELC 266
Query: 278 ---DPMRRISYEDL 288
DP +R + +
Sbjct: 267 WSGDPKKRPHFSYI 280
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 48/219 (21%), Positives = 83/219 (37%), Gaps = 43/219 (19%)
Query: 107 EGRKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFL--------RE 158
+G +Y+I +Y + G L +++S L + V L L +
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGK 160
Query: 159 NNVCHFDLKPQNILIKNN-TLKLADFGFAQFLAPNDQGDSIQ-----GSPLYMAPEILAG 212
+ H DLK +NIL+K N T +AD G A + I G+ YM PE+L
Sbjct: 161 PAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE 220
Query: 213 S------PYNAKADLWSLGVLVFEALFG----------HAPYASCNLSQLRAQALSSA-- 254
S AD++S G++++E PY S + +
Sbjct: 221 SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVC 280
Query: 255 -----PITIPPNSLSPDCMDFLSRLLQK----DPMRRIS 284
P + P S +C+ + +L+ + +P R++
Sbjct: 281 IKKLRP-SFPNRWSSDECLRQMGKLMTECWAHNPASRLT 318
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-27
Identities = 56/241 (23%), Positives = 92/241 (38%), Gaps = 54/241 (22%)
Query: 103 LRAPEGRKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVC 162
+ Y+++ + DL + K SE + Q V Q++ LK++ V
Sbjct: 92 FTPASSLRNFYDFYLVMPFMQT-DLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVV 148
Query: 163 HFDLKPQNILIKNN-TLKLADFGFAQFLAPNDQGDSIQGSPL--------YMAPEILAGS 213
H DLKP N+ + + LK+ DFG A+ + Y APE++
Sbjct: 149 HRDLKPGNLAVNEDCELKILDFGLARHADAE----------MTGYVVTRWYRAPEVILSW 198
Query: 214 P-YNAKADLWSLGVLVFEALFGHAPY-ASCNLSQL---------------------RAQA 250
YN D+WS+G ++ E L G + L QL A++
Sbjct: 199 MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS 258
Query: 251 -LSSAPITIPPNSL-------SPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCA 302
+ S P T P SP D L ++L+ D +R++ +HP+ + P
Sbjct: 259 YIQSLPQT-PRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEE 317
Query: 303 E 303
E
Sbjct: 318 E 318
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 56/243 (23%), Positives = 97/243 (39%), Gaps = 46/243 (18%)
Query: 103 LRAPEGRKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVC 162
+ + + VY+++E D +LC I+ +L + + Q++ +K L +
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGII 186
Query: 163 HFDLKPQNILIKNN-TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADL 221
H DLKP NI++K++ TLK+ DFG A+ + + Y APE++ G Y D+
Sbjct: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 246
Query: 222 WSLGVLVFEALFGHA-----------------------------------------PYAS 240
WS+G ++ E + YA
Sbjct: 247 WSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAG 306
Query: 241 CNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAP 300
+L +L A + + D LS++L DP +RIS +D HPY ++ + P
Sbjct: 307 LTFPKLFPDSLFPA-DSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 365
Query: 301 CAE 303
Sbjct: 366 AEV 368
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 59/258 (22%), Positives = 93/258 (36%), Gaps = 71/258 (27%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
VY++ +Y + DL + IR+ L Q V QL+ +K+L + H D+KP NIL+
Sbjct: 86 VYLVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLN 143
Query: 175 NN-TLKLADFGFAQFLAPNDQGDSIQGSPL----------------------YMAPEILA 211
+K+ADFG ++ + + + Y APEIL
Sbjct: 144 AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILL 203
Query: 212 GSP-YNAKADLWSLG-----VLVFEALF-------------------------------- 233
GS Y D+WSLG +L + +F
Sbjct: 204 GSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFA 263
Query: 234 --------GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISY 285
N + + + P + + +D L +LLQ +P +RIS
Sbjct: 264 KTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323
Query: 286 EDLFSHPYPDLIHAPCAE 303
D HP+ + H P E
Sbjct: 324 NDALKHPFVSIFHNPNEE 341
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 40/210 (19%), Positives = 78/210 (37%), Gaps = 43/210 (20%)
Query: 116 YIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLREN--------NVCHFDLK 167
+++ +Y + G L ++ + ++ + L L + H DLK
Sbjct: 116 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 174
Query: 168 PQNILIKNN-TLKLADFGFAQFLAPNDQGDSIQ-----GSPLYMAPEILAGS------PY 215
+NIL+K N T +AD G A I G+ YMAPE+L S
Sbjct: 175 SKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFES 234
Query: 216 NAKADLWSLGVLVFEALFG----------HAPYASCNLSQLRAQALSSA-------PITI 258
+AD++++G++ +E PY S + + P I
Sbjct: 235 FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRP-NI 293
Query: 259 PPNSLSPDCMDFLSRLLQ----KDPMRRIS 284
P S + + ++++++ + R++
Sbjct: 294 PNRWQSCEALRVMAKIMRECWYANGAARLT 323
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 4e-23
Identities = 52/253 (20%), Positives = 85/253 (33%), Gaps = 85/253 (33%)
Query: 115 VYIILEYCDGGDLCSFIRSH---------EKLSEFQCQQFVRQLVLALKFLRENNVCHFD 165
V+++ +Y + DL I+ H +L + + Q++ + +L N V H D
Sbjct: 95 VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRD 153
Query: 166 LKPQNILI-----KNNTLKLADFGFAQFLAPNDQGDSIQGSPL--------------YMA 206
LKP NIL+ + +K+AD GFA+ SPL Y A
Sbjct: 154 LKPANILVMGEGPERGRVKIADMGFARLF----------NSPLKPLADLDPVVVTFWYRA 203
Query: 207 PEILAGSP-YNAKADLWSLG-------------------------------VLVFEAL-- 232
PE+L G+ Y D+W++G +F +
Sbjct: 204 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 263
Query: 233 --------FGHAPYASCNLSQLRAQALSSAPITIPP----NSLSPDCMDFLSRLLQKDPM 280
P S + R ++ + L +LL DP+
Sbjct: 264 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPI 323
Query: 281 RRISYEDLFSHPY 293
+RI+ E PY
Sbjct: 324 KRITSEQAMQDPY 336
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 49/287 (17%), Positives = 92/287 (32%), Gaps = 83/287 (28%)
Query: 99 GLSNLRAPEGRKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRE 158
L +L P+ + +YI+LE D DL ++ L+E + + L+L F+ E
Sbjct: 89 RLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHE 147
Query: 159 NNVCHFDLKPQNILIKNN-TLKLADFGFAQFLAPNDQGDSIQGSPL-------------- 203
+ + H DLKP N L+ + ++K+ DFG A+ + + +
Sbjct: 148 SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQ 207
Query: 204 ---------YMAPEILAGSP-YNAKADLWSLGVLVFEALFGHAPYASCNL---------S 244
Y APE++ Y D+WS G + E L + + S
Sbjct: 208 LTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSS 267
Query: 245 QLRAQALSSAPITIPPNSL----------------------SPDCMDFLSRL-------- 274
++ ++ P+ + ++
Sbjct: 268 CFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINL 327
Query: 275 --------------LQK----DPMRRISYEDLFSHPYPDLIHAPCAE 303
L+ +P +RI+ + HPY + E
Sbjct: 328 KQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLE 374
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 4e-22
Identities = 54/229 (23%), Positives = 91/229 (39%), Gaps = 64/229 (27%)
Query: 124 GGDLCSFIRS--HEKLSEFQCQQFVRQLVLALKFL-RENNVCHFDLKPQNILIK------ 174
G +L + I+ H + +Q +QL+L L ++ R + H D+KP+N+L++
Sbjct: 113 GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 172
Query: 175 -NNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE--- 230
+K+AD G A + +SIQ + Y +PE+L G+P+ AD+WS L+FE
Sbjct: 173 NLIQIKIADLGNACW-YDEHYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
Query: 231 --ALF-GHAP-YASCNLSQLRAQALSSAPITIPPNSL----------------------- 263
LF + + + A + P+ L
Sbjct: 231 GDFLFEPDEGHSYTKDDDHI---AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKL 287
Query: 264 -------------------SPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
+ + DFLS +LQ DP +R L +HP+
Sbjct: 288 KFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPW 336
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 4e-22
Identities = 34/157 (21%), Positives = 67/157 (42%), Gaps = 31/157 (19%)
Query: 99 GLSNLRAPEGRKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRE 158
+ ++ P+ ++ +Y++LE D D R+ L+E + + L++ +K++
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHS 174
Query: 159 NNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL-------------- 203
+ H DLKP N L+ ++ ++K+ DFG A+ + + G+S
Sbjct: 175 AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTK 234
Query: 204 --------------YMAPEILAGSP-YNAKADLWSLG 225
Y APE++ Y D+WS+G
Sbjct: 235 NLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG 271
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 11/42 (26%), Positives = 21/42 (50%)
Query: 262 SLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAE 303
+ S D + L R+L +P +RI+ + +HP+ + E
Sbjct: 368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVE 409
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 50/188 (26%), Positives = 94/188 (50%), Gaps = 17/188 (9%)
Query: 115 VYIILEYCDGGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
YII E+ G+L ++R + +S Q+ A+++L + N H +L +N L
Sbjct: 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCL 350
Query: 173 I-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPYNAKADLWSLGVLV 228
+ +N+ +K+ADFG ++ + D + G+ + APE LA + ++ K+D+W+ GVL+
Sbjct: 351 VGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 409
Query: 229 FEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL----QKDPMRRI 283
+E +G +PY +LSQ+ + L P C + + L+ Q +P R
Sbjct: 410 WEIATYGMSPYPGIDLSQVY-ELLEKDYRMERP----EGCPEKVYELMRACWQWNPSDRP 464
Query: 284 SYEDLFSH 291
S+ ++
Sbjct: 465 SFAEIHQA 472
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 4e-21
Identities = 40/218 (18%), Positives = 78/218 (35%), Gaps = 41/218 (18%)
Query: 107 EGRKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLREN------- 159
G +++I + + G L F++++ +S + + L +L E+
Sbjct: 89 RGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDG 147
Query: 160 ---NVCHFDLKPQNILIKNN-TLKLADFGFAQFLAPNDQGD---SIQGSPLYMAPEILAG 212
+ H D+K +N+L+KNN T +ADFG A G+ YMAPE+L G
Sbjct: 148 HKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG 207
Query: 213 SP-----YNAKADLWSLGVLVFEALFGHAPYASCNLSQLR--AQALSSAPI--------- 256
+ + D++++G++++E + + + P
Sbjct: 208 AINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVV 267
Query: 257 ------TIPPNSLSPDCMDFLSRLL----QKDPMRRIS 284
+ M L + D R+S
Sbjct: 268 HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 6e-21
Identities = 50/186 (26%), Positives = 82/186 (44%), Gaps = 15/186 (8%)
Query: 115 VYIILEYCDGGDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+YI+ EY G L F++ L Q Q+ + ++ N H DL+ NIL
Sbjct: 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 312
Query: 173 I-KNNTLKLADFGFAQFLAPNDQGDSIQGS-PL-YMAPEILAGSPYNAKADLWSLGVLVF 229
+ +N K+ADFG A+ + N+ P+ + APE + K+D+WS G+L+
Sbjct: 313 VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLT 372
Query: 230 EAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL----QKDPMRRIS 284
E G PY ++ Q + PP C + L L+ +K+P R +
Sbjct: 373 ELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE-----CPESLHDLMCQCWRKEPEERPT 427
Query: 285 YEDLFS 290
+E L +
Sbjct: 428 FEYLQA 433
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 7e-21
Identities = 43/196 (21%), Positives = 89/196 (45%), Gaps = 26/196 (13%)
Query: 109 RKRPRYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLK 167
+ P + ++ E+ + G L ++R+ + + + +L E V H DL
Sbjct: 74 EQAP--ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 131
Query: 168 PQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPYNAKADLWS 223
+N L+ +N +K++DFG +F+ +DQ S G+ + +PE+ + S Y++K+D+WS
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190
Query: 224 LGVLVFEAL-FGHAPYASCNLSQLRAQALS----SAPITIPPNSLSPDCMDFLSRLL--- 275
GVL++E G PY + + S++ + P + +++
Sbjct: 191 FGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---------RLASTHVYQIMNHC 241
Query: 276 -QKDPMRRISYEDLFS 290
++ P R ++ L
Sbjct: 242 WRERPEDRPAFSRLLR 257
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 9e-21
Identities = 52/198 (26%), Positives = 95/198 (47%), Gaps = 27/198 (13%)
Query: 109 RKRPRYVYIILEYCDGGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDL 166
R+ P YII E+ G+L ++R + +S Q+ A+++L + N H DL
Sbjct: 80 REPP--FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 137
Query: 167 KPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPYNAKADLW 222
+N L+ +N+ +K+ADFG ++ + D + G+ + APE LA + ++ K+D+W
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 223 SLGVLVFEAL-FGHAPYASCNLSQLRAQALS----SAPITIPPNSLSPDCMDFLSRLL-- 275
+ GVL++E +G +PY +LSQ+ P C + + L+
Sbjct: 197 AFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---------EGCPEKVYELMRA 247
Query: 276 --QKDPMRRISYEDLFSH 291
Q +P R S+ ++
Sbjct: 248 CWQWNPSDRPSFAEIHQA 265
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 9e-21
Identities = 38/138 (27%), Positives = 69/138 (50%), Gaps = 6/138 (4%)
Query: 115 VYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
V +I + G L ++R H + + + Q+ + +L + + H DL +N+L+
Sbjct: 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV 150
Query: 174 K-NNTLKLADFGFAQFLAPNDQGDSIQGS--PL-YMAPEILAGSPYNAKADLWSLGVLVF 229
K +K+ DFG A+ L ++ +G P+ +MA E + Y ++D+WS GV V+
Sbjct: 151 KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVW 210
Query: 230 EAL-FGHAPYASCNLSQL 246
E + FG PY S++
Sbjct: 211 ELMTFGSKPYDGIPASEI 228
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 9e-21
Identities = 50/186 (26%), Positives = 82/186 (44%), Gaps = 15/186 (8%)
Query: 115 VYIILEYCDGGDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+YI+ EY G L F++ L Q Q+ + ++ N H DL+ NIL
Sbjct: 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 395
Query: 173 I-KNNTLKLADFGFAQFLAPNDQGDSIQGS-PL-YMAPEILAGSPYNAKADLWSLGVLVF 229
+ +N K+ADFG A+ + N+ P+ + APE + K+D+WS G+L+
Sbjct: 396 VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLT 455
Query: 230 EAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL----QKDPMRRIS 284
E G PY ++ Q + PP C + L L+ +K+P R +
Sbjct: 456 ELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE-----CPESLHDLMCQCWRKEPEERPT 510
Query: 285 YEDLFS 290
+E L +
Sbjct: 511 FEYLQA 516
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 47/191 (24%), Positives = 83/191 (43%), Gaps = 27/191 (14%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+YI+ EY G L ++RS + L +F + A+++L NN H DL +N+
Sbjct: 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNV 320
Query: 172 LI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL-YMAPEILAGSPYNAKADLWSLGVLVF 229
L+ ++N K++DFG + + + P+ + APE L ++ K+D+WS G+L++
Sbjct: 321 LVSEDNVAKVSDFGLTKEASSTQDTGKL---PVKWTAPEALREKKFSTKSDVWSFGILLW 377
Query: 230 EAL-FGHAPYASCNLSQLRAQALSS-----APITIPPNSLSPDCMDFLSRLL----QKDP 279
E FG PY L + + AP C + ++ D
Sbjct: 378 EIYSFGRVPYPRIPLKDVV-PRVEKGYKMDAP---------DGCPPAVYDVMKNCWHLDA 427
Query: 280 MRRISYEDLFS 290
R ++ L
Sbjct: 428 ATRPTFLQLRE 438
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-20
Identities = 48/191 (25%), Positives = 83/191 (43%), Gaps = 27/191 (14%)
Query: 115 VYIILEYCDGGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+YI+ EY G L ++RS + L +F + A+++L NN H DL +N+L
Sbjct: 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVL 149
Query: 173 I-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL-YMAPEILAGSPYNAKADLWSLGVLVFE 230
+ ++N K++DFG + + + P+ + APE L ++ K+D+WS G+L++E
Sbjct: 150 VSEDNVAKVSDFGLTKEASSTQDTGKL---PVKWTAPEALREKKFSTKSDVWSFGILLWE 206
Query: 231 AL-FGHAPYASCNLSQLRAQALSS-----APITIPPNSLSPDCMDFLSRLL----QKDPM 280
FG PY L + + AP C + ++ D
Sbjct: 207 IYSFGRVPYPRIPLKDVV-PRVEKGYKMDAP---------DGCPPAVYEVMKNCWHLDAA 256
Query: 281 RRISYEDLFSH 291
R S+ L
Sbjct: 257 MRPSFLQLREQ 267
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-20
Identities = 44/197 (22%), Positives = 89/197 (45%), Gaps = 26/197 (13%)
Query: 109 RKRPRYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLK 167
++RP ++II EY G L +++R + Q + + + A+++L H DL
Sbjct: 90 KQRP--IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 147
Query: 168 PQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPYNAKADLWS 223
+N L+ +K++DFG ++++ +D+ S GS + PE+L S +++K+D+W+
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 206
Query: 224 LGVLVFEAL-FGHAPYASCNLSQLRAQALS----SAPITIPPNSLSPDCMDFLSRLL--- 275
GVL++E G PY S+ P + + ++
Sbjct: 207 FGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---------HLASEKVYTIMYSC 257
Query: 276 -QKDPMRRISYEDLFSH 291
+ R +++ L S+
Sbjct: 258 WHEKADERPTFKILLSN 274
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-20
Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 27/193 (13%)
Query: 115 VYIILEYCDGGDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+YII EY + G L F+++ KL+ + Q+ + F+ E N H DL+ NIL
Sbjct: 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141
Query: 173 I-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPYNAKADLWSLGVLV 228
+ + K+ADFG A+ + +++ + +G+ + APE + + K+D+WS G+L+
Sbjct: 142 VSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200
Query: 229 FEAL-FGHAPYASCNLSQLRAQALSS-----APITIPPNSLSPDCMDFLSRLL----QKD 278
E + G PY ++ Q L P +C + L +L+ ++
Sbjct: 201 TEIVTHGRIPYPGMTNPEVI-QNLERGYRMVRP---------DNCPEELYQLMRLCWKER 250
Query: 279 PMRRISYEDLFSH 291
P R +++ L S
Sbjct: 251 PEDRPTFDYLRSV 263
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 49/192 (25%), Positives = 91/192 (47%), Gaps = 27/192 (14%)
Query: 115 VYIILEYCDGGDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+YII E+ G L F++S E K + F Q+ + F+ + N H DL+ NIL
Sbjct: 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 316
Query: 173 I-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPYNAKADLWSLGVLV 228
+ + K+ADFG A+ + +++ + +G+ + APE + + K+D+WS G+L+
Sbjct: 317 VSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 375
Query: 229 FEAL-FGHAPYASCNLSQLRAQALSS-----APITIPPNSLSPDCMDFLSRLL----QKD 278
E + +G PY + ++ +AL P +C + L ++ +
Sbjct: 376 MEIVTYGRIPYPGMSNPEVI-RALERGYRMPRP---------ENCPEELYNIMMRCWKNR 425
Query: 279 PMRRISYEDLFS 290
P R ++E + S
Sbjct: 426 PEERPTFEYIQS 437
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 5e-20
Identities = 50/189 (26%), Positives = 81/189 (42%), Gaps = 17/189 (8%)
Query: 115 VYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
++L Y GDL +FIR+ + F Q+ +KFL H DL +N ++
Sbjct: 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML 225
Query: 174 -KNNTLKLADFGFAQFLAPNDQGDSIQGS----PL-YMAPEILAGSPYNAKADLWSLGVL 227
+ T+K+ADFG A+ + + + P+ +MA E L + K+D+WS GVL
Sbjct: 226 DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 285
Query: 228 VFEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL----QKDPMRR 282
++E + G PY N + L + P C D L ++ R
Sbjct: 286 LWELMTRGAPPYPDVNTFDIT-VYLLQGRRLLQP----EYCPDPLYEVMLKCWHPKAEMR 340
Query: 283 ISYEDLFSH 291
S+ +L S
Sbjct: 341 PSFSELVSR 349
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-20
Identities = 49/189 (25%), Positives = 81/189 (42%), Gaps = 17/189 (8%)
Query: 115 VYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
++L Y GDL +FIR+ + F Q+ +K+L H DL +N ++
Sbjct: 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML 161
Query: 174 -KNNTLKLADFGFAQFLAPND---QGDSIQGS-PL-YMAPEILAGSPYNAKADLWSLGVL 227
+ T+K+ADFG A+ + + + P+ +MA E L + K+D+WS GVL
Sbjct: 162 DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 221
Query: 228 VFEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL----QKDPMRR 282
++E + G PY N + L + P C D L ++ R
Sbjct: 222 LWELMTRGAPPYPDVNTFDIT-VYLLQGRRLLQP----EYCPDPLYEVMLKCWHPKAEMR 276
Query: 283 ISYEDLFSH 291
S+ +L S
Sbjct: 277 PSFSELVSR 285
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 6e-20
Identities = 48/187 (25%), Positives = 93/187 (49%), Gaps = 16/187 (8%)
Query: 115 VYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+ II EY + G L F+R + + S Q +R + +K+L N H DL +NIL+
Sbjct: 121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV 180
Query: 174 -KNNTLKLADFGFAQFLAPNDQGD-SIQGSPL---YMAPEILAGSPYNAKADLWSLGVLV 228
N K++DFG ++ L + + + G + + APE ++ + + +D+WS G+++
Sbjct: 181 NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVM 240
Query: 229 FEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL----QKDPMRRI 283
+E + +G PY + ++ +A++ P DC + +L+ Q++ RR
Sbjct: 241 WEVMTYGERPYWELSNHEVM-KAINDGFRLPTP----MDCPSAIYQLMMQCWQQERARRP 295
Query: 284 SYEDLFS 290
+ D+ S
Sbjct: 296 KFADIVS 302
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 6e-20
Identities = 48/197 (24%), Positives = 94/197 (47%), Gaps = 28/197 (14%)
Query: 109 RKRPRYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLK 167
++ P +YI+ EY G L +++RSH + L Q + + + FL + H DL
Sbjct: 74 KEYP--IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLA 131
Query: 168 PQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPYNAKADLWS 223
+N L+ ++ +K++DFG +++ +DQ S G+ + APE+ Y++K+D+W+
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWA 190
Query: 224 LGVLVFEAL-FGHAPYASCNLSQLRAQALSS-----APITIPPNSLSPDCMDFLSRLL-- 275
G+L++E G PY S++ +S P D + +++
Sbjct: 191 FGILMWEVFSLGKMPYDLYTNSEVV-LKVSQGHRLYRP---------HLASDTIYQIMYS 240
Query: 276 --QKDPMRRISYEDLFS 290
+ P +R +++ L S
Sbjct: 241 CWHELPEKRPTFQQLLS 257
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 7e-20
Identities = 47/200 (23%), Positives = 88/200 (44%), Gaps = 20/200 (10%)
Query: 107 EGRKRPRYVYIILEYCDGGDLCSFIRSH------EKLSEFQCQQFVRQLVLALKFLRENN 160
+ R +IL + GDL +F+ + L +F+ + +++L N
Sbjct: 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN 157
Query: 161 VCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPYN 216
H DL +N ++ ++ T+ +ADFG ++ + D S L ++A E LA + Y
Sbjct: 158 FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYT 217
Query: 217 AKADLWSLGVLVFEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL 275
+D+W+ GV ++E + G PYA +++ + + PP CM+ + L+
Sbjct: 218 VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPE-----CMEEVYDLM 272
Query: 276 ----QKDPMRRISYEDLFSH 291
DP +R S+ L
Sbjct: 273 YQCWSADPKQRPSFTCLRME 292
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 7e-20
Identities = 52/187 (27%), Positives = 93/187 (49%), Gaps = 16/187 (8%)
Query: 115 VYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
V I+ EY + G L SF+R H+ + + Q +R + +K+L + H DL +NILI
Sbjct: 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI 180
Query: 174 -KNNTLKLADFGFAQFLAPNDQGD-SIQGSPL---YMAPEILAGSPYNAKADLWSLGVLV 228
N K++DFG + L + + + +G + + +PE +A + + +D+WS G+++
Sbjct: 181 NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 229 FEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL----QKDPMRRI 283
+E + +G PY + + +A+ PP DC L +L+ QKD R
Sbjct: 241 WEVMSYGERPYWEMSNQDVI-KAVDEGYRLPPP----MDCPAALYQLMLDCWQKDRNNRP 295
Query: 284 SYEDLFS 290
+E + S
Sbjct: 296 KFEQIVS 302
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 7e-20
Identities = 39/138 (28%), Positives = 71/138 (51%), Gaps = 6/138 (4%)
Query: 115 VYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+ ++ +Y G L +R H L + Q+ + +L E+ + H +L +N+L+
Sbjct: 89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL 148
Query: 174 K-NNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPYNAKADLWSLGVLVF 229
K + +++ADFG A L P+D+ + +MA E + Y ++D+WS GV V+
Sbjct: 149 KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVW 208
Query: 230 EAL-FGHAPYASCNLSQL 246
E + FG PYA L+++
Sbjct: 209 ELMTFGAEPYAGLRLAEV 226
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 8e-20
Identities = 50/189 (26%), Positives = 85/189 (44%), Gaps = 17/189 (8%)
Query: 115 VYIILEYCDGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+++L Y GDL FIRS ++ + F Q+ +++L E H DL +N ++
Sbjct: 98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML 157
Query: 174 -KNNTLKLADFGFAQFLAPNDQGDSIQGS----PL-YMAPEILAGSPYNAKADLWSLGVL 227
++ T+K+ADFG A+ + + Q P+ + A E L + K+D+WS GVL
Sbjct: 158 DESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVL 217
Query: 228 VFEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL----QKDPMRR 282
++E L G PY + L + P C D L +++ + DP R
Sbjct: 218 LWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEY-----CPDSLYQVMQQCWEADPAVR 272
Query: 283 ISYEDLFSH 291
++ L
Sbjct: 273 PTFRVLVGE 281
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-19
Identities = 37/138 (26%), Positives = 68/138 (49%), Gaps = 6/138 (4%)
Query: 115 VYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
V +I + G L ++R H + + + Q+ + +L + + H DL +N+L+
Sbjct: 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV 150
Query: 174 K-NNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPYNAKADLWSLGVLVF 229
K +K+ DFG A+ L ++ +G + +MA E + Y ++D+WS GV V+
Sbjct: 151 KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVW 210
Query: 230 EAL-FGHAPYASCNLSQL 246
E + FG PY S++
Sbjct: 211 ELMTFGSKPYDGIPASEI 228
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 43/190 (22%), Positives = 86/190 (45%), Gaps = 23/190 (12%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
+++E + G L +++ + + + + V Q+ + +K+L E+N H DL +N+L+
Sbjct: 92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV 151
Query: 174 KNNTLKLADFGFAQFLAPNDQGDSIQGS---PL-YMAPEILAGSPYNAKADLWSLGVLVF 229
+ K++DFG ++ L ++ Q P+ + APE + +++K+D+WS GVL++
Sbjct: 152 TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMW 211
Query: 230 EAL-FGHAPYASCNLSQLRAQALS----SAPITIPPNSLSPDCMDFLSRLL----QKDPM 280
EA +G PY S++ A P C + L+ D
Sbjct: 212 EAFSYGQKPYRGMKGSEVTAMLEKGERMGCP---------AGCPREMYDLMNLCWTYDVE 262
Query: 281 RRISYEDLFS 290
R + +
Sbjct: 263 NRPGFAAVEL 272
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 2e-19
Identities = 39/230 (16%), Positives = 77/230 (33%), Gaps = 54/230 (23%)
Query: 106 PEGRKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRE------- 158
R Y +++EY G L ++ H + + L +L
Sbjct: 79 VTADGRMEY-LLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDH 136
Query: 159 --NNVCHFDLKPQNILIKNN-TLKLADFGFAQFLAPNDQGDSIQ---------GSPLYMA 206
+ H DL +N+L+KN+ T ++DFG + L N + G+ YMA
Sbjct: 137 YKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMA 196
Query: 207 PEILAGS-------PYNAKADLWSLGVLVFEALFG-------------HAPYASCNLSQL 246
PE+L G+ + D+++LG++ +E + + +
Sbjct: 197 PEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHP 256
Query: 247 RAQALSSA-------PITIPPN-SLSPDCMDFLSRLL----QKDPMRRIS 284
+ + P P + + L + +D R++
Sbjct: 257 TFEDMQVLVSREKQRP-KFPEAWKENSLAVRSLKETIEDCWDQDAEARLT 305
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-19
Identities = 42/200 (21%), Positives = 87/200 (43%), Gaps = 20/200 (10%)
Query: 107 EGRKRPRYVYIILEYCDGGDLCSFIRSH------EKLSEFQCQQFVRQLVLALKFLRENN 160
+ +IL + GDL +++ + + +F+ + L +++L N
Sbjct: 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN 167
Query: 161 VCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPYN 216
H DL +N ++ + T+ +ADFG ++ + D + + + ++A E LA Y
Sbjct: 168 FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT 227
Query: 217 AKADLWSLGVLVFEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL 275
+K+D+W+ GV ++E G PY ++ L + P + C+D L ++
Sbjct: 228 SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPED-----CLDELYEIM 282
Query: 276 ----QKDPMRRISYEDLFSH 291
+ DP+ R ++ L
Sbjct: 283 YSCWRTDPLDRPTFSVLRLQ 302
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 39/228 (17%), Positives = 77/228 (33%), Gaps = 66/228 (28%)
Query: 130 FIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT---------- 177
FI+ + ++ Q+ ++ FL N + H DLKP+NIL +
Sbjct: 106 FIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK 165
Query: 178 ----------LKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVL 227
+K+ DFG A + ++ ++ + Y APE++ ++ D+WS+G +
Sbjct: 166 RDERTLINPDIKVVDFGSATYD--DEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCI 223
Query: 228 VFE-----ALF-GHA------------------------------------PYASCNLSQ 245
+ E +F H S
Sbjct: 224 LIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRY 283
Query: 246 LRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
+ + + D + ++L+ DP +RI+ + HP+
Sbjct: 284 VSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPF 331
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 38/117 (32%), Positives = 58/117 (49%), Gaps = 10/117 (8%)
Query: 137 LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN---NTLKLADFGFAQFLAPND 193
S ++F ++ L L +N + H DLKP+NIL+K + +K+ DFG + +
Sbjct: 197 FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE---H 253
Query: 194 QGDS--IQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYA-SCNLSQLR 247
Q IQ S Y APE++ G+ Y D+WSLG ++ E L G+ QL
Sbjct: 254 QRVYTYIQ-SRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLA 309
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-19
Identities = 46/191 (24%), Positives = 88/191 (46%), Gaps = 24/191 (12%)
Query: 115 VYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
I+ EY + G L +F+R+H+ + + Q +R + +++L + H DL +N+L+
Sbjct: 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV 184
Query: 174 -KNNTLKLADFGFAQFLAPNDQGDSIQGS---PL-YMAPEILAGSPYNAKADLWSLGVLV 228
N K++DFG ++ L + P+ + APE +A +++ +D+WS GV++
Sbjct: 185 DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVM 244
Query: 229 FEAL-FGHAPYASCNLSQLRAQALS----SAPITIPPNSLSPDCMDFLSRLL----QKDP 279
+E L +G PY + + + AP C L +L+ KD
Sbjct: 245 WEVLAYGERPYWNMTNRDVISSVEEGYRLPAP---------MGCPHALHQLMLDCWHKDR 295
Query: 280 MRRISYEDLFS 290
+R + + S
Sbjct: 296 AQRPRFSQIVS 306
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 48/187 (25%), Positives = 86/187 (45%), Gaps = 17/187 (9%)
Query: 115 VYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+YI++E GGD +F+R+ +L Q V +++L H DL +N L+
Sbjct: 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV 246
Query: 174 -KNNTLKLADFGFAQFLAPNDQGDSIQGSPLY----MAPEILAGSPYNAKADLWSLGVLV 228
+ N LK++DFG ++ + + G APE L Y++++D+WS G+L+
Sbjct: 247 TEKNVLKISDFGMSREE-ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILL 305
Query: 229 FEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL----QKDPMRRI 283
+E G +PY + + Q R + P C D + RL+ +P +R
Sbjct: 306 WETFSLGASPYPNLSNQQTREFVEKGGRLPCPEL-----CPDAVFRLMEQCWAYEPGQRP 360
Query: 284 SYEDLFS 290
S+ ++
Sbjct: 361 SFSTIYQ 367
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 4e-19
Identities = 47/196 (23%), Positives = 81/196 (41%), Gaps = 24/196 (12%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQ----------QFVRQLVLALKFLRENNVCHF 164
+I+E GDL S++RS Q ++ + +L N H
Sbjct: 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHR 162
Query: 165 DLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPYNAKAD 220
DL +N ++ ++ T+K+ DFG + + D L +M+PE L + +D
Sbjct: 163 DLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSD 222
Query: 221 LWSLGVLVFE-ALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL---- 275
+WS GV+++E A PY + Q+ + + P N C D L L+
Sbjct: 223 VWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDN-----CPDMLFELMRMCW 277
Query: 276 QKDPMRRISYEDLFSH 291
Q +P R S+ ++ S
Sbjct: 278 QYNPKMRPSFLEIISS 293
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-19
Identities = 49/213 (23%), Positives = 77/213 (36%), Gaps = 64/213 (30%)
Query: 143 QQFVRQLVLALKFLRENNVCHFDLKPQNILI--------------------KNNTLKLAD 182
+ QL AL+FL EN + H DLKP+NIL KN ++++AD
Sbjct: 126 RHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185
Query: 183 FGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYA-SC 241
FG A F ++ +I + Y PE++ + D+WS+G ++FE G +
Sbjct: 186 FGSATFD--HEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243
Query: 242 NLSQLRA-----------------------------QALSSAPITIPPNSLS-------- 264
N L SS + N
Sbjct: 244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQD 303
Query: 265 ----PDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
D + R+L+ DP +RI+ + HP+
Sbjct: 304 SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPF 336
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 9e-19
Identities = 49/185 (26%), Positives = 89/185 (48%), Gaps = 14/185 (7%)
Query: 115 VYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
V+II+E C G+L SF++ + L + QL AL +L H D+ +N+L+
Sbjct: 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV 149
Query: 174 -KNNTLKLADFGFAQFLAPNDQGDSIQG-SPL-YMAPEILAGSPYNAKADLWSLGVLVFE 230
N+ +KL DFG ++++ + + +G P+ +MAPE + + + +D+W GV ++E
Sbjct: 150 SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 209
Query: 231 AL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL----QKDPMRRISY 285
L G P+ + + + + P P+C L L+ DP RR +
Sbjct: 210 ILMHGVKPFQGVKNNDVI-GRIENGERLPMP----PNCPPTLYSLMTKCWAYDPSRRPRF 264
Query: 286 EDLFS 290
+L +
Sbjct: 265 TELKA 269
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-18
Identities = 44/191 (23%), Positives = 86/191 (45%), Gaps = 24/191 (12%)
Query: 115 VYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+ +++E GG L F+ ++ + + Q+ + +K+L E N H DL +N+L+
Sbjct: 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL 143
Query: 174 -KNNTLKLADFGFAQFLAPNDQGDSIQGS---PL-YMAPEILAGSPYNAKADLWSLGVLV 228
+ K++DFG ++ L +D + + + PL + APE + +++++D+WS GV +
Sbjct: 144 VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTM 203
Query: 229 FEAL-FGHAPYASCNLSQLRAQALS----SAPITIPPNSLSPDCMDFLSRLL----QKDP 279
+EAL +G PY ++ A P P+C L L+
Sbjct: 204 WEALSYGQKPYKKMKGPEVMAFIEQGKRMECP---------PECPPELYALMSDCWIYKW 254
Query: 280 MRRISYEDLFS 290
R + +
Sbjct: 255 EDRPDFLTVEQ 265
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 2e-18
Identities = 49/185 (26%), Positives = 89/185 (48%), Gaps = 14/185 (7%)
Query: 115 VYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
V+II+E C G+L SF++ + L + QL AL +L H D+ +N+L+
Sbjct: 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV 524
Query: 174 -KNNTLKLADFGFAQFLAPNDQGDSIQG-SPL-YMAPEILAGSPYNAKADLWSLGVLVFE 230
N+ +KL DFG ++++ + + +G P+ +MAPE + + + +D+W GV ++E
Sbjct: 525 SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 584
Query: 231 AL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL----QKDPMRRISY 285
L G P+ + + + + P P+C L L+ DP RR +
Sbjct: 585 ILMHGVKPFQGVKNNDVI-GRIENGERLPMP----PNCPPTLYSLMTKCWAYDPSRRPRF 639
Query: 286 EDLFS 290
+L +
Sbjct: 640 TELKA 644
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-18
Identities = 33/138 (23%), Positives = 60/138 (43%), Gaps = 7/138 (5%)
Query: 115 VYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+ ++ E G L +R H+ ++ Q+ + +L H DL +N+L+
Sbjct: 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL 154
Query: 174 K-NNTLKLADFGFAQFLAPNDQG-DSIQGSPL---YMAPEILAGSPYNAKADLWSLGVLV 228
+ +K+ DFG + L ND + + + APE L ++ +D W GV +
Sbjct: 155 ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 214
Query: 229 FEAL-FGHAPYASCNLSQ 245
+E +G P+ N SQ
Sbjct: 215 WEMFTYGQEPWIGLNGSQ 232
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-18
Identities = 51/216 (23%), Positives = 86/216 (39%), Gaps = 31/216 (14%)
Query: 109 RKRPRYVYIILEYCDGGDLCSFIRSH-------EKLSEFQCQQFVRQLVLALKFLRENNV 161
+ P +I++E GGDL SF+R L+ R + ++L EN+
Sbjct: 104 QSLP--RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF 161
Query: 162 CHFDLKPQNILI----KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSP 214
H D+ +N L+ K+ DFG A+ + + L +M PE
Sbjct: 162 IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI 221
Query: 215 YNAKADLWSLGVLVFEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSR 273
+ +K D WS GVL++E G+ PY S + ++ S + P N C + R
Sbjct: 222 FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKN-----CPGPVYR 276
Query: 274 LL----QKDPMRRISYEDLFSH-----PYPDLIHAP 300
++ Q P R ++ + PD+I+
Sbjct: 277 IMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTA 312
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-18
Identities = 39/193 (20%), Positives = 76/193 (39%), Gaps = 28/193 (14%)
Query: 115 VYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
++ E+ G L ++++ ++ ++ + +QL A+ FL EN + H ++ +NIL+
Sbjct: 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILL 146
Query: 174 ---------KNNTLKLADFGFAQFLAPNDQGDSIQGSPL-YMAPE-ILAGSPYNAKADLW 222
+KL+D G + + P D + ++ PE I N D W
Sbjct: 147 IREEDRKTGNPPFIKLSDPGISITVLPKDILQ----ERIPWVPPECIENPKNLNLATDKW 202
Query: 223 SLGVLVFEAL-FGHAPYASCNLSQLRAQALS----SAPITIPPNSLSPDCMDFLSRLLQK 277
S G ++E G P ++ + + AP +L +CM
Sbjct: 203 SFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCM-------DY 255
Query: 278 DPMRRISYEDLFS 290
+P R S+ +
Sbjct: 256 EPDHRPSFRAIIR 268
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-18
Identities = 49/202 (24%), Positives = 81/202 (40%), Gaps = 26/202 (12%)
Query: 109 RKRPRYVYIILEYCDGGDLCSFIRSH-------EKLSEFQCQQFVRQLVLALKFLRENNV 161
+ P +I+LE GGDL SF+R L+ R + ++L EN+
Sbjct: 145 QSLP--RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF 202
Query: 162 CHFDLKPQNILI----KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSP 214
H D+ +N L+ K+ DFG A+ + + L +M PE
Sbjct: 203 IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI 262
Query: 215 YNAKADLWSLGVLVFEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSR 273
+ +K D WS GVL++E G+ PY S + ++ S + P N C + R
Sbjct: 263 FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKN-----CPGPVYR 317
Query: 274 LL----QKDPMRRISYEDLFSH 291
++ Q P R ++ +
Sbjct: 318 IMTQCWQHQPEDRPNFAIILER 339
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-18
Identities = 46/206 (22%), Positives = 86/206 (41%), Gaps = 38/206 (18%)
Query: 115 VYIILEYCDGGDLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRE 158
+ +I YC GDL F+ L V Q+ +++L
Sbjct: 87 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS 146
Query: 159 NNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSP 214
++V H DL +N+L+ +K++D G + + D + S L +MAPE +
Sbjct: 147 HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK 206
Query: 215 YNAKADLWSLGVLVFEAL-FGHAPYASCN----LSQLRAQALSSAPITIPPNSLSPDCMD 269
++ +D+WS GV+++E +G PY + + +R + + P DC
Sbjct: 207 FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCP---------DDCPA 257
Query: 270 FLSRLL----QKDPMRRISYEDLFSH 291
++ L+ + P RR ++D+ S
Sbjct: 258 WVYALMIECWNEFPSRRPRFKDIHSR 283
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 5e-18
Identities = 36/111 (32%), Positives = 60/111 (54%), Gaps = 8/111 (7%)
Query: 143 QQFVRQLVLALKFLREN--NVCHFDLKPQNILIKN---NTLKLADFGFAQFLAPNDQGDS 197
++F +Q+ AL FL ++ H DLKP+NIL+ N + +K+ DFG + L +
Sbjct: 160 RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQ 217
Query: 198 IQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYA-SCNLSQLR 247
S Y +PE+L G PY+ D+WSLG ++ E G ++ + + Q+
Sbjct: 218 YIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMN 268
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 6e-18
Identities = 42/201 (20%), Positives = 83/201 (41%), Gaps = 29/201 (14%)
Query: 115 VYIILEYCDGGDLCSFIRSH---------------EKLSEFQCQQFVRQLVLALKFLREN 159
+ ++ EY GDL F+RSH L Q Q+ + +L
Sbjct: 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL 177
Query: 160 NVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPY 215
+ H DL +N L+ + +K+ DFG ++ + D + L +M PE + +
Sbjct: 178 HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF 237
Query: 216 NAKADLWSLGVLVFEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRL 274
++D+WS GV+++E +G P+ + ++ + P C + +
Sbjct: 238 TTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRA-----CPPEVYAI 292
Query: 275 L----QKDPMRRISYEDLFSH 291
+ Q++P +R S +D+ +
Sbjct: 293 MRGCWQREPQQRHSIKDVHAR 313
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 7e-18
Identities = 52/242 (21%), Positives = 86/242 (35%), Gaps = 74/242 (30%)
Query: 124 GGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN----- 176
G L I + + + +++ AL +LR+ ++ H DLKP+NIL+ +
Sbjct: 119 GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKS 178
Query: 177 ---------------------TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPY 215
+KL DFG A F +D SI + Y APE++ +
Sbjct: 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK--SDYHGSIINTRQYRAPEVILNLGW 236
Query: 216 NAKADLWSLGVLVFE-----ALF-GH-----------------------------APYAS 240
+ +D+WS G ++ E LF H + Y +
Sbjct: 237 DVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVN 296
Query: 241 CNLSQLRAQALSSAPITIPPNSLS---------PDCMDFLSRLLQKDPMRRISYEDLFSH 291
+ +L +S+ +I DFL +LQ DP R S +L H
Sbjct: 297 KDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH 356
Query: 292 PY 293
+
Sbjct: 357 KF 358
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 38/143 (26%), Positives = 64/143 (44%), Gaps = 19/143 (13%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALK--------------FLRENN 160
V +I EYC GDL +F+R ++ E + + + FL N
Sbjct: 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN 184
Query: 161 VCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSPYN 216
H D+ +N+L+ + K+ DFG A+ + + + L +MAPE + Y
Sbjct: 185 CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT 244
Query: 217 AKADLWSLGVLVFE-ALFGHAPY 238
++D+WS G+L++E G PY
Sbjct: 245 VQSDVWSYGILLWEIFSLGLNPY 267
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-17
Identities = 40/201 (19%), Positives = 86/201 (42%), Gaps = 30/201 (14%)
Query: 115 VYIILEYCDGGDLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRE 158
+ ++ EY GDL F+R+H +L Q Q+ + +L
Sbjct: 92 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS 151
Query: 159 NNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSP 214
+ H DL +N L+ N +K+ DFG ++ + D + L +M PE +
Sbjct: 152 QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK 211
Query: 215 YNAKADLWSLGVLVFEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSR 273
+ ++D+WS GV+++E +G P+ + +++ + P C +
Sbjct: 212 FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRV-----CPKEVYD 266
Query: 274 LL----QKDPMRRISYEDLFS 290
++ Q++P +R++ ++++
Sbjct: 267 VMLGCWQREPQQRLNIKEIYK 287
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-17
Identities = 33/139 (23%), Positives = 63/139 (45%), Gaps = 11/139 (7%)
Query: 115 VYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+II+E G+L ++ ++ L + Q+ A+ +L N H D+ +NIL+
Sbjct: 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILV 146
Query: 174 -KNNTLKLADFGFAQFLAPND----QGDSIQGSPL-YMAPEILAGSPYNAKADLWSLGVL 227
+KL DFG ++++ D + P+ +M+PE + + +D+W V
Sbjct: 147 ASPECVKLGDFGLSRYIEDEDYYKASVTRL---PIKWMSPESINFRRFTTASDVWMFAVC 203
Query: 228 VFEAL-FGHAPYASCNLSQ 245
++E L FG P+
Sbjct: 204 MWEILSFGKQPFFWLENKD 222
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 82.7 bits (204), Expect = 3e-17
Identities = 44/191 (23%), Positives = 87/191 (45%), Gaps = 24/191 (12%)
Query: 115 VYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+ +++E GG L F+ E++ + + Q+ + +K+L E N H +L +N+L+
Sbjct: 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL 469
Query: 174 -KNNTLKLADFGFAQFLAPNDQGDSIQGS---PL-YMAPEILAGSPYNAKADLWSLGVLV 228
+ K++DFG ++ L +D + + + PL + APE + +++++D+WS GV +
Sbjct: 470 VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTM 529
Query: 229 FEAL-FGHAPYASCNLSQLRAQALS----SAPITIPPNSLSPDCMDFLSRLL----QKDP 279
+EAL +G PY ++ A P P+C L L+
Sbjct: 530 WEALSYGQKPYKKMKGPEVMAFIEQGKRMECP---------PECPPELYALMSDCWIYKW 580
Query: 280 MRRISYEDLFS 290
R + +
Sbjct: 581 EDRPDFLTVEQ 591
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 39/145 (26%), Positives = 70/145 (48%), Gaps = 21/145 (14%)
Query: 115 VYIILEYCDGGDLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRE 158
+ +I+E+C G+L +++RS + L+ + Q+ ++FL
Sbjct: 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 166
Query: 159 NNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSP 214
H DL +NIL+ + N +K+ DFG A+ + + + L +MAPE +
Sbjct: 167 RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 226
Query: 215 YNAKADLWSLGVLVFE-ALFGHAPY 238
Y ++D+WS GVL++E G +PY
Sbjct: 227 YTIQSDVWSFGVLLWEIFSLGASPY 251
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-17
Identities = 50/202 (24%), Positives = 88/202 (43%), Gaps = 30/202 (14%)
Query: 115 VYIILEYCDGGDLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRE 158
+Y+I+EY G+L ++R+ E+++ QL +++L
Sbjct: 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175
Query: 159 NNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSP 214
H DL +N+L+ +NN +K+ADFG A+ + D L +MAPE L
Sbjct: 176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 235
Query: 215 YNAKADLWSLGVLVFEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSR 273
Y ++D+WS GVL++E G +PY + +L + P N C + L
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPAN-----CTNELYM 290
Query: 274 LL----QKDPMRRISYEDLFSH 291
++ P +R +++ L
Sbjct: 291 MMRDCWHAVPSQRPTFKQLVED 312
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 6e-17
Identities = 40/147 (27%), Positives = 61/147 (41%), Gaps = 23/147 (15%)
Query: 115 VYIILEYCDGGDLCSFIRSH------------------EKLSEFQCQQFVRQLVLALKFL 156
+I EYC GDL +F+R L F Q+ + FL
Sbjct: 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161
Query: 157 RENNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAG 212
N H DL +NIL+ K+ DFG A+ + + + L +MAPE +
Sbjct: 162 ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN 221
Query: 213 SPYNAKADLWSLGVLVFE-ALFGHAPY 238
Y ++D+WS G+ ++E G +PY
Sbjct: 222 CVYTFESDVWSYGIFLWELFSLGSSPY 248
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 7e-17
Identities = 34/132 (25%), Positives = 70/132 (53%), Gaps = 7/132 (5%)
Query: 115 VYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+ +++EY G L F++ H +L + + Q+ +++L H DL +NIL+
Sbjct: 101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV 160
Query: 174 K-NNTLKLADFGFAQFLAPNDQGDSIQG---SPL-YMAPEILAGSPYNAKADLWSLGVLV 228
+ +K+ADFG A+ L + ++ SP+ + APE L+ + ++ ++D+WS GV++
Sbjct: 161 ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVL 220
Query: 229 FEAL-FGHAPYA 239
+E + +
Sbjct: 221 YELFTYCDKSCS 232
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 7e-17
Identities = 42/153 (27%), Positives = 73/153 (47%), Gaps = 21/153 (13%)
Query: 115 VYIILEYCDGGDLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRE 158
+Y+I+EY G+L ++++ E+LS Q+ +++L
Sbjct: 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 209
Query: 159 NNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSP 214
H DL +N+L+ ++N +K+ADFG A+ + D L +MAPE L
Sbjct: 210 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI 269
Query: 215 YNAKADLWSLGVLVFE-ALFGHAPYASCNLSQL 246
Y ++D+WS GVL++E G +PY + +L
Sbjct: 270 YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 50/202 (24%), Positives = 88/202 (43%), Gaps = 30/202 (14%)
Query: 115 VYIILEYCDGGDLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRE 158
+Y+I+EY G+L ++R+ E+++ QL +++L
Sbjct: 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 221
Query: 159 NNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAGSP 214
H DL +N+L+ +NN +K+ADFG A+ + D L +MAPE L
Sbjct: 222 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 281
Query: 215 YNAKADLWSLGVLVFE-ALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSR 273
Y ++D+WS GVL++E G +PY + +L + P N C + L
Sbjct: 282 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPAN-----CTNELYM 336
Query: 274 LL----QKDPMRRISYEDLFSH 291
++ P +R +++ L
Sbjct: 337 MMRDCWHAVPSQRPTFKQLVED 358
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 42/151 (27%), Positives = 66/151 (43%), Gaps = 28/151 (18%)
Query: 116 YIILEYCDGGDLCSFIRSH-----------------------EKLSEFQCQQFVRQLVLA 152
Y+I EYC GDL +++RS L+ F Q+
Sbjct: 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKG 184
Query: 153 LKFLRENNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPE 208
++FL + H DL +N+L+ +K+ DFG A+ + + + L +MAPE
Sbjct: 185 MEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE 244
Query: 209 ILAGSPYNAKADLWSLGVLVFE-ALFGHAPY 238
L Y K+D+WS G+L++E G PY
Sbjct: 245 SLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-16
Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 24/155 (15%)
Query: 113 RYVYIILEYCDGGDLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFL 156
Y+Y+ +EY G+L F+R LS Q F + + +L
Sbjct: 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 158
Query: 157 RENNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMAPEILAG 212
+ H DL +NIL+ +N K+ADFG ++ + L +MA E L
Sbjct: 159 SQKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKKTMGRLPVRWMAIESLNY 215
Query: 213 SPYNAKADLWSLGVLVFE-ALFGHAPYASCNLSQL 246
S Y +D+WS GVL++E G PY ++L
Sbjct: 216 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 250
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 8e-16
Identities = 31/132 (23%), Positives = 68/132 (51%), Gaps = 7/132 (5%)
Query: 115 VYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+ +I+E+ G L ++ ++ K++ Q ++ Q+ + +L H DL +N+L+
Sbjct: 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV 159
Query: 174 -KNNTLKLADFGFAQFLAPNDQGDSIQG---SPL-YMAPEILAGSPYNAKADLWSLGVLV 228
+ +K+ DFG + + + + +++ SP+ + APE L S + +D+WS GV +
Sbjct: 160 ESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTL 219
Query: 229 FEAL-FGHAPYA 239
E L + + +
Sbjct: 220 HELLTYCDSDSS 231
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 8e-16
Identities = 34/122 (27%), Positives = 67/122 (54%), Gaps = 6/122 (4%)
Query: 115 VYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+ +I+EY G L +++ H+ ++ + Q+ Q+ +++L H DL +NIL+
Sbjct: 88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 147
Query: 174 -KNNTLKLADFGFAQFLAPNDQGDSIQG---SPL-YMAPEILAGSPYNAKADLWSLGVLV 228
N +K+ DFG + L + + ++ SP+ + APE L S ++ +D+WS GV++
Sbjct: 148 ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 207
Query: 229 FE 230
+E
Sbjct: 208 YE 209
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 34/122 (27%), Positives = 67/122 (54%), Gaps = 6/122 (4%)
Query: 115 VYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+ +I+EY G L +++ H+ ++ + Q+ Q+ +++L H DL +NIL+
Sbjct: 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 178
Query: 174 -KNNTLKLADFGFAQFLAPNDQGDSIQG---SPL-YMAPEILAGSPYNAKADLWSLGVLV 228
N +K+ DFG + L + + ++ SP+ + APE L S ++ +D+WS GV++
Sbjct: 179 ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 238
Query: 229 FE 230
+E
Sbjct: 239 YE 240
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 45/207 (21%), Positives = 80/207 (38%), Gaps = 38/207 (18%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQ------------------------QFVRQLV 150
+ ++ EY GDL F+RS + RQ+
Sbjct: 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA 184
Query: 151 LALKFLRENNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMA 206
+ +L E H DL +N L+ +N +K+ADFG ++ + D + + +M
Sbjct: 185 AGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMP 244
Query: 207 PEILAGSPYNAKADLWSLGVLVFEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSP 265
PE + + Y ++D+W+ GV+++E +G PY ++ + P N
Sbjct: 245 PESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPEN---- 300
Query: 266 DCMDFLSRLL----QKDPMRRISYEDL 288
C L L+ K P R S+ +
Sbjct: 301 -CPLELYNLMRLCWSKLPADRPSFCSI 326
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-15
Identities = 32/131 (24%), Positives = 64/131 (48%), Gaps = 7/131 (5%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 173
+ +++EY G L ++ H + Q F +Q+ + +L + H DL +N+L+
Sbjct: 110 LQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD 168
Query: 174 KNNTLKLADFGFAQFLAPNDQGDSIQG---SPL-YMAPEILAGSPYNAKADLWSLGVLVF 229
+ +K+ DFG A+ + + ++ SP+ + APE L + +D+WS GV ++
Sbjct: 169 NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLY 228
Query: 230 EAL-FGHAPYA 239
E L + +
Sbjct: 229 ELLTHCDSSQS 239
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 28/174 (16%), Positives = 49/174 (28%), Gaps = 34/174 (19%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 174
++ E+ GG L + S + ++ L A V P + +
Sbjct: 106 GLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS 163
Query: 175 NN-TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF 233
+ + LA M N + D+ +G ++ L
Sbjct: 164 IDGDVVLAYPA-------------------TMPDA-------NPQDDIRGIGASLYALLV 197
Query: 234 GHAPY-ASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLS----RLLQKDPMRR 282
P + S L +A I P + D +S R +Q D R
Sbjct: 198 NRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR 251
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 39/161 (24%), Positives = 66/161 (40%), Gaps = 29/161 (18%)
Query: 115 VYIILEYCDGGDLCSFIRSH------------------------EKLSEFQCQQFVRQLV 150
+ +I+EY G L F+R L+ F Q+
Sbjct: 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQIS 160
Query: 151 LALKFLRENNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPL---YMA 206
+++L E + H DL +NIL+ + +K++DFG ++ + D + +MA
Sbjct: 161 QGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMA 220
Query: 207 PEILAGSPYNAKADLWSLGVLVFE-ALFGHAPYASCNLSQL 246
E L Y ++D+WS GVL++E G PY +L
Sbjct: 221 IESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 7e-13
Identities = 32/123 (26%), Positives = 57/123 (46%), Gaps = 5/123 (4%)
Query: 128 CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLADFGFA 186
+ L+ + Q+ ++FL H DL +NIL+ + N +K+ DFG A
Sbjct: 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 240
Query: 187 QFLAPNDQGDSIQGSPL---YMAPEILAGSPYNAKADLWSLGVLVFEAL-FGHAPYASCN 242
+ + + + L +MAPE + Y ++D+WS GVL++E G +PY
Sbjct: 241 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300
Query: 243 LSQ 245
+ +
Sbjct: 301 IDE 303
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 4e-12
Identities = 42/267 (15%), Positives = 73/267 (27%), Gaps = 97/267 (36%)
Query: 124 GGDLCSFIRS--HEKLSEFQCQQFVRQLVLALKFL-RENNVCHFDLKPQNILIKNNTLKL 180
G L +I ++ L ++ ++Q++ L +L + + H D+KP+NIL+ N +
Sbjct: 128 GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYI 187
Query: 181 ADFGFAQFLAPNDQGDSIQGSPLYM----------------------------------- 205
GS +
Sbjct: 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH 247
Query: 206 -------------APEILAGSPYNAKADLWSLGVLVFE---------------------- 230
+ E+L GS YN AD+WS + FE
Sbjct: 248 KHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH 307
Query: 231 -----ALFGHAPYASCNLSQLRAQALSS-----APITIPPNSLS--------------PD 266
L G P + + + + P L
Sbjct: 308 IALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAG 367
Query: 267 CMDFLSRLLQKDPMRRISYEDLFSHPY 293
DFL +L+ P +R + + HP+
Sbjct: 368 FTDFLLPMLELIPEKRATAAECLRHPW 394
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 4e-09
Identities = 25/91 (27%), Positives = 45/91 (49%), Gaps = 8/91 (8%)
Query: 153 LKFLRENNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDS-----IQGSPLYMA 206
L +L + H D+K NIL+ +N K+ DFG ++ + + ++G+ Y+
Sbjct: 152 LHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK-KGT-ELDQTHLSTVVKGTLGYID 209
Query: 207 PEILAGSPYNAKADLWSLGVLVFEALFGHAP 237
PE K+D++S GV++FE L +
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 9e-09
Identities = 31/87 (35%), Positives = 47/87 (54%), Gaps = 7/87 (8%)
Query: 153 LKFLRENNVCHFDLKPQNILIKNN-TLKLADFGFAQFLAPNDQGDSIQ----GSPLYMAP 207
+ FL EN+ H D+K NIL+ T K++DFG A+ + + G+ YMAP
Sbjct: 146 INFLHENHHIHRDIKSANILLDEAFTAKISDFGLAR-ASEKFAQTVMTSRIVGTTAYMAP 204
Query: 208 EILAGSPYNAKADLWSLGVLVFEALFG 234
E L G K+D++S GV++ E + G
Sbjct: 205 EALRGE-ITPKSDIYSFGVVLLEIITG 230
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 29/144 (20%), Positives = 61/144 (42%), Gaps = 13/144 (9%)
Query: 106 PEGRKRPRYVYIILEYCDGGDLCS-FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHF 164
+ Y ++I++ G DL + + ++ S Q +++ L+++ E+ H
Sbjct: 118 LHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHG 176
Query: 165 DLKPQNILI---KNNTLKLADFGFA-QFLAPN-------DQGDSIQGSPLYMAPEILAGS 213
D+K N+L+ + + L D+G A ++ D G+ + + + G
Sbjct: 177 DIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV 236
Query: 214 PYNAKADLWSLGVLVFEALFGHAP 237
+ + DL LG + + L GH P
Sbjct: 237 APSRRGDLEILGYCMIQWLTGHLP 260
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 9e-07
Identities = 19/80 (23%), Positives = 33/80 (41%), Gaps = 5/80 (6%)
Query: 111 RPRYVYIILEYCDGG-DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLREN-NVCHFDLKP 168
+ ++I+LE+ GG DL + S + + QL +L + H DL
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHW 190
Query: 169 QNILIKN-NTLKLADFGFAQ 187
N+L+K + KL +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGK 210
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 25/129 (19%), Positives = 55/129 (42%), Gaps = 13/129 (10%)
Query: 113 RYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
Y ++++E G DL + + Q +++ L+++ EN H D+K N+L
Sbjct: 125 SYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLL 183
Query: 173 I---KNNTLKLADFGFAQFLAPN--------DQGDSIQGSPLYMAPEILAGSPYNAKADL 221
+ + + LAD+G + PN + G+ + + + G + ++D+
Sbjct: 184 LGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDV 243
Query: 222 WSLG-VLVF 229
LG ++
Sbjct: 244 EILGYCMLR 252
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 22/79 (27%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 163 HFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDS--IQGSPLYMAPEILAGSPYNAKA 219
H D+K NIL+ + + DFG A+ + D + ++G+ ++APE L+ + K
Sbjct: 157 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 216
Query: 220 DLWSLGVLVFEALFGHAPY 238
D++ GV++ E + G +
Sbjct: 217 DVFGYGVMLLELITGQRAF 235
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 3e-06
Identities = 58/419 (13%), Positives = 106/419 (25%), Gaps = 163/419 (38%)
Query: 56 TIRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRKRPRYV 115
T Y E Q D + N KY+ ++ + + R L LR P
Sbjct: 109 TRMYIE-QRDRLYNDNQVF--AKYN------VSRLQPYLKLRQALLELR-PAK------- 151
Query: 116 YIILEYCDGG--------DLCSFIRSHEKLSEFQCQQF------VRQLVLALKFLRENNV 161
+++ G D+C S++ + + F L+ L +
Sbjct: 152 NVLI-DGVLGSGKTWVALDVC---LSYKVQCKMDFKIFWLNLKNCNSPETVLEML--QKL 205
Query: 162 CHFDLKPQNILIKNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKA-- 219
+ I N +D L + ++ +L PY
Sbjct: 206 LY--------QIDPNWTSRSDHSSNIKLRIHSIQAELR--------RLLKSKPYE-NCLL 248
Query: 220 ---DLWSLGVL-VF-----------------------------------------EALFG 234
++ + F ++L
Sbjct: 249 VLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL- 307
Query: 235 HAPYASCNLSQLRAQALSSAPITIPPNSLSPDCM-DFLSRL-----LQKDPMRRI---SY 285
Y C L + L++ P + S+ + + D L+ + D + I S
Sbjct: 308 -LKYLDCRPQDLPREVLTTNPRRL---SIIAESIRDGLATWDNWKHVNCDKLTTIIESSL 363
Query: 286 EDL----FSHPYPDL------IHAP--------CAESHQTAIRIVTD-----AIHHDREN 322
L + + L H P + +V + +
Sbjct: 364 NVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKE 423
Query: 323 NSRRAFSLYCE---------ALN------YLIPLAYDVLAEAIPNLKSGLEIGETGDMY 366
++ S+Y E AL+ Y IP +D P L D Y
Sbjct: 424 STISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYL----------DQY 472
|
| >2cpt_A SKD1 protein, vacuolar sorting protein 4B; MIT, helix bundle, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: a.7.14.1 Length = 117 | Back alignment and structure |
|---|
Score = 43.9 bits (103), Expect = 8e-06
Identities = 11/44 (25%), Positives = 20/44 (45%)
Query: 298 HAPCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIPL 341
+ + + Q AI + + A D+ N A LY A+ Y + +
Sbjct: 8 MSSTSPNLQKAIDLASKAAQEDKAGNYEEALQLYQHAVQYFLHV 51
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 9e-06
Identities = 33/136 (24%), Positives = 61/136 (44%), Gaps = 15/136 (11%)
Query: 108 GRKRPRYVYIILEYCDGGDLCSFIR--SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFD 165
G + +Y +++L G L S + LSE Q +L+ AL+FL EN H +
Sbjct: 126 GVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGN 184
Query: 166 LKPQNILI---KNNTLKLADFGFAQFLAPN--------DQGDSIQGSPLYMAPEILAGSP 214
+ +NI + + + LA +GFA P+ +G +++ ++ G
Sbjct: 185 VTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG 244
Query: 215 YNAKADLWSLG-VLVF 229
+ ++DL SLG ++
Sbjct: 245 PSRRSDLQSLGYCMLK 260
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 9e-06
Identities = 28/119 (23%), Positives = 51/119 (42%), Gaps = 21/119 (17%)
Query: 132 RSHEKLSEFQCQQF--------VRQLVLALKFLRENNVCHFDLKPQNILI----KNNTLK 179
S E L F ++ Q++ ++F+ + H D+KP N L+ + N +
Sbjct: 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 146
Query: 180 LADFGFAQF--------LAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLG-VLVF 229
+ DFG A+ P + ++ G+ Y + G + + DL SLG VL++
Sbjct: 147 IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMY 205
|
| >2v6x_A Vacuolar protein sorting-associated protein 4; protein transport, vacuole, endosome, transport, ESCRT-III, VPS2, VPS4, SKD1, VPS4B, VPS4A; 1.98A {Saccharomyces cerevisiae} Length = 85 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 1e-05
Identities = 11/43 (25%), Positives = 17/43 (39%)
Query: 298 HAPCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIP 340
H + I +V AI D A++ Y L+YL+
Sbjct: 3 HMSTGDFLTKGIELVQKAIDLDTATQYEEAYTAYYNGLDYLML 45
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 22/97 (22%), Positives = 44/97 (45%), Gaps = 15/97 (15%)
Query: 148 QLVLALKFLRENNVCHFDLKPQNILI------KNNTLKLADFGFA-QFL-------APND 193
Q++ ++ + E ++ + D+KP N LI N + + DFG + P
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 173
Query: 194 QGDSIQGSPLYMAPEILAGSPYNAKADLWSLG-VLVF 229
+ ++ G+ YM+ G + + DL +LG V ++
Sbjct: 174 EKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMY 210
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 32/131 (24%), Positives = 55/131 (41%), Gaps = 15/131 (11%)
Query: 113 RYVYIILEYCDGGDLCS-FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
Y +++E G L F K S Q++ ++++ N H D+KP N
Sbjct: 78 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNF 136
Query: 172 LI----KNNTLKLADFGFAQFL--------APNDQGDSIQGSPLYMAPEILAGSPYNAKA 219
L+ K N + + DFG A+ P + ++ G+ Y + G + +
Sbjct: 137 LMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRD 196
Query: 220 DLWSLG-VLVF 229
DL SLG VL++
Sbjct: 197 DLESLGYVLMY 207
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 22/97 (22%), Positives = 46/97 (47%), Gaps = 15/97 (15%)
Query: 148 QLVLALKFLRENNVCHFDLKPQNILI------KNNTLKLADFGFA-QFLAPN-------D 193
QL+ ++++ N+ + D+KP+N LI + + DF A +++ P
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYR 172
Query: 194 QGDSIQGSPLYMAPEILAGSPYNAKADLWSLG-VLVF 229
+ S+ G+ YM+ G + + DL +LG + ++
Sbjct: 173 EHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMY 209
|
| >1wfd_A Hypothetical protein 1500032H18; MIT domain, structural genomics, riken structural genomics/proteomics initiative, RSGI, unknown function; NMR {Mus musculus} SCOP: a.7.14.1 Length = 93 | Back alignment and structure |
|---|
Score = 38.3 bits (89), Expect = 4e-04
Identities = 8/35 (22%), Positives = 18/35 (51%)
Query: 306 QTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIP 340
A+ ++ A+ D E+ ++A Y E ++ L+
Sbjct: 13 TAAVAVLKRAVELDAESRYQQALVCYQEGIDMLLQ 47
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 406 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.56 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.14 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.92 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.92 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.92 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.56 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.31 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.23 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.04 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.96 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.93 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.91 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.83 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.8 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.51 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.47 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.26 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.2 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.05 | |
| 4a5x_A | 86 | MITD1, MIT domain-containing protein 1; protein tr | 96.81 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.8 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.64 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.56 | |
| 2w2u_A | 83 | Hypothetical P60 katanin; hydrolase transport comp | 96.29 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.29 | |
| 2v6y_A | 83 | AAA family ATPase, P60 katanin; MIT, VPS4, archaea | 95.98 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.94 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.93 | |
| 1wfd_A | 93 | Hypothetical protein 1500032H18; MIT domain, struc | 95.74 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.2 | |
| 2v6x_A | 85 | Vacuolar protein sorting-associated protein 4; pro | 95.11 | |
| 2ymb_A | 257 | MITD1, MIT domain-containing protein 1; protein tr | 94.75 | |
| 2cpt_A | 117 | SKD1 protein, vacuolar sorting protein 4B; MIT, he | 94.52 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.43 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.46 | |
| 2w2u_A | 83 | Hypothetical P60 katanin; hydrolase transport comp | 85.95 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 84.56 | |
| 2v6x_A | 85 | Vacuolar protein sorting-associated protein 4; pro | 84.29 | |
| 4gco_A | 126 | Protein STI-1; structural genomics, PSI-biology, m | 80.67 | |
| 2rpa_A | 78 | Katanin P60 ATPase-containing subunit A1; AAA ATPa | 80.32 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-58 Score=444.80 Aligned_cols=241 Identities=25% Similarity=0.448 Sum_probs=217.1
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHH
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLC 128 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~ 128 (406)
.+||+|+||.||++... +..||+|++..........+.+|+.+|++++|||+++ +.+.+|||||||+||+|.
T Consensus 80 ~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~ 159 (346)
T 4fih_A 80 IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 159 (346)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHH
T ss_pred EEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHH
Confidence 46999999999999974 5679999988776667778999999999999999876 778999999999999999
Q ss_pred HHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCcccCCCCCCC
Q psy5368 129 SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDSIQGSPLYMA 206 (406)
Q Consensus 129 ~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~~~gt~~y~a 206 (406)
+++.+ +++++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+.+... ....+.+||+.|||
T Consensus 160 ~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmA 238 (346)
T 4fih_A 160 DIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 238 (346)
T ss_dssp HHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCC
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccccCcCcCC
Confidence 99976 5799999999999999999999999999999999999998 789999999999877544 34567889999999
Q ss_pred hhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC-CCCChHHHHHHHHhcccCCCCCCCH
Q psy5368 207 PEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP-NSLSPDCMDFLSRLLQKDPMRRISY 285 (406)
Q Consensus 207 PE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~~li~~~L~~dP~~Rps~ 285 (406)
||++.+..|+.++||||+||++|||++|++||.+.+..++...+........+. ..+|+++.+||.+||+.||++|||+
T Consensus 239 PEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta 318 (346)
T 4fih_A 239 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATA 318 (346)
T ss_dssp HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCH
Confidence 999999999999999999999999999999999999988888887765444332 3689999999999999999999999
Q ss_pred HHHhcCCCCCCCC
Q psy5368 286 EDLFSHPYPDLIH 298 (406)
Q Consensus 286 ~ell~hp~~~~~~ 298 (406)
+|+++||||+...
T Consensus 319 ~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 319 AELLKHPFLAKAG 331 (346)
T ss_dssp HHHTTCGGGGGCC
T ss_pred HHHhcCHhhcCCC
Confidence 9999999998654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-58 Score=437.51 Aligned_cols=244 Identities=25% Similarity=0.444 Sum_probs=217.3
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||+||++... +..+|+|.+.... ......+.+|+++|++|+|||+++ +.+++|||||||+|
T Consensus 37 ~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~g 116 (311)
T 4aw0_A 37 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 116 (311)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence 467899999999999864 4678999886543 234567899999999999999876 78899999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC---CCCcccC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND---QGDSIQG 200 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~---~~~~~~g 200 (406)
|+|.++|++.+.+++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+.+.... ...+.+|
T Consensus 117 G~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~G 196 (311)
T 4aw0_A 117 GELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 196 (311)
T ss_dssp EEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCS
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCccc
Confidence 99999999989999999999999999999999999999999999999998 7799999999999875432 3456789
Q ss_pred CCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCC
Q psy5368 201 SPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPM 280 (406)
Q Consensus 201 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~ 280 (406)
|+.|||||++.+..|+.++||||+||++|+|+||++||.+.+..++...+.... ..+| ..+|+++++||.+||+.||+
T Consensus 197 Tp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~~~p-~~~s~~~~dli~~lL~~dp~ 274 (311)
T 4aw0_A 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE-YDFP-EKFFPKARDLVEKLLVLDAT 274 (311)
T ss_dssp CGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCC-TTCCHHHHHHHHHHSCSSGG
T ss_pred CcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCC-cccCHHHHHHHHHHccCCHh
Confidence 999999999999999999999999999999999999999999999998888774 3444 47999999999999999999
Q ss_pred CCCCHHH------HhcCCCCCCCCCCC
Q psy5368 281 RRISYED------LFSHPYPDLIHAPC 301 (406)
Q Consensus 281 ~Rps~~e------ll~hp~~~~~~~~~ 301 (406)
+|||++| +++||||+...+..
T Consensus 275 ~R~t~~e~~~~~~i~~Hp~F~~idw~~ 301 (311)
T 4aw0_A 275 KRLGCEEMEGYGPLKAHPFFESVTWEN 301 (311)
T ss_dssp GSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred HCcChHHHcCCHHHHCCCCcCCCCHHH
Confidence 9999987 68999999887643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-57 Score=428.86 Aligned_cols=239 Identities=21% Similarity=0.405 Sum_probs=203.8
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCccc----------CCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRKR----------PRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~~----------~~~~~lV~E~ 121 (406)
..+||+|+||+||+|... +..||+|.+...... ....|.+|+.++++|+|||+++. .+.+||||||
T Consensus 31 ~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy 110 (290)
T 3fpq_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred eeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeC
Confidence 457999999999999875 456888887654322 34579999999999999998862 3568999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCcceEee--CCeeEEEecccccccCCCCCCCc
Q psy5368 122 CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENN--VCHFDLKPQNILIK--NNTLKLADFGFAQFLAPNDQGDS 197 (406)
Q Consensus 122 ~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dlkp~NIll~--~~~~kL~DFGla~~~~~~~~~~~ 197 (406)
|+||+|.+++++.+.+++..++.++.||+.||+|||++| |+||||||+|||++ ++.+||+|||+|+... .....+
T Consensus 111 ~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~-~~~~~~ 189 (290)
T 3fpq_A 111 MTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-ASFAKA 189 (290)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC-TTSBEE
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC-CCccCC
Confidence 999999999999899999999999999999999999999 99999999999997 5799999999997543 334456
Q ss_pred ccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcc
Q psy5368 198 IQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASC-NLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQ 276 (406)
Q Consensus 198 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~ 276 (406)
.+||+.|||||++.+ .|+.++|||||||++|||+||++||.+. +...+...+.....+...+..+++++.+||.+||+
T Consensus 190 ~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~ 268 (290)
T 3fpq_A 190 VIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 268 (290)
T ss_dssp SCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSC
T ss_pred cccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHcc
Confidence 789999999999875 5999999999999999999999999765 45555566655544433344688999999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCC
Q psy5368 277 KDPMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 277 ~dP~~Rps~~ell~hp~~~~ 296 (406)
.||++|||++|+++||||+.
T Consensus 269 ~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 269 QNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp SSGGGSCCHHHHHTSGGGC-
T ss_pred CChhHCcCHHHHhcCccccC
Confidence 99999999999999999974
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-57 Score=431.05 Aligned_cols=242 Identities=26% Similarity=0.415 Sum_probs=206.2
Q ss_pred eeeecceeeeEEEeeeee-----eceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEecc
Q psy5368 56 TIRYGELQYDTVQNSQIR-----LGTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYC 122 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~-----~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~ 122 (406)
...||+|+||+||++... +..+|+|.+..... .....+.+|+.++++++|||+++ +++.+|||||||
T Consensus 29 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~ 108 (304)
T 3ubd_A 29 LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFL 108 (304)
T ss_dssp EEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCC
T ss_pred EEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcC
Confidence 457899999999999752 34589988765432 23446889999999999999876 788999999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCcccC
Q psy5368 123 DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDSIQG 200 (406)
Q Consensus 123 ~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~~~g 200 (406)
+||+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+..... ....+.+|
T Consensus 109 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~G 188 (304)
T 3ubd_A 109 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG 188 (304)
T ss_dssp TTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CCCCSCCC
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCcccccccc
Confidence 9999999999989999999999999999999999999999999999999998 779999999999865433 34567789
Q ss_pred CCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCC
Q psy5368 201 SPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPM 280 (406)
Q Consensus 201 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~ 280 (406)
|+.|||||++.+..|+.++||||+||++|||+||++||.+.+..++...+.... ...| ..+|+++.+||.+||+.||+
T Consensus 189 T~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~p-~~~s~~~~~li~~~L~~dP~ 266 (304)
T 3ubd_A 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK-LGMP-QFLSPEAQSLLRMLFKRNPA 266 (304)
T ss_dssp CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCC-TTSCHHHHHHHHHHTCSSGG
T ss_pred CcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC-CCCC-CcCCHHHHHHHHHHcccCHH
Confidence 999999999999999999999999999999999999999999999988888764 3333 47999999999999999999
Q ss_pred CCCC-----HHHHhcCCCCCCCCC
Q psy5368 281 RRIS-----YEDLFSHPYPDLIHA 299 (406)
Q Consensus 281 ~Rps-----~~ell~hp~~~~~~~ 299 (406)
+||| ++|+++||||+...+
T Consensus 267 ~R~ta~~~~~~eil~Hp~f~~idw 290 (304)
T 3ubd_A 267 NRLGAGPDGVEEIKRHSFFSTIDW 290 (304)
T ss_dssp GSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred HCCCCCcCCHHHHHcCccccCCCH
Confidence 9998 589999999997654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-57 Score=444.77 Aligned_cols=242 Identities=25% Similarity=0.443 Sum_probs=217.8
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
-.+||+|+||.||++... +..||+|++..........+.+|+.+|++|+|||+++ +.+.+|||||||+||+|
T Consensus 156 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L 235 (423)
T 4fie_A 156 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 235 (423)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred eeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcH
Confidence 357999999999999974 5679999998777667778999999999999999876 77899999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCcccCCCCCC
Q psy5368 128 CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDSIQGSPLYM 205 (406)
Q Consensus 128 ~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~~~gt~~y~ 205 (406)
.++++. +.+++.++..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+.+... ....+.+||+.||
T Consensus 236 ~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~Ym 314 (423)
T 4fie_A 236 TDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWM 314 (423)
T ss_dssp HHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTC
T ss_pred HHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccccccCcCcC
Confidence 999976 5799999999999999999999999999999999999998 789999999999877544 3456788999999
Q ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC-CCCChHHHHHHHHhcccCCCCCCC
Q psy5368 206 APEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP-NSLSPDCMDFLSRLLQKDPMRRIS 284 (406)
Q Consensus 206 aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~~li~~~L~~dP~~Rps 284 (406)
|||++.+..|+.++|||||||++|||++|++||.+.+..++...+.......... ..+|+++++||.+||+.||++|||
T Consensus 315 APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t 394 (423)
T 4fie_A 315 APELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRAT 394 (423)
T ss_dssp CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCC
T ss_pred CHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcC
Confidence 9999999999999999999999999999999999999998888888775544332 378999999999999999999999
Q ss_pred HHHHhcCCCCCCCC
Q psy5368 285 YEDLFSHPYPDLIH 298 (406)
Q Consensus 285 ~~ell~hp~~~~~~ 298 (406)
++|+|+||||+...
T Consensus 395 a~ell~Hp~~~~~~ 408 (423)
T 4fie_A 395 AAELLKHPFLAKAG 408 (423)
T ss_dssp HHHHTTCGGGGGCC
T ss_pred HHHHhcCHHhcCCC
Confidence 99999999998654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-57 Score=439.06 Aligned_cols=240 Identities=25% Similarity=0.460 Sum_probs=206.3
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
-..||+|+||+||++... +..||+|.+...... ....+.+|+.++++|+|||+++ +.+.+|||||||+||
T Consensus 29 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg 108 (350)
T 4b9d_A 29 LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGG 108 (350)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence 356899999999999864 567999988765433 3457899999999999999876 778899999999999
Q ss_pred CHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCC
Q psy5368 126 DLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGS 201 (406)
Q Consensus 126 sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt 201 (406)
+|.++|..++ .+++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+...... .....+||
T Consensus 109 ~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT 188 (350)
T 4b9d_A 109 DLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGT 188 (350)
T ss_dssp BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSC
T ss_pred cHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccccccCCC
Confidence 9999997653 579999999999999999999999999999999999998 7899999999998764332 23456799
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
+.|||||++.+..|+.++||||+||++|||+||++||.+.+..++...+........+ ..+|+++.+||.+||+.||++
T Consensus 189 ~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~ 267 (350)
T 4b9d_A 189 PYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVS-LHYSYDLRSLVSQLFKRNPRD 267 (350)
T ss_dssp CTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCC-TTSCHHHHHHHHHHTCSSGGG
T ss_pred ccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCC-ccCCHHHHHHHHHHccCChhH
Confidence 9999999999999999999999999999999999999999999999998887655443 479999999999999999999
Q ss_pred CCCHHHHhcCCCCCC
Q psy5368 282 RISYEDLFSHPYPDL 296 (406)
Q Consensus 282 Rps~~ell~hp~~~~ 296 (406)
|||++|+++||||+.
T Consensus 268 R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 268 RPSVNSILEKGFIAK 282 (350)
T ss_dssp SCCHHHHHTSHHHHT
T ss_pred CcCHHHHhcCHHhhc
Confidence 999999999999974
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-57 Score=420.78 Aligned_cols=237 Identities=26% Similarity=0.502 Sum_probs=193.2
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
..||+|+||+||++... +..+|+|.+..... .....+.+|+.++++++|||+++ +.+.+|+||||| +|
T Consensus 19 ~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g 97 (275)
T 3hyh_A 19 KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GN 97 (275)
T ss_dssp EEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CE
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CC
Confidence 45677778888877653 45788887765432 23457899999999999999876 788999999999 67
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLY 204 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y 204 (406)
+|.+++.+++++++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+.........+.+||+.|
T Consensus 98 ~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y 177 (275)
T 3hyh_A 98 ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNY 177 (275)
T ss_dssp EHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------------CTT
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCCeeECccc
Confidence 9999999999999999999999999999999999999999999999998 779999999999887766666778999999
Q ss_pred CChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 205 MAPEILAGSPY-NAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 205 ~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
||||++.+..| +.++||||+||++|+|+||+.||.+.+...+...+.... ...| ..+|+++++||.+||+.||++||
T Consensus 178 ~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~-~~~p-~~~s~~~~~li~~~L~~dP~~R~ 255 (275)
T 3hyh_A 178 AAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV-YTLP-KFLSPGAAGLIKRMLIVNPLNRI 255 (275)
T ss_dssp SCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCC-TTSCHHHHHHHHHHSCSSGGGSC
T ss_pred CChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCCC-CCCCHHHHHHHHHHccCChhHCc
Confidence 99999998876 579999999999999999999999999988888887763 3333 47999999999999999999999
Q ss_pred CHHHHhcCCCCCC
Q psy5368 284 SYEDLFSHPYPDL 296 (406)
Q Consensus 284 s~~ell~hp~~~~ 296 (406)
|++|+++||||+.
T Consensus 256 s~~eil~hpw~k~ 268 (275)
T 3hyh_A 256 SIHEIMQDDWFKV 268 (275)
T ss_dssp CHHHHHHCHHHHT
T ss_pred CHHHHHcCccccc
Confidence 9999999999973
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-56 Score=429.82 Aligned_cols=241 Identities=26% Similarity=0.399 Sum_probs=207.7
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
..+||+|+||.||++... +..||+|.+..+. ...+|+.++++|+|||+++ +.+.+|||||||+||+|
T Consensus 63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 137 (336)
T 4g3f_A 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred CcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence 457999999999999974 5679999886542 2467999999999999876 77889999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC-eeEEEecccccccCCCCC------CCccc
Q psy5368 128 CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN-TLKLADFGFAQFLAPNDQ------GDSIQ 199 (406)
Q Consensus 128 ~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~-~~kL~DFGla~~~~~~~~------~~~~~ 199 (406)
.++|++.+++++.+++.++.||+.||+|||++||+||||||+|||++ ++ .+||+|||+|+.+..... ....+
T Consensus 138 ~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~ 217 (336)
T 4g3f_A 138 GQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217 (336)
T ss_dssp HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCC
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccc
Confidence 99999889999999999999999999999999999999999999998 55 699999999987754332 23467
Q ss_pred CCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-CCCCCCChHHHHHHHHhcccC
Q psy5368 200 GSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPIT-IPPNSLSPDCMDFLSRLLQKD 278 (406)
Q Consensus 200 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~s~~l~~li~~~L~~d 278 (406)
||+.|||||++.+..|+.++||||+||++|||+||++||.+.+..++...+....... ..+..+|+++.+||.+||+.|
T Consensus 218 GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~d 297 (336)
T 4g3f_A 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKE 297 (336)
T ss_dssp CCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSS
T ss_pred cCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCC
Confidence 9999999999999999999999999999999999999999888777777777664432 223479999999999999999
Q ss_pred CCCCCCHHHH-------------hcCCCCCCCCCCC
Q psy5368 279 PMRRISYEDL-------------FSHPYPDLIHAPC 301 (406)
Q Consensus 279 P~~Rps~~el-------------l~hp~~~~~~~~~ 301 (406)
|.+|||+.|+ ++|||+.....|.
T Consensus 298 P~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr 333 (336)
T 4g3f_A 298 PVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR 333 (336)
T ss_dssp GGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred HhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence 9999999997 5799998766554
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-55 Score=413.21 Aligned_cols=233 Identities=21% Similarity=0.366 Sum_probs=204.9
Q ss_pred eeeecceeeeEEEeeeee-------eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEecc
Q psy5368 56 TIRYGELQYDTVQNSQIR-------LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYC 122 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~-------~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~ 122 (406)
.+.||+|+||+||+|.+. +..||+|.+........++|.+|++++++|+|||+++ +.+.+|||||||
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~ 97 (299)
T 4asz_A 18 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYM 97 (299)
T ss_dssp EEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcC
Confidence 467999999999999863 3468999887665555678999999999999999877 677899999999
Q ss_pred CCCCHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccc
Q psy5368 123 DGGDLCSFIRSH-------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQF 188 (406)
Q Consensus 123 ~ggsL~~~l~~~-------------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~ 188 (406)
+||||.++|+.+ ..+++.++..++.||+.||+|||+++|+||||||+|||++ ++.+||+|||+|+.
T Consensus 98 ~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~ 177 (299)
T 4asz_A 98 KHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRD 177 (299)
T ss_dssp TTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHH
T ss_pred CCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCccccee
Confidence 999999999764 3699999999999999999999999999999999999999 67999999999987
Q ss_pred cCCCCC---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q psy5368 189 LAPNDQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLS 264 (406)
Q Consensus 189 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s 264 (406)
...... .....||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..++...+..+.....|+ .+|
T Consensus 178 ~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~-~~~ 256 (299)
T 4asz_A 178 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPR-TCP 256 (299)
T ss_dssp HTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCCCCT-TCC
T ss_pred cCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCc-cch
Confidence 644332 334568999999999999999999999999999999998 999999999999999888886665554 799
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHh
Q psy5368 265 PDCMDFLSRLLQKDPMRRISYEDLF 289 (406)
Q Consensus 265 ~~l~~li~~~L~~dP~~Rps~~ell 289 (406)
+++.+|+.+||+.||++|||+++++
T Consensus 257 ~~~~~li~~cl~~dP~~RPs~~~i~ 281 (299)
T 4asz_A 257 QEVYELMLGCWQREPHMRKNIKGIH 281 (299)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHH
Confidence 9999999999999999999999984
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-54 Score=414.85 Aligned_cols=235 Identities=22% Similarity=0.358 Sum_probs=201.5
Q ss_pred eeeecceeeeEEEeeeee-------eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEecc
Q psy5368 56 TIRYGELQYDTVQNSQIR-------LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYC 122 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~-------~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~ 122 (406)
..+||+|+||.||+|++. ...||||.+........++|.+|+++|++|+|||+++ +.+.+|||||||
T Consensus 46 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~ 125 (329)
T 4aoj_A 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYM 125 (329)
T ss_dssp EEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred EEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 457999999999999864 3568999987665556678999999999999999876 667899999999
Q ss_pred CCCCHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccc
Q psy5368 123 DGGDLCSFIRSH---------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFA 186 (406)
Q Consensus 123 ~ggsL~~~l~~~---------------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla 186 (406)
++|+|.++++.. +++++.++..|+.||+.||+|||+++|+||||||+|||++ ++.+||+|||+|
T Consensus 126 ~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla 205 (329)
T 4aoj_A 126 RHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205 (329)
T ss_dssp TTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred CCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccc
Confidence 999999999754 3599999999999999999999999999999999999999 679999999999
Q ss_pred cccCCCC---CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q psy5368 187 QFLAPND---QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNS 262 (406)
Q Consensus 187 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (406)
+...... ......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..++...+..+.....|+ .
T Consensus 206 ~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~~p~-~ 284 (329)
T 4aoj_A 206 RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPR-A 284 (329)
T ss_dssp --------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCCCCCT-T
T ss_pred eeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCcc-c
Confidence 8764433 2345679999999999999999999999999999999999 999999999999988888876666554 7
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 263 LSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 263 ~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
+|+++.+|+.+||+.||++|||++|++++
T Consensus 285 ~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 285 CPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp CCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred ccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 99999999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=405.44 Aligned_cols=234 Identities=22% Similarity=0.357 Sum_probs=190.9
Q ss_pred eeeecceeeeEEEeeeeeeceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCCCCHH
Q psy5368 56 TIRYGELQYDTVQNSQIRLGTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDGGDLC 128 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ggsL~ 128 (406)
..+||+|+||+||+|.++ +.||||.++.... ...+.|.+|+.++++++|||++. ..+.+|||||||+||+|.
T Consensus 41 ~~~iG~G~fG~Vy~~~~~-~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmEy~~gGsL~ 119 (307)
T 3omv_A 41 STRIGSGSFGTVYKGKWH-GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLY 119 (307)
T ss_dssp EEECCCCSSSEEEEEESS-SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCSSCBHH
T ss_pred eeEEeeCCCcEEEEEEEC-CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEEcCCCCCHH
Confidence 567999999999999875 4688887764432 23457999999999999999887 556689999999999999
Q ss_pred HHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC---CCCCcccCCCC
Q psy5368 129 SFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN---DQGDSIQGSPL 203 (406)
Q Consensus 129 ~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~---~~~~~~~gt~~ 203 (406)
++|... .++++.++..|+.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+..... ......+||+.
T Consensus 120 ~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ 199 (307)
T 3omv_A 120 KHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVL 199 (307)
T ss_dssp HHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTT
T ss_pred HHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCC
Confidence 999765 5799999999999999999999999999999999999999 569999999999876432 23355689999
Q ss_pred CCChhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhcCCCC---CCCCCCChHHHHHHHHhcc
Q psy5368 204 YMAPEILAG---SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQA-LSSAPIT---IPPNSLSPDCMDFLSRLLQ 276 (406)
Q Consensus 204 y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~-~~~~~~~---~~~~~~s~~l~~li~~~L~ 276 (406)
|||||++.+ ..|+.++|||||||+||||+||+.||.+.+........ ....... ..+..+|+++.+|+.+||+
T Consensus 200 ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~ 279 (307)
T 3omv_A 200 WMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVK 279 (307)
T ss_dssp SCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTC
T ss_pred ccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcC
Confidence 999999974 35899999999999999999999999886654443333 3332221 1234789999999999999
Q ss_pred cCCCCCCCHHHHhc
Q psy5368 277 KDPMRRISYEDLFS 290 (406)
Q Consensus 277 ~dP~~Rps~~ell~ 290 (406)
.||++|||+.|+++
T Consensus 280 ~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 280 KVKEERPLFPQILS 293 (307)
T ss_dssp SSSTTSCCHHHHHH
T ss_pred CCHhHCcCHHHHHH
Confidence 99999999998753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-54 Score=408.06 Aligned_cols=235 Identities=20% Similarity=0.347 Sum_probs=205.5
Q ss_pred eeeecceeeeEEEeeeee-------eceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIR-------LGTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~-------~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~ 121 (406)
..+||+|+||+||+|.+. ...||||.+..... ...++|.+|+.++++|+|||+++ ..+.+||||||
T Consensus 31 ~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey 110 (308)
T 4gt4_A 31 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSY 110 (308)
T ss_dssp EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEc
Confidence 457999999999999863 35689998865443 33568999999999999999876 56778999999
Q ss_pred cCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecc
Q psy5368 122 CDGGDLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFG 184 (406)
Q Consensus 122 ~~ggsL~~~l~~~----------------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFG 184 (406)
|++|||.++|..+ ..+++.++..|+.||+.||+|||+++|+||||||+|||++ ++.+||+|||
T Consensus 111 ~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFG 190 (308)
T 4gt4_A 111 CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLG 190 (308)
T ss_dssp CSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSC
T ss_pred CCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcc
Confidence 9999999999653 3589999999999999999999999999999999999999 6799999999
Q ss_pred cccccCCCC---CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCC
Q psy5368 185 FAQFLAPND---QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPP 260 (406)
Q Consensus 185 la~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (406)
+|+...... ......||+.|||||++.++.|+.++|||||||+||||+| |..||.+.+..++...+..+...+.|+
T Consensus 191 lar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~ 270 (308)
T 4gt4_A 191 LFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPD 270 (308)
T ss_dssp CBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCCCCT
T ss_pred cceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence 998764332 2345679999999999999999999999999999999998 899999999999998888876655544
Q ss_pred CCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 261 NSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 261 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
.+|+++.+|+.+||+.||++|||+.||+++
T Consensus 271 -~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 271 -DCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -cchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 799999999999999999999999999875
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-54 Score=407.87 Aligned_cols=243 Identities=21% Similarity=0.379 Sum_probs=184.6
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCccc------------------CCe
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRKR------------------PRY 114 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~~------------------~~~ 114 (406)
-..||+|+||+||++... +..+|+|++...... ....+.+|+.+|++|+|||+++. ..+
T Consensus 10 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~ 89 (299)
T 4g31_A 10 IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVY 89 (299)
T ss_dssp EEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEE
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcE
Confidence 357899999999999864 567899988755433 34578999999999999998862 224
Q ss_pred EEEEEeccCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccC
Q psy5368 115 VYIILEYCDGGDLCSFIRSHEK---LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLA 190 (406)
Q Consensus 115 ~~lV~E~~~ggsL~~~l~~~~~---l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~ 190 (406)
+|||||||+||+|.+++..+.. .++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+...
T Consensus 90 l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~ 169 (299)
T 4g31_A 90 LYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 169 (299)
T ss_dssp EEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC----
T ss_pred EEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecC
Confidence 7999999999999999987654 45677899999999999999999999999999999998 7899999999998765
Q ss_pred CCCC-------------CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCC
Q psy5368 191 PNDQ-------------GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLS-QLRAQALSSAPI 256 (406)
Q Consensus 191 ~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~ 256 (406)
.... ....+||+.|||||++.+..|+.++||||+||++|||++ ||.+.... .....+.....+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~p 246 (299)
T 4g31_A 170 QDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFP 246 (299)
T ss_dssp ----------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCCC
T ss_pred CCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCCC
Confidence 4322 234579999999999999999999999999999999996 77653221 222222222111
Q ss_pred CCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCc
Q psy5368 257 TIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCA 302 (406)
Q Consensus 257 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~ 302 (406)
.. ....++.+.+||.+||+.||++|||+.|+++||||+...+|..
T Consensus 247 ~~-~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~~ 291 (299)
T 4g31_A 247 PL-FTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGK 291 (299)
T ss_dssp HH-HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-----
T ss_pred CC-CcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCCc
Confidence 11 1245677899999999999999999999999999998877653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-53 Score=416.43 Aligned_cols=246 Identities=25% Similarity=0.363 Sum_probs=206.8
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCcc------------cCCeEEEEE
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRK------------RPRYVYIIL 119 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~------------~~~~~~lV~ 119 (406)
...||+|+||+||++... +..||+|++..... .....+.+|+.+|+.|+|||++. +.+.+||||
T Consensus 59 ~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivm 138 (398)
T 4b99_A 59 IETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVL 138 (398)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEE
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEE
Confidence 457899999999999864 56799998865432 23457889999999999999876 236789999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-----C
Q psy5368 120 EYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-----D 193 (406)
Q Consensus 120 E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-----~ 193 (406)
|||+ |+|.+++..++++++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+.+... .
T Consensus 139 E~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~ 217 (398)
T 4b99_A 139 DLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQY 217 (398)
T ss_dssp ECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CC
T ss_pred eCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCcccccc
Confidence 9996 58999999888999999999999999999999999999999999999999 779999999999876432 2
Q ss_pred CCCcccCCCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---------------
Q psy5368 194 QGDSIQGSPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPIT--------------- 257 (406)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--------------- 257 (406)
...+.+||+.|||||++.+. .++.++||||+|||+|||++|++||.+.+..+....+.......
T Consensus 218 ~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~ 297 (398)
T 4b99_A 218 FMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRA 297 (398)
T ss_dssp CCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHH
T ss_pred ccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhh
Confidence 34567899999999998875 46999999999999999999999999998888777765431110
Q ss_pred ----CC----------CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCc
Q psy5368 258 ----IP----------PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCA 302 (406)
Q Consensus 258 ----~~----------~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~ 302 (406)
.+ ...+|+++.+||.+||+.||++|||++|+|+||||+..+.|..
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~ 356 (398)
T 4b99_A 298 YIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDD 356 (398)
T ss_dssp HHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGG
T ss_pred hhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCcc
Confidence 00 0246899999999999999999999999999999997765543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-52 Score=402.49 Aligned_cols=237 Identities=22% Similarity=0.322 Sum_probs=191.1
Q ss_pred eeeecceeeeEEEeeeee-----eceeEEeeeecCCccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIR-----LGTVKYSQVRYDTITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~-----~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~ 123 (406)
...||+|+||+||++..+ ...||+|.+... ....++.+|+++|..+ +|||++. ..+++|||||||+
T Consensus 26 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~ 103 (361)
T 4f9c_A 26 EDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLE 103 (361)
T ss_dssp EEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCC
T ss_pred EEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCC
Confidence 457899999999999753 456888877543 3456788999999998 6999876 7789999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-C-CeeEEEecccccccCCCC--------
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-N-NTLKLADFGFAQFLAPND-------- 193 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~-~~~kL~DFGla~~~~~~~-------- 193 (406)
||+|.+++ +.+++.+++.++.||+.||+|||++||+||||||+|||++ + +.+||+|||+|+......
T Consensus 104 g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 180 (361)
T 4f9c_A 104 HESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQ 180 (361)
T ss_dssp CCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC-
T ss_pred cccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccccccc
Confidence 99999998 4699999999999999999999999999999999999998 3 699999999997653321
Q ss_pred ---------------------CCCcccCCCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHH
Q psy5368 194 ---------------------QGDSIQGSPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASC-NLSQLRAQA 250 (406)
Q Consensus 194 ---------------------~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~-~~~~~~~~~ 250 (406)
...+.+||+.|+|||++.+. .|+.++||||+|||+|||+||++||... +..+....+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I 260 (361)
T 4f9c_A 181 SEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQI 260 (361)
T ss_dssp -------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence 12345799999999999876 4899999999999999999999999543 332222222
Q ss_pred Hhc-------------------------------------CCC---------------CCCCCCCChHHHHHHHHhcccC
Q psy5368 251 LSS-------------------------------------API---------------TIPPNSLSPDCMDFLSRLLQKD 278 (406)
Q Consensus 251 ~~~-------------------------------------~~~---------------~~~~~~~s~~l~~li~~~L~~d 278 (406)
... ... ......+|+++.|||.+||+.|
T Consensus 261 ~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~d 340 (361)
T 4f9c_A 261 MTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLN 340 (361)
T ss_dssp HHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSC
T ss_pred HHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCC
Confidence 110 000 0011257899999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCC
Q psy5368 279 PMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 279 P~~Rps~~ell~hp~~~~~ 297 (406)
|++|||++|+|+||||+..
T Consensus 341 P~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 341 PASRITAEEALLHPFFKDM 359 (361)
T ss_dssp TTTSCCHHHHHTSGGGTTC
T ss_pred hhHCcCHHHHhcCcccCCC
Confidence 9999999999999999865
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=404.30 Aligned_cols=235 Identities=21% Similarity=0.380 Sum_probs=199.3
Q ss_pred eeeecceeeeEEEeeeeee-------ceeEEeeeecCCcc-chhhhhhHHhhcccCCC-CCCcc-------cCCeEEEEE
Q psy5368 56 TIRYGELQYDTVQNSQIRL-------GTVKYSQVRYDTIT-SHSEFERPRAGLSNLRA-PEGRK-------RPRYVYIIL 119 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-------~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h-~ni~~-------~~~~~~lV~ 119 (406)
...||+|+||.||+|.+.. +.||+|.+...... ....|.+|+.+|.+++| ||+++ ..+.+||||
T Consensus 69 ~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~ 148 (353)
T 4ase_A 69 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 148 (353)
T ss_dssp EEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEE
T ss_pred eeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEE
Confidence 4579999999999998643 46888888655433 34579999999999976 88875 345689999
Q ss_pred eccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEe
Q psy5368 120 EYCDGGDLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLAD 182 (406)
Q Consensus 120 E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~D 182 (406)
|||++|+|.++|+.. ..+++.++..++.||+.||+|||+++|+||||||+|||++ ++.+||+|
T Consensus 149 Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~D 228 (353)
T 4ase_A 149 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICD 228 (353)
T ss_dssp ECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred EcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECc
Confidence 999999999999753 3489999999999999999999999999999999999998 67999999
Q ss_pred cccccccCCCCC---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH-HHHHHHHhcCCCC
Q psy5368 183 FGFAQFLAPNDQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLS-QLRAQALSSAPIT 257 (406)
Q Consensus 183 FGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~-~~~~~~~~~~~~~ 257 (406)
||+|+.+..... .....||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+.. .+...+..+....
T Consensus 229 FGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~ 308 (353)
T 4ase_A 229 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 308 (353)
T ss_dssp CGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC
T ss_pred chhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCC
Confidence 999987654432 235678999999999999999999999999999999998 99999987644 4455555555555
Q ss_pred CCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 258 IPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 258 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
.| ..+|+++.+|+.+||+.||++|||+.|+++|
T Consensus 309 ~p-~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 309 AP-DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp CC-TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC-ccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 44 4789999999999999999999999999987
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=424.80 Aligned_cols=247 Identities=28% Similarity=0.428 Sum_probs=219.5
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
...||+|+||.||++... +..+|+|.+..........+.+|+.+|+.|+|||+++ +.+.+|||||||+||+|
T Consensus 162 ~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L 241 (573)
T 3uto_A 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 241 (573)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBH
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcH
Confidence 357999999999999874 4678999887766556678999999999999999876 78899999999999999
Q ss_pred HHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee---CCeeEEEecccccccCCCCCCCcccCCCC
Q psy5368 128 CSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK---NNTLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 128 ~~~l~~-~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~---~~~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
.++|.. ++.+++.+++.++.||+.||+|||++||+||||||+|||++ .+.+||+|||+|+.+.........+||+.
T Consensus 242 ~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~ 321 (573)
T 3uto_A 242 FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAE 321 (573)
T ss_dssp HHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGG
T ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEECcc
Confidence 999964 45899999999999999999999999999999999999997 36899999999998877666677889999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCChHHHHHHHHhcccCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIP--PNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~s~~l~~li~~~L~~dP~~ 281 (406)
|||||++.+..|+.++||||+||++|+|++|.+||.+.+..+....+......... ...+|+++++||.+||+.||.+
T Consensus 322 y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~ 401 (573)
T 3uto_A 322 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNT 401 (573)
T ss_dssp GCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGG
T ss_pred ccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhH
Confidence 99999999999999999999999999999999999999999988888776432211 2368999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCCCc
Q psy5368 282 RISYEDLFSHPYPDLIHAPCA 302 (406)
Q Consensus 282 Rps~~ell~hp~~~~~~~~~~ 302 (406)
|||+.|+|+||||+...+|..
T Consensus 402 R~t~~e~l~Hpw~~~~~~~~~ 422 (573)
T 3uto_A 402 RMTIHQALEHPWLTPGNAPGR 422 (573)
T ss_dssp SCCHHHHHHSTTTSCCCCTTT
T ss_pred CcCHHHHhcCcCcCCCCCCCc
Confidence 999999999999998776643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=415.77 Aligned_cols=242 Identities=24% Similarity=0.385 Sum_probs=204.3
Q ss_pred ceeeecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhh---hHHhhcccCCCCCCcc------cCCeEEEEEe
Q psy5368 55 STIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFE---RPRAGLSNLRAPEGRK------RPRYVYIILE 120 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~---~E~~~l~~l~h~ni~~------~~~~~~lV~E 120 (406)
...+||+|+||.||++... +..+|+|.+..... .....+. +++.+++.++|||++. +.+++|||||
T Consensus 193 i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmE 272 (689)
T 3v5w_A 193 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 272 (689)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEe
Confidence 3467899999999999874 45789998765332 1222233 3467888999999876 7889999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCccc
Q psy5368 121 YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQ 199 (406)
Q Consensus 121 ~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~ 199 (406)
||+||+|.++|.+.+.+++..++.++.||+.||+|||++||+||||||+|||++ +|.+||+|||+|+..... ...+.+
T Consensus 273 y~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~-~~~t~~ 351 (689)
T 3v5w_A 273 LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASV 351 (689)
T ss_dssp CCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-CCCSCC
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC-CCCCcc
Confidence 999999999999989999999999999999999999999999999999999999 789999999999876544 345678
Q ss_pred CCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhc
Q psy5368 200 GSPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASC---NLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL 275 (406)
Q Consensus 200 gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~---~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L 275 (406)
||+.|||||++.+ ..|+.++||||+||++|||++|.+||.+. +...+...+... ....| ..+|+++++||.+||
T Consensus 352 GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~-~~~~p-~~~S~~a~dLI~~lL 429 (689)
T 3v5w_A 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-AVELP-DSFSPELRSLLEGLL 429 (689)
T ss_dssp SCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC-CCCCC-TTSCHHHHHHHHHHT
T ss_pred CCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC-CCCCC-ccCCHHHHHHHHHHc
Confidence 9999999999975 57999999999999999999999999764 344455555444 33444 479999999999999
Q ss_pred ccCCCCCCC-----HHHHhcCCCCCCCCC
Q psy5368 276 QKDPMRRIS-----YEDLFSHPYPDLIHA 299 (406)
Q Consensus 276 ~~dP~~Rps-----~~ell~hp~~~~~~~ 299 (406)
+.||.+|++ ++|+++||||+.+.|
T Consensus 430 ~~dP~~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 430 QRDVNRRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp CSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred cCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence 999999998 799999999998765
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=377.94 Aligned_cols=234 Identities=18% Similarity=0.192 Sum_probs=182.8
Q ss_pred eeeecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCccc----------CCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRKR----------PRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~----------~~~~~lV~E~~~gg 125 (406)
..+||+|+||+||+|.+.+..||||.+.... .....+..|+..+.+++|||+++. ...+|||||||+||
T Consensus 8 ~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~g 86 (303)
T 3hmm_A 8 QESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG 86 (303)
T ss_dssp EEEEEECSSSEEEEEEETTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred EEEEeeCCCeEEEEEEECCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCC
Confidence 4579999999999999998999999886432 122234567778889999998861 12579999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccccCCCcceEee-CCeeEEEecccccccCCCCC--
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLREN--------NVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ-- 194 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~--------givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~-- 194 (406)
+|.++|+. .++++..+.+++.|++.||+|||++ +|+||||||+|||++ ++.+||+|||+|+.......
T Consensus 87 sL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 165 (303)
T 3hmm_A 87 SLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 165 (303)
T ss_dssp BHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEE
T ss_pred cHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCce
Confidence 99999976 4699999999999999999999987 999999999999999 77999999999987654332
Q ss_pred ---CCcccCCCCCCChhhhcCC------CCCchhhHHHHHHHHHHHHhCCCCCCCC---------------CHHHHHHHH
Q psy5368 195 ---GDSIQGSPLYMAPEILAGS------PYNAKADLWSLGVLVFEALFGHAPYASC---------------NLSQLRAQA 250 (406)
Q Consensus 195 ---~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltg~~pf~~~---------------~~~~~~~~~ 250 (406)
.....||+.|||||++.+. .++.++|||||||+||||+||.+||... ....+...+
T Consensus 166 ~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 245 (303)
T 3hmm_A 166 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245 (303)
T ss_dssp SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHH
T ss_pred eeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHH
Confidence 2345799999999999765 3678999999999999999997765321 233444443
Q ss_pred HhcC-CCCCCCC----CCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 251 LSSA-PITIPPN----SLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 251 ~~~~-~~~~~~~----~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
.... .+..|.. ..++.+.+|+.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 3332 2222221 123568899999999999999999999863
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=373.50 Aligned_cols=242 Identities=28% Similarity=0.529 Sum_probs=212.0
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...||+|+||.||++.. .+..|++|.+..... .....+.+|+.+++.++|||+++ ..+.+|+||||++||
T Consensus 20 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~ 99 (328)
T 3fe3_A 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG 99 (328)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCC
Confidence 45678888888888875 456788888765432 23456889999999999999876 778899999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLY 204 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y 204 (406)
+|.+++..++.+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||++.............||+.|
T Consensus 100 ~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y 179 (328)
T 3fe3_A 100 EVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPY 179 (328)
T ss_dssp BHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGTTSSSGGG
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccccccCCcce
Confidence 9999998888999999999999999999999999999999999999999 779999999999887666666677899999
Q ss_pred CChhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 205 MAPEILAGSPYN-AKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 205 ~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
+|||++.+..++ .++||||+||++|+|++|+.||.+.+...+...+..... ..| ..+|+++.+|+.+||+.||.+||
T Consensus 180 ~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~p-~~~s~~~~~li~~~L~~dP~~R~ 257 (328)
T 3fe3_A 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIP-FYMSTDCENLLKRFLVLNPIKRG 257 (328)
T ss_dssp CCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCC-TTSCHHHHHHHHHHCCSSTTTSC
T ss_pred eCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCC-CCCCHHHHHHHHHHCCCChhHCc
Confidence 999999988865 799999999999999999999999999998888877633 333 36899999999999999999999
Q ss_pred CHHHHhcCCCCCCCCC
Q psy5368 284 SYEDLFSHPYPDLIHA 299 (406)
Q Consensus 284 s~~ell~hp~~~~~~~ 299 (406)
|++|+++||||+....
T Consensus 258 t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 258 TLEQIMKDRWINAGHE 273 (328)
T ss_dssp CHHHHTTCTTTTTTCT
T ss_pred CHHHHhcCHhhcCCCc
Confidence 9999999999986543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=372.44 Aligned_cols=243 Identities=27% Similarity=0.441 Sum_probs=212.2
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc------chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT------SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~------~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~ 121 (406)
...||+|+||.||++... +..+++|.+...... ....+.+|+.++.+++|||++. ..+.+|+||||
T Consensus 17 ~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~ 96 (361)
T 2yab_A 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILEL 96 (361)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEc
Confidence 457899999999999864 456888877654432 2457899999999999999876 67889999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC----eeEEEecccccccCCCCCCC
Q psy5368 122 CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN----TLKLADFGFAQFLAPNDQGD 196 (406)
Q Consensus 122 ~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~----~~kL~DFGla~~~~~~~~~~ 196 (406)
|+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ ++ .+||+|||++..........
T Consensus 97 ~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 176 (361)
T 2yab_A 97 VSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176 (361)
T ss_dssp CCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCC
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccc
Confidence 99999999998888999999999999999999999999999999999999997 33 69999999998877666666
Q ss_pred cccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCChHHHHHHHHh
Q psy5368 197 SIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIP--PNSLSPDCMDFLSRL 274 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~s~~l~~li~~~ 274 (406)
...||+.|+|||++.+..++.++||||+||++|+|++|.+||.+.+..+....+........+ ...+|+++.+||.+|
T Consensus 177 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 256 (361)
T 2yab_A 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKL 256 (361)
T ss_dssp CCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHH
T ss_pred cCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHH
Confidence 778999999999999999999999999999999999999999999988888877765332211 136899999999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 275 LQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 275 L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
|..||.+|||+.|+++||||+...
T Consensus 257 L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 257 LVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp SCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred CCCChhHCcCHHHHhcCcCcCCCc
Confidence 999999999999999999998543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=362.77 Aligned_cols=243 Identities=26% Similarity=0.434 Sum_probs=211.1
Q ss_pred ceeeecceeeeEEEeeee--eeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 55 STIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
....||+|+||+||++.. .+..+++|.+..........+.+|+.++++++|||+++ ..+.+|+|||||+||+
T Consensus 24 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (297)
T 3fxz_A 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (297)
T ss_dssp CCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred eeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCC
Confidence 345789999999999974 45678999887776667778999999999999999876 6678999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCCC
Q psy5368 127 LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPLY 204 (406)
Q Consensus 127 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~y 204 (406)
|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++ ++.+||+|||++....... ......||+.|
T Consensus 104 L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y 182 (297)
T 3fxz_A 104 LTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182 (297)
T ss_dssp HHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGG
T ss_pred HHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccCCcCc
Confidence 99999774 699999999999999999999999999999999999998 7799999999998765443 33456799999
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-CCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITI-PPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
+|||++.+..++.++||||+||++|+|++|..||.+.+.......+........ .+..+++.+.+|+.+||+.||++||
T Consensus 183 ~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 262 (297)
T 3fxz_A 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRG 262 (297)
T ss_dssp CCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSC
T ss_pred cChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCc
Confidence 999999999999999999999999999999999999887776666655443332 2347899999999999999999999
Q ss_pred CHHHHhcCCCCCCCC
Q psy5368 284 SYEDLFSHPYPDLIH 298 (406)
Q Consensus 284 s~~ell~hp~~~~~~ 298 (406)
|++|+++||||+...
T Consensus 263 s~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 263 SAKELLQHQFLKIAK 277 (297)
T ss_dssp CHHHHTTCGGGGGCC
T ss_pred CHHHHhhChhhcccC
Confidence 999999999998654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=368.16 Aligned_cols=242 Identities=24% Similarity=0.414 Sum_probs=210.9
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++... +..+++|.+.... ......+.+|+.++..++|||++. ..+.+|+||||++|
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~g 89 (337)
T 1o6l_A 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 456788999999988764 4568888776542 234557889999999999999876 67889999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCC-CCCCCcccCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAP-NDQGDSIQGSP 202 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~-~~~~~~~~gt~ 202 (406)
|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++.... .......+||+
T Consensus 90 g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~ 169 (337)
T 1o6l_A 90 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 169 (337)
T ss_dssp CBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECG
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcccccccCh
Confidence 99999999888999999999999999999999999999999999999998 78999999999986432 33455678999
Q ss_pred CCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCC
Q psy5368 203 LYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRR 282 (406)
Q Consensus 203 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 282 (406)
.|+|||++.+..++.++||||+||++|||++|..||.+.+...+...+.... ...| ..+|+++.+||.+||+.||++|
T Consensus 170 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p-~~~s~~~~~li~~lL~~dP~~R 247 (337)
T 1o6l_A 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFP-RTLSPEAKSLLAGLLKKDPKQR 247 (337)
T ss_dssp GGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCC-TTSCHHHHHHHHHHTCSSTTTS
T ss_pred hhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCC-CCCCHHHHHHHHHHhhcCHHHh
Confidence 9999999999999999999999999999999999999999888888777653 3333 3689999999999999999999
Q ss_pred C-----CHHHHhcCCCCCCCCC
Q psy5368 283 I-----SYEDLFSHPYPDLIHA 299 (406)
Q Consensus 283 p-----s~~ell~hp~~~~~~~ 299 (406)
| +++++++||||+...+
T Consensus 248 ~g~~~~~~~ei~~h~~f~~~~~ 269 (337)
T 1o6l_A 248 LGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp TTCSTTTHHHHHTSGGGTTCCH
T ss_pred cCCCCCCHHHHHcCCCcCCCCH
Confidence 9 8999999999987654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=385.16 Aligned_cols=325 Identities=22% Similarity=0.359 Sum_probs=239.7
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...||+|+||+||++... +..+++|.+.... ......+.+|+.++++++|||+++ ..+.+|+|||||+||
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 106 (486)
T 3mwu_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG 106 (486)
T ss_dssp EEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCC
Confidence 446777888888887753 4568888765432 234567899999999999999876 678899999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee----CCeeEEEecccccccCCCCCCCcccCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK----NNTLKLADFGFAQFLAPNDQGDSIQGS 201 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~----~~~~kL~DFGla~~~~~~~~~~~~~gt 201 (406)
+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++............||
T Consensus 107 ~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt 186 (486)
T 3mwu_A 107 ELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGT 186 (486)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTG
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCC
Confidence 9999998888999999999999999999999999999999999999996 347999999999887766666677899
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCChHHHHHHHHhcccCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP--NSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~~li~~~L~~dP 279 (406)
+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+..++...+.........+ ..+|+++.+||.+||+.||
T Consensus 187 ~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp 265 (486)
T 3mwu_A 187 AYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHP 265 (486)
T ss_dssp GGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSST
T ss_pred CCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCCh
Confidence 99999999986 49999999999999999999999999999888888887764432222 2689999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCcc--chHHHHHhhhhhcccccccchHHHHHHHHHHHhhhhhhhHHHHHhhccchhhhh
Q psy5368 280 MRRISYEDLFSHPYPDLIHAPCAE--SHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIPLAYDVLAEAIPNLKSGL 357 (406)
Q Consensus 280 ~~Rps~~ell~hp~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 357 (406)
.+|||+.++++||||+........ ..+.....+....+...+. ++-..++.++.. ......+.-
T Consensus 266 ~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~l~~ia~--------~l~~~~~~~ 331 (486)
T 3mwu_A 266 SLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEK------KLAQAALLYMAS--------KLTTLDETK 331 (486)
T ss_dssp TTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSC------HHHHHHHHHHHH--------HHCCHHHHH
T ss_pred hhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHH------HHHHHHHHHHHH--------HhccHHHHH
Confidence 999999999999999865433221 1111111111111111111 111122222111 110112223
Q ss_pred hhchhhhhHHhccchHHHHHHHHHHHHHHHHhhhhcCC
Q psy5368 358 EIGETGDMYLAEGNYELALEKLKASLAILIQFCEAETS 395 (406)
Q Consensus 358 ~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~ 395 (406)
++.+..+.++.+|+.....+.+.+++..++..++..++
T Consensus 332 ~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~ 369 (486)
T 3mwu_A 332 QLTEIFRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSN 369 (486)
T ss_dssp HHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHTCCGG
T ss_pred HHHHHHHHhCCCCCceeeHHHHHHHHHHhhhhhcccch
Confidence 44445556677787777778888777777776654443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=361.95 Aligned_cols=242 Identities=28% Similarity=0.462 Sum_probs=209.0
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc------chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT------SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~------~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~ 121 (406)
...||+|+||.||++... +..+++|.+...... ....+.+|+.++++++|||+++ ..+.+|+||||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 95 (326)
T 2y0a_A 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95 (326)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEc
Confidence 456788889999988864 456888877654322 3467899999999999999876 67789999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC----eeEEEecccccccCCCCCCC
Q psy5368 122 CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN----TLKLADFGFAQFLAPNDQGD 196 (406)
Q Consensus 122 ~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~----~~kL~DFGla~~~~~~~~~~ 196 (406)
+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ ++ .+||+|||+++.........
T Consensus 96 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 175 (326)
T 2y0a_A 96 VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175 (326)
T ss_dssp CCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCC
T ss_pred CCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccc
Confidence 99999999998888999999999999999999999999999999999999998 34 69999999998876665666
Q ss_pred cccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCChHHHHHHHHh
Q psy5368 197 SIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIP--PNSLSPDCMDFLSRL 274 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~s~~l~~li~~~ 274 (406)
...||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+..+....+......... ...+|+.+.+||.+|
T Consensus 176 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 255 (326)
T 2y0a_A 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRL 255 (326)
T ss_dssp CCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHH
T ss_pred cccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHH
Confidence 778999999999999999999999999999999999999999998888777776655322211 136899999999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCC
Q psy5368 275 LQKDPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 275 L~~dP~~Rps~~ell~hp~~~~~ 297 (406)
|+.||++|||+.++++||||+..
T Consensus 256 L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 256 LVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp SCSSGGGSCCHHHHHHSTTTSCC
T ss_pred ccCChhhCCCHHHHhcCCCccCC
Confidence 99999999999999999999854
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=371.15 Aligned_cols=242 Identities=26% Similarity=0.426 Sum_probs=206.5
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC---ccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT---ITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~ 123 (406)
...||+|+||.||++... +..+++|.+.... ......+.+|..++..+ +|||++. ..+.+|+|||||+
T Consensus 28 ~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 107 (353)
T 3txo_A 28 IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVN 107 (353)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCC
Confidence 456789999999998864 4568888776542 23345678899999988 7999876 7788999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCC-CCCCCcccCC
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAP-NDQGDSIQGS 201 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~-~~~~~~~~gt 201 (406)
||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++.... .......+||
T Consensus 108 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt 187 (353)
T 3txo_A 108 GGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGT 187 (353)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---------CC
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCccccccCCC
Confidence 999999999888999999999999999999999999999999999999998 77999999999986432 2344567899
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
+.|+|||++.+..++.++||||+||++|||++|..||.+.+..++...+..... ..+ ..+++++.+||.+||+.||.+
T Consensus 188 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p-~~~~~~~~~li~~lL~~dP~~ 265 (353)
T 3txo_A 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYP-TWLHEDATGILKSFMTKNPTM 265 (353)
T ss_dssp GGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCC-TTSCHHHHHHHHHHTCSSGGG
T ss_pred cCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCC-CCCCHHHHHHHHHHhhhCHHH
Confidence 999999999998899999999999999999999999999999999888887643 333 368999999999999999999
Q ss_pred CCCH------HHHhcCCCCCCCCC
Q psy5368 282 RISY------EDLFSHPYPDLIHA 299 (406)
Q Consensus 282 Rps~------~ell~hp~~~~~~~ 299 (406)
||++ +++++||||+...+
T Consensus 266 R~~~~~~~~~~~il~hp~f~~~~w 289 (353)
T 3txo_A 266 RLGSLTQGGEHAILRHPFFKEIDW 289 (353)
T ss_dssp STTSGGGTCTHHHHTSGGGTTCCH
T ss_pred ccCCcccCCHHHHhhCCcccCCCH
Confidence 9998 89999999998754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=373.83 Aligned_cols=243 Identities=28% Similarity=0.464 Sum_probs=205.5
Q ss_pred ceeeecceeeeEEEeeeee--eceeEEeeeecCCcc---chhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEecc
Q psy5368 55 STIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT---SHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYC 122 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~---~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~ 122 (406)
...+||+|+||.||++... +..+++|.+...... ....+.+|..++.++ +|||+++ ..+.+|+|||||
T Consensus 56 ~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~ 135 (396)
T 4dc2_A 56 LLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 135 (396)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcC
Confidence 3467899999999999875 346788877654322 234578899999887 8999876 778899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEeccccccc-CCCCCCCcccC
Q psy5368 123 DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFL-APNDQGDSIQG 200 (406)
Q Consensus 123 ~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~-~~~~~~~~~~g 200 (406)
+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++.. .........+|
T Consensus 136 ~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~g 215 (396)
T 4dc2_A 136 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 215 (396)
T ss_dssp TTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCB
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCccccccC
Confidence 9999999999888999999999999999999999999999999999999998 779999999999863 33445567789
Q ss_pred CCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHhcCCCCCCCCCCChHHHHHH
Q psy5368 201 SPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASC---------NLSQLRAQALSSAPITIPPNSLSPDCMDFL 271 (406)
Q Consensus 201 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~---------~~~~~~~~~~~~~~~~~~~~~~s~~l~~li 271 (406)
|+.|+|||++.+..++.++||||+||++|||++|+.||... ....+...+... ....|. .+|+++.+||
T Consensus 216 t~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-~~~~p~-~~s~~~~~li 293 (396)
T 4dc2_A 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPR-SLSVKAASVL 293 (396)
T ss_dssp CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC-CCCCCT-TSCHHHHHHH
T ss_pred CcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc-ccCCCC-cCCHHHHHHH
Confidence 99999999999999999999999999999999999999642 223344444443 444444 6999999999
Q ss_pred HHhcccCCCCCCCH------HHHhcCCCCCCCCC
Q psy5368 272 SRLLQKDPMRRISY------EDLFSHPYPDLIHA 299 (406)
Q Consensus 272 ~~~L~~dP~~Rps~------~ell~hp~~~~~~~ 299 (406)
.+||+.||.+||++ +|+++||||+...+
T Consensus 294 ~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w 327 (396)
T 4dc2_A 294 KSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 327 (396)
T ss_dssp HHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred HHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence 99999999999985 89999999998765
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=385.87 Aligned_cols=241 Identities=24% Similarity=0.440 Sum_probs=211.3
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++... +..+++|.+.... ......+.+|+.++++++|||+++ ..+.+|+|||||.|
T Consensus 31 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 110 (484)
T 3nyv_A 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 110 (484)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCC
Confidence 567899999999998864 4578888876543 234567899999999999999876 67889999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee----CCeeEEEecccccccCCCCCCCcccC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK----NNTLKLADFGFAQFLAPNDQGDSIQG 200 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~----~~~~kL~DFGla~~~~~~~~~~~~~g 200 (406)
|+|.+++..++.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.............|
T Consensus 111 ~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~g 190 (484)
T 3nyv_A 111 GELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIG 190 (484)
T ss_dssp CBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTT
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCC
Confidence 99999999888999999999999999999999999999999999999994 56899999999988766665566789
Q ss_pred CCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCChHHHHHHHHhcccC
Q psy5368 201 SPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP--NSLSPDCMDFLSRLLQKD 278 (406)
Q Consensus 201 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~~li~~~L~~d 278 (406)
|+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+..++...+.........+ ..+|+++.+||.+||+.|
T Consensus 191 t~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 269 (484)
T 3nyv_A 191 TAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYV 269 (484)
T ss_dssp GGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSS
T ss_pred CccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCC
Confidence 999999999977 59999999999999999999999999999988888887764332222 268999999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCC
Q psy5368 279 PMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 279 P~~Rps~~ell~hp~~~~~ 297 (406)
|.+|||+.++++||||+..
T Consensus 270 p~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 270 PSMRISARDALDHEWIQTY 288 (484)
T ss_dssp GGGSCCHHHHHTSHHHHHH
T ss_pred hhHCcCHHHHhhChhhccc
Confidence 9999999999999999754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=359.08 Aligned_cols=240 Identities=27% Similarity=0.519 Sum_probs=208.6
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++... +..+++|.+.... ......+.+|+.++..++|||+++ +.+.+|+||||++|
T Consensus 11 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~g 90 (318)
T 1fot_A 11 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG 90 (318)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCC
Confidence 356788888888887753 4567888776532 234556788999999999999876 67789999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++.... .....+||+.
T Consensus 91 g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--~~~~~~gt~~ 168 (318)
T 1fot_A 91 GELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYTLCGTPD 168 (318)
T ss_dssp CBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--CBCCCCSCTT
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--ccccccCCcc
Confidence 99999999988999999999999999999999999999999999999998 78999999999987543 3345679999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
|+|||++.+..++.++||||+||++|||++|..||.+.+.......+.... ...+ ..+++++.+||.+||+.||++||
T Consensus 169 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~p-~~~~~~~~~li~~lL~~dp~~R~ 246 (318)
T 1fot_A 169 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRFP-PFFNEDVKDLLSRLITRDLSQRL 246 (318)
T ss_dssp TCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-CCCC-TTSCHHHHHHHHHHTCSCTTTCT
T ss_pred ccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCC-CCCCHHHHHHHHHHhccCHHHcC
Confidence 999999999999999999999999999999999999999888888887763 3333 36899999999999999999999
Q ss_pred -----CHHHHhcCCCCCCCCC
Q psy5368 284 -----SYEDLFSHPYPDLIHA 299 (406)
Q Consensus 284 -----s~~ell~hp~~~~~~~ 299 (406)
+++++++||||+...+
T Consensus 247 ~~~~~~~~~i~~hp~f~~~~~ 267 (318)
T 1fot_A 247 GNLQNGTEDVKNHPWFKEVVW 267 (318)
T ss_dssp TSSTTTTHHHHTSGGGSSCCH
T ss_pred CCcCCCHHHHhcCccccCCCH
Confidence 9999999999987654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=363.27 Aligned_cols=242 Identities=24% Similarity=0.407 Sum_probs=210.8
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC---ccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT---ITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~ 123 (406)
...||+|+||.||++... +..+++|.+.... ......+.+|..++..+ +||+++. ..+.+|+||||++
T Consensus 25 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~ 104 (353)
T 2i0e_A 25 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 104 (353)
T ss_dssp EEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCC
Confidence 457899999999999874 4568888776542 23445678899999988 8999765 6788999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCC-CCCCCcccCC
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAP-NDQGDSIQGS 201 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~-~~~~~~~~gt 201 (406)
||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++.... .......+||
T Consensus 105 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt 184 (353)
T 2i0e_A 105 GGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGT 184 (353)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSC
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcccccccCC
Confidence 999999999888999999999999999999999999999999999999998 77999999999986432 3345567899
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+.... ...| ..+|+++.+||.+||+.||.+
T Consensus 185 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~p-~~~s~~~~~li~~lL~~dP~~ 262 (353)
T 2i0e_A 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYP-KSMSKEAVAICKGLMTKHPGK 262 (353)
T ss_dssp GGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCC-TTSCHHHHHHHHHHTCSCTTS
T ss_pred ccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-CCCC-CCCCHHHHHHHHHHhhcCHHH
Confidence 99999999999999999999999999999999999999999988888887763 3343 379999999999999999999
Q ss_pred CCC-----HHHHhcCCCCCCCCC
Q psy5368 282 RIS-----YEDLFSHPYPDLIHA 299 (406)
Q Consensus 282 Rps-----~~ell~hp~~~~~~~ 299 (406)
||+ ++++++||||+...+
T Consensus 263 R~~~~~~~~~~i~~h~~f~~~~w 285 (353)
T 2i0e_A 263 RLGCGPEGERDIKEHAFFRYIDW 285 (353)
T ss_dssp CTTCSTTHHHHHHTSGGGTTCCH
T ss_pred cCCCCCCCHHHHhcCccccCCCH
Confidence 995 699999999997765
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=365.57 Aligned_cols=242 Identities=26% Similarity=0.434 Sum_probs=210.5
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC---ccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT---ITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~ 123 (406)
...||+|+||.||++... +..+++|.+.... ......+.+|..++..+ +|||+++ +.+.+|+|||||+
T Consensus 22 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~ 101 (345)
T 1xjd_A 22 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 101 (345)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCC
Confidence 457889999999999864 4568888776542 23445678899998877 9999876 7788999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCC-CCCCCcccCC
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAP-NDQGDSIQGS 201 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~-~~~~~~~~gt 201 (406)
||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++.... .......+||
T Consensus 102 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt 181 (345)
T 1xjd_A 102 GGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGT 181 (345)
T ss_dssp TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSC
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCC
Confidence 999999999888999999999999999999999999999999999999998 77999999999976432 2344567899
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
+.|+|||++.+..++.++||||+||++|||++|..||.+.+..++...+.... ...+ ..+|+++.+||.+||+.||++
T Consensus 182 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p-~~~s~~~~~li~~lL~~dp~~ 259 (345)
T 1xjd_A 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYP-RWLEKEAKDLLVKLFVREPEK 259 (345)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCC-TTSCHHHHHHHHHHSCSSGGG
T ss_pred cccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-CCCC-cccCHHHHHHHHHHhcCCHhH
Confidence 99999999999999999999999999999999999999999888888887763 3333 468999999999999999999
Q ss_pred CCCHH-HHhcCCCCCCCCC
Q psy5368 282 RISYE-DLFSHPYPDLIHA 299 (406)
Q Consensus 282 Rps~~-ell~hp~~~~~~~ 299 (406)
||++. ++++||||+...+
T Consensus 260 R~~~~~~i~~hp~f~~~~w 278 (345)
T 1xjd_A 260 RLGVRGDIRQHPLFREINW 278 (345)
T ss_dssp SBTTBSCGGGSGGGTTCCH
T ss_pred cCCChHHHHcCccccCCCH
Confidence 99998 9999999997764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=357.02 Aligned_cols=244 Identities=26% Similarity=0.436 Sum_probs=213.5
Q ss_pred ceeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 55 STIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
....||+|+||.||++... +..|++|.+..........+.+|+.++++++|||++. ..+..|+||||++|++
T Consensus 49 ~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 128 (321)
T 2c30_A 49 SYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGA 128 (321)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCB
T ss_pred ccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCC
Confidence 3458999999999999874 5679999887766666778999999999999999876 6678999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCCC
Q psy5368 127 LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPLY 204 (406)
Q Consensus 127 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~y 204 (406)
|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++....... ......||+.|
T Consensus 129 L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y 207 (321)
T 2c30_A 129 LTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYW 207 (321)
T ss_dssp HHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGG
T ss_pred HHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCccc
Confidence 9998864 5799999999999999999999999999999999999999 7799999999998765432 33556799999
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC-CCCChHHHHHHHHhcccCCCCCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP-NSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.......... ..+++++.+|+.+||+.||++||
T Consensus 208 ~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 287 (321)
T 2c30_A 208 MAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERA 287 (321)
T ss_dssp CCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSC
T ss_pred cCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCc
Confidence 99999999999999999999999999999999999988888777776664433322 26899999999999999999999
Q ss_pred CHHHHhcCCCCCCCCC
Q psy5368 284 SYEDLFSHPYPDLIHA 299 (406)
Q Consensus 284 s~~ell~hp~~~~~~~ 299 (406)
|+.++++||||.....
T Consensus 288 s~~ell~hp~~~~~~~ 303 (321)
T 2c30_A 288 TAQELLDHPFLLQTGL 303 (321)
T ss_dssp CHHHHHTSGGGGGCCC
T ss_pred CHHHHhcChhhccCCC
Confidence 9999999999986544
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=364.99 Aligned_cols=242 Identities=23% Similarity=0.441 Sum_probs=210.9
Q ss_pred ceeeecceeeeEEEeeeee--eceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 55 STIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
....||+|+||.||++... +..+++|.+...... ....+.+|+.++++++|||+++ ..+..|+|||||+|
T Consensus 33 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g 112 (362)
T 2bdw_A 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 112 (362)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence 3456899999999999864 457888887655432 3457889999999999999876 67789999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeC----CeeEEEecccccccCCCCCCCcccC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN----NTLKLADFGFAQFLAPNDQGDSIQG 200 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~----~~~kL~DFGla~~~~~~~~~~~~~g 200 (406)
|+|.+++..++.+++..+..++.||+.||.|||++||+||||||+|||++. +.+||+|||++.............|
T Consensus 113 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~g 192 (362)
T 2bdw_A 113 GELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 192 (362)
T ss_dssp CBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCS
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCC
Confidence 999999988888999999999999999999999999999999999999972 3699999999988766655566789
Q ss_pred CCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCChHHHHHHHHhcccC
Q psy5368 201 SPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP--NSLSPDCMDFLSRLLQKD 278 (406)
Q Consensus 201 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~~li~~~L~~d 278 (406)
|+.|+|||++.+..++.++||||+||++|+|++|.+||.+.+...+...+.........+ ..+|+++.+||.+||+.|
T Consensus 193 t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 272 (362)
T 2bdw_A 193 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVN 272 (362)
T ss_dssp CTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSS
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCC
Confidence 999999999999999999999999999999999999999999888888877764332222 268999999999999999
Q ss_pred CCCCCCHHHHhcCCCCCC
Q psy5368 279 PMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 279 P~~Rps~~ell~hp~~~~ 296 (406)
|++|||+.++++||||..
T Consensus 273 P~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 273 PKKRITADQALKVPWICN 290 (362)
T ss_dssp GGGSCCHHHHTTSHHHHT
T ss_pred hhhCcCHHHHhcCcccCC
Confidence 999999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=362.42 Aligned_cols=240 Identities=25% Similarity=0.421 Sum_probs=211.8
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++... +..+++|.+.... ......+.+|+.++..++|||+++ +.+.+|+||||++|
T Consensus 46 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 125 (350)
T 1rdq_E 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence 457899999999999864 5678888776543 234557889999999999999876 67889999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++..... .....||+.
T Consensus 126 g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~~~~~gt~~ 203 (350)
T 1rdq_E 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPE 203 (350)
T ss_dssp CBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCCCEECGG
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--cccccCCcc
Confidence 99999999888999999999999999999999999999999999999998 779999999999876432 345679999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...+.... ...+ ..+++++.+||.+||+.||.+||
T Consensus 204 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p-~~~~~~~~~li~~lL~~dp~~R~ 281 (350)
T 1rdq_E 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP-SHFSSDLKDLLRNLLQVDLTKRF 281 (350)
T ss_dssp GCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCC-TTCCHHHHHHHHHHSCSCTTTCT
T ss_pred ccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC-CCCC-CCCCHHHHHHHHHHhhcCHHhcc
Confidence 999999999999999999999999999999999999999888888887763 3333 36899999999999999999999
Q ss_pred C-----HHHHhcCCCCCCCCC
Q psy5368 284 S-----YEDLFSHPYPDLIHA 299 (406)
Q Consensus 284 s-----~~ell~hp~~~~~~~ 299 (406)
+ ++++++||||+...+
T Consensus 282 ~~~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 282 GNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp TSSTTTTHHHHTSGGGTTCCH
T ss_pred CCccCCHHHHHhCcCcCCCCH
Confidence 8 999999999987654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=371.12 Aligned_cols=241 Identities=25% Similarity=0.432 Sum_probs=206.5
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...||+|+||.||++.. .+..+++|.+...... ....+.+|+.+++.++|||+++ ..+..|+|||||+||
T Consensus 16 ~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 95 (444)
T 3soa_A 16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG 95 (444)
T ss_dssp EEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCC
T ss_pred EEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCC
Confidence 45678888888888875 3456777776654422 3457899999999999999876 778899999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee----CCeeEEEecccccccCCCC-CCCcccC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK----NNTLKLADFGFAQFLAPND-QGDSIQG 200 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~----~~~~kL~DFGla~~~~~~~-~~~~~~g 200 (406)
+|.+.+..++.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....... ......|
T Consensus 96 ~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~g 175 (444)
T 3soa_A 96 ELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAG 175 (444)
T ss_dssp BHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCS
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccC
Confidence 9999999989999999999999999999999999999999999999997 3589999999997765443 2345679
Q ss_pred CCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCChHHHHHHHHhcccC
Q psy5368 201 SPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP--NSLSPDCMDFLSRLLQKD 278 (406)
Q Consensus 201 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~~li~~~L~~d 278 (406)
|+.|+|||++.+..++.++||||+||++|+|++|.+||.+.+..++...+.........+ ..+|+++.+||.+||+.|
T Consensus 176 t~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 255 (444)
T 3soa_A 176 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTIN 255 (444)
T ss_dssp CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSS
T ss_pred CcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCC
Confidence 999999999999999999999999999999999999999999888888887764432222 368999999999999999
Q ss_pred CCCCCCHHHHhcCCCCCC
Q psy5368 279 PMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 279 P~~Rps~~ell~hp~~~~ 296 (406)
|.+|||+.|+++||||+.
T Consensus 256 P~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 256 PSKRITAAEALKHPWISH 273 (444)
T ss_dssp TTTSCCHHHHHHSCTTHH
T ss_pred hhHCCCHHHHhcCccccC
Confidence 999999999999999964
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=360.69 Aligned_cols=242 Identities=28% Similarity=0.467 Sum_probs=204.5
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccc---hhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITS---HSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~---~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~ 123 (406)
...||+|+||.||++... +..+++|.+....... ...+.+|..++.++ +|||+++ ..+.+|+||||++
T Consensus 14 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~ 93 (345)
T 3a8x_A 14 LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 93 (345)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCC
Confidence 456899999999999864 4568888877654332 34578899999887 8999876 6788999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccC-CCCCCCcccCC
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLA-PNDQGDSIQGS 201 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~-~~~~~~~~~gt 201 (406)
||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++... ........+||
T Consensus 94 gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt 173 (345)
T 3a8x_A 94 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT 173 (345)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSC
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCcccccCCC
Confidence 999999998888999999999999999999999999999999999999998 7799999999998643 23345567899
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC---------CCHHHHHHHHHhcCCCCCCCCCCChHHHHHHH
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYAS---------CNLSQLRAQALSSAPITIPPNSLSPDCMDFLS 272 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~---------~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~ 272 (406)
+.|+|||++.+..++.++||||+||++|||++|+.||.. .....+...+... ....| ..+|+++.+||.
T Consensus 174 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-~~~~p-~~~s~~~~~li~ 251 (345)
T 3a8x_A 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIP-RSLSVKAASVLK 251 (345)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-CCCCC-TTSCHHHHHHHH
T ss_pred ccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-CCCCC-CCCCHHHHHHHH
Confidence 999999999999999999999999999999999999975 2334444445444 33444 368999999999
Q ss_pred HhcccCCCCCCCH------HHHhcCCCCCCCCC
Q psy5368 273 RLLQKDPMRRISY------EDLFSHPYPDLIHA 299 (406)
Q Consensus 273 ~~L~~dP~~Rps~------~ell~hp~~~~~~~ 299 (406)
+||+.||.+||++ +++++||||+...+
T Consensus 252 ~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w 284 (345)
T 3a8x_A 252 SFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 284 (345)
T ss_dssp HHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred HHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence 9999999999995 89999999987664
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=354.44 Aligned_cols=261 Identities=25% Similarity=0.342 Sum_probs=198.0
Q ss_pred ccccceEEEeeeeee-EEEeeeeecCCcceeeeeeccccccccceeeecCceeeecceeeeEEEeeeeeeceeEEeeeec
Q psy5368 6 TVRYGTVRLGSVKYG-QVQLSTVRYGKVRYSQVRSDTVRSGTVRYDIVGSSTIRYGELQYDTVQNSQIRLGTVKYSQVRY 84 (406)
Q Consensus 6 ~g~~~~V~ig~~~~g-y~vv~~lg~G~~~~~~~~~d~~~~~~~~~~i~~~~~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~ 84 (406)
.++...+.-++.+.+ |+++++||.|.++.||.+.+. .+..+++|.+..
T Consensus 7 ~~~~~~~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-------------------------------~~~~vavK~~~~ 55 (311)
T 3niz_A 7 HSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-------------------------------QGRIVALKRIRL 55 (311)
T ss_dssp --------CEECSSCEEEEEEEEEECSSCEEEEEEET-------------------------------TSCEEEEEEEC-
T ss_pred ccccccceeecchHhhhHhhhhccCCCCeEEEEEEEC-------------------------------CCCEEEEEEEec
Confidence 456666666777765 777777776666666555431 123466676654
Q ss_pred CCcc--chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHH
Q psy5368 85 DTIT--SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKF 155 (406)
Q Consensus 85 ~~~~--~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~ 155 (406)
.... ....+.+|+.++++++|||+++ ..+.+|+|||||++ +|.+++.... .+++..+..++.||+.||.|
T Consensus 56 ~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~ 134 (311)
T 3niz_A 56 DAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134 (311)
T ss_dssp -----CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHH
T ss_pred ccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHH
Confidence 3322 2457889999999999999876 67789999999986 8988887654 59999999999999999999
Q ss_pred HHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCcccCCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHH
Q psy5368 156 LRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDSIQGSPLYMAPEILAG-SPYNAKADLWSLGVLVFEAL 232 (406)
Q Consensus 156 lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell 232 (406)
||++||+||||||+|||++ ++.+||+|||+++..... .......||+.|+|||++.+ ..++.++||||+||++|+|+
T Consensus 135 LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 214 (311)
T 3niz_A 135 CHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMI 214 (311)
T ss_dssp HHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHH
T ss_pred HHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHH
Confidence 9999999999999999998 779999999999876533 23345578999999999987 56899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhcCCCCCC----------------------------CCCCChHHHHHHHHhcccCCCCCCC
Q psy5368 233 FGHAPYASCNLSQLRAQALSSAPITIP----------------------------PNSLSPDCMDFLSRLLQKDPMRRIS 284 (406)
Q Consensus 233 tg~~pf~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~s~~l~~li~~~L~~dP~~Rps 284 (406)
+|+.||.+.+..+....+........+ ...+++++.+||.+||+.||++|||
T Consensus 215 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 294 (311)
T 3niz_A 215 TGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS 294 (311)
T ss_dssp HSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCC
T ss_pred hCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCC
Confidence 999999887766555554431111000 1246789999999999999999999
Q ss_pred HHHHhcCCCCCCCC
Q psy5368 285 YEDLFSHPYPDLIH 298 (406)
Q Consensus 285 ~~ell~hp~~~~~~ 298 (406)
++|+++||||+...
T Consensus 295 ~~ell~hp~f~~~~ 308 (311)
T 3niz_A 295 ARDAMNHPYFKDLD 308 (311)
T ss_dssp HHHHHTSGGGTTSC
T ss_pred HHHHhcCcccccCC
Confidence 99999999998654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=376.00 Aligned_cols=240 Identities=24% Similarity=0.445 Sum_probs=199.3
Q ss_pred eecceeeeEEEeeeee--eceeEEeeeecCCc-------------cchhhhhhHHhhcccCCCCCCcc------cCCeEE
Q psy5368 58 RYGELQYDTVQNSQIR--LGTVKYSQVRYDTI-------------TSHSEFERPRAGLSNLRAPEGRK------RPRYVY 116 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~-------------~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~ 116 (406)
.||+|+||+||++... +..+++|.+..... .....+.+|+.++++++|||+++ ..+.+|
T Consensus 43 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 122 (504)
T 3q5i_A 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFY 122 (504)
T ss_dssp EEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred EecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 3455555555555542 23455665543321 23457899999999999999876 778899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeC-C---eeEEEecccccccCCC
Q psy5368 117 IILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-N---TLKLADFGFAQFLAPN 192 (406)
Q Consensus 117 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~-~---~~kL~DFGla~~~~~~ 192 (406)
+|||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. + .+||+|||++......
T Consensus 123 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 202 (504)
T 3q5i_A 123 LVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD 202 (504)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTT
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCC
Confidence 99999999999999988889999999999999999999999999999999999999983 3 6999999999887766
Q ss_pred CCCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCChHHHHH
Q psy5368 193 DQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP--NSLSPDCMDF 270 (406)
Q Consensus 193 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~~l 270 (406)
.......||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+..++...+.........+ ..+|+++.+|
T Consensus 203 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 281 (504)
T 3q5i_A 203 YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKEL 281 (504)
T ss_dssp SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHH
T ss_pred CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHH
Confidence 66667789999999999874 59999999999999999999999999999998888887764332211 3689999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 271 LSRLLQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 271 i~~~L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
|.+||+.||.+|||++|+++||||+...
T Consensus 282 i~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 282 IKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp HHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred HHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 9999999999999999999999998654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=366.19 Aligned_cols=245 Identities=25% Similarity=0.398 Sum_probs=211.4
Q ss_pred ceeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 55 STIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
....||+|+||.||++... +..+++|.+..........+.+|+.++.+++|||++. ..+.+|+|||||+||+
T Consensus 55 i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~ 134 (387)
T 1kob_A 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 134 (387)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCc
Confidence 3457899999999999874 4567788776654445567899999999999999876 6778999999999999
Q ss_pred HHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee---CCeeEEEecccccccCCCCCCCcccCCC
Q psy5368 127 LCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK---NNTLKLADFGFAQFLAPNDQGDSIQGSP 202 (406)
Q Consensus 127 L~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~---~~~~kL~DFGla~~~~~~~~~~~~~gt~ 202 (406)
|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++............||+
T Consensus 135 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~ 214 (387)
T 1kob_A 135 LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATA 214 (387)
T ss_dssp HHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSG
T ss_pred HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceeeeccCC
Confidence 999997654 799999999999999999999999999999999999997 3579999999998876555555667999
Q ss_pred CCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCChHHHHHHHHhcccCCC
Q psy5368 203 LYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIP--PNSLSPDCMDFLSRLLQKDPM 280 (406)
Q Consensus 203 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~s~~l~~li~~~L~~dP~ 280 (406)
.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+........+ ...+|+++.+||.+||+.||.
T Consensus 215 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 294 (387)
T 1kob_A 215 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPR 294 (387)
T ss_dssp GGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGG
T ss_pred CccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChh
Confidence 999999999999999999999999999999999999998888777777665332211 236899999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCC
Q psy5368 281 RRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 281 ~Rps~~ell~hp~~~~~~~ 299 (406)
+|||+.++++||||+....
T Consensus 295 ~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 295 KRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp GSCCHHHHHTSTTTSSCCT
T ss_pred HCcCHHHHhhCccccCCcc
Confidence 9999999999999987543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=375.04 Aligned_cols=242 Identities=24% Similarity=0.410 Sum_probs=202.2
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++... +..+++|.+.... ......+.+|+.+++.++|||++. ..+.+|+|||||+|
T Consensus 153 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 232 (446)
T 4ejn_A 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 232 (446)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSS
T ss_pred eEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCC
Confidence 467999999999999864 4578999876542 233456789999999999999866 67789999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCcceEee-CCeeEEEecccccccCC-CCCCCcccCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRE-NNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAP-NDQGDSIQGS 201 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~-~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~-~~~~~~~~gt 201 (406)
|+|.+++...+.+++..+..++.||+.||+|||+ +||+||||||+|||++ ++.+||+|||+++.... ........||
T Consensus 233 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt 312 (446)
T 4ejn_A 233 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT 312 (446)
T ss_dssp CBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSC
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCC
Confidence 9999999888899999999999999999999998 9999999999999998 77999999999976433 2344567899
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+...+.... ...+ ..+++++.+||.+||+.||.+
T Consensus 313 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p-~~~~~~~~~li~~~L~~dP~~ 390 (446)
T 4ejn_A 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFP-RTLGPEAKSLLSGLLKKDPKQ 390 (446)
T ss_dssp GGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCC-TTSCHHHHHHHHHHTCSSTTT
T ss_pred ccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-CCCC-ccCCHHHHHHHHHHcccCHHH
Confidence 99999999999999999999999999999999999999999888888777663 3333 368999999999999999999
Q ss_pred CC-----CHHHHhcCCCCCCCCC
Q psy5368 282 RI-----SYEDLFSHPYPDLIHA 299 (406)
Q Consensus 282 Rp-----s~~ell~hp~~~~~~~ 299 (406)
|| +++|+++||||+...+
T Consensus 391 R~~~~~~t~~ell~hp~f~~~~~ 413 (446)
T 4ejn_A 391 RLGGGSEDAKEIMQHRFFAGIVW 413 (446)
T ss_dssp STTCSTTTHHHHHTSGGGTTCCH
T ss_pred hCCCCCCCHHHHHhCccccCCCH
Confidence 99 9999999999997654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=348.10 Aligned_cols=241 Identities=23% Similarity=0.412 Sum_probs=210.1
Q ss_pred eeeecceeeeEEEeeeeee--ceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQIRL--GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
...||+|+||.||++.... ..+++|++..........+.+|+.++++++|||+++ ..+..|+||||+++++|
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (277)
T 3f3z_A 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL 93 (277)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred eeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcH
Confidence 4567888888888887643 357888887766667788999999999999999876 67789999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEe---e-CCeeEEEecccccccCCCCCCCcccCCCC
Q psy5368 128 CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI---K-NNTLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 128 ~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll---~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
.+++..++.+++..+..++.|++.||.|||++||+|+||||+||++ + ++.+||+|||++.............||+.
T Consensus 94 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~ 173 (277)
T 3f3z_A 94 FERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPY 173 (277)
T ss_dssp HHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTT
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCC
Confidence 9999888899999999999999999999999999999999999999 4 56899999999988776666667789999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCChHHHHHHHHhcccCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP--NSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~~li~~~L~~dP~~ 281 (406)
|+|||++.+. ++.++||||+|+++|+|++|..||...+..+....+.......... ..+++++.+|+.+||+.||.+
T Consensus 174 y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 252 (277)
T 3f3z_A 174 YVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQ 252 (277)
T ss_dssp TCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTT
T ss_pred ccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhh
Confidence 9999998765 8999999999999999999999999998888887777664322211 168999999999999999999
Q ss_pred CCCHHHHhcCCCCCCC
Q psy5368 282 RISYEDLFSHPYPDLI 297 (406)
Q Consensus 282 Rps~~ell~hp~~~~~ 297 (406)
|||+.++++||||+..
T Consensus 253 R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 253 RITSLQALEHEWFEKQ 268 (277)
T ss_dssp SCCHHHHTTSHHHHHH
T ss_pred CcCHHHHhcCHHHhcc
Confidence 9999999999999753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=356.90 Aligned_cols=242 Identities=25% Similarity=0.411 Sum_probs=199.7
Q ss_pred ceeeecceeeeEEEeeee-----eeceeEEeeeecCCc----cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEE
Q psy5368 55 STIRYGELQYDTVQNSQI-----RLGTVKYSQVRYDTI----TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIIL 119 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~-----~~~~v~vk~~~~~~~----~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~ 119 (406)
....||+|+||.||++.. .+..+++|.+..... .....+.+|+.+++.++|||+++ ..+.+|+||
T Consensus 21 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 100 (327)
T 3a62_A 21 LLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLIL 100 (327)
T ss_dssp EEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEE
T ss_pred EEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEE
Confidence 345789999999998875 345688887765432 23456788999999999999876 677899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCc
Q psy5368 120 EYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDS 197 (406)
Q Consensus 120 E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~ 197 (406)
|||+|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++..... .....
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 180 (327)
T 3a62_A 101 EYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT 180 (327)
T ss_dssp ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----------CT
T ss_pred eCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCCccccc
Confidence 9999999999999888999999999999999999999999999999999999998 779999999999764332 23455
Q ss_pred ccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhccc
Q psy5368 198 IQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 198 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~ 277 (406)
..||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.... ...+ ..+++++.+||.+||+.
T Consensus 181 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~p-~~~~~~~~~li~~~L~~ 258 (327)
T 3a62_A 181 FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK-LNLP-PYLTQEARDLLKKLLKR 258 (327)
T ss_dssp TSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCC-TTSCHHHHHHHHHHSCS
T ss_pred cCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-CCCC-CCCCHHHHHHHHHHHhc
Confidence 679999999999999999999999999999999999999999998888887777653 3333 36899999999999999
Q ss_pred CCCCCC-----CHHHHhcCCCCCCCC
Q psy5368 278 DPMRRI-----SYEDLFSHPYPDLIH 298 (406)
Q Consensus 278 dP~~Rp-----s~~ell~hp~~~~~~ 298 (406)
||.+|| ++.++++||||+...
T Consensus 259 dp~~R~~~~~~~~~e~l~hp~f~~~~ 284 (327)
T 3a62_A 259 NAASRLGAGPGDAGEVQAHPFFRHIN 284 (327)
T ss_dssp CGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred CHhhccCCCCCCHHHHHcCCcccCCC
Confidence 999999 889999999998654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=365.40 Aligned_cols=242 Identities=23% Similarity=0.381 Sum_probs=207.3
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
...||+|+||.||++... +..+++|.+..........+.+|+.++.+++|||+++ ..+.+|+|||||++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 457999999999999863 5678899887766556678999999999999999876 67789999999999999
Q ss_pred HHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee---CCeeEEEecccccccCCCCCCCcccCCCC
Q psy5368 128 CSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK---NNTLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 128 ~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~---~~~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++............||+.
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~ 253 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPE 253 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCT
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCc
Confidence 9998665 4699999999999999999999999999999999999994 45899999999988776666666779999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCChHHHHHHHHhcccCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIP--PNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~s~~l~~li~~~L~~dP~~ 281 (406)
|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+........+ ...+++++.+||.+||+.||.+
T Consensus 254 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 333 (373)
T 2x4f_A 254 FLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSW 333 (373)
T ss_dssp TCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGG
T ss_pred EeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhh
Confidence 99999999999999999999999999999999999999888887777765432221 1368999999999999999999
Q ss_pred CCCHHHHhcCCCCCCC
Q psy5368 282 RISYEDLFSHPYPDLI 297 (406)
Q Consensus 282 Rps~~ell~hp~~~~~ 297 (406)
|||+.|+++||||+..
T Consensus 334 Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 334 RISASEALKHPWLSDH 349 (373)
T ss_dssp SCCHHHHHHSHHHHCH
T ss_pred CCCHHHHhcCcCcCCC
Confidence 9999999999999754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=360.99 Aligned_cols=243 Identities=25% Similarity=0.441 Sum_probs=204.1
Q ss_pred ceeeecceeeeEEEeeeeee--ceeEEeeeecCCcc---chhhhhhHHhh-cccCCCCCCcc------cCCeEEEEEecc
Q psy5368 55 STIRYGELQYDTVQNSQIRL--GTVKYSQVRYDTIT---SHSEFERPRAG-LSNLRAPEGRK------RPRYVYIILEYC 122 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~~---~~~~~~~E~~~-l~~l~h~ni~~------~~~~~~lV~E~~ 122 (406)
....||+|+||.||++.... ..+++|.+...... ....+.+|..+ ++.++|||+++ ..+.+|+||||+
T Consensus 42 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~ 121 (373)
T 2r5t_A 42 FLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 121 (373)
T ss_dssp EEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCC
Confidence 35678999999999998743 45788877655432 23456777776 57899999876 678899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccC-CCCCCCcccC
Q psy5368 123 DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLA-PNDQGDSIQG 200 (406)
Q Consensus 123 ~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~-~~~~~~~~~g 200 (406)
+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++... ........+|
T Consensus 122 ~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~g 201 (373)
T 2r5t_A 122 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCG 201 (373)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSC
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCCccccccC
Confidence 9999999999888999999999999999999999999999999999999998 7899999999998643 3345567789
Q ss_pred CCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCC
Q psy5368 201 SPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPM 280 (406)
Q Consensus 201 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~ 280 (406)
|+.|+|||++.+..++.++|||||||++|||++|..||.+.+..++...+.... ...+ ..+++++.+||.+||+.||.
T Consensus 202 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~~-~~~~~~~~~li~~lL~~dp~ 279 (373)
T 2r5t_A 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-LQLK-PNITNSARHLLEGLLQKDRT 279 (373)
T ss_dssp CCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC-CCCC-SSSCHHHHHHHHHHTCSSGG
T ss_pred CccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-cCCC-CCCCHHHHHHHHHHcccCHH
Confidence 999999999999999999999999999999999999999999988888887763 3333 36999999999999999999
Q ss_pred CCCCH----HHHhcCCCCCCCCC
Q psy5368 281 RRISY----EDLFSHPYPDLIHA 299 (406)
Q Consensus 281 ~Rps~----~ell~hp~~~~~~~ 299 (406)
+||++ .++++||||+...+
T Consensus 280 ~R~~~~~~~~~i~~h~~f~~~~w 302 (373)
T 2r5t_A 280 KRLGAKDDFMEIKSHVFFSLINW 302 (373)
T ss_dssp GSTTTTTTHHHHHTSGGGTTCCH
T ss_pred hCCCCCCCHHHHhCCccccCCCH
Confidence 99986 69999999997765
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=361.47 Aligned_cols=241 Identities=26% Similarity=0.390 Sum_probs=207.4
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
...||+|+||.||++... +..+++|.+... ......+.+|+.+++.++|||+++ ..+.+|+|||||+|++|
T Consensus 10 ~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L 88 (321)
T 1tki_A 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI 88 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBH
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCH
Confidence 456788888888888764 345677766543 234557889999999999999876 67889999999999999
Q ss_pred HHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee---CCeeEEEecccccccCCCCCCCcccCCCC
Q psy5368 128 CSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK---NNTLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 128 ~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~---~~~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.............||+.
T Consensus 89 ~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~ 168 (321)
T 1tki_A 89 FERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE 168 (321)
T ss_dssp HHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGG
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCChh
Confidence 99997654 799999999999999999999999999999999999998 46899999999988766555566779999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCChHHHHHHHHhcccCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIP--PNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~s~~l~~li~~~L~~dP~~ 281 (406)
|+|||++.+..++.++||||+||++|+|++|..||.+.+.......+......... ...+|+++.+|+.+||..||.+
T Consensus 169 y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 248 (321)
T 1tki_A 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKS 248 (321)
T ss_dssp GSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGG
T ss_pred hcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhH
Confidence 99999999988999999999999999999999999999988888887776433221 1368999999999999999999
Q ss_pred CCCHHHHhcCCCCCCC
Q psy5368 282 RISYEDLFSHPYPDLI 297 (406)
Q Consensus 282 Rps~~ell~hp~~~~~ 297 (406)
|||+.|+++||||+..
T Consensus 249 Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 249 RMTASEALQHPWLKQK 264 (321)
T ss_dssp SCCHHHHHHSHHHHSC
T ss_pred CcCHHHHhcChhhccC
Confidence 9999999999999753
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=373.92 Aligned_cols=240 Identities=26% Similarity=0.458 Sum_probs=205.0
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...||+|+||.||++... +..+++|.+.... ......+.+|+.+++.++|||+++ ..+.+|+|||||+||
T Consensus 42 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 121 (494)
T 3lij_A 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121 (494)
T ss_dssp EEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCC
Confidence 456788888888888864 4467888776543 234567899999999999999876 677899999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee----CCeeEEEecccccccCCCCCCCcccCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK----NNTLKLADFGFAQFLAPNDQGDSIQGS 201 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~----~~~~kL~DFGla~~~~~~~~~~~~~gt 201 (406)
+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.............||
T Consensus 122 ~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt 201 (494)
T 3lij_A 122 ELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGT 201 (494)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSC
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCC
Confidence 9999998888999999999999999999999999999999999999997 235999999999887766666677899
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCChHHHHHHHHhcccCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP--NSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~~li~~~L~~dP 279 (406)
+.|+|||++. ..++.++||||+||++|+|++|.+||.+.+..++...+.........+ ..+|+++.+||.+||+.||
T Consensus 202 ~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp 280 (494)
T 3lij_A 202 AYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDS 280 (494)
T ss_dssp TTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSST
T ss_pred cCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCCh
Confidence 9999999986 459999999999999999999999999999988888887764433222 3689999999999999999
Q ss_pred CCCCCHHHHhcCCCCCC
Q psy5368 280 MRRISYEDLFSHPYPDL 296 (406)
Q Consensus 280 ~~Rps~~ell~hp~~~~ 296 (406)
.+|||+.++++||||+.
T Consensus 281 ~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 281 QRRISAQQALEHPWIKE 297 (494)
T ss_dssp TTSCCHHHHHTCHHHHH
T ss_pred hhCccHHHHhcCccccc
Confidence 99999999999999974
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=364.16 Aligned_cols=239 Identities=27% Similarity=0.523 Sum_probs=199.9
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++.. .+..+++|.+.... ......+.+|+.+++.++|||+++ ..+.+|+||||+ +
T Consensus 14 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~ 92 (336)
T 3h4j_B 14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-G 92 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-C
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-C
Confidence 34567777777777775 34568888765432 223457899999999999999876 677899999999 6
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
|+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++............+||+.
T Consensus 93 g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~ 172 (336)
T 3h4j_B 93 GELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN 172 (336)
T ss_dssp EEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCCCTTSTT
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcccccccCCcC
Confidence 79999998888999999999999999999999999999999999999999 66999999999988776666677789999
Q ss_pred CCChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCC
Q psy5368 204 YMAPEILAGSPY-NAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRR 282 (406)
Q Consensus 204 y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 282 (406)
|+|||++.+..+ ++++||||+||++|+|++|..||.+.....+...+... . ...+..+|+++.+|+.+||+.||.+|
T Consensus 173 y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~-~-~~~p~~~s~~~~~li~~~L~~dP~~R 250 (336)
T 3h4j_B 173 YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC-V-YVMPDFLSPGAQSLIRRMIVADPMQR 250 (336)
T ss_dssp TSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSS-C-CCCCTTSCHHHHHHHHTTSCSSGGGS
T ss_pred cCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC-C-CCCcccCCHHHHHHHHHHcCCChhHC
Confidence 999999998876 68999999999999999999999876544433222222 1 12234689999999999999999999
Q ss_pred CCHHHHhcCCCCCCC
Q psy5368 283 ISYEDLFSHPYPDLI 297 (406)
Q Consensus 283 ps~~ell~hp~~~~~ 297 (406)
||++|+++||||+..
T Consensus 251 pt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 251 ITIQEIRRDPWFNVN 265 (336)
T ss_dssp CCHHHHTTCHHHHTT
T ss_pred cCHHHHHhChhhccC
Confidence 999999999999753
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=351.89 Aligned_cols=243 Identities=27% Similarity=0.435 Sum_probs=208.6
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc------chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT------SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~------~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~ 121 (406)
...||+|+||.||++... +..+++|.+...... ....+.+|+.++.+++|||++. ..+.+|+||||
T Consensus 17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 96 (321)
T 2a2a_A 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILEL 96 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEc
Confidence 456788888888888763 456788877654322 2457899999999999999865 67789999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC----eeEEEecccccccCCCCCCC
Q psy5368 122 CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN----TLKLADFGFAQFLAPNDQGD 196 (406)
Q Consensus 122 ~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~----~~kL~DFGla~~~~~~~~~~ 196 (406)
+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++ ++ .+||+|||++..........
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 176 (321)
T 2a2a_A 97 VSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176 (321)
T ss_dssp CCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCC
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCcccccc
Confidence 99999999999888899999999999999999999999999999999999998 44 69999999998877665666
Q ss_pred cccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCChHHHHHHHHh
Q psy5368 197 SIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIP--PNSLSPDCMDFLSRL 274 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~s~~l~~li~~~ 274 (406)
...||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+..+....+........+ ...+|+.+.+||.+|
T Consensus 177 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~ 256 (321)
T 2a2a_A 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKL 256 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTT
T ss_pred ccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHH
Confidence 678999999999999999999999999999999999999999998888877776655322111 136899999999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 275 LQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 275 L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
|+.||++|||+.++++||||+...
T Consensus 257 l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 257 LVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp SCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred cCCChhhCcCHHHHhcCccccCCC
Confidence 999999999999999999998543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=360.37 Aligned_cols=241 Identities=27% Similarity=0.453 Sum_probs=188.3
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
...||+|+||.||++... +..+++|.+.... .....+.+|+.++++++|||+++ ..+.+|+|||||+||+|
T Consensus 25 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L 103 (361)
T 3uc3_A 25 VKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL 103 (361)
T ss_dssp EEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCH
Confidence 345677777777777753 4567888776543 33467899999999999999876 67889999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC--eeEEEecccccccCCCCCCCcccCCCCC
Q psy5368 128 CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN--TLKLADFGFAQFLAPNDQGDSIQGSPLY 204 (406)
Q Consensus 128 ~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~--~~kL~DFGla~~~~~~~~~~~~~gt~~y 204 (406)
.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ ++ .+||+|||+++............||+.|
T Consensus 104 ~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y 183 (361)
T 3uc3_A 104 YERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 183 (361)
T ss_dssp HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------------CTT
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCc
Confidence 99998888999999999999999999999999999999999999998 33 4999999999865555555667899999
Q ss_pred CChhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCC
Q psy5368 205 MAPEILAGSPYNAK-ADLWSLGVLVFEALFGHAPYASCN----LSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 205 ~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP 279 (406)
+|||++.+..++.+ +||||+||++|+|++|+.||.+.. .......+............+++++.+||.+||+.||
T Consensus 184 ~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 263 (361)
T 3uc3_A 184 IAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADP 263 (361)
T ss_dssp SCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCT
T ss_pred CChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCCh
Confidence 99999998887665 899999999999999999998744 3344444444432222223689999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCC
Q psy5368 280 MRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 280 ~~Rps~~ell~hp~~~~~ 297 (406)
++|||+.|+++||||...
T Consensus 264 ~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 264 ATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp TTSCCHHHHHTSHHHHTT
T ss_pred hHCcCHHHHHhCcchhcC
Confidence 999999999999999643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=368.41 Aligned_cols=247 Identities=24% Similarity=0.419 Sum_probs=210.5
Q ss_pred ceeeecceeeeEEEeeeee--eceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccC
Q psy5368 55 STIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ 123 (406)
....||+|+||.||++... +..+++|.+.... ......+.+|+.++..++|||+++ +.+.+|+|||||+
T Consensus 73 ~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ 152 (410)
T 3v8s_A 73 VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP 152 (410)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 3567899999999999874 3567888775422 223445889999999999999876 7788999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC--CCCcccC
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND--QGDSIQG 200 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~--~~~~~~g 200 (406)
||+|.++++. ..+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++...... .....+|
T Consensus 153 gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~g 231 (410)
T 3v8s_A 153 GGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 231 (410)
T ss_dssp TEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCS
T ss_pred CCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcC
Confidence 9999999976 4799999999999999999999999999999999999998 7899999999998765443 2346789
Q ss_pred CCCCCChhhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCC-CCCChHHHHHHHHh
Q psy5368 201 SPLYMAPEILAGSP----YNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSA-PITIPP-NSLSPDCMDFLSRL 274 (406)
Q Consensus 201 t~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~-~~~s~~l~~li~~~ 274 (406)
|+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+.......+.... ....|. ..+|+++++||.+|
T Consensus 232 t~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l 311 (410)
T 3v8s_A 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAF 311 (410)
T ss_dssp CGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred CccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHH
Confidence 99999999998765 7899999999999999999999999999888888887642 122332 36999999999999
Q ss_pred cccCCCC--CCCHHHHhcCCCCCCCCCCCc
Q psy5368 275 LQKDPMR--RISYEDLFSHPYPDLIHAPCA 302 (406)
Q Consensus 275 L~~dP~~--Rps~~ell~hp~~~~~~~~~~ 302 (406)
|+.+|.+ ||+++|+++||||+...+...
T Consensus 312 L~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~ 341 (410)
T 3v8s_A 312 LTDREVRLGRNGVEEIKRHLFFKNDQWAWE 341 (410)
T ss_dssp SSCGGGCTTSSCHHHHHTSGGGCCSSCCST
T ss_pred ccChhhhCCCCCHHHHhcCccccCCCHHHH
Confidence 9999988 999999999999998876443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=372.70 Aligned_cols=249 Identities=24% Similarity=0.422 Sum_probs=210.6
Q ss_pred CceeeecceeeeEEEeeeeee--ceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEecc
Q psy5368 54 SSTIRYGELQYDTVQNSQIRL--GTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYC 122 (406)
Q Consensus 54 ~~~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~ 122 (406)
....+||+|+||+||++.... ..+++|.+.... ......+.+|..++..++|||++. +.+.+|+|||||
T Consensus 77 ~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~ 156 (437)
T 4aw2_A 77 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYY 156 (437)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecC
Confidence 345678999999999999754 567888776432 122334889999999999999876 778899999999
Q ss_pred CCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC--CCcc
Q psy5368 123 DGGDLCSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ--GDSI 198 (406)
Q Consensus 123 ~ggsL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~--~~~~ 198 (406)
+||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++....... ....
T Consensus 157 ~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 236 (437)
T 4aw2_A 157 VGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 236 (437)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSC
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccc
Confidence 99999999987 46899999999999999999999999999999999999999 78999999999977654432 3446
Q ss_pred cCCCCCCChhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCC--CCCChHHHHH
Q psy5368 199 QGSPLYMAPEILA-----GSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSA-PITIPP--NSLSPDCMDF 270 (406)
Q Consensus 199 ~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~--~~~s~~l~~l 270 (406)
+||+.|+|||++. ...++.++||||+||++|||++|+.||.+.+..+....+.... ....|. ..+|+++.+|
T Consensus 237 ~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dL 316 (437)
T 4aw2_A 237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDL 316 (437)
T ss_dssp CSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHH
T ss_pred cCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHH
Confidence 7999999999997 5669999999999999999999999999999888888776532 122222 3589999999
Q ss_pred HHHhcccCCCC--CCCHHHHhcCCCCCCCCCCCc
Q psy5368 271 LSRLLQKDPMR--RISYEDLFSHPYPDLIHAPCA 302 (406)
Q Consensus 271 i~~~L~~dP~~--Rps~~ell~hp~~~~~~~~~~ 302 (406)
|.+||..+|++ ||+++|+++||||+...+...
T Consensus 317 i~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l 350 (437)
T 4aw2_A 317 IRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI 350 (437)
T ss_dssp HHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred HHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence 99999988888 999999999999998876543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=346.21 Aligned_cols=242 Identities=29% Similarity=0.410 Sum_probs=194.2
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccc--hhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITS--HSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~--~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...||+|+||+||++... +..+++|.+....... ...+.+|+.++++++|||+++ ..+.+|+||||+++
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 85 (292)
T 3o0g_A 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred eeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-
Confidence 345677777777777753 4567888776544322 367889999999999999876 67789999999986
Q ss_pred CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCcccCCC
Q psy5368 126 DLCSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDSIQGSP 202 (406)
Q Consensus 126 sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~~~gt~ 202 (406)
+|.+.+.. ++.+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++..... .......||+
T Consensus 86 ~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~ 165 (292)
T 3o0g_A 86 DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTL 165 (292)
T ss_dssp EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCCSCG
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCCcccc
Confidence 66666654 57899999999999999999999999999999999999999 779999999999876533 3345567899
Q ss_pred CCCChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhcCCCC-----------------------
Q psy5368 203 LYMAPEILAGSP-YNAKADLWSLGVLVFEALFGHAP-YASCNLSQLRAQALSSAPIT----------------------- 257 (406)
Q Consensus 203 ~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p-f~~~~~~~~~~~~~~~~~~~----------------------- 257 (406)
.|+|||++.+.. ++.++||||+||++|+|++|..| |.+.+..+....+.......
T Consensus 166 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (292)
T 3o0g_A 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPAT 245 (292)
T ss_dssp GGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTT
T ss_pred CCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCC
Confidence 999999998766 89999999999999999987776 66666666655554321100
Q ss_pred ----CCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 258 ----IPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 258 ----~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
.....+++++.+|+.+||+.||++|||++|+++||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 246 TSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred cchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 00124789999999999999999999999999999998643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=357.05 Aligned_cols=243 Identities=26% Similarity=0.434 Sum_probs=190.8
Q ss_pred ceeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 55 STIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
....||+|+||.||++... +..+++|.+.... ....+.+|+.++.+++|||+++ ..+.+|+||||+++++
T Consensus 57 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 134 (349)
T 2w4o_A 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE 134 (349)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCC
Confidence 3567999999999999975 3568888876542 4467889999999999999876 6778999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee----CCeeEEEecccccccCCCCCCCcccCCC
Q psy5368 127 LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK----NNTLKLADFGFAQFLAPNDQGDSIQGSP 202 (406)
Q Consensus 127 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~----~~~~kL~DFGla~~~~~~~~~~~~~gt~ 202 (406)
|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++............||+
T Consensus 135 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~ 214 (349)
T 2w4o_A 135 LFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTP 214 (349)
T ss_dssp HHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------------CG
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCC
Confidence 999998888899999999999999999999999999999999999997 5689999999998776555556678999
Q ss_pred CCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCCCCCCC--CCCChHHHHHHHHhcccCC
Q psy5368 203 LYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQ-LRAQALSSAPITIPP--NSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 203 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~--~~~s~~l~~li~~~L~~dP 279 (406)
.|+|||++.+..++.++|||||||++|+|++|..||....... +...+.........+ ..++.++.+||.+||+.||
T Consensus 215 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 294 (349)
T 2w4o_A 215 GYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDP 294 (349)
T ss_dssp GGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSG
T ss_pred CccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCCh
Confidence 9999999999999999999999999999999999998766544 445555443222221 3689999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCC
Q psy5368 280 MRRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 280 ~~Rps~~ell~hp~~~~~~~ 299 (406)
++|||+.++++||||.....
T Consensus 295 ~~Rpt~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 295 KKRLTTFQALQHPWVTGKAA 314 (349)
T ss_dssp GGSCCHHHHHHSTTTTSTTC
T ss_pred hhCcCHHHHhcCcccCCCcc
Confidence 99999999999999986554
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=361.76 Aligned_cols=242 Identities=24% Similarity=0.411 Sum_probs=203.6
Q ss_pred eeeecceeeeEEEeeeeee--ceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIRL--GTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||.+.... ..+++|.+.... ......+.+|+.++..++|||++. ..+.+|+|||||+|
T Consensus 20 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~g 99 (384)
T 4fr4_A 20 LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLG 99 (384)
T ss_dssp EEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCC
Confidence 3456777777777777543 457888765432 234557889999999999999876 67889999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
|+|.+++..++.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++............||+.
T Consensus 100 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~ 179 (384)
T 4fr4_A 100 GDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKP 179 (384)
T ss_dssp EEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCCCCSCGG
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCceeccCCCcc
Confidence 99999999888999999999999999999999999999999999999998 77999999999998776666677889999
Q ss_pred CCChhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhccc
Q psy5368 204 YMAPEILAG---SPYNAKADLWSLGVLVFEALFGHAPYASC---NLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 204 y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~pf~~~---~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~ 277 (406)
|+|||++.+ ..++.++||||+||++|+|++|..||... ....+...+... ....+ ..+|+++.+||.+||+.
T Consensus 180 Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~p-~~~s~~~~~li~~lL~~ 257 (384)
T 4fr4_A 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-VVTYP-SAWSQEMVSLLKKLLEP 257 (384)
T ss_dssp GCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC-CCCCC-TTSCHHHHHHHHHHSCS
T ss_pred ccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc-ccCCC-CcCCHHHHHHHHHHhcC
Confidence 999999974 45899999999999999999999999753 344444444433 33333 36899999999999999
Q ss_pred CCCCCCC-HHHHhcCCCCCCCCC
Q psy5368 278 DPMRRIS-YEDLFSHPYPDLIHA 299 (406)
Q Consensus 278 dP~~Rps-~~ell~hp~~~~~~~ 299 (406)
||.+||+ ++++++||||+...+
T Consensus 258 dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 258 NPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp SGGGSCCSHHHHHTSGGGTTCCH
T ss_pred CHhHhcccHHHHHcChhhhcCCH
Confidence 9999998 899999999987654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=345.29 Aligned_cols=240 Identities=25% Similarity=0.370 Sum_probs=195.5
Q ss_pred eeeecceeeeEEEeeeee-eceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR-LGTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~-~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...||+|+||.||++... +..+++|++..... .....+.+|+.++++++|||+++ ..+.+|+||||+++ +
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 85 (288)
T 1ob3_A 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-D 85 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-E
T ss_pred hhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-C
Confidence 356788999999998864 45688887765432 23467889999999999999876 67789999999986 9
Q ss_pred HHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCcccCCCC
Q psy5368 127 LCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDSIQGSPL 203 (406)
Q Consensus 127 L~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~~~gt~~ 203 (406)
|.+++... +.+++..+..++.||+.||+|||++||+||||||+||+++ ++.+||+|||++...... .......||+.
T Consensus 86 l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~ 165 (288)
T 1ob3_A 86 LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLW 165 (288)
T ss_dssp HHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCT
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccccccccccc
Confidence 99999765 5799999999999999999999999999999999999998 779999999999876533 23345578999
Q ss_pred CCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-----------------C--------
Q psy5368 204 YMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI-----------------T-------- 257 (406)
Q Consensus 204 y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-----------------~-------- 257 (406)
|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+...... .
T Consensus 166 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (288)
T 1ob3_A 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLP 245 (288)
T ss_dssp TCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCC
T ss_pred ccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCcc
Confidence 9999999764 5899999999999999999999999998876666555431000 0
Q ss_pred --CCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy5368 258 --IPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 258 --~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 296 (406)
.....+++++.+|+.+||+.||++|||++|+++||||+.
T Consensus 246 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 246 WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp GGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred HHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 001247899999999999999999999999999999974
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=343.90 Aligned_cols=244 Identities=23% Similarity=0.435 Sum_probs=210.3
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...||+|+||.||++... +..+++|.+...... ....+.+|+.++++++|||+++ ..+..|+||||++++
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 90 (284)
T 3kk8_A 11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 90 (284)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred hhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCC
Confidence 456788888888888764 456888877654322 3457889999999999999876 677889999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC---eeEEEecccccccCCCCCCCcccCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN---TLKLADFGFAQFLAPNDQGDSIQGS 201 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~---~~kL~DFGla~~~~~~~~~~~~~gt 201 (406)
+|.+.+..++.+++..+..++.|++.||.|||++||+||||||+||+++ ++ .+||+|||++.............||
T Consensus 91 ~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 170 (284)
T 3kk8_A 91 ELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGT 170 (284)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSC
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCC
Confidence 9999998888999999999999999999999999999999999999997 33 4999999999887766666667899
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCChHHHHHHHHhcccCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP--NSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~~li~~~L~~dP 279 (406)
+.|+|||++.+..++.++||||+|+++|+|++|..||.+.+.......+.........+ ..+++++.+|+.+||+.||
T Consensus 171 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp 250 (284)
T 3kk8_A 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNP 250 (284)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSST
T ss_pred cCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccCh
Confidence 99999999999999999999999999999999999999998888887777664332222 3689999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCC
Q psy5368 280 MRRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 280 ~~Rps~~ell~hp~~~~~~~ 299 (406)
++|||+.|+++||||+....
T Consensus 251 ~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 251 KKRITADQALKVPWICNRER 270 (284)
T ss_dssp TTSCCHHHHTTSHHHHSCCC
T ss_pred hhCCCHHHHhcCccccCChh
Confidence 99999999999999986543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=354.39 Aligned_cols=241 Identities=24% Similarity=0.407 Sum_probs=186.8
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCC-CCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLR-APEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
.+.||+|+||.||++... +..+++|.+... ....+.+|+.++..+. |||+++ +....|+|||||+||+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 467999999999999974 457888887542 3467889999999997 999876 6788999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeC-C---eeEEEecccccccCCCC-CCCcccCC
Q psy5368 127 LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-N---TLKLADFGFAQFLAPND-QGDSIQGS 201 (406)
Q Consensus 127 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~-~---~~kL~DFGla~~~~~~~-~~~~~~gt 201 (406)
|.+++..++.+++.++..++.||+.||+|||++||+||||||+|||++. + .+||+|||+++...... ......||
T Consensus 93 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t 172 (325)
T 3kn6_A 93 LFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFT 172 (325)
T ss_dssp HHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----------
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCC
Confidence 9999999889999999999999999999999999999999999999983 3 79999999998654432 33556789
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhcCCCCCCC---CCCChHHHHHH
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCN-------LSQLRAQALSSAPITIPP---NSLSPDCMDFL 271 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~-------~~~~~~~~~~~~~~~~~~---~~~s~~l~~li 271 (406)
+.|+|||++.+..++.++||||+||++|+|++|..||.+.+ ..++...+..... ..+. ..+|+++.+||
T Consensus 173 ~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~s~~~~~li 251 (325)
T 3kn6_A 173 LHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF-SFEGEAWKNVSQEAKDLI 251 (325)
T ss_dssp -----------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC-CCCSHHHHTSCHHHHHHH
T ss_pred cCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC-CCCcccccCCCHHHHHHH
Confidence 99999999999999999999999999999999999998643 3455555554432 2222 25899999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy5368 272 SRLLQKDPMRRISYEDLFSHPYPDLIHAP 300 (406)
Q Consensus 272 ~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 300 (406)
.+||+.||.+|||++++++||||+.....
T Consensus 252 ~~~L~~dP~~Rpt~~ell~h~w~~~~~~~ 280 (325)
T 3kn6_A 252 QGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280 (325)
T ss_dssp HHHHCCCTTTCCCTTTSTTCGGGCTTCCC
T ss_pred HHHCCCChhHCCCHHHHhcChhhccCccC
Confidence 99999999999999999999999876443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=343.25 Aligned_cols=240 Identities=29% Similarity=0.491 Sum_probs=196.4
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...||+|+||.||++... +..+++|.+.... ......+.+|+.++++++|||+++ ..+..|+||||+++++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 106 (285)
T 3is5_A 27 KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGE 106 (285)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCB
T ss_pred cceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCc
Confidence 456777788888877753 4467777766544 234578999999999999999876 6778999999999999
Q ss_pred HHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee----CCeeEEEecccccccCCCCCCCcc
Q psy5368 127 LCSFIRS----HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK----NNTLKLADFGFAQFLAPNDQGDSI 198 (406)
Q Consensus 127 L~~~l~~----~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~----~~~~kL~DFGla~~~~~~~~~~~~ 198 (406)
|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||+++ ++.+||+|||++............
T Consensus 107 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 186 (285)
T 3is5_A 107 LLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA 186 (285)
T ss_dssp HHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------
T ss_pred HHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCc
Confidence 9999854 36799999999999999999999999999999999999995 357999999999877666666677
Q ss_pred cCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC-CCCCChHHHHHHHHhccc
Q psy5368 199 QGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIP-PNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 199 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~~li~~~L~~ 277 (406)
.||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+..+.............. ...+++++.+|+.+||+.
T Consensus 187 ~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 265 (285)
T 3is5_A 187 AGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTK 265 (285)
T ss_dssp CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCS
T ss_pred ccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccC
Confidence 8999999999986 46899999999999999999999999999888877776655433222 235899999999999999
Q ss_pred CCCCCCCHHHHhcCCCCCC
Q psy5368 278 DPMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 278 dP~~Rps~~ell~hp~~~~ 296 (406)
||++|||+.|+++||||+.
T Consensus 266 dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 266 DPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CTTTSCCHHHHHTSGGGGC
T ss_pred ChhhCcCHHHHhcCHHhhc
Confidence 9999999999999999974
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=371.31 Aligned_cols=239 Identities=23% Similarity=0.339 Sum_probs=185.7
Q ss_pred eecceeeeEEEeeee--eeceeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCccc------------CCeEEEEEec
Q psy5368 58 RYGELQYDTVQNSQI--RLGTVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRKR------------PRYVYIILEY 121 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~------------~~~~~lV~E~ 121 (406)
.||+|+||.||++.. .+..|++|++.... .....++.+|+.+++.++|||+++. ...+|+||||
T Consensus 69 ~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~ 148 (464)
T 3ttj_A 69 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 148 (464)
T ss_dssp EEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEEC
T ss_pred EeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeC
Confidence 345555555555543 23457788776432 2335578899999999999998762 2457999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccC
Q psy5368 122 CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQG 200 (406)
Q Consensus 122 ~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~g 200 (406)
|++ +|.+.+.. .+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++............|
T Consensus 149 ~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~g 225 (464)
T 3ttj_A 149 MDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 225 (464)
T ss_dssp CSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CCCC----C
T ss_pred CCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCcccCCCcc
Confidence 976 67777743 599999999999999999999999999999999999999 77999999999988776666677889
Q ss_pred CCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC---------------------C
Q psy5368 201 SPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITI---------------------P 259 (406)
Q Consensus 201 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~---------------------~ 259 (406)
|+.|+|||++.+..|+.++||||+||++|||++|++||.+.+..+....+........ .
T Consensus 226 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (464)
T 3ttj_A 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYA 305 (464)
T ss_dssp CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCC
T ss_pred cccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccC
Confidence 9999999999999999999999999999999999999999887776666554211100 0
Q ss_pred C--------CC-----------CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy5368 260 P--------NS-----------LSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 260 ~--------~~-----------~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 299 (406)
. .. .++++.+||.+||+.||++|||++|+++||||+....
T Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 364 (464)
T 3ttj_A 306 GLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 364 (464)
T ss_dssp CCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred CCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence 0 00 1567999999999999999999999999999986543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=364.65 Aligned_cols=255 Identities=23% Similarity=0.403 Sum_probs=212.3
Q ss_pred cccccceeeecCceeeecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------c
Q psy5368 43 RSGTVRYDIVGSSTIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------R 111 (406)
Q Consensus 43 ~~~~~~~~i~~~~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~ 111 (406)
......| .....||+|+||.||++... +..+++|.+..... .....+.+|..++..++|||++. +
T Consensus 57 ~~~~~~f----~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 57 RLQRDDF----EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp SCCGGGE----EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred cCChhhE----EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3344556 34567899999999999874 56789998765321 22345788999999999999875 7
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEeccccccc
Q psy5368 112 PRYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFL 189 (406)
Q Consensus 112 ~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~ 189 (406)
.+++|+|||||+||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++..
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~ 212 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKL 212 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheec
Confidence 78899999999999999999775 4799999999999999999999999999999999999999 789999999999876
Q ss_pred CCCCC--CCcccCCCCCCChhhhc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCC
Q psy5368 190 APNDQ--GDSIQGSPLYMAPEILA-------GSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSA-PITIP 259 (406)
Q Consensus 190 ~~~~~--~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~ 259 (406)
..... ....+||+.|+|||++. +..++.++|||||||++|||++|+.||.+.+..+....+.... ....+
T Consensus 213 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p 292 (412)
T 2vd5_A 213 RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLP 292 (412)
T ss_dssp CTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred cCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCC
Confidence 54432 33568999999999997 4568999999999999999999999999999888877776532 12222
Q ss_pred --CCCCChHHHHHHHHhcccCCCCC---CCHHHHhcCCCCCCCCCCCc
Q psy5368 260 --PNSLSPDCMDFLSRLLQKDPMRR---ISYEDLFSHPYPDLIHAPCA 302 (406)
Q Consensus 260 --~~~~s~~l~~li~~~L~~dP~~R---ps~~ell~hp~~~~~~~~~~ 302 (406)
+..+|+++++||.+||. +|.+| |+++|+++||||+...+...
T Consensus 293 ~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l 339 (412)
T 2vd5_A 293 LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL 339 (412)
T ss_dssp ----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 24799999999999999 99998 59999999999998876543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=361.39 Aligned_cols=244 Identities=28% Similarity=0.429 Sum_probs=190.8
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCC--ccchhhhhhHHhhcccCC-CCCCcc--------cCCeEEEEEeccC
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDT--ITSHSEFERPRAGLSNLR-APEGRK--------RPRYVYIILEYCD 123 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~-h~ni~~--------~~~~~~lV~E~~~ 123 (406)
..||+|+||.||++... +..+++|++.... ......+.+|+.++..+. |||++. ....+|+|||||+
T Consensus 15 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~ 94 (388)
T 3oz6_A 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME 94 (388)
T ss_dssp EC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS
T ss_pred EEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC
Confidence 45677777777777643 4568888775432 234557889999999997 999865 3347899999997
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC----------
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN---------- 192 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~---------- 192 (406)
+ +|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+.....
T Consensus 95 ~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 172 (388)
T 3oz6_A 95 T-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172 (388)
T ss_dssp E-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGC
T ss_pred c-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccccccccccc
Confidence 5 99999977 5799999999999999999999999999999999999999 779999999999865331
Q ss_pred ------------CCCCcccCCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--
Q psy5368 193 ------------DQGDSIQGSPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPIT-- 257 (406)
Q Consensus 193 ------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-- 257 (406)
.......||+.|+|||++.+ ..++.++||||+||++|||++|++||.+.+.......+.......
T Consensus 173 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~ 252 (388)
T 3oz6_A 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSN 252 (388)
T ss_dssp CC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred ccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 11234679999999999987 679999999999999999999999999988777666654321110
Q ss_pred -------------------------------------------CCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 258 -------------------------------------------IPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 258 -------------------------------------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
.+...+++++.+|+.+||+.||++|||++|+++||||
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~ 332 (388)
T 3oz6_A 253 EDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFV 332 (388)
T ss_dssp HHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTT
T ss_pred HHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHH
Confidence 0122678999999999999999999999999999999
Q ss_pred CCCCCCCc
Q psy5368 295 DLIHAPCA 302 (406)
Q Consensus 295 ~~~~~~~~ 302 (406)
+..+.+..
T Consensus 333 ~~~~~~~~ 340 (388)
T 3oz6_A 333 SIFHNPNE 340 (388)
T ss_dssp TTTCCGGG
T ss_pred HHhcCCcc
Confidence 87765543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=348.32 Aligned_cols=243 Identities=28% Similarity=0.382 Sum_probs=195.2
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...||+|+||.||++... +..+++|.+..... .....+.+|+.++++++|||+++ ..+.+|+||||+++ +
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~ 88 (317)
T 2pmi_A 10 LEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-D 88 (317)
T ss_dssp ---------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCCC-B
T ss_pred eeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecCC-C
Confidence 456799999999999764 45788888765543 23467889999999999999876 67789999999985 9
Q ss_pred HHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCcc
Q psy5368 127 LCSFIRSH------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDSI 198 (406)
Q Consensus 127 L~~~l~~~------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~~ 198 (406)
|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++..... ......
T Consensus 89 L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 168 (317)
T 2pmi_A 89 LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE 168 (317)
T ss_dssp HHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCCCC
T ss_pred HHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcccCCCC
Confidence 99999654 3599999999999999999999999999999999999998 779999999999876533 234456
Q ss_pred cCCCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------------------
Q psy5368 199 QGSPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI--------------------- 256 (406)
Q Consensus 199 ~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--------------------- 256 (406)
.||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+....+......
T Consensus 169 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (317)
T 2pmi_A 169 VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQ 248 (317)
T ss_dssp CSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCC
T ss_pred cccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhccccccc
Confidence 789999999999874 6899999999999999999999999998877766665432100
Q ss_pred -----------CCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy5368 257 -----------TIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 257 -----------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 299 (406)
...+..+++++.+||.+||+.||++|||++|+++||||+....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 249 RPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp CCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred ccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 0011257889999999999999999999999999999987554
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=349.02 Aligned_cols=238 Identities=24% Similarity=0.400 Sum_probs=191.3
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCCc--------------------------cchhhhhhHHhhcccCCCCCC
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI--------------------------TSHSEFERPRAGLSNLRAPEG 108 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~--------------------------~~~~~~~~E~~~l~~l~h~ni 108 (406)
..||+|+||.||++... +..+++|.+..... .....+.+|+.++++++|||+
T Consensus 19 ~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 98 (298)
T 2zv2_A 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNV 98 (298)
T ss_dssp EEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTB
T ss_pred eEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCC
Confidence 44566666666666542 34456665543321 123568899999999999998
Q ss_pred cc--------cCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeE
Q psy5368 109 RK--------RPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLK 179 (406)
Q Consensus 109 ~~--------~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~k 179 (406)
++ ..+.+|+||||+++++|.+++. ..++++..+..++.||+.||+|||++||+||||||+|||++ ++.+|
T Consensus 99 v~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~k 177 (298)
T 2zv2_A 99 VKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIK 177 (298)
T ss_dssp CCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEE
T ss_pred CeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCCEE
Confidence 76 2568999999999999988653 35799999999999999999999999999999999999998 77999
Q ss_pred EEecccccccCCCC-CCCcccCCCCCCChhhhcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Q psy5368 180 LADFGFAQFLAPND-QGDSIQGSPLYMAPEILAGSP---YNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP 255 (406)
Q Consensus 180 L~DFGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 255 (406)
|+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.........+.....
T Consensus 178 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 257 (298)
T 2zv2_A 178 IADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQAL 257 (298)
T ss_dssp ECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred EecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccC
Confidence 99999998765432 234567999999999998765 37889999999999999999999999888777777666543
Q ss_pred CCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy5368 256 ITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPD 295 (406)
Q Consensus 256 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~ 295 (406)
.......+++++.+||.+||+.||++|||+.|+++||||+
T Consensus 258 ~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 258 EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 3222347899999999999999999999999999999985
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=371.00 Aligned_cols=240 Identities=26% Similarity=0.487 Sum_probs=209.2
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++... +..+++|.+..... .....+.+|+.+++.++|||+++ ..+.+|+|||||+|
T Consensus 21 ~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~g 100 (476)
T 2y94_A 21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSG 100 (476)
T ss_dssp EEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 456788888888888764 56788887765432 23457899999999999999876 67889999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
|+|.+++..++.+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||++............+||+.
T Consensus 101 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~ 180 (476)
T 2y94_A 101 GELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN 180 (476)
T ss_dssp EEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBCCCCSCST
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccccccccCCCcC
Confidence 99999998888999999999999999999999999999999999999999 67999999999988766655667789999
Q ss_pred CCChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCC
Q psy5368 204 YMAPEILAGSPY-NAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRR 282 (406)
Q Consensus 204 y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 282 (406)
|+|||++.+..+ +.++||||+||++|+|++|..||.+.+...+...+..... . .+..+++++.+||.+||+.||.+|
T Consensus 181 y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~-~p~~~s~~~~~Li~~~L~~dP~~R 258 (476)
T 2y94_A 181 YAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-Y-TPQYLNPSVISLLKHMLQVDPMKR 258 (476)
T ss_dssp TCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC-C-CCTTCCHHHHHHHHHHTCSSTTTS
T ss_pred eEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc-C-CCccCCHHHHHHHHHHcCCCchhC
Confidence 999999998775 6899999999999999999999999888888887776632 2 234689999999999999999999
Q ss_pred CCHHHHhcCCCCCCC
Q psy5368 283 ISYEDLFSHPYPDLI 297 (406)
Q Consensus 283 ps~~ell~hp~~~~~ 297 (406)
||++++++||||+..
T Consensus 259 pt~~eil~hp~~~~~ 273 (476)
T 2y94_A 259 ATIKDIREHEWFKQD 273 (476)
T ss_dssp CCHHHHHTCHHHHTT
T ss_pred cCHHHHHhCHHhhhc
Confidence 999999999999753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=354.40 Aligned_cols=242 Identities=24% Similarity=0.387 Sum_probs=197.9
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...||+|+||.||++... +..+++|.+..... .....+.+|+.+++.++|||+++ ..+..|+|||||+|++
T Consensus 12 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~ 91 (323)
T 3tki_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91 (323)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCc
Confidence 456788888888888754 45688887754432 23467899999999999999876 6778899999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC---CCCcccCCC
Q psy5368 127 LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND---QGDSIQGSP 202 (406)
Q Consensus 127 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~---~~~~~~gt~ 202 (406)
|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++...... ......||+
T Consensus 92 L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~ 171 (323)
T 3tki_A 92 LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171 (323)
T ss_dssp GGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCG
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCc
Confidence 999998878899999999999999999999999999999999999999 6799999999997653222 234567999
Q ss_pred CCCChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCC
Q psy5368 203 LYMAPEILAGSPY-NAKADLWSLGVLVFEALFGHAPYASCNLSQL-RAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPM 280 (406)
Q Consensus 203 ~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~ 280 (406)
.|+|||++.+..+ +.++||||+||++|+|++|..||........ ............+...+++++.+|+.+||+.||+
T Consensus 172 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 251 (323)
T 3tki_A 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPS 251 (323)
T ss_dssp GGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTT
T ss_pred CccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccCChh
Confidence 9999999988775 7799999999999999999999987654322 2222223222222347899999999999999999
Q ss_pred CCCCHHHHhcCCCCCCC
Q psy5368 281 RRISYEDLFSHPYPDLI 297 (406)
Q Consensus 281 ~Rps~~ell~hp~~~~~ 297 (406)
+|||++|+++||||+..
T Consensus 252 ~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 252 ARITIPDIKKDRWYNKP 268 (323)
T ss_dssp TSCCHHHHTTCTTTTCC
T ss_pred hCcCHHHHhhChhhccc
Confidence 99999999999999854
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=360.52 Aligned_cols=249 Identities=18% Similarity=0.277 Sum_probs=198.5
Q ss_pred eeeecce--eeeEEEeeeee--eceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccC
Q psy5368 56 TIRYGEL--QYDTVQNSQIR--LGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G--~~g~Vy~~~~~--~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ 123 (406)
...||+| +||.||++... +..|++|.+...... ....+.+|+.+++.++|||+++ ..+.+|+|||||+
T Consensus 30 ~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 109 (389)
T 3gni_B 30 LTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 109 (389)
T ss_dssp EEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred EecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccC
Confidence 4567888 89999998874 567899988755422 2456888999999999999876 6778999999999
Q ss_pred CCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC--------
Q psy5368 124 GGDLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-------- 192 (406)
Q Consensus 124 ggsL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-------- 192 (406)
+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||.+......
T Consensus 110 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 189 (389)
T 3gni_B 110 YGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVH 189 (389)
T ss_dssp TCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBC
T ss_pred CCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccc
Confidence 99999999876 6799999999999999999999999999999999999999 789999999988654221
Q ss_pred CCCCcccCCCCCCChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--------------
Q psy5368 193 DQGDSIQGSPLYMAPEILAG--SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI-------------- 256 (406)
Q Consensus 193 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-------------- 256 (406)
.......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.......+......
T Consensus 190 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (389)
T 3gni_B 190 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELT 269 (389)
T ss_dssp CCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------------
T ss_pred cccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccccccc
Confidence 12233478999999999988 57999999999999999999999999876544433332221110
Q ss_pred ------------------------------CCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCccc
Q psy5368 257 ------------------------------TIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAES 304 (406)
Q Consensus 257 ------------------------------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~~~ 304 (406)
...+..+++++.+||.+||+.||++|||+.|+++||||+....+..+.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~~~~~~ 347 (389)
T 3gni_B 270 MSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEA 347 (389)
T ss_dssp ------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC---CCSS
T ss_pred ccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhhcchhh
Confidence 001235789999999999999999999999999999999876554443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=349.96 Aligned_cols=241 Identities=26% Similarity=0.379 Sum_probs=195.8
Q ss_pred eeecceeeeEEEeeee--eeceeEEeeeecCCccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 57 IRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
..||+|+||.||++.. .+..+++|.+..........+.+|+.++.++ +|||+++ ..+.+|+||||++|++|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 4689999999999985 4567899988776655677899999999885 7999876 67789999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC---eeEEEecccccccCCCC--------CC
Q psy5368 128 CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN---TLKLADFGFAQFLAPND--------QG 195 (406)
Q Consensus 128 ~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~---~~kL~DFGla~~~~~~~--------~~ 195 (406)
.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++ ++ .+||+|||++....... ..
T Consensus 99 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 178 (316)
T 2ac3_A 99 LSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178 (316)
T ss_dssp HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----------------
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccccccccc
Confidence 99998888999999999999999999999999999999999999998 33 39999999987654221 12
Q ss_pred CcccCCCCCCChhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------------HHHHHHHHHhcCC
Q psy5368 196 DSIQGSPLYMAPEILAG-----SPYNAKADLWSLGVLVFEALFGHAPYASCN---------------LSQLRAQALSSAP 255 (406)
Q Consensus 196 ~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~pf~~~~---------------~~~~~~~~~~~~~ 255 (406)
....||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.. ...+...+... .
T Consensus 179 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~-~ 257 (316)
T 2ac3_A 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEG-K 257 (316)
T ss_dssp ---CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHC-C
T ss_pred ccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhcc-C
Confidence 24458999999999975 458899999999999999999999998754 23344444444 2
Q ss_pred CCCCC---CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 256 ITIPP---NSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 256 ~~~~~---~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
...+. ..+++++.+|+.+||+.||.+|||+.|+++||||+...
T Consensus 258 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 258 YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 33332 36899999999999999999999999999999998654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=351.63 Aligned_cols=243 Identities=25% Similarity=0.357 Sum_probs=192.5
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...||+|+||+||++.. .+..+++|.+...... ....+.+|+.++++++|||+++ ..+.+|+||||+++
T Consensus 39 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 117 (329)
T 3gbz_A 39 ITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN- 117 (329)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred EEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCC-
Confidence 34667788888888764 3456788877544322 2456889999999999999876 77889999999985
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee------CCeeEEEecccccccCCC-CCCCcc
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK------NNTLKLADFGFAQFLAPN-DQGDSI 198 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~------~~~~kL~DFGla~~~~~~-~~~~~~ 198 (406)
+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++...... ......
T Consensus 118 ~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 197 (329)
T 3gbz_A 118 DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE 197 (329)
T ss_dssp EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC---------
T ss_pred CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCC
Confidence 9999999988999999999999999999999999999999999999995 235999999999876533 233455
Q ss_pred cCCCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC-----------------
Q psy5368 199 QGSPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP----------------- 260 (406)
Q Consensus 199 ~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~----------------- 260 (406)
.||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+..........
T Consensus 198 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (329)
T 3gbz_A 198 IITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPK 277 (329)
T ss_dssp --CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred cCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhh
Confidence 689999999999875 48999999999999999999999999988777666665431111000
Q ss_pred -----------CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy5368 261 -----------NSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 261 -----------~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 299 (406)
..+++++.+||.+||+.||++|||++|+++||||+...+
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 278 FRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp CCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 016789999999999999999999999999999997654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=351.96 Aligned_cols=244 Identities=26% Similarity=0.391 Sum_probs=193.1
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccc-hhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITS-HSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~-~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...||+|+||.||++... +..+++|.+....... ...+.+|+.++++++|||+++ ..+..|+||||+++ +
T Consensus 7 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 85 (324)
T 3mtl_A 7 LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-D 85 (324)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCSE-E
T ss_pred EEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccccc-C
Confidence 346778888888888764 4567888776543222 336778999999999999876 67788999999975 9
Q ss_pred HHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCC
Q psy5368 127 LCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPL 203 (406)
Q Consensus 127 L~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~ 203 (406)
|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....... ......||+.
T Consensus 86 l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~ 165 (324)
T 3mtl_A 86 LKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLW 165 (324)
T ss_dssp HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------------CGG
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccccCccc
Confidence 999997754 699999999999999999999999999999999999998 7799999999997654332 3345578999
Q ss_pred CCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC-----------------------
Q psy5368 204 YMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIP----------------------- 259 (406)
Q Consensus 204 y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----------------------- 259 (406)
|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+....+........+
T Consensus 166 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (324)
T 3mtl_A 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAE 245 (324)
T ss_dssp GCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCC
T ss_pred ccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccch
Confidence 999999987 56899999999999999999999999998887776665542111100
Q ss_pred -----CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy5368 260 -----PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAP 300 (406)
Q Consensus 260 -----~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 300 (406)
...+++++.+||.+||+.||.+|||++|+++||||......
T Consensus 246 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 246 ALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp CHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred hhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 12468899999999999999999999999999999876543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=344.94 Aligned_cols=242 Identities=26% Similarity=0.410 Sum_probs=204.3
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
...||+|+||.||++... +..+++|.+..........+.+|+.++.+++|||+++ ..+.+|+||||+++++|
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (304)
T 2jam_A 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL 93 (304)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred eeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccH
Confidence 456788888888888763 5568888877655455667899999999999999765 67789999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEe---e-CCeeEEEecccccccCCCCCCCcccCCCC
Q psy5368 128 CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI---K-NNTLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 128 ~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll---~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
.+++...+.+++..+..++.|++.||.|||++||+|+||||+||++ + ++.+||+|||++..... .......||+.
T Consensus 94 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~~ 172 (304)
T 2jam_A 94 FDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-GIMSTACGTPG 172 (304)
T ss_dssp HHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-BTTHHHHSCCC
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-CccccccCCCC
Confidence 9999888899999999999999999999999999999999999999 4 56899999999875432 23344568999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCChHHHHHHHHhcccCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIP--PNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~s~~l~~li~~~L~~dP~~ 281 (406)
|+|||++.+..++.++||||+||++|+|++|..||...+...+...+......... ...+|+++.+|+.+||+.||++
T Consensus 173 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 252 (304)
T 2jam_A 173 YVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNE 252 (304)
T ss_dssp BCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTT
T ss_pred ccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhH
Confidence 99999999999999999999999999999999999999888888777766432211 2368999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCC
Q psy5368 282 RISYEDLFSHPYPDLIH 298 (406)
Q Consensus 282 Rps~~ell~hp~~~~~~ 298 (406)
|||++++++||||+...
T Consensus 253 Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 253 RYTCEKALSHPWIDGNT 269 (304)
T ss_dssp SCCHHHHHTSHHHHSSC
T ss_pred CcCHHHHhcCccccCCC
Confidence 99999999999998654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=351.61 Aligned_cols=244 Identities=25% Similarity=0.430 Sum_probs=192.8
Q ss_pred eeeecceeeeEEEeeeee-eceeEEeeeecCCcc--chhhhhhHHhhcccCCC--CCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR-LGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRA--PEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~-~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h--~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++... ...+++|.+...... ....+.+|+.++.+++| ||++. ..+.+|+|||+ .+
T Consensus 14 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~ 92 (343)
T 3dbq_A 14 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GN 92 (343)
T ss_dssp EEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CS
T ss_pred EEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CC
Confidence 456778888888887653 345788877654322 23578999999999987 88765 67789999995 57
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeCCeeEEEecccccccCCCCC---CCcccCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLADFGFAQFLAPNDQ---GDSIQGS 201 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~~~~kL~DFGla~~~~~~~~---~~~~~gt 201 (406)
++|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++++.+||+|||+++....... .....||
T Consensus 93 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt 172 (343)
T 3dbq_A 93 IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGT 172 (343)
T ss_dssp EEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCCC------------CCC
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEECCcEEEeecccccccCcccccccCCCCcCC
Confidence 7999999998999999999999999999999999999999999999999999999999999987654332 3456799
Q ss_pred CCCCChhhhcC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCCCCCCCCChHHHH
Q psy5368 202 PLYMAPEILAG-----------SPYNAKADLWSLGVLVFEALFGHAPYASCNL-SQLRAQALSSAPITIPPNSLSPDCMD 269 (406)
Q Consensus 202 ~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~elltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~s~~l~~ 269 (406)
+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ......+.........+...++++.+
T Consensus 173 ~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 252 (343)
T 3dbq_A 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQD 252 (343)
T ss_dssp CSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHH
T ss_pred cCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHH
Confidence 99999999864 6689999999999999999999999987433 23333333332222333467889999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy5368 270 FLSRLLQKDPMRRISYEDLFSHPYPDLIHAP 300 (406)
Q Consensus 270 li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 300 (406)
|+.+||+.||.+|||+.++++||||+....|
T Consensus 253 li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~ 283 (343)
T 3dbq_A 253 VLKCCLKRDPKQRISIPELLAHPYVQIQTHP 283 (343)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTSHHHHSCCC-
T ss_pred HHHHHcCCChhHCCCHHHHHhCccccccCCc
Confidence 9999999999999999999999999865443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=343.37 Aligned_cols=239 Identities=26% Similarity=0.340 Sum_probs=190.9
Q ss_pred eecceeeeEEEeeee--eeceeEEeeeecCC-----ccchhhhhhHHhhcccCC---CCCCcc------cCC-----eEE
Q psy5368 58 RYGELQYDTVQNSQI--RLGTVKYSQVRYDT-----ITSHSEFERPRAGLSNLR---APEGRK------RPR-----YVY 116 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~-----~~~~~~~~~E~~~l~~l~---h~ni~~------~~~-----~~~ 116 (406)
.||+|+||+||++.. .+..+++|.+.... ......+.+|+.+++.++ |||+++ ... .++
T Consensus 16 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~ 95 (308)
T 3g33_A 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVT 95 (308)
T ss_dssp EECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEE
T ss_pred EEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEE
Confidence 345555555555552 23456777665332 122346778888877775 999876 111 589
Q ss_pred EEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC
Q psy5368 117 IILEYCDGGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND 193 (406)
Q Consensus 117 lV~E~~~ggsL~~~l~~~~~--l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~ 193 (406)
+||||+.+ +|.+++..... +++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++......
T Consensus 96 lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 174 (308)
T 3g33_A 96 LVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM 174 (308)
T ss_dssp EEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCC
T ss_pred EEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCCc
Confidence 99999975 99999987654 99999999999999999999999999999999999998 7799999999998877666
Q ss_pred CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--------------
Q psy5368 194 QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIP-------------- 259 (406)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-------------- 259 (406)
......||+.|+|||++.+..++.++||||+||++|+|++|++||.+.+..+....+.........
T Consensus 175 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 254 (308)
T 3g33_A 175 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAF 254 (308)
T ss_dssp CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGS
T ss_pred ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence 667788999999999999999999999999999999999999999998887777666542111000
Q ss_pred -----------CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy5368 260 -----------PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 260 -----------~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 297 (406)
...+++++.+||.+||+.||++|||+.|+++||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 255 PPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp CCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred CCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 12578899999999999999999999999999999854
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=347.16 Aligned_cols=244 Identities=27% Similarity=0.395 Sum_probs=195.9
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccc--hhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITS--HSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~--~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...||+|+||.||++... +..+++|++....... ...+.+|+.++.+++|||+++ ..+..++||||++++
T Consensus 8 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (311)
T 4agu_A 8 IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHT 87 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred eeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCc
Confidence 356788888888888764 4568888775543222 456789999999999999876 677899999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPL 203 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~ 203 (406)
+|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++....... ......||+.
T Consensus 88 ~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 167 (311)
T 4agu_A 88 VLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRW 167 (311)
T ss_dssp HHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------------GG
T ss_pred hHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCCcCCcc
Confidence 9999998888999999999999999999999999999999999999999 7799999999998765332 3345678999
Q ss_pred CCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--------------------CCCC---
Q psy5368 204 YMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP--------------------ITIP--- 259 (406)
Q Consensus 204 y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~--------------------~~~~--- 259 (406)
|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..+....+..... ...+
T Consensus 168 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (311)
T 4agu_A 168 YRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDM 247 (311)
T ss_dssp GCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSC
T ss_pred ccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCcccc
Confidence 999999986 5689999999999999999999999999887665554432110 0000
Q ss_pred ------CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy5368 260 ------PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 260 ------~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 299 (406)
...+++++.+|+.+||+.||.+|||++|+++||||+....
T Consensus 248 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 293 (311)
T 4agu_A 248 EPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293 (311)
T ss_dssp CCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred chhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence 0257889999999999999999999999999999997654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=354.85 Aligned_cols=240 Identities=26% Similarity=0.445 Sum_probs=198.3
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC-----ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEecc
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT-----ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYC 122 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~-----~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~ 122 (406)
...||+|+||.||++... +..+++|.+.... ......+.+|+.+++.++|||+++ ..+.+|+|||||
T Consensus 29 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 108 (351)
T 3c0i_A 29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFM 108 (351)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCC
Confidence 445677888888888753 4568888765322 124567899999999999999876 678899999999
Q ss_pred CCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC---eeEEEecccccccCCCCC
Q psy5368 123 DGGDLCSFIRSH----EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN---TLKLADFGFAQFLAPNDQ 194 (406)
Q Consensus 123 ~ggsL~~~l~~~----~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~---~~kL~DFGla~~~~~~~~ 194 (406)
+|++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ ++ .+||+|||++........
T Consensus 109 ~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~ 188 (351)
T 3c0i_A 109 DGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL 188 (351)
T ss_dssp SSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSC
T ss_pred CCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCe
Confidence 999999888543 3589999999999999999999999999999999999997 23 499999999987755432
Q ss_pred -CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCChHHHHHH
Q psy5368 195 -GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP--NSLSPDCMDFL 271 (406)
Q Consensus 195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~~li 271 (406)
.....||+.|+|||++.+..++.++||||+||++|+|++|..||.+.. ..+...+........+. ..+|+++.+||
T Consensus 189 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 267 (351)
T 3c0i_A 189 VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISESAKDLV 267 (351)
T ss_dssp BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCCHHHHHHH
Confidence 345679999999999999999999999999999999999999998854 44555555543222211 36899999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCCCC
Q psy5368 272 SRLLQKDPMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 272 ~~~L~~dP~~Rps~~ell~hp~~~~ 296 (406)
.+||+.||++|||+.++++||||+.
T Consensus 268 ~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 268 RRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp HHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred HHHCCCChhHCcCHHHHhcChhhcC
Confidence 9999999999999999999999974
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=350.42 Aligned_cols=256 Identities=24% Similarity=0.303 Sum_probs=193.9
Q ss_pred ccccccceEEEeeeeee-EEEeeeeecCCcceeeeeeccccccccceeeecCceeeecceeeeEEEeeeee--eceeEEe
Q psy5368 4 YGTVRYGTVRLGSVKYG-QVQLSTVRYGKVRYSQVRSDTVRSGTVRYDIVGSSTIRYGELQYDTVQNSQIR--LGTVKYS 80 (406)
Q Consensus 4 ~~~g~~~~V~ig~~~~g-y~vv~~lg~G~~~~~~~~~d~~~~~~~~~~i~~~~~~~lG~G~~g~Vy~~~~~--~~~v~vk 80 (406)
|.+++|+|+.+|+.+.+ |.++++|| +|+||+||++... +..+++|
T Consensus 41 ~~~~~~~p~~~~~~~~~~y~~~~~LG--------------------------------~G~~g~Vy~~~~~~~~~~vavK 88 (311)
T 3p1a_A 41 LQSPGYDPSRPESFFQQSFQRLSRLG--------------------------------HGSYGEVFKVRSKEDGRLYAVK 88 (311)
T ss_dssp CCCTTCCTTSSSCHHHHHEEEEEEEE--------------------------------EETTEEEEEEEETTTSCEEEEE
T ss_pred cCCCCCCCCCccchhhhheeeeheec--------------------------------cCCCeEEEEEEECCCCeEEEEE
Confidence 45667777777666664 66655555 5555555555542 4467777
Q ss_pred eeecCCcc--chhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHH
Q psy5368 81 QVRYDTIT--SHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLV 150 (406)
Q Consensus 81 ~~~~~~~~--~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~ql~ 150 (406)
++...... ....+.+|+..+.++ +|||++. ..+..|+||||+ +++|.+++... ..+++..+..++.||+
T Consensus 89 ~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~ 167 (311)
T 3p1a_A 89 RSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTL 167 (311)
T ss_dssp EESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHH
T ss_pred EecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence 66543222 233455566555555 9999876 677899999999 66999998665 4699999999999999
Q ss_pred HHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHH
Q psy5368 151 LALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVF 229 (406)
Q Consensus 151 ~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 229 (406)
.||+|||++||+||||||+|||++ ++.+||+|||++.............||+.|+|||++.+ .++.++|||||||++|
T Consensus 168 ~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ 246 (311)
T 3p1a_A 168 LALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTIL 246 (311)
T ss_dssp HHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHH
T ss_pred HHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHH
Confidence 999999999999999999999998 77999999999988766666666779999999999886 6999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy5368 230 EALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 230 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 296 (406)
||++|..||.... ....+.........+..+++++.+|+.+||+.||++|||++++++||||+.
T Consensus 247 el~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 247 EVACNMELPHGGE---GWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHTCCCCSSHH---HHHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHhCCCCCCCcc---HHHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 9999977765432 222232222211122368999999999999999999999999999999974
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=349.48 Aligned_cols=244 Identities=25% Similarity=0.392 Sum_probs=203.9
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCC--ccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccCCC
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDT--ITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
..||+|+||.||++... +..+++|.+.... ......+.+|+.++..+ .|||++. ..+..|+|||||++|
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (327)
T 3lm5_A 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114 (327)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence 57899999999999864 5678888776433 23356789999999999 4599765 678899999999999
Q ss_pred CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeC----CeeEEEecccccccCCCCCCCccc
Q psy5368 126 DLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN----NTLKLADFGFAQFLAPNDQGDSIQ 199 (406)
Q Consensus 126 sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~----~~~kL~DFGla~~~~~~~~~~~~~ 199 (406)
+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++. +.+||+|||+++............
T Consensus 115 ~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 194 (327)
T 3lm5_A 115 EIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM 194 (327)
T ss_dssp EGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------C
T ss_pred cHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcccccccc
Confidence 999998543 57999999999999999999999999999999999999984 689999999998876665566678
Q ss_pred CCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCChHHHHHHHHhccc
Q psy5368 200 GSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIP--PNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 200 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~s~~l~~li~~~L~~ 277 (406)
||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+..+....+......... ...+++.+.+||.+||+.
T Consensus 195 gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 274 (327)
T 3lm5_A 195 GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVK 274 (327)
T ss_dssp CCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCS
T ss_pred CCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCC
Confidence 999999999999999999999999999999999999999998888777766655332222 236899999999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCCCC
Q psy5368 278 DPMRRISYEDLFSHPYPDLIHAP 300 (406)
Q Consensus 278 dP~~Rps~~ell~hp~~~~~~~~ 300 (406)
||.+|||++++++||||+...+.
T Consensus 275 dP~~Rpt~~~ll~h~~~~~~~~~ 297 (327)
T 3lm5_A 275 NPEKRPTAEICLSHSWLQQWDFE 297 (327)
T ss_dssp SGGGSCCHHHHTTCGGGCCCCTT
T ss_pred ChhhCcCHHHHhCCHhhcccccc
Confidence 99999999999999999877653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=379.50 Aligned_cols=242 Identities=24% Similarity=0.416 Sum_probs=212.0
Q ss_pred eeeecceeeeEEEeeeeee--ceeEEeeeecCC---ccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIRL--GTVKYSQVRYDT---ITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~ 123 (406)
..+||+|+||.||++.... ..+|+|.+.... ......+.+|..++..+ +||+++. +.+.+||||||++
T Consensus 346 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~ 425 (674)
T 3pfq_A 346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 425 (674)
T ss_dssp EEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCC
T ss_pred EEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcC
Confidence 3579999999999999754 458999876532 23455678899999988 6788654 7788999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccC-CCCCCCcccCC
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLA-PNDQGDSIQGS 201 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~-~~~~~~~~~gt 201 (406)
||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++... .........||
T Consensus 426 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT 505 (674)
T 3pfq_A 426 GGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGT 505 (674)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSC
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCcccccccCC
Confidence 999999999888999999999999999999999999999999999999999 7799999999998643 33345667899
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..++...+.... ...| ..+|+++.+||.+||+.||.+
T Consensus 506 ~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~p-~~~s~~~~~li~~lL~~dP~~ 583 (674)
T 3pfq_A 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYP-KSMSKEAVAICKGLMTKHPGK 583 (674)
T ss_dssp SSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC-CCCC-TTSCHHHHHHHHHHSCSSSTT
T ss_pred CcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-CCCC-ccCCHHHHHHHHHHccCCHHH
Confidence 99999999999999999999999999999999999999999999988888763 3344 379999999999999999999
Q ss_pred CCCH-----HHHhcCCCCCCCCC
Q psy5368 282 RISY-----EDLFSHPYPDLIHA 299 (406)
Q Consensus 282 Rps~-----~ell~hp~~~~~~~ 299 (406)
||++ +|+++||||+...+
T Consensus 584 R~~~~~~~~~ei~~h~ff~~i~w 606 (674)
T 3pfq_A 584 RLGCGPEGERDIKEHAFFRYIDW 606 (674)
T ss_dssp CTTCSTTHHHHHHSSGGGSSCCH
T ss_pred CCCCCCCcHHHHhcCccccCCCH
Confidence 9997 99999999998765
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=356.73 Aligned_cols=245 Identities=25% Similarity=0.441 Sum_probs=197.8
Q ss_pred ceeeecceeeeEEEeeeee-eceeEEeeeecCCcc--chhhhhhHHhhcccCCC--CCCcc------cCCeEEEEEeccC
Q psy5368 55 STIRYGELQYDTVQNSQIR-LGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRA--PEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~-~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h--~ni~~------~~~~~~lV~E~~~ 123 (406)
....||+|+||.||++... +..+++|.+...... ....+.+|+.++.+++| ||++. ..+.+|+||| +.
T Consensus 60 ~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~ 138 (390)
T 2zmd_A 60 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CG 138 (390)
T ss_dssp EEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CC
T ss_pred EEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cC
Confidence 3567999999999999864 456888877654322 34578999999999974 88765 6678999999 55
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeCCeeEEEecccccccCCCC---CCCcccC
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLADFGFAQFLAPND---QGDSIQG 200 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~~~~kL~DFGla~~~~~~~---~~~~~~g 200 (406)
+++|.+++.....+++.++..++.||+.||.|||++||+||||||+|||++++.+||+|||+++...... ......|
T Consensus 139 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~kl~DFG~a~~~~~~~~~~~~~~~~g 218 (390)
T 2zmd_A 139 NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVG 218 (390)
T ss_dssp SEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESSSCEEECCCSSSCCC---------CCSCC
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEECCeEEEEecCccccccCCCccccCCCCCc
Confidence 7899999999889999999999999999999999999999999999999999999999999998765433 2345679
Q ss_pred CCCCCChhhhcC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCCCCCCCCCChHHH
Q psy5368 201 SPLYMAPEILAG-----------SPYNAKADLWSLGVLVFEALFGHAPYASCN-LSQLRAQALSSAPITIPPNSLSPDCM 268 (406)
Q Consensus 201 t~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~elltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~s~~l~ 268 (406)
|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... .......+.........+...+.++.
T Consensus 219 t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (390)
T 2zmd_A 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQ 298 (390)
T ss_dssp CGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHH
T ss_pred CCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccchHHHH
Confidence 999999999975 368999999999999999999999998754 23333444433222222335688999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy5368 269 DFLSRLLQKDPMRRISYEDLFSHPYPDLIHAP 300 (406)
Q Consensus 269 ~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 300 (406)
+||.+||+.||.+|||+.|+++||||+....|
T Consensus 299 ~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 330 (390)
T 2zmd_A 299 DVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330 (390)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTSHHHHSCC--
T ss_pred HHHHHHcccChhhCCCHHHHhhCcCccccCcc
Confidence 99999999999999999999999999865443
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=343.62 Aligned_cols=241 Identities=24% Similarity=0.403 Sum_probs=198.0
Q ss_pred ceeeecceeeeEEEeeeeeeceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 55 STIRYGELQYDTVQNSQIRLGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
....||+|+||.||++...+..+++|.+...... ....+.+|+.++++++|||+++ ..+..++||||+++|+
T Consensus 41 i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 120 (309)
T 3p86_A 41 IKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120 (309)
T ss_dssp EEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCB
T ss_pred eeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCc
Confidence 3567899999999999988888999987655432 2357889999999999999876 6677899999999999
Q ss_pred HHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCcceEee-CCeeEEEecccccccCCCC-CCCccc
Q psy5368 127 LCSFIRSHEK---LSEFQCQQFVRQLVLALKFLRENN--VCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQ 199 (406)
Q Consensus 127 L~~~l~~~~~---l~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~ 199 (406)
|.+++...+. +++..+..++.||+.||+|||++| |+||||||+|||++ ++.+||+|||+++...... ......
T Consensus 121 L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 200 (309)
T 3p86_A 121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA 200 (309)
T ss_dssp HHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----------------
T ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccccccccCC
Confidence 9999987653 999999999999999999999999 99999999999999 6699999999997654332 234567
Q ss_pred CCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCC
Q psy5368 200 GSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 200 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP 279 (406)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.........+..+++++.+||.+||+.||
T Consensus 201 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 280 (309)
T 3p86_A 201 GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEP 280 (309)
T ss_dssp -CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred CCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCCh
Confidence 99999999999999999999999999999999999999999988887777765544444455799999999999999999
Q ss_pred CCCCCHHHHhc--CCCCC
Q psy5368 280 MRRISYEDLFS--HPYPD 295 (406)
Q Consensus 280 ~~Rps~~ell~--hp~~~ 295 (406)
.+|||+.++++ +++++
T Consensus 281 ~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 281 WKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp GGSCCHHHHHHHHHHHHC
T ss_pred hhCcCHHHHHHHHHHHHH
Confidence 99999999987 34443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=373.76 Aligned_cols=243 Identities=21% Similarity=0.348 Sum_probs=208.6
Q ss_pred ceeeecceeeeEEEeeeee--eceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccC
Q psy5368 55 STIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ 123 (406)
....||+|+||.||++... +..+++|.+.... ......+.+|+.++..++|||++. +.+.+|+|||||+
T Consensus 188 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~ 267 (576)
T 2acx_A 188 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 267 (576)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCC
Confidence 3567899999999999874 5678898876542 233456889999999999999876 6788999999999
Q ss_pred CCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccC
Q psy5368 124 GGDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQG 200 (406)
Q Consensus 124 ggsL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~g 200 (406)
||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++............|
T Consensus 268 gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~G 347 (576)
T 2acx_A 268 GGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVG 347 (576)
T ss_dssp SCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEECCCS
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCccccccCC
Confidence 999999998754 499999999999999999999999999999999999999 78999999999988765555556789
Q ss_pred CCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcc
Q psy5368 201 SPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCN----LSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQ 276 (406)
Q Consensus 201 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~ 276 (406)
|+.|+|||++.+..++.++||||+||++|||++|..||.+.+ ...+...+... ....+ ..+|+++.+||.+||+
T Consensus 348 T~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-~~~~p-~~~s~~~~dLI~~lL~ 425 (576)
T 2acx_A 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-PEEYS-ERFSPQARSLCSQLLC 425 (576)
T ss_dssp CGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-CCCCC-TTSCHHHHHHHHHHTC
T ss_pred CccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-cccCC-ccCCHHHHHHHHHhcc
Confidence 999999999999999999999999999999999999998753 34455444443 33343 4799999999999999
Q ss_pred cCCCCCC-----CHHHHhcCCCCCCCCC
Q psy5368 277 KDPMRRI-----SYEDLFSHPYPDLIHA 299 (406)
Q Consensus 277 ~dP~~Rp-----s~~ell~hp~~~~~~~ 299 (406)
.||.+|| +++|+++||||+...+
T Consensus 426 ~dP~~R~g~~~~sa~eil~HpfF~~i~w 453 (576)
T 2acx_A 426 KDPAERLGCRGGSAREVKEHPLFKKLNF 453 (576)
T ss_dssp SSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred CCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence 9999999 7899999999997654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=339.00 Aligned_cols=239 Identities=21% Similarity=0.401 Sum_probs=199.0
Q ss_pred eeeecceeeeEEEeeeeee--ceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCcc----------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIRL--GTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRK----------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~----------~~~~~~lV~E~ 121 (406)
...||+|+||.||++.... ..+++|.+..... .....+.+|+.++++++|||+++ ....+|+||||
T Consensus 31 ~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 110 (290)
T 1t4h_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEe
Confidence 4578999999999998643 4567776654432 23457899999999999999876 24668999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCcceEee--CCeeEEEecccccccCCCCCCCc
Q psy5368 122 CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENN--VCHFDLKPQNILIK--NNTLKLADFGFAQFLAPNDQGDS 197 (406)
Q Consensus 122 ~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dlkp~NIll~--~~~~kL~DFGla~~~~~~~~~~~ 197 (406)
+++++|.+++...+.+++..+..++.||+.||.|||++| |+|+||||+||+++ ++.+||+|||++..... .....
T Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~-~~~~~ 189 (290)
T 1t4h_A 111 MTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKA 189 (290)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-TSBEE
T ss_pred cCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc-ccccc
Confidence 999999999998889999999999999999999999999 99999999999997 56999999999975433 33345
Q ss_pred ccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcc
Q psy5368 198 IQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCN-LSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQ 276 (406)
Q Consensus 198 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~ 276 (406)
..||+.|+|||++.+ .++.++||||+||++|+|++|..||.... .......+.........+...++++.+|+.+||+
T Consensus 190 ~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 268 (290)
T 1t4h_A 190 VIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 268 (290)
T ss_dssp SCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSC
T ss_pred ccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHcc
Confidence 678999999998875 48999999999999999999999998844 4445554544433333344678999999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCC
Q psy5368 277 KDPMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 277 ~dP~~Rps~~ell~hp~~~~ 296 (406)
.||.+|||+.++++||||+.
T Consensus 269 ~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 269 QNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp SSGGGSCCHHHHHTSGGGC-
T ss_pred CChhhCCCHHHHhhCccccc
Confidence 99999999999999999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=353.06 Aligned_cols=242 Identities=24% Similarity=0.394 Sum_probs=201.3
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...||+|+||.||++... +..+++|.+..... .....+.+|+.++++++|||++. ..+..|+||||++|++
T Consensus 38 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 117 (360)
T 3eqc_A 38 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 117 (360)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCC
Confidence 456788888888888765 45677887765432 23457899999999999999876 6778999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCC
Q psy5368 127 LCSFIRSHEKLSEFQCQQFVRQLVLALKFLREN-NVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLY 204 (406)
Q Consensus 127 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~-givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y 204 (406)
|.+++...+.+++..+..++.|++.||.|||++ ||+||||||+|||++ ++.+||+|||++...... ......||+.|
T Consensus 118 L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~gt~~y 196 (360)
T 3eqc_A 118 LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSY 196 (360)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-C----CCCCTT
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-cccCCCCCCCe
Confidence 999999888999999999999999999999996 999999999999998 779999999998765322 23456789999
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------------------------------------
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLR------------------------------------- 247 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~------------------------------------- 247 (406)
+|||++.+..++.++||||+||++|+|++|+.||...+...+.
T Consensus 197 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (360)
T 3eqc_A 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMA 276 (360)
T ss_dssp CCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCC
T ss_pred ECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCccc
Confidence 9999999999999999999999999999999999876654432
Q ss_pred -----HHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 248 -----AQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 248 -----~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
..+........+...++.++.+||.+||+.||++|||++++++||||+...
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 277 IFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp HHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred chhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 233334444445556899999999999999999999999999999998543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=339.53 Aligned_cols=242 Identities=29% Similarity=0.478 Sum_probs=202.2
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc------chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT------SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~------~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~ 121 (406)
...||+|+||.||++... +..+++|.+...... ....+.+|+.++++++|||+++ .....++||||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 89 (283)
T 3bhy_A 10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILEL 89 (283)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred HHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEee
Confidence 456788888888888764 457788876654322 3567899999999999999866 66789999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC----eeEEEecccccccCCCCCCC
Q psy5368 122 CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN----TLKLADFGFAQFLAPNDQGD 196 (406)
Q Consensus 122 ~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~----~~kL~DFGla~~~~~~~~~~ 196 (406)
+++++|.+++..+..+++..+..++.||+.||.|||++|++|+||||+||+++ ++ .+||+|||++..........
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~ 169 (283)
T 3bhy_A 90 VSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK 169 (283)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCccc
Confidence 99999999998888999999999999999999999999999999999999998 33 79999999998876655556
Q ss_pred cccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCChHHHHHHHHh
Q psy5368 197 SIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIP--PNSLSPDCMDFLSRL 274 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~s~~l~~li~~~ 274 (406)
...||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+........+ ...+++.+.+|+.+|
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 249 (283)
T 3bhy_A 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRL 249 (283)
T ss_dssp --CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTT
T ss_pred ccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHH
Confidence 667999999999999999999999999999999999999999998887777766554322111 136889999999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCC
Q psy5368 275 LQKDPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 275 L~~dP~~Rps~~ell~hp~~~~~ 297 (406)
|..||++|||+.++++||||+..
T Consensus 250 l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 250 LVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp SCSSGGGSCCHHHHHHCHHHHHH
T ss_pred ccCCHhHCcCHHHHHhCHHHHHH
Confidence 99999999999999999999754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=349.29 Aligned_cols=234 Identities=29% Similarity=0.444 Sum_probs=198.6
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCcc--------chhhhhhHHhhcccCCCCCCcc------cCCeEEEEE
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTIT--------SHSEFERPRAGLSNLRAPEGRK------RPRYVYIIL 119 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~--------~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~ 119 (406)
...||+|+||.||++.. .+..+++|.+...... ....+.+|+.++++++|||+++ ..+.+++||
T Consensus 29 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 108 (335)
T 3dls_A 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVM 108 (335)
T ss_dssp EEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEE
Confidence 45678888888888864 3456788877654322 3346888999999999999876 678899999
Q ss_pred eccCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCc
Q psy5368 120 EYCDGG-DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDS 197 (406)
Q Consensus 120 E~~~gg-sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~ 197 (406)
||+.+| +|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...........
T Consensus 109 e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 188 (335)
T 3dls_A 109 EKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT 188 (335)
T ss_dssp ECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCE
T ss_pred EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCCCceec
Confidence 999766 9999999988999999999999999999999999999999999999998 67999999999988776666667
Q ss_pred ccCCCCCCChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcc
Q psy5368 198 IQGSPLYMAPEILAGSPY-NAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQ 276 (406)
Q Consensus 198 ~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~ 276 (406)
..||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... . ......++..+++++.+|+.+||+
T Consensus 189 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~--~~~~~~~~~~~~~~l~~li~~~L~ 260 (335)
T 3dls_A 189 FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------T--VEAAIHPPYLVSKELMSLVSGLLQ 260 (335)
T ss_dssp ECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------G--TTTCCCCSSCCCHHHHHHHHHHTC
T ss_pred cCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------H--HhhccCCCcccCHHHHHHHHHHcc
Confidence 789999999999998876 8899999999999999999999976321 1 111223344689999999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCC
Q psy5368 277 KDPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 277 ~dP~~Rps~~ell~hp~~~~~ 297 (406)
.||++|||++++++||||+..
T Consensus 261 ~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 261 PVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp SSGGGSCCHHHHHHCTTTTCC
T ss_pred CChhhCcCHHHHhcCccccCC
Confidence 999999999999999999853
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=351.76 Aligned_cols=237 Identities=25% Similarity=0.379 Sum_probs=200.7
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...||+|+||.||++... +..+++|.+.... ....+|++++.++ +|||++. +.+.+|+|||||+||+
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~ 102 (342)
T 2qr7_A 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGE 102 (342)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCc
Confidence 457899999999999864 4568888876543 3456788888888 7999876 7788999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeC--C---eeEEEecccccccCCC-CCCCcccC
Q psy5368 127 LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN--N---TLKLADFGFAQFLAPN-DQGDSIQG 200 (406)
Q Consensus 127 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~--~---~~kL~DFGla~~~~~~-~~~~~~~g 200 (406)
|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||+.+ + .+||+|||+++..... .......|
T Consensus 103 L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g 182 (342)
T 2qr7_A 103 LLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY 182 (342)
T ss_dssp HHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSC
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCC
Confidence 9999998889999999999999999999999999999999999999852 2 4999999999876543 23455678
Q ss_pred CCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHhcCCCCCC--CCCCChHHHHHHHHhc
Q psy5368 201 SPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYAS---CNLSQLRAQALSSAPITIP--PNSLSPDCMDFLSRLL 275 (406)
Q Consensus 201 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~---~~~~~~~~~~~~~~~~~~~--~~~~s~~l~~li~~~L 275 (406)
|+.|+|||++.+..++.++||||+||++|+|++|..||.+ .+..++...+......... ...+|+++.+||.+||
T Consensus 183 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 262 (342)
T 2qr7_A 183 TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKML 262 (342)
T ss_dssp CSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHT
T ss_pred CccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHC
Confidence 9999999999988899999999999999999999999986 4566677766665432221 2368999999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCC
Q psy5368 276 QKDPMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 276 ~~dP~~Rps~~ell~hp~~~~ 296 (406)
..||++|||+.++++||||..
T Consensus 263 ~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 263 HVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp CSSTTTSCCHHHHTTSHHHHT
T ss_pred CCChhHCcCHHHHhcCCeecC
Confidence 999999999999999999964
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=339.28 Aligned_cols=240 Identities=25% Similarity=0.446 Sum_probs=202.9
Q ss_pred eeeecceeeeEEEeeeeee--ceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIRL--GTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++.... ..+++|.+.... ......+.+|+.++++++|||++. ..+..++||||+++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 93 (279)
T 3fdn_A 14 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 93 (279)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred eeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCC
Confidence 4567888999999887643 357888765432 223457889999999999999876 67789999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
++|.+++.....+++..+..++.||+.||.|||++||+|+||||+||+++ ++.++|+|||++...... ......||+.
T Consensus 94 ~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~ 172 (279)
T 3fdn_A 94 GTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTDLCGTLD 172 (279)
T ss_dssp EEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---------CCCCT
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-cccccCCCCC
Confidence 99999998888999999999999999999999999999999999999998 779999999998654433 3345678999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
|+|||++.+..++.++||||+|+++|+|++|..||...+..+....+.... ... +..+++++.+|+.+||+.||.+||
T Consensus 173 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~li~~~l~~~p~~Rp 250 (279)
T 3fdn_A 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTF-PDFVTEGARDLISRLLKHNPSQRP 250 (279)
T ss_dssp TCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCC-CTTSCHHHHHHHHHHCCSSGGGSC
T ss_pred ccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC-CCC-CCcCCHHHHHHHHHHhccChhhCC
Confidence 999999999999999999999999999999999999998888877766653 233 336899999999999999999999
Q ss_pred CHHHHhcCCCCCCCC
Q psy5368 284 SYEDLFSHPYPDLIH 298 (406)
Q Consensus 284 s~~ell~hp~~~~~~ 298 (406)
|++|+++||||+...
T Consensus 251 s~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 251 MLREVLEHPWITANS 265 (279)
T ss_dssp CHHHHHHCHHHHHHC
T ss_pred CHHHHhhCccccCCc
Confidence 999999999998654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=364.00 Aligned_cols=247 Identities=22% Similarity=0.343 Sum_probs=185.6
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCcc-----------cCCeEEEEEe
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRK-----------RPRYVYIILE 120 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~-----------~~~~~~lV~E 120 (406)
...||+|+||.||++... +..|++|++.... ......+.+|+.+++.++|||++. ....+|+|||
T Consensus 58 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 137 (458)
T 3rp9_A 58 RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLE 137 (458)
T ss_dssp CCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEC
T ss_pred eeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEe
Confidence 456899999999999753 5678999876532 223467899999999999999876 2257899999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC------
Q psy5368 121 YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND------ 193 (406)
Q Consensus 121 ~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~------ 193 (406)
|+. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++......
T Consensus 138 ~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 216 (458)
T 3rp9_A 138 IAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216 (458)
T ss_dssp CCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCC
T ss_pred ccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcccccccc
Confidence 995 59999999888899999999999999999999999999999999999999 6799999999998764322
Q ss_pred ----------------------CCCcccCCCCCCChhhh-cCCCCCchhhHHHHHHHHHHHHh-----------CCCCCC
Q psy5368 194 ----------------------QGDSIQGSPLYMAPEIL-AGSPYNAKADLWSLGVLVFEALF-----------GHAPYA 239 (406)
Q Consensus 194 ----------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~ellt-----------g~~pf~ 239 (406)
.....+||+.|+|||++ .+..++.++||||||||+|||++ |+++|.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~ 296 (458)
T 3rp9_A 217 PISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFP 296 (458)
T ss_dssp C---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC
T ss_pred ccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCC
Confidence 12345789999999986 45669999999999999999999 778887
Q ss_pred CCCH--------------------HHHHHHHHh-----------------------cCCC------CCCCCCCChHHHHH
Q psy5368 240 SCNL--------------------SQLRAQALS-----------------------SAPI------TIPPNSLSPDCMDF 270 (406)
Q Consensus 240 ~~~~--------------------~~~~~~~~~-----------------------~~~~------~~~~~~~s~~l~~l 270 (406)
+.+. .+....+.. .... .......++++.+|
T Consensus 297 g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 376 (458)
T 3rp9_A 297 GSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHL 376 (458)
T ss_dssp --------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHH
T ss_pred CCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHH
Confidence 6542 111111110 0000 00012468999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCCCCCCCCCcc
Q psy5368 271 LSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAE 303 (406)
Q Consensus 271 i~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~~ 303 (406)
|.+||+.||++|||++|+|+||||+..+.+..+
T Consensus 377 l~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e 409 (458)
T 3rp9_A 377 LKRMLVFNPNKRITINECLAHPFFKEVRIAEVE 409 (458)
T ss_dssp HHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGC
T ss_pred HHHHhccCccccCCHHHHhcCHhhhhcCCCccC
Confidence 999999999999999999999999988765543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=350.68 Aligned_cols=240 Identities=28% Similarity=0.465 Sum_probs=207.5
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc--------chhhhhhHHhhcccC-CCCCCcc------cCCeEEEE
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT--------SHSEFERPRAGLSNL-RAPEGRK------RPRYVYII 118 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~--------~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV 118 (406)
...||+|+||.||++... +..|++|.+...... ....+.+|+.++.++ +|||++. ..+..|+|
T Consensus 99 ~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 178 (365)
T 2y7j_A 99 KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178 (365)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEE
T ss_pred ceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEE
Confidence 368999999999999874 567899977654321 134678899999999 8999876 67789999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCc
Q psy5368 119 LEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDS 197 (406)
Q Consensus 119 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~ 197 (406)
|||++|++|.+++.....+++..+..++.||+.||.|||+.||+|+||||+||+++ ++.+||+|||++...........
T Consensus 179 ~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~~~~ 258 (365)
T 2y7j_A 179 FDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE 258 (365)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCC
T ss_pred EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCCccccc
Confidence 99999999999998888999999999999999999999999999999999999999 67999999999988776666667
Q ss_pred ccCCCCCCChhhhcC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCChHHHH
Q psy5368 198 IQGSPLYMAPEILAG------SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP--NSLSPDCMD 269 (406)
Q Consensus 198 ~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~~ 269 (406)
..||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.........+ ..+++.+.+
T Consensus 259 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 338 (365)
T 2y7j_A 259 LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKD 338 (365)
T ss_dssp CCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHH
T ss_pred CCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHH
Confidence 789999999999863 358889999999999999999999999988777777766653322211 368899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCC
Q psy5368 270 FLSRLLQKDPMRRISYEDLFSHPYPD 295 (406)
Q Consensus 270 li~~~L~~dP~~Rps~~ell~hp~~~ 295 (406)
|+.+||+.||++|||+.++++||||+
T Consensus 339 li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 339 LISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred HHHHHcCCChhHCcCHHHHhcCcccC
Confidence 99999999999999999999999996
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=357.49 Aligned_cols=243 Identities=24% Similarity=0.397 Sum_probs=200.5
Q ss_pred CceeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCccc------------CCeEEEEE
Q psy5368 54 SSTIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRKR------------PRYVYIIL 119 (406)
Q Consensus 54 ~~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~------------~~~~~lV~ 119 (406)
.....||+|+||.||++... +..|++|++... .....+|+++++.++|||++.. ..++++||
T Consensus 57 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 132 (420)
T 1j1b_A 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132 (420)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----TTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred EeeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc----chhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence 44678999999999999974 567899987543 2345689999999999998762 23467999
Q ss_pred eccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-C-CeeEEEecccccccCCCC
Q psy5368 120 EYCDGGDLCSFIR----SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-N-NTLKLADFGFAQFLAPND 193 (406)
Q Consensus 120 E~~~ggsL~~~l~----~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~-~~~kL~DFGla~~~~~~~ 193 (406)
||+++ +|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++ + +.+||+|||+++......
T Consensus 133 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~ 211 (420)
T 1j1b_A 133 DYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211 (420)
T ss_dssp ECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred hcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCC
Confidence 99986 7777664 346799999999999999999999999999999999999999 4 478999999998876666
Q ss_pred CCCcccCCCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC----------------CC
Q psy5368 194 QGDSIQGSPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSA----------------PI 256 (406)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~----------------~~ 256 (406)
......||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+....+.... ..
T Consensus 212 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~ 291 (420)
T 1j1b_A 212 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 291 (420)
T ss_dssp CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCC
T ss_pred CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhh
Confidence 66677899999999999775 69999999999999999999999999988666555544310 00
Q ss_pred CCC-----------CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q psy5368 257 TIP-----------PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPC 301 (406)
Q Consensus 257 ~~~-----------~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~ 301 (406)
..+ +..+++++.+||.+||+.||.+|||+.|+++||||+....+.
T Consensus 292 ~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 347 (420)
T 1j1b_A 292 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 347 (420)
T ss_dssp CCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred ccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccccc
Confidence 111 125689999999999999999999999999999998765543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=363.89 Aligned_cols=241 Identities=29% Similarity=0.503 Sum_probs=191.6
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc--------cchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEe
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI--------TSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILE 120 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~--------~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E 120 (406)
...||+|+||.||++... +..+++|.+..... .....+.+|+.++++++|||+++ ..+..|+|||
T Consensus 140 ~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~lv~e 219 (419)
T 3i6u_A 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLE 219 (419)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESSEEEEEEE
T ss_pred EeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecCceEEEEE
Confidence 457999999999999864 35788887765321 12235889999999999999876 4566899999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeC----CeeEEEecccccccCCCCCCC
Q psy5368 121 YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN----NTLKLADFGFAQFLAPNDQGD 196 (406)
Q Consensus 121 ~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~----~~~kL~DFGla~~~~~~~~~~ 196 (406)
||++|+|.+++..++.+++..+..++.||+.||+|||++||+||||||+|||++. ..+||+|||+++.........
T Consensus 220 ~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~ 299 (419)
T 3i6u_A 220 LMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 299 (419)
T ss_dssp CCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC------
T ss_pred cCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCCcccc
Confidence 9999999999988889999999999999999999999999999999999999972 259999999998876665566
Q ss_pred cccCCCCCCChhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCCCCCC--CCCChHHHHH
Q psy5368 197 SIQGSPLYMAPEILAG---SPYNAKADLWSLGVLVFEALFGHAPYASCNLS-QLRAQALSSAPITIPP--NSLSPDCMDF 270 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~--~~~s~~l~~l 270 (406)
...||+.|+|||++.+ ..++.++||||+||++|+|++|..||...... .+...+........+. ..+++++.+|
T Consensus 300 ~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 379 (419)
T 3i6u_A 300 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDL 379 (419)
T ss_dssp -----CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHH
T ss_pred ccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHH
Confidence 7789999999999864 56888999999999999999999999875433 2333333332222211 3689999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCCCC
Q psy5368 271 LSRLLQKDPMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 271 i~~~L~~dP~~Rps~~ell~hp~~~~ 296 (406)
+.+||+.||++|||++|+++||||+.
T Consensus 380 i~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 380 VKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp HHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred HHHHccCChhHCcCHHHHhCCcccCC
Confidence 99999999999999999999999974
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=348.89 Aligned_cols=240 Identities=25% Similarity=0.403 Sum_probs=206.7
Q ss_pred ceeeecceeeeEEEeeee--eeceeEEeeeecCCccc---hhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccC
Q psy5368 55 STIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITS---HSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~---~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ 123 (406)
....||+|+||.||++.. .+..|++|.+....... ...+.+|+.++++++|||++. ..+..|+||||++
T Consensus 58 ~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 137 (348)
T 1u5q_A 58 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 137 (348)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC
Confidence 346789999999999985 45678899886543322 346889999999999999876 6678899999997
Q ss_pred CCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCC
Q psy5368 124 GGDLCSFIR-SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGS 201 (406)
Q Consensus 124 ggsL~~~l~-~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt 201 (406)
|+|.+++. ....+++..+..++.|++.||.|||++||+||||||+|||++ ++.+||+|||++..... .....||
T Consensus 138 -g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---~~~~~gt 213 (348)
T 1u5q_A 138 -GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSFVGT 213 (348)
T ss_dssp -EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCCCCSC
T ss_pred -CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC---CCcccCC
Confidence 48888885 456899999999999999999999999999999999999999 67999999999976543 2356799
Q ss_pred CCCCChhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccC
Q psy5368 202 PLYMAPEILA---GSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKD 278 (406)
Q Consensus 202 ~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~d 278 (406)
+.|+|||++. ...++.++|||||||++|||++|..||.+.+.......+.........+..+++.+.+|+.+||+.|
T Consensus 214 ~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 293 (348)
T 1u5q_A 214 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKI 293 (348)
T ss_dssp GGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred cceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccC
Confidence 9999999985 4678999999999999999999999999988877777777766666656689999999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCC
Q psy5368 279 PMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 279 P~~Rps~~ell~hp~~~~~~ 298 (406)
|++|||++++++|||+....
T Consensus 294 P~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 294 PQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp GGGSCCHHHHTTCHHHHSCC
T ss_pred hhhCcCHHHHhhChhhhccC
Confidence 99999999999999997544
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=337.55 Aligned_cols=246 Identities=21% Similarity=0.391 Sum_probs=209.8
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++... +..+++|.+..... .....+.+|+.++++++|||+++ ..+..|+||||+++
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 99 (294)
T 2rku_A 20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 99 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCC
Confidence 456788889999988864 34577777655432 23456889999999999999876 67789999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCcccCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDSIQGSP 202 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~~~gt~ 202 (406)
++|.+++...+.+++.++..++.|++.||.|||++||+|+||||+||+++ ++.+||+|||++...... .......||+
T Consensus 100 ~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 179 (294)
T 2rku_A 100 RSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP 179 (294)
T ss_dssp CBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCC
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccccccccCCC
Confidence 99999998888999999999999999999999999999999999999999 679999999999876533 2334567899
Q ss_pred CCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCC
Q psy5368 203 LYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRR 282 (406)
Q Consensus 203 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 282 (406)
.|+|||++.+..++.++||||+|+++|+|++|+.||......+....+.... ... +..+++.+.+|+.+||+.||++|
T Consensus 180 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~li~~~l~~~p~~R 257 (294)
T 2rku_A 180 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSI-PKHINPVAASLIQKMLQTDPTAR 257 (294)
T ss_dssp SSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCC-CTTSCHHHHHHHHHHTCSSGGGS
T ss_pred CcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc-CCC-ccccCHHHHHHHHHHcccChhhC
Confidence 9999999999989999999999999999999999999988877776665543 233 33689999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCCCcc
Q psy5368 283 ISYEDLFSHPYPDLIHAPCAE 303 (406)
Q Consensus 283 ps~~ell~hp~~~~~~~~~~~ 303 (406)
||++++++||||.....|...
T Consensus 258 ps~~~ll~~~~~~~~~~~~~~ 278 (294)
T 2rku_A 258 PTINELLNDEFFTSGYIPARL 278 (294)
T ss_dssp CCGGGGGGSHHHHTSCCCSCC
T ss_pred cCHHHHhhChheecCCcCCCC
Confidence 999999999999877665543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=356.40 Aligned_cols=249 Identities=24% Similarity=0.343 Sum_probs=193.6
Q ss_pred ceeeecceeeeEEEeeeee--eceeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCcc------cC-----CeEEEEE
Q psy5368 55 STIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRK------RP-----RYVYIIL 119 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~------~~-----~~~~lV~ 119 (406)
....||+|+||.||++... +..|++|++.... ......+.+|+.++++++|||++. .. +.+|+||
T Consensus 30 ~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~ 109 (432)
T 3n9x_A 30 IKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVL 109 (432)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred EEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEE
Confidence 3557899999999999764 3568888876532 233467899999999999999876 12 5799999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC----
Q psy5368 120 EYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ---- 194 (406)
Q Consensus 120 E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~---- 194 (406)
||+++ +|.++++....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.......
T Consensus 110 e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 188 (432)
T 3n9x_A 110 EIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188 (432)
T ss_dssp ECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---------
T ss_pred ecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccccccccc
Confidence 99965 9999999888899999999999999999999999999999999999999 67999999999987654321
Q ss_pred -------------------CCcccCCCCCCChhhh-cCCCCCchhhHHHHHHHHHHHHh-----------CCCCCCCCCH
Q psy5368 195 -------------------GDSIQGSPLYMAPEIL-AGSPYNAKADLWSLGVLVFEALF-----------GHAPYASCNL 243 (406)
Q Consensus 195 -------------------~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~ellt-----------g~~pf~~~~~ 243 (406)
.....||+.|+|||++ .+..++.++||||+|||+|||++ |.++|.+.+.
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~ 268 (432)
T 3n9x_A 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSC 268 (432)
T ss_dssp ----------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCS
T ss_pred ccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccc
Confidence 2567799999999986 45669999999999999999998 4455544321
Q ss_pred -----------------HHHHHHHH-----------------------hcCCCCCC------CCCCChHHHHHHHHhccc
Q psy5368 244 -----------------SQLRAQAL-----------------------SSAPITIP------PNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 244 -----------------~~~~~~~~-----------------------~~~~~~~~------~~~~s~~l~~li~~~L~~ 277 (406)
......+. .......+ ...+++++.+||.+||+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~ 348 (432)
T 3n9x_A 269 FPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKF 348 (432)
T ss_dssp CC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCS
T ss_pred cccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcC
Confidence 11111111 11111111 025799999999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCCCCCccc
Q psy5368 278 DPMRRISYEDLFSHPYPDLIHAPCAES 304 (406)
Q Consensus 278 dP~~Rps~~ell~hp~~~~~~~~~~~~ 304 (406)
||++|||++|+|+||||+..+.+..+.
T Consensus 349 dP~~R~ta~e~L~Hp~f~~~~~~~~e~ 375 (432)
T 3n9x_A 349 NPNKRITIDQALDHPYLKDVRKKKLEN 375 (432)
T ss_dssp STTTSCCHHHHHTCGGGTTTCCTTTC-
T ss_pred CcccCCCHHHHhcChhhhhccCcccCc
Confidence 999999999999999999887766543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=336.37 Aligned_cols=240 Identities=25% Similarity=0.483 Sum_probs=196.2
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++... +..+++|.+.... ......+.+|+.+++.++|||+++ ..+..|+||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (276)
T 2h6d_A 16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95 (276)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCC
Confidence 345677778888887753 5578888775432 233457889999999999999876 67789999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
++|.+++...+.+++..+..++.||+.||.|||++|++|+||||+||+++ ++.+||+|||++.............||+.
T Consensus 96 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 175 (276)
T 2h6d_A 96 GELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN 175 (276)
T ss_dssp CBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC------------
T ss_pred CcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcceecccCCcc
Confidence 99999998888999999999999999999999999999999999999999 67999999999987765555556678999
Q ss_pred CCChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCC
Q psy5368 204 YMAPEILAGSPY-NAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRR 282 (406)
Q Consensus 204 y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 282 (406)
|+|||.+.+..+ +.++||||+|+++|+|++|..||...+.......+..... .. +..++.++.+++.+||+.||.+|
T Consensus 176 y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~-~~~~~~~l~~li~~~l~~~p~~R 253 (276)
T 2h6d_A 176 YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF-YI-PEYLNRSVATLLMHMLQVDPLKR 253 (276)
T ss_dssp -CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CC-CTTSCHHHHHHHHHHTCSSGGGS
T ss_pred ccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-cC-chhcCHHHHHHHHHHccCChhhC
Confidence 999999988765 6899999999999999999999999888887777666532 22 34689999999999999999999
Q ss_pred CCHHHHhcCCCCCCC
Q psy5368 283 ISYEDLFSHPYPDLI 297 (406)
Q Consensus 283 ps~~ell~hp~~~~~ 297 (406)
||+.++++||||+..
T Consensus 254 ps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 254 ATIKDIREHEWFKQD 268 (276)
T ss_dssp CCHHHHHHSHHHHTT
T ss_pred CCHHHHHhChhhccC
Confidence 999999999999753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=352.32 Aligned_cols=243 Identities=23% Similarity=0.389 Sum_probs=199.6
Q ss_pred CceeeecceeeeEEEeeeee-eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------------cCCeEEEEEe
Q psy5368 54 SSTIRYGELQYDTVQNSQIR-LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------------RPRYVYIILE 120 (406)
Q Consensus 54 ~~~~~lG~G~~g~Vy~~~~~-~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------------~~~~~~lV~E 120 (406)
.....||+|+||.||++... .+.+++|++... .....+|+.+++.++|||+++ ...++|+|||
T Consensus 43 ~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e 118 (394)
T 4e7w_A 43 TNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD----KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118 (394)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEEECC----TTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred EEeEEEeeCCCeEEEEEEECCCCeEEEEEEecC----cchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence 44667899999999999873 345888877543 233457999999999999876 2234789999
Q ss_pred ccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee--CCeeEEEecccccccCCCCC
Q psy5368 121 YCDGGDLCSFIR----SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK--NNTLKLADFGFAQFLAPNDQ 194 (406)
Q Consensus 121 ~~~ggsL~~~l~----~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~--~~~~kL~DFGla~~~~~~~~ 194 (406)
||++ ++.+.+. ..+.+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++.......
T Consensus 119 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~ 197 (394)
T 4e7w_A 119 YVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP 197 (394)
T ss_dssp CCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC
T ss_pred ccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC
Confidence 9987 5554443 356899999999999999999999999999999999999998 67999999999988776666
Q ss_pred CCcccCCCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----------------CC
Q psy5368 195 GDSIQGSPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP----------------IT 257 (406)
Q Consensus 195 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~----------------~~ 257 (406)
.....||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+..+....+..... ..
T Consensus 198 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~ 277 (394)
T 4e7w_A 198 NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHK 277 (394)
T ss_dssp CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSC
T ss_pred CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhc
Confidence 7778899999999999775 599999999999999999999999999887666655543210 00
Q ss_pred C-----------CCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q psy5368 258 I-----------PPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPC 301 (406)
Q Consensus 258 ~-----------~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~ 301 (406)
. .+..+++++.+||.+||+.||.+|||+.|+++||||+....+.
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 332 (394)
T 4e7w_A 278 FPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGE 332 (394)
T ss_dssp CCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSC
T ss_pred cccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccc
Confidence 0 1124789999999999999999999999999999999876543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=345.99 Aligned_cols=238 Identities=21% Similarity=0.372 Sum_probs=190.6
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCccc---------------------
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRKR--------------------- 111 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~~--------------------- 111 (406)
...||+|+||.||++... +..+++|.+...... ....+.+|+.++++++|||+++.
T Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~ 90 (332)
T 3qd2_B 11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWL 90 (332)
T ss_dssp EEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---
T ss_pred eeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhh
Confidence 456788888888888864 567899988754433 45679999999999999998762
Q ss_pred ------------------------------------------CCeEEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHH
Q psy5368 112 ------------------------------------------PRYVYIILEYCDGGDLCSFIRSHE---KLSEFQCQQFV 146 (406)
Q Consensus 112 ------------------------------------------~~~~~lV~E~~~ggsL~~~l~~~~---~l~~~~~~~i~ 146 (406)
..+.|+|||||+|++|.+++.... ..++..+..++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~ 170 (332)
T 3qd2_B 91 KDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIF 170 (332)
T ss_dssp -----------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHH
T ss_pred ccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHH
Confidence 124899999999999999998764 35677899999
Q ss_pred HHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-------------CCCcccCCCCCCChhhhcC
Q psy5368 147 RQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-------------QGDSIQGSPLYMAPEILAG 212 (406)
Q Consensus 147 ~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-------------~~~~~~gt~~y~aPE~~~~ 212 (406)
.||+.||+|||++||+||||||+|||++ ++.+||+|||+++...... ......||+.|+|||++.+
T Consensus 171 ~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 250 (332)
T 3qd2_B 171 IQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG 250 (332)
T ss_dssp HHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHC
T ss_pred HHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcC
Confidence 9999999999999999999999999999 7799999999998776542 2234569999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q psy5368 213 SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHP 292 (406)
Q Consensus 213 ~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp 292 (406)
..++.++||||+||++|+|++|..|+.. ........... .........++++.+|+.+||+.||++|||++|+++||
T Consensus 251 ~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 327 (332)
T 3qd2_B 251 NNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNL-KFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENA 327 (332)
T ss_dssp CCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTT-CCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHST
T ss_pred CCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhcc-CCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhch
Confidence 9999999999999999999998777532 12222222222 11111124678899999999999999999999999999
Q ss_pred CCCC
Q psy5368 293 YPDL 296 (406)
Q Consensus 293 ~~~~ 296 (406)
||+.
T Consensus 328 ~f~~ 331 (332)
T 3qd2_B 328 IFEN 331 (332)
T ss_dssp TCCC
T ss_pred hhhc
Confidence 9985
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=365.51 Aligned_cols=242 Identities=24% Similarity=0.404 Sum_probs=206.8
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++... +..+++|.+..... .....+.+|+.++.+++|||++. ....+|+|||||+|
T Consensus 190 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~g 269 (543)
T 3c4z_A 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNG 269 (543)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccC
Confidence 457899999999999874 56788888765432 33456889999999999999875 67889999999999
Q ss_pred CCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC-CCcc
Q psy5368 125 GDLCSFIRSH----EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ-GDSI 198 (406)
Q Consensus 125 gsL~~~l~~~----~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~-~~~~ 198 (406)
|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....... ....
T Consensus 270 g~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 349 (543)
T 3c4z_A 270 GDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY 349 (543)
T ss_dssp CBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBCCC
T ss_pred CCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcccccc
Confidence 9999999764 3699999999999999999999999999999999999999 77999999999987755443 3445
Q ss_pred cCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHh
Q psy5368 199 QGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASC----NLSQLRAQALSSAPITIPPNSLSPDCMDFLSRL 274 (406)
Q Consensus 199 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~ 274 (406)
+||+.|+|||++.+..++.++||||+||++|||++|..||.+. ....+...+... ....+ ..+|+++.+||.+|
T Consensus 350 ~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~-~~~~p-~~~s~~~~~li~~l 427 (543)
T 3c4z_A 350 AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-AVTYP-DKFSPASKDFCEAL 427 (543)
T ss_dssp CSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-CCCCC-TTSCHHHHHHHHHH
T ss_pred cCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-ccCCC-cccCHHHHHHHHHh
Confidence 8999999999999999999999999999999999999999875 345566665554 33333 47999999999999
Q ss_pred cccCCCCCCC-----HHHHhcCCCCCCCCC
Q psy5368 275 LQKDPMRRIS-----YEDLFSHPYPDLIHA 299 (406)
Q Consensus 275 L~~dP~~Rps-----~~ell~hp~~~~~~~ 299 (406)
|+.||.+||+ ++++++||||+...+
T Consensus 428 L~~dP~~R~~~~~~~a~ei~~Hpff~~i~w 457 (543)
T 3c4z_A 428 LQKDPEKRLGFRDGSCDGLRTHPLFRDISW 457 (543)
T ss_dssp SCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred ccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence 9999999996 489999999997654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=356.57 Aligned_cols=236 Identities=24% Similarity=0.395 Sum_probs=189.1
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcc-cCCCCCCcc----------cCCeEEEEEeccC
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLS-NLRAPEGRK----------RPRYVYIILEYCD 123 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~-~l~h~ni~~----------~~~~~~lV~E~~~ 123 (406)
..||+|+||.||++... +..+++|.+.. ...+.+|+.++. ..+|||++. ..+++|||||||+
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 57999999999999874 45688887752 356788888874 458999876 2567899999999
Q ss_pred CCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee----CCeeEEEecccccccCCCCCCCc
Q psy5368 124 GGDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK----NNTLKLADFGFAQFLAPNDQGDS 197 (406)
Q Consensus 124 ggsL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~----~~~~kL~DFGla~~~~~~~~~~~ 197 (406)
||+|.+++...+ .+++.++..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++..........
T Consensus 143 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~ 222 (400)
T 1nxk_A 143 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 222 (400)
T ss_dssp SEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-------
T ss_pred CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCcccc
Confidence 999999998754 599999999999999999999999999999999999998 35899999999987765555567
Q ss_pred ccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhcCCCCCC---CCCCChHHHHH
Q psy5368 198 IQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQ----LRAQALSSAPITIP---PNSLSPDCMDF 270 (406)
Q Consensus 198 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~----~~~~~~~~~~~~~~---~~~~s~~l~~l 270 (406)
.+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+... ....+..... ..+ ...+|+++.+|
T Consensus 223 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~s~~~~~l 301 (400)
T 1nxk_A 223 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPNPEWSEVSEEVKML 301 (400)
T ss_dssp ----CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC-CCCTTTTTTSCHHHHHH
T ss_pred CCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc-cCCCcccccCCHHHHHH
Confidence 789999999999999999999999999999999999999998754321 2333333322 222 13689999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 271 LSRLLQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 271 i~~~L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
|.+||+.||++|||+.++++||||....
T Consensus 302 i~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 302 IRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred HHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 9999999999999999999999997543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=337.10 Aligned_cols=244 Identities=23% Similarity=0.400 Sum_probs=207.7
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc---------cchhhhhhHHhhcccCC-CCCCcc------cCCeEEE
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---------TSHSEFERPRAGLSNLR-APEGRK------RPRYVYI 117 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---------~~~~~~~~E~~~l~~l~-h~ni~~------~~~~~~l 117 (406)
...||+|+||.||++... +..+++|.+..... .....+.+|+.++.+++ |||+++ ..+..|+
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l 101 (298)
T 1phk_A 22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101 (298)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred eeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEE
Confidence 456788888999988863 35688887765431 12346789999999995 999876 6778999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCC
Q psy5368 118 ILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGD 196 (406)
Q Consensus 118 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~ 196 (406)
||||+++++|.+++..+..+++..+..++.||+.||.|||++|++|+||||+||+++ ++.+||+|||++..........
T Consensus 102 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 181 (298)
T 1phk_A 102 VFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR 181 (298)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBC
T ss_pred EEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcCCCcccc
Confidence 999999999999999888999999999999999999999999999999999999999 6799999999998876666666
Q ss_pred cccCCCCCCChhhhc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCChHHH
Q psy5368 197 SIQGSPLYMAPEILA------GSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP--NSLSPDCM 268 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~ 268 (406)
...||+.|+|||++. ...++.++||||||+++|+|++|..||...+.......+.........+ ..+++++.
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 261 (298)
T 1phk_A 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK 261 (298)
T ss_dssp CCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHH
T ss_pred cccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHH
Confidence 678999999999985 4568899999999999999999999999988887777776654332222 26899999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy5368 269 DFLSRLLQKDPMRRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 269 ~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 299 (406)
+|+.+||+.||.+|||+.++++||||+....
T Consensus 262 ~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 262 DLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292 (298)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred HHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence 9999999999999999999999999986543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=339.27 Aligned_cols=243 Identities=28% Similarity=0.446 Sum_probs=199.6
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
...||+|+||.||++... +..+++|.+..........+.+|+.++..++|||+++ ..+..|+||||+++++|
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 103 (302)
T 2j7t_A 24 VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV 103 (302)
T ss_dssp EEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEH
T ss_pred cceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcH
Confidence 445788888888888764 4567888776665566778999999999999999876 66789999999999999
Q ss_pred HHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCcccCCCCC
Q psy5368 128 CSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDSIQGSPLY 204 (406)
Q Consensus 128 ~~~l~~-~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~~~gt~~y 204 (406)
.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++ ++.+||+|||++...... .......||+.|
T Consensus 104 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y 183 (302)
T 2j7t_A 104 DAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYW 183 (302)
T ss_dssp HHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-----CCGGG
T ss_pred HHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccccccCChhh
Confidence 999865 46799999999999999999999999999999999999999 779999999997543211 223445689999
Q ss_pred CChhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-CCCCCChHHHHHHHHhcccC
Q psy5368 205 MAPEILA-----GSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITI-PPNSLSPDCMDFLSRLLQKD 278 (406)
Q Consensus 205 ~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~~li~~~L~~d 278 (406)
+|||++. +..++.++|||||||++|+|++|..||...+.......+........ .+..++.++.+|+.+||+.|
T Consensus 184 ~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 263 (302)
T 2j7t_A 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKN 263 (302)
T ss_dssp CCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSC
T ss_pred cCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHHHHHHcccC
Confidence 9999983 66789999999999999999999999999888777776666544333 23478999999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCC
Q psy5368 279 PMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 279 P~~Rps~~ell~hp~~~~~~ 298 (406)
|.+|||+.++++||||+...
T Consensus 264 p~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 264 PETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp TTTSCCHHHHTTSTTTTTCC
T ss_pred hhhCCCHHHHhcChHHhhhc
Confidence 99999999999999998654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=350.02 Aligned_cols=238 Identities=25% Similarity=0.396 Sum_probs=197.4
Q ss_pred ceeeecceeeeEEEeeee--eeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc----------------------
Q psy5368 55 STIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK---------------------- 110 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~---------------------- 110 (406)
....||+|+||.||++.. .+..+|+|++... .....+|+.+++.++|||+++
T Consensus 11 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 86 (383)
T 3eb0_A 11 LGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD----PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDH 86 (383)
T ss_dssp EEEEEECC-CEEEEEEEETTTCCEEEEEEEECC----TTSCCHHHHHHTTCCCTTBCCEEEEEEEC--------------
T ss_pred EEEEEEeccCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHHcCCCCccchhheeeecCccccccccccccc
Confidence 355778899999998875 3467888877543 334568999999999999875
Q ss_pred ----------------------cCCeEEEEEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q psy5368 111 ----------------------RPRYVYIILEYCDGGDLCSFIR----SHEKLSEFQCQQFVRQLVLALKFLRENNVCHF 164 (406)
Q Consensus 111 ----------------------~~~~~~lV~E~~~ggsL~~~l~----~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~ 164 (406)
...++++||||+++ +|.+.+. ....+++..++.++.||+.||.|||++||+||
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~ 165 (383)
T 3eb0_A 87 NKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHR 165 (383)
T ss_dssp -----------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECS
T ss_pred ccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccC
Confidence 23348899999985 8877774 35689999999999999999999999999999
Q ss_pred cCCCcceEee--CCeeEEEecccccccCCCCCCCcccCCCCCCChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy5368 165 DLKPQNILIK--NNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSP-YNAKADLWSLGVLVFEALFGHAPYASC 241 (406)
Q Consensus 165 Dlkp~NIll~--~~~~kL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~ 241 (406)
||||+|||++ ++.+||+|||+++............||+.|+|||++.+.. ++.++||||+||++|+|++|++||.+.
T Consensus 166 Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 245 (383)
T 3eb0_A 166 DIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGE 245 (383)
T ss_dssp CCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCC
Confidence 9999999997 5699999999999877776777788999999999998754 899999999999999999999999998
Q ss_pred CHHHHHHHHHhcCCC----------------CC-----------CCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 242 NLSQLRAQALSSAPI----------------TI-----------PPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 242 ~~~~~~~~~~~~~~~----------------~~-----------~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
+..+....+...... .. .+..+|+++.+|+.+||+.||.+|||+.|+++||||
T Consensus 246 ~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 325 (383)
T 3eb0_A 246 TSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325 (383)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred ChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHH
Confidence 877766665431100 00 123578999999999999999999999999999999
Q ss_pred CCC
Q psy5368 295 DLI 297 (406)
Q Consensus 295 ~~~ 297 (406)
+..
T Consensus 326 ~~~ 328 (383)
T 3eb0_A 326 DHL 328 (383)
T ss_dssp HHH
T ss_pred HHH
Confidence 754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=336.56 Aligned_cols=240 Identities=25% Similarity=0.459 Sum_probs=206.5
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++... +..+++|.+.... ......+.+|+.++.+++|||+++ ..+..|+||||+++
T Consensus 19 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 98 (284)
T 2vgo_A 19 GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR 98 (284)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred eheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCC
Confidence 456789999999998864 3457888775432 223457899999999999999875 67789999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
++|.+++...+.+++..+..++.||+.||.|||++||+|+||||+||+++ ++.+||+|||++...... ......|++.
T Consensus 99 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~ 177 (284)
T 2vgo_A 99 GELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-RRRTMCGTLD 177 (284)
T ss_dssp EEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-CBCCCCSCGG
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-ccccccCCCC
Confidence 99999998888999999999999999999999999999999999999998 779999999998765432 3345678999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
|+|||++.+..++.++||||+|+++|+|++|..||...+.......+.... ...+ ..+++++.+||.+||+.||.+||
T Consensus 178 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~li~~~l~~~p~~Rp 255 (284)
T 2vgo_A 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD-LKFP-PFLSDGSKDLISKLLRYHPPQRL 255 (284)
T ss_dssp GCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCC-TTSCHHHHHHHHHHSCSSGGGSC
T ss_pred cCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc-cCCC-CcCCHHHHHHHHHHhhcCHhhCC
Confidence 999999999999999999999999999999999999988877777666543 3333 36899999999999999999999
Q ss_pred CHHHHhcCCCCCCCC
Q psy5368 284 SYEDLFSHPYPDLIH 298 (406)
Q Consensus 284 s~~ell~hp~~~~~~ 298 (406)
|++++++||||+...
T Consensus 256 s~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 256 PLKGVMEHPWVKANS 270 (284)
T ss_dssp CHHHHHTCHHHHHHC
T ss_pred CHHHHhhCHHHHhhc
Confidence 999999999997543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=337.50 Aligned_cols=240 Identities=23% Similarity=0.464 Sum_probs=175.6
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++.. .+..+++|.+..... .....+.+|+.++.+++|||+++ ..+..|+||||+++
T Consensus 16 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (278)
T 3cok_A 16 GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN 95 (278)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCC
Confidence 34567788888888875 345688887754321 22467899999999999999865 67789999999999
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCC
Q psy5368 125 GDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGS 201 (406)
Q Consensus 125 gsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt 201 (406)
++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++....... ......||
T Consensus 96 ~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 175 (278)
T 3cok_A 96 GEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGT 175 (278)
T ss_dssp EEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------------
T ss_pred CcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcceeccCC
Confidence 9999999876 5799999999999999999999999999999999999998 6799999999998765332 23456789
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
+.|+|||++.+..++.++||||+|+++|+|++|+.||...+.......+... ... .+..++.++.+|+.+||+.||++
T Consensus 176 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~li~~~l~~dp~~ 253 (278)
T 3cok_A 176 PNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA-DYE-MPSFLSIEAKDLIHQLLRRNPAD 253 (278)
T ss_dssp ----------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS-CCC-CCTTSCHHHHHHHHHHSCSSGGG
T ss_pred CCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc-ccC-CccccCHHHHHHHHHHcccCHhh
Confidence 9999999999988999999999999999999999999887655544433322 122 23468999999999999999999
Q ss_pred CCCHHHHhcCCCCCCC
Q psy5368 282 RISYEDLFSHPYPDLI 297 (406)
Q Consensus 282 Rps~~ell~hp~~~~~ 297 (406)
|||++++++||||...
T Consensus 254 Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 254 RLSLSSVLDHPFMSRN 269 (278)
T ss_dssp SCCHHHHTTSTTTC--
T ss_pred CCCHHHHhcCccccCC
Confidence 9999999999999754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=338.45 Aligned_cols=241 Identities=26% Similarity=0.417 Sum_probs=185.5
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCcc-c-hhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTIT-S-HSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~-~-~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...||+|+||.||++.. .+..+++|.+...... . ...+.++...++.++|||++. ..+..|+||||++|
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~- 90 (290)
T 3fme_A 12 IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT- 90 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-
T ss_pred HHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-
Confidence 45678888888888886 4567888877654322 2 223445555688899999876 67789999999975
Q ss_pred CHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCcceEee-CCeeEEEecccccccCCCCCCCccc
Q psy5368 126 DLCSFIRS----HEKLSEFQCQQFVRQLVLALKFLREN-NVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQ 199 (406)
Q Consensus 126 sL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~lH~~-givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~ 199 (406)
+|.+++.. ...+++..+..++.||+.||+|||++ ||+||||||+||+++ ++.+||+|||++.............
T Consensus 91 ~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 170 (290)
T 3fme_A 91 SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA 170 (290)
T ss_dssp EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---------------C
T ss_pred chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccccccccC
Confidence 98887753 46899999999999999999999998 999999999999999 6799999999998776665556667
Q ss_pred CCCCCCChhhh----cCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHh
Q psy5368 200 GSPLYMAPEIL----AGSPYNAKADLWSLGVLVFEALFGHAPYAS-CNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRL 274 (406)
Q Consensus 200 gt~~y~aPE~~----~~~~~~~~~DiwSlG~il~elltg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~ 274 (406)
||+.|+|||++ .+..++.++||||+||++|+|++|..||.. ..................+...+++++.+|+.+|
T Consensus 171 ~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 250 (290)
T 3fme_A 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQC 250 (290)
T ss_dssp CCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHH
T ss_pred CCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHHHHHHHH
Confidence 99999999996 456789999999999999999999999986 3444555555555556666668999999999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCC
Q psy5368 275 LQKDPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 275 L~~dP~~Rps~~ell~hp~~~~~ 297 (406)
|+.||++|||+.++++||||+..
T Consensus 251 l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 251 LKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp TCSSGGGSCCHHHHTTSHHHHHH
T ss_pred hhcChhhCcCHHHHHhCcccccC
Confidence 99999999999999999999743
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=345.44 Aligned_cols=247 Identities=21% Similarity=0.323 Sum_probs=200.2
Q ss_pred ceeeecceeeeEEEeeeee--eceeEEeeeecCCccc-----hhhhhhHHhhcccCCCCCCcc------cCCeEEEEEec
Q psy5368 55 STIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITS-----HSEFERPRAGLSNLRAPEGRK------RPRYVYIILEY 121 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~-----~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~ 121 (406)
....||+|+||.||++... +..+++|.+....... ...+.+|+.++++++|||+++ ..+..++||||
T Consensus 14 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 93 (346)
T 1ua2_A 14 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 93 (346)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred EEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEc
Confidence 3456788889999988864 4568888776433221 346789999999999999876 66788999999
Q ss_pred cCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCcc
Q psy5368 122 CDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDSI 198 (406)
Q Consensus 122 ~~ggsL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~~ 198 (406)
+++ +|.+++..+. .+++..+..++.|++.||+|||++||+||||||+|||++ ++.+||+|||+++..... ......
T Consensus 94 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 172 (346)
T 1ua2_A 94 MET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ 172 (346)
T ss_dssp CSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred CCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcccCCcc
Confidence 986 9999987654 699999999999999999999999999999999999998 779999999999876433 234556
Q ss_pred cCCCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----CC--------------
Q psy5368 199 QGSPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPIT----IP-------------- 259 (406)
Q Consensus 199 ~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~----~~-------------- 259 (406)
.||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..+....+....... .+
T Consensus 173 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (346)
T 1ua2_A 173 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 252 (346)
T ss_dssp CCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCC
T ss_pred cccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccccccccc
Confidence 789999999999764 48999999999999999999999999988777766665421100 00
Q ss_pred --------CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCc
Q psy5368 260 --------PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCA 302 (406)
Q Consensus 260 --------~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~ 302 (406)
...+++++.+||.+||+.||++|||++|+++||||+....|..
T Consensus 253 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~ 303 (346)
T 1ua2_A 253 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 303 (346)
T ss_dssp CCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred CCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCC
Confidence 0346789999999999999999999999999999997765543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=342.64 Aligned_cols=246 Identities=21% Similarity=0.395 Sum_probs=210.8
Q ss_pred ceeeecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccC
Q psy5368 55 STIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ 123 (406)
....||+|+||.||++... +..+++|.+..... .....+.+|+.+++.++|||+++ ..+.+|+||||++
T Consensus 45 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 124 (335)
T 2owb_A 45 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 124 (335)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCC
Confidence 3567899999999999874 34577777655432 23457889999999999999876 6778999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCcccCC
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDSIQGS 201 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~~~gt 201 (406)
+++|.+++..++.+++.++..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++...... .......||
T Consensus 125 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 204 (335)
T 2owb_A 125 RRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGT 204 (335)
T ss_dssp TCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSC
T ss_pred CCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccccccCCC
Confidence 999999998888999999999999999999999999999999999999999 679999999999876533 233456799
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+.... ... +..+++++.+|+.+||+.||++
T Consensus 205 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~li~~~l~~dp~~ 282 (335)
T 2owb_A 205 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSI-PKHINPVAASLIQKMLQTDPTA 282 (335)
T ss_dssp CSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCC-CTTSCHHHHHHHHHHTCSSGGG
T ss_pred ccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC-CCC-CccCCHHHHHHHHHHccCChhH
Confidence 99999999999999999999999999999999999999988877776666553 233 3368999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCCCc
Q psy5368 282 RISYEDLFSHPYPDLIHAPCA 302 (406)
Q Consensus 282 Rps~~ell~hp~~~~~~~~~~ 302 (406)
|||++++++||||.....|..
T Consensus 283 Rps~~ell~~~~~~~~~~~~~ 303 (335)
T 2owb_A 283 RPTINELLNDEFFTSGYIPAR 303 (335)
T ss_dssp SCCGGGGGGSHHHHTSCCCSC
T ss_pred CcCHHHHhcCccccCCCcccc
Confidence 999999999999987665543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=345.46 Aligned_cols=242 Identities=24% Similarity=0.372 Sum_probs=196.5
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCccc---hhhhhhHHhhcccCCCCCCcccC----------CeEEEEEe
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITS---HSEFERPRAGLSNLRAPEGRKRP----------RYVYIILE 120 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~---~~~~~~E~~~l~~l~h~ni~~~~----------~~~~lV~E 120 (406)
...||+|+||.||++.. .+..+++|.+....... ...+.+|+.++.+++|||+++.- ...|+|||
T Consensus 17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e 96 (311)
T 3ork_A 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 96 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred EEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEe
Confidence 45678888888888874 34568888876554333 34688999999999999987621 23599999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC----CC
Q psy5368 121 YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND----QG 195 (406)
Q Consensus 121 ~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~----~~ 195 (406)
|++|++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||++....... ..
T Consensus 97 ~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 176 (311)
T 3ork_A 97 YVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176 (311)
T ss_dssp CCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-------------
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccc
Confidence 999999999999888999999999999999999999999999999999999998 7799999999998765432 22
Q ss_pred CcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCChHHHHHHHH
Q psy5368 196 DSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIP--PNSLSPDCMDFLSR 273 (406)
Q Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~s~~l~~li~~ 273 (406)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+................. ...+|+++.+|+.+
T Consensus 177 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 256 (311)
T 3ork_A 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLK 256 (311)
T ss_dssp -----CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHH
T ss_pred cccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHH
Confidence 3456899999999999999999999999999999999999999999888777666665433211 23689999999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCC
Q psy5368 274 LLQKDPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 274 ~L~~dP~~Rps~~ell~hp~~~~~ 297 (406)
||+.||.+||++.+++.|+|++..
T Consensus 257 ~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 257 ALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp HTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHhcCHhhChhhHHHHHHHHHHHh
Confidence 999999999999999999998753
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=350.51 Aligned_cols=264 Identities=23% Similarity=0.352 Sum_probs=198.0
Q ss_pred cccccccceEEEeeeee----eEEEeeeeecCCcceeeeeeccccccccceeeecCceeeecceeeeEEEeeeeeeceeE
Q psy5368 3 RYGTVRYGTVRLGSVKY----GQVQLSTVRYGKVRYSQVRSDTVRSGTVRYDIVGSSTIRYGELQYDTVQNSQIRLGTVK 78 (406)
Q Consensus 3 ~~~~g~~~~V~ig~~~~----gy~vv~~lg~G~~~~~~~~~d~~~~~~~~~~i~~~~~~~lG~G~~g~Vy~~~~~~~~v~ 78 (406)
....++|++|.+|+... +|.+++.||.|++|.||.+.+.. .+..++
T Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~------------------------------~~~~va 54 (371)
T 2xrw_A 5 SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAI------------------------------LERNVA 54 (371)
T ss_dssp GGGGGGEEEEEETTEEEEEETTEEEEEEEEECSSEEEEEEEETT------------------------------TTEEEE
T ss_pred ccccCcceEeecCCcccchhhheeEeeeeEecCCEEEEEEEECC------------------------------CCceEE
Confidence 45678899999987432 28887777766666555554322 133567
Q ss_pred EeeeecCC--ccchhhhhhHHhhcccCCCCCCcc------c------CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHH
Q psy5368 79 YSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRK------R------PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQ 144 (406)
Q Consensus 79 vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~------~------~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~ 144 (406)
+|.+.... ......+.+|+.+++.++|||++. . ...+|+|||||++ +|.+++. ..+++..+..
T Consensus 55 vK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~ 131 (371)
T 2xrw_A 55 IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSY 131 (371)
T ss_dssp EEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHH
T ss_pred EEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHh--hccCHHHHHH
Confidence 77665432 223456889999999999999875 1 2378999999975 8999886 4699999999
Q ss_pred HHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCCCChhhhcCCCCCchhhHHH
Q psy5368 145 FVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWS 223 (406)
Q Consensus 145 i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 223 (406)
++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++............||+.|+|||++.+..++.++||||
T Consensus 132 i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 211 (371)
T 2xrw_A 132 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWS 211 (371)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHH
T ss_pred HHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHH
Confidence 999999999999999999999999999999 7799999999998776555556678999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC----------------------------------CC------CC
Q psy5368 224 LGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIP----------------------------------PN------SL 263 (406)
Q Consensus 224 lG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----------------------------------~~------~~ 263 (406)
+||++|+|++|..||.+.+.......+........+ +. ..
T Consensus 212 lG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (371)
T 2xrw_A 212 VGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLK 291 (371)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccc
Confidence 999999999999999998877766666543221100 00 01
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy5368 264 SPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 264 s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 299 (406)
++++.+||.+||+.||++|||++|+++||||+....
T Consensus 292 ~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 327 (371)
T 2xrw_A 292 ASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 327 (371)
T ss_dssp HHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred cHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence 567999999999999999999999999999985443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=348.86 Aligned_cols=243 Identities=26% Similarity=0.437 Sum_probs=197.0
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecC-----CccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEecc
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYD-----TITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYC 122 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~-----~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~ 122 (406)
...||+|+||.||++... +..+++|.+... .......+.+|+.++++++|||+++ ..+..|+|||||
T Consensus 31 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 110 (345)
T 3hko_A 31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELC 110 (345)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCC
Confidence 456788888888888753 345777766543 2234567899999999999999876 677899999999
Q ss_pred CCCCHHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q psy5368 123 DGGDLCSFIRS----------------------------------------HEKLSEFQCQQFVRQLVLALKFLRENNVC 162 (406)
Q Consensus 123 ~ggsL~~~l~~----------------------------------------~~~l~~~~~~~i~~ql~~aL~~lH~~giv 162 (406)
+||+|.+++.. ...+++..+..++.||+.||+|||++||+
T Consensus 111 ~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iv 190 (345)
T 3hko_A 111 HGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGIC 190 (345)
T ss_dssp CSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred CCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 99999999842 11246788899999999999999999999
Q ss_pred cccCCCcceEee-CC--eeEEEecccccccCCCC-----CCCcccCCCCCCChhhhcC--CCCCchhhHHHHHHHHHHHH
Q psy5368 163 HFDLKPQNILIK-NN--TLKLADFGFAQFLAPND-----QGDSIQGSPLYMAPEILAG--SPYNAKADLWSLGVLVFEAL 232 (406)
Q Consensus 163 H~Dlkp~NIll~-~~--~~kL~DFGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell 232 (406)
||||||+||+++ ++ .+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 191 H~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~ 270 (345)
T 3hko_A 191 HRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270 (345)
T ss_dssp CCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHH
T ss_pred ccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHH
Confidence 999999999998 44 79999999998653322 2345679999999999976 67899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhcCCCCCCCC--CCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 233 FGHAPYASCNLSQLRAQALSSAPITIPPN--SLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 233 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
+|+.||.+.+..+....+.........+. .+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus 271 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 271 MGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 99999999988888777776643332222 4899999999999999999999999999999998654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=347.56 Aligned_cols=236 Identities=24% Similarity=0.304 Sum_probs=193.4
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCccchhhhhhHHhhcccCC-----CCCCcc------cCCeEEEEEecc
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITSHSEFERPRAGLSNLR-----APEGRK------RPRYVYIILEYC 122 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~-----h~ni~~------~~~~~~lV~E~~ 122 (406)
..+||+|+||.||++.. .+..+++|.+... ......+.+|+.++..++ |||++. ..+..|+||||+
T Consensus 40 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 118 (360)
T 3llt_A 40 IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL 118 (360)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC
T ss_pred EEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC
Confidence 45678888888888876 3456888877532 233456778999888886 899776 667899999999
Q ss_pred CCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee--------------------------
Q psy5368 123 DGGDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-------------------------- 174 (406)
Q Consensus 123 ~ggsL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-------------------------- 174 (406)
+++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 119 -~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (360)
T 3llt_A 119 -GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197 (360)
T ss_dssp -CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEES
T ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccC
Confidence 889999998764 599999999999999999999999999999999999996
Q ss_pred CCeeEEEecccccccCCCCCCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Q psy5368 175 NNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSA 254 (406)
Q Consensus 175 ~~~~kL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 254 (406)
++.+||+|||++..... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+....+....
T Consensus 198 ~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 275 (360)
T 3llt_A 198 STGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESII 275 (360)
T ss_dssp CCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHT
T ss_pred CCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhc
Confidence 45899999999976533 3445679999999999999999999999999999999999999999887766655554321
Q ss_pred CCC-------------------------CCC-------------------CCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 255 PIT-------------------------IPP-------------------NSLSPDCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 255 ~~~-------------------------~~~-------------------~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
... .+. ...++.+.+||.+||+.||++|||++|+|+
T Consensus 276 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 276 QPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp CCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 110 000 012467889999999999999999999999
Q ss_pred CCCCC
Q psy5368 291 HPYPD 295 (406)
Q Consensus 291 hp~~~ 295 (406)
||||+
T Consensus 356 hp~f~ 360 (360)
T 3llt_A 356 HKFLE 360 (360)
T ss_dssp SGGGC
T ss_pred CcccC
Confidence 99985
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=357.23 Aligned_cols=259 Identities=21% Similarity=0.287 Sum_probs=198.7
Q ss_pred cccccccceEEEeeeeee-EEEeeeeecCCcceeeeeeccccccccceeeecCceeeecceeeeEEEeeeeeeceeEEee
Q psy5368 3 RYGTVRYGTVRLGSVKYG-QVQLSTVRYGKVRYSQVRSDTVRSGTVRYDIVGSSTIRYGELQYDTVQNSQIRLGTVKYSQ 81 (406)
Q Consensus 3 ~~~~g~~~~V~ig~~~~g-y~vv~~lg~G~~~~~~~~~d~~~~~~~~~~i~~~~~~~lG~G~~g~Vy~~~~~~~~v~vk~ 81 (406)
+|..|||+++.+|+.+.| |.++++||.|+++.||.+.+... +..+++|.
T Consensus 20 ~~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~------------------------------~~~vavK~ 69 (397)
T 1wak_A 20 DYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQG------------------------------KKFVAMKV 69 (397)
T ss_dssp --CC--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTT------------------------------TEEEEEEE
T ss_pred cCCCCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCC------------------------------CeEEEEEE
Confidence 588999999999999998 99998888777777766654321 23466776
Q ss_pred eecCCccchhhhhhHHhhcccCC--------CCCCcc----------cCCeEEEEEeccCCCCHHHHHHhC--CCCCHHH
Q psy5368 82 VRYDTITSHSEFERPRAGLSNLR--------APEGRK----------RPRYVYIILEYCDGGDLCSFIRSH--EKLSEFQ 141 (406)
Q Consensus 82 ~~~~~~~~~~~~~~E~~~l~~l~--------h~ni~~----------~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~ 141 (406)
+... ......+.+|+.+++.++ |+|+++ ....+|+||||+ +++|.+.+... +.+++..
T Consensus 70 ~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~ 147 (397)
T 1wak_A 70 VKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPC 147 (397)
T ss_dssp ECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHH
T ss_pred EecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHH
Confidence 6432 233467889999999996 556654 345789999999 55777777554 4699999
Q ss_pred HHHHHHHHHHHHHHHHHC-CcccccCCCcceEee-CC-------------------------------------------
Q psy5368 142 CQQFVRQLVLALKFLREN-NVCHFDLKPQNILIK-NN------------------------------------------- 176 (406)
Q Consensus 142 ~~~i~~ql~~aL~~lH~~-givH~Dlkp~NIll~-~~------------------------------------------- 176 (406)
++.++.||+.||+|||++ ||+||||||+|||++ ++
T Consensus 148 ~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (397)
T 1wak_A 148 VKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEP 227 (397)
T ss_dssp HHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSG
T ss_pred HHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCccccccccccccc
Confidence 999999999999999998 999999999999998 32
Q ss_pred ------eeEEEecccccccCCCCCCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------H
Q psy5368 177 ------TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNL------S 244 (406)
Q Consensus 177 ------~~kL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~------~ 244 (406)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+. .
T Consensus 228 ~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~ 305 (397)
T 1wak_A 228 KNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDE 305 (397)
T ss_dssp GGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHH
T ss_pred ccccccceEeccccccccccc--cCccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchH
Confidence 699999999987643 24456789999999999999999999999999999999999999986542 1
Q ss_pred HHHHHHHhc--CCC---------------------C-----------------CCCCCCChHHHHHHHHhcccCCCCCCC
Q psy5368 245 QLRAQALSS--API---------------------T-----------------IPPNSLSPDCMDFLSRLLQKDPMRRIS 284 (406)
Q Consensus 245 ~~~~~~~~~--~~~---------------------~-----------------~~~~~~s~~l~~li~~~L~~dP~~Rps 284 (406)
.....+... ..+ . ..+...++.+.+||.+||+.||++|||
T Consensus 306 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 385 (397)
T 1wak_A 306 DHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRAT 385 (397)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCC
T ss_pred HHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCC
Confidence 111111110 000 0 001123467889999999999999999
Q ss_pred HHHHhcCCCCC
Q psy5368 285 YEDLFSHPYPD 295 (406)
Q Consensus 285 ~~ell~hp~~~ 295 (406)
+.|+++||||+
T Consensus 386 ~~e~l~hp~~~ 396 (397)
T 1wak_A 386 AAECLRHPWLN 396 (397)
T ss_dssp HHHHHTSGGGG
T ss_pred HHHHhhCcccc
Confidence 99999999996
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=353.90 Aligned_cols=244 Identities=24% Similarity=0.379 Sum_probs=183.0
Q ss_pred eeeecceeeeEEEeeeee----eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc--------cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIR----LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK--------RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~----~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~--------~~~~~~lV~E~~~ 123 (406)
..+||+|+||.||++... ...+++|.+... .....+.+|+.++++++|||++. ....+|+||||+.
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 347999999999999864 456888877643 33457889999999999999875 4678899999997
Q ss_pred CCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEe----e-CCeeEEEeccccccc
Q psy5368 124 GGDLCSFIRSH---------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI----K-NNTLKLADFGFAQFL 189 (406)
Q Consensus 124 ggsL~~~l~~~---------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll----~-~~~~kL~DFGla~~~ 189 (406)
+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ + ++.+||+|||+++..
T Consensus 104 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 182 (405)
T 3rgf_A 104 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182 (405)
T ss_dssp E-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC--
T ss_pred C-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceec
Confidence 5 998888532 249999999999999999999999999999999999999 3 469999999999876
Q ss_pred CCC----CCCCcccCCCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHhcCC
Q psy5368 190 APN----DQGDSIQGSPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLS---------QLRAQALSSAP 255 (406)
Q Consensus 190 ~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~---------~~~~~~~~~~~ 255 (406)
... .......||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.... +....+.....
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g 262 (405)
T 3rgf_A 183 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 262 (405)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHC
T ss_pred CCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhC
Confidence 533 223456789999999999874 4899999999999999999999999765432 22222221100
Q ss_pred CCC------------------------------------CCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy5368 256 ITI------------------------------------PPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 256 ~~~------------------------------------~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 299 (406)
... .....++++.+||.+||+.||.+|||++|+|+||||.....
T Consensus 263 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~ 342 (405)
T 3rgf_A 263 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPL 342 (405)
T ss_dssp CCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSC
T ss_pred CCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCC
Confidence 000 00123778999999999999999999999999999998766
Q ss_pred CCc
Q psy5368 300 PCA 302 (406)
Q Consensus 300 ~~~ 302 (406)
|..
T Consensus 343 ~~~ 345 (405)
T 3rgf_A 343 PTS 345 (405)
T ss_dssp CCS
T ss_pred Ccc
Confidence 554
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=340.88 Aligned_cols=257 Identities=22% Similarity=0.362 Sum_probs=207.8
Q ss_pred eeeccccccccceeeecCceeeecceeeeEEEeeee--eeceeEEeeeecCCccchhhhhhHHhhcccC-CCCCCcc---
Q psy5368 37 VRSDTVRSGTVRYDIVGSSTIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITSHSEFERPRAGLSNL-RAPEGRK--- 110 (406)
Q Consensus 37 ~~~d~~~~~~~~~~i~~~~~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~--- 110 (406)
+...........| .....||+|+||.||++.. .+..+++|.+.... .....+.+|+.++.++ +|||++.
T Consensus 14 ~~~~~l~~~~~~y----~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~ 88 (326)
T 2x7f_A 14 IDLSALRDPAGIF----ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYG 88 (326)
T ss_dssp --CCCCCCCTTTE----EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEE
T ss_pred ccchhccCCCCcE----EEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeee
Confidence 3444555555666 3456789999999999987 45678888776543 4456899999999999 8999866
Q ss_pred ---c------CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCee
Q psy5368 111 ---R------PRYVYIILEYCDGGDLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTL 178 (406)
Q Consensus 111 ---~------~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~ 178 (406)
. .+.+|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++ ++.+
T Consensus 89 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp EEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCE
T ss_pred EEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCE
Confidence 1 56889999999999999999865 4799999999999999999999999999999999999998 7799
Q ss_pred EEEecccccccCCCC-CCCcccCCCCCCChhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy5368 179 KLADFGFAQFLAPND-QGDSIQGSPLYMAPEILA-----GSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALS 252 (406)
Q Consensus 179 kL~DFGla~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 252 (406)
||+|||++....... ......||+.|+|||++. +..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 169 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 248 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 248 (326)
T ss_dssp EECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred EEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc
Confidence 999999997664332 234567899999999997 56689999999999999999999999999887777776666
Q ss_pred cCCCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 253 SAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 253 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
..........+++.+.+||.+||..||.+|||+.++++||||+...
T Consensus 249 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 249 NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp SCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred CccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 6555555567899999999999999999999999999999998543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=334.24 Aligned_cols=243 Identities=24% Similarity=0.377 Sum_probs=199.5
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...||+|+||.||++... +..+++|.+..... .....+.+|+.+++.++|||+++ ..+..|+||||+++++
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 91 (276)
T 2yex_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91 (276)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCc
Confidence 346788888888888763 45688887765432 33567899999999999999876 6678899999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC---CCCCcccCCC
Q psy5368 127 LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN---DQGDSIQGSP 202 (406)
Q Consensus 127 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~---~~~~~~~gt~ 202 (406)
|.+++.....+++..+..++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++...... .......||+
T Consensus 92 L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 171 (276)
T 2yex_A 92 LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171 (276)
T ss_dssp GGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCG
T ss_pred HHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCcccc
Confidence 999998777899999999999999999999999999999999999999 679999999999765322 2234567899
Q ss_pred CCCChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCC
Q psy5368 203 LYMAPEILAGSPY-NAKADLWSLGVLVFEALFGHAPYASCNLSQ-LRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPM 280 (406)
Q Consensus 203 ~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~ 280 (406)
.|+|||++.+..+ +.++||||+|+++|+|++|..||....... .............+...+++.+.+|+.+||+.||.
T Consensus 172 ~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 251 (276)
T 2yex_A 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPS 251 (276)
T ss_dssp GGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTT
T ss_pred CccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCch
Confidence 9999999988765 779999999999999999999998765432 22223332222222236899999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCC
Q psy5368 281 RRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 281 ~Rps~~ell~hp~~~~~~ 298 (406)
+|||++|+++||||+...
T Consensus 252 ~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 252 ARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp TSCCHHHHTTCTTTTCCC
T ss_pred hCCCHHHHhcCccccChh
Confidence 999999999999998653
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=345.13 Aligned_cols=243 Identities=21% Similarity=0.332 Sum_probs=193.3
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCccc------------CCeEEEEE
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRKR------------PRYVYIIL 119 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~~------------~~~~~lV~ 119 (406)
...||+|+||.||++... +..|++|++..... .....+.+|+.+++.++|||+++. ...+|+||
T Consensus 30 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~ 109 (367)
T 1cm8_A 30 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 109 (367)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred eEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEE
Confidence 456788888888888753 56788888754332 224578899999999999998761 13469999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcc
Q psy5368 120 EYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSI 198 (406)
Q Consensus 120 E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~ 198 (406)
||+ +++|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++.... .....
T Consensus 110 e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~--~~~~~ 185 (367)
T 1cm8_A 110 PFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS--EMTGY 185 (367)
T ss_dssp ECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS--SCCSS
T ss_pred ecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc--ccCcC
Confidence 999 7799999977 5799999999999999999999999999999999999999 77999999999987543 34456
Q ss_pred cCCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------------------
Q psy5368 199 QGSPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI--------------------- 256 (406)
Q Consensus 199 ~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--------------------- 256 (406)
.+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+....+......
T Consensus 186 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 265 (367)
T 1cm8_A 186 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL 265 (367)
T ss_dssp CSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHS
T ss_pred cCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhC
Confidence 78999999999987 67999999999999999999999999998876665555431100
Q ss_pred --------CCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCc
Q psy5368 257 --------TIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCA 302 (406)
Q Consensus 257 --------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~ 302 (406)
.......++++.+|+.+||+.||.+|||++++++||||+..+.+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~ 319 (367)
T 1cm8_A 266 PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 319 (367)
T ss_dssp CCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred CCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCcc
Confidence 0011257899999999999999999999999999999998765543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=344.26 Aligned_cols=246 Identities=22% Similarity=0.336 Sum_probs=197.3
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCccc--------------CCeEEE
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRKR--------------PRYVYI 117 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~~--------------~~~~~l 117 (406)
...||+|+||.||++... +..+++|.+...... ....+.+|+.+++.++|||+++. .+.+|+
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l 101 (351)
T 3mi9_A 22 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL 101 (351)
T ss_dssp EEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEE
T ss_pred EEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEE
Confidence 345677777777777652 456788876544322 24578899999999999998761 457899
Q ss_pred EEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC---
Q psy5368 118 ILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN--- 192 (406)
Q Consensus 118 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~--- 192 (406)
||||+++ +|.+.+... ..+++.++..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus 102 v~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 180 (351)
T 3mi9_A 102 VFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180 (351)
T ss_dssp EEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSS
T ss_pred EEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccc
Confidence 9999976 888887654 5799999999999999999999999999999999999999 779999999999876422
Q ss_pred --CCCCcccCCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CC-----
Q psy5368 193 --DQGDSIQGSPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP--NS----- 262 (406)
Q Consensus 193 --~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~----- 262 (406)
.......||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+.......+........+. ..
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 260 (351)
T 3mi9_A 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE 260 (351)
T ss_dssp SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCG
T ss_pred cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccch
Confidence 22345678999999999986 458999999999999999999999999988777766655431111110 00
Q ss_pred -----------------------CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCc
Q psy5368 263 -----------------------LSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCA 302 (406)
Q Consensus 263 -----------------------~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~ 302 (406)
.++++.+||.+||+.||++|||++|+++||||.....|+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 323 (351)
T 3mi9_A 261 LYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 323 (351)
T ss_dssp GGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCC
T ss_pred hhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCccc
Confidence 2678999999999999999999999999999998776654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=336.20 Aligned_cols=243 Identities=25% Similarity=0.421 Sum_probs=183.0
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...||+|+||.||++.. .+..+++|.+.... ......+.+|+.++.+++|||+++ ..+..|+||||+++++
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 99 (303)
T 2vwi_A 20 QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS 99 (303)
T ss_dssp EEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCB
T ss_pred hheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCc
Confidence 45789999999999975 45678888776543 234567889999999999999876 5678899999999999
Q ss_pred HHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC----
Q psy5368 127 LCSFIRS--------HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND---- 193 (406)
Q Consensus 127 L~~~l~~--------~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~---- 193 (406)
|.+++.. .+.+++..+..++.||+.||.|||++|++|+||||+||+++ ++.+||+|||++.......
T Consensus 100 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 179 (303)
T 2vwi_A 100 VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 179 (303)
T ss_dssp HHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-------
T ss_pred hHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccc
Confidence 9999974 35699999999999999999999999999999999999998 7799999999997654322
Q ss_pred --CCCcccCCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--------CCC
Q psy5368 194 --QGDSIQGSPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIP--------PNS 262 (406)
Q Consensus 194 --~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~ 262 (406)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..................... ...
T Consensus 180 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (303)
T 2vwi_A 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKK 259 (303)
T ss_dssp --------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCC
T ss_pred hhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhh
Confidence 2234568999999999876 56899999999999999999999999987766655555444332221 135
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 263 LSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 263 ~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
+++++.+|+.+||+.||.+|||+.++++||||+...
T Consensus 260 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 260 YGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred hhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 789999999999999999999999999999998543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=330.43 Aligned_cols=235 Identities=20% Similarity=0.281 Sum_probs=193.1
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC--ccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT--ITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++... +..+++|.+.... ......+.+|+..+..+ +|||+++ ..+..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 95 (289)
T 1x8b_A 16 LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNG 95 (289)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred hhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCC
Confidence 456788999999998874 5678888776543 23355788999999999 9999876 67889999999999
Q ss_pred CCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC-------------------eeEE
Q psy5368 125 GDLCSFIRSH----EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN-------------------TLKL 180 (406)
Q Consensus 125 gsL~~~l~~~----~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~-------------------~~kL 180 (406)
++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++ ++ .+||
T Consensus 96 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl 175 (289)
T 1x8b_A 96 GSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKI 175 (289)
T ss_dssp CBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEE
T ss_pred CcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEE
Confidence 9999999765 6799999999999999999999999999999999999997 22 6899
Q ss_pred EecccccccCCCCCCCcccCCCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC
Q psy5368 181 ADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIP 259 (406)
Q Consensus 181 ~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (406)
+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+|+.... ....+........
T Consensus 176 ~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~~~~~~- 248 (289)
T 1x8b_A 176 GDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQGRLPRI- 248 (289)
T ss_dssp CCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHHTTCCCCC-
T ss_pred cccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHHHcCCCCCC-
Confidence 999999876543 234589999999999876 56789999999999999999998876543 2333444433333
Q ss_pred CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy5368 260 PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 260 ~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 297 (406)
+..+++++.+|+.+||+.||++|||+.++++||||...
T Consensus 249 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 249 PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred CcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 34789999999999999999999999999999999853
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=340.13 Aligned_cols=246 Identities=27% Similarity=0.392 Sum_probs=195.1
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCccc--------------------CC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRKR--------------------PR 113 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~--------------------~~ 113 (406)
...||+|+||.||++... +..+++|.+..........+.+|+.++++++|||+++. .+
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~ 95 (320)
T 2i6l_A 16 LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELN 95 (320)
T ss_dssp EEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCS
T ss_pred EEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccC
Confidence 345678888888888764 45788888776655556788999999999999997652 36
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee--CCeeEEEecccccccCC
Q psy5368 114 YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK--NNTLKLADFGFAQFLAP 191 (406)
Q Consensus 114 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~--~~~~kL~DFGla~~~~~ 191 (406)
..|+||||++ |+|.+++.. +++++..+..++.||+.||+|||++||+||||||+||+++ ++.+||+|||+++....
T Consensus 96 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~ 173 (320)
T 2i6l_A 96 SVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDP 173 (320)
T ss_dssp EEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--
T ss_pred ceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCC
Confidence 7899999997 599999864 6799999999999999999999999999999999999998 45899999999987643
Q ss_pred C----CCCCcccCCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---------
Q psy5368 192 N----DQGDSIQGSPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPIT--------- 257 (406)
Q Consensus 192 ~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--------- 257 (406)
. .......+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.......
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (320)
T 2i6l_A 174 HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELL 253 (320)
T ss_dssp ------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHH
T ss_pred CcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhh
Confidence 2 22344567999999999876 678999999999999999999999999988766655554432110
Q ss_pred ---------------C----CCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCcc
Q psy5368 258 ---------------I----PPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAE 303 (406)
Q Consensus 258 ---------------~----~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~~ 303 (406)
. ....+++++.+|+.+||+.||++|||++++++||||+....|..+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~~~ 318 (320)
T 2i6l_A 254 SVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDE 318 (320)
T ss_dssp TTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC----
T ss_pred hcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCccCC
Confidence 0 012589999999999999999999999999999999988776654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=335.58 Aligned_cols=239 Identities=24% Similarity=0.375 Sum_probs=189.4
Q ss_pred eecceeeeEEEeeee--eeceeEEeeeecCCcc---chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 58 RYGELQYDTVQNSQI--RLGTVKYSQVRYDTIT---SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
.||+|+||.||++.. .+..+++|.+...... ....+.+|+.++.+++|||+++ ..+.+|+||||++|++
T Consensus 18 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~ 97 (294)
T 4eqm_A 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPT 97 (294)
T ss_dssp EEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred EEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCC
Confidence 344555555555543 2345777766543322 2457889999999999999876 6778999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC--CCCcccCCCC
Q psy5368 127 LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND--QGDSIQGSPL 203 (406)
Q Consensus 127 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~--~~~~~~gt~~ 203 (406)
|.+++...+++++..+..++.||+.||+|||++||+||||||+||+++ ++.+||+|||++....... ......||+.
T Consensus 98 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~ 177 (294)
T 4eqm_A 98 LSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ 177 (294)
T ss_dssp HHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------------CCS
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCcc
Confidence 999999888999999999999999999999999999999999999998 7799999999998765432 2344579999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC---CCCCCChHHHHHHHHhcccCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITI---PPNSLSPDCMDFLSRLLQKDPM 280 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~s~~l~~li~~~L~~dP~ 280 (406)
|+|||++.+..++.++||||+||++|+|++|+.||.+.+................ ....+|+.+.+++.+||+.||.
T Consensus 178 y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 257 (294)
T 4eqm_A 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKA 257 (294)
T ss_dssp SCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGG
T ss_pred ccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHh
Confidence 9999999999999999999999999999999999999888777666665543322 1236899999999999999999
Q ss_pred CCCCHHHHhcCCCCCC
Q psy5368 281 RRISYEDLFSHPYPDL 296 (406)
Q Consensus 281 ~Rps~~ell~hp~~~~ 296 (406)
+||+..+.+.+.|...
T Consensus 258 ~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 258 NRYKTIQEMKDDLSSV 273 (294)
T ss_dssp GSCSSHHHHHHHHHTS
T ss_pred HccccHHHHHHHHHHH
Confidence 9996666555555443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=335.37 Aligned_cols=242 Identities=28% Similarity=0.462 Sum_probs=203.2
Q ss_pred ceeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 55 STIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
....||+|+||.||++... +..+++|.+... .....+.+|+.++.+++|||+++ ..+.+|+||||+++++
T Consensus 33 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 110 (314)
T 3com_A 33 VLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGS 110 (314)
T ss_dssp EEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred hheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCC
Confidence 3456899999999999875 567888887654 34567899999999999999876 5678899999999999
Q ss_pred HHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCC
Q psy5368 127 LCSFIR-SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPL 203 (406)
Q Consensus 127 L~~~l~-~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~ 203 (406)
|.+++. ....+++..+..++.||+.||.|||+.|++|+||||+||+++ ++.+||+|||++....... ......||+.
T Consensus 111 L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 190 (314)
T 3com_A 111 VSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPF 190 (314)
T ss_dssp HHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGG
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccCCCCC
Confidence 999997 456899999999999999999999999999999999999998 7799999999997765432 2345678999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC-CCCCChHHHHHHHHhcccCCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIP-PNSLSPDCMDFLSRLLQKDPMRR 282 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~~li~~~L~~dP~~R 282 (406)
|+|||++.+..++.++||||||+++|+|++|..||...........+......... +..+++++.+|+.+||..||.+|
T Consensus 191 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 270 (314)
T 3com_A 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQR 270 (314)
T ss_dssp GCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTS
T ss_pred ccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhC
Confidence 99999999999999999999999999999999999988776665555554333322 23578999999999999999999
Q ss_pred CCHHHHhcCCCCCCCC
Q psy5368 283 ISYEDLFSHPYPDLIH 298 (406)
Q Consensus 283 ps~~ell~hp~~~~~~ 298 (406)
||+.++++||||+...
T Consensus 271 pt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 271 ATATQLLQHPFVRSAK 286 (314)
T ss_dssp CCHHHHTTSHHHHTCC
T ss_pred cCHHHHHhCHHHhcCC
Confidence 9999999999998654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=344.97 Aligned_cols=235 Identities=22% Similarity=0.364 Sum_probs=201.5
Q ss_pred eeeecceeeeEEEeeeee---------eceeEEeeeecCCc-cchhhhhhHHhhcccC-CCCCCcc------cCCeEEEE
Q psy5368 56 TIRYGELQYDTVQNSQIR---------LGTVKYSQVRYDTI-TSHSEFERPRAGLSNL-RAPEGRK------RPRYVYII 118 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~---------~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV 118 (406)
...||+|+||.||++... ...+++|.+..... .....+.+|+.+++.+ +|||+++ ..+.+|+|
T Consensus 86 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv 165 (370)
T 2psq_A 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 165 (370)
T ss_dssp EEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEE
Confidence 467999999999999863 23588887765432 2345789999999999 8999876 66788999
Q ss_pred EeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEE
Q psy5368 119 LEYCDGGDLCSFIRSHE----------------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLA 181 (406)
Q Consensus 119 ~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~ 181 (406)
|||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+
T Consensus 166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~ 245 (370)
T 2psq_A 166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 245 (370)
T ss_dssp EECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEEC
T ss_pred EEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEc
Confidence 99999999999998753 489999999999999999999999999999999999998 7799999
Q ss_pred ecccccccCCCC---CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCC
Q psy5368 182 DFGFAQFLAPND---QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPIT 257 (406)
Q Consensus 182 DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 257 (406)
|||+++...... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....++...+.......
T Consensus 246 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 325 (370)
T 2psq_A 246 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD 325 (370)
T ss_dssp CCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC
T ss_pred cccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 999998765432 2233457789999999999999999999999999999999 999999998888887777765544
Q ss_pred CCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 258 IPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 258 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
.+ ..+++++.+|+.+||+.||.+|||+.|++++
T Consensus 326 ~~-~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 326 KP-ANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp CC-TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC-CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 44 3789999999999999999999999999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=344.63 Aligned_cols=243 Identities=26% Similarity=0.443 Sum_probs=201.2
Q ss_pred CceeeecceeeeEEEeeee-----eeceeEEeeeecCC----ccchhhhhhHHhhcccC-CCCCCcc------cCCeEEE
Q psy5368 54 SSTIRYGELQYDTVQNSQI-----RLGTVKYSQVRYDT----ITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYI 117 (406)
Q Consensus 54 ~~~~~lG~G~~g~Vy~~~~-----~~~~v~vk~~~~~~----~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~l 117 (406)
.....||+|+||.||++.. .+..+++|.+.... ......+.+|+.++..+ .|||++. ..+.+|+
T Consensus 57 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 136 (355)
T 1vzo_A 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHL 136 (355)
T ss_dssp EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEE
T ss_pred EEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEE
Confidence 3456789999999999986 35678888775432 23456788999999999 6999765 6678999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC--C
Q psy5368 118 ILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND--Q 194 (406)
Q Consensus 118 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~--~ 194 (406)
|||||++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++...... .
T Consensus 137 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 216 (355)
T 1vzo_A 137 ILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER 216 (355)
T ss_dssp EECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGG
T ss_pred EeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCc
Confidence 999999999999998888999999999999999999999999999999999999998 7799999999997654322 2
Q ss_pred CCcccCCCCCCChhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhcCCCCCCCCCCChHHH
Q psy5368 195 GDSIQGSPLYMAPEILAGS--PYNAKADLWSLGVLVFEALFGHAPYASC----NLSQLRAQALSSAPITIPPNSLSPDCM 268 (406)
Q Consensus 195 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~s~~l~ 268 (406)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||... ....+...+... ....+ ..+++.+.
T Consensus 217 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~ 294 (355)
T 1vzo_A 217 AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EPPYP-QEMSALAK 294 (355)
T ss_dssp GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-CCCCC-TTSCHHHH
T ss_pred ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc-CCCCC-cccCHHHH
Confidence 3446799999999999863 4789999999999999999999999753 344444444443 22333 36899999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q psy5368 269 DFLSRLLQKDPMRRI-----SYEDLFSHPYPDLIH 298 (406)
Q Consensus 269 ~li~~~L~~dP~~Rp-----s~~ell~hp~~~~~~ 298 (406)
+||.+||..||.+|| |++++++||||....
T Consensus 295 ~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 295 DLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp HHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 999999999999999 999999999998654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=338.22 Aligned_cols=243 Identities=23% Similarity=0.386 Sum_probs=189.7
Q ss_pred ceeeecceeeeEEEeeeeeec-----eeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCcccCC------e------E
Q psy5368 55 STIRYGELQYDTVQNSQIRLG-----TVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRKRPR------Y------V 115 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~~-----~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~~~------~------~ 115 (406)
....||+|+||.||++..... .+++|.+.... ......+.+|+.++++++|||+++.-+ . .
T Consensus 27 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (323)
T 3qup_A 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIP 106 (323)
T ss_dssp EEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CE
T ss_pred EeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCcc
Confidence 456789999999999986543 57888776543 234567999999999999999876222 2 3
Q ss_pred EEEEeccCCCCHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccc
Q psy5368 116 YIILEYCDGGDLCSFIRSHE------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQF 188 (406)
Q Consensus 116 ~lV~E~~~ggsL~~~l~~~~------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~ 188 (406)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++.
T Consensus 107 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~ 186 (323)
T 3qup_A 107 MVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK 186 (323)
T ss_dssp EEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred EEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeecccccc
Confidence 89999999999999996542 599999999999999999999999999999999999999 67999999999987
Q ss_pred cCCCCC---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q psy5368 189 LAPNDQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLS 264 (406)
Q Consensus 189 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s 264 (406)
...... .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+........++ .++
T Consensus 187 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~ 265 (323)
T 3qup_A 187 IYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPP-ECM 265 (323)
T ss_dssp --------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT-TCC
T ss_pred ccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCCCCC-ccC
Confidence 644332 233456788999999999999999999999999999999 999999998888888777765554444 789
Q ss_pred hHHHHHHHHhcccCCCCCCC-------HHHHhcCCCCCCCC
Q psy5368 265 PDCMDFLSRLLQKDPMRRIS-------YEDLFSHPYPDLIH 298 (406)
Q Consensus 265 ~~l~~li~~~L~~dP~~Rps-------~~ell~hp~~~~~~ 298 (406)
+++.+|+.+||+.||.+||| ++++++|||+....
T Consensus 266 ~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 266 EEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 99999999999999999999 77788899987543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=349.36 Aligned_cols=244 Identities=24% Similarity=0.362 Sum_probs=183.7
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCccc------------CCeEEEEE
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRKR------------PRYVYIIL 119 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~------------~~~~~lV~ 119 (406)
...||+|+||.||++.. .+..|++|++.... ......+.+|+.+++.++|||++.. ...+|+||
T Consensus 34 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~ 113 (367)
T 2fst_X 34 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113 (367)
T ss_dssp EEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred eeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEe
Confidence 45689999999999975 34578888876532 2235578899999999999998762 25679999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcc
Q psy5368 120 EYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSI 198 (406)
Q Consensus 120 E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~ 198 (406)
|++ +++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.... .....
T Consensus 114 e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~ 189 (367)
T 2fst_X 114 HLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD--EMTGY 189 (367)
T ss_dssp ECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----------------
T ss_pred ccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc--cCCCc
Confidence 999 6799999876 6799999999999999999999999999999999999999 67999999999976543 24456
Q ss_pred cCCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----------------------
Q psy5368 199 QGSPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP---------------------- 255 (406)
Q Consensus 199 ~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~---------------------- 255 (406)
.||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.......+.....
T Consensus 190 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 269 (367)
T 2fst_X 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 269 (367)
T ss_dssp -CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTS
T ss_pred CcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhcc
Confidence 79999999999987 6799999999999999999999999999887666555543110
Q ss_pred CCCCC-------CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCcc
Q psy5368 256 ITIPP-------NSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAE 303 (406)
Q Consensus 256 ~~~~~-------~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~~ 303 (406)
...+. ...++++.+||.+||+.||.+|||+.++++||||+..+.|..+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~ 324 (367)
T 2fst_X 270 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 324 (367)
T ss_dssp CCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGC
T ss_pred CCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCC
Confidence 00010 2468899999999999999999999999999999987765543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=344.63 Aligned_cols=242 Identities=24% Similarity=0.348 Sum_probs=195.2
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccc--hhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITS--HSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~--~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...||+|+||.||++... +..+++|.+....... ...+.+|+.++.+++|||+++ ..+..|+||||++++
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 109 (331)
T 4aaa_A 30 LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHT 109 (331)
T ss_dssp EEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred eeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcc
Confidence 456788888888888864 4568888776544332 345789999999999999876 677889999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCcccCCCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDSIQGSPL 203 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~~~gt~~ 203 (406)
+|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++...... .......||+.
T Consensus 110 ~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~ 189 (331)
T 4aaa_A 110 ILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRW 189 (331)
T ss_dssp HHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------------CCCCCT
T ss_pred hHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccCCCcCCcc
Confidence 9999888778899999999999999999999999999999999999998 779999999999765443 23345678999
Q ss_pred CCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC------------------CCCC-----
Q psy5368 204 YMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP------------------ITIP----- 259 (406)
Q Consensus 204 y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~------------------~~~~----- 259 (406)
|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+....+..... ...+
T Consensus 190 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (331)
T 4aaa_A 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKER 269 (331)
T ss_dssp TCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSC
T ss_pred ccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCcccccc
Confidence 9999999875 689999999999999999999999999876665544432100 0000
Q ss_pred ------CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy5368 260 ------PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 260 ------~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 297 (406)
...+++++.+|+.+||+.||++|||+.|+++||||+..
T Consensus 270 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 270 EPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp CCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred chhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 12578999999999999999999999999999999743
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=340.87 Aligned_cols=247 Identities=27% Similarity=0.372 Sum_probs=198.6
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc-----------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK-----------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~-----------~~~~~~lV~E~ 121 (406)
...||+|+||.||++... +..+++|.+..... .....+.+|+.++++++|||+++ .....|+||||
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 95 (353)
T 2b9h_A 16 KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL 95 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECC
T ss_pred eeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEec
Confidence 456788888888888864 45688887754322 23456889999999999999875 13678999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC------
Q psy5368 122 CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ------ 194 (406)
Q Consensus 122 ~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~------ 194 (406)
+.+ +|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........
T Consensus 96 ~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 173 (353)
T 2b9h_A 96 MQT-DLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173 (353)
T ss_dssp CSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----------
T ss_pred cCc-cHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCcc
Confidence 974 99999976 5799999999999999999999999999999999999998 67999999999987643221
Q ss_pred -----CCcccCCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-------------
Q psy5368 195 -----GDSIQGSPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP------------- 255 (406)
Q Consensus 195 -----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~------------- 255 (406)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (353)
T 2b9h_A 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIES 253 (353)
T ss_dssp ------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCC
T ss_pred ccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhcccccccc
Confidence 123568999999998765 6789999999999999999999999999876655444332100
Q ss_pred ----------CCCC-------CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCccc
Q psy5368 256 ----------ITIP-------PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAES 304 (406)
Q Consensus 256 ----------~~~~-------~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~~~ 304 (406)
...+ ...+++++.+|+.+||+.||++|||+.++++||||+....+..+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~ 319 (353)
T 2b9h_A 254 PRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEP 319 (353)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSC
T ss_pred chhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCccccc
Confidence 0000 125789999999999999999999999999999999877665543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=331.88 Aligned_cols=240 Identities=25% Similarity=0.447 Sum_probs=205.6
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...||+|+||.||++... +..+++|.+.... ......+.+|+.++++++|||+++ ..+..|+||||++++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 106 (287)
T 2wei_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG 106 (287)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCC
Confidence 456788888888888763 5568888776543 234567899999999999999865 677899999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeC----CeeEEEecccccccCCCCCCCcccCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN----NTLKLADFGFAQFLAPNDQGDSIQGS 201 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~----~~~kL~DFGla~~~~~~~~~~~~~gt 201 (406)
+|.+++.....+++..+..++.||+.||.|||++|++|+||||+||+++. +.+||+|||++.............||
T Consensus 107 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~ 186 (287)
T 2wei_A 107 ELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGT 186 (287)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHH
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCc
Confidence 99999988889999999999999999999999999999999999999972 36999999999877666555666789
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCChHHHHHHHHhcccCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP--NSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~~li~~~L~~dP 279 (406)
+.|+|||.+.+. ++.++||||||+++|+|++|..||.+.+..+....+.........+ ..+|+++.+|+.+||+.||
T Consensus 187 ~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp 265 (287)
T 2wei_A 187 AYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHP 265 (287)
T ss_dssp HTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSG
T ss_pred ccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccCh
Confidence 999999998765 8999999999999999999999999998888877776664322211 3689999999999999999
Q ss_pred CCCCCHHHHhcCCCCCC
Q psy5368 280 MRRISYEDLFSHPYPDL 296 (406)
Q Consensus 280 ~~Rps~~ell~hp~~~~ 296 (406)
++|||+.++++||||+.
T Consensus 266 ~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 266 SLRITATQCLEHPWIQK 282 (287)
T ss_dssp GGSCCHHHHHHSHHHHH
T ss_pred hhCcCHHHHhcCHHHhc
Confidence 99999999999999874
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=333.64 Aligned_cols=241 Identities=25% Similarity=0.421 Sum_probs=207.9
Q ss_pred ceeeecceeeeEEEeeeee--eceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 55 STIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
....||+|+||.||++... +..+++|.+..... .....+.+|+.+++.++|||+++ ..+..|+||||++++
T Consensus 26 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 105 (303)
T 3a7i_A 26 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG 105 (303)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred HhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCC
Confidence 3467899999999999753 45788888765543 34567899999999999999866 667889999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPL 203 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~ 203 (406)
+|.+++.. +++++..+..++.||+.||.|||++||+|+||||+||+++ ++.+||+|||++....... ......||+.
T Consensus 106 ~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 184 (303)
T 3a7i_A 106 SALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF 184 (303)
T ss_dssp EHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGG
T ss_pred cHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCccCCCcC
Confidence 99999865 5799999999999999999999999999999999999998 6799999999998765433 2345678999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
|+|||++.+..++.++||||||+++|+|++|..||...........+........ +..++..+.+|+.+||+.||.+||
T Consensus 185 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rp 263 (303)
T 3a7i_A 185 WMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL-EGNYSKPLKEFVEACLNKEPSFRP 263 (303)
T ss_dssp GCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-CSSCCHHHHHHHHHHCCSSGGGSC
T ss_pred ccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCC-ccccCHHHHHHHHHHcCCChhhCc
Confidence 9999999999999999999999999999999999999888777776666644443 347899999999999999999999
Q ss_pred CHHHHhcCCCCCCC
Q psy5368 284 SYEDLFSHPYPDLI 297 (406)
Q Consensus 284 s~~ell~hp~~~~~ 297 (406)
|+.++++||||...
T Consensus 264 s~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 264 TAKELLKHKFILRN 277 (303)
T ss_dssp CHHHHTTCHHHHHH
T ss_pred CHHHHhhChhhhcC
Confidence 99999999998643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=342.51 Aligned_cols=241 Identities=29% Similarity=0.498 Sum_probs=191.6
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc--------cchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEe
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI--------TSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILE 120 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~--------~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E 120 (406)
...||+|+||.||++... +..+++|.+..... .....+.+|+.++++++|||+++ ..+..|+|||
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~e 94 (322)
T 2ycf_A 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLE 94 (322)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEE
T ss_pred eeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCceEEEEe
Confidence 345677777888877653 34677776654321 22346889999999999999876 3445899999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC---eeEEEecccccccCCCCCCC
Q psy5368 121 YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN---TLKLADFGFAQFLAPNDQGD 196 (406)
Q Consensus 121 ~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~---~~kL~DFGla~~~~~~~~~~ 196 (406)
|+++++|.+++..+..+++..+..++.||+.||.|||++||+||||||+|||++ ++ .+||+|||++..........
T Consensus 95 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 174 (322)
T 2ycf_A 95 LMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 174 (322)
T ss_dssp CCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHH
T ss_pred cCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecccccccc
Confidence 999999999998888999999999999999999999999999999999999998 33 49999999998765443334
Q ss_pred cccCCCCCCChhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCCCCC--CCCCChHHHHH
Q psy5368 197 SIQGSPLYMAPEILA---GSPYNAKADLWSLGVLVFEALFGHAPYASCNLS-QLRAQALSSAPITIP--PNSLSPDCMDF 270 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~--~~~~s~~l~~l 270 (406)
...||+.|+|||++. ...++.++|||||||++|+|++|..||...... .+...+........+ ...+++++.+|
T Consensus 175 ~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (322)
T 2ycf_A 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDL 254 (322)
T ss_dssp HHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred cccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHH
Confidence 567899999999974 466899999999999999999999999765432 233333333222111 13689999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCCCC
Q psy5368 271 LSRLLQKDPMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 271 i~~~L~~dP~~Rps~~ell~hp~~~~ 296 (406)
+.+||+.||++|||+.++++||||+.
T Consensus 255 i~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 255 VKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred HHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 99999999999999999999999974
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=340.98 Aligned_cols=238 Identities=23% Similarity=0.365 Sum_probs=192.2
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc--------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK--------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~--------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++... +..+++|.+.... ......+.+|+.++++++|||+++ .....|+||||+++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 93 (319)
T 4euu_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (319)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTT
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCC
Confidence 345677777777777764 4568888776543 334567889999999999999876 23478999999999
Q ss_pred CCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEe----e-CCeeEEEecccccccCCCCCCC
Q psy5368 125 GDLCSFIRSHE---KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI----K-NNTLKLADFGFAQFLAPNDQGD 196 (406)
Q Consensus 125 gsL~~~l~~~~---~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll----~-~~~~kL~DFGla~~~~~~~~~~ 196 (406)
++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||+ + ++.+||+|||+++.........
T Consensus 94 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~ 173 (319)
T 4euu_A 94 GSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV 173 (319)
T ss_dssp CBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBC
T ss_pred CCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCcee
Confidence 99999997654 39999999999999999999999999999999999998 4 4479999999998877666666
Q ss_pred cccCCCCCCChhhhc--------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcCCCC-------
Q psy5368 197 SIQGSPLYMAPEILA--------GSPYNAKADLWSLGVLVFEALFGHAPYASCN----LSQLRAQALSSAPIT------- 257 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlG~il~elltg~~pf~~~~----~~~~~~~~~~~~~~~------- 257 (406)
...||+.|+|||++. +..++.++|||||||++|+|++|..||.... ..+....+....+..
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 253 (319)
T 4euu_A 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQK 253 (319)
T ss_dssp CCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEEC
T ss_pred ecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhc
Confidence 778999999999986 5678999999999999999999999997432 234444444443221
Q ss_pred -----------CCC-----CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q psy5368 258 -----------IPP-----NSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293 (406)
Q Consensus 258 -----------~~~-----~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~ 293 (406)
.+. ..+++.+.+|+.+||+.||++|||++|+++||-
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 254 AENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp STTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred ccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 111 123567899999999999999999999999964
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=338.91 Aligned_cols=235 Identities=21% Similarity=0.348 Sum_probs=199.1
Q ss_pred eeeecceeeeEEEeeeee-----eceeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIR-----LGTVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~-----~~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ 123 (406)
...||+|+||.||++... ...+++|.+.... ......+.+|+.++++++|||+++ ..+..|+||||++
T Consensus 54 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 133 (325)
T 3kul_A 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYME 133 (325)
T ss_dssp EEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCT
T ss_pred eeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCC
Confidence 467899999999999873 2348888876543 223457999999999999999876 5667899999999
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC----CCc
Q psy5368 124 GGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ----GDS 197 (406)
Q Consensus 124 ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~----~~~ 197 (406)
|++|.++++.. +.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....... ...
T Consensus 134 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 213 (325)
T 3kul_A 134 NGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTG 213 (325)
T ss_dssp TCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC-
T ss_pred CCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccC
Confidence 99999999765 5799999999999999999999999999999999999998 67999999999987654322 122
Q ss_pred ccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcc
Q psy5368 198 IQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQ 276 (406)
Q Consensus 198 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~ 276 (406)
..+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++...+........+ ..+++++.+|+.+||.
T Consensus 214 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~ 292 (325)
T 3kul_A 214 GKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAP-MGCPHALHQLMLDCWH 292 (325)
T ss_dssp --CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC-TTCCHHHHHHHHHHTC
T ss_pred CCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCC-CCcCHHHHHHHHHHcc
Confidence 345778999999998899999999999999999999 99999999998888888777554444 3799999999999999
Q ss_pred cCCCCCCCHHHHhcC
Q psy5368 277 KDPMRRISYEDLFSH 291 (406)
Q Consensus 277 ~dP~~Rps~~ell~h 291 (406)
.||.+|||+.++++.
T Consensus 293 ~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 293 KDRAQRPRFSQIVSV 307 (325)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CChhhCcCHHHHHHH
Confidence 999999999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=344.76 Aligned_cols=245 Identities=23% Similarity=0.345 Sum_probs=191.5
Q ss_pred ceeeecceeeeEEEeeee-eeceeEEeeeecCCccc-----------hhhhhhHHhhcccCCCCCCcc-----------c
Q psy5368 55 STIRYGELQYDTVQNSQI-RLGTVKYSQVRYDTITS-----------HSEFERPRAGLSNLRAPEGRK-----------R 111 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~-~~~~v~vk~~~~~~~~~-----------~~~~~~E~~~l~~l~h~ni~~-----------~ 111 (406)
....||+|+||.||++.. .+..+++|.+....... ...+.+|+.++++++|||+++ .
T Consensus 26 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (362)
T 3pg1_A 26 VQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPA 105 (362)
T ss_dssp EEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTT
T ss_pred EeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCC
Confidence 356789999999999875 34568888775433221 267899999999999999875 2
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEeccccccc
Q psy5368 112 PRYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFL 189 (406)
Q Consensus 112 ~~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~ 189 (406)
...+|+||||++ |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...
T Consensus 106 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (362)
T 3pg1_A 106 MHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARED 184 (362)
T ss_dssp CCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC----
T ss_pred cceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCccccc
Confidence 336799999997 49999887654 799999999999999999999999999999999999998 779999999999876
Q ss_pred CCCCCCCcccCCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-------------
Q psy5368 190 APNDQGDSIQGSPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAP------------- 255 (406)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~------------- 255 (406)
..........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+....+.....
T Consensus 185 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 264 (362)
T 3pg1_A 185 TADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSP 264 (362)
T ss_dssp -----------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCH
T ss_pred ccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccch
Confidence 65656666789999999999987 6799999999999999999999999999887666655543110
Q ss_pred ----------CCCC-------CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy5368 256 ----------ITIP-------PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAP 300 (406)
Q Consensus 256 ----------~~~~-------~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 300 (406)
...+ ....++.+.+||.+||+.||.+|||+.|+++||||+....|
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 326 (362)
T 3pg1_A 265 SARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP 326 (362)
T ss_dssp HHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred hhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence 0111 12468899999999999999999999999999999976543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=331.97 Aligned_cols=242 Identities=29% Similarity=0.487 Sum_probs=202.5
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCcc--------cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRK--------RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~--------~~~~~~lV~E~~~ 123 (406)
...||+|+||.||++... +..+++|.+...... ....+.+|+.++++++|||+++ ..+.+|+||||++
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 90 (279)
T 2w5a_A 11 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 90 (279)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCT
T ss_pred ehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCC
Confidence 456788888888888763 456788877654322 3457899999999999999765 3567899999999
Q ss_pred CCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccccCCCcceEee-CCeeEEEecccccccCCCC
Q psy5368 124 GGDLCSFIRSH----EKLSEFQCQQFVRQLVLALKFLRENN-----VCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND 193 (406)
Q Consensus 124 ggsL~~~l~~~----~~l~~~~~~~i~~ql~~aL~~lH~~g-----ivH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~ 193 (406)
+++|.+++... ..+++..+..++.|++.||+|||++| |+|+||||+||+++ ++.+||+|||++.......
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~ 170 (279)
T 2w5a_A 91 GGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT 170 (279)
T ss_dssp TEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---C
T ss_pred CCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccc
Confidence 99999999653 34999999999999999999999999 99999999999999 6799999999997764332
Q ss_pred C-CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHH
Q psy5368 194 Q-GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLS 272 (406)
Q Consensus 194 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~ 272 (406)
. .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+...+...+........+ ..+++++.+++.
T Consensus 171 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~-~~~~~~l~~li~ 249 (279)
T 2w5a_A 171 SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP-YRYSDELNEIIT 249 (279)
T ss_dssp HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCC-TTSCHHHHHHHH
T ss_pred ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCC-cccCHHHHHHHH
Confidence 1 23456899999999999999999999999999999999999999999888888777776554444 378999999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 273 RLLQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 273 ~~L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
+||+.||.+|||+.++++|+|+....
T Consensus 250 ~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 250 RMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp HHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred HHcCCCcccCCCHHHHHhChhhhhhc
Confidence 99999999999999999999997543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=343.48 Aligned_cols=241 Identities=22% Similarity=0.424 Sum_probs=202.5
Q ss_pred eeeecceeeeEEEeeeeeeceeEEeeeecCCccch-----------------hhhhhHHhhcccCCCCCCcc------cC
Q psy5368 56 TIRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSH-----------------SEFERPRAGLSNLRAPEGRK------RP 112 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~-----------------~~~~~E~~~l~~l~h~ni~~------~~ 112 (406)
...||+|+||.||++...+..+++|.+........ ..+.+|+.++.+++|||+++ ..
T Consensus 36 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 115 (348)
T 2pml_X 36 IRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNY 115 (348)
T ss_dssp EEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESS
T ss_pred EEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 45678888888888887667788887765432221 78999999999999999765 66
Q ss_pred CeEEEEEeccCCCCHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCcceEee-CCeeEEEe
Q psy5368 113 RYVYIILEYCDGGDLCSF------IRS--HEKLSEFQCQQFVRQLVLALKFLRE-NNVCHFDLKPQNILIK-NNTLKLAD 182 (406)
Q Consensus 113 ~~~~lV~E~~~ggsL~~~------l~~--~~~l~~~~~~~i~~ql~~aL~~lH~-~givH~Dlkp~NIll~-~~~~kL~D 182 (406)
+.+|+||||+++++|.++ +.. ...+++..+..++.||+.||.|||+ +||+|+||||+||+++ ++.+||+|
T Consensus 116 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl~d 195 (348)
T 2pml_X 116 DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSD 195 (348)
T ss_dssp SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSCEEECC
T ss_pred CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCcEEEec
Confidence 789999999999999998 655 5689999999999999999999999 9999999999999998 77999999
Q ss_pred cccccccCCCCCCCcccCCCCCCChhhhcCC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCCCC
Q psy5368 183 FGFAQFLAPNDQGDSIQGSPLYMAPEILAGS-PYNA-KADLWSLGVLVFEALFGHAPYASCNL-SQLRAQALSSAPITIP 259 (406)
Q Consensus 183 FGla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwSlG~il~elltg~~pf~~~~~-~~~~~~~~~~~~~~~~ 259 (406)
||++...... ......||+.|+|||++.+. .++. ++||||+||++|+|++|..||...+. .+....+... ....+
T Consensus 196 fg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~-~~~~~ 273 (348)
T 2pml_X 196 FGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTK-NIEYP 273 (348)
T ss_dssp CTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSC-CCCCC
T ss_pred cccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc-CcCCc
Confidence 9999876443 33456789999999999887 6666 99999999999999999999998776 5665555544 23333
Q ss_pred C------------------CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 260 P------------------NSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 260 ~------------------~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
. ..+++++.+|+.+||+.||.+|||+.++++||||+...
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 274 LDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp CSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred cchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 1 46899999999999999999999999999999998654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=357.61 Aligned_cols=231 Identities=13% Similarity=0.117 Sum_probs=185.8
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC---ccchhhhhhHH---hhcccCCCCCCccc-------------CC-
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT---ITSHSEFERPR---AGLSNLRAPEGRKR-------------PR- 113 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~---~~~~~~~~~E~---~~l~~l~h~ni~~~-------------~~- 113 (406)
...||+|+||.||++... +..+++|.+.... ......+.+|+ ..+++++|||+++. .+
T Consensus 78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 157 (377)
T 3byv_A 78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157 (377)
T ss_dssp EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence 567899999999999964 5689999887432 23356788999 67777799997541 10
Q ss_pred ----------------eEEEEEeccCCCCHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHHCCcccccCCCcc
Q psy5368 114 ----------------YVYIILEYCDGGDLCSFIRSHEKLSE-------FQCQQFVRQLVLALKFLRENNVCHFDLKPQN 170 (406)
Q Consensus 114 ----------------~~~lV~E~~~ggsL~~~l~~~~~l~~-------~~~~~i~~ql~~aL~~lH~~givH~Dlkp~N 170 (406)
..|+||||+ +|+|.+++...+.+++ ..+..++.||+.||+|||++||+||||||+|
T Consensus 158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~N 236 (377)
T 3byv_A 158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVD 236 (377)
T ss_dssp CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 388999999 5799999987655555 8888899999999999999999999999999
Q ss_pred eEee-CCeeEEEecccccccCCCCCCCcccCCCCCCChhhhcCC-----------CCCchhhHHHHHHHHHHHHhCCCCC
Q psy5368 171 ILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGS-----------PYNAKADLWSLGVLVFEALFGHAPY 238 (406)
Q Consensus 171 Ill~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwSlG~il~elltg~~pf 238 (406)
||++ ++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||++|||++|+.||
T Consensus 237 Ill~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf 313 (377)
T 3byv_A 237 IVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI 313 (377)
T ss_dssp EEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC
T ss_pred EEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCC
Confidence 9999 77999999999986432 3345567 999999999887 8999999999999999999999999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy5368 239 ASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 296 (406)
.+.+.......+.. ....+|+++.+||.+||+.||++|||+.++++||||+.
T Consensus 314 ~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 314 TKDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp ------CCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred cccccccchhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 87554332222211 12368999999999999999999999999999999964
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=335.76 Aligned_cols=237 Identities=23% Similarity=0.427 Sum_probs=193.9
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCccchhhhhhHHhhcccCC-CCCCcc--------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITSHSEFERPRAGLSNLR-APEGRK--------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~--------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++.. .+..+++|.+.. .....+.+|+.++.+++ |||++. .....++||||+++
T Consensus 41 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 117 (330)
T 3nsz_A 41 VRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 117 (330)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCC
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCc
Confidence 45788888999998865 345788887653 34567999999999997 999776 26778999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC-eeEEEecccccccCCCCCCCcccCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN-TLKLADFGFAQFLAPNDQGDSIQGSP 202 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~-~~kL~DFGla~~~~~~~~~~~~~gt~ 202 (406)
++|.+++. .+++..+..++.||+.||+|||++||+||||||+|||++ ++ .+||+|||+++............||+
T Consensus 118 ~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 194 (330)
T 3nsz_A 118 TDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR 194 (330)
T ss_dssp CCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCG
T ss_pred hhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccc
Confidence 99999884 489999999999999999999999999999999999999 55 89999999998877666666778999
Q ss_pred CCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHh------------cCCCCC----------
Q psy5368 203 LYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCN-LSQLRAQALS------------SAPITI---------- 258 (406)
Q Consensus 203 ~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~-~~~~~~~~~~------------~~~~~~---------- 258 (406)
.|+|||++.+ ..++.++||||+||++|+|++|..||.... ..+....+.. ......
T Consensus 195 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (330)
T 3nsz_A 195 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGR 274 (330)
T ss_dssp GGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCC
T ss_pred cccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhh
Confidence 9999999987 669999999999999999999999995432 2221111110 000000
Q ss_pred -------------CCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 259 -------------PPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 259 -------------~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
.+..+++++.+||.+||+.||++|||++|+++||||+...
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 275 HSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp CCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred ccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 0113799999999999999999999999999999998654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=330.84 Aligned_cols=242 Identities=25% Similarity=0.416 Sum_probs=197.2
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
...||+|+||.||++... +..|++|.+..........+.+|+.+++.++|||+++ ..+..++||||+++++|
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 106 (295)
T 2clq_A 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL 106 (295)
T ss_dssp BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEH
T ss_pred cEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCH
Confidence 458999999999999863 4578888887766556678999999999999999876 66788999999999999
Q ss_pred HHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee--CCeeEEEecccccccCCCC-CCCcccCC
Q psy5368 128 CSFIRSHE---KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK--NNTLKLADFGFAQFLAPND-QGDSIQGS 201 (406)
Q Consensus 128 ~~~l~~~~---~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~--~~~~kL~DFGla~~~~~~~-~~~~~~gt 201 (406)
.+++.... .+++..+..++.||+.||.|||++||+|+||||+||+++ ++.+||+|||++....... ......||
T Consensus 107 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 186 (295)
T 2clq_A 107 SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGT 186 (295)
T ss_dssp HHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCC
T ss_pred HHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCC
Confidence 99997652 567999999999999999999999999999999999998 5699999999998765432 23456789
Q ss_pred CCCCChhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHhcCCCCCCCCCCChHHHHHHHHhccc
Q psy5368 202 PLYMAPEILAGSP--YNAKADLWSLGVLVFEALFGHAPYASCNLSQ-LRAQ-ALSSAPITIPPNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 202 ~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~pf~~~~~~~-~~~~-~~~~~~~~~~~~~~s~~l~~li~~~L~~ 277 (406)
+.|+|||++.+.. ++.++||||||+++|+|++|+.||....... .... ......... +..+++++.+|+.+||+.
T Consensus 187 ~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~ 265 (295)
T 2clq_A 187 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEI-PESMSAEAKAFILKCFEP 265 (295)
T ss_dssp GGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCC-CTTSCHHHHHHHHHTTCS
T ss_pred ccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccc-cccCCHHHHHHHHHHccC
Confidence 9999999997654 8899999999999999999999997643222 2222 222222233 347899999999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCC
Q psy5368 278 DPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 278 dP~~Rps~~ell~hp~~~~~~ 298 (406)
||++|||+.++++||||+...
T Consensus 266 dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 266 DPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp STTTSCCHHHHHTSGGGCC--
T ss_pred ChhhCCCHHHHhcChhhhhcc
Confidence 999999999999999998543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=326.63 Aligned_cols=234 Identities=21% Similarity=0.378 Sum_probs=201.5
Q ss_pred eeeecceeeeEEEeeee-eeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHH
Q psy5368 56 TIRYGELQYDTVQNSQI-RLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLC 128 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~-~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~ 128 (406)
...||+|+||.||++.. ....+++|.+.... ....++.+|+.++++++|||+++ ..+..|+||||+++++|.
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (269)
T 4hcu_A 15 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 93 (269)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred eheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHH
Confidence 45678999999999887 34567888776543 34567999999999999999876 667899999999999999
Q ss_pred HHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC--CCCcccCCCCC
Q psy5368 129 SFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND--QGDSIQGSPLY 204 (406)
Q Consensus 129 ~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~--~~~~~~gt~~y 204 (406)
+++... +.+++..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++....... ......+|+.|
T Consensus 94 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y 173 (269)
T 4hcu_A 94 DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKW 173 (269)
T ss_dssp HHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGG
T ss_pred HHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccccCccccccc
Confidence 999764 4699999999999999999999999999999999999998 6799999999998654332 23344567889
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
+|||++.+..++.++||||+|+++|+|++ |..||...+..+....+........ +..+++++.+++.+||+.||++||
T Consensus 174 ~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp 252 (269)
T 4hcu_A 174 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PRLASTHVYQIMNHCWRERPEDRP 252 (269)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-CTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred CCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC-CCcCCHHHHHHHHHHccCCcccCc
Confidence 99999999999999999999999999999 9999999999888888877644443 346899999999999999999999
Q ss_pred CHHHHhcC
Q psy5368 284 SYEDLFSH 291 (406)
Q Consensus 284 s~~ell~h 291 (406)
|+.++++|
T Consensus 253 s~~~ll~~ 260 (269)
T 4hcu_A 253 AFSRLLRQ 260 (269)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999876
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=351.99 Aligned_cols=230 Identities=23% Similarity=0.405 Sum_probs=200.3
Q ss_pred eeeecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc-------cCCeEEEEEeccCCCCHH
Q psy5368 56 TIRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK-------RPRYVYIILEYCDGGDLC 128 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~-------~~~~~~lV~E~~~ggsL~ 128 (406)
...||+|+||.||++...+..|++|.+.... ....|.+|+.++++++|||+++ ..+.+|+|||||++|+|.
T Consensus 198 ~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~ 275 (450)
T 1k9a_A 198 LQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 275 (450)
T ss_dssp EEEEEECSSEEEEEEEETTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHH
T ss_pred EeeecCcCCeeEEEEEecCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHH
Confidence 4679999999999999988899999887543 5678999999999999999876 334799999999999999
Q ss_pred HHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCCC
Q psy5368 129 SFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLYM 205 (406)
Q Consensus 129 ~~l~~~~~--l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y~ 205 (406)
+++...+. +++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++..... .....+++.|+
T Consensus 276 ~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~~~~~~y~ 353 (450)
T 1k9a_A 276 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWT 353 (450)
T ss_dssp HHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--------CCCTTTS
T ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--ccCCCCCccee
Confidence 99987653 79999999999999999999999999999999999999 779999999999865332 22335788999
Q ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCC
Q psy5368 206 APEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRIS 284 (406)
Q Consensus 206 aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps 284 (406)
|||++.+..++.++|||||||++|||+| |..||.+.+..+....+..+.....+ ..+|+++.+|+.+||+.||.+|||
T Consensus 354 aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p-~~~~~~l~~li~~cl~~dp~~Rpt 432 (450)
T 1k9a_A 354 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP-DGCPPAVYDVMKNCWHLDAATRPT 432 (450)
T ss_dssp CHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCC-TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC-CcCCHHHHHHHHHHcCCChhHCcC
Confidence 9999999999999999999999999998 99999998888887777776555444 479999999999999999999999
Q ss_pred HHHHhc
Q psy5368 285 YEDLFS 290 (406)
Q Consensus 285 ~~ell~ 290 (406)
+.++++
T Consensus 433 ~~~l~~ 438 (450)
T 1k9a_A 433 FLQLRE 438 (450)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=328.10 Aligned_cols=235 Identities=21% Similarity=0.335 Sum_probs=191.9
Q ss_pred ceeeecceeeeEEEeeeeeeceeEEeeeecCCcc----chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 55 STIRYGELQYDTVQNSQIRLGTVKYSQVRYDTIT----SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~----~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
....||+|+||.||++...+..+++|.+...... ....+.+|+.+++.++|||+++ ..+..|+||||+++
T Consensus 11 ~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (271)
T 3dtc_A 11 LEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARG 90 (271)
T ss_dssp EEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTT
T ss_pred eeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCC
Confidence 3567899999999999988888999877654322 2457889999999999999876 56778999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCCcceEee---------CCeeEEEecccccccCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENN---VCHFDLKPQNILIK---------NNTLKLADFGFAQFLAPN 192 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dlkp~NIll~---------~~~~kL~DFGla~~~~~~ 192 (406)
++|.+++. .+.+++..+..++.|++.||.|||++| |+||||||+||+++ ++.+||+|||++......
T Consensus 91 ~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~ 169 (271)
T 3dtc_A 91 GPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT 169 (271)
T ss_dssp EEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-------
T ss_pred CCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccc
Confidence 99999985 468999999999999999999999999 89999999999997 457999999999765543
Q ss_pred CCCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHH
Q psy5368 193 DQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLS 272 (406)
Q Consensus 193 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~ 272 (406)
. .....||+.|+|||.+.+..++.++||||+|+++|+|++|+.||.+.+.................+..+++++.+++.
T Consensus 170 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 248 (271)
T 3dtc_A 170 T-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLME 248 (271)
T ss_dssp -------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHH
T ss_pred c-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHH
Confidence 3 235578999999999999999999999999999999999999999988877777766665544445579999999999
Q ss_pred HhcccCCCCCCCHHHHhcC
Q psy5368 273 RLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 273 ~~L~~dP~~Rps~~ell~h 291 (406)
+||+.||.+|||+.+++++
T Consensus 249 ~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 249 DCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCcccCcCHHHHHHH
Confidence 9999999999999999875
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=343.89 Aligned_cols=243 Identities=25% Similarity=0.365 Sum_probs=193.0
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCccc-----------CCeEEEEEecc
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRKR-----------PRYVYIILEYC 122 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~~-----------~~~~~lV~E~~ 122 (406)
..||+|+||.||++... +..+++|.+..... .....+.+|+.++.+++|||++.. ....|+||||+
T Consensus 33 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~ 112 (364)
T 3qyz_A 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112 (364)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECC
T ss_pred EEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEccc
Confidence 34556666666666542 34577887754332 234678899999999999998752 24689999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC----CCc
Q psy5368 123 DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ----GDS 197 (406)
Q Consensus 123 ~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~----~~~ 197 (406)
.+ +|.++++. +.+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||++........ ...
T Consensus 113 ~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 190 (364)
T 3qyz_A 113 ET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190 (364)
T ss_dssp SE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCC
T ss_pred Cc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccc
Confidence 75 99999976 5799999999999999999999999999999999999999 67999999999987643322 345
Q ss_pred ccCCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-------------------
Q psy5368 198 IQGSPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPIT------------------- 257 (406)
Q Consensus 198 ~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~------------------- 257 (406)
..||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+..+....+.......
T Consensus 191 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (364)
T 3qyz_A 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 270 (364)
T ss_dssp CCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHT
T ss_pred cccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHh
Confidence 679999999998765 458999999999999999999999999887666555543211000
Q ss_pred ------C----CCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q psy5368 258 ------I----PPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPC 301 (406)
Q Consensus 258 ------~----~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~ 301 (406)
. ....+++++.+||.+||+.||++|||+.|+++||||+....++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~ 324 (364)
T 3qyz_A 271 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 324 (364)
T ss_dssp SCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred cCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcc
Confidence 0 0125789999999999999999999999999999999765443
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=348.54 Aligned_cols=238 Identities=23% Similarity=0.325 Sum_probs=193.4
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccC------CCCCCcc------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNL------RAPEGRK------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l------~h~ni~~------~~~~~~lV~E~ 121 (406)
...||+|+||.||++... +..|++|.+.... .....+.+|+.++..+ +|+|++. ..+.+|+||||
T Consensus 102 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 180 (429)
T 3kvw_A 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFEL 180 (429)
T ss_dssp EEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECC
T ss_pred EEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEec
Confidence 467899999999999864 3568888775432 2345677788877777 5557655 57789999999
Q ss_pred cCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCe--eEEEecccccccCCCCCCC
Q psy5368 122 CDGGDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNT--LKLADFGFAQFLAPNDQGD 196 (406)
Q Consensus 122 ~~ggsL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~--~kL~DFGla~~~~~~~~~~ 196 (406)
+. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++ ++. +||+|||++.... ....
T Consensus 181 ~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~--~~~~ 257 (429)
T 3kvw_A 181 LS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH--QRVY 257 (429)
T ss_dssp CC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT--CCCC
T ss_pred cC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecC--Cccc
Confidence 96 59999997764 599999999999999999999999999999999999999 444 9999999997653 3344
Q ss_pred cccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC------------------
Q psy5368 197 SIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITI------------------ 258 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~------------------ 258 (406)
...||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+....+........
T Consensus 258 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~ 337 (429)
T 3kvw_A 258 TYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKG 337 (429)
T ss_dssp SSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTS
T ss_pred ccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCC
Confidence 56899999999999999999999999999999999999999999887766555543210000
Q ss_pred ---------------------------------------CCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy5368 259 ---------------------------------------PPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 259 ---------------------------------------~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 297 (406)
.+...++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 338 YPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp CBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC--
T ss_pred CcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccC
Confidence 011247889999999999999999999999999999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=348.02 Aligned_cols=262 Identities=24% Similarity=0.335 Sum_probs=196.3
Q ss_pred cccccccceEEEeeeeee--EEEeeeeecCCcceeeeeeccccccccceeeecCceeeecceeeeEEEeeeeeeceeEEe
Q psy5368 3 RYGTVRYGTVRLGSVKYG--QVQLSTVRYGKVRYSQVRSDTVRSGTVRYDIVGSSTIRYGELQYDTVQNSQIRLGTVKYS 80 (406)
Q Consensus 3 ~~~~g~~~~V~ig~~~~g--y~vv~~lg~G~~~~~~~~~d~~~~~~~~~~i~~~~~~~lG~G~~g~Vy~~~~~~~~v~vk 80 (406)
+|.+|||+|+++|+.+.. |.++++||.|+++.||.+.+.. .+..+++|
T Consensus 1 ~y~~~~~~p~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~------------------------------~~~~vaiK 50 (373)
T 1q8y_A 1 DYRPGGYHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMV------------------------------NNTHVAMK 50 (373)
T ss_dssp ------CCCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETT------------------------------TTEEEEEE
T ss_pred CCCCCCceeeecCCcccCCeEEEEEeeeecCCeEEEEEEecC------------------------------CCcEEEEE
Confidence 589999999999999874 9998888877766666655332 22346667
Q ss_pred eeecCCccchhhhhhHHhhcccCC-----------CCCCccc----------CCeEEEEEeccCCCCHHHHHHhC--CCC
Q psy5368 81 QVRYDTITSHSEFERPRAGLSNLR-----------APEGRKR----------PRYVYIILEYCDGGDLCSFIRSH--EKL 137 (406)
Q Consensus 81 ~~~~~~~~~~~~~~~E~~~l~~l~-----------h~ni~~~----------~~~~~lV~E~~~ggsL~~~l~~~--~~l 137 (406)
.+... ......+.+|+.++.+++ |||+++. ...+++|||++ +++|.+++... ..+
T Consensus 51 ~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~ 128 (373)
T 1q8y_A 51 IVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGI 128 (373)
T ss_dssp EECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCC
T ss_pred EecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCC
Confidence 66432 223456888999998886 6787651 12789999999 88999999764 459
Q ss_pred CHHHHHHHHHHHHHHHHHHHHC-CcccccCCCcceEee-C------CeeEEEecccccccCCCCCCCcccCCCCCCChhh
Q psy5368 138 SEFQCQQFVRQLVLALKFLREN-NVCHFDLKPQNILIK-N------NTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEI 209 (406)
Q Consensus 138 ~~~~~~~i~~ql~~aL~~lH~~-givH~Dlkp~NIll~-~------~~~kL~DFGla~~~~~~~~~~~~~gt~~y~aPE~ 209 (406)
++..+..++.||+.||+|||++ ||+||||||+|||++ + +.+||+|||++..... ......||+.|+|||+
T Consensus 129 ~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~ 206 (373)
T 1q8y_A 129 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEV 206 (373)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHH
T ss_pred cHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCC--CCCCCCCCccccCcHH
Confidence 9999999999999999999998 999999999999996 1 2799999999987643 2344578999999999
Q ss_pred hcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhcC-CC--------------------------
Q psy5368 210 LAGSPYNAKADLWSLGVLVFEALFGHAPYASCNL------SQLRAQALSSA-PI-------------------------- 256 (406)
Q Consensus 210 ~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~------~~~~~~~~~~~-~~-------------------------- 256 (406)
+.+..++.++|||||||++|+|++|..||.+.+. ......+.... ..
T Consensus 207 ~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (373)
T 1q8y_A 207 LLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISK 286 (373)
T ss_dssp HHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCC
T ss_pred HhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhccccc
Confidence 9999999999999999999999999999986542 11111111100 00
Q ss_pred -------------CCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 257 -------------TIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 257 -------------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
...+..+++++.+||.+||+.||++|||++|+++||||+...
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 287 LKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp CCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred ccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhccc
Confidence 000113457899999999999999999999999999998653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=346.04 Aligned_cols=238 Identities=21% Similarity=0.323 Sum_probs=203.3
Q ss_pred eeeecceeeeEEEeeeee-------eceeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIR-------LGTVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~-------~~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~ 121 (406)
...||+|+||.||++... ...|++|.+.... ......+.+|+.++.+++|||+++ ..+..|+||||
T Consensus 76 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 155 (367)
T 3l9p_A 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 155 (367)
T ss_dssp EEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEe
Confidence 457899999999999853 2368888876432 233457899999999999999876 56678999999
Q ss_pred cCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC---eeEEEecccccccC
Q psy5368 122 CDGGDLCSFIRSHE-------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN---TLKLADFGFAQFLA 190 (406)
Q Consensus 122 ~~ggsL~~~l~~~~-------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~---~~kL~DFGla~~~~ 190 (406)
|+||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++ ++ .+||+|||+++...
T Consensus 156 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~ 235 (367)
T 3l9p_A 156 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 235 (367)
T ss_dssp CTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHH
T ss_pred CCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccc
Confidence 99999999997653 499999999999999999999999999999999999998 33 59999999997542
Q ss_pred C---CCCCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChH
Q psy5368 191 P---NDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPD 266 (406)
Q Consensus 191 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 266 (406)
. ........||+.|+|||++.+..++.++|||||||++|||++ |..||...+..++...+........+ ..+++.
T Consensus 236 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~ 314 (367)
T 3l9p_A 236 RAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP-KNCPGP 314 (367)
T ss_dssp HHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC-TTCCHH
T ss_pred cccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC-ccCCHH
Confidence 2 233445668999999999999999999999999999999998 99999999998888888777554443 478999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 267 CMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 267 l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
+.+|+.+||+.||.+|||+.+++++.++
T Consensus 315 l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 315 VYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 9999999999999999999999998664
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=343.19 Aligned_cols=237 Identities=22% Similarity=0.377 Sum_probs=196.1
Q ss_pred ceeeecceeeeEEEeeeee-------eceeEEeeeecCCcc-chhhhhhHHhhcccC-CCCCCcc-------cCCeEEEE
Q psy5368 55 STIRYGELQYDTVQNSQIR-------LGTVKYSQVRYDTIT-SHSEFERPRAGLSNL-RAPEGRK-------RPRYVYII 118 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~-------~~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l-~h~ni~~-------~~~~~~lV 118 (406)
....||+|+||.||++.+. ...+++|.+...... ....+.+|+.++.++ +|||+++ ....+++|
T Consensus 26 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv 105 (359)
T 3vhe_A 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 105 (359)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEE
T ss_pred eceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEE
Confidence 3567899999999999743 256889988654322 345799999999999 8899876 34558999
Q ss_pred EeccCCCCHHHHHHhCCC--------------------------------------------------------------
Q psy5368 119 LEYCDGGDLCSFIRSHEK-------------------------------------------------------------- 136 (406)
Q Consensus 119 ~E~~~ggsL~~~l~~~~~-------------------------------------------------------------- 136 (406)
||||++|+|.+++.....
T Consensus 106 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (359)
T 3vhe_A 106 VEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDL 185 (359)
T ss_dssp EECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CT
T ss_pred EEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccch
Confidence 999999999999976543
Q ss_pred ----CCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC---CCcccCCCCCCChh
Q psy5368 137 ----LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ---GDSIQGSPLYMAPE 208 (406)
Q Consensus 137 ----l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~---~~~~~gt~~y~aPE 208 (406)
+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....... .....||+.|+|||
T Consensus 186 ~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE 265 (359)
T 3vhe_A 186 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 265 (359)
T ss_dssp TTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHH
T ss_pred hccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChh
Confidence 89999999999999999999999999999999999998 77999999999986643322 33456889999999
Q ss_pred hhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCCHHH
Q psy5368 209 ILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYED 287 (406)
Q Consensus 209 ~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~e 287 (406)
++.+..++.++|||||||++|+|+| |..||.+...................+..+++++.+++.+||+.||.+|||+.+
T Consensus 266 ~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 345 (359)
T 3vhe_A 266 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 345 (359)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 9999999999999999999999998 999998877554444444433333334578999999999999999999999999
Q ss_pred HhcC
Q psy5368 288 LFSH 291 (406)
Q Consensus 288 ll~h 291 (406)
+++|
T Consensus 346 ll~~ 349 (359)
T 3vhe_A 346 LVEH 349 (359)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=338.57 Aligned_cols=235 Identities=22% Similarity=0.337 Sum_probs=201.8
Q ss_pred eeeecceeeeEEEeeeeee-------ceeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIRL-------GTVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-------~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~ 121 (406)
...||+|+||.||++.... ..+++|.+...... ....+.+|+.++.+++|||+++ ..+..|+||||
T Consensus 52 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 131 (343)
T 1luf_A 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEY 131 (343)
T ss_dssp EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEec
Confidence 4678999999999999764 56888887654322 3457899999999999999876 66788999999
Q ss_pred cCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC
Q psy5368 122 CDGGDLCSFIRSH------------------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN 176 (406)
Q Consensus 122 ~~ggsL~~~l~~~------------------------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~ 176 (406)
+++|+|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++ ++
T Consensus 132 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~ 211 (343)
T 1luf_A 132 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM 211 (343)
T ss_dssp CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred CCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCC
Confidence 9999999999764 5699999999999999999999999999999999999998 67
Q ss_pred eeEEEecccccccCCC---CCCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q psy5368 177 TLKLADFGFAQFLAPN---DQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALS 252 (406)
Q Consensus 177 ~~kL~DFGla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 252 (406)
.+||+|||+++..... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++...+..
T Consensus 212 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 291 (343)
T 1luf_A 212 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD 291 (343)
T ss_dssp CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT
T ss_pred eEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhC
Confidence 9999999999765432 22334567899999999999899999999999999999999 9999999998888888777
Q ss_pred cCCCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 253 SAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 253 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
......+ ..+++++.+|+.+||+.||.+|||+.+++++
T Consensus 292 ~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 292 GNILACP-ENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp TCCCCCC-TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcCCCC-CCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 6554444 4789999999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=332.18 Aligned_cols=244 Identities=27% Similarity=0.346 Sum_probs=200.4
Q ss_pred ceeeecceeeeEEEeeeee---eceeEEeeeecCCc--cchhhhhhHHhhcccC---CCCCCcc-----------cCCeE
Q psy5368 55 STIRYGELQYDTVQNSQIR---LGTVKYSQVRYDTI--TSHSEFERPRAGLSNL---RAPEGRK-----------RPRYV 115 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~---~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l---~h~ni~~-----------~~~~~ 115 (406)
....||+|+||.||++... +..+++|.+..... .....+.+|+.+++.+ +|||+++ .....
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 94 (326)
T 1blx_A 15 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL 94 (326)
T ss_dssp EEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEE
T ss_pred eeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceE
Confidence 3456789999999998762 34678887654332 2234677888877776 8999875 34568
Q ss_pred EEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC
Q psy5368 116 YIILEYCDGGDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN 192 (406)
Q Consensus 116 ~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~ 192 (406)
++||||++ |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++......
T Consensus 95 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (326)
T 1blx_A 95 TLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 173 (326)
T ss_dssp EEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG
T ss_pred EEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccccCC
Confidence 89999998 59999998754 499999999999999999999999999999999999998 779999999999876544
Q ss_pred CCCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----------------
Q psy5368 193 DQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI---------------- 256 (406)
Q Consensus 193 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---------------- 256 (406)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 253 (326)
T 1blx_A 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 253 (326)
T ss_dssp GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGG
T ss_pred CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhh
Confidence 4445667899999999999999999999999999999999999999998877766665532100
Q ss_pred ---------CCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy5368 257 ---------TIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 257 ---------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 299 (406)
......+++.+.+|+.+||+.||.+|||+.++++||||+....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 254 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp SCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred hcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 0011357899999999999999999999999999999987654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=329.62 Aligned_cols=235 Identities=23% Similarity=0.411 Sum_probs=188.6
Q ss_pred eeeecceeeeEEEeeeeee-----ceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIRL-----GTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-----~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++.... ..+++|....... .....+.+|+.++++++|||+++ ..+..|+||||+++
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~~~~ 99 (281)
T 1mp8_A 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTL 99 (281)
T ss_dssp EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEEECCTT
T ss_pred EeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEEEEecCCC
Confidence 5567889999999887632 2467776654322 23457899999999999999876 55678999999999
Q ss_pred CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC--CCcccC
Q psy5368 125 GDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ--GDSIQG 200 (406)
Q Consensus 125 gsL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~--~~~~~g 200 (406)
++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++ ++.+||+|||+++....... .....+
T Consensus 100 ~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 179 (281)
T 1mp8_A 100 GELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 179 (281)
T ss_dssp EEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------------C
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcccccccccCCC
Confidence 99999998664 799999999999999999999999999999999999999 78999999999987654332 233456
Q ss_pred CCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCC
Q psy5368 201 SPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 201 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP 279 (406)
|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+........++ .+|+++.+++.+||+.||
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~l~~li~~~l~~~p 258 (281)
T 1mp8_A 180 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP-NCPPTLYSLMTKCWAYDP 258 (281)
T ss_dssp CGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT-TCCHHHHHHHHHHTCSSG
T ss_pred cccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCC-CCCHHHHHHHHHHccCCh
Confidence 788999999998899999999999999999997 999999988888877777665544443 799999999999999999
Q ss_pred CCCCCHHHHhcC
Q psy5368 280 MRRISYEDLFSH 291 (406)
Q Consensus 280 ~~Rps~~ell~h 291 (406)
++|||+.+++++
T Consensus 259 ~~Rps~~~l~~~ 270 (281)
T 1mp8_A 259 SRRPRFTELKAQ 270 (281)
T ss_dssp GGSCCHHHHHHH
T ss_pred hhCcCHHHHHHH
Confidence 999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=337.77 Aligned_cols=231 Identities=22% Similarity=0.343 Sum_probs=191.7
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
...||+|+||+||++... +..+++|.+..........+.+|+.++.+++|||+++ ..+..++||||+++++|
T Consensus 15 ~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 94 (310)
T 3s95_A 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL 94 (310)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred cceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcH
Confidence 567899999999999864 4567888776555556678999999999999999876 67889999999999999
Q ss_pred HHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC----------
Q psy5368 128 CSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG---------- 195 (406)
Q Consensus 128 ~~~l~~-~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~---------- 195 (406)
.+++.. ...+++.++..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++........
T Consensus 95 ~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 174 (310)
T 3s95_A 95 RGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174 (310)
T ss_dssp HHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---------------
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccccccccccc
Confidence 999987 46799999999999999999999999999999999999999 679999999999876433221
Q ss_pred -----CcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhcCCCCCCCCCCCh
Q psy5368 196 -----DSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQ-----LRAQALSSAPITIPPNSLSP 265 (406)
Q Consensus 196 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~s~ 265 (406)
....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ........ ..+..+|+
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 250 (310)
T 3s95_A 175 DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR----YCPPNCPP 250 (310)
T ss_dssp -----CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH----TCCTTCCT
T ss_pred ccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc----cCCCCCCH
Confidence 14579999999999999999999999999999999999999987642111 00111111 12346889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 266 DCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 266 ~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
++.+|+.+||+.||++|||+.++++
T Consensus 251 ~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 251 SFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp THHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=339.91 Aligned_cols=240 Identities=23% Similarity=0.363 Sum_probs=188.4
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCccc------CC------eEEEEEe
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRKR------PR------YVYIILE 120 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~~------~~------~~~lV~E 120 (406)
..||+|+||.||++... +..+++|.+...... ....+.+|+.+++.++|||++.. .+ .+|+|||
T Consensus 48 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e 127 (371)
T 4exu_A 48 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMP 127 (371)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEE
T ss_pred eEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEc
Confidence 34566666666666542 456788877654322 24578899999999999998762 22 2399999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCccc
Q psy5368 121 YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQ 199 (406)
Q Consensus 121 ~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~ 199 (406)
|+. ++|.+++. ..+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++.... ......
T Consensus 128 ~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--~~~~~~ 202 (371)
T 4exu_A 128 FMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA--EMTGYV 202 (371)
T ss_dssp CCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----------CTT
T ss_pred ccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc--CcCCcc
Confidence 997 49988873 4599999999999999999999999999999999999999 67999999999976543 334567
Q ss_pred CCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----------------------
Q psy5368 200 GSPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI---------------------- 256 (406)
Q Consensus 200 gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---------------------- 256 (406)
||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+....+......
T Consensus 203 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (371)
T 4exu_A 203 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLP 282 (371)
T ss_dssp CCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSC
T ss_pred cCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccC
Confidence 8999999999987 67999999999999999999999999998876666555431110
Q ss_pred CCC-------CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q psy5368 257 TIP-------PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPC 301 (406)
Q Consensus 257 ~~~-------~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~ 301 (406)
..+ ...+++++.+||.+||+.||++|||+.|+++||||+....+.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 334 (371)
T 4exu_A 283 QTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPE 334 (371)
T ss_dssp CCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred CCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcc
Confidence 000 125689999999999999999999999999999998765543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=332.02 Aligned_cols=234 Identities=21% Similarity=0.367 Sum_probs=186.9
Q ss_pred eeeecceeeeEEEeeee------eeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc--------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQI------RLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK--------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~------~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~--------~~~~~~lV~E~ 121 (406)
...||+|+||.||++.. .+..+++|.+..........+.+|+.++.+++|||+++ ....+++||||
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 94 (295)
T 3ugc_A 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY 94 (295)
T ss_dssp EEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEEC
T ss_pred hheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEe
Confidence 34567777777777763 34568888887665555678999999999999999876 23457999999
Q ss_pred cCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC----C
Q psy5368 122 CDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ----G 195 (406)
Q Consensus 122 ~~ggsL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~----~ 195 (406)
+++++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++ ++.+||+|||++........ .
T Consensus 95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 174 (295)
T 3ugc_A 95 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK 174 (295)
T ss_dssp CTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC------------
T ss_pred CCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeec
Confidence 99999999998764 599999999999999999999999999999999999999 77999999999987654322 2
Q ss_pred CcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhcCCCCCC
Q psy5368 196 DSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLS----------------QLRAQALSSAPITIP 259 (406)
Q Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~----------------~~~~~~~~~~~~~~~ 259 (406)
....+++.|+|||++.+..++.++||||+|+++|+|+||..||...... .....+........
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 253 (295)
T 3ugc_A 175 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR- 253 (295)
T ss_dssp -CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCC-
T ss_pred cCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCC-
Confidence 3344677799999999999999999999999999999999998754221 22222333333333
Q ss_pred CCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 260 PNSLSPDCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 260 ~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
+..+|+++.+|+.+||+.||++|||+.++++
T Consensus 254 ~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 254 PDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 3478999999999999999999999999976
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=325.55 Aligned_cols=234 Identities=22% Similarity=0.384 Sum_probs=201.2
Q ss_pred eeeecceeeeEEEeeeeeec-eeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHH
Q psy5368 56 TIRYGELQYDTVQNSQIRLG-TVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLC 128 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~-~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~ 128 (406)
...||+|+||.||++....+ .+++|.+.... .....+.+|+.++.+++|||+++ ..+..|+||||+++++|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (268)
T 3sxs_A 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLL 91 (268)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred eeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHH
Confidence 45679999999999987654 57888776543 34567999999999999999876 667889999999999999
Q ss_pred HHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC--CCcccCCCCC
Q psy5368 129 SFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ--GDSIQGSPLY 204 (406)
Q Consensus 129 ~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~--~~~~~gt~~y 204 (406)
+++...+ .+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++........ .....+|+.|
T Consensus 92 ~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y 171 (268)
T 3sxs_A 92 NYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKW 171 (268)
T ss_dssp HHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGG
T ss_pred HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCccc
Confidence 9997754 599999999999999999999999999999999999998 77999999999987654332 2334467789
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
+|||++.+..++.++||||+|+++|+|++ |..||...+.......+........ +..+++.+.+++.+||+.||.+||
T Consensus 172 ~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rp 250 (268)
T 3sxs_A 172 SAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR-PHLASDTIYQIMYSCWHELPEKRP 250 (268)
T ss_dssp CCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC-CTTSCHHHHHHHHHTTCSSGGGSC
T ss_pred CCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCC-CCcChHHHHHHHHHHcCCChhhCc
Confidence 99999999889999999999999999999 9999999998888877776654443 346899999999999999999999
Q ss_pred CHHHHhcC
Q psy5368 284 SYEDLFSH 291 (406)
Q Consensus 284 s~~ell~h 291 (406)
|+.+++++
T Consensus 251 s~~~ll~~ 258 (268)
T 3sxs_A 251 TFQQLLSS 258 (268)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=326.62 Aligned_cols=234 Identities=21% Similarity=0.383 Sum_probs=199.7
Q ss_pred eeeecceeeeEEEeeeeeec-eeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHH
Q psy5368 56 TIRYGELQYDTVQNSQIRLG-TVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLC 128 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~-~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~ 128 (406)
...||+|+||.||++....+ .+++|.+.... ....++.+|+.++.+++|||+++ ..+.+|+||||+++++|.
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (283)
T 3gen_A 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 107 (283)
T ss_dssp EEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHH
T ss_pred HhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHH
Confidence 46789999999999987654 57888776543 34577999999999999999876 677899999999999999
Q ss_pred HHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC--CCCcccCCCCC
Q psy5368 129 SFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND--QGDSIQGSPLY 204 (406)
Q Consensus 129 ~~l~~-~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~--~~~~~~gt~~y 204 (406)
+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++....... ......+|+.|
T Consensus 108 ~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y 187 (283)
T 3gen_A 108 NYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW 187 (283)
T ss_dssp HHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGG
T ss_pred HHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccccccCCccCccc
Confidence 99976 45799999999999999999999999999999999999998 6799999999998664332 22334567889
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
+|||++.+..++.++||||+|+++|+|+| |+.||...+.......+........ +..+++.+.+|+.+||+.||.+||
T Consensus 188 ~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rp 266 (283)
T 3gen_A 188 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-PHLASEKVYTIMYSCWHEKADERP 266 (283)
T ss_dssp CCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC-CTTCCHHHHHHHHHTTCSSGGGSC
T ss_pred CCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC-CCcCCHHHHHHHHHHccCChhHCc
Confidence 99999998899999999999999999998 9999999998888887777644443 346899999999999999999999
Q ss_pred CHHHHhcC
Q psy5368 284 SYEDLFSH 291 (406)
Q Consensus 284 s~~ell~h 291 (406)
|++++++|
T Consensus 267 s~~~ll~~ 274 (283)
T 3gen_A 267 TFKILLSN 274 (283)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999976
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=342.03 Aligned_cols=236 Identities=21% Similarity=0.356 Sum_probs=203.6
Q ss_pred ceeeecceeeeEEEeeeeee---------ceeEEeeeecCCcc-chhhhhhHHhhcccC-CCCCCcc------cCCeEEE
Q psy5368 55 STIRYGELQYDTVQNSQIRL---------GTVKYSQVRYDTIT-SHSEFERPRAGLSNL-RAPEGRK------RPRYVYI 117 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~---------~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~l 117 (406)
....||+|+||.||++.... ..+++|.+...... ....+.+|+.++.++ +|||+++ ..+..|+
T Consensus 73 i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l 152 (382)
T 3tt0_A 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV 152 (382)
T ss_dssp EEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEE
Confidence 34679999999999998532 45888887654322 345789999999999 9999876 6677899
Q ss_pred EEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEE
Q psy5368 118 ILEYCDGGDLCSFIRSHE----------------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKL 180 (406)
Q Consensus 118 V~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL 180 (406)
||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||
T Consensus 153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL 232 (382)
T 3tt0_A 153 IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKI 232 (382)
T ss_dssp EEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEE
T ss_pred EEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEE
Confidence 999999999999998754 499999999999999999999999999999999999999 779999
Q ss_pred EecccccccCCCC---CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCC
Q psy5368 181 ADFGFAQFLAPND---QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPI 256 (406)
Q Consensus 181 ~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 256 (406)
+|||+++...... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++...+......
T Consensus 233 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 312 (382)
T 3tt0_A 233 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM 312 (382)
T ss_dssp CSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred cccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999998765432 2334457788999999999999999999999999999999 99999999988888887777555
Q ss_pred CCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 257 TIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 257 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
..+ ..+++++.+|+.+||+.||++|||+++++++
T Consensus 313 ~~~-~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 313 DKP-SNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp CCC-SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCC-ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 544 4799999999999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=341.59 Aligned_cols=245 Identities=27% Similarity=0.395 Sum_probs=191.4
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCccc-------------CCeEEEEEe
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRKR-------------PRYVYIILE 120 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~-------------~~~~~lV~E 120 (406)
...||+|+||.||++... +..+++|.+.... .......+++..+..++|||+++. ..++++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e 106 (360)
T 3e3p_A 28 ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVME 106 (360)
T ss_dssp C----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEee
Confidence 456899999999999874 5678888775543 334467778888899999998762 223789999
Q ss_pred ccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCCcceEee--CCeeEEEecccccccCCC
Q psy5368 121 YCDGGDLCSFIR----SHEKLSEFQCQQFVRQLVLALKFLR--ENNVCHFDLKPQNILIK--NNTLKLADFGFAQFLAPN 192 (406)
Q Consensus 121 ~~~ggsL~~~l~----~~~~l~~~~~~~i~~ql~~aL~~lH--~~givH~Dlkp~NIll~--~~~~kL~DFGla~~~~~~ 192 (406)
|+++ +|.+.+. ....+++..+..++.|++.||.||| ++||+||||||+|||++ ++.+||+|||+++.....
T Consensus 107 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~ 185 (360)
T 3e3p_A 107 YVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS 185 (360)
T ss_dssp CCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTT
T ss_pred cccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCC
Confidence 9987 6655543 4567999999999999999999999 99999999999999998 569999999999887766
Q ss_pred CCCCcccCCCCCCChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--------------
Q psy5368 193 DQGDSIQGSPLYMAPEILAGSP-YNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPIT-------------- 257 (406)
Q Consensus 193 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-------------- 257 (406)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+.......
T Consensus 186 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (360)
T 3e3p_A 186 EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTD 265 (360)
T ss_dssp SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCC
T ss_pred CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhh
Confidence 6666778999999999997654 8999999999999999999999999988777666654321000
Q ss_pred ----------------CCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCc
Q psy5368 258 ----------------IPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCA 302 (406)
Q Consensus 258 ----------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~ 302 (406)
......++++.+||.+||+.||.+|||+.|+++||||+....+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 326 (360)
T 3e3p_A 266 VDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT 326 (360)
T ss_dssp GGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred ccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence 001135688999999999999999999999999999998766544
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=322.08 Aligned_cols=231 Identities=16% Similarity=0.278 Sum_probs=198.8
Q ss_pred eeeecceeeeEEEeeeeeeceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCcc------c--CCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIRLGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRK------R--PRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~------~--~~~~~lV~E~~~gg 125 (406)
...||+|+||.||++...+..+++|.+...... ....+.+|+.++++++|||+++ . .+..++||||+++|
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~ 94 (271)
T 3kmu_A 15 LTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYG 94 (271)
T ss_dssp EEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTC
T ss_pred HHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCC
Confidence 467899999999999998888999988765422 3457999999999999999766 3 37889999999999
Q ss_pred CHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccC
Q psy5368 126 DLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENN--VCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQG 200 (406)
Q Consensus 126 sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~g 200 (406)
+|.+++.... .+++..+..++.||+.||.|||++| |+||||||+||+++ ++.++|+|||++... ......|
T Consensus 95 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~----~~~~~~~ 170 (271)
T 3kmu_A 95 SLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF----QSPGRMY 170 (271)
T ss_dssp BHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT----SCTTCBS
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee----cccCccC
Confidence 9999998765 4999999999999999999999999 99999999999999 668999999887543 2234568
Q ss_pred CCCCCChhhhcCCCCCc---hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhccc
Q psy5368 201 SPLYMAPEILAGSPYNA---KADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 201 t~~y~aPE~~~~~~~~~---~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~ 277 (406)
|+.|+|||++.+..++. ++|||||||++|+|++|+.||.+.+.......+.........+..+++++.+++.+||+.
T Consensus 171 t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 250 (271)
T 3kmu_A 171 APAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNE 250 (271)
T ss_dssp CGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 99999999998865544 899999999999999999999998888877777665544444557999999999999999
Q ss_pred CCCCCCCHHHHhc
Q psy5368 278 DPMRRISYEDLFS 290 (406)
Q Consensus 278 dP~~Rps~~ell~ 290 (406)
||++|||++++++
T Consensus 251 ~p~~Rps~~~il~ 263 (271)
T 3kmu_A 251 DPAKRPKFDMIVP 263 (271)
T ss_dssp SGGGSCCHHHHHH
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=336.05 Aligned_cols=235 Identities=21% Similarity=0.312 Sum_probs=194.8
Q ss_pred eeeecceeeeEEEeeeeeec------eeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIRLG------TVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~------~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ 123 (406)
...||+|+||.||++..... .+++|.+.... ......+.+|+.++.+++|||+++ ..+..++||||++
T Consensus 18 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~ 97 (325)
T 3kex_A 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLP 97 (325)
T ss_dssp EEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEEEEECCT
T ss_pred eeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEEEEEeCC
Confidence 35677888888888775322 25666554332 334567889999999999999876 4567899999999
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC---CCcc
Q psy5368 124 GGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ---GDSI 198 (406)
Q Consensus 124 ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~---~~~~ 198 (406)
+|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++....... ....
T Consensus 98 ~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 177 (325)
T 3kex_A 98 LGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEA 177 (325)
T ss_dssp TCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC----
T ss_pred CCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCC
Confidence 99999999775 5799999999999999999999999999999999999998 67999999999987654432 2445
Q ss_pred cCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhccc
Q psy5368 199 QGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 199 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~ 277 (406)
.||+.|+|||++.+..++.++|||||||++|+|+| |..||.+.........+........+ ..++.++.+++.+||..
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~ 256 (325)
T 3kex_A 178 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP-QICTIDVYMVMVKCWMI 256 (325)
T ss_dssp -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC-TTBCTTTTHHHHHHTCS
T ss_pred CCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC-CcCcHHHHHHHHHHcCC
Confidence 67889999999999999999999999999999999 99999998888877777766444443 36889999999999999
Q ss_pred CCCCCCCHHHHhcC
Q psy5368 278 DPMRRISYEDLFSH 291 (406)
Q Consensus 278 dP~~Rps~~ell~h 291 (406)
||.+|||+.+++++
T Consensus 257 dp~~Rps~~el~~~ 270 (325)
T 3kex_A 257 DENIRPTFKELANE 270 (325)
T ss_dssp CTTTSCCHHHHHHH
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999886
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=342.63 Aligned_cols=234 Identities=23% Similarity=0.399 Sum_probs=200.0
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...||+|+||.||++... +..|++|.+...... ....+.+|+.++++++|||+++ ..+.+|+|||||++|+
T Consensus 119 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~ 198 (377)
T 3cbl_A 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 198 (377)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred eeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCC
Confidence 467999999999999985 567899877654322 2457899999999999999876 5677899999999999
Q ss_pred HHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC---CCCcccCC
Q psy5368 127 LCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND---QGDSIQGS 201 (406)
Q Consensus 127 L~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~---~~~~~~gt 201 (406)
|.++++..+ .+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++...... ......++
T Consensus 199 L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~ 278 (377)
T 3cbl_A 199 FLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVP 278 (377)
T ss_dssp HHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEE
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCC
Confidence 999997654 699999999999999999999999999999999999999 7799999999997654321 11223356
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPM 280 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~ 280 (406)
+.|+|||++.+..++.++|||||||++|||+| |..||.+.+..+....+........+ ..+|+++.+|+.+||+.||+
T Consensus 279 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~ 357 (377)
T 3cbl_A 279 VKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCP-ELCPDAVFRLMEQCWAYEPG 357 (377)
T ss_dssp GGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCC-TTCCHHHHHHHHHHTCSSGG
T ss_pred cCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCHHHHHHHHHHcCCCch
Confidence 78999999998889999999999999999998 99999999888887777766555444 36899999999999999999
Q ss_pred CCCCHHHHhc
Q psy5368 281 RRISYEDLFS 290 (406)
Q Consensus 281 ~Rps~~ell~ 290 (406)
+|||++++++
T Consensus 358 ~Rps~~~i~~ 367 (377)
T 3cbl_A 358 QRPSFSTIYQ 367 (377)
T ss_dssp GSCCHHHHHH
T ss_pred hCcCHHHHHH
Confidence 9999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=331.19 Aligned_cols=235 Identities=23% Similarity=0.364 Sum_probs=199.8
Q ss_pred eeeecceeeeEEEeeeee-------eceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIR-------LGTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~-------~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~ 121 (406)
...||+|+||.||++... ...+++|.+..... .....+.+|+.++++++|||+++ ..+..|+||||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 107 (314)
T 2ivs_A 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEY 107 (314)
T ss_dssp EEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEee
Confidence 456899999999998752 25678887765432 23457889999999999999876 66778999999
Q ss_pred cCCCCHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC
Q psy5368 122 CDGGDLCSFIRSHEK------------------------LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN 176 (406)
Q Consensus 122 ~~ggsL~~~l~~~~~------------------------l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~ 176 (406)
+++++|.+++..... +++..+..++.||+.||.|||++||+||||||+||+++ ++
T Consensus 108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~ 187 (314)
T 2ivs_A 108 AKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR 187 (314)
T ss_dssp CTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT
T ss_pred cCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCC
Confidence 999999999987543 89999999999999999999999999999999999999 67
Q ss_pred eeEEEecccccccCCCC---CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q psy5368 177 TLKLADFGFAQFLAPND---QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALS 252 (406)
Q Consensus 177 ~~kL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 252 (406)
.+||+|||++....... ......+|+.|+|||++.+..++.++||||+||++|+|++ |..||.+.+...+...+..
T Consensus 188 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 267 (314)
T 2ivs_A 188 KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKT 267 (314)
T ss_dssp EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred CEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhc
Confidence 99999999998764432 2234457888999999999889999999999999999999 9999999888888777766
Q ss_pred cCCCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 253 SAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 253 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
......+ ..+++++.+|+.+||+.||.+|||+.+++++
T Consensus 268 ~~~~~~~-~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 268 GHRMERP-DNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp TCCCCCC-TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcCCCC-ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 6544443 4799999999999999999999999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=330.65 Aligned_cols=245 Identities=25% Similarity=0.444 Sum_probs=192.1
Q ss_pred eeeecceeeeEEEeeeee-eceeEEeeeecCCcc--chhhhhhHHhhcccCCC--CCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR-LGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRA--PEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~-~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h--~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++... +..+++|.+...... ....+.+|+.++.+++| ||++. ..+..|+||| +.+
T Consensus 33 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~ 111 (313)
T 3cek_A 33 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 111 (313)
T ss_dssp EEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCS
T ss_pred EEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCC
Confidence 456788999999988764 345788877654322 34678999999999974 88765 6778999999 457
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeCCeeEEEecccccccCCCCC---CCcccCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLADFGFAQFLAPNDQ---GDSIQGS 201 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~~~~kL~DFGla~~~~~~~~---~~~~~gt 201 (406)
++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++++.+||+|||++........ .....||
T Consensus 112 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt 191 (313)
T 3cek_A 112 IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGT 191 (313)
T ss_dssp EEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCC--------------CC
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEECCeEEEeeccccccccCccccccccCCCCC
Confidence 7999999998899999999999999999999999999999999999999999999999999987644322 2345689
Q ss_pred CCCCChhhhcC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCCCCCCCCChHHHH
Q psy5368 202 PLYMAPEILAG-----------SPYNAKADLWSLGVLVFEALFGHAPYASCNL-SQLRAQALSSAPITIPPNSLSPDCMD 269 (406)
Q Consensus 202 ~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~elltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~s~~l~~ 269 (406)
+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+.........+...++++.+
T Consensus 192 ~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (313)
T 3cek_A 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQD 271 (313)
T ss_dssp GGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHH
T ss_pred CCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcccchHHHHH
Confidence 99999999976 4688899999999999999999999987543 23333333332222233467899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q psy5368 270 FLSRLLQKDPMRRISYEDLFSHPYPDLIHAPC 301 (406)
Q Consensus 270 li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~ 301 (406)
|+.+||+.||.+|||+.++++||||+....|.
T Consensus 272 li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~ 303 (313)
T 3cek_A 272 VLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 303 (313)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTSHHHHCC----
T ss_pred HHHHHccCCcccCcCHHHHhcCccccCCCCch
Confidence 99999999999999999999999998655443
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=336.79 Aligned_cols=238 Identities=22% Similarity=0.315 Sum_probs=197.1
Q ss_pred ceeeecceeeeEEEeeee-------eeceeEEeeeecCC-ccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEE
Q psy5368 55 STIRYGELQYDTVQNSQI-------RLGTVKYSQVRYDT-ITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIIL 119 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~-------~~~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~ 119 (406)
....||+|+||.||++.. ....+++|.+.... ......+.+|+.++.++ +|||+++ ..+..|+||
T Consensus 49 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 128 (344)
T 1rjb_A 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 128 (344)
T ss_dssp EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEE
Confidence 356899999999999986 23468888776443 23456799999999999 9999876 667889999
Q ss_pred eccCCCCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-C
Q psy5368 120 EYCDGGDLCSFIRSHE-----------------------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-N 175 (406)
Q Consensus 120 E~~~ggsL~~~l~~~~-----------------------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~ 175 (406)
||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++ +
T Consensus 129 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~ 208 (344)
T 1rjb_A 129 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG 208 (344)
T ss_dssp ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETT
T ss_pred ecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCC
Confidence 9999999999997653 279999999999999999999999999999999999999 7
Q ss_pred CeeEEEecccccccCCCCC---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q psy5368 176 NTLKLADFGFAQFLAPNDQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQAL 251 (406)
Q Consensus 176 ~~~kL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~ 251 (406)
+.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|+| |..||.+...........
T Consensus 209 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 288 (344)
T 1rjb_A 209 KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 288 (344)
T ss_dssp TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred CcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHH
Confidence 7999999999986643332 234457889999999999999999999999999999998 999998877555544444
Q ss_pred hcCCCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q psy5368 252 SSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHP 292 (406)
Q Consensus 252 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp 292 (406)
........+..+++++.+|+.+||+.||.+|||+.++++|.
T Consensus 289 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 289 QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 44333333447899999999999999999999999999873
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=333.92 Aligned_cols=235 Identities=20% Similarity=0.325 Sum_probs=194.5
Q ss_pred eeeecceeeeEEEeeeeee--c----eeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIRL--G----TVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~--~----~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ 123 (406)
...||+|+||+||++.... . ++++|.+.... ......+.+|+.++++++|||+++ ..+..++|+||++
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~ 99 (327)
T 3poz_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMP 99 (327)
T ss_dssp EEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEEEEECCT
T ss_pred ceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 4578899999999988632 2 24667664433 234568999999999999999876 3455789999999
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC---Ccc
Q psy5368 124 GGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG---DSI 198 (406)
Q Consensus 124 ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~---~~~ 198 (406)
+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++........ ...
T Consensus 100 ~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 179 (327)
T 3poz_A 100 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179 (327)
T ss_dssp TCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCC
Confidence 99999999874 5799999999999999999999999999999999999999 789999999999876544322 234
Q ss_pred cCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhccc
Q psy5368 199 QGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 199 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~ 277 (406)
.+|+.|+|||++.+..++.++|||||||++|+|+| |..||.+.+...+...+........+ ..++.++.+++.+||+.
T Consensus 180 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~ 258 (327)
T 3poz_A 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP-PICTIDVYMIMVKCWMI 258 (327)
T ss_dssp CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC-TTBCHHHHHHHHHHTCS
T ss_pred CccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCC-ccCCHHHHHHHHHHcCC
Confidence 46788999999999999999999999999999999 99999998888877777666544444 36899999999999999
Q ss_pred CCCCCCCHHHHhcC
Q psy5368 278 DPMRRISYEDLFSH 291 (406)
Q Consensus 278 dP~~Rps~~ell~h 291 (406)
||.+|||+.+++++
T Consensus 259 ~p~~Rps~~ell~~ 272 (327)
T 3poz_A 259 DADSRPKFRELIIE 272 (327)
T ss_dssp CGGGSCCHHHHHHH
T ss_pred ChhhCCCHHHHHHH
Confidence 99999999999875
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=349.46 Aligned_cols=240 Identities=14% Similarity=0.140 Sum_probs=180.3
Q ss_pred CceeeecceeeeEEEeeeee--eceeEEeeeecCCcc---chhhhhhHH---hhcccCCCCCCcccC-------------
Q psy5368 54 SSTIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT---SHSEFERPR---AGLSNLRAPEGRKRP------------- 112 (406)
Q Consensus 54 ~~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~---~~~~~~~E~---~~l~~l~h~ni~~~~------------- 112 (406)
.....||+|+||.||++... +..+++|.+...... ....+.+|+ ..|+. +|||+++.-
T Consensus 65 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 65 KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEET
T ss_pred eeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecC
Confidence 34567899999999999864 457899988775432 244567774 45555 799965411
Q ss_pred -----------------CeEEEEEeccCCCCHHHHHHhC-CCCCHHHH------HHHHHHHHHHHHHHHHCCcccccCCC
Q psy5368 113 -----------------RYVYIILEYCDGGDLCSFIRSH-EKLSEFQC------QQFVRQLVLALKFLRENNVCHFDLKP 168 (406)
Q Consensus 113 -----------------~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~------~~i~~ql~~aL~~lH~~givH~Dlkp 168 (406)
..+|+|||||+ |+|.+++... ..+++..+ ..++.||+.||+|||++||+||||||
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp 222 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTP 222 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCH
Confidence 44899999998 7999999764 34555555 67889999999999999999999999
Q ss_pred cceEee-CCeeEEEecccccccCCCCCCCcccCCCCCCChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy5368 169 QNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAG--SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQ 245 (406)
Q Consensus 169 ~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~ 245 (406)
+|||++ ++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.....
T Consensus 223 ~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~ 300 (371)
T 3q60_A 223 DNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300 (371)
T ss_dssp GGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTC
T ss_pred HHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccc
Confidence 999999 679999999999876422 224567799999999987 679999999999999999999999998764321
Q ss_pred HHH--H---H-HhcCCCCCC-CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy5368 246 LRA--Q---A-LSSAPITIP-PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 246 ~~~--~---~-~~~~~~~~~-~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 297 (406)
... . . ........+ ...+|+++.+||.+||+.||++|||+.++++||||+..
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 301 KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp TTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred ccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 100 0 0 000011111 13689999999999999999999999999999999743
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=337.79 Aligned_cols=261 Identities=21% Similarity=0.298 Sum_probs=203.7
Q ss_pred cccccceEEEeeeeee-EEEeeeeecCCcceeeeeeccccccccceeeecCceeeecceeeeEEEeeeeeeceeEEeeee
Q psy5368 5 GTVRYGTVRLGSVKYG-QVQLSTVRYGKVRYSQVRSDTVRSGTVRYDIVGSSTIRYGELQYDTVQNSQIRLGTVKYSQVR 83 (406)
Q Consensus 5 ~~g~~~~V~ig~~~~g-y~vv~~lg~G~~~~~~~~~d~~~~~~~~~~i~~~~~~~lG~G~~g~Vy~~~~~~~~v~vk~~~ 83 (406)
..+|++++.+|+.+.+ |.+++.||.|.++.||.+.+.... ...+++|.+.
T Consensus 4 ~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----------------------------~~~vavK~~~ 54 (355)
T 2eu9_A 4 DKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARG-----------------------------KSQVALKIIR 54 (355)
T ss_dssp CTTSCBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTT-----------------------------TEEEEEEEEC
T ss_pred ccCCCcccccCceecccEEEEEEeeccCCeEEEEEEecCCC-----------------------------ceEEEEEEEc
Confidence 5788999999999986 999888776666666555432211 1246666654
Q ss_pred cCCccchhhhhhHHhhcccCCCCC------Ccc------cCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHH
Q psy5368 84 YDTITSHSEFERPRAGLSNLRAPE------GRK------RPRYVYIILEYCDGGDLCSFIRSHE--KLSEFQCQQFVRQL 149 (406)
Q Consensus 84 ~~~~~~~~~~~~E~~~l~~l~h~n------i~~------~~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~ql 149 (406)
.. ......+.+|+.+++.++|++ ++. ..+..|+||||+ +++|.+++.... .+++..+..++.||
T Consensus 55 ~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi 132 (355)
T 2eu9_A 55 NV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQL 132 (355)
T ss_dssp SC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHH
T ss_pred cc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHH
Confidence 32 233457888999999997765 322 567899999999 568888886653 79999999999999
Q ss_pred HHHHHHHHHCCcccccCCCcceEe-------------------e-CCeeEEEecccccccCCCCCCCcccCCCCCCChhh
Q psy5368 150 VLALKFLRENNVCHFDLKPQNILI-------------------K-NNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEI 209 (406)
Q Consensus 150 ~~aL~~lH~~givH~Dlkp~NIll-------------------~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y~aPE~ 209 (406)
+.||+|||++||+||||||+|||+ + ++.+||+|||+++... .......||+.|+|||+
T Consensus 133 ~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~ 210 (355)
T 2eu9_A 133 CHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH--EHHTTIVATRHYRPPEV 210 (355)
T ss_dssp HHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETT--SCCCSSCSCGGGCCHHH
T ss_pred HHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccc--ccccCCcCCCcccCCee
Confidence 999999999999999999999999 3 5689999999997643 23345679999999999
Q ss_pred hcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--------------------------------
Q psy5368 210 LAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPIT-------------------------------- 257 (406)
Q Consensus 210 ~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-------------------------------- 257 (406)
+.+..++.++|||||||++|+|++|..||...+..+....+.......
T Consensus 211 ~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (355)
T 2eu9_A 211 ILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVK 290 (355)
T ss_dssp HTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHH
T ss_pred eecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhcccc
Confidence 999999999999999999999999999999887665444333211000
Q ss_pred ----------CCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 258 ----------IPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 258 ----------~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
......++++.+||.+||+.||++|||+.|+++||||+...
T Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 291 ENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp HHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred ccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCC
Confidence 00112245789999999999999999999999999998653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=330.03 Aligned_cols=237 Identities=22% Similarity=0.348 Sum_probs=199.3
Q ss_pred ceeeecceeeeEEEeeee-------eeceeEEeeeecCCc-cchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEE
Q psy5368 55 STIRYGELQYDTVQNSQI-------RLGTVKYSQVRYDTI-TSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIIL 119 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~-------~~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~ 119 (406)
....||+|+||.||++.. ....+++|.+..... .....+.+|+.++.++ +|||+++ ..+..++||
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 106 (313)
T 1t46_A 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVIT 106 (313)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEE
Confidence 356789999999999975 235788888765433 2346789999999999 9999876 667789999
Q ss_pred eccCCCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEE
Q psy5368 120 EYCDGGDLCSFIRSHE------------------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKL 180 (406)
Q Consensus 120 E~~~ggsL~~~l~~~~------------------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL 180 (406)
||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 186 (313)
T 1t46_A 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKI 186 (313)
T ss_dssp ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEE
T ss_pred ecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEE
Confidence 9999999999997654 489999999999999999999999999999999999998 679999
Q ss_pred EecccccccCCCCC---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCC
Q psy5368 181 ADFGFAQFLAPNDQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPI 256 (406)
Q Consensus 181 ~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 256 (406)
+|||++........ .....+|+.|+|||++.+..++.++|||||||++|+|+| |..||.+................
T Consensus 187 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 266 (313)
T 1t46_A 187 CDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR 266 (313)
T ss_dssp CCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCC
T ss_pred ccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCC
Confidence 99999987654432 234457888999999999999999999999999999999 99999887765555444444334
Q ss_pred CCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 257 TIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 257 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
...+..+++++.+|+.+||+.||.+|||+.+++++
T Consensus 267 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 267 MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 44445789999999999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=324.54 Aligned_cols=233 Identities=21% Similarity=0.358 Sum_probs=198.1
Q ss_pred eeecceeeeEEEeeeee----eceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCCC
Q psy5368 57 IRYGELQYDTVQNSQIR----LGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDGG 125 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~----~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~gg 125 (406)
+.||+|+||.||++... ...+++|.+...... ....+.+|+.+++.++|||+++ ..+..|+||||++++
T Consensus 23 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~ 102 (291)
T 1xbb_A 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 102 (291)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcEEEEEeCCCC
Confidence 37999999999999653 456888877654322 2457899999999999999876 556789999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC----CCcccC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ----GDSIQG 200 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~----~~~~~g 200 (406)
+|.+++..++.+++..+..++.||+.||.|||++||+|+||||+||+++ ++.+||+|||++........ .....+
T Consensus 103 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 182 (291)
T 1xbb_A 103 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 182 (291)
T ss_dssp EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CC
T ss_pred CHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCC
Confidence 9999999988899999999999999999999999999999999999998 77999999999987654332 223346
Q ss_pred CCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCC
Q psy5368 201 SPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 201 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP 279 (406)
++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+...+...+........+ ..+++++.+++.+||+.||
T Consensus 183 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dp 261 (291)
T 1xbb_A 183 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP-AGCPREMYDLMNLCWTYDV 261 (291)
T ss_dssp CGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC-TTCCHHHHHHHHHHTCSST
T ss_pred CceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCHHHHHHHHHHcCCCh
Confidence 788999999998889999999999999999999 99999999988888777776555444 3789999999999999999
Q ss_pred CCCCCHHHHhc
Q psy5368 280 MRRISYEDLFS 290 (406)
Q Consensus 280 ~~Rps~~ell~ 290 (406)
.+|||+.++++
T Consensus 262 ~~Rps~~~l~~ 272 (291)
T 1xbb_A 262 ENRPGFAAVEL 272 (291)
T ss_dssp TTSCCHHHHHH
T ss_pred hhCcCHHHHHH
Confidence 99999999976
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=332.75 Aligned_cols=235 Identities=24% Similarity=0.395 Sum_probs=197.2
Q ss_pred eeeecceeeeEEEeeeeeec----eeEEeeeecCC-ccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIRLG----TVKYSQVRYDT-ITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~----~v~vk~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~ 123 (406)
...||+|+||.||++..... .+++|.+.... ......+.+|+.++.++ +|||+++ ..+.+|+||||++
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 109 (327)
T 1fvr_A 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 109 (327)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred eeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCC
Confidence 56789999999999987543 34777665432 23456789999999999 9999876 6778999999999
Q ss_pred CCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccc
Q psy5368 124 GGDLCSFIRSHE----------------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFA 186 (406)
Q Consensus 124 ggsL~~~l~~~~----------------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla 186 (406)
+++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++
T Consensus 110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~ 189 (327)
T 1fvr_A 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189 (327)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred CCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcC
Confidence 999999997654 699999999999999999999999999999999999998 669999999999
Q ss_pred cccCCCCCCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCh
Q psy5368 187 QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSP 265 (406)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~ 265 (406)
+............+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++...+........+ ..+++
T Consensus 190 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~ 268 (327)
T 1fvr_A 190 RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP-LNCDD 268 (327)
T ss_dssp ESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCC-TTBCH
T ss_pred ccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCCCCC-CCCCH
Confidence 76544444455567889999999998889999999999999999998 99999999988888777666444433 37899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 266 DCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 266 ~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
++.+|+.+||+.||.+|||+++++++
T Consensus 269 ~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 269 EVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999999885
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=325.80 Aligned_cols=236 Identities=20% Similarity=0.343 Sum_probs=196.1
Q ss_pred ceeeecceeeeEEEeeeeeec-----eeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccC
Q psy5368 55 STIRYGELQYDTVQNSQIRLG-----TVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCD 123 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~~-----~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ 123 (406)
....||+|+||.||++..... .+++|.+.... ......+.+|+.++++++|||+++ ..+..|+||||++
T Consensus 16 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~ 95 (281)
T 3cc6_A 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYP 95 (281)
T ss_dssp EEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEEEEECCT
T ss_pred EEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEEEEecCC
Confidence 346788899999999876432 37888776543 234567899999999999999876 4456789999999
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC--CCCccc
Q psy5368 124 GGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND--QGDSIQ 199 (406)
Q Consensus 124 ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~--~~~~~~ 199 (406)
+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++....... ......
T Consensus 96 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 175 (281)
T 3cc6_A 96 YGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTR 175 (281)
T ss_dssp TCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCC
T ss_pred CCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccccccccCC
Confidence 99999999765 4699999999999999999999999999999999999998 7799999999998765432 223445
Q ss_pred CCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccC
Q psy5368 200 GSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKD 278 (406)
Q Consensus 200 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~d 278 (406)
+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+........+ ..+++.+.+++.+||+.|
T Consensus 176 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~ 254 (281)
T 3cc6_A 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKP-DLCPPVLYTLMTRCWDYD 254 (281)
T ss_dssp CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCC-TTCCHHHHHHHHHHTCSS
T ss_pred CCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCC-CCCCHHHHHHHHHHccCC
Confidence 6888999999998899999999999999999998 99999888777777666666444433 368999999999999999
Q ss_pred CCCCCCHHHHhcC
Q psy5368 279 PMRRISYEDLFSH 291 (406)
Q Consensus 279 P~~Rps~~ell~h 291 (406)
|++|||+.+++++
T Consensus 255 p~~Rps~~ell~~ 267 (281)
T 3cc6_A 255 PSDRPRFTELVCS 267 (281)
T ss_dssp GGGSCCHHHHHHH
T ss_pred chhCcCHHHHHHH
Confidence 9999999999875
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=328.42 Aligned_cols=243 Identities=26% Similarity=0.430 Sum_probs=199.6
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC----ccchhhhhhHHhhcccCCCCCCcc--------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT----ITSHSEFERPRAGLSNLRAPEGRK--------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~----~~~~~~~~~E~~~l~~l~h~ni~~--------~~~~~~lV~E~ 121 (406)
...||+|+||.||++... +..+++|.+.... ......+.+|+.++++++|||+++ .....|+||||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (305)
T 2wtk_C 10 GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY 89 (305)
T ss_dssp CCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEEC
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehh
Confidence 456788888888888763 3467888765432 233567899999999999999765 34578999999
Q ss_pred cCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC---CC
Q psy5368 122 CDGGDLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND---QG 195 (406)
Q Consensus 122 ~~ggsL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~---~~ 195 (406)
++++ |.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++....... ..
T Consensus 90 ~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~ 168 (305)
T 2wtk_C 90 CVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC 168 (305)
T ss_dssp CSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEE
T ss_pred ccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcccccccc
Confidence 9875 88888653 5799999999999999999999999999999999999998 7799999999998764322 22
Q ss_pred CcccCCCCCCChhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHH
Q psy5368 196 DSIQGSPLYMAPEILAGSP--YNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSR 273 (406)
Q Consensus 196 ~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~ 273 (406)
....||+.|+|||++.+.. ++.++||||+|+++|+|++|..||.+.+.......+..... .. +..+++.+.+|+.+
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~-~~-~~~~~~~l~~li~~ 246 (305)
T 2wtk_C 169 RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY-AI-PGDCGPPLSDLLKG 246 (305)
T ss_dssp CCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-CC-CSSSCHHHHHHHHH
T ss_pred ccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC-CC-CCccCHHHHHHHHH
Confidence 3456899999999998754 47799999999999999999999999988888777766532 33 34689999999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCCCCCC
Q psy5368 274 LLQKDPMRRISYEDLFSHPYPDLIHAPC 301 (406)
Q Consensus 274 ~L~~dP~~Rps~~ell~hp~~~~~~~~~ 301 (406)
||+.||.+|||+.++++||||+....+.
T Consensus 247 ~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 274 (305)
T 2wtk_C 247 MLEYEPAKRFSIRQIRQHSWFRKKHPPA 274 (305)
T ss_dssp HTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred HccCChhhCCCHHHHhcCcccccCCCCc
Confidence 9999999999999999999998765443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=336.00 Aligned_cols=234 Identities=21% Similarity=0.358 Sum_probs=184.5
Q ss_pred cceeeeEEEeeee---eeceeEEeeeecCCccchhhhhhHHhhcccCCCCC------Ccc------cCCeEEEEEeccCC
Q psy5368 60 GELQYDTVQNSQI---RLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPE------GRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 60 G~G~~g~Vy~~~~---~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~n------i~~------~~~~~~lV~E~~~g 124 (406)
|+|+||.||++.. .+..+++|.+... ......+.+|+.++..++|++ ++. ..+.+|+||||+ +
T Consensus 23 g~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 100 (339)
T 1z57_A 23 GEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-G 100 (339)
T ss_dssp EEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-C
T ss_pred ecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-C
Confidence 4444555555543 2345777766532 233467889999999997765 333 677899999999 7
Q ss_pred CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeC--------------------CeeEEEe
Q psy5368 125 GDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN--------------------NTLKLAD 182 (406)
Q Consensus 125 gsL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~--------------------~~~kL~D 182 (406)
++|.+++...+ ++++..+..++.||+.||+|||++||+||||||+|||++. +.+||+|
T Consensus 101 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 180 (339)
T 1z57_A 101 LSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180 (339)
T ss_dssp CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECC
T ss_pred CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEee
Confidence 89999998765 6899999999999999999999999999999999999973 3699999
Q ss_pred cccccccCCCCCCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC------
Q psy5368 183 FGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI------ 256 (406)
Q Consensus 183 FGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------ 256 (406)
||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+......
T Consensus 181 fg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~ 258 (339)
T 1z57_A 181 FGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMI 258 (339)
T ss_dssp CSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHH
T ss_pred CcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 999976533 334567899999999999999999999999999999999999999988766554443221100
Q ss_pred ------------------------------------CCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy5368 257 ------------------------------------TIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 257 ------------------------------------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 297 (406)
.......++++.+|+.+||+.||.+|||+.|+++||||+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 259 QKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLL 335 (339)
T ss_dssp HHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGG
T ss_pred hhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHH
Confidence 00011235678999999999999999999999999999854
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=339.65 Aligned_cols=236 Identities=22% Similarity=0.372 Sum_probs=189.6
Q ss_pred CceeeecceeeeEEEeeeee-----eceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEec
Q psy5368 54 SSTIRYGELQYDTVQNSQIR-----LGTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEY 121 (406)
Q Consensus 54 ~~~~~lG~G~~g~Vy~~~~~-----~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~ 121 (406)
.....||+|+||.||++... ...|++|.+..... .....+.+|+.++.+++|||+++ ..+..|+||||
T Consensus 48 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 127 (373)
T 2qol_A 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEY 127 (373)
T ss_dssp CCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeC
Confidence 44678999999999999864 45689998765432 23457999999999999999876 56778999999
Q ss_pred cCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC----C
Q psy5368 122 CDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ----G 195 (406)
Q Consensus 122 ~~ggsL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~----~ 195 (406)
+++|+|.+++...+ .+++.++..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++....... .
T Consensus 128 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 207 (373)
T 2qol_A 128 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT 207 (373)
T ss_dssp CTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------------
T ss_pred CCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceec
Confidence 99999999998764 699999999999999999999999999999999999998 67999999999987654322 1
Q ss_pred CcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHh
Q psy5368 196 DSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRL 274 (406)
Q Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~ 274 (406)
....+++.|+|||++.+..++.++|||||||++|||++ |+.||...+..++...+........ +..++.++.+|+.+|
T Consensus 208 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~-~~~~~~~l~~li~~c 286 (373)
T 2qol_A 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-PMDCPAALYQLMLDC 286 (373)
T ss_dssp ------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC-CTTCBHHHHHHHHHH
T ss_pred cCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-CccccHHHHHHHHHH
Confidence 12235678999999999999999999999999999998 9999999988888777766533333 337899999999999
Q ss_pred cccCCCCCCCHHHHhc
Q psy5368 275 LQKDPMRRISYEDLFS 290 (406)
Q Consensus 275 L~~dP~~Rps~~ell~ 290 (406)
|+.||.+||++.++++
T Consensus 287 l~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 287 WQKDRNNRPKFEQIVS 302 (373)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred hCcChhhCcCHHHHHH
Confidence 9999999999999876
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=334.26 Aligned_cols=235 Identities=17% Similarity=0.233 Sum_probs=188.4
Q ss_pred ceeeecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCccc----------CCeEEEEEeccCC
Q psy5368 55 STIRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRKR----------PRYVYIILEYCDG 124 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~----------~~~~~lV~E~~~g 124 (406)
....||+|+||.||++...+..|++|.+.... .......+|+.++.+++|||+++. ...+|+|||||++
T Consensus 28 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~ 106 (322)
T 3soc_A 28 LLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEK 106 (322)
T ss_dssp EEEEEECSTTCEEEEEEETTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred hhheecccCceEEEEEEECCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCC
Confidence 35578999999999999888889999886543 233456779999999999998761 3457999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC----------CcccccCCCcceEee-CCeeEEEecccccccCCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLREN----------NVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND 193 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~----------givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~ 193 (406)
|+|.++++. ..+++..+..++.|++.||+|||+. ||+||||||+|||++ ++.+||+|||+++......
T Consensus 107 g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~ 185 (322)
T 3soc_A 107 GSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185 (322)
T ss_dssp CBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTS
T ss_pred CCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccccccccc
Confidence 999999977 4699999999999999999999999 999999999999999 6699999999998765433
Q ss_pred C---CCcccCCCCCCChhhhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCC----------------HHHHHHH
Q psy5368 194 Q---GDSIQGSPLYMAPEILAGS-----PYNAKADLWSLGVLVFEALFGHAPYASCN----------------LSQLRAQ 249 (406)
Q Consensus 194 ~---~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltg~~pf~~~~----------------~~~~~~~ 249 (406)
. .....||+.|+|||++.+. .++.++|||||||++|||+||+.||.+.. .......
T Consensus 186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (322)
T 3soc_A 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEV 265 (322)
T ss_dssp CCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHH
T ss_pred CccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhh
Confidence 2 3346799999999999873 45668999999999999999999997642 2333333
Q ss_pred HHhcCCCCCCCC-----CCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 250 ALSSAPITIPPN-----SLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 250 ~~~~~~~~~~~~-----~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
..........+. ..++++.+|+.+||+.||++|||+.++++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 266 VVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp HTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 333322221111 123459999999999999999999999863
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=334.23 Aligned_cols=241 Identities=23% Similarity=0.347 Sum_probs=191.6
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCccc------C------CeEEEEE
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRKR------P------RYVYIIL 119 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~~------~------~~~~lV~ 119 (406)
...||+|+||.||++... +..+++|.+...... ....+.+|+.+++.++|||++.. . ..+|+||
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 108 (353)
T 3coi_A 29 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 108 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred eeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEe
Confidence 456788888888888753 457888877654322 24578899999999999998762 1 2359999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcc
Q psy5368 120 EYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSI 198 (406)
Q Consensus 120 E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~ 198 (406)
||+++ +|.+++. ..+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++..... .....
T Consensus 109 e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~--~~~~~ 183 (353)
T 3coi_A 109 PFMQT-DLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA--EMTGY 183 (353)
T ss_dssp ECCSE-EGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----------
T ss_pred ccccC-CHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC--Ccccc
Confidence 99974 9988774 3599999999999999999999999999999999999999 67999999999976543 23456
Q ss_pred cCCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-----------------------
Q psy5368 199 QGSPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSA----------------------- 254 (406)
Q Consensus 199 ~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~----------------------- 254 (406)
.+|+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..+....+....
T Consensus 184 ~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (353)
T 3coi_A 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSL 263 (353)
T ss_dssp CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTS
T ss_pred ccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhC
Confidence 78999999999987 678999999999999999999999999988666555443310
Q ss_pred ------CCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q psy5368 255 ------PITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPC 301 (406)
Q Consensus 255 ------~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~ 301 (406)
........+++++.+||.+||+.||++|||+.++++||||+....+.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~ 316 (353)
T 3coi_A 264 PQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPE 316 (353)
T ss_dssp CBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred cCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCcc
Confidence 00111125789999999999999999999999999999998765443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=330.76 Aligned_cols=246 Identities=20% Similarity=0.308 Sum_probs=204.4
Q ss_pred cccccccceeeecCceeeecceeeeEEEeeeee-------eceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc--
Q psy5368 41 TVRSGTVRYDIVGSSTIRYGELQYDTVQNSQIR-------LGTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK-- 110 (406)
Q Consensus 41 ~~~~~~~~~~i~~~~~~~lG~G~~g~Vy~~~~~-------~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~-- 110 (406)
+.......| .....||+|+||.||++... ...+++|.+..... .....+.+|+.++++++|||+++
T Consensus 19 ~~~~~~~~y----~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 19 EWEVAREKI----TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp TTBCCGGGE----EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred hhcchhhhe----eeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 334444455 34567899999999998764 35688887764432 23446889999999999999765
Q ss_pred ----cCCeEEEEEeccCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-C
Q psy5368 111 ----RPRYVYIILEYCDGGDLCSFIRSH----------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-N 175 (406)
Q Consensus 111 ----~~~~~~lV~E~~~ggsL~~~l~~~----------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~ 175 (406)
..+..|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++ +
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 174 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCC
Confidence 667789999999999999999653 3579999999999999999999999999999999999999 6
Q ss_pred CeeEEEecccccccCCCC---CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q psy5368 176 NTLKLADFGFAQFLAPND---QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQAL 251 (406)
Q Consensus 176 ~~~kL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~ 251 (406)
+.+||+|||++....... ......+|+.|+|||++.+..++.++||||+||++|+|++ |..||.+.+.......+.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 799999999997654332 1233456889999999999999999999999999999999 899999998888887777
Q ss_pred hcCCCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 252 SSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 252 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
.......+ ..+++.+.+|+.+||+.||.+|||+.+++++
T Consensus 255 ~~~~~~~~-~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 255 EGGLLDKP-DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp TTCCCCCC-TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCcCCCC-CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 66544443 4789999999999999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=346.03 Aligned_cols=233 Identities=23% Similarity=0.371 Sum_probs=202.3
Q ss_pred eeeecceeeeEEEeeeee-eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCCCCHHH
Q psy5368 56 TIRYGELQYDTVQNSQIR-LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDGGDLCS 129 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~-~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ggsL~~ 129 (406)
...||+|+||.||++..+ ...|++|.+.... .....+.+|+.++++++|||+++ ..+.+|+|||||++|+|.+
T Consensus 193 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~e~~~~g~L~~ 271 (454)
T 1qcf_A 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLD 271 (454)
T ss_dssp EEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEECCCTTCBHHH
T ss_pred EEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEEeecCCCcHHH
Confidence 468999999999999975 4568898887543 45678999999999999999876 4567899999999999999
Q ss_pred HHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC--CCCcccCCCCC
Q psy5368 130 FIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND--QGDSIQGSPLY 204 (406)
Q Consensus 130 ~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~--~~~~~~gt~~y 204 (406)
+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++...... ......+++.|
T Consensus 272 ~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y 351 (454)
T 1qcf_A 272 FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW 351 (454)
T ss_dssp HHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGG
T ss_pred HHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccc
Confidence 99754 3789999999999999999999999999999999999999 6799999999998764321 12334467889
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
+|||++....++.++|||||||++|||+| |+.||.+.+..++...+........+ ..+|+++.+|+.+||+.||++||
T Consensus 352 ~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~RP 430 (454)
T 1qcf_A 352 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP-ENCPEELYNIMMRCWKNRPEERP 430 (454)
T ss_dssp SCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCC-TTSCHHHHHHHHHHTCSSGGGSC
T ss_pred cCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCHHHHHHHHHHccCChhHCc
Confidence 99999998899999999999999999999 99999999988888887776554444 47899999999999999999999
Q ss_pred CHHHHhc
Q psy5368 284 SYEDLFS 290 (406)
Q Consensus 284 s~~ell~ 290 (406)
|++++++
T Consensus 431 t~~~i~~ 437 (454)
T 1qcf_A 431 TFEYIQS 437 (454)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999876
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=324.73 Aligned_cols=237 Identities=24% Similarity=0.415 Sum_probs=185.1
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCccc-------------------CCe
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRKR-------------------PRY 114 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~-------------------~~~ 114 (406)
...||+|+||.||++.. .+..+++|.+... ......+.+|+.++++++|||+++. .+.
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (303)
T 1zy4_A 11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKST 89 (303)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEE
T ss_pred hheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCc
Confidence 35678888888888875 3456788877542 2345678999999999999998752 467
Q ss_pred EEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC
Q psy5368 115 VYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN 192 (406)
Q Consensus 115 ~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~ 192 (406)
.|+||||+++++|.+++...+ .+++..+..++.||+.||+|||++||+|+||||+||+++ ++.+||+|||++......
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 169 (303)
T 1zy4_A 90 LFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169 (303)
T ss_dssp EEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-
T ss_pred eEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccc
Confidence 899999999999999998654 688999999999999999999999999999999999998 779999999999765432
Q ss_pred ---------------CCCCcccCCCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCC
Q psy5368 193 ---------------DQGDSIQGSPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASC-NLSQLRAQALSSAP 255 (406)
Q Consensus 193 ---------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~-~~~~~~~~~~~~~~ 255 (406)
.......||+.|+|||++.+. .++.++||||+||++|+|++ ||... ........+... .
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~-~ 245 (303)
T 1zy4_A 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSV-S 245 (303)
T ss_dssp ------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHST-T
T ss_pred cchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhcccc-c
Confidence 122345689999999999865 68999999999999999998 55432 223333333332 2
Q ss_pred CCCC---CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy5368 256 ITIP---PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 256 ~~~~---~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 297 (406)
...+ +...++.+.+|+.+||+.||.+|||+.++++||||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 246 IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 2222 23567889999999999999999999999999999753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=324.38 Aligned_cols=236 Identities=22% Similarity=0.365 Sum_probs=201.5
Q ss_pred eeecceeeeEEEeeee----eeceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCCCC
Q psy5368 57 IRYGELQYDTVQNSQI----RLGTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDGGD 126 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~----~~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ggs 126 (406)
..||+|+||.||++.. ....+++|.+..... .....+.+|+.++.+++|||+++ ..+..++||||+++++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 95 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGP 95 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTEE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEEEEeCCCCC
Confidence 4789999999999975 244588887765432 33567899999999999999876 4566899999999999
Q ss_pred HHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC----CCcccC
Q psy5368 127 LCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ----GDSIQG 200 (406)
Q Consensus 127 L~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~----~~~~~g 200 (406)
|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++........ .....+
T Consensus 96 L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 175 (287)
T 1u59_A 96 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 175 (287)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCC
T ss_pred HHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccc
Confidence 99999654 4699999999999999999999999999999999999998 77999999999987654322 233456
Q ss_pred CCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCC
Q psy5368 201 SPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 201 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP 279 (406)
|+.|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+........++ .+|+++.+++.+||+.||
T Consensus 176 ~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~-~~~~~l~~li~~~l~~~p 254 (287)
T 1u59_A 176 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP-ECPPELYALMSDCWIYKW 254 (287)
T ss_dssp CGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCT-TCCHHHHHHHHHTTCSSG
T ss_pred cccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCC-CcCHHHHHHHHHHcCCCh
Confidence 889999999998889999999999999999998 999999988888877777765555443 799999999999999999
Q ss_pred CCCCCHHHHhcCCC
Q psy5368 280 MRRISYEDLFSHPY 293 (406)
Q Consensus 280 ~~Rps~~ell~hp~ 293 (406)
.+|||+.+++++.+
T Consensus 255 ~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 255 EDRPDFLTVEQRMR 268 (287)
T ss_dssp GGSCCHHHHHHHHH
T ss_pred hhCcCHHHHHHHHH
Confidence 99999999998743
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=324.20 Aligned_cols=234 Identities=22% Similarity=0.361 Sum_probs=182.1
Q ss_pred eeeecceeeeEEEeeeeeeceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCCCCHH
Q psy5368 56 TIRYGELQYDTVQNSQIRLGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDGGDLC 128 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ggsL~ 128 (406)
...||+|+||.||++.... .+++|.+...... ....+.+|+.++++++|||++. .....++||||+++++|.
T Consensus 29 ~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~~~~~~L~ 107 (289)
T 3og7_A 29 GQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLY 107 (289)
T ss_dssp EEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCCEEEHH
T ss_pred eeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEEecCCCcHH
Confidence 5678999999999998644 5888877654322 3457899999999999999876 556689999999999999
Q ss_pred HHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC---CCCCcccCCCC
Q psy5368 129 SFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN---DQGDSIQGSPL 203 (406)
Q Consensus 129 ~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~---~~~~~~~gt~~ 203 (406)
+++... ..+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++...... .......||+.
T Consensus 108 ~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 187 (289)
T 3og7_A 108 HHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187 (289)
T ss_dssp HHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------------------CCCT
T ss_pred HHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCcc
Confidence 999644 4799999999999999999999999999999999999999 779999999999765432 22344578999
Q ss_pred CCChhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcCCCCC---CCCCCChHHHHHHHHhcc
Q psy5368 204 YMAPEILA---GSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLR-AQALSSAPITI---PPNSLSPDCMDFLSRLLQ 276 (406)
Q Consensus 204 y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~-~~~~~~~~~~~---~~~~~s~~l~~li~~~L~ 276 (406)
|+|||++. +..++.++||||+||++|+|++|+.||.+....... ..+........ ....+|+++.+|+.+||+
T Consensus 188 y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 267 (289)
T 3og7_A 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLK 267 (289)
T ss_dssp TCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTC
T ss_pred ccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHcc
Confidence 99999997 566889999999999999999999999886544433 33333322211 123688999999999999
Q ss_pred cCCCCCCCHHHHhc
Q psy5368 277 KDPMRRISYEDLFS 290 (406)
Q Consensus 277 ~dP~~Rps~~ell~ 290 (406)
.||.+|||+.++++
T Consensus 268 ~~p~~Rps~~ell~ 281 (289)
T 3og7_A 268 KKRDERPSFPRILA 281 (289)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhhCCCHHHHHH
Confidence 99999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=336.96 Aligned_cols=251 Identities=20% Similarity=0.255 Sum_probs=199.9
Q ss_pred eeeccccccccceeeecCceeeecceeeeEEEeeeee-eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc-----
Q psy5368 37 VRSDTVRSGTVRYDIVGSSTIRYGELQYDTVQNSQIR-LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK----- 110 (406)
Q Consensus 37 ~~~d~~~~~~~~~~i~~~~~~~lG~G~~g~Vy~~~~~-~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~----- 110 (406)
+........+.+| .....||+|+||.||++... +..+++|............+.+|+.+++.++|||+++
T Consensus 29 ~~~~~~~~~~~~y----~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 104 (321)
T 2qkw_B 29 VPLVDLEEATNNF----DHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC 104 (321)
T ss_dssp -CCSCCCCCCCCC----SCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC
T ss_pred ecHHHHHHHHhcc----CccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3344455566666 45567899999999999864 5678899877666566778999999999999999876
Q ss_pred -cCCeEEEEEeccCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecc
Q psy5368 111 -RPRYVYIILEYCDGGDLCSFIRSHE----KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFG 184 (406)
Q Consensus 111 -~~~~~~lV~E~~~ggsL~~~l~~~~----~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFG 184 (406)
..+..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp CCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCT
T ss_pred cCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecc
Confidence 6678899999999999999996543 599999999999999999999999999999999999999 6799999999
Q ss_pred cccccCCCC---CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHH-hcC
Q psy5368 185 FAQFLAPND---QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQL------RAQAL-SSA 254 (406)
Q Consensus 185 la~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~------~~~~~-~~~ 254 (406)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+. ..... ...
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 997654322 22345689999999999988999999999999999999999999976542211 11111 111
Q ss_pred CCC-----CC---CCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 255 PIT-----IP---PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 255 ~~~-----~~---~~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
... .. +...+..+.+++.+||+.||++|||+.+++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000 00 11345678999999999999999999999976
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=323.40 Aligned_cols=231 Identities=23% Similarity=0.390 Sum_probs=192.0
Q ss_pred ceeeecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc-------cCCeEEEEEeccCCCCH
Q psy5368 55 STIRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK-------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~-------~~~~~~lV~E~~~ggsL 127 (406)
....||+|+||.||++...+..+++|.+... .....+.+|+.++.+++|||+++ ..+.+|+||||+++++|
T Consensus 25 ~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L 102 (278)
T 1byg_A 25 LLQTIGKGEFGDVMLGDYRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 102 (278)
T ss_dssp EEEEEEECSSCEEEEEEETTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred EEeEEecCCCceEEEEEEcCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCH
Confidence 3457899999999999988888999987644 35567999999999999999765 34578999999999999
Q ss_pred HHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCC
Q psy5368 128 CSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLY 204 (406)
Q Consensus 128 ~~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y 204 (406)
.+++...+ .+++..+..++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++...... .....+++.|
T Consensus 103 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~y 180 (278)
T 1byg_A 103 VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKW 180 (278)
T ss_dssp HHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------------CCTTT
T ss_pred HHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc--ccCCCccccc
Confidence 99997654 389999999999999999999999999999999999998 779999999998765432 2334578899
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
+|||++.+..++.++||||||+++|+|++ |..||...+..+....+........+ ..+++.+.+++.+||+.||.+||
T Consensus 181 ~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rp 259 (278)
T 1byg_A 181 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP-DGCPPAVYEVMKNCWHLDAAMRP 259 (278)
T ss_dssp SCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCC-TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred cCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCc-ccCCHHHHHHHHHHhcCChhhCC
Confidence 99999999999999999999999999998 99999998888877777666444433 47899999999999999999999
Q ss_pred CHHHHhc
Q psy5368 284 SYEDLFS 290 (406)
Q Consensus 284 s~~ell~ 290 (406)
|+.++++
T Consensus 260 s~~~l~~ 266 (278)
T 1byg_A 260 SFLQLRE 266 (278)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999876
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=325.05 Aligned_cols=230 Identities=18% Similarity=0.282 Sum_probs=188.8
Q ss_pred eeeecceeeeEEEeeeeee---------ceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEe
Q psy5368 56 TIRYGELQYDTVQNSQIRL---------GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILE 120 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~---------~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E 120 (406)
...||+|+||.||++.... ..+++|.+..........+.+|+.++++++|||+++ ..+..|+|||
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 92 (289)
T 4fvq_A 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQE 92 (289)
T ss_dssp EEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEE
T ss_pred eeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEE
Confidence 3457788888888877543 358888876665566678999999999999999876 5677899999
Q ss_pred ccCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCe--------eEEEecccccccC
Q psy5368 121 YCDGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNT--------LKLADFGFAQFLA 190 (406)
Q Consensus 121 ~~~ggsL~~~l~~~~~-l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~--------~kL~DFGla~~~~ 190 (406)
|++|++|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++ ++. +||+|||++....
T Consensus 93 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~ 172 (289)
T 4fvq_A 93 FVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL 172 (289)
T ss_dssp CCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTS
T ss_pred CCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCccccccc
Confidence 9999999999987654 99999999999999999999999999999999999998 444 9999999986543
Q ss_pred CCCCCCcccCCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHH
Q psy5368 191 PNDQGDSIQGSPLYMAPEILAG-SPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCM 268 (406)
Q Consensus 191 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~ 268 (406)
. .....||+.|+|||++.+ ..++.++||||+||++|+|++ +.+||............... ... +...++++.
T Consensus 173 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~l~ 246 (289)
T 4fvq_A 173 P---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR--HQL-PAPKAAELA 246 (289)
T ss_dssp C---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT--CCC-CCCSSCTTH
T ss_pred C---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhcc--CCC-CCCCCHHHH
Confidence 2 234568899999999988 679999999999999999999 55666665555444333322 222 235788999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q psy5368 269 DFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 269 ~li~~~L~~dP~~Rps~~ell~h 291 (406)
+|+.+||+.||.+|||+.++++|
T Consensus 247 ~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 247 NLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999999987
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=336.97 Aligned_cols=235 Identities=23% Similarity=0.327 Sum_probs=188.6
Q ss_pred eeeecceeeeEEEeeeeee-----ceeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc-------cCCeEEEEEecc
Q psy5368 56 TIRYGELQYDTVQNSQIRL-----GTVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK-------RPRYVYIILEYC 122 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-----~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~-------~~~~~~lV~E~~ 122 (406)
...||+|+||.||++.... ..+++|.+.... ......+.+|+.++++++|||+++ ..+..|+||||+
T Consensus 94 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~ 173 (373)
T 3c1x_A 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 173 (373)
T ss_dssp EEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECC
T ss_pred CcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECC
Confidence 4679999999999998743 246777665432 233567999999999999999765 345779999999
Q ss_pred CCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-----CC
Q psy5368 123 DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-----QG 195 (406)
Q Consensus 123 ~ggsL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-----~~ 195 (406)
++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++...... ..
T Consensus 174 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~ 253 (373)
T 3c1x_A 174 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 253 (373)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------------
T ss_pred CCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccccccccc
Confidence 9999999997654 689999999999999999999999999999999999999 6799999999998654332 12
Q ss_pred CcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHh
Q psy5368 196 DSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRL 274 (406)
Q Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~ 274 (406)
....+|+.|+|||++.+..++.++|||||||++|||+| |.+||...+..+....+........ +..+++.+.+++.+|
T Consensus 254 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~-p~~~~~~l~~li~~c 332 (373)
T 3c1x_A 254 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-PEYCPDPLYEVMLKC 332 (373)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCC-CTTCCHHHHHHHHHH
T ss_pred CCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCC-CCCCCHHHHHHHHHH
Confidence 33456788999999999999999999999999999999 7889988777666666666644433 347899999999999
Q ss_pred cccCCCCCCCHHHHhcC
Q psy5368 275 LQKDPMRRISYEDLFSH 291 (406)
Q Consensus 275 L~~dP~~Rps~~ell~h 291 (406)
|+.||++|||+.+++++
T Consensus 333 l~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 333 WHPKAEMRPSFSELVSR 349 (373)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred cCCChhhCcCHHHHHHH
Confidence 99999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=356.82 Aligned_cols=234 Identities=21% Similarity=0.357 Sum_probs=200.7
Q ss_pred eeeecceeeeEEEeeeee----eceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR----LGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~----~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~g 124 (406)
.+.||+|+||.||++.+. ...+++|.+...... ...++.+|+.++.+++|||+++ ..+.+++|||||++
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAEL 453 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTT
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCC
Confidence 357999999999999653 356889887654332 3568999999999999999876 45568899999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC----CCccc
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ----GDSIQ 199 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~----~~~~~ 199 (406)
|+|.+++..++.+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++....... .....
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~ 533 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 533 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCC
Confidence 99999999888999999999999999999999999999999999999998 77999999999987654332 22334
Q ss_pred CCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccC
Q psy5368 200 GSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKD 278 (406)
Q Consensus 200 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~d 278 (406)
+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+........+. .+|+++.+||.+||+.|
T Consensus 534 ~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~-~~~~~l~~li~~cl~~d 612 (635)
T 4fl3_A 534 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA-GCPREMYDLMNLCWTYD 612 (635)
T ss_dssp -CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT-TCCHHHHHHHHHHTCSS
T ss_pred CceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC-CCCHHHHHHHHHHcCCC
Confidence 6788999999999999999999999999999998 999999999988888888776555544 79999999999999999
Q ss_pred CCCCCCHHHHhc
Q psy5368 279 PMRRISYEDLFS 290 (406)
Q Consensus 279 P~~Rps~~ell~ 290 (406)
|++|||+.++++
T Consensus 613 P~~RPs~~~l~~ 624 (635)
T 4fl3_A 613 VENRPGFAAVEL 624 (635)
T ss_dssp TTTSCCHHHHHH
T ss_pred HhHCcCHHHHHH
Confidence 999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=317.57 Aligned_cols=234 Identities=21% Similarity=0.369 Sum_probs=200.8
Q ss_pred eeeecceeeeEEEeeeee-eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHH
Q psy5368 56 TIRYGELQYDTVQNSQIR-LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLC 128 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~-~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~ 128 (406)
...||+|+||.||++... ...+++|.+.... .....+.+|+.++.+++|||+++ ..+..|+||||+++++|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (267)
T 3t9t_A 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLS 91 (267)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHH
T ss_pred eeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHH
Confidence 456899999999999874 3467888776543 34568999999999999999876 567789999999999999
Q ss_pred HHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC--CCCcccCCCCC
Q psy5368 129 SFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND--QGDSIQGSPLY 204 (406)
Q Consensus 129 ~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~--~~~~~~gt~~y 204 (406)
+++... +.+++..+..++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++....... ......+++.|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y 171 (267)
T 3t9t_A 92 DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKW 171 (267)
T ss_dssp HHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGG
T ss_pred HHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccccccccccccc
Confidence 999775 4699999999999999999999999999999999999998 6799999999998654321 22344567889
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
+|||++.+..++.++||||+|+++|+|++ |..||...+.......+........ +..+++.+.+++.+||+.||++||
T Consensus 172 ~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rp 250 (267)
T 3t9t_A 172 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PRLASTHVYQIMNHCWRERPEDRP 250 (267)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-CTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred cChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC-CccCcHHHHHHHHHHccCChhhCc
Confidence 99999998889999999999999999999 9999999998888887777644433 346899999999999999999999
Q ss_pred CHHHHhcC
Q psy5368 284 SYEDLFSH 291 (406)
Q Consensus 284 s~~ell~h 291 (406)
|+.+++++
T Consensus 251 s~~~ll~~ 258 (267)
T 3t9t_A 251 AFSRLLRQ 258 (267)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999874
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=325.32 Aligned_cols=231 Identities=24% Similarity=0.392 Sum_probs=187.5
Q ss_pred eeeecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc----cCCeEEEEEeccCCCCHHHHH
Q psy5368 56 TIRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK----RPRYVYIILEYCDGGDLCSFI 131 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~----~~~~~~lV~E~~~ggsL~~~l 131 (406)
...||+|+||.||++...++.+++|.+... .....+.+|+.++++++|||+++ ..+..|+||||+++++|.+++
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~~~L~~~l 90 (307)
T 2eva_A 13 EEVVGRGAFGVVCKAKWRAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVL 90 (307)
T ss_dssp EEEEECCSSSEEEEEEETTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTTCBHHHHH
T ss_pred eeEeecCCCceEEEEEECCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCCCCHHHHH
Confidence 467899999999999988888999987543 34567999999999999999876 334578999999999999999
Q ss_pred HhCC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCCcceEee-CC-eeEEEecccccccCCCCCCCcccCCCC
Q psy5368 132 RSHE---KLSEFQCQQFVRQLVLALKFLRE---NNVCHFDLKPQNILIK-NN-TLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 132 ~~~~---~l~~~~~~~i~~ql~~aL~~lH~---~givH~Dlkp~NIll~-~~-~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
.... .+++..+..++.|++.||.|||+ +||+||||||+||+++ ++ .+||+|||++...... .....||+.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~ 168 (307)
T 2eva_A 91 HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAA 168 (307)
T ss_dssp HCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------------CCTT
T ss_pred hccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--cccCCCCCc
Confidence 8765 47899999999999999999999 8999999999999998 44 4899999999765432 234568999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCN--LSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
|+|||++.+..++.++|||||||++|+|++|+.||.... ................ +..+|+.+.+|+.+||+.||.+
T Consensus 169 y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~ 247 (307)
T 2eva_A 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL-IKNLPKPIESLMTRCWSKDPSQ 247 (307)
T ss_dssp SSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCC-BTTCCHHHHHHHHHHTCSSGGG
T ss_pred eEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCc-ccccCHHHHHHHHHHhcCChhh
Confidence 999999999999999999999999999999999998643 2333333444433333 3378999999999999999999
Q ss_pred CCCHHHHhcC
Q psy5368 282 RISYEDLFSH 291 (406)
Q Consensus 282 Rps~~ell~h 291 (406)
|||+++++++
T Consensus 248 Rps~~ell~~ 257 (307)
T 2eva_A 248 RPSMEEIVKI 257 (307)
T ss_dssp SCCHHHHHHH
T ss_pred CcCHHHHHHH
Confidence 9999999873
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=328.39 Aligned_cols=235 Identities=20% Similarity=0.357 Sum_probs=194.6
Q ss_pred eeeecceeeeEEEeeeeeec------eeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEecc
Q psy5368 56 TIRYGELQYDTVQNSQIRLG------TVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYC 122 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~------~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~ 122 (406)
...||+|+||.||++..... .+++|.+..... .....+.+|+.++.+++|||+++ ..+..++||||+
T Consensus 49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 128 (333)
T 1mqb_A 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 128 (333)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence 56899999999999987532 388888765432 23446889999999999999876 667899999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC----CC
Q psy5368 123 DGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ----GD 196 (406)
Q Consensus 123 ~ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~----~~ 196 (406)
++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++........ ..
T Consensus 129 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 208 (333)
T 1mqb_A 129 ENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 208 (333)
T ss_dssp TTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------------
T ss_pred CCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccC
Confidence 999999999765 5799999999999999999999999999999999999999 67999999999987654321 12
Q ss_pred cccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhc
Q psy5368 197 SIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL 275 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L 275 (406)
...+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++...+........+ ..+++.+.+|+.+||
T Consensus 209 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l 287 (333)
T 1mqb_A 209 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP-MDCPSAIYQLMMQCW 287 (333)
T ss_dssp --CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC-TTCBHHHHHHHHHHT
T ss_pred CCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCc-ccCCHHHHHHHHHHc
Confidence 2345778999999999999999999999999999999 99999998888888777766444433 378999999999999
Q ss_pred ccCCCCCCCHHHHhcC
Q psy5368 276 QKDPMRRISYEDLFSH 291 (406)
Q Consensus 276 ~~dP~~Rps~~ell~h 291 (406)
+.||.+||++.+++++
T Consensus 288 ~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 288 QQERARRPKFADIVSI 303 (333)
T ss_dssp CSSTTTSCCHHHHHHH
T ss_pred CCChhhCcCHHHHHHH
Confidence 9999999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=329.21 Aligned_cols=235 Identities=21% Similarity=0.348 Sum_probs=194.0
Q ss_pred eeeecceeeeEEEeeee------eeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc--------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQI------RLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK--------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~------~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~--------~~~~~~lV~E~ 121 (406)
...||+|+||.||++.. .+..+++|.+..........+.+|+.++++++|||++. ..+..|+||||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 107 (327)
T 3lxl_A 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEY 107 (327)
T ss_dssp EEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEEC
T ss_pred hhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEee
Confidence 45678888888888873 34568888887665555667999999999999999765 45678999999
Q ss_pred cCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC----CC
Q psy5368 122 CDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND----QG 195 (406)
Q Consensus 122 ~~ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~----~~ 195 (406)
+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||++....... ..
T Consensus 108 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 187 (327)
T 3lxl_A 108 LPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR 187 (327)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECS
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCccceee
Confidence 9999999999764 5699999999999999999999999999999999999998 7899999999998765433 22
Q ss_pred CcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------------HHHHHHHHhcCCCCCCC
Q psy5368 196 DSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNL---------------SQLRAQALSSAPITIPP 260 (406)
Q Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~---------------~~~~~~~~~~~~~~~~~ 260 (406)
....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+........ +
T Consensus 188 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 266 (327)
T 3lxl_A 188 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPA-P 266 (327)
T ss_dssp SCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCC-C
T ss_pred ccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCC-C
Confidence 345578889999999998899999999999999999999999865432 223333333333333 3
Q ss_pred CCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 261 NSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 261 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
..+++++.+|+.+||+.||.+|||+.+++++
T Consensus 267 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 267 PACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4789999999999999999999999999664
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=320.13 Aligned_cols=233 Identities=20% Similarity=0.346 Sum_probs=188.9
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCccch-------hhhhhHHhhcccCCCCCCccc----CCeEEEEEecc
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITSH-------SEFERPRAGLSNLRAPEGRKR----PRYVYIILEYC 122 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~~-------~~~~~E~~~l~~l~h~ni~~~----~~~~~lV~E~~ 122 (406)
...||+|+||.||++.. .+..+++|.+........ ..+.+|+.++++++|||+++. ....++||||+
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~lv~e~~ 103 (287)
T 4f0f_A 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVMEFV 103 (287)
T ss_dssp EEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTEEEEECC
T ss_pred hhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCeEEEEec
Confidence 45689999999999886 356688887765443222 578899999999999998761 22227999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCcceEee-CCe-----eEEEecccccccCCCC
Q psy5368 123 DGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENN--VCHFDLKPQNILIK-NNT-----LKLADFGFAQFLAPND 193 (406)
Q Consensus 123 ~ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dlkp~NIll~-~~~-----~kL~DFGla~~~~~~~ 193 (406)
++++|.+++... ..+++..+..++.|++.||+|||++| |+||||||+||+++ ++. +||+|||+++....
T Consensus 104 ~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~-- 181 (287)
T 4f0f_A 104 PCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-- 181 (287)
T ss_dssp TTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS--
T ss_pred CCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc--
Confidence 999999988655 47999999999999999999999999 99999999999997 333 99999999975432
Q ss_pred CCCcccCCCCCCChhhhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhcCCCCCCCCCCChHHHH
Q psy5368 194 QGDSIQGSPLYMAPEILA--GSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQL--RAQALSSAPITIPPNSLSPDCMD 269 (406)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~s~~l~~ 269 (406)
......||+.|+|||++. ...++.++||||+||++|+|++|+.||...+.... ...+.........+..+|+++.+
T Consensus 182 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 261 (287)
T 4f0f_A 182 SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRN 261 (287)
T ss_dssp CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHH
T ss_pred cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcccCHHHHH
Confidence 334567899999999984 45578999999999999999999999987654333 33344433333344578999999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q psy5368 270 FLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 270 li~~~L~~dP~~Rps~~ell~ 290 (406)
|+.+||+.||.+|||++++++
T Consensus 262 li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 262 VIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=321.85 Aligned_cols=235 Identities=22% Similarity=0.327 Sum_probs=194.2
Q ss_pred ceeeecceeeeEEEeeeeeec-----eeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc-------cCCeEEEEEec
Q psy5368 55 STIRYGELQYDTVQNSQIRLG-----TVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK-------RPRYVYIILEY 121 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~~-----~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~-------~~~~~~lV~E~ 121 (406)
....||+|+||.||++..... .+++|.+.... ......+.+|+.++++++|||+++ ..+..|+||||
T Consensus 29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 108 (298)
T 3f66_A 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 108 (298)
T ss_dssp EEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEEC
T ss_pred hcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeC
Confidence 356789999999999985322 36777665433 223457899999999999999765 45577999999
Q ss_pred cCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-----C
Q psy5368 122 CDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-----Q 194 (406)
Q Consensus 122 ~~ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-----~ 194 (406)
+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||+++...... .
T Consensus 109 ~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 188 (298)
T 3f66_A 109 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN 188 (298)
T ss_dssp CTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC--
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchhcccc
Confidence 9999999999764 4699999999999999999999999999999999999999 6699999999997654322 2
Q ss_pred CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHH
Q psy5368 195 GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSR 273 (406)
Q Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~ 273 (406)
.....+|+.|+|||.+.+..++.++||||+||++|+|++ |.+||...+..+....+........ +..+++.+.+++.+
T Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~ 267 (298)
T 3f66_A 189 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-PEYCPDPLYEVMLK 267 (298)
T ss_dssp ---CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCC-CTTCCHHHHHHHHH
T ss_pred ccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCC-CccCCHHHHHHHHH
Confidence 234457888999999999999999999999999999999 7788888777777776666644433 44689999999999
Q ss_pred hcccCCCCCCCHHHHhc
Q psy5368 274 LLQKDPMRRISYEDLFS 290 (406)
Q Consensus 274 ~L~~dP~~Rps~~ell~ 290 (406)
||+.||.+|||+.++++
T Consensus 268 ~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 268 CWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HcCCChhhCcCHHHHHH
Confidence 99999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=318.68 Aligned_cols=233 Identities=23% Similarity=0.378 Sum_probs=199.4
Q ss_pred eeeecceeeeEEEeeeeeec-eeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCCCCHHH
Q psy5368 56 TIRYGELQYDTVQNSQIRLG-TVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDGGDLCS 129 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~-~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ggsL~~ 129 (406)
...||+|+||.||++....+ .+++|.+.... .....+.+|+.++++++|||+++ ..+..++||||+++++|.+
T Consensus 18 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~ 96 (279)
T 1qpc_A 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVD 96 (279)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHH
T ss_pred eeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEecCCCCCHHH
Confidence 45789999999999987544 67888776543 45678999999999999999876 4556899999999999999
Q ss_pred HHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC--CCCcccCCCCC
Q psy5368 130 FIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND--QGDSIQGSPLY 204 (406)
Q Consensus 130 ~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~--~~~~~~gt~~y 204 (406)
++.... .+++..+..++.|++.||.|||++||+|+||||+||+++ ++.+||+|||++....... ......+++.|
T Consensus 97 ~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y 176 (279)
T 1qpc_A 97 FLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 176 (279)
T ss_dssp HTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTT
T ss_pred HHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCc
Confidence 996543 799999999999999999999999999999999999999 6699999999998765432 22344567889
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+........ +..+++++.+|+.+||+.||++||
T Consensus 177 ~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rp 255 (279)
T 1qpc_A 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-PDNCPEELYQLMRLCWKERPEDRP 255 (279)
T ss_dssp SCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred cChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCC-cccccHHHHHHHHHHhccChhhCC
Confidence 99999998889999999999999999999 9999999888888777766644433 347899999999999999999999
Q ss_pred CHHHHhc
Q psy5368 284 SYEDLFS 290 (406)
Q Consensus 284 s~~ell~ 290 (406)
|++++++
T Consensus 256 s~~~l~~ 262 (279)
T 1qpc_A 256 TFDYLRS 262 (279)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999876
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=322.03 Aligned_cols=235 Identities=25% Similarity=0.402 Sum_probs=200.7
Q ss_pred ceeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 55 STIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
....||+|+||.||++... +..+++|.+... ......+.+|+.++++++|||+++ ..+..|+||||++|++
T Consensus 17 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 95 (288)
T 3kfa_A 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 95 (288)
T ss_dssp EEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEE
T ss_pred EEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCc
Confidence 3457899999999999875 346778877543 344567999999999999999766 6778899999999999
Q ss_pred HHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC--CCcccCC
Q psy5368 127 LCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ--GDSIQGS 201 (406)
Q Consensus 127 L~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~--~~~~~gt 201 (406)
|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++ ++.+||+|||++........ .....+|
T Consensus 96 L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 175 (288)
T 3kfa_A 96 LLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 175 (288)
T ss_dssp HHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEEC
T ss_pred HHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccc
Confidence 99999874 3599999999999999999999999999999999999998 67999999999987654332 2334567
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPM 280 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~ 280 (406)
+.|+|||++.+..++.++||||+|+++|+|++ |..||...+.......+........+ ..+|+.+.+|+.+||..||.
T Consensus 176 ~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dp~ 254 (288)
T 3kfa_A 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP-EGCPEKVYELMRACWQWNPS 254 (288)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCC-TTCCHHHHHHHHHHTCSSGG
T ss_pred cCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCC-CCCCHHHHHHHHHHhCCChh
Confidence 88999999999999999999999999999999 99999998888877777666444443 47899999999999999999
Q ss_pred CCCCHHHHhcC
Q psy5368 281 RRISYEDLFSH 291 (406)
Q Consensus 281 ~Rps~~ell~h 291 (406)
+|||+.++++.
T Consensus 255 ~Rps~~~~~~~ 265 (288)
T 3kfa_A 255 DRPSFAEIHQA 265 (288)
T ss_dssp GSCCHHHHHHH
T ss_pred hCcCHHHHHHH
Confidence 99999999763
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=327.41 Aligned_cols=236 Identities=21% Similarity=0.383 Sum_probs=194.9
Q ss_pred ceeeecceeeeEEEeeee-------eeceeEEeeeecCCcc-chhhhhhHHhhcccC-CCCCCcc-------cCCeEEEE
Q psy5368 55 STIRYGELQYDTVQNSQI-------RLGTVKYSQVRYDTIT-SHSEFERPRAGLSNL-RAPEGRK-------RPRYVYII 118 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~-------~~~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l-~h~ni~~-------~~~~~~lV 118 (406)
....||+|+||.||++.. ....+++|.+...... ....+.+|+.++.++ +|||+++ ..+.+|+|
T Consensus 31 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv 110 (316)
T 2xir_A 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 110 (316)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEE
T ss_pred eeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEE
Confidence 355789999999999874 2356888887654322 345789999999999 7899765 34568999
Q ss_pred EeccCCCCHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEE
Q psy5368 119 LEYCDGGDLCSFIRSHEK----------------LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLA 181 (406)
Q Consensus 119 ~E~~~ggsL~~~l~~~~~----------------l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~ 181 (406)
|||+++++|.+++..... +++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~ 190 (316)
T 2xir_A 111 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 190 (316)
T ss_dssp EECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEC
Confidence 999999999999987653 89999999999999999999999999999999999998 7799999
Q ss_pred ecccccccCCCCC---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH-HHHHHhcCCC
Q psy5368 182 DFGFAQFLAPNDQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQL-RAQALSSAPI 256 (406)
Q Consensus 182 DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~-~~~~~~~~~~ 256 (406)
|||+++....... .....+|+.|+|||++.+..++.++|||||||++|+|+| |..||.+...... ...+......
T Consensus 191 Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~ 270 (316)
T 2xir_A 191 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 270 (316)
T ss_dssp CCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCC
T ss_pred CCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccC
Confidence 9999986644332 234557889999999999999999999999999999998 9999988764443 3334444333
Q ss_pred CCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 257 TIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 257 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
. .+..+++++.+++.+||+.||.+|||+.++++|
T Consensus 271 ~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 271 R-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp C-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3 334689999999999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=320.93 Aligned_cols=234 Identities=19% Similarity=0.308 Sum_probs=185.4
Q ss_pred eecceeeeEEEeeeeee-----ceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCC
Q psy5368 58 RYGELQYDTVQNSQIRL-----GTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDG 124 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~-----~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~g 124 (406)
.||+|+||.||++.+.. ..+++|.+.... ......+.+|+.++.+++|||+++ .....++||||+++
T Consensus 25 ~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 104 (291)
T 1u46_A 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPL 104 (291)
T ss_dssp ECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTT
T ss_pred eecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCceeeEecccC
Confidence 34555555555555321 136777665432 223567899999999999999876 33457899999999
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC----CCcc
Q psy5368 125 GDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ----GDSI 198 (406)
Q Consensus 125 gsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~----~~~~ 198 (406)
++|.+++... +.+++..+..++.||+.||.|||++|++|+||||+||+++ ++.+||+|||++........ ....
T Consensus 105 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 184 (291)
T 1u46_A 105 GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 184 (291)
T ss_dssp CBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC----
T ss_pred CCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccC
Confidence 9999999764 5799999999999999999999999999999999999998 78999999999987654432 2334
Q ss_pred cCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhccc
Q psy5368 199 QGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 199 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~ 277 (406)
.+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+.........+..+|+++.+++.+||+.
T Consensus 185 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 264 (291)
T 1u46_A 185 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAH 264 (291)
T ss_dssp -CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccC
Confidence 57788999999998889999999999999999999 99999999988888777665444444457999999999999999
Q ss_pred CCCCCCCHHHHhcC
Q psy5368 278 DPMRRISYEDLFSH 291 (406)
Q Consensus 278 dP~~Rps~~ell~h 291 (406)
||.+|||+.+++++
T Consensus 265 ~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 265 KPEDRPTFVALRDF 278 (291)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred CcccCcCHHHHHHH
Confidence 99999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=346.86 Aligned_cols=233 Identities=25% Similarity=0.412 Sum_probs=201.6
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
...||+|+||.||++... +..|++|.+.... .....|.+|+.++++++|||+++ ..+.+|||||||++|+|
T Consensus 225 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L 303 (495)
T 1opk_A 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 303 (495)
T ss_dssp EEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred eeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCH
Confidence 467999999999999986 4568888876543 35678999999999999999876 56778999999999999
Q ss_pred HHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC--CCCcccCCC
Q psy5368 128 CSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND--QGDSIQGSP 202 (406)
Q Consensus 128 ~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~--~~~~~~gt~ 202 (406)
.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++...... ......+++
T Consensus 304 ~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~ 383 (495)
T 1opk_A 304 LDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 383 (495)
T ss_dssp HHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCG
T ss_pred HHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCc
Confidence 9999864 3599999999999999999999999999999999999998 6799999999998764332 123344677
Q ss_pred CCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCC
Q psy5368 203 LYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 203 ~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
.|+|||++.+..++.++|||||||++|||+| |..||.+.+..++...+........+ ..+++++.+|+.+||+.||.+
T Consensus 384 ~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~ 462 (495)
T 1opk_A 384 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP-EGCPEKVYELMRACWQWNPSD 462 (495)
T ss_dssp GGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCC-TTCCHHHHHHHHHHTCSSGGG
T ss_pred ceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCHHHHHHHHHHcCcChhH
Confidence 8999999998889999999999999999999 99999998888877777666544444 478999999999999999999
Q ss_pred CCCHHHHhc
Q psy5368 282 RISYEDLFS 290 (406)
Q Consensus 282 Rps~~ell~ 290 (406)
|||+.++++
T Consensus 463 RPs~~el~~ 471 (495)
T 1opk_A 463 RPSFAEIHQ 471 (495)
T ss_dssp SCCHHHHHH
T ss_pred CcCHHHHHH
Confidence 999999976
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=331.37 Aligned_cols=241 Identities=24% Similarity=0.400 Sum_probs=174.0
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc-cchhhhhhHHh-hcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI-TSHSEFERPRA-GLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~-~~~~~~~~E~~-~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...||+|+||.||++... +..+++|.+..... ....++.+|+. +++.++|||+++ ..+..|+||||+++
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~- 105 (327)
T 3aln_A 27 LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST- 105 (327)
T ss_dssp -CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-
T ss_pred hheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-
Confidence 456899999999999875 56789998865432 22345666665 788899999876 66789999999986
Q ss_pred CHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcc
Q psy5368 126 DLCSFIRS-----HEKLSEFQCQQFVRQLVLALKFLREN-NVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSI 198 (406)
Q Consensus 126 sL~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~lH~~-givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~ 198 (406)
+|.+++.. ...+++..+..++.|++.||.|||++ ||+||||||+||+++ ++.+||+|||+++...........
T Consensus 106 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 185 (327)
T 3aln_A 106 SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD 185 (327)
T ss_dssp EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC----------
T ss_pred ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccccccccC
Confidence 89888863 56899999999999999999999999 999999999999998 779999999999877655555556
Q ss_pred cCCCCCCChhhh----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCCCCCC---CCCChHHHHH
Q psy5368 199 QGSPLYMAPEIL----AGSPYNAKADLWSLGVLVFEALFGHAPYASCNLS-QLRAQALSSAPITIPP---NSLSPDCMDF 270 (406)
Q Consensus 199 ~gt~~y~aPE~~----~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~---~~~s~~l~~l 270 (406)
.||+.|+|||++ .+..++.++|||||||++|+|++|..||...... +....+........+. ..+++++.+|
T Consensus 186 ~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 265 (327)
T 3aln_A 186 AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINF 265 (327)
T ss_dssp --------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHH
T ss_pred CCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHH
Confidence 799999999998 4566899999999999999999999999875422 2222222222222221 3589999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy5368 271 LSRLLQKDPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 271 i~~~L~~dP~~Rps~~ell~hp~~~~~ 297 (406)
+.+||+.||++|||+.++++||||...
T Consensus 266 i~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 266 VNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp HHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 999999999999999999999999743
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=325.13 Aligned_cols=235 Identities=20% Similarity=0.328 Sum_probs=188.9
Q ss_pred eeeecceeeeEEEeeeeee--c----eeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIRL--G----TVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~--~----~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ 123 (406)
...||+|+||.||++.... . ++++|.+.... ......+.+|+.++.+++|||++. ..+..++|+||++
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~v~~~~~ 99 (327)
T 3lzb_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMP 99 (327)
T ss_dssp EEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEEEECCCS
T ss_pred EEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceEEEEecC
Confidence 3456777777777776532 2 24666554332 344668999999999999999876 3345789999999
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC---CCcc
Q psy5368 124 GGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ---GDSI 198 (406)
Q Consensus 124 ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~---~~~~ 198 (406)
+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....... ....
T Consensus 100 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~ 179 (327)
T 3lzb_A 100 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179 (327)
T ss_dssp SCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----------------
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCC
Confidence 99999999774 5799999999999999999999999999999999999998 78999999999987644332 2234
Q ss_pred cCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhccc
Q psy5368 199 QGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 199 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~ 277 (406)
.+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.....+...+........+ ..++.++.+|+.+||+.
T Consensus 180 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~ 258 (327)
T 3lzb_A 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP-PICTIDVYMIMRKCWMI 258 (327)
T ss_dssp CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC-TTBCHHHHHHHHHHTCS
T ss_pred CccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC-ccCCHHHHHHHHHHcCC
Confidence 46778999999999999999999999999999999 99999998888887777666544444 36899999999999999
Q ss_pred CCCCCCCHHHHhcC
Q psy5368 278 DPMRRISYEDLFSH 291 (406)
Q Consensus 278 dP~~Rps~~ell~h 291 (406)
||.+|||+.++++.
T Consensus 259 dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 259 DADSRPKFRELIIE 272 (327)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhHCcCHHHHHHH
Confidence 99999999999873
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=328.07 Aligned_cols=235 Identities=22% Similarity=0.367 Sum_probs=200.3
Q ss_pred eeeecceeeeEEEeeeee---------eceeEEeeeecCCc-cchhhhhhHHhhcccC-CCCCCcc------cCCeEEEE
Q psy5368 56 TIRYGELQYDTVQNSQIR---------LGTVKYSQVRYDTI-TSHSEFERPRAGLSNL-RAPEGRK------RPRYVYII 118 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~---------~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV 118 (406)
...||+|+||.||++... ...|++|.+..... .....+.+|+.++.++ +|||+++ ..+.+|+|
T Consensus 40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 119 (334)
T 2pvf_A 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 119 (334)
T ss_dssp EEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEE
T ss_pred eeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEE
Confidence 467899999999999752 34588887765432 2345789999999999 9999876 66788999
Q ss_pred EeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEE
Q psy5368 119 LEYCDGGDLCSFIRSHE----------------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLA 181 (406)
Q Consensus 119 ~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~ 181 (406)
|||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+
T Consensus 120 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~ 199 (334)
T 2pvf_A 120 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199 (334)
T ss_dssp EECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEEC
T ss_pred EECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEc
Confidence 99999999999998654 389999999999999999999999999999999999998 7799999
Q ss_pred ecccccccCCCC---CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCC
Q psy5368 182 DFGFAQFLAPND---QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPIT 257 (406)
Q Consensus 182 DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 257 (406)
|||++....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++...+.......
T Consensus 200 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 279 (334)
T 2pvf_A 200 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD 279 (334)
T ss_dssp CCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC
T ss_pred cccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCC
Confidence 999998765432 2234456788999999998889999999999999999999 999999999888887777765444
Q ss_pred CCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 258 IPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 258 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
.+ ..+++++.+++.+||+.||.+|||+.+++++
T Consensus 280 ~~-~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 280 KP-ANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp CC-TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC-ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 44 4789999999999999999999999999875
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=328.02 Aligned_cols=235 Identities=24% Similarity=0.389 Sum_probs=193.9
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCcc------chhhhhhHHhhcccCCC--CCCcc------cCCeEEEEE
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTIT------SHSEFERPRAGLSNLRA--PEGRK------RPRYVYIIL 119 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~------~~~~~~~E~~~l~~l~h--~ni~~------~~~~~~lV~ 119 (406)
...||+|+||.||++.. .+..+++|.+...... ....+.+|+.++.+++| +|++. ..+..++||
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~ 127 (320)
T 3a99_A 48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 127 (320)
T ss_dssp EEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEE
Confidence 45567888888888765 3456888877654432 23567889999999964 88765 677899999
Q ss_pred eccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee--CCeeEEEecccccccCCCCCCC
Q psy5368 120 EYCDG-GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK--NNTLKLADFGFAQFLAPNDQGD 196 (406)
Q Consensus 120 E~~~g-gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~--~~~~kL~DFGla~~~~~~~~~~ 196 (406)
|++.+ ++|.+++..++.+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||++...... ...
T Consensus 128 e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~-~~~ 206 (320)
T 3a99_A 128 ERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYT 206 (320)
T ss_dssp ECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSS-CBC
T ss_pred EcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccccc-ccc
Confidence 99986 89999999888999999999999999999999999999999999999998 469999999999876533 334
Q ss_pred cccCCCCCCChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhc
Q psy5368 197 SIQGSPLYMAPEILAGSPY-NAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL 275 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L 275 (406)
...||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.... .+... ... .+..+++++.+|+.+||
T Consensus 207 ~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~-~~~-~~~~~~~~~~~li~~~l 278 (320)
T 3a99_A 207 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG-QVF-FRQRVSSECQHLIRWCL 278 (320)
T ss_dssp CCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-CCC-CSSCCCHHHHHHHHHHT
T ss_pred CCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcc-ccc-ccccCCHHHHHHHHHHc
Confidence 5678999999999987765 688999999999999999999997632 12222 122 23478999999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCCCC
Q psy5368 276 QKDPMRRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 276 ~~dP~~Rps~~ell~hp~~~~~~~ 299 (406)
+.||++|||++++++||||+....
T Consensus 279 ~~dp~~Rps~~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 279 ALRPSDRPTFEEIQNHPWMQDVLL 302 (320)
T ss_dssp CSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred cCChhhCcCHHHHhcCHhhcCccC
Confidence 999999999999999999987654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=341.97 Aligned_cols=239 Identities=23% Similarity=0.362 Sum_probs=199.9
Q ss_pred eeeecceeeeEEEeeeeee-ceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCCCCHHH
Q psy5368 56 TIRYGELQYDTVQNSQIRL-GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDGGDLCS 129 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ggsL~~ 129 (406)
...||+|+||.||++.... ..|++|.+.... .....|.+|+.++++++|||+++ ..+.+|+|||||++|+|.+
T Consensus 189 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e~~~~gsL~~ 267 (452)
T 1fmk_A 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLD 267 (452)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTTCBHHH
T ss_pred eeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEehhhcCCCHHH
Confidence 4579999999999999865 468888876544 34578999999999999999876 4467899999999999999
Q ss_pred HHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC--CCCcccCCCCC
Q psy5368 130 FIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND--QGDSIQGSPLY 204 (406)
Q Consensus 130 ~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~--~~~~~~gt~~y 204 (406)
++... ..+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++...... ......+++.|
T Consensus 268 ~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y 347 (452)
T 1fmk_A 268 FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347 (452)
T ss_dssp HHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGG
T ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccc
Confidence 99643 5699999999999999999999999999999999999998 6799999999998764332 12234467889
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+..+.....++ .+|+.+.+|+.+||+.||++||
T Consensus 348 ~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~Rp 426 (452)
T 1fmk_A 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP-ECPESLHDLMCQCWRKEPEERP 426 (452)
T ss_dssp SCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT-TSCHHHHHHHHHHTCSSGGGSC
T ss_pred cCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC-CCCHHHHHHHHHHccCChhhCc
Confidence 99999999999999999999999999999 999999999888888877765554443 7899999999999999999999
Q ss_pred CHHHHhcC--CCCCC
Q psy5368 284 SYEDLFSH--PYPDL 296 (406)
Q Consensus 284 s~~ell~h--p~~~~ 296 (406)
|++++++. .++..
T Consensus 427 t~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 427 TFEYLQAFLEDYFTS 441 (452)
T ss_dssp CHHHHHHHHHTTTSC
T ss_pred CHHHHHHHHHHHhcc
Confidence 99999873 55543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=332.77 Aligned_cols=237 Identities=26% Similarity=0.407 Sum_probs=166.2
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc----------cCCeEEEEEeccCC
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK----------RPRYVYIILEYCDG 124 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~----------~~~~~~lV~E~~~g 124 (406)
..||+|+||.||++... +..+++|.+... .....+....+..++|||++. ....+++|||||+|
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~g 110 (336)
T 3fhr_A 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEG 110 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTT
T ss_pred eeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCC
Confidence 45899999999999875 567888887542 122222333456679999765 24558999999999
Q ss_pred CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee----CCeeEEEecccccccCCCCCCCcc
Q psy5368 125 GDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK----NNTLKLADFGFAQFLAPNDQGDSI 198 (406)
Q Consensus 125 gsL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~----~~~~kL~DFGla~~~~~~~~~~~~ 198 (406)
|+|.+++...+ .+++.++..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++...... .....
T Consensus 111 g~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~ 189 (336)
T 3fhr_A 111 GELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTP 189 (336)
T ss_dssp EEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---------
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecccc-ccccC
Confidence 99999998764 699999999999999999999999999999999999997 336999999999865433 33456
Q ss_pred cCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---cCCCCCC---CCCCChHHHHHHH
Q psy5368 199 QGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALS---SAPITIP---PNSLSPDCMDFLS 272 (406)
Q Consensus 199 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~---~~~~~~~---~~~~s~~l~~li~ 272 (406)
.||+.|+|||++.+..++.++||||+||++|+|++|..||.............. ......+ ...+++++.+|+.
T Consensus 190 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 269 (336)
T 3fhr_A 190 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIR 269 (336)
T ss_dssp --------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHHHHHH
T ss_pred CCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHH
Confidence 789999999999888899999999999999999999999987654433211111 1111111 1368999999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 273 RLLQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 273 ~~L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
+||+.||.+|||++++++||||+...
T Consensus 270 ~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 270 LLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp HHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred HHCCCChhHCcCHHHHhcCccccccc
Confidence 99999999999999999999998643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=321.08 Aligned_cols=233 Identities=16% Similarity=0.191 Sum_probs=187.1
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...||+|+||.||++.. .+..+++|.+... .....+.+|+.++..+ +|+|++. .....|+||||+ +++
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 91 (298)
T 1csn_A 15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPS 91 (298)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCC
Confidence 34567777777887773 4556788876543 3445688999999999 7787654 677899999999 889
Q ss_pred HHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCe-----eEEEecccccccCCCCC-----
Q psy5368 127 LCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNT-----LKLADFGFAQFLAPNDQ----- 194 (406)
Q Consensus 127 L~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~-----~kL~DFGla~~~~~~~~----- 194 (406)
|.+++...+ ++++..+..++.||+.||+|||++||+||||||+||+++ ++. +||+|||+++.......
T Consensus 92 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 171 (298)
T 1csn_A 92 LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP 171 (298)
T ss_dssp HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCC
T ss_pred HHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccccccccc
Confidence 999998754 699999999999999999999999999999999999997 433 99999999987654422
Q ss_pred ---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcC---CCCCCCCCCCh
Q psy5368 195 ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCN---LSQLRAQALSSA---PITIPPNSLSP 265 (406)
Q Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~---~~~~~~~~~~~~---~~~~~~~~~s~ 265 (406)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+ .......+.... ........+|+
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 1csn_A 172 YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPE 251 (298)
T ss_dssp CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCH
T ss_pred ccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcH
Confidence 345679999999999999999999999999999999999999998743 333333332221 11111236899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 266 DCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 266 ~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
++.+|+.+||+.||++|||++++++.
T Consensus 252 ~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 252 EFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred HHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 99999999999999999999998763
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=324.30 Aligned_cols=236 Identities=19% Similarity=0.274 Sum_probs=198.3
Q ss_pred ceeeecceeeeEEEeeeeeeceeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 55 STIRYGELQYDTVQNSQIRLGTVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
....||+|+||.||++.... .+++|.+.... ......+.+|+.++++++|||+++ ..+.+++||||++|++
T Consensus 37 ~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~ 115 (319)
T 2y4i_B 37 IGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRT 115 (319)
T ss_dssp CCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEE
T ss_pred EeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCc
Confidence 34578999999999998754 58888776443 233467899999999999999876 6677899999999999
Q ss_pred HHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeCCeeEEEecccccccCCC------CCCCccc
Q psy5368 127 LCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLADFGFAQFLAPN------DQGDSIQ 199 (406)
Q Consensus 127 L~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~~~~kL~DFGla~~~~~~------~~~~~~~ 199 (406)
|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++++.+||+|||++...... .......
T Consensus 116 L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 195 (319)
T 2y4i_B 116 LYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQN 195 (319)
T ss_dssp HHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC--CCEECCCSCCC----------CCSCBCCS
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeCCCEEEeecCCccccccccccccccccccCC
Confidence 999997755 699999999999999999999999999999999999999999999999998654321 2223445
Q ss_pred CCCCCCChhhhcC---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHH
Q psy5368 200 GSPLYMAPEILAG---------SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDF 270 (406)
Q Consensus 200 gt~~y~aPE~~~~---------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~l 270 (406)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.........+..++.++.++
T Consensus 196 g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 275 (319)
T 2y4i_B 196 GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDI 275 (319)
T ss_dssp GGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHH
T ss_pred CcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHH
Confidence 8999999999975 3578899999999999999999999999998888888777766665555789999999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q psy5368 271 LSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 271 i~~~L~~dP~~Rps~~ell~h 291 (406)
+.+||..||.+|||+.++++.
T Consensus 276 i~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 276 LLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp HHHHHCSSTTTSCCHHHHHHH
T ss_pred HHHHhcCChhhCcCHHHHHHH
Confidence 999999999999999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=319.14 Aligned_cols=228 Identities=23% Similarity=0.390 Sum_probs=190.1
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCccc----------------------C
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRKR----------------------P 112 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~----------------------~ 112 (406)
..||+|+||.||++... +..+++|.+... ...+.+|+.++.+++|||+++. .
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 92 (284)
T 2a19_B 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKT 92 (284)
T ss_dssp EEEECSSSCCEEEEEETTTCCEEEEEEEECC----SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEE
T ss_pred eeeccCCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCc
Confidence 45666777777777653 456788877643 2568899999999999998762 3
Q ss_pred CeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEeccccccc
Q psy5368 113 RYVYIILEYCDGGDLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFL 189 (406)
Q Consensus 113 ~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~ 189 (406)
..+|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++ ++.+||+|||++...
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 172 (284)
T 2a19_B 93 KCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL 172 (284)
T ss_dssp EEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEES
T ss_pred ceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheec
Confidence 4579999999999999999764 5799999999999999999999999999999999999998 779999999999887
Q ss_pred CCCCCCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHH
Q psy5368 190 APNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMD 269 (406)
Q Consensus 190 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ 269 (406)
..........||+.|+|||++.+..++.++||||||+++|+|++|..||... ......+... ..+..+++++.+
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~----~~~~~~~~~~~~ 246 (284)
T 2a19_B 173 KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG----IISDIFDKKEKT 246 (284)
T ss_dssp SCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT----CCCTTSCHHHHH
T ss_pred cccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc----cccccCCHHHHH
Confidence 7666666677999999999999999999999999999999999999987532 2222222222 223468999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 270 FLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 270 li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
|+.+||+.||.+|||+.+++++++.
T Consensus 247 li~~~l~~dp~~Rps~~e~l~~l~~ 271 (284)
T 2a19_B 247 LLQKLLSKKPEDRPNTSEILRTLTV 271 (284)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHHHHHH
Confidence 9999999999999999999998764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=328.24 Aligned_cols=231 Identities=16% Similarity=0.217 Sum_probs=185.8
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...||+|+||.||++.. .+..+++|.+... .....+.+|+.+++++ +|||++. ..+..|+||||+ +++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (330)
T 2izr_A 14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMK--SRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPS 90 (330)
T ss_dssp EEECCC-CTTSEEEEEETTTTEEEEEEEEETT--CSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEeeccCCceEEEEEECCCCcEEEEEEeccc--cchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCC
Confidence 44567777788887774 3456788876544 2345689999999999 9999765 677889999999 889
Q ss_pred HHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCe-----eEEEecccccccCCCCC-----
Q psy5368 127 LCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNT-----LKLADFGFAQFLAPNDQ----- 194 (406)
Q Consensus 127 L~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~-----~kL~DFGla~~~~~~~~----- 194 (406)
|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++ ++. +||+|||+++.......
T Consensus 91 L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~ 170 (330)
T 2izr_A 91 LEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIP 170 (330)
T ss_dssp HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCC
T ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCcccc
Confidence 99999864 6899999999999999999999999999999999999998 444 99999999987644332
Q ss_pred ---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcCCC---CCCCCCCCh
Q psy5368 195 ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCN---LSQLRAQALSSAPI---TIPPNSLSP 265 (406)
Q Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~---~~~~~~~~~~~~~~---~~~~~~~s~ 265 (406)
.....||+.|+|||++.+..++.++|||||||++|||++|..||.+.+ ..+....+...... ......+|
T Consensus 171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p- 249 (330)
T 2izr_A 171 YREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP- 249 (330)
T ss_dssp CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-
T ss_pred ccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-
Confidence 246679999999999999999999999999999999999999998743 33333333222111 11112344
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 266 DCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 266 ~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
++.+++.+||+.||.+||+++++++
T Consensus 250 ~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 250 EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 9999999999999999999988876
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=321.93 Aligned_cols=241 Identities=26% Similarity=0.394 Sum_probs=180.3
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccc-h-hhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITS-H-SEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~-~-~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
...||+|+||.||++... +..+++|.+....... . ..+.++..+++.++|||+++ ..+..|+||||+ ++
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 108 (318)
T 2dyl_A 30 LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GT 108 (318)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SE
T ss_pred cceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CC
Confidence 456899999999999874 5678899887554222 2 23444556788889999876 677899999999 55
Q ss_pred CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCC
Q psy5368 126 DLCSFIRS-HEKLSEFQCQQFVRQLVLALKFLREN-NVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSP 202 (406)
Q Consensus 126 sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~lH~~-givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~ 202 (406)
.+..+... ...+++..+..++.||+.||.|||++ ||+|+||||+||+++ ++.+||+|||++.............||+
T Consensus 109 ~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 188 (318)
T 2dyl_A 109 CAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCA 188 (318)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------------CC
T ss_pred cHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccccccCCCc
Confidence 66666543 46899999999999999999999995 999999999999998 7799999999998766555555667999
Q ss_pred CCCChhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCCC-CCCChHHHHHHHHhc
Q psy5368 203 LYMAPEILA-----GSPYNAKADLWSLGVLVFEALFGHAPYASC-NLSQLRAQALSSAPITIPP-NSLSPDCMDFLSRLL 275 (406)
Q Consensus 203 ~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~-~~~~~~~~~~~~~~~~~~~-~~~s~~l~~li~~~L 275 (406)
.|+|||++. ...++.++|||||||++|+|++|+.||... ...+....+........+. ..+++++.+|+.+||
T Consensus 189 ~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 268 (318)
T 2dyl_A 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCL 268 (318)
T ss_dssp TTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHT
T ss_pred cccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHc
Confidence 999999995 456889999999999999999999999873 4555555666554444443 268999999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCC
Q psy5368 276 QKDPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 276 ~~dP~~Rps~~ell~hp~~~~~ 297 (406)
+.||.+|||++++++||||+..
T Consensus 269 ~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 269 TKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp CSCTTTSCCHHHHTTSHHHHHH
T ss_pred cCChhHCcCHHHHhhCHHHHhc
Confidence 9999999999999999999743
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=328.35 Aligned_cols=237 Identities=20% Similarity=0.318 Sum_probs=197.0
Q ss_pred ceeeecceeeeEEEeeeeee-------ceeEEeeeecCCc-cchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEE
Q psy5368 55 STIRYGELQYDTVQNSQIRL-------GTVKYSQVRYDTI-TSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIIL 119 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~-------~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~ 119 (406)
....||+|+||.||++.... ..+++|.+..... .....+.+|+.++.++ +|||+++ ..+..|+||
T Consensus 50 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 129 (333)
T 2i1m_A 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVIT 129 (333)
T ss_dssp EEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEE
Confidence 35679999999999998632 3578887765432 2345789999999999 8999876 667889999
Q ss_pred eccCCCCHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecc
Q psy5368 120 EYCDGGDLCSFIRSH--------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFG 184 (406)
Q Consensus 120 E~~~ggsL~~~l~~~--------------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFG 184 (406)
||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||
T Consensus 130 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 209 (333)
T 2i1m_A 130 EYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFG 209 (333)
T ss_dssp ECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCG
T ss_pred ecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECccc
Confidence 999999999999653 3589999999999999999999999999999999999999 6799999999
Q ss_pred cccccCCCCC---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCC
Q psy5368 185 FAQFLAPNDQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPP 260 (406)
Q Consensus 185 la~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (406)
++........ .....+|+.|+|||++.+..++.++|||||||++|+|+| |..||.+...................+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 289 (333)
T 2i1m_A 210 LARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQP 289 (333)
T ss_dssp GGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCC
T ss_pred cccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCC
Confidence 9986543322 234457888999999999999999999999999999998 999998876555544444443333334
Q ss_pred CCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 261 NSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 261 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
..+++++.+|+.+||+.||.+|||+.+++++
T Consensus 290 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 290 AFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 4689999999999999999999999999874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=350.41 Aligned_cols=232 Identities=22% Similarity=0.370 Sum_probs=197.1
Q ss_pred eecceeeeEEEeeeee----eceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCCCCH
Q psy5368 58 RYGELQYDTVQNSQIR----LGTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~----~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ggsL 127 (406)
.||+|+||.||+|... ...|++|.+..... .....+.+|+.++++++|||+++ ..+.+|+|||||++|+|
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~E~~~~g~L 422 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPL 422 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEEECCTTCBH
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEEEeCCCCcH
Confidence 6999999999999874 34588888765432 34668999999999999999876 34568999999999999
Q ss_pred HHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC----CCcccCC
Q psy5368 128 CSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ----GDSIQGS 201 (406)
Q Consensus 128 ~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~----~~~~~gt 201 (406)
.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++....... .....++
T Consensus 423 ~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~ 502 (613)
T 2ozo_A 423 HKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 502 (613)
T ss_dssp HHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------C
T ss_pred HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCc
Confidence 9999654 4699999999999999999999999999999999999998 77999999999987643322 1223356
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPM 280 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~ 280 (406)
+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+..+.....++ .+++++.+|+.+||+.||+
T Consensus 503 ~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~-~~~~~l~~li~~cl~~dP~ 581 (613)
T 2ozo_A 503 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP-ECPPELYALMSDCWIYKWE 581 (613)
T ss_dssp CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCT-TCCHHHHHHHHHTTCSSTT
T ss_pred cceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCC-cCCHHHHHHHHHHcCCChh
Confidence 88999999999999999999999999999998 999999998888888887776555544 6999999999999999999
Q ss_pred CCCCHHHHhc
Q psy5368 281 RRISYEDLFS 290 (406)
Q Consensus 281 ~Rps~~ell~ 290 (406)
+||++.++++
T Consensus 582 ~RPs~~~l~~ 591 (613)
T 2ozo_A 582 DRPDFLTVEQ 591 (613)
T ss_dssp TSCCHHHHHH
T ss_pred HCcCHHHHHH
Confidence 9999999854
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=334.98 Aligned_cols=247 Identities=23% Similarity=0.314 Sum_probs=195.5
Q ss_pred cccccceeeecCceeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCC-CCC-----Ccc----
Q psy5368 43 RSGTVRYDIVGSSTIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLR-APE-----GRK---- 110 (406)
Q Consensus 43 ~~~~~~~~i~~~~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~-h~n-----i~~---- 110 (406)
......| .....||+|+||.||++... +..|++|.+... ......+.+|+.++..++ |++ ++.
T Consensus 50 ~~~~~~y----~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 50 EKWMDRY----EIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp CEETTTE----EEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred CEeeeeE----EEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 3344455 33567899999999999764 456888877643 223456778888888885 444 333
Q ss_pred --cCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCCcceEee---CCeeEEE
Q psy5368 111 --RPRYVYIILEYCDGGDLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLR--ENNVCHFDLKPQNILIK---NNTLKLA 181 (406)
Q Consensus 111 --~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH--~~givH~Dlkp~NIll~---~~~~kL~ 181 (406)
..+..|+||||+++ +|.+++... +.+++..++.++.||+.||.||| +.||+||||||+|||++ ++.+||+
T Consensus 125 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp EEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred eccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 56789999999965 999999776 46999999999999999999999 57999999999999995 4589999
Q ss_pred ecccccccCCCCCCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC---
Q psy5368 182 DFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITI--- 258 (406)
Q Consensus 182 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--- 258 (406)
|||+++.... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+..+....+........
T Consensus 204 DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 281 (382)
T 2vx3_A 204 DFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI 281 (382)
T ss_dssp CCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred eccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9999987643 34456799999999999999999999999999999999999999999887776666554211000
Q ss_pred --------------C-----------------CCC----------------------------CChHHHHHHHHhcccCC
Q psy5368 259 --------------P-----------------PNS----------------------------LSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 259 --------------~-----------------~~~----------------------------~s~~l~~li~~~L~~dP 279 (406)
+ +.. .++++.+||.+||+.||
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 361 (382)
T 2vx3_A 282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP 361 (382)
T ss_dssp HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence 0 000 01378999999999999
Q ss_pred CCCCCHHHHhcCCCCCCC
Q psy5368 280 MRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 280 ~~Rps~~ell~hp~~~~~ 297 (406)
++|||++|+|+||||+..
T Consensus 362 ~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 362 KTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TTSCCHHHHTTSGGGCC-
T ss_pred hhCCCHHHHhcCcccccC
Confidence 999999999999999854
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=322.13 Aligned_cols=236 Identities=21% Similarity=0.369 Sum_probs=190.1
Q ss_pred ceeeecceeeeEEEeeeeee-----ceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCcccC-----------CeEE
Q psy5368 55 STIRYGELQYDTVQNSQIRL-----GTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRKRP-----------RYVY 116 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~-----~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~~~-----------~~~~ 116 (406)
....||+|+||.||++.... ..+++|.+...... ....+.+|+.++++++|||+++.- ...+
T Consensus 38 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 117 (313)
T 3brb_A 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPM 117 (313)
T ss_dssp EEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEE
T ss_pred eccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccE
Confidence 35578999999999997643 25888877654322 345789999999999999987622 2459
Q ss_pred EEEeccCCCCHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEeccccccc
Q psy5368 117 IILEYCDGGDLCSFIRS------HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFL 189 (406)
Q Consensus 117 lV~E~~~ggsL~~~l~~------~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~ 189 (406)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++...
T Consensus 118 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~ 197 (313)
T 3brb_A 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKI 197 (313)
T ss_dssp EEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC---
T ss_pred EEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceec
Confidence 99999999999999953 24699999999999999999999999999999999999999 669999999999766
Q ss_pred CCCC---CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCh
Q psy5368 190 APND---QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSP 265 (406)
Q Consensus 190 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~ 265 (406)
.... ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.........+........+ ..+++
T Consensus 198 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 276 (313)
T 3brb_A 198 YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQP-EDCLD 276 (313)
T ss_dssp -------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCB-TTCCH
T ss_pred ccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCCC-ccccH
Confidence 4332 2234457888999999999999999999999999999999 99999998888887777776554444 37899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 266 DCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 266 ~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
++.+|+.+||..||.+|||+.+++++
T Consensus 277 ~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 277 ELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=317.26 Aligned_cols=237 Identities=23% Similarity=0.303 Sum_probs=196.3
Q ss_pred CceeeecceeeeEEEeeeeeec-----eeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc-------cCCeEEEEEe
Q psy5368 54 SSTIRYGELQYDTVQNSQIRLG-----TVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK-------RPRYVYIILE 120 (406)
Q Consensus 54 ~~~~~lG~G~~g~Vy~~~~~~~-----~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~-------~~~~~~lV~E 120 (406)
.....||+|+||.||++..... .+++|.+..... .....+.+|+.++++++|||+++ ..+..++|||
T Consensus 24 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e 103 (298)
T 3pls_A 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLP 103 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEC
T ss_pred ccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEe
Confidence 4567899999999999986322 477777654332 23457899999999999999876 2334489999
Q ss_pred ccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-----C
Q psy5368 121 YCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-----D 193 (406)
Q Consensus 121 ~~~ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-----~ 193 (406)
|+.+++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||+++..... .
T Consensus 104 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 183 (298)
T 3pls_A 104 YMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQ 183 (298)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSC
T ss_pred cccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccc
Confidence 99999999999774 5799999999999999999999999999999999999999 669999999999765332 2
Q ss_pred CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHH
Q psy5368 194 QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLS 272 (406)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~ 272 (406)
......+|+.|+|||.+.+..++.++||||+||++|+|++ |.+||...+.......+........ +..+++++.+|+.
T Consensus 184 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~ 262 (298)
T 3pls_A 184 QHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ-PEYCPDSLYQVMQ 262 (298)
T ss_dssp CSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCC-CTTCCHHHHHHHH
T ss_pred cCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCC-CccchHHHHHHHH
Confidence 2344567889999999999999999999999999999999 6666777777777766666644443 3468999999999
Q ss_pred HhcccCCCCCCCHHHHhcC
Q psy5368 273 RLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 273 ~~L~~dP~~Rps~~ell~h 291 (406)
+||+.||.+|||++++++.
T Consensus 263 ~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 263 QCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCChhhCcCHHHHHHH
Confidence 9999999999999998763
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=323.94 Aligned_cols=231 Identities=20% Similarity=0.344 Sum_probs=183.2
Q ss_pred eeeecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhccc--CCCCCCccc----------CCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSN--LRAPEGRKR----------PRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~--l~h~ni~~~----------~~~~~lV~E~~~ 123 (406)
...||+|+||+||++...+..+++|.+... ....+.+|.+++.. ++|||+++. ....|+||||++
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~ 89 (301)
T 3q4u_A 13 LECVGKGRYGEVWRGSWQGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHE 89 (301)
T ss_dssp EEEEEECSSEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCT
T ss_pred EEeeccCCCcEEEEEEECCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhcc
Confidence 457899999999999988888999987543 34455666666555 899998762 345889999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HCCcccccCCCcceEee-CCeeEEEecccccccCCCCC
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLR--------ENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ 194 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH--------~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~ 194 (406)
+|+|.++++. ..+++..+..++.||+.||+||| ++||+||||||+|||++ ++.+||+|||+++.......
T Consensus 90 ~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 168 (301)
T 3q4u_A 90 MGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 168 (301)
T ss_dssp TCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTT
T ss_pred CCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccc
Confidence 9999999954 57999999999999999999999 99999999999999999 77999999999976544332
Q ss_pred -----CCcccCCCCCCChhhhcCC------CCCchhhHHHHHHHHHHHHhC----------CCCCCCC-----CHHHHHH
Q psy5368 195 -----GDSIQGSPLYMAPEILAGS------PYNAKADLWSLGVLVFEALFG----------HAPYASC-----NLSQLRA 248 (406)
Q Consensus 195 -----~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltg----------~~pf~~~-----~~~~~~~ 248 (406)
.....||+.|+|||++.+. .++.++|||||||++|||+|| ..||... .......
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 248 (301)
T 3q4u_A 169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRK 248 (301)
T ss_dssp EEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHH
T ss_pred cccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhH
Confidence 2345799999999999886 455799999999999999999 8888653 2233333
Q ss_pred HHHhcCC-CCCCC----CCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 249 QALSSAP-ITIPP----NSLSPDCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 249 ~~~~~~~-~~~~~----~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
....... ...+. ..+++++.+|+.+||+.||.+|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 249 VVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp HHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 3222221 12221 124577999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=318.63 Aligned_cols=234 Identities=19% Similarity=0.336 Sum_probs=190.2
Q ss_pred eeeecceeeeEEEeeee------eeceeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc--------cCCeEEEEEe
Q psy5368 56 TIRYGELQYDTVQNSQI------RLGTVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK--------RPRYVYIILE 120 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~------~~~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~--------~~~~~~lV~E 120 (406)
...||+|+||.||++.+ .+..+++|.+.... ......+.+|+.++.+++|||+++ ....+++|||
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 105 (302)
T 4e5w_A 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 105 (302)
T ss_dssp EEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEE
T ss_pred hhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEE
Confidence 46789999999999873 45678888876543 234567899999999999999876 2266899999
Q ss_pred ccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC----
Q psy5368 121 YCDGGDLCSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ---- 194 (406)
Q Consensus 121 ~~~ggsL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~---- 194 (406)
|+++++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++........
T Consensus 106 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 185 (302)
T 4e5w_A 106 FLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTV 185 (302)
T ss_dssp CCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEEC
T ss_pred eCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCCcceec
Confidence 9999999999954 45799999999999999999999999999999999999998 78999999999987654432
Q ss_pred CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---------------CHHHHHHHHHhcCCCCCC
Q psy5368 195 GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASC---------------NLSQLRAQALSSAPITIP 259 (406)
Q Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~---------------~~~~~~~~~~~~~~~~~~ 259 (406)
.....||+.|+|||++.+..++.++||||+||++|+|++|..|+... ........+........
T Consensus 186 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 264 (302)
T 4e5w_A 186 KDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPC- 264 (302)
T ss_dssp CCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCC-
T ss_pred cCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCC-
Confidence 33456788899999999999999999999999999999999886432 12223333333333333
Q ss_pred CCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 260 PNSLSPDCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 260 ~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
+..+|+++.+|+.+||+.||.+|||+.++++
T Consensus 265 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 265 PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 3478999999999999999999999999975
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=325.74 Aligned_cols=256 Identities=19% Similarity=0.251 Sum_probs=201.5
Q ss_pred eeeeeccccccccceeee--cCceeeecceeeeEEEeeeeeeceeEEeeeecCC----ccchhhhhhHHhhcccCCCCCC
Q psy5368 35 SQVRSDTVRSGTVRYDIV--GSSTIRYGELQYDTVQNSQIRLGTVKYSQVRYDT----ITSHSEFERPRAGLSNLRAPEG 108 (406)
Q Consensus 35 ~~~~~d~~~~~~~~~~i~--~~~~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~----~~~~~~~~~E~~~l~~l~h~ni 108 (406)
..+..++....+.+|+.. ......||+|+||.||++...+..+++|.+.... ......+.+|+.++++++|||+
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 92 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL 92 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTB
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCe
Confidence 445556666667766321 1223789999999999999988899999876532 2234578999999999999998
Q ss_pred cc------cCCeEEEEEeccCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCee
Q psy5368 109 RK------RPRYVYIILEYCDGGDLCSFIRS---HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTL 178 (406)
Q Consensus 109 ~~------~~~~~~lV~E~~~ggsL~~~l~~---~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~ 178 (406)
++ ..+..|+||||+++++|.+++.. ..++++..+..++.||+.||.|||++||+||||||+||+++ ++.+
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~ 172 (307)
T 2nru_A 93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTA 172 (307)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCE
T ss_pred EEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcE
Confidence 76 56778999999999999999964 34699999999999999999999999999999999999999 6699
Q ss_pred EEEecccccccCCCCC---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHH
Q psy5368 179 KLADFGFAQFLAPNDQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLS----QLRAQAL 251 (406)
Q Consensus 179 kL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~----~~~~~~~ 251 (406)
||+|||++........ .....||+.|+|||.+.+ .++.++||||||+++|+|++|..||...... .+...+.
T Consensus 173 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 251 (307)
T 2nru_A 173 KISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIE 251 (307)
T ss_dssp EECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHH
T ss_pred EEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhh
Confidence 9999999976543322 234578999999999876 4889999999999999999999999875422 2222221
Q ss_pred hcC---------CCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 252 SSA---------PITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 252 ~~~---------~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
... .....+...++.+.+++.+||+.||.+|||+.+++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 252 DEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp TTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred hhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 111 0111112345779999999999999999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=328.18 Aligned_cols=229 Identities=19% Similarity=0.259 Sum_probs=186.1
Q ss_pred eeeecceeeeEEEeeeee----------eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc---------------
Q psy5368 56 TIRYGELQYDTVQNSQIR----------LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK--------------- 110 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~----------~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~--------------- 110 (406)
...||+|+||.||++... +..+++|..... ..+.+|+.++.+++|||+++
T Consensus 47 ~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~ 121 (352)
T 2jii_A 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPT 121 (352)
T ss_dssp EEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCC
T ss_pred EEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCccc
Confidence 456778888888888763 456888877543 57899999999999998764
Q ss_pred -------cCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC--ee
Q psy5368 111 -------RPRYVYIILEYCDGGDLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN--TL 178 (406)
Q Consensus 111 -------~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~--~~ 178 (406)
..+..|+||||+ +++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++ .+
T Consensus 122 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~ 200 (352)
T 2jii_A 122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQV 200 (352)
T ss_dssp CCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEE
T ss_pred hhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceE
Confidence 368899999999 89999999876 6899999999999999999999999999999999999999 44 89
Q ss_pred EEEecccccccCCCC--------CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHH
Q psy5368 179 KLADFGFAQFLAPND--------QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCN--LSQLRA 248 (406)
Q Consensus 179 kL~DFGla~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~--~~~~~~ 248 (406)
||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ...+..
T Consensus 201 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 280 (352)
T 2jii_A 201 TLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMK 280 (352)
T ss_dssp EECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHH
T ss_pred EEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHH
Confidence 999999997654322 1234579999999999999999999999999999999999999998753 333322
Q ss_pred HHH--hcCCCCCCC-----CCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 249 QAL--SSAPITIPP-----NSLSPDCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 249 ~~~--~~~~~~~~~-----~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
... .......+. ..+++++.+|+.+||+.||++|||++++++
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 281 QKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp HHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 222 111111111 257899999999999999999999999876
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=332.65 Aligned_cols=255 Identities=17% Similarity=0.260 Sum_probs=198.9
Q ss_pred eeeeccccccccceeeecCceeeecceeeeEEEeeeee-eceeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCcc---
Q psy5368 36 QVRSDTVRSGTVRYDIVGSSTIRYGELQYDTVQNSQIR-LGTVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRK--- 110 (406)
Q Consensus 36 ~~~~d~~~~~~~~~~i~~~~~~~lG~G~~g~Vy~~~~~-~~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~--- 110 (406)
.+..++.......| .....||+|+||.||++... +..+++|.+...... ....+.+|+.++..++|||+++
T Consensus 19 ~~~~~~~~~~~~~y----~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 19 RFSLRELQVASDNF----SNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp ECCTHHHHTTTTSS----CSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred eecHHHHHHHhhcc----ccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 44556666677777 55678999999999999864 567889887655433 3447899999999999999876
Q ss_pred ---cCCeEEEEEeccCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCCcceEee-CCeeE
Q psy5368 111 ---RPRYVYIILEYCDGGDLCSFIRSHE----KLSEFQCQQFVRQLVLALKFLREN---NVCHFDLKPQNILIK-NNTLK 179 (406)
Q Consensus 111 ---~~~~~~lV~E~~~ggsL~~~l~~~~----~l~~~~~~~i~~ql~~aL~~lH~~---givH~Dlkp~NIll~-~~~~k 179 (406)
..+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ ||+||||||+|||++ ++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 5667799999999999999997653 499999999999999999999999 999999999999999 66999
Q ss_pred EEecccccccCCCCC--CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHH
Q psy5368 180 LADFGFAQFLAPNDQ--GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCN--------LSQLRAQ 249 (406)
Q Consensus 180 L~DFGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~--------~~~~~~~ 249 (406)
|+|||++........ .....||+.|+|||++.+..++.++||||+||++|+|++|..||.... .......
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 999999987653332 334558999999999998889999999999999999999999995211 1111111
Q ss_pred HHhcCCCC-C-----C---CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 250 ALSSAPIT-I-----P---PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 250 ~~~~~~~~-~-----~---~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
........ . . +...++.+.+++.+||+.||.+|||+.++++|..-
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 00110000 0 0 01223679999999999999999999999998543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=332.00 Aligned_cols=235 Identities=16% Similarity=0.195 Sum_probs=180.9
Q ss_pred eeeecceeeeEEEeeeee-----eceeEEeeeecCCcc-----------chhhhhhHHhhcccCCCCCCcc------c--
Q psy5368 56 TIRYGELQYDTVQNSQIR-----LGTVKYSQVRYDTIT-----------SHSEFERPRAGLSNLRAPEGRK------R-- 111 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~-----~~~v~vk~~~~~~~~-----------~~~~~~~E~~~l~~l~h~ni~~------~-- 111 (406)
...||+|+||.||++... ...+++|........ ....+.+|+..+..++|||++. .
T Consensus 42 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~ 121 (345)
T 2v62_A 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEF 121 (345)
T ss_dssp EEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEES
T ss_pred EeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccccccc
Confidence 456788888888888863 345777766544321 2234667888999999999876 2
Q ss_pred --CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC--eeEEEecccc
Q psy5368 112 --PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN--TLKLADFGFA 186 (406)
Q Consensus 112 --~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~--~~kL~DFGla 186 (406)
....|+||||+ +++|.+++...+.+++.++..++.||+.||+|||++||+||||||+|||++ ++ .+||+|||++
T Consensus 122 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a 200 (345)
T 2v62_A 122 KGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLS 200 (345)
T ss_dssp SSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTC
T ss_pred CCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCc
Confidence 67899999999 999999998777999999999999999999999999999999999999998 44 8999999999
Q ss_pred cccCCCCC--------CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHH---hc
Q psy5368 187 QFLAPNDQ--------GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASC--NLSQLRAQAL---SS 253 (406)
Q Consensus 187 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~--~~~~~~~~~~---~~ 253 (406)
+....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+. +......... ..
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 280 (345)
T 2v62_A 201 YRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDE 280 (345)
T ss_dssp EESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHT
T ss_pred eecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhccc
Confidence 77643221 13457999999999999999999999999999999999999999652 2222211111 11
Q ss_pred CCC----CCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 254 API----TIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 254 ~~~----~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
.+. ..+...+|+++.+|+.+||+.||++|||++++++.
T Consensus 281 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 281 LPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp TTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred ccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 110 11222689999999999999999999999998764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=319.48 Aligned_cols=232 Identities=17% Similarity=0.229 Sum_probs=188.1
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc-------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK-------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~-------~~~~~~lV~E~~~ggs 126 (406)
...||+|+||.||++.. .+..+++|.+.... ....+.+|+.++..++|++++. ..+..++||||+ +++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (296)
T 3uzp_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS 90 (296)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCC
Confidence 45678889999999884 45678888765543 3457899999999999988543 667789999999 889
Q ss_pred HHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee----CCeeEEEecccccccCCCCC-------
Q psy5368 127 LCSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK----NNTLKLADFGFAQFLAPNDQ------- 194 (406)
Q Consensus 127 L~~~l~~-~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~----~~~~kL~DFGla~~~~~~~~------- 194 (406)
|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||++........
T Consensus 91 L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 170 (296)
T 3uzp_A 91 LEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 170 (296)
T ss_dssp HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCC
T ss_pred HHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccc
Confidence 9999974 45799999999999999999999999999999999999993 66899999999987654432
Q ss_pred -CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhc---CCCCCCCCCCChHH
Q psy5368 195 -GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNL---SQLRAQALSS---APITIPPNSLSPDC 267 (406)
Q Consensus 195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~---~~~~~~~~~~---~~~~~~~~~~s~~l 267 (406)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+... ......+... .+.......+|+++
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 250 (296)
T 3uzp_A 171 ENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEF 250 (296)
T ss_dssp CSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHH
T ss_pred cccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHH
Confidence 2456799999999999999999999999999999999999999986431 1111121111 11111123689999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q psy5368 268 MDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 268 ~~li~~~L~~dP~~Rps~~ell~ 290 (406)
.+|+.+||+.||++|||++++++
T Consensus 251 ~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 251 ATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHHHHHhcCcCcCCCHHHHHH
Confidence 99999999999999999999876
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=340.83 Aligned_cols=239 Identities=21% Similarity=0.319 Sum_probs=186.1
Q ss_pred CceeeecceeeeE-EEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccCCC
Q psy5368 54 SSTIRYGELQYDT-VQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 54 ~~~~~lG~G~~g~-Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
.....||+|+||+ |+++...+..||+|++.... ...+.+|+.+++.+ +|||+++ .....|+|||||.|
T Consensus 27 ~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g- 102 (432)
T 3p23_A 27 CPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA- 102 (432)
T ss_dssp EEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred ecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCCC-
Confidence 3456789999997 56666677889999886432 34578899999999 8999876 67788999999965
Q ss_pred CHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee----CC--eeEEEecccccccCCCC----C
Q psy5368 126 DLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK----NN--TLKLADFGFAQFLAPND----Q 194 (406)
Q Consensus 126 sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~----~~--~~kL~DFGla~~~~~~~----~ 194 (406)
+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++ ++ .+||+|||+++...... .
T Consensus 103 ~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~ 182 (432)
T 3p23_A 103 TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR 182 (432)
T ss_dssp EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---------
T ss_pred CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceee
Confidence 9999997664 466667789999999999999999999999999999995 22 57899999998765432 2
Q ss_pred CCcccCCCCCCChhhhcC---CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCC-CCCCCChHHHH
Q psy5368 195 GDSIQGSPLYMAPEILAG---SPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITI-PPNSLSPDCMD 269 (406)
Q Consensus 195 ~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~~ 269 (406)
.....||+.|+|||++.+ ..++.++||||+||++|+|++ |..||.................... +....+..+.+
T Consensus 183 ~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (432)
T 3p23_A 183 RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARE 262 (432)
T ss_dssp ---CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHH
T ss_pred ccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccccHHHHH
Confidence 345679999999999984 567889999999999999999 9999976654444332222111111 12234566899
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy5368 270 FLSRLLQKDPMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 270 li~~~L~~dP~~Rps~~ell~hp~~~~ 296 (406)
||.+||+.||.+|||++++++||||..
T Consensus 263 li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 263 LIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred HHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 999999999999999999999999975
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=325.80 Aligned_cols=238 Identities=21% Similarity=0.326 Sum_probs=198.6
Q ss_pred eeeecceeeeEEEeeeee-------eceeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIR-------LGTVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~-------~~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~ 121 (406)
...||+|+||.||++... ...+++|.+.... .....++.+|+.++++++|||+++ .....|+||||
T Consensus 35 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (327)
T 2yfx_A 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMEL 114 (327)
T ss_dssp EEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred EEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEec
Confidence 456899999999998843 3358888876432 233557899999999999999876 56678999999
Q ss_pred cCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee----CCeeEEEecccccccC
Q psy5368 122 CDGGDLCSFIRSHE-------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK----NNTLKLADFGFAQFLA 190 (406)
Q Consensus 122 ~~ggsL~~~l~~~~-------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~----~~~~kL~DFGla~~~~ 190 (406)
+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++ +..+||+|||++....
T Consensus 115 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~ 194 (327)
T 2yfx_A 115 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 194 (327)
T ss_dssp CTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHH
T ss_pred CCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccc
Confidence 99999999998753 489999999999999999999999999999999999998 2369999999997653
Q ss_pred CCC---CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChH
Q psy5368 191 PND---QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPD 266 (406)
Q Consensus 191 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 266 (406)
... ......+|+.|+|||++.+..++.++|||||||++|+|+| |..||...+.......+........ +..+++.
T Consensus 195 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 273 (327)
T 2yfx_A 195 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP-PKNCPGP 273 (327)
T ss_dssp C------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC-CTTCCHH
T ss_pred cccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCC-CCCCCHH
Confidence 322 2344567899999999999899999999999999999998 9999999988888877777654444 3478999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy5368 267 CMDFLSRLLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 267 l~~li~~~L~~dP~~Rps~~ell~hp~~ 294 (406)
+.+|+.+||+.||.+|||+.+++++.|+
T Consensus 274 l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 274 VYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 9999999999999999999999998774
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=331.13 Aligned_cols=234 Identities=17% Similarity=0.244 Sum_probs=181.1
Q ss_pred eeeecceeeeEEEeeeeee-------ceeEEeeeecCCcc-----------chhhhhhHHhhcccCCCCCCccc------
Q psy5368 56 TIRYGELQYDTVQNSQIRL-------GTVKYSQVRYDTIT-----------SHSEFERPRAGLSNLRAPEGRKR------ 111 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-------~~v~vk~~~~~~~~-----------~~~~~~~E~~~l~~l~h~ni~~~------ 111 (406)
...||+|+||.||++.... ..+++|........ ....+.+|+..+..++|||++..
T Consensus 40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 119 (364)
T 3op5_A 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLH 119 (364)
T ss_dssp EEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEE
T ss_pred EEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeee
Confidence 4567888888888887643 45788876554311 11223445667788899998761
Q ss_pred ----CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee---CCeeEEEec
Q psy5368 112 ----PRYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK---NNTLKLADF 183 (406)
Q Consensus 112 ----~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~---~~~~kL~DF 183 (406)
..+.||||||| |++|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+||
T Consensus 120 ~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DF 198 (364)
T 3op5_A 120 DKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDY 198 (364)
T ss_dssp EETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCC
T ss_pred ccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEEC
Confidence 25589999999 99999999876 5799999999999999999999999999999999999997 469999999
Q ss_pred ccccccCCCCC--------CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHh--
Q psy5368 184 GFAQFLAPNDQ--------GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQ-ALS-- 252 (406)
Q Consensus 184 Gla~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~-~~~-- 252 (406)
|+++....... .....||+.|+|||++.+..++.++|||||||++|+|+||+.||.+......... ...
T Consensus 199 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~ 278 (364)
T 3op5_A 199 GLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRY 278 (364)
T ss_dssp TTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHH
T ss_pred CcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHh
Confidence 99976543321 1344599999999999999999999999999999999999999986432111111 100
Q ss_pred -cC-----CCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 253 -SA-----PITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 253 -~~-----~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
.. ....+...+|+++.+|+..||..||.+||++.++++
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 279 RENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred hhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 00 001223468999999999999999999999998875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=320.61 Aligned_cols=235 Identities=23% Similarity=0.322 Sum_probs=183.3
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccc---hhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITS---HSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~---~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++... +..+++|.+....... ...+.+|+.++.+++|||+++ ..+.+|+||||++|
T Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 118 (309)
T 2h34_A 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLING 118 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCC
T ss_pred EEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCC
Confidence 345677777777777653 4567888765443222 357889999999999999875 67789999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC--CCCcccCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND--QGDSIQGS 201 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~--~~~~~~gt 201 (406)
++|.+++...+.+++..+..++.||+.||.|||++||+|+||||+||+++ ++.+||+|||++....... ......||
T Consensus 119 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 198 (309)
T 2h34_A 119 VDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGT 198 (309)
T ss_dssp EEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------------CC
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccccccCCC
Confidence 99999999888999999999999999999999999999999999999998 7799999999987654432 23355789
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCCCCCCChHHHHHHHHhcccCCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI-TIPPNSLSPDCMDFLSRLLQKDPM 280 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~s~~l~~li~~~L~~dP~ 280 (406)
+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+...+...+...... ...+..+|+++.+++.+||+.||+
T Consensus 199 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 278 (309)
T 2h34_A 199 LYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPE 278 (309)
T ss_dssp GGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGG
T ss_pred cCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHH
Confidence 9999999999999999999999999999999999999987766554444433221 122347899999999999999999
Q ss_pred CCC-CHHHHhc
Q psy5368 281 RRI-SYEDLFS 290 (406)
Q Consensus 281 ~Rp-s~~ell~ 290 (406)
+|| +++++++
T Consensus 279 ~Rp~s~~~l~~ 289 (309)
T 2h34_A 279 DRYVTCGDLSA 289 (309)
T ss_dssp GSCSSHHHHHH
T ss_pred HHHHhHHHHHH
Confidence 999 8888775
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=317.77 Aligned_cols=237 Identities=25% Similarity=0.424 Sum_probs=186.5
Q ss_pred ceeeecceeeeEEEeeee--eeceeEEeeeecCCcc---chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccC
Q psy5368 55 STIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTIT---SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ 123 (406)
....||+|+||.||++.. .+..+++|.+...... ....+.+|+.++++++|||+++ ..+..++||||++
T Consensus 36 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 115 (310)
T 2wqm_A 36 IEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 115 (310)
T ss_dssp EEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred EEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCC
Confidence 356789999999999985 4567889887653322 3456889999999999999876 6678999999999
Q ss_pred CCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCc
Q psy5368 124 GGDLCSFIRS----HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDS 197 (406)
Q Consensus 124 ggsL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~ 197 (406)
+++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++ ++.+||+|||++....... ....
T Consensus 116 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 195 (310)
T 2wqm_A 116 AGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 195 (310)
T ss_dssp SCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------------
T ss_pred CCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCccccc
Confidence 9999999964 45799999999999999999999999999999999999999 7799999999997664432 2344
Q ss_pred ccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhc
Q psy5368 198 IQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASC--NLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL 275 (406)
Q Consensus 198 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L 275 (406)
..|++.|+|||++.+..++.++||||||+++|+|++|..||.+. +.......+........+...+++++.+|+.+||
T Consensus 196 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 275 (310)
T 2wqm_A 196 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCI 275 (310)
T ss_dssp ---CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHT
T ss_pred cCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHHHc
Confidence 56899999999999999999999999999999999999999764 3445555555554444444578999999999999
Q ss_pred ccCCCCCCCHHHHhcC
Q psy5368 276 QKDPMRRISYEDLFSH 291 (406)
Q Consensus 276 ~~dP~~Rps~~ell~h 291 (406)
+.||.+|||+.+++++
T Consensus 276 ~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 276 NPDPEKRPDVTYVYDV 291 (310)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred CCChhhCCCHHHHHHH
Confidence 9999999999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=338.58 Aligned_cols=235 Identities=22% Similarity=0.338 Sum_probs=179.8
Q ss_pred eeeecceeeeEEEe-eeeeeceeEEeeeecCCccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQN-SQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~-~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
...||+|+||+||. +...+..||+|.+... ....+.+|+.++.++ +|||+++ ..+.+|+|||||. |+|
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 56789999998854 4445678999987653 245678999999876 8999876 6788999999996 599
Q ss_pred HHHHHhCCCC-------CHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeC--------------CeeEEEecccc
Q psy5368 128 CSFIRSHEKL-------SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN--------------NTLKLADFGFA 186 (406)
Q Consensus 128 ~~~l~~~~~l-------~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~--------------~~~kL~DFGla 186 (406)
.+++...... ++..+..++.||+.||+|||++||+||||||+|||++. ..+||+|||++
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a 175 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTC
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccc
Confidence 9999876432 23345789999999999999999999999999999973 27999999999
Q ss_pred cccCCCCC-----CCcccCCCCCCChhhhcC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q psy5368 187 QFLAPNDQ-----GDSIQGSPLYMAPEILAG-------SPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSS 253 (406)
Q Consensus 187 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 253 (406)
+....... .....||+.|+|||++.+ ..++.++|||||||++|||+| |..||.+...... .+...
T Consensus 176 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~--~i~~~ 253 (434)
T 2rio_A 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES--NIIRG 253 (434)
T ss_dssp EECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH--HHHHT
T ss_pred eecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH--HHhcC
Confidence 87654332 234579999999999976 568999999999999999999 9999987654432 22222
Q ss_pred C-CCCCC----CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy5368 254 A-PITIP----PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 254 ~-~~~~~----~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 296 (406)
. ..... ...+++++.+|+.+||+.||.+|||+.++++||||..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 254 IFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp CCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred CCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 1 11111 1134578999999999999999999999999999963
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=316.14 Aligned_cols=232 Identities=18% Similarity=0.240 Sum_probs=183.5
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc-------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK-------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~-------~~~~~~lV~E~~~ggs 126 (406)
...||+|+||.||++.. .+..+++|..... .....+.+|+.++..++|++++. .....++||||+ +++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (296)
T 4hgt_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS 90 (296)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred eeeecCCCCeEEEEEEEcCCCceEEEEeeccc--ccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCC
Confidence 44567777777777764 3456777765443 23346889999999999988553 677889999999 889
Q ss_pred HHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEe---e-CCeeEEEecccccccCCCCC-------
Q psy5368 127 LCSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI---K-NNTLKLADFGFAQFLAPNDQ------- 194 (406)
Q Consensus 127 L~~~l~~-~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll---~-~~~~kL~DFGla~~~~~~~~------- 194 (406)
|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ + ++.+||+|||+++.......
T Consensus 91 L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 170 (296)
T 4hgt_A 91 LEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 170 (296)
T ss_dssp HHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCC
T ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCC
Confidence 9999975 4579999999999999999999999999999999999999 4 66899999999987654432
Q ss_pred -CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh---cCCCCCCCCCCChHH
Q psy5368 195 -GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLS---QLRAQALS---SAPITIPPNSLSPDC 267 (406)
Q Consensus 195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~---~~~~~~~~---~~~~~~~~~~~s~~l 267 (406)
.....||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.. .....+.. ..+.......+|+++
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 250 (296)
T 4hgt_A 171 ENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEF 250 (296)
T ss_dssp CSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHH
T ss_pred cccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHH
Confidence 23567999999999999999999999999999999999999999864321 11111111 111111123689999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q psy5368 268 MDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 268 ~~li~~~L~~dP~~Rps~~ell~ 290 (406)
.+|+.+||+.||++|||++++++
T Consensus 251 ~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 251 ATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCHHHHHH
Confidence 99999999999999999999876
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=321.52 Aligned_cols=234 Identities=22% Similarity=0.370 Sum_probs=190.2
Q ss_pred eeeecceeeeEEEeeee------eeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc--------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQI------RLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK--------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~------~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~--------~~~~~~lV~E~ 121 (406)
...||+|+||.||++.. .+..+++|.+..........+.+|+.++++++|||+++ ....+++||||
T Consensus 46 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 125 (326)
T 2w1i_A 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY 125 (326)
T ss_dssp EEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECC
T ss_pred eeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEEC
Confidence 45678888888888873 34568888887665555678999999999999999876 23368999999
Q ss_pred cCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC----C
Q psy5368 122 CDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ----G 195 (406)
Q Consensus 122 ~~ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~----~ 195 (406)
+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++........ .
T Consensus 126 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 205 (326)
T 2w1i_A 126 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK 205 (326)
T ss_dssp CTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECS
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccc
Confidence 9999999999876 4699999999999999999999999999999999999999 77999999999987654432 2
Q ss_pred CcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhcCCCCCC
Q psy5368 196 DSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLS----------------QLRAQALSSAPITIP 259 (406)
Q Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~----------------~~~~~~~~~~~~~~~ 259 (406)
....+++.|+|||++.+..++.++|||||||++|+|+||..||...... .+...+........
T Consensus 206 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 284 (326)
T 2w1i_A 206 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR- 284 (326)
T ss_dssp SCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCC-
T ss_pred cCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCC-
Confidence 3345677899999999888999999999999999999999998643111 11222222222222
Q ss_pred CCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 260 PNSLSPDCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 260 ~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
+..+++++.+|+.+||+.||++|||+.++++
T Consensus 285 ~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 285 PDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 3478999999999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=320.10 Aligned_cols=235 Identities=25% Similarity=0.396 Sum_probs=190.6
Q ss_pred ceeeecceeeeEEEeeee--eeceeEEeeeecCCc------cchhhhhhHHhhcccC----CCCCCcc------cCCeEE
Q psy5368 55 STIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTI------TSHSEFERPRAGLSNL----RAPEGRK------RPRYVY 116 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~------~~~~~~~~E~~~l~~l----~h~ni~~------~~~~~~ 116 (406)
....||+|+||.||++.. .+..+++|.+..... .....+.+|+.++.++ +|||+++ ..+..+
T Consensus 35 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~ 114 (312)
T 2iwi_A 35 LGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFM 114 (312)
T ss_dssp EEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CE
T ss_pred EeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEE
Confidence 345688999999999876 345688887765433 2334577899999988 8999866 567789
Q ss_pred EEEec-cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee--CCeeEEEecccccccCCCC
Q psy5368 117 IILEY-CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK--NNTLKLADFGFAQFLAPND 193 (406)
Q Consensus 117 lV~E~-~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~--~~~~kL~DFGla~~~~~~~ 193 (406)
+|||+ +.+++|.+++..++.+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++......
T Consensus 115 ~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~- 193 (312)
T 2iwi_A 115 LVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE- 193 (312)
T ss_dssp EEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSS-
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccC-
Confidence 99999 78999999999888999999999999999999999999999999999999998 568999999999876543
Q ss_pred CCCcccCCCCCCChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHH
Q psy5368 194 QGDSIQGSPLYMAPEILAGSPY-NAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLS 272 (406)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~ 272 (406)
......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.... . +... .... +..+++++.+|+.
T Consensus 194 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~----~~~~-~~~~-~~~~~~~~~~li~ 265 (312)
T 2iwi_A 194 PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--E----ILEA-ELHF-PAHVSPDCCALIR 265 (312)
T ss_dssp CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HHHT-CCCC-CTTSCHHHHHHHH
T ss_pred cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--H----Hhhh-ccCC-cccCCHHHHHHHH
Confidence 3345668999999999987665 458999999999999999999997632 1 2222 2222 3468999999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 273 RLLQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 273 ~~L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
+||+.||++|||++++++||||+...
T Consensus 266 ~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 266 RCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp HHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred HHccCChhhCcCHHHHhcChhhcCch
Confidence 99999999999999999999998654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=320.80 Aligned_cols=231 Identities=19% Similarity=0.314 Sum_probs=184.0
Q ss_pred eecceeeeEEEeeee------eeceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc--------cCCeEEEEEecc
Q psy5368 58 RYGELQYDTVQNSQI------RLGTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK--------RPRYVYIILEYC 122 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~------~~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~--------~~~~~~lV~E~~ 122 (406)
.||+|+||.||.+.+ .+..+++|.+..... .....+.+|+.++++++|||+++ ....+++||||+
T Consensus 38 ~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 117 (318)
T 3lxp_A 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYV 117 (318)
T ss_dssp EEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCC
T ss_pred eecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecc
Confidence 445555666654432 345688888765432 23457899999999999999876 246789999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC----CCc
Q psy5368 123 DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ----GDS 197 (406)
Q Consensus 123 ~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~----~~~ 197 (406)
++++|.+++... .+++..+..++.||+.||.|||++||+|+||||+||+++ ++.+||+|||++........ ...
T Consensus 118 ~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 196 (318)
T 3lxp_A 118 PLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 196 (318)
T ss_dssp TTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---
T ss_pred cCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccccccccccC
Confidence 999999999764 599999999999999999999999999999999999999 67899999999987654432 334
Q ss_pred ccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHHHhcCCCCCCCCC
Q psy5368 198 IQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLS---------------QLRAQALSSAPITIPPNS 262 (406)
Q Consensus 198 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~---------------~~~~~~~~~~~~~~~~~~ 262 (406)
..+|+.|+|||++.+..++.++||||+||++|+|++|..||...... .....+....... .+..
T Consensus 197 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 275 (318)
T 3lxp_A 197 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLP-RPDK 275 (318)
T ss_dssp CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCC-CCTT
T ss_pred CCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCC-CCcc
Confidence 55788899999999988999999999999999999999999764321 1222222332223 3347
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 263 LSPDCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 263 ~s~~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
+++++.+|+.+||+.||.+|||+.++++
T Consensus 276 ~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 276 CPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 8999999999999999999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=343.36 Aligned_cols=238 Identities=24% Similarity=0.367 Sum_probs=203.9
Q ss_pred eeeecceeeeEEEeeeeee-ceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCCCCHHH
Q psy5368 56 TIRYGELQYDTVQNSQIRL-GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDGGDLCS 129 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ggsL~~ 129 (406)
...||+|+||.||++.+.. ..|++|.+.... .....|.+|+.++++++|||+++ ..+.+|||||||++|+|.+
T Consensus 272 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~e~~~~gsL~~ 350 (535)
T 2h8h_A 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLD 350 (535)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTTEEHHH
T ss_pred heecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEeeehhcCCcHHH
Confidence 4579999999999999865 468888877544 34578999999999999999876 4467899999999999999
Q ss_pred HHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC--CCCcccCCCCC
Q psy5368 130 FIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND--QGDSIQGSPLY 204 (406)
Q Consensus 130 ~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~--~~~~~~gt~~y 204 (406)
++... ..+++.++..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++...... ......++..|
T Consensus 351 ~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y 430 (535)
T 2h8h_A 351 FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 430 (535)
T ss_dssp HHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGG
T ss_pred HHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccc
Confidence 99643 5699999999999999999999999999999999999998 6699999999997654321 12334467889
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
+|||++.+..++.++|||||||++|||++ |+.||.+....++...+........+. .+++++.+||.+||+.||++||
T Consensus 431 ~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RP 509 (535)
T 2h8h_A 431 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP-ECPESLHDLMCQCWRKEPEERP 509 (535)
T ss_dssp SCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCT-TCCHHHHHHHHHHTCSSGGGSC
T ss_pred cCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC-CCCHHHHHHHHHHcCCChhHCc
Confidence 99999999899999999999999999999 999999999888888877765544443 7899999999999999999999
Q ss_pred CHHHHhcC--CCCC
Q psy5368 284 SYEDLFSH--PYPD 295 (406)
Q Consensus 284 s~~ell~h--p~~~ 295 (406)
|++++++. .++.
T Consensus 510 t~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 510 TFEYLQAFLEDYFT 523 (535)
T ss_dssp CHHHHHHHHHTSSC
T ss_pred CHHHHHHHHHHHhh
Confidence 99999874 5554
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=335.39 Aligned_cols=236 Identities=23% Similarity=0.365 Sum_probs=188.4
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc--------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK--------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~--------~~~~~~lV~E~~~g 124 (406)
...||+|+||.||++... +..+++|.+.... ......+.+|+.++++++|||+++ .....|+|||||+|
T Consensus 14 ~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~ 93 (396)
T 4eut_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTT
T ss_pred EEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCC
Confidence 345677777777777754 4568888776543 234567889999999999999876 23478999999999
Q ss_pred CCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEe----e-CCeeEEEecccccccCCCCCCC
Q psy5368 125 GDLCSFIRSHE---KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI----K-NNTLKLADFGFAQFLAPNDQGD 196 (406)
Q Consensus 125 gsL~~~l~~~~---~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll----~-~~~~kL~DFGla~~~~~~~~~~ 196 (406)
|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||+ + ++.+||+|||+++.........
T Consensus 94 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~ 173 (396)
T 4eut_A 94 GSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV 173 (396)
T ss_dssp EEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSS
T ss_pred CCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCccc
Confidence 99999997543 39999999999999999999999999999999999998 4 3479999999998876666566
Q ss_pred cccCCCCCCChhhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhcCCCCC------
Q psy5368 197 SIQGSPLYMAPEILAG--------SPYNAKADLWSLGVLVFEALFGHAPYASC----NLSQLRAQALSSAPITI------ 258 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltg~~pf~~~----~~~~~~~~~~~~~~~~~------ 258 (406)
...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||... ...+....+....+...
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 253 (396)
T 4eut_A 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQK 253 (396)
T ss_dssp CSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEEC
T ss_pred cccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhhee
Confidence 6789999999999875 45788999999999999999999999642 33445555555433211
Q ss_pred ------------CC-----CCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 259 ------------PP-----NSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 259 ------------~~-----~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
+. ..+++.+.+++.+||+.||++|||+++++++
T Consensus 254 ~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 254 AENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp STTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred ccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 10 1234578899999999999999999998664
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=321.09 Aligned_cols=239 Identities=17% Similarity=0.271 Sum_probs=181.1
Q ss_pred eeeecceeeeEEEeeeeeeceeEEeeeecCCccchhhhh--hHHhhcccCCCCCCcc-----------cCCeEEEEEecc
Q psy5368 56 TIRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFE--RPRAGLSNLRAPEGRK-----------RPRYVYIILEYC 122 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~--~E~~~l~~l~h~ni~~-----------~~~~~~lV~E~~ 122 (406)
...||+|+||.||++...+..+++|.+.... ...+. .|+..+..++|||+++ ....+|+|||||
T Consensus 18 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 94 (336)
T 3g2f_A 18 LELIGRGRYGAVYKGSLDERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYY 94 (336)
T ss_dssp EEEEEECSSEEEEEEEETTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCC
T ss_pred eeecccCCCeEEEEEEECCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecC
Confidence 4678999999999998888889999886432 23333 4455566799999765 233678999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------CcccccCCCcceEee-CCeeEEEecccccccCCC
Q psy5368 123 DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLREN---------NVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN 192 (406)
Q Consensus 123 ~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~---------givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~ 192 (406)
++|+|.+++... ..++..+..++.||+.||.|||++ ||+||||||+|||++ ++.+||+|||+++.....
T Consensus 95 ~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~ 173 (336)
T 3g2f_A 95 PNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173 (336)
T ss_dssp TTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred CCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccc
Confidence 999999999765 459999999999999999999999 999999999999999 679999999999876432
Q ss_pred C---------CCCcccCCCCCCChhhhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCC-C-------------
Q psy5368 193 D---------QGDSIQGSPLYMAPEILAG-------SPYNAKADLWSLGVLVFEALFGHAPYASC-N------------- 242 (406)
Q Consensus 193 ~---------~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~elltg~~pf~~~-~------------- 242 (406)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|..||... .
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~ 253 (336)
T 3g2f_A 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVG 253 (336)
T ss_dssp SCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHC
T ss_pred cccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccC
Confidence 2 1234569999999999987 34667899999999999999997665332 1
Q ss_pred ----HHHHHHHHHhcC-CCCCCCC-----CCChHHHHHHHHhcccCCCCCCCHHHHhc------CCCCCCCC
Q psy5368 243 ----LSQLRAQALSSA-PITIPPN-----SLSPDCMDFLSRLLQKDPMRRISYEDLFS------HPYPDLIH 298 (406)
Q Consensus 243 ----~~~~~~~~~~~~-~~~~~~~-----~~s~~l~~li~~~L~~dP~~Rps~~ell~------hp~~~~~~ 298 (406)
............ ....+.. .+++++.+||.+||+.||++|||+.|+++ ++|-+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~ 325 (336)
T 3g2f_A 254 NHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKS 325 (336)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC---
T ss_pred CCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhccc
Confidence 112222222211 1122211 13457999999999999999999999954 68877544
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=322.63 Aligned_cols=234 Identities=20% Similarity=0.309 Sum_probs=175.2
Q ss_pred CceeeecceeeeEEEeeee--eeceeEEeeeecCCccchhhhhhHHhhcccCC-CCCCcc--------------cCCeEE
Q psy5368 54 SSTIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITSHSEFERPRAGLSNLR-APEGRK--------------RPRYVY 116 (406)
Q Consensus 54 ~~~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~--------------~~~~~~ 116 (406)
.....||+|+||.||++.. .+..+++|.+..........+.+|+.++.++. |||+++ ....++
T Consensus 31 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~ 110 (337)
T 3ll6_A 31 RVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFL 110 (337)
T ss_dssp EEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEE
T ss_pred EEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEE
Confidence 3456789999999999987 45678999887666556678999999999996 999875 334579
Q ss_pred EEEeccCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCcceEee-CCeeEEEecccccccC
Q psy5368 117 IILEYCDGGDLCSFIRS---HEKLSEFQCQQFVRQLVLALKFLRENN--VCHFDLKPQNILIK-NNTLKLADFGFAQFLA 190 (406)
Q Consensus 117 lV~E~~~ggsL~~~l~~---~~~l~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dlkp~NIll~-~~~~kL~DFGla~~~~ 190 (406)
+||||+. |+|.+++.. .+.+++..+..++.||+.||.|||++| |+||||||+|||++ ++.+||+|||+++...
T Consensus 111 lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 189 (337)
T 3ll6_A 111 LLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTIS 189 (337)
T ss_dssp EEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCS
T ss_pred EEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceecc
Confidence 9999996 599999864 457999999999999999999999999 99999999999999 6799999999998765
Q ss_pred CCCCC-------------CcccCCCCCCChhhh---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Q psy5368 191 PNDQG-------------DSIQGSPLYMAPEIL---AGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSA 254 (406)
Q Consensus 191 ~~~~~-------------~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 254 (406)
..... ....||+.|+|||++ .+..++.++|||||||++|+|++|..||........... .
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~----~ 265 (337)
T 3ll6_A 190 HYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG----K 265 (337)
T ss_dssp SCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred ccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC----c
Confidence 43221 144589999999998 566789999999999999999999999987654433222 1
Q ss_pred CCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q psy5368 255 PITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHP 292 (406)
Q Consensus 255 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp 292 (406)
....+....++.+.+|+.+||+.||.+|||+.+++++.
T Consensus 266 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 266 YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 22223346788999999999999999999999999873
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=352.73 Aligned_cols=260 Identities=21% Similarity=0.296 Sum_probs=192.2
Q ss_pred ccccceEEEeeeeeeEEEeeeeecCCcceeeeeeccccccccceeeecCceeeecceeeeEEEeeeeeeceeEEeeeecC
Q psy5368 6 TVRYGTVRLGSVKYGQVQLSTVRYGKVRYSQVRSDTVRSGTVRYDIVGSSTIRYGELQYDTVQNSQIRLGTVKYSQVRYD 85 (406)
Q Consensus 6 ~g~~~~V~ig~~~~gy~vv~~lg~G~~~~~~~~~d~~~~~~~~~~i~~~~~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~ 85 (406)
.|||+|+..|...+.|.++++||.|++|.||.+.+.... ..+++|.+...
T Consensus 1 GGG~~p~~pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg------------------------------~~VAVKvi~~~ 50 (676)
T 3qa8_A 1 GGGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTG------------------------------EQVAIKQCRQE 50 (676)
T ss_dssp ----------------CCCCCCCBCSSSBCCCCCCTTTT------------------------------CCEEECCCCSC
T ss_pred CCCCCCCCCCCCCCCeEEEEEEeeCCCeEEEEEEECCCC------------------------------cEEEEEEeccc
Confidence 389999999999877999999998888888776644322 34566655433
Q ss_pred C-ccchhhhhhHHhhcccCCCCCCcc------------cCCeEEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHH
Q psy5368 86 T-ITSHSEFERPRAGLSNLRAPEGRK------------RPRYVYIILEYCDGGDLCSFIRSHE---KLSEFQCQQFVRQL 149 (406)
Q Consensus 86 ~-~~~~~~~~~E~~~l~~l~h~ni~~------------~~~~~~lV~E~~~ggsL~~~l~~~~---~l~~~~~~~i~~ql 149 (406)
. ......+.+|+.++.+++|||++. ..+..|+|||||+||+|.+++.... .+++..+..++.||
T Consensus 51 ~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QL 130 (676)
T 3qa8_A 51 LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130 (676)
T ss_dssp CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHH
Confidence 2 223457899999999999999865 2677899999999999999998754 69999999999999
Q ss_pred HHHHHHHHHCCcccccCCCcceEee-CC---eeEEEecccccccCCCCCCCcccCCCCCCChhhhcCCCCCchhhHHHHH
Q psy5368 150 VLALKFLRENNVCHFDLKPQNILIK-NN---TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLG 225 (406)
Q Consensus 150 ~~aL~~lH~~givH~Dlkp~NIll~-~~---~~kL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 225 (406)
+.||+|||++||+||||||+||+++ ++ .+||+|||++.............||+.|+|||++.+..++.++||||+|
T Consensus 131 l~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLG 210 (676)
T 3qa8_A 131 SSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFG 210 (676)
T ss_dssp HHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHH
T ss_pred HHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHH
Confidence 9999999999999999999999998 33 4999999999887766666677899999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHH---------HHHHhcC----------CCCCC---CCCCChHHHHHHHHhcccCCCCCC
Q psy5368 226 VLVFEALFGHAPYASCNLSQLR---------AQALSSA----------PITIP---PNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 226 ~il~elltg~~pf~~~~~~~~~---------~~~~~~~----------~~~~~---~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
|++|+|++|..||.+....... ..+.... ....+ ...+++.+.+|+.+||..||++||
T Consensus 211 viLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRP 290 (676)
T 3qa8_A 211 TLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRG 290 (676)
T ss_dssp HHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---
T ss_pred HHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCc
Confidence 9999999999999765322110 0000000 00000 113567899999999999999999
Q ss_pred CHHHHhcCCCCC
Q psy5368 284 SYEDLFSHPYPD 295 (406)
Q Consensus 284 s~~ell~hp~~~ 295 (406)
|+.++++||||+
T Consensus 291 Ta~elL~hp~F~ 302 (676)
T 3qa8_A 291 TDPQNPNVGCFQ 302 (676)
T ss_dssp CCTTCCCCTTHH
T ss_pred CHHHHhcCHHHH
Confidence 999999999975
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=322.54 Aligned_cols=235 Identities=20% Similarity=0.267 Sum_probs=186.8
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCccc----------CCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRKR----------PRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~----------~~~~~lV~E~~~ 123 (406)
...||+|+||.||++.. .+..+++|.+..........+.+|+.+++.++|||+++. ....|+||||++
T Consensus 34 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~ 113 (317)
T 2buj_A 34 IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFK 113 (317)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCT
T ss_pred EEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCC
Confidence 45678888999988885 456788998776655566789999999999999998762 346789999999
Q ss_pred CCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC---
Q psy5368 124 GGDLCSFIRS----HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG--- 195 (406)
Q Consensus 124 ggsL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~--- 195 (406)
+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++.........
T Consensus 114 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~ 193 (317)
T 2buj_A 114 RGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQ 193 (317)
T ss_dssp TCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHH
T ss_pred CCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccc
Confidence 9999999975 46799999999999999999999999999999999999998 779999999998764322111
Q ss_pred -------CcccCCCCCCChhhhcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcCCCCCCCCCC
Q psy5368 196 -------DSIQGSPLYMAPEILAGSP---YNAKADLWSLGVLVFEALFGHAPYASCN--LSQLRAQALSSAPITIPPNSL 263 (406)
Q Consensus 196 -------~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~ 263 (406)
....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.... .......+... .....+..+
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 272 (317)
T 2buj_A 194 ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ-LSIPQSPRH 272 (317)
T ss_dssp HHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC---CCCCTTS
T ss_pred cccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc-CCCCccccC
Confidence 1234799999999998654 6889999999999999999999995421 11111222222 111222368
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 264 SPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 264 s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
++++.+|+.+||+.||.+|||+.+++++
T Consensus 273 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 273 SSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 9999999999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=316.42 Aligned_cols=233 Identities=21% Similarity=0.314 Sum_probs=181.2
Q ss_pred ceeeecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhc--ccCCCCCCcc------cC----CeEEEEEecc
Q psy5368 55 STIRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGL--SNLRAPEGRK------RP----RYVYIILEYC 122 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l--~~l~h~ni~~------~~----~~~~lV~E~~ 122 (406)
....||+|+||.||++...+..+++|.+... ....+.+|.+++ ..++|||+++ .. ..+|+||||+
T Consensus 41 ~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 117 (337)
T 3mdy_A 41 MVKQIGKGRYGEVWMGKWRGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYH 117 (337)
T ss_dssp EEEEEEEETTEEEEEEEETTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCC
T ss_pred EEeEeecCCCeEEEEEEECCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEecc
Confidence 3567899999999999988888999987543 233444454444 4459999876 22 6889999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccccCCCcceEee-CCeeEEEecccccccCCCC
Q psy5368 123 DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLREN--------NVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND 193 (406)
Q Consensus 123 ~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~--------givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~ 193 (406)
++|+|.++++. ..+++..+..++.|++.||.|||++ ||+||||||+|||++ ++.+||+|||++.......
T Consensus 118 ~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 196 (337)
T 3mdy_A 118 ENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT 196 (337)
T ss_dssp TTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred CCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeecccc
Confidence 99999999976 4799999999999999999999999 999999999999998 7799999999997664433
Q ss_pred C-----CCcccCCCCCCChhhhcCCCCCch------hhHHHHHHHHHHHHhC----------CCCCCCC-----CHHHHH
Q psy5368 194 Q-----GDSIQGSPLYMAPEILAGSPYNAK------ADLWSLGVLVFEALFG----------HAPYASC-----NLSQLR 247 (406)
Q Consensus 194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~------~DiwSlG~il~elltg----------~~pf~~~-----~~~~~~ 247 (406)
. .....||+.|+|||++.+..++.. +|||||||++|||+|| ..||... ......
T Consensus 197 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 276 (337)
T 3mdy_A 197 NEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMR 276 (337)
T ss_dssp ------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHH
T ss_pred ccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhH
Confidence 2 235579999999999988766654 9999999999999999 7777553 223333
Q ss_pred HHHHhcCC-CCCCC----CCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 248 AQALSSAP-ITIPP----NSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 248 ~~~~~~~~-~~~~~----~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
........ ...+. ..+++++.+|+.+||+.||.+|||+.++++|
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 277 EIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp HHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 33322221 11211 1456679999999999999999999999876
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=344.02 Aligned_cols=235 Identities=23% Similarity=0.412 Sum_probs=198.3
Q ss_pred eeeecceeeeEEEeeeeee-----ceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIRL-----GTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-----~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~g 124 (406)
...||+|+||.||+|.... ..+++|....... .....+.+|+.++++++|||+++ ..+..|+||||+++
T Consensus 395 ~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~lv~E~~~~ 474 (656)
T 2j0j_A 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTL 474 (656)
T ss_dssp EEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTT
T ss_pred eeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceEEEEEcCCC
Confidence 4679999999999998742 3467776654322 22467899999999999999876 45668999999999
Q ss_pred CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC--CCcccC
Q psy5368 125 GDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ--GDSIQG 200 (406)
Q Consensus 125 gsL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~--~~~~~g 200 (406)
|+|.+++..++ .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....... .....+
T Consensus 475 g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~ 554 (656)
T 2j0j_A 475 GELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 554 (656)
T ss_dssp CBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------C
T ss_pred CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCC
Confidence 99999998654 699999999999999999999999999999999999999 78999999999987654332 223456
Q ss_pred CCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCC
Q psy5368 201 SPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 201 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP 279 (406)
|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+........++ .+|+.+.+|+.+||+.||
T Consensus 555 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~l~~li~~~l~~dP 633 (656)
T 2j0j_A 555 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP-NCPPTLYSLMTKCWAYDP 633 (656)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCT-TCCHHHHHHHHHHTCSSG
T ss_pred CcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCc-cccHHHHHHHHHHcCCCh
Confidence 788999999998899999999999999999997 999999999888888887776555544 799999999999999999
Q ss_pred CCCCCHHHHhcC
Q psy5368 280 MRRISYEDLFSH 291 (406)
Q Consensus 280 ~~Rps~~ell~h 291 (406)
.+|||+.++++.
T Consensus 634 ~~RPs~~el~~~ 645 (656)
T 2j0j_A 634 SRRPRFTELKAQ 645 (656)
T ss_dssp GGSCCHHHHHHH
T ss_pred hHCcCHHHHHHH
Confidence 999999999853
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=316.62 Aligned_cols=232 Identities=19% Similarity=0.259 Sum_probs=187.7
Q ss_pred eeeecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhccc--CCCCCCcc------cC----CeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSN--LRAPEGRK------RP----RYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~--l~h~ni~~------~~----~~~~lV~E~~~ 123 (406)
...||+|+||.||++...+..+++|.+... ....+.+|++++.. ++|||+++ .. ..+|+||||++
T Consensus 47 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~ 123 (342)
T 1b6c_B 47 QESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 123 (342)
T ss_dssp EEEEEEETTEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCT
T ss_pred EeeecCCCCcEEEEEEEcCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecC
Confidence 457899999999999988888999987543 34567888888876 79999876 22 27899999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HCCcccccCCCcceEee-CCeeEEEecccccccCCCC-
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLR--------ENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND- 193 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH--------~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~- 193 (406)
+|+|.+++.. ..+++..+..++.|++.||.||| ++||+||||||+|||++ ++.+||+|||++.......
T Consensus 124 ~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 202 (342)
T 1b6c_B 124 HGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 202 (342)
T ss_dssp TCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTT
T ss_pred CCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceecccccc
Confidence 9999999976 47999999999999999999999 89999999999999998 7799999999998765443
Q ss_pred ----CCCcccCCCCCCChhhhcCCC------CCchhhHHHHHHHHHHHHhC----------CCCCCCC-----CHHHHHH
Q psy5368 194 ----QGDSIQGSPLYMAPEILAGSP------YNAKADLWSLGVLVFEALFG----------HAPYASC-----NLSQLRA 248 (406)
Q Consensus 194 ----~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlG~il~elltg----------~~pf~~~-----~~~~~~~ 248 (406)
......||+.|+|||++.+.. ++.++|||||||++|+|+|| ..||... ....+..
T Consensus 203 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 282 (342)
T 1b6c_B 203 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 282 (342)
T ss_dssp EEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHH
T ss_pred ccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHH
Confidence 234567999999999998763 34689999999999999999 7888764 2344444
Q ss_pred HHHhcCCC-CCCC----CCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 249 QALSSAPI-TIPP----NSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 249 ~~~~~~~~-~~~~----~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
.+...... ..+. ...++.+.+|+.+||+.||++|||+.++++|
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 283 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp HHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 44333222 2221 1234579999999999999999999999876
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=331.21 Aligned_cols=232 Identities=14% Similarity=0.115 Sum_probs=186.6
Q ss_pred ceeeecceeeeEEEeeeee--eceeEEeeeecCCcc---chhhhhhHHhhcccCCCC-CC---------------c----
Q psy5368 55 STIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT---SHSEFERPRAGLSNLRAP-EG---------------R---- 109 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~---~~~~~~~E~~~l~~l~h~-ni---------------~---- 109 (406)
....||+|+||.||++... +..||+|.+...... ....+.+|+.++..++|. |. +
T Consensus 82 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (413)
T 3dzo_A 82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 161 (413)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred EecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence 4568999999999999975 678999977643322 256789999999999872 10 0
Q ss_pred --------c-----cCCeEEEEEeccCCCCHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCc
Q psy5368 110 --------K-----RPRYVYIILEYCDGGDLCSFIRS-------HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 169 (406)
Q Consensus 110 --------~-----~~~~~~lV~E~~~ggsL~~~l~~-------~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~ 169 (406)
. ....++++|+++ +++|.++++. .+.+++..+..++.||+.||+|||++||+||||||+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~ 240 (413)
T 3dzo_A 162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPV 240 (413)
T ss_dssp ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccc
Confidence 0 123467888887 5699999841 235888899999999999999999999999999999
Q ss_pred ceEee-CCeeEEEecccccccCCCCCCCcccCCCCCCChhhh----------cCCCCCchhhHHHHHHHHHHHHhCCCCC
Q psy5368 170 NILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEIL----------AGSPYNAKADLWSLGVLVFEALFGHAPY 238 (406)
Q Consensus 170 NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DiwSlG~il~elltg~~pf 238 (406)
|||++ ++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|+|++|+.||
T Consensus 241 NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf 317 (413)
T 3dzo_A 241 DIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317 (413)
T ss_dssp GEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCC
T ss_pred eEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 99999 679999999998765433 345567 999999999 5556889999999999999999999999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy5368 239 ASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 296 (406)
...+.......+... ...+|+++.+||.+||+.||++|||+.++++||||+.
T Consensus 318 ~~~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 318 TDDAALGGSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp CTTGGGSCSGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred CCcchhhhHHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 886644333222211 1268899999999999999999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=327.83 Aligned_cols=232 Identities=17% Similarity=0.222 Sum_probs=186.8
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc-------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK-------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~-------~~~~~~lV~E~~~ggs 126 (406)
..+||+|+||.||++... +..|++|..... .....+.+|+.++..|+|++.+. .....+|||||+ +++
T Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~s 88 (483)
T 3sv0_A 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (483)
T ss_dssp CCCCEECSSCEEEEEEETTTCCEEEEEEEETT--CSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEeeCCCEEEEEEEECCCCcEEEEEEeccc--cccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCC
Confidence 345788888888888753 567888866544 23456899999999998876432 667889999999 889
Q ss_pred HHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEe---e-CCeeEEEecccccccCCCCC-------
Q psy5368 127 LCSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI---K-NNTLKLADFGFAQFLAPNDQ------- 194 (406)
Q Consensus 127 L~~~l~~-~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll---~-~~~~kL~DFGla~~~~~~~~------- 194 (406)
|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ + ++.+||+|||+++.......
T Consensus 89 L~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 168 (483)
T 3sv0_A 89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168 (483)
T ss_dssp HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCC
T ss_pred HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccc
Confidence 9999975 4579999999999999999999999999999999999999 3 67999999999987654432
Q ss_pred -CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcC---CCCCCCCCCChHH
Q psy5368 195 -GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNL---SQLRAQALSSA---PITIPPNSLSPDC 267 (406)
Q Consensus 195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~---~~~~~~~~~~~---~~~~~~~~~s~~l 267 (406)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ......+.... ........+++++
T Consensus 169 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l 248 (483)
T 3sv0_A 169 ENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEF 248 (483)
T ss_dssp CCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHH
T ss_pred cccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHH
Confidence 2256799999999999999999999999999999999999999987542 22222222211 1111113689999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q psy5368 268 MDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 268 ~~li~~~L~~dP~~Rps~~ell~ 290 (406)
.+|+.+||+.||++||++.++++
T Consensus 249 ~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 249 ASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999988765
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=322.30 Aligned_cols=227 Identities=15% Similarity=0.149 Sum_probs=180.5
Q ss_pred eeeecceeeeEEEeee-------eeeceeEEeeeecCCccchhhhhhHHhhcccCC---CCCCcc------cCCeEEEEE
Q psy5368 56 TIRYGELQYDTVQNSQ-------IRLGTVKYSQVRYDTITSHSEFERPRAGLSNLR---APEGRK------RPRYVYIIL 119 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~-------~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~---h~ni~~------~~~~~~lV~ 119 (406)
...||+|+||.||++. .....+++|.+... ...++.+|+.++..++ |+|++. ..+..|+||
T Consensus 70 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~ 146 (365)
T 3e7e_A 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVG 146 (365)
T ss_dssp EEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEE
T ss_pred EEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEE
Confidence 4579999999999994 24567888877643 3456777777777775 888765 577889999
Q ss_pred eccCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeC------------CeeEEEe
Q psy5368 120 EYCDGGDLCSFIRS-----HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN------------NTLKLAD 182 (406)
Q Consensus 120 E~~~ggsL~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~------------~~~kL~D 182 (406)
|||+||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++. +.+||+|
T Consensus 147 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~D 226 (365)
T 3e7e_A 147 ELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALID 226 (365)
T ss_dssp CCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECC
T ss_pred eccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEee
Confidence 99999999999974 457999999999999999999999999999999999999975 6899999
Q ss_pred cccccccC---CCCCCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC
Q psy5368 183 FGFAQFLA---PNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIP 259 (406)
Q Consensus 183 FGla~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (406)
||+|+.+. .........||+.|+|||++.+..++.++|||||||++|||+||+.||........ .......
T Consensus 227 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------~~~~~~~ 300 (365)
T 3e7e_A 227 LGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC------KPEGLFR 300 (365)
T ss_dssp CTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE------EECSCCT
T ss_pred CchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce------eechhcc
Confidence 99997543 22233556799999999999999999999999999999999999999965322100 0011111
Q ss_pred CCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 260 PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 260 ~~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
....++.+.+++..||+.+|.+|++..+.+.+
T Consensus 301 ~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 301 RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 22356789999999999999999765554443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=307.84 Aligned_cols=216 Identities=24% Similarity=0.402 Sum_probs=172.6
Q ss_pred eeecceeeeEEEeeee--eeceeEEeeeecCCccchhhhhhHHhhc-ccCCCCCCcc------c----CCeEEEEEeccC
Q psy5368 57 IRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITSHSEFERPRAGL-SNLRAPEGRK------R----PRYVYIILEYCD 123 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~~~~~~~E~~~l-~~l~h~ni~~------~----~~~~~lV~E~~~ 123 (406)
..||+|+||.||++.. .+..+++|.+.. ...+.+|+.++ +.++|||+++ . .+.+|+||||++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 98 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 98 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence 4689999999999986 345788887743 35678898887 6669999876 2 567899999999
Q ss_pred CCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee----CCeeEEEecccccccCCCCCCCc
Q psy5368 124 GGDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK----NNTLKLADFGFAQFLAPNDQGDS 197 (406)
Q Consensus 124 ggsL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~----~~~~kL~DFGla~~~~~~~~~~~ 197 (406)
||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++....
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~------- 171 (299)
T 3m2w_A 99 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------- 171 (299)
T ss_dssp SCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-------
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc-------
Confidence 999999998764 699999999999999999999999999999999999998 3589999999986542
Q ss_pred ccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC---CCCCCC---CCCChHHHHHH
Q psy5368 198 IQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSA---PITIPP---NSLSPDCMDFL 271 (406)
Q Consensus 198 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~---~~~~~~---~~~s~~l~~li 271 (406)
+..++.++||||+||++|+|++|..||.+.............. ....+. ..+++++.+|+
T Consensus 172 --------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (299)
T 3m2w_A 172 --------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLI 237 (299)
T ss_dssp --------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHH
T ss_pred --------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHH
Confidence 2347889999999999999999999998765443321111111 111111 35799999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy5368 272 SRLLQKDPMRRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 272 ~~~L~~dP~~Rps~~ell~hp~~~~~~ 298 (406)
.+||+.||.+|||+.|+++||||....
T Consensus 238 ~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 238 RNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp HHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred HHHcccChhhCCCHHHHhcChhhcccc
Confidence 999999999999999999999998654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=315.04 Aligned_cols=230 Identities=16% Similarity=0.165 Sum_probs=182.7
Q ss_pred ceeeecceeeeEEEeeeeeeceeEEeeeecCCcc--------chhhhhhHHhhcccCC---------CCCCcc-------
Q psy5368 55 STIRYGELQYDTVQNSQIRLGTVKYSQVRYDTIT--------SHSEFERPRAGLSNLR---------APEGRK------- 110 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~--------~~~~~~~E~~~l~~l~---------h~ni~~------- 110 (406)
....||+|+||.||++...+..+|+|.+...... ....+.+|+.+++.++ |||++.
T Consensus 24 ~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~ 103 (336)
T 2vuw_A 24 RCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCV 103 (336)
T ss_dssp TCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEE
T ss_pred heeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEe
Confidence 3467999999999999988888999988765321 2367888999888886 666543
Q ss_pred -----------------------------cCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCC
Q psy5368 111 -----------------------------RPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLR-ENN 160 (406)
Q Consensus 111 -----------------------------~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH-~~g 160 (406)
..+.+|||||||++|++.+.+.+ +.+++..++.++.||+.||+||| ++|
T Consensus 104 ~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ 182 (336)
T 2vuw_A 104 QGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLR 182 (336)
T ss_dssp ESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred cCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 17899999999999977776644 67899999999999999999999 999
Q ss_pred cccccCCCcceEee-CC--------------------eeEEEecccccccCCCCCCCcccCCCCCCChhhhcCCCCCchh
Q psy5368 161 VCHFDLKPQNILIK-NN--------------------TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKA 219 (406)
Q Consensus 161 ivH~Dlkp~NIll~-~~--------------------~~kL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 219 (406)
|+||||||+|||++ ++ .+||+|||+|+.... ....||+.|+|||++.+.. +.++
T Consensus 183 ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~~~g~~-~~~~ 257 (336)
T 2vuw_A 183 FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDLFTGDG-DYQF 257 (336)
T ss_dssp CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSGGGCCCS-SHHH
T ss_pred EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChhhhcCCC-ccce
Confidence 99999999999998 44 899999999987643 2457999999999998776 8999
Q ss_pred hHHHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHHhcCCCC-CCC----CCCChHHHHHHHHhcccCCCCCCCHHHHh-cC
Q psy5368 220 DLWSLGVL-VFEALFGHAPYASCNL-SQLRAQALSSAPIT-IPP----NSLSPDCMDFLSRLLQKDPMRRISYEDLF-SH 291 (406)
Q Consensus 220 DiwSlG~i-l~elltg~~pf~~~~~-~~~~~~~~~~~~~~-~~~----~~~s~~l~~li~~~L~~dP~~Rps~~ell-~h 291 (406)
||||++++ .+++++|..||..... ......+....... .+. ..+|+++.+||.+||++| |++|++ +|
T Consensus 258 Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 258 DIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred ehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 99998777 7778899999954221 12222333221111 111 146889999999999976 999999 99
Q ss_pred CCCC
Q psy5368 292 PYPD 295 (406)
Q Consensus 292 p~~~ 295 (406)
|||+
T Consensus 333 p~f~ 336 (336)
T 2vuw_A 333 SLFK 336 (336)
T ss_dssp GGGC
T ss_pred CCcC
Confidence 9985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=347.60 Aligned_cols=227 Identities=19% Similarity=0.222 Sum_probs=181.4
Q ss_pred ceeeecceeeeEEEeeeee---eceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCC-----eEEEEE
Q psy5368 55 STIRYGELQYDTVQNSQIR---LGTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPR-----YVYIIL 119 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~---~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~-----~~~lV~ 119 (406)
....||+|+||.||++... +..|++|.+..... .....+.+|+.++.+++|||+++ ..+ ..||||
T Consensus 84 i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~ 163 (681)
T 2pzi_A 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVM 163 (681)
T ss_dssp EEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred EEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEE
Confidence 3457899999999999864 35688887754332 23457889999999999999876 112 279999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeCCeeEEEecccccccCCCCCCCccc
Q psy5368 120 EYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLADFGFAQFLAPNDQGDSIQ 199 (406)
Q Consensus 120 E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~~~~kL~DFGla~~~~~~~~~~~~~ 199 (406)
||++|++|.+++.. .+++.++..++.||+.||.|||++||+||||||+|||++++.+||+|||+++..... ....
T Consensus 164 E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~~~kl~DFG~a~~~~~~---~~~~ 238 (681)
T 2pzi_A 164 EYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINSF---GYLY 238 (681)
T ss_dssp ECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSCEEECCCTTCEETTCC---SCCC
T ss_pred EeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCCcEEEEecccchhcccC---CccC
Confidence 99999999998754 799999999999999999999999999999999999999889999999999876433 4567
Q ss_pred CCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCC
Q psy5368 200 GSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 200 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP 279 (406)
||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+.... ......+....++.+.+||.+||+.||
T Consensus 239 gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dP 309 (681)
T 2pzi_A 239 GTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD--------GLPEDDPVLKTYDSYGRLLRRAIDPDP 309 (681)
T ss_dssp CCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS--------SCCTTCHHHHHCHHHHHHHHHHTCSSG
T ss_pred CCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc--------cccccccccccCHHHHHHHhhhccCCh
Confidence 99999999999776 488999999999999999999998753211 000011111346789999999999999
Q ss_pred CCCCCHHHHhcCCCCC
Q psy5368 280 MRRISYEDLFSHPYPD 295 (406)
Q Consensus 280 ~~Rps~~ell~hp~~~ 295 (406)
.+||+..+.+.|+|+.
T Consensus 310 ~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 310 RQRFTTAEEMSAQLTG 325 (681)
T ss_dssp GGSCSSHHHHHHHHHH
T ss_pred hhCCCHHHHHHHHHHH
Confidence 9999988887776653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=284.34 Aligned_cols=206 Identities=17% Similarity=0.125 Sum_probs=161.7
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCCccc---hhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITS---HSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~---~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
..||+|+||.||++... +..+++|.+....... ...+.+|+..+.+++|||++. ..+..|+||||++|+
T Consensus 37 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~ 116 (286)
T 3uqc_A 37 IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGG 116 (286)
T ss_dssp EEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEE
T ss_pred EEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCC
Confidence 45677777777777764 4578888876554332 367899999999999999875 677899999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLY 204 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y 204 (406)
+|.++++. + ....++..++.||+.||+|||++||+||||||+|||++ ++.+||+++| |
T Consensus 117 ~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-------------------~ 175 (286)
T 3uqc_A 117 SLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------------------T 175 (286)
T ss_dssp EHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-------------------C
T ss_pred CHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-------------------c
Confidence 99999954 3 46667899999999999999999999999999999999 7789987543 3
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhcCCCC--CCCCCCChHHHHHHHHhcccCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRA---QALSSAPIT--IPPNSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~---~~~~~~~~~--~~~~~~s~~l~~li~~~L~~dP 279 (406)
++ .++.++|||||||++|+|+||+.||.+.+...... ......... .....+|+++.+|+.+||+.||
T Consensus 176 ~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 248 (286)
T 3uqc_A 176 MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDG 248 (286)
T ss_dssp CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTS
T ss_pred cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCC
Confidence 33 37899999999999999999999998765322110 000110000 0113689999999999999999
Q ss_pred CCCCCHHHHhcC
Q psy5368 280 MRRISYEDLFSH 291 (406)
Q Consensus 280 ~~Rps~~ell~h 291 (406)
++| |+.++++.
T Consensus 249 ~~R-s~~el~~~ 259 (286)
T 3uqc_A 249 GIR-SASTLLNL 259 (286)
T ss_dssp SCC-CHHHHHHH
T ss_pred ccC-CHHHHHHH
Confidence 999 99999874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.3e-32 Score=276.91 Aligned_cols=174 Identities=15% Similarity=0.112 Sum_probs=120.6
Q ss_pred ecceeeeEEEeeee--eeceeEEeeeecCCc----------cchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEE
Q psy5368 59 YGELQYDTVQNSQI--RLGTVKYSQVRYDTI----------TSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIIL 119 (406)
Q Consensus 59 lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~----------~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~ 119 (406)
.+.|+.|.+..+.. -+..+++|.+..... ....+|.+|+++|+++ .|+|+++ +++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 45666665555443 245567776654421 2234699999999999 7898775 888999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCc
Q psy5368 120 EYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDS 197 (406)
Q Consensus 120 E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~ 197 (406)
|||+|++|.++|..++++++. +|+.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+..... ....+
T Consensus 322 Eyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t 398 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTN 398 (569)
T ss_dssp ECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHH
T ss_pred ecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccC
Confidence 999999999999998889875 4889999999999999999999999999999 779999999999876543 33456
Q ss_pred ccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Q psy5368 198 IQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHA 236 (406)
Q Consensus 198 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~ 236 (406)
.+||+.|||||++.+. +..++|+||+|++++++.++..
T Consensus 399 ~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 399 LVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp HHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred ceechhhccHHHhCCC-CCCcccccccccchhhhccccc
Confidence 7899999999999765 6778999999999888766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-28 Score=249.08 Aligned_cols=175 Identities=15% Similarity=0.152 Sum_probs=141.1
Q ss_pred eeeecceeeeEEEeeeeeeceeEEeeeecCCccc--------hhhhhhHHhhcccCCCCCCcc------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIRLGTVKYSQVRYDTITS--------HSEFERPRAGLSNLRAPEGRK------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~--------~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~ 121 (406)
...||+|+||.||++......+++|+........ .+++.+|++++++++|||++. ..+..||||||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~ 420 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSY 420 (540)
T ss_dssp -------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEEC
T ss_pred CCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEEC
Confidence 4589999999999998878888888754433221 234799999999999999883 45566999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeCCeeEEEecccccccCCCCC-------
Q psy5368 122 CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLADFGFAQFLAPNDQ------- 194 (406)
Q Consensus 122 ~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~~~~kL~DFGla~~~~~~~~------- 194 (406)
|+|++|.+++.. +..++.|++.||+|||++||+||||||+|||+++ .+||+|||+++.......
T Consensus 421 ~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~-~~kL~DFGla~~~~~~~~~~~~~~~ 491 (540)
T 3en9_A 421 INGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK-DLYIIDFGLGKISNLDEDKAVDLIV 491 (540)
T ss_dssp CCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS-SEEECCCTTCEECCCHHHHHHHHHH
T ss_pred CCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC-eEEEEECccCEECCCccccccchhh
Confidence 999999999865 6689999999999999999999999999999999 999999999988754322
Q ss_pred -CCcccCCCCCCChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy5368 195 -GDSIQGSPLYMAPEILAG--SPYNAKADLWSLGVLVFEALFGHAPYA 239 (406)
Q Consensus 195 -~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~ 239 (406)
.....||+.|||||++.. ..|+..+|+||..+-..+-..++.+|.
T Consensus 492 ~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 492 FKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred hhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 135679999999999987 568888999999998888887777664
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.1e-23 Score=195.97 Aligned_cols=138 Identities=16% Similarity=0.105 Sum_probs=108.9
Q ss_pred eeeecceeeeEEEeeeee-eceeEEeeeecCCcc------------------chhhhhhHHhhcccCCCCCCcc--cCCe
Q psy5368 56 TIRYGELQYDTVQNSQIR-LGTVKYSQVRYDTIT------------------SHSEFERPRAGLSNLRAPEGRK--RPRY 114 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~-~~~v~vk~~~~~~~~------------------~~~~~~~E~~~l~~l~h~ni~~--~~~~ 114 (406)
...||+|+||.||++... +..+++|........ ....+.+|+.++++++|+++.. ..+.
T Consensus 95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~v~~~~~~~~ 174 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEG 174 (282)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEET
T ss_pred cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCCcCeEEeccc
Confidence 478999999999999983 457888877543211 2346889999999998544433 3345
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeCCeeEEEecccccccCCCCC
Q psy5368 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLADFGFAQFLAPNDQ 194 (406)
Q Consensus 115 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~~~~kL~DFGla~~~~~~~~ 194 (406)
.|+|||||+|++|.+ +. ......++.|++.||.|||++||+||||||+|||++++.+||+|||+|+.
T Consensus 175 ~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~~~~vkl~DFG~a~~------ 241 (282)
T 1zar_A 175 NAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIIDFPQSVE------ 241 (282)
T ss_dssp TEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTEEEECCCTTCEE------
T ss_pred eEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEECCcEEEEECCCCeE------
Confidence 699999999999988 42 12455799999999999999999999999999999988999999999863
Q ss_pred CCcccCCCCCCChhhhcC
Q psy5368 195 GDSIQGSPLYMAPEILAG 212 (406)
Q Consensus 195 ~~~~~gt~~y~aPE~~~~ 212 (406)
+..++|||++.+
T Consensus 242 ------~~~~~a~e~l~r 253 (282)
T 1zar_A 242 ------VGEEGWREILER 253 (282)
T ss_dssp ------TTSTTHHHHHHH
T ss_pred ------CCCCCHHHHHHH
Confidence 445789998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=6.5e-20 Score=169.89 Aligned_cols=131 Identities=18% Similarity=0.112 Sum_probs=100.1
Q ss_pred ceeeecceeeeEEEeeee--eece--eEEeeeecCCccc------------------------hhhhhhHHhhcccCCCC
Q psy5368 55 STIRYGELQYDTVQNSQI--RLGT--VKYSQVRYDTITS------------------------HSEFERPRAGLSNLRAP 106 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~--~~~~--v~vk~~~~~~~~~------------------------~~~~~~E~~~l~~l~h~ 106 (406)
....||+|+||.||++.. .+.. +++|..+...... ...+.+|+..+..++|+
T Consensus 51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 130 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA 130 (258)
T ss_dssp EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence 346799999999999987 4456 8888754432110 12578899999999877
Q ss_pred CCcc----cCCeEEEEEeccCC-C----CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCCCcceEeeCC
Q psy5368 107 EGRK----RPRYVYIILEYCDG-G----DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLR-ENNVCHFDLKPQNILIKNN 176 (406)
Q Consensus 107 ni~~----~~~~~~lV~E~~~g-g----sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH-~~givH~Dlkp~NIll~~~ 176 (406)
++.. ..+..+|||||+.+ | +|.++... .++..+..++.|++.+|.||| +.||+||||||+|||+++
T Consensus 131 ~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~- 206 (258)
T 1zth_A 131 GVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID- 206 (258)
T ss_dssp TCCCCCEEEEETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS-
T ss_pred CCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC-
Confidence 6421 12345799999942 3 77776532 345677899999999999999 999999999999999999
Q ss_pred eeEEEeccccccc
Q psy5368 177 TLKLADFGFAQFL 189 (406)
Q Consensus 177 ~~kL~DFGla~~~ 189 (406)
.++|+|||+|...
T Consensus 207 ~~~liDFG~a~~~ 219 (258)
T 1zth_A 207 KVYFIDMGQAVTL 219 (258)
T ss_dssp SEEECCCTTCEET
T ss_pred cEEEEECcccccC
Confidence 9999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.56 E-value=1.9e-15 Score=146.52 Aligned_cols=130 Identities=15% Similarity=0.029 Sum_probs=91.3
Q ss_pred cCceeeecceeeeEEEeeeee-eceeEEeeeecCCcc-----chh---------h--------hhhHHhhcccCCCCCCc
Q psy5368 53 GSSTIRYGELQYDTVQNSQIR-LGTVKYSQVRYDTIT-----SHS---------E--------FERPRAGLSNLRAPEGR 109 (406)
Q Consensus 53 ~~~~~~lG~G~~g~Vy~~~~~-~~~v~vk~~~~~~~~-----~~~---------~--------~~~E~~~l~~l~h~ni~ 109 (406)
.+-...||+|++|.||.+... +..+|+|..+..... ... . ..+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 355678999999999999864 457888865432110 000 0 13466677777544432
Q ss_pred c----cCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeCC---------
Q psy5368 110 K----RPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN--------- 176 (406)
Q Consensus 110 ~----~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~~--------- 176 (406)
. .....+|||||++|++|.++. .......++.||+.+|.+||++|||||||||.|||++++
T Consensus 177 vp~p~~~~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~ 250 (397)
T 4gyi_A 177 VPEPIAQSRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSI 250 (397)
T ss_dssp CCCEEEEETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSE
T ss_pred CCeeeeccCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccccccc
Confidence 1 111236999999998886543 123456788999999999999999999999999999833
Q ss_pred --eeEEEecccccc
Q psy5368 177 --TLKLADFGFAQF 188 (406)
Q Consensus 177 --~~kL~DFGla~~ 188 (406)
.+.|+||+-+..
T Consensus 251 ~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 251 TLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEEEECCCTTCEE
T ss_pred ccceEEEEeCCccc
Confidence 389999997754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.14 E-value=9.6e-11 Score=107.83 Aligned_cols=125 Identities=13% Similarity=0.119 Sum_probs=93.2
Q ss_pred eecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccCCC----CCCc---ccCCeEEEEEeccCCCCHHHH
Q psy5368 58 RYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLRA----PEGR---KRPRYVYIILEYCDGGDLCSF 130 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h----~ni~---~~~~~~~lV~E~~~ggsL~~~ 130 (406)
..+.|+.+.||+....++.+.+|............+.+|+.+++.|.. |.++ ...+..|+||||++|.+|.+.
T Consensus 21 ~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 100 (263)
T 3tm0_A 21 DTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE 100 (263)
T ss_dssp CCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred eccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhc
Confidence 346677788999886667777876654322344568899998888743 2222 256788999999999999876
Q ss_pred HHhCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------------------
Q psy5368 131 IRSHEKLSEFQCQQFVRQLVLALKFLRE---------------------------------------------------- 158 (406)
Q Consensus 131 l~~~~~l~~~~~~~i~~ql~~aL~~lH~---------------------------------------------------- 158 (406)
+. +......++.+++.+|..||+
T Consensus 101 ~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 175 (263)
T 3tm0_A 101 YE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLK 175 (263)
T ss_dssp CC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHH
T ss_pred cC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHH
Confidence 31 222345788999999999998
Q ss_pred -------CCcccccCCCcceEeeCCe-eEEEeccccc
Q psy5368 159 -------NNVCHFDLKPQNILIKNNT-LKLADFGFAQ 187 (406)
Q Consensus 159 -------~givH~Dlkp~NIll~~~~-~kL~DFGla~ 187 (406)
..++|+|++|.||+++++. +.|+||+.+.
T Consensus 176 ~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 176 TEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred hcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 4489999999999999765 5699999764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.92 E-value=1.9e-09 Score=98.45 Aligned_cols=118 Identities=19% Similarity=0.092 Sum_probs=83.0
Q ss_pred cceeeeEEEeeeeee-ceeEEeeeecCCccchhhhhhHHhhcccCCCCCC-cc-------cCCeEEEEEeccCCCCHHHH
Q psy5368 60 GELQYDTVQNSQIRL-GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEG-RK-------RPRYVYIILEYCDGGDLCSF 130 (406)
Q Consensus 60 G~G~~g~Vy~~~~~~-~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni-~~-------~~~~~~lV~E~~~ggsL~~~ 130 (406)
+.|..+.||+..... ..+.+|..... ....+.+|+.+++.+++.++ +. ..+..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 355668999987543 34666654432 33567889988888855443 21 445689999999998884
Q ss_pred HHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--------------------------------------------------
Q psy5368 131 IRSHEKLSEFQCQQFVRQLVLALKFLRENN-------------------------------------------------- 160 (406)
Q Consensus 131 l~~~~~l~~~~~~~i~~ql~~aL~~lH~~g-------------------------------------------------- 160 (406)
. ...+ ...++.+++..|..||+..
T Consensus 104 ~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 177 (264)
T 1nd4_A 104 S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKAR 177 (264)
T ss_dssp T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHT
T ss_pred c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHh
Confidence 1 1122 2356777888888888643
Q ss_pred --------cccccCCCcceEeeCCe-eEEEecccccc
Q psy5368 161 --------VCHFDLKPQNILIKNNT-LKLADFGFAQF 188 (406)
Q Consensus 161 --------ivH~Dlkp~NIll~~~~-~kL~DFGla~~ 188 (406)
++|+|++|.||+++++. +.|+|||.+..
T Consensus 178 ~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 178 MPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999999765 56999998743
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.92 E-value=1.6e-09 Score=104.57 Aligned_cols=131 Identities=12% Similarity=0.139 Sum_probs=94.3
Q ss_pred eeeecceeeeEEEeeeeeeceeEEeeee--cCC-ccchhhhhhHHhhcccCCCCCC-----cc---cC---CeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIRLGTVKYSQVR--YDT-ITSHSEFERPRAGLSNLRAPEG-----RK---RP---RYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~~v~vk~~~--~~~-~~~~~~~~~E~~~l~~l~h~ni-----~~---~~---~~~~lV~E~ 121 (406)
-..++.|.++.||+....++.+.+|... ... ......+.+|..+++.|+..++ +. +. +..|+||||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 4567899999999998777777777654 222 1234578889999888864332 11 22 458899999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q psy5368 122 CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRE------------------------------------------- 158 (406)
Q Consensus 122 ~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~------------------------------------------- 158 (406)
++|.++.+.. ...++......++.+++..|..||+
T Consensus 123 v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (359)
T 3dxp_A 123 VSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSL 200 (359)
T ss_dssp CCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHH
T ss_pred cCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHH
Confidence 9998775421 1347888889999999999999997
Q ss_pred ---------------CCcccccCCCcceEeeC-C--eeEEEecccccc
Q psy5368 159 ---------------NNVCHFDLKPQNILIKN-N--TLKLADFGFAQF 188 (406)
Q Consensus 159 ---------------~givH~Dlkp~NIll~~-~--~~kL~DFGla~~ 188 (406)
..++|+|++|.|||+++ + .+.|+||+.+..
T Consensus 201 ~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 201 MDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999983 3 368999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.92 E-value=9.5e-10 Score=103.62 Aligned_cols=173 Identities=14% Similarity=0.149 Sum_probs=115.0
Q ss_pred eeecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccCCC-CC-----Ccc---cC---CeEEEEEeccCC
Q psy5368 57 IRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLRA-PE-----GRK---RP---RYVYIILEYCDG 124 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h-~n-----i~~---~~---~~~~lV~E~~~g 124 (406)
..++.|..+.||+.. ..+.+|..... .....+.+|+.+++.+.. .. +.. .. ...|+|||+++|
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEEC---CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 357899999999875 44555543221 334678899998877733 22 211 11 234799999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------------
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRE---------------------------------------------- 158 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~---------------------------------------------- 158 (406)
.+|.+... ..++..+...++.+++..|..||+
T Consensus 101 ~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 178 (304)
T 3sg8_A 101 VPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYR 178 (304)
T ss_dssp EECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHH
T ss_pred eECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHH
Confidence 88876443 357888888899999999998886
Q ss_pred ------------CCcccccCCCcceEeeC--C-eeEEEecccccccCCCCCCCcccCCCCC---CChhhhcC-----CCC
Q psy5368 159 ------------NNVCHFDLKPQNILIKN--N-TLKLADFGFAQFLAPNDQGDSIQGSPLY---MAPEILAG-----SPY 215 (406)
Q Consensus 159 ------------~givH~Dlkp~NIll~~--~-~~kL~DFGla~~~~~~~~~~~~~gt~~y---~aPE~~~~-----~~~ 215 (406)
..++|+|++|.||++++ + .+.|+||+.+........ ....... ..|+.... ...
T Consensus 179 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D---l~~~~~~~~~~~~~~~~~~l~~Y~~~ 255 (304)
T 3sg8_A 179 DILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND---FISLMEDDEEYGMEFVSKILNHYKHK 255 (304)
T ss_dssp HHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH---HHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred HHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH---HHHHHhhccccCHHHHHHHHHHcCCC
Confidence 13699999999999996 5 578999999865322111 1111111 33433221 111
Q ss_pred ---------CchhhHHHHHHHHHHHHhCCCCCC
Q psy5368 216 ---------NAKADLWSLGVLVFEALFGHAPYA 239 (406)
Q Consensus 216 ---------~~~~DiwSlG~il~elltg~~pf~ 239 (406)
....+.|+++.++|.+.+|..+|-
T Consensus 256 ~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 256 DIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 123689999999999999988763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=2.4e-06 Score=80.33 Aligned_cols=125 Identities=17% Similarity=0.067 Sum_probs=84.4
Q ss_pred eeecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccCCCC------CCc----ccCCeEEEEEeccCCCC
Q psy5368 57 IRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAP------EGR----KRPRYVYIILEYCDGGD 126 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~------ni~----~~~~~~~lV~E~~~ggs 126 (406)
..++.|..+.||+. ++...+|.- . .......+.+|..+|..|.+. .+. ...+..++|||+++|.+
T Consensus 25 ~~l~~G~~n~v~~v---g~~~VlR~~-~-~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 25 ESLGEGFRNYAILV---NGDWVFRFP-K-SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEECSSEEEEEE---TTTEEEEEE-S-SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eecCCCcceeEEEE---CCEEEEEec-C-CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 45678888889887 345555542 1 112345788999999888653 211 13455789999999988
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------------
Q psy5368 127 LCSFIRSHEKLSEFQCQQFVRQLVLALKFLREN----------------------------------------------- 159 (406)
Q Consensus 127 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~----------------------------------------------- 159 (406)
|.+... ..++......++.++...|..||+.
T Consensus 100 l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 177 (306)
T 3tdw_A 100 LGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQ 177 (306)
T ss_dssp CHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHH
T ss_pred Cchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHH
Confidence 876432 2345555556666666666666542
Q ss_pred -------------CcccccCCCcceEeeC----Ce-eEEEecccccc
Q psy5368 160 -------------NVCHFDLKPQNILIKN----NT-LKLADFGFAQF 188 (406)
Q Consensus 160 -------------givH~Dlkp~NIll~~----~~-~kL~DFGla~~ 188 (406)
.++|+|++|.||++++ +. +.|+||+.+..
T Consensus 178 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 178 SYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3589999999999986 55 48999998754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=7.3e-06 Score=79.79 Aligned_cols=70 Identities=9% Similarity=-0.096 Sum_probs=43.6
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCC-------ccchhhhhhHHhhcccCCC------CCCcc-cCCeEEEEE
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDT-------ITSHSEFERPRAGLSNLRA------PEGRK-RPRYVYIIL 119 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~-------~~~~~~~~~E~~~l~~l~h------~ni~~-~~~~~~lV~ 119 (406)
...+|.|..+.||++.. .++.+.+|...... .....++..|.+++..+.. |.+.. +....++||
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d~~~~~lvm 114 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVM 114 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEcCCccEEEE
Confidence 34689999999999964 34567777543211 1123456778888876632 22221 344568999
Q ss_pred eccCCC
Q psy5368 120 EYCDGG 125 (406)
Q Consensus 120 E~~~gg 125 (406)
|+++|.
T Consensus 115 E~l~g~ 120 (397)
T 2olc_A 115 EDLSHL 120 (397)
T ss_dssp CCCTTS
T ss_pred EeCCCc
Confidence 999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.93 E-value=8.6e-05 Score=70.12 Aligned_cols=29 Identities=28% Similarity=0.473 Sum_probs=25.8
Q ss_pred CCcccccCCCcceEee-CCeeEEEeccccc
Q psy5368 159 NNVCHFDLKPQNILIK-NNTLKLADFGFAQ 187 (406)
Q Consensus 159 ~givH~Dlkp~NIll~-~~~~kL~DFGla~ 187 (406)
..++|+|+++.|||++ ++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 5799999999999997 6789999999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=1.2e-05 Score=76.92 Aligned_cols=30 Identities=13% Similarity=0.221 Sum_probs=25.6
Q ss_pred CCcccccCCCcceEeeCC-eeEEEecccccc
Q psy5368 159 NNVCHFDLKPQNILIKNN-TLKLADFGFAQF 188 (406)
Q Consensus 159 ~givH~Dlkp~NIll~~~-~~kL~DFGla~~ 188 (406)
..++|+|++|.|||++++ .+.|+||+.+..
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 469999999999999966 478999998753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.83 E-value=6.5e-05 Score=68.73 Aligned_cols=116 Identities=15% Similarity=0.159 Sum_probs=75.8
Q ss_pred EEEeeeeee--ceeEEeeeecCCccchhhhhhHHhhcccCCC----CCCc---ccCCeEEEEEeccCCCCHHHHHHhCCC
Q psy5368 66 TVQNSQIRL--GTVKYSQVRYDTITSHSEFERPRAGLSNLRA----PEGR---KRPRYVYIILEYCDGGDLCSFIRSHEK 136 (406)
Q Consensus 66 ~Vy~~~~~~--~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h----~ni~---~~~~~~~lV~E~~~ggsL~~~l~~~~~ 136 (406)
.||+..... ..+.+|.... .....+.+|...|+.|.. |.++ .+.+..|+|||+++|.++.+.....
T Consensus 40 ~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~-- 114 (272)
T 4gkh_A 40 TIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY-- 114 (272)
T ss_dssp EEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC--
T ss_pred eEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC--
Confidence 577765432 2455554332 234568889888877632 3332 2567889999999998887765432
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHC---------------------------------------------------------
Q psy5368 137 LSEFQCQQFVRQLVLALKFLREN--------------------------------------------------------- 159 (406)
Q Consensus 137 l~~~~~~~i~~ql~~aL~~lH~~--------------------------------------------------------- 159 (406)
......+..++...|.-||+.
T Consensus 115 --~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 192 (272)
T 4gkh_A 115 --PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPD 192 (272)
T ss_dssp --GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCC
T ss_pred --HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCC
Confidence 122334555666666666631
Q ss_pred -CcccccCCCcceEeeCCe-eEEEecccccc
Q psy5368 160 -NVCHFDLKPQNILIKNNT-LKLADFGFAQF 188 (406)
Q Consensus 160 -givH~Dlkp~NIll~~~~-~kL~DFGla~~ 188 (406)
.++|+|+++.|||++++. +-|+||+.+..
T Consensus 193 ~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 193 SVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp EEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 168999999999999664 56999998753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00044 Score=60.87 Aligned_cols=122 Identities=18% Similarity=0.151 Sum_probs=80.0
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccC
Q psy5368 124 GGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRE-NNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQG 200 (406)
Q Consensus 124 ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~-~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~g 200 (406)
..||.+.|+.. .++++++++.++.|.+.+|.-+-. +.-..+=+.|..|++. +|.+...+ ..+. ..
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~ 99 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AG 99 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cc
Confidence 35799999755 589999999999999999877622 2222344557888888 77777653 1110 12
Q ss_pred CCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhccc
Q psy5368 201 SPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 201 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~ 277 (406)
...+.|||... ...+.+.=|||+|+++|..+-=..| .-.+..+|+.+..||..|..-
T Consensus 100 ~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 100 EPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp -------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHHHHHHTTC
T ss_pred ccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHHHHHHHhc
Confidence 33467888763 3356788999999999998742111 112237999999999999866
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00016 Score=67.50 Aligned_cols=29 Identities=21% Similarity=0.439 Sum_probs=25.1
Q ss_pred CcccccCCCcceEeeCCeeEEEecccccc
Q psy5368 160 NVCHFDLKPQNILIKNNTLKLADFGFAQF 188 (406)
Q Consensus 160 givH~Dlkp~NIll~~~~~kL~DFGla~~ 188 (406)
.++|+|+.|.||+.+++.+.++||..+..
T Consensus 174 ~l~HgDl~~~Nil~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFLDTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEEECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEEECCCCEEEEecccccC
Confidence 38999999999997788899999987643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00016 Score=70.90 Aligned_cols=32 Identities=19% Similarity=0.431 Sum_probs=27.4
Q ss_pred HHCCcccccCCCcceEeeCCeeEEEecccccc
Q psy5368 157 RENNVCHFDLKPQNILIKNNTLKLADFGFAQF 188 (406)
Q Consensus 157 H~~givH~Dlkp~NIll~~~~~kL~DFGla~~ 188 (406)
+...++|+|++|.|||++++.++++||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDSTQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSCEEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCCCEEEeCccccc
Confidence 35679999999999999966699999998754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0013 Score=60.65 Aligned_cols=72 Identities=14% Similarity=0.064 Sum_probs=47.3
Q ss_pred eeeecceeeeEEEeeeeeec-eeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQIRLG-TVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~-~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ggsL 127 (406)
...+|.|..+.||+.+..++ .+.+|............|.+|+..|+.|.....+. ..+.-++||||++++..
T Consensus 20 v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 20 VAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWDDRTLAMEWVDERPP 97 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEETTEEEEECCCCCCC
T ss_pred EEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEeccCceEEEEeecccCC
Confidence 45679999999999997654 56666544444344556888998888774332121 11223689999987653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00072 Score=63.36 Aligned_cols=129 Identities=16% Similarity=0.091 Sum_probs=72.1
Q ss_pred eeecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccCC-----CCCCcc---------cCCeEEEEEecc
Q psy5368 57 IRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLR-----APEGRK---------RPRYVYIILEYC 122 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~-----h~ni~~---------~~~~~~lV~E~~ 122 (406)
..++.|..+.+|+.....+...+|..... .....+..|+.++..|+ -|.++. ..+..++||+|+
T Consensus 28 ~~i~~G~~n~~~~v~~~~g~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKDPLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred eccCCCcccceEEEEeCCccEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 35677888899998876666666655432 12334556666665552 344332 235678999999
Q ss_pred CCCCHH-----------HH---HHhC-CC--------CC---HHHHHH------------HHHHHHHHHHHHHH------
Q psy5368 123 DGGDLC-----------SF---IRSH-EK--------LS---EFQCQQ------------FVRQLVLALKFLRE------ 158 (406)
Q Consensus 123 ~ggsL~-----------~~---l~~~-~~--------l~---~~~~~~------------i~~ql~~aL~~lH~------ 158 (406)
+|.++. +. ++.. .. .. |..... +...+...++.+.+
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 986531 11 1111 11 11 111000 00113344555542
Q ss_pred -CCcccccCCCcceEeeCCee-EEEeccccc
Q psy5368 159 -NNVCHFDLKPQNILIKNNTL-KLADFGFAQ 187 (406)
Q Consensus 159 -~givH~Dlkp~NIll~~~~~-kL~DFGla~ 187 (406)
.+++|+|+++.|||++++.+ .++||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 36999999999999997655 799998764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0016 Score=61.17 Aligned_cols=69 Identities=13% Similarity=0.020 Sum_probs=48.7
Q ss_pred eeeecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccCCC------CCCc---ccCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLRA------PEGR---KRPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h------~ni~---~~~~~~~lV~E~~~ggs 126 (406)
...++.|..+.+|+.....+.+.+|..... ....+.+|+..|+.|.. |.++ ...+..++||||++|.+
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 456889999999998876666777655432 35568888888877732 3322 24467899999999876
Q ss_pred H
Q psy5368 127 L 127 (406)
Q Consensus 127 L 127 (406)
+
T Consensus 118 ~ 118 (312)
T 3jr1_A 118 N 118 (312)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >4a5x_A MITD1, MIT domain-containing protein 1; protein transport, ESCRT, cytokinesis, midbody; HET: P15; 1.91A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.00067 Score=50.65 Aligned_cols=47 Identities=15% Similarity=0.181 Sum_probs=42.4
Q ss_pred ccchhhhhhhchhhhhHHhccchHHHHHHHHHHHHHHHHhhhhcCCC
Q psy5368 350 IPNLKSGLEIGETGDMYLAEGNYELALEKLKASLAILIQFCEAETSS 396 (406)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~~ 396 (406)
.||-..+.+..+.|..++..|+|+.|+.+|+++|+.|++++..|+.+
T Consensus 10 ~~~~~~A~~lv~~Ave~D~~g~y~eAl~lY~~Aie~ll~alk~e~d~ 56 (86)
T 4a5x_A 10 DPQSTAAATVLKRAVELDSESRYPQALVCYQEGIDLLLQVLKGTKDN 56 (86)
T ss_dssp -CHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHHHHTCCCH
T ss_pred ChHHHHHHHHHHHHHHHHHcCCHHHHHHHHHHHHHHHHHHHhhCCCH
Confidence 56778889999999999999999999999999999999999888766
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0032 Score=58.98 Aligned_cols=128 Identities=11% Similarity=0.039 Sum_probs=71.3
Q ss_pred eecceeeeEEEeeeeeec-eeEEeeeecCCccchhhhhhHHhhcccCC-----CCCCcc--------cCCeEEEEEeccC
Q psy5368 58 RYGELQYDTVQNSQIRLG-TVKYSQVRYDTITSHSEFERPRAGLSNLR-----APEGRK--------RPRYVYIILEYCD 123 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~~-~v~vk~~~~~~~~~~~~~~~E~~~l~~l~-----h~ni~~--------~~~~~~lV~E~~~ 123 (406)
.++ |..+.||+.....+ .+.+|...... .....+..|..++..|. -|.++. ..+..++|||+++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 456 77888998776444 56666554221 23456666777666552 233222 2456688999998
Q ss_pred CCCHH-----H------HH---Hh---C------CCCCHHHH----H------------------HHHHHHHHHHHHH--
Q psy5368 124 GGDLC-----S------FI---RS---H------EKLSEFQC----Q------------------QFVRQLVLALKFL-- 156 (406)
Q Consensus 124 ggsL~-----~------~l---~~---~------~~l~~~~~----~------------------~i~~ql~~aL~~l-- 156 (406)
|.++. . .+ +. . ..++.... . ..+.+++..+.-+
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 85431 1 11 11 0 01222111 0 1111222222222
Q ss_pred --HHCCcccccCCCcceEeeCCeeEEEecccccc
Q psy5368 157 --RENNVCHFDLKPQNILIKNNTLKLADFGFAQF 188 (406)
Q Consensus 157 --H~~givH~Dlkp~NIll~~~~~kL~DFGla~~ 188 (406)
....++|+|+++.|||+++ .+.++||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWRD-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEESS-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEcC-CCEEEECCCCCc
Confidence 1235899999999999995 899999987643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0021 Score=61.51 Aligned_cols=28 Identities=39% Similarity=0.723 Sum_probs=24.3
Q ss_pred CcccccCCCcceEeeCCeeEEEeccccc
Q psy5368 160 NVCHFDLKPQNILIKNNTLKLADFGFAQ 187 (406)
Q Consensus 160 givH~Dlkp~NIll~~~~~kL~DFGla~ 187 (406)
.++|+|+++.|||++++.+.++||..+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKCLRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-CEEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCcEEEEEecCCC
Confidence 5899999999999997779999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0053 Score=57.77 Aligned_cols=30 Identities=27% Similarity=0.311 Sum_probs=25.9
Q ss_pred CCcccccCCCcceEeeC-----CeeEEEecccccc
Q psy5368 159 NNVCHFDLKPQNILIKN-----NTLKLADFGFAQF 188 (406)
Q Consensus 159 ~givH~Dlkp~NIll~~-----~~~kL~DFGla~~ 188 (406)
..++|+|+++.|||++. +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 46999999999999985 5789999998754
|
| >2w2u_A Hypothetical P60 katanin; hydrolase transport complex, nucleotide-binding, ESCRT, AAA-ATPase, cytokinesis, ATP-binding; 2.20A {Sulfolobus acidocaldarius} | Back alignment and structure |
|---|
Probab=96.29 E-value=0.0038 Score=46.13 Aligned_cols=46 Identities=20% Similarity=0.119 Sum_probs=41.0
Q ss_pred chhhhhhhchhhhhHHhccchHHHHHHHHHHHHHHHHhhhhcCCCc
Q psy5368 352 NLKSGLEIGETGDMYLAEGNYELALEKLKASLAILIQFCEAETSSS 397 (406)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~~~ 397 (406)
-+.+|.+..+.|...++.|+|..|+.+|+++|+.|++++..|+..+
T Consensus 15 ~~~~Ai~lv~~Ave~D~~g~y~eAl~lY~~aie~l~~alk~e~d~~ 60 (83)
T 2w2u_A 15 LEEMARKYAINAVKADKEGNAEEAITNYKKAIEVLAQLVSLYRDGS 60 (83)
T ss_dssp HHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHHHHHSTTSS
T ss_pred HHHHHHHHHHHHHHHHHhccHHHHHHHHHHHHHHHHHHHHHCCCHH
Confidence 4677888888899999999999999999999999999998887653
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.29 E-value=0.031 Score=52.84 Aligned_cols=30 Identities=20% Similarity=0.501 Sum_probs=25.8
Q ss_pred CCcccccCCCcceEee-CCeeEEEecccccc
Q psy5368 159 NNVCHFDLKPQNILIK-NNTLKLADFGFAQF 188 (406)
Q Consensus 159 ~givH~Dlkp~NIll~-~~~~kL~DFGla~~ 188 (406)
..++|+|+.+.||+++ ++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3599999999999998 56899999987654
|
| >2v6y_A AAA family ATPase, P60 katanin; MIT, VPS4, archaea, AAA-ATPase, ATP-binding, microtubule INT and trafficking domain, nucleotide-binding; HET: SRT; 2.40A {Sulfolobus solfataricus} PDB: 2v6y_B* | Back alignment and structure |
|---|
Probab=95.98 E-value=0.0066 Score=44.91 Aligned_cols=44 Identities=18% Similarity=0.040 Sum_probs=39.3
Q ss_pred hhhhhhhchhhhhHHhccchHHHHHHHHHHHHHHHHhhhhcCCC
Q psy5368 353 LKSGLEIGETGDMYLAEGNYELALEKLKASLAILIQFCEAETSS 396 (406)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~~ 396 (406)
+.+|.+..+.|...++.|+|..|+.+|+++|+.|++++..|+..
T Consensus 8 ~~~Ai~lv~~Ave~D~~g~y~eAl~lY~~aie~l~~~lk~e~d~ 51 (83)
T 2v6y_A 8 EDMARKYAILAVKADKEGKVEDAITYYKKAIEVLSQIIVLYPES 51 (83)
T ss_dssp HHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHHHHHCTTC
T ss_pred HHHHHHHHHHHHHHHHhccHHHHHHHHHHHHHHHHHHHHHCCCH
Confidence 45788888888899999999999999999999999999888655
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.94 E-value=0.01 Score=58.12 Aligned_cols=66 Identities=9% Similarity=-0.093 Sum_probs=40.0
Q ss_pred eeecceeeeEEEeeeee---------eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEecc
Q psy5368 57 IRYGELQYDTVQNSQIR---------LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYC 122 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~---------~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~ 122 (406)
..++.|..+.+|+.... ...+.++..... .....+.+|..++..|...++.. ..+ .+|+||+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~--g~v~e~l 154 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG--GRLEEYI 154 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT--EEEECCC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC--CEEEEEe
Confidence 45778888999998864 244555544221 11145667888888775444322 111 2899999
Q ss_pred CCCC
Q psy5368 123 DGGD 126 (406)
Q Consensus 123 ~ggs 126 (406)
+|.+
T Consensus 155 ~G~~ 158 (429)
T 1nw1_A 155 PSRP 158 (429)
T ss_dssp CEEE
T ss_pred CCcc
Confidence 8744
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.93 E-value=0.0067 Score=58.45 Aligned_cols=127 Identities=14% Similarity=0.129 Sum_probs=71.1
Q ss_pred eecceeeeEEEeeeee---------eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccC
Q psy5368 58 RYGELQYDTVQNSQIR---------LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCD 123 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~---------~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ 123 (406)
.+..|-.+.+|+.... ...+.++.. .........+.+|..+++.|...++.+ ..+ .+||||++
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~-g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--g~v~e~i~ 133 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLY-GAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE--GRLEQYIP 133 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEEC-C---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--EEEEECCS
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEEC-CCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--ccEEEEec
Confidence 4566778888888763 234544443 222234556778988888774433322 112 28999999
Q ss_pred CCCHH--------------HHH---HhC-----CCC--CHHHHHHHHHHHHH-------------------HHHHHH---
Q psy5368 124 GGDLC--------------SFI---RSH-----EKL--SEFQCQQFVRQLVL-------------------ALKFLR--- 157 (406)
Q Consensus 124 ggsL~--------------~~l---~~~-----~~l--~~~~~~~i~~ql~~-------------------aL~~lH--- 157 (406)
|.+|. +.| +.- +.. -+.++.++..++-. .+..|.
T Consensus 134 G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L 213 (379)
T 3feg_A 134 SRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLL 213 (379)
T ss_dssp EEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHH
T ss_pred CccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHH
Confidence 85542 111 111 112 24555555544422 233332
Q ss_pred -H----CCcccccCCCcceEeeC-----CeeEEEeccccc
Q psy5368 158 -E----NNVCHFDLKPQNILIKN-----NTLKLADFGFAQ 187 (406)
Q Consensus 158 -~----~givH~Dlkp~NIll~~-----~~~kL~DFGla~ 187 (406)
+ ..++|+|+.+.||++++ +.+.++||..+.
T Consensus 214 ~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 214 ESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred hhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 24899999999999984 489999999874
|
| >1wfd_A Hypothetical protein 1500032H18; MIT domain, structural genomics, riken structural genomics/proteomics initiative, RSGI, unknown function; NMR {Mus musculus} SCOP: a.7.14.1 | Back alignment and structure |
|---|
Probab=95.74 E-value=0.0061 Score=46.15 Aligned_cols=45 Identities=18% Similarity=0.226 Sum_probs=39.7
Q ss_pred chhhhhhhchhhhhHHhccchHHHHHHHHHHHHHHHHhhhhcCCC
Q psy5368 352 NLKSGLEIGETGDMYLAEGNYELALEKLKASLAILIQFCEAETSS 396 (406)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~~ 396 (406)
-+..|.+....|...+..|+|+.|+.+|+++++.|+.++..|+..
T Consensus 11 ~l~~Ai~lv~~Ave~D~~g~y~eAl~~Y~~Aie~l~~alk~e~~~ 55 (93)
T 1wfd_A 11 DSTAAVAVLKRAVELDAESRYQQALVCYQEGIDMLLQVLKGTKES 55 (93)
T ss_dssp HHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHHHHTCCCH
T ss_pred HHHHHHHHHHHHHHHHHhCCHHHHHHHHHHHHHHHHHHHHHCCCH
Confidence 356778888888888999999999999999999999999888765
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.20 E-value=0.056 Score=53.38 Aligned_cols=69 Identities=13% Similarity=-0.136 Sum_probs=39.4
Q ss_pred eeecceeeeEEEeeeeee--ceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc----cCCeEEEEEeccCCCCH
Q psy5368 57 IRYGELQYDTVQNSQIRL--GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK----RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~--~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~----~~~~~~lV~E~~~ggsL 127 (406)
..|+.|..+.+|+..... ..+.++..... .....+..+|..++..|...++.. .... .+||||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~-~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~-G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPK-TDEIINREREKKISCILYNKNIAKKIYVFFTN-GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC--CCSCSCHHHHHHHHHHHTTSSSBCCEEEEETT-EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCC-hhhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC-eEEEEeeCCccC
Confidence 457888889999988755 45555543221 122222357888888886555432 1111 269999997443
|
| >2v6x_A Vacuolar protein sorting-associated protein 4; protein transport, vacuole, endosome, transport, ESCRT-III, VPS2, VPS4, SKD1, VPS4B, VPS4A; 1.98A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=95.11 E-value=0.013 Score=43.44 Aligned_cols=45 Identities=20% Similarity=0.164 Sum_probs=38.4
Q ss_pred chhhhhhhchhhhhHHhccchHHHHHHHHHHHHHHHHhhhhcCCC
Q psy5368 352 NLKSGLEIGETGDMYLAEGNYELALEKLKASLAILIQFCEAETSS 396 (406)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~~ 396 (406)
-+.+|......|...+..|+|+.|+++|+++++.|+..+..|+..
T Consensus 9 ~l~~A~~l~~~Av~~D~~g~y~eAl~~Y~~aie~l~~a~k~e~~~ 53 (85)
T 2v6x_A 9 FLTKGIELVQKAIDLDTATQYEEAYTAYYNGLDYLMLALKYEKNP 53 (85)
T ss_dssp HHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHHHHHCCCH
T ss_pred HHHHHHHHHHHHHHHHHcCCHHHHHHHHHHHHHHHHHHHHhCCCH
Confidence 355677777788888999999999999999999999999877654
|
| >2ymb_A MITD1, MIT domain-containing protein 1; protein transport, membrane, PLD; 3.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.75 E-value=0.0053 Score=55.17 Aligned_cols=51 Identities=14% Similarity=0.188 Sum_probs=0.0
Q ss_pred hhccchhhhhhhchhhhhHHhccchHHHHHHHHHHHHHHHHhhhhcCCCcc
Q psy5368 348 EAIPNLKSGLEIGETGDMYLAEGNYELALEKLKASLAILIQFCEAETSSSQ 398 (406)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~~~~ 398 (406)
...|.+.+|.+..+.|..+++.|+|..|+++|+.+++.|++++..|+..+.
T Consensus 15 g~dp~~~~Ai~lv~~AVe~D~~g~y~eAl~lY~eaIe~Ll~alk~e~d~~~ 65 (257)
T 2ymb_A 15 RQDPQSTAAATVLKRAVELDSESRYPQALVCYQEGIDLLLQVLKGTKDNTK 65 (257)
T ss_dssp ---------------------------------------------------
T ss_pred CCChhHHHHHHHHHHHHHHHHcCCHHHHHHHHHHHHHHHHHHHHhCCCHHH
Confidence 346788999999999999999999999999999999999999998877643
|
| >2cpt_A SKD1 protein, vacuolar sorting protein 4B; MIT, helix bundle, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: a.7.14.1 | Back alignment and structure |
|---|
Probab=94.52 E-value=0.028 Score=44.31 Aligned_cols=44 Identities=18% Similarity=0.342 Sum_probs=37.3
Q ss_pred hhhhhhhchhhhhHHhccchHHHHHHHHHHHHHHHHhhhhcCCC
Q psy5368 353 LKSGLEIGETGDMYLAEGNYELALEKLKASLAILIQFCEAETSS 396 (406)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~~ 396 (406)
+..|.+....|..++..++|+.|+.+|+++++.|+.++..|+..
T Consensus 15 l~kAi~lv~~Ave~D~ag~y~eAl~lY~~Aie~l~~alk~e~~~ 58 (117)
T 2cpt_A 15 LQKAIDLASKAAQEDKAGNYEEALQLYQHAVQYFLHVVKYEAQG 58 (117)
T ss_dssp HHHHHHHHHHHHHHHHHTCHHHHHHHHHHHHHHHHHHHHTSCCC
T ss_pred HHHHHHHHHHHHHHHHccCHHHHHHHHHHHHHHHHHHHHhccCC
Confidence 45667777777788889999999999999999999999877544
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.46 E-value=0.045 Score=53.43 Aligned_cols=29 Identities=24% Similarity=0.564 Sum_probs=24.4
Q ss_pred CcccccCCCcceEeeCCeeEEEecccccc
Q psy5368 160 NVCHFDLKPQNILIKNNTLKLADFGFAQF 188 (406)
Q Consensus 160 givH~Dlkp~NIll~~~~~kL~DFGla~~ 188 (406)
.++|+|+.+.||+-+++.+.++||..+..
T Consensus 263 ~~~H~D~~~~N~l~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLLQTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEEECSSCEEECCCTTCEE
T ss_pred eEECCCCCccceecCCCcEEEEecccCCc
Confidence 48999999999994467899999998743
|
| >2w2u_A Hypothetical P60 katanin; hydrolase transport complex, nucleotide-binding, ESCRT, AAA-ATPase, cytokinesis, ATP-binding; 2.20A {Sulfolobus acidocaldarius} | Back alignment and structure |
|---|
Probab=85.95 E-value=0.37 Score=35.32 Aligned_cols=46 Identities=22% Similarity=0.253 Sum_probs=41.0
Q ss_pred CCccchHHHHHhhhhhcccccccchHHHHHHHHHHHhhhhhhhHHH
Q psy5368 300 PCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIPLAYDV 345 (406)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 345 (406)
|+......+..++..++..|..++...++..|.+++++|++.+.++
T Consensus 11 ~~~~~~~~Ai~lv~~Ave~D~~g~y~eAl~lY~~aie~l~~alk~e 56 (83)
T 2w2u_A 11 AQVMLEEMARKYAINAVKADKEGNAEEAITNYKKAIEVLAQLVSLY 56 (83)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHHHHHS
T ss_pred CchHHHHHHHHHHHHHHHHHHhccHHHHHHHHHHHHHHHHHHHHHC
Confidence 5666778899999999999999999999999999999998877663
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=84.56 E-value=0.48 Score=43.21 Aligned_cols=40 Identities=15% Similarity=0.119 Sum_probs=27.7
Q ss_pred eeeeeeEEEeeeeecCCcceeeeeeccccccccceeeecC
Q psy5368 15 GSVKYGQVQLSTVRYGKVRYSQVRSDTVRSGTVRYDIVGS 54 (406)
Q Consensus 15 g~~~~gy~vv~~lg~G~~~~~~~~~d~~~~~~~~~~i~~~ 54 (406)
|+.++.|++++.||.|+||.|+.+.+.......+.|++..
T Consensus 9 G~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~ 48 (275)
T 3hyh_A 9 GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINK 48 (275)
T ss_dssp -----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEEC
T ss_pred CCEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeH
Confidence 4445559999999999999999999988888888876643
|
| >2v6x_A Vacuolar protein sorting-associated protein 4; protein transport, vacuole, endosome, transport, ESCRT-III, VPS2, VPS4, SKD1, VPS4B, VPS4A; 1.98A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=84.29 E-value=1.2 Score=32.71 Aligned_cols=47 Identities=23% Similarity=0.372 Sum_probs=41.3
Q ss_pred CCCCccchHHHHHhhhhhcccccccchHHHHHHHHHHHhhhhhhhHH
Q psy5368 298 HAPCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIPLAYD 344 (406)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 344 (406)
++++......+..++..++..|..++...++..|.+++++|+..+.+
T Consensus 3 ~m~~~~~l~~A~~l~~~Av~~D~~g~y~eAl~~Y~~aie~l~~a~k~ 49 (85)
T 2v6x_A 3 HMSTGDFLTKGIELVQKAIDLDTATQYEEAYTAYYNGLDYLMLALKY 49 (85)
T ss_dssp CCCCSCHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCccHHHHHHHHHHHHHHHHHHHcCCHHHHHHHHHHHHHHHHHHHHh
Confidence 46667778899999999999999999999999999999998886654
|
| >4gco_A Protein STI-1; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, tetratricopeptide repeat domain; 1.60A {Caenorhabditis elegans} | Back alignment and structure |
|---|
Probab=80.67 E-value=1.4 Score=34.42 Aligned_cols=26 Identities=19% Similarity=0.500 Sum_probs=19.0
Q ss_pred hchhhhhHHhccchHHHHHHHHHHHH
Q psy5368 359 IGETGDMYLAEGNYELALEKLKASLA 384 (406)
Q Consensus 359 ~~~~~~~~~~~~~~~~a~~~~~~~~~ 384 (406)
....|..+++.|+|+.|+++|+++|.
T Consensus 16 ~~~~G~~~~~~g~~~~A~~~~~~al~ 41 (126)
T 4gco_A 16 EKNKGNEYFKKGDYPTAMRHYNEAVK 41 (126)
T ss_dssp HHHHHHHHHHTTCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCHHHHHHHHHHHHH
Confidence 34557777888888888888887764
|
| >2rpa_A Katanin P60 ATPase-containing subunit A1; AAA ATPase, ATP-binding, cell cycle, cell division, cytoplas hydrolase, microtubule; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=80.32 E-value=1.2 Score=32.05 Aligned_cols=51 Identities=16% Similarity=0.137 Sum_probs=38.9
Q ss_pred hhhhhhhchhhhhHHhccchHHHHHHHHHHHHHHHHhhhhcCCCccccccc
Q psy5368 353 LKSGLEIGETGDMYLAEGNYELALEKLKASLAILIQFCEAETSSSQLKPLL 403 (406)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (406)
+.+..+.-+.|..+.-.|||++|+-+|+.++..+-.++..=...++.+.|+
T Consensus 9 ~~~i~e~~k~ARe~Al~GnYdta~~yY~g~~~qI~k~l~~~~d~~~r~kW~ 59 (78)
T 2rpa_A 9 LQMIVENVKLAREYALLGNYDSAMVYYQGVLDQMNKYLYSVKDTHLRQKWQ 59 (78)
T ss_dssp SHHHHHHHHHHHHHHHHTCCHHHHHHHHHHHHHHHHHHHTCSCHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHhcChHHHHHHHHHHHHHHHHHHHhcCCHHHHHhHH
Confidence 344455556677777889999999999999999988887666556666664
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 406 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-55 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-52 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-52 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-52 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-50 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-49 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-49 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-48 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-48 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-48 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-47 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-47 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-46 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-44 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-43 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-42 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-40 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-40 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-38 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-37 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-37 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-37 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-37 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-37 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-36 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-36 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-36 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-35 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-35 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-35 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-35 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-34 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-33 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-33 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-33 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-32 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-31 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-31 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-28 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-23 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-12 | |
| d1wr0a1 | 77 | a.7.14.1 (A:5-81) Vacuolar sorting protein 4b (VPS | 6e-05 | |
| d1wfda_ | 93 | a.7.14.1 (A:) Hypothetical protein 1500032H18Rik { | 7e-04 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 7e-55
Identities = 56/183 (30%), Positives = 97/183 (53%), Gaps = 4/183 (2%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
VY+ILEY G + ++ K E + ++ +L AL + V H D+KP+N+
Sbjct: 78 ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 137
Query: 172 LI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
L+ LK+ADFG++ P+ + ++ G+ Y+ PE++ G ++ K DLWSLGVL +E
Sbjct: 138 LLGSAGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYE 196
Query: 231 ALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFS 290
L G P+ + + + +S T P ++ D +SRLL+ +P +R ++
Sbjct: 197 FLVGKPPFEANTYQET-YKRISRVEFTFPDF-VTEGARDLISRLLKHNPSQRPMLREVLE 254
Query: 291 HPY 293
HP+
Sbjct: 255 HPW 257
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 1e-52
Identities = 48/232 (20%), Positives = 95/232 (40%), Gaps = 17/232 (7%)
Query: 77 VKYSQVRYDTITSHSEFERPRAGLSNLRAP----------EGRKRPRYVYIILEYCDGGD 126
Q R T + F+ L L+ P K + + ++ E G
Sbjct: 39 WCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGT 98
Query: 127 LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENN--VCHFDLKPQNILI--KNNTLKLAD 182
L ++++ + + + + RQ++ L+FL + H DLK NI I ++K+ D
Sbjct: 99 LKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD 158
Query: 183 FGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYA-SC 241
G A ++ G+P +MAPE+ Y+ D+++ G+ + E PY+
Sbjct: 159 LGLATLK-RASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 216
Query: 242 NLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
N +Q+ + S P+ + + ++++ R S +DL +H +
Sbjct: 217 NAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 268
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (449), Expect = 1e-52
Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 12/236 (5%)
Query: 81 QVRYDTITSHSEFERPRAGLSNLRAP------EGRKRPRYVYIILEYCDGGDLCSFI-RS 133
V + + +S LR P + + + +I E+ GG+L +
Sbjct: 58 FVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE 117
Query: 134 HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI---KNNTLKLADFGFAQFLA 190
H K+SE + +++RQ+ L + ENN H DLKP+NI+ ++N LKL DFG L
Sbjct: 118 HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177
Query: 191 PNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQA 250
P G+ + APE+ G P D+WS+GVL + L G +P+ N +
Sbjct: 178 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV 237
Query: 251 LSSAPITIPP--NSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAES 304
S + +S D DF+ +LL DP R++ HP+ +AP +S
Sbjct: 238 KSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 174 bits (442), Expect = 2e-52
Identities = 54/191 (28%), Positives = 96/191 (50%), Gaps = 9/191 (4%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+ +++ + G+L ++ LSE + ++ +R L+ + L + N+ H DLKP+NI
Sbjct: 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENI 141
Query: 172 LI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSP------YNAKADLWSL 224
L+ + +KL DFGF+ L P ++ + G+P Y+APEI+ S Y + D+WS
Sbjct: 142 LLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 201
Query: 225 GVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP--NSLSPDCMDFLSRLLQKDPMRR 282
GV+++ L G P+ + +S P + S D +SR L P +R
Sbjct: 202 GVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKR 261
Query: 283 ISYEDLFSHPY 293
+ E+ +HP+
Sbjct: 262 YTAEEALAHPF 272
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 5e-52
Identities = 64/228 (28%), Positives = 110/228 (48%), Gaps = 15/228 (6%)
Query: 81 QVRYDTITSHSEFERPRAGLSNLRAP------EGRKRPRYVYIILEYCDGGDLCSFIRSH 134
+ + ++ L++ P + ++I++E+C GG + + +
Sbjct: 44 VIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL 103
Query: 135 EK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLADFGFAQFLA-P 191
E+ L+E Q Q +Q + AL +L +N + H DLK NIL + +KLADFG +
Sbjct: 104 ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163
Query: 192 NDQGDSIQGSPLYMAPEILAG-----SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQL 246
+ DS G+P +MAPE++ PY+ KAD+WSLG+ + E P+ N ++
Sbjct: 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV 223
Query: 247 RAQALSSAPITIP-PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
+ S P T+ P+ S + DFL + L+K+ R + L HP+
Sbjct: 224 LLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPF 271
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (441), Expect = 8e-52
Identities = 51/187 (27%), Positives = 81/187 (43%), Gaps = 7/187 (3%)
Query: 111 RPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 170
R ++++EYC G + L E + + L +L +N+ H D+K N
Sbjct: 86 REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGN 145
Query: 171 ILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGS---PYNAKADLWSLGV 226
IL+ + +KL DFG A +AP +S G+P +MAPE++ Y+ K D+WSLG+
Sbjct: 146 ILLSEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 202
Query: 227 LVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYE 286
E P + N + + S +F+ LQK P R + E
Sbjct: 203 TCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSE 262
Query: 287 DLFSHPY 293
L H +
Sbjct: 263 VLLKHRF 269
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (431), Expect = 2e-50
Identities = 56/188 (29%), Positives = 102/188 (54%), Gaps = 6/188 (3%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
++Y+I++ GG+L I +E + + Q++ A+K+L + + H DLKP+N+
Sbjct: 79 GGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENL 138
Query: 172 LI----KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVL 227
L +++ + ++DFG ++ P + G+P Y+APE+LA PY+ D WS+GV+
Sbjct: 139 LYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 198
Query: 228 VFEALFGHAPYASCNLSQLRAQALSSAPITIPP--NSLSPDCMDFLSRLLQKDPMRRISY 285
+ L G+ P+ N ++L Q L + P + +S DF+ L++KDP +R +
Sbjct: 199 AYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTC 258
Query: 286 EDLFSHPY 293
E HP+
Sbjct: 259 EQALQHPW 266
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 1e-49
Identities = 61/195 (31%), Positives = 95/195 (48%), Gaps = 12/195 (6%)
Query: 110 KRPRYVYIILEYCDGGDLCSFIRSHEK----LSEFQCQQFVRQLVLALKFLRE-----NN 160
+ +YI++EYC+GGDL S I K L E + + QL LALK +
Sbjct: 75 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT 134
Query: 161 VCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQ-GDSIQGSPLYMAPEILAGSPYNAK 218
V H DLKP N+ + +KL DFG A+ L + + G+P YM+PE + YN K
Sbjct: 135 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEK 194
Query: 219 ADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKD 278
+D+WSLG L++E P+ + + +L + IP S + + ++R+L
Sbjct: 195 SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR-YSDELNEIITRMLNLK 253
Query: 279 PMRRISYEDLFSHPY 293
R S E++ +P
Sbjct: 254 DYHRPSVEEILENPL 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 3e-49
Identities = 51/192 (26%), Positives = 93/192 (48%), Gaps = 12/192 (6%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+Y L Y G+L +IR E + + ++V AL++L + H DLKP+NI
Sbjct: 80 DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENI 139
Query: 172 LI-KNNTLKLADFGFAQFLAPNDQGD---SIQGSPLYMAPEILAGSPYNAKADLWSLGVL 227
L+ ++ +++ DFG A+ L+P + S G+ Y++PE+L +DLW+LG +
Sbjct: 140 LLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCI 199
Query: 228 VFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRIS--- 284
+++ + G P+ + N + + + P P D + +LL D +R+
Sbjct: 200 IYQLVAGLPPFRAGNEYLIFQKIIKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEE 257
Query: 285 ---YEDLFSHPY 293
Y L +HP+
Sbjct: 258 MEGYGPLKAHPF 269
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 6e-49
Identities = 52/221 (23%), Positives = 96/221 (43%), Gaps = 12/221 (5%)
Query: 85 DTITSHSEFERPRAGLSNLRAP------EGRKRPRYVYIILEYCDGGDLCSFIRSHEKLS 138
+ ++ L R+ Y+ LEYC GG+L I +
Sbjct: 42 RAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMP 101
Query: 139 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGD- 196
E Q+F QL+ + +L + H D+KP+N+L+ + + LK++DFG A N++
Sbjct: 102 EPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161
Query: 197 --SIQGSPLYMAPEILAGSPYNA-KADLWSLGVLVFEALFGHAPY-ASCNLSQLRAQALS 252
+ G+ Y+APE+L ++A D+WS G+++ L G P+ + Q +
Sbjct: 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 221
Query: 253 SAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
P + + L ++L ++P RI+ D+ +
Sbjct: 222 KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 262
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 1e-48
Identities = 57/189 (30%), Positives = 101/189 (53%), Gaps = 8/189 (4%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 170
+ +I E+ G D+ I + +L+E + +V Q+ AL+FL +N+ HFD++P+N
Sbjct: 73 MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPEN 132
Query: 171 ILI---KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVL 227
I+ +++T+K+ +FG A+ L P D + +P Y APE+ + D+WSLG L
Sbjct: 133 IIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTL 192
Query: 228 VFEALFGHAPYASCNLSQLRAQALSSAPITIPPN---SLSPDCMDFLSRLLQKDPMRRIS 284
V+ L G P+ + Q+ + + +A T +S + MDF+ RLL K+ R++
Sbjct: 193 VYVLLSGINPFLAETNQQI-IENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT 251
Query: 285 YEDLFSHPY 293
+ HP+
Sbjct: 252 ASEALQHPW 260
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 166 bits (421), Expect = 2e-48
Identities = 57/188 (30%), Positives = 100/188 (53%), Gaps = 6/188 (3%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 170
+ +ILE+ GG+L I + + K+SE + ++RQ LK + E+++ H D+KP+N
Sbjct: 98 KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN 157
Query: 171 ILI---KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVL 227
I+ K +++K+ DFG A L P++ + + APEI+ P D+W++GVL
Sbjct: 158 IMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVL 217
Query: 228 VFEALFGHAPYASCNLSQLRAQALSSAPITIPP--NSLSPDCMDFLSRLLQKDPMRRISY 285
+ L G +P+A + + +S+SP+ DF+ LLQK+P +R++
Sbjct: 218 GYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTV 277
Query: 286 EDLFSHPY 293
D HP+
Sbjct: 278 HDALEHPW 285
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 5e-48
Identities = 52/226 (23%), Positives = 94/226 (41%), Gaps = 45/226 (19%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRE-NNVCHFDLKPQN 170
+ I +E+ DGG L ++ ++ E + ++ L +LRE + + H D+KP N
Sbjct: 76 DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSN 135
Query: 171 ILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVF 229
IL+ +KL DFG + L + +S G+ YM+PE L G+ Y+ ++D+WS+G+ +
Sbjct: 136 ILVNSRGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 194
Query: 230 EALFGHAPYASCN------------------------------------------LSQLR 247
E G P + + +L
Sbjct: 195 EMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELL 254
Query: 248 AQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
++ P +P S + DF+++ L K+P R + L H +
Sbjct: 255 DYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 5e-48
Identities = 52/193 (26%), Positives = 101/193 (52%), Gaps = 12/193 (6%)
Query: 113 RYVYIILEYCDGGDLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 170
+ + I++E DGG+L S I+ + +E + + ++ + A+++L N+ H D+KP+N
Sbjct: 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 141
Query: 171 ILI----KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGV 226
+L N LKL DFGFA+ ++ + +P Y+APE+L Y+ D+WSLGV
Sbjct: 142 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 201
Query: 227 LVFEALFGHAPYASCNLSQLRAQALS---SAPITIP---PNSLSPDCMDFLSRLLQKDPM 280
+++ L G+ P+ S + + + P + +S + + LL+ +P
Sbjct: 202 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 261
Query: 281 RRISYEDLFSHPY 293
+R++ + +HP+
Sbjct: 262 QRMTITEFMNHPW 274
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 1e-47
Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 10/222 (4%)
Query: 81 QVRYDTITSHSEFERPRAGLSNLRAP------EGRKRPRYVYIILEYCDGGDLCSFIRSH 134
Q+ + + P + +++++EY GG L +
Sbjct: 52 QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-E 110
Query: 135 EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLADFGFAQFLA-PN 192
+ E Q R+ + AL+FL N V H D+K NIL+ + ++KL DFGF +
Sbjct: 111 TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170
Query: 193 DQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALS 252
+ ++ G+P +MAPE++ Y K D+WSLG++ E + G PY + N + +
Sbjct: 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230
Query: 253 SAPITIP-PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
+ + P LS DFL+R L D +R S ++L H +
Sbjct: 231 NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 5e-47
Identities = 59/185 (31%), Positives = 96/185 (51%), Gaps = 5/185 (2%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
++ ++EY +GGDL I+S K + + +++L L+FL + + DLK NI
Sbjct: 75 KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNI 134
Query: 172 LI-KNNTLKLADFGFAQFLAPND-QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVF 229
L+ K+ +K+ADFG + D + ++ G+P Y+APEIL G YN D WS GVL++
Sbjct: 135 LLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLY 194
Query: 230 EALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYE-DL 288
E L G +P+ + +L P P L + D L +L ++P +R+ D+
Sbjct: 195 EMLIGQSPFHGQDEEELFHSIRMDNP--FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDI 252
Query: 289 FSHPY 293
HP
Sbjct: 253 RQHPL 257
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 6e-46
Identities = 50/232 (21%), Positives = 100/232 (43%), Gaps = 17/232 (7%)
Query: 77 VKYSQVRYDTITSHSEFERPRAGLSNLRAP-----EGRKRPRYVYIILEYCDGGDLCSFI 131
VK V T F+ L R G + I+ ++C+G L +
Sbjct: 35 VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHL 94
Query: 132 RSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLADFGFAQFL 189
E K + RQ + +L ++ H DLK NI + ++ T+K+ DFG A
Sbjct: 95 HIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154
Query: 190 APND---QGDSIQGSPLYMAPEILAG---SPYNAKADLWSLGVLVFEALFGHAPYASCN- 242
+ Q + + GS L+MAPE++ +PY+ ++D+++ G++++E + G PY++ N
Sbjct: 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214
Query: 243 ---LSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291
+ + + S ++ ++ ++ L+K R + + +
Sbjct: 215 RDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 4e-44
Identities = 54/235 (22%), Positives = 96/235 (40%), Gaps = 21/235 (8%)
Query: 78 KYSQVRYDTITSHSEFERPRAGLSNLRAP--------EGRKRPRYVYIILEYCDGG-DLC 128
K + + + + L + + + +RP +ILE + DL
Sbjct: 39 KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 98
Query: 129 SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN--TLKLADFGFA 186
FI L E + F Q++ A++ V H D+K +NILI N LKL DFG
Sbjct: 99 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 158
Query: 187 QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAK-ADLWSLGVLVFEALFGHAPYASCNLSQ 245
L + G+ +Y PE + Y+ + A +WSLG+L+++ + G P+
Sbjct: 159 ALL-KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--- 214
Query: 246 LRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAP 300
+ + +S +C + L P R ++E++ +HP+ + P
Sbjct: 215 ----EIIRGQVFFRQR-VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 264
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 4e-43
Identities = 59/190 (31%), Positives = 104/190 (54%), Gaps = 9/190 (4%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
V +ILE GG+L F+ E L+E + +F++Q++ + +L + HFDLKP+NI
Sbjct: 85 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 144
Query: 172 LIKNN-----TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGV 226
++ + +K+ DFG A + ++ +I G+P ++APEI+ P +AD+WS+GV
Sbjct: 145 MLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 204
Query: 227 LVFEALFGHAPYASCNLSQLRAQALSSAPITIP---PNSLSPDCMDFLSRLLQKDPMRRI 283
+ + L G +P+ + A +S+ ++ S DF+ RLL KDP +R+
Sbjct: 205 ITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 263
Query: 284 SYEDLFSHPY 293
+ +D HP+
Sbjct: 264 TIQDSLQHPW 273
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-42
Identities = 47/184 (25%), Positives = 82/184 (44%), Gaps = 7/184 (3%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 169
+YI+ EY G L ++RS + L +F + A+++L NN H DL +
Sbjct: 73 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR 132
Query: 170 NILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLV 228
N+L+ ++N K++DFG + + D+ + + APE L ++ K+D+WS G+L+
Sbjct: 133 NVLVSEDNVAKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILL 190
Query: 229 FEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYED 287
+E FG PY L + + + P P + + D R S+
Sbjct: 191 WEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG-CPPAVYEVMKNCWHLDAAMRPSFLQ 249
Query: 288 LFSH 291
L
Sbjct: 250 LREQ 253
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-42
Identities = 48/235 (20%), Positives = 99/235 (42%), Gaps = 15/235 (6%)
Query: 77 VKYSQVRYDTITSHSEFERPRAGLSNLRAP-----EGRKRPRYVYIILEYCDGGDLCSFI 131
VK + + E + L P G +++E + G L ++
Sbjct: 39 VKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYL 98
Query: 132 RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLADFGFAQFLA 190
+ + + + + V Q+ + +K+L E+N H DL +N+L+ + K++DFG ++ L
Sbjct: 99 QQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 158
Query: 191 PNDQ----GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL-FGHAPYASCNLSQ 245
++ + + APE + +++K+D+WS GVL++EA +G PY S+
Sbjct: 159 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 218
Query: 246 LRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDL---FSHPYPDLI 297
+ A + P + D ++ D R + + + Y D++
Sbjct: 219 VTAMLEKGERMGCPAG-CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-41
Identities = 53/215 (24%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 92 EFERPRAGLSNLRAP------EGRKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQF 145
L N R P + + ++EY +GG+L + +E + + +
Sbjct: 51 HTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 110
Query: 146 VRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLADFGFAQFL-APNDQGDSIQGSPL 203
++V AL++L +V + D+K +N+++ K+ +K+ DFG + + + G+P
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 170
Query: 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSL 263
Y+APE+L + Y D W LGV+++E + G P+ + + +L + + I P L
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-FELILMEEIRFPRT-L 228
Query: 264 SPDCMDFLSRLLQKDPMRRISY-----EDLFSHPY 293
SP+ L+ LL+KDP +R+ +++ H +
Sbjct: 229 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 148 bits (374), Expect = 1e-41
Identities = 54/190 (28%), Positives = 96/190 (50%), Gaps = 9/190 (4%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
P + IL+ +GGDL + H SE + + +++L L+ + V + DLKP NI
Sbjct: 79 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI 138
Query: 172 LI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILA-GSPYNAKADLWSLGVLVF 229
L+ ++ ++++D G A + + G+ YMAPE+L G Y++ AD +SLG ++F
Sbjct: 139 LLDEHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 197
Query: 230 EALFGHAPYASCNLSQLRAQALSSAPITIP-PNSLSPDCMDFLSRLLQKDPMRRIS---- 284
+ L GH+P+ + + + P+S SP+ L LLQ+D RR+
Sbjct: 198 KLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGR 257
Query: 285 -YEDLFSHPY 293
+++ P+
Sbjct: 258 GAQEVKESPF 267
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 146 bits (370), Expect = 2e-41
Identities = 61/188 (32%), Positives = 113/188 (60%), Gaps = 10/188 (5%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+ +++I++Y +GG+L S +R ++ + + ++ LAL++L ++ + DLKP+NI
Sbjct: 76 AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENI 135
Query: 172 LI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFE 230
L+ KN +K+ DFGFA+++ D ++ G+P Y+APE+++ PYN D WS G+L++E
Sbjct: 136 LLDKNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYE 193
Query: 231 ALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI-----SY 285
L G+ P+ N + + + +A + PP + D D LSRL+ +D +R+
Sbjct: 194 MLAGYTPFYDSNTMKT-YEKILNAELRFPPF-FNEDVKDLLSRLITRDLSQRLGNLQNGT 251
Query: 286 EDLFSHPY 293
ED+ +HP+
Sbjct: 252 EDVKNHPW 259
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 142 bits (360), Expect = 2e-40
Identities = 49/190 (25%), Positives = 88/190 (46%), Gaps = 7/190 (3%)
Query: 110 KRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 169
YI++EY DG L + + ++ + + + AL F +N + H D+KP
Sbjct: 81 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPA 140
Query: 170 NILI-KNNTLKLADFGFAQFLAPNDQGD----SIQGSPLYMAPEILAGSPYNAKADLWSL 224
NI+I N +K+ DFG A+ +A + ++ G+ Y++PE G +A++D++SL
Sbjct: 141 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 200
Query: 225 GVLVFEALFGHAPYASCNLSQLRAQALSSAPI--TIPPNSLSPDCMDFLSRLLQKDPMRR 282
G +++E L G P+ + + Q + PI + LS D + + L K+P R
Sbjct: 201 GCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 260
Query: 283 ISYEDLFSHP 292
Sbjct: 261 YQTAAEMRAD 270
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 2e-40
Identities = 50/230 (21%), Positives = 93/230 (40%), Gaps = 16/230 (6%)
Query: 92 EFERPRAGLSNLRAP-----EGRKRPRYVYIILEYCDGGDLCSFIRSHEK-LSEFQCQQF 145
E R + L P G + + +++E GG L F+ + + +
Sbjct: 55 EMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 114
Query: 146 VRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLADFGFAQFLAPNDQ----GDSIQG 200
+ Q+ + +K+L E N H DL +N+L+ N K++DFG ++ L +D + +
Sbjct: 115 LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 201 SPLYMAPEILAGSPYNAKADLWSLGVLVFEAL-FGHAPYASCNLSQLRAQALSSAPITIP 259
+ APE + +++++D+WS GV ++EAL +G PY ++ A + P
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP 234
Query: 260 PNSLSPDCMDFLSRLLQKDPMRRISYEDL---FSHPYPDLIHAPCAESHQ 306
P P+ +S R + + Y L H
Sbjct: 235 PE-CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHHH 283
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 7e-39
Identities = 48/211 (22%), Positives = 88/211 (41%), Gaps = 12/211 (5%)
Query: 89 SHSEFERPRAGLSNLRAP-----EGRKRPRYVYIILEYCDGGDLCSFIRSHE--KLSEFQ 141
S F + L+ +YII EY + G L F+++ KL+ +
Sbjct: 51 SPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINK 110
Query: 142 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLADFGFAQFLAPNDQG--DSI 198
Q+ + F+ E N H DL+ NIL+ + + K+ADFG A+ + N+ +
Sbjct: 111 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 170
Query: 199 QGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL-FGHAPYASCNLSQLRAQALSSAPIT 257
+ + APE + + K+D+WS G+L+ E + G PY ++ +
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 230
Query: 258 IPPNSLSPDCMDFLSRLLQKDPMRRISYEDL 288
P N + + ++ P R +++ L
Sbjct: 231 RPDN-CPEELYQLMRLCWKERPEDRPTFDYL 260
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 2e-38
Identities = 54/207 (26%), Positives = 82/207 (39%), Gaps = 27/207 (13%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+ ++ E+ D + E + + + QL+ L FL + V H DLKPQNIL
Sbjct: 89 KLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNIL 148
Query: 173 I-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEA 231
+ + +KLADFG A+ + S+ + Y APE+L S Y DLWS+G + E
Sbjct: 149 VTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 208
Query: 232 LFGHAPYASCNLSQLRAQAL-------------------------SSAPITIPPNSLSPD 266
+ + + L S+ PI +
Sbjct: 209 FRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDEL 268
Query: 267 CMDFLSRLLQKDPMRRISYEDLFSHPY 293
D L + L +P +RIS SHPY
Sbjct: 269 GKDLLLKCLTFNPAKRISAYSALSHPY 295
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 5e-38
Identities = 41/185 (22%), Positives = 86/185 (46%), Gaps = 6/185 (3%)
Query: 112 PRYVYIILEYCDGGDLCSFIR-SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 170
R ++II EY G L +++R + Q + + + A+++L H DL +N
Sbjct: 71 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARN 130
Query: 171 ILI-KNNTLKLADFGFAQFLAPND--QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVL 227
L+ +K++DFG ++++ ++ + + PE+L S +++K+D+W+ GVL
Sbjct: 131 CLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL 190
Query: 228 VFEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYE 286
++E G PY S+ A+ ++ P+ S + + R +++
Sbjct: 191 MWEIYSLGKMPYERFTNSET-AEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFK 249
Query: 287 DLFSH 291
L S+
Sbjct: 250 ILLSN 254
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 2e-37
Identities = 41/183 (22%), Positives = 78/183 (42%), Gaps = 7/183 (3%)
Query: 115 VYIILEYCDGGDLCSFIRSHEKL-SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
V +I + G L ++R H+ + Q+ + +L + + H DL +N+L+
Sbjct: 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV 144
Query: 174 -KNNTLKLADFGFAQFLAPNDQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVF 229
+K+ DFG A+ L ++ + + +MA E + Y ++D+WS GV V+
Sbjct: 145 KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVW 204
Query: 230 EAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDL 288
E + FG PY S++ + + PP + D + + D R + +L
Sbjct: 205 ELMTFGSKPYDGIPASEISSILEKGERLPQPPI-CTIDVYMIMVKCWMIDADSRPKFREL 263
Query: 289 FSH 291
Sbjct: 264 IIE 266
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 3e-37
Identities = 56/194 (28%), Positives = 102/194 (52%), Gaps = 12/194 (6%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+++IL+Y +GG+L + + E+ +E + Q +V ++VLAL+ L + + + D+K +NI
Sbjct: 101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENI 160
Query: 172 LI-KNNTLKLADFGFAQFLAP--NDQGDSIQGSPLYMAPEILAGSP--YNAKADLWSLGV 226
L+ N + L DFG ++ ++ G+ YMAP+I+ G ++ D WSLGV
Sbjct: 161 LLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGV 220
Query: 227 LVFEALFGHAPYASCNLSQLRAQALSSAPITIP--PNSLSPDCMDFLSRLLQKDPMRRIS 284
L++E L G +P+ +A+ + P P +S D + RLL KDP +R+
Sbjct: 221 LMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLG 280
Query: 285 Y-----EDLFSHPY 293
+++ H +
Sbjct: 281 CGPRDADEIKEHLF 294
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 3e-37
Identities = 47/208 (22%), Positives = 84/208 (40%), Gaps = 28/208 (13%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEK-----------------------LSEFQCQQFVRQ 148
+Y+I EYC GDL +++RS + L+ F Q
Sbjct: 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ 172
Query: 149 LVLALKFLRENNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQ---GDSIQGSPLY 204
+ ++FL + H DL +N+L+ +K+ DFG A+ + + + + +
Sbjct: 173 VAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKW 232
Query: 205 MAPEILAGSPYNAKADLWSLGVLVFEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSL 263
MAPE L Y K+D+WS G+L++E G PY + + + + P
Sbjct: 233 MAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYA 292
Query: 264 SPDCMDFLSRLLQKDPMRRISYEDLFSH 291
+ + + D +R S+ +L S
Sbjct: 293 TEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 5e-37
Identities = 48/198 (24%), Positives = 82/198 (41%), Gaps = 19/198 (9%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKF 155
Y+Y+ +EY G+L F+R LS Q F + + +
Sbjct: 83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY 142
Query: 156 LRENNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSP 214
L + H DL +NIL+ +N K+ADFG ++ + + +MA E L S
Sbjct: 143 LSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV 202
Query: 215 YNAKADLWSLGVLVFEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSR 273
Y +D+WS GVL++E + G PY ++L + + P N + D + +
Sbjct: 203 YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN-CDDEVYDLMRQ 261
Query: 274 LLQKDPMRRISYEDLFSH 291
++ P R S+ +
Sbjct: 262 CWREKPYERPSFAQILVS 279
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 7e-37
Identities = 46/183 (25%), Positives = 86/183 (46%), Gaps = 6/183 (3%)
Query: 114 YVYIILEYCDGGDLCSFI-RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
V+II+E C G+L SF+ L + QL AL +L H D+ +N+L
Sbjct: 81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVL 140
Query: 173 I-KNNTLKLADFGFAQFLAPND--QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVF 229
+ N+ +KL DFG ++++ + + + +MAPE + + + +D+W GV ++
Sbjct: 141 VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 200
Query: 230 EAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDL 288
E L G P+ + + + + + +PPN P +++ DP RR + +L
Sbjct: 201 EILMHGVKPFQGVKNNDVIGRIENGERLPMPPN-CPPTLYSLMTKCWAYDPSRRPRFTEL 259
Query: 289 FSH 291
+
Sbjct: 260 KAQ 262
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 7e-37
Identities = 47/180 (26%), Positives = 78/180 (43%), Gaps = 7/180 (3%)
Query: 115 VYIILEYCDGGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+YI+ EY G L F++ L Q Q+ + ++ N H DL+ NIL
Sbjct: 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 145
Query: 173 I-KNNTLKLADFGFAQFLAPND--QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVF 229
+ +N K+ADFG A+ + N+ + + APE + K+D+WS G+L+
Sbjct: 146 VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLT 205
Query: 230 EAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDL 288
E G PY ++ Q + PP D + + +K+P R ++E L
Sbjct: 206 ELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE-CPESLHDLMCQCWRKEPEERPTFEYL 264
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 8e-37
Identities = 47/250 (18%), Positives = 87/250 (34%), Gaps = 35/250 (14%)
Query: 90 HSEFERPRAGLSNLRAP------EGRKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ 143
+ R L L P + + ++ ++ + + L+ +
Sbjct: 44 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIK 103
Query: 144 QFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLADFGFA-QFLAPNDQGDSIQGS 201
++ + L++L ++ + H DLKP N+L+ +N LKLADFG A F +PN +
Sbjct: 104 AYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVT 163
Query: 202 PLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQL-------------- 246
Y APE+L G Y D+W++G ++ E L +
Sbjct: 164 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 223
Query: 247 ------------RAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYP 294
++ P+ ++ D +D + L +P RI+ Y
Sbjct: 224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283
Query: 295 DLIHAPCAES 304
P
Sbjct: 284 SNRPGPTPGC 293
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 8e-37
Identities = 42/217 (19%), Positives = 77/217 (35%), Gaps = 37/217 (17%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+Y++ ++C+ K + + ++ ++ L+ L ++ N + H D+K N+LI
Sbjct: 91 SIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI 150
Query: 174 -KNNTLKLADFGFAQFLAPNDQGD-----SIQGSPLYMAPEILAGS-PYNAKADLWSLGV 226
++ LKLADFG A+ + + + Y PE+L G Y DLW G
Sbjct: 151 TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGC 210
Query: 227 LVFEALFGHAPYASCNLSQLRAQALS------------------------------SAPI 256
++ E A
Sbjct: 211 IMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKD 270
Query: 257 TIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
+ P +D + +LL DP +RI +D +H +
Sbjct: 271 RLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (339), Expect = 9e-37
Identities = 56/186 (30%), Positives = 99/186 (53%), Gaps = 10/186 (5%)
Query: 114 YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 173
+Y+++EY GG++ S +R + SE + + Q+VL ++L ++ + DLKP+N+LI
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI 174
Query: 174 -KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL 232
+ +++ DFGFA+ + ++ G+P +APEI+ YN D W+LGVL++E
Sbjct: 175 DQQGYIQVTDFGFAKR--VKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 233 FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI-----SYED 287
G+ P+ + Q+ + +S P+ S D D L LLQ D +R D
Sbjct: 233 AGYPPFFADQPIQIYEKIVSGKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVND 290
Query: 288 LFSHPY 293
+ +H +
Sbjct: 291 IKNHKW 296
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 1e-36
Identities = 37/184 (20%), Positives = 79/184 (42%), Gaps = 4/184 (2%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKL-SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 170
+ ++ E+ + G L ++R+ L + + + +L E V H DL +N
Sbjct: 72 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARN 131
Query: 171 ILI-KNNTLKLADFGFAQFLAPND--QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVL 227
L+ +N +K++DFG +F+ + + + +PE+ + S Y++K+D+WS GVL
Sbjct: 132 CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVL 191
Query: 228 VFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYED 287
++E + + +S+ P S ++ ++ P R ++
Sbjct: 192 MWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSR 251
Query: 288 LFSH 291
L
Sbjct: 252 LLRQ 255
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 2e-36
Identities = 49/225 (21%), Positives = 89/225 (39%), Gaps = 33/225 (14%)
Query: 109 RKRPRYVYIILEYCDGG---DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFD 165
+K Y+ ++L+Y + R+ + L + ++ QL +L ++ +CH D
Sbjct: 88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 147
Query: 166 LKPQNILI--KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAP-EILAGSPYNAKADLW 222
+KPQN+L+ LKL DFG A+ L + S S Y AP I + Y + D+W
Sbjct: 148 IKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVW 207
Query: 223 SLGVLVFEALFGHAPYASCNLSQLRAQAL---------------------------SSAP 255
S G ++ E L G + + + + +
Sbjct: 208 SAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPW 267
Query: 256 ITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAP 300
+ P+ + SRLL+ P R++ + +H + D + P
Sbjct: 268 TKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 133 bits (334), Expect = 3e-36
Identities = 44/220 (20%), Positives = 91/220 (41%), Gaps = 42/220 (19%)
Query: 113 RYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
R ++ E+ + D + L+++ + ++ +++ AL + + H D+KP N++
Sbjct: 105 RTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM 161
Query: 173 I--KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSP-YNAKADLWSLGVLVF 229
I ++ L+L D+G A+F P + + S + PE+L Y+ D+WSLG ++
Sbjct: 162 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 221
Query: 230 EALFGHAPYASCN------------------------------------LSQLRAQALSS 253
+F P+ + L + +
Sbjct: 222 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER 281
Query: 254 APITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY 293
+ + +SP+ +DFL +LL+ D R++ + HPY
Sbjct: 282 FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 4e-36
Identities = 42/209 (20%), Positives = 79/209 (37%), Gaps = 12/209 (5%)
Query: 92 EFERPRAGLSNLRAP-----EGRKRPRYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQF 145
+F R + +L G + ++ E G L +R H+ ++
Sbjct: 57 DFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY 116
Query: 146 VRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQ----GDSIQG 200
Q+ + +L H DL +N+L+ + +K+ DFG + L ND + +
Sbjct: 117 AVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 201 SPLYMAPEILAGSPYNAKADLWSLGVLVFEAL-FGHAPYASCNLSQLRAQALSSAPITIP 259
+ APE L ++ +D W GV ++E +G P+ N SQ+ +
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 236
Query: 260 PNSLSPDCMDFLSRLLQKDPMRRISYEDL 288
P D + + + P R ++ L
Sbjct: 237 PEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 131 bits (329), Expect = 8e-36
Identities = 45/186 (24%), Positives = 82/186 (44%), Gaps = 10/186 (5%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 170
V II E+ + G L SF+R ++ + Q +R + +K+L + N H DL +N
Sbjct: 99 STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARN 158
Query: 171 ILI-KNNTLKLADFGFAQFLAPNDQGDS------IQGSPLYMAPEILAGSPYNAKADLWS 223
IL+ N K++DFG ++FL + + + + APE + + + +D+WS
Sbjct: 159 ILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWS 218
Query: 224 LGVLVFEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRR 282
G++++E + +G PY + A+ PP + QKD R
Sbjct: 219 YGIVMWEVMSYGERPYWDMTNQDV-INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHR 277
Query: 283 ISYEDL 288
+ +
Sbjct: 278 PKFGQI 283
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (326), Expect = 2e-35
Identities = 50/209 (23%), Positives = 98/209 (46%), Gaps = 13/209 (6%)
Query: 92 EFERPRAGLSNLRAP------EGRKRPRYVYIILEYCDGGDLCSFI--RSHEKLSEFQCQ 143
EF + A + ++ P R YII E+ G+L ++ + +++S
Sbjct: 59 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 118
Query: 144 QFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDS--IQG 200
Q+ A+++L + N H DL +N L+ +N+ +K+ADFG ++ + + +
Sbjct: 119 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 201 SPLYMAPEILAGSPYNAKADLWSLGVLVFEAL-FGHAPYASCNLSQLRAQALSSAPITIP 259
+ APE LA + ++ K+D+W+ GVL++E +G +PY +LSQ+ + P
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP 238
Query: 260 PNSLSPDCMDFLSRLLQKDPMRRISYEDL 288
+ + Q +P R S+ ++
Sbjct: 239 EG-CPEKVYELMRACWQWNPSDRPSFAEI 266
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 130 bits (326), Expect = 2e-35
Identities = 54/253 (21%), Positives = 96/253 (37%), Gaps = 36/253 (14%)
Query: 77 VKYSQVRYDTITSHSEFERPRAGLSNLRAP------EGRKRPRYVYIILEYCDGGDLCSF 130
+K ++ + S R + L L+ + + + ++ E+ D
Sbjct: 31 LKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLL 90
Query: 131 IRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLADFGFAQFL 189
L + F+ QL+ + + + V H DLKPQN+LI + LK+ADFG A+
Sbjct: 91 DVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF 150
Query: 190 -APNDQGDSIQGSPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLR 247
P + + Y AP++L GS Y+ D+WS+G + E + G + + +
Sbjct: 151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL 210
Query: 248 AQ---------------------------ALSSAPITIPPNSLSPDCMDFLSRLLQKDPM 280
+ P L +D LS++L+ DP
Sbjct: 211 MRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPN 270
Query: 281 RRISYEDLFSHPY 293
+RI+ + H Y
Sbjct: 271 QRITAKQALEHAY 283
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 129 bits (326), Expect = 2e-35
Identities = 40/234 (17%), Positives = 75/234 (32%), Gaps = 28/234 (11%)
Query: 88 TSHSEFERPRAGLSNLRAPEGRKR-------PRYVYIILEYCDGGDLCSFIRSHEKLSEF 140
T H + ++ G Y +++E F K S
Sbjct: 44 TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLK 103
Query: 141 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILI----KNNTLKLADFGFAQFLAPNDQGD 196
Q++ ++++ N H D+KP N L+ K N + + DFG A+
Sbjct: 104 TVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163
Query: 197 --------SIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRA 248
++ G+ Y + G + + DL SLG ++ G P+ + R
Sbjct: 164 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ 223
Query: 249 QALS------SAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYE---DLFSHPY 293
+ S PI + + +L+ + Y LF + +
Sbjct: 224 KYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 129 bits (326), Expect = 3e-35
Identities = 48/234 (20%), Positives = 90/234 (38%), Gaps = 36/234 (15%)
Query: 90 HSEFERPRAGLSNLRAP------EGRKRPRYVYIILEYCDGGDLCSFIRSHEK------- 136
++F+R A ++ P + + ++ EY GDL F+RS
Sbjct: 60 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119
Query: 137 -----------------LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTL 178
LS + RQ+ + +L E H DL +N L+ +N +
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVV 179
Query: 179 KLADFGFAQFLAPND---QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL-FG 234
K+ADFG ++ + D + +M PE + + Y ++D+W+ GV+++E +G
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239
Query: 235 HAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDL 288
PY ++ + P N + + + K P R S+ +
Sbjct: 240 LQPYYGMAHEEVIYYVRDGNILACPEN-CPLELYNLMRLCWSKLPADRPSFCSI 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-34
Identities = 46/198 (23%), Positives = 87/198 (43%), Gaps = 22/198 (11%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKF 155
+Y+I+EY G+L ++++ E+LS Q+ +++
Sbjct: 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 150
Query: 156 LRENNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQ---GDSIQGSPLYMAPEILA 211
L H DL +N+L+ ++N +K+ADFG A+ + D + + +MAPE L
Sbjct: 151 LASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF 210
Query: 212 GSPYNAKADLWSLGVLVFEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDF 270
Y ++D+WS GVL++E G +PY + +L + P N + +
Sbjct: 211 DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSN-CTNELYMM 269
Query: 271 LSRLLQKDPMRRISYEDL 288
+ P +R +++ L
Sbjct: 270 MRDCWHAVPSQRPTFKQL 287
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 8e-34
Identities = 52/223 (23%), Positives = 85/223 (38%), Gaps = 36/223 (16%)
Query: 116 YIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-K 174
++ + G DL +++ LS F+ Q++ LK++ NV H DLKP N+L+
Sbjct: 86 VYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 144
Query: 175 NNTLKLADFGFAQFLAPN----DQGDSIQGSPLYMAPEILAGS-PYNAKADLWSLGVLVF 229
LK+ DFG A+ P+ + Y APEI+ S Y D+WS+G ++
Sbjct: 145 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILA 204
Query: 230 EALFGHAPYASCNLSQLRAQALS-----------------------------SAPITIPP 260
E L + + L P
Sbjct: 205 EMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLF 264
Query: 261 NSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAE 303
+ +D L ++L +P +RI E +HPY + + P E
Sbjct: 265 PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 307
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 1e-33
Identities = 49/216 (22%), Positives = 84/216 (38%), Gaps = 16/216 (7%)
Query: 91 SEFERPRAGLSNLRAP-------EGRKRPRYVYIILEYCDGGDLCSFIRSHE-KLSEFQC 142
S+F + + P + ++L Y GDL +FIR+ +
Sbjct: 73 SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 132
Query: 143 QQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGD----- 196
F Q+ +KFL H DL +N ++ + T+K+ADFG A+ + +
Sbjct: 133 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 192
Query: 197 SIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL-FGHAPYASCNLSQLRAQALSSAP 255
+ +MA E L + K+D+WS GVL++E + G PY N + L
Sbjct: 193 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 252
Query: 256 ITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291
+ P + + + R S+ +L S
Sbjct: 253 LLQPEY-CPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 9e-33
Identities = 46/203 (22%), Positives = 87/203 (42%), Gaps = 21/203 (10%)
Query: 110 KRPRYVYIILEYCDGGDLCSFIRSHEK----------------LSEFQCQQFVRQLVLAL 153
K + +I+E+C G+L +++RS L+ + Q+ +
Sbjct: 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGM 147
Query: 154 KFLRENNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQG---DSIQGSPLYMAPEI 209
+FL H DL +NIL+ + N +K+ DFG A+ + + + +MAPE
Sbjct: 148 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 207
Query: 210 LAGSPYNAKADLWSLGVLVFEALFGHA-PYASCNLSQLRAQALSSAPITIPPNSLSPDCM 268
+ Y ++D+WS GVL++E A PY + + + L P+ +P+
Sbjct: 208 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY 267
Query: 269 DFLSRLLQKDPMRRISYEDLFSH 291
+ +P +R ++ +L H
Sbjct: 268 QTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 9e-33
Identities = 43/210 (20%), Positives = 88/210 (41%), Gaps = 14/210 (6%)
Query: 92 EFERPRAGLSNLRAP------EGRKRPRYVYIILEYCDGGDLCSFIRSHEK-LSEFQCQQ 144
+F + + + + II EY + G L F+R + S Q
Sbjct: 55 DFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVG 114
Query: 145 FVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGD----SIQ 199
+R + +K+L N H DL +NIL+ N K++DFG ++ L + + +
Sbjct: 115 MLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174
Query: 200 GSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL-FGHAPYASCNLSQLRAQALSSAPITI 258
+ APE ++ + + +D+WS G++++E + +G PY + ++ +
Sbjct: 175 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT 234
Query: 259 PPNSLSPDCMDFLSRLLQKDPMRRISYEDL 288
P + + + Q++ RR + D+
Sbjct: 235 PMD-CPSAIYQLMMQCWQQERARRPKFADI 263
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 1e-32
Identities = 45/221 (20%), Positives = 86/221 (38%), Gaps = 22/221 (9%)
Query: 92 EFERPRAGLSNLRAP------EGRKRPRYVYIILEYCDGGDLCSFIRSHEK--------- 136
EF + + + + +I+E GDL S++RS
Sbjct: 69 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 128
Query: 137 -LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPND- 193
S + Q ++ + +L N H DL +N ++ ++ T+K+ DFG + + D
Sbjct: 129 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 188
Query: 194 --QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEAL-FGHAPYASCNLSQLRAQA 250
+G +M+PE L + +D+WS GV+++E PY + Q+
Sbjct: 189 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248
Query: 251 LSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291
+ + P N + + Q +P R S+ ++ S
Sbjct: 249 MEGGLLDKPDN-CPDMLFELMRMCWQYNPKMRPSFLEIISS 288
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 7e-32
Identities = 60/261 (22%), Positives = 95/261 (36%), Gaps = 37/261 (14%)
Query: 77 VKYSQVRYDTITSHSEFERPRAGLSNLRAP------EGRKRPRYVYIILEYCDGGDLCSF 130
+K ++ +T S R + L L P + +Y++ E+
Sbjct: 32 LKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFM 91
Query: 131 IRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLADFGFAQF 188
S + + ++ QL+ L F + V H DLKPQN+LI +KLADFG A+
Sbjct: 92 DASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARA 151
Query: 189 LA-PNDQGDSIQGSPLYMAPEILAGSPYN-AKADLWSLGVLVFEALFGHAPYASCNLSQL 246
P + Y APEIL G Y D+WSLG + E + A + +
Sbjct: 152 FGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 211
Query: 247 RAQAL---------------------------SSAPITIPPNSLSPDCMDFLSRLLQKDP 279
+ + + L D LS++L DP
Sbjct: 212 LFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 271
Query: 280 MRRISYEDLFSHPYPDLIHAP 300
+RIS + +HP+ + P
Sbjct: 272 NKRISAKAALAHPFFQDVTKP 292
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 118 bits (297), Expect = 3e-31
Identities = 31/197 (15%), Positives = 64/197 (32%), Gaps = 20/197 (10%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 171
+ ++++ K S +Q++ ++ + E ++ + D+KP N
Sbjct: 73 GLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNF 132
Query: 172 LI------KNNTLKLADFGFAQFLAPNDQGDSIQ--------GSPLYMAPEILAGSPYNA 217
LI N + + DFG +F I G+ YM+ G +
Sbjct: 133 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSR 192
Query: 218 KADLWSLGVLVFEALFGHAPYASCNLSQLRA--QALSSAPITIPPNSLSPDC----MDFL 271
+ DL +LG + L G P+ + + + + + P L ++
Sbjct: 193 RDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYM 252
Query: 272 SRLLQKDPMRRISYEDL 288
Y+ L
Sbjct: 253 HYARNLAFDATPDYDYL 269
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 4e-31
Identities = 44/200 (22%), Positives = 78/200 (39%), Gaps = 23/200 (11%)
Query: 112 PRYVYIILEYCDGGDLCSFIRSHE------------------KLSEFQCQQFVRQLVLAL 153
+I EYC GDL +F+R L F Q+ +
Sbjct: 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM 158
Query: 154 KFLRENNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQ---GDSIQGSPLYMAPEI 209
FL N H DL +NIL+ K+ DFG A+ + + + + +MAPE
Sbjct: 159 AFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPES 218
Query: 210 LAGSPYNAKADLWSLGVLVFEAL-FGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCM 268
+ Y ++D+WS G+ ++E G +PY + + + + P +
Sbjct: 219 IFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMY 278
Query: 269 DFLSRLLQKDPMRRISYEDL 288
D + DP++R +++ +
Sbjct: 279 DIMKTCWDADPLKRPTFKQI 298
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 7e-31
Identities = 47/230 (20%), Positives = 90/230 (39%), Gaps = 35/230 (15%)
Query: 106 PEGRKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFD 165
E Y+++ + G + HEKL E + Q V Q++ L+++ + H D
Sbjct: 89 DETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRD 146
Query: 166 LKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGS-PYNAKADLWS 223
LKP N+ + ++ LK+ DFG A+ + + + Y APE++ Y D+WS
Sbjct: 147 LKPGNLAVNEDCELKILDFGLARQ--ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWS 204
Query: 224 LGVLVFEALFGHAPYASCNLSQLRAQ-----------------------------ALSSA 254
+G ++ E + G + + + L
Sbjct: 205 VGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKK 264
Query: 255 PITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAES 304
+ SP ++ L ++L D +R++ + +HPY + +H E
Sbjct: 265 DFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEP 314
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 4e-30
Identities = 60/254 (23%), Positives = 100/254 (39%), Gaps = 37/254 (14%)
Query: 77 VKYSQVRYDTITSHSEFERPRAGLSNLRAP------EGRKRPRYVYIILEYCDGGDLCSF 130
+K ++ D S R L L+ + + + ++ E+CD F
Sbjct: 32 LKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYF 91
Query: 131 IRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLADFGFAQFL 189
+ L + F+ QL+ L F NV H DLKPQN+LI +N LKLA+FG A+
Sbjct: 92 DSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF 151
Query: 190 APNDQGDSIQG-SPLYMAPEILAGSP-YNAKADLWSLGVLVFEALFGHAP-YASCNLSQL 246
+ S + + Y P++L G+ Y+ D+WS G + E P + ++
Sbjct: 152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211
Query: 247 RAQAL---------------------------SSAPITIPPNSLSPDCMDFLSRLLQKDP 279
+ ++ + L+ D L LL+ +P
Sbjct: 212 LKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNP 271
Query: 280 MRRISYEDLFSHPY 293
++RIS E+ HPY
Sbjct: 272 VQRISAEEALQHPY 285
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 1e-28
Identities = 48/233 (20%), Positives = 85/233 (36%), Gaps = 44/233 (18%)
Query: 113 RYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 172
+ VY+++E D + + Q++ +K L + H DLKP NI+
Sbjct: 95 QDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 151
Query: 173 IKNN-TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEA 231
+K++ TLK+ DFG A+ + + Y APE++ G Y D+WS+G ++ E
Sbjct: 152 VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211
Query: 232 LFGHAPYASCNLSQLRAQALSSAPITIP-------------------------------- 259
+ + + + + P
Sbjct: 212 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDS 271
Query: 260 --------PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAES 304
+ D LS++L DP +RIS +D HPY ++ + P
Sbjct: 272 LFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVE 324
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 4e-28
Identities = 49/219 (22%), Positives = 86/219 (39%), Gaps = 34/219 (15%)
Query: 116 YIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-K 174
++ + G D + I +KL++ Q + Q++ LK++ ++ H DLKP N+ + +
Sbjct: 98 VYLVTHLMGAD-LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 156
Query: 175 NNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGS-PYNAKADLWSLGVLVFEALF 233
+ LK+ DFG A+ +D+ + Y APEI+ YN D+WS+G ++ E L
Sbjct: 157 DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214
Query: 234 GHAPYASCNLSQLRAQALS-----------------------------SAPITIPPNSLS 264
G + + L +
Sbjct: 215 GRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGAN 274
Query: 265 PDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAE 303
P +D L ++L D +RI+ +H Y H P E
Sbjct: 275 PLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 313
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 2e-27
Identities = 39/222 (17%), Positives = 77/222 (34%), Gaps = 41/222 (18%)
Query: 107 EGRKRPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFL--------RE 158
+ ++++ +Y + G L ++ + ++ + L L +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 159 NNVCHFDLKPQNILI-KNNTLKLADFGFAQFLAPNDQGDSIQ-----GSPLYMAPEILAG 212
+ H DLK +NIL+ KN T +AD G A I G+ YMAPE+L
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 213 S------PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPIT--------- 257
S +AD++++G++ +E + QL L + +
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246
Query: 258 -------IPPNSLSPDCM----DFLSRLLQKDPMRRISYEDL 288
IP S + + + + R++ +
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 96.6 bits (239), Expect = 7e-23
Identities = 49/261 (18%), Positives = 92/261 (35%), Gaps = 61/261 (23%)
Query: 112 PRYVYIILEYCDGGDLCSFI---RSHEKLSEFQCQQFVRQLVLALKFLREN-NVCHFDLK 167
P V++++ + G+ + H + +Q +QL+L L ++ + H D+K
Sbjct: 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIK 153
Query: 168 PQNILI-----KNNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLW 222
P+N+L+ N +++ ++ + + Y +PE+L G+P+ AD+W
Sbjct: 154 PENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIW 213
Query: 223 SLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI-----TIP------------------ 259
S L+FE + G + A I +P
Sbjct: 214 STACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRG 273
Query: 260 -----------------------PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPY--- 293
+ + DFLS +LQ DP +R L +HP+
Sbjct: 274 LLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 333
Query: 294 ---PDLIHAPCAESHQTAIRI 311
+ I P E + + I
Sbjct: 334 TLGMEEIRVPDRELYGSGSDI 354
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 62.1 bits (150), Expect = 5e-12
Identities = 23/179 (12%), Positives = 51/179 (28%), Gaps = 39/179 (21%)
Query: 72 IRLGTVKYSQVRYDTITSHSEFER-----PRAGLSNLRAPEGRKRPRYV-----YIILEY 121
++G + +V+ F R L+ +G P+ +++E
Sbjct: 32 HKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMEL 91
Query: 122 CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLA 181
D +L + + ++ + + H DL N+L+ + +
Sbjct: 92 IDAKELYRVR-------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWII 144
Query: 182 DFGFAQFLAPNDQGDSIQGSPLYMAPEILA----------GSPYNAKADLWSLGVLVFE 230
DF + + EIL Y + D+ S + +
Sbjct: 145 DFPQSVEVGEE------------GWREILERDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
| >d1wr0a1 a.7.14.1 (A:5-81) Vacuolar sorting protein 4b (VPS4B, SKD1 protein) {Human (Homo sapiens) [TaxId: 9606]} Length = 77 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Spectrin repeat-like superfamily: MIT domain family: MIT domain domain: Vacuolar sorting protein 4b (VPS4B, SKD1 protein) species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (91), Expect = 6e-05
Identities = 11/44 (25%), Positives = 20/44 (45%)
Query: 299 APCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIPLA 342
+ + + Q AI + + A D+ N A LY A+ Y + +
Sbjct: 2 SSTSPNLQKAIDLASKAAQEDKAGNYEEALQLYQHAVQYFLHVV 45
|
| >d1wfda_ a.7.14.1 (A:) Hypothetical protein 1500032H18Rik {Mouse (Mus musculus) [TaxId: 10090]} Length = 93 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Spectrin repeat-like superfamily: MIT domain family: MIT domain domain: Hypothetical protein 1500032H18Rik species: Mouse (Mus musculus) [TaxId: 10090]
Score = 36.4 bits (84), Expect = 7e-04
Identities = 8/34 (23%), Positives = 19/34 (55%)
Query: 308 AIRIVTDAIHHDRENNSRRAFSLYCEALNYLIPL 341
A+ ++ A+ D E+ ++A Y E ++ L+ +
Sbjct: 15 AVAVLKRAVELDAESRYQQALVCYQEGIDMLLQV 48
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 406 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.07 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.74 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.54 | |
| d1wr0a1 | 77 | Vacuolar sorting protein 4b (VPS4B, SKD1 protein) | 97.48 | |
| d1wfda_ | 93 | Hypothetical protein 1500032H18Rik {Mouse (Mus mus | 97.44 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.25 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.97 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.55 | |
| d1elra_ | 128 | Hop {Human (Homo sapiens) [TaxId: 9606]} | 90.43 | |
| d2crba1 | 83 | Nuclear receptor binding factor 2, NRBF2, N-termin | 87.76 | |
| d1wr0a1 | 77 | Vacuolar sorting protein 4b (VPS4B, SKD1 protein) | 87.48 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 86.57 | |
| d2fbna1 | 153 | Putative 70 kda peptidylprolyl isomerase PFL2275c | 85.96 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 85.57 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 85.3 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 85.01 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 84.43 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 83.71 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 82.48 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 81.71 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 81.68 | |
| d1kt1a1 | 168 | FKBP51, C-terminal domain {Monkey (Saimiri bolivie | 80.86 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 80.02 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-56 Score=417.12 Aligned_cols=241 Identities=27% Similarity=0.435 Sum_probs=213.1
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
-..||+|+||+||++... +..+|+|.+........+.+.+|+.++++++|||+++ ..+++|||||||+||+|
T Consensus 25 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L 104 (293)
T d1yhwa1 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (293)
T ss_dssp CEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred EEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcH
Confidence 456899999999999864 6679999888776666778999999999999999876 77889999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCCCC
Q psy5368 128 CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPLYM 205 (406)
Q Consensus 128 ~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~y~ 205 (406)
.+++.+ +.+++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+...... ......||+.|+
T Consensus 105 ~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~ 183 (293)
T d1yhwa1 105 TDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 183 (293)
T ss_dssp HHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGC
T ss_pred HHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccccccCCCcc
Confidence 998876 5799999999999999999999999999999999999998 7799999999998775443 445667999999
Q ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC-CCCCChHHHHHHHHhcccCCCCCCC
Q psy5368 206 APEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIP-PNSLSPDCMDFLSRLLQKDPMRRIS 284 (406)
Q Consensus 206 aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~~li~~~L~~dP~~Rps 284 (406)
|||++.+..|+.++||||+||++|+|+||++||.+.+.......+........+ +..+|+++++||.+||+.||++|||
T Consensus 184 aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s 263 (293)
T d1yhwa1 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS 263 (293)
T ss_dssp CHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCC
T ss_pred ChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcC
Confidence 999999999999999999999999999999999998877777666665443332 3478999999999999999999999
Q ss_pred HHHHhcCCCCCCC
Q psy5368 285 YEDLFSHPYPDLI 297 (406)
Q Consensus 285 ~~ell~hp~~~~~ 297 (406)
++|+++||||+..
T Consensus 264 ~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 264 AKELLQHQFLKIA 276 (293)
T ss_dssp HHHHTTCGGGGGC
T ss_pred HHHHhcCHhhCCC
Confidence 9999999999853
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-55 Score=418.26 Aligned_cols=243 Identities=26% Similarity=0.425 Sum_probs=196.4
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...||+|+||+||++... +..+|+|.+...... ....+.+|+.++++++|||+++ +++++|||||||+|||
T Consensus 14 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~ 93 (307)
T d1a06a_ 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE 93 (307)
T ss_dssp EEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence 457899999999999864 456899988755433 3456889999999999999876 7889999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee----CCeeEEEecccccccCCCCCCCcccCCC
Q psy5368 127 LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK----NNTLKLADFGFAQFLAPNDQGDSIQGSP 202 (406)
Q Consensus 127 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~----~~~~kL~DFGla~~~~~~~~~~~~~gt~ 202 (406)
|.+++..++.+++.++..++.||+.||+|||++||+||||||+|||+. ++.+||+|||+|+...........+||+
T Consensus 94 L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~ 173 (307)
T d1a06a_ 94 LFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTP 173 (307)
T ss_dssp HHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------------C
T ss_pred HHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCc
Confidence 999999988999999999999999999999999999999999999995 5689999999998876666667788999
Q ss_pred CCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCChHHHHHHHHhcccCCC
Q psy5368 203 LYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIP--PNSLSPDCMDFLSRLLQKDPM 280 (406)
Q Consensus 203 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~s~~l~~li~~~L~~dP~ 280 (406)
.|||||++.+..|+.++||||+||++|+|++|++||.+.+..++...+......... ...+|+++.+||.+||+.||+
T Consensus 174 ~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 253 (307)
T d1a06a_ 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPE 253 (307)
T ss_dssp TTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGG
T ss_pred cccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHh
Confidence 999999999999999999999999999999999999999988888888776443222 237899999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCC
Q psy5368 281 RRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 281 ~Rps~~ell~hp~~~~~~ 298 (406)
+|||++|+++||||+...
T Consensus 254 ~R~s~~eil~hp~~~~~~ 271 (307)
T d1a06a_ 254 KRFTCEQALQHPWIAGDT 271 (307)
T ss_dssp GSCCHHHHHHSTTTTSSC
T ss_pred HCcCHHHHhcCHhhCCCC
Confidence 999999999999998654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-56 Score=411.19 Aligned_cols=237 Identities=26% Similarity=0.458 Sum_probs=210.0
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||+||++... +..+|+|.+.... ......+.+|+.++++++|||+++ +++.+|+|||||+|
T Consensus 11 ~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~ 90 (263)
T d2j4za1 11 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 90 (263)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence 457899999999999874 4568888776432 234567899999999999999876 77889999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+..... ......||+.
T Consensus 91 g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-~~~~~~Gt~~ 169 (263)
T d2j4za1 91 GTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTTLCGTLD 169 (263)
T ss_dssp CBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-CCEETTEEGG
T ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-cccccCCCCc
Confidence 99999999888999999999999999999999999999999999999998 679999999999876533 3456679999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
|+|||++.+..++.++||||+||++|+|++|+.||.+.+..++...+.... ...| ..+|+++.+||.+||+.||++||
T Consensus 170 Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-~~~p-~~~s~~~~~li~~~L~~dp~~R~ 247 (263)
T d2j4za1 170 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFP-DFVTEGARDLISRLLKHNPSQRP 247 (263)
T ss_dssp GCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCC-TTSCHHHHHHHHHHTCSSGGGSC
T ss_pred ccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCC-ccCCHHHHHHHHHHccCCHhHCc
Confidence 999999999999999999999999999999999999999888888877663 3333 46999999999999999999999
Q ss_pred CHHHHhcCCCCC
Q psy5368 284 SYEDLFSHPYPD 295 (406)
Q Consensus 284 s~~ell~hp~~~ 295 (406)
|++|+++||||.
T Consensus 248 t~~eil~hp~~~ 259 (263)
T d2j4za1 248 MLREVLEHPWIT 259 (263)
T ss_dssp CHHHHHTCHHHH
T ss_pred CHHHHHcCcCcC
Confidence 999999999986
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-56 Score=415.57 Aligned_cols=241 Identities=24% Similarity=0.392 Sum_probs=201.8
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...||+|+||+||++... +..+|+|.+..... ...+.+.+|+.++++++|||+++ +++.+|||||||+||+
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~ 89 (271)
T d1nvra_ 10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 89 (271)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCc
Confidence 357899999999999864 45789998765543 33457899999999999999876 7788999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC---CCCcccCCC
Q psy5368 127 LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND---QGDSIQGSP 202 (406)
Q Consensus 127 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~---~~~~~~gt~ 202 (406)
|.+++..++.+++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+...... .....+||+
T Consensus 90 L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~ 169 (271)
T d1nvra_ 90 LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 169 (271)
T ss_dssp GGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCG
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCc
Confidence 999998888999999999999999999999999999999999999998 6799999999998764332 345678999
Q ss_pred CCCChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCC
Q psy5368 203 LYMAPEILAGSPY-NAKADLWSLGVLVFEALFGHAPYASCNLSQL-RAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPM 280 (406)
Q Consensus 203 ~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~ 280 (406)
.|||||++.+..+ +.++||||+||++|||+||++||...+.... ............+...+|+++.+|+.+||+.||+
T Consensus 170 ~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 249 (271)
T d1nvra_ 170 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPS 249 (271)
T ss_dssp GGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTT
T ss_pred CccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChh
Confidence 9999999998876 5789999999999999999999977654333 2333333333333347899999999999999999
Q ss_pred CCCCHHHHhcCCCCCC
Q psy5368 281 RRISYEDLFSHPYPDL 296 (406)
Q Consensus 281 ~Rps~~ell~hp~~~~ 296 (406)
+|||++|+++||||+.
T Consensus 250 ~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 250 ARITIPDIKKDRWYNK 265 (271)
T ss_dssp TSCCHHHHTTCTTTTC
T ss_pred HCcCHHHHhcCHhhCc
Confidence 9999999999999973
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-55 Score=407.72 Aligned_cols=238 Identities=21% Similarity=0.410 Sum_probs=202.5
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCcc----------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRK----------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~----------~~~~~~lV~E~ 121 (406)
..+||+|+||+||++... +..||+|.+...... ....+.+|++++++++|||+++ ....+|+||||
T Consensus 14 ~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~ 93 (270)
T d1t4ha_ 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 93 (270)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeC
Confidence 346899999999999875 346888887654322 3457899999999999999876 24568999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCcceEee--CCeeEEEecccccccCCCCCCCc
Q psy5368 122 CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENN--VCHFDLKPQNILIK--NNTLKLADFGFAQFLAPNDQGDS 197 (406)
Q Consensus 122 ~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dlkp~NIll~--~~~~kL~DFGla~~~~~~~~~~~ 197 (406)
|+||+|.+++.+.+.+++.+++.++.||+.||+|||++| |+||||||+|||++ ++.+||+|||+|+.... .....
T Consensus 94 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~-~~~~~ 172 (270)
T d1t4ha_ 94 MTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKA 172 (270)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-TSBEE
T ss_pred CCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC-CccCC
Confidence 999999999998889999999999999999999999999 99999999999996 56999999999976433 33456
Q ss_pred ccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcc
Q psy5368 198 IQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCN-LSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQ 276 (406)
Q Consensus 198 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~ 276 (406)
..||+.|||||++.+ .++.++||||+||++|||++|+.||.+.. ...+...+.....+...+..+++++.+||.+||+
T Consensus 173 ~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~ 251 (270)
T d1t4ha_ 173 VIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 251 (270)
T ss_dssp SCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSC
T ss_pred cccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHcc
Confidence 789999999999876 59999999999999999999999997654 5555566655544333344689999999999999
Q ss_pred cCCCCCCCHHHHhcCCCCC
Q psy5368 277 KDPMRRISYEDLFSHPYPD 295 (406)
Q Consensus 277 ~dP~~Rps~~ell~hp~~~ 295 (406)
.||++|||++|+++||||+
T Consensus 252 ~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 252 QNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp SSGGGSCCHHHHHTSGGGC
T ss_pred CCHhHCcCHHHHhCCcccC
Confidence 9999999999999999985
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-55 Score=413.86 Aligned_cols=241 Identities=28% Similarity=0.446 Sum_probs=210.5
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
...||+|+||+||++... +..+|+|.+........+.+.+|++++++++|||+++ +.+.+|+|||||+||+|
T Consensus 17 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L 96 (288)
T d2jfla1 17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred eEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcH
Confidence 346899999999999864 4568999887766666778999999999999999876 78889999999999999
Q ss_pred HHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCcccCCCCC
Q psy5368 128 CSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDSIQGSPLY 204 (406)
Q Consensus 128 ~~~l~~-~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~~~gt~~y 204 (406)
.+++.+ .+++++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+..... .......||+.|
T Consensus 97 ~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y 176 (288)
T d2jfla1 97 DAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYW 176 (288)
T ss_dssp HHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTT
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccccccccccccc
Confidence 999765 45799999999999999999999999999999999999999 779999999999765322 123456799999
Q ss_pred CChhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC-CCCCChHHHHHHHHhcccC
Q psy5368 205 MAPEILA-----GSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIP-PNSLSPDCMDFLSRLLQKD 278 (406)
Q Consensus 205 ~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~~li~~~L~~d 278 (406)
+|||++. +..|+.++||||+||++|||+||++||.+.+..+....+......... +..+|+++.+||.+||+.|
T Consensus 177 ~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~d 256 (288)
T d2jfla1 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKN 256 (288)
T ss_dssp CCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSS
T ss_pred CCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCC
Confidence 9999984 456899999999999999999999999999888888888877554433 2378999999999999999
Q ss_pred CCCCCCHHHHhcCCCCCC
Q psy5368 279 PMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 279 P~~Rps~~ell~hp~~~~ 296 (406)
|++|||++|+++||||+.
T Consensus 257 p~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 257 VDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp TTTSCCHHHHTTSGGGCC
T ss_pred hhHCcCHHHHhcCcccCC
Confidence 999999999999999974
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-55 Score=405.55 Aligned_cols=237 Identities=29% Similarity=0.501 Sum_probs=196.6
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCcc--------cCCeEEEEEeccCC
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRK--------RPRYVYIILEYCDG 124 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~--------~~~~~~lV~E~~~g 124 (406)
..||+|+||+||++... +..+|+|.+...... ....+.+|++++++++|||+++ ..+.+|+|||||+|
T Consensus 10 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~ 89 (269)
T d2java1 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG 89 (269)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTT
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCC
Confidence 57899999999999864 457899988765433 2446889999999999999876 34668999999999
Q ss_pred CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccccCCCcceEee-CCeeEEEecccccccCCCC-
Q psy5368 125 GDLCSFIRS----HEKLSEFQCQQFVRQLVLALKFLRENN-----VCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND- 193 (406)
Q Consensus 125 gsL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~lH~~g-----ivH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~- 193 (406)
|+|.+++.+ ++.+++..++.++.||+.||+|||++| |+||||||+|||++ ++.+||+|||+|+......
T Consensus 90 g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 169 (269)
T d2java1 90 GDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 169 (269)
T ss_dssp EEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-----
T ss_pred CcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCC
Confidence 999999853 457999999999999999999999976 99999999999999 7799999999998875543
Q ss_pred CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHH
Q psy5368 194 QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSR 273 (406)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~ 273 (406)
......||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.+..++...+........+ ..+|+++.+|+.+
T Consensus 170 ~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~s~~l~~li~~ 248 (269)
T d2java1 170 FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP-YRYSDELNEIITR 248 (269)
T ss_dssp ------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCC-TTSCHHHHHHHHH
T ss_pred ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC-cccCHHHHHHHHH
Confidence 345678999999999999999999999999999999999999999999999988888877555444 4799999999999
Q ss_pred hcccCCCCCCCHHHHhcCCCC
Q psy5368 274 LLQKDPMRRISYEDLFSHPYP 294 (406)
Q Consensus 274 ~L~~dP~~Rps~~ell~hp~~ 294 (406)
||+.||.+|||++|+++|||+
T Consensus 249 ~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 249 MLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HTCSSGGGSCCHHHHHTSTTC
T ss_pred HcCCChhHCcCHHHHHhCCcC
Confidence 999999999999999999995
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.2e-55 Score=420.43 Aligned_cols=247 Identities=28% Similarity=0.434 Sum_probs=218.3
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
...||+|+||.||++... +..+|+|.+........+.+.+|+.++++++|||+++ +.+.+|||||||+||+|
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L 110 (350)
T d1koaa2 31 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 110 (350)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBH
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCH
Confidence 457899999999999874 5678999887666556678999999999999999876 78899999999999999
Q ss_pred HHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee---CCeeEEEecccccccCCCCCCCcccCCCC
Q psy5368 128 CSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK---NNTLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 128 ~~~l~~-~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~---~~~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
.+++.+ .+++++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+.+..........||+.
T Consensus 111 ~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~ 190 (350)
T d1koaa2 111 FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAE 190 (350)
T ss_dssp HHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTT
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccceecCccc
Confidence 999954 45799999999999999999999999999999999999996 46899999999998876666677889999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCChHHHHHHHHhcccCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP--NSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~~li~~~L~~dP~~ 281 (406)
|||||++.+..++.++||||+||++|+|++|+.||.+.+..++...+.......... ..+|+++++||.+||+.||++
T Consensus 191 Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 270 (350)
T d1koaa2 191 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNT 270 (350)
T ss_dssp TCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGG
T ss_pred ccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhH
Confidence 999999999999999999999999999999999999999988888887764332221 368999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCCCc
Q psy5368 282 RISYEDLFSHPYPDLIHAPCA 302 (406)
Q Consensus 282 Rps~~ell~hp~~~~~~~~~~ 302 (406)
|||++|+++||||+....+..
T Consensus 271 R~t~~eil~hp~~~~~~~~~~ 291 (350)
T d1koaa2 271 RMTIHQALEHPWLTPGNAPGR 291 (350)
T ss_dssp SCCHHHHHHSTTTSCTTCCSC
T ss_pred CcCHHHHhcCcccCCCCCCCc
Confidence 999999999999987665543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-55 Score=409.15 Aligned_cols=243 Identities=25% Similarity=0.441 Sum_probs=211.0
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||+||++... +..+|+|.+.... ......+.+|++++++++|||+++ +.+.+|+|||||+|
T Consensus 13 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~g 92 (288)
T d1uu3a_ 13 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 92 (288)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCC
Confidence 467899999999999864 5678999876432 233457899999999999999876 77889999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC---CCCcccC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND---QGDSIQG 200 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~---~~~~~~g 200 (406)
|+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++ ++.+||+|||+|+.+.... ......|
T Consensus 93 g~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~G 172 (288)
T d1uu3a_ 93 GELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 172 (288)
T ss_dssp EEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCC
T ss_pred CCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccccccccC
Confidence 99999999989999999999999999999999999999999999999998 6799999999998775432 2345679
Q ss_pred CCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCC
Q psy5368 201 SPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPM 280 (406)
Q Consensus 201 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~ 280 (406)
|+.|+|||++.+..|+.++||||+||++|+|+||+.||.+.+..++...+.... ...| ..+|+++++||.+||+.||+
T Consensus 173 T~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~-~~~p-~~~s~~~~~li~~~L~~dP~ 250 (288)
T d1uu3a_ 173 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFP-EKFFPKARDLVEKLLVLDAT 250 (288)
T ss_dssp CGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC-CCCC-TTCCHHHHHHHHTTSCSSGG
T ss_pred CccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC-CCCC-ccCCHHHHHHHHHHccCCHh
Confidence 999999999999999999999999999999999999999999988888887764 3343 47999999999999999999
Q ss_pred CCCCHHH------HhcCCCCCCCCCC
Q psy5368 281 RRISYED------LFSHPYPDLIHAP 300 (406)
Q Consensus 281 ~Rps~~e------ll~hp~~~~~~~~ 300 (406)
+|||++| +++||||+...+.
T Consensus 251 ~R~t~~e~~~~~~i~~Hpff~~i~w~ 276 (288)
T d1uu3a_ 251 KRLGCEEMEGYGPLKAHPFFESVTWE 276 (288)
T ss_dssp GSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred HCcCHHHHcCCHHHHcCCccCCCCHH
Confidence 9999987 6889999987653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-54 Score=410.69 Aligned_cols=240 Identities=25% Similarity=0.380 Sum_probs=212.0
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccc---hhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITS---HSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~---~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
-+.||+|+||+||++... +..||+|.+....... ...+.+|+.++++++|||+++ +.+.+|+|||||++
T Consensus 20 l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~ 99 (309)
T d1u5ra_ 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG 99 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCC
Confidence 457899999999999864 4568999887654333 346889999999999999876 77889999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
|+|..++..++++++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+.... .....||+.
T Consensus 100 g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---~~~~~GT~~ 176 (309)
T d1u5ra_ 100 SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSFVGTPY 176 (309)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCCCCSCGG
T ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---CCccccCcc
Confidence 99988888888999999999999999999999999999999999999999 77999999999987543 345679999
Q ss_pred CCChhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCC
Q psy5368 204 YMAPEILAG---SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPM 280 (406)
Q Consensus 204 y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~ 280 (406)
|||||++.+ +.|+.++|||||||++|||++|..||.+.+..+....+........++..+|+++.+||.+||+.||.
T Consensus 177 Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 256 (309)
T d1u5ra_ 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQ 256 (309)
T ss_dssp GCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGG
T ss_pred ccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChh
Confidence 999999964 45899999999999999999999999999988888888887776666668999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCC
Q psy5368 281 RRISYEDLFSHPYPDLIH 298 (406)
Q Consensus 281 ~Rps~~ell~hp~~~~~~ 298 (406)
+|||++|+++||||....
T Consensus 257 ~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 257 DRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp GSCCHHHHTTCHHHHSCC
T ss_pred HCcCHHHHHhCHHhcCCC
Confidence 999999999999997543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-55 Score=415.75 Aligned_cols=239 Identities=24% Similarity=0.398 Sum_probs=200.6
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
..||+|+||+||++... +..+|+|.+...... ....+.+|+.+|++++|||+++ +.+++|||||||+||+|
T Consensus 12 ~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L 91 (322)
T d1s9ja_ 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 91 (322)
T ss_dssp EEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEH
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcH
Confidence 56899999999999864 456888887655333 3457899999999999999876 77889999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCCC
Q psy5368 128 CSFIRSHEKLSEFQCQQFVRQLVLALKFLREN-NVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLYM 205 (406)
Q Consensus 128 ~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~-givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y~ 205 (406)
.+++.+++.+++..++.++.||+.||.|||++ ||+||||||+|||++ ++.+||+|||+|+..... ...+.+||+.|+
T Consensus 92 ~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~~~~GT~~Y~ 170 (322)
T d1s9ja_ 92 DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYM 170 (322)
T ss_dssp HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-TC---CCSSCCC
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-ccccccCCcccc
Confidence 99999888999999999999999999999974 999999999999998 779999999999876432 345678999999
Q ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----------------------------------------
Q psy5368 206 APEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQ---------------------------------------- 245 (406)
Q Consensus 206 aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~---------------------------------------- 245 (406)
|||++.+..|+.++||||+||++|||++|+.||.+.+...
T Consensus 171 APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (322)
T d1s9ja_ 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAI 250 (322)
T ss_dssp CHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCH
T ss_pred CchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhH
Confidence 9999999999999999999999999999999997654322
Q ss_pred --HHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy5368 246 --LRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 246 --~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 296 (406)
....+....+...+...+|.++.+||.+||+.||++|||++|+|+||||+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 251 FELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp HHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred HHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 112222222333344457899999999999999999999999999999974
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-54 Score=406.51 Aligned_cols=244 Identities=27% Similarity=0.460 Sum_probs=212.9
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc------chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT------SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~------~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~ 121 (406)
...||+|+||+||++... +..+|+|.+...... ....+.+|+.+|++++|||+++ +.+.+||||||
T Consensus 15 ~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (293)
T d1jksa_ 15 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 94 (293)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457899999999999864 557899987654322 2457899999999999999876 78899999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC----eeEEEecccccccCCCCCCC
Q psy5368 122 CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN----TLKLADFGFAQFLAPNDQGD 196 (406)
Q Consensus 122 ~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~----~~kL~DFGla~~~~~~~~~~ 196 (406)
|+||+|.+++.+++.+++..++.++.||+.||+|||++||+||||||+|||++ ++ .+||+|||+|..........
T Consensus 95 ~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~ 174 (293)
T d1jksa_ 95 VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 174 (293)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCS
T ss_pred CCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCcccc
Confidence 99999999999888999999999999999999999999999999999999998 33 59999999999887666677
Q ss_pred cccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCChHHHHHHHHh
Q psy5368 197 SIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIP--PNSLSPDCMDFLSRL 274 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~s~~l~~li~~~ 274 (406)
...||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+....+........+ +..+|+++++||.+|
T Consensus 175 ~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 254 (293)
T d1jksa_ 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRL 254 (293)
T ss_dssp CCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTT
T ss_pred ccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHH
Confidence 788999999999999999999999999999999999999999999988888887766432211 136899999999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCCCC
Q psy5368 275 LQKDPMRRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 275 L~~dP~~Rps~~ell~hp~~~~~~~ 299 (406)
|+.||++|||++|+++||||+...+
T Consensus 255 L~~dP~~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 255 LVKDPKKRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp SCSSGGGSCCHHHHHHSTTTCC---
T ss_pred ccCChhHCcCHHHHhcCcccCCCCh
Confidence 9999999999999999999986543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.2e-54 Score=414.73 Aligned_cols=243 Identities=25% Similarity=0.403 Sum_probs=214.9
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
...||+|+||.||++... +..+|+|.+..........+.+|+.+|++|+|||+++ +++.+|||||||+||+|
T Consensus 34 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L 113 (352)
T d1koba_ 34 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 113 (352)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBH
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChH
Confidence 356899999999999863 5678999887665555668899999999999999876 78899999999999999
Q ss_pred HHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee---CCeeEEEecccccccCCCCCCCcccCCCC
Q psy5368 128 CSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK---NNTLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 128 ~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~---~~~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
.+++...+ ++++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+............||+.
T Consensus 114 ~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~ 193 (352)
T d1koba_ 114 FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAE 193 (352)
T ss_dssp HHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGG
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceeeccCccc
Confidence 99876554 799999999999999999999999999999999999997 46899999999998877666677789999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCChHHHHHHHHhcccCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITI--PPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
|+|||++.+..++.++||||+||++|+|+||++||.+.+..++...+........ ....+|+++.+||.+||+.||.+
T Consensus 194 y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 273 (352)
T d1koba_ 194 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRK 273 (352)
T ss_dssp GCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGG
T ss_pred ccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhH
Confidence 9999999999999999999999999999999999999999888888877643222 12378999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCC
Q psy5368 282 RISYEDLFSHPYPDLIH 298 (406)
Q Consensus 282 Rps~~ell~hp~~~~~~ 298 (406)
|||++|+++||||+...
T Consensus 274 R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 274 RLTVHDALEHPWLKGDH 290 (352)
T ss_dssp SCCHHHHHTSTTTSSCC
T ss_pred CcCHHHHhcCHhhCCCc
Confidence 99999999999998654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=409.79 Aligned_cols=241 Identities=24% Similarity=0.421 Sum_probs=213.8
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
-+.||+|+||.||++... +..+|+|.+.... ......+.+|+.+|++++|||+++ +.+++|+|||||+|
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~g 89 (337)
T d1o6la_ 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCC
Confidence 356899999999999863 5678999876542 234567899999999999999876 78899999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCC-CCCCCcccCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAP-NDQGDSIQGSP 202 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~-~~~~~~~~gt~ 202 (406)
|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ +|.+||+|||+|+.... .......+||+
T Consensus 90 g~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~ 169 (337)
T d1o6la_ 90 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 169 (337)
T ss_dssp CBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECG
T ss_pred CchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcccccceeCH
Confidence 99999999999999999999999999999999999999999999999998 78999999999987644 34456678999
Q ss_pred CCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCC
Q psy5368 203 LYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRR 282 (406)
Q Consensus 203 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 282 (406)
.|+|||++.+..|+.++||||+||++|||++|++||.+.+..++...+.... ...| ..+|+++++||.+||++||.+|
T Consensus 170 ~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~-~~~p-~~~s~~~~dli~~~L~~dP~~R 247 (337)
T d1o6la_ 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFP-RTLSPEAKSLLAGLLKKDPKQR 247 (337)
T ss_dssp GGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCC-TTSCHHHHHHHHHHTCSSTTTS
T ss_pred HHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC-CCCC-ccCCHHHHHHHHhhccCCchhh
Confidence 9999999999999999999999999999999999999999999888887764 4444 4799999999999999999999
Q ss_pred CC-----HHHHhcCCCCCCCC
Q psy5368 283 IS-----YEDLFSHPYPDLIH 298 (406)
Q Consensus 283 ps-----~~ell~hp~~~~~~ 298 (406)
|+ ++|+++||||+...
T Consensus 248 ~~~~~~~~~eil~Hp~f~~i~ 268 (337)
T d1o6la_ 248 LGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp TTCSTTTHHHHHTSGGGTTCC
T ss_pred cccccccHHHHHcCcccccCC
Confidence 95 89999999998764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.1e-53 Score=402.16 Aligned_cols=240 Identities=27% Similarity=0.512 Sum_probs=212.5
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~g 124 (406)
...||+|+||+||++... +..+|+|.+.... ......+.+|+.++++++|||+++ +.+.+|+|||||+|
T Consensus 9 ~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 88 (316)
T d1fota_ 9 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG 88 (316)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCC
Confidence 356789999999999864 5678999876432 234567899999999999999876 78899999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCC
Q psy5368 125 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 125 gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
|+|..++.....+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+.... ...+.+||+.
T Consensus 89 g~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~--~~~~~~Gt~~ 166 (316)
T d1fota_ 89 GELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYTLCGTPD 166 (316)
T ss_dssp CBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--CBCCCCSCTT
T ss_pred ccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc--ccccccCccc
Confidence 99999999999999999999999999999999999999999999999998 77999999999987643 3446789999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
|+|||++.+..|+.++||||+||++|+|+||+.||.+.+..++...+..... ..| ..+|+++.+++.+||+.||.+||
T Consensus 167 Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~p-~~~s~~~~~li~~~L~~dp~~R~ 244 (316)
T d1fota_ 167 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-RFP-PFFNEDVKDLLSRLITRDLSQRL 244 (316)
T ss_dssp TCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-CCC-TTSCHHHHHHHHHHTCSCTTTCT
T ss_pred ccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC-CCC-CCCCHHHHHHHHHHhhhCHHhcc
Confidence 9999999999999999999999999999999999999999999888887743 333 36999999999999999999996
Q ss_pred -----CHHHHhcCCCCCCCCC
Q psy5368 284 -----SYEDLFSHPYPDLIHA 299 (406)
Q Consensus 284 -----s~~ell~hp~~~~~~~ 299 (406)
|++++++||||+...+
T Consensus 245 ~~~r~t~~~il~Hp~f~~i~~ 265 (316)
T d1fota_ 245 GNLQNGTEDVKNHPWFKEVVW 265 (316)
T ss_dssp TSSTTTTHHHHTSGGGSSCCH
T ss_pred ccchhhHHHHHcCcccccCCH
Confidence 9999999999987654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.4e-53 Score=393.35 Aligned_cols=241 Identities=24% Similarity=0.391 Sum_probs=210.3
Q ss_pred eeeecceeeeEEEeeee--eeceeEEeeeecCCccc---------hhhhhhHHhhcccCC-CCCCcc------cCCeEEE
Q psy5368 56 TIRYGELQYDTVQNSQI--RLGTVKYSQVRYDTITS---------HSEFERPRAGLSNLR-APEGRK------RPRYVYI 117 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~~~---------~~~~~~E~~~l~~l~-h~ni~~------~~~~~~l 117 (406)
...||+|+||+||++.. .+..+|+|.+....... ...+.+|+.++++++ |||+++ +++++||
T Consensus 8 ~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~i 87 (277)
T d1phka_ 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 87 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEE
Confidence 56789999999999986 34678898876654322 235889999999997 999875 8889999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCC
Q psy5368 118 ILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGD 196 (406)
Q Consensus 118 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~ 196 (406)
|||||+||||.++|+.++++++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++.........
T Consensus 88 vmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 167 (277)
T d1phka_ 88 VFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR 167 (277)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBC
T ss_pred EEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccCCCcee
Confidence 999999999999999989999999999999999999999999999999999999998 7799999999999887666667
Q ss_pred cccCCCCCCChhhhcC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCChHHH
Q psy5368 197 SIQGSPLYMAPEILAG------SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIP--PNSLSPDCM 268 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~s~~l~ 268 (406)
...||+.|+|||.+.+ ..++.++||||+||++|+|++|++||.+.+.......+......... ...+|++++
T Consensus 168 ~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 247 (277)
T d1phka_ 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK 247 (277)
T ss_dssp CCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHH
T ss_pred eeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHH
Confidence 7889999999999863 34788999999999999999999999999988888887776433222 227999999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy5368 269 DFLSRLLQKDPMRRISYEDLFSHPYPDL 296 (406)
Q Consensus 269 ~li~~~L~~dP~~Rps~~ell~hp~~~~ 296 (406)
+|+.+||++||++|||++|+++||||+.
T Consensus 248 ~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 248 DLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred HHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 9999999999999999999999999973
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-53 Score=395.21 Aligned_cols=239 Identities=21% Similarity=0.366 Sum_probs=204.3
Q ss_pred ceeeecceeeeEEEeeeeee----ceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccC
Q psy5368 55 STIRYGELQYDTVQNSQIRL----GTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCD 123 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~----~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ 123 (406)
.+++||+|+||+||+|.+.. ..||+|.+...... ..++|.+|+.++++++|||+++ ..+..|||||||+
T Consensus 11 e~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~ 90 (277)
T d1xbba_ 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAE 90 (277)
T ss_dssp EEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCT
T ss_pred cCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCC
Confidence 34679999999999998643 45889987654322 2457999999999999999876 4456789999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC----CCcc
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ----GDSI 198 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~----~~~~ 198 (406)
+|+|.+++.+...+++.++..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+....... ....
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence 999999999989999999999999999999999999999999999999998 78999999999987654332 2345
Q ss_pred cCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhccc
Q psy5368 199 QGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 199 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~ 277 (406)
.||+.|+|||++.+..++.++|||||||++|||+| |++||.+.+..++...+..+..+..|. .+|+++.+|+.+||+.
T Consensus 171 ~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~-~~~~~~~~li~~cl~~ 249 (277)
T d1xbba_ 171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA-GCPREMYDLMNLCWTY 249 (277)
T ss_dssp CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT-TCCHHHHHHHHHHTCS
T ss_pred CCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCc-ccCHHHHHHHHHHcCC
Confidence 68999999999999999999999999999999998 899999999988888888776666554 7999999999999999
Q ss_pred CCCCCCCHHHH---hcCCCC
Q psy5368 278 DPMRRISYEDL---FSHPYP 294 (406)
Q Consensus 278 dP~~Rps~~el---l~hp~~ 294 (406)
||++|||++++ |+|+|+
T Consensus 250 dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 250 DVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp STTTSCCHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHhhCHHh
Confidence 99999999998 456654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-52 Score=403.11 Aligned_cols=239 Identities=26% Similarity=0.419 Sum_probs=212.2
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCC---ccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCC
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDT---ITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGG 125 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~gg 125 (406)
..||+|+||.||++... +..+|+|.+.... ......+.+|+.+|+.++|||+++ ....+|+||||+.||
T Consensus 47 ~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g 126 (350)
T d1rdqe_ 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126 (350)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccccccc
Confidence 47899999999999874 5678999876432 233457899999999999999876 778889999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLY 204 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y 204 (406)
+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+.... ......||+.|
T Consensus 127 ~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--~~~~~~Gt~~Y 204 (350)
T d1rdqe_ 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--RTWTLCGTPEA 204 (350)
T ss_dssp BHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--CBCCCEECGGG
T ss_pred chhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc--ccccccCcccc
Confidence 9999999888999999999999999999999999999999999999998 77999999999988753 33457899999
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC-
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI- 283 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp- 283 (406)
||||++.+..++.++|||||||++|+|+||+.||.+.+...+...+..... .. +..+|+++.+||.+||+.||.+|+
T Consensus 205 ~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~-p~~~s~~~~~li~~~L~~dP~kR~~ 282 (350)
T d1rdqe_ 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-RF-PSHFSSDLKDLLRNLLQVDLTKRFG 282 (350)
T ss_dssp CCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CC-CTTCCHHHHHHHHHHSCSCTTTCTT
T ss_pred CCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-CC-CccCCHHHHHHHHHHhhhCHHhccc
Confidence 999999999999999999999999999999999999999888888877743 33 347999999999999999999995
Q ss_pred ----CHHHHhcCCCCCCCCC
Q psy5368 284 ----SYEDLFSHPYPDLIHA 299 (406)
Q Consensus 284 ----s~~ell~hp~~~~~~~ 299 (406)
|++++++||||+...+
T Consensus 283 ~~r~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 283 NLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp SSTTTTHHHHTSGGGTTCCH
T ss_pred cccccHHHHHcCccccCCCH
Confidence 9999999999987653
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=395.55 Aligned_cols=247 Identities=20% Similarity=0.297 Sum_probs=204.0
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCCccc-----hhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccC
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITS-----HSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~-----~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ 123 (406)
.+||+|+||+||++... +..+|+|++....... ...+.+|+.++++++|||+++ ..+++|||||||.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 47999999999999864 4578999876543222 346889999999999999876 7788999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCC
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGS 201 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt 201 (406)
++++..++..+..+++.++..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+...... ......||
T Consensus 84 ~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt 163 (299)
T d1ua2a_ 84 TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVT 163 (299)
T ss_dssp EEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCC
T ss_pred chHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccceecC
Confidence 987777776667899999999999999999999999999999999999999 6799999999998765443 34556799
Q ss_pred CCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-------------------CCC--
Q psy5368 202 PLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI-------------------TIP-- 259 (406)
Q Consensus 202 ~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-------------------~~~-- 259 (406)
+.|+|||++.+. .|+.++||||+||++|||+||.+||.+.+..+....+...... ..+
T Consensus 164 ~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
T d1ua2a_ 164 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGI 243 (299)
T ss_dssp CTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCC
T ss_pred hhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCC
Confidence 999999998754 5899999999999999999999999998887777666532100 000
Q ss_pred -----CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCcc
Q psy5368 260 -----PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAE 303 (406)
Q Consensus 260 -----~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~~ 303 (406)
...+++++.+||.+||+.||++|||++|+|+||||+....|.+.
T Consensus 244 ~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~ 292 (299)
T d1ua2a_ 244 PLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 292 (299)
T ss_dssp CHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCS
T ss_pred ChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCC
Confidence 02468899999999999999999999999999999987766543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-52 Score=388.18 Aligned_cols=235 Identities=21% Similarity=0.352 Sum_probs=192.6
Q ss_pred eeeecceeeeEEEeeeeeeceeEEeeeecCC--ccchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCCCCHH
Q psy5368 56 TIRYGELQYDTVQNSQIRLGTVKYSQVRYDT--ITSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDGGDLC 128 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ggsL~ 128 (406)
...||+|+||+||+|+.+ +.||+|.+.... ....+.|.+|+.++++++|||++. ..+.+|||||||+||+|.
T Consensus 13 ~~~lG~G~fg~Vy~~~~~-~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey~~~g~L~ 91 (276)
T d1uwha_ 13 GQRIGSGSFGTVYKGKWH-GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLY 91 (276)
T ss_dssp CSEEEECSSCEEEEEESS-SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCCEEEHH
T ss_pred EEEEeeCCCcEEEEEEEC-CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEecCCCCCHH
Confidence 457999999999999865 469999876543 233567999999999999999876 556789999999999999
Q ss_pred HHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC---CCCcccCCCC
Q psy5368 129 SFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND---QGDSIQGSPL 203 (406)
Q Consensus 129 ~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~---~~~~~~gt~~ 203 (406)
+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+...... ......||+.
T Consensus 92 ~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~ 171 (276)
T d1uwha_ 92 HHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171 (276)
T ss_dssp HHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGG
T ss_pred HHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcc
Confidence 999765 5699999999999999999999999999999999999999 6799999999998765332 3345679999
Q ss_pred CCChhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhcCCCC---CCCCCCChHHHHHHHHhcc
Q psy5368 204 YMAPEILAG---SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQ-ALSSAPIT---IPPNSLSPDCMDFLSRLLQ 276 (406)
Q Consensus 204 y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~-~~~~~~~~---~~~~~~s~~l~~li~~~L~ 276 (406)
|||||++.+ ..|+.++|||||||++|||+||+.||.+.+....... +....... ..+..+|+++.+|+.+||+
T Consensus 172 y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~ 251 (276)
T d1uwha_ 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLK 251 (276)
T ss_dssp GCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTC
T ss_pred cCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcC
Confidence 999999975 3589999999999999999999999998765444333 33332221 2234789999999999999
Q ss_pred cCCCCCCCHHHHhcC
Q psy5368 277 KDPMRRISYEDLFSH 291 (406)
Q Consensus 277 ~dP~~Rps~~ell~h 291 (406)
.||++|||++|++++
T Consensus 252 ~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 252 KKRDERPLFPQILAS 266 (276)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CCHhHCcCHHHHHHH
Confidence 999999999999876
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-52 Score=395.32 Aligned_cols=241 Identities=26% Similarity=0.442 Sum_probs=209.5
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCC---ccchhhhhhHHhhcc-cCCCCCCcc------cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDT---ITSHSEFERPRAGLS-NLRAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~---~~~~~~~~~E~~~l~-~l~h~ni~~------~~~~~~lV~E~~~ 123 (406)
...||+|+||+||++... +..+|+|.+.... ......+.+|..++. .++|||+++ +.+.+|||||||+
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~ 86 (320)
T d1xjda_ 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 86 (320)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecC
Confidence 357899999999999873 4678999886532 233446677777665 689999877 7888999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCcccCC
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDSIQGS 201 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~~~gt 201 (406)
||+|.+++..++.+++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++..... .......||
T Consensus 87 ~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt 166 (320)
T d1xjda_ 87 GGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGT 166 (320)
T ss_dssp TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSC
T ss_pred CCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccccccCCC
Confidence 999999999989999999999999999999999999999999999999999 679999999999876543 334556799
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
+.|+|||++.+..++.++||||+||++|+|+||+.||.+.+..++...+.... +..| ..+|+++.+||.+||+.||.+
T Consensus 167 ~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~p-~~~s~~~~dli~~~L~~dP~~ 244 (320)
T d1xjda_ 167 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYP-RWLEKEAKDLLVKLFVREPEK 244 (320)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCC-TTSCHHHHHHHHHHSCSSGGG
T ss_pred CCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCC-ccCCHHHHHHHHHhcccCCCC
Confidence 99999999999999999999999999999999999999999999888887764 3333 468999999999999999999
Q ss_pred CCCHH-HHhcCCCCCCCC
Q psy5368 282 RISYE-DLFSHPYPDLIH 298 (406)
Q Consensus 282 Rps~~-ell~hp~~~~~~ 298 (406)
|||+. ++++||||+...
T Consensus 245 R~s~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 245 RLGVRGDIRQHPLFREIN 262 (320)
T ss_dssp SBTTBSCGGGSGGGTTCC
T ss_pred CcCHHHHHHhCchhccCC
Confidence 99996 899999998754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-51 Score=399.98 Aligned_cols=242 Identities=24% Similarity=0.372 Sum_probs=199.9
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCc---cchhhhhh---HHhhcccCCCCCCcc------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI---TSHSEFER---PRAGLSNLRAPEGRK------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~---~~~~~~~~---E~~~l~~l~h~ni~~------~~~~~~lV~E~ 121 (406)
.+.||+|+||.||++... +..+|+|.+..... .....+.+ |+.+++.++|||++. ..+.+|+||||
T Consensus 9 ~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~ 88 (364)
T d1omwa3 9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 88 (364)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEe
Confidence 357899999999999864 45789998754321 22223444 477888999999876 77889999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccC
Q psy5368 122 CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQG 200 (406)
Q Consensus 122 ~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~g 200 (406)
|+||+|.++|.++..+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+..... ......|
T Consensus 89 ~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~-~~~~~~G 167 (364)
T d1omwa3 89 MNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVG 167 (364)
T ss_dssp CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-CCCSCCS
T ss_pred cCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-ccccccc
Confidence 99999999999889999999999999999999999999999999999999998 679999999999876544 3455679
Q ss_pred CCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cCCCCCCCCCCChHHHHHHHHhccc
Q psy5368 201 SPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALS--SAPITIPPNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 201 t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~s~~l~~li~~~L~~ 277 (406)
|+.|+|||++.+ ..|+.++||||+||++|||+||+.||.+.+.......... ...... +..+|+++.+||.+||+.
T Consensus 168 T~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~ 246 (364)
T d1omwa3 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL-PDSFSPELRSLLEGLLQR 246 (364)
T ss_dssp CGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCC-CSSSCHHHHHHHHHHTCS
T ss_pred ccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCC-CCCCCHHHHHHHHHHccc
Confidence 999999999975 5689999999999999999999999987654333222222 222222 347999999999999999
Q ss_pred CCCCCCC-----HHHHhcCCCCCCCCC
Q psy5368 278 DPMRRIS-----YEDLFSHPYPDLIHA 299 (406)
Q Consensus 278 dP~~Rps-----~~ell~hp~~~~~~~ 299 (406)
||++||| ++|+++||||+...+
T Consensus 247 dP~~R~t~~~~~a~eil~Hp~f~~i~~ 273 (364)
T d1omwa3 247 DVNRRLGCLGRGAQEVKESPFFRSLDW 273 (364)
T ss_dssp STTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred CHHHhCCCcccCHHHHHcCccccCCCH
Confidence 9999999 799999999987653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=399.01 Aligned_cols=239 Identities=26% Similarity=0.415 Sum_probs=210.2
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
...||+|+||+||++... +..+|+|.+.... .....+.+|+++|+.++|||+++ +.+++|||||||+||+|
T Consensus 10 ~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L 88 (321)
T d1tkia_ 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI 88 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBH
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcH
Confidence 457899999999999864 4568888876543 33456889999999999999876 78899999999999999
Q ss_pred HHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeC---CeeEEEecccccccCCCCCCCcccCCCC
Q psy5368 128 CSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN---NTLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 128 ~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~---~~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
.+++..++ ++++.+++.++.||+.||+|||++||+||||||+|||++. ..+||+|||+++............+|+.
T Consensus 89 ~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~ 168 (321)
T d1tkia_ 89 FERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE 168 (321)
T ss_dssp HHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGG
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcccccccccc
Confidence 99998765 7999999999999999999999999999999999999972 3799999999988766666667789999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC---CCCChHHHHHHHHhcccCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP---NSLSPDCMDFLSRLLQKDPM 280 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~s~~l~~li~~~L~~dP~ 280 (406)
|+|||.+.+..++.++||||+||++|+|++|.+||.+.+..++...+...... .+. ..+|+++++||.+||+.||.
T Consensus 169 y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dp~ 247 (321)
T d1tkia_ 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT-FDEEAFKEISIEAMDFVDRLLVKERK 247 (321)
T ss_dssp GSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-CCHHHHTTSCHHHHHHHHTTSCSSGG
T ss_pred cccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CChhhccCCCHHHHHHHHHHccCChh
Confidence 99999999999999999999999999999999999999999988888776432 221 26899999999999999999
Q ss_pred CCCCHHHHhcCCCCCC
Q psy5368 281 RRISYEDLFSHPYPDL 296 (406)
Q Consensus 281 ~Rps~~ell~hp~~~~ 296 (406)
+|||++|+++||||+.
T Consensus 248 ~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 248 SRMTASEALQHPWLKQ 263 (321)
T ss_dssp GSCCHHHHHHSHHHHS
T ss_pred HCcCHHHHhcCHhhcc
Confidence 9999999999999964
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-51 Score=387.49 Aligned_cols=235 Identities=21% Similarity=0.361 Sum_probs=192.8
Q ss_pred eeeecceeeeEEEeeeeeec-----eeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIRLG-----TVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~-----~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ 123 (406)
..+||+|+||+||+|..... .|++|.+...... ..+.|.+|+.+|++++|||+++ ..+.+|+|||||+
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~ 110 (299)
T d1jpaa_ 31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME 110 (299)
T ss_dssp EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecC
Confidence 46899999999999987422 3677776544332 3457999999999999999876 6678899999999
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC------
Q psy5368 124 GGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG------ 195 (406)
Q Consensus 124 ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~------ 195 (406)
+|+|.+++... +.+++.++..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+........
T Consensus 111 ~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 190 (299)
T d1jpaa_ 111 NGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA 190 (299)
T ss_dssp TEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------------
T ss_pred CCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeec
Confidence 99999998775 4799999999999999999999999999999999999999 679999999999876544322
Q ss_pred CcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHh
Q psy5368 196 DSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRL 274 (406)
Q Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~ 274 (406)
....||+.|||||++.+..++.++|||||||++|||+| |++||.+.+..++...+..+.....+ ..+|+++.+|+.+|
T Consensus 191 ~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~l~~li~~c 269 (299)
T d1jpaa_ 191 LGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPP-MDCPSALHQLMLDC 269 (299)
T ss_dssp -----CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC-TTCCHHHHHHHHHH
T ss_pred ccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC-ccchHHHHHHHHHH
Confidence 12357889999999999999999999999999999998 89999999999888888777555544 37999999999999
Q ss_pred cccCCCCCCCHHHHhcC
Q psy5368 275 LQKDPMRRISYEDLFSH 291 (406)
Q Consensus 275 L~~dP~~Rps~~ell~h 291 (406)
|+.||++|||+.|++++
T Consensus 270 l~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 270 WQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp TCSSTTTSCCHHHHHHH
T ss_pred cCCCHhHCcCHHHHHHH
Confidence 99999999999998764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=385.08 Aligned_cols=237 Identities=22% Similarity=0.381 Sum_probs=204.5
Q ss_pred eecceeeeEEEeeeeee----ceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCCCCH
Q psy5368 58 RYGELQYDTVQNSQIRL----GTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~----~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ggsL 127 (406)
+||+|+||.||+|..+. ..||||.+..... ...++|.+|++++++++|||+++ ..+.+|||||||+||+|
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvmE~~~~g~L 95 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPL 95 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTEEH
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEEEeCCCCcH
Confidence 59999999999997632 2588998765432 23567999999999999999876 45668999999999999
Q ss_pred HHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC----CCcccCC
Q psy5368 128 CSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ----GDSIQGS 201 (406)
Q Consensus 128 ~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~----~~~~~gt 201 (406)
.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+.+..... .....||
T Consensus 96 ~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt 175 (285)
T d1u59a_ 96 HKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175 (285)
T ss_dssp HHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCC
T ss_pred HHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccC
Confidence 9998654 5799999999999999999999999999999999999998 77999999999987754432 2345688
Q ss_pred CCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCC
Q psy5368 202 PLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPM 280 (406)
Q Consensus 202 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~ 280 (406)
+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++...+..+..+..|+ .+|+++.+|+.+||+.||+
T Consensus 176 ~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~-~~~~~l~~li~~cl~~~p~ 254 (285)
T d1u59a_ 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP-ECPPELYALMSDCWIYKWE 254 (285)
T ss_dssp GGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCT-TCCHHHHHHHHHTTCSSGG
T ss_pred ccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC-cCCHHHHHHHHHHcCCCHh
Confidence 99999999999999999999999999999998 999999988888888888776666654 7999999999999999999
Q ss_pred CCCCHHHH---hcCCCCC
Q psy5368 281 RRISYEDL---FSHPYPD 295 (406)
Q Consensus 281 ~Rps~~el---l~hp~~~ 295 (406)
+|||+.++ |+|+|+.
T Consensus 255 ~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 255 DRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp GSCCHHHHHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHHHHHH
Confidence 99999888 5566653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-51 Score=391.32 Aligned_cols=236 Identities=22% Similarity=0.321 Sum_probs=197.3
Q ss_pred eeeecceeeeEEEeeeeeec-------eeEEeeeecCC-ccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEe
Q psy5368 56 TIRYGELQYDTVQNSQIRLG-------TVKYSQVRYDT-ITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILE 120 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~-------~v~vk~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E 120 (406)
..+||+|+||+||+|..... .|++|.+.... ......+.+|+.++.++ +|||+++ ..+.+|+|||
T Consensus 42 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 121 (325)
T d1rjba_ 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 121 (325)
T ss_dssp EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEE
Confidence 46899999999999987532 47888765433 33455789999999998 8999876 7788999999
Q ss_pred ccCCCCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC
Q psy5368 121 YCDGGDLCSFIRSHE-----------------------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN 176 (406)
Q Consensus 121 ~~~ggsL~~~l~~~~-----------------------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~ 176 (406)
||+||+|.++|+.+. .+++..++.++.||+.||+|||++||+||||||+|||++ ++
T Consensus 122 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~ 201 (325)
T d1rjba_ 122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK 201 (325)
T ss_dssp CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTT
T ss_pred cCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCC
Confidence 999999999997642 489999999999999999999999999999999999998 77
Q ss_pred eeEEEecccccccCCCCC---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q psy5368 177 TLKLADFGFAQFLAPNDQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALS 252 (406)
Q Consensus 177 ~~kL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 252 (406)
.+||+|||+|+....... .....||+.|||||++.+..++.++|||||||++|||+| |.+||.+.+.......+..
T Consensus 202 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~ 281 (325)
T d1rjba_ 202 VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ 281 (325)
T ss_dssp EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH
T ss_pred eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 999999999987654433 234568999999999999999999999999999999998 8999998776655555554
Q ss_pred cCCCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 253 SAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 253 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
.......+..+|+++.+||.+||+.||++|||++||++|
T Consensus 282 ~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 282 NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 433333344799999999999999999999999999876
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=376.79 Aligned_cols=234 Identities=21% Similarity=0.370 Sum_probs=195.4
Q ss_pred eeeecceeeeEEEeeeeee-ceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHH
Q psy5368 56 TIRYGELQYDTVQNSQIRL-GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLC 128 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~ 128 (406)
...||+|+||+||+|...+ ..||+|++.... ...++|.+|+.++++++|||+++ .++.+|+|||||++|+|.
T Consensus 10 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~ 88 (263)
T d1sm2a_ 10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 88 (263)
T ss_dssp EEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred EEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHH
Confidence 4578999999999999754 469999886543 45678999999999999999876 667889999999999999
Q ss_pred HHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC--CCcccCCCCC
Q psy5368 129 SFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ--GDSIQGSPLY 204 (406)
Q Consensus 129 ~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~--~~~~~gt~~y 204 (406)
+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++ ++.+||+|||+|+....... .....||+.|
T Consensus 89 ~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y 168 (263)
T d1sm2a_ 89 DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKW 168 (263)
T ss_dssp HHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------------CTTS
T ss_pred HHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeecceecCccc
Confidence 998765 4689999999999999999999999999999999999999 67999999999987654432 2345689999
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
+|||++.+..++.++|||||||++|||+| |.+||...+..++...+..+.....| ..+|+++.+|+.+||+.||++||
T Consensus 169 ~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p-~~~~~~l~~li~~cl~~~p~~Rp 247 (263)
T d1sm2a_ 169 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP-RLASTHVYQIMNHCWKERPEDRP 247 (263)
T ss_dssp CCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCC-TTSCHHHHHHHHHHTCSSGGGSC
T ss_pred CChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCc-cccCHHHHHHHHHHccCCHhHCc
Confidence 99999999999999999999999999999 68888888888888888777555544 46899999999999999999999
Q ss_pred CHHHHhcC
Q psy5368 284 SYEDLFSH 291 (406)
Q Consensus 284 s~~ell~h 291 (406)
|++|+++|
T Consensus 248 s~~~il~~ 255 (263)
T d1sm2a_ 248 AFSRLLRQ 255 (263)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-51 Score=380.70 Aligned_cols=238 Identities=22% Similarity=0.368 Sum_probs=205.5
Q ss_pred eeeecceeeeEEEeeeeee-ceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCCCCHHH
Q psy5368 56 TIRYGELQYDTVQNSQIRL-GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDGGDLCS 129 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ggsL~~ 129 (406)
...||+|+||+||+|..+. ..||||++.... ...+.|.+|+.++++++|||+++ ..+.+|+|||||++|+|.+
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~~g~L~~ 96 (272)
T d1qpca_ 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVD 96 (272)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHH
T ss_pred eEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEeCCCCcHHH
Confidence 4578999999999999865 468999886543 45678999999999999999887 5566799999999999999
Q ss_pred HHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC--CCCcccCCCCC
Q psy5368 130 FIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND--QGDSIQGSPLY 204 (406)
Q Consensus 130 ~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~--~~~~~~gt~~y 204 (406)
++... .++++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+...... ......||+.|
T Consensus 97 ~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y 176 (272)
T d1qpca_ 97 FLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 176 (272)
T ss_dssp HTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTT
T ss_pred HHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccccccccCCcccc
Confidence 87433 3699999999999999999999999999999999999999 6799999999998875443 33456789999
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
+|||++.+..++.++|||||||++|||+| |.+||...+..++...+..+.....| ..+|+++.+|+.+||+.||++||
T Consensus 177 ~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p-~~~~~~l~~li~~cl~~~P~~Rp 255 (272)
T d1qpca_ 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP-DNCPEELYQLMRLCWKERPEDRP 255 (272)
T ss_dssp SCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC-TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred cChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCc-ccChHHHHHHHHHHcCCCHhHCc
Confidence 99999999999999999999999999999 56677777888888877776555554 47999999999999999999999
Q ss_pred CHHHHhc--CCCCC
Q psy5368 284 SYEDLFS--HPYPD 295 (406)
Q Consensus 284 s~~ell~--hp~~~ 295 (406)
|++++++ |+||.
T Consensus 256 t~~ei~~~L~~~ft 269 (272)
T d1qpca_ 256 TFDYLRSVLEDFFT 269 (272)
T ss_dssp CHHHHHHHHHHHHH
T ss_pred CHHHHHHHhhhhhh
Confidence 9999988 67764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=394.07 Aligned_cols=235 Identities=24% Similarity=0.410 Sum_probs=195.7
Q ss_pred eecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhccc-CCCCCCcc----------cCCeEEEEEeccCC
Q psy5368 58 RYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSN-LRAPEGRK----------RPRYVYIILEYCDG 124 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~-l~h~ni~~----------~~~~~~lV~E~~~g 124 (406)
.||+|+||+||++... +..+|+|.+.. ...+.+|+.++.+ ++|||+++ ...++|+|||||+|
T Consensus 19 ~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~g 93 (335)
T d2ozaa1 19 VLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 93 (335)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred EeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCC
Confidence 5899999999999863 46789988743 4568899998765 48999876 24668999999999
Q ss_pred CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee----CCeeEEEecccccccCCCCCCCcc
Q psy5368 125 GDLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK----NNTLKLADFGFAQFLAPNDQGDSI 198 (406)
Q Consensus 125 gsL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~----~~~~kL~DFGla~~~~~~~~~~~~ 198 (406)
|+|.++|.++ ..+++.+++.++.||+.||+|||++||+||||||+|||++ .+.+||+|||+|+...........
T Consensus 94 g~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~ 173 (335)
T d2ozaa1 94 GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 173 (335)
T ss_dssp EEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCC
T ss_pred CcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCCccccc
Confidence 9999999875 3699999999999999999999999999999999999997 347999999999988777777788
Q ss_pred cCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---CCCCCCC---CCCChHHHHHHH
Q psy5368 199 QGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSS---APITIPP---NSLSPDCMDFLS 272 (406)
Q Consensus 199 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~---~~~~~~~---~~~s~~l~~li~ 272 (406)
.||+.|+|||++.+..|+.++||||+||++|+|+||++||.+.+.......+... .....+. ..+|+++.+||.
T Consensus 174 ~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 253 (335)
T d2ozaa1 174 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 253 (335)
T ss_dssp SCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHH
T ss_pred cCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHH
Confidence 8999999999999999999999999999999999999999876644443333222 1222222 158999999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCCCCC
Q psy5368 273 RLLQKDPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 273 ~~L~~dP~~Rps~~ell~hp~~~~~ 297 (406)
+||+.||++|||+.|+++||||...
T Consensus 254 ~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 254 NLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp HHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred HHccCChhHCcCHHHHHcCHHhhCC
Confidence 9999999999999999999999643
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=372.99 Aligned_cols=234 Identities=21% Similarity=0.377 Sum_probs=206.7
Q ss_pred eeeecceeeeEEEeeeeeec-eeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCHH
Q psy5368 56 TIRYGELQYDTVQNSQIRLG-TVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDLC 128 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~-~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL~ 128 (406)
...||+|+||+||+|+.+.+ .||+|.++... ....+|.+|+.++++++|||+++ .++.+++||||+++|+|.
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~ 87 (258)
T d1k2pa_ 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 87 (258)
T ss_dssp CCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHH
T ss_pred eEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHH
Confidence 35689999999999998654 68999887654 35678999999999999999876 678899999999999999
Q ss_pred HHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC--CCcccCCCCC
Q psy5368 129 SFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ--GDSIQGSPLY 204 (406)
Q Consensus 129 ~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~--~~~~~gt~~y 204 (406)
+++... ..+++..+.+++.|+++||+|||++||+||||||+|||++ ++.+||+|||+++....... .....||+.|
T Consensus 88 ~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y 167 (258)
T d1k2pa_ 88 NYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW 167 (258)
T ss_dssp HHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGG
T ss_pred HhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCc
Confidence 997654 5799999999999999999999999999999999999999 57999999999987654432 2345689999
Q ss_pred CChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCC
Q psy5368 205 MAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRI 283 (406)
Q Consensus 205 ~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 283 (406)
+|||.+.+..++.++|||||||++|||+| |+.||.+.+..++...+..+.....| ..+++++.+|+.+||+.||++||
T Consensus 168 ~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p-~~~~~~l~~li~~cl~~dP~~RP 246 (258)
T d1k2pa_ 168 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP-HLASEKVYTIMYSCWHEKADERP 246 (258)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC-TTCCHHHHHHHHHTTCSSGGGSC
T ss_pred CCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc-ccccHHHHHHHHHHccCCHhHCc
Confidence 99999999999999999999999999998 89999999999998888877655544 47899999999999999999999
Q ss_pred CHHHHhcC
Q psy5368 284 SYEDLFSH 291 (406)
Q Consensus 284 s~~ell~h 291 (406)
|++++++|
T Consensus 247 t~~eil~~ 254 (258)
T d1k2pa_ 247 TFKILLSN 254 (258)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999987
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-50 Score=379.65 Aligned_cols=233 Identities=25% Similarity=0.398 Sum_probs=199.8
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
...||+|+||+||+|... +..||+|.+..+. ...++|.+|+.++++++|||+++ ..+.+|+|||||++|+|
T Consensus 22 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l 100 (287)
T d1opja_ 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 100 (287)
T ss_dssp EEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred eeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcch
Confidence 457999999999999975 3468999876543 45678999999999999999876 67788999999999999
Q ss_pred HHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC--CCcccCCC
Q psy5368 128 CSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ--GDSIQGSP 202 (406)
Q Consensus 128 ~~~l~~~--~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~--~~~~~gt~ 202 (406)
.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+....... .....||+
T Consensus 101 ~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~ 180 (287)
T d1opja_ 101 LDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180 (287)
T ss_dssp HHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECG
T ss_pred HHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceeeccccccc
Confidence 9999765 4799999999999999999999999999999999999998 67999999999987654432 23345889
Q ss_pred CCCChhhhcCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCC
Q psy5368 203 LYMAPEILAGSPYNAKADLWSLGVLVFEALFGH-APYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMR 281 (406)
Q Consensus 203 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 281 (406)
.|+|||++.+..|+.++|||||||++|||++|. +||.+.+...+...+.....+..+ ..+|+++.+|+.+||+.||++
T Consensus 181 ~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~ 259 (287)
T d1opja_ 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP-EGCPEKVYELMRACWQWNPSD 259 (287)
T ss_dssp GGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC-TTCCHHHHHHHHHHTCSSGGG
T ss_pred cccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCC-ccchHHHHHHHHHHcCCCHhH
Confidence 999999999999999999999999999999955 556667777776666666554444 379999999999999999999
Q ss_pred CCCHHHHhc
Q psy5368 282 RISYEDLFS 290 (406)
Q Consensus 282 Rps~~ell~ 290 (406)
|||++|+++
T Consensus 260 Rps~~ei~~ 268 (287)
T d1opja_ 260 RPSFAEIHQ 268 (287)
T ss_dssp SCCHHHHHH
T ss_pred CcCHHHHHH
Confidence 999999976
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=377.55 Aligned_cols=235 Identities=25% Similarity=0.393 Sum_probs=197.4
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCcc------chhhhhhHHhhcccCC--CCCCcc------cCCeEEEEE
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT------SHSEFERPRAGLSNLR--APEGRK------RPRYVYIIL 119 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~------~~~~~~~E~~~l~~l~--h~ni~~------~~~~~~lV~ 119 (406)
...||+|+||+||++... +..||+|.+...... ...++.+|+.++++++ |||+++ ..+..|+||
T Consensus 9 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~ 88 (273)
T d1xwsa_ 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 88 (273)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEE
Confidence 457899999999999864 467899987654322 2345789999999996 899875 778899999
Q ss_pred eccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-C-CeeEEEecccccccCCCCCCC
Q psy5368 120 EYCDG-GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-N-NTLKLADFGFAQFLAPNDQGD 196 (406)
Q Consensus 120 E~~~g-gsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~-~~~kL~DFGla~~~~~~~~~~ 196 (406)
||+.+ +++.+++..+..+++.+++.++.||+.||+|||++||+||||||+|||++ + +.+||+|||+|+.... ....
T Consensus 89 e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~-~~~~ 167 (273)
T d1xwsa_ 89 ERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYT 167 (273)
T ss_dssp ECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS-SCBC
T ss_pred EeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc-cccc
Confidence 99976 68899998888999999999999999999999999999999999999998 4 5899999999986543 3345
Q ss_pred cccCCCCCCChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhc
Q psy5368 197 SIQGSPLYMAPEILAGSPY-NAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLL 275 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L 275 (406)
...||+.|+|||++.+..+ +.++||||+||++|+|+||+.||.+.+ .+... .... +..+|+++.+||.+||
T Consensus 168 ~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~-~~~~-~~~~s~~~~~li~~~L 239 (273)
T d1xwsa_ 168 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG-QVFF-RQRVSSECQHLIRWCL 239 (273)
T ss_dssp CCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-CCCC-SSCCCHHHHHHHHHHT
T ss_pred ccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc-ccCC-CCCCCHHHHHHHHHHc
Confidence 6789999999999987765 567999999999999999999998632 22333 2233 3479999999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCCCC
Q psy5368 276 QKDPMRRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 276 ~~dP~~Rps~~ell~hp~~~~~~~ 299 (406)
+.||++|||++|+++||||+....
T Consensus 240 ~~dp~~R~s~~eil~hp~~~~~~~ 263 (273)
T d1xwsa_ 240 ALRPSDRPTFEEIQNHPWMQDVLL 263 (273)
T ss_dssp CSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred cCCHhHCcCHHHHhcCHhhCCCCC
Confidence 999999999999999999987644
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-50 Score=377.64 Aligned_cols=245 Identities=28% Similarity=0.412 Sum_probs=199.8
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
+.||+|+||+||+|... +..+|+|.+..... .....+.+|++++++++|||+++ +++++|+|||||.+ +
T Consensus 8 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~ 86 (298)
T d1gz8a_ 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-D 86 (298)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-E
T ss_pred cEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-c
Confidence 56889999999999864 56788998765432 23567899999999999999876 78899999999976 5
Q ss_pred HHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-CCCCcccCCC
Q psy5368 127 LCSFIRS--HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN-DQGDSIQGSP 202 (406)
Q Consensus 127 L~~~l~~--~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~-~~~~~~~gt~ 202 (406)
+.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+..... .......||+
T Consensus 87 ~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~ 166 (298)
T d1gz8a_ 87 LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL 166 (298)
T ss_dssp HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCC
T ss_pred hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccceeecccc
Confidence 5555533 35799999999999999999999999999999999999998 779999999999877543 3455668999
Q ss_pred CCCChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-----------------CCC-----
Q psy5368 203 LYMAPEILAGSP-YNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI-----------------TIP----- 259 (406)
Q Consensus 203 ~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-----------------~~~----- 259 (406)
.|+|||++.... ++.++||||+||++|+|++|+.||.+.+..+....+...... ..+
T Consensus 167 ~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (298)
T d1gz8a_ 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 246 (298)
T ss_dssp TTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCC
T ss_pred eeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccccccccccc
Confidence 999999987766 578999999999999999999999998877766655432100 000
Q ss_pred -----CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCc
Q psy5368 260 -----PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCA 302 (406)
Q Consensus 260 -----~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~ 302 (406)
...+|+++.+|+.+||+.||++|||++|+++||||+....|-+
T Consensus 247 ~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~p 294 (298)
T d1gz8a_ 247 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294 (298)
T ss_dssp CHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred chhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCCCC
Confidence 0146789999999999999999999999999999998776643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-50 Score=379.16 Aligned_cols=243 Identities=26% Similarity=0.318 Sum_probs=199.1
Q ss_pred eeecceeeeEEEeeeee---eceeEEeeeecCCcc--chhhhhhHHhhcccC---CCCCCcc-----------cCCeEEE
Q psy5368 57 IRYGELQYDTVQNSQIR---LGTVKYSQVRYDTIT--SHSEFERPRAGLSNL---RAPEGRK-----------RPRYVYI 117 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~---~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l---~h~ni~~-----------~~~~~~l 117 (406)
..||+|+||+||++... +..||+|.+...... ....+.+|+.+++.| +|||+++ ...++|+
T Consensus 13 ~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~ 92 (305)
T d1blxa_ 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 92 (305)
T ss_dssp EEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEE
T ss_pred EEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEE
Confidence 45788999999998763 234788887654322 344677888887766 8999875 2356899
Q ss_pred EEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCC
Q psy5368 118 ILEYCDGGDLCSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQG 195 (406)
Q Consensus 118 V~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~ 195 (406)
+||||+++++...... ...+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++........
T Consensus 93 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~~~ 172 (305)
T d1blxa_ 93 VFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL 172 (305)
T ss_dssp EEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGG
T ss_pred EEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhcccccC
Confidence 9999998766555443 34799999999999999999999999999999999999998 679999999999876666666
Q ss_pred CcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-------------------
Q psy5368 196 DSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI------------------- 256 (406)
Q Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------------------- 256 (406)
....||+.|+|||++.+..|+.++||||+||++|||+||++||.+.+..+....+......
T Consensus 173 ~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (305)
T d1blxa_ 173 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHS 252 (305)
T ss_dssp CCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCC
T ss_pred CCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhcc
Confidence 7788999999999999999999999999999999999999999999887776666432100
Q ss_pred ------CCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy5368 257 ------TIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 257 ------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 299 (406)
......+|+++.+||.+||++||++|||++|+|+||||+.++.
T Consensus 253 ~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 253 KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp CCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 0012257899999999999999999999999999999987653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=371.22 Aligned_cols=235 Identities=20% Similarity=0.359 Sum_probs=194.6
Q ss_pred ceeeecceeeeEEEeeeeeec------eeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEec
Q psy5368 55 STIRYGELQYDTVQNSQIRLG------TVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEY 121 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~~------~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~ 121 (406)
..++||+|+||.||+|.++.. .||+|++...... ...+|.+|+.++++++|||+++ ..+..++||||
T Consensus 11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~ 90 (283)
T d1mqba_ 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 90 (283)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEe
Confidence 467899999999999987543 5888987654433 2447899999999999999876 66788999999
Q ss_pred cCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC----C
Q psy5368 122 CDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ----G 195 (406)
Q Consensus 122 ~~ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~----~ 195 (406)
|.+++|.+++... +.+++.++..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+....... .
T Consensus 91 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~ 170 (283)
T d1mqba_ 91 MENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 170 (283)
T ss_dssp CTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------------
T ss_pred cccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCccceEe
Confidence 9999999988765 5799999999999999999999999999999999999999 67999999999987654322 2
Q ss_pred CcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHh
Q psy5368 196 DSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRL 274 (406)
Q Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~ 274 (406)
....||+.|+|||++.+..++.++|||||||++|||++ |.+|+...+..++...+..+.....+. .+|+++.+|+.+|
T Consensus 171 ~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~~l~~li~~c 249 (283)
T d1mqba_ 171 SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM-DCPSAIYQLMMQC 249 (283)
T ss_dssp ---CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT-TCBHHHHHHHHHH
T ss_pred ccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCch-hhHHHHHHHHHHH
Confidence 33468999999999999999999999999999999999 566677777788877777765555543 6999999999999
Q ss_pred cccCCCCCCCHHHHhc
Q psy5368 275 LQKDPMRRISYEDLFS 290 (406)
Q Consensus 275 L~~dP~~Rps~~ell~ 290 (406)
|+.||++|||+.|+++
T Consensus 250 l~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 250 WQQERARRPKFADIVS 265 (283)
T ss_dssp TCSSTTTSCCHHHHHH
T ss_pred CcCCHhHCcCHHHHHH
Confidence 9999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-50 Score=372.36 Aligned_cols=235 Identities=23% Similarity=0.408 Sum_probs=192.6
Q ss_pred eeeecceeeeEEEeeeeee-----ceeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCC
Q psy5368 56 TIRYGELQYDTVQNSQIRL-----GTVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDG 124 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-----~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~g 124 (406)
...||+|+||.||+|.... ..|++|.+...... ....+.+|+.++++++|||+++ ..+.+|+|||||++
T Consensus 12 ~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv~E~~~~ 91 (273)
T d1mp8a_ 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTL 91 (273)
T ss_dssp EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEEECCTT
T ss_pred EEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEEEEeccC
Confidence 4678999999999998642 24677766543322 2457999999999999999876 56778999999999
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC--CCCcccC
Q psy5368 125 GDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND--QGDSIQG 200 (406)
Q Consensus 125 gsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~--~~~~~~g 200 (406)
|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||+|+...... ......|
T Consensus 92 g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~g 171 (273)
T d1mp8a_ 92 GELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 171 (273)
T ss_dssp EEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------------C
T ss_pred CcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcceeccceec
Confidence 9999988654 4799999999999999999999999999999999999998 7899999999998765433 2344568
Q ss_pred CCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCC
Q psy5368 201 SPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDP 279 (406)
Q Consensus 201 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP 279 (406)
|+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..++...+..+.....++ .+|+++.+||.+||+.||
T Consensus 172 t~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~~li~~cl~~dp 250 (273)
T d1mp8a_ 172 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP-NCPPTLYSLMTKCWAYDP 250 (273)
T ss_dssp CGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT-TCCHHHHHHHHHHTCSSG
T ss_pred CcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC-CCCHHHHHHHHHHcCCCH
Confidence 999999999999999999999999999999998 899999999999988888876666554 799999999999999999
Q ss_pred CCCCCHHHHhcC
Q psy5368 280 MRRISYEDLFSH 291 (406)
Q Consensus 280 ~~Rps~~ell~h 291 (406)
++|||++|+++|
T Consensus 251 ~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 251 SRRPRFTELKAQ 262 (273)
T ss_dssp GGSCCHHHHHHH
T ss_pred hHCcCHHHHHHH
Confidence 999999999876
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.5e-49 Score=370.16 Aligned_cols=238 Identities=25% Similarity=0.392 Sum_probs=194.1
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccc---hhhhhhHHhhcccCCCCCCcc----------cCCeEEEEEe
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITS---HSEFERPRAGLSNLRAPEGRK----------RPRYVYIILE 120 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~---~~~~~~E~~~l~~l~h~ni~~----------~~~~~~lV~E 120 (406)
...||+|+||+||++... ++.+|+|.+......+ ...+.+|+.++++++|||+++ ....+|||||
T Consensus 12 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE 91 (277)
T d1o6ya_ 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 91 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEE
Confidence 356889999999999853 5678999887654333 346899999999999999876 1235899999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC----CC
Q psy5368 121 YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND----QG 195 (406)
Q Consensus 121 ~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~----~~ 195 (406)
||+|++|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||++ ++..+++|||.+....... ..
T Consensus 92 ~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~ 171 (277)
T d1o6ya_ 92 YVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 171 (277)
T ss_dssp CCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---------
T ss_pred CCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccccccccc
Confidence 999999999999889999999999999999999999999999999999999998 7799999999987654332 34
Q ss_pred CcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCChHHHHHHHH
Q psy5368 196 DSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPIT--IPPNSLSPDCMDFLSR 273 (406)
Q Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~s~~l~~li~~ 273 (406)
....||+.|+|||++.+..+++++||||+||++|+|+||++||.+.+..+....+....... .....+|+++.+||.+
T Consensus 172 ~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~ 251 (277)
T d1o6ya_ 172 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLK 251 (277)
T ss_dssp -------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHH
T ss_pred ccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHH
Confidence 45679999999999999999999999999999999999999999999888877777664432 2224789999999999
Q ss_pred hcccCCCCCC-CHHHHhcCCCC
Q psy5368 274 LLQKDPMRRI-SYEDLFSHPYP 294 (406)
Q Consensus 274 ~L~~dP~~Rp-s~~ell~hp~~ 294 (406)
||++||.+|| |++++ .|+|.
T Consensus 252 ~L~~dp~~R~~sa~~l-~~~l~ 272 (277)
T d1o6ya_ 252 ALAKNPENRYQTAAEM-RADLV 272 (277)
T ss_dssp HTCSSGGGSCSSHHHH-HHHHH
T ss_pred HccCCHhHCHhHHHHH-HHHHH
Confidence 9999999999 55555 45553
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.7e-49 Score=371.55 Aligned_cols=239 Identities=25% Similarity=0.342 Sum_probs=196.8
Q ss_pred eeecceeeeEEEeeeee-eceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCCH
Q psy5368 57 IRYGELQYDTVQNSQIR-LGTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGDL 127 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~-~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggsL 127 (406)
.+||+|+||+||++... +..+|+|++..... .....+.+|+.++++++|||+++ ..+..|++||++.++++
T Consensus 8 ~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~ 87 (286)
T d1ob3a_ 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLK 87 (286)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHH
T ss_pred cEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhH
Confidence 45789999999999864 35789998866532 23567999999999999999876 77889999999988777
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCCCC
Q psy5368 128 CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPLYM 205 (406)
Q Consensus 128 ~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~y~ 205 (406)
..+...++.+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|....... ......|++.|+
T Consensus 88 ~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~ 167 (286)
T d1ob3a_ 88 KLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR 167 (286)
T ss_dssp HHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTC
T ss_pred HHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccceecccchhh
Confidence 77777678899999999999999999999999999999999999998 7799999999998765443 344556899999
Q ss_pred ChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------------------------C
Q psy5368 206 APEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI---------------------------T 257 (406)
Q Consensus 206 aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---------------------------~ 257 (406)
|||.+.+. .++.++||||+||++|||++|++||.+.+..+...++...... .
T Consensus 168 ~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (286)
T d1ob3a_ 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWE 247 (286)
T ss_dssp CHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGG
T ss_pred hHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchh
Confidence 99999765 4789999999999999999999999998877766655421000 0
Q ss_pred CCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy5368 258 IPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPD 295 (406)
Q Consensus 258 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~ 295 (406)
.....+|+++.+||.+||+.||++|||++|+++||||+
T Consensus 248 ~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~ 285 (286)
T d1ob3a_ 248 SFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (286)
T ss_dssp GTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred hhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 01124688999999999999999999999999999997
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-50 Score=369.63 Aligned_cols=231 Identities=23% Similarity=0.390 Sum_probs=196.6
Q ss_pred eeeecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc-------cCCeEEEEEeccCCCCHH
Q psy5368 56 TIRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK-------RPRYVYIILEYCDGGDLC 128 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~-------~~~~~~lV~E~~~ggsL~ 128 (406)
...||+|+||.||+|..++..||+|.++.+ ...+.+.+|++++++++|||+++ ..+.+|+||||+++|+|.
T Consensus 12 ~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~ 89 (262)
T d1byga_ 12 LQTIGKGEFGDVMLGDYRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 89 (262)
T ss_dssp EEEEEECSSCEEEEEEETTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHH
T ss_pred eEEEecCCCeEEEEEEECCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHH
Confidence 356899999999999998889999988654 34567999999999999999876 345689999999999999
Q ss_pred HHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCCC
Q psy5368 129 SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLYM 205 (406)
Q Consensus 129 ~~l~~~~--~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y~ 205 (406)
+++.+++ .+++..++.++.||+.||.|||+++|+||||||+|||++ ++.+||+|||+++..... .....+|+.|+
T Consensus 90 ~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--~~~~~~~~~y~ 167 (262)
T d1byga_ 90 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWT 167 (262)
T ss_dssp HHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------------CCTTTS
T ss_pred HHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC--CccccccccCC
Confidence 9996543 599999999999999999999999999999999999999 779999999999865433 34456899999
Q ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCCCC
Q psy5368 206 APEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRRIS 284 (406)
Q Consensus 206 aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps 284 (406)
|||++.+..+++++|||||||++|||+| |++||...+..++...+..+..+..++ .+++++.+|+.+||+.||.+|||
T Consensus 168 aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~~li~~cl~~dP~~Rps 246 (262)
T d1byga_ 168 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD-GCPPAVYEVMKNCWHLDAAMRPS 246 (262)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCT-TCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc-cCCHHHHHHHHHHcccCHhHCcC
Confidence 9999999999999999999999999998 799999999889888888776666655 68999999999999999999999
Q ss_pred HHHHhcC
Q psy5368 285 YEDLFSH 291 (406)
Q Consensus 285 ~~ell~h 291 (406)
+.+++++
T Consensus 247 ~~~l~~~ 253 (262)
T d1byga_ 247 FLQLREQ 253 (262)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-49 Score=368.60 Aligned_cols=242 Identities=23% Similarity=0.353 Sum_probs=202.3
Q ss_pred ceeeecceeeeEEEeeeeee-ceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccCCCCHH
Q psy5368 55 STIRYGELQYDTVQNSQIRL-GTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCDGGDLC 128 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~~-~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ggsL~ 128 (406)
-...||+|+||.||+|..+. ..||+|.+.... ...+.|.+|+.++++++|||+++ ..+.+|+|||||++|+|.
T Consensus 21 i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~~g~l~ 99 (285)
T d1fmka3 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLL 99 (285)
T ss_dssp EEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTTCBHH
T ss_pred EeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEecCCCchh
Confidence 35578999999999999855 468899876543 45678999999999999999877 455678999999999999
Q ss_pred HHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC--CCCcccCCCC
Q psy5368 129 SFIRS--HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND--QGDSIQGSPL 203 (406)
Q Consensus 129 ~~l~~--~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~--~~~~~~gt~~ 203 (406)
.++.. .+.+++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+....+. ......||+.
T Consensus 100 ~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~ 179 (285)
T d1fmka3 100 DFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 179 (285)
T ss_dssp HHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGG
T ss_pred hhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceeecccccccc
Confidence 98843 35799999999999999999999999999999999999999 6799999999998764433 2334568999
Q ss_pred CCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcccCCCCC
Q psy5368 204 YMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQKDPMRR 282 (406)
Q Consensus 204 y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 282 (406)
|+|||++.++.++.++|||||||++|||+| |.+|+......++...+........++ .+|+++.+|+.+||+.||++|
T Consensus 180 y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~R 258 (285)
T d1fmka3 180 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP-ECPESLHDLMCQCWRKEPEER 258 (285)
T ss_dssp GSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT-TSCHHHHHHHHHHTCSSGGGS
T ss_pred ccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCc-ccCHHHHHHHHHHcccCHhHC
Confidence 999999999999999999999999999999 566677778888888877776555544 799999999999999999999
Q ss_pred CCHHHHhc--CCCCCCCC
Q psy5368 283 ISYEDLFS--HPYPDLIH 298 (406)
Q Consensus 283 ps~~ell~--hp~~~~~~ 298 (406)
||++++++ ++||....
T Consensus 259 ps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 259 PTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp CCHHHHHHHHHTTTSCSC
T ss_pred cCHHHHHHHHhhhhcCCC
Confidence 99999988 88987653
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-49 Score=379.58 Aligned_cols=244 Identities=23% Similarity=0.369 Sum_probs=199.9
Q ss_pred CceeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc------------cCCeEEEEE
Q psy5368 54 SSTIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK------------RPRYVYIIL 119 (406)
Q Consensus 54 ~~~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~------------~~~~~~lV~ 119 (406)
...++||+|+||+||++... +..+|+|++.... ....+|+.+|++++|||+++ +..++||||
T Consensus 23 ~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred EeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 34567999999999999974 4578999886542 34568999999999999876 234578999
Q ss_pred eccCCCCHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC-eeEEEecccccccCCCCC
Q psy5368 120 EYCDGGDLCSFI---RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN-TLKLADFGFAQFLAPNDQ 194 (406)
Q Consensus 120 E~~~ggsL~~~l---~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~-~~kL~DFGla~~~~~~~~ 194 (406)
|||+++.+..+. .....+++..++.++.||+.||+|||++||+||||||+|||++ ++ .+||+|||+++.......
T Consensus 99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~ 178 (350)
T d1q5ka_ 99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178 (350)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC
T ss_pred eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCcc
Confidence 999875333322 3455799999999999999999999999999999999999998 54 899999999998877777
Q ss_pred CCcccCCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC----------------CCC
Q psy5368 195 GDSIQGSPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSA----------------PIT 257 (406)
Q Consensus 195 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~----------------~~~ 257 (406)
..+..||+.|+|||.+.+ ..++.++||||+||++|||++|++||...+..+....+.... ...
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~ 258 (350)
T d1q5ka_ 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258 (350)
T ss_dssp CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCC
T ss_pred cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhcc
Confidence 777889999999999876 468999999999999999999999999888776665554210 000
Q ss_pred -----------CCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q psy5368 258 -----------IPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPC 301 (406)
Q Consensus 258 -----------~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~ 301 (406)
.....+++++.+||.+||+.||++|||+.|+|+||||+....+.
T Consensus 259 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 313 (350)
T d1q5ka_ 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313 (350)
T ss_dssp CCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred ccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCC
Confidence 11225789999999999999999999999999999998765443
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-49 Score=374.00 Aligned_cols=235 Identities=21% Similarity=0.339 Sum_probs=200.1
Q ss_pred eeeecceeeeEEEeeeeeec------eeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIRLG------TVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~------~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ 123 (406)
...||+|+||+||+|..... .|++|++.... ....++|.+|+.++++++|||+++ ..+..++++|++.
T Consensus 14 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v~e~~~ 93 (317)
T d1xkka_ 14 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMP 93 (317)
T ss_dssp EEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCT
T ss_pred eeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEEEEecc
Confidence 36889999999999986432 47888775433 344668999999999999999887 4556789999999
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC---CCcc
Q psy5368 124 GGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ---GDSI 198 (406)
Q Consensus 124 ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~---~~~~ 198 (406)
+|+|.+++..+ ..+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+....... ....
T Consensus 94 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 173 (317)
T d1xkka_ 94 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173 (317)
T ss_dssp TCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC-------
T ss_pred CCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccccccccccc
Confidence 99999988765 5799999999999999999999999999999999999999 77999999999987654432 2334
Q ss_pred cCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhccc
Q psy5368 199 QGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 199 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~ 277 (406)
.||+.|+|||++.++.++.++|||||||++|||+| |.+||.+.+..++...+..+..+..|+ .+|+++.+|+.+||+.
T Consensus 174 ~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~-~~~~~~~~li~~cl~~ 252 (317)
T d1xkka_ 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP-ICTIDVYMIMVKCWMI 252 (317)
T ss_dssp -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCT-TBCHHHHHHHHHHTCS
T ss_pred ccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc-ccCHHHHHHHHHhCCC
Confidence 68999999999999999999999999999999998 899999998888888887776665554 6999999999999999
Q ss_pred CCCCCCCHHHHhcC
Q psy5368 278 DPMRRISYEDLFSH 291 (406)
Q Consensus 278 dP~~Rps~~ell~h 291 (406)
||.+|||+.|+++|
T Consensus 253 dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 253 DADSRPKFRELIIE 266 (317)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999987
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=376.81 Aligned_cols=261 Identities=20% Similarity=0.305 Sum_probs=202.2
Q ss_pred cccceEEEeeee---ee-EEEeeeeecCCcceeeeeeccccccccceeeecCceeeecceeeeEEEeeeeeeceeEEeee
Q psy5368 7 VRYGTVRLGSVK---YG-QVQLSTVRYGKVRYSQVRSDTVRSGTVRYDIVGSSTIRYGELQYDTVQNSQIRLGTVKYSQV 82 (406)
Q Consensus 7 g~~~~V~ig~~~---~g-y~vv~~lg~G~~~~~~~~~d~~~~~~~~~~i~~~~~~~lG~G~~g~Vy~~~~~~~~v~vk~~ 82 (406)
+||+++.+++.. .. |.++++||.|+||.||.+.+.. .+..+|+|.+
T Consensus 2 ~~~~~~~~~~~~~~~~~~Y~~i~~lG~G~fg~V~~~~~~~------------------------------~~~~vAiK~i 51 (346)
T d1cm8a_ 2 SGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGR------------------------------TGAKVAIKKL 51 (346)
T ss_dssp CSBCCEECSSSEECCBSSEEEEEEC------CEEEEEETT------------------------------TCCEEEEEEC
T ss_pred CCcEEEeccCceeecCCcEEEEEEEecCCCeEEEEEEECC------------------------------CCCEEEEEEE
Confidence 799999999874 33 8888877766666665555332 1345788877
Q ss_pred ecCCcc--chhhhhhHHhhcccCCCCCCccc------------CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHH
Q psy5368 83 RYDTIT--SHSEFERPRAGLSNLRAPEGRKR------------PRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQ 148 (406)
Q Consensus 83 ~~~~~~--~~~~~~~E~~~l~~l~h~ni~~~------------~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~q 148 (406)
...... ..+.+.+|+.+|++++|||+++. ..++|+||||| +.+|..+++. +++++..++.++.|
T Consensus 52 ~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~q 129 (346)
T d1cm8a_ 52 YRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQ 129 (346)
T ss_dssp SSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHH
T ss_pred chhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHH
Confidence 643322 24578899999999999998762 23579999999 5688887754 68999999999999
Q ss_pred HHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCCCChhhhcCC-CCCchhhHHHHHH
Q psy5368 149 LVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGS-PYNAKADLWSLGV 226 (406)
Q Consensus 149 l~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~ 226 (406)
|+.||+|||++||+||||||+|||++ ++.+||+|||+|+.... ......||+.|+|||++.+. .++.++||||+||
T Consensus 130 i~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGv 207 (346)
T d1cm8a_ 130 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGC 207 (346)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHH
T ss_pred HHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchH
Confidence 99999999999999999999999999 77999999999987643 34567799999999998774 5789999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhcCC-----------------------------CCCCCCCCChHHHHHHHHhccc
Q psy5368 227 LVFEALFGHAPYASCNLSQLRAQALSSAP-----------------------------ITIPPNSLSPDCMDFLSRLLQK 277 (406)
Q Consensus 227 il~elltg~~pf~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~s~~l~~li~~~L~~ 277 (406)
++|+|++|++||.+.+.......+..... .......+++++.+||.+||..
T Consensus 208 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~ 287 (346)
T d1cm8a_ 208 IMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVL 287 (346)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCS
T ss_pred HHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcC
Confidence 99999999999998876655444332100 0011135789999999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCCCCC
Q psy5368 278 DPMRRISYEDLFSHPYPDLIHAPC 301 (406)
Q Consensus 278 dP~~Rps~~ell~hp~~~~~~~~~ 301 (406)
||.+|||++|+|+||||+....+.
T Consensus 288 dP~~R~ta~eiL~Hp~f~~~~~~~ 311 (346)
T d1cm8a_ 288 DAEQRVTAGEALAHPYFESLHDTE 311 (346)
T ss_dssp STTTSCCHHHHHHSGGGTTTC---
T ss_pred ChhHCcCHHHHhcChhhCcCCCcc
Confidence 999999999999999999766443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-49 Score=372.41 Aligned_cols=235 Identities=23% Similarity=0.380 Sum_probs=201.4
Q ss_pred eeeecceeeeEEEeeeeeec----eeEEeeeecCC-ccchhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEeccC
Q psy5368 56 TIRYGELQYDTVQNSQIRLG----TVKYSQVRYDT-ITSHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILEYCD 123 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~----~v~vk~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E~~~ 123 (406)
..+||+|+||.||+|.+... .|+||++.... ......|.+|+.+|.++ +|||+++ ..+.+|+|||||+
T Consensus 15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~ 94 (309)
T d1fvra_ 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 94 (309)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence 46799999999999998653 46777765433 33456799999999999 7999877 7788999999999
Q ss_pred CCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccc
Q psy5368 124 GGDLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFA 186 (406)
Q Consensus 124 ggsL~~~l~~~----------------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla 186 (406)
||+|.++|+.+ ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|
T Consensus 95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a 174 (309)
T d1fvra_ 95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 174 (309)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEcccccc
Confidence 99999999754 4699999999999999999999999999999999999999 679999999999
Q ss_pred cccCCCCCCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCCCh
Q psy5368 187 QFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFG-HAPYASCNLSQLRAQALSSAPITIPPNSLSP 265 (406)
Q Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~ 265 (406)
+............||+.|+|||.+.+..++.++|||||||++|||++| .+||.+.+..++...+..+..+..+. .+|+
T Consensus 175 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~~~~-~~~~ 253 (309)
T d1fvra_ 175 RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL-NCDD 253 (309)
T ss_dssp ESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCT-TBCH
T ss_pred ccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCc-cCCH
Confidence 876655555666799999999999999999999999999999999996 56899999999888887776555544 7999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 266 DCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 266 ~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
++.+||.+||+.||++|||+++++++
T Consensus 254 ~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 254 EVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-49 Score=371.74 Aligned_cols=235 Identities=21% Similarity=0.363 Sum_probs=185.8
Q ss_pred eeeecceeeeEEEeeeeee-------ceeEEeeeecCCc-cchhhhhhHHhhcccC-CCCCCcc-------cCCeEEEEE
Q psy5368 56 TIRYGELQYDTVQNSQIRL-------GTVKYSQVRYDTI-TSHSEFERPRAGLSNL-RAPEGRK-------RPRYVYIIL 119 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-------~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~-------~~~~~~lV~ 119 (406)
...||+|+||.||+|.... +.||+|++..... .....+.+|...+.++ +|+|++. ..+.+++||
T Consensus 18 ~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~ 97 (299)
T d1ywna1 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 97 (299)
T ss_dssp EEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred eeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEE
Confidence 4678999999999998643 4688898765432 2345688888888887 5677654 456789999
Q ss_pred eccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEe
Q psy5368 120 EYCDGGDLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLAD 182 (406)
Q Consensus 120 E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~D 182 (406)
|||++|+|.++++.. ..+++.++..++.||+.||+|||++||+||||||+|||++ ++.+||+|
T Consensus 98 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~D 177 (299)
T d1ywna1 98 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICD 177 (299)
T ss_dssp ECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC
T ss_pred EecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEcc
Confidence 999999999999754 2489999999999999999999999999999999999998 67999999
Q ss_pred cccccccCCCC---CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHH-HHHHHhcCCCC
Q psy5368 183 FGFAQFLAPND---QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFG-HAPYASCNLSQL-RAQALSSAPIT 257 (406)
Q Consensus 183 FGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg-~~pf~~~~~~~~-~~~~~~~~~~~ 257 (406)
||+|+...... ......||+.|+|||++.+..++.++|||||||++|||+|| .+||.+....+. ...+..+....
T Consensus 178 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~ 257 (299)
T d1ywna1 178 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 257 (299)
T ss_dssp ------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCC
T ss_pred CcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 99998654433 23456799999999999999999999999999999999986 568887654443 44444444444
Q ss_pred CCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 258 IPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 258 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
.+ ..+|+++.+|+.+||+.||++|||++|+++|
T Consensus 258 ~~-~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 258 AP-DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp CC-TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC-ccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 43 4789999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=364.15 Aligned_cols=234 Identities=19% Similarity=0.314 Sum_probs=190.3
Q ss_pred eeecceeeeEEEeeeeee-----ceeEEeeeecCCcc---chhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccC
Q psy5368 57 IRYGELQYDTVQNSQIRL-----GTVKYSQVRYDTIT---SHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCD 123 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~-----~~v~vk~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ 123 (406)
..||+|+||.||+|.... ..||+|.+...... ..++|.+|+.++++++|||+++ ..+..++|||||+
T Consensus 14 ~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~lv~e~~~ 93 (273)
T d1u46a_ 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAP 93 (273)
T ss_dssp EECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCT
T ss_pred EEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchheeeeeec
Confidence 468999999999998643 25788877654322 2457899999999999999876 4567789999999
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC----CCc
Q psy5368 124 GGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ----GDS 197 (406)
Q Consensus 124 ggsL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~----~~~ 197 (406)
+|+|.+++..+ +.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....... ...
T Consensus 94 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~ 173 (273)
T d1u46a_ 94 LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 173 (273)
T ss_dssp TCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC---
T ss_pred CcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCc
Confidence 99999987654 5799999999999999999999999999999999999999 77999999999988755433 234
Q ss_pred ccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHhcc
Q psy5368 198 IQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRLLQ 276 (406)
Q Consensus 198 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~ 276 (406)
..|++.|+|||.+.+..++.++|||||||++|||+| |.+||.+.+..+....+.........+..+|+++.+|+.+||+
T Consensus 174 ~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~ 253 (273)
T d1u46a_ 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWA 253 (273)
T ss_dssp --CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTC
T ss_pred cccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcC
Confidence 457889999999999999999999999999999998 8999999999998888876644333345799999999999999
Q ss_pred cCCCCCCCHHHHhc
Q psy5368 277 KDPMRRISYEDLFS 290 (406)
Q Consensus 277 ~dP~~Rps~~ell~ 290 (406)
.||++|||+.++++
T Consensus 254 ~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 254 HKPEDRPTFVALRD 267 (273)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhHCcCHHHHHH
Confidence 99999999999863
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=370.40 Aligned_cols=245 Identities=21% Similarity=0.301 Sum_probs=193.3
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCcc--------------cCCeEEEE
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRK--------------RPRYVYII 118 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~--------------~~~~~~lV 118 (406)
..||+|+||+||+|... +..||+|++..... ....++.+|+.+|++++|||++. ..+.+|+|
T Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv 95 (318)
T d3blha1 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLV 95 (318)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEE
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEE
Confidence 35677777778877753 45688887654432 23457889999999999999766 24568999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCC-----
Q psy5368 119 LEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPN----- 192 (406)
Q Consensus 119 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~----- 192 (406)
||||.++++.........+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus 96 ~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~ 175 (318)
T d3blha1 96 FDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 175 (318)
T ss_dssp EECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----C
T ss_pred EeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeeccccccccc
Confidence 99998876666555667899999999999999999999999999999999999998 779999999999765432
Q ss_pred CCCCcccCCCCCCChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC-----------
Q psy5368 193 DQGDSIQGSPLYMAPEILAGS-PYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPITIPP----------- 260 (406)
Q Consensus 193 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~----------- 260 (406)
.......||+.|+|||++.+. .+++++||||+||++|||++|+.||.+.+.......+........+.
T Consensus 176 ~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 255 (318)
T d3blha1 176 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELY 255 (318)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC---
T ss_pred ccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhh
Confidence 223456799999999999865 68999999999999999999999999888766665554321110000
Q ss_pred -------------------CCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q psy5368 261 -------------------NSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPC 301 (406)
Q Consensus 261 -------------------~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~ 301 (406)
...++++.+||.+||++||++|||++|+|+||||+....|+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~ 315 (318)
T d3blha1 256 EKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 315 (318)
T ss_dssp ----CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCC
T ss_pred hhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCC
Confidence 01267789999999999999999999999999999766655
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-48 Score=367.74 Aligned_cols=234 Identities=22% Similarity=0.334 Sum_probs=200.8
Q ss_pred eeeecceeeeEEEeeeeee-------ceeEEeeeecCCccc-hhhhhhHHhhcccCCCCCCcc------cCCeEEEEEec
Q psy5368 56 TIRYGELQYDTVQNSQIRL-------GTVKYSQVRYDTITS-HSEFERPRAGLSNLRAPEGRK------RPRYVYIILEY 121 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-------~~v~vk~~~~~~~~~-~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~ 121 (406)
...||+|+||+||+|+..+ ..||+|++....... ..+|.+|+.++++++|||++. ..+..++||||
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~ 97 (301)
T d1lufa_ 18 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEY 97 (301)
T ss_dssp EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEe
Confidence 4568999999999998753 568999876544332 457999999999999999876 66778999999
Q ss_pred cCCCCHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC
Q psy5368 122 CDGGDLCSFIRSHE------------------------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN 176 (406)
Q Consensus 122 ~~ggsL~~~l~~~~------------------------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~ 176 (406)
+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++ ++
T Consensus 98 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~ 177 (301)
T d1lufa_ 98 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM 177 (301)
T ss_dssp CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred cCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCC
Confidence 99999999996532 389999999999999999999999999999999999999 67
Q ss_pred eeEEEecccccccCCCC---CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHh
Q psy5368 177 TLKLADFGFAQFLAPND---QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFG-HAPYASCNLSQLRAQALS 252 (406)
Q Consensus 177 ~~kL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg-~~pf~~~~~~~~~~~~~~ 252 (406)
.+||+|||+|+.+.... ......||+.|+|||.+.+..++.++|||||||++|||++| .+||.+.+..++...+..
T Consensus 178 ~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~ 257 (301)
T d1lufa_ 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD 257 (301)
T ss_dssp CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT
T ss_pred cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHc
Confidence 99999999998664332 23456688999999999999999999999999999999998 478999999999888888
Q ss_pred cCCCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 253 SAPITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 253 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
+.....+. .+|+++.+|+.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~p~-~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 258 GNILACPE-NCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TCCCCCCT-TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCc-cchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 76555543 79999999999999999999999999965
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=376.93 Aligned_cols=259 Identities=23% Similarity=0.349 Sum_probs=196.5
Q ss_pred ccceEEEeee-ee---eEEEeeeeecCCcceeeeeeccccccccceeeecCceeeecceeeeEEEeeeeeeceeEEeeee
Q psy5368 8 RYGTVRLGSV-KY---GQVQLSTVRYGKVRYSQVRSDTVRSGTVRYDIVGSSTIRYGELQYDTVQNSQIRLGTVKYSQVR 83 (406)
Q Consensus 8 ~~~~V~ig~~-~~---gy~vv~~lg~G~~~~~~~~~d~~~~~~~~~~i~~~~~~~lG~G~~g~Vy~~~~~~~~v~vk~~~ 83 (406)
-||||.+|+. +. .|+++++||.|+||.||.+.+... +..+|+|.+.
T Consensus 2 ~~~~~~~~~~~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t------------------------------~~~vAvK~i~ 51 (355)
T d2b1pa1 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL------------------------------DRNVAIKKLS 51 (355)
T ss_dssp CEEEEEETTEEEEEETTEEEEEECSCC--CEEEEEEETTT------------------------------TEEEEEEEEE
T ss_pred CCEEEEeCCcceeecCCeEEEEEeecCcCeEEEEEEECCC------------------------------CCEEEEEEEC
Confidence 4899999994 32 399999999888888877765432 2346777765
Q ss_pred cCCc--cchhhhhhHHhhcccCCCCCCcc------------cCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHH
Q psy5368 84 YDTI--TSHSEFERPRAGLSNLRAPEGRK------------RPRYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQL 149 (406)
Q Consensus 84 ~~~~--~~~~~~~~E~~~l~~l~h~ni~~------------~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql 149 (406)
.... ....++.+|+.++++++|||++. ...++|+|||||.+ ++.+.+ ...+++..++.++.||
T Consensus 52 ~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~-~l~~~~--~~~~~~~~i~~~~~qi 128 (355)
T d2b1pa1 52 RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVI--QMELDHERMSYLLYQM 128 (355)
T ss_dssp STTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHH--TSCCCHHHHHHHHHHH
T ss_pred hhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccch-HHHHhh--hcCCCHHHHHHHHHHH
Confidence 4432 22346889999999999999866 34688999999976 555554 3579999999999999
Q ss_pred HHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHH
Q psy5368 150 VLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLV 228 (406)
Q Consensus 150 ~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 228 (406)
+.||.|||++||+||||||+|||++ ++.+|++|||+++............+|+.|+|||++.+..+++++||||+||++
T Consensus 129 l~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l 208 (355)
T d2b1pa1 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 208 (355)
T ss_dssp HHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred HHHHHHhhhcccccccCCccccccccccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchH
Confidence 9999999999999999999999999 779999999999887777777778899999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhcCCC---------------------CCC-------------C------CCCChHHH
Q psy5368 229 FEALFGHAPYASCNLSQLRAQALSSAPI---------------------TIP-------------P------NSLSPDCM 268 (406)
Q Consensus 229 ~elltg~~pf~~~~~~~~~~~~~~~~~~---------------------~~~-------------~------~~~s~~l~ 268 (406)
++|++|++||.+.+.......+...... ... + ...|+++.
T Consensus 209 ~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 288 (355)
T d2b1pa1 209 GEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQAR 288 (355)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHH
T ss_pred HHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHH
Confidence 9999999999988766655554321110 000 0 01356789
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy5368 269 DFLSRLLQKDPMRRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 269 ~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 299 (406)
+||.+||..||++|||++|+|+||||+....
T Consensus 289 dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~ 319 (355)
T d2b1pa1 289 DLLSKMLVIDPAKRISVDDALQHPYINVWYD 319 (355)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred HHHHHHCcCChhHCcCHHHHhcCcccCCCCC
Confidence 9999999999999999999999999986543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=363.53 Aligned_cols=235 Identities=22% Similarity=0.301 Sum_probs=194.1
Q ss_pred eeeecceeeeEEEeeeeeec-----eeEEeeeecCC-ccchhhhhhHHhhcccCCCCCCcc-------cCCeEEEEEecc
Q psy5368 56 TIRYGELQYDTVQNSQIRLG-----TVKYSQVRYDT-ITSHSEFERPRAGLSNLRAPEGRK-------RPRYVYIILEYC 122 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~-----~v~vk~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~-------~~~~~~lV~E~~ 122 (406)
+.+||+|+||+||+|..... .||||++.... .....+|.+|++++++++|||+++ .++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46799999999999987432 47888876432 233467999999999999999866 456889999999
Q ss_pred CCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCC-----C
Q psy5368 123 DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQ-----G 195 (406)
Q Consensus 123 ~ggsL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~-----~ 195 (406)
++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++ ++.+||+|||+++....... .
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 191 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceec
Confidence 9999999997654 688999999999999999999999999999999999999 66999999999987654322 2
Q ss_pred CcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCCCCCCChHHHHHHHHh
Q psy5368 196 DSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYAS-CNLSQLRAQALSSAPITIPPNSLSPDCMDFLSRL 274 (406)
Q Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~ 274 (406)
....||+.|+|||.+.+..++.++||||||+++|||+||..||.. .+..++...+..+..+..| ..+++++.+|+.+|
T Consensus 192 ~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p-~~~~~~l~~li~~c 270 (311)
T d1r0pa_ 192 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP-EYCPDPLYEVMLKC 270 (311)
T ss_dssp TCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCC-TTCCHHHHHHHHHH
T ss_pred ccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCc-ccCcHHHHHHHHHH
Confidence 335689999999999999999999999999999999997666654 4455556666666555444 47899999999999
Q ss_pred cccCCCCCCCHHHHhcC
Q psy5368 275 LQKDPMRRISYEDLFSH 291 (406)
Q Consensus 275 L~~dP~~Rps~~ell~h 291 (406)
|+.||++|||+.|+++|
T Consensus 271 l~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 271 WHPKAEMRPSFSELVSR 287 (311)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred cCCCHhHCcCHHHHHHH
Confidence 99999999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=369.19 Aligned_cols=243 Identities=25% Similarity=0.348 Sum_probs=190.6
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCCc-cchhhhhhHHhhcccCCCCCCccc-----------CCeEEEEEecc
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDTI-TSHSEFERPRAGLSNLRAPEGRKR-----------PRYVYIILEYC 122 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~~-----------~~~~~lV~E~~ 122 (406)
..||+|+||+||+|... +..+|+|.+..... .....+.+|+.+|++|+|||+++. ..++|+++ ++
T Consensus 14 ~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~-~~ 92 (345)
T d1pmea_ 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVT-HL 92 (345)
T ss_dssp EECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEE-EC
T ss_pred EEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEE-ee
Confidence 45688888888888753 56789998765432 234578999999999999998751 12355555 55
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC----CCCc
Q psy5368 123 DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND----QGDS 197 (406)
Q Consensus 123 ~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~----~~~~ 197 (406)
.||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+...... ....
T Consensus 93 ~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 171 (345)
T d1pmea_ 93 MGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 171 (345)
T ss_dssp CCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCC
T ss_pred cCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeecc
Confidence 58899999976 4799999999999999999999999999999999999998 6799999999997654332 2355
Q ss_pred ccCCCCCCChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--------------------
Q psy5368 198 IQGSPLYMAPEILAG-SPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI-------------------- 256 (406)
Q Consensus 198 ~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-------------------- 256 (406)
..||+.|+|||++.. ..++.++||||+||++|+|++|+.||.+.+..+...........
T Consensus 172 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (345)
T d1pmea_ 172 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 251 (345)
T ss_dssp CCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHT
T ss_pred ccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhccccc
Confidence 679999999999855 45789999999999999999999999987765544443221000
Q ss_pred ----CC-----CCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q psy5368 257 ----TI-----PPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPC 301 (406)
Q Consensus 257 ----~~-----~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~ 301 (406)
.. ....+|+++.+|+.+||+.||.+|||++|+|+||||+....+.
T Consensus 252 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~ 305 (345)
T d1pmea_ 252 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 305 (345)
T ss_dssp SCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred CCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCc
Confidence 00 0125788999999999999999999999999999998665543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=361.88 Aligned_cols=234 Identities=21% Similarity=0.361 Sum_probs=198.3
Q ss_pred eeeecceeeeEEEeeeeee---------ceeEEeeeecCCcc-chhhhhhHHhhcccC-CCCCCcc------cCCeEEEE
Q psy5368 56 TIRYGELQYDTVQNSQIRL---------GTVKYSQVRYDTIT-SHSEFERPRAGLSNL-RAPEGRK------RPRYVYII 118 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~---------~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV 118 (406)
.+.||+|+||.||+++... ..||+|++..+... ...++.+|...+.++ +|||++. +++.+|+|
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v 97 (299)
T d1fgka_ 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 97 (299)
T ss_dssp EEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEE
Confidence 3578999999999998533 35788888665432 346788999999888 8999876 67789999
Q ss_pred EeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEE
Q psy5368 119 LEYCDGGDLCSFIRSHE----------------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLA 181 (406)
Q Consensus 119 ~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~ 181 (406)
||||++|+|.++|..+. .+++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+
T Consensus 98 ~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~ 177 (299)
T d1fgka_ 98 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 177 (299)
T ss_dssp ECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEEC
T ss_pred EEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEec
Confidence 99999999999997543 489999999999999999999999999999999999999 7799999
Q ss_pred ecccccccCCCC---CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCC
Q psy5368 182 DFGFAQFLAPND---QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPIT 257 (406)
Q Consensus 182 DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 257 (406)
|||+++...... ......||+.|+|||.+.++.|+.++|||||||++|||++ |.+||.+.+...+...+..+..+.
T Consensus 178 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~~~ 257 (299)
T d1fgka_ 178 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD 257 (299)
T ss_dssp STTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred cchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 999998765443 2344678999999999999999999999999999999998 799999999998888887776665
Q ss_pred CCCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 258 IPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 258 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
.+. .+|+++.+||.+||+.||++|||+.|+++
T Consensus 258 ~p~-~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 258 KPS-NCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp CCS-SCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCc-cchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 554 79999999999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.8e-47 Score=365.95 Aligned_cols=237 Identities=22% Similarity=0.410 Sum_probs=193.4
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCC-CCCCcc--------cCCeEEEEEeccCCC
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLR-APEGRK--------RPRYVYIILEYCDGG 125 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~--------~~~~~~lV~E~~~gg 125 (406)
.+||+|+||+||+|... +..||+|.+.. ....++.+|+.+|.+++ |||++. ...++|+|||||+++
T Consensus 41 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~ 117 (328)
T d3bqca1 41 RKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 117 (328)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSC
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCC
Confidence 46788888888888863 45688888754 33567899999999995 999875 456799999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CC-eeEEEecccccccCCCCCCCcccCCCC
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NN-TLKLADFGFAQFLAPNDQGDSIQGSPL 203 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~-~~kL~DFGla~~~~~~~~~~~~~gt~~ 203 (406)
+|.++. +.+++..++.++.||+.||+|||++||+||||||+|||++ ++ .+||+|||+|+............+|+.
T Consensus 118 ~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~ 194 (328)
T d3bqca1 118 DFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 194 (328)
T ss_dssp BGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGG
T ss_pred cHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCcccccccCcc
Confidence 997763 5799999999999999999999999999999999999998 44 799999999998877777778889999
Q ss_pred CCChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHh-------------cC--------------
Q psy5368 204 YMAPEILAGSP-YNAKADLWSLGVLVFEALFGHAPYASCNLS-QLRAQALS-------------SA-------------- 254 (406)
Q Consensus 204 y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~-~~~~~~~~-------------~~-------------- 254 (406)
|+|||.+.+.. ++.++||||+||++|+|++|+.||...... .....+.. ..
T Consensus 195 y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (328)
T d3bqca1 195 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRH 274 (328)
T ss_dssp GCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCC
T ss_pred ccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccc
Confidence 99999988754 799999999999999999999999765421 11111110 00
Q ss_pred --------CCCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy5368 255 --------PITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 255 --------~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 299 (406)
........+|+++.+||.+||+.||++|||++|+|+||||+...+
T Consensus 275 ~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 275 SRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp CCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred cccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 000011247889999999999999999999999999999987543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-47 Score=355.55 Aligned_cols=243 Identities=28% Similarity=0.374 Sum_probs=197.4
Q ss_pred eeecceeeeEEEeeeee--eceeEEeeeecCCcc--chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEeccCCCC
Q psy5368 57 IRYGELQYDTVQNSQIR--LGTVKYSQVRYDTIT--SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E~~~ggs 126 (406)
.+||+|+||+||++... +..||+|.++..... ...++.+|+.+++.++|||+++ .....++|+|++.+++
T Consensus 8 ~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~ 87 (292)
T d1unla_ 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDL 87 (292)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEH
T ss_pred eEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccc
Confidence 35677777777777653 345788887654432 3567899999999999999866 7788999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC-CCCcccCCCCC
Q psy5368 127 LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND-QGDSIQGSPLY 204 (406)
Q Consensus 127 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~-~~~~~~gt~~y 204 (406)
|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++ ++.+||+|||.|+...... ......+++.|
T Consensus 88 l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~ 167 (292)
T d1unla_ 88 KKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWY 167 (292)
T ss_dssp HHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGG
T ss_pred cccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccceeeccccch
Confidence 999998888999999999999999999999999999999999999999 7799999999998775543 34455678899
Q ss_pred CChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhcCC---------------------------
Q psy5368 205 MAPEILAGSP-YNAKADLWSLGVLVFEALFGHAPY-ASCNLSQLRAQALSSAP--------------------------- 255 (406)
Q Consensus 205 ~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf-~~~~~~~~~~~~~~~~~--------------------------- 255 (406)
+|||.+.+.. ++.++||||+||++|||++|+.|| .+.+..+....+.....
T Consensus 168 ~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (292)
T d1unla_ 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTS 247 (292)
T ss_dssp CCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCC
T ss_pred hhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccch
Confidence 9999998765 689999999999999999999885 55555555444432110
Q ss_pred CCCCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy5368 256 ITIPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHA 299 (406)
Q Consensus 256 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 299 (406)
.......+++.+.+|+.+||+.||.+|||++|+|+||||+....
T Consensus 248 ~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~ 291 (292)
T d1unla_ 248 LVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291 (292)
T ss_dssp CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred hhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence 00111256889999999999999999999999999999986543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-48 Score=368.46 Aligned_cols=241 Identities=27% Similarity=0.447 Sum_probs=199.5
Q ss_pred eeeecceeeeEEEeeee-----eeceeEEeeeecCC----ccchhhhhhHHhhcccCCC-CCCcc------cCCeEEEEE
Q psy5368 56 TIRYGELQYDTVQNSQI-----RLGTVKYSQVRYDT----ITSHSEFERPRAGLSNLRA-PEGRK------RPRYVYIIL 119 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~-----~~~~v~vk~~~~~~----~~~~~~~~~E~~~l~~l~h-~ni~~------~~~~~~lV~ 119 (406)
...||+|+||+||++.. .+..+|+|.+.... ......+.+|+.++++++| ||++. +...+|+||
T Consensus 29 ~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~ 108 (322)
T d1vzoa_ 29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL 108 (322)
T ss_dssp EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeee
Confidence 45789999999999975 23468998775432 2345678999999999977 68765 788899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCC--CCC
Q psy5368 120 EYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND--QGD 196 (406)
Q Consensus 120 E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~--~~~ 196 (406)
|||.+|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+.+.... ...
T Consensus 109 e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~ 188 (322)
T d1vzoa_ 109 DYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY 188 (322)
T ss_dssp CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGC
T ss_pred ecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhccccccccc
Confidence 9999999999999989999999999999999999999999999999999999999 7799999999998764332 345
Q ss_pred cccCCCCCCChhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhcCCCCCCCCCCChHHHHH
Q psy5368 197 SIQGSPLYMAPEILAGS--PYNAKADLWSLGVLVFEALFGHAPYASCNLSQ----LRAQALSSAPITIPPNSLSPDCMDF 270 (406)
Q Consensus 197 ~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~s~~l~~l 270 (406)
...|++.|+|||.+.+. .++.++||||+||+||+|+||+.||.+.+... +....... ....+ ..+|+++.+|
T Consensus 189 ~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~-~~~~~-~~~s~~~~~l 266 (322)
T d1vzoa_ 189 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EPPYP-QEMSALAKDL 266 (322)
T ss_dssp GGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-CCCCC-TTSCHHHHHH
T ss_pred ccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC-CCCCc-ccCCHHHHHH
Confidence 56799999999999765 47889999999999999999999997765333 33332222 33333 3699999999
Q ss_pred HHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q psy5368 271 LSRLLQKDPMRRI-----SYEDLFSHPYPDLIH 298 (406)
Q Consensus 271 i~~~L~~dP~~Rp-----s~~ell~hp~~~~~~ 298 (406)
+.+||++||++|| |++|+++||||+...
T Consensus 267 i~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 267 IQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp HHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred HHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 9999999999999 489999999998654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-47 Score=360.10 Aligned_cols=235 Identities=20% Similarity=0.309 Sum_probs=202.8
Q ss_pred ceeeecceeeeEEEeeeee-------eceeEEeeeecCCcc-chhhhhhHHhhcccCCCCCCcc------cCCeEEEEEe
Q psy5368 55 STIRYGELQYDTVQNSQIR-------LGTVKYSQVRYDTIT-SHSEFERPRAGLSNLRAPEGRK------RPRYVYIILE 120 (406)
Q Consensus 55 ~~~~lG~G~~g~Vy~~~~~-------~~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~------~~~~~~lV~E 120 (406)
..+.||+|+||+||+|.+. ...||||++...... ....|.+|+.++++++|||++. ..+..++|||
T Consensus 24 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 103 (308)
T d1p4oa_ 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 103 (308)
T ss_dssp EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEe
Confidence 3467999999999999874 357899988754322 2346899999999999999876 6677899999
Q ss_pred ccCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEeccccccc
Q psy5368 121 YCDGGDLCSFIRSH----------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFL 189 (406)
Q Consensus 121 ~~~ggsL~~~l~~~----------~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~ 189 (406)
||++|+|.+++... ..+++..+..++.|+++||.|||+++|+||||||+|||++ ++.+||+|||+|+..
T Consensus 104 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~ 183 (308)
T d1p4oa_ 104 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 183 (308)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGG
T ss_pred ecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceec
Confidence 99999999998543 2479999999999999999999999999999999999999 669999999999866
Q ss_pred CCCCC---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCCCh
Q psy5368 190 APNDQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFG-HAPYASCNLSQLRAQALSSAPITIPPNSLSP 265 (406)
Q Consensus 190 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~s~ 265 (406)
..... .....||+.|+|||.+.+..++.++|||||||++|||+|| .+||.+.+..+....+..+.....++ .+|+
T Consensus 184 ~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p~-~~~~ 262 (308)
T d1p4oa_ 184 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD-NCPD 262 (308)
T ss_dssp GGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCT-TCCH
T ss_pred cCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCCcc-cchH
Confidence 44332 3344689999999999999999999999999999999998 58999999999988888776655544 7999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 266 DCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 266 ~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
.+.+|+.+||+.||++|||++++++
T Consensus 263 ~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 263 MLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=357.98 Aligned_cols=235 Identities=22% Similarity=0.346 Sum_probs=198.5
Q ss_pred eeeecceeeeEEEeeeeee-------ceeEEeeeecCCcc-chhhhhhHHhhcccC-CCCCCcc------cCCeEEEEEe
Q psy5368 56 TIRYGELQYDTVQNSQIRL-------GTVKYSQVRYDTIT-SHSEFERPRAGLSNL-RAPEGRK------RPRYVYIILE 120 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~-------~~v~vk~~~~~~~~-~~~~~~~E~~~l~~l-~h~ni~~------~~~~~~lV~E 120 (406)
..+||+|+||.||+|++.. +.||+|++...... ....+.+|+.++.++ +|||+++ ..+.+|+|||
T Consensus 28 ~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE 107 (311)
T d1t46a_ 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107 (311)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEE
Confidence 5689999999999998632 46899988754433 344789999999999 6999876 6667899999
Q ss_pred ccCCCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEE
Q psy5368 121 YCDGGDLCSFIRSHE------------------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLA 181 (406)
Q Consensus 121 ~~~ggsL~~~l~~~~------------------~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~ 181 (406)
||++|+|.++++... .+++..+..++.||+.||+|||++|++||||||+||+++ ++.+|++
T Consensus 108 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~ 187 (311)
T d1t46a_ 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKIC 187 (311)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEEC
T ss_pred cCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCccccc
Confidence 999999999997643 589999999999999999999999999999999999998 7799999
Q ss_pred ecccccccCCCCC---CCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCC
Q psy5368 182 DFGFAQFLAPNDQ---GDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALF-GHAPYASCNLSQLRAQALSSAPIT 257 (406)
Q Consensus 182 DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 257 (406)
|||+++....... .....||+.|+|||++.+..++.++|||||||++|||+| |.+||...+..+....+.......
T Consensus 188 DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~ 267 (311)
T d1t46a_ 188 DFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM 267 (311)
T ss_dssp CCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCC
T ss_pred ccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 9999987654432 244678999999999999999999999999999999998 777787777655555554443333
Q ss_pred CCCCCCChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 258 IPPNSLSPDCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 258 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
..+..+|+++.+||.+||+.||++|||++++++
T Consensus 268 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 268 LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 444578999999999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=362.38 Aligned_cols=242 Identities=23% Similarity=0.328 Sum_probs=187.1
Q ss_pred ecceeeeEEEeeee--eeceeEEeeeecCCc--cchhhhhhHHhhcccCCCCCCccc-----------CCeEEEEEeccC
Q psy5368 59 YGELQYDTVQNSQI--RLGTVKYSQVRYDTI--TSHSEFERPRAGLSNLRAPEGRKR-----------PRYVYIILEYCD 123 (406)
Q Consensus 59 lG~G~~g~Vy~~~~--~~~~v~vk~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~~-----------~~~~~lV~E~~~ 123 (406)
||+|+||+||+|.. .+..||+|.+..... .....+.+|+.+|++++|||+++. ....++||+++.
T Consensus 26 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~ 105 (348)
T d2gfsa1 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM 105 (348)
T ss_dssp CGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECC
T ss_pred EecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeec
Confidence 34444555555543 234678887764432 234578899999999999998752 223356667777
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee-CCeeEEEecccccccCCCCCCCcccCCC
Q psy5368 124 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPNDQGDSIQGSP 202 (406)
Q Consensus 124 ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~~~~~~~gt~ 202 (406)
||+|.+++.. +++++.+++.++.||+.||+|||++||+||||||+|||++ ++.+|++|||++.... .......||+
T Consensus 106 gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~--~~~~~~~g~~ 182 (348)
T d2gfsa1 106 GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATR 182 (348)
T ss_dssp SEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT--GGGSSSCHHH
T ss_pred CCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC--cccccccccc
Confidence 9999999854 5799999999999999999999999999999999999998 7799999999986543 3345567899
Q ss_pred CCCChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----------------------CCC
Q psy5368 203 LYMAPEILAGSP-YNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALSSAPI----------------------TIP 259 (406)
Q Consensus 203 ~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----------------------~~~ 259 (406)
.|+|||.+.+.. ++.++||||+||++|+|++|++||.+.+.......+...... ..+
T Consensus 183 ~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (348)
T d2gfsa1 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMP 262 (348)
T ss_dssp HTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCC
T ss_pred cccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCC
Confidence 999999987754 688999999999999999999999998876666555432111 000
Q ss_pred -------CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCcc
Q psy5368 260 -------PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLIHAPCAE 303 (406)
Q Consensus 260 -------~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~~ 303 (406)
...+++++.+||.+||+.||.+|||++|+|+||||+....|..+
T Consensus 263 ~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~ 313 (348)
T d2gfsa1 263 KMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 313 (348)
T ss_dssp CCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSC
T ss_pred CcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccC
Confidence 12578999999999999999999999999999999977665544
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=346.68 Aligned_cols=234 Identities=18% Similarity=0.188 Sum_probs=182.2
Q ss_pred eeeecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc----------cCCeEEEEEeccCCC
Q psy5368 56 TIRYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK----------RPRYVYIILEYCDGG 125 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~----------~~~~~~lV~E~~~gg 125 (406)
...||+|+||.||+|+.++..||+|.+.... ........|+..+.+++|||+++ ....+|+|||||++|
T Consensus 8 ~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g 86 (303)
T d1vjya_ 8 QESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG 86 (303)
T ss_dssp EEEEECCSSSEEEEEEETTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred EEEEeeCCCeEEEEEEECCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCC
Confidence 3569999999999999988899999886432 11223445667778899999887 123679999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH--------CCcccccCCCcceEee-CCeeEEEecccccccCCCC---
Q psy5368 126 DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRE--------NNVCHFDLKPQNILIK-NNTLKLADFGFAQFLAPND--- 193 (406)
Q Consensus 126 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~--------~givH~Dlkp~NIll~-~~~~kL~DFGla~~~~~~~--- 193 (406)
+|.+++++. ++++..+..++.|++.||+|+|+ +||+||||||+|||++ ++.+||+|||+++......
T Consensus 87 ~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~ 165 (303)
T d1vjya_ 87 SLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 165 (303)
T ss_dssp BHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEE
T ss_pred CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcce
Confidence 999999874 79999999999999999999996 5999999999999998 7799999999998765433
Q ss_pred --CCCcccCCCCCCChhhhcCCC------CCchhhHHHHHHHHHHHHhCCCCCCCC---------------CHHHHHHHH
Q psy5368 194 --QGDSIQGSPLYMAPEILAGSP------YNAKADLWSLGVLVFEALFGHAPYASC---------------NLSQLRAQA 250 (406)
Q Consensus 194 --~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlG~il~elltg~~pf~~~---------------~~~~~~~~~ 250 (406)
......||+.|+|||++.+.. ++.++|||||||+||||+||..||... ....+....
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (303)
T d1vjya_ 166 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245 (303)
T ss_dssp CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHH
T ss_pred eccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHH
Confidence 234567999999999987643 577899999999999999998877431 233343333
Q ss_pred HhcCC-CCCCCC----CCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy5368 251 LSSAP-ITIPPN----SLSPDCMDFLSRLLQKDPMRRISYEDLFSH 291 (406)
Q Consensus 251 ~~~~~-~~~~~~----~~s~~l~~li~~~L~~dP~~Rps~~ell~h 291 (406)
..... +..+.. ..+..+.+|+.+||+.||++|||+.|++++
T Consensus 246 ~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 33222 111111 123458999999999999999999999764
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-44 Score=341.53 Aligned_cols=237 Identities=17% Similarity=0.238 Sum_probs=185.6
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc-------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK-------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~-------~~~~~~lV~E~~~ggs 126 (406)
...||+|+||.||+|... +..||+|..... ....++.+|+++++.++|+|++. ..+..++|||||. ++
T Consensus 12 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~ 88 (299)
T d1ckia_ 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PS 88 (299)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEESC--TTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC-CB
T ss_pred eEEEeeCCCcEEEEEEECCCCCEEEEEEEchh--ccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC-Cc
Confidence 356788888888888764 457888876654 23456889999999999887543 6778899999995 57
Q ss_pred HHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee----CCeeEEEecccccccCCCC--------
Q psy5368 127 LCSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK----NNTLKLADFGFAQFLAPND-------- 193 (406)
Q Consensus 127 L~~~l~~-~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~----~~~~kL~DFGla~~~~~~~-------- 193 (406)
|.+.+.. .+.+++..+..++.|++.||+|||++||+||||||+|||++ +..+||+|||+|+......
T Consensus 89 l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 168 (299)
T d1ckia_ 89 LEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 168 (299)
T ss_dssp HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCC
T ss_pred hhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceecc
Confidence 7776654 45899999999999999999999999999999999999986 3379999999998765433
Q ss_pred CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------cCCCCCCCCCCChHH
Q psy5368 194 QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCNLSQLRAQALS------SAPITIPPNSLSPDC 267 (406)
Q Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~------~~~~~~~~~~~s~~l 267 (406)
......||+.|+|||++.+..++.++|||||||++|||+||+.||...........+.. ..+.......+|+++
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 248 (299)
T d1ckia_ 169 ENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEF 248 (299)
T ss_dssp BCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHH
T ss_pred ccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHH
Confidence 23456799999999999999999999999999999999999999987654333222111 111111223689999
Q ss_pred HHHHHHhcccCCCCCCCHHH---HhcCCCCC
Q psy5368 268 MDFLSRLLQKDPMRRISYED---LFSHPYPD 295 (406)
Q Consensus 268 ~~li~~~L~~dP~~Rps~~e---ll~hp~~~ 295 (406)
.+|+.+||+.||++||++.+ +|+|+|.+
T Consensus 249 ~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 249 ATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999875 46676643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.6e-42 Score=323.84 Aligned_cols=232 Identities=16% Similarity=0.193 Sum_probs=183.1
Q ss_pred eeeecceeeeEEEeeeee--eceeEEeeeecCCccchhhhhhHHhhcccCCC-CCCcc------cCCeEEEEEeccCCCC
Q psy5368 56 TIRYGELQYDTVQNSQIR--LGTVKYSQVRYDTITSHSEFERPRAGLSNLRA-PEGRK------RPRYVYIILEYCDGGD 126 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~~--~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h-~ni~~------~~~~~~lV~E~~~ggs 126 (406)
...||+|+||+||+|... ++.+|+|..... .....+.+|++.+..|.| +|++. .....|+||||+ +++
T Consensus 10 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~ 86 (293)
T d1csna_ 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPS 86 (293)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEccc--cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCC
Confidence 346788888888888753 456888866443 334567888888888876 45433 678899999999 679
Q ss_pred HHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEee------CCeeEEEecccccccCCCC------
Q psy5368 127 LCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK------NNTLKLADFGFAQFLAPND------ 193 (406)
Q Consensus 127 L~~~l~~~~-~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~------~~~~kL~DFGla~~~~~~~------ 193 (406)
|.+++...+ .+++.++..++.|++.||+|||++||+||||||+|||++ ++.+||+|||+|+......
T Consensus 87 l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~ 166 (293)
T d1csna_ 87 LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP 166 (293)
T ss_dssp HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCC
T ss_pred HHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcccccee
Confidence 999997654 799999999999999999999999999999999999996 3579999999998764332
Q ss_pred --CCCcccCCCCCCChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhc---CCCCCCCCCCCh
Q psy5368 194 --QGDSIQGSPLYMAPEILAGSPYNAKADLWSLGVLVFEALFGHAPYASCN---LSQLRAQALSS---APITIPPNSLSP 265 (406)
Q Consensus 194 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~---~~~~~~~~~~~---~~~~~~~~~~s~ 265 (406)
......||+.|||||++.+..++.++|||||||++|||+||..||.+.. .......+... .........+|+
T Consensus 167 ~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (293)
T d1csna_ 167 YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPE 246 (293)
T ss_dssp CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCH
T ss_pred ecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCH
Confidence 2345679999999999999999999999999999999999999997643 22222222221 111111236899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q psy5368 266 DCMDFLSRLLQKDPMRRISYEDLFS 290 (406)
Q Consensus 266 ~l~~li~~~L~~dP~~Rps~~ell~ 290 (406)
++.+++..|+..+|++||+++.+.+
T Consensus 247 ~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 247 EFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHhcCCcccCcCHHHHHH
Confidence 9999999999999999999876643
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.2e-42 Score=334.54 Aligned_cols=256 Identities=24% Similarity=0.363 Sum_probs=189.2
Q ss_pred cceEEEeeeee-e-EEEeeeeecCCcceeeeeeccccccccceeeecCceeeecceeeeEEEeeeeeeceeEEeeeecCC
Q psy5368 9 YGTVRLGSVKY-G-QVQLSTVRYGKVRYSQVRSDTVRSGTVRYDIVGSSTIRYGELQYDTVQNSQIRLGTVKYSQVRYDT 86 (406)
Q Consensus 9 ~~~V~ig~~~~-g-y~vv~~lg~G~~~~~~~~~d~~~~~~~~~~i~~~~~~~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~ 86 (406)
||||++|+.+. | |+++++||.|+||.||.+.+... +..||+|++....
T Consensus 1 ~~p~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~------------------------------g~~vAvKvi~~~~ 50 (362)
T d1q8ya_ 1 YHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVN------------------------------NTHVAMKIVRGDK 50 (362)
T ss_dssp CCCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTT------------------------------TEEEEEEEECSCH
T ss_pred CCCCCCCCCccCCcEEEEEEEeeCCCeEEEEEEECCC------------------------------CCEEEEEEEeccc
Confidence 89999999997 6 99999888777777766664322 2457788776432
Q ss_pred ccchhhhhhHHhhcccCCCCC-----------Ccc--------cCCeEEEEEeccCCCCHHHH-HH--hCCCCCHHHHHH
Q psy5368 87 ITSHSEFERPRAGLSNLRAPE-----------GRK--------RPRYVYIILEYCDGGDLCSF-IR--SHEKLSEFQCQQ 144 (406)
Q Consensus 87 ~~~~~~~~~E~~~l~~l~h~n-----------i~~--------~~~~~~lV~E~~~ggsL~~~-l~--~~~~l~~~~~~~ 144 (406)
...+.+.+|+.+++.++|+| ++. .....+++++++..+..... .. ....+++..++.
T Consensus 51 -~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 129 (362)
T d1q8ya_ 51 -VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129 (362)
T ss_dssp -HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHH
T ss_pred -cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHH
Confidence 23456788999998887654 433 33455677777765543333 22 335799999999
Q ss_pred HHHHHHHHHHHHHH-CCcccccCCCcceEee-CC------eeEEEecccccccCCCCCCCcccCCCCCCChhhhcCCCCC
Q psy5368 145 FVRQLVLALKFLRE-NNVCHFDLKPQNILIK-NN------TLKLADFGFAQFLAPNDQGDSIQGSPLYMAPEILAGSPYN 216 (406)
Q Consensus 145 i~~ql~~aL~~lH~-~givH~Dlkp~NIll~-~~------~~kL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 216 (406)
++.||+.||+|||+ .||+||||||+|||++ ++ .++++|||.|.... .......||+.|+|||++.+..++
T Consensus 130 i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~ 207 (362)
T d1q8ya_ 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWG 207 (362)
T ss_dssp HHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCC
T ss_pred HHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeecccccccc--cccccccccccccChhhccccCCC
Confidence 99999999999998 8999999999999998 22 59999999997653 344567799999999999999999
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh--cC---------------------CCCCC--------
Q psy5368 217 AKADLWSLGVLVFEALFGHAPYASCNLS------QLRAQALS--SA---------------------PITIP-------- 259 (406)
Q Consensus 217 ~~~DiwSlG~il~elltg~~pf~~~~~~------~~~~~~~~--~~---------------------~~~~~-------- 259 (406)
.++||||+||++++|++|+.||...... ........ +. .....
T Consensus 208 ~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (362)
T d1q8ya_ 208 CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLE 287 (362)
T ss_dssp THHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHH
T ss_pred ccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchh
Confidence 9999999999999999999999754321 11111000 00 00000
Q ss_pred ---------CCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy5368 260 ---------PNSLSPDCMDFLSRLLQKDPMRRISYEDLFSHPYPDLI 297 (406)
Q Consensus 260 ---------~~~~s~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 297 (406)
....++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 288 ~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 288 DVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp HHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred hhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCC
Confidence 01235779999999999999999999999999999844
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=1.9e-23 Score=182.78 Aligned_cols=158 Identities=13% Similarity=0.099 Sum_probs=112.3
Q ss_pred eeeecceeeeEEEeeee-eeceeEEeeeecCCcc------------------chhhhhhHHhhcccCCCCCCccc--CCe
Q psy5368 56 TIRYGELQYDTVQNSQI-RLGTVKYSQVRYDTIT------------------SHSEFERPRAGLSNLRAPEGRKR--PRY 114 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~~-~~~~v~vk~~~~~~~~------------------~~~~~~~E~~~l~~l~h~ni~~~--~~~ 114 (406)
...||+|+||+||+|.. +++.||+|..+..... ......+|...+.++.|++++.. ...
T Consensus 5 g~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~~ 84 (191)
T d1zara2 5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEG 84 (191)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEET
T ss_pred CCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEecC
Confidence 57899999999999985 4567888865432110 01234567888889999887652 122
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCcceEeeCCeeEEEecccccccCCCCC
Q psy5368 115 VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLADFGFAQFLAPNDQ 194 (406)
Q Consensus 115 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~ql~~aL~~lH~~givH~Dlkp~NIll~~~~~kL~DFGla~~~~~~~~ 194 (406)
.++||||+++..+. .++...+..++.|++.+|+|||++||+||||||+|||++++.++|+|||+|.....+..
T Consensus 85 ~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~~~liDFG~a~~~~~~~~ 157 (191)
T d1zara2 85 NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIIDFPQSVEVGEEGW 157 (191)
T ss_dssp TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTEEEECCCTTCEETTSTTH
T ss_pred CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCCEEEEECCCcccCCCCCc
Confidence 36999999986543 35566678899999999999999999999999999999988999999999876532211
Q ss_pred CCcccCCCCCCCh--h---hhcCCCCCchhhHHHHHHH
Q psy5368 195 GDSIQGSPLYMAP--E---ILAGSPYNAKADLWSLGVL 227 (406)
Q Consensus 195 ~~~~~gt~~y~aP--E---~~~~~~~~~~~DiwSlG~i 227 (406)
. .|... + ....+.|+.++|+||+.--
T Consensus 158 ~-------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 158 R-------EILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp H-------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred H-------HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 0 01110 0 0113557889999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.07 E-value=4.5e-06 Score=73.98 Aligned_cols=121 Identities=12% Similarity=0.108 Sum_probs=78.5
Q ss_pred eeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccC----CCCCCcc---cCCeEEEEEeccCCCCHHHHHHhCC
Q psy5368 63 QYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNL----RAPEGRK---RPRYVYIILEYCDGGDLCSFIRSHE 135 (406)
Q Consensus 63 ~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l----~h~ni~~---~~~~~~lV~E~~~ggsL~~~l~~~~ 135 (406)
+.+.||+....++...+|............+.+|...+..| .-|.++. .++..|+||++++|.++.+.....
T Consensus 26 s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~- 104 (263)
T d1j7la_ 26 SPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE- 104 (263)
T ss_dssp SSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC-
T ss_pred CCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc-
Confidence 34678988777777777766655545555678888776555 3455443 577889999999998875543111
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHH---------------------------------------------------------
Q psy5368 136 KLSEFQCQQFVRQLVLALKFLRE--------------------------------------------------------- 158 (406)
Q Consensus 136 ~l~~~~~~~i~~ql~~aL~~lH~--------------------------------------------------------- 158 (406)
.....++.++...+..||+
T Consensus 105 ----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 180 (263)
T d1j7la_ 105 ----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPE 180 (263)
T ss_dssp ----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCC
T ss_pred ----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCc
Confidence 1111223333333333331
Q ss_pred --CCcccccCCCcceEeeCCee-EEEecccccc
Q psy5368 159 --NNVCHFDLKPQNILIKNNTL-KLADFGFAQF 188 (406)
Q Consensus 159 --~givH~Dlkp~NIll~~~~~-kL~DFGla~~ 188 (406)
..++|+|+.|.|||++++.+ -|+||+.+..
T Consensus 181 ~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 181 EELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12789999999999997765 5999998743
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.74 E-value=2.3e-05 Score=73.93 Aligned_cols=29 Identities=28% Similarity=0.386 Sum_probs=26.0
Q ss_pred CcccccCCCcceEeeCCeeEEEecccccc
Q psy5368 160 NVCHFDLKPQNILIKNNTLKLADFGFAQF 188 (406)
Q Consensus 160 givH~Dlkp~NIll~~~~~kL~DFGla~~ 188 (406)
.++|+|++|.|||++++.++|+||..+..
T Consensus 224 ~LiHGDl~~gNIlv~~~~~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHETKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSSCEEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCCceEEechhhccc
Confidence 58999999999999988899999988743
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.54 E-value=4.7e-05 Score=69.83 Aligned_cols=126 Identities=11% Similarity=0.009 Sum_probs=72.9
Q ss_pred eeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccCCCCC-------------CcccCCeEEEEEeccCCCCH-
Q psy5368 62 LQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPE-------------GRKRPRYVYIILEYCDGGDL- 127 (406)
Q Consensus 62 G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~n-------------i~~~~~~~~lV~E~~~ggsL- 127 (406)
+.-+.||+.+..++.-.|.|+......+..++..|...+..|...+ .....+..+.++++++|..+
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred cccceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 3347899998766554444455444456677888887776663322 22366778999999987432
Q ss_pred ----HHH------H---Hh----C-----CCCC-------------------HH---HHHHHHHHHHHHHHHHH----HC
Q psy5368 128 ----CSF------I---RS----H-----EKLS-------------------EF---QCQQFVRQLVLALKFLR----EN 159 (406)
Q Consensus 128 ----~~~------l---~~----~-----~~l~-------------------~~---~~~~i~~ql~~aL~~lH----~~ 159 (406)
..+ + +. . ..++ .. .....+.++...+.-.- ..
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 111 1 00 0 0111 11 11222333333332221 13
Q ss_pred CcccccCCCcceEeeCCeeEEEecccccc
Q psy5368 160 NVCHFDLKPQNILIKNNTLKLADFGFAQF 188 (406)
Q Consensus 160 givH~Dlkp~NIll~~~~~kL~DFGla~~ 188 (406)
+++|+|+++.|||++++. .++||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~~~-~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDGP-MFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSSE-EECCCTTCCE
T ss_pred eeecCCCCcccEEEeCCc-eEEechhccc
Confidence 689999999999998664 5899998753
|
| >d1wr0a1 a.7.14.1 (A:5-81) Vacuolar sorting protein 4b (VPS4B, SKD1 protein) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Spectrin repeat-like superfamily: MIT domain family: MIT domain domain: Vacuolar sorting protein 4b (VPS4B, SKD1 protein) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.48 E-value=2.1e-05 Score=55.91 Aligned_cols=52 Identities=19% Similarity=0.376 Sum_probs=46.6
Q ss_pred HhhccchhhhhhhchhhhhHHhccchHHHHHHHHHHHHHHHHhhhhcCCCcc
Q psy5368 347 AEAIPNLKSGLEIGETGDMYLAEGNYELALEKLKASLAILIQFCEAETSSSQ 398 (406)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~~~~ 398 (406)
+..++.+.+|++....|..++..|+|+.|+++|+++++.|++++..|+.+..
T Consensus 2 s~~~~~l~~A~~l~~~Av~~D~~~~y~~A~~~Y~~a~~~l~~~l~~e~~~~~ 53 (77)
T d1wr0a1 2 SSTSPNLQKAIDLASKAAQEDKAGNYEEALQLYQHAVQYFLHVVKYEAQGDK 53 (77)
T ss_dssp TTSCHHHHHHHHHHHHHHHHHHTTCCSSHHHHHHHHHHHHHHHHHHSCCTGG
T ss_pred CCChHHHHHHHHHHHHHHHHHHcCCHHHHHHHHHHHHHHHHHHHhccCCCHH
Confidence 4457788999999999999999999999999999999999999998876643
|
| >d1wfda_ a.7.14.1 (A:) Hypothetical protein 1500032H18Rik {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Spectrin repeat-like superfamily: MIT domain family: MIT domain domain: Hypothetical protein 1500032H18Rik species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.44 E-value=2.1e-05 Score=58.08 Aligned_cols=49 Identities=16% Similarity=0.178 Sum_probs=44.7
Q ss_pred hhccchhhhhhhchhhhhHHhccchHHHHHHHHHHHHHHHHhhhhcCCC
Q psy5368 348 EAIPNLKSGLEIGETGDMYLAEGNYELALEKLKASLAILIQFCEAETSS 396 (406)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~~ 396 (406)
...+.+..|++..+.|..++..|+|+.|+++|+++|+.|++++..|+..
T Consensus 7 ~~~~~~~~A~~l~~~Av~~D~~g~y~eA~~~Y~~aie~l~~~~~~e~~~ 55 (93)
T d1wfda_ 7 GQDSDSTAAVAVLKRAVELDAESRYQQALVCYQEGIDMLLQVLKGTKES 55 (93)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHHHHTCCCH
T ss_pred CCChHHHHHHHHHHHHHHHHHcCCHHHHHHHHHHHHHHHHHHhhccCCH
Confidence 3456788899999999999999999999999999999999999988877
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.25 E-value=0.00014 Score=63.53 Aligned_cols=61 Identities=18% Similarity=0.157 Sum_probs=38.0
Q ss_pred eEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccCCCC-----CCc---ccCCeEEEEEeccCCCCH
Q psy5368 65 DTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAP-----EGR---KRPRYVYIILEYCDGGDL 127 (406)
Q Consensus 65 g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~-----ni~---~~~~~~~lV~E~~~ggsL 127 (406)
+.||+.....+...+.|.... .....+.+|+..++.|... .++ .+.+..++||++++|.++
T Consensus 25 ~~v~r~~~~~~~~~vlK~~~~--~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 25 AAVFRLSAQGRPVLFVKTDLS--GALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CEEEEEECTTSCCEEEEEECS--CTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred CeEEEEEeCCCCEEEEEeCCc--cCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 568888766554434333332 2234577788877766443 322 266788999999998665
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.97 E-value=0.0038 Score=56.00 Aligned_cols=129 Identities=16% Similarity=0.046 Sum_probs=68.9
Q ss_pred eecceeeeEEEeeeeeeceeEEeeeecCCccchhhhhhHHhhcccCCCCC--------------CcccCCeEEEEEeccC
Q psy5368 58 RYGELQYDTVQNSQIRLGTVKYSQVRYDTITSHSEFERPRAGLSNLRAPE--------------GRKRPRYVYIILEYCD 123 (406)
Q Consensus 58 ~lG~G~~g~Vy~~~~~~~~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~n--------------i~~~~~~~~lV~E~~~ 123 (406)
.+..|.-.+.|..+.+.++..++..... ....++..|++++..|...+ +....+....++.+..
T Consensus 25 ~i~~G~~N~ny~v~t~~g~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~ 102 (316)
T d2ppqa1 25 GIAEGVENSNFLLHTTKDPLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 102 (316)
T ss_dssp EECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred cCCCCcccCeEEEEECCCcEEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeecc
Confidence 3557777888988877777666654332 23345556666666653322 1224455667777777
Q ss_pred CCCHHH-----------HH---HhC-C--------CC------------------CHHHHHHHHHHHHHHHHHHH----H
Q psy5368 124 GGDLCS-----------FI---RSH-E--------KL------------------SEFQCQQFVRQLVLALKFLR----E 158 (406)
Q Consensus 124 ggsL~~-----------~l---~~~-~--------~l------------------~~~~~~~i~~ql~~aL~~lH----~ 158 (406)
|..... .+ +.. . .. ........+..+...+.-.+ .
T Consensus 103 g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~ 182 (316)
T d2ppqa1 103 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP 182 (316)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred cccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccccc
Confidence 643310 00 000 0 00 11111122223333333333 2
Q ss_pred CCcccccCCCcceEeeCCe-eEEEecccccc
Q psy5368 159 NNVCHFDLKPQNILIKNNT-LKLADFGFAQF 188 (406)
Q Consensus 159 ~givH~Dlkp~NIll~~~~-~kL~DFGla~~ 188 (406)
.|+||+|+.++||+++++. .-++||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4799999999999999664 58999998743
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.55 E-value=0.0074 Score=56.07 Aligned_cols=68 Identities=10% Similarity=-0.044 Sum_probs=40.6
Q ss_pred eeecceeeeEEEeeeeeec--------eeEEeeeecCCccchhhhhhHHhhcccCCCCCCcc-----cCCeEEEEEeccC
Q psy5368 57 IRYGELQYDTVQNSQIRLG--------TVKYSQVRYDTITSHSEFERPRAGLSNLRAPEGRK-----RPRYVYIILEYCD 123 (406)
Q Consensus 57 ~~lG~G~~g~Vy~~~~~~~--------~v~vk~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~-----~~~~~~lV~E~~~ 123 (406)
..|+.|-...+|+...... ...+.++... ........+|..+++.+.-.++.+ ..+ .+|+||++
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~--g~I~efi~ 124 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG--GRLEEYIP 124 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT--EEEECCCC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC--ceEEEEec
Confidence 3577888899998875432 1122333322 233445678888888775445432 111 47999999
Q ss_pred CCCH
Q psy5368 124 GGDL 127 (406)
Q Consensus 124 ggsL 127 (406)
|.+|
T Consensus 125 g~~l 128 (395)
T d1nw1a_ 125 SRPL 128 (395)
T ss_dssp EEEC
T ss_pred cccC
Confidence 8544
|
| >d1elra_ a.118.8.1 (A:) Hop {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: TPR-like family: Tetratricopeptide repeat (TPR) domain: Hop species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.43 E-value=0.095 Score=39.66 Aligned_cols=32 Identities=19% Similarity=0.311 Sum_probs=26.2
Q ss_pred hhhhhhchhhhhHHhccchHHHHHHHHHHHHH
Q psy5368 354 KSGLEIGETGDMYLAEGNYELALEKLKASLAI 385 (406)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~ 385 (406)
++|+..+..|..+++.|+|+.|+++|+++|..
T Consensus 2 ~~a~~~k~~G~~~~~~~~y~~Ai~~y~~al~~ 33 (128)
T d1elra_ 2 KQALKEKELGNDAYKKKDFDTALKHYDKAKEL 33 (128)
T ss_dssp HHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHcCCHHHHHHHHHHHHHh
Confidence 35677778888899999999999999988853
|
| >d2crba1 a.7.16.1 (A:8-90) Nuclear receptor binding factor 2, NRBF2, N-terminal domain {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Spectrin repeat-like superfamily: MIT domain-like family: MIT domain domain: Nuclear receptor binding factor 2, NRBF2, N-terminal domain species: Mouse (Mus musculus) [TaxId: 10090]
Probab=87.76 E-value=0.25 Score=33.92 Aligned_cols=42 Identities=26% Similarity=0.275 Sum_probs=33.4
Q ss_pred hhhchhhhhHHhccchHHHHHHHHHHHHHHHHhhhhcCCCccc
Q psy5368 357 LEIGETGDMYLAEGNYELALEKLKASLAILIQFCEAETSSSQL 399 (406)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~~~~~ 399 (406)
--....|+.+...|.|++||+|++.+.+.|...+.. +.+.++
T Consensus 9 H~~~RrAer~l~~~rydeAIech~kA~~yl~eA~kl-t~s~~~ 50 (83)
T d2crba1 9 HQQSRRADRLLAAGKYEEAISCHRKATTYLSEAMKL-TESEQA 50 (83)
T ss_dssp HHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHHHTT-CCCHHH
T ss_pred HHHHHHHHHHHHcCCHHHHHHHHHHHHHHHHHHHhC-CCcHHH
Confidence 334556888899999999999999999999999864 444333
|
| >d1wr0a1 a.7.14.1 (A:5-81) Vacuolar sorting protein 4b (VPS4B, SKD1 protein) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Spectrin repeat-like superfamily: MIT domain family: MIT domain domain: Vacuolar sorting protein 4b (VPS4B, SKD1 protein) species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.48 E-value=0.17 Score=34.78 Aligned_cols=46 Identities=24% Similarity=0.385 Sum_probs=40.4
Q ss_pred CCccchHHHHHhhhhhcccccccchHHHHHHHHHHHhhhhhhhHHH
Q psy5368 300 PCAESHQTAIRIVTDAIHHDRENNSRRAFSLYCEALNYLIPLAYDV 345 (406)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 345 (406)
++.+....+..++.+++..|..++...++..|.+++++|++.+.++
T Consensus 3 ~~~~~l~~A~~l~~~Av~~D~~~~y~~A~~~Y~~a~~~l~~~l~~e 48 (77)
T d1wr0a1 3 STSPNLQKAIDLASKAAQEDKAGNYEEALQLYQHAVQYFLHVVKYE 48 (77)
T ss_dssp TSCHHHHHHHHHHHHHHHHHHTTCCSSHHHHHHHHHHHHHHHHHHS
T ss_pred CChHHHHHHHHHHHHHHHHHHcCCHHHHHHHHHHHHHHHHHHHhcc
Confidence 4556778889999999999999999999999999999988876654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.57 E-value=0.24 Score=42.90 Aligned_cols=34 Identities=12% Similarity=-0.007 Sum_probs=24.8
Q ss_pred eEEEeeeeecCCcceeeeeeccccccccceeeec
Q psy5368 20 GQVQLSTVRYGKVRYSQVRSDTVRSGTVRYDIVG 53 (406)
Q Consensus 20 gy~vv~~lg~G~~~~~~~~~d~~~~~~~~~~i~~ 53 (406)
.|+++++||.|+||.||.+.+.......+.|++.
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~ 36 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR 36 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEE
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEe
Confidence 3777888888888888888777766666776553
|
| >d2fbna1 a.118.8.1 (A:22-174) Putative 70 kda peptidylprolyl isomerase PFL2275c {Plasmodium falciparum [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: TPR-like family: Tetratricopeptide repeat (TPR) domain: Putative 70 kda peptidylprolyl isomerase PFL2275c species: Plasmodium falciparum [TaxId: 5833]
Probab=85.96 E-value=0.18 Score=39.28 Aligned_cols=35 Identities=23% Similarity=0.466 Sum_probs=30.9
Q ss_pred chhhhhhhchhhhhHHhccchHHHHHHHHHHHHHH
Q psy5368 352 NLKSGLEIGETGDMYLAEGNYELALEKLKASLAIL 386 (406)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~ 386 (406)
.+.++......|..+|++|+|..|+.+|+++|..+
T Consensus 13 ~~~~a~~~~~~G~~~f~~~~y~~A~~~Y~~al~~~ 47 (153)
T d2fbna1 13 KVQSAFDIKEEGNEFFKKNEINEAIVKYKEALDFF 47 (153)
T ss_dssp HHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHcCCHHHHHHHHHHHHhhC
Confidence 46677888899999999999999999999999754
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=85.57 E-value=0.19 Score=45.04 Aligned_cols=16 Identities=19% Similarity=0.165 Sum_probs=14.4
Q ss_pred eeeecceeeeEEEeee
Q psy5368 56 TIRYGELQYDTVQNSQ 71 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~ 71 (406)
..+||+|+||+||+|+
T Consensus 18 ~~~LG~G~fg~Vy~~~ 33 (362)
T d1q8ya_ 18 VRKLGWGHFSTVWLAK 33 (362)
T ss_dssp EEEEEECSSEEEEEEE
T ss_pred EEEEeeCCCeEEEEEE
Confidence 5788999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.30 E-value=0.21 Score=45.02 Aligned_cols=16 Identities=13% Similarity=-0.099 Sum_probs=12.0
Q ss_pred eeeecceeeeEEEeee
Q psy5368 56 TIRYGELQYDTVQNSQ 71 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~ 71 (406)
-.+||+|+||+||+|.
T Consensus 22 ~~~LG~G~fg~V~~~~ 37 (355)
T d2b1pa1 22 LKPIGSGAQGIVCAAY 37 (355)
T ss_dssp EEECSCC--CEEEEEE
T ss_pred EEEeecCcCeEEEEEE
Confidence 4578999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.01 E-value=0.18 Score=45.15 Aligned_cols=16 Identities=19% Similarity=0.148 Sum_probs=7.6
Q ss_pred eeeecceeeeEEEeee
Q psy5368 56 TIRYGELQYDTVQNSQ 71 (406)
Q Consensus 56 ~~~lG~G~~g~Vy~~~ 71 (406)
-..||+|+||+||++.
T Consensus 23 i~~lG~G~fg~V~~~~ 38 (346)
T d1cm8a_ 23 LQPVGSGAYGAVCSAV 38 (346)
T ss_dssp EEEC------CEEEEE
T ss_pred EEEEecCCCeEEEEEE
Confidence 3468999999999885
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.43 E-value=0.27 Score=44.02 Aligned_cols=40 Identities=23% Similarity=0.171 Sum_probs=29.0
Q ss_pred eeeee-e--EEEeeeeecCCcceeeeeeccccccccceeeecC
Q psy5368 15 GSVKY-G--QVQLSTVRYGKVRYSQVRSDTVRSGTVRYDIVGS 54 (406)
Q Consensus 15 g~~~~-g--y~vv~~lg~G~~~~~~~~~d~~~~~~~~~~i~~~ 54 (406)
|+.+. | |.++++||.|+||.||.+.+.......+.|++..
T Consensus 1 ~~~~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~ 43 (345)
T d1pmea_ 1 GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP 43 (345)
T ss_dssp CCCCCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECC
T ss_pred CCccCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEeh
Confidence 34445 3 9999999999999999999888877788876643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=83.71 E-value=0.24 Score=43.18 Aligned_cols=33 Identities=9% Similarity=-0.118 Sum_probs=26.0
Q ss_pred eeee-EEEeeeeecCCcceeeeeeccccccccce
Q psy5368 17 VKYG-QVQLSTVRYGKVRYSQVRSDTVRSGTVRY 49 (406)
Q Consensus 17 ~~~g-y~vv~~lg~G~~~~~~~~~d~~~~~~~~~ 49 (406)
+++| |+++++||.|+||.||.+.+.......+.
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAv 35 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAI 35 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEE
Confidence 3455 99999999999999999997765444444
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=82.48 E-value=0.44 Score=42.03 Aligned_cols=45 Identities=13% Similarity=0.061 Sum_probs=34.8
Q ss_pred cceEEEeeeeeeEEEeeeeecCCcceeeeeeccccccccceeeecC
Q psy5368 9 YGTVRLGSVKYGQVQLSTVRYGKVRYSQVRSDTVRSGTVRYDIVGS 54 (406)
Q Consensus 9 ~~~V~ig~~~~gy~vv~~lg~G~~~~~~~~~d~~~~~~~~~~i~~~ 54 (406)
++++..+. .+.|+++++||.|+||.||.+.+.......+.|++..
T Consensus 26 ~~~~~~~~-~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~ 70 (328)
T d3bqca1 26 SHVVEWGN-QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP 70 (328)
T ss_dssp GCCCCCCC-GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS
T ss_pred hcccCCCC-CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH
Confidence 44555542 2359999999999999999999888888888876553
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.71 E-value=0.46 Score=41.67 Aligned_cols=33 Identities=12% Similarity=0.021 Sum_probs=26.9
Q ss_pred eEEEeeeeecCCcceeeeeeccccccccceeee
Q psy5368 20 GQVQLSTVRYGKVRYSQVRSDTVRSGTVRYDIV 52 (406)
Q Consensus 20 gy~vv~~lg~G~~~~~~~~~d~~~~~~~~~~i~ 52 (406)
.|.++++||.|+||.||.+.+.......+.|++
T Consensus 11 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i 43 (318)
T d3blha1 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV 43 (318)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC
T ss_pred CEEEEEEEecCcCeEEEEEEECCCCCEEEEEEE
Confidence 488999999999999999988777777777654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.68 E-value=0.23 Score=44.40 Aligned_cols=43 Identities=19% Similarity=0.009 Sum_probs=33.1
Q ss_pred cccceEEEee-eee---eEEEeeeeecCCcceeeeeeccccccccce
Q psy5368 7 VRYGTVRLGS-VKY---GQVQLSTVRYGKVRYSQVRSDTVRSGTVRY 49 (406)
Q Consensus 7 g~~~~V~ig~-~~~---gy~vv~~lg~G~~~~~~~~~d~~~~~~~~~ 49 (406)
++|+.+-++. ++. .|+++++||.|+||.||.+.+.......+.
T Consensus 2 ~~~~~~~~~~~~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAi 48 (348)
T d2gfsa1 2 PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAV 48 (348)
T ss_dssp CCEEEEECSSSEEEEETTEEEEEECGGGTTSSEEEEEETTTTEEEEE
T ss_pred CCcEEEecCCccccCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEE
Confidence 5677777744 554 299999999999999999998766555544
|
| >d1kt1a1 a.118.8.1 (A:254-421) FKBP51, C-terminal domain {Monkey (Saimiri boliviensis) [TaxId: 27679]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: TPR-like family: Tetratricopeptide repeat (TPR) domain: FKBP51, C-terminal domain species: Monkey (Saimiri boliviensis) [TaxId: 27679]
Probab=80.86 E-value=0.61 Score=36.61 Aligned_cols=34 Identities=24% Similarity=0.403 Sum_probs=28.8
Q ss_pred hhhhhhhchhhhhHHhccchHHHHHHHHHHHHHH
Q psy5368 353 LKSGLEIGETGDMYLAEGNYELALEKLKASLAIL 386 (406)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~ 386 (406)
+..+-.....|..+++.|+|..|+++|+++|..+
T Consensus 12 ~~~a~~~~e~G~~~~~~~~~~~A~~~Y~~al~~~ 45 (168)
T d1kt1a1 12 LEQAAIVKEKGTVYFKGGKYVQAVIQYGKIVSWL 45 (168)
T ss_dssp HHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHcCCHHHHHHHHHHHHHHH
Confidence 3445666788999999999999999999999764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.02 E-value=0.49 Score=42.27 Aligned_cols=46 Identities=13% Similarity=-0.042 Sum_probs=33.6
Q ss_pred cccceEEEeeeeeeEEEeeeeecCCcceeeeeeccccccccceeeecC
Q psy5368 7 VRYGTVRLGSVKYGQVQLSTVRYGKVRYSQVRSDTVRSGTVRYDIVGS 54 (406)
Q Consensus 7 g~~~~V~ig~~~~gy~vv~~lg~G~~~~~~~~~d~~~~~~~~~~i~~~ 54 (406)
+|.+|.+..+. .|..+++||.|+||.||.+.+.......+.|++..
T Consensus 10 ~~~~p~~~~~~--~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~ 55 (350)
T d1q5ka_ 10 PGQGPDRPQEV--SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ 55 (350)
T ss_dssp ESSSSCCCEEE--EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC
T ss_pred CCCCCCCcccC--CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECc
Confidence 45555544332 48889999999999999999887777777775543
|